PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Burg, JS; McGuire, LM; Burright, RG; Donovick, PJ				Burg, JS; McGuire, LM; Burright, RG; Donovick, PJ			Prevalence of traumatic brain injury in an inpatient psychiatric population	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						traumatic brain injury; psychiatric patients; neuropsychology; Head Injury Questionnaire; health psychology	HEAD-INJURY; SEQUELAE	This study investigated the prevalence of traumatic brain injury (TBI) in an inpatient psychiatric population. We hypothesized increased prevalence of TBI relative to the general population due to a variety of risk factors observed in psychiatric patients. One hundred (mean age=34) psychiatric inpatients completed the revised Head Injury Questionnaire. Chart review of 17 subjects reporting injuries established whether injuries were documented in medical records. Sixty-eight percent of this psychiatric population reported one or more injuries in which they were unconscious or dazed This number is higher than the prevalence in the general population. Injuries were generally of mild to moderate severity; multiple injuries were common. Chart review of 17 subjects reporting TBI indicated that histories of TBI had not been noted in the medical record. Finally, 63% of TBI subjects reported that their injury predated the onset of their psychiatric symptoms These results suggest a possible role of TBI in psychiatric symptomatology, and have implications for psychiatric treatment in this population.	SUNY BINGHAMTON,DEPT PSYCHOL,ENVIRONM NEUROPSYCHOL LAB,BINGHAMTON,NY 13902; UNITED HLTH SERV,DEPT PSYCHIAT & NEUROSCI,BINGHAMTON,NY								CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; Kraus Jess F., 1994, P3; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; OSHANICK GJ, 1994, NEUROPSYCHIATRY TRAU, P163; Robinson Robert G., 1994, P219; SEGALOWITZ SJ, 1993, M INT NEUR SOC GALV; SOLOMON DA, 1992, NEUROPSYCHOL REV, V3, P249, DOI 10.1007/BF01109050; Taylor Craig A., 1994, P81; WILCOX JA, 1987, PSYCHIAT RES, V21, P303, DOI 10.1016/0165-1781(87)90013-8	10	19	19	0	3	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	SEP	1996	3	3					243	251		10.1007/BF01993910			9	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	VJ512	WOS:A1996VJ51200006	24226761				2022-02-06	
J	Gutman, SA; NapierKlemic, J				Gutman, SA; NapierKlemic, J			The experience of head injury on the impairment of gender identity and gender role	AMERICAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						activity configuration analysis; personality development		Objectives. This study explored the disruption of gender identity and gender role as a result a traumatic brain injury (TBI). Method. Four adults (two men, two women) who sustained a TBI between the ages of 18 and 30 years and were at least I year postinjury participated in six I-hr interviews concerning changes in (a) perceived masculinity or femininity, (b) involvement in intimate relationships, (c) enactment of gender roles, and (d) organization of activities that support gender roles. Results. The men expressed greater feelings, of gender inadequacy postinjury than did the women and appeared to have greater difficulty resolving rites of passage (e.g., achievement of the adult work role, marriage, parenting) and developmental issues characteristic of the life which they experienced their injury The men appeared to depend more heavily on traditional gender-specific activities before and after injury to define and support gender vole; the women relied more on cross-gender activities. The women appeared to be able to maintain more preinjury activities postinjury than did the men. Conclusion. Postinjury possession of a personally satisfying sense of gender appears to be related to the ability to maintain much of the preinjury activities that defined and supported the participants' sense of masculinity or femininity The ability to satisfactorily resolve rites of passage or developmental issues characteristic of the life stage at which the brain injury occurred appears to be related to the ability to participate in activities that define and express gender role during that particular life stage.	BEECHWOOD HEAD TRAUMA CTR,LANGHORNE,PA		Gutman, SA (corresponding author), NYU,DEPT OCCUPAT THERAPY,35 W 4TH ST,11TH FLOOR,NEW YORK,NY 10012, USA.						ALONI R, 1993, SEX DISABIL, V11, P121; ANDAMO EM, 1980, SEX DISABIL, V3, P26, DOI 10.1007/BF01102600; BAILEY MP, 1985, QUALITATIVE RES METH, P317; Bogdan R., 1992, QUALITATIVE RES ED I; BOLDRINI P, 1991, ARCH PHYS MED REHAB, V72, P202; CHAMPAGNE MP, 1982, SEX DISABIL, V5, P172, DOI 10.1007/BF01116416; Chandani A., 1989, BR J OCCUP THER, V52, P233, DOI 10.1177/030802268905200609; CLARK RV, 1993, SEX DISABIL, V11, P235; Cole S. S, 1993, SEX DISABIL, V11, P189, DOI DOI 10.1007/BF01102578; COLE SS, 1991, SEX DISABIL, V9, P3; DAVIS DL, 1990, J HEAD TRAUMA REHAB, V5, P31, DOI DOI 10.1097/00001199-199005020-00006; DEMTRAL GD, 1982, SEXUALITY DISBILITY, V6, P38; DIASIOSERRETT K, 1994, CAN AM OCC THER C BO; DUCHARME S, 1992, SEX DISABIL, V10, P193; EVANS J, 1985, AM J OCCUP THER, V39, P664, DOI 10.5014/ajot.39.10.664; FINGER WW, 1993, SEX DISABIL, V11, P39; FINGER WW, 1993, SEX DISABIL, V11, P3; FLINN S, 1982, SEX DISABIL, V5, P230, DOI 10.1007/BF01119864; FRENCH ME, 1992, SEX DISABIL, V10, P3; Gill K.M, 1990, J HEAD TRAUMA REHAB, V5, P38, DOI [DOI 10.1097/00001199-199005020-00007, 10.1097/00001199-199005020-00007]; Goffman E., 1963, STIGMA NOTES MANAGEM; GRAVES WH, 1993, SEX DISABIL, V11, P243; GREEN DT, 1982, SEX DISABIL, V6, P20; HAHN H, 1981, SEX DISABIL, V4, P220, DOI 10.1007/BF01103307; HEPNER PJ, 1978, SEX DISABIL, V2, P38; HOWARD R, 1992, HEADLINES        JAN, P9; JOE BE, 1992, OT WEEK         0709, V6, P12; KAHN L, 1992, HEADLINES        JAN, P12; Kempton W., 1991, SEX DISABIL, V9, P93, DOI [DOI 10.1007/BF01101735, 10.1007/BF01101735]; KREFTING L, 1989, OCCUP THER J RES, V9, P67, DOI 10.1177/153944928900900201; LEFEBVRE KA, 1990, J HEAD TRAUMA REHABI, V5, P25; Mapou R. L., 1990, J HEAD TRAUMA REHAB, V5, P67, DOI DOI 10.1097/00001199-199005020-00011; Medlar T. M., 1993, SEX DISABIL, V11, P57, DOI DOI 10.1007/BF01102309; MONEY J, 1988, GAY STRAIGHT IN BETW; Money J, 1984, INT J FAM PSYCHIAT, V5, P317; Neistadt M. E., 1987, CHOICES GUIDE SEX CO; NEISTADT ME, 1986, AM J OCCUP THER, V40, P542, DOI 10.5014/ajot.40.8.542; NEISTADT ME, 1988, OT WEEK         0512, V2, P6; NEISTADT ME, 1988, OT WEEK         0512, V2, P30; PAYNE MJ, 1988, AM J OCCUP THER, V42, P227, DOI 10.5014/ajot.42.4.227; RHODES R, 1993, SEXUALITY DISABILITI, P2; STAMBROOK M, 1991, J CLIN EXP NEUROPSYC, V13, P521, DOI 10.1080/01688639108401068; Strauss AL, 1987, QUALITATIVE ANAL SOC, DOI DOI 10.1017/CBO9780511557842; Strauss D, 1991, SEX DISABIL, V9, P49; STRAVOS MK, 1991, SEX DISABIL, V1, P69; Tepper MS., 1992, SEX DISABIL, V10, P15, DOI [10.1007/BF01102245, DOI 10.1007/BF01102245]; TRUDEL G, 1992, SEX DISABIL, V10, P173; Valentich M, 1984, SEX DISABIL, V7; WALTER E, 1982, SEX DISABIL, V5, P9, DOI 10.1007/BF01243807; WEINSTEIN BD, 1992, OCCUPATIONAL THERAPY, V4, P32; Zasler ND, 1991, SEX DISABIL, V9, P11	51	19	19	0	5	AMER OCCUPATION THERAPY ASSN	ROCKVILLE	1383 PICCARD DRIVE PO BOX ROCKVILLE, MD 20850-4375	0272-9490			AM J OCCUP THER	Am. J. Occup. Ther.	JUL-AUG	1996	50	7					535	544		10.5014/ajot.50.7.535			10	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	UY446	WOS:A1996UY44600007	8819605				2022-02-06	
J	Stein, SC				Stein, SC			Management of minor closed head injury	NEUROSURGERY QUARTERLY			English	Article						head injury; intracranial hematoma; cranial computed tomography	TRAUMATIC INTRACRANIAL HEMATOMA; BRAIN INJURY; COMPUTED-TOMOGRAPHY; CLINICAL INDICATORS; MODERATE; MILD; CHILDREN; CT; RISK; ADMISSION	The literature on the diagnosis and treatment of minor closed head injury (CHI) in the computed tomography (CT) scan era was reviewed. Working definitions were developed for the categories of minor CHI (minimal, mild, and moderate), and the natural history of each category was reviewed. The risks of intracranial complications and surgical lesions were calculated for each category. For minimal CHI, they are almost no risks, for mild CHI, the risks are 15% and 2.5%, respectively. Patients with moderate CHI can expect an intracranial lesion rate of 30%; 8% require neurosurgical intervention. Additional evidence was documented from the literature to allow comparisons among various treatment options with reference to clinical outcomes. It is concluded that most patients with minimal CHI can be safely discharged from the Emergency Department (ED) unless risk factors, which might indicate the need for CT scanning or hospitalization, are present. Those having mild CHI should have urgent CT scanning; patients in whom the scan is normal can be safely discharged from the ED. Moderate CHI requires both hospital admission and urgent CT scanning. Based on the natural history evidence of similar risk in children and adolescents, the same recommendations are made in the pediatric age group with minor CHI. Cost factors and the public health impact of this management scheme are discussed.	UNIV MED & DENT NEW JERSEY,ROBERT WOOD JOHNSON MED SCH,COOPER HOSP,MED CTR,DEPT SURG,CAMDEN,NJ 08103								ANDERSON DW, 1983, NEUROEPIDEMIOLOGY, V2, P70; Bailey B. N., 1989, TXB HEAD INJURY, P308; BONADIO WA, 1989, AM J DIS CHILD, V143, P194, DOI 10.1001/archpedi.1989.02150140084025; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DERSHEWITZ RA, 1983, PEDIATRICS, V72, P602; DIETRICH AM, 1993, ANN EMERG MED, V22, P1535, DOI 10.1016/S0196-0644(05)81254-5; EISENBERG HM, 1989, MILD MODERATE HEAD I, P95; GODANO U, 1992, CHILD NERV SYST, V8, P136, DOI 10.1007/BF00298269; HAHN YS, 1993, PEDIATR NEUROSURG, V19, P135, DOI 10.1159/000120718; HARAD FT, 1992, J TRAUMA, V32, P359, DOI 10.1097/00005373-199203000-00014; HENNES H, 1988, AM J DIS CHILD, V142, P1045, DOI 10.1001/archpedi.1988.02150100039021; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KRAUS JF, 1984, AM J EPIDEMIOL, V119, P186, DOI 10.1093/oxfordjournals.aje.a113737; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; LANGFITT TW, 1981, CLIN NEUROSURG, V29, P353; LIGUORI G, 1989, CHILD NERV SYST, V5, P160, DOI 10.1007/BF00272119; LIVINGSTON DH, 1991, J TRAUMA, V31, P483, DOI 10.1097/00005373-199104000-00006; MCMILLAN TM, 1987, J NEUROL NEUROSUR PS, V50, P393, DOI 10.1136/jnnp.50.4.393; MENDELOW AD, 1982, BRIT MED J, V285, P1530, DOI 10.1136/bmj.285.6354.1530; MIKHAIL MG, 1992, AM J EMERG MED, V10, P24, DOI 10.1016/0735-6757(92)90119-I; MILLER JD, 1986, NEUROSURG REV, V9, P135, DOI 10.1007/BF01743065; MILLER JD, 1990, NEUROSURGERY, V27, P669, DOI 10.1227/00006123-199011000-00001; MILLER JD, 1989, MILD MODERATE HEAD I, P117; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; MOHANTY SK, 1991, J TRAUMA, V31, P801, DOI 10.1097/00005373-199106000-00010; NEDD K, 1993, BRAIN INJURY, V7, P469, DOI 10.3109/02699059309008174; PITTS LH, 1989, MILD MODERATE HEAD I, P107; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; RIVERA F, 1987, PEDIATRICS, V80, P579; ROS S P, 1989, Pediatric Emergency Care, V5, P216, DOI 10.1097/00006565-198912000-00003; ROS SP, 1992, PEDIATR EMERG CARE, V8, P328, DOI 10.1097/00006565-199212000-00005; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; SAHGAL V, 1989, SCAND J REHABIL MED, V21, P71; SAINSBURY CPQ, 1984, ARCH DIS CHILD, V59, P856, DOI 10.1136/adc.59.9.856; Schafermeyer Robert, 1993, Emergency Medicine Clinics of North America, V11, P187; SHACKFORD SR, 1992, J TRAUMA, V33, P385, DOI 10.1097/00005373-199209000-00009; SPETTELL CM, 1991, ARCH PHYS MED REHAB, V72, P320; STEIN SC, 1992, J NEUROSURG, V77, P562, DOI 10.3171/jns.1992.77.4.0562; STEIN SC, 1995, BRAIN INJURY, V9, P437, DOI 10.3109/02699059509008203; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TABADDOR K, 1984, NEUROSURGERY, V14, P701, DOI 10.1227/00006123-198406000-00010; TAHERI PA, 1993, ARCH SURG-CHICAGO, V128, P289; TEASDALE G, 1989, MILD MODERATE HEAD I, P227; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363; TEPAS JJ, 1989, J PEDIATR SURG, V24, P156, DOI 10.1016/S0022-3468(89)80237-4; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; ZIMMERMAN RA, 1981, J NEURORADIOLOGY, V8, P257	49	19	19	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	1050-6438			NEUROSURG QUART	Neurosurg. Q.	JUN	1996	6	2					108	115		10.1097/00013414-199606000-00004			8	Neurosciences; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	UL555	WOS:A1996UL55500004					2022-02-06	
J	Goshen, E; Zwas, ST; Shahar, E; Tadmor, R				Goshen, E; Zwas, ST; Shahar, E; Tadmor, R			The role of Tc-99(m)-HMPAO brain SPET in paediatric traumatic brain injury	NUCLEAR MEDICINE COMMUNICATIONS			English	Article							HM-PAO-SPECT; HEAD-INJURY; CT; DISORDERS; CHILDREN; MR	Twenty-eight paediatric patients suffering from chronic sequelae of traumatic brain injury (TBI) were examined by EEG, radionuclide imaging with Tc-99(m)-hexamethylpropyleneamine oxime (Tc-99(m)-HMPAO), computed tomography (CT) and,when available, magnetic resonance imaging (MRI), the results of which were evaluated retrospectively Our findings indicate that neuro-SPET (single photon emission tomography) with Tc-99(m)-HMPAO is more sensitive than morphological or electrophysiological tests in detecting functional lesions. In our group, 15 of 32 CT scans were normal, compared with 3 of 35 SPET studies. SPET identified approximately 2.5 times more lesions than CT (86 vs 34). SPET was found to be particularly sensitive in detecting organic abnormalities in the basal ganglia and cerebellar regions, with a 3.6:1 detection rate in the basal ganglia and a 5:1 detection rate in the cerebellum compared with CT. In conclusion, neuro-SPET appears to be very useful when evaluating paediatric post-TBI patients in whom other modalities are not successful.			Goshen, E (corresponding author), CHAIM SHEBA MED CTR,DEPT NUCL MED,IL-52621 RAMAT GAN,ISRAEL.						ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; ADAMS C, 1992, PEDIATR NEUROL, V8, P97, DOI 10.1016/0887-8994(92)90028-W; CHOKSEY MS, 1991, J NEUROL NEUROSUR PS, V54, P1; Goncalves J M, 1992, Acta Neurochir Suppl (Wien), V55, P11; GRAY B, 1992, J NUCL MED, V35, P52; ICHISE M, 1994, J NUCL MED, V35, P217; JACOBS A, 1994, J NUCL MED, V35, P942; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; LEGIDO A, 1993, J CHILD NEUROL, V8, P227, DOI 10.1177/088307389300800304; OTUAMA LA, 1993, SEMIN NUCL MED, V23, P255, DOI 10.1016/S0001-2998(05)80106-0; PRAYER L, 1993, ACTA RADIOL, V34, P593; REID RH, 1990, CLIN NUCL MED, V15, P383, DOI 10.1097/00003072-199006000-00003; SHAHAR E, 1990, ARCH NEUROL-CHICAGO, V47, P578, DOI 10.1001/archneur.1990.00530050102019; TIKOFSKY RS, 1994, J NUCL MED, V35, P947	14	19	20	0	0	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0143-3636			NUCL MED COMMUN	Nucl. Med. Commun.	MAY	1996	17	5					418	422		10.1097/00006231-199605000-00011			5	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	UL550	WOS:A1996UL55000011	8736519				2022-02-06	
J	Boswell, WC; Boyd, CR; Schaffner, D; Williams, JS; Frantz, E				Boswell, WC; Boyd, CR; Schaffner, D; Williams, JS; Frantz, E			Prevention of pediatric mortality from trauma: Are current measures adequate?	SOUTHERN MEDICAL JOURNAL			English	Article							ALL-TERRAIN VEHICLES; INJURY SEVERITY; HEAD-INJURIES; BICYCLISTS; VICTORIA; CHILD; CARE	Trauma accounts for nearly half of pediatric deaths in the United States. We reviewed all pediatric trauma-related deaths that occurred over a 5-year period at two Georgia trauma centers to determine the number of trauma deaths in children, mechanism of injury, cause of death, and compliance with safety standards. Of the 69 fatalities, 31 were caused by motor vehicle accidents. Twenty-five of these victims (81%) were unrestrained; 17 were 4 years old or less, and only 1 of them was restrained in a car seat. Pedestrian versus vehicle accidents resulted in 19 deaths, 10 of the victims being 4 years old or less. Bicycle versus vehicle accidents resulted in 4 deaths, 2 of them due to closed head injury; none of the victims wore headgear. Ah-terrain vehicle accidents resulted in 2 deaths from massive head injury; neither victim wore a helmet. One death occurred from bicycle handlebar injury; 12 deaths resulted from causes other than vehicle accidents. Major causes of pediatric fatalities were motor vehicle accidents (45%), pedestrian-vehicle accidents (28%), and bicycle accidents (6%). This study indicates that when safety measures such as restraint systems, helmets, or proper supervision are ignored, children may die as a result of trauma.	MEM MED CTR,DEPT SURG EDUC,SAVANNAH,GA 31403; MEM MED CTR,TRAUMA SERV,SAVANNAH,GA 31403; SCOTTISH RITE CHILDRENS MED CTR,DEPT SURG,ATLANTA,GA								BROWNE GJ, 1987, PREVENTION COALITION, P65; CYNECKI MJ, 1984, DOT HS806676 PUBL; EVANS L, 1987, J TRAUMA, V27, P746, DOI 10.1097/00005373-198707000-00009; FIFE D, 1983, J TRAUMA, V23, P745, DOI 10.1097/00005373-198308000-00011; FRIEDMAN R, 1988, LARYNGOSCOPE, V98, P1251; GOLLADAY ES, 1985, J TRAUMA, V25, P232, DOI 10.1097/00005373-198503000-00012; HAMILTON SM, 1991, J TRAUMA, V31, P951, DOI 10.1097/00005373-199107000-00011; MCDERMOTT FT, 1982, MED J AUSTRALIA, V2, P30, DOI 10.5694/j.1326-5377.1982.tb124205.x; ORSAY EM, 1988, JAMA-J AM MED ASSOC, V260, P3598, DOI 10.1001/jama.260.24.3598; PAULSON JA, 1981, CLIN PEDIATR, V20, P285, DOI 10.1177/000992288102000409; PETERSON TD, 1991, AM FAM PHYSICIAN, V44, P1307; POLLACK CV, 1990, J TRAUMA, V30, P888, DOI 10.1097/00005373-199007000-00021; SHELNESS A, 1983, SAE CHILD INJURY RES, P207; SHERG RG, 1991, DEC P NAT C CHILD PA; SMITH SM, 1986, JAMA-J AM MED ASSOC, V255, P2454, DOI 10.1001/jama.255.18.2454; SPAITE DW, 1991, J TRAUMA, V31, P1510, DOI 10.1097/00005373-199111000-00008; STEVENS WS, 1986, J PEDIATR-US, V109, P25, DOI 10.1016/S0022-3476(86)80566-2; WAGENAAR AC, 1987, J TRAUMA, V27, P726, DOI 10.1097/00005373-198707000-00006; WOOD T, 1988, ACCIDENT ANAL PREV, V20, P177, DOI 10.1016/0001-4575(88)90002-4; 1990, GOVT OFFICE HIGHWAY; 1987, JAMA-J AM MED ASSOC, V257, P3334	21	19	20	0	2	SOUTHERN MEDICAL ASSN	BIRMINGHAM	35 LAKESHORE DR PO BOX 190088, BIRMINGHAM, AL 35219	0038-4348			SOUTHERN MED J	South.Med.J.	FEB	1996	89	2					218	220		10.1097/00007611-199602000-00012			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	TU577	WOS:A1996TU57700012	8578354				2022-02-06	
J	ALLISON, SC; ABRAHAM, LD				ALLISON, SC; ABRAHAM, LD			CORRELATION OF QUANTITATIVE MEASURES WITH THE MODIFIED ASHWORTH SCALE IN THE ASSESSMENT OF PLANTAR FLEXOR SPASTICITY IN PATIENTS WITH TRAUMATIC BRAIN INJURY	JOURNAL OF NEUROLOGY			English	Article						SPASTICITY; ANKLE; REFLEX; VIBRATION; ASHWORTH SCALE	PRESYNAPTIC INHIBITION; HYPERTONIA; MECHANISMS; BACLOFEN; REFLEXES; GAIT	This study of plantar flexor spasticity describes relationships among a traditional qualitative spasticity scale, three potential quantitative spasticity measures and a measure of voluntary ankle muscle function. Thirty-four volunteer adult patients with traumatic brain injuries participated. There were 28 males and 6 females; the mean age was 30.3 years. A battery of five randomly sequenced tests was performed for each subject on one ankle. Tests were: modified Ashworth scale (MAS) scoring; H-reflex testing with and without Achilles tendon vibration; H-reflex testing with and without dorsiflexor contraction; reflex threshold angle and timed toe tapping (TTT). Twenty-six subjects returned to have the second ankle tested, resulting in 60 ankles for the analyses. Spearman's coefficients for correlation of quantitative spasticity measures with MAS scores ranged from 0.39 to 0.49 with associated probabilities less than or equal to 0.002. Pearson coefficients for correlation of quantitative spasticity measures with TTT scores were lower but also significant (P less than or equal to 0.07). Multiple correlation for the set of quantitative measures yielded R = 0.614 (P < 0.001) with MAS scores and R = 0.365 (P = 0.045) with TTT scores. These findings reveal statistically significant relationships of low to moderate strength among potential quantitative spasticity measures, a traditional qualitative spasticity scale and a simple measure of voluntary ankle muscle function. Understanding these relationships is an essential part of the ongoing search for quantitative spasticity measures.	BAYLOR UNIV,ACAD HLTH SCI,GRAD PROGRAM PHYS THERAPY,FT SAM HOUSTON,TX 78234; UNIV TEXAS,DEPT KINESIOL & HLTH EDUC,AUSTIN,TX 78712								ALLISON SC, IN PRESS RELIABILITY; BOHANNON RW, 1987, ARCH PHYS MED REHAB, V68, P777; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BOORMAN GI, 1992, ABSTR SOC NEUROSCI, V18, P1408; CRONE C, 1987, J PHYSIOL-LONDON, V389, P163, DOI 10.1113/jphysiol.1987.sp016652; GILLIES JD, 1969, J PHYSIOL-LONDON, V205, P329, DOI 10.1113/jphysiol.1969.sp008968; GIULIANI C, 1988, NEUROL REP, V12, P4; Guilford J. P., 1956, FUNDAMENTAL STATISTI; Hagbarth K-E, 1973, HUMAN REFLEXES PATHO, P428; HUGENHOLTZ H, 1992, CAN J NEUROL SCI, V19, P188, DOI 10.1017/S0317167100042244; Hugon M, 1973, NEW DEVELOPMENTS ELE, P277; ILES JF, 1986, J NEUROL NEUROSUR PS, V49, P937, DOI 10.1136/jnnp.49.8.937; KATZ RT, 1989, ARCH PHYS MED REHAB, V70, P144; KATZ RT, 1992, ARCH PHYS MED REHAB, V73, P339, DOI 10.1016/0003-9993(92)90007-J; LANCE JW, 1973, NEW DEVELOPMENTS ELE, V3, P444; LANDAU WM, 1974, ARCH NEUROL-CHICAGO, V31, P217; LATASH ML, 1993, HUMAN KINETICS; LEONARD CT, 1990, DEV MED CHILD NEUROL, V32, P974; LEVIN MF, 1993, J NEUROL, V240, P63, DOI 10.1007/BF00858718; MILANOV I, 1992, J NEUROL, V239, P287; MILANOV IG, 1992, ACTA NEUROL SCAND, V85, P305; NANCE PW, 1989, PARAPLEGIA, V27, P296, DOI 10.1038/sc.1989.44; PIERROTDESEILLI.E, 1990, NEW TRENDS ADV TECHN, P264; ROSE SA, 1991, PHYS THER, V71, P961, DOI 10.1093/ptj/71.12.961; SAHRMANN SA, 1977, ANN NEUROL, V2, P460, DOI 10.1002/ana.410020604; Sloan R L, 1992, Int J Rehabil Res, V15, P158, DOI 10.1097/00004356-199206000-00009	26	19	20	0	3	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0340-5354			J NEUROL	J. Neurol.	OCT	1995	242	10					699	706		10.1007/BF00866923			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RZ790	WOS:A1995RZ79000015	8568534				2022-02-06	
J	FLAKOLL, PJ; WENTZEL, LS; HYMAN, SA				FLAKOLL, PJ; WENTZEL, LS; HYMAN, SA			PROTEIN AND GLUCOSE-METABOLISM DURING ISOLATED CLOSED-HEAD INJURY	AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM			English	Article						PROTEOLYSIS; PROTEIN SYNTHESIS; AMINO ACID OXIDATION; GLUCOSE PRODUCTION; HEAD TRAUMA; INSULIN RESISTANCE	AMINO-ACIDS; HYPERGLYCEMIA; INSULIN; PROTEOLYSIS; HUMANS; TRAUMA	Patients with isolated closed-head injuries are characterized by excessive nitrogen loss, hyperglycemia, and increased caloric demand. However, the relative contributions of specific metabolic events such as protein breakdown and synthesis or glucose production and utilization to the physiological changes prevalent during isolated closed-head injury remains unestablished. By use of isotopic dilutions of L-[1-C-13]leucine and D-[3-H-3]glucose, components of protein and glucose metabolism were examined in patients with isolated closed-head injury (n = 7). Normal overnight-fasted volunteers (n = 8) were also studied as a reference point for comparison. Despite prevailing hyperinsulinemia (29 +/- 5 mu U/ml), head-injured patients had elevated plasma leucine concentrations (183 +/- 22 vs. 144 +/- 8 mu mol/l), whole body proteolysis (331 +/- 44 vs. 150 +/- 7 mg . kg(-1). h(-1)), protein synthesis (248 +/- 38 vs. 126 +/- 11 mg . kg(-1). h(-1)), and amino acid oxidation (84 +/- 11 vs. 23 +/- 3 mg . kg(-1). h(-1)). Therefore nitrogen loss normally associated with isolated closed-head injury is primarily due to an increase in the rate of whole body proteolysis, with a greater proportion of the resultant amino acids being oxidized for energy. Furthermore, head-injured patients were hyperglycemic (6.7 +/- 0.3 mu mol/l) with increased rates of glucose turnover (an estimate of production and utilization) compared with the controls (4.0 +/- 0.7 vs. 2.5 +/- 0.2 mg . kg(-1). min(-1)). Hence, these data suggest that head injury, even in the absence of peripheral trauma, induces a physiological state of accelerated metabolism associated with resistance to insulin action.	VANDERBILT UNIV, MED CTR, DEPT BIOCHEM & ANESTHESIOL, NASHVILLE, TN 37232 USA		FLAKOLL, PJ (corresponding author), VANDERBILT UNIV, MED CTR, DEPT SURG, 750 MRB, NASHVILLE, TN 37232 USA.				NIDDK NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK-26657, DK-20593, DK-43290] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK026657, R29DK043290, P60DK020593] Funding Source: NIH RePORTER		ALDEN PB, 1987, J TRAUMA, V27, P1039, DOI 10.1097/00005373-198709000-00014; ALLSOP JR, 1978, J APPL PHYSIOL, V45, P137, DOI 10.1152/jappl.1978.45.1.137; ANTON AH, 1962, J PHARMACOL EXP THER, V138, P306; Bergmeyer H.U, 1971, METHODS ENZYMATIC AN, V1; BOREL MJ, 1993, FRONTIERS ENDOCRINOL, P149; CHIOLERO R, 1989, JPEN-PARENTER ENTER, V13, P5, DOI 10.1177/014860718901300105; CLIFTON GL, 1986, J NEUROSURG, V64, P895, DOI 10.3171/jns.1986.64.6.0895; CLIFTON GL, 1985, J NEUROSURG, V62, P186, DOI 10.3171/jns.1985.62.2.0186; DEUTSCHMAN CS, 1987, WORLD J SURG, V11, P182, DOI 10.1007/BF01656401; DRUCKER D, 1985, CRIT CARE MED, V13, P477, DOI 10.1097/00003246-198506000-00007; FLAKOLL PJ, 1993, AM J PHYSIOL, V265, pE715, DOI 10.1152/ajpendo.1993.265.5.E715; FLAKOLL PJ, 1994, METABOLISM, V43, P1509, DOI 10.1016/0026-0495(94)90009-4; FLAKOLL PJ, 1989, AM J PHYSIOL, V257, pE839, DOI 10.1152/ajpendo.1989.257.6.E839; FREXESSTEED M, 1990, AM J PHYSIOL, V258, pE907, DOI 10.1152/ajpendo.1990.258.6.E907; FUKAGAWA NK, 1989, AM J PHYSIOL, V256, pE288, DOI 10.1152/ajpendo.1989.256.2.E288; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; HEINRIKSON RL, 1984, ANAL BIOCHEM, V136, P65, DOI 10.1016/0003-2697(84)90307-5; JEEVANANDAM P, 1994, AM J PHYSIOL, V266, pE366; JENNET B, 1978, LANCET, V1, P878; KING LR, 1981, NEUROSURGERY, V9, P229, DOI 10.1227/00006123-198109000-00002; LAM AM, 1991, J NEUROSURG, V75, P545, DOI 10.3171/jns.1991.75.4.0545; MATTHEWS DE, 1990, AM J PHYSIOL, V258, pE948, DOI 10.1152/ajpendo.1990.258.6.E948; MCCALLISTER B, 1983, J SURG RES, V35, P426, DOI 10.1016/0022-4804(83)90033-1; MICHAUD LJ, 1991, J TRAUMA, V31, P1356, DOI 10.1097/00005373-199110000-00007; NAIR KS, 1983, DIABETOLOGIA, V25, P400, DOI 10.1007/BF00282518; Ott L, 1990, Nutr Clin Pract, V5, P68, DOI 10.1177/011542659000500268; PETERSEN SR, 1993, J TRAUMA, V34, P653, DOI 10.1097/00005373-199305000-00007; PULSINELLI WA, 1983, AM J MED, V74, P540, DOI 10.1016/0002-9343(83)91007-0; RIZZA RA, 1981, AM J PHYSIOL, V240, pE630, DOI 10.1152/ajpendo.1981.240.6.E630; ROBERTSON CS, 1985, J NEUROSURG, V63, P714, DOI 10.3171/jns.1985.63.5.0714; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; ROSENBLATT J, 1988, AM J PHYSIOL, V254, pE526, DOI 10.1152/ajpendo.1988.254.4.E526; RUDMAN D, 1977, J CLIN ENDOCR METAB, V45, P747, DOI 10.1210/jcem-45-4-747; SHIMAZU T, 1981, DIABETOLOGIA, V20, P343, DOI 10.1007/BF00254502; SNEDECOR GW, 1967, STATISTICIAL METHODS; SUDO M, 1991, AM J PHYSIOL, V261, pE298, DOI 10.1152/ajpendo.1991.261.3.E298; WELSH FA, 1980, STROKE, V11, P355, DOI 10.1161/01.STR.11.4.355	37	19	20	0	1	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0193-1849			AM J PHYSIOL-ENDOC M	Am. J. Physiol.-Endocrinol. Metab.	OCT	1995	269	4					E636	E641		10.1152/ajpendo.1995.269.4.E636			6	Endocrinology & Metabolism; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Physiology	TA573	WOS:A1995TA57300005	7485475				2022-02-06	
J	LAZAR, MF; MENALDINO, S				LAZAR, MF; MENALDINO, S			COGNITIVE OUTCOME AND BEHAVIORAL-ADJUSTMENT IN CHILDREN FOLLOWING TRAUMATIC BRAIN INJURY - A DEVELOPMENTAL PERSPECTIVE	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article							CLOSED HEAD-INJURY; SEQUELAE; ADOLESCENTS; DAMAGE; MOTOR	The study of long-term cognitive outcome following traumatic brain injury in children is important in guiding educational planning. It is critical to examine outcome from a developmental perspective to allow appreciation of the interaction between recovery processes and the significant maturational changes that take place during childhood. Behavioral adjustment and adaptive functioning are additional important variables to include in consideration of outcome. Methodologically sound longitudinal studies, more investigations that include preschoolers and adolescents, and studies that follow children as they make the transition into adulthood would enhance school planning and guide policy planning in education and health care management.	UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104; MOSSREHAB HOSP,DRUCKER BRAIN INJURY CTR,PHILADELPHIA,PA		LAZAR, MF (corresponding author), UNIV PENN,SCH MED,DEPT PEDIAT PSYCHOL,CHILDRENS SEASHORE HOUSE,PHILADELPHIA,PA 19104, USA.						ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BERNSTEIN JH, 1990, NEUROMETHODS, V17; BLAZYK S, 1983, SOC WORK HEALTH CARE, V8, P55, DOI 10.1300/J010v08n04_05; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BRUCE DA, 1978, J NEUROSURG, V48, P679, DOI 10.3171/jns.1978.48.5.0679; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; DALBY PR, 1991, DEV NEUROPSYCHOL, V7, P35, DOI 10.1080/87565649109540476; DEPOMPEI R, 1991, NEUROREHABILITATION, V1, P29; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; EWINGCOBBS L, 1985, HEAD INJURY REHABILI; FINGER S, 1991, DEV NEUROPSYCHOL, V7, P261, DOI 10.1080/87565649109540494; Fletcher J, 1987, NEUROBEHAVIORAL RECO; FLETCHER J, 1988, HDB PEDIATRIC PSYCHO; FLETCHER JM, 1990, J CONSULT CLIN PSYCH, V58, P93, DOI 10.1037/0022-006X.58.1.93; Goldstein FC, 1985, DEV NEUROPSYCHOL, V1, P195, DOI 10.1080/87565648509540310; HANSON SL, 1992, PHYSICAL MED REHABIL, V6, P483; HOLMES JM, 1987, HDB COGNITIVE SOCIAL, V2; JACOBSON MS, 1986, PEDIATRICS, V77, P236; KLONOFF H, 1993, J NEUROL NEUROSUR PS, V56, P410, DOI 10.1136/jnnp.56.4.410; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P211; KNIGHTS R M, 1991, Brain Injury, V5, P339, DOI 10.3109/02699059109008107; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lash M, 1993, NeuroRehabilitation, V3, P13, DOI 10.3233/NRE-1993-3304; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1984, AGING RECOVERY FUNCT; MICHAUD LJ, 1993, ARCH PHYS MED REHAB, V74, P368; MICHAUD LJ, 1993, PEDIATR CLIN N AM, V40, P553; MILTON SB, 1991, J HEAD TRAUMA REHAB, V6, P35; MOORE CM, 1994, 22ND ANN M INT NEUR; PERROTT SB, 1991, DEV NEUROPSYCHOL, V7, P69, DOI 10.1080/87565649109540477; RIVARA JB, 1992, ARCH PHYS MED REHAB, V73, P899; ROSS B, 1991, PHYS MED REHABIL CLI, V2, P781; RUTTER M, 1981, AM J PSYCHIAT, V138, P1533; SAVAGE RC, 1991, J HEAD TRAUMA REHAB, V6, P1; SHAFFER D, 1980, J AM ACAD CHILD PSY, V19, P592, DOI 10.1016/S0002-7138(09)60964-X; TELZROW CF, 1987, J LEARN DISABIL, V20, P536, DOI 10.1177/002221948702000905; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; YLVISAKER M, 1989, MILD MODERATE HEAD I	41	19	20	0	2	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21701	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1995	10	5					55	63		10.1097/00001199-199510000-00007			9	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	RY617	WOS:A1995RY61700007					2022-02-06	
J	WILDBURGER, R; ZARKOVIC, N; EGGER, G; PETEK, W; MEINITZER, A; BOROVIC, S; ZARKOVIC, K; LI, LB; STIPANCIC, I; TRBOJEVICCEPE, M; CVORISCEC, D; DOKO, M				WILDBURGER, R; ZARKOVIC, N; EGGER, G; PETEK, W; MEINITZER, A; BOROVIC, S; ZARKOVIC, K; LI, LB; STIPANCIC, I; TRBOJEVICCEPE, M; CVORISCEC, D; DOKO, M			COMPARISON OF THE VALUES OF BASIC FIBROBLAST GROWTH-FACTOR DETERMINED BY AN IMMUNOASSAY IN THE SERA OF PATIENTS WITH TRAUMATIC BRAIN INJURY AND ENHANCED OSTEOGENESIS AND THE EFFECTS OF THE SAME SERA ON THE FIBROBLAST GROWTH IN-VITRO	EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY			English	Article							HEAD-INJURY; AFFINITY-CHROMATOGRAPHY; HEPARIN-SEPHAROSE; PITUITARY; INVITRO; CALLUS; FGF	In patients with severe traumatic brain injury, the early healing of fractures is accompanied by hypertrophic callus formation or heterotopic ossifications, which might even result in ankylosis of the affected joints. Analysis of the sera of patients with traumatic brain injury revealed post-traumatic dynamic changes of basic fibroblast growth factor immunoreactivity, similar to those observed during fracture healing associated with enhanced osteogenesis. The aim of this study was to determine whether such changes in basic fibroblast growth factor concentrations could be related to the phenomenon of enhanced osteogenesis. Basic fibroblast growth factor immunoreactivity was determined (using an IEMA kit) in the sera of patients with traumatic brain injury and bone fractures (n = 8) and in the sera of patients with either traumatic brain injury alone (n = 10) or bone fractures alone (n = 7), and the effects of these sera on L929 fibroblast growth were analysed in vitro. The results did not prove a causative relationship between the changes of basic fibroblast growth factor immunoreactivity and in vitro growth promoting effects of the sera. However, it is apparent that, in addition to changes in the growth-promoting activity and basic fibroblast growth factor concentration of serum, other as yet unknown post-traumatic changes can cause enhanced osteogenesis.	GRAZ UNIV,TRAUMATOL CLIN,GRAZ,AUSTRIA; RUDJER BOSKOVIC INST,ZAGREB,CROATIA; GRAZ UNIV,INST GEN & EXPTL PATHOL,GRAZ,AUSTRIA; GRAZ UNIV,SURG CLIN,CLIN CHEM LAB,GRAZ,AUSTRIA; CTR HOSP CTR REBRO,INST NEUROPATHOL,ZAGREB,CROATIA; UNIV TRADIT CHINESE MED,DEPT EXPTL NEUROSCI,BEIJING,PEOPLES R CHINA; GEN HOSP,DEPT SURG,ZAGREB,CROATIA; UNIV CLIN REBRO,CLIN INST LAB DIAGNOSIS,ZAGREB,CROATIA; CLIN HOSP SISTERS MERCY,DEPT SURG,ZAGREB,CROATIA				Stipancic, Igor/ABC-9391-2021; Zarkovic, Neven/AAG-5836-2019	Zarkovic, Neven/0000-0001-5032-0369			BAIRD A, 1986, RECENT PROG HORM RES, V42, P143; BIDNER SM, 1990, J BONE JOINT SURG AM, V72A, P1144, DOI 10.2106/00004623-199072080-00004; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; CANALIS E, 1988, TRIANGLE, V27, P11; CUEVAS P, 1988, BIOCHEM BIOPH RES CO, V156, P611, DOI 10.1016/S0006-291X(88)80887-8; FINKLESTEIN SP, 1990, STROKE, V21, P122; FRAUTSCHY SA, 1991, BRAIN RES, V12, P291; GAUTHIER T, 1987, BIOCHEM BIOPH RES CO, V145, P775, DOI 10.1016/0006-291X(87)91032-1; GOSPODAROWICZ D, 1987, ENDOCR REV, V8, P95, DOI 10.1210/edrv-8-2-95; GOSPODAROWICZ D, 1984, P NATL ACAD SCI-BIOL, V81, P6963, DOI 10.1073/pnas.81.22.6963; GOSPODAROWICZ D, 1975, J BIOL CHEM, V250, P2515; HAUSCHKA PV, 1986, J BIOL CHEM, V261, P2665; KATO Y, 1985, J CELL BIOL, V100, P477, DOI 10.1083/jcb.100.2.477; LOGAN A, 1992, J NEUROSCI, V12, P3828; MAZUE G, 1992, TOXICOL LETT, V38, P64; PERKINS R, 1987, J BONE JOINT SURG BR, V69, P521, DOI 10.1302/0301-620X.69B4.3611150; RENFREE KJ, 1994, SPINE, V19, P740, DOI 10.1097/00007632-199404000-00002; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RIVA MA, 1992, MOL BRAIN RES, V15, P311, DOI 10.1016/0169-328X(92)90123-S; RODAN SB, 1992, CYTOKINES BONE METAB, P115; SMITH R, 1987, J BONE JOINT SURG BR, V69, P518, DOI 10.1302/0301-620X.69B4.3611149; SPENCER RF, 1987, J BONE JOINT SURG BR, V69, P525, DOI 10.1302/0301-620X.69B4.3611151; TAKAMI K, 1992, EXP BRAIN RES, V90, P1; WILDBURGER R, 1992, ZBL CHIR, V117, P515; WILDBURGER R, 1994, BONE MINER, V27, P183, DOI 10.1016/S0169-6009(08)80192-4	25	19	20	0	0	WALTER DE GRUYTER & CO	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0939-4974			EUR J CLIN CHEM CLIN	Eur. J. Clin. Chem. Clin. Biochem.	OCT	1995	33	10					693	698					6	Biochemistry & Molecular Biology; Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Medical Laboratory Technology	TE478	WOS:A1995TE47800005	8608189				2022-02-06	
J	DELATORRE, JC				DELATORRE, JC			TREATMENT OF HEAD-INJURY IN MICE, USING A FRUCTOSE 1,6-DIPHOSPHATE AND DIMETHYL-SULFOXIDE COMBINATION	NEUROSURGERY			English	Article						ATP HEAD INJURY; CA1 HIPPOCAMPUS; DIMETHYL SULFOXIDE; FREE RADICALS; FRUCTOSE 1,6-DIPHOSPHATE; NEURONAL DAMAGE	BRAIN INJURY; DIMETHYLSULFOXIDE THERAPY; LIPID-PEROXIDATION; 1-6 DIPHOSPHATE; ISCHEMIA; TRAUMA; EDEMA; FRUCTOSE-1,6-DIPHOSPHATE; DAMAGE; SHOCK	MICE WERE SUBJECTED to moderate (800 g/cm force) or severe (900 g/cm force) head injury and treated 5 minutes later with various compounds. Treatments consisted of intravenous administration of the following compounds: 1) fructose 1,6-diphosphate (FDP), 2) dimethyl sulfoxide (DMSO), 3) FDP + DMSO, and 4) vehicle nontreated, Sensory-motor evaluations 1 and 2 hours after 800 g/cm-force head injury showed that significant protection of motor function (grip test) was achieved with FDP + DMSO but not with treatment by either drug alone. Evaluation of mice following a severe 900-g/cm force injury demonstrated significant survival after treatment with FDP + DMSO but not with the vehicle or treatment by either of these agents alone. Histopathological morphometry indicated that cortical and hippocampal CA1 neurons were markedly protected from damage when mice were treated with combined FDP + DMSO. More modest protection of CA1 but not of cortical neurons was observed after treatment with DMSO alone but not after treatment with FDP alone or administration of the vehicle. These findings indicate that combining FDP with DMSO results in considerable synergy in protecting animals from sensory-motor loss and neuronal brain damage and in ultimate survival stemming from a moderate or severe closed head injury.	UNIV NEW MEXICO,DEPT PHYSIOL,ALBUQUERQUE,NM 87131		DELATORRE, JC (corresponding author), UNIV NEW MEXICO,DIV NEUROSURG,915 STANFORD DR NE,ALBUQUERQUE,NM 87131, USA.						ASHWOODS.MJ, 1967, ANN NY ACAD SCI, V141, P45, DOI 10.1111/j.1749-6632.1967.tb34865.x; BEHARRY S, 1992, J BIOENERG BIOMEMBR, V24, P507, DOI 10.1007/BF00762369; BENESCH R, 1967, BIOCHEM BIOPH RES CO, V26, P162, DOI 10.1016/0006-291X(67)90228-8; BENESCH R, 1969, NATURE, V221, P618, DOI 10.1038/221618a0; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; BROWN AW, 1968, BRIT J EXP PATHOL, V49, P87; BROWN FD, 1983, ANN NY ACAD SCI, V411, P245, DOI 10.1111/j.1749-6632.1983.tb47305.x; Bures J., 1976, TECHNIQUES BASIC EXP; CAMP PE, 1981, NEUROSURGERY, V9, P28, DOI 10.1227/00006123-198107000-00005; De La Torre J. C., 1994, Society for Neuroscience Abstracts, V20, P194; DELATORRE JC, 1973, J NEUROSURG, V38, P345, DOI 10.3171/jns.1973.38.3.0345; DELATORRE JC, 1976, DYNAMICS BRAIN EDEMA, P306; DELATORRE JC, 1990, CAN J PHYSL PHARM, V69, P191; DELATORRE JC, 1983, ANN NY ACAD SCI, V1, P402; FARIAS LA, 1990, STROKE, V21, P606, DOI 10.1161/01.STR.21.4.606; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HARRIS RJ, 1981, J CEREBR BLOOD F MET, V1, P203, DOI 10.1038/jcbfm.1981.21; HECKLER FR, 1983, J HAND SURG, V8, P622; IAPICHINO G, 1978, IRCS (International Research Communications System) Medical Science Library Compendium, V6, P157; IKEDA Y, 1990, NEUROSURGERY, V27, P1; KARACA M, 1991, EUR J CLIN PHARMACOL, V40, P113, DOI 10.1007/BF00315149; KUBLER W, 1970, Journal of Molecular and Cellular Cardiology, V1, P351, DOI 10.1016/0022-2828(70)90034-9; KULUZ JW, 1993, STROKE, V24, P1576, DOI 10.1161/01.STR.24.10.1576; Levin HS., 1982, NEUROBEHAVIORAL CONS; MARCEL GA, 1979, J MED, V10, P409; MARKOV A, 1983, CLIN RES, V31, pA503; MARKOV AK, 1986, ANN EMERG MED, V15, P1470, DOI 10.1016/S0196-0644(86)80946-5; MARKOV AK, 1981, SURGERY, V90, P482; MARKOV AK, 1987, MICROCIRCULATION UPD, V1, P709; MARKOV AK, 1994, EUR HEART J S, V15, P277; MARSHALL LF, 1984, NEUROSURGERY, V14, P659, DOI 10.1227/00006123-198406000-00002; MULLAN S, 1988, CEREBRAL ARTERIAL SP, P646; REPINE JE, 1979, J CLIN INVEST, V64, P1642, DOI 10.1172/JCI109626; ROMSON JL, 1983, CIRCULATION, V67, P1016, DOI 10.1161/01.CIR.67.5.1016; SIESJO BK, 1981, J CEREBR BLOOD F MET, V1, P155, DOI 10.1038/jcbfm.1981.18; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; SUTTON R L, 1990, Society for Neuroscience Abstracts, V16, P777; WALLER FT, 1979, NEUROSURGERY, V5, P583; WAXMAN K, 1991, ARCH SURG-CHICAGO, V126, P1237; WEISSMAN.G, 1967, ANN NY ACAD SCI, V141, P326, DOI 10.1111/j.1749-6632.1967.tb34897.x; WIESER PB, 1977, BIOCHEM PHARMACOL, V26, P775, DOI 10.1016/0006-2952(77)90223-4; WILLMORE LJ, 1984, BRAIN RES, V296, P389, DOI 10.1016/0006-8993(84)90080-5	44	19	19	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0148-396X			NEUROSURGERY	Neurosurgery	AUG	1995	37	2					273	279		10.1227/00006123-199508000-00012			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	RK745	WOS:A1995RK74500038	7477779				2022-02-06	
J	LEHMANN, U; REIF, W; HOBBENSIEFKEN, G; SEEKAMP, A; REGEL, G; STURM, JA; DWENGER, A; SCHWEITZER, G; MANN, D; ELLERBECK, M; TSCHERNE, H				LEHMANN, U; REIF, W; HOBBENSIEFKEN, G; SEEKAMP, A; REGEL, G; STURM, JA; DWENGER, A; SCHWEITZER, G; MANN, D; ELLERBECK, M; TSCHERNE, H			THE INFLUENCE OF PRIMARY FRACTURE STABILIZATION ON BRAIN INJURY IN MULTIPLE TRAUMA - A SHEEP MODEL	UNFALLCHIRURG			English	Article								Severe head trauma (BI) associated with long bone fractures is present in about 60% of polytraumatized patients admitted to hospital. However, there is no consensus regarding early fracture stabilization in such patients. In an experimental sheep study, the influence of intramedullary nailing of the femur (IMNF) on a cold-induced, vasogenic brain edema (method of Klatzo) in combination with traumatic hemorrhagic shock (THS) was investigated. Three animal groups (n=6) were explored: group A, only BI; group B, BI and THS; group C, BI, THS and IMNF. The animals remained intubated, on controlled ventilation, sedated and received analgesia during the whole experiment. For a period of 6 h after the cold-induced brain injury the hemodynamic changes were measured and the intracranial pressure (ICP) was recorded in the left and the right hemisphere continuously. The hemorrhagic shock (MAP = 60 mm Hg) was maintained over 1.5 h. At the end of the reperfusion period (2 h) the nailing of the femur was performed. The animals were killed and the percentage water content of the brain was determined and compared with the brain water content of a control group (n = 6). There were no significant differences in ICP between groups A, B and C before or after IMNF, but in group C the ICP increased significantly after nailing. Brain water content in group C was significantly higher than in the control group and slightly significantly higher than in groups A and B. Brain edema and ICP are increased by IMNF. Primary nailing of the femur in patients with severe brain injury should be considered carefully. Alternatively, another technique for stabilization could be used.			LEHMANN, U (corresponding author), HANNOVER MED SCH,UNFALLCHIRURG KLIN,KONSTANTY GUTSCHOW STR 8,D-30625 HANNOVER,GERMANY.		Seekamp, Andreas/E-3252-2010					0	19	19	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	AUG	1995	98	8					437	441					5	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	RR060	WOS:A1995RR06000006	7570037				2022-02-06	
J	POURCHER, E; BARUCH, P; BOUCHARD, RH; FILTEAU, MJ; BERGERON, D				POURCHER, E; BARUCH, P; BOUCHARD, RH; FILTEAU, MJ; BERGERON, D			NEUROLEPTIC ASSOCIATED TARDIVE DYSKINESIAS IN YOUNG-PEOPLE WITH PSYCHOSES	BRITISH JOURNAL OF PSYCHIATRY			English	Article; Proceedings Paper	2nd International Congress of the Movement-Disorder-Society	JUN, 1994	MUNICH, GERMANY	Movement Disorder Soc			SCHIZOPHRENIA; DYSFUNCTION	Background. Apart from ageing, the factors associated with vulnerability to the emergence of tardive dyskinesia are poorly defined. Method. Risk factors associated with the presence of a chronic choreic or dystonic disorder were assessed in a cross-sectional comparison of anamnestic and clinical data in a homogeneous group of 64 young psychotic patients (under 40 years of age) on chronic low to moderate doses of neuroleptics. Results. Dyskinetic subjects presented more indirect indicators of occult brain damage, such as a perinatal event or traumatic brain injuries in infancy and early childhood; neurological examination showed more anomalies in dyskinetic patients than in non-dyskinetics, with a higher prevalence of facial release reflexes. Conclusion. These data may support the hypothesis that occult acquired brain damage is important in the genesis of this 'drug-induced' disorder.	UNIV LAVAL ROBERT GIFFARD,CTR RECH,BEAUPORT,PQ,CANADA								American Psychiatric Association, 1987, DIAGN STAT MAN MENT, V3; CHOUINARD G, 1982, AM J PSYCHIAT, V139, P312; CHOUINARD G, 1986, PSYCHOPHARMACOL BULL, V22, P259; Guy WA., 1976, ABNORMAL INVOLUNTARY; JUNCOS JL, 1989, ANN NEUROL, V25, P473, DOI 10.1002/ana.410250509; KANE JM, 1984, PSYCHOPHARMACOL BULL, V20, P39; KING DJ, 1991, BRIT J PSYCHIAT, V158, P770, DOI 10.1192/bjp.158.6.770; MCCREADIE RG, 1992, BRIT J PSYCHIAT, V161, P799; OCALLAGHAN E, 1990, BRIT J PSYCHIAT, V157, P578, DOI 10.1192/bjp.157.4.578; SCHOOLER NR, 1982, ARCH GEN PSYCHIAT, V39, P486; WADDINGTON JL, 1987, ARCH GEN PSYCHIAT, V44, P907; WEGNER JT, 1985, ARCH GEN PSYCHIAT, V42, P860; YASSA R, 1985, CAN J PSYCHIAT, V30, P344, DOI 10.1177/070674378503000508; YOUSSEF HA, 1988, BIOL PSYCHIAT, V23, P791, DOI 10.1016/0006-3223(88)90067-4	14	19	19	0	0	ROYAL COLLEGE OF PSYCHIATRISTS	LONDON	BRITISH JOURNAL OF PSYCHIATRY 17 BELGRAVE SQUARE, LONDON, ENGLAND SW1X 8PG	0007-1250			BRIT J PSYCHIAT	Br. J. Psychiatry	JUN	1995	166						768	772		10.1192/bjp.166.6.768			5	Psychiatry	Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH); Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	RF270	WOS:A1995RF27000012	7663825				2022-02-06	
J	HAYES, RL; YANG, K; WHITSON, JS; XUE, JJ; KAMPFL, A; MU, XS; ZHAO, X; FAUSTINELLA, F; CLIFTON, GL				HAYES, RL; YANG, K; WHITSON, JS; XUE, JJ; KAMPFL, A; MU, XS; ZHAO, X; FAUSTINELLA, F; CLIFTON, GL			RESCUE OF INJURY-INDUCED NEUROFILAMENT LOSS BY BDNF GENE TRANSFECTION IN PRIMARY SEPTOHIPPOCAMPAL CELL-CULTURES	NEUROSCIENCE LETTERS			English	Article						GENE TRANSFER; LIPOSOME; BDNF; SEPTOHIPPOCAMPAL CELL CULTURE; NEURAL INJURY; NEUROFILAMENT	TRAUMATIC BRAIN INJURY; NERVE GROWTH-FACTOR; ANTIBODIES; INVIVO; VECTOR	We employed primary septo-hippocampal cell cultures to determine the ability of liposome-mediated BDNF gene transfection to facilitate recovery of neurofilament loss caused by depolarization injury. After BDNF gene transfection in uninjured cultures, RT-PCR and immunohistochemical staining confirmed increases in BDNF mRNA and protein in transfected cells. Three days after depolarization injury, Western blot and immunohistochemical analyses detected significant loss of neurofilament proteins in non-transfected cultures, while BDNF transfection produced marked increases in neurofilament proteins following either pre-injury transfection or transfection 24 h following injury. Immunohistochemical studies also detected enhanced immunolabeling of BDNF and total neurofilament protein (phosphorylated and non-phosphorylated) in injured neurons following BDNF transfection or administration of exogenous BDNF protein, compared to untransfected, injured controls.			HAYES, RL (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT NEUROSURG, 6431 FANNIN ST, HOUSTON, TX 77030 USA.						BARINAGA M, 1994, SCIENCE, V264, P772, DOI 10.1126/science.8171331; CLARK EA, 1991, J NEUROCHEM, V57, P802, DOI 10.1111/j.1471-4159.1991.tb08222.x; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; FANG XJ, 1989, HEPATOLOGY, V10, P781; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GIORDANO T, 1991, EXP CELL RES, V992, P993; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; HEFTI F, 1986, J NEUROSCI, V6, P2155; HORWITZ M S, 1990, P1679; HUG P, 1991, BIOCHIM BIOPHYS ACTA, V1097, P1, DOI 10.1016/0925-4439(91)90016-3; IP NY, 1993, J NEUROSCI, V13, P3394; JOHNSON PA, 1992, MOL BRAIN RES, V12, P95, DOI 10.1016/0169-328X(92)90072-J; KAMPFL AW, 1994, SOC NEUR ABSTR; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; LI AP, 1992, IN VITRO CELL DEV-AN, V28A, P373; MACGREGOR GR, 1989, NUCLEIC ACIDS RES, V17, P2365, DOI 10.1093/nar/17.6.2365; NABEL EG, 1992, HUM GENE THER, V3, P649, DOI 10.1089/hum.1992.3.6-649; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; ROESSLER BJ, 1994, NEUROSCI LETT, V167, P5, DOI 10.1016/0304-3940(94)91015-4; SAATMAN KE, 1994, SOC NEUR ABSTR; SHAW G, 1986, EUR J CELL BIOL, V42, P1; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; TAFT WC, 1992, J NEUROTRAUM, V9, P281, DOI 10.1089/neu.1992.9.281; TAFT WC, UNPUB J NEUROTRAUMA; THOMPSON TA, 1993, IN VITRO CELL DEV-AN, V29, P165, DOI 10.1007/BF02630949; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WHITSON JS, UNPUB J NEUROSCI; WHITSON JS, SOC NEUR ABSTR; WOLF D, 1988, MOL BIOL MED, V5, P43; YANG K, 1994, NEUROSCI LETT, V182, P287, DOI 10.1016/0304-3940(94)90818-4; YANG K, 1994, NEUROSCI LETT, V182, P291, DOI 10.1016/0304-3940(94)90819-2	32	19	19	0	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 19	1995	191	1-2					121	125		10.1016/0304-3940(95)11561-X			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	RA274	WOS:A1995RA27400030	7544881				2022-02-06	
J	ALDIN, ASN; MUBAIDIN, A; WRIEKAT, AL; ALQAM, M				ALDIN, ASN; MUBAIDIN, A; WRIEKAT, AL; ALQAM, M			RISK-FACTORS OF ASEPTIC INTRACRANIAL VENOUS OCCLUSIVE DISEASE	ACTA NEUROLOGICA SCANDINAVICA			English	Article						ASEPTIC INTRACRANIAL VENOUS OCCLUSIVE DISEASE; DURAL SINUS THROMBOSIS; SUPERIOR SAGITTAL SINUS THROMBOSIS; BEHCETS DISEASE; PUERPERIUM; THROMBOPHELIA; FAMILIAL MEDITERRANEAN FEVER	SAGITTAL SINUS THROMBOSIS; PROTEIN-S DEFICIENCY; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; CLOSED HEAD-INJURY; DURAL SINUS; BEHCETS-DISEASE; CLINICAL COURSE; SUPERIOR; DIAGNOSIS; PATIENT	Introduction - Risk factors for aseptic intracranial venous occlusive disease are varied but only few epidemiologic studies were performed to verify the relative importance of particular factors. Patients and methods - A 2-year hospital-based prospective study was conducted in two hospitals to identify the clinical characteristics and risk factors of patients with confirmed aseptic intracranial venous occlusive disease. Results - 21 patients were identified, representing 0.9% of the total neurological admissions. Men were more commonly affected than women; 81% of the patients presented in a clinical picture indistinguishable from idiopathic intracranial hypertension. Risk factors included Behcet's disease in 4, the puerperium in 3, thrombophelia in 3, familial Mediterranean fever in 2, malignancies in 1, lupus anticoagulant in 1, and the contraceptive pill in 1. Conclusion - Aseptic intracranial venous occlusive disease proved to be not rare in Arabs. It should be considered seriously in the differential diagnosis of idiopathic intracranial hypertension, particularly in males. Several risk factors were incriminated.	KING HUSSEIN MED CTR,AMMAN,JORDAN		ALDIN, ASN (corresponding author), JORDAN UNIV HOSP,POB 13046,AMMAN,JORDAN.						ALFARO A, 1992, J NEUROL NEUROSUR PS, V55, P412, DOI 10.1136/jnnp.55.5.412; ALKAWI MZ, 1992, J TROP GEOGR NEUROL, V2, P49; BANSAL BC, 1980, JPN HEART J, V21, P171; BARNES BD, 1983, NEUROLOGY, V33, P508, DOI 10.1212/WNL.33.4.508; BORER H, 1991, SCHWEIZ MED WSCHR, V121, P788; CHAUDHURI R, 1992, J COMPUT ASSIST TOMO, V16, P30, DOI 10.1097/00004728-199201000-00006; COCHRAN FB, 1990, AM J MED GENET, V35, P519, DOI 10.1002/ajmg.1320350415; CROS D, 1990, STROKE, V21, P632; ELRAMAHI KM, 1991, J NEUROL NEUROSUR PS, V54, P826, DOI 10.1136/jnnp.54.9.826; ESKRIDGE JM, 1991, J VASC INT RADIOL, V22, P89; FELDENZER JA, 1987, STROKE, V18, P656, DOI 10.1161/01.STR.18.3.656; FURUTA M, 1991, Nippon Ganka Gakkai Zasshi, V95, P199; GARCIAMONCO JC, 1991, NEUROLOGY, V41, P1324, DOI 10.1212/WNL.41.8.1324; GILMAN JK, 1983, SOUTHERN MED J, V76, P658; GREEN D, 1992, NEUROLOGY, V42, P1029, DOI 10.1212/WNL.42.5.1029; HAMMANS SR, 1989, J NEUROL NEUROSUR PS, V52, P287, DOI 10.1136/jnnp.52.2.287; HEISTINGER M, 1992, ANN HEMATOL, V64, P105, DOI 10.1007/BF01715355; HESSELBROCK R, 1985, NEUROSURGERY, V16, P825, DOI 10.1227/00006123-198506000-00017; HICKEY WF, 1982, AM J MED, V73, P740; HORST A, 1991, SCHWEIZ MED WSCHR, V121, P1601; HUSS GP, 1992, NERVENARZT, V63, P352; Iijima S, 1980, Rinsho Shinkeigaku, V20, P333; KOBAYASHI S, 1980, CLIN NEUROL, V20, P904; KONISHI Y, 1987, PEDIATR NEUROL, V3, P222, DOI 10.1016/0887-8994(87)90022-1; Mohamed A, 1991, Clin Exp Neurol, V28, P23; MORIYAMA E, 1992, Neurologia Medico-Chirurgica, V32, P232, DOI 10.2176/nmc.32.232; MURAMATSU S, 1990, THROMB RES, V57, P593, DOI 10.1016/0049-3848(90)90076-O; MURPHY MF, 1983, BRIT MED J, V287, P1344, DOI 10.1136/bmj.287.6402.1344; OJEDA VJ, 1982, MED J AUSTRALIA, V2, P584, DOI 10.5694/j.1326-5377.1982.tb132581.x; OMARDEEN F, 1992, W INDIAN MED J, V41, P31; PATCHELL RA, 1986, NEUROLOGY, V36, P745, DOI 10.1212/WNL.36.6.745; PRATS JM, 1992, NEUROLOGY, V42, P2303, DOI 10.1212/WNL.42.12.2303-a; ROOS KL, 1990, OBSTET GYNECOL, V76, P492; SACCO RL, 1987, ANN NEUROL, V22, P115; SASAKI A, 1991, Neurologia Medico-Chirurgica, V31, P978, DOI 10.2176/nmc.31.978; SCOTT EB, 1992, AM J PHYS MED REHAB, V71, P119, DOI 10.1097/00002060-199204000-00011; SHIOZAWA Z, 1986, ANN NEUROL, V20, P272, DOI 10.1002/ana.410200216; SHIOZAWA Z, 1985, J NEUROL, V232, P280, DOI 10.1007/BF00313866; SHIOZAWA Z, 1982, ANN NEUROL, V12, P578, DOI 10.1002/ana.410120613; Shiozawa Z, 1982, Rinsho Shinkeigaku, V22, P815; STEPHENS PH, 1991, BRIT J ANAESTH, V67, P476, DOI 10.1093/bja/67.4.476; STERN JM, 1989, S AFR MED J, V75, P243; STRINGER WL, 1983, NEUROSURGERY, V12, P95; Takashima S, 1988, Rinsho Shinkeigaku, V28, P812; THRON A, 1986, J NEUROL, V233, P283, DOI 10.1007/BF00314160; Ueda T, 1982, No To Shinkei, V34, P349; Usui Y, 1986, Rinsho Hoshasen, V31, P413; WATANABE M, 1992, PLANT CELL PHYSIOL, V33, P343; YONEKURA S, 1991, JPN J MED, V30, P175	49	19	19	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-6314			ACTA NEUROL SCAND	Acta Neurol. Scand.	DEC	1994	90	6					412	416					5	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PW675	WOS:A1994PW67500007	7892760				2022-02-06	
J	DESMOND, DW; TATEMICHI, TK; FIGUEROA, M; GROPEN, TI; STERN, Y				DESMOND, DW; TATEMICHI, TK; FIGUEROA, M; GROPEN, TI; STERN, Y			DISORIENTATION FOLLOWING STROKE - FREQUENCY, COURSE, AND CLINICAL CORRELATES	JOURNAL OF NEUROLOGY			English	Article						DISORIENTATION; STROKE; DEMENTIA; MEMORY; ATTENTION	CLOSED-HEAD-INJURY; DEMENTIA; MEMORY; ALZHEIMERS; LANGUAGE; DISEASE; COHORT	To investigate the frequency, course, and clinical correlates of disorientation following stroke, we administered the Mini-Mental State Examination orientation subtest to 177 alert patients 7-10 days and 3 months after stroke and 240 stroke-free nondemented subjects. Disorientation was defined as a score less than or equal to 8/10. Seventy-two (40.7%) of the patients were disoriented 7-10 days after stroke and 39 patients (22.0% of the sample) remained disoriented 3 months later. A logistic regression analysis determined that persistent disorientation was significantly related to stroke status [odds ratio (OR)=5.8], after adjusting for memory and attentional deficits and demographic variables. Among stroke patients, disorientation was associated with severe hemispheral stroke syndromes (OR=7.7), but not infarct location or vascular risk factor history, after adjusting for memory and attentional deficits and demographic variables. Sensitivity and specificity analyses determined that disorientation was an inaccurate marker for dementia or deficits in memory or attention, while intact orientation was associated with a low probability of dementia or memory dysfunction in most patients but not preserved attention. We conclude that disorientation is common and persistent following stroke and associated with severe hemispheral stroke syndromes but not infarct location. While disorientation is a poor marker for dementia or deficits in memory or attention, intact orientation should suggest that cognitive functions are likely to be preserved.	NEUROL INST,NEW YORK,NY 10032; COLUMBIA UNIV,COLL PHYS & SURG,DEPT NEUROL,NEW YORK,NY; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PSYCHIAT,NEW YORK,NY; COLUMBIA UNIV,COLL PHYS & SURG,GERTRUDE H SERGIEVSKY CTR,NEW YORK,NY					Stern, Yaakov/0000-0001-7542-3241; Desmond, David/0000-0002-6961-5658	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS026179, K08NS001635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG007232] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01-AG07232] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K08-NS01635, R01-NS26179] Funding Source: Medline		BENTON AL, 1968, NEUROPSYCHOLOGIA, V6, P53, DOI 10.1016/0028-3932(68)90038-9; DESMOND D W, 1992, Neurology, V42, P426; DESMOND DW, 1993, ARCH NEUROL-CHICAGO, V50, P162, DOI 10.1001/archneur.1993.00540020040015; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; GOTTLIEB G, 1965, J COMP PHYSIOL PSYCH, V60, P368, DOI 10.1037/h0022555; GROHER M, 1977, J SPEECH HEAR RES, V20, P212, DOI 10.1044/jshr.2002.212; HALLIDAY AM, 1968, BRIT J PSYCHIAT, V114, P997, DOI 10.1192/bjp.114.513.997; HIGH WM, 1990, J CLIN EXP NEUROPSYC, V12, P703, DOI 10.1080/01688639008401013; HUBER SJ, 1989, ARCH NEUROL-CHICAGO, V46, P1287, DOI 10.1001/archneur.1989.00520480029015; HUNTER R, 1989, PSYCHOL MED, V19, P847, DOI 10.1017/S0033291700005560; KOPELMAN MD, 1986, BRIT J PSYCHIAT, V148, P517, DOI 10.1192/bjp.148.5.517; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; MAHURIN RK, 1991, J GERONTOL, V46, pP58, DOI 10.1093/geronj/46.2.P58; MESULAM MM, 1990, ANN NEUROL, V28, P597, DOI 10.1002/ana.410280502; STERN Y, 1992, ARCH NEUROL-CHICAGO, V49, P453, DOI 10.1001/archneur.1992.00530290035009; TATEMICHI TK, 1992, NEUROLOGY, V42, P1185, DOI 10.1212/WNL.42.6.1185; THASE ME, 1982, J MENT DEFIC RES, V26, P239; VALENTINE M, 1968, BRIT J PSYCHIAT, V114, P989, DOI 10.1192/bjp.114.513.989; Wade D T, 1989, Int Disabil Stud, V11, P34	20	19	19	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0340-5354			J NEUROL	J. Neurol.	OCT	1994	241	10					585	591		10.1007/BF00920621			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	PL348	WOS:A1994PL34800003	7836961				2022-02-06	
J	JANECZKO, K				JANECZKO, K			AGE-DEPENDENT CHANGES IN THE PROLIFERATIVE RESPONSE OF S-100 PROTEIN-POSITIVE GLIAL-CELLS TO INJURY IN THE RAT-BRAIN	INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE			English	Article						BRAIN INJURY; ASTROCYTE PROLIFERATION; BRAIN DEVELOPMENT; AUTORADIOGRAPHY; S-100 PROTEIN IMMUNOCYTOCHEMISTRY	FIBRILLARY ACIDIC PROTEIN; NEURON-RICH REGIONS; NEONATAL RAT; CEREBRAL-CORTEX; ADULT-RAT; IMMUNOHISTOCHEMICAL OBSERVATIONS; POSTNATAL-DEVELOPMENT; GLUTAMINE-SYNTHETASE; GROWTH-FACTOR; ASTROCYTES	A mechanical injury was inflicted to the left cerebral hemisphere in rats of four age groups: newborns, 6, 14 and 30 days old. The injury was followed by [H-3]thymidine injections at different time intervals. Brain sections were immunostained for S-100 protein and subjected to autoradiography. During microscopic observations of the injury region, locations and numbers of the autoradiographically labeled astrocytes expressing S-100 protein were recorded. On the basis of the observations, injury-induced changes in the total number of proliferating astrocytes, as well as in their distribution, were analysed quantitatively. In rats injured neonatally, as well as those injured on postnatal days 6 and 14, the reactive increase in the number of proliferating astrocytes began on the first post-traumatic day. In 30-day-old rats the increase was slower and appeared on day 2. The maximal increase in the astrocyte proliferative activity occurred in 6-day-old rats as early as day 1 after injury and was about eight times higher than that recorded in newborns, and nearly twice as high as that recorded in brains of 30-day-old rats. The results suggest that the intensity of astrocyte proliferative response to injury cannot be regarded as simply being proportional to the developmental progress of the brain tissue. Rather, these results indicate that changes in glial proliferative responses to injury follow a developmental time course, with a peak around the end of the first postnatal week.			JANECZKO, K (corresponding author), JAGIELLONIAN UNIV,INST ZOOL,DEPT NEUROANAT,PL-30060 KRAKOW,POLAND.			Janeczko, Krzysztof/0000-0002-9544-918X			Berry M, 1983, Acta Neurochir Suppl (Wien), V32, P31; CHAN CLH, 1990, DEV BRAIN RES, V55, P275, DOI 10.1016/0165-3806(90)90209-H; COCCHIA D, 1981, CELL TISSUE RES, V214, P529; DAHL D, 1986, ASTROCYTES, V3, P1; FERRER I, 1992, PROG NEUROBIOL, V39, P1, DOI 10.1016/0301-0082(92)90029-E; GHANDOUR MS, 1981, DEV NEUROSCI-BASEL, V4, P66, DOI 10.1159/000112742; GIULIAN D, 1988, J NEUROSCI, V8, P709; GOMEZ LA, 1990, INT J DEV NEUROSCI, V8, P55; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; JACOBSON M, 1991, DEV NEUROBIOLOGY; JANAS MS, 1991, ANAT EMBRYOL, V184, P549, DOI 10.1007/BF00942577; JANAS MS, 1991, ANAT EMBRYOL, V184, P559, DOI 10.1007/BF00942578; JANECZKO K, 1988, BRAIN RES, V456, P280, DOI 10.1016/0006-8993(88)90229-6; JANECZKO K, 1991, BRAIN RES, V564, P86, DOI 10.1016/0006-8993(91)91355-5; JANECZKO K, 1989, BRAIN RES, V485, P236, DOI 10.1016/0006-8993(89)90566-0; KONDO H, 1984, CELL TISSUE RES, V238, P503; LEGRAND C, 1981, NEUROPATH APPL NEURO, V7, P299, DOI 10.1111/j.1365-2990.1981.tb00101.x; LUDWIN SK, 1976, J COMP NEUROL, V165, P197, DOI 10.1002/cne.901650206; MALHOTRA SK, 1990, CYTOBIOS, V61, P133; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P501, DOI 10.1098/rstb.1990.0122; MAXWELL WL, 1990, PHILOS T R SOC B, V328, P479, DOI 10.1098/rstb.1990.0121; MIYAKE T, 1989, BRAIN RES, V489, P31, DOI 10.1016/0006-8993(89)90005-X; MIYAKE T, 1989, BRAIN RES, V493, P376, DOI 10.1016/0006-8993(89)91174-8; MOORE BW, 1977, NEUROCHEM RES, V2, P549, DOI 10.1007/BF00966014; MOORE IE, 1987, NEUROPATH APPL NEURO, V13, P219, DOI 10.1111/j.1365-2990.1987.tb00185.x; NAGANO N, 1993, GLIA, V8, P71, DOI 10.1002/glia.440080202; PFEIFFER B, 1992, HISTOCHEMISTRY, V97, P405, DOI 10.1007/BF00270387; RAPPORT MM, 1974, T AM SOC NEUROCHEM, V5, P58; SARNAT HB, 1992, J NEUROPATH EXP NEUR, V51, P58, DOI 10.1097/00005072-199201000-00008; SCHMIDTKASTNER R, 1990, J CHEM NEUROANAT, V3, P179; TANAKA H, 1992, EXP NEUROL, V116, P264, DOI 10.1016/0014-4886(92)90006-C; TANAKA H, 1991, ACTA HISTOCHEM CYTOC, V24, P11, DOI 10.1267/ahc.24.11	32	19	19	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0736-5748			INT J DEV NEUROSCI	Int. J. Dev. Neurosci.	AUG	1994	12	5					431	440		10.1016/0736-5748(94)90027-2			10	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Developmental Biology; Neurosciences & Neurology	PF198	WOS:A1994PF19800007	7817786				2022-02-06	
J	NORWOOD, S; MYERS, MB				NORWOOD, S; MYERS, MB			OUTCOMES FOLLOWING INJURY IN A PREDOMINANTLY RURAL-POPULATION-BASED TRAUMA CENTER	ARCHIVES OF SURGERY			English	Article							VOLUME; CARE; MORTALITY; IMPACT; SYSTEM	Objective: To determine the incidence, severity, and outcomes of injury in patients treated in a rural-based level I trauma center and to compare the outcomes with a nationally indexed patient population-the Major Trauma Outcome Study. Design: Retrospective evaluation of trauma registry data. Setting: State of Illinois designated level I trauma center located in Urbana. Patients: A total of 2246 trauma patients admitted from August 1989 through August 1992, with a mortality cohort of 158 patients. There were 1735 patients (77%) with Injury Severity Scores less than or equal to 19 and 511 patients (23%) with more severe injuries (Injury Severity Scores greater than or equal to 20). Main Outcome Measures: Mortality rates using the TRISS method, the Major Trauma Outcome Study, and final patient dispositions. Results: The overall mortality rate, excluding those patients who were pronounced dead on arrival, was 125/2213 (5.6%). Eighty-six (69%) of these 125 patients had neurological Abbreviated Injury Scores of 3 or greater, with neurotrauma being a major contributer to their deaths. The m-statistic was 0.99 and the z-statistic was -3.30 for the entire group. The observed probability of survival met or exceeded the expected probability of survival when compared with the Major Trauma Outcome Study in all categories. Conclusion: Acceptable mortality rates compared with the Major Trauma Outcome Study can be achieved in a rural-community-based level I trauma center despite relatively small numbers of critically injured patients. Such outcomes may assist in justifying resource allocation for trauma centers in rural areas.	CARLE FDN HOSP,URBANA,IL		NORWOOD, S (corresponding author), E TEXAS MED CTR,TRAUMA SERV,1021 E IDEL ST,POB 7677,TYLER,TX 75711, USA.						BAKER CC, 1986, ANN EMERG MED, V18, P1389; BAKER SP, 1987, NEW ENGL J MED, V316, P1384, DOI 10.1056/NEJM198705283162206; BAKER SP, 1984, INJURY FACT BOOK; BLAISDELL FW, 1989, ARCH SURG-CHICAGO, V124, P1122; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CONN AK, 1989, EMERG CARE Q, V5, P75; EXPOSITO TJ, 1991, ADV TRAUMA CRITICAL, V6, P115; FLORA JD, 1978, J TRAUMA, V18, P701, DOI 10.1097/00005373-197810000-00003; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; MARTIN GD, 1990, J TRAUMA, V30, P1014, DOI 10.1097/00005373-199008000-00011; MCCLAIN PW, 1990, TRAUMA REGISTRY USER; RINKER CF, 1989, AM J SURG, V158, P548, DOI 10.1016/0002-9610(89)90189-X; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; SHATNEY CH, 1993, J TRAUMA, V35, P171; SMITH RF, 1990, J TRAUMA, V30, P1066, DOI 10.1097/00005373-199009000-00002; WADDELL TK, 1991, J TRAUMA, V31, P958, DOI 10.1097/00005373-199107000-00012; WENNEKER WW, 1990, AM J SURG, V160, P655, DOI 10.1016/S0002-9610(05)80768-8; ZUCKLICK LC, 1991, ARCH SURG-CHICAGO, V126, P1427; 1984, MONTHLY VITAL STAT R, V32, P13; 1993, RESOURCES OPTIMAL CA, P7; 1979, ACS B 63, V8, P43	22	19	20	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0004-0010			ARCH SURG-CHICAGO	Arch. Surg.	AUG	1994	129	8					800	805					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	PB266	WOS:A1994PB26600003	8048848				2022-02-06	
J	LEVIN, BE; PAN, SJ; DUNNMEYNELL, A				LEVIN, BE; PAN, SJ; DUNNMEYNELL, A			CHRONIC ALTERATIONS IN RAT-BRAIN ALPHA-ADRENOCEPTORS FOLLOWING TRAUMATIC BRAIN INJURY	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						BRAIN INJURY; HEAD TRAUMA; NOREPINEPHRINE; RECOVERY OF FUNCTION; PLASTICITY	SENSORIMOTOR CORTEX INJURY; CENTRAL NORADRENERGIC NEURONS; LOCUS COERULEUS NEURONS; MOTOR RECOVERY; BEAM-WALKING; CEREBELLAR NOREPINEPHRINE; FACILITATE RECOVERY; FUNCTIONAL RECOVERY; AXONAL INJURY; LESION SIZE	Norepinephrine (NE) has been implicated in cerebral plasticity and recovery of function after brain injury. To examine the status of noradrenergic mechanisms in the brain following traumatic brain injury (TBI), male Sprague-Dawley rats underwent right sensorimotor cortex contusions and were observed for the next 30 days for recovery of motor function by measurement of the time taken to perform a modified beam walking task. At 30 days, their brains were assayed by receptor autoradiography for alpha(1)- and alpha(2)-adrenoceptor binding with 1 nM [H-3]prazosin and 1 nM [H-3]paraminoclonidine, respectively. One day after contusion, TBI rats took 60% longer to run the beam than sham-lesioned controls. Run times were directly proportional (r = 0.784; P = 0.012) to lesion volume determined at 30 days. The motor deficit persisted for 8 days, after which TBI and control rats had similar run times, largely due to increased run times in sham rats. At 30 days, TBI rats had a generalized, bilateral decrease in [3H]prazosin binding across all brain areas read (F[1,13] = 9.23; P = 0.009) with specific 12%-21% decreases in the cortex contralateral to the lesion and bilaterally in the dorsomedial hypothalamic and three thalamic nuclei. On the other hand, [H-3]paraminoclonidine binding did not differ from sham lesion controls in any brain area of TBI rats. Thus, unilateral TBI is followed by widespread, bilateral changes in alpha(1)-adrenoceptor binding which would leave the animal vulnerable to any factors which reduced the access of NE to its postsynaptic adrenoceptors. This is compatible with the observation that alpha(1)-antagonists and alpha(2)-agonists can transiently reinstate the motor deficit after recovery has occurred.	UNIV MED & DENT NEW JERSEY,NEW JERSEY MED SCH,DEPT NEUROSCI,NEWARK,NJ 07103		LEVIN, BE (corresponding author), DEPT VET AFFAIRS MED CTR,NEUROL SERV 127,385 TREMONT AVE,E ORANGE,NJ 07018, USA.						ABERCROMBIE ED, 1989, J NEUROSCI, V9, P4062; ACHESON AL, 1981, J NEUROSCI, V1, P493; BOYESON MG, 1992, BRAIN RES BULL, V29, P435, DOI 10.1016/0361-9230(92)90080-H; BOYESON MG, 1990, PHARMACOL BIOCHEM BE, V35, P497, DOI 10.1016/0091-3057(90)90279-Q; BOYESON MG, 1993, RESTOR NEUROL NEUROS, V5, P283, DOI 10.3233/RNN-1993-5404; BOYESON MG, 1992, PHARMACOL BIOCHEM BE, V43, P771, DOI 10.1016/0091-3057(92)90407-7; BOYESON MG, 1992, BEHAV NEUROSCI, V106, P964, DOI 10.1037/0735-7044.106.6.964; CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112; CURET O, 1987, J PHARMACOL EXP THER, V240, P327; Dunn-Meynell A., 1993, Society for Neuroscience Abstracts, V19, P1882; DUNNMEYNELL AA, 1993, BRAIN RES, V623, P25, DOI 10.1016/0006-8993(93)90005-8; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; GENTILE AM, 1978, BEHAV BIOL, V22, P417, DOI 10.1016/S0091-6773(78)92547-6; Goldstein L B, 1990, Restor Neurol Neurosci, V1, P311, DOI 10.3233/RNN-1990-1501; GOLDSTEIN LB, 1990, J NEUROSCI METH, V31, P101, DOI 10.1016/0165-0270(90)90154-8; GOLDSTEIN LB, 1991, RESTOR NEUROL NEUROS, V3, P41, DOI 10.3233/RNN-1991-3105; GOLDSTEIN LB, 1990, BEHAV NEUROSCI, V104, P320, DOI 10.1037/0735-7044.104.2.320; GRABOWSKI M, 1991, BRAIN RES, V547, P249, DOI 10.1016/0006-8993(91)90968-2; GUSTAFSON I, 1992, J NEUROL SCI, V113, P165, DOI 10.1016/0022-510X(92)90244-F; LEVIN BE, 1988, BRAIN RES, V443, P261, DOI 10.1016/0006-8993(88)91620-4; LEVIN BE, 1993, MOL BRAIN RES, V18, P59, DOI 10.1016/0169-328X(93)90173-M; LEVIN BE, 1985, BRAIN RES, V359, P215, DOI 10.1016/0006-8993(85)91431-3; LEVIN BE, 1983, BRAIN RES, V289, P205, DOI 10.1016/0006-8993(83)90021-5; LEVIN BE, 1991, EXP NEUROL, V113, P237, DOI 10.1016/0014-4886(91)90180-K; OLTMANS GA, 1981, BRAIN RES, V222, P411, DOI 10.1016/0006-8993(81)91046-5; PAPPIUS HM, 1991, NEUROCHEM RES, V16, P941, DOI 10.1007/BF00965837; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; PRASAD MR, 1992, J NEUROTRAUM, V9, P269, DOI 10.1089/neu.1992.9.269; ROBINSON RG, 1980, BRAIN RES, V188, P63, DOI 10.1016/0006-8993(80)90557-0; SUTTON RL, 1992, RESTOR NEUROL NEUROS, V4, P1, DOI 10.3233/RNN-1992-4101; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Ungerstedt U, 1971, ACTA PHYSIOL SC S367, V82, P1; WILMOT CA, 1988, BRAIN RES, V453, P157, DOI 10.1016/0006-8993(88)90154-0	35	19	20	0	0	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.	JUL	1994	7	1					5	12					8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PD027	WOS:A1994PD02700002	21551766				2022-02-06	
J	KAGAN, RJ; BAKER, RJ				KAGAN, RJ; BAKER, RJ			THE IMPACT OF THE VOLUME OF NEUROTRAUMA EXPERIENCE ON MORTALITY AFTER HEAD-INJURY	AMERICAN SURGEON			English	Article							TRAUMA; COUNTY	The volume of neurotrauma experience and mortality after head injury were evaluated in 4667 patients admitted to 10 Level I trauma centers. The hospitals were divided into three groups based on the number of severely head-injured patients admitted each month. The mean number of patients admitted each month to Hospital Groups 1, 2, and 3 with a Glasgow Coma Scale (GCS) score >10 was 100.0, 18.2, and 10.6. Mortality was significantly lower for patients admitted to Group 1 than for those admitted to Group 2 or 3; however, the difference between Groups 2 and 3 was not significant. The mean number of admissions with a GCS score less-than-or-equal-to 10 was 8.3, 6.5, and 2.8, and mortality rates were 26.7 per cent, 36.5 per cent, and 41.4 per cent, respectively. Mortality for Group 1 patients was significantly lower than for those in Groups 2 or 3. Patient age also had a profound impact on survival among all hospital groups. We conclude that the volume of neurotrauma experience correlates with mortality after head injury.	CHICAGO DEPT PUBL HLTH,DEPT SURG,CHICAGO,IL; JEFFERSON MED COLL,DEPT SURG,WILMINGTON,DE; MED CTR,DELAWARE,DEPT SURG,WILMINGTON,DE		KAGAN, RJ (corresponding author), UNIV CINCINNATI,COLL MED,DEPT SURG,231 BETHESDA AVE,CINCINNATI,OH 45267, USA.						ANNEGERS JF, 1979, CENTRAL NERVOUS SYST, P1; BOWERS SA, 1980, NEUROSURGERY, V6, P237; CALES RH, 1984, ANN EMERG MED, V13, P15; COOPER PR, 1985, CENTRAL NERVOUS SYST, P217; DAVIS RA, 1984, SURG GYNECOL OBSTET, V159, P597; GARNICK DW, 1989, JAMA-J AM MED ASSOC, V262, P547, DOI 10.1001/jama.262.4.547; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; JANE JA, 1982, CLIN NEUR, V29, P346; JENNETT B, 1978, INJURY, V10, P31; KALSBEEK WD, 1980, J NEUROSURG, V53, pS19; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; KLAUBER MR, 1985, J NEUROSURG, V62, P508; LILLEHEI KO, 1985, ANN EMERG MED, V14, P789, DOI 10.1016/S0196-0644(85)80059-7; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; PAL J, 1989, J TRAUMA, V29, P746, DOI 10.1097/00005373-198906000-00008; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; WEST JG, 1983, ARCH SURG-CHICAGO, V118, P740	19	19	19	0	1	SOUTHEASTERN SURGICAL CONGRESS	ATLANTA	1776 PEACHTREE RD, NW., SUITE 410N, ATLANTA, GA 30309-2352	0003-1348			AM SURGEON	Am. Surg.	JUN	1994	60	6					394	400					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	NN591	WOS:A1994NN59100005	8198326				2022-02-06	
J	KLUGER, Y; JAROSZ, D; PAUL, DB; TOWNSEND, RN; DIAMOND, DL				KLUGER, Y; JAROSZ, D; PAUL, DB; TOWNSEND, RN; DIAMOND, DL			DIVING INJURIES - A PREVENTABLE CATASTROPHE	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article							CORD INJURY	During a 5-year period from January 1987 through January 1992, 58 patients were admitted to the Allegheny General Hospital trauma center for non-scuba, non-suicidal diving injuries. There were 46 men and 12 women (mean age, 23 years). Forty-five patients were injured in swimming pools. Twenty-two patients had blood alcohol levels >100 mg/dL. Cervical spine injury was the most common pathologic entity encountered in this group of patients. Closed head injury, pelvic fracture, thoracic vertebral fracture, and rib fractures were other injuries identified. Some patients had multiple organ failure syndrome. Aquatic recreational activities carry a risk for injury that is preventable. The mechanism, clinical data, and complications of 58 patients are presented and the importance of prevention is discussed.	ALLEGHENY GEN HOSP,TRAUMA INTENS CARE UNIT,PITTSBURGH,PA 15212		KLUGER, Y (corresponding author), ALLEGHENY GEN HOSP,DIV GEN SURG,320 E N AVE,PITTSBURGH,PA 15212, USA.						Albrand O W, 1975, Surg Neurol, V4, P461; Albrand O W, 1976, Am J Sports Med, V4, P107, DOI 10.1177/036354657600400303; BAILES JE, 1990, SURG NEUROL, V34, P155, DOI 10.1016/0090-3019(90)90064-V; FIFE D, 1986, SPINE, V11, P2, DOI 10.1097/00007632-198601000-00002; KEWALRAMANI LS, 1975, J TRAUMA, V15, P130, DOI 10.1097/00005373-197502000-00005; KIWERSKI J, 1980, PARAPLEGIA, V18, P101, DOI 10.1038/sc.1980.16; LEDSOME JR, 1981, AM REV RESPIR DIS, V124, P41; RAYMOND CA, 1988, JAMA-J AM MED ASSOC, V260, P1199; RICHARDS RN, 1973, PHYSICIAN SPORTSMED, V1, P63; SCHER AT, 1981, S AFR MED J, V59, P603; 1992, THINK 1ST PROGRAM	11	19	19	0	1	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	MAR	1994	36	3					349	351		10.1097/00005373-199403000-00011			3	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	NC960	WOS:A1994NC96000011	8145314				2022-02-06	
J	SOUSTIEL, JF; HAFNER, H; GUILBURD, JN; ZAAROOR, M; LEVI, L; FEINSOD, M				SOUSTIEL, JF; HAFNER, H; GUILBURD, JN; ZAAROOR, M; LEVI, L; FEINSOD, M			A PHYSIOLOGICAL COMA SCALE - GRADING OF COMA BY COMBINED USE OF BRAIN-STEM TRIGEMINAL AND AUDITORY-EVOKED POTENTIALS AND THE GLASGOW COMA SCALE	ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY			English	Article						COMA; BRAIN-STEM EVOKED POTENTIALS; OUTCOME PROGNOSIS	SEVERE HEAD-INJURY; CENTRAL SOMATOSENSORY CONDUCTION; POST-TRAUMATIC COMA; PREDICTION; PRESSURE; DAMAGE; DEATH	Forty-five comatose patients were prospectively studied by means of clinical examination and evoked potentials. In each patient, clinical data included Glasgow Coma Scale (GCS) score, age, pupillary response to light, corneal reflex, and eye movements. Neurophysiological evaluation was based on brain-stem trigeminal evoked potentials (BTEPs) and brain-stem auditory evoked potentials (BAEPs). For each physiological test, a progressive grading system was designed. This system was based on the evaluation of central conduction times along the trigeminal and the auditory pathways within the brain-stem. The accuracy of the clinical and the neurophysiological indicants in predicting ''favorable'' or ''unfavorable'' outcome was assessed singly and in combination. Of the clinical indicants, the GCS provided the most accurate prognosis (80%). Similar results were provided by the BAEP and the BTEP, with significant improvement in the confidence of outcome prediction. No significant difference in the accuracy of outcome predictions could be found between combined clinical data and neurophysiological data. However, the combination of clinical and neurophysiological data markedly increased both the accuracy and the confidence of outcome prediction, reaching 86% correct predictions at the over 90% confidence level with only 2% false pessimistic errors. According to these findings, a clinical-physiological coma scale, the trigeminal-auditory Glasgow (Coma Scale) score (TAG score) was designed. The TAG score demonstrated the highest accuracy at each confidence level as compared to other single indicants. We concluded that the TAG score may improve the evaluation of deep comatose patients and assist the physician in the management of such patients.	TECHNION ISRAEL INST TECHNOL,BRUCE RAPPAPORT FAC MED,HAIFA,ISRAEL		SOUSTIEL, JF (corresponding author), TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,DEPT NEUROSURG,POB 9602,IL-31096 HAIFA,ISRAEL.						ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; BUCHNER H, 1988, ELECTROEN CLIN NEURO, V69, P14, DOI 10.1016/0013-4694(88)90031-4; CANT BR, 1986, ELECTROEN CLIN NEURO, V65, P188, DOI 10.1016/0168-5597(86)90053-5; CHOI SC, 1988, J NEUROSURG, V69, P381, DOI 10.3171/jns.1988.69.3.0381; CORDOBES F, 1985, ACTA NEUROCHIR WIEN, V81, P27; FACCO E, 1985, ELECTROEN CLIN NEURO, V62, P332, DOI 10.1016/0168-5597(85)90041-3; FERBERT A, 1990, BRAIN, V113, P49, DOI 10.1093/brain/113.1.49; GANES T, 1988, ELECTROEN CLIN NEURO, V69, P6, DOI 10.1016/0013-4694(88)90030-2; GARCIALARREA L, 1987, ELECTROEN CLIN NEURO, V68, P446, DOI 10.1016/0168-5597(87)90056-6; GARCIALARREA L, 1992, J NEUROL NEUROSUR PS, V55, P792, DOI 10.1136/jnnp.55.9.792; GREENBERG RP, 1977, J NEUROSURG, V47, P163, DOI 10.3171/jns.1977.47.2.0163; HUME AL, 1981, ANN NEUROL, V10, P411, DOI 10.1002/ana.410100503; JENNETT B, 1981, MANAGEMENT HEAD INJU, P317; JENNETT B, 1977, LANCET, V1, P480; KARNAZE DS, 1985, NEUROLOGY, V35, P1122, DOI 10.1212/WNL.35.8.1122; LINDSAY K, 1990, NEUROSURGERY, V26, P278, DOI 10.1227/00006123-199002000-00015; LINDSAY KW, 1981, J NEUROL NEUROSUR PS, V44, P796, DOI 10.1136/jnnp.44.9.796; MCCORMICK WF, 1985, NEUROSURGERY, V2, P1544; NARAYAN RK, 1981, J NEUROSURG, V54, P751, DOI 10.3171/jns.1981.54.6.0751; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P583, DOI 10.1016/0013-4694(83)90026-3; SOUSTIEL JF, 1991, ELECTROEN CLIN NEURO, V80, P119, DOI 10.1016/0168-5597(91)90149-R; TEASDALE G, 1974, LANCET, V2, P81	23	19	23	0	2	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0013-4694			ELECTROEN CLIN NEURO	Electroencephalogr. Clin. Neurophysiol.	NOV	1993	87	5					277	283		10.1016/0013-4694(93)90180-4			7	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	MJ399	WOS:A1993MJ39900002	7693438				2022-02-06	
J	SPENCE, SE; GODFREY, HPD; KNIGHT, RG; BISHARA, SN				SPENCE, SE; GODFREY, HPD; KNIGHT, RG; BISHARA, SN			1ST IMPRESSIONS COUNT - A CONTROLLED INVESTIGATION OF SOCIAL SKILL FOLLOWING CLOSED-HEAD INJURY	BRITISH JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							VERBAL IMPAIRMENT; RELATIVES	This study examined social skills in 14 closed head injured (CHI) patients who were assessed at four months post-injury and compared with 19 orthopaedic control (OC) patients. Social skills deficits were found to be more common in the CHI patients, of whom over half were classified as socially unskilled. CHI patients displayed poorer social skills in the earlier (but not later) part of an extended social interaction, indicating that they make a poor first impression. It is suggested that poor initial impression formation skills may be one reason why CHI patients fail to establish and maintain friendships. Implications of these findings for patient management are discussed. Close others of CHI patients reported higher levels of mood disturbance. Higher levels of close other hostility were associated with social skills deficits in CHI patients.	UNIV OTAGO, DEPT PSYCHOL, CTR COMMUNITY COUNSELLING, POB 56, DUNEDIN, NEW ZEALAND; UNIV OTAGO, DEPT SURG, DUNEDIN, NEW ZEALAND								Argyle M., 1985, ANATOMY RELATIONSHIP; Benton A., 1978, MULTILINGUAL APHASIA; ELLEY WB, 1985, NEW ZEAL J EDUC STUD, V20, P115; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GODFREY H P D, 1991, Brain Injury, V5, P207, DOI 10.3109/02699059109008091; GODFREY HPD, 1989, PSYCHOL MED, V19, P175, DOI 10.1017/S0033291700011120; Goodglass H., 1972, ASSESSMENT APHASIA R; GORDON WP, 1987, BRAIN LANG, V31, P1, DOI 10.1016/0093-934X(87)90056-3; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Nelson H. E, 1982, NATIONAL ADULT READI; NEWTON A, 1985, BRIT J CLIN PSYCHOL, V24, P225, DOI 10.1111/j.2044-8260.1985.tb00655.x; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; ROSENBERRY T L, 1980, Neurochemistry International, V2, P135, DOI 10.1016/0197-0186(80)90020-0; RUSSELL WR, 1961, TRAUMATIC AMNESIAS; SARNO MT, 1986, ARCH PHYS MED REHAB, V67, P400; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; SARNO MT, 1988, SCAND J REHABIL MED, P55; SARNO MT, 1984, J NERV MENT DIS, V172, P475, DOI 10.1097/00005053-198408000-00006; SARNO MT, 1987, APHASIOLOGY, V1, P331; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; Zuckerman M., 1985, MULTIPLE AFFECT ADJE	25	19	19	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0144-6657	2044-8260		BRIT J CLIN PSYCHOL	Br. J. Clin. Psychol.	SEP	1993	32		3				309	318		10.1111/j.2044-8260.1993.tb01061.x			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	LZ987	WOS:A1993LZ98700006	8251961				2022-02-06	
J	REID, DB; KELLY, MP				REID, DB; KELLY, MP			WECHSLER MEMORY SCALE-REVISED IN CLOSED HEAD-INJURY	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article							BRAIN-DAMAGE; SEQUELAE	This study was undertaken to determine the ability of the Wechsler Memory Scale-Revised (WMS-R) to differentiate a group of closed head injury patients from a group of controls and determine how injury severity and attentional deficits are associated with WMS-R performance. The relationship of WMS-R performance to everyday memory also was assessed. The head injured group performed more poorly than controls on all five WMS-R indices and exhibited greater impairments on tasks that measure retention. In the original sample only the Visual Memory Index correlated with injury severity; in a larger sample, all four memory indices correlated modestly with injury severity. Patients who performed more poorly on the WMS-R also received poorer ratings on an independent assessment of everyday memory.	UNIV MARYLAND,MONTEBELLO HOSP,SCH MED,2201 ARGONNE DR,BALTIMORE,MD 21218; WRIGHT STATE UNIV,DAYTON,OH 45435								BROOKS DN, 1980, J NEUROL NEUROSUR PS, V43, P529, DOI 10.1136/jnnp.43.6.529; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; BUTTERS N, 1988, CLIN NEUROPSYCHOL, V2, P133; CROSSEN JR, 1988, CLIN NEUROPSYCHOL, V2, P393; Erikson R.C., 1977, PSYCHOL BULL, V84, P1130; Fischer J.S., 1988, CLIN NEUROPSYCHOL, V2, P149, DOI [10.1080/13854048808520097, DOI 10.1080/13854048808520097]; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; Gronwall D, 1974, PSYCHOL EFFECTS CONC; GRONWALL DMA, 1980, 9TH ANN M INT NEUR S; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; KNIGHT RG, 1984, J CONSULT CLIN PSYCH, V52, P769; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Levin HS., 1982, NEUROBEHAVIORAL CONS; LEWIN W, 1968, BMJ-BRIT MED J, V1, P465, DOI 10.1136/bmj.1.5590.465; LEZAK MD, 1978, AM J PHYS MED REHAB, V57, P9; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PRIGATANO GP, 1978, J CLIN PSYCHOL, V34, P816, DOI 10.1002/1097-4679(197810)34:4<816::AID-JCLP2270340402>3.0.CO;2-Q; RUSSELL EW, 1975, J CONSULT CLIN PSYCH, V39, P133; Ryan J. J., 1988, CLIN NEUROPSYCHOL, V2, P173; Seretny M L, 1986, Arch Clin Neuropsychol, V1, P5, DOI 10.1016/0887-6177(86)90021-1; SUNDERLAND A, 1983, J VERB LEARN VERB BE, V22, P341, DOI 10.1016/S0022-5371(83)90229-3; SUNDERLAND A, 1990, NEUROPSYCHOLOGY EVER, P169; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; Walsh K.W, 1978, NEUROPSYCHOLOGY; Wechsler D, 1987, WECHSLER MEMORY SCAL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; YOUNG B, 1981, J NEUROSURG, V54, P300, DOI 10.3171/jns.1981.54.3.0300; [No title captured]	30	19	19	0	3	CLINICAL PSYCHOLOGY PUBL CO	BRANDON	4 CONANT SQUARE, BRANDON, VT 05733	0021-9762			J CLIN PSYCHOL	J. Clin. Psychol.	MAR	1993	49	2					245	254		10.1002/1097-4679(199303)49:2<245::AID-JCLP2270490219>3.0.CO;2-1			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	KZ345	WOS:A1993KZ34500017	8486808				2022-02-06	
J	ZWIL, AS; MCALLISTER, TW; COHEN, I; HALPERN, LR				ZWIL, AS; MCALLISTER, TW; COHEN, I; HALPERN, LR			ULTRA-RAPID CYCLING BIPOLAR AFFECTIVE-DISORDER FOLLOWING A CLOSED-HEAD INJURY	BRAIN INJURY			English	Article							BRAIN INJURY; SECONDARY MANIA; LITHIUM-CARBONATE; ILLNESS; TRAUMA	A young adult with no prior history of affective disease suffered the onset of a rapid cycling bipolar illness, marginally responsive to psychotropic medications, following a mild closed-head injury, and persisting after the cognitive effects of the injury had resolved. A concurrence of findings on the neurological examination, neurobehavioural examination, SPECT scan, EEG and neuropsychological test battery suggested the presence of a diffuse cerebral injury with a predominance of left frontotemporal findings. This case demonstrates that a severe and disabling mood disorder may follow a mild head injury, and that its course may be independent of cognitive impairment and recovery.	THOMAS JEFFERSON UNIV,PHILADELPHIA,PA 19107; THOMAS JEFFERSON UNIV,JEFFERSON MED COLL,DEPT PSYCHIAT & HUMAN BEHAV,PHILADELPHIA,PA 19107; DARTMOUTH COLL,HITCHCOCK MED CTR,DARTMOUTH MED SCH,DEPT PSYCHIAT,HANOVER,NH 03756; NEW HAMPSHIRE HOSP,CONCORD,NH; BRYN MAWR HOSP,DEPT PSYCHIAT,BRYN MAWR,PA; UNIV PENN,DEPT PSYCHIAT,PHILADELPHIA,PA 19104								ALARCON RD, 1985, COMPR PSYCHIAT, V26, P522, DOI 10.1016/0010-440X(85)90019-7; BRACKEN P, 1987, BRIT J PSYCHIAT, V150, P690, DOI 10.1192/bjp.150.5.690; CLARK AF, 1987, BRIT J PSYCHIAT, V150, P841, DOI 10.1192/bjp.150.6.841; COHN CK, 1977, DIS NERV SYST, V38, P630; CUMMINGS JL, 1986, PSYCHIAT CLIN N AM, V9, P293; DUNNER DL, 1974, ARCH GEN PSYCHIAT, V30, P229; DUNNER DL, 1977, COMPR PSYCHIAT, V18, P561, DOI 10.1016/S0010-440X(97)90006-7; FLORHENRY P, 1983, BIOL PSYCHIAT, V18, P1045; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gualtieri C T, 1988, Brain Inj, V2, P101, DOI 10.3109/02699058809150936; JENNER FA, 1967, BRIT J PSYCHIAT, V113, P895, DOI 10.1192/bjp.113.501.895; KRAUTHAMMER C, 1978, ARCH GEN PSYCHIAT, V35, P1333; MCALLISTER TW, IN PRESS PSYCHIATRIC; NIZAMIE SH, 1988, ACTA PSYCHIAT SCAND, V77, P637, DOI 10.1111/j.1600-0447.1988.tb05181.x; POPE HG, 1988, COMPR PSYCHIAT, V29, P34, DOI 10.1016/0010-440X(88)90035-1; RIESS H, 1987, J CLIN PSYCHIAT, V48, P29; ROBINSON RG, 1988, AM J PSYCHIAT, V145, P172; SHUKLA S, 1987, AM J PSYCHIAT, V144, P93; SINANAN K, 1984, BRIT J PSYCHIAT, V144, P330, DOI 10.1192/bjp.144.3.330; STARKSTEIN SE, 1990, ANN NEUROL, V27, P652, DOI 10.1002/ana.410270612; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; STARKSTEIN SE, 1988, J NERV MENT DIS, V176, P87, DOI 10.1097/00005053-198802000-00004; STEWART JT, 1988, J CLIN PSYCHIAT, V49, P74; YATHAM LN, 1988, ACTA PSYCHIAT SCAND, V77, P359, DOI 10.1111/j.1600-0447.1988.tb05135.x; ZWIL AS, 1990, BIOL PSYCHAITRY, V27, pA55; [No title captured]; [No title captured]	27	19	19	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAR-APR	1993	7	2					147	152		10.3109/02699059309008168			6	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	KZ726	WOS:A1993KZ72600006	8095835				2022-02-06	
J	HARIRI, RJ; GHAJAR, JBG; BAHRAMIAN, K; SHARIF, S; BARIE, PS				HARIRI, RJ; GHAJAR, JBG; BAHRAMIAN, K; SHARIF, S; BARIE, PS			ALTERATIONS IN INTRACRANIAL-PRESSURE AND CEREBRAL BLOOD-VOLUME IN ENDOTOXEMIA	SURGERY GYNECOLOGY & OBSTETRICS			English	Article							TRAUMATIC BRAIN INJURY; OXYGEN-CONSUMPTION; SEPSIS SYNDROME; SEPTIC SHOCK; FLOW; PH; METABOLISM; DIAMETER; DOGS; RAT	Marked deterioration of neurologic function accompanies organ dysfunction in systemic sepsis. Although previous hypotheses have suggested that cerebral hypoperfusion, anoxia or progressive edema of the brain may be causative, the pathogenesis remains unknown. Patients with sepsis with stable or supported hemodynamics and adequate oxygenation may manifest confusion, stupor or coma. Recent evidence has demonstrated that the brain is the source of many classical mediators of inflammation after various forms of injury. These mediators, including the leukotrienes, have pronounced effect on cerebrovascular function. Endotoxin is known to stimulate the release of arachidonate from cell membranes, the rate limiting step in leukotriene synthesis. The current studies were performed to test the hypothesis that neurologic dysfunction associated with endotoxemia is characterized by alterations in cerebrovascular permeability or vasomotor function manifested by intracranial hypertension, or both. We studied the response of miniature swine to experimental endotoxemic shock and compared this response with hemorrhagic hypotension. We observed a dramatic elevation of intracranial pressure in swine subjected to endotoxemic shock, despite arterial hypotension. Moreover, estimation of cerebral blood volume (CBV) by reflectance infrared photoplethysmography demonstrated a dramatic increase in CBV, which corresponded to this elevation in intracranial pressure. However, cerebral cortical oxygen saturation was significantly reduced despite this net increase in CBV, indicative of an increase in the venous volume of the brain, while arterial volume remained the same or decreased from baseline levels. Oxygen extraction across the brain decreased during this same period compared with baseline and control values. These results demonstrate that endotoxemia is associated with the development of intracranial hypertension and an increase in CBV secondary to elevation of cerebrovascular venous volume coupled with reduced oxygen extraction across the brain. This evidence of cerebrovascular dysfunction probably represents blood flow maldistribution, similar to that seen in other organs with sepsis, suggesting a cause for altered neurologic function in systemic sepsis.			HARIRI, RJ (corresponding author), CORNELL UNIV,MED CTR,COLL MED,DEPT SURG,DIV NEUROSURG,AITKEN NEUROSURG LAB,1300 YORK AVE,NEW YORK,NY 10021, USA.		Barie, Philip/AAN-8811-2020				ARCHIE JP, 1977, ANN SURG, V186, P171, DOI 10.1097/00000658-197708000-00008; BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; BONE RC, 1989, CRIT CARE MED, V17, P398; BOWTON DL, 1989, CRIT CARE MED, V17, P399, DOI 10.1097/00003246-198905000-00004; BRYAN WJ, 1977, P SOC EXP BIOL MED, V156, P205; DAHN MS, 1987, SURGERY, V101, P69; DODGE PR, 1965, NEW ENGL J MED, V272, P954, DOI 10.1056/NEJM196505062721806; EKSTROMJODAL B, 1982, ACTA ANAESTH SCAND, V26, P163, DOI 10.1111/j.1399-6576.1982.tb01746.x; ELLMAN H, 1984, CRIT CARE MED, V12, P629, DOI 10.1097/00003246-198408000-00004; FISH RE, 1986, CIRC SHOCK, V18, P267; FREUND HR, 1978, ANN SURG, V188, P423, DOI 10.1097/00000658-197809000-00017; GHAJAR JBG, 1985, J NEUROSURG, V63, P985, DOI 10.3171/jns.1985.63.6.0985; HARADA J, 1991, J NEUROSURG, V75, P103, DOI 10.3171/jns.1991.75.1.0103; HARIRI RJ, 1989, J TRAUMA, V29, P1203, DOI 10.1097/00005373-198909000-00003; HARIRI RJ, 1990, STROKE S, V21, P81; HARIRI RJ, UNPUB; HINSHAW LB, 1970, ARCH SURG-CHICAGO, V100, P600; JEPPSSON B, 1981, AM J SURG, V141, P136, DOI 10.1016/0002-9610(81)90026-X; KONTOS HA, 1977, STROKE, V8, P358, DOI 10.1161/01.STR.8.3.358; KUSCHINSKY W, 1972, CIRC RES, V31, P240, DOI 10.1161/01.RES.31.2.240; LAW WR, 1985, CIRC SHOCK, V15, P49; LEFER AM, 1989, CIRC SHOCK, V27, P3; LIU MS, 1988, J SURG RES, V45, P472, DOI 10.1016/0022-4804(88)90198-9; MENDELOW AD, 1981, STROKE, V12, P58, DOI 10.1161/01.STR.12.1.58; MENDELSON Y, 1988, MED INSTRUM, V22, P167; MENDELSON Y, 1983, ADV EXP MED BIOL, V159, P93; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; PARKER MM, 1984, ANN INTERN MED, V100, P483, DOI 10.7326/0003-4819-100-4-483; PULSINELLI WA, 1982, ANN NEUROL, V11, P499, DOI 10.1002/ana.410110510; SHEPARD SR, 1990, ACT NEUR S, V51, P58; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; SMITH EF, 1988, CIRC SHOCK, V25, P21; WAHL M, 1970, PFLUG ARCH EUR J PHY, V316, P152, DOI 10.1007/BF00586483; WYATT JS, 1986, LANCET, V2, P1063, DOI 10.1016/S0140-6736(86)90467-8; YOSHIYA I, 1980, MED BIOL ENG COMPUT, V18, P27, DOI 10.1007/BF02442476; 1990, CURRENT TRENDS INCRE, V39, P31	37	19	19	0	0	FRANKLIN H MARTIN FOUNDATION	CHICAGO	55 E ERIE ST, CHICAGO, IL 60611	0039-6087			SURG GYNECOL OBSTET	Surg. Gynecol. Obstet.	FEB	1993	176	2					155	166					12	Obstetrics & Gynecology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Surgery	KK498	WOS:A1993KK49800010	8421804				2022-02-06	
J	MCBURNEY, RN; DALY, D; FISCHER, JB; HU, LY; SUBBARAO, K; KNAPP, AG; KOBAYASHI, K; MARGOLIN, L; REDDY, NL; GOLDIN, SM				MCBURNEY, RN; DALY, D; FISCHER, JB; HU, LY; SUBBARAO, K; KNAPP, AG; KOBAYASHI, K; MARGOLIN, L; REDDY, NL; GOLDIN, SM			NEW CNS-SPECIFIC CALCIUM-ANTAGONISTS	JOURNAL OF NEUROTRAUMA			English	Article							TRANSMITTER RELEASE; SUPERFUSION SYSTEM; VERTEBRATE CELLS; CHANNELS; INHIBITION; RECEPTOR; BRAIN; CONE	Ischemic insults to the brain in stroke or traumatic brain injury produce excessive release of glutamate from depolarized nerve terminals. This excessive glutamate release in turn stimulates massive calcium entry into nerve cells, activating a biochemical cascade that results in cell death. A major pathway of calcium entry into depolarized nerve cells is through voltage-sensitive, high threshold calcium channels. A large fraction of this calcium entry is mediated through "R-type" calcium channels, channels resistant to blockage by dihydropyridine calcium antagonists such as nimodipine. A newly discovered compound derived from spider venom, CNS 2103, antagonizes both R-type channels and dihydropyridine-sensitive ("L-type") calcium channels. This broad spectrum of action, coupled with selectivity for calcium channels over other classes of voltage-sensitive and ligand-gated ion channels, makes CNS 2103 an interesting lead for development of drugs to treat ischemic brain injury. Activation of presynaptic ("N-type") calcium channels in nerve terminals is a primary cause of excessive neurotransmitter release in brain ischemia. Prevention of glutamate release by blockade of N-type channels in glutamatergic nerve terminals may, at an early stage in the pathophysiological cascade, abort the process leading to nerve cell death. Cambridge NeuroScience has developed a novel rapid kinetic approach for monitoring glutamate release from brain nerve terminals in vitro, and this has led to CNS 1145, a substituted guanidine that selectively blocks a kinetic component of calcium-dependent glutamate release mediated by persistent depolarization. Additional evidence suggests that CNS 1145 antagonizes presynaptic N-type calcium channels, and this may account at least in part for its ability to block glutamate release.			MCBURNEY, RN (corresponding author), CAMBRIDGE NEUROSCI INC, 1 KENDALL SQ, BLDG 700, CAMBRIDGE, MA 02139 USA.		Subbarao, Krishna/X-3870-2019	Subbarao, Krishna/0000-0002-2075-1835			[Anonymous], 1990, Lancet, V336, P1205; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; BEAN BP, 1989, ANNU REV PHYSIOL, V51, P367, DOI 10.1146/annurev.ph.51.030189.002055; BEKKERS JM, 1990, NATURE, V346, P724, DOI 10.1038/346724a0; CHOI DW, 1990, CEREBROVAS BRAIN MET, V2, P105; HESS P, 1990, ANNU REV NEUROSCI, V13, P337, DOI 10.1146/annurev.neuro.13.1.337; HILLE B, 1975, BIOPHYS J, V15, P615, DOI 10.1016/S0006-3495(75)85842-5; Hille B, 1984, IONIC CHANNELS EXCIT, P226; JANIS RA, 1991, CALCIUM CHANNELS THE, P197; KANDEL ER, 1991, PRINCIPLES NEURAL SC, P194; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; KEANA JFW, 1989, P NATL ACAD SCI USA, V86, P5631, DOI 10.1073/pnas.86.14.5631; LLINAS R, 1989, P NATL ACAD SCI USA, V86, P1689, DOI 10.1073/pnas.86.5.1689; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MAZZO DJ, 1983, ANAL PROFILE DRUG SU, V15, P1; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; NACHSHEN DA, 1985, J PHYSIOL-LONDON, V361, P251, DOI 10.1113/jphysiol.1985.sp015644; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OLIVERA BM, 1985, SCIENCE, V230, P1338, DOI 10.1126/science.4071055; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RITCHIE JM, 1977, REV PHYSIOL BIOCH P, V79, P1, DOI 10.1007/BFb0037088; SCOTT RH, 1990, MOL PHARMACOL, V38, P711; SEABROOK GR, 1989, BRIT J PHARMACOL, V97, P1125, DOI 10.1111/j.1476-5381.1989.tb12570.x; SIESJO BK, 1988, ANN NY ACAD SCI, V522, P638; SUSZKIW JB, 1986, J NEUROSCI, V6, P1349; TEASDALE G, 1992, J NEUROTRAUM, V9, pS545; TRIMBLE WS, 1991, ANNU REV NEUROSCI, V14, P93, DOI 10.1146/annurev.neuro.14.1.93; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TSUBOKAWA M, 1991, ABST SOC NEUR ANN M, V17, P1161; TURNER TJ, 1989, ANAL BIOCHEM, V178, P8, DOI 10.1016/0003-2697(89)90347-3; TURNER TJ, 1989, BIOCHEMISTRY-US, V28, P586, DOI 10.1021/bi00428a026	31	19	20	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY	1992	9			2			S531	S543					13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HU819	WOS:A1992HU81900010	1319500				2022-02-06	
J	YUAN, XQ; WADE, CE				YUAN, XQ; WADE, CE			TRAUMATIC BRAIN INJURY ATTENUATES THE EFFECTIVENESS OF LACTATED RINGERS SOLUTION RESUSCITATION OF HEMORRHAGIC-SHOCK IN RATS	SURGERY GYNECOLOGY & OBSTETRICS			English	Article							CEREBRAL BLOOD-FLOW; FLUID-PERCUSSION MODEL; HEAD-INJURY; INTRACRANIAL-PRESSURE; VOLUME; MORTALITY	Traumatic brain injury suppresses spontaneous cardiovascular compensation for hemorrhage, prompting us to examine the possibility that trauma to the brain modifies hemodynamic response to therapy in hemorrhage. Thirty rats that were anesthetized were randomly assigned to four groups-hemorrhagic shock (H), hemorrhagic shock after brain trauma (TH), hemorrhagic shock treated with lactated Ringer's (LR) solution (HR), and hemorrhagic shock after brain trauma treated with LR (THR). After hemorrhage, group TH had significantly lower mean arterial pressure (MAP), cardiac index (CI) and stroke volume index (SVI) than group H. Throughout the postresuscitative period, group HR had significantly higher MAP, CI, SVI and central venous pressure than group H. At 50 and 70 minutes after the start of hemorrhage, group THR showed significantly lower MAP, CI and SVI than group HR. This difference in hemodynamics is not because of transcapillary refill effect, because brain trauma did not cause changes in hematocrit and plasma protein levels. As heart rate, preload and afterload were not significantly different between groups THR and HR, the attenuation of fluid resuscitation can be attributed mainly to a depressed cardiac function. Furthermore, neither brain trauma nor fluid replacement altered the content of water in the brain in hemorrhaged rats. These data indicate that brain trauma not only suppresses spontaneous hemodynamic recovery from hemorrhage, but also impedes the efficacy of LR resuscitation. The results of the current study suggested that a more aggressive fluid replacement may be needed to treat hemorrhagic shock in individuals with brain injury.	LETTERMAN ARMY INST RES,DIV MIL TRAUMA RES,SAN FRANCISCO,CA 94129								Altman PL, 1974, BIOLOGY DATA BOOK, VIII, P1847; BAUE AE, 1988, HARDYS TXB SURGERY, P30; CRUICKSHANK JM, 1988, POSTGRAD MED, P140; DAVIS DH, 1980, J NEUROSURG, V52, P745, DOI 10.3171/jns.1980.52.6.0745; DAVIS RA, 1984, SURG GYNECOL OBSTET, V159, P597; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; GUNNAR W, 1988, SURGERY, V103, P398; HANNON JP, 1989, CIRC SHOCK, V29, P205; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; NEWFIELD P, 1980, CRIT CARE MED, V8, P254, DOI 10.1097/00003246-198004000-00123; NILSSON B, 1977, J NEUROSURG, V47, P262, DOI 10.3171/jns.1977.47.2.0262; PILATI CF, 1990, P SOC EXP BIOL MED, V193, P225; ROBERTSON CS, 1988, J TRAUMA, V28, P1523, DOI 10.1097/00005373-198811000-00002; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1984, J NEUROSURG, V61, P76, DOI 10.3171/jns.1984.61.1.0076; SALTER G, 1977, ANN SURG, V181, P1; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SMITH SD, 1982, J TRAUMA, V22, P588, DOI 10.1097/00005373-198207000-00011; STENING WA, 1986, AUST NZ J SURG, V56, P549, DOI 10.1111/j.1445-2197.1986.tb07098.x; WADE CE, 1989, CIRC SHOCK, V29, P193; WOOD JH, 1985, STROKE, V16, P765, DOI 10.1161/01.STR.16.5.765; WRIGHT CS, 1983, CAN J SURG, V26, P20; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289; YUAN XQ, 1991, J NEUROSURG, V75, P408, DOI 10.3171/jns.1991.75.3.0408; [No title captured]	29	19	19	0	0	FRANKLIN H MARTIN FOUNDATION	CHICAGO	55 E ERIE ST, CHICAGO, IL 60611	0039-6087			SURG GYNECOL OBSTET	Surg. Gynecol. Obstet.	APR	1992	174	4					305	312					8	Obstetrics & Gynecology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Obstetrics & Gynecology; Surgery	HM797	WOS:A1992HM79700008	1553610				2022-02-06	
J	MEYER, CA; MIRVIS, SE; WOLF, AL; THOMPSON, RK; GUTIERREZ, MA				MEYER, CA; MIRVIS, SE; WOLF, AL; THOMPSON, RK; GUTIERREZ, MA			ACUTE TRAUMATIC MIDBRAIN HEMORRHAGE - EXPERIMENTAL AND CLINICAL OBSERVATIONS WITH CT	RADIOLOGY			English	Article						BRAIN, CT; BRAIN, HEMORRHAGE; BRAIN, INFARCTION; BRAIN, INJURIES; MENINGES, INJURIES	BRAIN-STEM HEMORRHAGE; DIFFUSE AXONAL INJURY; COMPUTERIZED-TOMOGRAPHY; HEAD TRAUMA; MR; LESIONS; SCANS	Traumatic brain stem hemorrhage (TBH) after blunt head impact is an uncommon injury and has historically been associated with high mortality. Retrospective clinical review identified 64 patients with TBH admitted during a 5-year period. Complete imaging and clinical records for 45 of these patients demonstrated that TBH could be categorized into three groups. The most frequent site of hemorrhage, in 31 (69%) of 45 patients (group 1), was the midline rostral anterior brain stem, posterior to the interpeduncular cistern, and this injury was associated with a 71% survival rate. This pattern was also associated with a predominantly anterior site of head and/or face impact. Eight (18%) patients (group 2) had miscellaneous foci of acute brain stem hemorrhage, with seven (88%) surviving. Six (13%) patients (group 3) had brain stem hemorrhage associated with transtentorial herniation and brain stem compression, with 100% mortality. Experimental findings in a canine model and clinical results indicate that the anterior rostral midbrain is a common site of TBH and appears to arise from sudden craniocaudal displacement of the brain at impact. Survival is unexpectedly high with this location of traumatic midbrain hemorrhage.	MARYLAND INST EMERGENCY MED SERV SYST,DEPT RADIOL,22 S GREENE ST,BALTIMORE,MD 21202; MARYLAND INST EMERGENCY MED SERV SYST,DEPT NEUROSURG,BALTIMORE,MD 21202; WALTER REED ARMY MED CTR,DEPT RADIOL,WASHINGTON,DC 20307; UNIV MARYLAND,MED CTR,DIV NEUROSURG,BALTIMORE,MD 21201								ADAMS JH, 1977, BRAIN, V100, P489, DOI 10.1093/brain/100.3.489; ADAMS JH, 1985, CENTRAL NERVOUS SYST, P65; CARDOBES F, 1986, ACTA NEUROCHIR, V81, P27; CLIFTON GL, 1983, CLIN NEUROSCIENCES, V2, P1269; COOPER PR, 1979, NEUROSURGERY, V4, P115, DOI 10.1227/00006123-197902000-00002; COPE DN, 1990, KRUSENS HDB PHYSICAL, P1217; CROMPTON MR, 1971, LANCET, V1, P669; ESPERSEN JO, 1981, ACTA NEUROCHIR, V56, P201, DOI 10.1007/BF01407231; FRENCH BN, 1977, SURG NEUROL, V7, P171; FREYTAG E, 1963, ARCH PATHOL, V75, P402; FRIEDE RL, 1966, NEUROLOGY, V16, P1210, DOI 10.1212/WNL.16.12.1210; GALYON DD, 1988, PEDIATR NEUROSCI, V14, P272, DOI 10.1159/000120403; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTRY LR, 1988, AM J NEURORADIOL, V9, P91; GENTRY LR, 1989, RADIOLOGY, V171, P177, DOI 10.1148/radiology.171.1.2928523; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; HASSLER O, 1967, NEUROLOGY, V17, P368, DOI 10.1212/WNL.17.4.368; JACOBS L, 1976, NEUROLOGY, V26, P1111, DOI 10.1212/WNL.26.12.1111; KLINTWOR.GK, 1965, AM J PATHOL, V47, P525; LINDENBERG R, 1955, J NEUROPATH EXP NEUR, V14, P223, DOI 10.1097/00005072-195507000-00001; MARGOLIS MT, 1974, RADIOLOGY SKULL BRAI, V2; ROPPER AH, 1985, ANN NEUROL, V18, P80, DOI 10.1002/ana.410180114; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; THOMPSON RK, 1988, NEUROSURGERY, V22, P629, DOI 10.1227/00006123-198804000-00002; THOMPSON RK, 1988, NEUROSURGERY, V22, P623, DOI 10.1227/00006123-198804000-00001; TOMINSON BE, 1970, J CLIN PATHOL S4, V23, P154; TSAI FY, 1980, AM J ROENTGENOL, V134, P717, DOI 10.2214/ajr.134.4.717; WEINTRAUB CM, 1960, BRIT J SURG, V48, P62, DOI 10.1002/bjs.18004820711; YEAKLEY JW, 1986, RADIOLOGY, V158, P699, DOI 10.1148/radiology.158.3.3945742; ZUCCARELLO M, 1983, ACTA NEUROCHIR, V67, P103, DOI 10.1007/BF01401670; [No title captured]	31	19	20	1	1	RADIOLOGICAL SOC NORTH AMER	EASTON	20TH AND NORTHAMPTON STS, EASTON, PA 18042	0033-8419			RADIOLOGY	Radiology	JUN	1991	179	3					813	818		10.1148/radiology.179.3.2027997			6	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	FM910	WOS:A1991FM91000045	2027997				2022-02-06	
J	GIUNTA, G; PIAZZA, I				GIUNTA, G; PIAZZA, I			RECURRENT BACTERIAL-MENINGITIS OCCURRING 5 YEARS AFTER CLOSED HEAD-INJURY AND CAUSED BY AN INTRANASAL POSTTRAUMATIC MENINGO-ENCEPHALOCELE	POSTGRADUATE MEDICAL JOURNAL			English	Article							NASAL	A case of atypical presentation of a post-traumatic intranasal meningo-encephalocele is described in a patient with a history of recurrent bacterial meningitis occurring 5 years after closed head injury. The usefulness of the CT and MRI findings in diagnostic evaluation of this lesion is emphasized.	HOSP SAN DONA PIAVE,DEPT INTERNAL MED,VENICE,ITALY		GIUNTA, G (corresponding author), OSPED CIVILE,DIV MED 2,NAZARIO SAURO 25,30027 S DONA PIAVE,VENICE,ITALY.						BLUMENFELD R, 1965, ARCHIV OTOLARYNGOL, V82, P527; FRAZEE RC, 1988, POSTGRAD MED, V83, P267, DOI 10.1080/00325481.1988.11700238; Frazee RC, 1988, POSTGRAD MED, V83, P273; HEMMY DC, 1985, NEUROSSCIENCES, V12, P182; JONES RE, 1962, JAMA-J AM MED ASSOC, V181, P640, DOI 10.1001/jama.1962.03050330070019c; LOVE GL, 1983, ARCH OTOLARYNGOL, V109, P420; LUSK RP, 1986, OTOLARYNG HEAD NECK, V95, P303, DOI 10.1177/01945998860953P107; ROVIT RL, 1969, J NEUROSURG, V30, P406, DOI 10.3171/jns.1969.30.4.0406; SPETZLER RF, 1982, NEUROLOGICAL SURG, V4, P2209; VONESSEN C, 1981, ACTA NEUROCHIR, V59, P143, DOI 10.1007/BF01411199; Wilkins R. H., 1985, NEUROSURGERY, V14, P277	11	19	20	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0032-5473			POSTGRAD MED J	Postgrad. Med. J.	APR	1991	67	786					377	379		10.1136/pgmj.67.786.377			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FG645	WOS:A1991FG64500014	2068033	Green Published, Bronze			2022-02-06	
J	JACKSON, RD; MYSIW, WJ				JACKSON, RD; MYSIW, WJ			ABNORMAL CORTISOL DYNAMICS AFTER TRAUMATIC BRAIN INJURY - LACK OF UTILITY IN PREDICTING AGITATION OR THERAPEUTIC RESPONSE TO TRICYCLIC ANTIDEPRESSANTS	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article									OHIO STATE UNIV,DEPT MED,COLUMBUS,OH 43210; OHIO STATE UNIV,DEPT PHYS MED,COLUMBUS,OH 43210				Mysiw, Walter/E-3724-2011		NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [RR 0034] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR000034] Funding Source: NIH RePORTER		ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS, V2; BOOTH BJ, 1980, REHABILITATION HEAD; CARROLL BJ, 1986, J CLIN PSYCHIAT, V47, P10; CARROLL BJ, 1982, PHARMACOPSYCHIATRIA, V15, P19, DOI 10.1055/s-2007-1019504; COCCARO EF, 1984, J CLIN PSYCHIAT, V45, P382; CORRIGAN JD, IN PRESS ARCH PHYS M; COYLE JT, 1986, DIS NERV SYST, P880; DAVIS JM, 1985, COMPREHENSIVE TXB PS, V4, P1513; GWIRTSMAN H, 1982, J CLIN PSYCHIAT, V43, P321; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; JENNETT B, 1981, MANAGEMENT HEAD INJU, P23; KING LR, 1970, ANN SURG, V172, P975, DOI 10.1097/00000658-197012000-00008; KLEIN HE, 1984, BRIT J PSYCHIAT, V145, P591, DOI 10.1192/bjp.145.6.591; KLEIN HE, 1984, ACTA PSYCHIAT SCAND, V70, P239, DOI 10.1111/j.1600-0447.1984.tb01204.x; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Liddle GW, 1981, TXB ENDOCRINOLOGY, P249; LYNCH WJ, 1982, COGNITIVE REHABILITA, P63; MALKMUS D, 1980, REBHABILITATION HEAD; MANDEL P, 1979, PSYCHOPHARMACOLOGY A, P95; MASON JW, 1965, ARCH GEN PSYCHIAT, V13, P1; Mysiw W.J., 1987, J HEAD TRAUMA REHAB, V2, P34, DOI [10.1097/00001199-198712000-00007, DOI 10.1097/00001199-198712000-00007]; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; NELSON WH, 1982, ARCH GEN PSYCHIAT, V39, P1033; SCHILDKRAUT JJ, 1985, COMPREHENSIVE TX PSY, V4, P769; TREXLER L, 1982, COGNITIVE REHABILITA, P173; VANWOERKOM TCA, 1974, LANCET, P812; ZUNG WWK, 1984, J CLIN PSYCHIAT, V45, P437; 1982, WORKING BRAIN INJURE	28	19	19	0	0	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	0894-9115			AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	FEB	1989	68	1					18	23		10.1097/00002060-198902000-00006			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	T5779	WOS:A1989T577900006	2644950				2022-02-06	
J	BRAUN, CMJ; DAIGNEAULT, S; CHAMPAGNE, D				BRAUN, CMJ; DAIGNEAULT, S; CHAMPAGNE, D			INFORMATION-PROCESSING DEFICITS AS INDEXED BY REACTION-TIME PARAMETERS IN SEVERE CLOSED HEAD-INJURY	INTERNATIONAL JOURNAL OF CLINICAL NEUROPSYCHOLOGY			English	Article											BRAUN, CMJ (corresponding author), UNIV QUEBEC, DEPT PSYCHOL, CP 8888, SUCC A, MONTREAL H3C 3P8, QUEBEC, CANADA.						ALEXANDER MP, 1982, PSYCHIATRIC ASPECTS; BENTON AL, 1957, J ABNORM SOC PSYCH, V54, P109, DOI 10.1037/h0047176; BENTON AL, 1962, J NERV MENT DIS, V135, P415; BLACKBURN H L, 1955, Confin Neurol, V15, P327; BOHANNON WE, 1983, PSYCHIAT RES, V9, P17, DOI 10.1016/0165-1781(83)90084-7; BRACY OL, 1984, USING COMPUTERS CLIN, P257; BRACY OL, 1986, COGNITIVE REHABILITA, V4, P10; BRACY OL, 1983, COGNITIVE REHABILITA, V1, P7; BRAUN C, 1987, COGNITIVE REHABILITA, V5, P44; BRAUN C, 1987, P CLIN APHASIOLOGY C; BRAUN C, 1985, REV MODIFICATION COM, V15, P176; BRAUN CMJ, 1987, J CLIN EXP NEUROPSYC, V9, P48; BRAUN CMJ, 1988, J NEUROLOGICAL REHAB, V2, P109; BROOKS N, 1984, CLOSED HEAD INJURY P; BROUWER WH, 1984, COMMUNICATION; BROUWER WH, 1984, 13TH P ANN INS M SAN; BRUHN P, 1977, CORTEX, V13, P373, DOI 10.1016/S0010-9452(77)80018-X; Bruhn P, 1971, Cortex, V7, P278; CROMPTON M R, 1970, Brain Behavior and Evolution, V93, P785, DOI 10.1093/brain/93.4.785; DEE HL, 1971, ACTA PSYCHIAT SCAND, V47, P315, DOI 10.1111/j.1600-0447.1971.tb02217.x; DENCKER SJ, 1958, ACTA PSYCHIATRICA NE, V33, P120; Dirken, 1972, FUNCTIONAL AGE IND W; EWING R, 1980, Journal of Clinical Neuropsychology, V2, P147, DOI 10.1080/01688638008403789; FERRIS S, 1976, J AM GERIATR SOC, V24, P529, DOI 10.1111/j.1532-5415.1976.tb03277.x; GOLDSTEIN K, 1942, EFFECTS BRAIN DAMAGE; Green D.M., 1966, SOCIETY; GRONWALL D, 1974, LANCET, V2, P605; Gronwall D, 1974, PSYCHOL EFFECTS CONC; HANNAY H J, 1982, Journal of Clinical Neuropsychology, V4, P117; KLENSCH H, 1983, FORT NEUROL PSYCHIAT, V41, P575; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LITTLE MM, 1985, EVIDENCE SPECIFIC AT; MACFLYNN G, 1984, J NEUROL NEUROSUR PS, V47, P1326, DOI 10.1136/jnnp.47.12.1326; MILLER E, 1981, BRIT J CLIN PSYCHOL, V20, P69, DOI 10.1111/j.2044-8260.1981.tb00498.x; Miller E, 1970, Cortex, V6, P121; NORMAN B, 1961, ACTA PSYCHIAT SCAND, V37, P236; PIROZZOLO FJ, 1981, NEUROBIOL AGING, V2, P113, DOI 10.1016/0197-4580(81)90008-7; Posner, 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1987, NEUROPSYCHOLOGIA, V25, P135, DOI 10.1016/0028-3932(87)90049-2; Ruesch J, 1944, AM J PSYCHIAT, V100, P480, DOI 10.1176/ajp.100.4.480; Ruesch J, 1944, J NEUROSURG, V1, P243, DOI 10.3171/jns.1944.1.4.0243; SAVINO PJ, 1980, NEUROLOGY, V30, P963, DOI 10.1212/WNL.30.9.963; THOMAS C, 1977, THESIS OXFORD U; TOGLIA JU, 1979, LATE EFFECTS HEAD IN, P72; VANZOMEREN AH, 1976, CLIN NEUROL NEUROSUR, V79, P81, DOI 10.1016/0303-8467(76)90001-9; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1978, REACTION TIME ATTENT; VANZOMEREN AH, 1984, CLOSED HEAD INJURY P, P83	49	19	19	0	1	MELNIC PRESS INC	MADISON	PO BOX 6216, MADISON, WI 53716 USA	0197-3681			INT J CLIN NEUROPSYC			1989	11	4					167	176					10	Psychology, Clinical; Neurosciences	Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	CC367	WOS:A1989CC36700003					2022-02-06	
J	SAUNDERS, CE; COTA, R; BARTON, CA				SAUNDERS, CE; COTA, R; BARTON, CA			RELIABILITY OF HOME OBSERVATION FOR VICTIMS OF MILD CLOSED-HEAD INJURY	ANNALS OF EMERGENCY MEDICINE			English	Article											SAUNDERS, CE (corresponding author), VANDERBILT UNIV,MED CTR,SCH MED,DEPT SURG,NASHVILLE,TN 37232, USA.							0	19	20	0	0	MOSBY-YEAR BOOK INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318	0196-0644			ANN EMERG MED	Ann. Emerg. Med.	FEB	1986	15	2					160	163		10.1016/S0196-0644(86)80012-9			4	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AYW03	WOS:A1986AYW0300010	3946858				2022-02-06	
J	MCLEAN, JM; WRIGHT, RM; HENDERSON, JP; LISTER, JR				MCLEAN, JM; WRIGHT, RM; HENDERSON, JP; LISTER, JR			VERTEBRAL ARTERY RUPTURE ASSOCIATED WITH CLOSED HEAD-INJURY - REPORT OF 2 CASES	JOURNAL OF NEUROSURGERY			English	Article									ST FRANCIS MED CTR, DEPT RADIOL, PEORIA, IL USA		MCLEAN, JM (corresponding author), UNIV ILLINOIS, COLL MED, DEPT NEUROSCI, 530 NE GLEN OAK AVE, PEORIA, IL 61656 USA.						BLADIN P F, 1975, Proceedings of the Australian Association of Neurologists, V12, P35; CARPENTER S, 1961, J NEUROSURG, V18, P849, DOI 10.3171/jns.1961.18.6.0849; CONTOSTAVLOS D L, 1971, Journal of Forensic Sciences, V16, P40; DAVIDSON KC, 1975, RADIOLOGY, V115, P651, DOI 10.1148/15.3.651; DAVIS JM, 1983, NEURORADIOLOGY, V25, P55, DOI 10.1007/BF00333294; DEKLEYN A, 1933, DTSCH Z NERVENHEILKD, V132, P157; FIELDING JW, 1957, J BONE JOINT SURG AM, V39, P1280, DOI 10.2106/00004623-195739060-00005; FORD R, 1956, J FORENSIC SCI, V1, P117; FREYTAG E, 1963, ARCH PATHOL, V75, P402; GERLACH L, 1984, BEITR MORPHOL, V1, P104; GURDJIAN ES, 1963, J NEUROSURG, V20, P418, DOI 10.3171/jns.1963.20.5.0418; HARBITZ F, 1933, NORSK MAG LAEGEVID, V94, P241; HENKE W, 1863, HDB ANATOMIE MECHANI; Hinz P, 1968, Arch Orthop Unfallchir, V64, P268, DOI 10.1007/BF02171264; HOLZER J, 1955, DTSCH Z GERICHTL MED, V44, P422; KRAULAND W, 1949, Schweiz Z Pathol Bakteriol, V12, P113; MANT AK, 1972, J FORENSIC SCI SOC, V12, P567; MUNCK W, 1926, HOSPITAL STIDENDE, V69, P149; NEWBARR FD, 1958, J FORENSIC SCI, V3, P174; PAUL GA, 1980, J NEUROSURG, V53, P101, DOI 10.3171/jns.1980.53.1.0101; Schmidt H, 1942, BEITR PATHOL ANAT AL, V107, P256; SCHMITT HP, 1976, SCHWEIZ ARCH NEUROL, V119, P363; Schneider R C, 1972, Clin Neurosurg, V19, P312; SELECKI BR, 1969, MED J AUSTRALIA, V1, P1012, DOI 10.5694/j.1326-5377.1969.tb49865.x; Simonsen J, 1967, J Forensic Med, V14, P146; SIX EG, 1981, J NEUROSURG, V54, P814, DOI 10.3171/jns.1981.54.6.0814; TATLOW WFT, 1957, NEUROLOGY, V7, P331, DOI 10.1212/WNL.7.5.331; THORNSTEDT H, 1960, Dtsch Z Gesamte Gerichtl Med, V50, P254, DOI 10.1007/BF00586083; TOOLE JF, 1960, ARCH NEUROL-CHICAGO, V2, P616, DOI 10.1001/archneur.1960.03840120022003; WERNE SVEN, 1957, ACTA ORTHOPAED SCAND SUPPL, V23, P1; WHITE AA, 1978, CLIN BIOMECHANICS SP, pCH2; YATES PO, 1959, ARCH DIS CHILD, V34, P436, DOI 10.1136/adc.34.177.436; [No title captured]; [No title captured]; [No title captured]; [No title captured]	36	19	19	0	0	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.		1985	62	1					135	138		10.3171/jns.1985.62.1.0135			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	TX749	WOS:A1985TX74900021	3964845				2022-02-06	
J	RICHARDSON, JTE; SNAPE, W				RICHARDSON, JTE; SNAPE, W			THE EFFECTS OF CLOSED HEAD-INJURY UPON HUMAN-MEMORY - AN EXPERIMENTAL-ANALYSIS	COGNITIVE NEUROPSYCHOLOGY			English	Article											RICHARDSON, JTE (corresponding author), BRUNEL UNIV, DEPT PSYCHOL, UXBRIDGE UB8 3PH, MIDDX, ENGLAND.			Richardson, John/0000-0002-6267-0603			Anderson J.R., 1973, HUMAN ASS MEMORY; BROOKS D N, 1975, Cortex, V11, P329; BROOKS DN, 1976, J NEUROL NEUROSUR PS, V39, P593, DOI 10.1136/jnnp.39.6.593; BROOKS DN, 1974, J NEUROL NEUROSUR PS, V37, P794, DOI 10.1136/jnnp.37.7.794; BROOKS DN, 1972, J NERV MENT DIS, V155, P350; BROOKS DN, 1974, CORTEX, V11, P224; CLARK HH, 1973, J VERB LEARN VERB BE, V12, P335, DOI 10.1016/S0022-5371(73)80014-3; CONKEY RC, 1938, ARCH PSYCHOL, V33; DUNN J, 1974, RES NEUROLOGY NEUROS, V2, P1497; Eyseck MW, 1979, J RES PERS, V13, P365; Eysenck M. W., 1982, ATTENTION AROUSAL CO; GALBRAITH RC, 1973, MEM COGNITION, V1, P56, DOI 10.3758/BF03198068; Goldstein K., 1948, LANGUAGE LANGUAGE DI; JAMIESON KG, 1971, HEAD INJURIES; JONES DM, 1979, APPLIED PROBLEMS MEM; Kuera H., 1967, COMPUTATIONAL ANAL P; LEVIN HS, 1976, CORTEX, V12, P175, DOI 10.1016/S0010-9452(76)80021-4; LEVIN HS, 1976, DIS NERV SYST, V37, P68; Levin HS., 1982, NEUROBEHAVIORAL CONS; MANDLEBERG IA, 1975, J NEUROL NEUROSUR PS, V38, P1121, DOI 10.1136/jnnp.38.11.1121; MORRIS LW, 1977, STRESS ANXIETY, V4; MUELLER JH, 1979, PERS SOC PSYCHOL B, V5, P288, DOI 10.1177/014616727900500303; OMMAYA AK, 1976, HEAD INJURIES; PAIVIO A, 1968, J EXPT PSYCHOL MON 2, V76; PARKER SA, 1976, ACTA NEUROCHIR, V34, P71, DOI 10.1007/BF01405864; Richardson J. T., 1980, J MENTAL IMAGERY, V4; Richardson J. T. E., 1980, MENTAL IMAGERY HUMAN; RICHARDSON JT, 1974, J VERB LEARN VERB BE, V13, P709, DOI 10.1016/S0022-5371(74)80057-5; RICHARDSON JTE, 1979, BRIT J SOC CLIN PSYC, V18, P319, DOI 10.1111/j.2044-8260.1979.tb00342.x; RICHARDSON JTE, 1975, BRIT J MATH STAT PSY, V28, P235; RICHARDSON JTE, 1984, UNPUB EFFECTS MINOR; ROGERS JL, 1972, J EXP PSYCHOL, V92, P373, DOI 10.1037/h0032273; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Spielberger C.D., 1972, ANXIETY CURRENT TREN, VI; THOMSEN IV, 1977, SCAND J REHABIL MED, V9, P73; Thorndike E. L., 1944, TEACHERS WORD BOOK 3; [No title captured]	38	19	19	0	0	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0264-3294			COGN NEUROPSYCHOL	Cogn. Neuropsychol.		1984	1	3					217	231		10.1080/02643298408252023			15	Psychology; Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	TM318	WOS:A1984TM31800001					2022-02-06	
J	WEST, M; LABELLA, FS; HAVLICEK, V; PARKINSON, D				WEST, M; LABELLA, FS; HAVLICEK, V; PARKINSON, D			CEREBRAL CONCUSSION IN RATS RAPIDLY INDUCES HYPOTHALAMIC-SPECIFIC EFFECTS ON OPIATE AND CHOLINERGIC RECEPTORS	BRAIN RESEARCH			English	Article									UNIV MANITOBA,FAC MED,DEPT PHARMACOL & THERAPEUT,WINNIPEG R3E 0W3,MANITOBA,CANADA; UNIV MANITOBA,FAC MED,DEPT NEUROL SURG,WINNIPEG R3E 0W3,MANITOBA,CANADA		WEST, M (corresponding author), UNIV MANITOBA,FAC MED,DEPT PHYSIOL,WINNIPEG R3E 0W3,MANITOBA,CANADA.						[Anonymous], 1966, CLIN NEUROSURG, V12, P386; BAKAY L, 1977, J NEUROSURG, V47, P525, DOI 10.3171/jns.1977.47.4.0525; CHASON JL, 1966, J TRAUM, V6, P767, DOI 10.1097/00005373-196611000-00008; CHOW E, 1979, BRIT J PHARMACOL, V67, P345, DOI 10.1111/j.1476-5381.1979.tb08686.x; CREESE I, 1977, EUR J PHARMACOL, V46, P377, DOI 10.1016/0014-2999(77)90232-1; DENNYBROWN D, 1961, ARCH NEUROL-CHICAGO, V5, P1; FRENCH JD, 1952, AMA ARCH NEUROL PSY, V68, P591, DOI 10.1001/archneurpsyc.1952.02320230017002; GLOWINSKI J, 1966, J NEUROCHEM, V13, P655, DOI 10.1111/j.1471-4159.1966.tb09873.x; GROAT RA, 1950, NEUROPATH EXP NEUROL, V9, P150; Gurdjian ES, 1966, CLIN NEUROSURG, V12, P112; JOSEPH PD, 1971, BRAIN RES, V26, P15; MARTIN JB, 1977, CLIN NEUROENDOCRINOL, P247; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; PARKINSON D, 1978, NEUROSURGERY, V3, P176, DOI 10.1227/00006123-197809000-00008; PARKINSON D, 1976, MAYO CLIN P, V52, P492; PERT CB, 1973, SCIENCE, V179, P1011, DOI 10.1126/science.179.4077.1011; POVLISHOCK JT, 1979, ACTA NEUROPATHOL, V47, P1, DOI 10.1007/BF00698266; POVLISHOCK JT, 1978, BRAIN RES, V153, P223, DOI 10.1016/0006-8993(78)90404-3; Ranson SW, 1939, ARCH NEURO PSYCHIATR, V41, P1; RIPPERGER EA, 1975, HDB CLIN NEUROLOGY, V23, P91; SELLIER K, 1966, 3RD P INT C NEUR SUR, P87; SHAH KR, 1981, CANAD FED BIOL SOC M; Shetter A G, 1979, Adv Neurol, V22, P5; STALHAMMAR D, 1975, ACTA NEUROL SCAND, V52, P27; THOMAS LM, 1967, J NEUROSURG, V26, P316, DOI 10.3171/jns.1967.26.3.0316; TOWER DB, 1966, HEAD INJURY, P448; WINDLE WF, 1945, ANAT REC, V93, P201, DOI 10.1002/ar.1090930210; YAMAMURA HI, 1974, P NATL ACAD SCI USA, V71, P1725, DOI 10.1073/pnas.71.5.1725	29	19	19	0	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.		1981	225	2					271	277		10.1016/0006-8993(81)90835-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MR196	WOS:A1981MR19600004	6272930				2022-02-06	
J	LYNCH, S; YARNELL, PR				LYNCH, S; YARNELL, PR			RETROGRADE-AMNESIA - DELAYED FORGETTING AFTER CONCUSSION	AMERICAN JOURNAL OF PSYCHOLOGY			English	Article									UNIV CALIF,DAVIS,CA 95616; UNIV COLORADO,BOULDER,CO 80304								MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351	1	19	19	1	2	UNIV ILLINOIS PRESS	CHAMPAIGN	1325 S OAK ST, CHAMPAIGN, IL 61820	0002-9556			AM J PSYCHOL	Am. J. Psychol.		1973	86	3					643	645		10.2307/1421950			3	Psychology, Multidisciplinary	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Psychology	S1630	WOS:A1973S163000016	4780127				2022-02-06	
J	Symonds, CP				Symonds, CP			Disturbance of cerebral function in concussion	LANCET			English	Article																	Russell W Ritchie, 1934, Edinb Med J, V41, P129; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Symonds CP, 1932, LANCET, V1, P820; Trotter W, 1925, LANCET, V2, P953; TROTTER W, 1923, SYSTEM SURG, V3, P464	5	19	19	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet		1935	1						486	488					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V9599	WOS:000188727600178					2022-02-06	
J	Fouad, K; Popovich, PG; Kopp, MA; Schwab, JM				Fouad, Karim; Popovich, Phillip G.; Kopp, Marcel A.; Schwab, Jan M.			The neuroanatomical-functional paradox in spinal cord injury	NATURE REVIEWS NEUROLOGY			English	Article							OF-THE-ART; MULTIPLE-SCLEROSIS; NEUROLOGIC RECOVERY; CORTICOSPINAL TRACT; LOCOMOTOR RECOVERY; ENDOGENOUS REPAIR; PYRAMIDAL TRACT; MOTOR; PLASTICITY; LESIONS	In this Perspective, the authors discuss the mechanisms underlying the complex relationship between lesion size and functional recovery after spinal cord injury, highlighting various complications that can limit the accuracy of outcome prediction in patients and in animal models. Although lesion size is widely considered to be the most reliable predictor of outcome after CNS injury, lesions of comparable size can produce vastly different magnitudes of functional impairment and subsequent recovery. This neuroanatomical-functional paradox is likely to contribute to the many failed attempts to independently replicate findings from animal models of neurotrauma. In humans, the analogous clinical-radiological paradox could explain why individuals with similar injuries can respond differently to rehabilitation. We describe the neuroanatomical-functional paradox in the context of traumatic spinal cord injury (SCI) and discuss the underlying mechanisms of the paradox, including the concepts of lesion-affected and recovery-related networks. We also consider the various secondary complications that further limit the accuracy of outcome prediction in SCI and provide suggestions for how to increase the predictive, translational value of preclinical SCI models.	[Fouad, Karim] Univ Alberta, Fac Rehabil Med, Dept Phys Therapy, Edmonton, AB, Canada; [Fouad, Karim] Univ Alberta, Inst Neurosci & Mental Hlth, Edmonton, AB, Canada; [Popovich, Phillip G.; Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA; [Popovich, Phillip G.; Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Popovich, Phillip G.; Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA; [Popovich, Phillip G.; Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Neurol Inst, Columbus, OH 43210 USA; [Kopp, Marcel A.; Schwab, Jan M.] Charite Univ Med Berlin, Dept Neurol Expt Neurol, Clin & Expt Spinal Cord Injury Res, Berlin, Germany; [Kopp, Marcel A.; Schwab, Jan M.] Free Univ Berlin, Berlin, Germany; [Kopp, Marcel A.; Schwab, Jan M.] Humboldt Univ, Berlin, Germany; [Kopp, Marcel A.] Berlin Inst Hlth, QUEST Ctr Transforming Biomed Res, Berlin, Germany; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Dept Neurol, Spinal Cord Injury Med Neuroplegiol, Columbus, OH 43210 USA; [Schwab, Jan M.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Schwab, JM (corresponding author), Ohio State Univ, Wexner Med Ctr, Belford Ctr Spinal Cord Injury, Columbus, OH 43210 USA.; Schwab, JM (corresponding author), Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA.; Schwab, JM (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.; Schwab, JM (corresponding author), Ohio State Univ, Wexner Med Ctr, Neurol Inst, Columbus, OH 43210 USA.; Schwab, JM (corresponding author), Charite Univ Med Berlin, Dept Neurol Expt Neurol, Clin & Expt Spinal Cord Injury Res, Berlin, Germany.; Schwab, JM (corresponding author), Free Univ Berlin, Berlin, Germany.; Schwab, JM (corresponding author), Humboldt Univ, Berlin, Germany.; Schwab, JM (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurol, Spinal Cord Injury Med Neuroplegiol, Columbus, OH 43210 USA.; Schwab, JM (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA.	jan.schwab@osumc.edu	Kopp, Marcel/AAX-3960-2020; Popovich, Phillip/C-9187-2009	Kopp, Marcel/0000-0001-6832-9599; Schwab, Jan/0000-0001-6784-4919; Popovich, Phillip/0000-0003-1329-7395	Canadian Health Research Council (CIHR)Canadian Institutes of Health Research (CIHR); Wings for Life Spinal Cord Research Foundation; Craig H. Neilsen Foundation [596764]; Canadian Research Chair ProgramCanada Research Chairs; National Institutes of Neurological Disorders-NIH [R01 NS083942, R01 NS099532, R35 NS111582]; Ray W. Poppleton Endowment; National Institute of Disability, Independent Living and Rehabilitation Research (NIDILRR) [90SI5020]; National Institutes of Neurological Disorders - NIH [R01 NS118200]; European Union (EU Era Net - Neuron Program, SILENCE) [01EW170A]; William E. Hunt and Charlotte M. Curtis Endowment	The work of K.F. is supported by grants from the Canadian Health Research Council (CIHR), the Wings for Life Spinal Cord Research Foundation, the Craig H. Neilsen Foundation, the Canadian Research Chair Program. The work of P.G.P. is supported by the National Institutes of Neurological Disorders-NIH (Grants R01 NS083942, R01 NS099532 and R35 NS111582) and the Ray W. Poppleton Endowment. The work of J.M.S. is supported by the National Institute of Disability, Independent Living and Rehabilitation Research (NIDILRR Grant 90SI5020), the National Institutes of Neurological Disorders - NIH (Grant R01 NS118200), the European Union (EU Era Net - Neuron Program, SILENCE Grant 01EW170A), the Craig H. Neilsen Foundation (Grant 596764), the Wings for Life Spinal Cord Research Foundation and the William E. Hunt and Charlotte M. Curtis Endowment. J.M.S. is a Discovery Theme Initiative Scholar (Chronic Brain Injury) of Ohio State University.	Aboul-Enein F, 2006, ACTA NEUROPATHOL, V111, P539, DOI 10.1007/s00401-006-0047-y; Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Baldassarre A, 2016, BRAIN, V139, P2024, DOI 10.1093/brain/aww107; Ballermann M, 2006, EUR J NEUROSCI, V23, P1988, DOI 10.1111/j.1460-9568.2006.04726.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Barkhof F, 1999, MULT SCLER J, V5, P283, DOI 10.1177/135245859900500415; Barkhof F, 2002, CURR OPIN NEUROL, V15, P239, DOI 10.1097/00019052-200206000-00003; Bartus K, 2016, BRAIN, V139, P1394, DOI 10.1093/brain/aww039; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beauparlant J, 2013, BRAIN, V136, P3347, DOI 10.1093/brain/awt204; Begley CG, 2015, CIRC RES, V116, P116, DOI 10.1161/CIRCRESAHA.114.303819; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Bradbury EJ, 2006, NAT REV NEUROSCI, V7, P644, DOI 10.1038/nrn1964; Brustein E, 1998, J NEUROPHYSIOL, V80, P1245, DOI 10.1152/jn.1998.80.3.1245; Callahan A, 2017, EXP NEUROL, V295, P135, DOI 10.1016/j.expneurol.2017.05.012; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; Caudle KL, 2011, NEUROREHAB NEURAL RE, V25, P729, DOI 10.1177/1545968311407519; Chen HSM, 2017, NEUROIMAGE, V153, P122, DOI 10.1016/j.neuroimage.2017.03.065; Chen Q, 2008, EXP NEUROL, V209, P497, DOI 10.1016/j.expneurol.2007.11.025; Church JS, 2016, J NEUROSCI, V36, P6352, DOI 10.1523/JNEUROSCI.0353-16.2016; Conta AC, 2004, J COMP NEUROL, V479, P347, DOI 10.1002/cne.20319; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Curt A, 2012, SPINAL CORD, V50, P352, DOI 10.1038/sc.2011.113; Curt A, 2008, J NEUROTRAUM, V25, P677, DOI 10.1089/neu.2007.0468; Diamond B, 2009, NAT REV IMMUNOL, V9, P449, DOI 10.1038/nri2529; Dietz V, 2010, NAT REV NEUROL, V6, P167, DOI 10.1038/nrneurol.2009.227; DITUNNO JF, 1994, NEW ENGL J MED, V330, P550, DOI 10.1056/NEJM199402243300808; Doyle KP, 2015, J NEUROSCI, V35, P2133, DOI 10.1523/JNEUROSCI.4098-14.2015; Dreizin D, 2015, AM J ROENTGENOL, V205, P853, DOI 10.2214/AJR.14.13374; Duncan GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05473-1; Ehsanian R, 2020, SPINAL CORD, V58, P377, DOI 10.1038/s41393-019-0370-5; ELMASRY WS, 1993, PARAPLEGIA, V31, P273; Failli V, 2012, BRAIN, V135, P3238, DOI 10.1093/brain/aws267; Farhadi HF, 2018, J NEUROTRAUM, V35, P1398, DOI 10.1089/neu.2017.5510; Fawcett JW, 2007, SPINAL CORD, V45, P190, DOI 10.1038/sj.sc.3102007; Filli L, 2015, NEURAL REGEN RES, V10, P509, DOI 10.4103/1673-5374.155425; Filli L, 2014, J NEUROSCI, V34, P13399, DOI 10.1523/JNEUROSCI.0701-14.2014; Filli L, 2012, ANN NEUROL, V72, P491, DOI 10.1002/ana.23630; Fouad K, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113410; Fouad K, 2001, CURR BIOL, V11, P1766, DOI 10.1016/S0960-9822(01)00535-8; Fouad K, 2020, J NEUROTRAUM, V37, P831, DOI 10.1089/neu.2019.6674; Fouad K, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00085; Freria CM, 2017, J NEUROSCI, V37, P3568, DOI 10.1523/JNEUROSCI.2841-16.2017; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Gallagher MJ, 2019, J NEUROTRAUM, V36, P919, DOI 10.1089/neu.2018.5961; Gallagher MJ, 2018, CRIT CARE MED, V46, P1150, DOI 10.1097/CCM.0000000000003134; Ghasemlou N, 2005, EXP NEUROL, V196, P9, DOI 10.1016/j.expneurol.2005.05.017; Goldstein B, 1998, ARCH PHYS MED REHAB, V79, P107, DOI 10.1016/S0003-9993(98)90217-9; Hansen CN, 2013, J NEUROSCI, V33, P13101, DOI 10.1523/JNEUROSCI.1576-13.2013; Hotamisligil GS, 2017, IMMUNITY, V47, P406, DOI 10.1016/j.immuni.2017.08.009; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Huber E, 2018, NEUROLOGY, V90, pE1510, DOI 10.1212/WNL.0000000000005361; Hurd C, 2013, EXP NEUROL, V247, P605, DOI 10.1016/j.expneurol.2013.02.013; Inoue K, 2014, NEUROIMAGE-CLIN, V6, P388, DOI 10.1016/j.nicl.2014.10.002; Jaja BNR, 2019, J NEUROTRAUM, V36, P3044, DOI 10.1089/neu.2018.6245; James ND, 2011, J NEUROSCI, V31, P18543, DOI 10.1523/JNEUROSCI.4306-11.2011; Jayaprakash N, 2016, J NEUROSCI, V36, P5877, DOI 10.1523/JNEUROSCI.4203-15.2016; Kanagal SG, 2009, EXP NEUROL, V216, P193, DOI 10.1016/j.expneurol.2008.11.028; Kapur N, 2020, DISABIL REHABIL, V42, P1495, DOI 10.1080/09638288.2019.1572795; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kigerl KA, 2020, EXP NEUROL, V323, DOI 10.1016/j.expneurol.2019.113085; Kigerl KA, 2018, NEUROTHERAPEUTICS, V15, P60, DOI 10.1007/s13311-017-0583-2; Kigerl KA, 2016, J EXP MED, V213, P2603, DOI 10.1084/jem.20151345; Kirshblum S, 2004, ARCH PHYS MED REHAB, V85, P1811, DOI 10.1016/j.apmr.2004.03.015; Kirshblum S, 2011, ARCH PHYS MED REHAB, V92, P376, DOI 10.1016/j.apmr.2010.07.242; Kirshblum SC, 2016, ARCH PHYS MED REHAB, V97, P1647, DOI 10.1016/j.apmr.2016.02.012; Kobayakawa K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009430; Kopp MA, 2017, NEUROLOGY, V88, P892, DOI [10.1212/WNL.0000000000003652, 10.1212/wnl.0000000000003652]; Krajacic A, 2010, BEHAV BRAIN RES, V214, P323, DOI 10.1016/j.bbr.2010.05.053; Lam CJ, 2014, J NEUROTRAUM, V31, P1985, DOI 10.1089/neu.2014.3392; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Levine AJ, 2014, NAT NEUROSCI, V17, P586, DOI 10.1038/nn.3675; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Li YQ, 2017, NAT MED, V23, P733, DOI 10.1038/nm.4331; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu YY, 2018, NATURE, V561, P547, DOI 10.1038/s41586-018-0515-2; Loy DN, 2002, EXP NEUROL, V177, P575, DOI 10.1006/exnr.2002.7959; Loy DN, 2002, J NEUROSCI, V22, P315, DOI 10.1523/JNEUROSCI.22-01-00315.2002; Marik PE, 2013, CRIT CARE, V17, DOI 10.1186/cc12514; Marino RJ, 1999, ARCH PHYS MED REHAB, V80, P1391, DOI 10.1016/S0003-9993(99)90249-6; Martinez M, 2011, J NEUROPHYSIOL, V106, P1969, DOI 10.1152/jn.00368.2011; May Z, 2015, BEHAV BRAIN RES, V291, P26, DOI 10.1016/j.bbr.2015.04.058; Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Okuda DT, 2009, NEUROLOGY, V72, P800, DOI 10.1212/01.wnl.0000335764.14513.1a; Page SJ, 2013, ARCH PHYS MED REHAB, V94, P817, DOI 10.1016/j.apmr.2013.01.010; Pfyffer D, 2019, NEUROLOGY, V93, pE1550, DOI 10.1212/WNL.0000000000008318; Popovich PG, 2002, J NEUROPATH EXP NEUR, V61, P623, DOI 10.1093/jnen/61.7.623; Popovich PG, 2012, EXP NEUROL, V233, P615, DOI 10.1016/j.expneurol.2010.11.016; Pouratian N, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.11.FOCUS09239; Price CJ, 2017, NEUROIMAGE, V145, P200, DOI 10.1016/j.neuroimage.2016.08.006; Pukos N, 2019, GLIA, V67, P2178, DOI 10.1002/glia.23702; Raineteau O, 2001, NAT REV NEUROSCI, V2, P263, DOI 10.1038/35067570; Rorden C, 2004, NAT REV NEUROSCI, V5, P813, DOI 10.1038/nrn1521; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Santos-Benito FF, 2006, J NEUROTRAUM, V23, P521, DOI 10.1089/neu.2006.23.521; Schmidt EKA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226128; Schucht P, 2002, EXP NEUROL, V176, P143, DOI 10.1006/exnr.2002.7909; Schwab JM, 2014, EXP NEUROL, V258, P121, DOI 10.1016/j.expneurol.2014.04.023; Seitz RJ, 1999, STROKE, V30, P1844, DOI 10.1161/01.STR.30.9.1844; Shibata D, 2012, J NEUROIMMUNOL, V252, P106, DOI 10.1016/j.jneuroim.2012.08.006; Simard JM, 2012, EXP NEUROL, V233, P829, DOI 10.1016/j.expneurol.2011.11.048; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Steward O, 2012, EXP NEUROL, V233, P597, DOI 10.1016/j.expneurol.2011.06.017; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Talbott JF, 2015, J NEUROSURG-SPINE, V23, P495, DOI 10.3171/2015.1.SPINE141033; Tanadini LG, 2014, NEUROREHAB NEURAL RE, V28, P507, DOI 10.1177/1545968313520413; Torres-Espin A, 2018, BRAIN, V141, P1946, DOI 10.1093/brain/awy128; Vallotton K, 2019, NEUROLOGY, V92, pE2793, DOI 10.1212/WNL.0000000000007642; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; von Monakow C, 1914, LOKALISATION GEHIRN; Wang ZM, 2015, J NEUROSCI, V35, P3139, DOI 10.1523/JNEUROSCI.2832-14.2015; WATERS RL, 1991, PARAPLEGIA, V29, P573, DOI 10.1038/sc.1991.85; Watzlawick R, 2019, NEUROLOGY, V93, pE40, DOI 10.1212/WNL.0000000000007718; Wheeler-Kingshott CA, 2014, NEUROIMAGE, V84, P1082, DOI 10.1016/j.neuroimage.2013.07.014; Whishaw IQ, 1998, BEHAV BRAIN RES, V93, P167, DOI 10.1016/S0166-4328(97)00152-6; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; Wuerfel J, 2007, EUR J NEUROSCI, V26, P190, DOI 10.1111/j.1460-9568.2007.05644.x; Zdunczyk A, 2018, NEUROSURGERY, V83, P810, DOI 10.1093/neuros/nyx437; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	122	18	18	2	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1759-4758	1759-4766		NAT REV NEUROL	Nat. Rev. Neurol.	JAN	2021	17	1					53	62		10.1038/s41582-020-00436-x		DEC 2020	10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	PO5MY	WOS:000597771400001	33311711				2022-02-06	
J	Fusco, R; Gugliandolo, E; Siracusa, R; Scuto, M; Cordaro, M; D'Amico, R; Evangelista, M; Peli, A; Peritore, AF; Impellizzeri, D; Crupi, R; Cuzzocrea, S; Di Paola, R				Fusco, Roberta; Gugliandolo, Enrico; Siracusa, Rosalba; Scuto, Maria; Cordaro, Marika; D'Amico, Ramona; Evangelista, Maurizio; Peli, Angelo; Peritore, Alessio Filippo; Impellizzeri, Daniela; Crupi, Rosalia; Cuzzocrea, Salvatore; Di Paola, Rosanna			Formyl Peptide Receptor 1 Signaling in Acute Inflammation and Neural Differentiation Induced by Traumatic Brain Injury	BIOLOGY-BASEL			English	Article						traumatic brain injury; animal model; neurogenesis; inflammation	CONTROLLED CORTICAL IMPACT; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; LEUCYL-PHENYLALANINE; CHEMOTACTIC PEPTIDE; NLRP3 INFLAMMASOME; DENDRITIC CELLS; CEREBRAL-CORTEX; BINDING-SITES; MOUSE MODEL	Traumatic brain injury (TBI) is a shocking disease frequently followed by behavioral disabilities, including risk of cerebral atrophy and dementia. N-formylpeptide receptor 1 (FPR1) is expressed in cells and neurons in the central nervous system. It is involved in inflammatory processes and during the differentiation process in the neural stem cells. We investigate the effect of the absence of Fpr1 gene expression in mice subjected to TBI from the early stage of acute inflammation to neurogenesis and systematic behavioral testing four weeks after injury. C57BL/6 animals and Fpr1 KO mice were subjected to TBI and sacrificed 24 h or four weeks after injury. Twenty-four hours after injury, TBI Fpr1 KO mice showed reduced histological impairment, tissue damage and acute inflammation (MAPK activation, NF-kappa B signaling induction, NRLP3 inflammasome pathway activation and oxidative stress increase). Conversely, four weeks after TBI, the Fpr1 KO mice showed reduced survival of the proliferated cells in the Dentate Gyrus compared to the WT group. Behavioral analysis confirmed this trend. Moreover, TBI Fpr1 KO animals displayed reduced neural differentiation (evaluated by beta-III tubulin expression) and upregulation of astrocyte differentiation (evaluated by GFAP expression). Collectively, our study reports that, immediately after TBI, Fpr1 increased acute inflammation, while after four weeks, Fpr1 promoted neurogenesis.	[Fusco, Roberta; Gugliandolo, Enrico; Siracusa, Rosalba; Cordaro, Marika; D'Amico, Ramona; Peritore, Alessio Filippo; Impellizzeri, Daniela; Crupi, Rosalia; Cuzzocrea, Salvatore; Di Paola, Rosanna] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno Alcontres,31, I-98166 Messina, Italy; [Scuto, Maria] Univ Catania, Dept Biomed & Biotechnol Sci, Piazza Univ,2, I-95131 Catania, Italy; [Evangelista, Maurizio] Univ Cattolica Sacro Cuore, Inst Anaesthesiol & Reanimat, A Gemelli Hosp, I-00168 Rome, Italy; [Peli, Angelo] Univ Bologna, Alma Mater Studiorum, Dept Vet Med Sci, Via Zamboni 33, I-40126 Bologna, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA		Cuzzocrea, S; Di Paola, R (corresponding author), Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Viale Ferdinando Stagno Alcontres,31, I-98166 Messina, Italy.; Cuzzocrea, S (corresponding author), St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, 1402 South Grand Blvd, St Louis, MO 63104 USA.	rfusco@unime.it; egugliandolo@unime.it; rsiracusa@unime.it; mary-amir@hotmail.it; cordarom@unime.it; rdamico@unime.it; maurizio.evangelista@unicatt.it; angelo.peli@unibo.it; aperitore@unime.it; dimpellizzeri@unime.it; rcrupi@unime.it; salvator@unime.it; dipaolar@unime.it	Siracusa, Rosalba/AAC-3110-2022; PELI, ANGELO/AAX-8423-2021; Cordaro, Marika/K-7329-2016; evangelista, maurizio/G-6820-2012; FUSCO, Roberta/AAC-1745-2019; D'Amico, Ramona/AAC-9061-2019; di paola, rosanna/U-4356-2019	Siracusa, Rosalba/0000-0001-7868-2505; PELI, ANGELO/0000-0003-3488-2948; Cordaro, Marika/0000-0002-3980-0043; FUSCO, Roberta/0000-0003-0223-1403; Gugliandolo, Enrico/0000-0001-6840-3154; Cuzzocrea, Salvatore/0000-0001-6131-3690; Scuto, Maria/0000-0003-1019-5158; Crupi, Rosalia/0000-0002-7629-3132; Impellizzeri, Daniela/0000-0001-9492-3161; peritore, alessio filippo/0000-0001-8545-990X; D'Amico, Ramona/0000-0003-0389-3871; di paola, rosanna/0000-0001-6725-8581			Anton P, 1998, GUT, V42, P374, DOI 10.1136/gut.42.3.374; Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Becker EL, 1998, CELL TISSUE RES, V292, P129, DOI 10.1007/s004410051042; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Braun H, 2002, J NEUROTRAUM, V19, P975, DOI 10.1089/089771502320317122; Bye N, 2011, J NEUROSCI RES, V89, P986, DOI 10.1002/jnr.22635; Campolo M, 2018, METHODS MOL BIOL, V1727, P385, DOI 10.1007/978-1-4939-7571-6_30; Campolo M, 2013, J ENDOCRINOL, V217, P291, DOI 10.1530/JOE-13-0022; Cardini S, 2012, AM J RESP CELL MOL, V47, P332, DOI 10.1165/rcmb.2012-0036OC; Cattaneo F, 2010, NEUROCHEM RES, V35, P2018, DOI 10.1007/s11064-010-0301-5; Chen KQ, 2007, J IMMUNOL, V178, P1759, DOI 10.4049/jimmunol.178.3.1759; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Cordaro M, 2017, TOXICOL APPL PHARM, V329, P231, DOI 10.1016/j.taap.2017.06.005; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cowland JB, 1999, J LEUKOCYTE BIOL, V66, P989, DOI 10.1002/jlb.66.6.989; Cuadrado-Tejedor M, 2011, BRIT J PHARMACOL, V164, P2029, DOI 10.1111/j.1476-5381.2011.01517.x; Cui YH, 2002, NEUROBIOL DIS, V10, P366, DOI 10.1006/nbdi.2002.0517; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; D'amico R, 2019, PHYTOMEDICINE, V54, P27, DOI 10.1016/j.phymed.2018.09.191; Dahlgren C, 2016, BIOCHEM PHARMACOL, V114, P22, DOI 10.1016/j.bcp.2016.04.014; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Di Paola R, 2019, PHARMACOL RES, V141, P591, DOI 10.1016/j.phrs.2019.01.041; Di Paola R, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00382; Di Paola R, 2016, PHARMACOL RES, V111, P405, DOI 10.1016/j.phrs.2016.07.010; El Kebir D, 2008, J LEUKOCYTE BIOL, V84, P600, DOI 10.1189/jlb.1107765; Elliott EI, 2015, IMMUNOL REV, V265, P35, DOI 10.1111/imr.12286; Fusco R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194845; Fusco Roberta, 2018, Oncotarget, V9, P31355, DOI 10.18632/oncotarget.25823; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gao JL, 2011, BEHAV GENET, V41, P724, DOI 10.1007/s10519-011-9467-0; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; GEHRMANN J, 1995, BRAIN RES REV, V20, P269, DOI 10.1016/0165-0173(94)00015-H; Gemperle C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050195; Guevara AB, 2015, J HEAD TRAUMA REHAB, V30, pE26, DOI 10.1097/HTR.0000000000000046; Gugliandolo E, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00590; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Heo SC, 2014, STEM CELLS, V32, P779, DOI 10.1002/stem.1578; Hwang TL, 2010, BIOCHEM PHARMACOL, V80, P1190, DOI 10.1016/j.bcp.2010.06.028; Impellizzeri D, 2017, J NEUROTRAUM, V34, P2609, DOI 10.1089/neu.2016.4808; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; ISSEKUTZ AC, 1988, METHOD ENZYMOL, V162, P301; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Keitoku M, 1997, J MOL CELL CARDIOL, V29, P881, DOI 10.1006/jmcc.1996.0291; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim MK, 2007, FEBS LETT, V581, P1917, DOI 10.1016/j.febslet.2007.03.078; KOCHANEK PM, 1992, STROKE, V23, P1367, DOI 10.1161/01.STR.23.9.1367; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Loane D, 2014, NEUROTHERAPEUTICS, V11, P857, DOI 10.1007/s13311-014-0298-6; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Orihara Y, 2001, FORENSIC SCI INT, V123, P142, DOI 10.1016/S0379-0738(01)00537-0; Parrini M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17201-8; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Peritore AF, 2020, CNS NEUROL DISORD-DR, V19, P27, DOI 10.2174/1871527319666200107094732; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Pouliot M, 2002, J IMMUNOL, V169, P5279, DOI 10.4049/jimmunol.169.9.5279; Qian HH, 2017, MOL MED REP, V16, P3922, DOI 10.3892/mmr.2017.7079; Rothwell N, 2003, BRAIN BEHAV IMMUN, V17, P152, DOI 10.1016/S0889-1591(02)00098-3; SENGELOV H, 1994, BIOCHEM J, V299, P473, DOI 10.1042/bj2990473; Shin MK, 2011, J BIOL CHEM, V286, P17133, DOI 10.1074/jbc.M110.197772; Shojo H, 2017, CELL TRANSPLANT, V26, P1301, DOI 10.1177/0963689717715169; Siracusa R, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00233; Spurr L, 2011, INT IMMUNOPHARMACOL, V11, P55, DOI 10.1016/j.intimp.2010.10.006; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Viatour P, 2005, TRENDS BIOCHEM SCI, V30, P43, DOI 10.1016/j.tibs.2004.11.009; Viswanathan A, 2007, STEM CELLS, V25, P1263, DOI 10.1634/stemcells.2006-0522; Wang G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25946; Wang L, 2005, ANN CLIN LAB SCI, V35, P79; Wang XT, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0162-16.2016; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; XU J, 1990, J NEUROCHEM, V55, P907, DOI 10.1111/j.1471-4159.1990.tb04577.x; Yang D, 2002, J LEUKOCYTE BIOL, V72, P598; Yang D, 2001, J IMMUNOL, V166, P4092, DOI 10.4049/jimmunol.166.6.4092; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Yen TL, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041100; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00314-5; Zhao MF, 2016, MOL MED REP, V13, P13, DOI 10.3892/mmr.2015.4551	87	18	18	0	1	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2079-7737		BIOLOGY-BASEL	Biology-Basel	SEP	2020	9	9							238	10.3390/biology9090238			30	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	OH5OR	WOS:000582634900001	32825368	Green Submitted, Green Published, gold			2022-02-06	
J	Giromini, L; Viglione, DJ; Pignolo, C; Zennaro, A				Giromini, Luciano; Viglione, Donald J.; Pignolo, Claudia; Zennaro, Alessandro			An Inventory of Problems-29 Sensitivity Study Investigating Feigning of Four Different Symptom Presentations Via Malingering Experimental Paradigm	JOURNAL OF PERSONALITY ASSESSMENT			English	Article							DETECTING RANDOM; MMPI-2; VALIDITY; PATTERNS; SIMS	The Inventory of Problems-29 (IOP-29) is a newly developed, self-administered test designed to assist practitioners evaluating the credibility of various symptom presentations. In a recent simulation study comparing real patients against experimental feigners, its classification accuracy compared favorably with that of the Structured Inventory of Malingered Symptomatology and generalized better to different types of symptom reports (i.e., mood- or trauma-related vs. psychosis-related). Extending on these findings, this sensitivity study tested whether the IOP-29 would be similarly accurate in detecting feigning of conditions related to depression, mild traumatic brain injury, posttraumatic stress disorder (PTSD), and schizophrenia. Additionally, it also evaluated the susceptibility of the IOP-29 to uncooperative or random-like responding. Examination of 1,200 IOP-29 records from 400 nonclinical Italian volunteers who took the Italian version of the IOP-29 3 times, in 3 different conditions (i.e., standard instructions, feigned disorder, and random-like responding), confirmed that the IOP-29 might be similarly valid across a wide variety of mental health and cognitive complaints. Indeed, using the standard a priori cutoff of the IOP-29 (i.e., >= .50), sensitivity estimates ranged from .86 (for feigned PTSD) to .95 (for feigned depression) and did not significantly differ from one symptom presentation to another. These findings were obtained despite the fact that participants were coached to respond in a believable manner. Interestingly, the random-like responding generated extremely variable IOP-29 scores.	[Giromini, Luciano; Pignolo, Claudia; Zennaro, Alessandro] Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy; [Viglione, Donald J.] Alliant Int Univ, Calif Sch Profess Psychol, San Diego, CA USA		Giromini, L (corresponding author), Univ Turin, Dept Psychol, Via Po 14, I-10123 Turin, TO, Italy.	luciano.giromini@unito.it	Giromini, Luciano/AAF-9386-2019; Pignolo, Claudia/AAK-5032-2020	Giromini, Luciano/0000-0002-9540-4803; Pignolo, Claudia/0000-0002-6977-224X; ZENNARO, Alessandro/0000-0002-2774-307X			American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Archer RP, 1999, J PERS ASSESS, V73, P407, DOI 10.1207/S15327752JPA7303_8; Baer RA, 1999, J PERS ASSESS, V72, P308, DOI 10.1207/S15327752JP720213; Bagby R. M., 1991, PSYCHOL ASSESSMENT J, V3, P496, DOI DOI 10.1037/1040-3590.3.3.496; BEACH DA, 1989, J PSYCHOL, V123, P101, DOI 10.1080/00223980.1989.10542966; Burchett D, 2016, PSYCHOL ASSESSMENT, V28, P458, DOI 10.1037/pas0000205; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Butcher J.N., 2001, MINNESOTA MULTIPHASI; Cattell R.B., 1970, HDB 16 PERSONALITY F; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Charter RA, 2003, J CLIN PSYCHOL, V59, P985, DOI 10.1002/jclp.10183; Fronczyk K., 2014, ROCZNIKI PSYCHOL, V17, P459; Giromini L, 2018, PSYCHOL INJ LAW, V11, P340, DOI 10.1007/s12207-018-9314-1; Greene R. L., 2011, MMPI 2 MMPI 2 RF INT; Keeley JW, 2016, J PERS ASSESS, V98, P351, DOI 10.1080/00223891.2016.1158719; Kelley SE, 2019, ASSESSMENT, V26, P465, DOI 10.1177/1073191117738048; LePage JP, 2009, DEPRESS ANXIETY, V26, P592, DOI 10.1002/da.20397; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; NICHOLS DS, 1989, J CLIN PSYCHOL, V45, P239, DOI 10.1002/1097-4679(198903)45:2<239::AID-JCLP2270450210>3.0.CO;2-1; Osborne JW, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2010.00220; Pinsoneault TB, 2007, PSYCHOL ASSESSMENT, V19, P159, DOI 10.1037/1040-3590.19.1.159; Rogers R, 2003, ASSESSMENT, V10, P160, DOI 10.1177/1073191103010002007; Rogers R., 2011, RES METHODS FORENSIC, P174; Rogers R., 2018, CLIN ASSESSMENT MALI; Rogers R., 2013, HDB PSYCHOL FORENSIC, V11, P517; Smith, 2005, SIMS STRUCTURED INVE; Smith GP, 1997, J AM ACAD PSYCHIATRY, V25, P183; van Impelen A, 2014, CLIN NEUROPSYCHOL, V28, P1336, DOI 10.1080/13854046.2014.984763; Viglione D. J., 2018, J PERS ASSESS, P1; Viglione DJ, 2001, ASSESSMENT, V8, P237, DOI 10.1177/107319110100800301; Viglione DJ, 2017, J PERS ASSESS, V99, P534, DOI 10.1080/00223891.2016.1233882	33	18	18	0	5	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-3891	1532-7752		J PERS ASSESS	J. Pers. Assess.	JUL 3	2020	102	4					563	572		10.1080/00223891.2019.1566914			10	Psychology, Clinical; Psychology, Social	Social Science Citation Index (SSCI)	Psychology	ME8LY	WOS:000544906000001	30714835	Green Submitted			2022-02-06	
J	Quatman-Yates, CC; Hunter-Giordano, A; Shimamura, KK; Landel, R; Alsalaheen, BA; Hanke, TA; McCulloch, KL				Quatman-Yates, Catherine C.; Hunter-Giordano, Airelle; Shimamura, Kathy K.; Landel, Rob; Alsalaheen, Bara A.; Hanke, Timothy A.; McCulloch, Karen L.			Physical Therapy Evaluation and Treatment After Concussion/Mild Traumatic Brain Injury	JOURNAL OF ORTHOPAEDIC & SPORTS PHYSICAL THERAPY			English	Article							SPORTS-RELATED CONCUSSION; C-SPINE RULE; MOTOR SCREENING VOMS; ERROR SCORING SYSTEM; GAIT BALANCE CONTROL; FREE WAITING PERIOD; DUAL-TASK GAIT; POST-CONCUSSION; VESTIBULAR REHABILITATION; ACTIVE REHABILITATION		[Quatman-Yates, Catherine C.] Ohio State Univ, Dept Phys Therapy, Sports Med Res Inst, Chron Brain Injury Program, Columbus, OH 43210 USA; [Hunter-Giordano, Airelle] Univ Delaware, Practice Phys Therapist, Newark, DE USA; [Hunter-Giordano, Airelle] Univ Delaware, Clin Serv, Newark, DE USA; [Hunter-Giordano, Airelle] Univ Delaware, Sports & Orthoped Phys Therapy Residencies, Newark, DE USA; [Shimamura, Kathy K.] Azusa Pacific Univ, Dept Phys Therapy, Azusa, CA 91702 USA; [Shimamura, Kathy K.] Azusa Pacific Univ, Azusa, CA 91702 USA; [Landel, Rob] Univ Southern Calif, Clin Phys Therapy, Div Biokinesiol & Phys Therapy, Herman Ostrow Sch Dent, Los Angeles, CA 90007 USA; [Landel, Rob] USC Phys Therapy Associates, Los Angeles, CA USA; [Landel, Rob] Skill Works Inc, Long Beach, CA USA; [Alsalaheen, Bara A.] Univ Michigan Flint, Phys Therapy, Flint, MI USA; [Alsalaheen, Bara A.] Univ Michigan Ann Arbor, Neurol, Ann Arbor, MI USA; [Alsalaheen, Bara A.] Univ Michigan Ann Arbor, Michigan Med, Michigan NeuroSport, Ann Arbor, MI USA; [Hanke, Timothy A.] Midwestern Univ, Coll Hlth Sci, Phys Therapy Program, Downers Grove, IL 60515 USA; [McCulloch, Karen L.] Univ North Carolina Chapel Hill, Div Phys Therapy, Dept Allied Hlth Sci, Sch Med, Chapel Hill, NC USA; [McCulloch, Karen L.] Univ North Carolina Chapel Hill, Dept Exercise & Sports Sci, Chapel Hill, NC USA		Quatman-Yates, CC (corresponding author), Ohio State Univ, Dept Phys Therapy, Sports Med Res Inst, Chron Brain Injury Program, Columbus, OH 43210 USA.	catherine.quatman@osumc.edu; aohunter@udel.edu; kkumagaishimamura@apu.edu; rlandel@usc.edu; alsalahe@umich.edu; THANKE@midwestern.edu; kmac@med.unc.edu	Quatman-Yates, Catherine/AAK-4507-2021				Alsalaheen B, 2019, J ORTHOP SPORT PHYS, V49, P829, DOI 10.2519/jospt.2019.8869; Alsalaheen B, 2016, SPORTS MED, V46, P1487, DOI 10.1007/s40279-016-0532-y; Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; American Physical Therapy Association, 2013, APTA CLIN PRACT GUID, P258, DOI DOI 10.1016/J.PTSP.2013.06.002; Anderson V, 2018, INT J SPORTS MED, V39, P696, DOI 10.1055/a-0592-7512; Anzalone AJ, 2017, AM J SPORT MED, V45, P474, DOI 10.1177/0363546516668624; Balasundaram AP, 2013, PHYS THER SPORT, V14, P253, DOI 10.1016/j.ptsp.2013.06.002; Bandiera G, 2003, ANN EMERG MED, V42, P395, DOI 10.1016/S0196-0644(03)00422-0; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Bhattacharyya N, 2017, OTOLARYNG HEAD NECK, V156, pS1, DOI 10.1177/0194599816689667; Blake TA, 2016, BRAIN INJURY, V30, P132, DOI 10.3109/02699052.2015.1093659; Blanpied Peter R, 2017, J Orthop Sports Phys Ther, V47, pA1, DOI 10.2519/jospt.2017.0302; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2018, J NEUROTRAUM, V35, P2776, DOI 10.1089/neu.2018.5643; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Cancelliere C, 2017, J HEAD TRAUMA REHAB, V32, pE37, DOI 10.1097/HTR.0000000000000260; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Capo-Aponte JE, 2012, J REHABIL RES DEV, V49, P1377, DOI 10.1682/JRRD.2011.07.0128; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; Clausen M, 2016, J HEAD TRAUMA REHAB, V31, P215, DOI 10.1097/HTR.0000000000000145; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cossette I, 2014, ARCH PHYS MED REHAB, V95, P1594, DOI 10.1016/j.apmr.2014.03.019; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Darling SR, 2014, CLIN J SPORT MED, V24, P128, DOI 10.1097/JSM.0000000000000026; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; Delaney JS, 2005, J EMERG MED, V29, P189, DOI 10.1016/j.jemermed.2005.01.020; Dematteo C, 2015, MED SCI SPORT EXER, V47, P2283, DOI 10.1249/MSS.0000000000000682; Dobney DM, 2018, J HEAD TRAUMA REHAB, V33, pE11, DOI 10.1097/HTR.0000000000000339; Dorman JC, 2015, J SCI MED SPORT, V18, P2, DOI 10.1016/j.jsams.2013.11.010; Durish CL, 2018, J INT NEUROPSYCH SOC, V24, P759, DOI 10.1017/S1355617718000437; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Elbin RJ, 2018, J NEUROL PHYS THER, V42, P142, DOI 10.1097/NPT.0000000000000230; Elbin RJ, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0320-7; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Faux S, 2008, PAIN MED, V9, P1001, DOI 10.1111/j.1526-4637.2007.00404.x; Findling O, 2011, GAIT POSTURE, V34, P473, DOI 10.1016/j.gaitpost.2011.06.021; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Furman GR, 2013, AM J SPORT MED, V41, P1404, DOI 10.1177/0363546513484446; Gagnon I, 2016, SCAND J MED SCI SPOR, V26, P299, DOI 10.1111/sms.12441; Gagnon I, 2018, J NEUROTRAUM, V35, P1849, DOI 10.1089/neu.2018.5887; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Galea OA, 2018, NEUROREHAB NEURAL RE, V32, P115, DOI 10.1177/1545968318760728; Gall B, 2004, BRIT J SPORT MED, V38, P773, DOI 10.1136/bjsm.2003.009530; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Gauvin-Lepage J, 2020, CLIN J SPORT MED, V30, P423, DOI 10.1097/JSM.0000000000000634; Gera G, 2018, MIL MED, V183, P327, DOI 10.1093/milmed/usx162; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Goodrich GL, 2013, J REHABIL RES DEV, V50, P757, DOI 10.1682/JRRD.2012.10.0184; Gottshall K, 2003, LARYNGOSCOPE, V113, P1746, DOI 10.1097/00005537-200310000-00016; Grabowski P, 2017, PHYS THER SPORT, V23, P22, DOI 10.1016/j.ptsp.2016.06.001; Grandhi R, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7120160; Grill E, 2012, J VESTIBUL RES-EQUIL, V22, P261, DOI 10.3233/VES-120459; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Haider MN, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00395; Haider MN, 2020, CLIN J SPORT MED, V30, P513, DOI 10.1097/JSM.0000000000000687; Haider MN, 2018, BRIT J SPORT MED, V52, DOI 10.1136/bjsports-2016-096551; Hall CD, 2016, J NEUROL PHYS THER, V40, P124, DOI 10.1097/NPT.0000000000000120; Harpster K, 2019, DISABIL REHABIL, V41, P2855, DOI 10.1080/09638288.2018.1474952; Heyer GL, 2018, CLIN J SPORT MED, V28, P272, DOI 10.1097/JSM.0000000000000445; Hides JA, 2017, MED SCI SPORT EXER, V49, P2385, DOI 10.1249/MSS.0000000000001372; Hides JA, 2017, MUSCULOSKEL SCI PRAC, V29, P7, DOI 10.1016/j.msksp.2017.02.003; Hinds A, 2016, J NEUROL NEUROPHYSIO, V7, P388, DOI DOI 10.4172/2155-9562.1000388; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Howell DR, 2019, J SCI MED SPORT, V22, P521, DOI 10.1016/j.jsams.2018.11.014; Howell DR, 2018, AM J SPORT MED, V46, P3254, DOI 10.1177/0363546518796830; Howell DR, 2019, ARCH PHYS MED REHAB, V100, P613, DOI 10.1016/j.apmr.2018.07.441; Howell DR, 2018, CLIN J SPORT MED, V28, P262, DOI 10.1097/JSM.0000000000000439; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, J SCI MED SPORT, V21, P358, DOI 10.1016/j.jsams.2017.08.004; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2017, J NEUROTRAUM, V34, P838, DOI 10.1089/neu.2016.4609; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hugentobler JA, 2016, CLIN J SPORT MED, V26, P510, DOI 10.1097/JSM.0000000000000286; Hugentobler JA, 2015, INT J SPORTS PHYS TH, V10, P676; Hunt AW, 2016, J HEAD TRAUMA REHAB, V31, P252, DOI 10.1097/HTR.0000000000000174; Inness EL, 2019, J HEAD TRAUMA REHAB, V34, pE37, DOI 10.1097/HTR.0000000000000431; Institute of Medicine (IOM), 2011, CLIN PRACTICE GUIDEL; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jozefowicz-Korczynska M, 2018, ADV CLIN EXP MED, V27, P1355, DOI 10.17219/acem/69708; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kardouni JR, 2018, J ORTHOP SPORT PHYS, V48, P533, DOI 10.2519/jospt.2018.8053; Kennedy E, 2017, MUSCULOSKEL SCI PRAC, V29, P91, DOI 10.1016/j.msksp.2017.03.002; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Kleffelgaard I, 2013, PHYS THER, V93, P900, DOI 10.2522/ptj.20120381; Kleiner M, 2018, J ORTHOP SPORT PHYS, V48, P87, DOI 10.2519/jospt.2018.7432; Kozlowski KF, 2013, J ATHL TRAINING, V48, P627, DOI 10.4085/1062-6050-48.5.02; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Kristjansson E, 2009, J ORTHOP SPORT PHYS, V39, P364, DOI 10.2519/jospt.2009.2834; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P196, DOI 10.1097/00001199-200505000-00003; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lawrence DW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196062; Leddy J, 2021, CLIN J SPORT MED, V31, P7, DOI 10.1097/JSM.0000000000000686; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2019, JAMA PEDIATR, V173, P319, DOI 10.1001/jamapediatrics.2018.4397; Leddy JJ, 2018, CURR OPIN NEUROL, V31, P681, DOI 10.1097/WCO.0000000000000611; Leddy JJ, 2019, CLIN J SPORT MED, V29, P353, DOI 10.1097/JSM.0000000000000663; Leddy JJ, 2018, CURR SPORT MED REP, V17, P262, DOI 10.1249/JSR.0000000000000505; Leddy JJ, 2018, CLIN J SPORT MED, V28, P13, DOI 10.1097/JSM.0000000000000431; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lei-Rivera L, 2013, NEUROREHABILITATION, V32, P463, DOI 10.3233/NRE-130869; Leland Azadeh, 2017, Mater Sociomed, V29, P251, DOI 10.5455/msm.2017.29.251-256; Lennon A, 2018, J NEUROL PHYS THER, V42, P123, DOI 10.1097/NPT.0000000000000227; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lumba-Brown A, 2018, JAMA PEDIATR, V172, DOI 10.1001/jamapediatrics.2018.2847; Lundblad M, 2017, INT J SPORTS PHYS TH, V12, P286; Lynall RC, 2018, ARCH PHYS MED REHAB, V99, P880, DOI 10.1016/j.apmr.2017.12.011; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P273, DOI 10.1080/87565641.2015.1067706; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097470; MALEC JF, 1991, ARCH PHYS MED REHAB, V72, P138; Management of Concussion-mild Traumatic Brain Injury Working Group, 2016, VA DOD CLIN PRACT GU; Manikas V, 2017, J NEUROTRAUM, V34, P1932, DOI 10.1089/neu.2016.4762; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marshall CM, 2015, PHYSICIAN SPORTSMED, V43, P274, DOI 10.1080/00913847.2015.1064301; Marshall S, UPDATED CLIN PRACTIC, DOI DOI 10.1136/BJSPORTS-2017-097699; Marshall S, 2015, BRAIN INJURY, V29, P688, DOI 10.3109/02699052.2015.1004755; Massingale S, 2018, J NEUROL PHYS THER, V42, P149, DOI 10.1097/NPT.0000000000000225; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCulloch KL, 2015, J HEAD TRAUMA REHAB, V30, P56, DOI 10.1097/HTR.0000000000000104; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McPherson AL, 2019, AM J SPORT MED, V47, P1754, DOI 10.1177/0363546518785901; Moore Brian M, 2016, J Allied Health, V45, pe59; Moore JL, 2018, J NEUROL PHYS THER, V42, P174, DOI 10.1097/NPT.0000000000000229; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Moser Rosemarie Scolaro, 2012, Front Neurol, V3, P171, DOI 10.3389/fneur.2012.00171; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mueller MJ, 2002, PHYS THER, V82, P383, DOI 10.1093/ptj/82.4.383; Murray DA, 2017, BRIT J SPORT MED, V51, P442, DOI 10.1136/bjsports-2016-096081; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Murray NG, 2014, BRAIN INJURY, V28, P496, DOI 10.3109/02699052.2014.887144; Orr R, 2021, CLIN J SPORT MED, V31, P23, DOI 10.1097/JSM.0000000000000683; Pfaller AY, 2016, AM J SPORT MED, V44, P2941, DOI 10.1177/0363546516651821; Polinder S, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01113; Quatman-Yates C, 2018, ARCH PHYS MED REHAB, V99, P994, DOI 10.1016/j.apmr.2017.11.012; Quatman-Yates C, 2016, PHYS THER, V96, P1753, DOI 10.2522/ptj.20150557; Quatman-Yates C, 2014, PHYSICIAN SPORTSMED, V42, P32, DOI 10.3810/psm.2014.09.2073; Quatman-Yates CC, 2015, PEDIATR PHYS THER, V27, P316, DOI 10.1097/PEP.0000000000000193; Radomski MV, 2018, MIL MED, V183, pE214, DOI 10.1093/milmed/usx045; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Register-Mihalik JK, 2013, NEUROPSYCHOL REV, V23, P300, DOI 10.1007/s11065-013-9238-1; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Reneker JC, 2017, SCAND J MED SCI SPOR, V27, P2009, DOI 10.1111/sms.12827; Reneker JC, 2019, MUSCULOSKEL SCI PRAC, V42, P173, DOI 10.1016/j.msksp.2019.04.004; Reneker JC, 2018, MUSCULOSKEL SCI PRAC, V34, P8, DOI 10.1016/j.msksp.2017.11.012; Reneker Jennifer C, 2015, Inj Epidemiol, V2, P22; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Sambasivan K, 2015, J PEDIATR REHAB MED, V8, P335, DOI 10.3233/PRM-150351; Schneider KJ, 2018, J ORTHOP SPORT PHYS, V48, P974, DOI 10.2519/jospt.2018.8258; Schneider KJ, 2018, BRIT J SPORT MED, V52, P100, DOI 10.1136/bjsports-2017-098667; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Schneider KJ, 2017, J PEDIATR-US, V184, P235, DOI 10.1016/j.jpeds.2017.02.049; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Silverberg ND, 2016, JAMA PEDIATR, V170, P946, DOI 10.1001/jamapediatrics.2016.1187; Skora W, 2018, ANN AGR ENV MED, V25, P665, DOI 10.26444/aaem/81138; Solomito MJ, 2018, GAIT POSTURE, V64, P260, DOI 10.1016/j.gaitpost.2018.06.165; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stiell IG, 2003, NEW ENGL J MED, V349, P2510, DOI 10.1056/NEJMoa031375; Stiell IG, 2001, JAMA-J AM MED ASSOC, V286, P1841, DOI 10.1001/jama.286.15.1841; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Sufrinko AM, 2017, J PEDIATR-US, V185, P167, DOI 10.1016/j.jpeds.2017.02.072; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sveen U, 2013, DISABIL REHABIL, V35, P749, DOI 10.3109/09638288.2012.707741; Teel EF, 2016, CLIN J SPORT MED, V26, P162, DOI 10.1097/JSM.0000000000000210; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Treleaven J, 2019, MUSCULOSKEL SCI PRAC, V39, P45, DOI 10.1016/j.msksp.2018.11.010; Treleaven J, 2017, J ORTHOP SPORT PHYS, V47, P492, DOI 10.2519/jospt.2017.7052; Treleaven J, 2016, MANUAL THER, V22, P122, DOI 10.1016/j.math.2015.10.017; Treleaven J, 2011, MANUAL THER, V16, P252, DOI 10.1016/j.math.2010.11.002; Turner-Stokes L, 2011, J REHABIL MED, V43, P70, DOI 10.2340/16501977-0656; Turner-Stokes L, 2009, CLIN REHABIL, V23, P362, DOI 10.1177/0269215508101742; Turner-Stokes L, 2009, J REHABIL MED, V41, P528, DOI 10.2340/16501977-0383; US Food and Drug Administration, TRAUM BRAIN INJ WHAT; van der Walt K, 2019, MUSCULOSKEL SCI PRAC, V39, P130, DOI 10.1016/j.msksp.2018.12.004; Vartiainen MV, 2016, J CLIN EXP NEUROPSYC, V38, P293, DOI 10.1080/13803395.2015.1107031; Ventura RE, 2015, SEMIN NEUROL, V35, P599, DOI 10.1055/s-0035-1563567; Vidal PG, 2012, PEDIATR ANN, V41, pE186, DOI 10.3928/00904481-20120827-10; Walker WC, 2018, BRAIN INJURY, V32, P1156, DOI 10.1080/02699052.2018.1483529; Weightman MM, 2010, J HEAD TRAUMA REHAB, V25, P206, DOI 10.1097/HTR.0b013e3181dc82d3; Wilkerson GB, 2018, MED SCI SPORT EXER, V50, P1750, DOI 10.1249/MSS.0000000000001647; World Health Organization, 2009, INT CLASS FUNCT DIS; Yorke AM, 2016, PHYS THER, V96, P1018, DOI 10.2522/ptj.20140598; Yuan WH, 2017, J HEAD TRAUMA REHAB, V32, P378, DOI 10.1097/HTR.0000000000000318; Zhao L, 2011, SPORTS RELATED CONCU; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720; ZWEBER B, 1990, Occupational Therapy in Health Care, V7, P45, DOI 10.1080/J003v07n01_05	231	18	19	1	2	J O S P T	ALEXANDRIA	1111 NORTH FAIRFAX ST, STE 100, ALEXANDRIA, VA 22314-1436 USA	0190-6011	1938-1344		J ORTHOP SPORT PHYS	J. Orthop. Sports Phys. Ther.	APR	2020	50	4					CPG1	CPG73		10.2519/jospt.2020.0301			73	Orthopedics; Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation; Sport Sciences	PH8SY	WOS:000600676400001	32241234	Bronze			2022-02-06	
J	Jodra, P; Lago-Rodriguez, A; Sanchez-Oliver, AJ; Lopez-Samanes, A; Perez-Lopez, A; Veiga-Herreros, P; San Juan, AF; Dominguez, R				Jodra, P.; Lago-Rodriguez, A.; Sanchez-Oliver, A. J.; Lopez-Samanes, A.; Perez-Lopez, A.; Veiga-Herreros, P.; San Juan, A. F.; Dominguez, R.			Effects of caffeine supplementation on physical performance and mood dimensions in elite and trained-recreational athletes	JOURNAL OF THE INTERNATIONAL SOCIETY OF SPORTS NUTRITION			English	Article						Caffeine; Sport supplementation; Athletes; Boxing; Ergogenic aid	REPEATED-SPRINT PERFORMANCE; SPORTS-RELATED CONCUSSION; NUTRITIONAL SUPPLEMENTS; ERGOGENIC AIDS; MUSCLE PAIN; INGESTION; DEPRESSION; INCREASES; RESPONSES; ENDURANCE	Background: Caffeine supplementation (CAFF) has an established ergogenic effect on physical performance and the psychological response to exercise. However, few studies have compared the response to CAFF intake among athletes of different competition level. This study compares the acute effects of CAFF on anaerobic performance, mood and perceived effort in elite and moderately-trained recreational athletes. Methods: Participants for this randomized, controlled, crossover study were 8 elite athletes (in the senior boxing national team) and 10 trained-recreational athletes. Under two experimental conditions, CAFF supplementation (6 mg/kg) or placebo (PLAC), the athletes completed a Wingate test. Subjective exertion during the test was recorded as the rating of perceived exertion (RPE) both at the general level (RPEgeneral) and at the levels muscular (RPEmuscular) and cardiorespiratory (RPEcardio). Before the Wingate test, participants completed the questionnaires Profiles of Moods States (POMS) and Subjective Vitality Scale (SVS). Results: In response to CAFF intake, improvements were noted in W-peak (11.22 +/- 0.65 vs 10.70 +/- 0.84; p = 0.003; eta(2)(p) =0.44), W-avg (8.75 +/- 0.55 vs 8.41 0.46; p = 0.001; eta(2)(p) =0.53) and time taken to reach Wpeak (7.56 +/- 1.58 vs 9.11 +/- 1.53; p < 0.001; eta(2)(p) =0.57) both in the elite and trained-recreational athletes. However, only the elite athletes showed significant increases in tension (+ 325%), vigor (+ 31%) and SVS (+ 28%) scores after the intake of CAFF compared to levels recorded under the condition PLAC ( p < 0.05). Similarly, levels of vigor after consuming CAFF were significantly higher in the elite than the trained- recreational athletes (+ 5.8%). Conclusions: CAFF supplementation improved anaerobic performance in both the elite and recreational athletes. However, the ergogenic effect of CAFF on several mood dimensions and subjective vitality was greater in the elite athletes.	[Jodra, P.; Veiga-Herreros, P.] Univ Alfonso X Sabio, Fac Hlth Sci, Madrid, Spain; [Jodra, P.] Univ Alcala De Henares, Madrid, Spain; [Lago-Rodriguez, A.; Dominguez, R.] Univ Isabel I, Fac Hlth Sci, Burgos, Spain; [Sanchez-Oliver, A. J.] Univ Seville, Fac Educ Sci, Dept Human Motric & Sports Performance, Seville, Spain; [Lopez-Samanes, A.] Univ Francisco de Vitoria, Fac Hlth Sci, Sch Physiotherapy, Madrid, Spain; [Perez-Lopez, A.] Univ Alcala De Henares, Fac Med & Hlth Sci, Dept Biomed Sci, Madrid, Spain; [San Juan, A. F.] Univ Politecn Madrid, Sports Biomech Lab, Dept Hlth & Human Performance, Fac Phys Act & Sport Sci,INEF, Madrid, Spain		Lago-Rodriguez, A (corresponding author), Univ Isabel I, Fac Hlth Sci, Burgos, Spain.	angel.lago@ui1.es	Jodra, Pablo/U-8322-2017; San Juan, Alejandro/AAN-9136-2020; Rodriguez, Angel Lago/M-4351-2018; Sanchez-Oliver, Antonio J/AAD-6640-2019; Dominguez, Raul/AAX-1068-2021; Perez-Lopez, Alberto/I-7559-2015	Jodra, Pablo/0000-0003-3331-8464; San Juan, Alejandro/0000-0002-7083-7610; Rodriguez, Angel Lago/0000-0002-2942-5462; Sanchez-Oliver, Antonio J/0000-0001-9022-6043; Perez-Lopez, Alberto/0000-0003-0220-6240; Veiga Herreros, Pablo/0000-0002-5054-2815; Lopez Samanes, Alvaro/0000-0003-0721-0150; Dominguez, Raul/0000-0002-6891-391X	UAX; Banco Santander	This study was financed (supplementation, translation and publication costs) by a grant for the project Effects of caffeine supplementation on psychophysiological responses of performance and fatigue in the Olympic boxing team of the X Call for Research Projects of the UAX and Banco Santander.	Abidin M. A. H., 2018, SPORT SCI HLTH, V14, P673; Abo-Salem OM, 2004, J PHARMACOL EXP THER, V308, P358, DOI 10.1124/jpet.103.056036; Aguilar-Navarro M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020286; Ali A, 2016, J SPORT SCI, V34, P330, DOI 10.1080/02640414.2015.1052746; ALLEN DG, 1995, J PHYSIOL-LONDON, V487, P331, DOI 10.1113/jphysiol.1995.sp020883; Astorino TA, 2010, MED SCI SPORT EXER, V42, P2205, DOI 10.1249/MSS.0b013e3181e3a11d; Balaguer E, 2005, CAPLLETRA, P9; BAROR O, 1987, SPORTS MED, V4, P381, DOI 10.2165/00007256-198704060-00001; Boyett JC, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100639; Brosse AL, 2002, SPORT MED, V32, P741; Casado A, 2019, EUR J SPORT SCI, V19, P1045, DOI 10.1080/17461391.2019.1593510; Chtourou H, 2019, NUTRIENTS, V11, DOI 10.3390/nu11050992; Cohen J, 1988, TECHNOMETRICS, V31, P499, DOI [DOI 10.2307/1270020, DOI 10.1080/00401706.1989.10488618]; COLLOMP K, 1992, EUR J APPL PHYSIOL O, V64, P377, DOI 10.1007/BF00636227; Cuenca E, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091222; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Davis JM, 2003, AM J PHYSIOL-REG I, V284, pR399, DOI 10.1152/ajpregu.00386.2002; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Demirkan E, 2015, J STRENGTH COND RES, V29, P1876, DOI 10.1519/JSC.0000000000000833; Desbrow B, 2012, J SPORT SCI, V30, P115, DOI 10.1080/02640414.2011.632431; Doherty M, 2004, J SPORT SCI, V22, P637, DOI 10.1080/02640410310001655741; Dominguez R, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121360; Duncan MJ, 2019, EUR J SPORT SCI, V19, P103, DOI 10.1080/17461391.2018.1508505; Duncan MJ, 2013, EUR J SPORT SCI, V13, P392, DOI 10.1080/17461391.2011.635811; Duncan MJ, 2011, J STRENGTH COND RES, V25, P178, DOI 10.1519/JSC.0b013e318201bddb; Duncan MJ, 2011, J STRENGTH COND RES, V25, P178; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Ferreira LHB, 2018, MED SCI SPORT EXER, V50, P599; Fuentes I., 1995, 5 C NAC PSIC ACT FIS; Pallares JG, 2012, J STRENGTH COND RES, V26, P794, DOI 10.1519/JSC.0b013e31824741e7; Garcia-Pallares J, 2011, EUR J APPL PHYSIOL, V111, P1747, DOI 10.1007/s00421-010-1809-8; Glaister M, 2018, INT J SPORT PHYSIOL, V13, P402, DOI 10.1123/ijspp.2017-0312; Goods PSR, 2017, J SPORT SCI MED, V16, P93; Graham TE, 2001, SPORTS MED, V31, P785, DOI 10.2165/00007256-200131110-00002; Graham-Paulson T, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070393; Grgic J, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0216-0; Grgic J, 2018, EUR J SPORT SCI, V18, P219, DOI 10.1080/17461391.2017.1394371; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; HANIN YL, 1978, SPORT PSYCHOL ANAL A, P236; Hanin YL, 2007, EMOTIONS ATHLETIC PE; Jacobson B H, 1992, Br J Sports Med, V26, P276; Jodra P, 2020, INT J SPORT PHYSIOL, V15, P243, DOI 10.1123/ijspp.2019-0149; Jonvik KL, 2018, EUR J SPORT SCI, V18, P524, DOI 10.1080/17461391.2018.1433722; Salinero JJ, 2019, RES SPORTS MED, V27, P238, DOI 10.1080/15438627.2018.1552146; Kalmar JM, 2006, J APPL PHYSIOL, V100, P1757, DOI 10.1152/japplphysiol.01347.2005; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Killen LG, 2013, EUR J APPL PHYSIOL, V113, P721, DOI 10.1007/s00421-012-2480-z; Kristiansen M, 2005, INT J SPORT NUTR EXE, V15, P195, DOI 10.1123/ijsnem.15.2.195; Kumar N, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00009; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lane AM, 2005, J SPORT SCI MED, V4, P47; Lane AM, 2005, J SPORTS SCI MED, V4, P195; Laurence G, 2012, J SPORT SCI, V30, P1235, DOI 10.1080/02640414.2012.693620; Lieberman HR, 2001, NUTR REV, V59, P91, DOI 10.1111/j.1753-4887.2001.tb06995.x; Lopez-Dominguez R, 2018, RETOS-NUEV TEND EDUC, P272; Lopez-Gonzalez LM, 2018, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-018-0267-2; Lopez-Samanes A, 2017, NUTR HOSP, V34, P1463, DOI 10.20960/nh.1404; Lopez-Samanes A, 2015, STRENGTH COND J, V37, P1; Makdissi M, 2014, AUST FAM PHYSICIAN, V43, P94; Marcora SM, 2010, EUR J APPL PHYSIOL, V109, P763, DOI 10.1007/s00421-010-1418-6; Maughan RJ, 2018, INT J SPORT NUTR EXE, V28, P104, DOI 10.1123/ijsnem.2018-0020; McLellan TM, 2016, NEUROSCI BIOBEHAV R, V71, P294, DOI 10.1016/j.neubiorev.2016.09.001; McMillan TM, 2017, J NEUROL NEUROSUR PS, V88, P505, DOI 10.1136/jnnp-2016-314279; McNair DM, 1992, MANUAL PROFILE MOOD; Medicine GB, 1978, SCAND J REHABIL, V6, P197; Meeusen R, 2014, SPORTS MED, V44, P47, DOI 10.1007/s40279-014-0150-5; Moore RD, 2016, BRAIN IMAGING BEHAV, V10, P1108, DOI 10.1007/s11682-015-9473-6; Motl RW, 2003, J PAIN, V4, P316, DOI 10.1016/S1526-5900(03)00635-7; Negaresh R, 2019, EUR J SPORT SCI, V19, P499, DOI 10.1080/17461391.2018.1534990; Nehlig A, 2010, J ALZHEIMERS DIS, V20, pS85, DOI 10.3233/JAD-2010-091315; Pallares JG, 2013, MED SCI SPORT EXER, V45, P2184, DOI 10.1249/MSS.0b013e31829a6672; Paton CD, 2010, EUR J APPL PHYSIOL, V110, P1243, DOI 10.1007/s00421-010-1620-6; Petroczi A, 2008, J INT SOC SPORT NUTR, V5, DOI 10.1186/1550-2783-5-2; Plaskett CJ, 2001, J APPL PHYSIOL, V91, P1535, DOI 10.1152/jappl.2001.91.4.1535; Potach D, 2002, NSCA FUNDAM ENTREN P, P515; Richardson JTE, 2011, EDUC RES REV-NETH, V6, P135, DOI 10.1016/j.edurev.2010.12.001; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Sanchez-Oliver A, 2008, ARCH LATINOAM NUTR, V58, P221; Skinner TL, 2014, J SCI MED SPORT, V17, P516, DOI 10.1016/j.jsams.2013.07.006; Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0; Sokmen B, 2008, J STRENGTH COND RES, V22, P978, DOI 10.1519/JSC.0b013e3181660cec; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Souissi M, 2015, BIOL RHYTHM RES, V46, P291, DOI 10.1080/09291016.2014.994857; Souissi M, 2013, BIOL RHYTHM RES, V44, P897, DOI 10.1080/09291016.2013.780700; Souissi Makram, 2012, Asian J Sports Med, V3, P161; Stevens MJ, 2006, J SPORT SCI MED, V5, P143; Stojanovic E, 2019, APPL PHYSIOL NUTR ME, V44, P849, DOI 10.1139/apnm-2018-0671; Teychenne M, 2010, HEALTH EDUC RES, V25, P632, DOI 10.1093/her/cyq008; Tsitsimpikou C, 2011, INT J SPORT NUTR EXE, V21, P377, DOI 10.1123/ijsnem.21.5.377; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Wiles JD, 2006, J SPORT SCI, V24, P1165, DOI 10.1080/02640410500457687; Woolf K, 2008, INT J SPORT NUTR EXE, V18, P412, DOI 10.1123/ijsnem.18.4.412; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yrondi A, 2017, PRESSE MED, V46, P890, DOI 10.1016/j.lpm.2017.08.013; [No title captured]	96	18	18	5	24	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1550-2783		J INT SOC SPORT NUTR	J. Int. Soc. Sport Nutr.	JAN 3	2020	17	1							2	10.1186/s12970-019-0332-5			11	Nutrition & Dietetics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nutrition & Dietetics; Sport Sciences	KK2UH	WOS:000512602800001	31900166	Green Published, gold			2022-02-06	
J	Guan, FX; Huang, TJ; Wang, XX; Xing, Q; Gumpper, K; Li, P; Song, JS; Tan, T; Yang, GL; Zang, XX; Zhang, JW; Wang, YM; Yang, YL; Liu, YS; Zhang, YT; Yang, B; Ma, JJ; Ma, SS				Guan, Fangxia; Huang, Tuanjie; Wang, Xinxin; Xing, Qu; Gumpper, Kristyn; Li, Peng; Song, Jishi; Tan, Tao; Yang, Greta Luyuan; Zang, Xingxing; Zhang, Jiewen; Wang, Yuming; Yang, Yunlei; Liu, Yashi; Zhang, Yanting; Yang, Bo; Ma, Jianjie; Ma, Shanshan			The TRIM protein Mitsugumin 53 enhances survival and therapeutic efficacy of stem cells in murine traumatic brain injury	STEM CELL RESEARCH & THERAPY			English	Article						Neuroprotection; Mitsugumin 53; Stem cells; Traumatic brain injury; PI3K-Akt-GSK3 beta	OXIDATIVE STRESS; NEURAL DIFFERENTIATION; COGNITIVE FUNCTION; MOUSE MODEL; RAT MODEL; IN-VIVO; MG53; APOPTOSIS; TRANSPLANTATION; GROWTH	Background Traumatic brain injury (TBI) is a common neurotrauma leading to brain dysfunction and death. Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs) hold promise in the treatment of TBI. However, their efficacy is modest due to low survival and differentiation under the harsh microenvironment of the injured brain. MG53, a member of TRIM family protein, plays a vital role in cell and tissue damage repair. The present study aims to test whether MG53 preserves hUC-MSCs against oxidative stress and enhances stem cell survival and efficacy in TBI treatment. Methods In this study, we performed a series of in vitro and in vivo experiments in hUC-MSCs and mice to define the function of MG53 enhancing survival, neurogenesis, and therapeutic efficacy of stem cells in murine traumatic brain injury. Results We found that recombinant human MG53 (rhMG53) protein protected hUC-MSCs against H2O2-induced oxidative damage and stimulated hUC-MSC proliferation and migration. In a mouse model of contusion-induced TBI, intravenous administration of MG53 protein preserved the survival of transplanted hUC-MSCs, mitigated brain edema, reduced neurological deficits, and relieved anxiety and depressive-like behaviors. Co-treatment of MG53 and hUC-MSCs enhanced neurogenesis by reducing apoptosis and improving PI3K/Akt-GSK3 beta signaling. Conclusion MG53 enhances the efficacy of hUC-MSCs in the recovery of TBI, indicating that such adjunctive therapy may provide a novel strategy to lessen damage and optimize recovery for brain injury.	[Guan, Fangxia; Huang, Tuanjie; Xing, Qu; Li, Peng; Song, Jishi; Liu, Yashi; Zhang, Yanting; Ma, Shanshan] Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China; [Guan, Fangxia; Wang, Xinxin; Yang, Bo] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Guan, Fangxia; Zhang, Jiewen; Wang, Yuming] Henan Prov Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China; [Gumpper, Kristyn; Tan, Tao; Ma, Jianjie] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA; [Yang, Greta Luyuan] Stuyvest High Sch, 345 Chambers St, New York, NY 10282 USA; [Zang, Xingxing] Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA; [Yang, Yunlei] Einstein Coll Med, Dept Med & Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA		Ma, SS (corresponding author), Zhengzhou Univ, Sch Life Sci, Zhengzhou 450001, Henan, Peoples R China.; Ma, JJ (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA.	Jianjie.Ma@osumc.edu; mashanshan84@163.com		Gumpper-Fedus, Kristyn/0000-0003-2704-1868; Zang, Xingxing/0000-0001-5380-1942	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [NSFC 81601078]; Science and Technology Research Project from Henan Province [152102310272]	This work was supported by the National Natural Science Foundation of China (NSFC 81601078), Science and Technology Research Project from Henan Province (152102310272).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Cai CX, 2009, J BIOL CHEM, V284, P15894, DOI 10.1074/jbc.M109.009589; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Cao CM, 2010, CIRCULATION, V121, P2565, DOI 10.1161/CIRCULATIONAHA.110.954628; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Cheng T, 2015, CELL MOL NEUROBIOL, V35, P641, DOI 10.1007/s10571-015-0159-9; Chhor V, 2017, BRAIN BEHAV IMMUN, V63, P197, DOI 10.1016/j.bbi.2016.11.001; Cui YB, 2017, BEHAV BRAIN RES, V320, P291, DOI 10.1016/j.bbr.2016.12.021; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Duan W, 2016, MOL NEUROBIOL, V53, P1637, DOI 10.1007/s12035-015-9122-5; Duann P, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010755; Farahabadi SSH, 2015, NEUROSCIENCE, V297, P252, DOI 10.1016/j.neuroscience.2015.03.069; Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1; Fukumoto K, 2014, PSYCHOPHARMACOLOGY, V231, P2291, DOI 10.1007/s00213-013-3378-0; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Guo XB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04153-2; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hasan A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00028; Heredia L, 2014, J PHARMACOL TOX MET, V69, P108, DOI 10.1016/j.vascn.2013.12.005; Hill E, 2016, J PHYSIOL-LONDON, V594, P6595, DOI 10.1113/JP270658; Jia YL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5387; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Li H, 2016, BIOCHEM BIOPH RES CO, V479, P827, DOI 10.1016/j.bbrc.2016.09.123; Li X, 2014, J CELL MOL MED, V18, P2445, DOI 10.1111/jcmm.12424; Li XT, 2017, CNS NEUROL DISORD-DR, V16, P828, DOI 10.2174/1871527316666170518170422; Lin PH, 2012, FASEB J, V26, P1875, DOI 10.1096/fj.11-188599; Lin YL, 2017, ENDOCRINOLOGY, V158, P3004, DOI 10.1210/en.2017-00353; Liu H, 2017, CELL PHYSIOL BIOCHEM, V44, P1011, DOI 10.1159/000485401; Liu JX, 2015, J MOL CELL CARDIOL, V80, P10, DOI 10.1016/j.yjmcc.2014.12.010; Liu LY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088348, 10.1371/journal.pone.0104748]; Lu L, 2016, SCI REP-UK, V6, DOI 10.1038/srep19521; Ma SS, 2014, MOL CELL BIOCHEM, V385, P277, DOI 10.1007/s11010-013-1836-y; Molofsky AV, 2015, GLIA, V63, P1320, DOI 10.1002/glia.22836; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Ong QX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153487; Peng WJ, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0034-0; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Squillaro T, 2016, CELL TRANSPLANT, V25, P829, DOI 10.3727/096368915X689622; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Tong J, 2013, J NEUROTRAUM, V30, P247, DOI 10.1089/neu.2012.2493; Torrente D, 2014, HUM EXP TOXICOL, V33, P673, DOI 10.1177/0960327113509659; Tureyen K, 2004, J NEUROSCI METH, V139, P203, DOI 10.1016/j.jneumeth.2004.04.029; Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651; Wang S, 2013, BRAIN RES, V1532, P76, DOI 10.1016/j.brainres.2013.08.001; Wang XX, 2016, MOL CELLS, V39, P418, DOI 10.14348/molcells.2016.2345; Wei WJ, 2014, J PHARM PHARMACOL, V66, P988, DOI 10.1111/jphp.12225; Weisleder Noah, 2009, Commun Integr Biol, V2, P225; Weisleder N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003921; Wu Y, 2013, CLIN EXP PHARMACOL P, V40, P626, DOI 10.1111/1440-1681.12141; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Xu C, 2017, INT J NEUROSCI, V127, P1124, DOI 10.1080/00207454.2017.1325884; Yao WF, 2017, J CELL MOL MED, V21, P2503, DOI 10.1111/jcmm.13171; Yao YG, 2016, ONCOTARGET, V7, P22474, DOI 10.18632/oncotarget.7965; Yong KW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09596; Yue PJ, 2017, NEUROCHEM RES, V42, P1366, DOI 10.1007/s11064-017-2184-1; Zhang Y, 2011, CARDIOVASC RES, V91, P108, DOI 10.1093/cvr/cvr029; Zhang YT, 2016, TOXICOL LETT, V261, P49, DOI 10.1016/j.toxlet.2016.08.010; Zhao B, 2017, MED SCI MONITOR, V23, P1872, DOI 10.12659/MSM.901055; Zheng R, 2017, BIOCHEM BIOPH RES CO, V485, P6, DOI 10.1016/j.bbrc.2017.01.069; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59; Zhu H, 2011, J BIOL CHEM, V286, P12820, DOI 10.1074/jbc.C111.221440; Zhu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097423; Ziaei M, 2017, SURV OPHTHALMOL, V62, P803, DOI 10.1016/j.survophthal.2017.02.002	69	18	19	1	7	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1757-6512		STEM CELL RES THER	Stem Cell Res. Ther.	NOV 28	2019	10	1							352	10.1186/s13287-019-1433-4			16	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	JS0RQ	WOS:000500022500001	31779687	Green Published, gold			2022-02-06	
J	Stilling, J; Paxman, E; Mercier, L; Gan, LS; Wang, M; Amoozegar, F; Dukelow, SP; Monchi, O; Debert, C				Stilling, Joan; Paxman, Eric; Mercier, Leah; Gan, Liu Shi; Wang, Meng; Amoozegar, Farnaz; Dukelow, Sean P.; Monchi, Oury; Debert, Chantel			Treatment of Persistent Post-Traumatic Headache and Post-Concussion Symptoms Using Repetitive Transcranial Magnetic Stimulation: A Pilot, Double-Blind, Randomized Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						brain trauma; post-concussion syndrome; post-traumatic headache; randomized controlled trial; transcranial magnetic stimulation	MILD-TRAUMATIC-BRAIN; DORSOLATERAL PREFRONTAL CORTEX; MIGRAINE PROPHYLAXIS; FUNCTIONAL CONNECTIVITY; BETA-ENDORPHIN; UNITED-STATES; RTMS; INJURY; PAIN; EFFICACY	Persistent post-traumatic headache (PTH) after mild traumatic brain injury is one of the most prominent and highly reported persistent post-concussion symptoms (PPCS). Non-pharmacological treatments, including non-invasive neurostimulation technologies, have been proposed for use. Our objective was to evaluate headache characteristics at 1 month after repetitive transcranial magnetic stimulation (rTMS) treatment in participants with PTH and PPCS. A double-blind, randomized, sham-controlled, pilot clinical trial was performed on 20 participants (18-65 years) with persistent PTH (International Classification of Headache Disorders, 3rd edition) and PPCS (International Classification of Diseases, Tenth Revision). Ten sessions of rTMS therapy (10 Hz, 600 pulses, 70% resting motor threshold amplitude) were delivered to the left dorsolateral pre-frontal cortex. The primary outcome was a change in headache frequency or severity at 1 month post-rTMS. Two-week-long daily headache diaries and clinical questionnaires assessing function, PPCS, cognition, quality of life, and mood were completed at baseline, post-treatment, and at 1, 3, and 6 months post-rTMS. A two-way (treatment x time) mixed analyisis of variance indicated a significant overall time effect for average headache severity (F-(3,F-54) = 3.214; p = 0.03) and a reduction in headache frequency at 1 month post-treatment (#/2 weeks, REAL -5.2 [standard deviation {SD} = 5.8]; SHAM, -3.3 [SD = 7.7]). Secondary outcomes revealed an overall time interaction for headache impact, depression, post-concussion symptoms, and quality of life. There was a significant reduction in depression rating in the REAL group between baseline and 1 month post-treatment, with no change in the SHAM group (Personal Health Questionnaire-9; REAL, -4.3 [SD = 3.7[ p = 0.020]; SHAM, -0.7 [SD = 4.7; p = 1.0]; Bonferroni corrected). In the REAL group, 60% returned to work whereas only 10% returned in the SHAM group (p = 0.027). This pilot study demonstrates an overall time effect on headache severity, functional impact, depression, PPCS, and quality of life after rTMS treatment in participants with persistent PTH; however, findings were below clinical significance thresholds. There was a 100% response rate, no dropouts, and minimal adverse effects, warranting a larger phase II study. Clinicaltrials.gov: NCT03691272.	[Stilling, Joan; Paxman, Eric; Mercier, Leah; Gan, Liu Shi; Wang, Meng; Amoozegar, Farnaz; Dukelow, Sean P.; Monchi, Oury; Debert, Chantel] Univ Calgary, Calgary, AB, Canada; [Mercier, Leah; Gan, Liu Shi; Wang, Meng] Hotchkiss Brain Inst, Calgary, AB, Canada; [Stilling, Joan; Amoozegar, Farnaz; Dukelow, Sean P.; Monchi, Oury; Debert, Chantel] Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada; [Paxman, Eric] Univ Alberta, Dept Med, Edmonton, AB, Canada		Stilling, J (corresponding author), Univ Calgary, Div Phys Med & Rehabil, Dept Clin Neurosci, 1403-29 St Northwest, Calgary, AB T2N 2T9, Canada.	joan.stilling@ahs.ca		Debert, Chantel/0000-0002-2704-0438	University of Calgary, Cumming School of Medicine, Clinical Research Fund [CRF17-0107]; Hotchkiss Brain Institute; Department of Clinical Neurosciences	This study was funded through the University of Calgary, Cumming School of Medicine, Clinical Research Fund Grant (CRF17-0107) and the Hotchkiss Brain Institute and Department of Clinical Neurosciences Pilot fund Grant.	Bang HJ, 2004, CONTROL CLIN TRIALS, V25, P143, DOI 10.1016/j.cct.2003.10.016; Brighina F, 2004, J NEUROL SCI, V227, P67, DOI 10.1016/j.jns.2004.08.008; Broadbent HJ, 2011, WORLD J BIOL PSYCHIA, V12, P240, DOI 10.3109/15622975.2010.541281; Brunoni AR, 2017, JAMA PSYCHIAT, V74, P143, DOI 10.1001/jamapsychiatry.2016.3644; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Castien RF, 2012, CEPHALALGIA, V32, P710, DOI 10.1177/0333102412449933; Cnossen MC, 2018, J NEUROTRAUM, V35, P2691, DOI 10.1089/neu.2017.5486; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Diana M, 2017, NAT REV NEUROSCI, V18, P685, DOI 10.1038/nrn.2017.113; Dong Y, 2017, EUR J PHYS REHAB MED, V53, P256, DOI 10.23736/S1973-9087.16.04329-X; Duecker F, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00210; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Hocke LM, 2018, J NEUROTRAUM, V35, P1224, DOI 10.1089/neu.2017.5365; Kalita J, 2017, CEPHALALGIA, V37, P1222, DOI 10.1177/0333102416675619; Kalita J, 2016, J NEUROL, V263, P2238, DOI 10.1007/s00415-016-8257-2; Khedr EM, 2005, J NEUROL NEUROSUR PS, V76, P833, DOI 10.1136/jnnp.2004.055806; Kito S, 2012, BRAIN STIMUL, V5, P547, DOI 10.1016/j.brs.2011.09.004; Korley FK, 2016, J HEAD TRAUMA REHAB, V31, P379, DOI 10.1097/HTR.0000000000000187; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kwon M, 2014, PAIN PRACT, V14, P656, DOI 10.1111/papr.12145; Lan MJ, 2016, BRAIN STIMUL, V9, P579, DOI 10.1016/j.brs.2016.02.011; Leung A, 2018, MOL PAIN, V14, DOI 10.1177/1744806918810297; Leung A, 2018, NEUROMODULATION, V21, P390, DOI 10.1111/ner.12615; Leung A, 2016, MOL PAIN, V12, DOI 10.1177/1744806916662661; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Leung A, 2016, PAIN PHYSICIAN, V19, pE347; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Misra UK, 2013, J NEUROL, V260, P2793, DOI 10.1007/s00415-013-7072-2; Misra UK, 2013, CEPHALALGIA, V33, P316, DOI 10.1177/0333102412473372; Misra UK, 2012, NEUROL RES, V34, P547, DOI 10.1179/1743132812Y.0000000045; Misra UK, 2017, BRAIN STIMUL, V10, P618, DOI 10.1016/j.brs.2017.02.006; Moussavi Z, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41923-6; Niu X, 2019, J NEUROL NEUROSUR PS, V90, P326, DOI 10.1136/jnnp-2018-318886; O'Reardon JP, 2007, BIOL PSYCHIAT, V62, P1208, DOI 10.1016/j.biopsych.2007.01.018; Obermann M, 2009, NEUROLOGY, V73, P978, DOI 10.1212/WNL.0b013e3181b8791a; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Provost JS, 2010, EUR J NEUROSCI, V32, P873, DOI 10.1111/j.1460-9568.2010.07333.x; Salazar APS, 2018, ARCH PHYS MED REHAB, V99, P355, DOI 10.1016/j.apmr.2017.07.009; Schwedt TJ, 2015, PAIN MED, V16, P1827, DOI 10.1111/pme.12792; Seminowicz DA, 2017, J PAIN, V18, P1027, DOI 10.1016/j.jpain.2017.03.008; Shehata HS, 2016, J PAIN RES, V9, P771, DOI 10.2147/JPR.S116671; Stacey A, 2017, J NEUROTRAUM, V34, P1558, DOI 10.1089/neu.2016.4721; Stilling J, 2019, BRAIN INJURY, V33, P148; Stilling JM, 2019, HEADACHE, V59, P339, DOI 10.1111/head.13479; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tik M, 2017, NEUROIMAGE, V162, P289, DOI 10.1016/j.neuroimage.2017.09.022; Tripathi GM, 2018, BRAIN RES, V1696, P31, DOI 10.1016/j.brainres.2018.05.046; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wassermann E., 2018, OXFORD HDB TRANSCRAN	53	18	18	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					312	323		10.1089/neu.2019.6692		NOV 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000495445300001	31530227				2022-02-06	
J	Cole, E; Gillespie, S; Vulliamy, P; Brohi, K; Akkad, H; Apostolidou, K; Ardley, R; Aylwin, C; Bassford, C; Bonner, S; Brooks, A; Cairns, T; Cecconi, M; Clark, F; Dempsey, G; Davies, ED; Docking, R; Eddlestone, J; Ellis, D; Evans, J; Galea, M; Healy, M; Horner, D; Howarth, R; Jansen, J; Jones, J; Kaye, C; Keep, J; Kerslake, D; Kilic, J; Leong, M; Martinson, V; McIldowie, B; Michael, S; Millo, J; Morgan, M; O'Leary, R; Oram, J; De Gordoa, LOR; Porter, K; Raby, S; Service, J; Shaw, D; Smith, JD; Smith, N; Stotz, M; Thomas, E; Thomas, M; Vincent, A; Ward, G; Welters, I				Cole, E.; Gillespie, S.; Vulliamy, P.; Brohi, K.; Akkad, H.; Apostolidou, K.; Ardley, R.; Aylwin, C.; Bassford, C.; Bonner, S.; Brooks, A.; Cairns, T.; Cecconi, M.; Clark, F.; Dempsey, G.; Davies, E. Denison; Docking, R.; Eddlestone, J.; Ellis, D.; Evans, J.; Galea, M.; Healy, M.; Horner, D.; Howarth, R.; Jansen, J.; Jones, J.; Kaye, C.; Keep, J.; Kerslake, D.; Kilic, J.; Leong, M.; Martinson, V.; McIldowie, B.; Michael, S.; Millo, J.; Morgan, M.; O'Leary, R.; Oram, J.; De Gordoa, L. Ortiz-Ruiz; Porter, K.; Raby, S.; Service, J.; Shaw, D.; Smith, J. D.; Smith, N.; Stotz, M.; Thomas, E.; Thomas, M.; Vincent, A.; Ward, G.; Welters, I.		Organ Dysfunction Trauma ORDIT	Multiple organ dysfunction after trauma	BRITISH JOURNAL OF SURGERY			English	Article							PERSISTENT INFLAMMATION; FLUID RESUSCITATION; HEMORRHAGIC-SHOCK; BRAIN-INJURY; SOFA SCORE; FAILURE; DENVER; IMMUNOSUPPRESSION; EPIDEMIOLOGY; ASSOCIATION	BackgroundThe nature of multiple organ dysfunction syndrome (MODS) after traumatic injury is evolving as resuscitation practices advance and more patients survive their injuries to reach critical care. The aim of this study was to characterize contemporary MODS subtypes in trauma critical care at a population level. MethodsAdult patients admitted to major trauma centre critical care units were enrolled in this 4-week point-prevalence study. MODS was defined by a daily total Sequential Organ Failure Assessment (SOFA) score of more than 5. Hierarchical clustering of SOFA scores over time was used to identify MODS subtypes. ResultsSome 440 patients were enrolled, of whom 245 (557 per cent) developed MODS. MODS carried a high mortality rate (220 per cent versus 05 per cent in those without MODS; P<0001) and 240 per cent of deaths occurred within the first 48h after injury. Three patterns of MODS were identified, all present on admission. Cluster 1 MODS resolved early with a median time to recovery of 4days and a mortality rate of 144 per cent. Cluster 2 had a delayed recovery (median 13days) and a mortality rate of 35 per cent. Cluster 3 had a prolonged recovery (median 25days) and high associated mortality rate of 46 per cent. Multivariable analysis revealed distinct clinical associations for each form of MODS; 24-hour crystalloid administration was associated strongly with cluster 1 (P = 0009), traumatic brain injury with cluster 2 (P = 0002) and admission shock severity with cluster 3 (P = 0003). ConclusionContemporary MODS has at least three distinct types based on patterns of severity and recovery. Further characterization of MODS subtypes and their underlying pathophysiology may lead to future opportunities for early stratification and targeted interventions.	[Cole, E.; Gillespie, S.; Vulliamy, P.; Brohi, K.] Queen Mary Univ London, Blizard Inst, Ctr Trauma Sci, 4 Newark St, London E1 2AT, England; [Akkad, H.] Queen Mary Univ London, Ctr Trauma Sci, London, England; [Apostolidou, K.; O'Leary, R.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Ardley, R.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Aylwin, C.; Stotz, M.] Imperial Coll Healthcare NHS Trust, London, England; [Bassford, C.; Ward, G.] Univ Hosp Coventry & Warwickshire NHS Trust, Coventry, W Midlands, England; [Bonner, S.] South Tees Hosp NHS Fdn Trust, Middlesbrough, Cleveland, England; [Brooks, A.] Nottingham Univ Hosp NHS Trust, Nottingham, England; [Cairns, T.; Vincent, A.] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England; [Cecconi, M.] St Georges Univ Hosp NHS Fdn Trust, London, England; [Clark, F.] Univ Hosp North Midlands NHS Trust, Stoke On Trent, Staffs, England; [Dempsey, G.] Aintree Univ Hosp NHS Fdn Trust, Liverpool, Merseyside, England; [Davies, E. Denison] Lancashire Teaching Hosp NHS Fdn Trust, Preston, Lancs, England; [Docking, R.; Service, J.] Queen Elizabeth Univ Hosp Glasgow, Glasgow, Lanark, Scotland; [Eddlestone, J.; Ellis, D.] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England; [Evans, J.] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Galea, M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Healy, M.] Barts Hlth NHS Trust, London, England; [Horner, D.] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Howarth, R.] Lancashire Teaching Hosp NHS Fdn Trust, Preston, Lancs, England; [Jansen, J.] Aberdeen Royal Infirm, Aberdeen, Scotland; [Jansen, J.] Univ Alabama Birmingham, Birmingham, AL USA; [Jones, J.; Oram, J.] Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England; [Jansen, J.; Kaye, C.] Aberdeen Royal Infirm, Aberdeen, Scotland; [Keep, J.] Kings Coll Hosp NHS Fdn Trust, London, England; [Kerslake, D.] Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland; [Kilic, J.; De Gordoa, L. Ortiz-Ruiz] Brighton & Sussex Univ Hosp NHS Trust, Brighton, E Sussex, England; [Leong, M.; Millo, J.; Raby, S.] Oxford Univ Hosp NHS Fdn Trust, Oxford, England; [Martinson, V.; Smith, N.] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England; [McIldowie, B.; Thomas, M.] North Bristol NHS Trust, Bristol, Avon, England; [Michael, S.] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England; [Morgan, M.] Univ Hosp Wales, Cardiff, S Glam, Wales; [Porter, K.] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England; [Shaw, D.; Welters, I.] Royal Liverpool & Broadgreen Univ Hosp NHS Trust, Liverpool, Merseyside, England; [Smith, J. D.] Ninewells Hosp, Dundee, Scotland; [Thomas, E.] Plymouth Hosp NHS Trust, Plymouth, Devon, England		Cole, E (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Trauma Sci, 4 Newark St, London E1 2AT, England.	e.cole@qmul.ac.uk		Cole, Elaine/0000-0002-3642-3537; Welters, Ingeborg/0000-0002-3408-8798; Horner, Daniel Edward/0000-0002-0400-2017; Kaye, Callum/0000-0002-6904-7048; Morgan, Matt/0000-0002-2357-7190			Aisiku IP, 2016, J TRAUMA ACUTE CARE, V80, P308, DOI 10.1097/TA.0000000000000903; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; Antonelli M, 1999, INTENS CARE MED, V25, P389, DOI 10.1007/s001340050863; Brakenridge SC, 2011, J TRAUMA, V71, P299, DOI 10.1097/TA.0b013e318224d328; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Cole E., 2016, ORDIT ORGAN DYSFUNCT; Coucke W, 2012, CLIN CHIM ACTA, V413, P582, DOI 10.1016/j.cca.2011.11.030; Cryer HG, 1999, J TRAUMA, V46, P597, DOI 10.1097/00005373-199904000-00007; D'haeseleer P, 2005, NAT BIOTECHNOL, V23, P1499, DOI 10.1038/nbt1205-1499; Dewar DC, 2014, J TRAUMA ACUTE CARE, V77, P624, DOI 10.1097/TA.0000000000000406; Dewar DC, 2013, J TRAUMA ACUTE CARE, V74, P774, DOI 10.1097/TA.0b013e31827a6e69; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Duan CY, 2015, INT J CLIN EXP MED, V8, P11645; Efron PA, 2018, SURGERY, V164, P178, DOI 10.1016/j.surg.2018.04.011; Frohlich M, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0321-5; Frohlich M, 2014, J TRAUMA ACUTE CARE, V76, P921, DOI 10.1097/TA.0000000000000199; Gibbons FD, 2002, GENOME RES, V12, P1574, DOI 10.1101/gr.397002; Glen J, 2016, BMJ-BRIT MED J, V353, pi3051; GORIS RJA, 1985, ARCH SURG-CHICAGO, V120, P1109; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Huber-Lang M, 2018, NAT IMMUNOL, V19, P327, DOI 10.1038/s41590-018-0064-8; Hutchings L, 2017, J TRAUMA ACUTE CARE, V82, P534, DOI 10.1097/TA.0000000000001328; Hwabejire JO, 2016, AM J SURG, V211, P733, DOI 10.1016/j.amjsurg.2015.09.019; Kasotakis G, 2013, J TRAUMA ACUTE CARE, V74, P1215, DOI 10.1097/TA.0b013e3182826e13; Knox DB, 2015, INTENS CARE MED, V41, P814, DOI 10.1007/s00134-015-3764-7; Minei JP, 2012, CRIT CARE MED, V40, P1129, DOI 10.1097/CCM.0b013e3182376e9f; Moore FA, 1996, J TRAUMA, V40, P501, DOI 10.1097/00005373-199604000-00001; Namas RA, 2016, J CRIT CARE, V36, P146, DOI 10.1016/j.jcrc.2016.07.002; National Institute for Health and Care Excellence, 2016, MAJ TRAUM ASS IN MAN; Nomellini V, 2018, SHOCK, V49, P4, DOI 10.1097/SHK.0000000000000939; Rosenthal MD, 2016, SURG INFECT, V17, P167, DOI 10.1089/sur.2015.184; Rosenthal MD., 2015, J ADV NUTR HUM METAB, V1, pe784, DOI [10.14800/janhm.784, DOI 10.14800/JANHM.784]; Sakr Y, 2012, CRIT CARE, V16, DOI 10.1186/cc11868; Sauaia A, 2014, J TRAUMA ACUTE CARE, V76, P582, DOI 10.1097/TA.0000000000000147; Shepherd JM, 2017, SHOCK, V47, P429, DOI 10.1097/SHK.0000000000000779; Ulvik A, 2007, CRIT CARE, V11, DOI 10.1186/cc6111; Vanzant EL, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0788-x; Vanzant EL, 2014, J TRAUMA ACUTE CARE, V76, P21, DOI 10.1097/TA.0b013e3182ab1ab5; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Watters JM, 2006, J TRAUMA, V61, P300, DOI 10.1097/01.ta.0000224211.36154.44; White NJ, 2015, J THROMB HAEMOST, V13, P978, DOI 10.1111/jth.12919; Zygun D, 2005, CURR OPIN CRIT CARE, V11, P139, DOI 10.1097/01.ccx.0000155356.86241.c0; Zygun D, 2006, CRIT CARE, V10, DOI 10.1186/cc5007	44	18	19	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1323	1365-2168		BRIT J SURG	Br. J. Surg.	MAR	2020	107	4					402	412		10.1002/bjs.11361		NOV 2019	11	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	KR8AP	WOS:000494525200001	31691956	Green Submitted, Green Published, Green Accepted, hybrid			2022-02-06	
J	Khalid, F; Yang, GL; McGuire, JL; Robson, MJ; Foreman, B; Ngwenya, LB; Lorenz, JN				Khalid, Fatima; Yang, George L.; McGuire, Jennifer L.; Robson, Matthew J.; Foreman, Brandon; Ngwenya, Laura B.; Lorenz, John N.			Autonomic dysfunction following traumatic brain injury: translational insights	NEUROSURGICAL FOCUS			English	Article						traumatic brain injury; autonomic dysfunction; autoregulation; kidney; cardiovascular	PAROXYSMAL SYMPATHETIC HYPERACTIVITY; CRITICALLY-ILL PATIENTS; RENAL BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; INTESTINAL DYSFUNCTION; KIDNEY; DEATH; CLEARANCE; RAT; PLASMA	Although there is a substantial amount of research on the neurological consequences of traumatic brain injury (TBI), there is a knowledge gap regarding the relationship between TBI and the pathophysiology of organ system dysfunction and autonomic dysregulation. In particular, the mechanisms or incidences of renal or cardiac complications after TBI are mostly unknown. Autonomic dysfunction following TBI exacerbates secondary injury and may contribute to nonneurologial complications that prolong hospital length of stay. Gaining insights into the mechanisms of autonomic dysfunction can guide advancements in monitoring and treatment paradigms to improve acute survival and long-term prognosis of TBI patients. In this paper, the authors will review the literature on autonomic dysfunction after TBI and possible mechanisms of paroxysmal sympathetic hyperactivity. Specifically, they will discuss the link among the brain, heart, and kidneys and review data to direct future research on and interventions for TBI-induced autonomic dysfunction.	[Khalid, Fatima; Lorenz, John N.] Univ Cincinnati, Coll Med, Dept Pharmacol & Syst Physiol, Cincinnati, OH USA; [Yang, George L.; McGuire, Jennifer L.; Foreman, Brandon; Ngwenya, Laura B.] Univ Cincinnati, Coll Med, Dept Neurosurg, Cincinnati, OH 45267 USA; [McGuire, Jennifer L.; Robson, Matthew J.; Foreman, Brandon; Ngwenya, Laura B.] Univ Cincinnati, Collaborat Res Acute Neurol Injuries, James L Winkle Coll Pharm, Cincinnati, OH USA; [Robson, Matthew J.] Univ Cincinnati, Div Pharmaceut Sci, James L Winkle Coll Pharm, Cincinnati, OH USA; [Foreman, Brandon; Ngwenya, Laura B.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA		Ngwenya, LB (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45267 USA.	laura.ngwenya@uc.edu		Ngwenya, Laura/0000-0001-7103-971X; McGuire, Jennifer/0000-0003-3058-5241			Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bansal V, 2010, J TRAUMA, V68, P1059, DOI 10.1097/TA.0b013e3181d87373; Bansal V, 2009, J NEUROTRAUM, V26, P1353, DOI [10.1089/neu.2008.0858, 10.1089/neu.2008-0858]; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Belzberg H, 2007, J TRAUMA, V63, P1032, DOI 10.1097/01.ta.0000235995.86162.d2; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chaikittisilpa N, 2018, J NEUROSCI RES, V96, P661, DOI 10.1002/jnr.24100; Cheah CF, 2017, NEUROCRIT CARE, V26, P284, DOI 10.1007/s12028-016-0334-y; Chen JG, 2019, EUR J NEUROSCI, V50, P1972, DOI 10.1111/ejn.14374; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1981, NEUROSURGERY, V8, P309, DOI 10.1227/00006123-198103000-00002; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Del Rey A, 2008, HYPOTHALAMUS PITUITA, P394; Dias C, 2015, NEUROCRIT CARE, V22, P192, DOI 10.1007/s12028-014-0045-1; DOOLAN PD, 1962, AM J MED, V32, P65, DOI 10.1016/0002-9343(62)90183-3; Elrifai AM, 1996, STROKE, V27, P737, DOI 10.1161/01.STR.27.4.737; Erdos B, 2006, J HYPERTENS, V24, P109, DOI 10.1097/01.hjh.0000198026.99600.59; Erley CM, 2001, CRIT CARE MED, V29, P1544, DOI 10.1097/00003246-200108000-00008; Felder RB, 2010, EXP PHYSIOL, V95, P19, DOI 10.1113/expphysiol.2008.045948; Fukui S, 2003, ACT NEUR S, V86, P489; GERBER JG, 1979, AM J PHYSIOL, V237, pF441, DOI 10.1152/ajprenal.1979.237.6.F441; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Herijgers P, 1996, TRANSPLANTATION, V62, P330, DOI 10.1097/00007890-199608150-00005; Hoste EAJ, 2005, NEPHROL DIAL TRANSPL, V20, P747, DOI 10.1093/ndt/gfh707; Ito S, 2009, HYPERTENS RES, V32, P115, DOI 10.1038/hr.2008.27; Just A, 2007, AM J PHYSIOL-REG I, V292, pR1, DOI 10.1152/ajpregu.00332.2006; Krishnamoorthy V, 2017, NEUROCRIT CARE, V26, P379, DOI 10.1007/s12028-016-0335-x; Kvetnansky R, 2009, PHYSIOL REV, V89, P535, DOI 10.1152/physrev.00042.2006; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Lopez NE, 2012, J TRAUMA ACUTE CARE, V72, P1562, DOI 10.1097/TA.0b013e3182569875; Masuda T, 2002, STROKE, V33, P1671, DOI 10.1161/01.STR.0000016327.74392.02; McMahon CG, 2011, SHOCK, V35, P53, DOI 10.1097/SHK.0b013e3181e687c6; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; Mierzewska-Schmidt M, 2015, ANAESTH INTENSIVE TH, V47, P175, DOI 10.5603/AIT.2015.0017; Minville V, 2011, CRIT CARE, V15, DOI 10.1186/cc10013; Mirzayan MJ, 2008, NEUROL RES, V30, P457, DOI 10.1179/174313208X276907; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; Nosaka S, 1966, Jpn Circ J, V30, P509; Novitzky D, 1997, TRANSPLANT INT, V10, P24, DOI 10.1111/j.1432-2277.1997.tb00532.x; NOVITZKY D, 1986, ANN THORAC SURG, V41, P520, DOI 10.1016/S0003-4975(10)63032-9; OKAMOTO K, 1965, Jpn Circ J, V29, P251; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Perkes I, 2010, ANN NEUROL, V68, P126, DOI 10.1002/ana.22066; Prathep S, 2014, CRIT CARE MED, V42, P142, DOI 10.1097/CCM.0b013e318298a890; Qian R, 2015, AM J CARDIOVASC DIS, V5, P72; Sanchez-Fructuoso AI, 2004, TRANSPLANTATION, V78, P142, DOI 10.1097/01.TP.0000134769.65550.70; Schiller A, 2010, NEPHROL DIAL TRANSPL, V25, P1370, DOI 10.1093/ndt/gfq068; Serri K, 2016, SCAND J TRAUMA RESUS, V24, DOI 10.1186/s13049-016-0217-4; TANAKA I, 1984, BIOCHEM BIOPH RES CO, V124, P663, DOI 10.1016/0006-291X(84)91606-1; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tumer N, 2013, NEUROSCI LETT, V544, P62, DOI 10.1016/j.neulet.2013.03.042; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Vedantam A, 2017, NEUROSURG FOCUS, V43, DOI 10.3171/2017.7.FOCUS17418; Wei SG, 2013, HYPERTENSION, V62, P118, DOI 10.1161/HYPERTENSIONAHA.113.01404; Wu CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171999	62	18	18	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2019	47	5							E8	10.3171/2019.8.FOCUS19517			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	JJ2IT	WOS:000493985900008	31675718	gold			2022-02-06	
J	VanItallie, TB				VanItallie, Theodore B.			Traumatic brain injury (TBI) in collision sports: Possible mechanisms of transformation into chronic traumatic encephalopathy (CTE)	METABOLISM-CLINICAL AND EXPERIMENTAL			English	Article						Acquired seizure disorder; Alzheimer's disease; Parkinson's disease; Amyotrophic lateral sclerosis; Soccer ball 'heading'	AMYOTROPHIC-LATERAL-SCLEROSIS; HEAD-INJURY; RISK; NEUROINFLAMMATION; NEUROPATHOLOGY; DIAGNOSIS; PATHOLOGY; PLAYERS; DISEASE	Traumatic brain injury (TBI) is a leading cause of death and disability, contributing to -30% of all injuryrelated deaths in the US. TBI occurs when a force transmitted to the head causes neuropathologic damage and impairment of brain function. TBI doubles risk of suicide and is the major determinant of acquired seizure disorders. TBI arising from closed head trauma (CHT) significantly increases the risk of developing Alzheimer's disease (AD), Parkinson's disease (PD) and chronic traumatic encephalopathy (CU). Evidence for a possible role of TBI as a risk factor for sporadic amyotrophic lateral sclerosis (sALS) has been provided by studies of professional players of European football. Depending on age, genetic make-up (in particular, being a carrier of one or two ApoE4 alleles), the number of TBIs sustained, their severity, the time periods involved, and many other factors that affect vulnerability, decades may pass after occurrence of one or more TBIs before sequelae such as AD, PD, sALS or CTE become clinically evident. Among college and professional football players who experience repeated concussions and sub-concussive blows to the head, the risk of developing CTE increases with the number of years actively devoted to the sport, and the degree of exposure to physical impacts inherent in the position played. Following a moderate or severe concussion, or a series of mild blows to the head, the brain may undergo subtle pathophysiological changes that are unlikely to be detected with confidence using available diagnostic methods. Biomarkers are being sought that can help the attending physician infer the likely presence of an ongoing occult neurodegenerative process. One example of the adverse effect of collision on the brain is "heading" the soccer ball a feat that, repeated over years of competition, has been found to produce severe brain damage in veteran players. CTE has attracted increasing national attention because of its devastating effects in a high proportion of retired professional players of American football. In a study of brains from deceased former football players, contributed mostly by family members, CTE was neuropathologically diagnosed in 110 of 111 of National Football League (NFL) veterans. In the CU-positive subjects, the authors observed extensive brain atrophy, astrogliosis, myelinated axonopathy, microvascular injury, perivascular neuroinflammation, and phosphorylated tau protein pathology. CTE's neuropathology has been formally defined as a tauopathy characterized by a distinct perivascular accumulation of hyperphosphorylated tau in neurons and astrocytes within cerebral sulci. Although the mechanism that underlies the unforeseen emergence of CTE long after the occurrence of one or more closed head traumas is unknown, an explanation proposed by Albayram and associates is persuasive. They discovered TBI-induced neuronal production of the toxic compound cis P-tau, an abnormal and destructive isomer of the normal and benign trans P-tau, in mouse models of CTE. Cis P-tau produced a CTE-like syndrome via a process they termed cistauosis. Cistauosis can be blocked in laboratory animals by cis P-tau monoclonal antibody, which prevents later development of tau tangles, brain atrophy and virtual CU. In a subsequent study, the same group found in human samples obtained post-TBI from a variety of causes, that cis P-tau is induced in cortical axons and cerebrospinal fluid and positively correlates with axonal injury and clinical outcome. Thus, cis P-tau appears to contribute to short-term and long-term sequelae after TBI, but may be subject to neutralization by cis-antibody treatment. (C) 2019 Published by Elsevier Inc.	[VanItallie, Theodore B.] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA		VanItallie, TB (corresponding author), Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.				College International de Recherche Servier	This article is part of a supplement entitled 'Role of Environment in Initiation and Progression of Illnesses' which is sponsored by the College International de Recherche Servier.	Abner EL, 2014, DEMENT GERIATR COGN, V37, P294, DOI 10.1159/000355478; Albayram O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01068-4; [Anonymous], 2018, HEALTHDAY NEWS  0118; [Anonymous], 2001, NATL HOSP DISCHARGE; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Belli S, 2005, EUR J EPIDEMIOL, V20, P237, DOI 10.1007/s10654-004-6879-7; Castellani RJ, 2017, J ALZHEIMERS DIS, V60, P1209, DOI 10.3233/JAD-170669; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Clark M., 2016, TRANSLATIONAL RES TR; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Goldman SM, 2006, ANN NEUROL, V60, P65, DOI 10.1002/ana.20882; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Josephs KA, 2017, MAYO CLIN PROC, V92, P1291, DOI 10.1016/j.mayocp.2017.04.016; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Leo P, 2016, TRANSLATIONAL RES TR; McKee AC, 2015, HDB CLIN NEUROL, V227, P45; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Oliver JM, 2019, J NEUROSURG, V130, P1655, DOI 10.3171/2017.12.JNS172035; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Seo JS, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.56; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Turner RC, 2013, FRONT NEUROL, V3, DOI 10.3389/fneur.2012.00186; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; Wortzel HS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/424280	34	18	19	5	54	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0026-0495	1532-8600		METABOLISM	Metab.-Clin. Exp.	NOV	2019	100			S					153943	10.1016/j.metabol.2019.07.007			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	JI9PY	WOS:000493795600007	31610856				2022-02-06	
J	Zhang, D; Lu, ZF; Man, J; Cui, KF; Fu, XJ; Yu, L; Gao, YF; Liao, LH; Xiao, QQ; Guo, RM; Zhang, YX; Zhang, Z; Liu, XL; Lu, H; Wang, JP				Zhang, Di; Lu, Zhengfang; Man, Jiang; Cui, Kefei; Fu, Xiaojie; Yu, Lie; Gao, Yufeng; Liao, Linghui; Xiao, Qianqian; Guo, Ruiming; Zhang, Yongxin; Zhang, Zhen; Liu, Xianliang; Lu, Hong; Wang, Jianping			Wnt-3a alleviates neuroinflammation after ischemic stroke by modulating the responses of microglia/macrophages and astrocytes	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Wnt-3a; Ischemic stroke; Neuroinflammtion; Microglia/macrophage; Astrocyte; Polarization	TRAUMATIC BRAIN-INJURY; HEMORRHAGIC TRANSFORMATION; REACTIVE ASTROCYTES; MICROGLIA; NEUROPROTECTION; NEUROGENESIS; ACTIVATION; MECHANISMS; EXPRESSION; INHIBITOR	Neuroinflammation crucially influences functional recovery after ischemic stroke. Wnt-3a, a novel Wnt protein that specifically promotes Wnt/beta-catenin signaling pathway, has been shown to regulate apoptosis and cell proliferation, but how it affects ischemic stroke-induced toxic brain inflammation remains unknown. Using a transient middle cerebral artery occlusion (tMCAO) mouse model in this study, we found that intranasal Wnt-3a-treated tMCAO mice had apparently reduced infarct volume and decreased brain water content after being allowed to recover for 72 h, as well as better neurologic outcomes on days 3, 7, and 14. Mice received Wnt-3a had significantly fewer tMCAO-induced peri-infarct TUNEL-positive cells compared with those received vehicle. Further, Wnt-3a-delivered tMCAO mice had notably fewer peri-infarct CD68-positive cells and lower ionized calcium-binding adapter molecule (Iba)-1 protein level. Wnt-3a significantly downregulated the expression of inducible nitric oxide synthase (iNOS) and tumor necrosis factor (TNF)-alpha, and upregulated the expression of arginase 1 (Arg1) and CD206. Finally, Wnt-3a obviously decreased the number of tMCAO-induced peri-infarct glial fibrillary acidic protein (GFAP)/C3-positive cells, increased the number of GFAP/S100A10-positive cells, attenuated the protein levels of GFAP and interleukin 15 (IL15), and elevated IL33 protein level. Our findings suggest that intranasal Wnt-3a could ameliorate toxic responses of microglia/macrophages and astrocytes in ischemic brain injury, supporting that Wnt-3a might be potentially appropriate for ischemic stroke treatment functioning as an immunomodulatory agent.	[Zhang, Di; Lu, Zhengfang; Man, Jiang; Gao, Yufeng; Liao, Linghui; Xiao, Qianqian; Zhang, Yongxin; Zhang, Zhen; Liu, Xianliang; Wang, Jianping] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China; [Cui, Kefei] Zhengzhou Univ, Dept Ultrasound, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Fu, Xiaojie] Zhengzhou Univ, Dept Intervent Neuroradiol, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Yu, Lie; Lu, Hong] Zhengzhou Univ, Dept Neurol, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China; [Guo, Ruiming] Zhengzhou Univ, Dept Surg, Affiliated Hosp 1, Zhengzhou 450052, Henan, Peoples R China		Wang, JP (corresponding author), Zhengzhou Univ, Dept Neurol, Affiliated Hosp 5, Zhengzhou 450052, Henan, Peoples R China.	wjpwfy666@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81571137, 81771247]	This work was supported by grants from the National Natural Science Foundation of China (81571137 and 81771247).	Bourganis V, 2018, EUR J PHARM BIOPHARM, V128, P337, DOI 10.1016/j.ejpb.2018.05.009; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Crowe TP, 2018, LIFE SCI, V195, P44, DOI 10.1016/j.lfs.2017.12.025; Cuadrado A, 2018, REDOX BIOL, V14, P522, DOI 10.1016/j.redox.2017.10.010; D'Angelo B, 2016, NEUROPHARMACOLOGY, V101, P13, DOI 10.1016/j.neuropharm.2015.09.017; Duan JL, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1406-7; Erdo F, 2018, BRAIN RES BULL, V143, P155, DOI 10.1016/j.brainresbull.2018.10.009; Filous AR, 2016, PROG NEUROBIOL, V144, P173, DOI 10.1016/j.pneurobio.2016.03.009; Fujita A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1251-0; Ganger S, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10030116; Goetzl EJ, 2018, ANN NEUROL, V83, P544, DOI 10.1002/ana.25172; Gomez-Nicola D, 2008, GLIA, V56, P494, DOI 10.1002/glia.20628; Guo YN, 2015, 2015 12TH CHINA INTERNATIONAL FORUM ON SOLID STATE LIGHTING (SSLCHINA), P4, DOI 10.1109/SSLCHINA.2015.7360677; Halleskog C, 2013, J NEUROCHEM, V125, P803, DOI 10.1111/jnc.12250; Halleskog C, 2011, GLIA, V59, P119, DOI 10.1002/glia.21081; Hanson LR, 2013, JOVE-J VIS EXP, DOI 10.3791/4440; Hendrickx DAE, 2017, J NEUROIMMUNOL, V309, P12, DOI 10.1016/j.jneuroim.2017.04.007; Hu XM, 2015, NAT REV NEUROL, V11, P56, DOI 10.1038/nrneurol.2014.207; Huang SM, 2017, EXP NEUROL, V296, P32, DOI 10.1016/j.expneurol.2017.06.023; Jiang XY, 2018, PROG NEUROBIOL, V163, P144, DOI 10.1016/j.pneurobio.2017.10.001; Kanazawa M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102135; Kilander MBC, 2011, ACTA PHYSIOL, V203, P363, DOI 10.1111/j.1748-1716.2011.02324.x; Koizumi S, 2018, NEUROCHEM INT, V119, P107, DOI 10.1016/j.neuint.2018.01.007; Lambert C, 2016, MOL NEUROBIOL, V53, P2297, DOI 10.1007/s12035-015-9138-x; Lambertsen KL, 2019, ACTA NEUROPATHOL, V137, P693, DOI 10.1007/s00401-018-1930-z; Lan X, 2017, NAT REV NEUROL, V13, P420, DOI 10.1038/nrneurol.2017.69; Lee GA, 2018, BRAIN BEHAV IMMUN, V73, P562, DOI 10.1016/j.bbi.2018.06.021; Li MS, 2017, P NATL ACAD SCI USA, V114, pE396, DOI 10.1073/pnas.1612930114; Li ZG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00523; Liddelow SA, 2017, IMMUNITY, V46, P957, DOI 10.1016/j.immuni.2017.06.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu ZW, 2016, PROG NEUROBIOL, V144, P103, DOI 10.1016/j.pneurobio.2015.09.008; Luo QP, 2018, NEUROSCIENCE, V385, P75, DOI 10.1016/j.neuroscience.2018.05.047; Ma QQ, 2019, ASIA PAC J OPER RES, V36, DOI 10.1142/S0217595919500039; Ma YY, 2017, PROG NEUROBIOL, V157, P247, DOI 10.1016/j.pneurobio.2016.01.005; Matei N, 2018, J NEUROSCI, V38, P6787, DOI 10.1523/JNEUROSCI.2352-17.2018; Neal M, 2018, GLIA, V66, P2137, DOI 10.1002/glia.23467; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Ramagiri S, 2017, EUR J PHARMACOL, V803, P84, DOI 10.1016/j.ejphar.2017.03.028; Rana AK, 2018, NEUROPHARMACOLOGY, V139, P124, DOI 10.1016/j.neuropharm.2018.07.006; Shen ZB, 2018, REACT CHEM ENG, V3, P34, DOI 10.1039/c7re00201g; Tsuyama J, 2018, SEMIN IMMUNOPATHOL, V40, P523, DOI 10.1007/s00281-018-0707-8; Underly RG, 2017, J NEUROSCI, V37, P129, DOI 10.1523/JNEUROSCI.2891-16.2016; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Wang JP, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1226-1; Wang JP, 2017, NEUROSCIENCE, V364, P202, DOI 10.1016/j.neuroscience.2017.09.025; Wang JP, 2017, BEHAV BRAIN RES, V316, P145, DOI 10.1016/j.bbr.2016.09.007; Wang JY, 2017, TRANSL STROKE RES, V8, P284, DOI 10.1007/s12975-016-0514-2; Wang W, 2016, MOL NEUROBIOL, V53, P7028, DOI 10.1007/s12035-015-9607-2; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang YJ, 2018, ANTIOXID REDOX SIGN, V28, P141, DOI 10.1089/ars.2017.7003; Wei ZZ, 2018, J CEREBR BLOOD F MET, V38, P404, DOI 10.1177/0271678X17702669; Wicher G, 2017, J NEUROTRAUM, V34, P3173, DOI 10.1089/neu.2016.4900; Xiong XY, 2016, PROG NEUROBIOL, V142, P23, DOI 10.1016/j.pneurobio.2016.05.001; Xu XT, 2019, J CELL PHYSIOL, V234, P904, DOI 10.1002/jcp.26918; Yang YY, 2017, J NEUROSCI, V37, P4692, DOI 10.1523/JNEUROSCI.3233-16.2017; Yun SP, 2018, NAT MED, V24, P931, DOI 10.1038/s41591-018-0051-5; Zhang JY, 2018, J NEUROTRAUM, V35, P802, DOI 10.1089/neu.2016.4871	59	18	19	3	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	OCT	2019	75								105760	10.1016/j.intimp.2019.105760			9	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	JC0VV	WOS:000488998800013	31323530				2022-02-06	
J	Caccese, JB; Iverson, GL; Cameron, KL; Houston, MN; McGinty, GT; Jackson, JC; O'Donnell, P; Pasquina, PF; Broglio, SP; McCrea, M; McAllister, T; Buckley, TA				Caccese, Jaclyn B.; Iverson, Grant L.; Cameron, Kenneth L.; Houston, Megan N.; McGinty, Gerald T.; Jackson, Jonathan C.; O'Donnell, Patrick; Pasquina, Paul F.; Broglio, Steven P.; McCrea, Michael; McAllister, Thomas; Buckley, Thomas A.			Estimated Age of First Exposure to Contact Sports Is Not Associated with Greater Symptoms or Worse Cognitive Functioning in Male US Service Academy Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; mild traumatic brain injury; neurocognitive; repetitive head impacts	HEAD IMPACT BIOMECHANICS; RUGBY UNION PLAYERS; CONSTRUCT-VALIDITY; LATER-LIFE; CONCUSSION; EPIDEMIOLOGY; FOOTBALL; PARTICIPATION; ACCELERATION; INJURIES	This study examined the association between estimated age of first exposure (eAFE) to contact sport participation and neurocognitive performance and symptom ratings in U.S. service academy National Collegiate Athletic Association (NCAA) athletes. Male cadets (N = 891), who participate in lacrosse (n = 211), wrestling (n = 170), ice hockey (n = 81), soccer (n = 119), rugby (n = 10), or non-contact sports (n = 298), completed the Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) test before the season. Generalized linear modeling was used to predict each neurocognitive domain score and total symptom severity score. Predictor variables were entered in the following order: group (contact vs. non-contact); eAFE (eAFE <12 years vs. eAFE >= 12 years); group-by-eAFE; and covariates for learning accommodation status, concussion history, and age. The group-by-eAFE interaction was not significant for any of the ImPACT composite scores (Verbal Memory, Wald chi(2) = 0.073, p = 0.788; Visual Memory, Wald chi(2) = 2.71, p = 0.100; Visual Motor Speed, Wald chi(2) = 0.078, p = 0.780; Reaction Time, Wald chi(2) = 0.003, p = 0.955; Symptom Severity, Wald chi(2) = 2.87, p = 0.090). Learning accommodation history was associated with lower scores on Visual Motor Speed (chi(2) = 6.19, p = 0.013, B = -2.97). Older age was associated with faster reaction time (chi(2) = 4.40, p = 0.036, B = -0.006) and lesser symptom severity (chi(2) = 5.55, p = 0.019, B = -0.068). No other parameters were significant. We observed no association between eAFE, contact sport participation, neurocognitive functioning, or subjectively experienced symptoms in this cohort. Earlier eAFE to contact sport participation is not related to worse neurocognitive performance or greater subjectively experienced symptoms in male U.S. service academy NCAA athletes.	[Caccese, Jaclyn B.; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.] Univ Delaware, Interdisciplinary Biomech & Movement Sci Program, Newark, DE USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Charlestown, MA USA; [Iverson, Grant L.] MassGeneral Hosp, Children Sports Concuss Program, Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] Ctr Hlth & Rehabil Res, Charlestown, MA USA; [Cameron, Kenneth L.; Houston, Megan N.] US Mil Acad, Keller Army Hosp, West Point, NY USA; [McGinty, Gerald T.] US Air Force Acad, Academy, CO USA; [Jackson, Jonathan C.] US Air Force Acad, Med Grp 10, Boston, MA USA; [O'Donnell, Patrick] US Coast Guard Acad Reg Clin, New London, CT USA; [Pasquina, Paul F.] Uniformed Serv Univ Hlth Sci, Walter Reed Natl Mil Med Ctr, Ctr Rehabil Sci Res, Bethesda, MD 20814 USA; [Broglio, Steven P.] Univ Michigan, Michigan Concuss Ctr, Ann Arbor, MI 48109 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McAllister, Thomas] Indiana Univ Sch Med, Indianapolis, IN 46202 USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Interdisciplinary Biomech & Movement Sci Program, 100 Discovery Blvd, Newark, DE 19713 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Caccese, Jaclyn B./0000-0003-2329-3603; Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program [W81XWH-BA170608]	This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Fort Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Combat Casualty Care Program, endorsed by the Department of Defense under Award No. W81XWH-BA170608. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Office of the Assistant Secretary of Defense for Health Affairs.	Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Brett BL, 2019, SPORTS HEALTH, V11, P332, DOI 10.1177/1941738119849076; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Caccese JB, 2019, SPORTS MED, V49, P477, DOI 10.1007/s40279-019-01069-x; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Epstein HT, 1999, BRAIN DEV-JPN, V21, P535, DOI 10.1016/S0387-7604(99)00066-2; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hulteen RM, 2017, PREV MED, V95, P14, DOI 10.1016/j.ypmed.2016.11.027; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Irick E., 2015, NCAA SPORTS SPONSORS; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; King D, 2017, J NEUROSURG-PEDIATR, V19, P13, DOI 10.3171/2016.7.PEDS1684; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kramer JH, 2000, ARCH CLIN NEUROPSYCH, V15, P83, DOI 10.1016/S0887-6177(99)00022-0; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Larrabee G.J., 2018, COGNITIVE DEFICITS M; Lovell M.R., 2011, CLIN INTERPRETATION; Maerlender A, 2013, CLIN NEUROPSYCHOL, V27, P290, DOI 10.1080/13854046.2012.744098; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mihalik JP, 2012, ANN BIOMED ENG, V40, P141, DOI 10.1007/s10439-011-0405-3; National Federation of State High School Associations, 2018, 2017 18 HIGH SCH ATH; O'Connor KL, 2018, MIL MED, V183, pE580, DOI 10.1093/milmed/usx130; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Peng P, 2016, J LEARN DISABIL-US, V49, P3, DOI 10.1177/0022219414521667; Reynolds BB, 2016, AM J SPORT MED, V44, P2947, DOI 10.1177/0363546516648442; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stemper B.D., 2018, ANN BIOMED ENG, DOI [10.1007/s10439-018-02136-6., DOI 10.1007/S10439-018-02136-6.]; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Wilkinson G.S., 2006, WRAT 4 WIDE RANGE AC; Willer BS, 2018, J HEAD TRAUMA REHAB, V33, pE9, DOI 10.1097/HTR.0000000000000423; Yang JZ, 2012, J ATHL TRAINING, V47, P198; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	44	18	18	3	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					334	339		10.1089/neu.2019.6571		SEP 2019	6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000487163800001	31375052	Green Published			2022-02-06	
J	Li, FY; Wang, XD; Zhang, ZJ; Zhang, XL; Gao, PF				Li, Fayin; Wang, Xiaodong; Zhang, Zhijie; Zhang, Xianlong; Gao, Pengfei			Dexmedetomidine Attenuates Neuroinflammatory-Induced Apoptosis after Traumatic Brain Injury via Nrf2 signaling pathway	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							NEURONAL APOPTOSIS; OXIDATIVE STRESS; RATS; NEUROPROTECTION; INVOLVEMENT; MECHANISM; MICE	Objective Dexmedetomidine (DEX) exhibits neuroprotective effects as a multifunctional neuroprotective agent in numerous neurological disorders. However, in traumatic brain injury (TBI), the molecular mechanisms of these neuroprotective effects remain unclear. The present study investigated whether DEX, which has been reported to exert protective effects against TBI, could attenuate neuroinflammatory-induced apoptosis and clarified the underlying mechanisms. Methods A weight-drop model was established, and DEX was intraperitoneally injected 30 min after inducing TBI in rats. The water content in the brain tissue was measured. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assays were performed on histopathological tissue sections to evaluate neuronal apoptosis. Enzyme-linked immunosorbent assay and PCR were applied to detect the levels of the inflammatory factors, TNF-alpha, IL-1 beta, IL-6, and NF-kappa B. Results TBI-challenged rats exhibited significant neuronal apoptosis, which was characterized via the wet-to-dry weight ratio, neurobehavioral functions, TUNEL assay results and the levels of cleaved caspase-3, Bax upregulation and Bcl-2, which were attenuated by DEX. Western blot, immunohistochemistry, and PCR results revealed that DEX promoted Nrf2 expression and upregulated expression of the Nrf2 downstream factors, HO-1 and NQO-1. Furthermore, DEX treatment markedly prevented the downregulation of inflammatory response factors, TNF-alpha, IL-1 beta and NF-kappa B, and IL-6. Interpretation Administering DEX attenuated inflammation-induced brain injury in a TBI model, potentially via the Nrf2 signaling pathway.	[Li, Fayin; Zhang, Zhijie; Zhang, Xianlong; Gao, Pengfei] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Anesthesiol, 6 Beijing Rd West, Huaian 223002, Jiangsu, Peoples R China; [Wang, Xiaodong] Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Neurosurg, 6 Beijing Rd West, Huaian 223002, Jiangsu, Peoples R China		Gao, PF (corresponding author), Nanjing Med Univ, Affiliated Huaian Peoples Hosp 1, Dept Anesthesiol, 6 Beijing Rd West, Huaian 223002, Jiangsu, Peoples R China.	huaianpfg@126.com					Bortolotti P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01900; Cheng JX, 2018, J INT MED RES, V46, P2925, DOI 10.1177/0300060518781382; Chio CC, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0867-9; Dahmani S, 2008, ANESTHESIOLOGY, V108, P457, DOI 10.1097/ALN.0b013e318164ca81; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Fu CL, 2017, MOL MED REP, V15, P131, DOI 10.3892/mmr.2016.6012; Funakohi-Tago M, 2018, EUR J PHARMACOL, V834, P246, DOI 10.1016/j.ejphar.2018.07.043; Hu Y, 2018, ENVIRON TOXICOL PHAR, V62, P79, DOI 10.1016/j.etap.2018.05.012; Huang SX, 2018, NEUROCHEM RES, V43, P1814, DOI 10.1007/s11064-018-2597-5; Jiang L, 2017, BRAIN RES, V1660, P1, DOI 10.1016/j.brainres.2017.01.031; Kim E, 2017, NEUROSCI LETT, V649, P20, DOI 10.1016/j.neulet.2017.04.011; Li ZZ, 2018, BIOMED PHARMACOTHER, V106, P349, DOI 10.1016/j.biopha.2018.06.041; Liu XF, 2018, INT J BIOL SCI, V14, P1090, DOI 10.7150/ijbs.25996; Liu ZM, 2018, BIOCHEM BIOPH RES CO, V499, P112, DOI 10.1016/j.bbrc.2018.02.150; Muraoka S, 2018, WORLD NEUROSURG, V113, pE190, DOI 10.1016/j.wneu.2018.01.212; Silva MD, 2018, MOLECULES, V23, DOI 10.3390/molecules23071803; Sivandzade F, 2019, REDOX BIOL, V21, DOI 10.1016/j.redox.2018.11.017; Wang D, 2018, NEURAL REGEN RES, V13, P819, DOI 10.4103/1673-5374.232529; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Wu L, 2018, J CEREB BLOOD FLOW M, V13; Wu PS, 2018, J AGR FOOD CHEM, V66, P5790, DOI 10.1021/acs.jafc.8b00437; Xue ZL, 2017, BIOCHEM BIOPH RES CO, V486, P589, DOI 10.1016/j.bbrc.2017.03.097; Yang SH, 2018, MOLECULES, V23, DOI 10.3390/molecules23071774; Yao XL, 2017, J NEUROIMMUNOL, V310, P38, DOI 10.1016/j.jneuroim.2017.06.006; Zhang MH, 2018, MOL MED REP, V17, P8079, DOI 10.3892/mmr.2018.8898; Zhao WY, 2017, BRAIN RES, V1669, P141, DOI 10.1016/j.brainres.2017.06.006; Zheng B, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180892; Zhou J, 2018, AM J TRANSL RES, V10, P1887	29	18	19	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	SEP	2019	6	9					1825	1835		10.1002/acn3.50878		SEP 2019	11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA5LI	WOS:000484805300001	31478596	Green Published, gold			2022-02-06	
J	Malec, JF; Ketchum, JM; Hammond, FM; Corrigan, JD; Dams-O'Connor, K; Hart, T; Novack, T; Dahdah, M; Whiteneck, GG; Bogner, J				Malec, James F.; Ketchum, Jessica M.; Hammond, Flora M.; Corrigan, John D.; Dams-O'Connor, Kristen; Hart, Tessa; Novack, Thomas; Dahdah, Marie; Whiteneck, Gale G.; Bogner, Jennifer			Longitudinal Effects of Medical Comorbidities on Functional Outcome and Life Satisfaction After Traumatic Brain Injury: An Individual Growth Curve Analysis of NIDILRR Traumatic Brain Injury Model System Data	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						comorbidities; function; life satisfaction; medical conditions; outcomes; prevalence; rehabilitation; traumatic brain injury	DISABILITY; PREDICTORS	Objective: To explore associations of specific physical and neuropsychiatric medical conditions to motor and cognitive functioning and life satisfaction over the first 10 years following traumatic brain injury (TBI). Setting: Telephone follow-up through 6 TBI Model System centers. Participants: In total, 404 individuals or proxies with TBI enrolled in the TBI Model System longitudinal study participating in 10-year follow-up. Design: Individual growth curve analysis. Main Measures: FIM Motor and Cognitive subscales, Satisfaction With Life Scales, and Medical and Mental Health Comorbidities Interview. Results: Hypertension, diabetes, cancers, rheumatoid arthritis, and anxiety negatively affected the trajectory of motor functioning over time. Diabetes, cancers, chronic bronchitis, anxiety, and depression negatively impacted cognitive functioning. Numerous neuropsychiatric conditions (sleep disorder, alcoholism, drug addiction, anxiety, panic attacks, posttraumatic stress disorder, depression, and bipolar disorder), as well as hypertension, liver disease, and cancers, diminished life satisfaction. Other medical conditions had a negative effect on functioning and satisfaction at specific follow-up periods. Conclusion: Natural recovery after TBI may include delayed onset of functional decline or early recovery, followed by progressive deterioration, and is negatively affected by medical comorbidities. Results contribute to the growing evidence that TBI is most appropriately treated as a chronic medical condition complicated by a variety of comorbid conditions.	[Malec, James F.; Hammond, Flora M.] Indiana Univ Sch Med, 4141 Shore Dr, Indianapolis, IN 46254 USA; [Ketchum, Jessica M.; Whiteneck, Gale G.] Craig Hosp, Englewood, CO USA; [Corrigan, John D.; Bogner, Jennifer] Ohio State Univ, Columbus, OH 43210 USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Hart, Tessa] Moss Rehabil Res Inst, Elkins Pk, PA USA; [Novack, Thomas] Univ Alabama Birmingham, Birmingham, AL USA; [Dahdah, Marie] Baylor Scott & White Med Ctr Plano, Plano, TX USA		Hammond, FM (corresponding author), Indiana Univ Sch Med, 4141 Shore Dr, Indianapolis, IN 46254 USA.	flora.hammond@rhin.com	Ketchum, Jessica/AAE-8200-2020		Statistical Center [90DP0013, 90DP0084]; Moss TBI Model System [90DP0037]; North Texas TBI Model System [90DP0045]; National Institutes of Health National Center for Medical Rehabilitation Research(NICHD) [K01HD074651]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER	Statistical Center (Grant #90DP0013 and #90DP0084), Moss TBI Model System (Grant #90DP0037), North Texas TBI Model System (Grant #90DP0045), and from the National Institutes of Health National Center for Medical Rehabilitation Research(NICHD; K01HD074651). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this publication do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Bogner JA, 2017, J HEAD TRAUMA REHAB, V32, pE1, DOI 10.1097/HTR.0000000000000291; Centers for Disease Control and Prevention, 2017, NAT HLTH NUTR EX SUR; Corrigan J, 1999, TBI 21 CENT LEARN MO; GRANGER CV, 1993, AM J PHYS MED REHAB, V72, P84, DOI 10.1097/00002060-199304000-00005; Hammond FM, 2019, J HEAD TRAUMA REHAB, V34, pE1, DOI 10.1097/HTR.0000000000000465; Hammond FM, 2004, NEUROREHABILITATION, V19, P25; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Institute of Medicine, 2009, GULF WAR HLTH, V7; Kessler RC, 2004, INT J METH PSYCH RES, V13, P60, DOI 10.1002/mpr.166; LINACRE JM, 1994, ARCH PHYS MED REHAB, V75, P127; Malec JF, 2013, J HEAD TRAUMA REHAB, V28, P476, DOI 10.1097/HTR.0000000000000003; Malec JF, 2013, BRAIN INJURY PROFESS, P10; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; *SAS I INC, 2002, SAS; WHO, 2002, INN CAR CHRON COND B	18	18	18	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2019	34	5			SI		E24	E35		10.1097/HTR.0000000000000459			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IZ7NI	WOS:000487281100004	30829813	Green Published, Green Accepted			2022-02-06	
J	Cohen, E; Rodean, J; Diong, C; Hall, M; Freedman, SB; Aronson, PL; Simon, HK; Marin, JR; Samuels-Kalow, M; Alpern, ER; Morse, RB; Shah, SS; Peltz, A; Neuman, MI				Cohen, Eyal; Rodean, Jonathan; Diong, Christina; Hall, Matt; Freedman, Stephen B.; Aronson, Paul L.; Simon, Harold K.; Marin, Jennifer R.; Samuels-Kalow, Margaret; Alpern, Elizabeth R.; Morse, Rustin B.; Shah, Samir S.; Peltz, Alon; Neuman, Mark I.			Low-Value Diagnostic Imaging Use in the Pediatric Emergency Department in the United States and Canada	JAMA PEDIATRICS			English	Article							COMPUTED-TOMOGRAPHY; DEFENSIVE MEDICINE; CHILDREN; CARE; PHYSICIANS; MALPRACTICE; RADIOGRAPHY; YIELD	ImportanceDiagnostic imaging overuse in children evaluated in emergency departments (EDs) is a potential target for reducing low-value care. Variation in practice patterns across Canada and the United States stemming from organization of care, payment structures, and medicolegal environments may lead to differences in imaging overuse between countries. ObjectiveTo compare overall and low-value use of diagnostic imaging across pediatric ED visits in Ontario, Canada, and the United States. Design, Setting, and ParticipantsThis study used administrative health databases from 4 pediatric EDs in Ontario and 26 in the United States in calendar years 2006 through 2016. Individuals 18 years and younger who were discharged from the ED, including after visits for diagnoses in which imaging is not routinely recommended (eg, asthma, bronchiolitis, abdominal pain, constipation, concussion, febrile convulsion, seizure, and headache) were included. Data analysis occurred from April 2018 to October 2018. ExposuresDiagnostic imaging use. Main Outcome and MeasuresOverall and condition-specific low-value imaging use. Three-day and 7-day rates of hospital admission and those admissions resulting in intensive care, surgery, or in-hospital mortality were assessed as balancing measures. ResultsA total of 1783752 visits in Ontario and 21807332 visits in the United States were analyzed. Compared with visits in the United States, those in Canada had lower overall use of head computed tomography (Canada, 22942 [1.3%] vs the United States, 753270 [3.5%]; P<.001), abdomen computed tomography (5626 [0.3%] vs 211018 [1.0%]; P<.001), chest radiographic imaging (208843 [11.7%] vs 3408540 [15.6%]; P<.001), and abdominal radiographic imaging (77147 [4.3%] vs 3607141 [16.5%]; P<.001). Low-value imaging use was lower in Canada than the United States for multiple indications, including abdominal radiographic images for constipation (absolute difference, 23.7% [95% CI, 23.2%-24.3%]) and abdominal pain (20.6% [95% CI, 20.3%-21.0%]) and head computed tomographic scans for concussion (22.9% [95% CI, 22.3%-23.4%]). Abdominal computed tomographic use for constipation and abdominal pain, although low overall, were approximately 10-fold higher in the United States (0.1% [95% CI, 0.1%-0.2%] vs 1.2% [95% CI, 1.2%-1.2%]) and abdominal pain (0.8% [95% CI, 0.7%-0.9%] vs 7.0% [95% CI, 6.9%-7.1%]). Rates of 3-day and 7-day post-ED adverse outcomes were similar. Conclusions and RelevanceLow-value imaging rates were lower in pediatric EDs in Ontario compared with the United States, particularly those involving ionizing radiation. Lower use of imaging in Canada was not associated with higher rates of adverse outcomes, suggesting that usage may be safely reduced in the United States.	[Cohen, Eyal] Hosp Sick Children, Dept Pediat, Div Pediat Med, Toronto, ON, Canada; [Cohen, Eyal] Hosp Sick Children, Child Hlth Evaluat Sci, Toronto, ON, Canada; [Cohen, Eyal] Univ Toronto, Inst Hlth Policy Management & Evaluat, Dept Pediat, Toronto, ON, Canada; [Cohen, Eyal; Diong, Christina] ICES, Toronto, ON, Canada; [Rodean, Jonathan; Hall, Matt] Childrens Hosp Assoc, Lenexa, KS USA; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp Res Inst, Alberta Childrens Hosp,Dept Pediat, Sect Pediat Emergency Med,Cumming Sch Med, Calgary, AB, Canada; [Freedman, Stephen B.] Univ Calgary, Alberta Childrens Hosp Res Inst, Alberta Childrens Hosp,Dept Pediat, Sect Gastroenterol,Cumming Sch Med, Calgary, AB, Canada; [Aronson, Paul L.] Yale Sch Med, Sect Pediat Emergency Med, Dept Pediat, New Haven, CT USA; [Aronson, Paul L.] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Simon, Harold K.] Emory Univ, Sch Med, Dept Emergency Med, Div Emergency Med, Atlanta, GA USA; [Simon, Harold K.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Simon, Harold K.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Marin, Jennifer R.] Childrens Hosp Pittsburgh, Div Pediat Emergency Med, Pittsburgh, PA 15213 USA; [Samuels-Kalow, Margaret] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Alpern, Elizabeth R.] Northwestern Univ, Dept Pediat, Ann & Robert H Lurie Childrens Hosp Chicago, Div Emergency Med,Feinberg Sch Med, Chicago, IL 60611 USA; [Morse, Rustin B.] Childrens Hlth Syst Texas, Dallas, TX USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Hosp Med, Cincinnati, OH 45229 USA; [Shah, Samir S.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Infect Dis, Cincinnati, OH 45229 USA; [Peltz, Alon] Yale Sch Med, New Haven, CT USA; [Neuman, Mark I.] Harvard Med Sch, Boston Childrens Hosp, Div Emergency Med, Boston, MA 02115 USA		Cohen, E (corresponding author), Univ Toronto, Div Pediat Med, Hosp Sick Children, Dept Pediat, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	eyal.cohen@sickkids.ca	Hall, Matt/AAT-1349-2021; Freedman, Stephen/H-9102-2012	Hall, Matt/0000-0001-7778-5887; Freedman, Stephen/0000-0003-2319-6192; Alpern, Elizabeth/0000-0001-7887-3563; Marin, Jennifer/0000-0003-3090-664X	Agency for Healthcare Research and QualityUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS026006]; Alberta Children's Hospital Foundation Professorship in Child Health andWellness; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; AGENCY FOR HEALTHCARE RESEARCH AND QUALITYUnited States Department of Health & Human ServicesAgency for Healthcare Research & Quality [K08HS026006] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER	This study was supported by the Agency for Healthcare Research and Quality (grant K08HS026006 [Dr Aronson]) and the Alberta Children's Hospital Foundation Professorship in Child Health andWellness (Dr Freedman). In addition, ICES is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. Parts of the data and/or information compiled were provided by the Canadian Institute for Health Information.	Allie EH, 2018, AM J EMERG MED, V36, P769, DOI 10.1016/j.ajem.2017.10.009; American Academy of Pediatrics, 2013, 10 THINGS PHYS PAT S; Bakel LA, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0092; Berdahl CT, 2013, ANN EMERG MED, V62, P486, DOI 10.1016/j.annemergmed.2013.02.018; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Bourgeois FT, 2007, PEDIATR EMERG CARE, V23, P94, DOI 10.1097/PEC.0b013e3180302c22; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Canadian Association of Emergency Physicians, 2018, 10 THINGS PHYS PAT; Canadian Institute for Health Information, 2019, NAT AMB CAR REP SYST; Cheng AHY, 2017, CAN J EMERG MED, V19, pS9, DOI 10.1017/cem.2017.1; Chua KP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1809; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Emil S, 2007, J PEDIATR SURG, V42, P878, DOI 10.1016/j.jpedsurg.2006.12.054; Ferguson CC, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2016-2290; Feudtner C, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-199; Gallagher TH, 2006, ARCH INTERN MED, V166, P1605, DOI 10.1001/archinte.166.15.1605; Gong C, 2017, PEDIATR EMERG CARE, DOI [10.1097/PEC.0000000000001145, DOI 10.1097/PEC.000000000000114528441240]; Health Quality Ontario The Emergency Department Return Visit Quality Program, 2018, EM DEP RET VIS QUAL; Horner KB, 2016, AM J EMERG MED, V34, P2320, DOI 10.1016/j.ajem.2016.08.041; Hudgins JD, 2019, PEDIATR EMERG CARE, DOI [10.1097/PEC.0000000000001706, DOI 10.1097/PEC.000000000000170630624420]; Ivers N, 2018, JAMA INTERN MED, V178, P1250, DOI 10.1001/jamainternmed.2018.3568; Kimia AA, 2012, PEDIATR EMERG CARE, V28, P316, DOI 10.1097/PEC.0b013e31824d8b0b; Knapp JF, 2010, PEDIATR EMERG CARE, V26, P364, DOI 10.1097/PEC.0b013e3181db2262; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Levinson W, 2018, JAMA-J AM MED ASSOC, V319, P1975, DOI 10.1001/jama.2018.2202; Li GH, 2007, ACAD EMERG MED, V14, P582, DOI 10.1197/j.aem.2007.02.030; Lyons TW, 2016, SEIZURE-EUR J EPILEP, V35, P4, DOI 10.1016/j.seizure.2015.12.009; Mafi JN, 2018, BMJ QUAL SAF, V27, P333, DOI 10.1136/bmjqs-2017-007477; Niles LM, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0615; Papanicolas I, 2018, JAMA-J AM MED ASSOC, V319, P1024, DOI 10.1001/jama.2018.1150; Quinonez RA, 2013, J HOSP MED, V8, P479, DOI 10.1002/jhm.2064; Ralston SL, 2014, PEDIATRICS, V134, pE1474, DOI 10.1542/peds.2014-2742; Reuchlin-Vroklage LM, 2005, ARCH PEDIAT ADOL MED, V159, P671, DOI 10.1001/archpedi.159.7.671; Sharma S, 2003, PEDIATRICS, V111, P1, DOI 10.1542/peds.111.1.1; Steiner IP, 2003, CAN MED ASSOC J, V168, P1549; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Subcommittee on Febrile Seizures, 2011, Pediatrics, V127, P389, DOI 10.1542/peds.2010-3318; Tabbers MM, 2014, J PEDIATR GASTR NUTR, V58, P258, DOI 10.1097/MPG.0000000000000266; Wong AC, 2011, PEDIATR EMERG CARE, V27, P182, DOI 10.1097/PEC.0b013e31820d64f7; Woolhandler S, 2003, NEW ENGL J MED, V349, P768, DOI 10.1056/NEJMsa022033; Yan SC, 2016, WORLD NEUROSURG, V95, P53, DOI 10.1016/j.wneu.2016.07.069; Young W., 1996, PATTERNS HLTH CARE O, V2, P339	42	18	18	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6203	2168-6211		JAMA PEDIATR	JAMA Pediatr.	AUG	2019	173	8							e191439	10.1001/jamapediatrics.2019.1439			10	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	IP8LG	WOS:000480297300016	31157877	Green Published, Bronze			2022-02-06	
J	Mahan, MY; Thorpe, M; Ahmadi, A; Abdallah, T; Casey, H; Sturtevant, D; Judge-Yoakam, S; Hoover, C; Rafter, D; Miner, J; Richardson, C; Samadani, U				Mahan, Margaret Y.; Thorpe, Maxwell; Ahmadi, Aliya; Abdallah, Tessneem; Casey, Hannah; Sturtevant, Dylan; Judge-Yoakam, Senait; Hoover, Caleb; Rafter, Daniel; Miner, James; Richardson, Chad; Samadani, Uzma			Glial Fibrillary Acidic Protein (GFAP) Outperforms S100 Calcium-Binding Protein B (S100B) and Ubiquitin C-Terminal Hydrolase L1 (UCH-L1) as Predictor for Positive Computed Tomography of the Head in Trauma Subjects	WORLD NEUROSURGERY			English	Article						Calcium-binding protein B (S100 beta); Computed tomography (CT); Glial fibrillary acidic protein (GFAP); S100 ubiquitin carboxy-terminal hydrolase isozyme L1 (UCHL1); Traumatic brain injury (TBI)	GLASGOW COMA SCALE; BRAIN-INJURY; SERUM S100B; OUTCOME PREDICTION; DIAGNOSTIC MARKER; BLOOD BIOMARKERS; MILD; MODERATE; MANAGEMENT; CRITERIA	OBJECTIVE: Traumatic brain injuries (TBIs) are largely underdiagnosed and may have persistent refractory consequences. Current assessments for acute TBI are limited to physical examination and imaging. Biomarkers such as glial fibrillary acidic protein (GFAP), ubiquitin C-terminal hydrolase L1 (UCH-L1), and S100 calcium-binding protein B (S100B) have shown predictive value as indicators of TBI and potential screening tools. METHODS: In total, 37 controls and 118 unique trauma subjects who received a clinically ordered head computed tomography (CT) in the emergency department of a level 1 trauma center were evaluated. Blood samples collected at 0-8 hours (initial) and 12-32 hours (delayed) postinjury were analyzed for GFAP, UCH-L1, and S100B concentrations. These were then compared in CT-negative and CT-positive subjects. RESULTS: Median GFAP, UCH-L1, and S100B concentrations were greater in CT-positive subjects at both timepoints compared with CT-negative subjects. In addition, median UCH-L1 and S100B concentrations were lower at the delayed timepoint, whereas median GFAP concentrations were increased. As predictors of a positive CT of the head, GFAP outperformed UCH-L1 and S100B at both timepoints (initial: 0.89 sensitivity, 0.62 specificity; delayed: 0.94 sensitivity, 0.67 specificity). GFAP alone also outperformed all possible combinations of biomarkers. CONCLUSIONS: GFAP, UCH-L1, and S100B demonstrated utility for rapid prediction of a CT-positive TBI within 0-8 hours of injury. GFAP exhibited the greatest predictive power at 12-32 hours. Furthermore, these results suggest that GFAP alone has greater utility for predicting a positive CT of the head than UCH-L1, S100B, or any combination of the 3.	[Mahan, Margaret Y.; Thorpe, Maxwell; Ahmadi, Aliya; Abdallah, Tessneem; Casey, Hannah; Sturtevant, Dylan; Judge-Yoakam, Senait; Hoover, Caleb; Rafter, Daniel; Samadani, Uzma] Hennepin Healthcare, Dept Neurosurg, Minneapolis, MN 55415 USA; [Miner, James] Hennepin Healthcare, Dept Emergency Med, Minneapolis, MN USA; [Richardson, Chad] Hennepin Healthcare, Dept Gen Surg, Minneapolis, MN USA; [Mahan, Margaret Y.; Samadani, Uzma] Univ Minnesota, Dept Biomed Informat & Computat Biol, Minneapolis, MN 55455 USA; [Samadani, Uzma] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA		Samadani, U (corresponding author), Hennepin Healthcare, Dept Neurosurg, Minneapolis, MN 55415 USA.; Samadani, U (corresponding author), Univ Minnesota, Dept Biomed Informat & Computat Biol, Minneapolis, MN 55455 USA.; Samadani, U (corresponding author), Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.	uzma@samadani.com		Abdallah, Tessneem/0000-0002-1604-9621; Casey, Hannah/0000-0002-6562-4020; Mahan, Margaret/0000-0002-7332-9523	Minnesota Spinal Cord and Traumatic Brain Injury Research Fund; Rockswold Kaplan Endowed Chair; Abbott LaboratoriesAbbott Laboratories	This research was supported by funding from the Minnesota Spinal Cord and Traumatic Brain Injury Research Fund, Rockswold Kaplan Endowed Chair, and Abbott Laboratories. Dr. Uzma Samadani reports grant money to Hennepin Healthcare Research Institute to conduct research conceived and sponsored by Abbott Laboratories.	Abbasi Mohsen, 2014, Turk J Emerg Med, V14, P147, DOI 10.5505/1304.7361.2014.74317; Bishop P, 2016, BIOCHEM J, V473, P2453, DOI 10.1042/BCJ20160082; Brophy GM, 2011, J NEUROTRAUM, V28, P861, DOI 10.1089/neu.2010.1564; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; DAGOSTIN.R, 1973, BIOMETRIKA, V60, P613, DOI 10.1093/biomet/60.3.613; DAGOSTINO RB, 1971, BIOMETRIKA, V58, P341, DOI 10.1093/biomet/58.2.341; Dams-O'Connor K, 2017, J HEAD TRAUMA REHAB, V32, P147, DOI 10.1097/HTR.0000000000000263; Di Battista AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00110; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dutton RP, 2011, J TRAUMA, V70, P554, DOI 10.1097/TA.0b013e31820d1062; Easter JS, 2013, ACAD EMERG MED, V20, P753, DOI 10.1111/acem.12184; Ercole A, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0614-3; Fischer M, 2010, CRIT CARE, V14, DOI 10.1186/cc8963; Gill MR, 2004, ANN EMERG MED, V43, P215, DOI 10.1016/S0196-0644(03)00814-X; Gilquin B, 2010, MOL CELL BIOL, V30, P2724, DOI 10.1128/MCB.01468-09; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Honda M, 2010, J TRAUMA, V69, P104, DOI 10.1097/TA.0b013e3181bbd485; Hughes EG, 2004, MOL BRAIN RES, V124, P114, DOI 10.1016/j.molbrainres.2004.02.021; Mena JH, 2011, J TRAUMA, V71, P1185, DOI 10.1097/TA.0b013e31823321f8; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Jung CS, 2007, BRAIN, V130, P3336, DOI 10.1093/brain/awm263; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kim DS, 2013, J KOREAN NEUROSURG S, V54, P100, DOI 10.3340/jkns.2013.54.2.100; Kohavi R., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1137; Koskinen S, 2008, BRAIN INJURY, V22, P205, DOI 10.1080/02699050801938975; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Kreitzer N, 2017, AM J EMERG MED, V35, P875, DOI 10.1016/j.ajem.2017.01.051; KRUSKAL WH, 1953, J AM STAT ASSOC, V48, P907, DOI 10.2307/2281082; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Lumpkins KM, 2008, J TRAUMA, V65, P778, DOI 10.1097/TA.0b013e318185db2d; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mata-Mbemba D, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1781-9; McKinney W, 2010, P 9 PYTH SCI C, P56, DOI DOI 10.25080/MAJORA-92BF1922-00A; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Mondello S, 2016, SCI REP-UK, V6, DOI 10.1038/srep28203; Moschnegootz S, 2010, NEURORADIOL J, V23, P296, DOI 10.1177/197140091002300306; Muller K, 2007, J TRAUMA, V62, P1452, DOI 10.1097/TA.0b013e318047bfaa; Nayebaghayee Hossein, 2016, Asian J Neurosurg, V11, P46, DOI 10.4103/1793-5482.165780; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Owlia M, 2014, AM J MED, V127, P406, DOI 10.1016/j.amjmed.2014.01.023; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Peacock WF, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00641; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Sieber M, 2018, J FORENSIC LEG MED, V55, P65, DOI 10.1016/j.jflm.2018.02.016; Steiner Emanuel, 2016, J Trauma Manag Outcomes, V10, P5, DOI 10.1186/s13032-016-0035-8; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Studer M, 2015, BRAIN INJURY, V29, P1667, DOI 10.3109/02699052.2015.1075250; Sultan HY, 2004, EMERG MED J, V21, P420, DOI 10.1136/emj.2003.011353; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; WEINSTEIN DE, 1991, J CELL BIOL, V112, P1205, DOI 10.1083/jcb.112.6.1205; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Zhou JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040403	71	18	18	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2019	128						E434	E444		10.1016/j.wneu.2019.04.170			11	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IJ4SX	WOS:000475895100050	31051301				2022-02-06	
J	Olldashi, F; Latifi, R; Parsikia, A; Boci, A; Qesteri, O; Dasho, E; Bakiu, E				Olldashi, Fatos; Latifi, Rifat; Parsikia, Afshin; Boci, Arian; Qesteri, Orland; Dasho, Erion; Bakiu, Elvis			Telemedicine for Neurotrauma Prevents Unnecessary Transfers: An Update from a Nationwide Program in Albania and Analysis of 590 Patients	WORLD NEUROSURGERY			English	Article						Albania; Low- and middle-income countries; Neurotrauma; Spinal cord injuries; Telemedicine; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DIGITAL OBSERVATION CAMERA; DEVELOPING-COUNTRIES; MEDICAL SYSTEMS; MANAGEMENT; ARIZONA	BACKGROUND: The telemedicine program in Albania includes a specialized teleneurotrauma program. There is only 1 national trauma center with neurosurgery capability in the capital city of Tirana. Patients with isolated head or spine injury who require consultation with neurosurgeons located at the National Trauma Center receive telemedicine consultation. The aim of this follow-up study was to evaluate the effectiveness of a nationwide teleneurotrauma network in preventing unnecessary transfers for neurotrauma. METHODS: Retrospective analysis was performed of prospectively collected data on all telemedicine consultations for isolated neurotrauma from March 2014 to February 2018. All teleconsultations were coded using the International Classification of Diseases, Tenth Revision coding system (codes S00, S01-S010). RESULTS: Of 590 teleconsultations for neurotrauma, most patients (76%) were male (median age 46.5 years; range, 1-93 years); 403 (68.31%; mean age 45.12 years) did not require a transfer to the tertiary center, and 187 (mean age 42.47 years) were transferred. An average 12.5 (monthly average range, 8.5-16) patients were seen monthly with a steady increase to a mature telemedicine program at the present time. Most teleconsultations (70.67%) occurred during business hours (8:00 AM 4:30 PM); 173 (29.32%) occurred at night and on weekends. Analysis by diagnosis indicated that most cases of low severity were not transferred, whereas higher severity cases were twice as likely to be transferred (P < 0.05). CONCLUSIONS: Structured and coordinated telemedicine for neurotrauma increases access to care for neurosurgery patients in countries that do not have widespread neurosurgery services. Nearly 70% of patients may be treated locally by nonneurosurgeons.	[Olldashi, Fatos] Univ Hosp Trauma, Dept Neurosurg, Tirana, Albania; [Latifi, Rifat] New York Med Coll, Dept Surg, Sch Med, Valhalla, NY 10595 USA; [Latifi, Rifat] Westchester Med Ctr Hlth Network, Valhalla, NY 10595 USA; [Latifi, Rifat; Parsikia, Afshin; Boci, Arian; Dasho, Erion] Int Virtual E Hosp Fdn, Hope, ID 83836 USA; [Boci, Arian; Qesteri, Orland; Bakiu, Elvis] Integrated Telemed & E Hlth Program Albania, Tirana, Albania		Latifi, R (corresponding author), New York Med Coll, Dept Surg, Sch Med, Valhalla, NY 10595 USA.; Latifi, R (corresponding author), Westchester Med Ctr Hlth Network, Valhalla, NY 10595 USA.; Latifi, R (corresponding author), Int Virtual E Hosp Fdn, Hope, ID 83836 USA.	Rifat.Latifi@wmchealth.org		Latifi, Rifat/0000-0003-1091-3682			Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Boer C, 2012, CURR OPIN ANESTHESIO, V25, P556, DOI 10.1097/ACO.0b013e328357225c; Demaerschalk BM, 2012, TELEMED E-HEALTH, V18, P230, DOI 10.1089/tmj.2011.0116; Demaerschalk BM, 2010, STROKE, V41, P1251, DOI 10.1161/STROKEAHA.109.574509; El Khamlichi Abdeslam, 2005, Clin Neurosurg, V52, P214; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Kahn EN, 2016, WORLD NEUROSURG, V89, P133, DOI 10.1016/j.wneu.2016.01.075; Latifi R., 2012, TELEMEDICINE TRAUMA; Latifi R, 2006, TELEMED J E-HEALTH, V12, P332, DOI 10.1089/tmj.2006.12.332; Latifi R, 2018, WORLD NEUROSURG, V112, pE747, DOI 10.1016/j.wneu.2018.01.146; Latifi R, 2016, TELEMED E-HEALTH, V22, P1024, DOI 10.1089/tmj.2016.0050; Latifi R, 2016, INT J EMERG MED, V9, DOI 10.1186/s12245-016-0124-5; Latifi R, 2015, TELEMED E-HEALTH, V21, P503, DOI 10.1089/tmj.2014.0138; Latifi R, 2014, TELEMED E-HEALTH, V20, P1027, DOI 10.1089/tmj.2014.0026; Latifi R, 2014, WORLD J SURG, V38, P1898, DOI 10.1007/s00268-014-2538-7; Latifi Rifat, 2014, Am J Disaster Med, V9, P25, DOI 10.5055/ajdm.2014.0139; Latifi Rifat, 2009, Am J Surg, V198, P905, DOI 10.1016/j.amjsurg.2009.08.011; Lewis ER, 2012, TELEMED E-HEALTH, V18, P434, DOI 10.1089/tmj.2011.0199; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Migliaretti G, 2013, J TELEMED TELECARE, V19, P33, DOI 10.1177/1357633X12474738; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206	23	18	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2019	128						E340	E346		10.1016/j.wneu.2019.04.150			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	IJ4SX	WOS:000475895100039	31029813				2022-02-06	
J	Vigil, FA; Bozdemir, E; Bugay, V; Chung, SH; Hobbs, M; Sanchez, I; Hastings, SD; Veraza, RJ; Holstein, DM; Sprague, SM; Carver, CM; Cavazos, JE; Brenner, R; Lechleiter, JD; Shapiro, MS				Vigil, Fabio A.; Bozdemir, Eda; Bugay, Vladislav; Chung, Sang H.; Hobbs, MaryAnn; Sanchez, Isamar; Hastings, Shayne D.; Veraza, Rafael J.; Holstein, Deborah M.; Sprague, Shane M.; Carver, Chase M.; Cavazos, Jose E.; Brenner, Robert; Lechleiter, James D.; Shapiro, Mark S.			Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, "M-type") K+ currents in neurons	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cell death; K+ channels; KCNQ; seizures; traumatic brain injury	FAMILIAL NEONATAL CONVULSIONS; SOLUBLE CD40 LIGAND; POSTTRAUMATIC SEIZURES; BARRIER DISRUPTION; HEAD-INJURY; MICROGLIAL ACTIVATION; EPILEPTIFORM ACTIVITY; POTASSIUM CHANNELS; MILD IMPAIRMENT; EPILEPSY	Nearly three million people in the USA suffer traumatic brain injury (TBI) yearly; however, there are no pre- or post-TBI treatment options available. KCNQ2-5 voltage-gated K+ channels underlie the neuronal "M current", which plays a dominant role in the regulation of neuronal excitability. Our strategy towards prevention of TBI-induced brain damage is predicated on the suggested hyper-excitability of neurons induced by TBIs, and the decrease in neuronal excitation upon pharmacological augmentation of M/KCNQ K+ currents. Seizures are very common after a TBI, making further seizures and development of epilepsy disease more likely. Our hypothesis is that TBI-induced hyperexcitability and ischemia/hypoxia lead to metabolic stress, cell death and a maladaptive inflammatory response that causes further downstream morbidity. Using the mouse controlled closed-cortical impact blunt TBI model, we found that systemic administration of the prototype M-channel "opener", retigabine (RTG), 30 min after TBI, reduces the post-TBI cascade of events, including spontaneous seizures, enhanced susceptibility to chemo-convulsants, metabolic stress, inflammatory responses, blood-brain barrier breakdown, and cell death. This work suggests that acutely reducing neuronal excitability and energy demand via M-current enhancement may be a novel model of therapeutic intervention against post-TBI brain damage and dysfunction.	[Vigil, Fabio A.; Bugay, Vladislav; Hobbs, MaryAnn; Sanchez, Isamar; Hastings, Shayne D.; Veraza, Rafael J.; Carver, Chase M.; Brenner, Robert; Shapiro, Mark S.] Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, San Antonio, TX 78229 USA; [Bozdemir, Eda; Chung, Sang H.; Holstein, Deborah M.; Lechleiter, James D.] Univ Texas Hlth San Antonio, Dept Cell Syst & Anat, San Antonio, TX 78229 USA; [Sprague, Shane M.] Univ Texas Hlth San Antonio, Dept Neurosurg, San Antonio, TX 78229 USA; [Cavazos, Jose E.] Univ Texas Hlth San Antonio, Dept Neurol, San Antonio, TX 78229 USA		Shapiro, MS (corresponding author), Univ Texas Hlth San Antonio, Dept Cellular & Integrat Physiol, South Texas Res Facil, MS 8253,8403 Floyd Curl Dr, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu	Cavazos, Jose/J-4122-2016	Cavazos, Jose/0000-0001-5777-2608; Hastings, Shayne/0000-0002-6303-0181; Vigil, Fabio Antonio/0000-0001-5302-0388	DoD CDMRPUnited States Department of Defense [W81XWH-15-1-0284, W81XWH-13-1-0284]; Morrison Trust; UT Health SA; NIH-NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30 CA54174]; NIH-NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P01AG19316]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by DoD CDMRP grants W81XWH-15-1-0284 (M.S.S. and R.B.) and W81XWH-13-1-0284 (J.D.L.), and Morrison Trust Research grants to M.S.S. and R.B. Images were generated in the Core Optical Imaging Facility, supported by UT Health SA, NIH-NCI P30 CA54174 (CTRC at UT Health SA) and NIH-NIA P01AG19316.	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Allen NM, 2014, EPILEPSIA, V55, pE99, DOI 10.1111/epi.12715; Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Ambrosino P, 2015, BBA-MOL BASIS DIS, V1852, P1856, DOI 10.1016/j.bbadis.2015.06.012; Barrese V, 2015, J CEREBR BLOOD F MET, V35, P1593, DOI 10.1038/jcbfm.2015.83; Beacher NG, 2015, BMC ORAL HEALTH, V15, DOI 10.1186/s12903-015-0102-y; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Bellini G., 2010, GENEREVIEWS; Bhat SA, 2017, BRAIN BEHAV IMMUN, V59, P173, DOI 10.1016/j.bbi.2016.09.021; Bierbower SM, 2015, J NEUROSCI, V35, P2101, DOI 10.1523/JNEUROSCI.3805-14.2015; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brenner R, 2005, NAT NEUROSCI, V8, P1752, DOI 10.1038/nn1573; Brettschneider J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039216; Brown DA, 2009, BRIT J PHARMACOL, V156, P1185, DOI 10.1111/j.1476-5381.2009.00111.x; Calingasan NY, 2002, NEUROBIOL AGING, V23, P31, DOI 10.1016/S0197-4580(01)00246-9; da Fonseca ACC, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00362; Chen H, 2016, CLIN EXP PHARMACOL P, V43, P1107, DOI 10.1111/1440-1681.12650; Chen KQ, 2006, CELL MOL IMMUNOL, V3, P163; Chen YN, 2016, NEUROBIOL DIS, V94, P139, DOI 10.1016/j.nbd.2016.06.011; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Cooper E. C., 2012, JASPERS BASIC MECH E; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; DAILEY JW, 1995, NEUROSCI LETT, V195, P77, DOI 10.1016/0304-3940(95)11783-S; Danese S, 2006, J IMMUNOL, V176, P2617, DOI 10.4049/jimmunol.176.4.2617; Davies M, 2018, J NEUROTRAUM, V35, P790, DOI 10.1089/neu.2017.5354; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Durmaz R, 2003, CAN J NEUROL SCI, V30, P143, DOI 10.1017/S0317167100053415; Festjens N, 2007, CELL DEATH DIFFER, V14, P400, DOI 10.1038/sj.cdd.4402085; Frey LC, 2003, EPILEPSIA, V44, P11, DOI 10.1046/j.1528-1157.44.s10.4.x; Friedman L K, 2015, J Epilepsy Res, V5, P46, DOI 10.14581/jer.15010; Fusco C, 2015, EUR J PAEDIATR NEURO, V19, P102, DOI 10.1016/j.ejpn.2014.08.006; Gamper N, 2006, EMBO J, V25, P4996, DOI 10.1038/sj.emboj.7601374; Ge XT, 2018, J NEUROSCI METH, V308, P162, DOI 10.1016/j.jneumeth.2018.07.021; Giunta B, 2009, DRUG FUTURE, V34, P333, DOI 10.1358/dof.2009.034.04.1358595; GRAF D, 1995, EUR J IMMUNOL, V25, P1749, DOI 10.1002/eji.1830250639; Greene DL, 2017, CELL MOL LIFE SCI, V74, P495, DOI 10.1007/s00018-016-2359-y; Hanshaw RG, 2005, CHEMBIOCHEM, V6, P2214, DOI 10.1002/cbic.200500149; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kalappa BI, 2015, J NEUROSCI, V35, P8829, DOI 10.1523/JNEUROSCI.5176-14.2015; Ke ZJ, 2005, NEUROCHEM INT, V47, P204, DOI 10.1016/j.neuint.2005.03.002; Ke ZJ, 2005, J NEUROIMMUNOL, V164, P85, DOI 10.1016/j.jneuroim.2005.04.002; Keller CJ, 2010, BRAIN, V133, P1668, DOI 10.1093/brain/awq112; Kempuraj D., 2016, J NEUROL NEUROSURG S, V1, P1003; Kirmani BF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00032; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kumar M, 2016, MOL PHARMACOL, V89, P667, DOI 10.1124/mol.115.103200; Laskowitz D., 2016, TRANSLATIONAL RES TR; Lavrnja I, 2015, MEDIATORS INFLAMM, V2015; LEDERMAN S, 1992, J EXP MED, V175, P1091, DOI 10.1084/jem.175.4.1091; Lei J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1081-8; Linley JE, 2010, PFLUG ARCH EUR J PHY, V459, P657, DOI 10.1007/s00424-010-0784-6; Lippmann K, 2017, J CEREBR BLOOD F MET, V37, P1803, DOI 10.1177/0271678X16652631; Liu X, 2013, NEUROSCI BULL, V29, P565, DOI 10.1007/s12264-013-1326-y; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lorente L, 2014, THROMB RES, V134, P832, DOI 10.1016/j.thromres.2014.07.034; Lowenstein DH, 2009, EPILEPSIA, V50, P4, DOI 10.1111/j.1528-1167.2008.02004.x; Maljevic S, 2008, J PHYSIOL-LONDON, V586, P1791, DOI 10.1113/jphysiol.2008.150656; Mason S, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00043; Mee H, 2019, ACTA NEUROCHIR, V161, P457, DOI 10.1007/s00701-018-3683-9; Miceli F, 2015, EPILEPSIA, V56, pE15, DOI 10.1111/epi.12887; Michels M, 2015, MOL MED, V21, P219, DOI 10.2119/molmed.2015.00070; Mucha M, 2010, J NEUROSCI, V30, P13235, DOI 10.1523/JNEUROSCI.1981-10.2010; Nakamura R, 2013, J TOXICOL PATHOL, V26, P55, DOI 10.1293/tox.26.55; NILSSON P, 1994, BRAIN RES, V637, P227, DOI 10.1016/0006-8993(94)91237-8; NITSCH C, 1983, J NEUROL SCI, V59, P305, DOI 10.1016/0022-510X(83)90016-3; Nylen K, 2007, STROKE, V38, P1489, DOI 10.1161/STROKEAHA.106.478362; Orhan G, 2014, ANN NEUROL, V75, P382, DOI 10.1002/ana.24080; Owen RT, 2010, DRUG TODAY, V46, P815, DOI 10.1358/dot.2010.46.11.1556435; Paez-Segala MG, 2015, NAT METHODS, V12, P215, DOI [10.1038/NMETH.3225, 10.1038/nmeth.3225]; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; Petraglia AL, 2014, J NEUROTRAUM, V31, P1211, DOI 10.1089/neu.2013.3255; Qiu X, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.229; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Richards MC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013938; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Saadeldin IY, 2013, PEDIATR NEUROL, V48, P63, DOI 10.1016/j.pediatrneurol.2012.09.012; Salehi A, 2017, J CEREBR BLOOD F MET, V37, P2320, DOI 10.1177/0271678X17701460; Salemi J, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-3; Sasaki Y, 2001, BIOCHEM BIOPH RES CO, V286, P292, DOI 10.1006/bbrc.2001.5388; Schierhout G, 1998, J NEUROL NEUROSUR PS, V64, P108, DOI 10.1136/jnnp.64.1.108; Schimmel Samantha J, 2017, Brain Circ, V3, P135, DOI 10.4103/bc.bc_18_17; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Seiffert E, 2004, J NEUROSCI, V24, P7829, DOI 10.1523/JNEUROSCI.1751-04.2004; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Singh NA, 2003, BRAIN, V126, P2726, DOI 10.1093/brain/awg286; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Singh NA, 2008, J PHYSIOL-LONDON, V586, P3405, DOI 10.1113/jphysiol.2008.154971; Smith BA, 2012, ACS CHEM NEUROSCI, V3, P530, DOI 10.1021/cn3000197; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soh H, 2014, J NEUROSCI, V34, P5311, DOI 10.1523/JNEUROSCI.3919-13.2014; Soldovieri MV, 2014, HUM MUTAT, V35, P356, DOI 10.1002/humu.22500; Spaite DW, 2017, ANN EMERG MED, V69, P62, DOI 10.1016/j.annemergmed.2016.08.007; Stafstrom CE, 2011, NAT REV DRUG DISCOV, V10, P729, DOI 10.1038/nrd3561; Tan J, 1999, SCIENCE, V286, P2352, DOI 10.1126/science.286.5448.2352; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thapa A, 2010, SEIZURE-EUR J EPILEP, V19, P211, DOI 10.1016/j.seizure.2010.02.004; Tompson DJ, 2013, CURR CLIN PHARMACOL, V8, P319, DOI 10.2174/15748847113089990053; Trudeau, 2015, HDB ION CHANNELS; Tung CH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183726; Tykocki NR, 2019, J PHYSIOL-LONDON, V597, P935, DOI 10.1113/JP277021; Tzour A, 2017, J PHYSIOL-LONDON, V595, P713, DOI 10.1113/JP272547; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Verellen Rebecca M, 2010, Therapy, V7, P527, DOI 10.2217/thy.10.57; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vigil FA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04355-8; Volpi PC, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0197-y; Wang HQ, 2013, EPILEPSY RES, V107, P272, DOI 10.1016/j.eplepsyres.2013.10.006; Wang WH, 2018, J NEUROTRAUM, V35, P2306, DOI 10.1089/neu.2018.5688; Watts LT, 2014, J NEUROTRAUM, V31, P1063, DOI 10.1089/neu.2013.3193; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Whitmire LE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188064; YOUNG B, 1983, J NEUROSURG, V58, P231, DOI 10.3171/jns.1983.58.2.0231; ZAPPULLA RA, 1985, NEUROSURGERY, V16, P630, DOI 10.1227/00006123-198505000-00008; Zaugg Brian E, 2017, Retin Cases Brief Rep, V11, P38, DOI 10.1097/ICB.0000000000000283; Zhang DW, 2010, CELL MOL IMMUNOL, V7, P243, DOI 10.1038/cmi.2010.10; Zhang J, 2012, NEURON, V76, P1133, DOI 10.1016/j.neuron.2012.10.019; Zhou HZ, 2012, J NEUROPATH EXP NEUR, V71, P348, DOI 10.1097/NEN.0b013e31824ea078; Zimmermann LL, 2016, NEUROSURG CLIN N AM, V27, P499, DOI 10.1016/j.nec.2016.06.001	131	18	19	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	JUN	2020	40	6					1256	1273	0271678X19857818	10.1177/0271678X19857818		JUL 2019	18	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	LN5EH	WOS:000479389600001	31272312	Green Published			2022-02-06	
J	Abeare, C; Sabelli, A; Taylor, B; Holcomb, M; Dumitrescu, C; Kirsch, N; Erdodi, L				Abeare, Christopher; Sabelli, Alana; Taylor, Brian; Holcomb, Matthew; Dumitrescu, Claudiu; Kirsch, Ned; Erdodi, Laszlo			The Importance of Demographically Adjusted Cutoffs: Age and Education Bias in Raw Score Cutoffs Within the Trail Making Test	PSYCHOLOGICAL INJURY & LAW			English	Article						Trail making test; Performance validity; Demographic correction; Traumatic brain injury; Erdodi Index	TRAUMATIC BRAIN-INJURY; PERFORMANCE VALIDITY TESTS; ADULT INTELLIGENCE SCALE; VERBAL-LEARNING TEST; SYMPTOM VALIDITY; CLASSIFICATION ACCURACY; DIGIT SPAN; RECOGNITION TRIAL; TEST-II; INVALID PERFORMANCE	This study was designed to develop validity cutoffs by utilizing demographically adjusted T-scores on the trail making test (TMT), with the goal of eliminating potential age and education-related biases associated with the use of raw score cutoffs. Failure to correct for the effect of age and education on TMT performance may lead to increased false positive errors for older adults and examinees with lower levels of education. Data were collected from an archival sample of 100 adult outpatients (M-Age=38.8, 56% male; M-Ed=13.7) who were clinically referred for neuropsychological assessment at an academic medical center in the Midwestern USA after sustaining a traumatic brain injury (TBI). Performance validity was psychometrically determined using the Word Memory Test and two multivariate validity composites based on five embedded performance validity indicators. Cutoffs on the demographically corrected TMT T-scores had generally superior classification accuracy compared to the raw score cutoffs reported in the literature. As expected, the T-scores also eliminated age and education bias that was observed in the raw score cutoffs. Both T-score and raw score cutoffs were orthogonal to injury severity. Multivariate models of T-score based cutoff failed to improve classification accuracy over univariate T-score cutoffs. The present findings provide support for the use of demographically adjusted validity cutoffs within the TMT. They produced superior classification to raw score-based cutoffs, in addition to eliminating the bias against older adults and examinees with lower levels of education.	[Abeare, Christopher; Erdodi, Laszlo] Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Sabelli, Alana; Taylor, Brian] Univ Windsor, Brain Cognit Neurosci Program, Windsor, ON N9B 3P4, Canada; [Holcomb, Matthew] Jefferson Neurobehav Grp, New Orleans, LA USA; [Dumitrescu, Claudiu] Canandgua Vet Adm Hosp, Rochester, NY USA; [Kirsch, Ned] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Erdodi, L (corresponding author), Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434	University of Windsor, Faculty of Arts, Humanities, and Social Sciences Collaborative Research Grant	This project received financial support from the University of Windsor, Faculty of Arts, Humanities, and Social Sciences Collaborative Research Grant.	Abeare C., 2018, J HEAD TRAUMA REHABI, V1; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2008, ARCH CLIN NEUROPSYCH, V23, P129, DOI 10.1016/j.acn.2007.11.005; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2001, CLIN NEUROPSYCHOL, V15, P516, DOI 10.1076/clin.15.4.516.1884; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P189, DOI 10.1093/arclin/acs115; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Conners, 2004, CONNERS CONTINUOUS P; CORRIGAN JD, 1987, J CLIN PSYCHOL, V43, P402, DOI 10.1002/1097-4679(198707)43:4<402::AID-JCLP2270430411>3.0.CO;2-E; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Dunn, 2007, PPVT 4 PEABODY PICTU; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P755, DOI 10.1037/pas0000525; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, PSYCHOL INJ LAW, V10, P96, DOI 10.1007/s12207-017-9282-x; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Golden CJ, 1998, ARCH CLIN NEUROPSYCH, V13, P683, DOI 10.1016/S0887-6177(98)00006-7; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Hamdan Amer C., 2009, Psychol. Neurosci., V2, P199, DOI 10.3922/j.psns.2009.2.012; Hashimoto R, 2006, PSYCHIAT CLIN NEUROS, V60, P422, DOI 10.1111/j.1440-1819.2006.01526.x; HAYWARD L, 1987, AUST NZ J PSYCHIAT, V21, P87, DOI 10.3109/00048678709160904; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2007, CLIN NEUROPSYCHOL, V21, P209, DOI 10.1080/13825580601025932; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hester RL, 2005, CLIN NEUROPSYCHOL, V19, P45, DOI 10.1080/13854040490524137; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Horton AM, 2001, INT J NEUROSCI, V111, P123, DOI 10.3109/00207450108986557; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Lange RT, 2005, J CLIN EXP NEUROPSYC, V27, P897, DOI 10.1080/1380339049091290; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; McCrea M., 2008, MILD TRAUMATIC BRAIN; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Newcombe F., 1969, MISSILE WOUNDS BRAIN; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pearson, 2009, ADV CLIN SOL WAIS 4; Perianez JA, 2007, ARCH CLIN NEUROPSYCH, V22, P433, DOI 10.1016/j.acn.2007.01.022; Powell MR, 2011, CLIN NEUROPSYCHOL, V25, P108, DOI 10.1080/13854046.2010.532912; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rai J., 2019, PSYCHOL NEUROSCIENCE; Rasmusson DX, 1998, CLIN NEUROPSYCHOL, V12, P169, DOI 10.1076/clin.12.2.169.2005; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Salazar X.F., 2007, ASSESSMENT FEIGNED C, P405; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Solomon RE, 2010, CLIN NEUROPSYCHOL, V24, P1243, DOI 10.1080/13854046.2010.514864; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; SPREEN O, 1965, J NERV MENT DIS, V140, P323, DOI 10.1097/00005053-196505000-00002; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Webber TA, 2020, ASSESSMENT, V27, P1399, DOI 10.1177/1073191118804874; Wechsler D., 2008, TECHNICAL INTERPRETI; Wechsler D., 2009, WECHSLER MEMORY SCAL; Whiteside D, 2011, CLIN NEUROPSYCHOL, V25, P287, DOI 10.1080/13854046.2010.538436; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wolfson, 1993, HALSTEAD REITAN NEUR; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Yuspeh RL, 2000, ARCH CLIN NEUROPSYCH, V15, P687	122	18	18	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2019	12	2					170	182		10.1007/s12207-019-09353-x			13	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	IF6ZK	WOS:000473231100006					2022-02-06	
J	Chou, SHY; Macdonald, RL; Keller, E; Suarez, JI; Macdonald, RL; Amin-Hanjani, S; Brown, RD; Manoel, ALD; Derdeyn, CP; Etminan, N; Keller, E; LeRoux, PD; Mayer, S; Rinkel, G; Rufennacht, D; Stienen, MN; Torner, J; Vergouwen, MDI; Wong, GKC; Brown, RD; Morita, A; Bijlenga, P; Ko, N; McDougall, CG; Mocco, J; Murayama, Y; Werner, MJH; Mayer, S; Suarez, JI; Damani, R; Broderick, J; Dhar, R; Jauch, EC; Kirkpatrick, PJ; Martin, RH; Mocco, J; Muehlschlegel, S; Mutoh, T; Nyquist, P; Olson, D; Mejia-Mantilla, JH; Amin-Hanjani, S; Manoel, ALD; van der Jagt, M; Bambakidis, N; Brophy, G; Bulsara, K; Claassen, J; Connolly, ES; Hoffer, SA; Hoh, BL; Holloway, RG; Kelly, A; Mayer, S; Nakaji, P; Rabinstein, A; Suarez, JI; Vajkoczy, P; Vergouwen, MDI; Woo, H; Zipfel, GJ; Keller, E; Macdonald, RL; Chou, SHY; Dore, S; Dumont, AS; Gunel, M; Kasuya, H; Roederer, A; Ruigrok, Y; Vespa, PM; Sarrafzadeh-Khorrasani, AS; Derdeyn, CP; Etminan, N; Hackenberg, K; Huston, J; Krings, T; Lanzino, G; Meyers, PM; Rinkel, G; Rufennacht, D; Wintermark, M; Torner, J; Wong, GKC; Broderick, J; Daly, J; Ogilvy, C; Rhoney, DH; Roos, YB; Siddiqui, A; Etminan, N; Rinkel, G; Hackenberg, K; Algra, A; Frosen, J; Hasan, D; Juvela, S; Langer, DJ; Meyers, PM; Morita, A; Salman, RA; Stienen, MN; Vergouwen, MDI; Hanggi, D; Macdonald, RL; Schweizer, T; Visser-Meily, J; Amos, L; Ludet, C; Moy, C; Odenkirchen, J; Ala'i, S; Esterlitz, J; Joseph, K; Sheikh, M				Chou, Sherry H. -Y.; Macdonald, R. Loch; Keller, Emanuela; Suarez, Jose I.; Macdonald, R. Loch; Amin-Hanjani, Sepideh; Brown, Robert D., Jr.; Manoel, Airton Leonardo de Oliveira; Derdeyn, Colin P.; Etminan, Nima; Keller, Emanuela; LeRoux, Peter D.; Mayer, Stephan; Rinkel, Gabriel; Rufennacht, Daniel; Stienen, Martin N.; Torner, James; Vergouwen, Mervyn D. I.; Wong, George K. C.; Brown, Robert D., Jr.; Morita, Akio; Bijlenga, Philippe; Ko, Nerissa; McDougall, Cameron G.; Mocco, J.; Murayama, Yuuichi; Werner, Marieke J. H.; Mayer, Stephan; Suarez, Jose I.; Damani, Rahul; Broderick, Joseph; Dhar, Raj; Jauch, Edward C.; Kirkpatrick, Peter J.; Martin, Renee H.; Mocco, J.; Muehlschlegel, Susanne; Mutoh, Tatsushi; Nyquist, Paul; Olson, Daiwai; Mejia-Mantilla, Jorge H.; Amin-Hanjani, Sepideh; Manoel, Airton Leonardo de Oliveira; van der Jagt, Mathieu; Bambakidis, Nicholas; Brophy, Gretchen; Bulsara, Ketan; Claassen, Jan; Connolly, E. Sander; Hoffer, S. Alan; Hoh, Brian L.; Holloway, Robert G.; Kelly, Adam; Mayer, Stephan; Nakaji, Peter; Rabinstein, Alejandro; Suarez, Jose I.; Vajkoczy, Peter; Vergouwen, Mervyn D. I.; Woo, Henry; Zipfel, Gregory J.; Keller, Emanuela; Macdonald, R. Loch; Chou, Sherry H-Y; Dore, Sylvain; Dumont, Aaron S.; Gunel, Murat; Kasuya, Hidetoshi; Roederer, Alexander; Ruigrok, Ynte; Vespa, Paul M.; Sarrafzadeh-Khorrasani, Asita Simone; Derdeyn, Colin P.; Etminan, Nima; Hackenberg, Katharina; Huston, John, III; Krings, Timo; Lanzino, Giuseppe; Meyers, Philip M.; Rinkel, Gabriel; Rufennacht, Daniel; Wintermark, Max; Torner, James; Wong, George K. C.; Broderick, Joseph; Daly, Janis; Ogilvy, Christopher; Rhoney, Denise H.; Roos, Y. B.; Siddiqui, Adnan; Etminan, Nima; Rinkel, Gabriel; Hackenberg, Katharina; Algra, Ale; Frosen, Juhanna; Hasan, David; Juvela, Seppo; Langer, David J.; Meyers, Philip M.; Morita, Akio; Salman, Rustam Al-Shahi; Stienen, Martin N.; Vergouwen, Mervyn D. I.; Hanggi, Daniel; Macdonald, R. Loch; Schweizer, Tom; Visser-Meily, Johanna; Amos, Liz; Ludet, Christophe; Moy, Claudia; Odenkirchen, Joanne; Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza		Unruptured Intracranial Aneurysms	Biospecimens and Molecular and Cellular Biomarkers in Aneurysmal Subarachnoid Hemorrhage Studies: Common Data Elements and Standard Reporting Recommendations	NEUROCRITICAL CARE			English	Article						Biomarkers; Biospecimens; Cerebrospinal fluid; Subarachnoid hemorrhage; S100; Tumor necrosis factor alpha; interleukin-6; metalloproteinase-9; Plasma-type gelsolin; Apolipoprotein E; Cardiac troponin I; B-type natriuretic peptide; common data elements; Standard operating procedure	DELAYED CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; CARDIAC TROPONIN ELEVATION; APOLIPOPROTEIN-E GENOTYPE; NECROSIS-FACTOR-ALPHA; CEREBROSPINAL-FLUID; NEUROLOGICAL DEFICITS; INTRACEREBRAL MICRODIALYSIS; OUTCOME PREDICTION; VASOSPASM	IntroductionDevelopment of clinical biomarkers to guide therapy is an important unmet need in aneurysmal subarachnoid hemorrhage (SAH). A wide spectrum of plausible biomarkers has been reported for SAH, but none have been validated due to significant variabilities in study design, methodology, laboratory techniques, and outcome endpoints.MethodsA systematic review of SAH biomarkers was performed per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The panel's recommendations focused on harmonization of (1) target cellular and molecular biomarkers for future investigation in SAH, (2) standardization of best-practice procedures in biospecimen and biomarker studies, and (3) experimental method reporting requirements to facilitate meta-analyses and future validation of putative biomarkers.ResultsNo cellular or molecular biomarker has been validated for inclusion as core recommendation. Fifty-four studies met inclusion criteria and generated 33 supplemental and emerging biomarker targets. Core recommendations include best-practice protocols for biospecimen collection and handling as well as standardized reporting guidelines to capture the heterogeneity and variabilities in experimental methodologies and biomarker analyses platforms.ConclusionSignificant variabilities in study design, methodology, laboratory techniques, and outcome endpoints exist in SAH biomarker studies and present significant barriers toward validation and translation of putative biomarkers to clinical use. Adaptation of common data elements, recommended biospecimen protocols, and reporting guidelines will reduce heterogeneity and facilitate future meta-analyses and development of validated clinical biomarkers in SAH.	[Chou, Sherry H. -Y.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3550 Terrace St Suite 646, Pittsburgh, PA 15261 USA; [Chou, Sherry H. -Y.] Univ Pittsburgh, Sch Med, Dept Neurol, 3550 Terrace St Suite 646, Pittsburgh, PA 15261 USA; [Chou, Sherry H. -Y.] Univ Pittsburgh, Sch Med, Dept Neurosurg, 3550 Terrace St Suite 646, Pittsburgh, PA 15261 USA; [Macdonald, R. Loch] Univ Toronto, St Michaels Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Macdonald, R. Loch] St Michaels Hosp, Li Ka Shing Knowledge Inst, Labatt Family Ctr Excellence Brain Injury & Traum, Keenan Res Ctr Biomed Res, Toronto, ON, Canada; [Macdonald, R. Loch] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Macdonald, R. Loch] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Keller, Emanuela] Univ Spital Zurich, Dept Neurosurg, Neurocrit Care Unit, Zurich, Switzerland; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [LeRoux, Peter D.] Main Line Hlth, Wynnewood, PA USA; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Rufennacht, Daniel] Klin Hirslanden, Zurich, Switzerland; [Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Torner, James] Univ Iowa, Iowa City, IA USA; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Bijlenga, Philippe] Geneva Univ Hosp, Geneva, Switzerland; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Damani, Rahul] Baylor Coll Med, Houston, TX 77030 USA; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [van der Jagt, Mathieu] Erasmus MC, Rotterdam, Netherlands; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Torner, James] Univ Iowa, Iowa City, IA USA; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Amos, Liz] Natl Lib Med, Natl Informat Ctr Hlth Serv Res & Hlth Care Techn, Bethesda, MD USA; [Ludet, Christophe] Natl Lib Med, Bethesda, MD USA; [Moy, Claudia; Odenkirchen, Joanne] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza] Emmes Corp, Rockville, MD USA		Chou, SHY (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3550 Terrace St Suite 646, Pittsburgh, PA 15261 USA.; Chou, SHY (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurol, 3550 Terrace St Suite 646, Pittsburgh, PA 15261 USA.; Chou, SHY (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurosurg, 3550 Terrace St Suite 646, Pittsburgh, PA 15261 USA.	chouh@upmc.edu	de Oliveira Manoel, Airton Leonardo/C-4724-2018; Claassen, Jan/AAA-5451-2020; Wong, George Kwok Chu/L-4344-2016; Dore, Sylvain/AAG-1470-2020; DAMANI, RAHUL/R-7012-2018; van der Jagt, Mathieu/G-1905-2017	de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013; Derdeyn, Colin/0000-0002-5932-2683; DAMANI, RAHUL/0000-0001-7990-0965; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574; Al-Shahi Salman, Rustam/0000-0002-2108-9222; van der Jagt, Mathieu/0000-0003-2566-8325; Olson, DaiWai/0000-0002-9280-078X; Morita, Akio/0000-0002-2497-5772	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHSN271201200034C]	Logistical support for this project was provided in part through NIH Contract HHSN271201200034C, the Intramural Research Program of the NIH, NLM, The Neurocritical Care Society, and the CHI Baylor St Luke's Medical Center in Houston, TX. The development of the NINDS SAH CDEs was made possible thanks to the great investment of time and effort of WG members and the members of the NINDS CDE Project and NLM CDE project teams participating from 2015 to 2017.	Altman DG, 2012, BMC MED, V10, DOI 10.1371/journal.pmed.1001216; Amiri M, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00065; Appel D, 2018, NEUROCRIT CARE, V29, P84, DOI 10.1007/s12028-018-0520-1; Beeftink MMA, 2011, NEUROCRIT CARE, V15, P405, DOI 10.1007/s12028-011-9556-1; Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Carrette O, 2005, PROTEOMICS, V5, P3060, DOI 10.1002/pmic.200402039; Chaudhry SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122580; Chou SHY, 2011, TRANSL STROKE RES, V2, P600, DOI 10.1007/s12975-011-0117-x; Chou SHY, 2017, STROKE, V48, P2231, DOI 10.1161/STROKEAHA.117.017758; Chou SHY, 2012, J INVEST MED, V60, P1054, DOI 10.2310/JIM.0b013e3182686932; Chou SHY, 2011, STROKE, V42, P3624, DOI 10.1161/STROKEAHA.111.631135; Chou SHY, 2014, NEUROCRIT CARE, V21, P187, DOI 10.1007/s12028-014-0039-z; Coplin WM, 1999, ARCH NEUROL-CHICAGO, V56, P1348, DOI 10.1001/archneur.56.11.1348; Dai JX, 2016, J NEUROL SCI, V363, P84, DOI 10.1016/j.jns.2016.02.043; De Bold AJ, 2009, J INVEST MED, V57, P736, DOI [10.2310/JIM.0b013e3181ac4078, DOI 10.2310/JIM.0B013E3181AC4078]; Degos V, 2012, STROKE, V43, P1253, DOI 10.1161/STROKEAHA.111.638197; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; Frijns CJM, 2006, J NEUROL NEUROSUR PS, V77, P77, DOI 10.1136/jnnp.2005.064956; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Graetz D, 2010, NEUROL RES, V32, P728, DOI 10.1179/016164109X12464612122650; Hackenberg KAM, 2019, NEUROCRIT CARE, V30, P60, DOI 10.1007/s12028-019-00728-1; Halawa I, 2018, ACTA NEUROL SCAND, V137, P199, DOI 10.1111/ane.12873; Helbok R, 2011, NEUROCRIT CARE, V14, P162, DOI 10.1007/s12028-010-9472-9; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hesse C, 2000, NEUROCHEM RES, V25, P511, DOI 10.1023/A:1007516210548; Hillman J, 2006, ACTA NEUROCHIR, V148, P319, DOI 10.1007/s00701-005-0670-8; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; Hollig A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00694; Huhmer AF, 2006, DIS MARKERS, V22, P3; Hutchinson PJ, 2015, INTENS CARE MED, V41, P1517, DOI 10.1007/s00134-015-3930-y; Jacobsen A, 2014, ACTA NEUROL SCAND, V130, P156, DOI 10.1111/ane.12258; Jamaluddin MS, 2011, EXPERT REV MOL DIAGN, V11, P79, DOI [10.1586/erm.10.103, 10.1586/ERM.10.103]; Juvela S, 2009, J NEUROSURG, V110, P989, DOI 10.3171/2008.11.JNS081266; Kantor E, 2014, J NEUROSURG, V120, P386, DOI 10.3171/2013.10.JNS13219; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Kerner A, 2007, NEUROL RES, V29, P647, DOI 10.1179/016164107X248983; Kim GH, 2008, J NEUROSURG, V109, P38, DOI 10.3171/JNS/2008/109/7/0038; Kumar M, 2017, THROMB HAEMOSTASIS, V117, P691, DOI 10.1160/TH16-11-0834; Lanterna LA, 2005, NEUROLOGY, V64, P1238, DOI 10.1212/01.WNL.0000156523.77347.B4; Leclerc JL, 2015, P NATL ACAD SCI USA, V112, P1155, DOI 10.1073/pnas.1412833112; Lenski M, 2019, J NEUROSURG ANESTH, V31, P227, DOI 10.1097/ANA.0000000000000496; Leung CHS, 2002, STROKE, V33, P548, DOI 10.1161/hs0202.102326; Lewis SB, 2008, J CEREBR BLOOD F MET, V28, P1261, DOI 10.1038/jcbfm.2008.12; Lindgren C, 2014, NEUROCRIT CARE, V21, P91, DOI 10.1007/s12028-013-9945-8; Liu H, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.543; Lu G, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005363; Ma CX, 2015, J NEUROL SCI, V359, P67, DOI 10.1016/j.jns.2015.10.018; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mack WJ, 2002, J NEUROSURG, V96, P71, DOI 10.3171/jns.2002.96.1.0071; Mathiesen T, 1997, J NEUROSURG, V87, P215, DOI 10.3171/jns.1997.87.2.0215; Moher D, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b2535, 10.1371/journal.pmed.1000217, 10.1016/j.ijsu.2010.02.007]; Moore HM, 2012, CLIN CHIM ACTA, V413, P1305, DOI 10.1016/j.cca.2012.04.013; Muroi C, 2013, NEUROSURGERY, V72, P367, DOI 10.1227/NEU.0b013e31828048ce; Naidech AM, 2005, CIRCULATION, V112, P2851, DOI 10.1161/CIRCULATIONAHA.105.533620; Nakatsuka Y, 2018, MOL NEUROBIOL, V55, P6841, DOI 10.1007/s12035-018-0893-3; Niikawa Shuji, 1997, Neurologia Medico-Chirurgica, V37, P881, DOI 10.2176/nmc.37.881; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; Nishikawa H, 2018, TRANSL STROKE RES, V9, P110, DOI 10.1007/s12975-017-0564-0; Niskakangas T, 2001, STROKE, V32, P1181, DOI 10.1161/01.STR.32.5.1181; Oertel M, 2006, J CLIN NEUROSCI, V13, P834, DOI 10.1016/j.jocn.2005.11.030; Pan JW, 2013, CRIT CARE, V17, DOI 10.1186/cc12828; Pluta RM, 2005, PHARMACOL THERAPEUT, V105, P23, DOI 10.1016/j.pharmthera.2004.10.002; Provencio JJ, 2013, ACTA NEUROCHIR SUPPL, V115, P233, DOI 10.1007/978-3-7091-1192-5_42; Ramappa P, 2008, NEUROCRIT CARE, V8, P398, DOI 10.1007/s12028-007-9038-7; Rueffert H, 2011, NEUROCRIT CARE, V15, P410, DOI 10.1007/s12028-011-9542-7; Sarrafzadeh A, 2004, J NEUROSURG, V100, P400, DOI 10.3171/jns.2004.100.3.0400; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Schebesch KM, 2013, NEUROL RES, V35, P1038, DOI 10.1179/1743132813Y.0000000246; Shore PM, 2004, J NEUROTRAUM, V21, P1113; Skjoth-Rasmussen J, 2004, J NEUROSURG, V100, P8, DOI 10.3171/jns.2004.100.1.0008; Stranjalis G, 2007, ACTA NEUROCHIR, V149, P231, DOI 10.1007/s00701-006-1106-9; Suarez JI, 2019, NEUROCRIT CARE; Suarez JI, 2019, NEUROCRIT CARE; Taub PR, 2011, NEUROCRIT CARE, V15, P13, DOI 10.1007/s12028-011-9535-6; Teutsch SM, 2009, GENET MED, V11, P3, DOI 10.1097/GIM.0b013e318184137c; Triglia T, 2016, EUR J ANAESTH, V33, P662, DOI 10.1097/EJA.0000000000000494; Unterberg AW, 2001, J NEUROSURG, V94, P740, DOI 10.3171/jns.2001.94.5.0740; van der Bilt I, 2014, NEUROLOGY, V82, P351, DOI 10.1212/WNL.0000000000000057; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wang LC, 2018, EXP THER MED, V15, P1510, DOI 10.3892/etm.2017.5553; WEIR B, 1989, NEUROSURGERY, V25, P161, DOI 10.1227/00006123-198908000-00002; Wiesmann M, 1997, ACTA NEUROCHIR, V139, P1155, DOI 10.1007/BF01410976; Yarlagadda S, 2006, NEUROCRIT CARE, V5, P102, DOI 10.1385/NCC:5:2:102; Zhang LM, 2015, J STROKE CEREBROVASC, V24, P2375, DOI 10.1016/j.jstrokecerebrovasdis.2015.06.030; Zhong WY, 2017, TURK NEUROSURG, V27, P346, DOI 10.5137/1019-5149.JTN.16193-15.1	86	18	18	0	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30			1			46	59		10.1007/s12028-019-00725-4			14	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF3IS	WOS:000472974700006	31144274	Green Accepted			2022-02-06	
J	Klein, AP; Tetzlaff, JE; Bonis, JM; Nelson, LD; Mayer, AR; Huber, DL; Harezlak, J; Mathews, VP; Ulmer, JL; Sinson, GP; Nencka, AS; Koch, KM; Wu, YC; Saykin, AJ; DiFiori, JP; Giza, CC; Goldman, J; Guskiewicz, KM; Mihalik, JP; Duma, SM; Rowson, S; Brooks, A; Broglio, SP; McAllister, T; McCrea, MA; Meier, TB				Klein, Andrew P.; Tetzlaff, Julie E.; Bonis, Joshua M.; Nelson, Lindsay D.; Mayer, Andrew R.; Huber, Daniel L.; Harezlak, Jaroslaw; Mathews, Vincent P.; Ulmer, John L.; Sinson, Grant P.; Nencka, Andrew S.; Koch, Kevin M.; Wu, Yu-Chien; Saykin, Andrew J.; DiFiori, John P.; Giza, Christopher C.; Goldman, Joshua; Guskiewicz, Kevin M.; Mihalik, Jason P.; Duma, Stefan M.; Rowson, Steven; Brooks, Alison; Broglio, Steven P.; McAllister, Thomas; McCrea, Michael A.; Meier, Timothy B.			Prevalence of Potentially Clinically Significant Magnetic Resonance Imaging Findings in Athletes with and without Sport-Related Concussion	JOURNAL OF NEUROTRAUMA			English	Article						concussion; MRI; mTBI; sport; white matter hyperintensity	WHITE-MATTER HYPERINTENSITIES; INCIDENTAL FINDINGS; 1ST EXPOSURE; BRAIN; SYMPTOMS; FOOTBALL; MEMBERS; AGE	Previous studies have shown that mild traumatic brain injury (mTBI) can cause abnormalities in clinically relevant magnetic resonance imaging (MRI) sequences. No large-scale study, however, has prospectively assessed this in athletes with sport-related concussion (SRC). The aim of the current study was to characterize and compare the prevalence of acute, trauma-related MRI findings and clinically significant, non-specific MRI findings in athletes with and without SRC. College and high-school athletes were prospectively enrolled and participated in scanning sessions between January 2015 through August 2017. Concussed contact sport athletes (n = 138; 14 female [F]; 19.5 +/- 1.6 years) completed up to four scanning sessions after SRC. Non-concussed contact (n = 135; 15 F; 19.7 +/- 1.6) and non-contact athletes (n = 96; 15 F; 20.0 +/- 1.7) completed similar scanning sessions and served as controls. Board-certified neuroradiologists, blinded to SRC status, reviewed T-1-weighted and T-2-weighted fluid-attenuated inversion recovery and T-2*-weighted and T-2-weighted images for acute (i.e., injury-related) or non-acute findings that prompted recommendation for clinical follow-up. Concussed athletes were more likely to have MRI findings relative to contact (30.4% vs. 15.6%; odds ratio [OR] = 2.32; p = 0.01) and non-contact control athletes (19.8%; OR = 2.11; p = 0.04). Female athletes were more likely to have MRI findings than males (43.2% vs. 19.4%; OR = 2.62; p = 0.01). One athlete with SRC had an acute, injury-related finding; group differences were largely driven by increased rate of non-specific white matter hyperintensities in concussed athletes. This prospective, large-scale study demonstrates that <1% of SRCs are associated with acute injury findings on qualitative structural MRI, providing empirical support for clinical guidelines that do not recommend use of MRI after SRC.	[Klein, Andrew P.; Bonis, Joshua M.; Mathews, Vincent P.; Ulmer, John L.; Nencka, Andrew S.; Koch, Kevin M.] Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Tetzlaff, Julie E.] Med Coll Wisconsin, Dept Pathol, Pediat Div, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; Huber, Daniel L.; Sinson, Grant P.; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol,Dept Psychol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat,Dept Psychol, Mind Res Network,Lovelace Biomed & Environm Res I, Albuquerque, NM 87131 USA; [Harezlak, Jaroslaw] Indiana Univ, Dept Epidemiol & Biostat, Bloomington, IN USA; [Wu, Yu-Chien; Saykin, Andrew J.] Indiana Univ Sch Med, Dept Radiol & Imaging Sci, Indianapolis, IN 46202 USA; [DiFiori, John P.] Univ Calif Los Angeles, Dept Family Med & Orthoped, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Dept Pediat & Neurosurg, Los Angeles, CA USA; [Goldman, Joshua] Univ Calif Los Angeles, Dept Family Med, Los Angeles, CA USA; [Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27515 USA; [Duma, Stefan M.; Rowson, Steven] Virginia Tech, Dept Biomed Engn & Mech, Blacksburg, VA USA; [Brooks, Alison] Univ Wisconsin, Sch Med & Publ Hlth, Dept Orthoped & Rehabil, Madison, WI USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [McAllister, Thomas] Indiana Univ Sch Med, Dept Psychiat, Bloomington, IN USA		Klein, AP (corresponding author), Med Coll Wisconsin, Dept Radiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	AKlein@mcw.edu	Rowson, Steven/B-1270-2012; Tetzlaff, Julie/ABA-3395-2021; Koch, Kevin/AAD-6403-2021; Harezlak, Jaroslaw/P-8557-2014	Rowson, Steven/0000-0002-3227-0596; Huber, Daniel/0000-0003-2079-0647; Harezlak, Jaroslaw/0000-0002-3070-7686	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]; Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research [W81XWH-14-1-0561]; National Center for Advancing Translational Sciences, National Institutes of Health,United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436]; U.S. Army Medical Research Acquisition Activity, (Fort Detrick); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG053993] Funding Source: NIH RePORTER	This project was funded with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded, in part by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, (820 Chandler Street, Fort Detrick, MD 21702-5014) is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. This work was also supported by the Defense Health Program under the Department of Defense Broad Agency Announcement for Extramural Medical Research through Award No. W81XWH-14-1-0561. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DOD (DHP funds). The REDCap electronic database used for this project was supported by the National Center for Advancing Translational Sciences, National Institutes of Health, Award No. UL1TR001436. This research was completed, in part, with computational resources and technical support provided by the Research Computing Center at the Medical College of Wisconsin.	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bonow RH, 2017, J NEUROTRAUM, V34, P2706, DOI 10.1089/neu.2017.4970; Bos D, 2016, RADIOLOGY, V281, P507, DOI 10.1148/radiol.2016160218; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Carney N, 2014, NEUROSURGERY, V75, pS3, DOI 10.1227/NEU.0000000000000433; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haberg AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151080; Hamedani AG, 2013, NEUROLOGY, V81, P1308, DOI 10.1212/WNL.0b013e3182a8235b; Hollingshead AB., 1975, 4 FACTOR INDEX SOCIA; Jeerakathil T, 2004, STROKE, V35, P1857, DOI 10.1161/01.STR.0000135226.53499.85; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Lange RT, 2014, J NEUROTRAUM, V31, P198, DOI 10.1089/neu.2013.2866; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Morgan CD, 2015, CHILD NERV SYST, V31, P2305, DOI 10.1007/s00381-015-2916-y; Morris Z, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3016; Mustafi SM, 2018, J NEUROTRAUM, V35, P2653, DOI 10.1089/neu.2017.5158; Nencka AS, 2018, BRAIN IMAGING BEHAV, V12, P1121, DOI 10.1007/s11682-017-9775-y; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Schultz V, 2018, J NEUROTRAUM, V35, P278, DOI 10.1089/neu.2017.5145; Shoemaker JM, 2011, NEUROLOGY, V77, P2123, DOI 10.1212/WNL.0b013e31823d7687; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Tate DF, 2017, MIL MED, V182, pE1651, DOI 10.7205/MILMED-D-16-00132; Wardlaw JM, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001140; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	28	18	18	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1776	1785		10.1089/neu.2018.6055			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600008	30618331	Green Published			2022-02-06	
J	Raikes, AC; Athey, A; Alfonso-Miller, P; Killgore, WDS; Grandner, MA				Raikes, Adam C.; Athey, Amy; Alfonso-Miller, Pamela; Killgore, William D. S.; Grandner, Michael A.			Insomnia and daytime sleepiness: risk factors for sports-related concussion	SLEEP MEDICINE			English	Article						Sports-related concussion; Sleep quality; Insomnia severity index; Relative risk; Daytime sleepiness; College athletes	TRAUMATIC BRAIN-INJURY; SELF-REPORTED CONCUSSIONS; APNEA RISK; COLLEGIATE; DEPRIVATION; QUALITY; EPIDEMIOLOGY; PERFORMANCE; PREVALENCE; DURATION	Objective/Background: Poor quality and inadequate sleep are associated with impaired cognitive, motor, and behavioral components of sport performance and increased injury risk. While prior work identifies sports-related concussions as predisposing factors for poor sleep, the role of sleep as a sports-related concussion risk factor is unknown. The purpose of this study was to quantify the effect of poor sleep quality and insomnia symptoms on future sports-related concussion risk. Patients/Methods: In this study, 190 NCAA Division-1 athletes completed a survey battery, including the Insomnia Severity Index (ISI) and National Health and Nutrition Examination Survey (NHANES) Sleep module. Univariate risk ratios for future sports-related concussions were computed with ISI and NHANES sleepiness scores as independent predictors. An additional multiple logistic regression model including sport, sports-related concussion history, and significant univariate predictors jointly assessed the odds of sustaining a concussion. Results: Clinically moderate-to-severe insomnia severity (RR = 3.13, 95% CI: 1.320-7.424, p = 0.015) and excessive daytime sleepiness two or more times per month (RR = 2.856, 95% CI: 0.681-11.977, p = 0.037) increased concussion risk. These variables remained significant and comparable in magnitude in a multivariate model adjusted for sport participation. Conclusion: Insomnia and daytime sleepiness are independently associated with increased sports-related concussion risk. More completely identifying bidirectional relationships between concussions and sleep requires further research. Clinicians and athletes should be cognizant of this relationship and take proactive measures - including assessing and treating sleep-disordered breathing, limiting insomnia risk factors, improving sleep hygiene, and developing daytime sleepiness management strategies e to reduce sports-related concussion risk and support overall athletic performance. (C) 2019 Elsevier B.V. All rights reserved.	[Raikes, Adam C.; Killgore, William D. S.] Univ Arizona, Social Cognit & Affect Neurosci SCAN Lab, Tucson, AZ USA; [Athey, Amy] Univ Arizona, Dept Athlet, Tucson, AZ USA; [Alfonso-Miller, Pamela; Grandner, Michael A.] Univ Arizona, Sleep & Hlth Res Program, Tucson, AZ USA		Raikes, AC (corresponding author), 1501 N Campbell Ave,Rm 7304A,POB 245002, Tucson, AZ 85742 USA.	raikes.research@gmail.com	Raikes, Adam/M-2600-2019	Raikes, Adam/0000-0002-1609-6727; Alfonso-Miller, Pamela/0000-0002-1908-8415	Innovations grant from the National Collegiate Athletic Association; US Army Medical Research and Materiel Command grantU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH14-1-0571];  [R01 MD011600]; National Institute on Minority Health and Health DisparitiesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD) [R01MD011600] Funding Source: NIH RePORTER	The study was funded by an Innovations grant from the National Collegiate Athletic Association. Dr. Grandner is also supported by R01 MD011600. Drs. Raikes and Killgore are also supported by a US Army Medical Research and Materiel Command grant (W81XWH14-1-0571) to Dr. Killgore.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Allan AC, 2017, J HEAD TRAUMA REHAB, V32, pE35, DOI 10.1097/HTR.0000000000000222; Anderson C, 2011, BEHAV BRAIN RES, V217, P463, DOI 10.1016/j.bbr.2010.09.020; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Ben Cheikh R, 2017, J SPORT MED PHYS FIT, V57, P752, DOI 10.23736/S0022-4707.16.06323-4; Brett BL, 2018, ARCH CLIN NEUROPSYCH, V33, P984, DOI 10.1093/arclin/acy006; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Centers for disease control and prevention, 2017, NATL HLTH NUTR EXAMI; Chau K, 2015, ACCIDENT ANAL PREV, V81, P86, DOI 10.1016/j.aap.2015.04.031; Covassin T, 2016, J ATHL TRAINING, V51, P189, DOI 10.4085/1062-6050-51.3.05; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Dobrosielski DA, 2016, RESP CARE, V61, P1144, DOI 10.4187/respcare.04520; Emery CA, 2009, PAED CHILD HEALT-CAN, V14, P439, DOI 10.1093/pch/14.7.439; Emery CA, 2011, BRIT J SPORT MED, V45, P1289, DOI 10.1136/bjsports-2011-090538; Faul M, 2010, TRAUMATIC BRAIN INJU; Fichtenberg NL, 2001, AM J PHYS MED REHAB, V80, P339, DOI 10.1097/00002060-200105000-00003; Fowler P, 2015, INT J SPORT PHYSIOL, V10, P648, DOI 10.1123/ijspp.2014-0490; Fullagar HHK, 2016, INT J SPORT PHYSIOL, V11, P86, DOI 10.1123/ijspp.2015-0012; Fullagar HHK, 2015, SPORTS MED, V45, P161, DOI 10.1007/s40279-014-0260-0; Furtado F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163310; Gosselin N, 2016, SLEEP MED, V20, P155, DOI 10.1016/j.sleep.2015.10.011; Grolemond G, 2011, J STAT SOFTW, V40, P1; Gupta L, 2017, SPORTS MED, V47, P1317, DOI 10.1007/s40279-016-0650-6; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Heaton KJ, 2014, AVIAT SPACE ENVIR MD, V85, P497, DOI 10.3357/ASEM.3882.2014; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hoffman NL, 2019, SLEEP, V42, DOI 10.1093/sleep/zsy222; Hollis SJ, 2009, AM J SPORT MED, V37, P2328, DOI 10.1177/0363546509341032; Iverson GL, 2020, J ATTEN DISORD, V24, P1095, DOI 10.1177/1087054716657410; Juliff LE, 2015, J SCI MED SPORT, V18, P13, DOI 10.1016/j.jsams.2014.02.007; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2016, AM J SPORT MED, V44, P220, DOI 10.1177/0363546515612082; Keyes KM, 2015, PEDIATRICS, V135, P460, DOI 10.1542/peds.2014-2707; Knowles OE, 2018, J SCI MED SPORT, V21, P959, DOI 10.1016/j.jsams.2018.01.012; Knox CL, 2006, PEDIATRICS, V118, P549, DOI 10.1542/peds.2005-2913; Kontos AP, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P315, DOI 10.1007/0-387-32565-4_14; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Liu Y, 2016, MMWR-MORBID MORTAL W, V65, P137, DOI 10.15585/mmwr.mm6506a1; Luyster FS, 2017, NAT SCI SLEEP, V9, P31, DOI 10.2147/NSS.S125228; Ma J, 2009, J INT MED RES, V37, P1311, DOI 10.1177/147323000903700506; Mah CD, 2018, SLEEP HEALTH, V4, P251, DOI 10.1016/j.sleh.2018.02.005; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Milewski MD, 2014, J PEDIATR ORTHOPED, V34, P129, DOI 10.1097/BPO.0000000000000151; Nation AD, 2011, CLIN PEDIATR, V50, P200, DOI 10.1177/0009922810388511; Nelson LD, 2016, CLIN J SPORT MED, V26, P120, DOI 10.1097/JSM.0000000000000207; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Palagini L, 2017, SLEEP MED, V40, pE47, DOI 10.1016/j.sleep.2017.11.130; Palmer CA, 2017, SLEEP MED REV, V31, P6, DOI 10.1016/j.smrv.2015.12.006; Patrick Y, 2017, SLEEP BIOL RHYTHMS, V15, P217, DOI 10.1007/s41105-017-0099-5; Peck B, 2019, J SPORT REHABIL, V28, P126, DOI 10.1123/jsr.2017-0127; R Core Team, 2016, R LANG ENV STAT COMP; Raikes AC, 2019, SLEEP MED, V54, P62, DOI 10.1016/j.sleep.2018.09.018; Raikes AC, 2016, SLEEP, V39, P2141, DOI 10.5665/sleep.6314; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Renn RP, 2013, INT J PSYCHOPHYSIOL, V88, P64, DOI 10.1016/j.ijpsycho.2013.01.013; Ripley B.D, 2002, MODERN APPL STAT S, DOI DOI 10.1007/978-0-387-21706-2; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Short MA, 2018, SLEEP MED REV, V41, P185, DOI 10.1016/j.smrv.2018.03.006; Smith CD, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12637; Sufrinko AM, 2018, J HEAD TRAUMA REHAB, V33, pE64, DOI 10.1097/HTR.0000000000000387; Swinbourne R, 2016, EUR J SPORT SCI, V16, P850, DOI 10.1080/17461391.2015.1120781; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P2059, DOI 10.1111/sms.12855; von Rosen P, 2017, SCAND J MED SCI SPOR, V27, P1364, DOI 10.1111/sms.12735; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI [10.1007/978-3-319-24277-4, DOI 10.1007/978-3-319-24277-4_9]; Yang J, 2008, BRIT J SPORT MED, V42, P664, DOI 10.1136/bjsm.2007.040923; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	72	18	18	2	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	JUN	2019	58						66	74		10.1016/j.sleep.2019.03.008			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IC3GC	WOS:000470846500011	31132574	Green Accepted, Green Published			2022-02-06	
J	Vest, V; Bernardo-Colon, A; Watkins, D; Kim, B; Rex, TS				Vest, Victoria; Bernardo-Colon, Alexandra; Watkins, Dexter; Kim, Bohan; Rex, Tonia S.			Rapid Repeat Exposure to Subthreshold Trauma Causes Synergistic Axonal Damage and Functional Deficits in the Visual Pathway in a Mouse Model	JOURNAL OF NEUROTRAUMA			English	Article						axon degeneration; blast injury; CNS; neurotrauma; interinjury interval; optic nerve; repeat injury	CLOSED-HEAD MODEL; BRAIN-INJURY; OPTIC-NERVE; RETINAL DAMAGE; BLAST INJURY; EYE TRAUMA; TIME; NEUROINFLAMMATION; ENCEPHALOPATHY; CONCUSSION	We examined the effect of repeat exposure to a non-damaging insult on central nervous system axons using the optic projection as a model. The optic projection is attractive because its axons are spatially separated from the cell bodies, it is easily accessible, it is composed of long axons, and its function can be measured. We performed closed-system ocular neurotrauma in C57Bl/6 mice using bursts of 15 or 26-psi (pounds per square inch) overpressure air that caused no gross damage. We quantified the visual evoked potential (VEP) and total and degenerative axons in the optic nerve. Repeat exposure to a 15-psi air blast caused more axon damage and vision loss than a single exposure to a 26-psi air blast. However, an increased VEP latency was detected in both groups. Exposure to three 15-psi air blasts separated by 0.5 sec caused 15% axon degeneration at 2 weeks. In contrast, no axon degeneration above sham levels was detected when the interinjury interval was increased to 10 min. Exposure to 15-psi air blasts once a day for 6 consecutive days caused 3% axon degeneration. Therefore, repeat mild trauma within an interinjury interval of 1 min or less causes synergistic axon damage, whereas mild trauma repeated at a longer interinjury interval causes additive, cumulative damage. The synergistic damage may underlie the high incidence of traumatic brain injury and traumatic optic neuropathy in blast-injured service members given that explosive blasts are multiple injury events that occur in a very short time span. This study also supports the use of the VEP as a biomarker for traumatic optic neuropathy.	[Vest, Victoria; Bernardo-Colon, Alexandra; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, 11435 Med Res Bldg 4,2213 Garland Ave, Nashville, TN 37232 USA; [Kim, Bohan; Rex, Tonia S.] Vanderbilt Univ, Sch Med, Dept Ophthalmol & Visual Sci, Nashville, TN 37232 USA; [Watkins, Dexter] Vanderbilt Univ, Dept Mech Engn, Nashville, TN 37232 USA		Rex, TS (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, 11435 Med Res Bldg 4,2213 Garland Ave, Nashville, TN 37232 USA.	tonia.rex@vanderbilt.edu		Kim, Bohan/0000-0001-9277-3040	DoDUnited States Department of Defense [W81XWH-15-1-0096, W81XWH-17-2-0055]; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY022349]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 NS094595]; Potocsnak Discovery Grant in Regenerative Medicine; Ayers Foundation Regenerative Visual Neuroscience Pilot Grant; Jones Gift; Research Prevent Blindness, Inc.;  [P30EY008126]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY008126, R01EY022349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS094595] Funding Source: NIH RePORTER	The authors thank Dr. Robert Webster for helpful discussions. Support was provided by: DoD W81XWH-15-1-0096 and W81XWH-17-2-0055, NEI R01 EY022349, NIA R01 NS094595, Potocsnak Discovery Grant in Regenerative Medicine, Ayers Foundation Regenerative Visual Neuroscience Pilot Grant, Jones Gift, and P30EY008126, and Research Prevent Blindness, Inc.	Abbott CJ, 2013, BIOMED OPT EXPRESS, V4, P364, DOI 10.1364/BOE.4.000364; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Bond WS, 2016, MOL THER, V24, P230, DOI 10.1038/mt.2015.198; Bricker-Anthony C, 2017, OPTOMETRY VISION SCI, V94, P20, DOI 10.1097/OPX.0000000000000898; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Cockerham GC, 2011, NEW ENGL J MED, V364, P2172, DOI 10.1056/NEJMc1010683; Cockerham GC, 2009, J REHABIL RES DEV, V46, P811, DOI 10.1682/JRRD.2008.08.0109; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Curreri AG, 2009, CLIN SPORT MED, V28, P591, DOI 10.1016/j.csm.2009.07.004; Daniel S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0069-y; Defense & Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TBI; Doig RLO, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0380-1; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Faul M, 2010, TRAUMATIC BRAIN INJU; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Gaetz M, 2000, BRAIN INJURY, V14, P815; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Hilber David J, 2011, MSMR, V18, P2; Hines-Beard J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0499-5; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Huh JW, 2002, EXP NEUROL, V175, P198, DOI 10.1006/exnr.2002.7880; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Leong D, 2018, J NEURO-OPHTHALMOL, V38, P285, DOI 10.1097/WNO.0000000000000572; Levin LA, 1999, OPHTHALMOLOGY, V106, P1268, DOI 10.1016/S0161-6420(99)00707-1; MAHAPATRA A K, 1991, Indian Journal of Ophthalmology, V39, P20; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MCGWIN G, 2001, INVEST OPHTH VIS SCI, V47, P521; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Phillips BN, 2013, RETINA-J RET VIT DIS, V33, P371, DOI 10.1097/IAE.0b013e318261a726; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sarno S, 2000, VISION RES, V40, P3029, DOI 10.1016/S0042-6989(00)00137-1; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Solomon G, 2018, DEV NEUROPSYCHOL, V43, P279, DOI 10.1080/87565641.2018.1447575; Sosa MAG, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0483-z; Swanson TM, 2017, PUBLIC HEALTH REP, V132, P251, DOI 10.1177/0033354916687748; Tabatabaei SA, 2011, CLIN OPHTHALMOL, V5, P1021, DOI 10.2147/OPTH.S21409; Thomsen G., 2016, J TRAUMA ACUTE CARE, V82, P1039; Thomsen GM, 2016, J TRAUMA ACUTE CARE, V81, P1070, DOI 10.1097/TA.0000000000001248; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Tzekov R, 2014, J NEUROPATH EXP NEUR, V73, P345, DOI 10.1097/NEN.0000000000000059; Urosevich TG, 2018, MIL MED, V183, pE564, DOI 10.1093/milmed/usy102; Vlasov A, 2015, J TRAUMA ACUTE CARE, V79, pS210; Weichel EA, 2009, J HEAD TRAUMA REHAB, V24, P41, DOI 10.1097/HTR.0b013e3181956ffd; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Xu LY, 2016, EXP NEUROL, V275, P436, DOI 10.1016/j.expneurol.2014.11.004; Yuan AD, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a018309	65	18	18	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2019	36	10					1646	1654		10.1089/neu.2018.6046			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HX7CZ	WOS:000467562900015	30451083	Green Published			2022-02-06	
J	Corman, SR; Adame, BJ; Tsai, JY; Ruston, SW; Beaumont, JS; Kamrath, JK; Liu, YQ; Posteher, KA; Tremblay, R; van Raalte, LJ				Corman, Steven R.; Adame, Bradley J.; Tsai, Jiun-Yi; Ruston, Scott W.; Beaumont, Joshua S.; Kamrath, Jessica K.; Liu, Yanqin; Posteher, Karlee A.; Tremblay, Rikki; van Raalte, Lisa J.			Socioecological influences on concussion reporting by NCAA Division 1 athletes in high-risk sports	PLOS ONE			English	Article							VESTED INTEREST; SELF-EFFICACY; BEHAVIOR; KNOWLEDGE; ATTITUDE; PRESSURE; POSITION; IMPACT	Concussion among athletes is an issue of growing concern, with efforts underway to improve detection, diagnosis, and treatment. Success depends on communication by athletes, as brain-related symptoms are often not outwardly visible. Education programs to increase reporting behavior have not been successful to date. In accordance with the socio-ecological approach to health, we argue that multiple levels of influence on student athletes must be addressed, and report a multi-dimensional, mixed-methods research project conducted to identify possible points of intervention into changing the culture of concussion injury reporting among collegiate athletes. Using quantitative, qualitative and interpretive methods, we examine the individual-level vested interests athletes have in reporting or not reporting concussion symptoms, and how these interests interact with community-level team culture and interpersonal relationships, and social-level cultural narratives to influence concussion-reporting behavior. Our findings confirm the viability of this approach, identifying immediacy, separation of responsibility and pain-enduring story systems as particularly salient elements. We conclude that competing performance versus safety value structures, reflected in cultural narratives and team culture, create mixed-messages for athletes, which are resolved in favor of performance because athletes perceive concussion injuries to be of low immediacy.	[Corman, Steven R.; Adame, Bradley J.; Tsai, Jiun-Yi; Ruston, Scott W.; Liu, Yanqin; Tremblay, Rikki] Arizona State Univ, Ctr Strateg Commun, Hugh Downs Sch Human Commun, Tempe, AZ 85281 USA; [Tsai, Jiun-Yi] No Arizona Univ, Sch Commun, Flagstaff, AZ 86011 USA; [Ruston, Scott W.] Arizona State Univ, Global Secur Initiat, Tempe, AZ USA; [Beaumont, Joshua S.] Arizona State Univ, Coll Hlth Solut, Tempe, AZ USA; [Beaumont, Joshua S.] Arizona State Univ, Sun Devil Athlet, Tempe, AZ USA; [Kamrath, Jessica K.] Calif State Univ Fullerton, Dept Human Commun Studies, Fullerton, CA 92634 USA; [Posteher, Karlee A.] Calif State Univ Monterey Bay, Coll Business, Seaside, CA USA; [van Raalte, Lisa J.] Sam Houston State Univ, Dept Commun Studies, Huntsville, TX 77340 USA		Corman, SR (corresponding author), Arizona State Univ, Ctr Strateg Commun, Hugh Downs Sch Human Commun, Tempe, AZ 85281 USA.	steve.corman@asu.edu		van Raalte, Lisa/0000-0002-0053-7401; Liu, Yanqin/0000-0002-9436-8652; Tsai, Jiun-Yi/0000-0001-7333-2821	National Collegiate Athletic Assocation's Mind Matters Research Challenge	This project is supported by the National Collegiate Athletic Assocation's Mind Matters Research Challenge http://www.ncaa.org/sport-science-institute/topics/mind-matters-challenge.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame B, 2016, DISASTER PREV MANAG, V25, P282, DOI 10.1108/DPM-08-2015-0196; Adame BJ, 2015, HEALTH COMMUN, V30, P271, DOI 10.1080/10410236.2013.842527; Allport G.W, 1935, HDB SOCIAL PSYCHOL, P798; [Anonymous], 2010, J LEADERSH ORG STUD, V17, P71; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bandura A., 1997, HARVARD MENTAL HLTH, V13, P1; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; BECK KH, 1981, J APPL SOC PSYCHOL, V11, P401, DOI 10.1111/j.1559-1816.1981.tb00832.x; Bishop G., 2012, NY TIMES; Branigan E, 1992, NARRATIVE COMPREHENS; Burnsed B., 2015, NCAA CHAMPION; CACIOPPO JT, 1979, J PERS SOC PSYCHOL, V37, P97, DOI 10.1037/0022-3514.37.1.97; Centers for Disease Control and Prevention, 2013, FRAM ISS SOC EC MOD; Charmaz K., 2011, SAGE HDB QUALITATIVE, P359, DOI DOI 10.4236/IB.2011.33031; Charmaz K, 2003, STRATEGIES QUALITATI, V2nd ed, P249, DOI 10.1111/1467-9566.00338; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Crano WD, 2006, ANNU REV PSYCHOL, V57, P345, DOI 10.1146/annurev.psych.57.102904.190034; CRANO WD, 1995, BASIC APPL SOC PSYCH, V17, P1, DOI 10.1207/s15324834basp1701&2_1; CRANO WD, 1983, PERS SOC PSYCHOL B, V9, P597, DOI 10.1177/0146167283094009; Creswell J.W ., 2007, QUAL INQ; De Dominicis S, 2014, J APPL SOC PSYCHOL, V44, P364, DOI 10.1111/jasp.12229; Donnelly Peter., 2004, SPORTING BODIES DAMA, P29, DOI DOI 10.1016/S1476-2854(04)02001-1; Farrey T., 2014, ESPN POLL MOST PAREN; FISHER WR, 1989, COMMUN MONOGR, V56, P55, DOI 10.1080/03637758909390249; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Kroshus E, 2016, HEALTH EDUC BEHAV, V43, P442, DOI 10.1177/1090198115602676; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Krug EG, 2002, LANCET, V360, P1083, DOI 10.1016/S0140-6736(02)11133-0; Kutcher J, 2017, BACK GAME WHY CONCUS; Lehren AW, 2018, NBC NEWS; Maitland A, 2015, SPORT MANAG REV, V18, P501, DOI 10.1016/j.smr.2014.11.004; Miller CH, 2013, DISASTERS, V37, P1, DOI 10.1111/j.1467-7717.2012.01290.x; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Parker D, 1994, J SAFETY RES, V25, P63; Polkinghorne, 1988, NARRATIVE KNOWING HU; Putnam L.L., 1993, EMOTION ORG, P36; Register-Mihalik J, 2017, J ATHL TRAINING, V52, P195, DOI 10.4085/1062-6050-51.12.02; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Ruston S., 2016, MODELING SOCIOCULTUR, P27; Ruston SW, 2019, COMMUN SPORT, V7, P529, DOI 10.1177/2167479518786709; Saldana J, 2015, CODING MANUAL QUALIT; Sallis J.F., 2002, HLTH BEHAV HLTH ED T; Saunders B, 2018, QUAL QUANT; Schein Edgar H., 2016, ORG CULTURE LEADERSH; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Schroeder PJ, 2006, SPORT EDUC SOC, V11, P39, DOI 10.1080/13573320500453420; Schroeder PJ., 2010, J ISSUES INTERCOLLEG, V3, P98; Schwartz A., 2007, NY TIMES; Sheeran P, 2014, PSYCHOL BULL, V140, P511, DOI 10.1037/a0033065; Sitkin SB, 1995, ACAD MANAGE J, V38, P1573, DOI 10.2307/256844; SIVACEK J, 1982, J PERS SOC PSYCHOL, V43, P210, DOI 10.1037/0022-3514.43.2.210; Sjoberg L, 2000, RISK ANAL, V20, P1, DOI 10.1111/0272-4332.00001; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Tracy S.J., 2013, QUALITATIVE RES METH; Tracy SJ, 2010, QUAL INQ, V16, P837, DOI 10.1177/1077800410383121; Trethewey A, 2009, OUT THEIR HEADS THEI; Wachinger G, 2013, RISK ANAL, V33, P1049, DOI 10.1111/j.1539-6924.2012.01942.x; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; 2017, QUAL HEALTH RES, V27, P591, DOI DOI 10.1177/1049732316665344; 2015, MED SCI SPORT EXER, V47, P2487, DOI DOI 10.1249/MSS.0000000000000716; 2013, J ATHL TRAINING, V48, P636, DOI DOI 10.4085/1062-6050-48.3.10; 2005, ORGAN SCI, V16, P409, DOI DOI 10.1287/ORSC.1050.0133; 2015, AM J SPORTS MED, V43, P2654, DOI DOI 10.1177/0363546515599634; 1990, J APPL SOC PSYCHOL, V20, P1541, DOI DOI 10.1111/J.1559-1816.1990.TB01492.X	69	18	18	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2019	14	5							e0215424	10.1371/journal.pone.0215424			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	HX4MT	WOS:000467373000009	31067230	Green Published, Green Submitted, gold			2022-02-06	
J	Oliver, JM; Anzalone, AJ; Stone, JD; Turner, SM; Blueitt, D; Garrison, JC; Askow, AT; Luedke, JA; Jagim, AR				Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig; Askow, Andrew T.; Luedke, Joel A.; Jagim, Andrew R.			Fluctuations in blood biomarkers of head trauma in NCAA football athletes over the course of a season	JOURNAL OF NEUROSURGERY			English	Article						sports-related head trauma; sports-related concussion; mild traumatic brain injury; blood biomarkers of head trauma	SERUM NEUROFILAMENT LIGHT; BRAIN-INJURY; WHITE-MATTER; PROTEIN; TAU; INTEGRITY; IMPACTS; HOCKEY	OBJECTIVE Repetitive subconcussive head trauma is a consequence of participation in contact sports and may be linked to neurodegenerative diseases. The degree of neurological injury caused by subconcussive head trauma is not easily detectible, and this injury does not induce readily identifiable clinical signs or symptoms. Recent advancements in immunoassays make possible the detection and quantification of blood biomarkers linked to head trauma. Identification of a blood biomarker that can identify the extent of neurological injury associated with subconcussive head trauma may provide an objective measure for informed decisions concerning cumulative exposure to subconcussive head trauma. The purpose of the current study was to examine changes in the blood biomarkers of subconcussive head trauma over the course of an American football season. METHODS Thirty-five National Collegiate Athletic Association (NCAA) American football athletes underwent blood sampling throughout the course of a football season. Serial samples were obtained throughout the 2016 season, during which the number and magnitude of head impacts changed. Blood samples were analyzed for plasma concentrations of tau and serum concentrations of neurofilament light polypeptide (NF-L). Athletes were grouped based on their starter status, because athletes identified as starters are known to sustain a greater number of impacts. Between-group differences and time-course differences were assessed. RESULTS In nonstarters, plasma concentrations of tau decreased over the course of the season, with lower values observed in starters; this resulted in a lower area under the curve (AUC) (starters: 416.78 +/- 129.17 pg/ml/day; nonstarters: 520.84 +/- 163.19 pg/ml/day; p = 0.050). Plasma concentrations of tau could not be used to discern between starters and nonstarters. In contrast, serum concentrations of NF-L increased throughout the season as head impacts accumulated, specifically in those athletes categorized as starters. The higher serum concentrations of NF-L observed in starters resulted in a larger AUC (starters: 1605.03 +/- 655.09 pg/ml/day; nonstarters: 1067.29 +/- 272.33 pg/ml/day; p = 0.007). The AUC of the receiver operating characteristic curve analyses displayed fair to modest accuracy to identify athletes who were starters with the use of serum NF-L following periods of repetitive impacts. CONCLUSIONS The different patterns observed in serum NF-L and plasma tau concentrations provide preliminary evidence for the use of blood biomarkers to detect the neurological injury associated with repetitive subconcussive head trauma. Although further investigation is necessary, such findings might lay the foundation for the further development of an objective measure for the detection of neurological injury caused by subconcussive head trauma.	[Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig; Askow, Andrew T.] Texas Christian Univ, Sports Concuss Res Grp, Dept Kinesiol, Ft Worth, TX 76129 USA; [Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig] Texas Hlth Sports Med Concuss Ctr, Ft Worth, TX USA; [Oliver, Jonathan M.; Anzalone, Anthony J.; Stone, Jason D.; Turner, Stephanie M.; Blueitt, Damond; Garrison, J. Craig] Texas Hlth Sports Med, Ft Worth, TX USA; [Askow, Andrew T.; Jagim, Andrew R.] Univ Wisconsin, Exercise & Sport Sci Dept, La Crosse, WI 54601 USA; [Luedke, Joel A.] Univ Wisconsin, Athlet Dept, La Crosse, WI 54601 USA		Oliver, JM (corresponding author), Texas Christian Univ, Ft Worth, TX 76129 USA.	jonathan.oliver@tcu.edu	Jagim, Andrew/Y-2447-2019	Jagim, Andrew/0000-0002-6651-5096; Askow, Andrew/0000-0002-0757-8943	STRUCT Nutrition	This study was funded in part by a grant from STRUCT Nutrition.	Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P159, DOI 10.1097/HTR.0000000000000138; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Borna Merchant-, 2017, BRAIN IMAGING BEHAV; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fournier AJ, 2014, FASEB J, V28, P5277, DOI 10.1096/fj.14-251942; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; Ling H, 2015, MOL CELL NEUROSCI, V66, P114, DOI 10.1016/j.mcn.2015.03.012; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millecamps S, 2007, J NEUROSCI, V27, P4947, DOI 10.1523/JNEUROSCI.5299-06.2007; Naunheim RS, 2000, J TRAUMA, V48, P938, DOI 10.1097/00005373-200005000-00020; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Oliver JM, 2017, J NEUROTRAUM, V34, P3295, DOI 10.1089/neu.2017.5064; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Viano DC, 2005, NEUROSURGERY, V57, P1154, DOI 10.1227/01.NEU.0000187541.87937.D9; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; 2008, MOL NEUROBIOL, V38, P27, DOI DOI 10.1007/S12035-008-8033-0; 2015, BRAIN CONNECT, V5, P91, DOI DOI 10.1089/BRAIN.2014.0279; 2017, J NEUROTRAUM, V34, P66, DOI DOI 10.1089/NEU.2015.4333; 2010, J NEUROTRAUM, V27, P1429, DOI DOI 10.1089/NEU.2010.1288	40	18	18	1	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAY	2019	130	5					1655	1662		10.3171/2017.12.JNS172035			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HW0VW	WOS:000466401100030	29807487	Bronze			2022-02-06	
J	Das, N; Spence, JS; Aslan, S; Vanneste, S; Mudar, R; Rackley, A; Quiceno, M; Chapman, SB				Das, Namrafa; Spence, Jeffrey S.; Aslan, Sina; Vanneste, Sven; Mudar, Raksha; Rackley, Audette; Quiceno, Mary; Chapman, Sandra Bond			Cognitive Training and Transcranial Direct Current Stimulation in Mild Cognitive Impairment: A Randomized Pilot Trial	FRONTIERS IN NEUROSCIENCE			English	Article						mild cognitive impairment; Alzheimer's disease; transcranial direct current stimulation; cerebral blood flow; fMRI; cognitive training; strategic memory advanced reasoning training; brain modulation	TRAUMATIC BRAIN-INJURY; DISEASE; MEMORY; INHIBITION; ACTIVATION; DEMENTIA; RISK; TDCS	Background: Transcranial direct current stimulation (tDCS), a non-invasive stimulation, represents a potential intervention to enhance cognition across clinical populations including Alzheimer's disease and mild cognitive impairment (MCI). This randomized clinical trial in MCI investigated the effects of anodal tDCS (a-tDCS) delivered to left inferior frontal gyrus (IFG) combined with gist-reasoning training (SMART) versus sham tDCS (s-tDCS) plus SMART on measures of cognitive and neural changes in resting cerebral blood flow (rCBF). We were also interested in SMART effects on cognitive performance regardless of the tDCS group. Methods: Twenty-two MCI participants, who completed the baseline cognitive assessment (T1), were randomized into one of two groups: a-tDCS + SMART and s-tDCS + SMART. Of which, 20 participants completed resting pCASL MRI scan to measure rCBF. Eight SMART sessions were administered over 4 weeks with a-tDCS or s-tDCS stimulation for 20 min before each session. Participants were assessed immediately (T2) and 3-months after training (T3). Results: Significant group x time interactions showed cognitive gains at T2 in executive function (EF) measure of inhibition [DKEFS- Color word (p = 0.047)], innovation [TOSL (p = 0.01)] and on episodic memory [TOSL (p = 0.048)] in s-tDCS + SMART but not in a-tDCS + SMART group. Nonetheless, the gains did not persist for 3 months (T3) after the training. A voxel-based analysis showed significant increase in regional rCBF in the right middle frontal cortex (MFC) (cluster-wise p = 0.05, k = 1,168 mm(3)) in a-tDCS + SMART compared to s-tDCS + SMART. No significant relationship was observed between the increased CBF with cognition. Irrespective of group, the combined MCI showed gains at T2 in EF of conceptual reasoning [DKEFS card sort (p = 0.033)] and category fluency [COWAT (p = 0.055)], along with gains at T3 in EF of verbal fluency [COWAT (p = 0.009)]. Conclusion: One intriguing finding is a-tDCS to left IFG plus SMART increased blood flow to right MFC, however, the stimulation seemingly blocked cognitive benefits of SMART on EF (inhibition and innovation) and episodic memory compared to s-tDCS + SMART group. Although the sample size is small, this paper contributes to growing evidence that cognitive training provides a way to significantly enhance cognitive performance in adults showing memory loss, where the role of a-tDCS in augmenting these effects need further study.	[Das, Namrafa; Spence, Jeffrey S.; Aslan, Sina; Vanneste, Sven; Rackley, Audette; Chapman, Sandra Bond] Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75080 USA; [Aslan, Sina] Adv MRI LLC, Frisco, TX USA; [Mudar, Raksha] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL USA; [Quiceno, Mary] Univ North Texas, Hlth Sci Ctr, Ft Worth, TX USA; [Quiceno, Mary] Univ North Texas, Dept Internal Med & Geriatr, Ft Worth, TX USA; [Quiceno, Mary] Univ North Texas, TCU UNTHSC, Sch Med, Dept Med Educ, Ft Worth, TX USA		Chapman, SB (corresponding author), Univ Texas Dallas, Ctr BrainHlth, Dallas, TX 75080 USA.	schapman@utdallas.edu		Vanneste, Sven/0000-0003-1513-5752	BvB Dallas; Sammons Enterprises; Barbara Wallace and Kelly King Charitable Foundation Trust; Dallas Foundation; Golden Rule Family Foundation	This research project was supported by BvB Dallas, Sammons Enterprises, Barbara Wallace and Kelly King Charitable Foundation Trust, the AWARE fund of the Dallas Foundation, and the Golden Rule Family Foundation. ClinicalTrials.gov ID: NCT02588209.	Aisen PS, 2010, ALZHEIMERS DEMENT, V6, P239, DOI 10.1016/j.jalz.2010.03.006; Anand R, 2011, INT J GERIATR PSYCH, V26, P961, DOI 10.1002/gps.2633; Andrieu S, 2015, LANCET NEUROL, V14, P926, DOI 10.1016/S1474-4422(15)00153-2; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Belleville S, 2011, BRAIN, V134, P1623, DOI 10.1093/brain/awr037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benton AL, 1994, MULTILINGUAL APHASIA; Biundo R, 2015, BRAIN STIMUL, V8, P1223, DOI 10.1016/j.brs.2015.07.043; Boggio PS, 2012, BRAIN STIMUL, V5, P223, DOI 10.1016/j.brs.2011.06.006; Cattaneo Z, 2011, NEUROSCIENCE, V183, P64, DOI 10.1016/j.neuroscience.2011.03.058; Chapman SB, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00314; Chapman SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00338; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Chapman SB, 2002, ALZ DIS ASSOC DIS, V16, P177, DOI 10.1097/00002093-200207000-00008; Cohen AD, 2014, NEUROBIOL DIS, V72, P117, DOI 10.1016/j.nbd.2014.05.001; Cook LG, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00087; Cotelli M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00038; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diamond EL, 2007, NEUROLOGY, V69, P1331, DOI 10.1212/01.wnl.0000277292.37292.69; Edwards Jerri D, 2017, Alzheimers Dement (N Y), V3, P603, DOI 10.1016/j.trci.2017.09.002; Elder GJ, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0074-1; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Filbey FM, 2010, BRAIN IMAGING BEHAV, V4, P177, DOI 10.1007/s11682-010-9097-9; Floel A, 2012, NEUROBIOL AGING, V33, P1682, DOI 10.1016/j.neurobiolaging.2011.05.007; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gonzalez PC, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00416; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Han K, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.687; Hanten G, 2007, DEV NEUROPSYCHOL, V32, P585, DOI 10.1080/87565640701361112; Harvey PD, 2018, BIOL PSYCHIAT-COGN N, V3, P907, DOI 10.1016/j.bpsc.2018.06.008; Heilman KM, 2003, NEUROCASE, V9, P369, DOI 10.1076/neur.9.5.369.16553; Iyer MB, 2005, NEUROLOGY, V64, P872, DOI 10.1212/01.WNL.0000152986.07469.E9; Japee S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00023; Jean L, 2010, AM J GERIAT PSYCHIAT, V18, P281, DOI 10.1097/JGP.0b013e3181c37ce9; Lang N, 2003, SUPPL CLIN NEUROPHYS, V56, P277; Manenti R, 2016, MOVEMENT DISORD, V31, P715, DOI 10.1002/mds.26561; Manly JJ, 2008, ANN NEUROL, V63, P494, DOI 10.1002/ana.21326; Meinzer M, 2015, ALZHEIMERS DEMENT, V11, P1032, DOI 10.1016/j.jalz.2014.07.159; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris MC, 2009, EUR J NEUROL, V16, P1, DOI 10.1111/j.1468-1331.2009.02735.x; Motes MA, 2018, NEUROBIOL AGING, V62, P72, DOI 10.1016/j.neurobiolaging.2017.10.003; Mudar RA, 2019, BRAIN RES, V1704, P229, DOI 10.1016/j.brainres.2018.10.017; Mudar RA, 2017, INT J GERIATR PSYCH, V32, P548, DOI 10.1002/gps.4492; Murugaraja V, 2017, ASIAN J PSYCHIATR, V30, P135, DOI 10.1016/j.ajp.2017.09.001; Nitsche M. A., 2007, TRANSCRANIAL BRAIN S, V23; Peters MAK, 2013, NEUROPSYCHOLOGIA, V51, P1234, DOI 10.1016/j.neuropsychologia.2013.03.013; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Polania R, 2011, HUM BRAIN MAPP, V32, P1236, DOI 10.1002/hbm.21104; Prehn K, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00355; Reinhart RMG, 2017, ATTEN PERCEPT PSYCHO, V79, P3, DOI 10.3758/s13414-016-1224-2; Roberts RO, 2014, NEUROLOGY, V82, P317, DOI 10.1212/WNL.0000000000000055; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Siddiqui Shazia Veqar, 2008, Indian J Psychiatry, V50, P202, DOI 10.4103/0019-5545.43634; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Troyer AK, 2002, J GERONTOL B-PSYCHOL, V57, pP19, DOI 10.1093/geronb/57.1.P19; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Vas Asha K, 2015, Handb Clin Neurol, V128, P497, DOI 10.1016/B978-0-444-63521-1.00031-5; Vas AK, 2011, J HEAD TRAUMA REHAB, V26, P224, DOI 10.1097/HTR.0b013e318218dd3d; Venza EE, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01676; Wechsler D., 1997, WECHSLER MEMORY SCAL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Weiner M. W., 2013, ALZHEIMERS DEMENTI S, V9, P194, DOI [10.1016/j.jalz.2013.05, DOI 10.1016/J.JALZ.2013.05]; Wilkinson GaryS, 2006, WRAT4 WIDE RANGE ACH; Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yun K, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0218-6	70	18	19	3	22	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	APR 12	2019	13								307	10.3389/fnins.2019.00307			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HT3GB	WOS:000464451200001	31031581	Green Published, gold			2022-02-06	
J	Pham, L; Shultz, SR; Kim, HA; Brady, RD; Wortman, RC; Genders, SG; Hale, MW; O'Shea, RD; Djouma, E; van den Buuse, M; Church, JE; Christie, BR; Drummond, GR; Sobey, CG; McDonald, SJ				Pham, Louise; Shultz, Sandy R.; Kim, Hyun Ah; Brady, Rhys D.; Wortman, Ryan C.; Genders, Shannyn G.; Hale, Matthew W.; O'Shea, Ross D.; Djouma, Elvan; van den Buuse, Maarten; Church, Jarrod E.; Christie, Brian R.; Drummond, Grant R.; Sobey, Christopher G.; McDonald, Stuart J.			Mild Closed-Head Injury in Conscious Rats Causes Transient Neurobehavioral and Glial Disturbances: A Novel Experimental Model of Concussion	JOURNAL OF NEUROTRAUMA			English	Article						anesthesia; astrocytes; behavior; microglia; mild traumatic brain injury; neuroinflammation	TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; ELEVATED PLUS-MAZE; ANIMAL-MODELS; ANXIETY; ADULT; NEUROINFLAMMATION; DEPRESSION; VULNERABILITY; THRESHOLD	Rodent models can provide insights into the most pertinent issues surrounding concussion. Nonetheless, the relevance of some existing models to clinical concussion can be questioned, particularly with regard to the use of surgery and anesthesia and the mechanism and severity of injury. Accordingly, we have co-developed an awake closed-head injury (ACHI) model in rats. Here, we aimed to create a temporal profile of the neurobehavioral and neuropathological effects of a single ACHI. Adolescent male rats were placed in a restraint bag and a steel helmet was positioned over the head such that the impact target was centered over the left parietal cortex. Once positioned on a foam platform, a cortical impactor was used to strike the helmet. Sham animals underwent the same procedure without impact. When compared with sham rats, those given a single ACHI displayed evidence of sensorimotor deficits and reduced exploratory behavior within the first 20 min post-injury; however, these effects were resolved after 24 h. A single ACHI impaired spatial memory on the Y-maze task at both 5 min and 24 h post-ACHI; however, no deficits were apparent at 48 h. Immunostaining revealed region-specific increases in ionized calcium-binding adaptor molecule 1 and glial fibrillary acidic protein expression at 3 days post-impact, with no differences found at either 1 or 14 days. Taken together, our findings indicate that a single ACHI results in transient neurobehavioral and glial disturbances and as such, this model may be a valuable tool for pre-clinical concussion research.	[Pham, Louise; Kim, Hyun Ah; Genders, Shannyn G.; O'Shea, Ross D.; Djouma, Elvan; Church, Jarrod E.; Drummond, Grant R.; Sobey, Christopher G.; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Hale, Matthew W.; van den Buuse, Maarten] La Trobe Univ, Dept Psychol & Counseling, Bundoora, Vic, Australia; [Shultz, Sandy R.; Brady, Rhys D.; Wortman, Ryan C.; McDonald, Stuart J.] Monash Univ, Dept Neurosci, Melbourne, Vic, Australia; [Shultz, Sandy R.; Brady, Rhys D.] Univ Melbourne, Dept Med, Melbourne, Vic, Australia; [van den Buuse, Maarten] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia; [van den Buuse, Maarten] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Christie, Brian R.] Univ Victoria, Div Med Sci, Victoria, BC, Canada		McDonald, SJ (corresponding author), Monash Univ, Cent Clin Sch, Dept Neurosci, Melbourne, Vic 3004, Australia.	stuart.mcdonald@monash.edu	O'Shea, Ross D/B-5426-2012; Christie, Brian Ross/AAF-3766-2019	O'Shea, Ross D/0000-0002-8178-8797; Christie, Brian Ross/0000-0002-6830-0160; McDonald, Stuart/0000-0001-5190-3179; Church, Jarrod/0000-0001-8266-4043; van den Buuse, Maarten/0000-0002-7555-3799; Hale, Matthew/0000-0003-1686-0972	Australian National Health and Medical Research CouncilNational Health and Medical Research Council of Australia; Sport, Exercise, and Rehabilitation RFA of La Trobe University; Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Natural Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC)	CGS, SRS, and GRD acknowledge the Australian National Health and Medical Research Council for funding. SJM acknowledges funding from the Sport, Exercise, and Rehabilitation RFA of La Trobe University. BRC receives funding from the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council. The authors also thank Karen Griggs for her continued assistance with this work.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Brady RD, 2016, J MUSCULOSKEL NEURON, V16, P369; Brady RD, 2016, J NEUROTRAUM, V33, P2154, DOI 10.1089/neu.2014.3836; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dean O, 2009, BEHAV BRAIN RES, V198, P258, DOI 10.1016/j.bbr.2008.11.017; Dong YY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034435, 10.1371/journal.pone.0051643, 10.1371/journal.pone.0039386]; Echemendia RJ, 2017, BRIT J SPORT MED, V51, DOI DOI 10.1136/BJSPORTS-2017-097506; Fazio VC, 2007, NEUROREHABILITATION, V22, P207; Fehily B, 2017, CELL TRANSPLANT, V26, P1131, DOI 10.1177/0963689717714092; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gururajan A, 2015, NEUROSCIENCE, V284, P297, DOI 10.1016/j.neuroscience.2014.10.009; Gururajana A, 2014, NEUROSCI LETT, V576, P6, DOI 10.1016/j.neulet.2014.05.041; Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Iverson GL, 2015, NEUROSCI BIOBEHAV R, V56, P276, DOI 10.1016/j.neubiorev.2015.05.008; Jamnia N, 2017, J NEUROTRAUM, V34, P1351, DOI 10.1089/neu.2016.4517; Johnstone MR, 2018, BRAIN INJURY, V32, P257, DOI 10.1080/02699052.2017.1394492; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P268, DOI 10.1136/bjsports-2013-092247; Meconi A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197187; Namjoshi DR, 2017, EXP NEUROL, V292, P80, DOI 10.1016/j.expneurol.2017.03.003; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; Peng M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29874; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Statler KD, 2006, J NEUROTRAUM, V23, P97, DOI 10.1089/neu.2006.23.97; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Teel EF, 2017, J ATHL TRAINING, V52, P288, DOI 10.4085/1062-6050-52.1.12; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vink R, 2018, J NEUROSCI RES, V96, P527, DOI 10.1002/jnr.24079; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006; Wortman RC, 2018, J NEUROTRAUM, V35, pA199; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yonezaki K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122118	61	18	19	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2019	36	14					2260	2271		10.1089/neu.2018.6169		APR 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IH1NO	WOS:000464546500001	30843474				2022-02-06	
J	Abdelmalik, PA; Draghic, N; Ling, GSF				Abdelmalik, Peter A.; Draghic, Nicole; Ling, Geoffrey S. F.			Management of moderate and severe traumatic brain injury	TRANSFUSION			English	Article; Proceedings Paper	Annual Symposium on Remote Damage Control Resuscitation (RDCR)	JUN, 2018	Bergen, NORWAY				SEVERE HEAD-INJURY; ELEVATED INTRACRANIAL-PRESSURE; MIDDLE CEREBRAL-ARTERY; TRANEXAMIC ACID; DECOMPRESSIVE CRANIECTOMY; ANTIPLATELET AGENTS; FLUID RESUSCITATION; EARLY CRANIOPLASTY; HYPERTONIC SALINE; CLINICAL-TRIAL	Traumatic brain injury (TBI) is a common disorder with high morbidity and mortality, accounting for one in every three deaths due to injury. Older adults are especially vulnerable. They have the highest rates of TBI-related hospitalization and death. There are about 2.5 to 6.5 million US citizens living with TBI-related disabilities. The cost of care is very high. Aside from prevention, little can be done for the initial primary injury of neurotrauma. The tissue damage incurred directly from the inciting event, for example, a blow to the head or bullet penetration, is largely complete by the time medical care can be instituted. However, this event will give rise to secondary injury, which consists of a cascade of changes on a cellular and molecular level, including cellular swelling, loss of membrane gradients, influx of immune and inflammatory mediators, excitotoxic transmitter release, and changes in calcium dynamics. Clinicians can intercede with interventions to improve outcome in the mitigating secondary injury. The fundamental concepts in critical care management of moderate and severe TBI focus on alleviating intracranial pressure and avoiding hypotension and hypoxia. In addition to these important considerations, mechanical ventilation, appropriate transfusion of blood products, management of paroxysmal sympathetic hyperactivity, using nutrition as a therapy, and, of course, venous thromboembolism and seizure prevention are all essential in the management of moderate to severe TBI patients. These concepts will be reviewed using the recent 2016 Brain Trauma Foundation Guidelines to discuss best practices and identify future research priorities.	[Abdelmalik, Peter A.] SUNY Buffalo, Dept Neurol, Buffalo, NY USA; [Draghic, Nicole; Ling, Geoffrey S. F.] Inova Fairfax Hosp, Dept Clin Neurosci, Falls Church, VA USA; [Ling, Geoffrey S. F.] Johns Hopkins Med Inst, Neurosci Crit Care, Dept Neurol, Baltimore, MD 21205 USA; [Ling, Geoffrey S. F.] Johns Hopkins Med Inst, Neurosci Crit Care, Dept Neurosurg, Baltimore, MD 21205 USA; [Ling, Geoffrey S. F.] Johns Hopkins Med Inst, Neurosci Crit Care, Dept Anesthesiol Crit Care Med, Baltimore, MD 21205 USA		Ling, GSF (corresponding author), Johns Hopkins Univ Hosp, Div Neurocrit Care, 600 North Wolfe St,Phipps 455, Baltimore, MD 21287 USA.	gling1@jhmi.edu					Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; Adams H, 2016, NEUROSURG CLIN N AM, V27, P519, DOI 10.1016/j.nec.2016.05.007; Allison RZ, 2017, NEUROCRIT CARE, V26, P80, DOI 10.1007/s12028-016-0303-5; American College of Surgeons C on T, 2012, ADV TRAUM LIF SUPP A; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Asehnoune K, 2017, INTENS CARE MED, V43, P1340, DOI 10.1007/s00134-017-4895-9; Baguley IJ, 2008, SEMIN NEUROL, V28, P716, DOI 10.1055/s-0028-1105971; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bell RB, 2004, J ORAL MAXIL SURG, V62, P676, DOI 10.1016/j.joms.2003.08.032; Bender A, 2013, BRAIN INJURY, V27, P1073, DOI 10.3109/02699052.2013.794972; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; BULLARD DE, 1987, ANN NEUROL, V21, P609, DOI 10.1002/ana.410210617; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Choi PA, 2016, NEUROSURGERY, V80, P1; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2013, J NEUROTRAUM, V30, P512, DOI 10.1089/neu.2012.2573; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Diringer MN, 2004, NEUROCRIT CARE, V1, P219, DOI 10.1385/NCC:1:2:219; Downey DM, 2009, AM SURGEON, V75, P1100; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Dutton RP, 2002, J TRAUMA, V52, P1141, DOI 10.1097/00005373-200206000-00020; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x; Gardner AJ, 2016, HAND CLINIC, V138, P207, DOI 10.1016/B978-0-12-802973-2.00012-4; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; GOODNIGHT SH, 1974, NEW ENGL J MED, V290, P1043, DOI 10.1056/NEJM197405092901903; Gouello G, 2014, SCI WORLD J, DOI 10.1155/2014/207585; Grandhi R, 2015, J TRAUMA ACUTE CARE, V78, P614, DOI 10.1097/TA.0000000000000542; Griesdale DE, 2015, NEUROCRIT CARE, V23, P78, DOI 10.1007/s12028-014-0096-3; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Jokar A, 2017, CHIN J TRAUMATOL, V20, P49, DOI 10.1016/j.cjtee.2016.02.005; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Joseph DK, 2004, J TRAUMA, V57, P687, DOI 10.1097/01.TA.0000140645.84897.F2; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Li M, 2015, MEDICINE, V94; Liao KH, 2016, J CHIN MED ASSOC, V79, P58, DOI 10.1016/j.jcma.2015.10.002; Ling GSF, 2008, NEUROL CLIN, V26, P409, DOI 10.1016/j.ncl.2008.02.001; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Malcolm JG, 2018, NEUROSURGERY, V82, P278, DOI 10.1093/neuros/nyx182; Mantur M, 2011, CLIN CHIM ACTA, V412, P837, DOI 10.1016/j.cca.2011.02.017; Marshall A. H., 1999, Rhinology (Utrecht), V37, P182; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McGinn MJ, 2016, NEUROSURG CLIN N AM, V27, P397, DOI 10.1016/j.nec.2016.06.002; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; MEURMAN OH, 1979, ACTA OTO-LARYNGOL, V87, P366, DOI 10.3109/00016487909126434; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Mutch CA, 2016, NEUROSURG CLIN N AM, V27, P409, DOI 10.1016/j.nec.2016.05.011; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nirula R, 2014, J TRAUMA ACUTE CARE, V76, P944, DOI 10.1097/TA.0000000000000194; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Parry PV, 2017, NEUROSURGERY, V80, P92, DOI 10.1227/NEU.0000000000001406; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Pillai Promod, 2017, Int J Crit Illn Inj Sci, V7, P58, DOI 10.4103/IJCIIS.IJCIIS_8_17; Pretto Flores L, 2000, J Neurosurg Sci, V44, P77; Raslan Ahmed, 2007, Neurosurg Focus, V22, pE12; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Rockswold GL, 2009, NEUROSURGERY, V65, P1035, DOI 10.1227/01.NEU.0000359533.16214.04; Rossaint R, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1265-x; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Schreiber MA, 2015, J TRAUMA ACUTE CARE, V78, P687, DOI 10.1097/TA.0000000000000600; Sekhon MS, 2015, NEUROCRIT CARE, V23, P210, DOI 10.1007/s12028-015-0141-x; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stiver SI, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E5; Sunder R, 2013, CAN MED ASSOC J, V185, P416, DOI 10.1503/cmaj.120055; Syed A T, 2007, Int J Health Sci (Qassim), V1, P131; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Tunkel AR, 2017, CLIN INFECT DIS, V64, P701, DOI 10.1093/cid/cix152; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Vedantam A, 2016, J NEUROSURG, V125, P1229, DOI 10.3171/2015.11.JNS151515; Weekes Elizabeth, 1996, Journal of Parenteral and Enteral Nutrition, V20, P31, DOI 10.1177/014860719602000131; Wong DK, 2008, J TRAUMA, V65, P1303, DOI 10.1097/TA.0b013e318185e234; Yutthakasemsunt S, 2011, J NEUROTRAUM, V28, pA55; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023; Zimmermann LL, 2016, NEUROSURG CLIN N AM, V27, P499, DOI 10.1016/j.nec.2016.06.001	108	18	23	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0041-1132	1537-2995		TRANSFUSION	Transfusion	APR	2019	59			2	SI		1529	1538		10.1111/trf.15171			10	Hematology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Hematology	IA3SF	WOS:000469482400018	30980755	Bronze			2022-02-06	
J	Chrisman, SPD; Lowry, S; Herring, SA; Kroshus, E; Hoopes, TR; Higgins, SK; Rivara, FP				Chrisman, Sara P. D.; Lowry, Sarah; Herring, Stanley A.; Kroshus, Emily; Hoopes, Teah R.; Higgins, Shannon K.; Rivara, Frederick P.			Concussion Incidence, Duration, and Return to School and Sport in 5-to 14-Year-Old American Football Athletes	JOURNAL OF PEDIATRICS			English	Article							4TH INTERNATIONAL-CONFERENCE; STATES HIGH-SCHOOL; POSTCONCUSSIVE SYMPTOMS; CONSENSUS STATEMENT; BASE-LINE; CHILDREN; YOUTH; EPIDEMIOLOGY; ZURICH; INJURY	Objective To collect prospective data on concussion incidence, risk factors, duration of symptoms, and return to school and sport in 5-to 14-year-old American football participants. Study design We conducted a prospective cohort study over 2 years collecting data during two 10-week fall seasons. Youth with concussion were followed to determine time to return to school, sport, and baseline level of symptoms. Logistic regression was used to estimate the risk of sustaining a concussion associated with baseline demographic factors. Time to return to school, sport, and baseline symptoms were analyzed using Kaplan-Meier survival curves. Results Of 863 youth followed (996 player-seasons), 51 sustained a football-related concussion, for an athletelevel incidence of 5.1% per season. Youth with history of concussion had a 2-fold increased risk for sustaining an incident concussion (OR, 2.2; 95% CI, 1.1-4.8). Youth with depression had a 5-fold increased risk of concussion (OR, 5.6; 95% CI, 1.7-18.8). After a concussion, 50% of athletes returned to school by 3 days, 50% returned to sport by 13 days, and 50% returned to a baseline level of symptoms by 3 weeks. Conclusions Concussion rates in this study were slightly higher than previously reported, with 5 of every 100 youth sustaining a football-related concussion each season. One-half of youth were still symptomatic 3 weeks after injury. Further research is needed to address the risk of concussion in youth football.	[Chrisman, Sara P. D.; Lowry, Sarah; Kroshus, Emily; Hoopes, Teah R.; Higgins, Shannon K.; Rivara, Frederick P.] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,CW 8-6, Seattle, WA 98145 USA; [Chrisman, Sara P. D.; Kroshus, Emily; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Chrisman, Sara P. D.; Herring, Stanley A.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA; [Lowry, Sarah] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Herring, Stanley A.] Univ Washington, Dept Rehabil Med Orthoped & Sports Med, Seattle, WA 98195 USA		Chrisman, SPD (corresponding author), Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, POB 5371,CW 8-6, Seattle, WA 98145 USA.	sara.chrisman@seattlechildrens.org		Chrisman, Sara/0000-0001-5373-7223	Seattle Pediatric Concussion Research Collaborative; University of Washington Sports Health and Safety Institute	Funded by the Seattle Pediatric Concussion Research Collaborative and the University of Washington Sports Health and Safety Institute. S.H. was previously chair of the medical advisory committee, a member of the board of directors for USA Football, and a member of the medical advisory committee for Pop Warner Little Scholars. He is currently one of the team physicians for the Seattle Seahawks. The other authors declare no conflicts of interest.	Alic S., 2016, US FOOTBALL BLOG; Asken BM, 2018, AM J SPORTS MED, V46; Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babikian T, 2015, J NEUROTRAUM, V32, P1849, DOI 10.1089/neu.2015.3971; Brett BL, 2018, ARCH CLIN NEUROPSYCH; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Burman E, 2016, BMJ OPEN SPORT EXERC, V2, pe000092, DOI DOI 10.1136/BMJSEM-2015-000092; Castile L, 2012, BRIT J SPORT MED, V46, P603, DOI 10.1136/bjsports-2011-090115; Chin EY, 2016, AM J SPORTS MED; Choe Meeryo, 2018, Continuum (Minneap Minn), V24, P300, DOI 10.1212/CON.0000000000000569; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52; Chrisman SPD, 2014, J ADOLESC HLTH; COUNCIL SPORTS MED FITNESS, 2015, PEDIATRICS, V136, pE1419, DOI 10.1542/peds.2015-3282; Davis GA, 2017, BR J SPORTS MED; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fehr SD, 2017, CLIN J SPORT MED, V1; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gibson TB, 2015, JAMA PEDIATR, V169, P163, DOI 10.1001/jamapediatrics.2014.2320; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Hanninen T, 2017, J SCI MED SPORT, V20, P424, DOI 10.1016/j.jsams.2016.09.009; Heyer GL, 2016, J PEDIAT, V174; Hides JA, 2017, MED SCI SPORTS EXERC, P1; Howell DR, 2018, CLIN J SPORT MED, V1; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kerr ZY, 2017, AM J PREV MED, V53, P914, DOI 10.1016/j.amepre.2017.05.017; Kerr ZY, 2016, JAMA PEDIATR, V170, P647, DOI 10.1001/jamapediatrics.2016.0073; Kontos AP, 2013, J PEDIATR-US, V163, P717, DOI 10.1016/j.jpeds.2013.04.011; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kroshus E, 2017, CLIN J SPORT MED; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Langhorst P., 2016, ENGAGE SPORTS; Leopold SS, 2016, CLIN ORTHOP RELAT R, V474, P1533, DOI 10.1007/s11999-016-4835-y; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; McCarty CA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0459; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2012, J ATHL TRAINING, V47, P221; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Moran L., 2012, CHANGES, V29, P997; Myklebust G, 2005, BRIT J SPORT MED, V39, P127, DOI 10.1136/bjsm.2004.010900; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Parker A, 2018, EARLY INTERV PSYCHIA; Peterson AR, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116686784; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Smith JJ, 2014, SPORTS MED, V44, P1209, DOI 10.1007/s40279-014-0196-4; Stazyk K, 2017, BRAIN INJURY, V31, P631, DOI 10.1080/02699052.2017.1283533; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Terry DP, 2018, CLIN J SPORT MED, V1; Thomas DJ, 2017, CLIN J SPORT MED, V1; Tsushima WT, 2018, ARCH CLIN NEUROPSYCH; Vargas G, 2015, J ATHL TRAINING, V50; Yeung A, 2017, BRAIN INJURY, V31, P542, DOI 10.1080/02699052.2016.1271456; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458	63	18	18	1	5	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2019	207						176	184		10.1016/j.jpeds.2018.11.003			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	HQ1ME	WOS:000462161200034	30554790				2022-02-06	
J	Lee, H; Mizrahi, MA; Hartings, JA; Sharma, S; Pahren, L; Ngwenya, LB; Moseley, BD; Privitera, M; Tortella, FC; Foreman, B				Lee, Hyunjo; Mizrahi, Moshe A.; Hartings, Jed A.; Sharma, Sameer; Pahren, Laura; Ngwenya, Laura B.; Moseley, Brian D.; Privitera, Michael; Tortella, Frank C.; Foreman, Brandon			Continuous Electroencephalography After Moderate to Severe Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						continuous electroencephalography; electrographic seizures; ictal-interictal continuum; neurocritical care; neurotrauma; traumatic brain injury	INTERICTAL EPILEPTIFORM DISCHARGES; GENERALIZED PERIODIC DISCHARGES; CONTINUOUS EEG; CRITICALLY-ILL; ELECTROGRAPHIC SEIZURES; NONCONVULSIVE SEIZURES; SLEEP; COMA; PATHOPHYSIOLOGY; PROGNOSIS	Objectives: After traumatic brain injury, continuous electroencephalography is widely used to detect electrographic seizures. With the development of standardized continuous electroencephalography terminology, we aimed to describe the prevalence and burden of ictal-interictal patterns, including electrographic seizures after moderate-to-severe traumatic brain injury and to correlate continuous electroencephalography features with functional outcome. Design: Post hoc analysis of the prospective, randomized controlled phase 2 multicenter INTREPID2566 study (ClinicalTrials. gov: NCT00805818). Continuous electroencephalography was initiated upon admission to the ICU. The primary outcome was the 3-month Glasgow Outcome Scale-Extended. Consensus electroencephalography reviews were performed by raters certified in standardized continuous electroencephalography terminology blinded to clinical data. Rhythmic, periodic, or ictal patterns were referred to as " ictal-interictal continuum"; severe ictal-interictal continuum was defined as greater than or equal to 1.5 Hz lateralized rhythmic delta activity or generalized periodic discharges and any lateralized periodic discharges or electrographic seizures. Setting: Twenty U.S. level I trauma centers. Patients: Patients with nonpenetrating traumatic brain injury and postresuscitation Glasgow Coma Scale score of 4-12 were included. Interventions: None. Measurements and Main Results: Among 152 patients with continuous electroencephalography (age 34 +/- 14 yr; 88% male), 22 (14%) had severe ictal-interictal continuum including electrographic seizures in four (2.6%). Severe ictal-interictal continuum burden correlated with initial prognostic scores, including the International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury (r = 0.51; p = 0.01) and Injury Severity Score (r = 0.49; p = 0.01), but not with functional outcome. After controlling clinical covariates, unfavorable outcome was independently associated with absence of posterior dominant rhythm (common odds ratio, 3.38; 95% CI, 1.30-9.09), absence of N2 sleep transients (3.69; 1.69-8.20), predominant delta activity (2.82; 1.32-6.10), and discontinuous background (5.33; 2.28-12.96) within the first 72 hours of monitoring. Conclusions: Severe ictal-interictal continuum patterns, including electrographic seizures, were associated with clinical markers of injury severity but not functional outcome in this prospective cohort of patients with moderate-to-severe traumatic brain injury. Importantly, continuous electroencephalography background features were independently associated with functional outcome and improved the area under the curve of existing, validated predictive models.	[Lee, Hyunjo; Mizrahi, Moshe A.; Sharma, Sameer; Foreman, Brandon] Univ Cincinnati, Dept Neurol & Rehabil Med, Div Neurocrit Care, Cincinnati, OH 45221 USA; [Hartings, Jed A.; Ngwenya, Laura B.] Univ Cincinnati, Dept Neurosurg, Cincinnati, OH USA; [Hartings, Jed A.; Ngwenya, Laura B.] Univ Cincinnati, Neurotrauma Ctr, Gardner Neurosci Inst, Cincinnati, OH USA; [Pahren, Laura] Coll Engn & Appl Sci, Cincinnati, OH USA; [Ngwenya, Laura B.; Moseley, Brian D.; Privitera, Michael] Univ Cincinnati, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Tortella, Frank C.] Walter Reed Army Inst Res, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD USA		Foreman, B (corresponding author), Univ Cincinnati, Dept Neurol & Rehabil Med, Div Neurocrit Care, Cincinnati, OH 45221 USA.	foremabo@ucmail.uc.edu		Ngwenya, Laura/0000-0001-7103-971X	U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC); Neuren Pharmaceuticals Limited; National Institute Of Neurological Disorders And Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101123]; DODUnited States Department of Defense; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS101123] Funding Source: NIH RePORTER	The INTREPID<SUP>2566</SUP> trial was supported, in part, by grants from the U.S. Army Medical Research and Materiel Command (to Dr. Tortella) and by Neuren Pharmaceuticals Limited. Supported, in part, by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number K23NS101123 (to Dr. Foreman). Research funding for the parent randomized controlled trial was obtained in part through the DOD by one of the study authors (to Dr. Tortella), who served as principal investigator for the parent randomized controlled trial.	Alsherbini KA, 2017, J CLIN NEUROPHYSIOL, V34, P375, DOI 10.1097/WNP.0000000000000374; Beridze M, 2010, Georgian Med News, P28; BRICOLO A, 1979, REV EEG NEUROPHYSIOL, V9, P116, DOI 10.1016/S0370-4475(79)80066-0; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2014, ANN NEUROL, V75, P771, DOI 10.1002/ana.24166; Crepeau AZ, 2013, J CLIN NEUROPHYSIOL, V30, P247, DOI 10.1097/WNP.0b013e3182933d2f; Ebus S, 2012, EUR J PAEDIATR NEURO, V16, P697, DOI 10.1016/j.ejpn.2012.05.010; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Foreman B, 2012, NEUROLOGY, V79, P1951, DOI 10.1212/WNL.0b013e3182735cd7; Gaspard N, 2013, JAMA NEUROL, V70, P1288, DOI 10.1001/jamaneurol.2013.3475; GUTLING E, 1995, NEUROLOGY, V45, P915, DOI 10.1212/WNL.45.5.915; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Husson EC, 2010, J REHABIL MED, V42, P425, DOI 10.2340/16501977-0566; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JW, 2016, J CLIN NEUROPHYSIOL, V33, P133, DOI 10.1097/WNP.0000000000000230; Leitinger M, 2015, EPILEPSY BEHAV, V49, P158, DOI 10.1016/j.yebeh.2015.05.007; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lv YD, 2013, EPILEPSY BEHAV, V29, P205, DOI 10.1016/j.yebeh.2013.07.014; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; Rodriguez Ruiz A, 2017, JAMA NEUROL, V74, P181, DOI DOI 10.1001/jamaneurol.2016.4990; Ronne-Engstrom E, 2006, ACTA NEUROL SCAND, V114, P47, DOI 10.1111/j.1600-0404.2006.00652.x; RUMPL E, 1983, ELECTROEN CLIN NEURO, V56, P420, DOI 10.1016/0013-4694(83)90224-9; Sandsmark DK, 2016, J HEAD TRAUMA REHAB, V31, P101, DOI 10.1097/HTR.0000000000000217; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Struck AF, 2017, JAMA NEUROL, V74, P1419, DOI 10.1001/jamaneurol.2017.2459; Struck AF, 2016, NEUROCRIT CARE, V24, P324, DOI 10.1007/s12028-016-0245-y; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; SYNEK VM, 1988, J CLIN NEUROPHYSIOL, V5, P161, DOI 10.1097/00004691-198804000-00003; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; Valente M, 2002, CLIN NEUROPHYSIOL, V113, P1798, DOI 10.1016/S1388-2457(02)00218-3; van Putten MJAM, 2015, EPILEPSY BEHAV, V49, P228, DOI 10.1016/j.yebeh.2015.04.007; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa P, 2016, ANN NEUROL, V79, P579, DOI 10.1002/ana.24606; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Witsch J, 2017, JAMA NEUROL, V74, P299, DOI 10.1001/jamaneurol.2016.5325	46	18	19	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	APR	2019	47	4					574	582		10.1097/CCM.0000000000003639			9	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	IA2IZ	WOS:000469386100037	30624278	Green Accepted			2022-02-06	
J	Mccoy, DB; Dupont, SM; Gros, C; Cohen-Adad, J; Huie, RJ; Ferguson, A; Duong-Fernandez, X; Thomas, LH; Singh, V; Narvid, J; Pascual, L; Kyritsis, N; Beattie, MS; Bresnahan, JC; Dhall, S; Whetstone, W; Talbott, JF				Mccoy, D. B.; Dupont, S. M.; Gros, C.; Cohen-Adad, J.; Huie, R. J.; Ferguson, A.; Duong-Fernandez, X.; Thomas, L. H.; Singh, V; Narvid, J.; Pascual, L.; Kyritsis, N.; Beattie, M. S.; Bresnahan, J. C.; Dhall, S.; Whetstone, W.; Talbott, J. F.		TRACK-SCI Investigators	Convolutional Neural Network-Based Automated Segmentation of the Spinal Cord and Contusion Injury: Deep Learning Biomarker Correlates of Motor Impairment in Acute Spinal Cord Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							CLINICAL-PRACTICE GUIDELINE; MRI; RECOMMENDATIONS; MANAGEMENT; OUTCOMES; IMPACT; ROBUST; DTI; MT	BACKGROUND AND PURPOSE: Our aim was to use 2D convolutional neural networks for automatic segmentation of the spinal cord and traumatic contusion injury from axial T2-weighted MR imaging in a cohort of patients with acute spinal cord injury. MATERIALS AND METHODS: Forty-seven patients who underwent 3T MR imaging within 24 hours of spinal cord injury were included. We developed an image-analysis pipeline integrating 2D convolutional neural networks for whole spinal cord and intramedullary spinal cord lesion segmentation. Linear mixed modeling was used to compare test segmentation results between our spinal cord injury convolutional neural network (Brain and Spinal Cord Injury Center segmentation) and current state-of-the-art methods. Volumes of segmented lesions were then used in a linear regression analysis to determine associations with motor scores. RESULTS: Compared with manual labeling, the average test set Dice coefficient for the Brain and Spinal Cord Injury Center segmentation model was 0.93 for spinal cord segmentation versus 0.80 for PropSeg and 0.90 for DeepSeg (both components of the Spinal Cord Toolbox). Linear mixed modeling showed a significant difference between Brain and Spinal Cord Injury Center segmentation compared with PropSeg (P < .001) and DeepSeg (P < .05). Brain and Spinal Cord Injury Center segmentation showed significantly better adaptability to damaged areas compared with PropSeg (P < .001) and DeepSeg (P < .02). The contusion injury volumes based on automated segmentation were significantly associated with motor scores at admission (P = .002) and discharge (P = .009). CONCLUSIONS: Brain and Spinal Cord Injury Center segmentation of the spinal cord compares favorably with available segmentation tools in a population with acute spinal cord injury. Volumes of injury derived from automated lesion segmentation with Brain and Spinal Cord Injury Center segmentation correlate with measures of motor impairment in the acute phase. Targeted convolutional neural network training in acute spinal cord injury enhances algorithm performance for this patient population and provides clinically relevant metrics of cord injury.	[Mccoy, D. B.; Dupont, S. M.; Narvid, J.; Talbott, J. F.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Huie, R. J.; Ferguson, A.; Duong-Fernandez, X.; Thomas, L. H.; Kyritsis, N.; Beattie, M. S.; Bresnahan, J. C.; Dhall, S.; Whetstone, W.; Talbott, J. F.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol Surg, San Francisco, CA 94143 USA; [Mccoy, D. B.; Huie, R. J.; Ferguson, A.; Duong-Fernandez, X.; Thomas, L. H.; Kyritsis, N.; Beattie, M. S.; Bresnahan, J. C.; Dhall, S.; Whetstone, W.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA 94143 USA; [Singh, V] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Neurol, San Francisco, CA 94143 USA; [Pascual, L.] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Dept Orthoped Surg, San Francisco, CA 94143 USA; [Gros, C.; Cohen-Adad, J.] Polytech Montreal, NeuroPoly Lab, Inst Biomed Engn, Montreal, PQ, Canada		Talbott, JF (corresponding author), Zuckerberg San Francisco Gen Hosp, 1001 Potrero Ave,Room 1X57C, San Francisco, CA 94110 USA.	jason.talbott@ucsf.edu	Kyritsis, Nikos/AAD-5187-2021	Kyritsis, Nikos/0000-0001-7801-5796; Thomas, Leigh/0000-0002-7593-0240; Huie, J. Russell/0000-0001-5594-4277; Duong Fernandez, Xuan/0000-0001-8362-4166; Ferguson, Adam/0000-0001-7102-1608; singh, vineeta/0000-0003-3470-3532	Craig H. Neilsen Foundation; Department of DefenseUnited States Department of Defense [SC120259]	This work was supported by the Craig H. Neilsen Foundation and the Department of Defense grant SC120259.	Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Bozzo A, 2011, J NEUROTRAUM, V28, P1401, DOI 10.1089/neu.2009.1236; Burns Anthony S, 2012, Handb Clin Neurol, V109, P47, DOI 10.1016/B978-0-444-52137-8.00003-6; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; De Leener B, 2015, IEEE T MED IMAGING, V34, P1705, DOI 10.1109/TMI.2015.2437192; De Leener B, 2014, NEUROIMAGE, V98, P528, DOI 10.1016/j.neuroimage.2014.04.051; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Elizei SS, 2017, NEURAL REGEN RES, V12, P385, DOI 10.4103/1673-5374.202933; Farhadi HF, 2018, J NEUROTRAUM, V35, P1398, DOI 10.1089/neu.2017.5510; Fehlings MG, 2017, GLOB SPINE J, V7, p195S, DOI 10.1177/2192568217706367; Fehlings MG, 2017, GLOB SPINE J, V7, p221S, DOI 10.1177/2192568217703089; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fonov VS, 2014, NEUROIMAGE, V102, P817, DOI 10.1016/j.neuroimage.2014.08.057; Gillies RJ, 2016, RADIOLOGY, V278, P563, DOI 10.1148/radiol.2015151169; Gros C, 2019, NEUROIMAGE, V184, P901, DOI 10.1016/j.neuroimage.2018.09.081; Gros C, 2018, MED IMAGE ANAL, V44, P215, DOI 10.1016/j.media.2017.12.001; Haefeli J, 2017, AM J NEURORADIOL, V38, P648, DOI 10.3174/ajnr.A5021; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kinga D, 2015, P INT C LEARN REPR S; Kurpad S, 2017, GLOB SPINE J, V7, p151S, DOI 10.1177/2192568217703666; Martin AR, 2017, AM J NEURORADIOL, V38, P1257, DOI 10.3174/ajnr.A5163; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; McCoy D, 2018, P INT SOC MAGN RES M; McCoy DB, 2017, AM J NEURORADIOL, V38, P410, DOI 10.3174/ajnr.A5044; Nair V., 2010, P 27 INT C MACH LEAR; Pandit P, 2016, J ORTHOP RES, V34, P1373, DOI 10.1002/jor.23311; R Development Core Team, 2012, R LANG ENV STAT COMP; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Shah LM, 2016, NEUROSURGERY, V79, P626, DOI 10.1227/NEU.0000000000001336; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Sukhbaatar S., 2014, TRAINING CONVOLUTION; Talekar K, 2016, SEMIN ULTRASOUND CT, V37, P431, DOI 10.1053/j.sult.2016.05.007; Zou KH, 2004, ACAD RADIOL, V11, P178, DOI 10.1016/S1076-6332(03)00671-8	34	18	18	6	13	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	APR	2019	40	4					737	744		10.3174/ajnr.A6020			8	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	HY6ZO	WOS:000468280300028	30923086	Green Published, hybrid			2022-02-06	
J	Zhang, L; Wang, HD; Zhou, XM; Mao, L; Ding, K; Hu, ZG				Zhang, Li; Wang, Handong; Zhou, Xiaoming; Mao, Lei; Ding, Ke; Hu, Zhigang			Role of mitochondrial calcium uniporter-mediated Ca2+ and iron accumulation in traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						Ca2+; iron; mitochondrial calcium uniporter; neuroprotection; traumatic brain injury	RUTHENIUM RED; NEURONAL APOPTOSIS; RYANODINE RECEPTOR; OXIDATIVE STRESS; DYSFUNCTION; POLYAMINES; MODEL; MODULATION; PROTEINS; PROTECTS	Previous studies have suggested that the cellular Ca2+ and iron homeostasis, which can be regulated by mitochondria! calcium uniporter (MCU), is associated with oxidative stress, apoptosis and many neurological diseases. However, little is known about the role of MCU-mediated Ca2+ and iron accumulation in traumatic brain injury (TBI). Under physiological conditions, MCU can be inhibited by ruthenium red (RR) and activated by spermine (Sper). In the present study, we used RR and Sper to reveal the role of MCU in mouse and neuron TBI models. Our results suggested that the Ca2+ and iron concentrations were obviously increased after TBI. In addition, TBI models showed a significant generation of reactive oxygen species (ROS), decrease in adenosine triphosphate (ATP), deformation of mitochondria, up-regulation of deoxyribonucleic acid (DNA) damage and increase in apoptosis. Blockage of MCU by RR prevented Ca2+ and iron accumulation, abated the level of oxidative stress, improved the energy supply, stabilized mitochondria, reduced DNA damage and decreased apoptosis both in vivo and in vitro. Interestingly, Sper did not increase cellular Ca2+ and iron concentrations, but suppressed the Ca2+ and iron accumulation to benefit the mice in vivo. However, Sper had no significant impact on TBI in vitro. Taken together, our data demonstrated for the first time that blockage of MCU-mediated Ca2+ and iron accumulation was essential for TBI. These findings indicated that MCU could be a novel therapeutic target for treating TBI.	[Zhang, Li; Wang, Handong; Zhou, Xiaoming; Mao, Lei; Ding, Ke; Hu, Zhigang] Nanjing Univ, Jinling Hosp, Sch Med, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China.	njhdwang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81672503, 81702484]	This work was supported by Grants from the National Natural Science Foundation of China (No. 81672503 and 81702484).	Aon MA, 2003, J BIOL CHEM, V278, P44735, DOI 10.1074/jbc.M302673200; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Braun G, 2015, BRIT J PHARMACOL, V172, P1728, DOI 10.1111/bph.13019; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; De Stefani D, 2015, BBA-MOL CELL RES, V1853, P2006, DOI 10.1016/j.bbamcr.2015.04.008; Di Lisa F, 2009, J MOL CELL CARDIOL, V46, P775, DOI 10.1016/j.yjmcc.2009.03.006; Ding K, 2015, J SURG RES, V194, P239, DOI 10.1016/j.jss.2014.09.026; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; GILAD GM, 1992, BIOCHEM PHARMACOL, V44, P401, DOI 10.1016/0006-2952(92)90428-L; Gille G, 2011, J NEURAL TRANSM, V118, P349, DOI 10.1007/s00702-010-0503-7; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Jain S, 2016, PHYSIOL BEHAV, V164, P140, DOI 10.1016/j.physbeh.2016.05.052; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; Kalac P, 2014, FOOD CHEM, V161, P27, DOI 10.1016/j.foodchem.2014.03.102; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Liang LP, 2008, J NEUROSCI, V28, P11550, DOI 10.1523/JNEUROSCI.3016-08.2008; Liang N, 2014, J NEURAL TRANSM, V121, P593, DOI 10.1007/s00702-014-1166-6; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; MA JJ, 1993, J GEN PHYSIOL, V102, P1031, DOI 10.1085/jgp.102.6.1031; Malecot CO, 1998, BRIT J PHARMACOL, V124, P465, DOI 10.1038/sj.bjp.0701854; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Owens K, 2013, TRANSL STROKE RES, V4, P618, DOI 10.1007/s12975-013-0278-x; Paradkar PN, 2009, MOL CELL BIOL, V29, P1007, DOI 10.1128/MCB.01685-08; Paupe V, 2017, BIOCHEM BIOPH RES CO; PEGG AE, 1995, INT J BIOCHEM CELL B, V27, P425, DOI 10.1016/1357-2725(95)00007-C; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Salvi M, 2004, BBA-BIOMEMBRANES, V1661, P113, DOI 10.1016/j.bbamem.2003.12.005; Sato D, 2016, BIOPHYS J, V110, P382, DOI 10.1016/j.bpj.2015.12.009; Sripetchwandee J, 2014, ACTA PHYSIOL, V210, P330, DOI 10.1111/apha.12162; Sripetchwandee J, 2013, LIFE SCI, V92, P298, DOI 10.1016/j.lfs.2013.01.004; Sun M, 2015, J NEUROTRAUM, V32, P66, DOI 10.1089/neu.2012.2432; Urrutia PJ, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00038; Utkina-Sosunova IV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062448; Vergun O, 2003, BIOPHYS J, V85, P3358, DOI 10.1016/S0006-3495(03)74755-9; Wang C, 2015, NEUROCHEM RES, V40, P1739, DOI 10.1007/s11064-015-1657-3; WESTERGAARD E, 1973, J COMP NEUROL, V152, P17, DOI 10.1002/cne.901520103; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xu JG, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/187873; Yan HY, 2015, MOL NEUROBIOL, V52, P1637, DOI 10.1007/s12035-014-8942-z; Yan HY, 2015, BIOCHEM BIOPH RES CO, V456, P835, DOI 10.1016/j.bbrc.2014.12.073; Yang Q, 2016, CELL DEATH DIFFER, V23, P1850, DOI 10.1038/cdd.2016.71; Yang YQ, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00287; Zhang L, 2017, J LAB PRECIS MED, V2, P2, DOI DOI 10.1155/2017/2032697; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhao LT, 2015, BIOCHEM BIOPH RES CO, V461, P537, DOI 10.1016/j.bbrc.2015.04.066; Zhao Q, 2013, MOL MED REP, V7, P1073, DOI 10.3892/mmr.2013.1321; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004; Zhou S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00948	55	18	19	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-1838	1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	APR	2019	23	4					2995	3009		10.1111/jcmm.14206			15	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	HR2MD	WOS:000462970200063	30756474	gold, Green Published			2022-02-06	
J	Hu, JN; Chen, LF; Huang, XJ; Wu, K; Ding, SD; Wang, WK; Wang, B; Smith, C; Ren, CH; Ni, HQ; ZhuGe, QC; Yang, JJ				Hu, Jiangnan; Chen, Lefu; Huang, Xujun; Wu, Ke; Ding, Saidan; Wang, Weikan; Wang, Brian; Smith, Charity; Ren, Changhong; Ni, Haoqi; ZhuGe, Qichuan; Yang, Jianjing			Calpain inhibitor MDL28170 improves the transplantation-mediated therapeutic effect of bone marrow-derived mesenchymal stem cells following traumatic brain injury	STEM CELL RESEARCH & THERAPY			English	Article						Traumatic brain injury; Bone marrow-derived mesenchymal stem cells; Preconditioning; Calpain inhibitor; MDL28170; Transplantation	SPINAL-CORD; STROMAL CELLS; INFLAMMATION; EXPRESSION; MDL-28170; ANGIOGENESIS; INVOLVEMENT; MECHANISMS; APOPTOSIS; SURVIVAL	BackgroundStudies have shown that transplantation of bone marrow-derived mesenchymal stem cells (BMSCs) protects against brain damage. However, the low survival number of transplanted BMSCs remains a pertinent challenge and can be attributed to the unfavorable microenvironment of the injured brain. It is well known that calpain activation plays a critical role in traumatic brain injury (TBI)-mediated inflammation and cell death; previous studies showed that inhibiting calpain activation is neuroprotective after TBI. Thus, we investigated whether preconditioning with the calpain inhibitor, MDL28170, could enhance the survival of BMSCs transplanted at 24h post TBI to improve neurological function.MethodsTBI rat model was induced by the weight-drop method, using the gravitational forces of a free falling weight to produce a focal brain injury. MDL28170 was injected intracranially at the lesion site at 30min post TBI, and the secretion levels of neuroinflammatory factors were assessed 24h later. BMSCs labeled with green fluorescent protein (GFP) were locally administrated into the lesion site of TBI rat brains at 24h post TBI. Immunofluorescence and histopathology were performed to evaluate the BMSC survival and the TBI lesion volume. Modified neurological severity scores were chosen to evaluate the functional recovery. The potential mechanisms by which MDL28170 is involved in the regulation of inflammation signaling pathway and cell apoptosis were determined by western blot and immunofluorescence staining.ResultsOverall, we found that a single dose of MDL28170 at acute phase of TBI improved the microenvironment by inhibiting the inflammation, facilitated the survival of grafted GFP-BMSCs, and reduced the grafted cell apoptosis, leading to the reduction of lesion cavity. Furthermore, a significant neurological function improvement was observed when BMSCs were transplanted into a MDL28170-preconditioned TBI brains compared with the one without MDL28170-precondition group.ConclusionsTaken together, our data suggest that MDL28170 improves BMSC transplantation microenvironment and enhances the neurological function restoration after TBI via increased survival rate of BMSCs. We suggest that the calpain inhibitor, MDL28170, could be pursued as a new combination therapeutic strategy to advance the effects of transplanted BMSCs in cell-based regenerative medicine.	[Hu, Jiangnan; Chen, Lefu; Wu, Ke; Ding, Saidan; Ni, Haoqi; ZhuGe, Qichuan; Yang, Jianjing] Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China; [Hu, Jiangnan; Wang, Weikan; Wang, Brian; Smith, Charity] Univ North Texas, Hlth Sci Ctr, Dept Pharmaceut Sci, Ft Worth, TX 76107 USA; [Huang, Xujun] Hengdian Wenrong Hosp, Dept Intens Care Unit ICU, Jinhua 322100, Peoples R China; [Ren, Changhong] Capital Med Univ, Beijing Key Lab Hypox Conditioning Translat Med, Xuanwu Hosp, Beijing, Peoples R China		Hu, JN; ZhuGe, QC; Yang, JJ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Zhejiang Prov Key Lab Aging & Neurol Disorder Res, Wenzhou 325000, Peoples R China.; Hu, JN (corresponding author), Univ North Texas, Hlth Sci Ctr, Dept Pharmaceut Sci, Ft Worth, TX 76107 USA.	hu.jiangnan@hotmail.com; zhugeqichuan@vip.163.com; yangjianjing2@163.com	Hu, John/AAL-6376-2021; Hu, Jiangnan/ABD-5635-2021; Hu, Jiangnan/ABB-1329-2021	Hu, Jiangnan/0000-0002-0112-7578	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81771262]; Zhejiang Health Science and Technology Project [2016RCA022]; Zhejiang Key Research and Development Project [2017C03027]; American Heart Association Predoctoral FellowshipAmerican Heart Association [19PRE34380114]	This work was supported by the National Natural Science Foundation of China (No. 81771262), Zhejiang Health Science and Technology Project (2016RCA022), Zhejiang Key Research and Development Project (2017C03027) and American Heart Association Predoctoral Fellowship for Jiangnan Hu (19PRE34380114).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; [Anonymous], 1999, JAMA, V282, P974; Arataki S, 2005, J NEUROTRAUM, V22, P398, DOI 10.1089/neu.2005.22.398; Bennett MH, 2012, COCHRANE DB SYST REV, V12; Bhang SH, 2007, BIOCHEM BIOPH RES CO, V359, P40, DOI 10.1016/j.bbrc.2007.05.046; Carrico KM, 2009, J NEUROTRAUM, V26, P1369, DOI 10.1089/neu.2008-0870; Chen G, 1999, LIFE SCI, V64, P1231, DOI 10.1016/S0024-3205(99)00055-7; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Cox CS, 2011, NEUROSURGERY, V68, P588, DOI 10.1227/NEU.0b013e318207734c; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fairless R, 2005, INT J BIOCHEM CELL B, V37, P693, DOI 10.1016/j.biocel.2004.10.010; Fillmore N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120257; Guyton MK, 2010, J NEUROSCI RES, V88, P2398, DOI 10.1002/jnr.22408; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hill CE, 2010, J NEUROTRAUM, V27, P1685, DOI 10.1089/neu.2010.1272; Iguchi-Hashimoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027020; Imam SA, 2007, J NEUROIMMUNOL, V190, P139, DOI 10.1016/j.jneuroim.2007.07.016; Kanelos SK, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199812000-00003; Kawamura M, 2005, BRAIN RES, V1037, P59, DOI 10.1016/j.brainres.2004.12.050; Kunz S, 2004, PAIN, V110, P409, DOI 10.1016/j.pain.2004.04.031; Laurer HL, 2001, CURR PHARM DESIGN, V7, P1505, DOI 10.2174/1381612013397285; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Li XP, 2014, AM J PHYSIOL-HEART C, V306, pH833, DOI 10.1152/ajpheart.00893.2012; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Mahmood A, 2001, J NEUROSURG, V94, P589, DOI 10.3171/jns.2001.94.4.0589; Messer JS, 2017, CELL MOL LIFE SCI, V74, P1281, DOI 10.1007/s00018-016-2403-y; Napoli I, 2009, NEUROSCIENCE, V158, P1030, DOI 10.1016/j.neuroscience.2008.06.046; Nichols JE, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt151; Ray SK, 2003, CNS NEUROL DISORD-DR, V2, P173, DOI 10.2174/1568007033482887; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Ren CH, 2018, AGING DIS, V9, P869, DOI 10.14336/AD.2017.1106; Ren CH, 2018, EXP NEUROL, V304, P30, DOI 10.1016/j.expneurol.2018.02.013; Rhodes J, 2011, CURR OPIN CRIT CARE, V17, P122, DOI 10.1097/MCC.0b013e3283447948; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Sakata H, 2012, J NEUROSCI, V32, P3462, DOI 10.1523/JNEUROSCI.5686-11.2012; Schallert T, 1997, ADV NEUROL, V73, P229; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Shen Q, 2016, CELL PHYSIOL BIOCHEM, V38, P748, DOI 10.1159/000443031; SHOHAMI E, 1995, BRAIN RES, V674, P55, DOI 10.1016/0006-8993(94)01433-I; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Tao XG, 2017, CHINESE MED J-PEKING, V130, P187, DOI 10.4103/0366-6999.198001; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Uceyler N, 2007, BRAIN BEHAV IMMUN, V21, P553, DOI 10.1016/j.bbi.2006.10.003; Wang C, 2016, NEUROCHEM INT, V97, P15, DOI 10.1016/j.neuint.2016.04.015; Wang YB, 2018, EXPERT OPIN THER TAR, V22, P19, DOI 10.1080/14728222.2018.1409723; Xiong Y, 2012, ANN NY ACAD SCI, V1270, P51, DOI 10.1111/j.1749-6632.2012.06683.x; Xu XL, 2017, AGING DIS, V8, P590, DOI 10.14336/AD.2017.0430; Xu XL, 2017, AGING DIS, V8, P486, DOI 10.14336/AD.2017.0507; Yan FD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037948; Yang JJ, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00061; Yoshifuji H, 2005, INT IMMUNOL, V17, P1327, DOI 10.1093/intimm/dxh311; Yu CG, 2008, J NEUROTRAUM, V25, P833, DOI 10.1089/neu.2007.0490; Yu CG, 2007, NEUROCHEM RES, V32, P2046, DOI 10.1007/s11064-007-9347-4; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zhang H, 2017, BONE MARROW STEM CEL, P81, DOI DOI 10.1007/978-981-10-2929-5_4; Zhang ZX, 2008, CYTOTHERAPY, V10, P134, DOI 10.1080/14653240701883061; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	61	18	18	2	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	MAR 15	2019	10								96	10.1186/s13287-019-1210-4			13	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	HO9ZL	WOS:000461324500002	30876457	Green Published, gold			2022-02-06	
J	Pal, R; Ghosh, A; Kumar, R; Galwankar, S; Paul, SK; Pal, S; Sinha, D; Jaiswal, AK; Moscote-Salazar, LR; Agrawal, A				Pal, Ranabir; Ghosh, Amrita; Kumar, Raman; Galwankar, Sagar; Paul, Swapan Kumar; Pal, Shrayan; Sinha, Debashis; Jaiswal, A. K.; Rafael Moscote-Salazar, Luis; Agrawal, Amit			Public health crisis of road traffic accidents in India: Risk factor assessment and recommendations on prevention on the behalf of the Academy of Family Physicians of India	JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE			English	Article						Public health; road safety; road traffic injury; traumatic brain injury; vehicle		Roads are considered a sign of development bringing colossal benefits to community as socioeconomic and logistic facilitator. Yet, growth of road network has brought road crashes leading to civic pain from premature deaths of productive age group. In 2017, 16 citizens were killed and 53 injured every hour on Indian roads as per officially reported data, while a fair number go unreported. This is unacceptably high when compared with international standards. Risk correlates of road traffic injuries (RTIs) need to be redefined so as to form a continuum with other confounding factors that impact to take lives on road. Risk factors impacting RTIs vary from human components to the roles and responsibilities of healthcare stakeholders. We should have made roads safer for all citizens because a large percentage of population - children, pedestrians, cyclists, motorcyclists, and the elderly - are most vulnerable. A taskforce was set up by the Academy of Family Physicians of India to scientifically analyze the literature available to assess risks and put forward appropriate recommendations.	[Pal, Ranabir; Paul, Swapan Kumar] MGM Med Coll & LSK Hosp, Dept Community Med, Kishanganj 855107, Bihar, India; [Pal, Shrayan] MGM Med Coll & LSK Hosp, Dept Dermatol Venereol & Leprosy, Kishanganj, Bihar, India; [Ghosh, Amrita] Med Coll, Dept Biochem, Kolkata, W Bengal, India; [Kumar, Raman] Acad Family Phys India, New Delhi, India; [Sinha, Debashis] High Court Calcutta, New Delhi, India; [Sinha, Debashis] Supreme Court India, New Delhi, India; [Jaiswal, A. K.] All India Inst Med Sci, Dept Forens Med & Toxicol, New Delhi, India; [Agrawal, Amit] Narayana Med Coll Hosp, Dept Neurosurg, Nellore, Andhra Pradesh, India; [Galwankar, Sagar] Univ Florida, Dept Emergency Med, Jacksonville, FL USA; [Rafael Moscote-Salazar, Luis] Org Latinoamer Trauma & Cuidado, RED LATINO, Neurosurg Crit Care, Neurointens, Bogota, Colombia		Pal, R (corresponding author), MGM Med Coll & LSK Hosp, Dept Community Med, Kishanganj 855107, Bihar, India.	ranabirmon@yahoo.co.in	Moscote-Salazar, Luis Rafael/K-6307-2012	Moscote-Salazar, Luis Rafael/0000-0002-4180-6962			Agrawal A, 2018, NEUROL INDIA, V66, P976, DOI 10.4103/0028-3886.237027; Agrawal A, 2016, INDIAN J NEUROTRAUM, V13, P81, DOI 10.1055/s-0036-1586486; Agrawal Amit, 2016, Int J Crit Illn Inj Sci, V6, P65, DOI 10.4103/2229-5151.183025; Alam K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164362; [Anonymous], 2008, GLOBAL BURDEN DIS; Baluja A, 2018, INT J ACAD MED, V4, P119, DOI 10.4103/IJAM.IJAM_9_18; Bhandarkar P, 2018, J EMERG TRAUMA SHOCK, V11, P10, DOI 10.4103/JETS.JETS_70_17; Bhoi S, 2018, J EMERG TRAUMA SHOCK, V11, P160, DOI 10.4103/JETS.JETS_119_17; Biswas S., 2015, WHAT IS DELHIS NEW O; Citizen's Charter, 2013, CITIZENS CHARTER; Cummings P, 2002, BRIT MED J, V324, P1119, DOI 10.1136/bmj.324.7346.1119; Dandona R, 2006, J SAFETY RES, V37, P149, DOI 10.1016/j.jsr.2005.11.002; Dash DK, BOOMING SALE CARS BI; El-Menyar Ayman, 2016, J Emerg Trauma Shock, V9, P64, DOI 10.4103/0974-2700.179461; Fildes B, 1994, 61 MON U ACC RES CTR; Ghosh A, 2019, INT J ACAD MED; Gupta Amit, 2009, Indian J Community Med, V34, P75, DOI 10.4103/0970-0218.45383; Gurung B., 2010, TELEGRAPH; Gururaj G, 2004, J Indian Med Assoc, V102, P157; Gururaj G, 2004, J Coll Physicians Surg Pak, V14, P713; Gururaj G., 2005, BACKGROUND PAPERS BU, P325; Jaiswal A. K., 2018, Al Ameen Journal of Medical Sciences, V11, P154; Joshipura M. K., 2004, Indian Journal of Critical Care Medicine, V8, P93; Lahiri SK, 2005, INDIAN J PREV SOC ME, V36, P94, DOI 3 & 4; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Maheshwari R., HIGHWAY LIQUOR BAN S; McLean A, 1980, ALCOHOL DRUGS TRAFFI, P15; Mirkazemi Roksana, 2009, Indian J Community Med, V34, P301, DOI 10.4103/0970-0218.58387; Pal R, 2012, NEPAL J EPIDEMIOL, V2, P216, DOI 10.3126/nje.v2i4.7825; Pal R., 2012, INDIAN J PREV SOC ME, V43, P229; Pal Ranabir, 2017, J Family Med Prim Care, V6, P175, DOI 10.4103/jfmpc.jfmpc_221_15; Pal R, 2012, J KRISHNA INST MED S, V1, P4; Pal Ranabir, 2016, Int J Crit Illn Inj Sci, V6, P127; Pal R, 2016, J NEUROSCI RURAL PRA, V7, P483, DOI 10.4103/0976-3147.188633; Pal Ranabir, 2014, J Family Med Prim Care, V3, P295, DOI 10.4103/2249-4863.148086; Pal Ranabir, 2014, Int J Crit Illn Inj Sci, V4, P114, DOI 10.4103/2229-5151.134151; Peden M, 2008, WORLD REPORT CHILD I; Peden M., 2004, WORLD REPORT ROAD TR; Said PZ, 2018, ARCH MENT HLTH, V19, P97; Satapathy Mani Charan, 2016, Int J Crit Illn Inj Sci, V6, P16, DOI 10.4103/2229-5151.177359; Sharma N, ROAD ACCIDENTS INDIA; Shekhar Chandra, 2015, J Emerg Trauma Shock, V8, P131, DOI 10.4103/0974-2700.160700; Sheriff Akbar, 2011, Indian J Public Health, V55, P125, DOI 10.4103/0019-557X.85248; Shults RA, 2002, AM J PREV MED, V23, P72; Singh Anil Kumar, 2018, Asian J Neurosurg, V13, P714, DOI 10.4103/ajns.AJNS_131_16; Sleet D. A., 2002, TRAFFIC INJ PREV, V3, P266, DOI DOI 10.1080/15389580214623; Sreedharan Jayadevan, 2010, J Inj Violence Res, V2, P49, DOI 10.5249/jivr.v2i1.26; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sweedler BM, 1995, TRANSPORT RES CIRCUL, V437; Uc EY, 2009, NEUROLOGY, V73, P2112, DOI 10.1212/WNL.0b013e3181c67b77; UNECE, IT WORKS JOIN IT SER, pxi; Vyas D, 2016, J SURG RES, V203, P22, DOI 10.1016/j.jss.2016.03.026; Wadhwa N., ROAD ACCIDENTS INDIA	53	18	18	0	3	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	2249-4863	2278-7135		J FAM MED PRIM CARE	J. Fam. Med. Prim. Care	MAR	2019	8	3					775	783	PMID 31041200	10.4103/jfmpc.jfmpc_214_18			9	Primary Health Care	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	VJ9SP	WOS:000648425100002	31041200	gold, Green Published			2022-02-06	
J	Yoo, RE; Choi, SH; Oh, BM; Shin, SD; Lee, EJ; Shin, DJ; Jo, SW; Kang, KM; Yun, TJ; Kim, JH; Sohn, CH				Yoo, Roh-Eul; Choi, Seung Hong; Oh, Byung-Mo; Shin, Sang Do; Lee, Eun Jung; Shin, Dong Jae; Jo, Sang Won; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji-hoon; Sohn, Chul-Ho			Quantitative dynamic contrast-enhanced MR imaging shows widespread blood-brain barrier disruption in mild traumatic brain injury patients with post-concussion syndrome	EUROPEAN RADIOLOGY			English	Article						Blood-brain barrier; Magnetic resonance imaging; Perfusion; Permeability; Post-concussion syndrome (PCS)	HEAD-INJURY; PERMEABILITY; DYSFUNCTION; PERFUSION; LEAKAGE; SERUM; PROGRESSION; BREAKDOWN; MODELS; HEALTH	ObjectivesTo explore the utility of dynamic contrast-enhanced (DCE) MR imaging for quantitative analysis of blood-brain barrier disruption in mild traumatic brain injury (mTBI) patients with post-concussion syndrome (PCS).MethodsForty-four consecutive patients with PCS after mTBI and 32 controls were included in this retrospective study. K-trans and v(e) from DCE MR imaging were analyzed at contrast-enhancing lesions, T2 hyperintense white matter (WM) lesions, normal-appearing white matter (NAWM), and predilection sites for diffuse axonal injury (Location(DAI)). The Mann-Whitney U-test was performed to compare the parameters between mTBI patients and controls and the parameters were correlated with neuropsychological tests using Mann-Whitney U-test and Spearman rank correlation.ResultsThe median v(e) of the T2 hyperintense WM lesions in mTBI patients (n=21) was higher than that of NAWM in controls (p=.027). Both median K-trans and v(e) at NAWM were also significantly higher in mTBI patients than in controls (p=.023 and p=.029, respectively). In addition, mTBI patients had higher K-trans and v(e) at Location(DAI) than controls (p=.008 and p=.015, respectively). VLT (delayed recall) scores were significantly correlated with v(e) values at T2 hyperintense WM lesions (p=-0.767, p=.044). The median v(e) at Location(DAI) was significantly higher in patients with atypical performance in the digit span test (forward) than in those with average or good performance (p=.043).ConclusionsmTBI patients with PCS had higher K-trans and v(e) values than controls not only at T2 hyperintense WM lesions but also at NAWM and Location(DAI). BBB disruption may be implicated in development of PCS in mTBI patients.Key Points center dot mTBI patients with PCS had higher permeability than controls at T2 hyperintense WM lesions on DCE MR imaging.center dot mTBI patients with PCS had higher permeability than controls also at NAWM and predilection sites for DAI.center dot BBB disruption may be implicated in the development of PCS in mTBI patients.	[Yoo, Roh-Eul; Choi, Seung Hong; Kang, Koung Mi; Yun, Tae Jin; Kim, Ji-hoon; Sohn, Chul-Ho] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Radiol, 28 Yongon Dong, Seoul 110744, South Korea; [Choi, Seung Hong] Seoul Natl Univ, IBS, Ctr Nanoparticle Res, Seoul 151742, South Korea; [Choi, Seung Hong] Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151742, South Korea; [Oh, Byung-Mo] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Rehabil Med, 28 Yongon Dong, Seoul 110744, South Korea; [Shin, Sang Do] Seoul Natl Univ, Coll Med, Dept Emergency Med, 28 Yongon Dong, Seoul 110744, South Korea; [Lee, Eun Jung] Chung Ang Univ Hosp, Dept Radiol, Seoul, South Korea; [Shin, Dong Jae] Seran Gen Hosp, Dept Radiol, Seoul, South Korea; [Jo, Sang Won] Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea		Choi, SH (corresponding author), Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Radiol, 28 Yongon Dong, Seoul 110744, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, IBS, Ctr Nanoparticle Res, Seoul 151742, South Korea.; Choi, SH (corresponding author), Seoul Natl Univ, Sch Chem & Biol Engn, Seoul 151742, South Korea.	verocay@snuh.org	Sohn, ChulHo/AAV-4565-2021		Bayer HealthcareBayer AGBayer Healthcare Pharmaceuticals; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare of South Korea [HI16C1111]; Ministry of Science, ICT & Future Planning [2016M3C7A1914002]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2017R1A2B2006526]; Ministry of Education [2017R1D1A1B04034838]; Creative-Pioneering Researchers Program through Seoul National University (SNU);  [IBS-R006-D1]	This study was supported by a grant from Bayer Healthcare, the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare of South Korea (HI16C1111), and by the Ministry of Science, ICT & Future Planning (2016M3C7A1914002), by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (2017R1A2B2006526) and by the Ministry of Education (2017R1D1A1B04034838), by Creative-Pioneering Researchers Program through Seoul National University (SNU), and by Project Code (IBS-R006-D1).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adelson PD, 1998, ACT NEUR S, V71, P104; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; EVANS RW, 1992, NEUROL CLIN, V10, P815, DOI 10.1016/S0733-8619(18)30182-8; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Haroon HA, 2004, J MAGN RESON IMAGING, V19, P527, DOI 10.1002/jmri.20045; Harrer JU, 2004, J MAGN RESON IMAGING, V20, P748, DOI 10.1002/jmri.20182; Hawkins BT, 2005, PHARMACOL REV, V57, P173, DOI 10.1124/pr.57.2.4; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Kassner A, 2009, AM J NEURORADIOL, V30, P1864, DOI 10.3174/ajnr.A1774; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Liu W, 2013, NMR BIOMED, V26, P651, DOI 10.1002/nbm.2910; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Riedy G, 2015, RADIOLOGY, DOI [10.1148/radiol.2015150438:150438, DOI 10.1148/RADIOL.2015150438:150438]; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sharma HS, 2007, ANN NY ACAD SCI, V1122, P295, DOI 10.1196/annals.1403.022; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; van Vliet EA, 2014, NEUROBIOL DIS, V63, P74, DOI 10.1016/j.nbd.2013.11.019; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Winter C, 2015, NEUROL RES, V37, P599, DOI 10.1179/1743132815Y.0000000018; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Yun TJ, 2015, RADIOLOGY, V274, P830, DOI 10.1148/radiol.14132632; Zhang CE, 2017, NEUROLOGY, V88, P426, DOI 10.1212/WNL.0000000000003556; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	36	18	19	0	11	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-7994	1432-1084		EUR RADIOL	Eur. Radiol.	MAR	2019	29	3					1308	1317		10.1007/s00330-018-5656-z			10	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	HJ7RX	WOS:000457396100026	30066251				2022-02-06	
J	Giudice, JS; Park, G; Kong, K; Bailey, A; Kent, R; Panzer, MB				Giudice, J. Sebastian; Park, Gwansik; Kong, Kevin; Bailey, Ann; Kent, Richard; Panzer, Matthew B.			Development of Open-Source Dummy and Impactor Models for the Assessment of American Football Helmet Finite Element Models	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Hybrid-III; Anthropomorphic test device; Helmet impact testing; Computational model; Material properties	NATIONAL OPERATING COMMITTEE; PROFESSIONAL FOOTBALL; HYBRID III; BRAIN-INJURY; CONCUSSION; PERFORMANCE; STANDARDS	The objective of this study was to develop and validate a set of Hybrid-III head and neck (HIII-HN) and impactor models that can be used to assess American football design modifications with established dummy-based injury metrics. The model was validated in two bare-head impact test configurations used by the National Football League and research groups to rank and assess helmet performance. The first configuration was a rigid pendulum impact to three locations on the HIII head (front, rear, side) at 3m/s. The second configuration was a set of eight 5.5m/s impacts to the HIII head at different locations using a linear impactor with a compliant end cap. The ISO/TS 18571 objective rating metric was used to quantify the correlation between the experimental and model head kinematics (linear and rotational velocity and acceleration) and neck kinetics (neck force and moment). The HIII-HN model demonstrated good correlation with overall mean ISO scores of 0.69-0.78 in the pendulum impacts and 0.65-0.81 in the linear impacts. These publically available models will serve as an in silico design platform that will be useful for investigating novel football helmet designs and studying human head impact biomechanics, in general.	[Giudice, J. Sebastian; Kong, Kevin; Kent, Richard; Panzer, Matthew B.] Univ Virginia, Ctr Appl Biomech, Dept Mech & Aerosp Engn, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA; [Park, Gwansik; Bailey, Ann; Kent, Richard] Biomech Consulting & Res Biocore LLC, 1621 Quail Run, Charlottesville, VA 22911 USA		Panzer, MB (corresponding author), Univ Virginia, Ctr Appl Biomech, Dept Mech & Aerosp Engn, 4040 Lewis & Clark Dr, Charlottesville, VA 22911 USA.	panzer@virginia.edu		Giudice, Sebastian/0000-0003-1074-4890	Football Research, Inc. (FRI); Biomechanics Consulting and Research, LLC (Biocore)	The research presented in this paper was made possible by a grant from Football Research, Inc. (FRI) and Biomechanics Consulting and Research, LLC (Biocore). The views expressed are solely those of the authors and do not represent those of Biocore, FRI, or any of their affiliates or funding sources. The authors would like to thank our collaborators in the "Engineering Roadmap: Numerical Crowdsourcing Project'' for their support and feedback of this work (teams from Wake Forest University, University of Waterloo, and KTH Royal Institute of Technology). The authors also acknowledge Virginia Tech Helmet Lab and BioKinetics and Associates, Ltd. for generating the pendulum and linear impactor test data.	Alshareef A, 2018, J NEUROTRAUM, V35, P780, DOI 10.1089/neu.2017.5362; Barbat S., 2013, OBJECTIVE RATING MET; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Chang LT, 2003, J CHIN INST ENG, V26, P835, DOI 10.1080/02533839.2003.9670838; Cobb BR, 2016, P I MECH ENG P-J SPO, V230, P50, DOI 10.1177/1754337115599133; Davis Matthew L, 2016, Stapp Car Crash J, V60, P509; Funk JR, 2018, J BIOMECH ENG-T ASME, V140, DOI 10.1115/1.4039673; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Gehre C., 2009, 21 INT TECHN C ENH S P 21 INT TECHN C ENH; Hallquist J.O., 2007, LS DYNA KEYWORD USER, P970; HODGSON VR, 1975, MED SCI SPORT EXER, V7, P225; Kaleps I., 1988, SAE TECHNICAL PAPER; Kaleps I, 1988, MEASUREMENT HYBRID 3; Kostopoulos V, 2002, COMPOS PART B-ENG, V33, P99, DOI 10.1016/S1359-8368(01)00066-X; Mills NJ, 2008, INT J IMPACT ENG, V35, P1087, DOI 10.1016/j.ijimpeng.2007.05.006; Mills NJ, 2009, INT J IMPACT ENG, V36, P913, DOI 10.1016/j.ijimpeng.2008.12.011; Mustafa H, 2015, PROC TECH, V20, P91, DOI 10.1016/j.protcy.2015.07.016; National Football League (NFL), 2017, 2017 HELM LAB TEST P; National Operating Committee on Standards for Athletic Equipment (NOCSAE), 2017, ND00217M17A NOCSAE; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; NHTSA, 2008, 20814 NHTSA TP; Pellman EJ, 2006, NEUROSURGERY, V58, P78, DOI 10.1227/01.NEU.0000196265.35238.7C; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; SAE, 2007, J2111 SAE S; SAE, 1998, US MAN 50 PERC MAL H; Spittle E. K., 1992, HYBRID 2 HYBRID 3 DU; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Teng TL, 2013, P I MECH ENG L-J MAT, V227, P82, DOI 10.1177/1464420712451806; Viano DC, 2012, ANN BIOMED ENG, V40, P97, DOI 10.1007/s10439-011-0377-3; Viano DC, 2012, ANN BIOMED ENG, V40, P160, DOI 10.1007/s10439-011-0384-4; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Withnall, 2017, NFL LINEAR IMPACTOR; Wood GW, 2010, SAE INT J MATER MANU, V3, P186, DOI 10.4271/2010-01-0383	36	18	18	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	FEB	2019	47	2					464	474		10.1007/s10439-018-02155-3			11	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	HI3XA	WOS:000456383600011	30341737				2022-02-06	
J	Kramer, AH; Couillard, PL; Zygun, DA; Aries, MJ; Gallagher, CN				Kramer, Andreas H.; Couillard, Philippe L.; Zygun, David A.; Aries, Marcel J.; Gallagher, Clare N.			Continuous Assessment of "Optimal" Cerebral Perfusion Pressure in Traumatic Brain Injury: A Cohort Study of Feasibility, Reliability, and Relation to Outcome	NEUROCRITICAL CARE			English	Article						Autoregulation; Cerebral blood flow (CBF); Cerebral perfusion pressure (CPP); Inter-observer agreement; Pressure reactivity index (PRx); Traumatic brain injury (TBI)	CEREBROVASCULAR AUTOREGULATION; INTRACRANIAL-PRESSURE; THRESHOLDS; REACTIVITY; SCALE; MANAGEMENT; AGREEMENT; DURATION; INSULTS	BackgroundGuidelines recommend maintaining cerebral perfusion pressure (CPP) between 60 and 70mmHg in patients with severe traumatic brain injury (TBI), but acknowledge that optimal CPP may vary depending on cerebral blood flow autoregulation. Previous retrospective studies suggest that targeting CPP where the pressure reactivity index (PRx) is optimized (CPPopt) may be associated with improved recovery.MethodsWe performed a retrospective cohort study involving TBI patients who underwent PRx monitoring to assess issues of feasibility relevant to future interventional studies: (1) the proportion of time that CPPopt could be detected; (2) inter-observer variability in CPPopt determination; and (3) agreement between manual and automated CPPopt estimates. CPPopt was determined for consecutive 6-h epochs during the first week following TBI. Sixty PRx-CPP tracings were randomly selected and independently reviewed by six critical care professionals. We also assessed whether greater deviation between actual CPP and CPPopt (CPP) was associated with poor outcomes using multivariable models.ResultsIn 71 patients, CPPopt could be manually determined in 985 of 1173 (84%) epochs. Inter-observer agreement for detectability was moderate (kappa 0.46, 0.23-0.68). In cases where there was consensus that it could be determined, agreement for the specific CPPopt value was excellent (weighted kappa 0.96, 0.91-1.00). Automated CPPopt was within 5mmHg of manually determined CPPopt in 93% of epochs. Lower PRx was predictive of better recovery, but there was no association between CPP and outcome. Percentage time spent below CPPopt increased over time among patients with poor outcomes (p=0.03). This effect was magnified in patients with impaired autoregulation (defined as PRx>0.2; p=0.003).ConclusionProspective interventional clinical trials with regular determination of CPPopt and corresponding adjustment of CPP goals are feasible, but measures to maximize consistency in CPPopt determination are necessary. Although we could not confirm a clear association between CPP and outcome, time spent below CPPopt may be particularly harmful, especially when autoregulation is impaired.	[Kramer, Andreas H.; Couillard, Philippe L.] Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada; [Kramer, Andreas H.; Couillard, Philippe L.; Gallagher, Clare N.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Zygun, David A.] Univ Alberta, Dept Crit Care Med, Edmonton, AB, Canada; [Aries, Marcel J.] Univ Maastricht, Dept Intens Care, Maastricht, Netherlands		Kramer, AH (corresponding author), Univ Calgary, Dept Crit Care Med, Calgary, AB, Canada.	Andreas.Kramer@AlbertaHealthServices.ca			Department of Clinical Neurosciences at the University of Calgary; Alberta Health Services	This study was performed without any dedicated funding. One of the authors (CG) received funding from the Department of Clinical Neurosciences at the University of Calgary for the purchase of ICM+ licenses and equipment. Alberta Health Services provided information technology support.	Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2002, CRIT CARE MED, V30, P739, DOI 10.1097/00003246-200204000-00003; COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Depreitere B, 2014, J NEUROSURG, V120, P1451, DOI 10.3171/2014.3.JNS131500; Dias C, 2015, NEUROCRIT CARE, V23, P92, DOI 10.1007/s12028-014-0103-8; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Johnson U, 2014, NEUROCRIT CARE, V21, P259, DOI 10.1007/s12028-014-9954-2; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Kramer AH, 2016, NEUROCRIT CARE, V25, P10, DOI 10.1007/s12028-015-0232-8; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Liu XY, 2017, J NEUROTRAUM, V34, P3081, DOI 10.1089/neu.2017.5003; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Needham E, 2016, J NEUROTRAUM, V33, P1, DOI [10.1089/neu.2015.3905, DOI 10.1089/NEU.2015.3905]; O'Reilly C, GUIDELINES MANAGEMEN; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pesek M, 2014, NEUROSURGERY, V75, P163, DOI 10.1227/NEU.0000000000000367; Preiksaitis A, 2016, NEUROSURGERY, V79, P75, DOI 10.1227/NEU.0000000000001192; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steijn R, 2017, MINERVA ANESTHESIOL; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Thiara S, 2018, CAN J NEUROL SCI; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zeiler F.A., 2017, J NEUROTRAUM, DOI DOI 10.1089/neu.2017.5364	37	18	18	1	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	FEB	2019	30	1					51	61		10.1007/s12028-018-0570-4			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HJ8LA	WOS:000457449700007	29987688				2022-02-06	
J	Li, QQ; Wu, X; Yang, YY; Zhang, Y; He, F; Xu, X; Zhang, ZW; Tao, LY; Luo, CL				Li, Qianqian; Wu, Xiao; Yang, Yanyan; Zhang, Yue; He, Fang; Xu, Xiang; Zhang, Ziwei; Tao, Luyang; Luo, Chengliang			Tachykinin NK1 receptor antagonist L-733,060 and substance P deletion exert neuroprotection through inhibiting oxidative stress and cell death after traumatic brain injury in mice	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Substance P; Traumatic brain injury; Neurokinin-1 receptor (NK1R); Oxidative stress; Cell death	IN-VITRO; MEMBRANE PERMEABILIZATION; BARRIER DISRUPTION; CORTICAL-NEURONS; CYTOCHROME-C; MITOCHONDRIAL; APOPTOSIS; EDEMA; CONTRIBUTES; AUTOPHAGY	Substance P (SP) is believed to play a role in traumatic brain injury (TBI), and the inhibition of binding of SP to the tachykinin neurokinin-1 receptor (NK1R) using NK1R antagonists had made favorable effects on TBI. Our current study addresses the functional roles and underlying mechanisms of SP and NK1R antagonist L-733,060 following TBI. Adult male wild type C57BL/6 J and SP knock out (SP-KO) mice received a controlled cortical impact and outcome parameters were assessed. The results showed that TBI-induced motor and spatial memory deficits, lesion volume, brain water content and blood-brain barrier disruption were alleviated both in L-733,060-treated C57BL/6 J mice and vehicle-treated SP-KO mice. L-733,060 treatment and SP deletion inhibited TBI-induced the release of cytochrome c from mitochondria to cytoplasm, activation of caspase-3, oxidative stress and neuroinflammation. Higher SP levels in serum and cortex were observed in wild type mice undergoing TBI relative to wild type sham group, but very little expression of cortical SP was detected in the SP-/- mice either TBI or not. Upregulation of NK1R expression after TBI was observed, and there was no significant difference between wild type and SP-KO groups. in vitro, L-733,060 and SP deletion inhibited scratch injury-induced cell death, loss of mitochondrial membrane potential and reactive oxygen species (ROS) production following TBI. Together, the results of this study implicate a functional role for NK1-R antagonist L-733,060 and deletion of SP in TBI-induced neurological outcome, oxidative damage, neuroinflammation and cell death. Upregulation of NK1R maybe a consequence of TBI, independent of the levels of substance P. This study raises the possibility that targeting SP through its receptor NK1R or genetic deletion may have therapeutic efficacy in TBI.	[Li, Qianqian; Wu, Xiao; Yang, Yanyan; Zhang, Yue; He, Fang; Xu, Xiang; Zhang, Ziwei] Wannan Med Coll, Sch Forens Med, Wuhu 241002, Anhui, Peoples R China; [Tao, Luyang; Luo, Chengliang] Soochow Univ, Med Coll, Dept Forens Med, 178 Ganjiang East St, Suzhou 215123, Jiangsu, Peoples R China		Luo, CL (corresponding author), Soochow Univ, Med Coll, Dept Forens Med, 178 Ganjiang East St, Suzhou 215123, Jiangsu, Peoples R China.	clluo@suda.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81400999, 81373251, 81530062]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2014M551660]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by the National Natural Science Foundation of China (No. 81400999, No. 81373251, No. 81530062), China Postdoctoral Science Foundation (No. 2014M551660), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Babbitt SE, 2015, TRENDS BIOCHEM SCI, V40, P446, DOI 10.1016/j.tibs.2015.05.006; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Bermpohl D, 2006, J CEREBR BLOOD F MET, V26, P625, DOI 10.1038/sj.jcbfm.9600258; Carthew HL, 2012, NEUROSCIENCE, V214, P78, DOI 10.1016/j.neuroscience.2012.04.028; Chang LK, 2002, J CELL BIOL, V157, P771, DOI 10.1083/jcb.200112130; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Cook NL, 2009, J NEUROSCI RES, V87, P34, DOI 10.1002/jnr.21846; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Corrigan F, 2012, CNS NEUROSCI THER, V18, P513, DOI 10.1111/j.1755-5949.2012.00332.x; Cui T, 2015, CELL BIOCHEM BIOPHYS, V71, P595, DOI 10.1007/s12013-014-0239-3; Dang DK, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1087-7; Donkin JJ, 2011, J NEUROTRAUM, V28, P217, DOI 10.1089/neu.2010.1632; Donkin JJ, 2009, J CEREBR BLOOD F MET, V29, P1388, DOI 10.1038/jcbfm.2009.63; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Estaquier J, 2007, CELL DEATH DIFFER, V14, P1086, DOI 10.1038/sj.cdd.4402107; Halima B, 2018, J MED FOOD, V21, P70, DOI 10.1089/jmf.2017.0039; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hokfelt T, 2001, J INTERN MED, V249, P27, DOI 10.1046/j.0954-6820.2000.00773.x; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Leonard Anna V, 2013, Acta Neurochir Suppl, V118, P303, DOI 10.1007/978-3-7091-1434-6_59; Liang JW, 2018, DRUG DES DEV THER, V12, P845, DOI 10.2147/DDDT.S160046; Liao YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068963; Lin Y., 2013, WORLD NEUROSURG, V81, P420; Lorente L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0911-z; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Luo CL, 2015, J MOL NEUROSCI, V56, P988, DOI 10.1007/s12031-015-0568-8; MAGGI CA, 1995, GEN PHARMACOL-VASC S, V26, P911, DOI 10.1016/0306-3623(94)00292-U; Mannix RC, 2011, J CEREBR BLOOD F MET, V31, P351, DOI 10.1038/jcbfm.2010.99; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Ozay R, 2017, WORLD NEUROSURG, V97, P407, DOI 10.1016/j.wneu.2016.09.115; Park Sin-Young, 2014, Exp Neurobiol, V23, P104, DOI 10.5607/en.2014.23.1.104; Saffroy M, 2003, NEUROSCIENCE, V116, P761, DOI 10.1016/S0306-4522(02)00748-0; Santopietro John, 2015, N C Med J, V76, P96; Thornton E, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034138, 10.1371/journal.pone.0042630]; Vink R, 2003, ACT NEUR S, V86, P257; Vink R, 2010, NEUROTHERAPEUTICS, V7, P74, DOI 10.1016/j.nurt.2009.10.018; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Winter CD, 2002, J NEUROSCI METH, V119, P45, DOI 10.1016/S0165-0270(02)00153-X; Wu Q, 2018, INT J BIOCHEM CELL B, V94, P44, DOI 10.1016/j.biocel.2017.11.007; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Yu ZF, 1997, NEUROREPORT, V8, P2117, DOI 10.1097/00001756-199707070-00006; Yuan F, 2016, J NEUROCHEM, V136, P581, DOI 10.1111/jnc.13423; Zacest AC, 2010, ACTA NEUROCHIR SUPPL, V106, P211, DOI 10.1007/978-3-211-98811-4_39	50	18	19	0	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	FEB	2019	107						154	165		10.1016/j.biocel.2018.12.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	HZ0TO	WOS:000468555000017	30593954				2022-02-06	
J	Wirsching, A; Chen, ZX; Bevilacqua, ZW; Huibregtse, ME; Kawata, K				Wirsching, Angela; Chen, Zhongxue; Bevilacqua, Zachary W.; Huibregtse, Megan E.; Kawata, Keisuke			Association of Acute Increase in Plasma Neurofilament Light with Repetitive Subconcussive Head Impacts: A Pilot Randomized Control Trial	JOURNAL OF NEUROTRAUMA			English	Article						blood biomarker; concussion; neurofilament; soccer; subconcussion	TRAUMATIC BRAIN-INJURY; DEFAULT MODE NETWORK; EXPOSURE; DISEASE; PROTEIN; BLOOD; IMMUNOASSAY; BIOMARKERS; INTENSITY; MARKER	The purpose of the study was to examine an association of repetitive subconcussive head impacts with changes in plasma neurofilament light (NF-L) levels following 10 bouts of controlled soccer heading. In this randomized control trial, 37 healthy adult soccer players were randomly assigned into either a heading (n=19) or kicking-control group (n=18). The heading group executed 10 headers with soccer balls projected at a velocity of 25mph over 10min. Plasma samples were obtained at pre-heading baseline, 0h, 2h, and 24h post-heading. The kicking-control group followed the same protocol with 10 kicks. Plasma NF-L was measured using ultrasensitive single-molecule array technology. Data from 34 subjects were eligible for analysis (heading n=18 and kicking n=16). Ten subconcussive head impacts induced a gradual increase in plasma NF-L expression for the heading group (=0.0297, standard error [SE]=0.01, p=0.0049), whereas there was no significant time effect for the kicking-control group. A follow-up analysis revealed that a significant difference appeared at 24h post-heading (3.68 +/- 0.30pg/mL) compared with pre-heading (3.12 +/- 0.29pg/mL, p=0.0013; Cohen's d=1.898). At the 24h post-heading time-point, the plasma NF-L level for the heading group was significantly higher than that of the kicking-control group with an estimated mean difference of 0.66pg/mL (SE=0.22, p=0.0025). The data suggest that the increased level of plasma NF-L was driven by repetitive subconcussive head impacts and required longer than 2h after the head impacts for the increase to be detected. Plasma NF-L levels may serve as an objective marker to monitor acute axonal burden from subconcussive head impacts.	[Wirsching, Angela; Bevilacqua, Zachary W.; Huibregtse, Megan E.; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA; [Chen, Zhongxue] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA; [Kawata, Keisuke] Indiana Univ, Coll Arts & Sci, Neurosci Program, Bloomington, IN USA		Kawata, K (corresponding author), Indiana Univ, Sch Publ Hlth, 1025 E 7th St, Bloomington, IN 47405 USA.	kkawata@indiana.edu	Chen, Zhongxue/K-1372-2013	Chen, Zhongxue/0000-0003-2537-7843	Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health [ISCBIRF 0019939]; IU School of Public Health faculty research grant program [FRGP: 2246237]	The authors would like to thank Drs. Carrie Docherty and Jackie Kingma from Indiana University School of Public Health for their assistance in reviewing the study materials and the manuscript. This work was partly supported by the Indiana Spinal Cord and Brain Injury Research Fund from the Indiana State Department of Health (to K. Kawata: ISCBIRF 0019939) and the IU School of Public Health faculty research grant program (to K. Kawata: FRGP: 2246237). Sponsors had no role in the design or execution of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Bacioglu M, 2016, NEURON, V91, P494, DOI 10.1016/j.neuron.2016.07.007; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Bretzin AC, 2017, SPORTS HEALTH, V9, P168, DOI 10.1177/1941738116678615; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; FIFA, 2007, FIFA BIG COUNT 2006 FIFA BIG COUNT 2006; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hall AA, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00104; Haran FJ, 2013, INT J SPORTS MED, V34, P350, DOI 10.1055/s-0032-1304647; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Igarashi K, 2017, J GASTROEN HEPATOL, V32, P602, DOI 10.1111/jgh.13543; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kuhle J, 2016, CLIN CHEM LAB MED, V54, P1655, DOI 10.1515/cclm-2015-1195; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Ljungqvist J, 2017, J NEUROTRAUM, V34, P1124, DOI 10.1089/neu.2016.4496; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rohrer JD, 2016, NEUROLOGY, V87, P1329, DOI 10.1212/WNL.0000000000003154; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Weston PSJ, 2017, NEUROLOGY, V89, P2167, DOI 10.1212/WNL.0000000000004667; Wilson DH, 2016, JALA-J LAB AUTOM, V21, P533, DOI 10.1177/2211068215589580; Yap YC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176997; Zetterberg H, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037143	39	18	18	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2019	36	4					548	553		10.1089/neu.2018.5836			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HM4MQ	WOS:000459448300004	30019617				2022-02-06	
J	Xia, ZY; Alphonse, VD; Trigg, DB; Harrigan, TP; Paulson, JM; Luong, QT; Lloyd, EP; Barbee, MH; Craig, SL				Xia, Zhiyong; Alphonse, Vanessa D.; Trigg, Doug B.; Harrigan, Tim P.; Paulson, Jeff M.; Luong, Quang T.; Lloyd, Evan P.; Barbee, Meredith H.; Craig, Stephen L.			'Seeing' Strain in Soft Materials	MOLECULES			English	Article						spiropyran; impact strain; poly(dimethyl siloxane); mechanophore; strain sensing	COVALENT BONDS; ACTIVATION	Several technologies can be used for measuring strains of soft materials under high rate impact conditions. These technologies include high speed tensile test, split Hopkinson pressure bar test, digital image correlation and high speed X-ray imaging. However, none of these existing technologies can produce a continuous 3D spatial strain distribution in the test specimen. Here we report a novel passive strain sensor based on poly(dimethyl siloxane) (PDMS) elastomer with covalently incorporated spiropyran (SP) mechanophore to measure impact induced strains. We have shown that the incorporation of SP into PDMS at 0.25 wt% level can adequately measure impact strains via color change under a high strain rate of 1500 s(-1) within a fraction of a millisecond. Further, the color change is fully reversible and thus can be used repeatedly. This technology has a high potential to be used for quantifying brain strain for traumatic brain injury applications.	[Xia, Zhiyong; Alphonse, Vanessa D.; Trigg, Doug B.; Harrigan, Tim P.; Paulson, Jeff M.; Luong, Quang T.; Lloyd, Evan P.] Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA; [Barbee, Meredith H.; Craig, Stephen L.] Duke Univ, Dept Chem, Durham, NC 27708 USA		Xia, ZY (corresponding author), Johns Hopkins Univ, Appl Phys Lab, Johns Hopkins Rd, Laurel, MD 20723 USA.	Zhiyong.Xia@jhuapl.edu; vanessa.alphonse@jhuapl.edu; Doug.trigg@jhuapl.edu; Tim.harrigan@jhuapl.edu; jeff.paulson@jhuapl.edu; quang.luong@jhuapl.edu; Evan.lloyd@jhuapl.edu; Meredith.barbee@duke.edu; Stephen.craig@jhuapl.edu	Craig, Stephen L/D-3484-2011	Craig, Stephen L/0000-0002-8810-0369; Barbee, Meredith/0000-0002-7324-2866; Lloyd, Evan/0000-0001-6984-7400	Independent Research and Development Fund (IRAD) from the National Health Mission Area of the Johns Hopkins University/Applied Physics Laboratory - US Army Research Laboratory; Army Research Office [W911NF-15-0143]	This research was supported by the Independent Research and Development Fund (IRAD) from the National Health Mission Area of the Johns Hopkins University/Applied Physics Laboratory. The SP synthesis was partially funded by the US Army Research Laboratory and the Army Research Office under Grant W911NF-15-0143 to S.L.C.	Bauer W.H., 1977, ACTA CRSYT, V33, P2615, DOI [10.1107/S0567740877009029, DOI 10.1107/S0567740877009029]; Beberniss TJ, 2017, MECH SYST SIGNAL PR, V86, P35, DOI 10.1016/j.ymssp.2016.04.014; Chanda A, 2018, MECH ADV MATER STRUC, V25, P1335, DOI 10.1080/15376494.2016.1143749; Davis DA, 2009, NATURE, V459, P68, DOI 10.1038/nature07970; Flory P.J., 1989, STAT MECH CHAIN MOL, P16; Gossweiler GR, 2015, J AM CHEM SOC, V137, P6148, DOI 10.1021/jacs.5b02492; Gossweiler GR, 2014, ACS MACRO LETT, V3, P216, DOI 10.1021/mz500031q; Guglielmetti R., 2002, ORGANIC PHOTOCHROMIC; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Klukovich HM, 2013, NAT CHEM, V5, P110, DOI [10.1038/NCHEM.1540, 10.1038/nchem.1540]; Lane B, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8030371; Lee CK, 2010, J AM CHEM SOC, V132, P16107, DOI 10.1021/ja106332g; LIN S, 1997, P CTR DIS CONTR WAYN, P27; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Lukyanov BS., 2005, CHEM HETEROCYC COMPO, V41, P281, DOI [10.1007/s10593-005-0148-x, DOI 10.1007/S10593-005-0148-X]; Olsen Cody S, 2016, Inj Epidemiol, V3, P8; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Raisch M, 2018, ADV MATER, V30, DOI 10.1002/adma.201802813; Silberstein M.N., 2017, MECHANOCHEMISTRY MAT, P76; Treloar L.R.G., 2005, PHYS RUBBER ELASTICI, P213; Trexler MM, 2011, J MECH BEHAV BIOMED, V4, P1920, DOI 10.1016/j.jmbbm.2011.06.008; Voo L., 2016, P 13 PERS ARM SYST S; Wang JP, 2014, J AM CHEM SOC, V136, P15162, DOI 10.1021/ja509585g; Wang QM, 2015, J MECH PHYS SOLIDS, V82, P320, DOI 10.1016/j.jmps.2015.05.007; Wang ZY, 2007, EXP MECH, V47, P701, DOI 10.1007/s11340-006-9005-9; Weng SG, 2012, J APPL POLYM SCI, V124, P3765, DOI 10.1002/app.35366	26	18	18	2	18	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		1420-3049		MOLECULES	Molecules	FEB 1	2019	24	3							542	10.3390/molecules24030542			10	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	HL7PR	WOS:000458934000166	30717294	Green Published, Green Submitted, gold			2022-02-06	
J	Kan, C; Ding, N; Yang, JZ; Tan, ZY; McGuire, TL; Lu, HM; Zhang, KQ; Berger, DMP; Kessler, JA; Kan, LX				Kan, Chen; Ding, Na; Yang, Jiazhao; Tan, Zhenya; McGuire, Tammy L.; Lu, Haimei; Zhang, Keqin; Berger, Diana M. Palila; Kessler, John A.; Kan, Lixin			BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification	STEM CELL RESEARCH & THERAPY			English	Article						Heterotopic ossification (HO); Niche; Mesenchymal stem cells (MSCs); Niche supportive cells; Niche supportive molecules; Bone morphogenetic protein (BMP); Hedgehog (Hh)	TRAUMATIC BRAIN-INJURY; BONE-FORMATION; STEM/PROGENITOR CELLS; PROGENITOR CELLS; TRANSGENIC MICE; CONTRIBUTE; HETEROGENEITY; EXPRESSION; PREVENTS; MUSCLE	BackgroundHeterotopic ossification (HO), either acquired (aHO) or hereditary, such as fibrodysplasia ossificans progressiva (FOP), is a serious condition without effective treatment. Understanding of the core process of injury-induced HO is still severely limited.MethodsDouble-pulse thymidine analog labeling was used to explore the distinctive domains evolved in injury-induced lesions in an animal model of HO (Nse-BMP4). Histological studies were performed to see whether a similar zonal pattern is also consistently found in biopsies from patients with aHO and FOP. In vivo clonal analysis with Rainbow mice, genetic loss-of-function studies with diphtheria toxin A (DTA)-mediated depletion and lineage tracing with Zsgreen reporter mice were used to obtain further evidence that Tie2-cre-, Gli1-creERT-, and Glast-creERT-labeled cells contribute to HO as niche-dwelling progenitor/stem cells. Immunohistochemistry was used to test whether vasculature, neurites, macrophages, and mast cells are closely associated with the proposed niche and thus are possible candidate niche supportive cells. Similar methods also were employed to further understand the signaling pathways that regulate the niche and the resultant HO.ResultsWe found that distinctive domains evolved in injury-induced lesions, including, from outside-in, a mesenchymal stem cell (MSC) niche, a transient domain and an inner differentiated core in an animal model of HO (Nse-BMP4). A similar zonal structure was found in patients with aHO and FOP. In vivo clonal analysis with Rainbow mice and genetic loss-of-function studies with DTA provided evidence that Tie2-cre-, Gli1-creERT-, and Glast-creERT-labeled cells contribute to HO as niche-dwelling progenitor/stem cells; consistently, vasculature, neurites, macrophages, and mast cells are closely associated with the proposed niche and thus are possible candidate niche supportive cells. Further mechanistic study found that BMP and hedgehog (Hh) signaling co-regulate the niche and the resultant HO.ConclusionsAvailable data provide evidence of a potential core mechanism in which multiple disease-specific cellular and extracellular molecular elements form a unique local microenvironment, i.e., an injury-induced stem cell niche, which regulates the proliferation and osteogenic differentiation of mesenchymal stem cells (MSCs). The implication for HO is that therapeutic approaches must consider several different disease specific factors as parts of a functional unit, instead of treating one factor at a time.	[Kan, Chen; Ding, Na; Tan, Zhenya; Lu, Haimei; Kan, Lixin] Anhui Med Univ, Sch Basic Med Sci, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China; [Yang, Jiazhao] Chinese Univ Sci & Technol, Affiliated Hosp 1, Dept Traumat Orthoped, Anhui Prov Hosp, Hefei 233000, Anhui, Peoples R China; [McGuire, Tammy L.; Kessler, John A.; Kan, Lixin] Northwestern Univ, Dept Neurol, Ward Bldg 10-233,303 East Chicago Ave, Chicago, IL 60611 USA; [Zhang, Keqin] Tongji Univ, Sch Med, Tongji Hosp, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Berger, Diana M. Palila] Northwestern Univ, Feinberg Med Sch, Ctr Comparat Med, Chicago, IL 60611 USA		Kan, LX (corresponding author), Anhui Med Univ, Sch Basic Med Sci, 81 Meishan Rd, Hefei 230032, Anhui, Peoples R China.; Kan, LX (corresponding author), Northwestern Univ, Dept Neurol, Ward Bldg 10-233,303 East Chicago Ave, Chicago, IL 60611 USA.	l-kan@northwestern.edu	zhang, ke/AAH-8217-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472087]; Natural Science Foundation of Anhui provinceNatural Science Foundation of Anhui Province [1508085MC45]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 AR066539]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [R01AR066539] Funding Source: NIH RePORTER	LK was supported in part by the National Natural Science Foundation of China (81472087) and Natural Science Foundation of Anhui province (1508085MC45). This work was supported by NIH grant RO1 AR066539 (JAK).	Agarwal S, 2017, STEM CELLS, V35, P705, DOI 10.1002/stem.2515; Agarwal S, 2016, P NATL ACAD SCI USA, V113, pE338, DOI 10.1073/pnas.1515397113; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Almangour W, 2016, ANN PHYS REHABIL MED, V59, P263, DOI 10.1016/j.rehab.2016.03.009; Birbrair A, 2016, ANN NY ACAD SCI, V1370, P82, DOI 10.1111/nyas.13016; Davies OG, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00194; Dey D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1090; Fu HD, 2017, EXP THER MED, V14, P5424, DOI 10.3892/etm.2017.5210; Gannon FH, 2001, HUM PATHOL, V32, P842, DOI 10.1053/hupa.2001.26464; Hojo H, 2013, J BIOL CHEM, V288, P9924, DOI 10.1074/jbc.M112.409342; Hsieh HHS, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00074; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Kan C, 2018, BONE, V109, P43, DOI 10.1016/j.bone.2017.04.014; Kan C, 2018, BONE, V109, P71, DOI 10.1016/j.bone.2017.06.014; Kan LX, 2014, INFLAMM RES, V63, P207, DOI 10.1007/s00011-013-0690-4; Kan LX, 2013, BONE, V53, P194, DOI 10.1016/j.bone.2012.12.008; Kan LX, 2011, J CELL BIOCHEM, V112, P2759, DOI 10.1002/jcb.23259; Kan LX, 2009, STEM CELLS, V27, P150, DOI 10.1634/stemcells.2008-0576; Kan LX, 2004, AM J PATHOL, V165, P1107, DOI 10.1016/S0002-9440(10)63372-X; Kazmers NH, 2015, BONE, V81, P524, DOI 10.1016/j.bone.2015.09.002; Kendler A, 1996, J NEUROPATH EXP NEUR, V55, P1253, DOI 10.1097/00005072-199612000-00009; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kraft CT, 2016, J TRAUMA ACUTE CARE, V80, P156, DOI 10.1097/TA.0000000000000883; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Llorens-Martin M, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00076; Lounev VY, 2009, J BONE JOINT SURG AM, V91A, P652, DOI 10.2106/JBJS.H.01177; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Olmsted-Davis EA, 2017, STEM CELL TRANSL MED, V6, P1109, DOI 10.1002/sctm.16-0347; Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751; Pignolo RJ, 2013, PEDIATR ENDOCR REV P, V10, P437; Pluchino S, 2010, ARCH ITAL BIOL, V148, P173; Rinkevich Y, 2014, CELL REP, V7, P1270, DOI 10.1016/j.celrep.2014.04.018; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Wang P, 2017, INT J BIOL SCI, V13, P996, DOI 10.7150/ijbs.19986; Wosczyna MN, 2012, J BONE MINER RES, V27, P1004, DOI 10.1002/jbmr.1562; Yu VWC, 2016, CURR OPIN HEMATOL, V23, P331, DOI 10.1097/MOH.0000000000000265; Zhang C, 2016, FEBS J, V283, P1275, DOI 10.1111/febs.13667	42	18	19	1	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-6512			STEM CELL RES THER	Stem Cell Res. Ther.	JAN 11	2019	10								14	10.1186/s13287-018-1107-7			17	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	HH2AK	WOS:000455520800003	30635039	Green Published, gold			2022-02-06	
J	LaRocca, D; Barns, S; Hicks, SD; Brindle, A; Williams, J; Uhlig, R; Johnson, P; Neville, C; Middleton, FA				LaRocca, Daria; Barns, Sarah; Hicks, Steven D.; Brindle, Andrew; Williams, Jeremy; Uhlig, Richard; Johnson, Paul; Neville, Christopher; Middleton, Frank A.			Comparison of serum and saliva miRNAs for identification and characterization of mTBI in adult mixed martial arts fighters	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; CEREBROSPINAL-FLUID; BIOMARKERS; MICRORNAS; EXPRESSION; MIR-155; PLASMA; HEALTH; GENES	Traumatic brain injury (TBI) is a major cause of death and disability worldwide, with mild TBI (mTBI) accounting for 85% of cases. mTBI is also implicated in serious long-term sequelae including second impact syndrome and chronic traumatic encephalopathy. mTBI often goes undiagnosed due to delayed symptom onset and limited sensitivity of conventional assessment measures compared with severe TBI. Current efforts seek to identify accurate and reliable non-invasive biomarkers associated with functional measures relevant to long-term outcomes. Here we evaluated the utility of serum and salivary microRNAs (miRNAs) to serve as sensitive and specific peripheral biomarkers of possible mTBI. Our primary objectives were to establish the relationship between peripheral measures of miRNA, objective quantification of head impacts, and sensitive indices of balance and cognitive function in healthy young adult athletes. A secondary objective was to compare the sensitivity of miRNA versus commonly used blood-based protein biomarkers. 50 amateur mixed martial arts (MMA) fighters participated. 216 saliva and serum samples were collected at multiple time points, both pre- and post-fight. Levels of 10 serum proteins were compared in a subset of the fighters (n = 24). Levels of miRNAs were obtained by next generation sequencing. Functional outcomes were evaluated using a computerized assessment system that measured cognitive performance, body sway, and combined cognitive performance and body sway during dual task completion. Data were analyzed using multivariate logistic regression for predictive classification, analysis of variance, correlation analysis and principal component analysis. We identified a subset of salivary and serum miRNAs that showed robust utility at predicting TBI likelihood and demonstrated quantitative associations with head impacts as well as cognitive and balance measures. In contrast, serum proteins demonstrated far less utility. We also found that the timing of the responses varies in saliva and serum, which is a critical observation for biomarker studies to consider.	[LaRocca, Daria; Barns, Sarah; Middleton, Frank A.] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA; [Barns, Sarah; Brindle, Andrew; Williams, Jeremy; Uhlig, Richard] Quadrant Biosci Inc, 405 Irving Ave, Syracuse, NY USA; [Hicks, Steven D.] Penn State Coll Med, Dept Pediat, Hershey, PA USA; [Johnson, Paul] SUNY Upstate Med Univ, Coll Hlth Profess Clin Lab Sci, Syracuse, NY 13210 USA; [Neville, Christopher] SUNY Upstate Med Univ, Dept Phys Therapy Educ, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Middleton, Frank A.] SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA		Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.; Middleton, FA (corresponding author), SUNY Upstate Med Univ, Dept Pediat, Syracuse, NY 13210 USA.	middletf@upstate.edu		Hicks, Steven/0000-0002-9579-6798; Neville, Christopher/0000-0002-8601-976X; Johnson, Paul/0000-0003-2661-9197; Middleton, Frank/0000-0002-3107-7188	Quadrant Biosciences, Inc.; Research Foundation of the State University of New York [RF1128143-1-72906]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [KL2TR002015, UL1TR002014] Funding Source: NIH RePORTER	Part of the financial support for this work was funded by an award from Motion Intelligence, Inc. (now Quadrant Biosciences, Inc; https://quadrantbiosciences.com/).This award was issued to the corresponding author (F. Middleton) and administered through the Research Foundation of the State University of New York (grant number RF1128143-1-72906). The funder provided support in the form of salaries for authors SB, AB, JW and RU, who helped with data acquisition and project support, but did not have any additional role in the data analysis, decision to publish, or preparation of the initial manuscript. The specific roles of these authors are in the 'author contributions' section.	Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Cardoso AL, 2012, IMMUNOLOGY, V135, P73, DOI 10.1111/j.1365-2567.2011.03514.x; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaudet AD, 2016, J NEUROSCI, V36, P8516, DOI 10.1523/JNEUROSCI.0735-16.2016; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Harrison EB, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00228; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hicks SD, 2018, J NEUROTRAUM, V35, P64, DOI 10.1089/neu.2017.5111; Hutchison MG, 2014, AM J SPORT MED, V42, P1352, DOI 10.1177/0363546514526151; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ignacio C, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0195-x; Jee MK, 2012, HUM GENE THER, V23, P508, DOI 10.1089/hum.2011.121; Johnson JJ, 2018, JAMA PEDIATR, V172, P65, DOI 10.1001/jamapediatrics.2017.3884; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Koval ED, 2013, HUM MOL GENET, V22, P4127, DOI 10.1093/hmg/ddt261; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Laterza OF, 2009, CLIN CHEM, V55, P1977, DOI 10.1373/clinchem.2009.131797; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Lopez-Ramirez MA, 2016, FASEB J, V30, P2662, DOI 10.1096/fj.201600435RR; Lukiw WJ, 2007, NEUROREPORT, V18, P297, DOI 10.1097/WNR.0b013e3280148e8b; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Pasinetti Giulio M, 2012, Am J Neurodegener Dis, V1, P88; Phay M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137461; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Puhakka N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172521; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Roncon P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14143; Sajja VSSS, 2018, J NEUROTRAUM, V35, P353, DOI 10.1089/neu.2017.5009; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Sullan MJ, 2018, NEUROSCI BIOBEHAV R, V84, P316, DOI 10.1016/j.neubiorev.2017.08.016; Tan L, 2015, MOL NEUROBIOL, V51, P1249, DOI 10.1007/s12035-014-8803-9; Thome AD, 2016, J NEUROSCI, V36, P2383, DOI 10.1523/JNEUROSCI.3900-15.2016; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Yeri A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4726-6; You WD, 2016, CHIN J TRAUMATOL, V19, P11, DOI 10.1016/j.cjtee.2016.01.004; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9	44	18	19	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2019	14	1							e0207785	10.1371/journal.pone.0207785			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HG1BB	WOS:000454683200004	30601825	Green Published, Green Submitted, gold			2022-02-06	
J	Moye, LS; Novack, ML; Tipton, AF; Krishnan, H; Pandey, SC; Pradhan, AAA				Moye, Laura S.; Novack, Madeline L.; Tipton, Alycia F.; Krishnan, Harish; Pandey, Subhash C.; Pradhan, Amynah A. A.			The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target	CEPHALALGIA			English	Article						Delta opioid receptor; hyperalgesia; migraine; nitroglycerin; mild traumatic brain injury	TRAUMATIC BRAIN-INJURY; GENE-RELATED PEPTIDE; HEADACHE; NITROGLYCERIN; PREVALENCE; CGRP; PAIN; ALLODYNIA; BEHAVIORS; DISORDER	Background Post-traumatic headache is the most common and long-lasting impairment observed following mild traumatic brain injury, and frequently has migraine-like characteristics. The mechanisms underlying progression from mild traumatic brain injury to post-traumatic headache are not fully understood. The aim of this study was to develop a mouse model of post-traumatic headache and identify mechanisms and novel targets associated with this disorder. Methods We combined the closed head weight-drop method and the nitroglycerin chronic migraine model. To induce mild traumatic brain injury, a weight was dropped onto intact crania of mildly anesthetized mice, and mechanical responses to chronic-intermittent administration of nitroglycerin, a human migraine trigger, were determined at multiple time points post-injury. Results Low dose nitroglycerin (0.1 mg/kg) evoked acute periorbital and hind paw allodynia in both mild traumatic brain injury and sham animals. However, only mild traumatic brain injury mice developed chronic hypersensitivity to low dose nitroglycerin. Migraine medications, sumatriptan and topiramate, inhibited post-traumatic headache-associated allodynia. In addition, the delta opioid receptor agonist, SNC80, also blocked post-traumatic headache-associated allodynia. Finally, we examined the expression of calcitonin gene-related peptide within this model and found that it was increased in trigeminal ganglia two weeks post-mild traumatic brain injury. Conclusions Overall, we have established a mouse model of post-traumatic headache and identified the delta opioid receptor as a novel therapeutic target for this disorder.	[Moye, Laura S.; Novack, Madeline L.; Tipton, Alycia F.; Krishnan, Harish; Pandey, Subhash C.; Pradhan, Amynah A. A.] Univ Illinois, Dept Psychiat, 1601 W Taylor St,MC 912, Chicago, IL 60612 USA; [Pandey, Subhash C.] Ctr Alcohol Res Epigenet UIC Psychiat, Chicago, IL USA; [Pandey, Subhash C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA		Pradhan, AAA (corresponding author), Univ Illinois, Dept Psychiat, 1601 W Taylor St,MC 912, Chicago, IL 60612 USA.	pradhan4@uic.edu	Pradhan, Amynah/AAX-7719-2020	Pradhan, Amynah/0000-0001-9691-2976	DODUnited States Department of Defense [PR141746]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA040688]; NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA022538]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50AA022538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA040688] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Research was supported by DOD grant PR141746 (AAP), NIH Grant DA040688 (AAP), and the NIAAA funded Center for Alcohol Research in Epigenetics - AA022538 (SCP). LM is a member of the UIC Graduate Program for Neuroscience.	Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Bates EA, 2010, CEPHALALGIA, V30, P170, DOI 10.1111/j.1468-2982.2009.01864.x; Ben Aissa M., 2017, CEPHALALGIA; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal ME, 2008, NEUROLOGY, V71, P559, DOI 10.1212/01.wnl.0000323925.29520.e7; Bigal ME, 2013, HEADACHE, V53, P1230, DOI 10.1111/head.12179; Bree D, 2018, CEPHALALGIA, V38, P246, DOI 10.1177/0333102416681571; Brennan KC, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005784; Burstein R, 2010, ANN NEUROL, V68, P81, DOI 10.1002/ana.21994; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Charles A, 2016, CURR OPIN NEUROL, V29, P314, DOI 10.1097/WCO.0000000000000311; Christiansen I, 1999, CEPHALALGIA, V19, P660, DOI 10.1046/j.1468-2982.1999.019007660.x; Couch JR, 2001, HEADACHE, V41, P559, DOI 10.1046/j.1526-4610.2001.041006559.x; Daiutolo BV, 2016, J NEUROTRAUM, V33, P748, DOI 10.1089/neu.2015.4087; De Felice M, 2010, BRAIN, V133, P2475, DOI 10.1093/brain/awq159; Diener HC, 2007, CEPHALALGIA, V27, P814, DOI 10.1111/j.1468-2982.2007.01326.x; Edelmayer RM, 2012, PAIN, V153, P1949, DOI 10.1016/j.pain.2012.06.012; Edelmayer RM, 2012, METHODS MOL BIOL, V851, P109, DOI 10.1007/978-1-61779-561-9_7; Edvinsson L, 2017, HEADACHE, V57, P47, DOI 10.1111/head.13081; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Erickson JC, 2011, HEADACHE, V51, P932, DOI 10.1111/j.1526-4610.2011.01909.x; Farajdokht F, 2017, EUR J NEUROSCI, V45, P763, DOI 10.1111/ejn.13486; Filliol D, 2000, NAT GENET, V25, P195, DOI 10.1038/76061; Goadsby PJ, 2017, PHYSIOL REV, V97, P553, DOI 10.1152/physrev.00034.2015; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Greco R, 2011, CEPHALALGIA, V31, P190, DOI 10.1177/0333102410379887; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hou M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0750-1; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; IVERSEN HK, 1989, PAIN, V38, P17, DOI 10.1016/0304-3959(89)90067-5; Kansagara D., 2013, COMPLICATIONS MILD T; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Levy D, 2016, CEPHALALGIA, V36, P915, DOI 10.1177/0333102415617412; Lipton RB, 2013, HEADACHE, V53, P1300, DOI 10.1111/head.12154; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lutz PE, 2013, TRENDS NEUROSCI, V36, P195, DOI 10.1016/j.tins.2012.11.002; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Moye L.S., 2017, CURR PROTOC NEUROSCI, V80; Moye LS, 2017, J NEUROSCI RES, V95, P1347, DOI 10.1002/jnr.24001; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Pradhan AA, 2014, BRIT J PHARMACOL, V171, P2375, DOI 10.1111/bph.12591; Pradhan AA, 2014, PAIN, V155, P269, DOI 10.1016/j.pain.2013.10.004; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Rice FL, 2017, CEPHALALGIA, V37, P1350, DOI 10.1177/0333102416677051; Scofield DE, 2017, J NEUROTRAUM, V34, P3249, DOI 10.1089/neu.2017.5101; Sufka KJ, 2016, J HEADACHE PAIN, V17, DOI 10.1186/s10194-016-0624-y; Theeler B, 2013, HEADACHE, V53, P881, DOI 10.1111/head.12123; Theeler BJ, 2008, HEADACHE, V48, P876, DOI 10.1111/j.1526-4610.2008.01159.x; Tipton AF, 2016, CEPHALALGIA, V36, P1048, DOI 10.1177/0333102415623070; Tso AR, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0463-4; Tyburski AL, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0726-1; Vargas BB, 2012, CURR OPIN NEUROL, V25, P284, DOI 10.1097/WCO.0b013e3283535bf5; Visser WH, 1996, HEADACHE, V36, P471, DOI 10.1046/j.1526-4610.1996.3608471.x; Widerstrom-Noga EG, 2009, J REHABIL RES DEV, V46, P1, DOI 10.1682/JRRD.2008.03.0038; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4; Zohar O, 2011, ACTA NEUROBIOL EXP, V71, P36	58	18	18	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	JAN	2019	39	1					77	90		10.1177/0333102418777507			14	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HJ0YC	WOS:000456888100010	29771142	Bronze, Green Accepted			2022-02-06	
J	Robinson, ME; Mckee, AC; Salat, DH; Rasmusson, AM; Radigan, LJ; Catana, C; Milberg, WP; McGlinchey, RE				Robinson, Meghan E.; McKee, Ann C.; Salat, David H.; Rasmusson, Ann M.; Radigan, Lauren J.; Catana, Ciprian; Milberg, William P.; McGlinchey, Regina E.			Positron emission tomography of tau in Iraq and Afghanistan Veterans with blast neurotrauma	NEUROIMAGE-CLINICAL			English	Article						Blast; Positron emission tomography; Tau; Traumatic brain injury; Veteran	TRAUMATIC BRAIN-INJURY; SURFACE-BASED ANALYSIS; DEFAULT MODE NETWORK; WHITE-MATTER; HEAD TRAUMA; RISK-FACTOR; PET; EXPOSURE; SEGMENTATION; ACTIVATION	Military personnel are often exposed to multiple instances of various types of head trauma. As a result, there has been increasing concern recently over identifying when head trauma has resulted in a brain injury and what, if any, long-term consequences those brain injuries may have. Efforts to develop equipment to protect soldiers from these long-term consequences will first require understanding the types of head trauma that are likely responsible. In this study, we sought to identify the types of head trauma most likely to lead to the deposition of tau, a protein identified as a likely indicator of long-term negative consequences of brain injury. To define the types of head trauma in a military population, we applied a factor analysis to interviews from a larger cohort of 428 Veterans enrolled in the Translational Research Center for Traumatic Brain Injury and Stress Disorders. Three factors were identified: Blast Exposure, Symptom Duration, and Blunt Concussion. Sixteen male Veterans from this study and one additional male civilian (aged 25-69, mean 35.2 years) underwent simultaneous positron emission tomography/magnetic resonance imaging using a tracer that binds to tau protein, the ligand T807/AV-1451 (Flortaucipir). Standard uptake value ratios to the isthmus of the cingulate were calculated from a 20-minute time frame 70 min post-injection. We found that tracer uptake throughout the brain was associated with Blast Exposure factor beta weights, but not with either Symptom Duration or Blunt Concussion. Associations with uptake were located primarily in the cerebellar, occipital, inferior temporal and frontal regions. The data suggest that in this small, relatively young cohort of Veterans, elevated T807/AV-1451 uptake is associated with exposure to blast neurotrauma. These findings are unanticipated, as they do not match histopathological descriptions of tau pathology associated with head trauma. Continued work will be necessary to understand the nature of the regional T807/AV-1451 uptake and any associations with clinical symptoms.	[Robinson, Meghan E.; McKee, Ann C.; Salat, David H.; Radigan, Lauren J.; Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Boston, MA USA; [Robinson, Meghan E.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, Boston, MA USA; [Robinson, Meghan E.; McKee, Ann C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02215 USA; [McKee, Ann C.] VA Boston Healthcare Syst, Dept Pathol & Lab Med, Boston, MA USA; [McKee, Ann C.] Boston Univ, Sch Med, CTE Program, Alzheimers Dis Ctr, Boston, MA 02215 USA; [McKee, Ann C.] Boston Univ, Sch Med, Dept Pathol, Boston, MA 02215 USA; [Salat, David H.; Catana, Ciprian] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Dept Radiol, Boston, MA 02114 USA; [Salat, David H.; Catana, Ciprian] Harvard Med Sch, Boston, MA 02115 USA; [Rasmusson, Ann M.] VA Boston Healthcare Syst, Natl Ctr PTSD, Womens Hlth Sci Div, Dept Vet Affairs, Boston, MA USA; [Rasmusson, Ann M.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02215 USA; [Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, Ctr Geriatr Res Educ & Clin, Boston, MA USA; [Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Robinson, Meghan E.] One Baylor Plaza, Houston, TX 77030 USA		Robinson, ME (corresponding author), 150 South Huntington Ave, Boston, MA 02130 USA.	Meghan.Robinson@bcm.edu	Catana, Ciprian/A-1246-2013; Fortier, Catherine/AAS-2163-2021	Fortier, Catherine/0000-0002-8953-9904; Rasmusson, Ann/0000-0002-3488-9042	Merit Review AwardUS Department of Veterans Affairs [RX000991]; TRACTS National Network Research Center for TBI research from the United States Department of Veterans Affairs Rehabilitation Research and Development Service [B9254-C]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000991] Funding Source: NIH RePORTER	This work was supported by Merit Review Award (RX000991) and the TRACTS National Network Research Center for TBI research (B9254-C) from the United States Department of Veterans Affairs Rehabilitation Research and Development Service.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Blake D, 2006, J TRAUMA STRESS, V8, P75; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Calhoun VD, 2009, NEUROIMAGE, V45, pS163, DOI 10.1016/j.neuroimage.2008.10.057; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Di X, 2012, BRAIN CONNECT, V2, P275, DOI 10.1089/brain.2012.0086; First M. B., 1996, COMMUNICATION; Fischer BL, 2014, J NEUROTRAUM, V31, P169, DOI 10.1089/neu.2013.2877; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Izquierdo-Garcia D, 2014, J NUCL MED, V55, P1825, DOI 10.2967/jnumed.113.136341; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Johnson KA, 2016, ANN NEUROL, V79, P110, DOI 10.1002/ana.24546; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Ladefoged CN, 2017, NEUROIMAGE, V147, P346, DOI 10.1016/j.neuroimage.2016.12.010; Lemoine Laetitia, 2018, Alzheimers Dement (Amst), V10, P232, DOI 10.1016/j.dadm.2018.01.007; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marquie M, 2017, ANN NEUROL, V81, P117, DOI 10.1002/ana.24844; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; McGlinchey RE, 2017, INT J METH PSYCH RES, V26, DOI 10.1002/mpr.1556; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nakagawa A, 2011, J NEUROTRAUM, V28, P1101, DOI 10.1089/neu.2010.1442; Omalu B, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.9.FOCUS11178; Poole VN, 2014, DEV NEUROPSYCHOL, V39, P459, DOI 10.1080/87565641.2014.940619; Robinson ME, 2015, DEV NEUROPSYCHOL, V40, P74, DOI 10.1080/87565641.2015.1012204; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Salat DH, 2017, BRAIN INJURY, V31, P1204, DOI 10.1080/02699052.2017.1327672; Scholl M, 2016, NEURON, V89, P971, DOI 10.1016/j.neuron.2016.01.028; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; SKINNER HA, 1982, J STUD ALCOHOL, V43, P1157, DOI 10.15288/jsa.1982.43.1157; Smith S.M., 2009, NEUROIMAGE, V47, pS148; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; The Management of Concussion/ mTBI Working Group, 2009, VA DOD CLIN PRACT GU; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Vogel J. W., 2017, ALZHEIMERS DEMENT, V13, pP1548; Weathers F.W., 1993, ANN CONV INT SOC TRA; Williams DJ, 1996, PATHOLOGY, V28, P102, DOI 10.1080/00313029600169653; Wooten DW, 2017, J NUCL MED, V58, P484, DOI 10.2967/jnumed.115.170910; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Zarrinkoob L, 2015, J CEREBR BLOOD F MET, V35, P648, DOI 10.1038/jcbfm.2014.241	61	18	18	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	21								101651	10.1016/j.nicl.2019.101651			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HN6ZP	WOS:000460337700064	30642757	gold, Green Published			2022-02-06	
J	Asken, BM; Bauer, RM; DeKosky, ST; Houck, ZM; Moreno, CC; Jaffee, MS; Weber, AG; Clugston, JR				Asken, Breton M.; Bauer, Russell M.; DeKosky, Steven T.; Houck, Zachary M.; Moreno, Charles C.; Jaffee, Michael S.; Weber, Arthur G.; Clugston, James R.			Concussion Biomarkers Assessed in Collegiate Student-Athletes (BASICS) I Normative study	NEUROLOGY			English	Article							BRAIN-INJURY; SERUM-LEVELS; MARKERS; STRESS	Objective To describe variability in concussion biomarker concentrations collected from serum in a sample of healthy collegiate athletes, as well as report reliability metrics in a subsample of female athletes. Methods In this observational cohort study, beta-amyloid peptide 42 (A beta(42)), total tau, S100 calcium binding protein B (S100B), ubiquitin carboxy-terminal hydrolyzing enzyme L1 (UCH-L1), glial fibrillary acidic protein, microtubule associated protein 2, and 29,39-cyclic-nucleotide 39-phosphodiesterase (CNPase) serum concentrations were measured in 415 (61% male, 40% white, aged 19.0 +/- 1.2 years) nonconcussed collegiate athletes without recent exposure to head impacts. Standardized normative distributions are reported for each biomarker. We evaluated main effects (analyses of variance) of sex and race, reporting demographic-specific normative metrics when appropriate. In a subset of 31 female participants, test-retest reliability (Pearson r) and reliable change indices (80%, 90%, and 95% confidence intervals) across a 6- to 12-month interval are reported for A beta(42), total tau, S100B, and UCH-L1. Results Males exhibited higher UCH-L1 (p < 0.001, Cohen d = 0.75) and S100B (p < 0.001, d = 0.56) than females, while females had higher CNPase (p < 0.001, d = 0.43). Regarding race, black participants had higher baseline levels of UCH-L1 (p < 0.001, d = 0.61) and S100B (p < 0.001, d = 1.1) than white participants. Conversely, white participants had higher baseline levels of A beta(42) (p = 0.005, d = 0.28) and CNPase (p < 0.001, d = 0.46). Test-retest reliability was generally poor, ranging from -0.02 to 0.40, and A beta(42) significantly increased from time 1 to time 2. Conclusion Healthy collegiate athletes express concussion-related serum biomarkers in variable concentrations. Accounting for demographic factors such as sex and race is essential. Evidence suggested poor reliability for serum biomarkers; however, understanding how other factors influence biomarker expression, as well as knowledge of reliable change metrics, may improve clinical interpretation and future study designs.	[Asken, Breton M.; Houck, Zachary M.; Moreno, Charles C.] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA; [Bauer, Russell M.; DeKosky, Steven T.; Jaffee, Michael S.; Clugston, James R.] Univ Florida, Dept Neurol, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Dept Community Hlth & Family Med, Gainesville, FL USA; [Clugston, James R.] Univ Florida, Univ Athlet Assoc, Gainesville, FL USA; [Weber, Arthur G.] Banyan Biomarkers Inc, Alachua, FL USA		Asken, BM (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	basken8@phhp.ufl.edu		DeKosky, Steven/0000-0003-3743-2758; Asken, Breton/0000-0001-8419-142X; Clugston, James/0000-0002-2103-1039	GE; Banyan Biomarkers, Inc.; U.S. Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-06-1-0517]; NFL; University of FloridaUniversity of Florida	This work was primarily supported by funds provided in a grant from the Head Health Initiative, a collaboration between GE and the NFL, Banyan Biomarkers, Inc., and the U.S. Army Medical Research and Material Command (USAMRMC) under contract W81XWH-06-1-0517. The University of Florida owns stock in Banyan Biomarkers, Inc., which is the sponsor of the study. In addition, the university has licensed technology to Banyan concerning blood biomarkers or proteins thereby allowing Banyan to use the technology. The company is interested in making a biomarker test for traumatic brain injury. If the biomarker test is sold commercially, then the University of Florida could benefit financially. Please feel free to ask any further questions you might have about this matter.	Asken BM, 2018, NEUROLOGY, V91, pE2123, DOI 10.1212/WNL.0000000000006616; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Brooks BL, 2017, ARCH CLIN NEUROPSYCH, V32, P1001, DOI 10.1093/arclin/acx028; Brooks BL, 2016, ARCH CLIN NEUROPSYCH, V31, P1026, DOI 10.1093/arclin/acw079; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Hasselblatt M, 2004, NEUROLOGY, V62, P1634, DOI 10.1212/01.WNL.0000123092.97047.B1; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrea M, 2015, BRAIN INJURY, V29, P276, DOI 10.3109/02699052.2014.965216; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2017, J NEUROTRAUM, V34, P3134, DOI 10.1089/neu.2017.5046; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Nygaard O, 1997, CLIN CHEM, V43, P541; Otto M, 2000, INT J SPORTS MED, V21, P551, DOI 10.1055/s-2000-8480; Papa L, 2015, J NEUROTRAUM, V32, P661, DOI 10.1089/neu.2014.3655; Puvenna V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096296; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Scaccianoce S, 2004, BRAIN RES, V1004, P208, DOI 10.1016/j.brainres.2004.01.028; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Wiesmann M, 1998, CLIN CHEM, V44, P1056	32	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	DEC 4	2018	91	23					E2109	E2122		10.1212/WNL.0000000000006613			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	HK3XY	WOS:000457854000001	30404785	Green Published			2022-02-06	
J	Mesotten, D; Joosten, K; van Kempen, A; Verbruggen, S; Braegger, C; Bronsky, J; Cai, W; Campoy, C; Carnielli, V; Darmaun, D; Decsi, T; Domellof, M; Embleton, N; Fewtrell, M; Fidler Mis, N; Franz, A; Goulet, O; Hartman, C; Hill, S; Hojsak, I; Iacobelli, S; Jochum, F; Joosten, K; Kolacek, S; Koletzko, B; Ksiazyk, J; Lapillonne, A; Lohner, S; Mesotten, D; Mihalyi, K; Mihatsch, WA; Mimouni, F; Molgaard, C; Moltu, SJ; Nomayo, A; Picaud, JC; Prell, C; Puntis, J; Riskin, A; De Pipaon, MS; Senterre, T; Shamir, R; Simchowitz, V; Szitanyi, P; Tabbers, MM; Van Den Akker, CHB; Van Goudoever, JB; Van Kempen, A; Verbruggen, S; Wu, J; Yan, WH				Mesotten, D.; Joosten, K.; van Kempen, A.; Verbruggen, S.; Braegger, Christian; Bronsky, Jiri; Cai, Wei; Campoy, Cristina; Carnielli, Virgilio; Darmaun, Dominique; Decsi, Tamas; Domellof, Magnus; Embleton, Nicholas; Fewtrell, Mary; Fidler Mis, Natasa; Franz, Axel; Goulet, Olivier; Hartman, Corina; Hill, Susan; Hojsak, Iva; Iacobelli, Silvia; Jochum, Frank; Joosten, Koen; Kolacek, Sanja; Koletzko, Berthold; Ksiazyk, Janusz; Lapillonne, Alexandre; Lohner, Szimonetta; Mesotten, Dieter; Mihalyi, Krisztina; Mihatsch, Walter A.; Mimouni, Francis; Molgaard, Christian; Moltu, Sissel J.; Nomayo, Antonia; Picaud, Jean Charles; Prell, Christine; Puntis, John; Riskin, Arieh; Saenz De Pipaon, Miguel; Senterre, Thibault; Shamir, Raanan; Simchowitz, Venetia; Szitanyi, Peter; Tabbers, Merit M.; Van Den Akker, Chris H. B.; Van Goudoever, Johannes B.; Van Kempen, Anne; Verbruggen, Sascha; Wu, Jiang; Yan Weihui		ESPGHAN ESPEN ESPR CSPEN Wor	ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Carbohydrates	CLINICAL NUTRITION			English	Article						children; parenteral nutrition; glucose; carbohydrate; energy-resource; insulin; critical illness	TIGHT GLYCEMIC CONTROL; INTENSIVE-CARE-UNIT; CRITICALLY-ILL CHILDREN; TRAUMATIC BRAIN-INJURY; BIRTH-WEIGHT INFANTS; GLUCOSE-PRODUCTION; CRITICAL ILLNESS; PRETERM INFANTS; BLOOD-GLUCOSE; NEONATAL HYPERGLYCEMIA		[Mesotten, D.] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Intens Care Med, Leuven, Belgium; [Joosten, K.; Verbruggen, S.] Erasmus MC, Subdivis Intens Care, Dept Pediat & Pediat Surg, Sophia Childrens Hosp, Rotterdam, Netherlands; [van Kempen, A.] OLVG, Dept Pediat & Neonatol, Amsterdam, Netherlands; [Braegger, Christian] Univ Childrens Hosp, Zurich, Switzerland; [Bronsky, Jiri] Univ Hosp Motol, Prague, Czech Republic; [Cai, Wei] Shanghai Jiao Tong Univ, Shanghai, Peoples R China; [Campoy, Cristina] Univ Granada, Sch Med, Dept Paediat, Granada, Spain; [Carnielli, Virgilio] Polytech Univ Marche, Ancona, Italy; [Darmaun, Dominique] Univ Nantes, Nantes, France; [Decsi, Tamas] Univ Pecs, Dept Pediat, Pecs, Hungary; [Domellof, Magnus] Umea Univ, Dept Clin Sci, Pediat, Umea, Sweden; [Embleton, Nicholas] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England; [Fewtrell, Mary] UCL Great Ormond St Inst Child Hlth, London, England; [Fidler Mis, Natasa] Univ Med Ctr Ljubljana, Ljubljana, Slovenia; [Franz, Axel] Univ Childrens Hosp, Tubingen, Germany; [Goulet, Olivier] Univ Sordonne Paris Cite, Paris Descartes Med Sch, Paris, France; [Hartman, Corina] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Hartman, Corina] Carmel Hosp, Haifa, Israel; [Hill, Susan] Great Ormond St Hosp Sick Children, NHS Fdn Trust, London, England; [Hill, Susan] UCL Inst Child Hlth, London, England; [Hojsak, Iva] Univ JJ Strossmayer, Univ Zagreb, Sch Med Osijek, Sch Med,Childrens Hosp Zagreb, Osijek, Croatia; [Iacobelli, Silvia] CHU Reunion, St Pierre, Reunion, France; [Jochum, Frank; Nomayo, Antonia] Ev Waldkrankenhaus Spandau, Berlin, Germany; [Joosten, Koen] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat & Pediat Surg, Intens Care, Rotterdam, Netherlands; [Kolacek, Sanja] Univ Zagreb, Sch Med, Childrens Hosp, Zagreb, Croatia; [Koletzko, Berthold; Prell, Christine] LMU Ludwig Maximilians Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Ksiazyk, Janusz] Childrens Mem Hlth Inst, Dept Pediat Nutr & Metab Dis, Warsaw, Poland; [Lapillonne, Alexandre] Paris Descartes Univ, Paris, France; [Lohner, Szimonetta] Univ Pecs, Dept Pediat, Pecs, Hungary; [Mesotten, Dieter] Katholieke Univ Leuven, Leuven, Belgium; [Mihalyi, Krisztina] Univ Pecs, Dept Pediat, Pecs, Hungary; [Mihatsch, Walter A.] Univ Ulm, Ulm, Germany; [Mihatsch, Walter A.] Helios Hosp, Pforzheim, Germany; [Mimouni, Francis] Wilf Childrens Hosp, Shaare Zedek Med Ctr, Div Neonatol, Dept Pediat, Jerusalem, Israel; [Mimouni, Francis] Tel Aviv Univ, Tel Aviv, Israel; [Molgaard, Christian] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Molgaard, Christian] Rigshosp, Paediat Nutr Unit, Copenhagen, Denmark; [Moltu, Sissel J.] Oslo Univ Hosp, Oslo, Norway; [Picaud, Jean Charles] Claude Bernard Univ Lyon 1, Hop Croix Rousse, Lab CarMEN, Lyon, France; [Puntis, John] Gen Infirm Leeds, Leeds, W Yorkshire, England; [Riskin, Arieh] Technion, Rappaport Fac Med, Bnai Zion Med Ctr, Haifa, Israel; [Saenz De Pipaon, Miguel] Univ Autonoma Madrid, Paz Univ Hosp, Red Salud Materno Infantil & Desarrollo SAMID, Dept Neonatol, Madrid, Spain; [Senterre, Thibault] Univ Liege, CHR Citadelle, CHU Liege, Liege, Belgium; [Shamir, Raanan] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Shamir, Raanan] Tel Aviv Univ, Tel Aviv, Israel; [Simchowitz, Venetia] Great Ormond St NHS Trust, London, England; [Szitanyi, Peter] Charles Univ Prague, Fac Med 1, Gen Univ Hosp, Prague, Czech Republic; [Tabbers, Merit M.; Van Den Akker, Chris H. B.; Van Goudoever, Johannes B.] Amsterdam UMC, Emma Childrens Hosp, Amsterdam, Netherlands; [Van Kempen, Anne] OLVG, Amsterdam, Netherlands; [Verbruggen, Sascha] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat & Pediat Surg, Intens Care, Rotterdam, Netherlands; [Wu, Jiang] Xin Hua Hosp, Shanghai, Peoples R China; [Yan Weihui] Shanghai Jiao Tong Univ, Xinhua Hosp, Sch Med, Dept Gastroenterol & Nutr, Shanghai, Peoples R China		Mesotten, D (corresponding author), Katholieke Univ Leuven, Univ Hosp Leuven, Dept Intens Care Med, Leuven, Belgium.	walter.mihatsch@gmx.de	Verbruggen, Sascha/ABB-7745-2020; Domellof, Magnus/AAP-9542-2021; van den Akker, Chris/V-3058-2018; Campoy, Cristina/F-4946-2017; Lohner, Szimonetta/AAM-9339-2020; Ksiazyk, Janusz/L-8752-2017; Moltu, Sissel Jennifer/S-4683-2019; Mesotten, Dieter/ABE-4176-2020; Braegger, Christian Peter/ABC-9884-2021; Mis, Natasa Fidler/L-7045-2014; de Pipaon, Miguel Saenz/AAA-3851-2019; Hojsak, Iva/AAI-8937-2020; Franz, Axel/AAC-8067-2022; Molgaard, Christian/D-2052-2014	Verbruggen, Sascha/0000-0003-4866-9865; van den Akker, Chris/0000-0002-5494-730X; Campoy, Cristina/0000-0002-9860-6785; Lohner, Szimonetta/0000-0002-6292-4802; Ksiazyk, Janusz/0000-0002-9136-2722; Mesotten, Dieter/0000-0002-3258-4720; Mis, Natasa Fidler/0000-0003-3199-0484; Hojsak, Iva/0000-0003-3262-5964; Braegger, Christian/0000-0001-8069-9875; Darmaun, Dominique/0000-0002-0366-3227; Embleton, Nicholas/0000-0003-3750-5566; Molgaard, Christian/0000-0002-5311-9457; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Tabbers, Merit/0000-0001-9744-7308; van Kempen, Anne/0000-0003-3959-7353			Aarsland A, 1996, J CLIN INVEST, V98, P2008, DOI 10.1172/JCI119005; Agius L, 2013, BIOCHEM PHARMACOL, V85, P306, DOI 10.1016/j.bcp.2012.09.019; Agus MSD, 2012, NEW ENGL J MED, V367, P1208, DOI 10.1056/NEJMoa1206044; Alaedeen DI, 2006, J PEDIATR SURG, V41, P239, DOI 10.1016/j.jpedsurg.2005.10.045; Alsweiler JM, 2007, J PAEDIATR CHILD H, V43, P632, DOI 10.1111/j.1440-1754.2007.01158.x; Alsweiler JM, 2012, PEDIATRICS, V129, P639, DOI 10.1542/peds.2011-2470; ASKANAZI J, 1984, ANESTHESIOLOGY, V60, P106, DOI 10.1097/00000542-198402000-00005; Auerbach A, 2013, J PEDIATR-US, V163, P388, DOI 10.1016/j.jpeds.2013.01.051; Beardsall K, 2008, NEW ENGL J MED, V359, P1873, DOI 10.1056/NEJMoa0803725; Beardsall K, 2010, J PEDIATR-US, V157, P715, DOI 10.1016/j.jpeds.2010.04.032; Beardsall K, 2010, EARLY HUM DEV, V86, P263, DOI 10.1016/j.earlhumdev.2010.05.005; Boluyt N, 2006, PEDIATRICS, V117, P2231, DOI 10.1542/peds.2005-1919; BURKE JF, 1979, ANN SURG, V190, P274, DOI 10.1097/00000658-197909000-00002; Chacko SK, 2011, J PEDIATR-US, V158, P891, DOI 10.1016/j.jpeds.2010.12.040; Chacko SK, 2010, ARCH DIS CHILD-FETAL, V95, pF413, DOI 10.1136/adc.2009.178020; Chien JY, 2005, CRIT CARE MED, V33, P1688, DOI 10.1097/01.CCM.0000171183.79525.6B; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; COWETT RM, 1983, J CLIN INVEST, V71, P467, DOI 10.1172/JCI110791; de Betue CTI, 2012, CRIT CARE, V16, DOI 10.1186/cc11658; Dylewksi ML, 2013, PEDIATR CRIT CARE ME, V14, pE120, DOI 10.1097/PCC.0b013e3182712b2b; ELWYN DH, 1981, ACTA CHIR SCAND, P209; Faustino EVS, 2010, PEDIATR CRIT CARE ME, V11, P690, DOI 10.1097/PCC.0b013e3181e8f502; Finfer S, 2013, CRIT CARE, V17, DOI 10.1186/cc12537; Fivez T, 2016, NEW ENGL J MED, V374, P1111, DOI 10.1056/NEJMoa1514762; Fivez T, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0728-8; FORSYTH JS, 1995, ARCH DIS CHILD-FETAL, V73, pF4, DOI 10.1136/fn.73.1.F4; Geukers VG, 2012, NUTRITION, V28, P644, DOI 10.1016/j.nut.2011.09.018; Hagvik J, 2008, CLIN CHEM LAB MED, V46, P729, DOI 10.1515/CCLM.2008.142; Hirshberg E, 2008, PEDIATR CRIT CARE ME, V9, P361, DOI 10.1097/PCC.0b013e318172d401; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Inoue S, 2013, CRIT CARE, V17, DOI 10.1186/cc12567; Jain R, 1996, J CLIN LAB ANAL, V10, P13, DOI 10.1002/(SICI)1098-2825(1996)10:1<13::AID-JCLA3>3.0.CO;2-M; Jeschke MG, 2010, AM J RESP CRIT CARE, V182, P351, DOI 10.1164/rccm.201002-0190OC; JONES MO, 1993, J PEDIATR SURG, V28, P1121, DOI 10.1016/0022-3468(93)90144-A; Kalhan SC, 1999, EUR J CLIN NUTR, V53, pS94, DOI 10.1038/sj.ejcn.1600749; Kalhan SC, 2001, AM J PHYSIOL-ENDOC M, V281, pE991, DOI 10.1152/ajpendo.2001.281.5.E991; Kanji S, 2005, CRIT CARE MED, V33, P2778, DOI 10.1097/01.CCM.0000189939.10881.60; KAPLAN M, 1989, CRIT CARE MED, V17, P279, DOI 10.1097/00003246-198903000-00016; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Klein CJ, 1998, J AM DIET ASSOC, V98, P795, DOI 10.1016/S0002-8223(98)00179-5; Koletzko Berthold, 2005, J Pediatr Gastroenterol Nutr, V41 Suppl 2, pS1, DOI 10.1097/01.mpg.0000181841.07090.f4; Koretz RL, 2001, GASTROENTEROLOGY, V121, P970, DOI [10.1016/S0016-5085(01)92000-1, 10.1053/gast.2001.28031]; Kyle UG, 2010, INTENS CARE MED, V36, P312, DOI 10.1007/s00134-009-1703-1; LAFEBER HN, 1990, PEDIATR RES, V28, P153, DOI 10.1203/00006450-199028020-00015; Lang CH, 2007, AM J PHYSIOL-ENDOC M, V293, pE453, DOI 10.1152/ajpendo.00204.2007; Leite HP, 2013, JPEN-PARENTER ENTER, V37, P335, DOI 10.1177/0148607112458124; LUCAS A, 1988, BRIT MED J, V297, P1304, DOI 10.1136/bmj.297.6659.1304; MACFIE J, 1981, GASTROENTEROLOGY, V80, P103; Macrae D, 2014, NEW ENGL J MED, V370, P107, DOI 10.1056/NEJMoa1302564; Magnoni S, 2012, CRIT CARE MED, V40, P1785, DOI 10.1097/CCM.0b013e318246bd45; McKinlay CJD, 2015, NEW ENGL J MED, V373, P1507, DOI 10.1056/NEJMoa1504909; Mesotten D, 2004, J CLIN ENDOCR METAB, V89, P219, DOI 10.1210/jc.2003-030760; Mesotten D, 2012, JAMA-J AM MED ASSOC, V308, P1641, DOI 10.1001/jama.2012.12424; Mitanchez D, 2007, HORM RES, V68, P265, DOI 10.1159/000104174; Nayak PP, 2013, INTENS CARE MED, V39, P123, DOI 10.1007/s00134-012-2738-2; Newman JD, 2002, ANN CLIN BIOCHEM, V39, P509, DOI 10.1258/000456302320314539; NOSE O, 1987, PEDIATR RES, V21, P538, DOI 10.1203/00006450-198706000-00006; Ogilvy-Stuart AL, 2010, ARCH DIS CHILD-FETAL, V95, pF126, DOI 10.1136/adc.2008.154716; Ognibene KL, 2011, PEDIATR CRIT CARE ME, V12, pE386, DOI 10.1097/PCC.0b013e3182192c53; Peet AC, 2002, ANN CLIN BIOCHEM, V39, P502, DOI 10.1258/000456302320314520; PINEAULT M, 1988, AM J CLIN NUTR, V47, P298, DOI 10.1093/ajcn/47.2.298; Preissig CM, 2010, CRIT CARE, V14, DOI 10.1186/cc8865; Preissig CM, 2009, CRIT CARE, V13, DOI 10.1186/cc7732; Ramel SE, 2013, J PERINATOL, V33, P882, DOI 10.1038/jp.2013.77; ROBIN AP, 1981, ACTA CHIR BELG, V80, P133; RODRIGUEZ JL, 1985, CHEST, V88, P512, DOI 10.1378/chest.88.4.512; SAUER PJJ, 1986, CLIN SCI, V70, P587, DOI 10.1042/cs0700587; Schwarz JM, 1995, J CLIN INVEST, V96, P2735, DOI 10.1172/JCI118342; Scott MG, 2009, CLIN CHEM, V55, P18, DOI 10.1373/clinchem.2008.117291; Sheridan RL, 1998, JPEN-PARENTER ENTER, V22, P212, DOI 10.1177/0148607198022004212; Srinivasan Vijay, 2004, Pediatr Crit Care Med, V5, P329, DOI 10.1097/01.PCC.0000128607.68261.7C; Srinivasan V, 2014, PEDIATR DIABETES, V15, P75, DOI 10.1111/pedi.12134; Sunehag AL, 1999, DIABETES, V48, P791, DOI 10.2337/diabetes.48.4.791; Suresh D, 2010, PEDIATR DIABETES, V11, P70, DOI 10.1111/j.1399-5448.2009.00520.x; TALPERS SS, 1992, CHEST, V102, P551, DOI 10.1378/chest.102.2.551; Tang ZP, 2000, ARCH PATHOL LAB MED, V124, P1135; Tin W, 2014, SEMIN FETAL NEONAT M, V19, P27, DOI 10.1016/j.siny.2013.09.003; Tin W, 2012, PEDIATRICS, V130, pE1497, DOI 10.1542/peds.2012-0776; TULIKOURA I, 1982, SCAND J GASTROENTERO, V17, P177, DOI 10.3109/00365528209182037; Van den Berghe G, 1998, J CLIN ENDOCR METAB, V83, P1827, DOI 10.1210/jc.83.6.1827; van der Lugt NM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-52; van Kempen AAMW, 2006, AM J PHYSIOL-ENDOC M, V290, pE723, DOI 10.1152/ajpendo.00303.2005; van Kempen AAMW, 2005, CLIN NUTR, V24, P727, DOI 10.1016/j.clnu.2005.02.004; van Kempen AAMW, 2003, METABOLISM, V52, P945, DOI 10.1016/S0026-0495(03)00148-3; Van Kempen AAMW, 2003, PEDIATR RES, V53, P628, DOI 10.1203/01.PDR.0000054733.13366.AF; van Puffelen E, 2018, LANCET CHILD ADOLESC, V2, P505, DOI 10.1016/S2352-4642(18)30131-7; van Puffelen E, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1936-2; Vanhorebeek I, 2017, LANCET RESP MED, V5, P475, DOI 10.1016/S2213-2600(17)30186-8; Verbruggen SC, 2011, CLIN NUTR, V30, P469, DOI 10.1016/j.clnu.2011.02.001; Verbruggen SCAT, 2011, CLIN NUTR, V30, P786, DOI 10.1016/j.clnu.2011.05.011; Verbruggen SCAT, 2011, CRIT CARE MED, V39, P2518, DOI 10.1097/CCM.0b013e3182257410; Vermont CL, 2005, CRIT CARE MED, V33, P1610, DOI 10.1097/01.CCM.0000171272.50888.AD; Vespa P, 2012, CRIT CARE MED, V40, P1923, DOI 10.1097/CCM.0b013e31824e0fcc; Vlaardingerbroek H, 2013, J PEDIATR-US, V163, P638, DOI 10.1016/j.jpeds.2013.03.059; Vlasselaers D, 2009, LANCET, V373, P547, DOI 10.1016/S0140-6736(09)60044-1; Wintergerst KA, 2006, PEDIATRICS, V118, P173, DOI 10.1542/peds.2005-1819; Woo HC, 2014, ARCH DIS CHILD-FETAL, V99, pF153, DOI 10.1136/archdischild-2013-304682; Zhou W, 2015, J MATERN-FETAL NEO M, V28, P422, DOI 10.3109/14767058.2014.918599	98	18	22	0	8	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0261-5614	1532-1983		CLIN NUTR	Clin. Nutr.	DEC	2018	37	6	B				2337	2343		10.1016/j.clnu.2018.06.947			7	Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Nutrition & Dietetics	HF6VN	WOS:000454376500006	30037708	Bronze			2022-02-06	
J	Hernandez, A; Tan, CF; Plattner, F; Logsdon, AF; Pozo, K; Yousuf, MA; Singh, T; Turner, RC; Luke-Wold, BP; Huber, JD; Rosen, CL; Bibb, JA				Hernandez, Adan; Tan, Chunfeng; Plattner, Florian; Logsdon, Aric F.; Pozo, Karine; Yousuf, Mohammad A.; Singh, Tanvir; Turner, Ryan C.; Luke-Wold, Brandon P.; Huber, Jason D.; Rosen, Charles L.; Bibb, James A.			Exposure to mild blast forces induces neuropathological effects, neurophysiological deficits and biochemical changes	MOLECULAR BRAIN			English	Article						Blast-induced traumatic brain injury; Neuroinflammation; Microvascular damage; Axonal swelling; Short-term plasticity; Calpain; p25	TRAUMATIC BRAIN-INJURY; AXON INITIAL SEGMENT; SYNAPTIC PLASTICITY; MOUSE MODEL; KINASE; RAT; DEGENERATION; INFLAMMATION; NEUROTRAUMA; DYSFUNCTION	Direct or indirect exposure to an explosion can induce traumatic brain injury (TBI) of various severity levels. Primary TBI from blast exposure is commonly characterized by internal injuries, such as vascular damage, neuronal injury, and contusion, without external injuries. Current animal models of blast-induced TBI (bTBI) have helped to understand the deleterious effects of moderate to severe blast forces. However, the neurological effects of mild blast forces remain poorly characterized. Here, we investigated the effects caused by mild blast forces combining neuropathological, histological, biochemical and neurophysiological analysis. For this purpose, we employed a rodent blast TBI model with blast forces below the level that causes macroscopic neuropathological changes. We found that mild blast forces induced neuroinflammation in cerebral cortex, striatum and hippocampus. Moreover, mild blast triggered microvascular damage and axonal injury. Furthermore, mild blast caused deficits in hippocampal short-term plasticity and synaptic excitability, but no impairments in long-term potentiation. Finally, mild blast exposure induced proteolytic cleavage of spectrin and the cyclin-dependent kinase 5 activator, p35 in hippocampus. Together, these findings show that mild blast forces can cause aberrant neurological changes that critically impact neuronal functions. These results are consistent with the idea that mild blast forces may induce subclinical pathophysiological changes that may contribute to neurological and psychiatric disorders.	[Hernandez, Adan; Tan, Chunfeng; Plattner, Florian; Pozo, Karine; Yousuf, Mohammad A.; Singh, Tanvir] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Plattner, Florian] Univ Texas Southwestern Med Ctr Dallas, Ctr Translat Neurodegenerat Res, Dallas, TX 75390 USA; [Logsdon, Aric F.; Turner, Ryan C.; Luke-Wold, Brandon P.; Rosen, Charles L.] West Virginia Univ, Sch Med, Dept Neurosurg, Morgantown, WV 26506 USA; [Huber, Jason D.] West Virginia Univ, Sch Med, Dept Basic Pharmaceut Sci, Morgantown, WV 26506 USA; [Bibb, James A.] Univ Alabama Birmingham, Med Ctr, Dept Surg, 1720 2nd Ave S,THT 1052, Birmingham, AL 35294 USA; [Bibb, James A.] Univ Alabama Birmingham, Med Ctr, Dept Neurobiol, 1720 2nd Ave S,THT 1052, Birmingham, AL 35294 USA; [Bibb, James A.] Univ Alabama Birmingham, Med Ctr, Dept Neurol, 1720 2nd Ave S,THT 1052, Birmingham, AL 35294 USA		Bibb, JA (corresponding author), Univ Alabama Birmingham, Med Ctr, Dept Surg, 1720 2nd Ave S,THT 1052, Birmingham, AL 35294 USA.; Bibb, JA (corresponding author), Univ Alabama Birmingham, Med Ctr, Dept Neurobiol, 1720 2nd Ave S,THT 1052, Birmingham, AL 35294 USA.; Bibb, JA (corresponding author), Univ Alabama Birmingham, Med Ctr, Dept Neurol, 1720 2nd Ave S,THT 1052, Birmingham, AL 35294 USA.	jbibb@uab.edu		Hernandez-Cortes, Adan/0000-0002-7098-870X; Turner, Ryan/0000-0001-5523-0645	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [MH083711]; National Institute on Drug AbuseUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [DA033485]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS073855]; Friends of the Alzheimer's Center; American Foundation for Pharmaceutical Education; American Association of Pharmaceutical Scientists; Darrell K. Royal Research Fund for Alzheimer's Disease; Texas Institute for Brain Injury and Repair; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH083711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099918, R01NS073855] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [T32AG052354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA033485] Funding Source: NIH RePORTER	This work was supported by a Discovery Award from the Texas Institute for Brain Injury and Repair and was facilitated by grants to J.A.B. from the National Institute of Mental Health (MH083711), National Institute on Drug Abuse (DA033485) and National Institute of Neurological Disorders and Stroke (NS073855). This research was also supported in part through funding to F.P. from the Friends of the Alzheimer's Center and the Darrell K. Royal Research Fund for Alzheimer's Disease and pre-doctoral fellowships from the American Foundation for Pharmaceutical Education to A.F.L and B.P.L., as well as a pre-doctoral fellowship from the American Association of Pharmaceutical Scientists to B.P.L.	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bach-y-Rita P, 2003, BRAIN INJURY, V17, P643, DOI 10.1080/0269905031000107133; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Cernak I, 2010, J CEREBR BLOOD F MET, V30, P255, DOI 10.1038/jcbfm.2009.203; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; de Lanerolle NC, 2011, J NEUROPATH EXP NEUR, V70, P1046, DOI 10.1097/NEN.0b013e318235bef2; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Fischer Andrew H, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4986; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Hisanaga S, 2010, J NEUROCHEM, V115, P1309, DOI 10.1111/j.1471-4159.2010.07050.x; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Kochanek PM, 2013, J NEUROTRAUM, V30, P920, DOI 10.1089/neu.2013.2862; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Mez J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0407-7; Miller AP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00020; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Mishra V, 2016, SCI REP-UK, V6, DOI 10.1038/srep26992; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Plattner F, 2006, J BIOL CHEM, V281, P25457, DOI 10.1074/jbc.M603469200; Plattner F, 2014, NEURON, V81, P1070, DOI 10.1016/j.neuron.2014.01.022; REEVES TM, 1995, EXP BRAIN RES, V106, P248; Rubovitch V, 2011, EXP NEUROL, V232, P280, DOI 10.1016/j.expneurol.2011.09.018; Sahin B, 2004, EUR J BIOCHEM, V271, P3547, DOI 10.1111/j.1432-1033.2004.04291.x; Sajja VSSS, 2013, J NEUROSCI RES, V91, P593, DOI 10.1002/jnr.23179; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; SINCLAIR RA, 1981, J CLIN PATHOL, V34, P859, DOI 10.1136/jcp.34.8.859; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Turner RC, 2013, EXP NEUROL, V248, P520, DOI 10.1016/j.expneurol.2013.07.008; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf SJ, 2009, LANCET, V374, P405, DOI 10.1016/S0140-6736(09)60257-9; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yousuf MA, 2016, J NEUROCHEM, V138, P317, DOI 10.1111/jnc.13620; Zuckerman A, 2017, J NEUROTRAUM, V34, P145, DOI 10.1089/neu.2015.4310	46	18	18	0	0	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1756-6606			MOL BRAIN	Mol. Brain	NOV 9	2018	11								64	10.1186/s13041-018-0408-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HA0WO	WOS:000449932200001	30409147	Green Published, gold			2022-02-06	
J	Crespo-Castrillo, A; Yanguas-Casas, N; Arevalo, MA; Azcoitia, I; Barreto, GE; Garcia-Segura, LM				Crespo-Castrillo, Andrea; Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Azcoitia, Inigo; Barreto, George E.; Garcia-Segura, Luis M.			The Synthetic Steroid Tibolone Decreases Reactive Gliosis and Neuronal Death in the Cerebral Cortex of Female Mice After a Stab Wound Injury	MOLECULAR NEUROBIOLOGY			English	Article						Astrocytes; Microglia; Neuroinflammation; Neuroprotection; Steroid receptors; Brain trauma	TRAUMATIC BRAIN-INJURY; CORTICAL PERICONTUSIONAL ZONE; RECEPTOR MODULATORS DECREASE; PROGRAMMED CELL-DEATH; ESTROGEN-RECEPTOR; MICROGLIAL ACTIVATION; ANDROGEN RECEPTORS; OXIDATIVE STRESS; UP-REGULATION; ESTRADIOL	Previous studies have shown that estradiol reduces reactive gliosis after a stab wound injury in the cerebral cortex. Since the therapeutic use of estradiol is limited by its peripheral hormonal effects, it is of interest to determine whether synthetic estrogenic compounds with tissue-specific actions regulate reactive gliosis. Tibolone is a synthetic steroid that is widely used for the treatment of climacteric symptoms and/or the prevention of osteoporosis. In this study, we have assessed the effect of tibolone on reactive gliosis in the cerebral cortex after a stab wound brain injury in ovariectomized adult female mice. By 7days after brain injury, tibolone reduced the number of glial fibrillary acidic protein (GFAP) immunoreactive astrocytes, the number of ionized calcium binding adaptor molecule 1 (Iba1) immunoreactive microglia, and the number of microglial cells with a reactive phenotype in comparison to vehicle-injected animals. These effects on gliosis were associated with a reduction in neuronal loss in the proximity to the wound, suggesting that tibolone exerts beneficial homeostatic actions in the cerebral cortex after an acute brain injury.	[Crespo-Castrillo, Andrea; Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Garcia-Segura, Luis M.] Inst Cajal, CSIC, Madrid, Spain; [Yanguas-Casas, Natalia; Angeles Arevalo, Maria; Azcoitia, Inigo; Garcia-Segura, Luis M.] Inst Salud Carlos III, CIBERFES, Madrid, Spain; [Azcoitia, Inigo] Univ Complutense, Fac Biol, Dept Cell Biol, E-28040 Madrid, Spain; [Barreto, George E.] Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia		Garcia-Segura, LM (corresponding author), Inst Cajal, CSIC, Madrid, Spain.; Garcia-Segura, LM (corresponding author), Inst Salud Carlos III, CIBERFES, Madrid, Spain.; Barreto, GE (corresponding author), Pontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, Colombia.	gsampaio@javeriana.edu.co; lmgs@cajal.csic.es	Casas, Natalia Yanguas/AAB-6704-2019; Azcoitia, Inigo/A-6208-2011; Arevalo, Maria-Angeles/J-7000-2014; Garcia-Segura, Luis M/U-3711-2017; Barreto, George E./AAD-7420-2020	Casas, Natalia Yanguas/0000-0003-4368-0176; Azcoitia, Inigo/0000-0002-5791-9144; Arevalo, Maria-Angeles/0000-0002-4303-9576; Garcia-Segura, Luis M/0000-0002-2450-2916; Barreto, George E./0000-0002-6644-1971	Ministerio de Economia, Industria y Competitividad (MINECO), Spain [BFU2014-51836-C2-1-R, BFU2017-82754-R]; Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES); Instituto de Salud Carlos III, Madrid, SpainInstituto de Salud Carlos III; Fondos FederEuropean Commission	This work was supported by grants from Ministerio de Economia, Industria y Competitividad (MINECO), Spain (grant numbers BFU2014-51836-C2-1-R and BFU2017-82754-R), Centro de Investigacion Biomedica en Red de Fragilidad y Envejecimiento Saludable (CIBERFES), and Instituto de Salud Carlos III, Madrid, Spain and Fondos Feder.	Acaz-Fonseca E, 2016, PROG NEUROBIOL, V144, P5, DOI 10.1016/j.pneurobio.2016.06.002; Arevalo MA, 2013, HORM BEHAV, V63, P216, DOI 10.1016/j.yhbeh.2012.02.021; Arevalo MA, 2012, J NEUROENDOCRINOL, V24, P183, DOI 10.1111/j.1365-2826.2011.02156.x; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Rodriguez MA, 2014, J STEROID BIOCHEM, V144, P294, DOI 10.1016/j.jsbmb.2014.07.009; Avila-Rodriguez M, 2016, MOL CELL ENDOCRINOL, V433, P35, DOI 10.1016/j.mce.2016.05.024; Bao YJ, 2011, MOL CELL NEUROSCI, V48, P185, DOI 10.1016/j.mcn.2011.07.004; Barreto G, 2007, EUR J NEUROSCI, V25, P3039, DOI 10.1111/j.1460-9568.2007.05563.x; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Barreto GE, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00132; Behl C, 1997, MOL PHARMACOL, V51, P535, DOI 10.1124/mol.51.4.535; Beltran-Campos V, 2015, NEUROLOGIA, V30, P401, DOI 10.1016/j.nrl.2014.03.002; Blurton-Jones M, 2001, J COMP NEUROL, V433, P115, DOI 10.1002/cne.1129; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cerciat M, 2010, GLIA, V58, P93, DOI 10.1002/glia.20904; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; de Aguiar RB, 2006, PHARMACOL BIOCHEM BE, V85, P689, DOI 10.1016/j.pbb.2006.10.023; Chuffa LGD, 2017, STEROIDS, V118, P93, DOI 10.1016/j.steroids.2016.12.011; De Marinis E, 2013, J NEUROENDOCRINOL, V25, P260, DOI 10.1111/jne.12007; Diz-Chaves Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-71; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DonCarlos LL, 2006, NEUROSCIENCE, V138, P801, DOI 10.1016/j.neuroscience.2005.06.020; Escande A, 2009, J STEROID BIOCHEM, V116, P8, DOI 10.1016/j.jsbmb.2009.03.008; Farfan-Garcia ED, 2014, NEUROCHEM RES, V39, P1776, DOI 10.1007/s11064-014-1385-0; FERNAUDESPINOSA I, 1993, GLIA, V8, P277, DOI 10.1002/glia.440080408; Finley SK, 1999, J NEUROBIOL, V40, P446; Garcia-Ovejero D, 2002, J COMP NEUROL, V450, P256, DOI 10.1002/cne.10325; GARCIAESTRADA J, 1993, BRAIN RES, V628, P271, DOI 10.1016/0006-8993(93)90964-O; Gatson JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-30; Genazzani AR, 2006, MENOPAUSE, V13, P57, DOI 10.1097/01.gme.0000191372.79052.d3; Gibbs RB, 2002, NEUROSCIENCE, V113, P907, DOI 10.1016/S0306-4522(02)00239-7; Goc J, 2014, EUR J NEUROSCI, V39, P2151, DOI 10.1111/ejn.12548; Gonzalez-Giraldo Y, 2018, MOL NEUROBIOL, V55, P4453, DOI 10.1007/s12035-017-0667-3; Guzman CB, 2007, J NEUROENDOCRINOL, V19, P958, DOI 10.1111/j.1365-2826.2007.01611.x; Habib P, 2015, J STEROID BIOCHEM, V146, P3, DOI 10.1016/j.jsbmb.2014.02.018; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hatton WJ, 1999, J COMP NEUROL, V409, P169; Hidalgo-Lanussa O, 2018, MOL NEUROBIOL, V55, P5462, DOI 10.1007/s12035-017-0777-y; Howard CV, 1998, THREE DIMENSIONAL ME; HOZUMI I, 1990, BRAIN RES, V534, P291, DOI 10.1016/0006-8993(90)90142-X; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; Ishihara Y, 2015, J STEROID BIOCHEM, V145, P85, DOI 10.1016/j.jsbmb.2014.10.002; Jordan VC, 2007, NAT REV CANCER, V7, P46, DOI 10.1038/nrc2048; Perez-Alvarez MJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-157; Kawano H, 2012, CELL TISSUE RES, V349, P169, DOI 10.1007/s00441-012-1336-5; Kloosterboer HJ, 2004, MATURITAS, V48, pS30, DOI 10.1016/j.maturitas.2004.02.012; Kloosterboer HJ, 2001, J STEROID BIOCHEM, V76, P231, DOI 10.1016/S0960-0760(01)00044-9; Kloss CUA, 2001, EXP NEUROL, V168, P32, DOI 10.1006/exnr.2000.7575; Kuo J, 2010, J NEUROSCI, V30, P12950, DOI 10.1523/JNEUROSCI.1158-10.2010; Lee SW, 2018, J NEUROTRAUM, V35, P1681, DOI 10.1089/neu.2017.5530; Lei BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103969; Lenz KM, 2013, J NEUROSCI, V33, P2761, DOI 10.1523/JNEUROSCI.1268-12.2013; Li CY, 2015, MOL MED REP, V12, P4410, DOI 10.3892/mmr.2015.3942; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Li R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094320; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lu HH, 2018, J CELL PHYSIOL, V233, P1712, DOI 10.1002/jcp.26083; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; MATHEWSON AJ, 1985, BRAIN RES, V327, P61, DOI 10.1016/0006-8993(85)91499-4; Michell-Robinson MA, 2015, BRAIN, V138, P1138, DOI 10.1093/brain/awv066; MIYAKE T, 1988, BRAIN RES, V451, P133, DOI 10.1016/0006-8993(88)90757-3; Mosquera L, 2014, BRAIN RES, V1561, P11, DOI 10.1016/j.brainres.2014.03.002; Paxinos G., 2001, THE MOUSE BRAIN IN S; Pekny M, 2016, ACTA NEUROPATHOL, V131, P323, DOI 10.1007/s00401-015-1513-1; Perez-Alvarez MJ, 2015, MOL NEUROBIOL, V52, P1690, DOI 10.1007/s12035-014-8963-7; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Petrone AB, 2014, AGING DIS, V5, P340, DOI 10.14336/AD.2014.0500340; Pinto-Almazan R, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8630764; Pinto-Almazan R, 2012, J NEUROSCI RES, V90, P878, DOI 10.1002/jnr.22808; Potter KA, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046020; Qiu J, 2008, J NEUROENDOCRINOL, V20, P1310, DOI 10.1111/j.1365-2826.2008.01789.x; Reed MJ, 2004, MATURITAS, V48, pS4, DOI 10.1016/j.maturitas.2004.02.013; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Sierra A., 2007, GLIA, V55, P412, DOI [10. 1002/glia. 20468 17203473, DOI 10.1002/glia.22867, DOI 10.1002/GLIA.22867]; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Simoncini T, 2004, J CLIN ENDOCR METAB, V89, P4594, DOI 10.1210/jc.2003-032189; Simoncini T, 2000, MOL CELL ENDOCRINOL, V162, P87, DOI 10.1016/S0303-7207(00)00206-9; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Sofroniew MV, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020420; Sohrabji F, 2006, ENDOCRINE, V29, P191, DOI 10.1385/ENDO:29:2:191; Sohrabji F, 2015, FRONT NEUROENDOCRIN, V36, P1, DOI 10.1016/j.yfrne.2014.05.003; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Tapia-Gonzalez S, 2008, J ENDOCRINOL, V198, P219, DOI 10.1677/JOE-07-0294; Thakkar R, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12484; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Vergouwen MDI, 2000, BRAIN RES, V878, P88, DOI 10.1016/S0006-8993(00)02713-X; Verheul HAM, 2006, J STEROID BIOCHEM, V102, P195, DOI 10.1016/j.jsbmb.2006.09.037; Verheul HAM, 2007, DRUG METAB DISPOS, V35, P1105, DOI 10.1124/dmd.106.014118; Verheul HAM, 2007, REPROD SCI, V14, P160, DOI 10.1177/1933719106298684; Villapol S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00082; von Bernhardi R, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00124; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wolf SA, 2017, ANNU REV PHYSIOL, V79, P619, DOI 10.1146/annurev-physiol-022516-034406; Zhao TZ, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.449	98	18	18	1	10	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	NOV	2018	55	11					8651	8667		10.1007/s12035-018-1008-x			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU7ID	WOS:000445493600033	29582398				2022-02-06	
J	McGuine, TA; Pfaller, AY; Post, EG; Hetzel, SJ; Brooks, A; Broglio, SP				McGuine, Timothy A.; Pfaller, Adam Y.; Post, Eric G.; Hetzel, Scott J.; Brooks, Alison; Broglio, Steven P.			The Influence of Athletic Trainers on the Incidence and Management of Concussions in High School Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						adolescents; health care access; sport injury; epidemiology	SPORT-RELATED CONCUSSIONS; CONSENSUS STATEMENT; SECONDARY-SCHOOLS; FOOTBALL PLAYERS; KNOWLEDGE; INJURY; EPIDEMIOLOGY; BEHAVIORS	Context: In many US high schools, the athletic trainer (AT) has the responsibility to identify and manage athletes with concussions. Although the availability of ATs varies a great deal among schools, how the level of AT availability in high schools affects the reported incidence and management of sport-related concussions (SRCs) is unknown. Objective: To determine how the presence of an AT affects the reporting and management of SRCs. Design: Prospective cohort study. Patients or Other Participants: A total of 2459 (female = 37.5%, age = 16.1 +/- 1.2 years) athletes from 31 Wisconsin high schools were categorized as having low availability (LoAT), mid availability (MidAT), or high availability (HiAT) of ATs. Athletic trainers recorded the incidence, days lost from sport, and postconcussion management through return to sport. The incidence of SRC reporting among categories was examined using a multivariate Cox proportional hazards model. Fisher exact tests were used to determine if postconcussion management differed based on AT availability. Results: The incidence of reported SRCs was lower for the LoAT schools (2.4%) compared with the MidAT (5.6%, hazard ratio = 2.59, P = .043) and HiAT (7.0%, hazard ratio = 3.33, P = .002) schools. The median time before the first AT interaction was longer for LoAT schools (24.0 hours) than for MidAT (0.5 hours, post hoc P = .012) and HiAT (0.2 hours, post hoc P = .023) schools. The number of post-SRC interactions was different in all groups (LoAT = 2 interactions, MidAT = 3, and HiAT = 4; all post hoc P values < .05). Days lost were greater for MidAT and HiAT (both 14 days lost) schools compared with LoAT schools (11.5 days lost, post hoc P = .231 and P = .029, respectively). Athletes at LoAT schools were less likely to undergo a return-to-play protocol (9/18 SRCs, 50.0%) than athletes at MidAT (44/47 SRCs, 93.6%; post hoc P = .001) or HiAT (64/64 SRCs, 100%; post hoc P < .001) schools. Conclusions: The level of AT availability positively influenced the reported incidence of SRCs as well as postconcussion management activities in this sample of high schools.	[McGuine, Timothy A.; Pfaller, Adam Y.; Brooks, Alison] Univ Wisconsin, Dept Orthopaed & Rehabil, 1685 Highland Ave, Madison, WI 53705 USA; [Hetzel, Scott J.] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Post, Eric G.] San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA; [Broglio, Steven P.] Univ Michigan, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA		McGuine, TA (corresponding author), Univ Wisconsin, Dept Orthopaed & Rehabil, 1685 Highland Ave, Madison, WI 53705 USA.	mcguine@ortho.wisc.edu			NATA Research & Education Foundation	We acknowledge Jacob E. Resch, PhD, ATC, at the University of Virginia for assistance with the study concept and design; R. Dawn Comstock, PhD, at the University of Colorado School of Medicine for assistance with the concept and design of the study as well as advice regarding the methods used to collect the data; and the NATA Research & Education Foundation for funding.	Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Courson R, 2014, J ATHL TRAINING, V49, P128, DOI 10.4085/1062-6050-49.1.06; de Lench B, ATHLETIC TRAINERS EV; Feuer J., STUDY RAISES CONCERN; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2013, BRIT J SPORT MED, V47, P289, DOI 10.1136/bjsports-2013-092225; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hotz RL, WALL STREET J; Kroshus E, 2017, CLIN J SPORT MED, V27, P542, DOI 10.1097/JSM.0000000000000409; Kroshus E, 2017, HEALTH COMMUN, V32, P963, DOI 10.1080/10410236.2016.1196417; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Post EG, J ATHL TRAIN; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Svoskos A, HUFFPOST NEWS; Swanik CB, 2007, AM J SPORT MED, V35, P943, DOI 10.1177/0363546507299532; McLeod TCV, 2008, CLIN J SPORT MED, V18, P235, DOI 10.1097/JSM.0b013e3181705756; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Wilkerson GB, 2012, INT J ATHL THER TRAI, V17, P4, DOI 10.1123/ijatt.17.6.4; Williams RM, 2015, J ATHL TRAINING, V50, P262, DOI 10.4085/1062-6050-49.3.81; Williams RM, 2014, SPORTS HEALTH, V6, P434, DOI 10.1177/1941738114545612	33	18	18	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV	2018	53	11					1017	1024		10.4085/1062-6050-209-18			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HH3VE	WOS:000455647200001	30403363	Green Published, gold			2022-02-06	
J	Missault, S; Anckaerts, C; Blockx, I; Deleye, S; Van Dam, D; Barriche, N; De Pauw, G; Aertgeerts, S; Valkenburg, F; De Deyn, PP; Verhaeghe, J; Wyffels, L; Van der Linden, A; Staelens, S; Verhoye, M; Dedeurwaerdere, S				Missault, Stephan; Anckaerts, Cynthia; Blockx, Ines; Deleye, Steven; Van Dam, Debby; Barriche, Nora; De Pauw, Glenn; Aertgeerts, Stephanie; Valkenburg, Femke; De Deyn, Peter Paul; Verhaeghe, Jeroen; Wyffels, Leonie; Van der Linden, Annemie; Staelens, Steven; Verhoye, Marleen; Dedeurwaerdere, Stefanie			Neuroimaging of Subacute Brain Inflammation and Microstructural Changes Predicts Long-Term Functional Outcome after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						diffusion tensor imaging; MRI; PET; positron emission tomography; post-traumatic epilepsy; TSPO	CONTROLLED CORTICAL IMPACT; TRANSLOCATOR PROTEIN TSPO; SPIKE-WAVE DISCHARGES; SPRAGUE-DAWLEY RATS; POSTTRAUMATIC EPILEPSY; BINDING-AFFINITY; NERVOUS-SYSTEM; DENTATE GYRUS; MODEL; SEIZURES	There is currently a lack of prognostic biomarkers to predict the different sequelae following traumatic brain injury (TBI). The present study investigated the hypothesis that subacute neuroinflammation and microstructural changes correlate with chronic TBI deficits. Rats were subjected to controlled cortical impact (CCI) injury, sham surgery, or skin incision (naive). CCI-injured (n=18) and sham-operated rats (n=6) underwent positron emission tomography (PET) imaging with the translocator protein 18kDa (TSPO) radioligand [F-18]PBR111 and diffusion tensor imaging (DTI) in the subacute phase (3 weeks post-injury) to quantify inflammation and microstructural alterations. CCI-injured, sham-operated, and naive rats (n=8) underwent behavioral testing in the chronic phase (5.5-10 months post-injury): open field and sucrose preference tests, two one-week video-electroencephalogram (vEEG) monitoring periods, pentylenetetrazole (PTZ) seizure susceptibility tests, and a Morris water maze (MWM) test. In vivo imaging revealed pronounced neuroinflammation, decreased fractional anisotropy, and increased diffusivity in perilesional cortex and ipsilesional hippocampus of CCI-injured rats. Behavioral analysis revealed disinhibition, anhedonia, increased seizure susceptibility, and impaired learning in CCI-injured rats. Subacute TSPO expression and changes in DTI metrics significantly correlated with several chronic deficits (Pearson's |r|=0.50-0.90). Certain specific PET and DTI parameters had good sensitivity and specificity (area under the receiver operator characteristic [ROC] curve=0.85-1.00) to distinguish between TBI animals with and without particular behavioral deficits. Depending on the investigated behavioral deficit, PET or DTI data alone, or the combination, could very well predict the variability in functional outcome data (adjusted R-2=0.54-1.00). Taken together, both TSPO PET and DTI seem promising prognostic biomarkers to predict different chronic TBI sequelae.	[Missault, Stephan; Barriche, Nora; De Pauw, Glenn; Aertgeerts, Stephanie] Univ Antwerp, Fac Med & Hlth Sci, Expt Lab Translat Neurosci & Otolaryngol, Antwerp, Belgium; [Missault, Stephan; Anckaerts, Cynthia; Blockx, Ines; Van der Linden, Annemie; Verhoye, Marleen] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Bioimaging Lab, Antwerp, Belgium; [Deleye, Steven; Verhaeghe, Jeroen; Wyffels, Leonie; Staelens, Steven] Univ Antwerp, Fac Med & Hlth Sci, Mol Imaging Ctr Antwerp, Antwerp, Belgium; [Dedeurwaerdere, Stefanie] Univ Antwerp, Fac Med & Hlth Sci, Lab Expt Hematol, Antwerp, Belgium; [Van Dam, Debby; Valkenburg, Femke; De Deyn, Peter Paul] Univ Antwerp, Inst Born Bunge, Lab Neurochem & Behav, Antwerp, Belgium; [Van Dam, Debby; Valkenburg, Femke; De Deyn, Peter Paul] Univ Groningen, Dept Neurol, Groningen, Netherlands; [Van Dam, Debby; Valkenburg, Femke; De Deyn, Peter Paul] Univ Groningen, Alzheimer Res Ctr, Groningen, Netherlands; [Van Dam, Debby; Valkenburg, Femke; De Deyn, Peter Paul] Univ Med Ctr Groningen, Groningen, Netherlands; [Wyffels, Leonie] Univ Hosp Antwerp, Dept Nucl Med, Edegem, Belgium		Missault, S (corresponding author), Univ Antwerp, Univ Pl 1, B-2610 Antwerp, Belgium.	stephan.missault@uantwerpen.be	Verhaeghe, Jeroen/I-1539-2016; Staelens, Steven/D-8385-2017; Van Dam, Debby/G-1666-2018	Verhaeghe, Jeroen/0000-0002-4493-1902; Staelens, Steven/0000-0003-3376-0519; Verhoye, Marleen/0000-0002-6267-0611; Missault, Stephan/0000-0002-1141-4810; Van Dam, Debby/0000-0003-4739-6076	ERA-NET NEURON/Research Foundation Flanders [GA00913N]; Research Foundation FlandersFWO [11K3714N/11K3716N]; Hercules Foundation (Belgium); Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office [IAP7/16]	We thank Krystyna Szewczyk, Annemie Van Eetveldt, Philippe Joye, and Caroline Berghmans for their excellent technical assistance. This research was supported by ERA-NET NEURON/Research Foundation Flanders GA00913N. Stephan Missault has a PhD fellowship from the Research Foundation Flanders (11K3714N/11K3716N). The 7T PharmaScan MR system was purchased through Hercules Foundation funding (Belgium) under the promotership of Prof. Annemie Van der Linden. We also acknowledge the Interuniversity Poles of Attraction of the Belgian Federal Science Policy Office (IAP7/16), Belgian Alzheimer Research Foundation (SAO-FRA), agreement between Institute Born-Bunge and University of Antwerp, the Medical Research Foundation Antwerp, the Thomas Riellaerts Research Fund, the Alzheimer Research Center Groningen (UMCG), and Neurosearch Antwerp.	Albrecht DS, 2016, ACS CHEM NEUROSCI, V7, P470, DOI 10.1021/acschemneuro.6b00056; Amhaoul H, 2016, NEUROPHARMACOLOGY, V105, P175, DOI 10.1016/j.neuropharm.2016.01.018; Amhaoul H, 2015, NEUROBIOL DIS, V82, P526, DOI 10.1016/j.nbd.2015.09.004; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Bertoglio D, 2017, BRAIN BEHAV IMMUN, V61, P69, DOI 10.1016/j.bbi.2016.12.015; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Bourdier T, 2012, APPL RADIAT ISOTOPES, V70, P176, DOI 10.1016/j.apradiso.2011.07.014; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Defrise M, 1997, IEEE T MED IMAGING, V16, P145, DOI 10.1109/42.563660; Donat CK, 2016, NEUROMOL MED, V18, P158, DOI 10.1007/s12017-016-8385-y; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fisher RS, 2015, CURR OPIN NEUROL, V28, P130, DOI 10.1097/WCO.0000000000000174; Frey L, 2014, NEUROL RES, V36, P26, DOI 10.1179/1743132813Y.0000000269; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HUDSON HM, 1994, IEEE T MED IMAGING, V13, P601, DOI 10.1109/42.363108; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Huusko N, 2015, BRAIN STRUCT FUNCT, V220, P153, DOI 10.1007/s00429-013-0644-1; Ikegaya Y, 2000, NEUROSCIENCE, V98, P647, DOI 10.1016/S0306-4522(00)00188-3; Immonen R, 2013, J NEUROTRAUM, V30, P1305, DOI 10.1089/neu.2012.2815; Immonen RJ, 2009, NEUROIMAGE, V45, P1, DOI 10.1016/j.neuroimage.2008.11.022; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; James ML, 2012, ANESTHESIOLOGY, V116, P1299, DOI 10.1097/ALN.0b013e318253a02a; Johnstone VPA, 2015, J NEUROTRAUM, V32, P1333, DOI 10.1089/neu.2014.3785; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Katsifis A, 2011, NUCL MED BIOL, V38, P137, DOI 10.1016/j.nucmedbio.2010.07.008; Kelly Kevin M, 2004, Epilepsy Curr, V4, P176, DOI 10.1111/j.1535-7597.2004.04503.x; Kelly KM, 2015, EPILEPSY RES, V117, P104, DOI 10.1016/j.eplepsyres.2015.09.009; Kharatishvili I, 2007, BRAIN, V130, P3155, DOI 10.1093/brain/awm268; Kim H, 2017, J NEUROSURG, V127, P23, DOI 10.3171/2016.7.JNS161263; Kocka A, 2014, BEHAV SCI, V4, P352, DOI 10.3390/bs4040352; Koerte IK, 2016, TRANSLATIONAL RES TR; Li L, 2017, NEUROPHARMACOLOGY, V125, P117, DOI 10.1016/j.neuropharm.2017.06.023; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lyoo CH, 2015, J NUCL MED, V56, P701, DOI 10.2967/jnumed.114.146027; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Missault S, 2014, BRAIN BEHAV IMMUN, V42, P138, DOI 10.1016/j.bbi.2014.06.013; Missault S, 2017, EPILEPSIA, V58, P1615, DOI 10.1111/epi.13845; Mizrahi R, 2012, J CEREBR BLOOD F MET, V32, P968, DOI 10.1038/jcbfm.2012.46; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Owen DR, 2012, J CEREBR BLOOD F MET, V32, P1, DOI 10.1038/jcbfm.2011.147; Pearce PS, 2014, EPILEPSY BEHAV, V32, P121, DOI 10.1016/j.yebeh.2014.01.004; Rodgers KM, 2015, J NEUROSCI, V35, P9194, DOI 10.1523/JNEUROSCI.0919-15.2015; Roncaroli F, 2016, CLIN TRANSL IMAGING, V4, P145, DOI 10.1007/s40336-016-0168-9; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rowe RK, 2016, DEV NEUROSCI-BASEL, V38, P195, DOI 10.1159/000446773; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Save E, 1996, BEHAV NEUROSCI, V110, P74; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Shaw FZ, 2004, J NEUROPHYSIOL, V91, P63, DOI 10.1152/jn.00487.2003; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; Sick T, 2017, J NEUROTRAUM, V34, P2467, DOI 10.1089/neu.2016.4826; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Van den Eynde K, 2014, BEHAV BRAIN RES, V258, P179, DOI 10.1016/j.bbr.2013.10.005; van der Werf IM, 2017, BEHAV BRAIN RES, V328, P218, DOI 10.1016/j.bbr.2017.04.014; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wang SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063511; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Whiting M.D., 2006, ANIMAL MODELCOGNIT; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Young NH, 2008, PLOS MED, V5, P1186, DOI 10.1371/journal.pmed.0050168; Yu I, 2010, J NEUROTRAUM, V27, P1463, DOI 10.1089/neu.2009.1196	76	18	18	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					768	788		10.1089/neu.2018.5704		OCT 2018	21	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446275000001	30032713	Green Accepted, Green Submitted			2022-02-06	
J	Bigler, ED				Bigler, Erin D.			Structural neuroimaging in sport-related concussion	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Computed tomography (CT); Magnetic resonance imaging (MRI); Sports-related concussion (SRC); Mild traumatic brain injury (mTBI); Quantitative neuroimaging; Diffusion tensor imaging	TRAUMATIC BRAIN-INJURY; DEFAULT-MODE NETWORK; HIGH-SCHOOL FOOTBALL; WHITE-MATTER INTEGRITY; CAVUM SEPTUM PELLUCIDUM; HEAD IMPACT EXPOSURE; RETIRED NFL PLAYERS; DIFFUSION TENSOR; FUNCTIONAL CONNECTIVITY; PROFESSIONAL FOOTBALL	Structural neuroimaging of athletes who have sustained a sports-related concussion (SRC) can be viewed as either standard clinical imaging or with advanced neuroimaging methods that quantitatively assess brain structure. Negative findings from conventional computed tomography (CT) or magnetic resonance imaging (MRI) are the norm in SRC. Nonetheless, these conventional measures remain the first line of neuroimaging of the athlete as they do detect clinically significant pathologies, when present, such as hemorrhagic abnormalities in the form of hematomas, contusions and mircobleeds along with regions of focal encephalomalacia or other signal abnormalities, with CT best capable of detecting skull fractures. However, advanced neuroimaging techniques hold particular promise in detecting subtle neuropathology in the athlete which standard clinical neuroimaging cannot. To best understand what conventional as well as quantitative neuroimaging methods are detecting in SRC, this review begins by covering basic neuroanatomical principles associated with mild traumatic brain injury (mTBI) and the brain regions most vulnerable to injury from SRC, as these regions define where advanced neuroimaging methods most likely detect abnormalities. Advanced MRI techniques incorporate quantitative metrics that include volume, shape, thickness along with diffusion parameters that provide a more fine-grained analysis of brain structure. With advancements in image analysis, multiple quantitative neuroimaging metrics now can be utilized in assessing SRC. Such multimodality approaches are particularly relevant and important for assessing white matter and network integrity of the brain following injury, including SRC. This review focuses just on the structural side of neuroimaging in SRC, but these techniques also are being integrated with functional neuroimaging, where the combination of the two approaches may provide superior methods in assessing the pathological effects of SRC.	[Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Neurosci Ctr, 1001 SWKT, Provo, UT 84602 USA		Bigler, ED (corresponding author), Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84602 USA.; Bigler, ED (corresponding author), Brigham Young Univ, Neurosci Ctr, 1001 SWKT, Provo, UT 84602 USA.	erin_bigler@byu.edu			Chronic Effects of Neurotrauma Consortium from the Department of Defense [W81XWH-13-2-0095]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01 RX 002174]	No grant funding was used to write this review. Dr. Bigler co-directs the Neuropsychological Research and Assessment Laboratory at Brigham Young University, which does provide forensic consultation. During the writing of this review the Brain Imaging and Behavior Laboratory at Brigham Young University, which Dr. Bigler also directs was supported by funding from the Chronic Effects of Neurotrauma Consortium from the Department of Defense (W81XWH-13-2-0095) and the US Department of Veterans Affairs (I01 RX 002174). The views expressed here are those of the author and do not necessarily reflect the official policy of position of the Department of Defense, The Department of Veterans Affairs, nor the US Government. The assistance of Tracy Abildskov with illustrations and Jo Ann Petrie, Ph.D. with manuscript preparation is gratefully acknowledged.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; Amen DG, 2016, J ALZHEIMERS DIS, V53, P237, DOI 10.3233/JAD-160207; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Aviv RI, 2010, CAN ASSOC RADIOL J, V61, P29, DOI 10.1016/j.carj.2009.09.002; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Banks SJ, 2014, J NEUROPSYCH CLIN N, V26, P44, DOI 10.1176/appi.neuropsych.12070185; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Begonia MT, 2014, J BIOMECH, V47, P3704, DOI 10.1016/j.jbiomech.2014.09.026; Bernick C, 2015, BRIT J SPORT MED, V49, P1007, DOI 10.1136/bjsports-2014-093877; Bigler ED, 2004, STUD NEUROPSYCHOL DE, P71; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2016, BRAIN, V139, P3054, DOI 10.1093/brain/aww277; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Bigler ED, 2016, SPORTS MED ARTHROSC, V24, pE42, DOI 10.1097/JSA.0000000000000119; Bigler E, 2015, NEUROPSYCHOL REV, V25, P224, DOI 10.1007/s11065-015-9290-0; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BOGDANOFF B, 1989, NEUROLOGY, V39, P991, DOI 10.1212/WNL.39.7.991; Braitenberg V, 2001, J COMPUT NEUROSCI, V10, P71, DOI 10.1023/A:1008920127052; Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00252; Broglio SP, 2012, CURR OPIN PEDIATR, V24, P702, DOI 10.1097/MOP.0b013e3283595616; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Caeyenberghs K, 2017, NEUROIMAGE, V160, P113, DOI 10.1016/j.neuroimage.2016.12.003; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chamard E, 2016, J NEUROTRAUM, V33, P1220, DOI 10.1089/neu.2015.3948; Chamard E, 2013, BRAIN INJURY, V27, P1038, DOI 10.3109/02699052.2013.794968; Chappell MH, 2006, J MAGN RESON IMAGING, V24, P537, DOI 10.1002/jmri.20656; Chappell MH, 2008, MAGN RESON IMAGING, V26, P1398, DOI 10.1016/j.mri.2008.04.004; Chumbley J, 2010, NEUROIMAGE, V49, P3057, DOI 10.1016/j.neuroimage.2009.10.090; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Coughlin J. M, 2016, JAMA NEUROL, DOI [10.1001/jamaneuro1.2016.3764, DOI 10.1001/JAMANEURO1.2016.3764]; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cui JX, 2016, J NEUROPHYSIOL, V116, P2892, DOI 10.1152/jn.00603.2016; Dall'Acqua P, 2017, J NEUROTRAUM, V34, P3270, DOI 10.1089/neu.2017.5124; Dall'Acqua P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00127; Darling T, 2016, COMPUT METHOD BIOMEC, V19, P1432, DOI 10.1080/10255842.2016.1149574; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Degen RM, 2016, PHYSICIAN SPORTSMED, V44, P324, DOI 10.1080/00913847.2016.1177475; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Doolan AW, 2012, ANN BIOMED ENG, V40, P106, DOI 10.1007/s10439-011-0413-3; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Dretsch MN, 2017, J NEUROTRAUM, V34, P869, DOI 10.1089/neu.2016.4480; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P241, DOI 10.3171/2015.1.PEDS14510; Espana LY, 2017, J NEUROTRAUM, V34, P3143, DOI 10.1089/neu.2017.5002; Etgen Thorleif, 2008, BMJ Case Rep, V2008, pbcr0620080024, DOI 10.1136/bcr.06.2008.0024; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fuller P, 2011, J COMP NEUROL, V519, P933, DOI 10.1002/cne.22559; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Gangolli M, 2017, NEUROIMAGE, V153, P152, DOI 10.1016/j.neuroimage.2017.03.059; Ganpule S, 2017, J NEUROTRAUM, V34, P2154, DOI 10.1089/neu.2016.4744; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner AJ, 2017, INT J SPORTS MED, V38, P241, DOI 10.1055/s-0042-120843; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Hasiloglu ZI, 2011, AM J NEURORADIOL, V32, P99, DOI 10.3174/ajnr.A2250; Hay J, 2016, ANNU REV PATHOL-MECH, V11, P21, DOI 10.1146/annurev-pathol-012615-044116; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Herrera JJ, 2017, J NEUROTRAUM, V34, P291, DOI 10.1089/neu.2016.4407; Herweh C, 2016, NEURORADIOLOGY, V58, P911, DOI 10.1007/s00234-016-1705-y; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hobbs JG, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15617; Ibrahima F, 2015, INT J SURG CASE REP, V6, P203, DOI 10.1016/j.ijscr.2014.10.024; Inglese M, 2006, BRAIN INJURY, V20, P15, DOI 10.1080/02699050500309593; Insel TR, 2013, NEURON, V80, P561, DOI 10.1016/j.neuron.2013.09.041; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Jackson GD, 2017, NEUROLOGY, V88, P2017, DOI 10.1212/WNL.0000000000003962; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; JORDAN BD, 1992, RADIOLOGY, V185, P509, DOI 10.1148/radiology.185.2.1410364; Kamins J, 2017, BR J SPORTS MED; Kaur P, 2018, CURR NEUROPHARMACOL, V16, P1224, DOI 10.2174/1570159X15666170613083606; Keightley ML, 2012, CURR OPIN PEDIATR, V24, P709, DOI 10.1097/MOP.0b013e3283599a55; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Koerte IK, 2016, TRANSLATIONAL RES TR; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0571-y; Kulkarni P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125748; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Leh SE, 2017, J NEUROTRAUM, V34, P1402, DOI 10.1089/neu.2016.4591; Lepage C, 2018, BRAIN IMAGING BEHAV, V12, P870, DOI 10.1007/s11682-017-9744-5; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Liu S., 2015, BRAIN INFORMAT, V2, P167, DOI 10.1007/s40708-015-0019-x; LoBue C, 2017, CLIN NEUROPSYCHOL, V31, P85, DOI 10.1080/13854046.2016.1257069; Martin G, 2016, BRAIN INJURY, V30, P1517, DOI 10.1080/02699052.2016.1192683; Mayer AR, 2017, BRAIN IMAGING BEHAV, V11, P698, DOI 10.1007/s11682-016-9546-1; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2017, BITISH J SPORTS MED; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, J NEUROTRAUM, V33, P1349, DOI 10.1089/neu.2015.4118; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Merritt VC, 2016, J CLIN EXP NEUROPSYC, V38, P941, DOI 10.1080/13803395.2016.1177491; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Meyer JE, 2015, DEV NEUROPSYCHOL, V40, P24, DOI 10.1080/87565641.2014.1001065; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Militana AR, 2016, BRAIN IMAGING BEHAV, V10, P559, DOI 10.1007/s11682-015-9407-3; Mills KL, 2014, DEV COGN NEUROS-NETH, V9, P172, DOI 10.1016/j.dcn.2014.04.004; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Monea AG, 2014, J MECH BEHAV BIOMED, V33, P3, DOI 10.1016/j.jmbbm.2013.06.011; Morris Saint-Aaron, 2014, Neurosurgery, V75 Suppl 4, pS96, DOI 10.1227/NEU.0000000000000465; MORUZZI G, 1949, ELECTROEN CLIN NEURO, V1, P455, DOI 10.1016/0013-4694(49)90219-9; Multani N, 2016, J NEUROL, V263, P1332, DOI 10.1007/s00415-016-8141-0; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Mutch WAC, 2016, J NEUROSURG, V125, P648, DOI 10.3171/2015.6.JNS15972; Narayana PA, 2015, NEUROIMAGE-CLIN, V7, P87, DOI 10.1016/j.nicl.2014.07.010; Newsome MR, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00116; Ng TSC, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt239; Omidvarnia A, 2017, NEUROIMAGE-CLIN, V15, P682, DOI 10.1016/j.nicl.2017.05.019; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Pan J, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15607; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Prince C, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080105; Raji CA, 2016, AM J GERIAT PSYCHIAT, V24, P784, DOI 10.1016/j.jagp.2016.07.018; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Ropper AH, 2007, NEW ENGL J MED, V356, P166, DOI 10.1056/NEJMcp064645; Ruff RM, 1999, BRAIN INJURY, V13, P943; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Samadani U, 2015, J NEUROTRAUM, V32, P548, DOI 10.1089/neu.2014.3687; Scheibel RS, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00352; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schmidt JL, 2016, J BIOMECH, V49, P1042, DOI 10.1016/j.jbiomech.2016.02.018; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shaker M, 2017, MED IMAGE ANAL, V37, P56, DOI 10.1016/j.media.2017.01.005; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Shetty T, 2016, SPORTS HEALTH, V8, P26, DOI 10.1177/1941738115588745; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Singh S, 2017, J BIOMECH, V51, P32, DOI 10.1016/j.jbiomech.2016.11.055; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Solomon G., 2016, CLIN NEUROSURG, V63, P173, DOI [10.1227/01.neu.0000489753.67038.ae, DOI 10.1227/01.NEU.0000489753.67038.AE]; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stemper BD, 2015, ANN BIOMED ENG, V43, P1071, DOI 10.1007/s10439-014-1171-9; Stemper BD, 2014, PROG NEUROL SURG, V28, P14, DOI 10.1159/000358748; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Strain JF, 2015, JAMA NEUROL, V72, P773, DOI 10.1001/jamaneurol.2015.0206; Sundman M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00334; Sussman D, 2017, NEUROSCI LETT, V650, P52, DOI 10.1016/j.neulet.2017.04.026; Talavage TM, 2016, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00273; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Terry DP, 2018, BRAIN IMAGING BEHAV, V12, P631, DOI 10.1007/s11682-017-9719-6; Toth A., 2015, BRAIN NEUROTRAUMA MO; Treister Daniel S, 2014, Case Rep Radiol, V2014, P143408, DOI 10.1155/2014/143408; Tremblay S, 2017, EUR J NEUROSCI, V46, P1956, DOI 10.1111/ejn.13583; Turner R. C, 2016, BRAIN INJURY, P1, DOI [10.1080/02699052.2016, DOI 10.1080/02699052.2016]; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; Van Horn JD, 2017, TRENDS NEUROSCI, V40, P39, DOI 10.1016/j.tins.2016.10.007; Van Horn JD, 2014, BRAIN IMAGING BEHAV, V8, P323, DOI 10.1007/s11682-013-9255-y; van Kleeck A, 2010, AM J SPEECH-LANG PAT, V19, P341, DOI 10.1044/1058-0360(2010/09-0038); Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; von Holst H, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00023; Wilde EA, 2016, J NEUROTRAUM, V33, P672, DOI 10.1089/neu.2015.4035; Wilde EA, 2012, NEUROREHABILITATION, V31, P227, DOI 10.3233/NRE-2012-0793; Wright DK, 2017, J NEUROTRAUM, V34, P2109, DOI 10.1089/neu.2016.4730; Wu T, 2018, BRAIN IMAGING BEHAV, V12, P962, DOI 10.1007/s11682-017-9752-5; Xue WQ, 2015, FRONT COMPUT NEUROSC, V9, DOI 10.3389/fncom.2015.00022; Yu Z, 2009, J NEUROTRAUM, V26, P1135, DOI 10.1089/neu.2008.0810; Zhou YX, 2017, J MAGN RESON IMAGING, V46, P518, DOI 10.1002/jmri.25548; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	189	18	18	0	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		105	123		10.1016/j.ijpsycho.2017.09.006			19	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000015	28916167				2022-02-06	
J	Charriaut-Marlangue, C; Leconte, C; Csaba, Z; Chafa, L; Pansiot, J; Talatizi, M; Simon, K; Moretti, R; Marchand-Leroux, C; Baud, O; Besson, VC				Charriaut-Marlangue, Christiane; Leconte, Claire; Csaba, Zsolt; Chafa, Linda; Pansiot, Julien; Talatizi, Mustapha; Simon, Kristin; Moretti, Raffaella; Marchand-Leroux, Catherine; Baud, Olivier; Besson, Valerie C.			Sex differences in the effects of PARP inhibition on microglial phenotypes following neonatal stroke	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Amygdala; Cortex; Microglial phenotype; Neonatal stroke; Neurobehavioral deficits; Poly (ADP-ribose) polymerase inhibitor	TRAUMATIC BRAIN-INJURY; WHITE-MATTER INJURY; CEREBRAL-ISCHEMIA; HYPOXIA-ISCHEMIA; MEMORY DEFICITS; M2 MICROGLIA; FEMALE; INFLAMMATION; ACTIVATION; DIMORPHISM	Neonatal acute ischemic stroke is a cause of neonatal brain injury that occurs more frequently in males, resulting in associated neurobehavioral disorders. The bases for these sex differences are poorly understood but might include the number, morphology and activation of microglia in the developing brain when subjected to stroke. Interestingly, poly (ADP-ribose) polymerase (PARP) inhibition preferentially protects males against neonatal ischemia. This study aims to examine the effects of PJ34, a PARP inhibitor, on microglial phenotypes at 3 and 8 days and on neurobehavioral disorders in adulthood for both male and female P9 mice subjected to permanent middle cerebral artery occlusion (pMCAo). PJ34 significantly reduced the lesion size by 78% and reduced the density of CX3CR1(gfp)-labeled microglial cells by 46% when examined 3 days after pMCAo in male but not in female mice. Eight days after pMCAo, the number of Iba1(+)/Cox-2(+) cells did not differ between male and female mice in the cortical peri-infarct region. In the amygdala, Iba1(+)/Cox-2(+) (Ml-like) cell numbers were significantly decreased in PJ34-treated males but not in females. Conversely, Iba1(+)/Arg-1(+) (M2-like) and Arg-1(+)/Cox-2(+) (Mtransitional) cell numbers were significantly increased in P134-treated females. Regarding neurobehavioral disorders during adulthood, pMCAo induced a motor coordination deficit and a spatial learning deficit in female mice only. PJ34 prevented MBP fibers, motor coordination and learning disorders during adulthood in female mice. Our data show significant sex differences in the effects of PARP inhibition on microglia phenotypes following neonatal ischemia, associated with improved behavior and myelination during adulthood in females only. Our findings suggest that modulating microglial phenotypes may play key roles in behavior disorders and white matter injury following neonatal stroke.	[Charriaut-Marlangue, Christiane; Csaba, Zsolt; Chafa, Linda; Pansiot, Julien; Talatizi, Mustapha; Moretti, Raffaella; Baud, Olivier; Besson, Valerie C.] Univ Paris Diderot, INSERM, PROTECT U1141, Sorbonne Paris Cite,Hop Robert Debre, 48 Blvd Serurier, F-75019 Paris, France; [Leconte, Claire; Simon, Kristin; Marchand-Leroux, Catherine; Besson, Valerie C.] Univ Paris 05, Pharmacol Circulat Cerebrate EA4475, Fac Pharm Paris, Sorbonne Paris Cite, 4 Ave Observ, F-75006 Paris, France; [Baud, Olivier] Childrens Univ Hosp Geneva, Div Neonatol & Pediat Intens Care, Geneva, Switzerland; [Baud, Olivier] Univ Geneva, Geneva, Switzerland		Besson, VC (corresponding author), Univ Paris 05, Pharmacol Circulat Cerebrate EA4475, Fac Pharm Paris, Sorbonne Paris Cite, 4 Ave Observ, F-75006 Paris, France.	valerie.besson@parisdescartes.fr	BESSON, VALERIE/AAZ-9989-2020; , CHARRIAUT-MARLANGUE/H-3249-2019	BESSON, VALERIE/0000-0002-1491-2380; 	Fondation des Gueules Cassees; Fondation pour la Recherche sur les AVC	We thank Marielle Young-Ten for genotyping and the animal platform team (CRP2 - UMS 3612 CNRS - US25 INSERM-IRD, Faculte de Pharmacie de Paris, Universite Paris Descartes, Paris, France) for animal care. This work was supported by Fondation des Gueules Cassees (VCB; CML; www.gueules-cassees.asso.fr/) and Fondation pour la Recherche sur les AVC (VCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Back SA, 2017, ACTA NEUROPATHOL, V134, P331, DOI 10.1007/s00401-017-1718-6; Bai P, 2012, FEBS LETT, V586, P3771, DOI 10.1016/j.febslet.2012.09.026; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Berger NA, 2018, BRIT J PHARMACOL, V175, P192, DOI 10.1111/bph.13748; Besson VC, 2009, BRIT J PHARMACOL, V157, P695, DOI 10.1111/j.1476-5381.2009.00229.x; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Charriaut-Marlangue C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010061; Chen Y, 2014, CURR MED CHEM, V21, P2146, DOI 10.2174/0929867321666131228203906; Cismaru AL, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00055; Coq JO, 2016, DEV MED CHILD NEUROL, V58, P7, DOI 10.1111/dmcn.13040; Couturier JY, 2003, EXP NEUROL, V184, P973, DOI 10.1016/S0014-4886(03)00367-4; Crotti A, 2016, IMMUNITY, V44, P505, DOI 10.1016/j.immuni.2016.02.013; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Dispersyn G, 2017, J SLEEP RES, V26, P531, DOI 10.1111/jsr.12541; Ducrocq S, 2000, J NEUROCHEM, V74, P2504, DOI 10.1046/j.1471-4159.2000.0742504.x; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Faustino JV, 2011, J NEUROSCI, V31, P12992, DOI 10.1523/JNEUROSCI.2102-11.2011; Ferrazzano P, 2013, CNS NEUROL DISORD-DR, V12, P338, DOI 10.2174/1871527311312030007; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Frisch D, 2013, DEV DISABIL RES REV, V18, P84, DOI 10.1002/ddrr.1131; Golomb MR, 2009, SEMIN FETAL NEONAT M, V14, P318, DOI 10.1016/j.siny.2009.07.003; Golomb MR, 2004, J CHILD NEUROL, V19, P493, DOI 10.1177/08830738040190070301; Hagberg H, 2004, J NEUROCHEM, V90, P1068, DOI 10.1111/j.1471-4159.2004.02547.x; Hamby AM, 2007, STROKE, V38, P632, DOI 10.1161/01.STR.0000250742.61241.79; Hill CA, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/867531; Hu XJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050925; Im HY, 2018, HUM BRAIN MAPP, V39, P2725, DOI 10.1002/hbm.24035; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Joly LM, 2003, PEDIATR RES, V53, P776, DOI 10.1203/01.PDR.0000059751.00465.F6; Kauppinen TM, 2009, J CEREBR BLOOD F MET, V29, P820, DOI 10.1038/jcbfm.2009.9; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Krishnan ML, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00422-w; Liu FD, 2011, STROKE, V42, P1090, DOI 10.1161/STROKEAHA.110.594861; Mallard C, 2018, NEUROSCIENCE, DOI [10.1016/j.neuroscience.S0306-4522(18)30039-3, DOI 10.1016/J.NEUROSCIENCE]; McCullough LD, 2005, J CEREBR BLOOD F MET, V25, P502, DOI 10.1038/sj.jcbfm.9600059; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moretti R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0560-4; Nelson KB, 2007, STROKE, V38, P742, DOI 10.1161/01.STR.0000247921.97794.5e; Nissen JC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030561; Pereira LO, 2008, BRAIN RES, V1218, P257, DOI 10.1016/j.brainres.2008.04.010; Pimentel-Coelho PM, 2013, J NEUROSCI, V33, P11556, DOI 10.1523/JNEUROSCI.0535-13.2013; Prendergast BJ, 2014, NEUROSCI BIOBEHAV R, V40, P1, DOI 10.1016/j.neubiorev.2014.01.001; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sanches EF, 2015, NEUROSCIENCE, V290, P581, DOI 10.1016/j.neuroscience.2014.12.074; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma S, 2010, LIFE SCI, V87, P521, DOI 10.1016/j.lfs.2010.09.004; Sigurdardottir S, 2010, DEV MED CHILD NEUROL, V52, P1056, DOI 10.1111/j.1469-8749.2010.03698.x; Smith AL, 2015, BRAIN SCI, V5, P220, DOI 10.3390/brainsci5020220; Spychala MS, 2017, J NEUROSCI RES, V95, P462, DOI 10.1002/jnr.23962; Suenaga J, 2015, EXP NEUROL, V272, P109, DOI 10.1016/j.expneurol.2015.03.021; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Taylor GT, 2017, ACTA NEUROBIOL EXP, V77, P254, DOI 10.21307/ane-2017-059; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Tsuji M, 2010, EXP NEUROL, V226, P285, DOI 10.1016/j.expneurol.2010.09.002; Tyng CM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01454; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	61	18	18	1	9	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2018	73						375	389		10.1016/j.bbi.2018.05.022			15	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	GU6QO	WOS:000445440900039	29852289				2022-02-06	
J	Gardner, RC; Rubenstein, R; Wang, KKW; Korley, FK; Yue, JK; Yuh, EL; Mukherje, P; Valadka, AB; Okonkwo, DO; Diaz-Arrastia, R; Manley, GT				Gardner, Raquel C.; Rubenstein, Richard; Wang, Kevin K. W.; Korley, Frederick K.; Yue, John K.; Yuh, Esther L.; Mukherje, Pratik; Valadka, Alex B.; Okonkwo, David O.; Diaz-Arrastia, Ramon; Manley, Geoffrey T.		TRACK-TBI Investigators	Age-Related Differences in Diagnostic Accuracy of Plasma Glial Fibrillary Acidic Protein and Tau for Identifying Acute Intracranial Trauma on Computed Tomography: A TRACK-TBI Study	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; CT; geriatric; traumatic brain injury	COMMON DATA ELEMENTS; C-TERMINAL HYDROLASE-L1; BRAIN-INJURY; TRANSFORMING RESEARCH; CLINICAL KNOWLEDGE; OLDER-ADULTS; HEAD RULE; LEVEL I; MILD; DISEASE	Plasma tau and glial fibrillary acidic protein (GFAP) are promising biomarkers for identifying traumatic brain injury (TBI) patients with intracranial trauma on computed tomography (CT). Accuracy in older adults with mild TBI (mTBI), the fastest growing TBI population, is unknown. Our aim was to assess for age-related differences in diagnostic accuracy of plasma tau and GFAP for identifying intracranial trauma on CT. Samples from 169 patients (age <40 years [n=79], age 40-59 years [n=60], age 60 years+ [n=30]), a subset of patients from the Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) Pilot study who presented with mTBI (Glasgow Coma Scale score of 13-15), received head CT, and consented to blood draw within 24h of injury, were assayed for hyperphosphorylated-tau (P-tau), total-tau (T-tau; both via amplification-linked enhanced immunoassay using multi-arrayed fiberoptics), and GFAP (via sandwich enzyme-linked immunosorbent assay). P-tau, T-tau, P-tau:T-tau ratio, and GFAP concentration were significantly associated with CT findings. Overall, discriminative ability declined with increasing age for all assays, but this decline was only statistically significant for GFAP (area under the receiver operating characteristic curve [AUC]: old 0.73 [reference group; ref] vs. young 0.93 [p=0.037] or middle-aged 0.92 [p=0.0497]). P-tau concentration consistently showed the highest diagnostic accuracy across all age-groups (AUC: old 0.84 [ref] vs. young 0.95 [p=0.274] or middle-aged 0.93 [p=0.367]). Comparison of models including P-tau alone versus P-tau plus GFAP revealed significant added value of GFAP. In conclusion, the GFAP assay was less accurate for identifying intracranial trauma on CT among older versus younger mTBI patients. Mechanisms of this age-related difference, including role of assay methodology, specific TBI neuroanatomy, pre-existing conditions, and anti-thrombotic use, warrant further study.	[Gardner, Raquel C.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Gardner, Raquel C.] Univ Calif San Francisco, Weill Inst Neurosci, San Francisco, CA 94143 USA; [Yue, John K.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Yuh, Esther L.; Mukherje, Pratik] Univ Calif San Francisco, Dept Radiol, 505 Parnassus Ave, San Francisco, CA USA; [Gardner, Raquel C.] San Francisco VA Med Ctr, Dept Neurol, San Francisco, CA USA; [Gardner, Raquel C.] San Francisco VA Med Ctr, Ctr Populat Brain Hlth, San Francisco, CA USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Neurol, Brooklyn, NY 11203 USA; [Rubenstein, Richard] Suny Downstate Med Ctr, Lab Neurodegenerat Dis, Dept Physiol Pharmacol, Brooklyn, NY 11203 USA; [Rubenstein, Richard] Suny Downstate Med Ctr, CNS Biomarker Discovery, Brooklyn, NY 11203 USA; [Wang, Kevin K. W.] Univ Florida, Dept Emergency Med, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL USA; [Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Univ Florida, Dept Neurosci, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32610 USA; [Wang, Kevin K. W.] Univ Florida, Dept Chem, Program Neurotrauma Neuroprote & Biomarker Res, Gainesville, FL 32611 USA; [Wang, Kevin K. W.] Malcom Randall VA Med Ctr, Brain Rehabil Res Ctr, Gainesville, FL USA; [Korley, Frederick K.] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Yue, John K.; Yuh, Esther L.; Mukherje, Pratik; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Perelman Sch Med, Philadelphia, PA 19104 USA		Gardner, RC (corresponding author), Univ Calif San Francisco, Dept Neurol, Neurol 127, 4150 Clement St, San Francisco, CA 94121 USA.; Gardner, RC (corresponding author), San Francisco VA Med Ctr, Neurol 127, 4150 Clement St, San Francisco, CA 94121 USA.	raquel.gardner@ucsf.edu	Yue, John K/P-1348-2015	Yue, John K/0000-0001-9694-7722; Wang, Kevin/0000-0002-9343-6473	National Institutes of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755, RC2 NS069409, U01 NS086090, R21NS085455]; American Federation for Aging Research; Department of Defense (DoD)United States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]; University of Florida McKnight Brain Institute BSCIRTF fund; SUNY Downstate Medical Center; Office of the Assistant Secretary of Defense for Health Affairs through the DoD Broad Agency Announcement [W81XWH-11-2-0069, W81XWH-14-2-0166]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, K23NS095755] Funding Source: NIH RePORTER	This study was supported by the National Institutes of Neurological Disorders and Stroke (Beeson K23NS095755 to RCG, RC2 NS069409 to GTM, U01 NS086090 to GTM, and R21NS085455 to KWW), the American Federation for Aging Research (to RCG), the Department of Defense (DoD; W81XWH-13-1-0441 to GTM and W81XWH-14-2-0176 to GTM), the University of Florida McKnight Brain Institute BSCIRTF fund (to KWW), and the SUNY Downstate Medical Center (to RR). This study was also supported in part by the Office of the Assistant Secretary of Defense for Health Affairs through the DoD Broad Agency Announcement under award numbers W81XWH-11-2-0069 (RR) and W81XWH-14-2-0166 (RR).	Albrecht JS, 2016, J HEAD TRAUMA REHAB, V31, pE1, DOI 10.1097/HTR.0000000000000190; Altman J., 2015, ACAD EMERG MED, V22, pS255; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Dams-O'Connor K, 2016, J AM GERIATR SOC, V64, P844, DOI 10.1111/jgs.14014; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2001, DOI 10.1089/neu.2013.3047; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Faul M, 2016, PREHOSP EMERG CARE, V20, P594, DOI 10.3109/10903127.2016.1149651; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Garwe T, 2011, J TRAUMA, V70, P1118, DOI 10.1097/TA.0b013e3181e243b8; Hartl R, 2006, J TRAUMA, V60, P1250, DOI 10.1097/01.ta.0000203717.57821.8d; Hawley C, 2017, EMERG MED J, V34, P509, DOI 10.1136/emermed-2016-206506; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Katsanos AH, 2017, STROKE, V48, P2586, DOI 10.1161/STROKEAHA.117.018409; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Liu H, 2017, AGEING RES REV, V34, P64, DOI 10.1016/j.arr.2016.11.006; Manley G.T., 2017, J NEUROTRAUMA; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Mattsson N, 2016, NEUROLOGY, V87, P1827, DOI 10.1212/WNL.0000000000003246; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Mehan ND, 2012, NEUROBIOL AGING, V33, P1857, DOI 10.1016/j.neurobiolaging.2011.09.029; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; National Institute of Neurological Disorders and Stroke, NAT I NEUR DIS STROK; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Shahim P, 2016, J NEUROTRAUM, V33, P1995, DOI 10.1089/neu.2014.3741; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Wolf H, 2014, J NEUROSURG, V120, P447, DOI 10.3171/2013.10.JNS13726; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zoltewicz JS, 2012, BIOMARK INSIGHTS, V7, P71, DOI 10.4137/BMI.S9873	47	18	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT	2018	35	20					2341	2350		10.1089/neu.2018.5694			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GV6DE	WOS:000446196600001	29717620	Green Published			2022-02-06	
J	Resch, JE; Schneider, MW; Cullum, CM				Resch, Jacob E.; Schneider, Mathew W.; Cullum, C. Munro			The test-retest reliability of three computerized neurocognitive tests used in the assessment of sport concussion	INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY			English	Article						Concussion; Computerized neurocognitive test; Reliability; Mild traumatic brain injury	CNS VITAL SIGNS; NEUROPSYCHOLOGICAL ASSESSMENT; TEST BATTERY; TEST-PERFORMANCE; ASSESSMENT TOOLS; IMPACT; MANAGEMENT; SENSITIVITY; VALIDITY	Computerized neurocognitive tests (CNTs) are widely used at all competitive levels of sport to assess sport concussion (SC). Whereas there are multiple CNTs available, little is known about how some of the most popular platforms compare. The purpose of this study was to investigate the test-retest reliability of the Automated Neuropsychological Assessment Metrics (ANAM), Concussion Vital Signs (CVS) and the Immediate Postconcussion and Cognitive Testing battery (ImPACT) using clinically relevant time points in healthy college age participants. Participants were healthy college-age students (N = 128) randomly assigned into one of three groups which were administered ANAM, CVS, or ImPACT at Days 1, 45 and 50. Intraclass correlation coefficients (ICCs) and Pearson correlations were used to assess reliability of the various CNT scores and subtest scores between time points. Participants were tested approximately 47.1 +/- 2.75 days after time point 1 and approximately 7.0 +/- 2.45 days after time point 2. ICC values ranged from 0.18 (Procedural Reaction Time) to 0.53 (Mathematical Processing and Simple Reaction Time 1) for ANAM, 0.14 (Continuous Performance Test) to 0.85 (Reaction Time) for CVS, and 0.19 (Verbal Memory) to 0.89 (Visual Motor Speed) for ImPACT. Significant improvements (p < 0.05) across time were observed for (7/10) CNS Vital Signs composite scores, but no additional significant changes in performance were observed for the remaining CNTs. Overall, weak to strong reliability coefficients for ANAM, CVS, and ImPACT were observed when using clinically relevant time points of repeated administration.	[Resch, Jacob E.] Univ Virginia, Mem Gymnasium, 210 Emmet St S, Charlottesville, VA 22932 USA; [Schneider, Mathew W.] Univ Texas Arlington, 500 S Nedderman Dr, Arlington, TX USA; [Cullum, C. Munro] Univ Texas Southwestern, Med Ctr, 6333 Forest Pk Rd,1st Floor,BLA100, Dallas, TX 75235 USA		Resch, JE (corresponding author), Univ Virginia, Mem Gymnasium, 210 Emmet St S, Charlottesville, VA 22932 USA.	Jer6x@virginia.edu; Munro.cullum@utsouthwestern.edu	Cullum, C. Munro/AAC-2496-2019	Cullum, C. Munro/0000-0001-9706-5465			Alsalaheen B, 2016, J HEAD TRAUMA REHAB, V31, P242, DOI 10.1097/HTR.0000000000000175; Anastasi A, 1998, PSCYHOLOGICAL TESTIN; Baumgartner TA, 2007, MEASUREMENT EVALUATI; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; CNS Vital Signs, 2014, FAQS FREQ ASK QUEST; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, BRIT J SPORT MED, V37, P2, DOI 10.1136/bjsm.37.1.2; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Ferrara Michael S., 2001, J Athl Train, V36, P145; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Littleton AC, 2015, SPORTS HEALTH, V7, P443, DOI 10.1177/1941738115586997; Lovell M. R, 2011, IMMEDIATE POSTCONCUS; Lynall RC, 2013, J ATHL TRAINING, V48, P844, DOI 10.4085/1062-6050-48.6.04; Maxwell S. E., 2003, DESIGNING EXPT ANAL; McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Nelson L, 2015, AM J SPORTS MED; Nelson LD, 2016, J INT NEUROPSYCH SOC, V22, P24, DOI 10.1017/S1355617715001101; Rahman-Filipiak AAM, 2013, NEUROPSYCHOL REV, V23, P314, DOI 10.1007/s11065-013-9241-6; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Roebuck-Spencer T, 2007, ARCH CLIN NEUROPSYCH, V22, pS79, DOI 10.1016/j.acn.2006.10.011; Rogers C, 2015, RE CONCUSSION CNS VI; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805	38	18	18	0	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-8760	1872-7697		INT J PSYCHOPHYSIOL	Int. J. Psychophysiol.	OCT	2018	132		A		SI		31	38		10.1016/j.ijpsycho.2017.09.011			8	Psychology, Biological; Neurosciences; Physiology; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology; Physiology	GV7GC	WOS:000446289000006	28935224				2022-02-06	
J	Zhang, FC; Dong, HP; Lv, T; Jin, K; Jin, YC; Zhang, XH; Jiang, JY				Zhang, Fengchen; Dong, Haiping; Lv, Tao; Jin, Ke; Jin, Yichao; Zhang, Xiaohua; Jiang, Jiyao			Moderate hypothermia inhibits microglia activation after traumatic brain injury by modulating autophagy/apoptosis and the MyD88-dependent TLR4 signaling pathway	JOURNAL OF NEUROINFLAMMATION			English	Article						Apoptosis; Autophagy; Microglial activation; Toll-like receptor; Traumatic brain injury	TOLL-LIKE-RECEPTORS; NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; INFLAMMATORY FACTOR-I; INDUCED CELL-DEATH; AUTOPHAGY PATHWAY; RATS; EXPRESSION; DAMAGE; TRANSDUCTION	Background: Complex mechanisms participate in microglial activation after a traumatic brain injury (TBI). TBI can induce autophagy and apoptosis in neurons and glial cells, and moderate hypothermia plays a protective role in the acute phase of TBI. In the present study, we evaluated the effect of TBI and moderate hypothermia on microglial activation and investigated the possible roles of autophagy/apoptosis and toll-like receptor 4 (TLR4). Methods: The TBI model was induced with a fluid percussion TBI device. Moderate hypothermia was achieved under general anesthesia by partial immersion in a water bath for 4 h. All rats were killed 24 h after the TBI. Results: Our results showed downregulation of the microglial activation and autophagy, but upregulation of microglial apoptosis, upon post-TBI hypothermia treatment. The expression of TLR4 and downstream myeloid differentiation primary response 88 (MyD88) was attenuated. Moderate hypothermia reduced neural cell death post-TBI. Conclusions: Moderate hypothermia can reduce the number of activated microglia by inhibiting autophagy and promoting apoptosis, probably through a negative modulation between autophagy and apoptosis. Moderate hypothermia may attenuate the pro-inflammatory function of microglia by inhibiting the MyD88-dependent TLR4 signaling pathway.	[Zhang, Fengchen; Lv, Tao; Jin, Ke; Jin, Yichao; Zhang, Xiaohua; Jiang, Jiyao] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, 160 Pujian Rd, Shanghai 200127, Peoples R China; [Dong, Haiping] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Anesthesiol, 160 Pujian Rd, Shanghai 200127, Peoples R China		Jin, YC; Zhang, XH (corresponding author), Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, 160 Pujian Rd, Shanghai 200127, Peoples R China.	honam612@163.com; zxh1969@aliyun.com		Zhang, Xiaohua/0000-0001-9679-2767	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601061, 81471333]; Shanghai Youth Physician Training Assistance Scheme	This work was supported by grants from the National Natural Science Foundation of China (No. 81601061 to Y. Jin and No. 81471333 to X. Zhang) and the Shanghai Youth Physician Training Assistance Scheme.	Basak S, 2008, MOL CELL BIOL, V28, P3139, DOI 10.1128/MCB.01469-07; Beschorner R, 2000, ACTA NEUROPATHOL, V100, P627, DOI 10.1007/s004010000232; Bsibsi M, 2002, J NEUROPATH EXP NEUR, V61, P1013, DOI 10.1093/jnen/61.11.1013; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cui DM, 2017, CNS NEUROSCI THER, V23, P106, DOI 10.1111/cns.12633; Deptala A, 1998, CYTOMETRY, V33, P376, DOI 10.1002/(SICI)1097-0320(19981101)33:3<376::AID-CYTO13>3.0.CO;2-Q; Diskin T, 2005, J NEUROTRAUM, V22, P750, DOI 10.1089/neu.2005.22.750; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Huang CY, 2017, J NEUROIMMUNOL, V313, P61, DOI 10.1016/j.jneuroim.2017.10.011; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jin YC, 2017, WORLD NEUROSURG, V100, P351, DOI 10.1016/j.wneu.2017.01.033; Jin YC, 2016, WORLD NEUROSURG, V88, P433, DOI 10.1016/j.wneu.2015.10.055; Jin YC, 2015, WORLD NEUROSURG, V84, P420, DOI 10.1016/j.wneu.2015.03.039; Jin YC, 2015, J NEUROTRAUM, V32, P1090, DOI 10.1089/neu.2014.3649; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu CL, 2008, J CEREBR BLOOD F MET, V28, P674, DOI 10.1038/sj.jcbfm.9600587; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Nakajima Y, 2010, TOHOKU J EXP MED, V221, P229, DOI 10.1620/tjem.221.229; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Schluesener HJ, 1998, GLIA, V24, P244, DOI 10.1002/(SICI)1098-1136(199810)24:2<244::AID-GLIA9>3.0.CO;2-3; Schwab JM, 2001, J NEUROIMMUNOL, V119, P214, DOI 10.1016/S0165-5728(01)00375-7; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Xue ZL, 2017, BIOCHEM BIOPH RES CO, V486, P589, DOI 10.1016/j.bbrc.2017.03.097; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984	36	18	20	4	12	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	SEP 20	2018	15								273	10.1186/s12974-018-1315-1			12	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GU4CB	WOS:000445227200002	30236124	gold, Green Published			2022-02-06	
J	Wang, L; Zhao, CF; Wu, S; Xiao, GH; Xin, ZG; Lei, P; Xie, KL				Wang, Lu; Zhao, Chongfa; Wu, Shuang; Xiao, Guanghui; Xin Zhuge; Lei, Ping; Xie, Keliang			HYDROGEN GAS TREATMENT IMPROVES THE NEUROLOGICAL OUTCOME AFTER TRAUMATIC BRAIN INJURY VIA INCREASING MIR-21 EXPRESSION	SHOCK			English	Article						Hydrogen gas (H-2); miR-21; neurological outcome; oxidative stress; traumatic brain injury (TBI)	MICRORNA EXPRESSION; RICH SALINE; IN-VITRO; MICE; IMPACT; DAMAGE; RATS; CORTEX; MODEL	Hydrogen gas (H-2) exerts a beneficial effect against traumatic brain injury (TBI). microRNA-21 (miR-21) is one of the most highly expressed members of small non-coding microRNA family in mammalian cells. miR-21 can improve the neurological outcome after TBI. In the present study, we investigated whether H-2 treatment could improve the neurological outcome after TBI via increasing miR-21 expression. TBI was induced by controlled cortical impact in rats. H-2 treatment was given by exposure to 2% H-2 from 30 min to 5 h after TBI operation. Here, we found that H-2 treatment significantly increased the expression of miR-21 in brain from 6 h to 3 d after TBI. The level of miR-21 expression in brain was significantly decreased after intracerebroventricular infusion of miR-21 antagomir in TBI-challenged rats with or without H-2 treatment. Moreover, we found that H-2 treatment conferred a better neurological outcome after TBI by improving neurological dysfunction, alleviating brain edema as well as decreasing lesion volume and blood-brain barrier permeability, which were significantly prevented by miR-21 antagomir. Furthermore, intracerebroventricular infusion of miR-21 agomir increased the level of miR-21 expression and decreased the lesion volume after TBI. In addition, H-2 treatment decreased the levels of oxidative products (malondialdehyde and 8-iso-prostaglandin F2a) and increased the activities of endogenous antioxidant enzymes (superoxide dismutase and catalase) in brain after TBI, which were prevented by miR-21 antagomir. Taken together, these data indicate that H-2 treatment improves the neurological outcome after TBI via increasing miR-21 expression.	[Wang, Lu; Xiao, Guanghui; Xin Zhuge; Lei, Ping] Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Tianjin 300052, Peoples R China; [Zhao, Chongfa] Tianjin Haihe Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Wu, Shuang] Tianjin Stomatol Hosp, Dept Anesthesiol, Tianjin, Peoples R China; [Xie, Keliang] Tianjin Med Univ, Dept Anesthesiol, Tianjin Inst Anesthesiol, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China		Lei, P (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Geriatr Inst, Dept Geriatr, Tianjin 300052, Peoples R China.; Xie, KL (corresponding author), Tianjin Med Univ, Dept Anesthesiol, Tianjin Inst Anesthesiol, Gen Hosp, 154 Anshan Rd, Tianjin 300052, Peoples R China.	leiping1974@163.com; xiekeliang2009@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471842, 81772043]; Natural Science Foundation of Tianjin, ChinaNatural Science Foundation of Tianjin [17JCYBJC24800]	This work was supported by research grants from the National Natural Science Foundation of China (81471842, 81772043) and Natural Science Foundation of Tianjin, China (17JCYBJC24800).	Barzo P, 1996, J NEUROSURG, V85, P1113, DOI 10.3171/jns.1996.85.6.1113; Beaumont A, 2000, ACTA NEUROCHIR SUPPL, V76, P125; Chandran R, 2017, BRAIN INJURY, V31, P106, DOI 10.1080/02699052.2016.1213420; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; FEENEY DM, 1990, CAN J PSYCHOL, V44, P233, DOI 10.1037/h0084243; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2016, BRAIN RES, V1650, P31, DOI 10.1016/j.brainres.2016.07.015; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Hou ZG, 2012, BRAIN RES BULL, V88, P560, DOI 10.1016/j.brainresbull.2012.06.006; Ji XT, 2012, J SURG RES, V178, pE9, DOI 10.1016/j.jss.2011.12.038; Ji XT, 2010, BRAIN RES, V1354, P196, DOI 10.1016/j.brainres.2010.07.038; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Kumar A, 2008, NEONATOLOGY, V94, P96, DOI 10.1159/000116633; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Liu GD, 2013, INT J OPHTHALMOL-CHI, V6, P280, DOI 10.3980/j.issn.2222-3959.2013.03.05; Liu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103948; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; Marklund N, 2001, J NEUROTRAUM, V18, P1217, DOI 10.1089/089771501317095250; Meissner L, 2016, J NEUROTRAUM, V33, P713, DOI 10.1089/neu.2015.4077; Nagatani K, 2012, SHOCK, V37, P645, DOI 10.1097/SHK.0b013e31824ed57c; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Sakamoto M, 2002, NEUROL RES, V24, P301, DOI 10.1179/016164102101199783; Sun L, 2014, NEUROREPORT, V25, P718, DOI 10.1097/WNR.0000000000000181; Taheri S, 2016, J NEUROTRAUM, V33, P1818, DOI 10.1089/neu.2015.4281; Xie KL, 2010, SHOCK, V34, P90, DOI 10.1097/SHK.0b013e3181cdc4ae; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zhang YL, 2009, BRAIN RES, V1294, P153, DOI 10.1016/j.brainres.2009.07.077	35	18	18	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	SEP	2018	50	3					308	315		10.1097/SHK.0000000000001018			8	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	HF2AB	WOS:000454035600009	29028768	Bronze			2022-02-06	
J	Andrews, RJ; Fonda, JR; Levin, LK; McGlinchey, RE; Milberg, WP				Andrews, Ryan J.; Fonda, Jennifer R.; Levin, Laura K.; McGlinchey, Regina E.; Milberg, William P.			Comprehensive analysis of the predictors of neurobehavioral symptom reporting in veterans	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; POST-CONCUSSION SYNDROME; POSTCONCUSSION SYNDROME; OEF/OIF/OND VETERANS; VALIDITY; ASSOCIATION; DEPLOYMENT; IRAQ; PERFORMANCE	Objective This study assessed the strength of military-related concussion-, psychological-, and behavioralrelated measures to predict neurobehavioral symptom (NBS) reporting in order to help clarify the extent to which persistent NBS reflect lingering effects of concussion vs other psychological/behavioral factors among veterans. Methods Baseline analysis included 351 consecutively enrolled veterans in the Translational Research Center for Traumatic Brain Injury and Stress Disorders longitudinal cohort study. One hundred eighty-six returned for a follow-up evaluation averaging 24 months post baseline. The Neurobehavioral Symptom Inventory (NSI) was used to measure NBS reporting. Predictor variables included diagnosis of military-related mild traumatic brain injury (M-mTBI), psychological measures, including posttraumatic stress disorder, mood, anxiety, and substance abuse disorders, and behavioral measures, including self-reported current pain and sleep impairment. Hierarchical and multivariable regression analyses examined the relationships between the predictor variables and NSI scores. The k-fold cross-validation assessed generalizability and validity of the regressions. Results Baseline analysis revealed that psychological and behavioral conditions independently accounted for 42.5% of variance in the NSI total score compared to 1.5% for M-mTBI after controlling for psychological and behavioral conditions. Prospective analysis revealed that M-mTBI at baseline did not significantly predict NSI score at follow-up, while psychological and behavioral measures at baseline independently accounted for 24.5% of NSI variance. Posttraumatic stress disorder was the most consistent predictor. Cross-validation analyses supported generalizability of the results. Conclusions Psychological and behavioral-related measures are strong predictors of persistent NBS reporting in veterans, while M-mTBI is negligible. NBS more likely reflect influential comorbidities as opposed to brain injury, per se.	[Milberg, William P.] Boston Healthcare Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, Boston, MA USA; Translat Res Ctr TBI & Stress Disorders, Boston, MA USA		Milberg, WP (corresponding author), Boston Healthcare Syst, Dept Vet Affairs, Geriatr Res Educ & Clin Ctr, Boston, MA USA.	william_milberg@hms.harvard.edu	Fonda, Jennifer R./ABG-2890-2021	Fonda, Jennifer R./0000-0001-9482-2918	US Department of Veterans Affairs through the Translational Research Center for TBI and Stress Disorders (TRACTS); VA Rehabilitation Research & Development Traumatic Brain Injury National Network Research Center [B9254-C]; VA Clinical Science Research & Development Merit Review [CX001327]; NIH NCCIH grant [R21 AT009430-01]; National Center for Complementary & Integrative HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21AT009430] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001327, I50RX003001] Funding Source: NIH RePORTER	This study was supported by the US Department of Veterans Affairs through the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research & Development Traumatic Brain Injury National Network Research Center (B9254-C), a VA Clinical Science Research & Development Merit Review (CX001327), and NIH NCCIH grant (R21 AT009430-01).	Al Sayegh A, 2010, J NEUROL NEUROSUR PS, V81, P1128, DOI 10.1136/jnnp.2008.170092; Amick MM, 2018, J HEAD TRAUMA REHAB, V33, pE30, DOI 10.1097/HTR.0000000000000308; [Anonymous], 2010, VA CONS C PRACT REC; Armistead-Jehle P, 2017, PHYS MED REH CLIN N, V28, P323, DOI 10.1016/j.pmr.2016.12.008; Bender SD, 2013, PSYCHOL INJ LAW, V6, P113, DOI 10.1007/s12207-013-9156-9; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Fonda JR, 2017, AM J EPIDEMIOL, V186, P220, DOI 10.1093/aje/kwx044; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Friedman J., 2009, ELEMENTS STAT LEARNI, V2nd, DOI [10.1007/b94608, DOI 10.1007/B94608]; Garber BG, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/s12888-014-0325-5; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Kaplan DA, INFORM PAPER NEUROBE; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Marx BP, 2009, ARCH GEN PSYCHIAT, V66, P996, DOI 10.1001/archgenpsychiatry.2009.109; McGlinchey RE, 2017, INT J METHODS PSYCHI; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; O'Neil ME, COMPLICATIONS MILD T; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Potter SDS, 2016, J NEUROL NEUROSUR PS, V87, P1075, DOI 10.1136/jnnp-2015-312838; Roth R. S., 2013, INT J PHYS MED REHAB, V1, P1, DOI [10.4172/2329-9096.1000105, DOI 10.4172/2329-9096.1000105]; Schwab K, 2017, NEUROLOGY, V88, P1571, DOI 10.1212/WNL.0000000000003839; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Waldron-Perrine B, 2014, MIL MED, V179, P856, DOI 10.7205/MILMED-D-13-00282; Wisdom NM, 2014, CLIN NEUROPSYCHOL, V28, P128, DOI 10.1080/13854046.2013.863977; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393	39	18	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	AUG 21	2018	91	8					E732	E745		10.1212/WNL.0000000000006034			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GR1EJ	WOS:000442272400005	30054440	Green Published			2022-02-06	
J	Ganjam, GK; Terpolilli, NA; Diemert, S; Eisenbach, I; Hoffmann, L; Reuther, C; Herden, C; Roth, J; Plesnila, N; Culmsee, C				Ganjam, Goutham K.; Terpolilli, Nicole Angela; Diemert, Sebastian; Eisenbach, Ina; Hoffmann, Lena; Reuther, Christina; Herden, Christiane; Roth, Joachim; Plesnila, Nikolaus; Culmsee, Carsten			Cylindromatosis mediates neuronal cell death in vitro and in vivo	CELL DEATH AND DIFFERENTIATION			English	Article							NF-KAPPA-B; TRAUMATIC BRAIN-INJURY; APOPTOSIS-INDUCING FACTOR; FOCAL CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; CASPASE-8 ACTIVATION; PROGRAMMED NECROSIS; SIGNALING COMPLEX; TNF-ALPHA; DAMAGE	The tumor-suppressor cylindromatosis (CYLD) is a deubiquitinating enzyme and key regulator of cell proliferation and inflammation. A genome-wide siRNA screen linked CYLD to receptor interacting protein-1 (RIP1) kinase-mediated necroptosis; however, the exact mechanisms of CYLD-mediated cell death remain unknown. Therefore, we investigated the precise role of CYLD in models of neuronal cell death in vitro and evaluated whether CYLD deletion affects brain injury in vivo. In vitro, downregulation of CYLD increased RIP1 ubiquitination, prevented RIP1/RIP3 complex formation, and protected neuronal cells from oxidative death. Similar protective effects were achieved by siRNA silencing of RIP1 or RIP3 or by pharmacological inhibition of RIP1 with necrostatin-1. In vivo, CYLD knockout mice were protected from trauma-induced brain damage compared to wild-type littermate controls. These findings unravel the mechanisms of CYLD-mediated cell death signaling in damaged neurons in vitro and suggest a cell death-mediating role of CYLD in vivo.	[Ganjam, Goutham K.; Diemert, Sebastian; Eisenbach, Ina; Hoffmann, Lena; Reuther, Christina; Culmsee, Carsten] Univ Marburg, Inst Pharmacol & Clin Pharm, Biochem Pharmacol Ctr Marburg, MCMBB, Marburg, Germany; [Terpolilli, Nicole Angela; Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res, Munich, Germany; [Herden, Christiane] Univ Giessen, Inst Veterinarian Pathol, Giessen, Germany; [Roth, Joachim] Univ Giessen, Inst Veterinarian Physiol, Giessen, Germany		Culmsee, C (corresponding author), Univ Marburg, Inst Pharmacol & Clin Pharm, Biochem Pharmacol Ctr Marburg, MCMBB, Marburg, Germany.	culmsee@uni-marburg.de	Culmsee, Carsten/ABC-3120-2021; Terpolilli, Nicole/AAG-3598-2021; Plesnila, Nikolaus/T-7522-2019	Culmsee, Carsten/0000-0002-5121-5015; Plesnila, Nikolaus/0000-0001-8832-228X	DFGGerman Research Foundation (DFG)European Commission [Cu43/6-1]	This study was partly supported by the DFG (Cu43/6-1). SM-164 was a kind gift from Shamoeng Wang, University of Michigan, Ann Arbor, Michigan, USA. We thank Mathieu JM Bertrand, Inflammation Research Center, VIB, Ghent University, Gent, Belgium for valuable suggestions and comments in redrafting this manuscript. We thank the excellent technical support by Mrs. Katharina Elsasser and Ms. Eileen Daube.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Byun JY, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/796315; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Culmsee C, 2005, J NEUROSCI, V25, P10262, DOI 10.1523/JNEUROSCI.2818-05.2005; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Diemert S, 2012, J NEUROSCI METH, V203, P69, DOI 10.1016/j.jneumeth.2011.09.012; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; Ganjam GK, 2013, J COMP PHYSIOL B, V183, P1101, DOI 10.1007/s00360-013-0772-1; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guillen J, 2012, J AM ASSOC LAB ANIM, V51, P311; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hentze H, 2002, J BIOL CHEM, V277, P5588, DOI 10.1074/jbc.M110766200; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kilkenny C, 2010, J PHARMACOL PHARMACO, V1, P94, DOI 10.4103/0976-500X.72351; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Landshamer S, 2008, CELL DEATH DIFFER, V15, P1553, DOI 10.1038/cdd.2008.78; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Liu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24547; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; Moquin D, 2010, TRENDS BIOCHEM SCI, V35, P434, DOI 10.1016/j.tibs.2010.03.001; Moquin DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076841; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Neitemeier S, 2017, REDOX BIOL, V12, P558, DOI 10.1016/j.redox.2017.03.007; Neitemeier S, 2014, APOPTOSIS, V19, P1665, DOI 10.1007/s10495-014-1048-2; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Plesnila N, 2004, J CEREBR BLOOD F MET, V24, P458, DOI 10.1097/00004647-200404000-00011; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Schenk B, 2015, ONCOGENE, V34, P5796, DOI 10.1038/onc.2015.35; Schwaninger M, 2006, BIOCHEM SOC T, V34, P1291, DOI 10.1042/BST0341291; Schweighofer Hanna, 2016, Intensive Care Med Exp, V4, P19, DOI 10.1186/s40635-016-0091-4; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Slemmer JE, 2008, AM J PATHOL, V173, P1795, DOI 10.2353/ajpath.2008.080168; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Ting AT, 2016, TRENDS IMMUNOL, V37, P535, DOI 10.1016/j.it.2016.06.002; Tobaben S, 2011, CELL DEATH DIFFER, V18, P282, DOI 10.1038/cdd.2010.92; Vanden Berghe T, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.975093; Vanden Berghe T, 2016, CELL MOL LIFE SCI, V73, P2137, DOI 10.1007/s00018-016-2189-y; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang YQ, 2012, NEUROCHEM RES, V37, P1849, DOI 10.1007/s11064-012-0791-4; Wright A, 2007, DEV CELL, V13, P705, DOI 10.1016/j.devcel.2007.09.007; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Zhang HB, 2017, BRAIN INJURY, V31, P406, DOI 10.1080/02699052.2016.1225984; Zhang YY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14329	58	18	19	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1350-9047	1476-5403		CELL DEATH DIFFER	Cell Death Differ.	AUG	2018	25	8					1394	1407		10.1038/s41418-017-0046-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GR7PM	WOS:000442884000004	29352268	Green Published, hybrid			2022-02-06	
J	Sun, JB; Li, Y; Cai, YF; Huang, Y; Liu, S; Yeung, PKK; Deng, MZ; Sun, GS; Zilundu, PLM; Hu, QS; An, RX; Zhou, LH; Wang, LX; Cheng, X				Sun, Jing-Bo; Li, Yan; Cai, Ye-Feng; Huang, Yan; Liu, Shu; Yeung, Patrick K. K.; Deng, Min-Zhen; Sun, Guang-Shun; Zilundu, Prince L. M.; Hu, Qian-Sheng; An, Rui-Xin; Zhou, Li-Hua; Wang, Li-Xin; Cheng, Xiao			Scutellarin protects oxygen/glucose-deprived astrocytes and reduces focal cerebral ischemic injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; scutellarin; cerebral ischemic injury; oxygen glucose deprivation/reoxygenation; nicotinamide adenine dinucleotide phosphate oxidase 2; reactive oxygen species; connexin 43; neural regeneration	DIFFERENTIATED PC12 CELLS; HUMAN-NEUTROPHIL-ELASTASE; TRAUMATIC BRAIN-INJURY; NADPH OXIDASE; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; GAP-JUNCTIONS; CEREBROVASCULAR-DISEASE; REPERFUSION INJURY; DOWN-REGULATION	Scutellarin, a bioactive flavone isolated from Scutellaria baicalensis, has anti-inflammatory, anti-neurotoxic, anti-apoptotic and anti-oxidative effects and has been used to treat cardiovascular and cerebrovascular diseases in China. However, the mechanisms by which scutellarin mediates neuroprotection in cerebral ischemia remain unclear. The interaction between scutellarin and nicotinamide adenine dinucleotide phosphate oxidase 2 (NOX2) was assessed by molecular docking study, which showed that scutellarin selectively binds to NOX2 with high affinity. Cultures of primary astrocytes isolated from the cerebral cortex of neonatal Sprague-Dawley rats were pretreated with 2, 10 or 50 mu M scutellarin for 30 minutes. The astrocytes were then subjected to oxygen/glucose deprivation by incubation for 2 hours in glucose-free Dulbecco's modified Eagle's medium in a 95% N-2/5% CO2 incubator, followed by simulated reperfusion for 22 hours. Cell viability was assessed by cell counting kit-8 assay. Expression levels of NOX2, connexin 43 and caspase-3 were assessed by western blot assay. Reactive oxygen species were measured spectrophotometrically. Pretreatment with 10 or 50 mu M scutellarin substantially increased viability, reduced the expression of NOX2 and caspase-3, increased the expression of connexin 43, and diminished the levels of reactive oxygen species in astrocytes subjected to ischemia-reperfusion. We also assessed the effects of scutellarin in vivo in the rat transient middle cerebral artery occlusion model of cerebral ischemia-reperfusion injury. Rats were given intraperitoneal injection of 100 mg/kg scutellarin 2 hours before surgery. The Bederson scale was used to assess neurological deficit, and 2,3,5-triphenyltetrazolium chloride staining was used to measure infarct size. Western blot assay was used to assess expression of NOX2 and connexin 43 in brain tissue. Enzyme-linked immunosorbent assay was used to detect 8-hydroxydeoxyguanosine (8-OHdG), 4-hydroxy-2-nonenal (4-HNE) and 3-nitrotyrosin (3-NT) in brain tissue. Immunofluorescence double staining was used to determine the co-expression of caspase-3 and NeuN. Pretreatment with scutellarin improved the neurological function of rats with focal cerebral ischemia, reduced infarct size, diminished the expression of NOX2, reduced levels of 8-OHdG, 4-HNE and 3-NT, and reduced the number of cells co-expressing caspase-3 and NeuN in the injured brain tissue. Furthermore, we examined the effect of the NOX2 inhibitor apocynin. Apocynin substantially increased connexin 43 expression in vivo and in vitro. Collectively, our findings suggest that scutellarin protects against ischemic injury in vitro and in vivo by downregulating NOX2, upregulating connexin 43, decreasing oxidative damage, and reducing apoptotic cell death.	[Sun, Jing-Bo; Li, Yan; Cai, Ye-Feng; Huang, Yan; Deng, Min-Zhen; Wang, Li-Xin; Cheng, Xiao] Guangdong Prov Hosp Tradit Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Sun, Jing-Bo; Li, Yan; Cai, Ye-Feng; Huang, Yan; Deng, Min-Zhen; Wang, Li-Xin; Cheng, Xiao] Guangzhou Univ Tradit Chinese Med, Dept Inst Clin Med 2, Guangzhou, Guangdong, Peoples R China; [Sun, Jing-Bo; Li, Yan; Cai, Ye-Feng; Huang, Yan; Deng, Min-Zhen; Wang, Li-Xin; Cheng, Xiao] Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China; [Sun, Jing-Bo; Li, Yan; Cai, Ye-Feng; Huang, Yan; Deng, Min-Zhen; Wang, Li-Xin; Cheng, Xiao] Guangdong Prov Chinese Emergency Key Lab, Guangzhou, Guangdong, Peoples R China; [Liu, Shu] An Hui Med Univ, Dept Anat, Hefei, Anhui, Peoples R China; [Yeung, Patrick K. K.] Univ Hong Kong, Dept Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Sun, Guang-Shun; Hu, Qian-Sheng] Sun Yat Sen Univ, Zhong Shan Sch Med, Sch Publ Hlth, Dept Prevent Med, Guangzhou, Guangdong, Peoples R China; [Zilundu, Prince L. M.; An, Rui-Xin; Zhou, Li-Hua] Sun Yat Sen Univ, Guangzhou Dept Anat, Zhong Shan Sch Med, Guangzhou, Guangdong, Peoples R China		Cheng, X (corresponding author), Guangdong Prov Hosp Tradit Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China.; Cheng, X (corresponding author), Guangzhou Univ Tradit Chinese Med, Dept Inst Clin Med 2, Guangzhou, Guangdong, Peoples R China.; Cheng, X (corresponding author), Guangdong Prov Acad Chinese Med Sci, Guangzhou, Guangdong, Peoples R China.; Cheng, X (corresponding author), Guangdong Prov Chinese Emergency Key Lab, Guangzhou, Guangdong, Peoples R China.	chengxiaolucky@126.com	ZILUNDU, LM/AAS-6954-2021; Zilundu, Prince Last Mudenda/N-1596-2018	ZILUNDU, LM/0000-0002-8843-8853; Zilundu, Prince Last Mudenda/0000-0002-8843-8853	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303115, 81774042, 81771353]; Natural Science Foundation of Guangdong Province of ChinaNational Natural Science Foundation of Guangdong Province [S2013040016915]; Science and Technology Program of Guangzhou City of China [201508020050, 201604020003]; Pearl River S & T Nova Program of Guangzhou; Postdoctoral Foundation of ChinaChina Postdoctoral Science Foundation [BBK42913K09, 201003345, BBH429151701]; Hong Kong Scholar Program; Guangzhou University of TCM 2017 High Level University Construction Program [A1-AFD018171Z11096]; Specialty Program of Guangdong Province Hospital of Traditional Chinese Medicine of China [YN2016MJ07, YN2015QN16, YN2015B2025]	This study was financially supported by the National Natural Science Foundation of China, No. 81303115, 81774042, 81771353; the Natural Science Foundation of Guangdong Province of China, No. S2013040016915; the Science and Technology Program of Guangzhou City of China, No. 201508020050, 201604020003; the Pearl River S & T Nova Program of Guangzhou, the Postdoctoral Foundation of China, No. BBK42913K09, 201003345, BBH429151701; a grant from the Hong Kong Scholar Program, Guangzhou University of TCM 2017 High Level University Construction Program, No. A1-AFD018171Z11096; a grant from the Specialty Program of Guangdong Province Hospital of Traditional Chinese Medicine of China, No. YN2016MJ07, YN2015QN16, YN2015B2025.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Berthoud VM, 2009, ANTIOXID REDOX SIGN, V11, P339, DOI 10.1089/ars.2008.2119; Boitier E, 1999, J CELL BIOL, V145, P795, DOI 10.1083/jcb.145.4.795; Brennan-Minnella AM, 2015, ANTIOXID REDOX SIGN, V22, P161, DOI 10.1089/ars.2013.5767; Buch P, 2012, J ETHNOPHARMACOL, V142, P35, DOI 10.1016/j.jep.2012.04.007; Carbone F, 2015, ANTIOXID REDOX SIGN, V23, P460, DOI 10.1089/ars.2013.5778; Chai LJ, 2013, J ETHNOPHARMACOL, V150, P100, DOI 10.1016/j.jep.2013.08.011; Chen G, 2014, BRAIN, V137, P2193, DOI 10.1093/brain/awu140; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Chen JH, 2014, TOXICOL APPL PHARM, V279, P294, DOI 10.1016/j.taap.2014.07.005; Chen XH, 2016, CELL MOL NEUROBIOL, V36, P541, DOI 10.1007/s10571-015-0235-1; Cheng X, 2013, NEUROSCIENCE, V241, P268, DOI 10.1016/j.neuroscience.2013.03.006; Cheng X, 2017, J ETHNOPHARMACOL, V198, P148, DOI 10.1016/j.jep.2017.01.004; Cheng X, 2012, MOL MED REP, V6, P750, DOI 10.3892/mmr.2012.987; Contreras JE, 2004, BRAIN RES REV, V47, P290, DOI 10.1016/j.brainresrev.2004.08.002; Cuzzocrea S, 2001, PHARMACOL REV, V53, P135; Deng ZH, 2014, CELL MOL NEUROBIOL, V34, P871, DOI 10.1007/s10571-014-0066-5; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fan DF, 2016, BRAIN RES, V1633, P62, DOI 10.1016/j.brainres.2015.12.019; Fang M, 2015, BMC NEUROSCI, V16, DOI 10.1186/s12868-015-0219-6; Farahani R, 2005, GLIA, V50, P351, DOI 10.1002/glia.20213; Feng YH, 2016, ZHONGGUO ZUZHI GONGC, V20, P5953; Gao K, 2015, J CELL MOL MED, V19, P2469, DOI 10.1111/jcmm.12641; Garcia J, 2014, J MOL GRAPH MODEL, V51, P120, DOI 10.1016/j.jmgm.2014.05.002; Giaume C, 2010, BRAIN RES REV, V63, P160, DOI 10.1016/j.brainresrev.2009.11.005; Goldstein LB, 2006, STROKE, V37, P1583, DOI 10.1161/01.STR.0000223048.70103.F1; Guo C, 2012, J ETHNOPHARMACOL, V144, P768, DOI 10.1016/j.jep.2012.09.056; Guo H, 2011, CHINESE J PHYSIOL, V54, P399, DOI 10.4077/CJP.2011.AMM059; Guo LL, 2013, EXP TOXICOL PATHOL, V65, P579, DOI 10.1016/j.etp.2012.05.003; Hong H, 2004, PLANTA MED, V70, P427, DOI 10.1055/s-2004-818970; Jiang DP, 2011, AM J CHINESE MED, V39, P1193, DOI 10.1142/S0192415X11009494; Jiang DP, 2011, J KOREAN MED SCI, V26, P778, DOI 10.3346/jkms.2011.26.6.778; Jing YP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122781; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kahles T, 2013, ANTIOXID REDOX SIGN, V18, P1400, DOI 10.1089/ars.2012.4721; Li XJ, 2015, GLIA, V63, P1553, DOI 10.1002/glia.22826; Long LL, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/252530; Lu XY, 2014, NEUROCHEM INT, V69, P14, DOI 10.1016/j.neuint.2014.02.006; Ma MJ, 2013, BRAIN RES, V1519, P87, DOI 10.1016/j.brainres.2013.04.040; Manzanero S, 2013, NEUROCHEM INT, V62, P712, DOI 10.1016/j.neuint.2012.11.009; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Olmez I, 2012, NEUROCHEM INT, V60, P208, DOI 10.1016/j.neuint.2011.11.009; Pei HT, 2012, INT J MOL SCI, V13, P2551, DOI 10.3390/ijms13032551; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Schmidt A, 2013, EXPERT OPIN EMERG DR, V18, P109, DOI 10.1517/14728214.2013.790363; Schulz R, 2015, PHARMACOL THERAPEUT, V153, P90, DOI 10.1016/j.pharmthera.2015.06.005; Shichinohe H, 2015, BRAIN RES, V1602, P53, DOI 10.1016/j.brainres.2015.01.022; Song SX, 2013, MOL MED REP, V7, P327, DOI 10.3892/mmr.2012.1147; Song W, 2013, NEUROSCIENCE, V248, P136, DOI 10.1016/j.neuroscience.2013.05.063; Tang H, 2014, PHARMACOL BIOCHEM BE, V118, P51, DOI 10.1016/j.pbb.2014.01.003; Tang XN, 2012, NEUROL RES, V34, P338, DOI 10.1179/1743132812Y.0000000021; Tian L, 2016, ASIA PAC J CLIN TRIA, V1, P98; Upham BL, 2009, ANTIOXID REDOX SIGN, V11, P297, DOI 10.1089/ars.2008.2146; Wang LL, 2011, NEUROSCIENCE, V189, P397, DOI 10.1016/j.neuroscience.2011.04.070; Wang WJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146197; Wang Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep37098; Wang Z, 2016, LIFE SCI, V157, P200, DOI 10.1016/j.lfs.2016.01.018; Wardlaw JM, 1997, LANCET, V350, P607, DOI 10.1016/S0140-6736(97)03022-5; Xu M, 2016, ACTA PHARMACOL SIN, V37, P246, DOI 10.1038/aps.2015.125; Yuan Y, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0226-z; Zhang HF, 2015, N-S ARCH PHARMACOL, V388, P953, DOI 10.1007/s00210-015-1125-2; Zhang Y, 2018, J PHOTOCH PHOTOBIO B, V184, P1, DOI 10.1016/j.jphotobiol.2018.05.010; Zhou ZY, 2015, BIOCHEM BIOPH RES CO, V458, P656, DOI 10.1016/j.bbrc.2015.02.020	66	18	20	3	13	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	AUG	2018	13	8					1396	1407		10.4103/1673-5374.235293			12	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GQ8SX	WOS:000442030300022	30106052	gold, Green Published			2022-02-06	
J	Thau-Zuchman, O; Gomes, RN; Dyall, SC; Davies, M; Priestley, JV; Groenendijk, M; De Wilde, MC; Tremoleda, JL; Michael-Titus, AT				Thau-Zuchman, Orli; Gomes, Rita N.; Dyall, Simon C.; Davies, Meirion; Priestley, John V.; Groenendijk, Martine; De Wilde, Martijn C.; Tremoleda, Jordi L.; Michael-Titus, Adina T.			Brain Phospholipid Precursors Administered Post-Injury Reduce Tissue Damage and Improve Neurological Outcome in Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain phospholipids; functional improvement; medical multi-nutrient; neuroplasticity; neuroprotection; traumatic brain injury	CONTROLLED CORTICAL IMPACT; MILD ALZHEIMERS-DISEASE; CLOSED-HEAD-INJURY; PROTEIN 18 KDA; MICROGLIAL CELLS; HIPPOCAMPAL NEUROGENESIS; PHOSPHATIDE PRECURSORS; COGNITIVE IMPAIRMENT; DOCOSAHEXAENOIC ACID; REACTIVE ASTROCYTES	Traumatic brain injury (TBI) leads to cellular loss, destabilization of membranes, disruption of synapses and altered brain connectivity, and increased risk of neurodegenerative disease. A significant and long-lasting decrease in phospholipids (PLs), essential membrane constituents, has recently been reported in plasma and brain tissue, in human and experimental TBI. We hypothesized that supporting PL synthesis post-injury could improve outcome post-TBI. We tested this hypothesis using a multi-nutrient combination designed to support the biosynthesis of PLs and available for clinical use. The multi-nutrient, Fortasyn((R)) Connect (FC), contains polyunsaturated omega-3 fatty acids, choline, uridine, vitamins, cofactors required for PL biosynthesis, and has been shown to have significant beneficial effects in early Alzheimer's disease. Male C57BL/6 mice received a controlled cortical impact injury and then were fed a control diet or a diet enriched with FC for 70 days. FC led to a significantly improved sensorimotor outcome and cognition, reduced lesion size and oligodendrocyte loss, and it restored myelin. It reversed the loss of the synaptic protein synaptophysin and decreased levels of the axon growth inhibitor, Nogo-A, thus creating a permissive environment. It decreased microglia activation and the rise in beta-amyloid precursor protein and restored the depressed neurogenesis. The effects of this medical multi-nutrient suggest that support of PL biosynthesis post-TBI, a new treatment paradigm, has significant therapeutic potential in this neurological condition for which there is no satisfactory treatment. The multi-nutrient tested has been used in dementia patients and is safe and well tolerated, which would enable rapid clinical exploration in TBI.	[Thau-Zuchman, Orli; Gomes, Rita N.; Davies, Meirion; Priestley, John V.; Tremoleda, Jordi L.; Michael-Titus, Adina T.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, Ctr Neurosci & Trauma, London, England; [Groenendijk, Martine; De Wilde, Martijn C.] Nutricia Res Nutricia Adv Med Nutr, Utrecht, Netherlands; [Dyall, Simon C.] Bournemouth Univ, Royal London House, Bournemouth, Dorset, England		Thau-Zuchman, O (corresponding author), Queen Mary Univ London, Blizard Inst, Ctr Neurosci & Trauma, 4 Newark St, London E1 2AT, England.	o.thau-zuchman@qmul.ac.uk		Gomes, Rita/0000-0003-4237-2024; Dyall, Simon/0000-0001-7591-4219; Thau-Zuchman, Orli/0000-0003-0403-7962	Centre for Trauma Sciences, Barts Charity grant	O.T.Z., M.D., and J.L.T. were supported by the Centre for Trauma Sciences, Barts Charity grant. M.G. and M.C.d.W. are employees of Nutricia Research. A.M.T. is a scientific consultant for Nutricia Research.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; An CR, 2016, TRANSL STROKE RES, V7, P512, DOI 10.1007/s12975-016-0483-5; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Armstrong RC, 2016, NEUROPHARMACOLOGY, V110, P654, DOI 10.1016/j.neuropharm.2015.04.029; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bourourou M, 2016, NEUROPHARMACOLOGY, V108, P60, DOI 10.1016/j.neuropharm.2016.04.040; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Brown CE, 2008, NEUROSCIENTIST, V14, P139, DOI 10.1177/1073858407309854; Brown CE, 2010, J CEREBR BLOOD F MET, V30, P783, DOI 10.1038/jcbfm.2009.241; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; Cansev M, 2005, BRAIN RES, V1058, P101, DOI 10.1016/j.brainres.2005.07.054; Cansev M, 2015, NEUROBIOL AGING, V36, P344, DOI 10.1016/j.neurobiolaging.2014.07.021; Chen MK, 2008, PHARMACOL THERAPEUT, V118, P1, DOI 10.1016/j.pharmthera.2007.12.004; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Ciallella JR, 2002, J NEUROTRAUM, V19, P1555, DOI 10.1089/089771502762300229; Clarner T, 2012, GLIA, V60, P1468, DOI 10.1002/glia.22367; de Waal H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086558; de Wilde MC, 2016, ALZHEIMERS DEMENT, V12, P633, DOI 10.1016/j.jalz.2015.12.005; de Wilde MC, 2011, J ALZHEIMERS DIS, V27, P327, DOI 10.3233/JAD-2011-110635; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Dyall SC, 2007, NEUROBIOL AGING, V28, P424, DOI 10.1016/j.neurobiolaging.2006.01.002; Dyall SC, 2016, NEUROPHARMACOLOGY, V107, P387, DOI 10.1016/j.neuropharm.2016.03.055; Emmerich T, 2017, NEUROMOL MED, V19, P122, DOI 10.1007/s12017-016-8436-4; Emmerich T, 2016, J NEUROTRAUM, V33, P1331, DOI 10.1089/neu.2015.4061; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gaskin S, 2010, BEHAV PROCESS, V83, P61, DOI 10.1016/j.beproc.2009.10.003; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; GLENN JA, 1992, J ANAT, V180, P109; Gray C, 1998, BRAIN INJURY, V12, P429, DOI 10.1080/026990598122548; Haar CV, 2016, BRAIN RES, V1640, P114, DOI 10.1016/j.brainres.2015.12.030; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Harish G, 2015, J NEUROCHEM, V134, P156, DOI 10.1111/jnc.13082; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; HICKEY WF, 1988, SCIENCE, V239, P290, DOI 10.1126/science.3276004; Hill-Felberg SJ, 1999, J NEUROSCI RES, V57, P271, DOI 10.1002/(SICI)1097-4547(19990715)57:2<271::AID-JNR13>3.0.CO;2-Z; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Homayoun P, 1997, J NEUROCHEM, V69, P199; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Israelsson C, 2014, RESTOR NEUROL NEUROS, V32, P717, DOI 10.3233/RNN-140419; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamphuis PJ, 2009, EUR J NEUROL, V16, P12, DOI 10.1111/j.1468-1331.2009.02737.x; Kim E, 2002, NEUROREHABILITATION, V17, P297; Kimelberg HK, 2010, NEUROTHERAPEUTICS, V7, P338, DOI 10.1016/j.nurt.2010.07.006; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kulkarni SK, 2007, METHOD FIND EXP CLIN, V29, P343; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mannix Rebekah C, 2012, Int J Alzheimers Dis, V2012, P608732, DOI 10.1155/2012/608732; Marklund N, 2006, EXP NEUROL, V197, P70, DOI 10.1016/j.expneurol.2005.08.029; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Moessinger C, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0043-3; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nudo RJ, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00887; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Pallier PN, 2015, NEUROBIOL DIS, V82, P504, DOI 10.1016/j.nbd.2015.09.007; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Purdon AD, 2002, NEUROCHEM RES, V27, P1641, DOI 10.1023/A:1021635027211; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Rikkert MGMO, 2015, J ALZHEIMERS DIS, V44, P471, DOI 10.3233/JAD-141305; Roebuck-Spencer T., 2014, HDB NEUROPSYCHOLOGY, P3; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; SASTRY PS, 1985, PROG LIPID RES, V24, P69, DOI 10.1016/0163-7827(85)90011-6; Saunders JC, 2006, NEUROPSYCHOLOGY, V20, P224, DOI 10.1037/0894-4105.20.2.224; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheltens P, 2012, J ALZHEIMERS DIS, V31, P225, DOI 10.3233/JAD-2012-121189; Scheltens P, 2010, ALZHEIMERS DEMENT, V6, P1, DOI 10.1016/j.jalz.2009.10.003; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shi H, 2015, EXP NEUROL, V272, P17, DOI 10.1016/j.expneurol.2015.03.017; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Soininen H, 2017, LANCET NEUROL, V16, P965, DOI 10.1016/S1474-4422(17)30332-0; Spector AA, 2001, J MOL NEUROSCI, V16, P159, DOI 10.1385/JMN:16:2-3:159; Stocchetti N, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0887-8; Suehiro E, 2001, J NEUROSURG, V94, P493, DOI 10.3171/jns.2001.94.3.0493; SUSARLA BTS, 2014, ASN NEURO, V6; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tress O, 2012, J NEUROSCI, V32, P7499, DOI 10.1523/JNEUROSCI.0392-12.2012; Ulus IH, 1998, NEUROCHEM RES, V23, P727, DOI 10.1023/A:1022455325657; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; van Wijk N, 2014, J ALZHEIMERS DIS, V38, P459, DOI 10.3233/JAD-130998; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Volz LJ, 2015, BRAIN STRUCT FUNCT, V220, P1093, DOI 10.1007/s00429-013-0702-8; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wang Y, 2014, EUR J NUCL MED MOL I, V41, P1440, DOI 10.1007/s00259-014-2727-5; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Wurtman RJ, 2006, BRAIN RES, V1088, P83, DOI 10.1016/j.brainres.2006.03.019; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Wurtman RJ, 2009, ANNU REV NUTR, V29, P59, DOI 10.1146/annurev-nutr-080508-141059; Wurtman Richard J., 2009, V99, P71, DOI 10.1159/000192998; Xiong Y, 2011, J NEUROSURG, V114, P549, DOI 10.3171/2010.10.JNS10925; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yeh PH, 2014, HUM BRAIN MAPP, V35, P2652, DOI 10.1002/hbm.22358; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	128	18	19	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2019	36	1					25	42		10.1089/neu.2017.5579		JUL 2018	18	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HF0PB	WOS:000439793700001	29768974	Green Submitted, hybrid, Green Published, Green Accepted			2022-02-06	
J	Han, PF; Winkler, N; Hummel, C; Hhner, A; Gerber, J; Hummel, T				Han, Pengfei; Winkler, Nicole; Hummel, Cornelia; Haehner, Antje; Gerber, Johannes; Hummel, Thomas			Alterations of Brain Gray Matter Density and Olfactory Bulb Volume in Patients with Olfactory Loss after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						gray matter density; olfactory bulb volume; olfactory loss; post-injury duration; traumatic brain injury	ODOR DISCRIMINATION; INDUCED ACTIVATION; NORMATIVE DATA; HEAD-INJURY; DYSFUNCTION; IDENTIFICATION; ANOSMIA; MRI; PATHOPHYSIOLOGY; RETRONASAL	Olfactory loss and traumatic brain injury (TBI) both lead to anatomical brain alterations in humans. Little research has been done on the structural brain changes for TBI patients with olfactory loss. Using voxel-based morphometry, the gray matter (GM) density was examined for 22 TBI patients with hyposmia, 24 TBI patients with anosmia, and 22 age-matched controls. Olfactory bulb (OB) volumes were measured by manual segmentation of acquired T2-weighted coronal slices using a standardized protocol. Brain lesions in the olfactory-relevant areas also were examined for TBI patients. Results showed that patients with anosmia have more frequent lesions in the OB, orbitofrontal cortex (OFC), and the temporal lobe pole, compared with patients with hyposmia. GM density in the primary olfactory area was decreased in both groups of patients. In addition, compared with controls, patients with anosmia showed GM density reduction in several secondary olfactory eloquent regions, including the gyrus rectus, medial OFC, anterior cingulate cortex, insula, and cerebellum. However, patients with hyposmia showed a lesser degree of GM reduction, compared with healthy controls. Smaller OB volumes were found for patients with olfactory loss, compared with controls. TBI patients with anosmia had the smallest OB volumes, which were caused by the lesions for OB. In addition, post-TBI duration was negatively correlated with GM density in the secondary olfactory areas in patients with hyposmia, but was positively correlated with GM density in the frontal and temporal gyrus in patients with anosmia. The GM density and OB volume reduction among TBI patients with olfactory loss was largely dependent on the location and severity of brain lesions in olfactory-relevant regions. Longer post-TBI duration had an impact on brain GM density changes, which indicate a decreased olfactory function in patients with hyposmia and possible compensatory mechanisms in patients with anosmia.	[Han, Pengfei; Winkler, Nicole; Hummel, Cornelia; Haehner, Antje; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Fetscherstr 74, D-01307 Dresden, Germany; [Gerber, Johannes] Tech Univ Dresden, Dept Neuroradiol, Dresden, Germany		Han, PF (corresponding author), Tech Univ Dresden, Dept Otorhinolaryngol, Interdisciplinary Ctr Smell & Taste, Fetscherstr 74, D-01307 Dresden, Germany.	pengfeihan88@gmail.com	Gerber, Johannes/U-4918-2019	Gerber, Johannes/0000-0001-7465-8700; Han, Pengfei/0000-0001-8266-6655	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG HU 411/18-1]	This research as supported by a grant from the Deutsche Forschungsgemeinschaft to TH (DFG HU 411/18-1).	Alosco ML, 2017, J NEUROTRAUM, V34, P772, DOI 10.1089/neu.2016.4536; Andersson L, 2014, J PSYCHOSOM RES, V77, P401, DOI 10.1016/j.jpsychores.2014.09.014; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Banks SJ, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00414; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Billot PE, 2011, NEUROSCIENCE, V189, P370, DOI 10.1016/j.neuroscience.2011.05.035; Bitter T, 2010, BRAIN RES, V1347, P42, DOI 10.1016/j.brainres.2010.06.003; Bitter T, 2010, CHEM SENSES, V35, P407, DOI 10.1093/chemse/bjq028; Boyle JA, 2007, NEUROSCIENCE, V149, P223, DOI 10.1016/j.neuroscience.2007.06.045; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Cerf-Ducastel B, 2001, CHEM SENSES, V26, P625, DOI 10.1093/chemse/26.6.625; Charland-Verville V, 2012, AM J RHINOL ALLERGY, V26, P222, DOI 10.2500/ajra.2012.26.3769; Coelho DH, 2016, AURIS NASUS LARYNX, V43, P137, DOI 10.1016/j.anl.2015.08.006; Costanzo RM, 1991, SMELL TASTE HLTH DIS, P711; Damm M, 2004, HNO, V52, P112, DOI 10.1007/s00106-003-0877-z; de Guise E, 2015, BRAIN INJURY, V29, P730, DOI 10.3109/02699052.2015.1004748; de Kruijk JR, 2003, BRAIN INJURY, V17, P73, DOI 10.1080/0269905021000010221; DEKRUIJK JR, 2009, BRAIN INJURY, V17, P73, DOI DOI 10.1016/J.JSMC.2015.10.004; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; Delon-Martin C, 2013, NEUROIMAGE, V68, P55, DOI 10.1016/j.neuroimage.2012.11.044; Dixon KJ, 2017, PHYS MED REH CLIN N, V28, P215, DOI 10.1016/j.pmr.2016.12.001; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Frasnelli J, 2016, CLIN NEUROL NEUROSUR, V140, P68, DOI 10.1016/j.clineuro.2015.11.013; Frasnelli J, 2007, CEREB CORTEX, V17, P2268, DOI 10.1093/cercor/bhl135; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gardner AJ, 2017, PHYS MED REH CLIN N, V28, P413, DOI 10.1016/j.pmr.2016.12.014; Gottfried JA, 2006, ADV OTO-RHINO-LARYNG, V63, P44, DOI 10.1159/000093750; Grabenhorst F, 2007, J NEUROSCI, V27, P13532, DOI 10.1523/JNEUROSCI.3337-07.2007; Gudziol H, 2010, LARYNGO RHINO OTOL, V89, P477, DOI 10.1055/s-0030-1253372; Gudziol V, 2014, EUR ARCH OTO-RHINO-L, V271, P1533, DOI 10.1007/s00405-013-2687-6; Gulyas B, 2004, NEUROCHEM INT, V44, P595, DOI 10.1016/j.neuint.2003.10.003; Han PF, 2017, INT FORUM ALLERGY RH, V7, P551, DOI 10.1002/alr.21922; Hasan KM, 2014, J NEUROTRAUM, V31, P466, DOI [10.1089/NEU.2013.3085, 10.1089/neu.2013.3085]; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 1997, CHEM SENSES, V22, P39, DOI 10.1093/chemse/22.1.39; Kareken DA, 2003, NEUROPSYCHOLOGY, V17, P482, DOI 10.1037/0894-4105.17.3.482; Kobal G, 2000, EUR ARCH OTO-RHINO-L, V257, P205, DOI 10.1007/s004050050223; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Landis BN, 2010, J NEUROL, V257, P1303, DOI 10.1007/s00415-010-5513-8; LEVIN HS, 1985, BRAIN, V108, P579, DOI 10.1093/brain/108.3.579; Lieberman MD, 2009, SOC COGN AFFECT NEUR, V4, P423, DOI 10.1093/scan/nsp052; LIST J, 2015, FRONT HUM NEUROSCI, V9, DOI DOI 10.1378/CHEST.11-1603; Lotsch J, 2016, NEUROIMAGE-CLIN, V11, P99, DOI 10.1016/j.nicl.2016.01.011; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Miao XT, 2015, EUR ARCH OTO-RHINO-L, V272, P1945, DOI 10.1007/s00405-014-3278-x; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Peng P, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130207; Plailly J, 2006, NEUROIMAGE, V29, P302, DOI 10.1016/j.neuroimage.2005.06.056; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Rolls ET, 2016, BRAIN COGNITION, V110, P4, DOI 10.1016/j.bandc.2015.07.002; Rombaux P, 2006, LARYNGOSCOPE, V116, P901, DOI 10.1097/01.mlg.0000217533.60311.e7; Rombaux P, 2006, ARCH OTOLARYNGOL, V132, P1346, DOI 10.1001/archotol.132.12.1346; Savic I, 2004, HUM BRAIN MAPP, V21, P271, DOI 10.1002/hbm.20009; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Schriever VA, 2014, CHEM SENSES, V39, P343, DOI 10.1093/chemse/bju005; Segura B, 2013, BEHAV BRAIN RES, V246, P148, DOI 10.1016/j.bbr.2013.02.025; SHIGA H, 2017, SCI REP-UK, V7, DOI DOI 10.1111/J.1526-4637.2007.00404.X; Sobel N, 1998, J NEUROSCI, V18, P8990; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; SUMNER D, 1964, BRAIN, V87, P107, DOI 10.1093/brain/87.1.107; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varney NR, 2001, J HEAD TRAUMA REHAB, V16, P253, DOI 10.1097/00001199-200106000-00004; Vent J, 2010, BRAIN RES, V1320, P1, DOI 10.1016/j.brainres.2010.01.007; Welborn BL, 2009, SOC COGN AFFECT NEUR, V4, P328, DOI 10.1093/scan/nsp028; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; YAO L, 2014, CHEM SENSES, DOI DOI 10.1016/J.SLEEP.2007.11.023; Yao LY, 2013, EUR ARCH OTO-RHINO-L, V270, P2569, DOI 10.1007/s00405-013-2595-9; Yousem DM, 1997, ACAD RADIOL, V4, P264, DOI 10.1016/S1076-6332(97)80027-X; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; Yousem DM, 1998, ANN NY ACAD SCI, V855, P546, DOI 10.1111/j.1749-6632.1998.tb10624.x; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	84	18	18	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV	2018	35	22					2632	2640		10.1089/neu.2017.5393		JUL 2018	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	GZ0MO	WOS:000439632400001	29699465				2022-02-06	
J	Smith, NM; Giacci, MK; Gough, A; Bailey, C; McGonigle, T; Black, AMB; Clarke, TO; Bartlett, CA; Iyer, KS; Dunlop, SA; Fitzgerald, M				Smith, Nicole M.; Giacci, Marcus K.; Gough, Alexander; Bailey, Charlotte; McGonigle, Terence; Black, Anna M. B.; Clarke, Thomas O.; Bartlett, Carole A.; Iyer, K. Swaminathan; Dunlop, Sarah A.; Fitzgerald, Melinda			Inflammation and blood-brain barrier breach remote from the primary injury following neurotrauma	JOURNAL OF NEUROINFLAMMATION			English	Article						Neurotrauma; Secondary degeneration; Microglia; Macrophages; Cytokines; Blood-brain barrier	SPINAL-CORD-INJURY; SECONDARY DEGENERATION; CNS REMYELINATION; OXIDATIVE STRESS; M2 MICROGLIA; MACROPHAGES; INTEGRITY; TRANSECTION; DYNAMICS; PASSAGE	Background: Following injury to the central nervous system, increased microglia, secretion of pro-and anti-inflammatory cytokines, and altered blood-brain barrier permeability, a hallmark of degeneration, are observed at and immediately adjacent to the injury site. However, few studies investigate how regions remote from the primary injury could also suffer from inflammation and secondary degeneration. Methods: Adult female Piebald-Viral-Glaxo (PVG) rats underwent partial transection of the right optic nerve, with normal, age-matched, unoperated animals as controls. Perfusion-fixed brains and right optic nerves were harvested for immunohistochemical assessment of inflammatory markers and blood-brain barrier integrity; fresh-frozen brains were used for multiplex cytokine analysis. Results: Immediately ventral to the optic nerve injury, immunointensity of both the pro-inflammatory biomarker inducible nitric oxide synthase (iNOS) and the anti-inflammatory biomarker arginase-1 (Arg1) increased at 7 days post-injury, with colocalization of iNOS and Arg1 immunoreactivity within individual cells. CD11b+ and CD45+ cells were increased 7 days post-injury, with altered BBB permeability still evident at this time. In the lower and middle optic tract and superior colliculus, IBA1+ resident microglia were first increased at 3 days; ED1+ and CD11b+ cells were first increased in the middle and upper tract and superior colliculus 7 days post-injury. Increased fibrinogen immunoreactivity indicative of altered BBB permeability was first observed in the contralateral upper tract at 3 days and middle tract at 7 days post-injury. Multiplex cytokine analysis of brain homogenates indicated significant increases in the pro-inflammatory cytokines, IL-2 and TNF alpha, and anti-inflammatory cytokine IL-10 1 day post-injury, decreasing to control levels at 3 days for TNF alpha and 7 days for IL-2. IL-10 was significantly elevated at 1 and 7 days post-injury with a dip at 3 days post-injury. Conclusions: Partial injury to the optic nerve induces a complex remote inflammatory response, characterized by rapidly increased pro- and anti-inflammatory cytokines in brain homogenates, increased numbers of IBA1+ cells throughout the visual pathways, and increased CD11b+ and ED1+ inflammatory cells, particularly towards the synaptic terminals. BBB permeability can increase prior to inflammatory cell infiltration, dependent on the brain region.	[Smith, Nicole M.; Bailey, Charlotte; Iyer, K. Swaminathan] Univ Western Australia, Sch Mol Sci, Perth, WA 6009, Australia; [Giacci, Marcus K.; Gough, Alexander; Bartlett, Carole A.; Dunlop, Sarah A.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA 6009, Australia; [McGonigle, Terence; Black, Anna M. B.; Clarke, Thomas O.; Bartlett, Carole A.; Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Verdun St, Nedlands, WA, Australia; [Fitzgerald, Melinda] Sarich Neurosci Res Inst, Perron Inst Neurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA 6009, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Verdun St, Nedlands, WA, Australia.	lindy.fitzgerald@curtin.edu.au	Smith, Nicole/L-2502-2013; Fitzgerald, Melinda/C-4235-2011	Smith, Nicole/0000-0002-5519-8152; Fitzgerald, Melinda/0000-0002-4823-8179; Giacci, Marcus/0000-0002-8330-678X; Dunlop, Sarah/0000-0002-1306-3962	National Health and Medical Research Council (NHMRC), AustraliaNational Health and Medical Research Council of Australia [APP1082403]; Neurotrauma Research Program, WA; NHMRCNational Health and Medical Research Council of Australia [APP1087114]	National Health and Medical Research Council (NHMRC), Australia (APP1082403), and Neurotrauma Research Program, WA. MF is supported by an NHMRC Career Development Fellowship (APP1087114). The funding bodies played no part in the conduct of the study.	Alvarez JI, 2011, BBA-MOL BASIS DIS, V1812, P252, DOI 10.1016/j.bbadis.2010.06.017; BANATI RB, 1993, GLIA, V7, P111, DOI 10.1002/glia.440070117; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; Block F, 2005, PROG NEUROBIOL, V75, P342, DOI 10.1016/j.pneurobio.2005.03.004; Chan KC, 2015, INVEST OPHTH VIS SCI, V56, P1, DOI 10.1167/iovs.14-14287; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; De Bock M, 2013, PROG NEUROBIOL, V108, P1, DOI 10.1016/j.pneurobio.2013.06.001; DEMEURISSE G, 1990, EUR NEUROL, V30, P67, DOI 10.1159/000117313; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Echeverry S, 2011, J NEUROSCI, V31, P10819, DOI 10.1523/JNEUROSCI.1642-11.2011; Edwards JP, 2006, J LEUKOCYTE BIOL, V80, P1298, DOI 10.1189/jlb.0406249; Evangelho K, 2019, INT OPHTHALMOL, V39, P259, DOI 10.1007/s10792-017-0795-9; Finger S, 2004, ARCH NEUROL-CHICAGO, V61, P283, DOI 10.1001/archneur.61.2.283; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Harvey AR, 2006, PROG RETIN EYE RES, V25, P449, DOI 10.1016/j.preteyeres.2006.07.002; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Jia Z, 2012, SPINAL CORD, V50, P264, DOI 10.1038/sc.2011.111; Kastin AJ, 2003, MOL BRAIN RES, V114, P168, DOI 10.1016/S0169-328X(03)00167-0; Kim CC, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0581-z; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Lawlor M, 2017, SURV OPHTHALMOL, P1; LEENAERTS PL, 1994, CLIN EXP IMMUNOL, V97, P478; Liu J, 2012, J NEUROSCI, V32, P3044, DOI 10.1523/JNEUROSCI.6409-11.2012; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mietto BS, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/251204; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Perego C, 2016, NEUROBIOL DIS, V96, P284, DOI 10.1016/j.nbd.2016.09.017; Perego C, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-174; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.103/jid.2011.9, 10.1038/jid.2011.9]; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Ryu JK, 2015, NAT COMMUN, P6; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Smith NM, 2016, SCI REP-UK, V6, DOI 10.1038/srep22595; Thiel A, 2010, J NUCL MED, V51, P1404, DOI 10.2967/jnumed.110.076612; Turtzo LC, 2014, J NEUROINFLAMM, V11, P1742; Viscomi MT, 2014, MOL NEUROBIOL, V50, P368, DOI 10.1007/s12035-013-8629-x; Vogel DY, 2013, J NEUROINFLAMM, V10, P1742; WAGUESPACK PJ, 1994, BRAIN RES BULL, V34, P103, DOI 10.1016/0361-9230(94)90005-1; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weishaupt N, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00081; Xu N, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00209	52	18	19	0	8	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUL 7	2018	15								201	10.1186/s12974-018-1227-0			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GM2FX	WOS:000437899400001	29981582	Green Published, gold			2022-02-06	
J	Muelbl, MJ; Slaker, ML; Shah, AS; Nawarawong, NN; Gerndt, CH; Budde, MD; Stemper, BD; Olsen, CM				Muelbl, Matthew J.; Slaker, Megan L.; Shah, Alok S.; Nawarawong, Natalie N.; Gerndt, Clayton H.; Budde, Matthew D.; Stemper, Brian D.; Olsen, Christopher M.			Effects of Mild Blast Traumatic Brain Injury on Cognitive- and Addiction-Related Behaviors	SCIENTIFIC REPORTS			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CONDITIONED PLACE PREFERENCE; PREFRONTAL CORTEX; WORKING-MEMORY; NEUROPSYCHOLOGICAL OUTCOMES; PROACTIVE-INTERFERENCE; EXECUTIVE DYSFUNCTION; SUBSTANCE-ABUSE; DRUG-USE; AXIS-I	Traumatic brain injury (TBI) commonly results in cognitive and psychiatric problems. Cognitive impairments occur in approximately 30% of patients suffering from mild TBI (mTBI), and correlational evidence from clinical studies indicates that substance abuse may be increased following mTBI. However, understanding the lasting cognitive and psychiatric problems stemming from mTBI is difficult in clinical settings where pre-injury assessment may not be possible or accurate. Therefore, we used a previously characterized blast model of mTBI (bTBI) to examine cognitive-and addiction-related outcomes. We previously demonstrated that this model leads to bilateral damage of the medial prefrontal cortex (mPFC), a region critical for cognitive function and addiction. Rats were exposed to bTBI and tested in operant learning tasks several weeks after injury. bTBI rats made more errors during acquisition of a cue discrimination task compared to sham treated rats. Surprisingly, we observed no differences between groups in set shifting and delayed matching to sample, tasks known to require the mPFC. Separate rats performed cocaine self-administration. No group differences were found in intake or extinction, and only subtle differences were observed in drug-primed reinstatement 3-4 months after injury. These findings indicate that bTBI impairs acquisition of a visual discrimination task and that bTBI does not significantly increase the ability of cocaine exposure to trigger drug seeking.	[Muelbl, Matthew J.; Slaker, Megan L.; Nawarawong, Natalie N.; Gerndt, Clayton H.; Olsen, Christopher M.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Muelbl, Matthew J.; Slaker, Megan L.; Nawarawong, Natalie N.; Gerndt, Clayton H.; Olsen, Christopher M.] Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Med Coll Wisconsin, Dept Neurosurg, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Shah, Alok S.; Budde, Matthew D.; Stemper, Brian D.] Clement J Zablocki Vet Affairs Med Ctr, 5000 W Natl Ave, Milwaukee, WI 53295 USA		Olsen, CM (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.; Olsen, CM (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	colsen@mcw.edu	Stemper, Brian/AAX-7611-2020; Olsen, Christopher/G-9595-2013	Olsen, Christopher/0000-0003-2700-0310; gerndt, clayton/0000-0001-9226-1790	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DA039276]; Veterans Affairs Medical ResearchUS Department of Veterans Affairs; Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA042792, R21DA039276] Funding Source: NIH RePORTER	This research was supported by NIH DA039276 (C.M.O., M.D.B., B.D.S.), Veterans Affairs Medical Research (M.D.B., B.D.S.), and the Research and Education Initiative Fund, a component of the Advancing a Healthier Wisconsin Endowment at the Medical College of Wisconsin (C.M.O.). The authors wish to thank the NIDA drug supply program for providing cocaine. Behavioral studies were performed using equipment from investigator laboratories and the MCW Neuroscience Research Center Rodent Behavior Core. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Alwis DS, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00156; Aoki Y, 2016, NEUROSCI BIOBEHAV R, V66, P119, DOI 10.1016/j.neubiorev.2016.04.021; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Banuelos C, 2014, J NEUROSCI, V34, P3457, DOI 10.1523/JNEUROSCI.5192-13.2014; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Beas BS, 2013, NEUROBIOL AGING, V34, P2164, DOI 10.1016/j.neurobiolaging.2013.03.019; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bernheim A, 2016, NEUROSCI BIOBEHAV R, V69, P36, DOI 10.1016/j.neubiorev.2016.07.020; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Budde MD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00154; Cole W. R., 2016, TRANSLATIONAL RES TR; Cox BM, 2016, PSYCHOPHARMACOLOGY, V233, P2319, DOI 10.1007/s00213-016-4283-0; D'Souza MS, 2003, PHARMACOL BIOCHEM BE, V76, P335, DOI 10.1016/j.pbb.2003.08.004; de Boussard CN, 2005, J REHABIL MED, V37, P53, DOI 10.1080/16501970410015587; DeMar J, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00059; EDHOUSE WV, 1988, ANIM LEARN BEHAV, V16, P461, DOI 10.3758/BF03209387; Edwards S, 2013, BEHAV PHARMACOL, V24, P356, DOI 10.1097/FBP.0b013e3283644d15; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Enomoto T, 2011, BIOL PSYCHIAT, V69, P432, DOI 10.1016/j.biopsych.2010.09.038; Fann JR, 2004, ARCH GEN PSYCHIAT, V61, P53, DOI 10.1001/archpsyc.61.1.53; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fischer H, 2010, US MILITARY CASUALTY; Fleminger S, 2005, BRIT MED J, V331, P1419, DOI 10.1136/bmj.331.7530.1419; Floresco SB, 2008, BEHAV BRAIN RES, V190, P85, DOI 10.1016/j.bbr.2008.02.008; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; George SA, 2015, BEHAV BRAIN RES, V286, P256, DOI 10.1016/j.bbr.2015.02.051; Ghods-Sharifi S, 2008, NEUROBIOL LEARN MEM, V89, P567, DOI 10.1016/j.nlm.2007.10.007; Goldstein RZ, 2011, NAT REV NEUROSCI, V12, P652, DOI 10.1038/nrn3119; Gourley SL, 2016, NAT NEUROSCI, V19, P656, DOI 10.1038/nn.4275; Hahn RA, 1997, PREV MED, V26, P607, DOI 10.1006/pmed.1996.0124; Hall RCW, 2005, PSYCHOSOMATICS, V46, P195, DOI 10.1176/appi.psy.46.3.195; Hannan AJ, 2014, NEUROPATH APPL NEURO, V40, P13, DOI 10.1111/nan.12102; Ikegami A, 2007, BEHAV NEUROSCI, V121, P389, DOI 10.1037/0735-7044.121.2.389; Izquierdo A, 2017, NEUROSCIENCE, V345, P12, DOI 10.1016/j.neuroscience.2016.03.021; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kesner RP, 2011, NEUROBIOL LEARN MEM, V96, P417, DOI 10.1016/j.nlm.2011.07.002; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus J. F., 1994, TXB TRAUMATIC BRAIN, P3; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Lim YW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125130; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McQuail JA, 2016, J NEUROSCI, V36, P12537, DOI 10.1523/JNEUROSCI.2332-16.2016; Merkel SF, 2017, J NEUROTRAUM, V34, P165, DOI 10.1089/neu.2015.4275; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Muelbl MJ, 2016, PSYCHOPHARMACOLOGY, V233, P2799, DOI 10.1007/s00213-016-4323-9; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Neipert L, 2014, BRAIN INJURY, V28, P1667, DOI 10.3109/02699052.2014.947623; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Noel X, 2013, CURR OPIN NEUROBIOL, V23, P632, DOI 10.1016/j.conb.2013.01.018; Olsen CM, 2006, BRAIN RES, V1075, P229, DOI 10.1016/j.brainres.2006.01.003; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Pagulayan KF, 2018, J INT NEUROPSYCH SOC, V24, P324, DOI 10.1017/S1355617717001217; Perez-Garcia G, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00176; Perry JL, 2011, BRAIN RES REV, V65, P124, DOI 10.1016/j.brainresrev.2010.09.001; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Sajja VSSS, 2014, MOL CELL NEUROSCI, V59, P119, DOI 10.1016/j.mcn.2014.02.004; Seamans JK, 2008, NEUROTOX RES, V14, P249, DOI 10.1007/BF03033814; Shah Ms Alok S, 2012, Biomed Sci Instrum, V48, P393; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Sloan HL, 2006, BEHAV BRAIN RES, V171, P116, DOI 10.1016/j.bbr.2006.03.030; Sofuoglu M, 2016, J DUAL DIAGN, V12, P90, DOI 10.1080/15504263.2016.1146383; Stemper BD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00031; Suhr JA, 2002, J CLIN EXP NEUROPSYC, V24, P448, DOI 10.1076/jcen.24.4.448.1039; Tanielian T, 2008, MG720CCF RAND CORP; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomsen Morgane, 2005, Curr Protoc Neurosci, VChapter 9, DOI 10.1002/0471142301.ns0920s32; Toklu HZ, 2018, BEHAV BRAIN RES, V340, P14, DOI 10.1016/j.bbr.2017.04.025; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vonder Haar C, 2014, BRAIN INJURY, V28, P235, DOI 10.3109/02699052.2013.860473; Wang Y, 2017, J NEUROTRAUM, V34, P952, DOI 10.1089/neu.2016.4465; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; West SL, 2011, NEUROREHABILITATION, V29, P1, DOI 10.3233/NRE-2011-0671; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; White KG, 2004, J EXP PSYCHOL-ANIM B, V30, P83, DOI 10.1037/0097-7403.30.2.83	105	18	20	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 2	2018	8								9941	10.1038/s41598-018-28062-0			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL2MB	WOS:000436954400008	29967344	Green Published, gold			2022-02-06	
J	Abdul-Muneer, PM; Bhowmick, S; Briski, N				Abdul-Muneer, P. M.; Bhowmick, Saurav; Briski, Nicholas			Angiotensin II Causes Neuronal Damage in Stretch-Injured Neurons: Protective Effects of Losartan, an Angiotensin T-1 Receptor Blocker	MOLECULAR NEUROBIOLOGY			English	Article						Angiotensin II; AngT(1)R; Losartan; Oxidative stress; Neuroinflammation; Cell death	TRAUMATIC BRAIN-INJURY; ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; OXIDATIVE STRESS; TYPE-1 RECEPTOR; AT(1) RECEPTOR; HYPOTHALAMIC NEURONS; BARRIER PERMEABILITY; CARDIAC-HYPERTROPHY; OXIDASE ACTIVATION	Angiotensin II (Ang II) is a mediator of oxidative stress via activation/induction of reactive oxygen and nitrogen species-generating enzymes, NADPH oxidase (NOX) and inducible nitric oxide synthase (iNOS). We investigated the hypothesis that overproduction of Ang II during traumatic brain injury (TBI) induces the activation of the oxidative stress, which triggers neuroinflammation and cell apoptosis in a cell culture model of neuronal stretch injury. We first established that stretch injury causes a rapid increase in the level of Ang II, which causes the release of pro-inflammatory cytokines, IL-1 beta and TNF-alpha, via the induction of oxidative stress. Since angiotensin-converting enzyme (ACE) mediates the production of Ang II via the conversion of Ang I into Ang II, we analyzed the expression of ACE by western blotting. Further, we analyzed caspase-3-mediated apoptosis by TUNEL staining and annexin V western blotting. Angiotensin type I (AT(1)) receptor antagonist losartan attenuated Ang II-induced oxidative stress and associated neuroinflammation and cell death in cultured neurons. Remarkably, we noticed that the expression of Ang II type 1 receptor (AngT(1)R) upregulated in neuronal stretch injury; losartan mitigates this upregulation. Findings from this study significantly extend our understanding of the pathophysiology of TBI and may have significant implications for developing therapeutic strategies for TBI-associated brain dysfunctions.	[Abdul-Muneer, P. M.; Bhowmick, Saurav; Briski, Nicholas] JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA		Abdul-Muneer, PM (corresponding author), JFK Med Ctr, Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA.	mmuneer@jfkhealth.org	Bhowmick, Saurav/Y-6011-2019	Abdul-Muneer, P. M/0000-0001-8231-4385; Briski, Nicholas/0000-0003-0778-9019	Neuroscience Institute at JFK Medical Center, Edison, NJ	This work was funded by the Neuroscience Institute at JFK Medical Center, Edison, NJ to P.M. Abdul-Muneer.	Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Basso N, 2001, HYPERTENSION, V38, P1246, DOI 10.1161/hy1201.101214; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Benigni A, 2010, EMBO MOL MED, V2, P247, DOI 10.1002/emmm.201000080; Burnier M, 2000, LANCET, V355, P637, DOI 10.1016/S0140-6736(99)10365-9; Chen J, 2015, NEUROSCIENCE, V305, P117, DOI 10.1016/j.neuroscience.2015.07.076; Crowley SD, 2006, P NATL ACAD SCI USA, V103, P17985, DOI 10.1073/pnas.0605545103; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P281, DOI 10.1089/ars.2012.4918; El Bekay R, 2003, BLOOD, V102, P662, DOI 10.1182/blood-2002-09-2785; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleegal-DeMotta MA, 2009, J CEREBR BLOOD F MET, V29, P640, DOI 10.1038/jcbfm.2008.158; FYHRQUIST F, 1995, J HUM HYPERTENS, V9, pS19; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Guo DF, 2001, CELL RES, V11, P165, DOI 10.1038/sj.cr.7290083; Guo F, 2011, J INTERF CYTOK RES, V31, P351, DOI 10.1089/jir.2010.0073; Ha YW, 2016, METAL IONS LIFE SCI, V16, P585, DOI 10.1007/978-3-319-21756-7_16; Hans VHJ, 1999, NEUROREPORT, V10, P409; Hirooka Y, 2006, HYPERTENS RES, V29, P49, DOI 10.1291/hypres.29.49; Ito H, 2001, J HYPERTENS, V19, P591, DOI 10.1097/00004872-200103001-00011; Kalra D, 2002, CIRCULATION, V105, P2198, DOI 10.1161/01.CIR.0000015603.84788.47; Kario K, 1998, J AM COLL CARDIOL, V32, P444, DOI 10.1016/S0735-1097(98)00251-4; Kim-Mitsuyama S, 2005, STROKE, V36, P1077, DOI 10.1161/01.STR.0000163084.16505.e3; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Landmesser U, 2007, ARTERIOSCL THROM VAS, V27, P943, DOI 10.1161/01.ATV.0000258415.32883.bf; Lin YJ, 2014, BIOCHEM BIOPH RES CO, V451, P263, DOI 10.1016/j.bbrc.2014.07.119; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marques-Lopes J, 2015, SYNAPSE, V69, P148, DOI 10.1002/syn.21800; Matsumoto E, 2013, GENES CELLS, V18, P544, DOI 10.1111/gtc.12055; Mitra AK, 2010, AM J PHYSIOL-CELL PH, V299, pC561, DOI 10.1152/ajpcell.00127.2010; Mollnau H, 2002, CIRC RES, V90, pE58, DOI 10.1161/01.RES.0000012569.55432.02; Ongali B, 2014, NEUROBIOL DIS, V68, P126, DOI 10.1016/j.nbd.2014.04.018; Orfanos SE, 1999, CIRCULATION, V99, P1593, DOI 10.1161/01.CIR.99.12.1593; Oudit GY, 2007, CARDIOVASC RES, V75, P29, DOI 10.1016/j.cardiores.2007.04.007; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Rajagopalan S, 1996, J CLIN INVEST, V97, P1916, DOI 10.1172/JCI118623; Rueckschloss U, 2002, ARTERIOSCL THROM VAS, V22, P1845, DOI 10.1161/01.ATV.0000035392.38687.65; Sadoshima J, 2002, CIRC RES, V90, P754, DOI 10.1161/01.RES.0000016843.82450.8C; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Sauter NS, 2015, DIABETES, V64, P1273, DOI 10.2337/db14-1282; Shohami E, 1996, J CEREBR BLOOD F MET, V16, P378, DOI 10.1097/00004647-199605000-00004; SIEGL PKS, 1995, J HYPERTENS, V13, pS15, DOI 10.1097/00004872-199507001-00002; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soares HD, 1995, J NEUROSCI, V15, P8223; Sriramula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138372; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Wang HD, 2001, CIRC RES, V88, P947, DOI 10.1161/hh0901.089987; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiao L, 2013, AM J PHYSIOL-CELL PH, V304, pC1073, DOI 10.1152/ajpcell.00364.2012; Xu JA, 2010, AM J PHYSIOL-HEART C, V299, pH1328, DOI 10.1152/ajpheart.00538.2010; Xu SQ, 2011, BIOCHEM BIOPH RES CO, V410, P543, DOI 10.1016/j.bbrc.2011.06.021; Xu Y, 2007, MOL PHARMACOL, V72, P112, DOI 10.1124/mol.106.033761; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zhang M, 2010, NEUROSCIENCE, V171, P852, DOI 10.1016/j.neuroscience.2010.09.029	67	18	18	1	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2018	55	7					5901	5912		10.1007/s12035-017-0812-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI8VY	WOS:000434805100036	29119534				2022-02-06	
J	Bishop, SA; Neary, JP				Bishop, Scott A.; Neary, J. Patrick			Assessing prefrontal cortex oxygenation after sport concussion with near-infrared spectroscopy	CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING			English	Article						concussion; hypercapnia; near-infrared spectroscopy; pathophysiology	TEST-RETEST RELIABILITY; TRAUMATIC BRAIN-INJURY; CEREBRAL AUTOREGULATION; APPROXIMATE ENTROPY; SYMPTOM VALIDITY; HEART-RATE; REACTIVITY; MANAGEMENT; PERFORMANCE; COMPLEXITY	BackgroundClinicians typically rely on neuropsychological and balance tests to track concussion recovery. The aforementioned tests imply impairments that are based on performance, but these tests do not directly measure brain physiology throughout concussion recovery. Because of these issues, an objective biomarker that can index severity and the recovery timeline is needed. Moreover, the number of concussions occurring at a recreational level requires the biomarker to be easily administered in a cost effective manner, and the results easily interpreted. MethodsTo address these issues, near-infrared spectroscopy was used to assess the relative changes in oxy (HbO(2))- and deoxyhaemoglobin and the associated standard deviations (SD) in the prefrontal cortex. Resting haemoglobin, and haemoglobin changes in response to hypercapnia (five repeated 20s breath holds), was measured in all participants. Data were aggregated into healthy baselines (n=115), and concussed participants on days 1-3 (n=14), 4-6 (n=8), and 7-14 (n=11). The data were statistically compared using a 1x4 ANOVA. ResultsResting HbO(2) values progressively lowered from days 1-3 to 7-14 (with no differences compared to controls). The second major finding showed that hypercapnic HbO(2) SD was significantly lower than resting values on days 1-3 and 4-6, but reversed back towards the healthy control group on day 7-14. ConclusionMonitoring cerebral oxygenation changes is a viable biomarker to assess the physiological state of the brain following concussion.	[Bishop, Scott A.; Neary, J. Patrick] Univ Regina, Fac Kinesiol & Hlth Studies, 3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada		Neary, JP (corresponding author), Univ Regina, Fac Kinesiol & Hlth Studies, 3737 Wascana Pkwy, Regina, SK S4S 0A2, Canada.	patrick.neary@uregina.ca		Neary, J. Patrick/0000-0003-2480-8031	Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Saskatchewan Health Research Foundation (SHRF)	We wish to acknowledge all the volunteer subjects, who participated in this study, their dedication and time involved is greatly appreciated. We also wish to acknowledge the financial contribution from research grants provided by the Canadian Institutes of Health Research (CIHR) and the Saskatchewan Health Research Foundation (SHRF). Finally, we would like to acknowledge Drs Goodman, Bjornson, Bhambhani and Asmundsen for their contributions during the inception of this mild brain injury research programme.	[Anonymous], 2004, Paediatr Child Health, V9, P99; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2012, NEUROSCI LETT, V509, P1, DOI 10.1016/j.neulet.2011.12.009; Bishop S, 2017, BRAIN INJURY, P1; Bishop S.A., 2015, CURR RES CONCUSSION, V2, P49; Blake T, 2015, BRIT J SPORT MED, V48, P569; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Cerutti S, 2009, PHILOS T R SOC A, V367, P1337, DOI 10.1098/rsta.2008.0267; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Coveney PV, 2003, PHILOS T R SOC A, V361, P1057, DOI 10.1098/rsta.2003.1191; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Czosnyka M, 2001, J NEUROSURG, V95, P756, DOI 10.3171/jns.2001.95.5.0756; Dean PJA, 2012, BRAIN INJURY, V26, P14, DOI 10.3109/02699052.2011.635354; Duncan A, 1996, PEDIATR RES, V39, P889, DOI 10.1203/00006450-199605000-00025; Eckner JT, 2010, CURR SPORT MED REP, V9, P8, DOI 10.1249/JSR.0b013e3181caa778; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Field A., 2017, DISCOVERING STAT USI, V5th; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Fox DD, 2011, CLIN NEUROPSYCHOL, V25, P488, DOI 10.1080/13854046.2011.554443; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Huppert TJ, 2006, NEUROIMAGE, V29, P368, DOI 10.1016/j.neuroimage.2005.08.065; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Kennedy DO, 2011, BIOL PSYCHOL, V86, P298, DOI 10.1016/j.biopsycho.2010.12.010; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kontos AP, 2014, BRAIN IMAGING BEHAV, V8, P621, DOI 10.1007/s11682-014-9289-9; La Fountaine MF, 2009, AUTON NEUROSCI-BASIC, V148, P101, DOI 10.1016/j.autneu.2009.03.001; Lang EW, 2003, CRIT CARE MED, V31, P267, DOI 10.1097/00003246-200301000-00042; Lee JK, 2009, STROKE, V40, P1820, DOI 10.1161/STROKEAHA.108.536094; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Len TK, 2013, BRAIN INJURY, V27, P346, DOI 10.3109/02699052.2012.743185; Len TK, 2011, MED SCI SPORT EXER, V43, P2241, DOI 10.1249/MSS.0b013e3182249539; Lovallo William R., 2005, STRESS HLTH BIOL PSY; MacIntosh BJ, 2003, NEUROIMAGE, V20, P1246, DOI 10.1016/S1053-8119(03)00417-8; McCrory P, 2009, PHYSICIAN SPORTSMED, V37, P141, DOI 10.3810/psm.2009.06.1721; Meier TB, 2015, JAMA NEUROL, V87106, P1; Militana AR, 2015, BRAIN IMAGING BEHAV, V1, P1; Molinari F, 2006, J NEUROENG REHABIL, V3, P1; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Mutch WAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102181; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Onate JA, 2007, J ATHL TRAINING, V42, P446; Panerai RB, 2009, PHILOS T R SOC A, V367, P1319, DOI 10.1098/rsta.2008.0264; Papaioannou V, 2008, J CRIT CARE, V23, P380, DOI 10.1016/j.jcrc.2007.04.006; Park E, 2009, J CEREBR BLOOD F MET, V29, P575, DOI 10.1038/jcbfm.2008.151; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Randolph C, 2005, J ATHL TRAINING, V40, P139; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Resch JE, 2013, NEUROPSYCHOL REV, V23, P335, DOI 10.1007/s11065-013-9242-5; Resch JE, 2013, CLIN NEUROPSYCHOL, V27, P1265, DOI 10.1080/13854046.2013.845247; Ryan ML, 2011, ANESTHESIOL RES PRAC, V2011, DOI 10.1155/2011/416590; Sakagami M, 2006, NEURAL NETWORKS, V19, P1255, DOI 10.1016/j.neunet.2006.05.040; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Slobounov SM, 2011, NEUROIMAGE, V55, P1716, DOI 10.1016/j.neuroimage.2011.01.024; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Starling A. J., 2015, CONCUSSION, V1, P1; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Susco TM, 2004, J ATHL TRAINING, V39, P241; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Taylor AG, 2010, EXPLORE-NY, V6, P29, DOI 10.1016/j.explore.2009.10.004; Thayer JF, 2012, NEUROSCI BIOBEHAV R, V36, P747, DOI 10.1016/j.neubiorev.2011.11.009; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Vernieri F, 2004, STROKE, V35, P64, DOI 10.1161/01.STR.0000106486.26626.E2; Wilkins JC, 2004, J ATHL TRAINING, V39, P156; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wishart DS, 2006, NUCLEIC ACIDS RES, V34, pD668, DOI 10.1093/nar/gkj067; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	86	18	18	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1475-0961	1475-097X		CLIN PHYSIOL FUNCT I	Clin. Physiol. Funct. Imaging	JUL	2018	38	4					573	585		10.1111/cpf.12447			13	Physiology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Physiology	GJ0RJ	WOS:000434961600006	28626873	Green Published			2022-02-06	
J	Zeiler, FA; Donnelly, J; Nourallah, B; Thelin, EP; Calviello, L; Smielewski, P; Czosnyka, M; Ercole, A; Menon, DK				Zeiler, Frederick A.; Donnelly, Joseph; Nourallah, Basil; Thelin, Eric P.; Calviello, Leanne; Smielewski, Peter; Czosnyka, Marek; Ercole, Ari; Menon, David K.			Intracranial and Extracranial Injury Burden as Drivers of Impaired Cerebrovascular Reactivity in Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						biomarkers; dysautoregulation; imaging; injury burden; TBI	PRESSURE; AUTOREGULATION; SEVERITY	Impaired cerebrovascular reactivity has been associated with outcome following traumatic brain injury (TBI), but it is unknown how it is affected by trauma severity. Thus, we aimed to explore the relationship between intracranial (IC) and extracranial (EC) injury burden and cerebrovascular reactivity in TBI patients. We retrospectively included critically ill TBI patients. IC injury burden included detailed lesion and computerized tomography (CT) scoring (i.e., Marshall, Rotterdam, Helsinki, and Stockholm Scores) on admission. EC injury burden was characterized using the injury severity score (ISS) and the Acute Physiology and Chronic Health Evaluation II (APACHE II) score. Pressure reactivity index (PRx), pulse amplitude index (PAx), and RAC were used to assess autoregulation/cerebrovascular reactivity. We used univariate and multi-variate logistic regression techniques to explore relationships between IC and EC injury burden and autoregulation indices. A total of 358 patients were assessed. ISS and all IC CT scoring systems were poor predictors of impaired cerebrovascular reactivity. Only subdural hematomas and thickness of subarachnoid hemorrhage (SAH; p < 0.05, respectively) were consistently associated with dysfunctional cerebrovascular reactivity. High age (p < 0.01 for all) and admission APACHE II scores (p < 0.05 for all) were the two variables most strongly associated with abnormal cerebrovascular reactivity. In summary, diffuse IC injury markers (thickness of SAH and the presence of a subdural hematoma) and APACHE II were most associated with dysfunction in cerebrovascular reactivity after TBI. Standard CT scoring systems and evidence of macroscopic parenchymal damage are poor predictors, implicating potentially both microscopic injury patterns and host response as drivers of dysfunctional cerebrovascular reactivity. Age remains a major variable associated with cerebrovascular reactivity.	[Zeiler, Frederick A.; Nourallah, Basil; Ercole, Ari; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Cambridge, England; [Donnelly, Joseph; Calviello, Leanne; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Cambridge, England; [Thelin, Eric P.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Clinician Investigator Program, Winnipeg, MB, Canada; [Thelin, Eric P.] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Dept Surg, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca	Donnelly, Joseph/N-6803-2019; Thelin, Eric Peter/K-2144-2012; Donnelly, Joseph/E-9235-2018; Ercole, Ari/B-6288-2009	Donnelly, Joseph/0000-0002-6502-8069; Thelin, Eric Peter/0000-0002-2338-4364; Donnelly, Joseph/0000-0002-6502-8069; Ercole, Ari/0000-0001-8350-8093; czosnyka, marek/0000-0003-2446-8006; Zeiler, Frederick/0000-0003-1737-0510	Cambridge Commonwealth Trust Scholarship; Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery; University of Manitoba Clinician Investigator Program; R. Samuel McLaughlin Research and Education Award; Manitoba Medical Service Foundation; University of Manitoba Faculty of Medicine Dean's Fellowship Fund; Woolf Fisher Scholarship (New Zealand); National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award; National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Research Professorship; European Union Framework Program 7 grant (CENTER-TBI) [602150]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	This work was made possible through salary support through the Cambridge Commonwealth Trust Scholarship, the Royal College of Surgeons of Canada-Harry S. Morton Travelling Fellowship in Surgery, the University of Manitoba Clinician Investigator Program, R. Samuel McLaughlin Research and Education Award, the Manitoba Medical Service Foundation, and the University of Manitoba Faculty of Medicine Dean's Fellowship Fund.; JD is supported by a Woolf Fisher Scholarship (New Zealand).; These studies were supported by National Institute for Healthcare Research (NIHR, UK) through the Acute Brain Injury and Repair theme of the Cambridge NIHR Biomedical Research Centre, an NIHR Senior Investigator Award to DKM, and an NIHR Research Professorship to PJAH. Authors were also supported by a European Union Framework Program 7 grant (CENTER-TBI; Grant Agreement No. 602150)	Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2014, NEUROCRIT CARE, V21, P95, DOI 10.1007/s12028-014-0046-0; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lazaridis C, 2012, NEUROCRIT CARE, V16, P478, DOI 10.1007/s12028-012-9685-1; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zeiler F.A., 2017, J NEUROTRAUMA; Zeiler F.A., 2018, J NEUROTRAUMA; Zeiler FA, 2017, J NEUROTRAUM, V34, P3207, DOI 10.1089/neu.2017.5085	21	18	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1569	1577		10.1089/neu.2017.5595			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000436548100002	29431051	Green Submitted			2022-02-06	
J	Hogan, SR; Phan, JH; Alvarado-Velez, M; Wang, MD; Bellamkonda, RV; Fernandez, FM; LaPlaca, MC				Hogan, Scott R.; Phan, John H.; Alvarado-Velez, Melissa; Wang, May Dongmei; Bellamkonda, Ravi V.; Fernandez, Facundo M.; LaPlaca, Michelle C.			Discovery of Lipidome Alterations Following Traumatic Brain Injury via High-Resolution Metabolomics	JOURNAL OF PROTEOME RESEARCH			English	Article						biomarkers; traumatic brain injury; lipidomics; mass spectrometry; animal model	MITOCHONDRIAL OXIDATIVE DAMAGE; FREE FATTY-ACIDS; MASS-SPECTROMETRY; ARACHIDONIC-ACID; CEREBROSPINAL-FLUID; TIME-COURSE; RAT-BRAIN; MOUSE MODEL; BIOMARKERS; BLOOD	Traumatic brain injury (TBI) can occur across wide segments of the population, presenting in a heterogeneous manner that makes diagnosis inconsistent and management challenging. Biomarkers offer the potential to objectively relative concentrations of endogenous molecules in readily identify injury status, severity, and phenotype by measuring the accessible biofluids. Through a data-driven, discovery approach, novel biomarker candidates for TBI were identified in the serum lipidome of adult male Sprague-Dawley rats in the first week following moderate controlled cortical impact (CCI). Serum samples were analyzed in positive and negative modes by ultraperformance liquid chromatography-mass spectrometry (UPLC-MS). A predictive panel for the classification of injured and uninjured sera samples, consisting of 26 dysregulated species belonging to a variety of lipid classes, was developed with a cross-validated accuracy of 85.3% using omniClassifier software to optimize feature selection. Polyunsaturated fatty acids (PUFAs) and PUFA-containing diacylglycerols were found to be upregulated in sera from injured rats, while changes in sphingolipids and other membrane phospholipids were also observed, many of which map to known secondary injury pathways. Overall, the identified biomarker panel offers viable molecular candidates representing lipids that may readily cross the blood-brain barrier (BBB) and aid in the understanding of TBI pathophysiology.	[Hogan, Scott R.; Fernandez, Facundo M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Phan, John H.; Alvarado-Velez, Melissa; Wang, May Dongmei; Bellamkonda, Ravi V.; LaPlaca, Michelle C.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Alvarado-Velez, Melissa; Bellamkonda, Ravi V.] Duke Univ, Pratt Sch Engn, Dept Biomed Engn, Fitzpatrick CIEMAS, Room 1427,101 Sci Dr,Campus Box 90281, Durham, NC 27708 USA		Fernandez, FM (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; LaPlaca, MC (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	facundo.fernandez@chemistry.gatech.edu; michelle.laplaca@bme.gatech.edu	Fernandez, Facundo/B-7015-2008; Wang, May Dongmei/AAF-2065-2021	Fernandez, Facundo/0000-0002-0302-2534; Wang, May Dongmei/0000-0003-3961-3608	National Institutes of Health (GT BioMAT Training Grant)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32EB006343-05, R01NS079739, R21NS091832, R01NS101909-01]; Vasser-Wooley endowed funds; Parker H. Petit Institute for Bioengineering & Bioscience (GT); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [T32EB006343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS101029, R21NS091832] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (GT BioMAT Training Grant Nos. T32EB006343-05, to S.R.H., R01NS079739 to R.V.B. and M.C.L., R21NS091832 to M.C.L., and R01NS101909-01 to F.M.F. and M.C.L.), Vasser-Wooley endowed funds to F.M.F., and Parker H. Petit Institute for Bioengineering & Bioscience (GT). We gratefully acknowledge access to instrumentation from the Center for Chemical Evolution at Georgia Tech.	Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adibhatla RM, 2007, FUTURE LIPIDOL, V2, P403, DOI 10.2217/17460875.2.4.403; Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Anthonymuthu TS, 2016, BRAIN RES, V1640, P57, DOI 10.1016/j.brainres.2016.02.006; BANERJEE RK, 1966, MOL PHARMACOL, V2, P56; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayir H, 2007, ANN NEUROL, V62, P154, DOI 10.1002/ana.21168; Betancur MI, 2017, ACS BIOMATER SCI ENG, V3, P420, DOI 10.1021/acsbiomaterials.6b00805; Blache D, 1996, J LIPID MEDIAT CELL, V13, P127, DOI 10.1016/0929-7855(95)00056-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boccard J, 2013, ANAL CHIM ACTA, V769, P30, DOI 10.1016/j.aca.2013.01.022; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; da Silva TF, 2012, BBA-MOL BASIS DIS, V1822, P1501, DOI 10.1016/j.bbadis.2012.05.014; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Dayson H., 1993, INTRO BLOOD BRAIN BA; Ding Chris, 2005, Journal of Bioinformatics and Computational Biology, V3, P185, DOI 10.1142/S0219720005001004; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, 2010, TRAUMATIC BRAIN INJU; FOLCH J, 1957, J BIOL CHEM, V226, P497; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gutowski SM, 2015, BIOMATERIALS, V44, P55, DOI 10.1016/j.biomaterials.2014.12.009; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; Hainard A, 2013, TRANSLANT PROTEOMICS, V1, P57, DOI [10.1016/J.TRPROT.2013.04.003, DOI 10.1016/J.TRPROT.2013.04.003, 10.1016/j.trprot.2013.04.003]; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Hill RL, 2017, NEUROCHEM INT, V111, P45, DOI 10.1016/j.neuint.2017.03.015; Homayoun P, 2000, NEUROCHEM RES, V25, P269, DOI 10.1023/A:1007583806138; Homayoun P, 1997, J NEUROCHEM, V69, P199; Iannaccone PM, 2009, DIS MODEL MECH, V2, P206, DOI 10.1242/dmm.002733; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Ivanova PT, 2009, CURR OPIN CHEM BIOL, V13, P526, DOI 10.1016/j.cbpa.2009.08.011; JANERO DR, 1990, FREE RADICAL BIO MED, V9, P515, DOI 10.1016/0891-5849(90)90131-2; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Kay AD, 2003, J NEUROTRAUM, V20, P717, DOI 10.1089/089771503767869953; Kimball BA, 2016, CHEM SENSES, V41, P407, DOI 10.1093/chemse/bjw014; Kliman M, 2011, BBA-MOL CELL BIOL L, V1811, P935, DOI 10.1016/j.bbalip.2011.05.016; Kobeissy F. H, 2015, BRAIN NEUROTRAUMA MO; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levine JS, 2002, NEW ENGL J MED, V346, P752, DOI 10.1056/NEJMra002974; Licastro F, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00189; Lippi G, 2012, SEMIN THROMB HEMOST, V38, P565, DOI 10.1055/s-0032-1315961; MARINETTI GV, 1958, J BIOL CHEM, V233, P562; May JC, 2016, ANNU REV ANAL CHEM, V9, P387, DOI 10.1146/annurev-anchem-071015-041734; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McIntosh TK, 1998, NEUROPATH APPL NEURO, V24, P251; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2014, MED RES REV, V34, P503, DOI 10.1002/med.21295; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.bi.55.070186.000441; Osier N, 2016, METHODS MOL BIOL, V1462, P177, DOI 10.1007/978-1-4939-3816-2_11; Pardridge William M, 2005, NeuroRx, V2, P3; Parent BA, 2016, JAMA SURG, V151, DOI 10.1001/jamasurg.2016.0853; Parry RM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S7; Pasvogel AE, 2008, BIOL RES NURS, V10, P113, DOI 10.1177/1099800408323218; Pasvogel AE, 2010, BIOL RES NURS, V11, P325, DOI 10.1177/1099800409346056; Phan John H, 2014, ACM BCB, V2014, P514; Pilitsis JG, 2003, NEUROSCI LETT, V349, P136, DOI 10.1016/S0304-3940(03)00803-6; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Pitkanen A, 2006, MODELS OF SEIZURES AND EPILEPSY, P1; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Romisch-Margl W, 2012, METABOLOMICS, V8, P133, DOI 10.1007/s11306-011-0293-4; Roux A, 2016, J NEUROSCI METH, V272, P19, DOI 10.1016/j.jneumeth.2016.02.004; Sarafian MH, 2014, ANAL CHEM, V86, P5766, DOI 10.1021/ac500317c; Schiess R, 2009, MOL ONCOL, V3, P33, DOI 10.1016/j.molonc.2008.12.001; Schofield M, 1998, CHEM PHYS LIPIDS, V95, P23, DOI 10.1016/S0009-3084(98)00065-6; Semmes OJ, 2004, CANCER EPIDEM BIOMAR, V13, P1555; Sharp MK, 1998, ANN BIOMED ENG, V26, P788, DOI 10.1114/1.65; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; SHOHAMI E, 1989, J NEUROCHEM, V53, P1541, DOI 10.1111/j.1471-4159.1989.tb08550.x; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39; Soares HD, 1995, J NEUROSCI, V15, P8223; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Tang X, 2006, AM J PHYSIOL-HEART C, V290, pH37, DOI 10.1152/ajpheart.00491.2005; Thomale UW, 2002, ACTA NEUROCHIR SUPPL, V81, P229; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; WIELOCH T, 1982, PATHOL BIOL, V30, P269; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Zalewski A, 2006, CLIN CHEM, V52, P1645, DOI 10.1373/clinchem.2006.070672; Zhang ZQ, 2010, METHODS MOL BIOL, V662, P317, DOI 10.1007/978-1-60761-800-3_16; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	98	18	18	1	24	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1535-3893	1535-3907		J PROTEOME RES	J. Proteome Res.	JUN	2018	17	6					2131	2143		10.1021/acs.jproteome.8b00068			13	Biochemical Research Methods	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI4UT	WOS:000434367400013	29671324	Green Accepted			2022-02-06	
J	Meymandi, MS; Soltani, Z; Sepehri, G; Amiresmaili, S; Farahani, F; Aghtaei, MM				Meymandi, Manzumeh Shamsi; Soltani, Zahra; Sepehri, Gholamreza; Amiresmaili, Sedigheh; Farahani, Fatemeh; Aghtaei, Mohammadmehdi Moeini			Effects of pregabalin on brain edema, neurologic and histologic outcomes in experimental traumatic brain injury	BRAIN RESEARCH BULLETIN			English	Article						Pregabalin; Traumatic brain injury; Brain edema; Neurological outcome; Intracranial pressure	SPINAL-CORD-INJURY; SEX STEROID-HORMONES; INTRACRANIAL-PRESSURE; THERAPEUTIC TARGET; HEAD-INJURY; GABAPENTIN; RATS; PROGESTERONE; ISCHEMIA; BARRIER	Brain edema and increased intracranial pressure (ICP) are among the main causes of neurological disturbance and mortality following traumatic brain injury (TBI). Since pregabalin neuroprotective effects have been shown, this study was performed to evaluate the possible neuroprotective effects of pregabalin in experimental TBI of male rats. Adult male Wistar rats were divided into 4 groups: sham, vehicle, pregabalin 30 mg/kg and pregabalin 60 mg/kg. TBI was induced in vehicle and pregabalin groups by Marmarou method. Pregabalin was administered 30 min after TBI. Sham and vehicle groups received saline. Brain water and Evans blue content and histopathological changes were evaluated 24, 5 and 24 h after TBI, respectively. The ICP and neurological outcomes (veterinary coma scale, VCS) were recorded before, 1 h and 24 h post TBI. The results showed a significant reduction in brain water content and ICP, and a significant increase in VCS of pregabalin group (60 mg/kg) as compared to vehicle group (P < 0.05). Also, pregabalin reduced brain edema and apoptosis score as compared to vehicle group. Post TBI pregabalin administration revealed a delayed but significant improvement in ICP and neurological outcomes in experimental TBI. The underlying mechanism(s) was not determined and needs further investigation.	[Meymandi, Manzumeh Shamsi; Sepehri, Gholamreza] Kerman Univ Med Sci, Neurosci Res Ctr, Neuropharmacol Inst, Kerman, Iran; [Soltani, Zahra] Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran; [Amiresmaili, Sedigheh] Barn Univ Med Sci, Bam, Iran; [Soltani, Zahra; Farahani, Fatemeh] Kerman Univ Med Sci, Kerman Med Sch, Physiol & Pharmacol Dept, Kerman, Iran; [Meymandi, Manzumeh Shamsi; Aghtaei, Mohammadmehdi Moeini] Kerman Univ Med Sci, Stem Cell Res Ctr, Kerman Sch Med, Kerman, Iran		Soltani, Z (corresponding author), Kerman Univ Med Sci, Endocrinol & Metab Res Ctr, Inst Basic & Clin Physiol Sci, Kerman, Iran.	z.soltani@kmu.ac.ir	Soltani, Zahra/AAC-1350-2019; Sepehri, Gholamreza/AAZ-2101-2020; Meymandi, Manzumeh Shamsi/AAD-3763-2020; Sepehri, Gholamreza/AAC-9522-2019; Sheikholeslami-Farahani, Fatemeh/AAN-6125-2021	Soltani, Zahra/0000-0002-8423-6189; Sepehri, Gholamreza/0000-0001-7999-9934; Shamsi Meymandi, Manzumeh/0000-0002-4011-7364			Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Andre V, 2003, EPILEPSIA, V44, P893, DOI 10.1046/j.1528-1157.2003.61802.x; Asci S, 2016, BALK MED J, V33, P221, DOI 10.5152/balkanmedj.2015.15742; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Calabresi P, 2003, EXP NEUROL, V182, P461, DOI 10.1016/S0014-4886(03)00117-1; Calikoglu C, 2015, MED SCI MONITOR, V21; Celik M, 2015, INT J NEUROSCI, V125, P845, DOI 10.3109/00207454.2014.978976; Dehghan F, 2013, ARCH MED RES, V44, P251, DOI 10.1016/j.arcmed.2013.04.002; Field MJ, 1997, BRIT J PHARMACOL, V121, P1513, DOI 10.1038/sj.bjp.0701320; Gajraj NM, 2007, ANESTH ANALG, V105, P1805, DOI 10.1213/01.ane.0000287643.13410.5e; Gruenthal M, 1997, SPINAL CORD, V35, P686, DOI 10.1038/sj.sc.3100481; Ha KY, 2008, EUR SPINE J, V17, P864, DOI 10.1007/s00586-008-0653-6; Ha KY, 2011, J KOREAN MED SCI, V26, P404, DOI 10.3346/jkms.2011.26.3.404; Italiano D, 2013, CLIN PHARMACOKINET, V52, P627, DOI 10.1007/s40262-013-0067-4; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Khaksari M, 2013, IRAN J BASIC MED SCI, V16, P858; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; Kim YK, 2010, KOREAN J ANESTHESIOL, V58, P184, DOI 10.4097/kjae.2010.58.2.184; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kinoshita K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0138-3; Knotkova H, 2007, MED CLIN N AM, V91, P113, DOI 10.1016/j.mcna.2006.10.007; KONTOS HA, 1989, CHEM-BIOL INTERACT, V72, P229, DOI 10.1016/0009-2797(89)90001-X; Kusaka G, 2004, J NEUROSCI METH, V135, P121, DOI 10.1016/j.jneumeth.2003.12.013; LANGFITT TW, 1965, NEUROLOGY, V15, P622, DOI 10.1212/WNL.15.7.622; Li Z, 2011, EUR J PHARMACOL, V667, P80, DOI 10.1016/j.ejphar.2011.05.054; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marmarou Anthony, 2004, Cleve Clin J Med, V71 Suppl 1, pS6; McKee JA, 2005, NEUROCRIT CARE, V2, P342, DOI 10.1385/NCC:2:3:342; Mico JA, 2012, CNS DRUGS, V26, P637, DOI 10.2165/11634510-000000000-00000; MILDE LN, 1985, ANESTHESIOLOGY, V63, P371, DOI 10.1097/00000542-198510000-00005; Oaklander AL, 2005, ANN NEUROL, V58, P309, DOI 10.1002/ana.20583; Partridge BJ, 1998, ANESTHESIOLOGY, V88, P196, DOI 10.1097/00000542-199801000-00028; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; ROOF RL, 1992, RESTOR NEUROL NEUROS, V4, P425, DOI 10.3233/RNN-1992-4608; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Schulze-Bonhage A, 2013, EXPERT OPIN DRUG MET, V9, P105, DOI 10.1517/17425255.2013.749239; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; Shim JK, 2014, J THORAC CARDIOV SUR, V148, P298, DOI 10.1016/j.jtcvs.2014.02.076; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; Stein DG, 2001, TRENDS NEUROSCI, V24, P386, DOI 10.1016/S0166-2236(00)01821-X; Stocchetti N, 2003, Minerva Anestesiol, V69, P232; Tanabe M, 2008, J NEUROSCI RES, V86, P3258, DOI 10.1002/jnr.21786; Taylor CP, 1998, EPILEPSY RES, V29, P233, DOI 10.1016/s0920-1211(97)00084-3; Traa BS, 2008, PEDIATR RES, V64, P81, DOI 10.1203/PDR.0b013e318174e70e; Trahan E, 2006, J HEAD TRAUMA REHAB, V21, P226, DOI 10.1097/00001199-200605000-00003; Tzellos TG, 2010, HIPPOKRATIA, V14, P71; Wick Jeannette Y, 2012, Consult Pharm, V27, P392, DOI 10.4140/TCP.n.2012.392; Yakubu MA, 2002, AM J PHYSIOL-CELL PH, V283, pC1687, DOI 10.1152/ajpcell.00071.2002; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; ZUCCARELLO M, 1993, J NEUROTRAUM, V10, P397, DOI 10.1089/neu.1993.10.397	56	18	18	1	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0361-9230	1873-2747		BRAIN RES BULL	Brain Res. Bull.	JUN	2018	140						169	175		10.1016/j.brainresbull.2018.05.001			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GO0ZR	WOS:000439675700022	29730418				2022-02-06	
J	Rowe, RK; Harrison, JL; Zhang, HT; Bachstetter, AD; Hesson, DP; O'Hara, BF; Greene, MI; Lifshitz, J				Rowe, Rachel K.; Harrison, Jordan L.; Zhang, Hongtao; Bachstetter, Adam D.; Hesson, David P.; O'Hara, Bruce F.; Greene, Mark I.; Lifshitz, Jonathan			Novel TNF receptor-1 inhibitors identified as potential therapeutic candidates for traumatic brain injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Diffuse brain injury; Midline fluid percussion; Mouse; Concussion; Cytokines; Tumor necrosis factor	SLEEP REGULATION; MICROGLIAL ACTIVATION; PROTECTIVE ROLE; CELL-DEATH; KAPPA-B; CYTOKINES; MICE; INFLAMMATION; MOUSE; PATHOPHYSIOLOGY	Background: Traumatic brain injury (TBI) begins with the application of mechanical force to the head or brain, which initiates systemic and cellular processes that are hallmarks of the disease. The pathological cascade of secondary injury processes, including inflammation, can exacerbate brain injury-induced morbidities and thus represents a plausible target for pharmaceutical therapies. We have pioneered research on post-traumatic sleep, identifying that injury-induced sleep lasting for 6 h in brain-injured mice coincides with increased cortical levels of inflammatory cytokines, including tumor necrosis factor (TNF). Here, we apply post-traumatic sleep as a physiological bio-indicator of inflammation. We hypothesized the efficacy of novel TNF receptor (TNF-R) inhibitors could be screened using post-traumatic sleep and that these novel compounds would improve functional recovery following diffuse TBI in the mouse. Methods: Three inhibitors of TNF-R activation were synthesized based on the structure of previously reported TNF CIAM inhibitor F002, which lodges into a defined TNFR1 cavity at the TNF-binding interface, and screened for in vitro efficacy of TNF pathway inhibition (I.B phosphorylation). Compounds were screened for in vivo efficacy in modulating post-traumatic sleep. Compounds were then tested for efficacy in improving functional recovery and verification of cellular mechanism. Results: Brain-injured mice treated with Compound 7 (C7) or SGT11 slept significantly less than those treated with vehicle, suggesting a therapeutic potential to target neuroinflammation. SGT11 restored cognitive, sensorimotor, and neurological function. C7 and SGT11 significantly decreased cortical inflammatory cytokines 3 h post-TBI. Conclusions: Using sleep as a bio-indicator of TNF-R-dependent neuroinflammation, we identified C7 and SGT11 as potential therapeutic candidates for TBI.	[Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA; [Rowe, Rachel K.; Lifshitz, Jonathan] Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA; [Harrison, Jordan L.; Lifshitz, Jonathan] Univ Arizona, Coll Med Phoenix, Basic Med Sci, Phoenix, AZ USA; [Zhang, Hongtao; Hesson, David P.; Greene, Mark I.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bachstetter, Adam D.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Sanders Brown Ctr Aging, Lexington, KY USA; [Bachstetter, Adam D.] Univ Kentucky, Dept Neurosci, Lexington, KY USA; [O'Hara, Bruce F.] Univ Kentucky, Dept Biol, Lexington, KY USA		Rowe, RK (corresponding author), Phoenix Childrens Hosp, BARROW Neurol Inst, Phoenix, AZ 85016 USA.; Rowe, RK (corresponding author), Univ Arizona, Coll Med Phoenix, Dept Child Hlth, Phoenix, AZ 85004 USA.; Rowe, RK (corresponding author), Phoenix Vet Affairs Healthcare Syst, Phoenix, AZ 85012 USA.	rkro222@email.arizona.edu		Bachstetter, Adam/0000-0003-4646-6757; Rowe, Rachel/0000-0002-9034-3159; Zhang, Hongtao/0000-0001-9173-0049	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21 NS072611]; PCH Mission Support Funds; Diane and Bruce Halle Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31-NS090921]; Science Foundation Arizona Bisgrove Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS072611, F31NS090921] Funding Source: NIH RePORTER	Research reported in this manuscript was supported, in part, by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under award numbers R21 NS072611 and PCH Mission Support Funds. The generosity of the Diane and Bruce Halle Foundation and NIH fellowship F31-NS090921 supported JLH during the conduct of these studies. RKR was supported by a Science Foundation Arizona Bisgrove Scholarship during the conduct of these studies.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Belarbi K, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-23; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cavas M, 2005, TOXICOL LETT, V157, P221, DOI 10.1016/j.toxlet.2005.02.003; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chio CC, 2015, CURR MED CHEM, V22, P759, DOI 10.2174/0929867321666141106124657; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Clark IA, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-51; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Di Battista AP, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0500-3; Dong Y, 2016, P NATL ACAD SCI USA, V113, P12304, DOI 10.1073/pnas.1605195113; Donohue KD, 2008, BIOMED ENG ONLINE, V7, DOI 10.1186/1475-925X-7-14; Ennaceur A, 1997, BEHAV BRAIN RES, V88, P181, DOI 10.1016/S0166-4328(97)02297-3; Han XD, 2011, J NEUROTRAUM, V28, P995, DOI 10.1089/neu.2010.1563; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Janowitz T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000330; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Krueger JM, 2007, SLEEP MED CLIN, V2, P161, DOI 10.1016/j.jsmc.2007.03.003; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; KRUEGER JM, 1995, ADV NEUROIMMUNOL, V5, P171, DOI 10.1016/0960-5428(95)00007-O; Krueger JM, 2001, ANN NY ACAD SCI, V933, P211; KRUEGER JM, 1993, J IMMUNOL, V150, pA82; Lifshitz J, 2008, ANIMAL MODELS ACUTE; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Mang GM, 2014, SLEEP, V37, P1383, DOI 10.5665/sleep.3936; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; McShane BB, 2010, J NEUROSCI METH, V193, P321, DOI 10.1016/j.jneumeth.2010.08.024; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Murali R, 2005, P NATL ACAD SCI USA, V102, P10970, DOI 10.1073/pnas.0504301102; Nakachi H, 2012, EUR J PHARMACOL, V679, P132, DOI 10.1016/j.ejphar.2011.12.046; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Rochfort KD, 2015, BIOCHEM SOC T, V43, P702, DOI 10.1042/BST20140319; Rowe RK, 2016, METHODS MOL BIOL, V1462, P211, DOI 10.1007/978-1-4939-3816-2_13; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Signorell A, 2016, DESCTOOLS TOOLS DESC; Sun YX, 2013, NEUROL SCI, V34, P345, DOI 10.1007/s10072-012-1007-z; Tobinick E, 2012, CNS DRUGS, V26, P1051, DOI 10.1007/s40263-012-0013-2; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Wang Y, 2013, LAB INVEST, V93, P1024, DOI 10.1038/labinvest.2013.89; Wang YX, 2013, J SURG RES, V182, P127, DOI 10.1016/j.jss.2012.07.071; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247; Ziebell JM, 2011, BRAIN RES, V1414, P94, DOI 10.1016/j.brainres.2011.07.056; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	18	19	1	5	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAY 22	2018	15								154	10.1186/s12974-018-1200-y			14	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GH0WS	WOS:000433123500002	29789012	Green Published, gold			2022-02-06	
J	Staerk, L; Fosbol, EL; Lamberts, M; Bonde, AN; Gadsboll, K; Sindet-Pedersen, C; Holm, EA; Gerds, TA; Ozenne, B; Lip, GYH; Torp-Pedersen, C; Gislason, GH; Olesen, JB				Staerk, Laila; Fosbol, Emil Loldrup; Lamberts, Morten; Bonde, Anders Nissen; Gadsboll, Kasper; Sindet-Pedersen, Caroline; Holm, Ellen A.; Gerds, Thomas Alexander; Ozenne, Brice; Lip, Gregory Y. H.; Torp-Pedersen, Christian; Gislason, Gunnar Hilmar; Olesen, Jonas Bjerring			Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study	EUROPEAN HEART JOURNAL			English	Article						Atrial fibrillation; Traumatic injury; Oral anticoagulation; Warfarin; NOAC; Bleeding	MORTALITY; HEMORRHAGE; GUIDELINES; DABIGATRAN; VALIDITY; TRENDS; USAGE; FALL; AGE	Aims We examined the risks of all-cause mortality, stroke, major bleeding, and recurrent traumatic injury associated with resumption of vitamin K antagonists (VKAs) and non-VKAs oral anticoagulants (NOACs) following traumatic injury in atrial fibrillation (AF) patients. Methods and results This was a Danish nationwide registry-based study (2005-16), including 4541 oral anticoagulant (OAC)-treated AF patients experiencing traumatic injury (defined as traumatic brain injury, hip fracture, or traumatic torso or abdominal injury). Within 90 days following discharge from traumatic injury, 60.6% resumed VKA (median age = 80, CHA(2)DS(2)-VASc = 4, HAS-BLED = 2), 16.7% resumed NOAC (median age = 81, CHA(2)DS(2)-VASc = 4, HAS-BLED = 2), and 22.7% did not resume OAC treatment (median age = 81, CHA(2)DS(2)-VASc= 4, HAS-BLED = 3). Switch from VKA to NOAC occurred among 9.5%. Since 2009, the trend in OAC resumption increased (P-value <0.0001), in particular with NOACs (P-value <0.0001). Follow-up started 90 days after discharge, and time-varying multiple Cox regression analyses were used for comparisons. Compared with non-resumption, VKA and NOAC resumption were associated with lower hazard [95% confidence interval (CI)] of all-cause mortality [hazard ratio (HR) 0.48 (0.42-0.53) and HR 0.55 (0.47-0.66), respectively] and ischaemic stroke [HR 0.56 (0.43-0.72) and HR 0.54 (0.35-0.82), respectively], increased major bleeding hazard [HR 1.30 (1.03 1.64) and HR 1.15 (0.81 1.63), respectively], and similar hazard of recurrent traumatic injury [HR 0.93 (0.73-1.18) and HR 0.87 (0.60-1.27), respectively]. Conclusion AF patients resuming VKA and NOAC treatment following traumatic injury have lower hazard of all-cause mortality and ischaemic stroke, increased hazard of major bleeding but without additional hazards of recurrent traumatic injury. Withholding OAC following a traumatic injury in AF patients may not be warranted.	[Staerk, Laila; Lamberts, Morten; Bonde, Anders Nissen; Gadsboll, Kasper; Sindet-Pedersen, Caroline; Gislason, Gunnar Hilmar; Olesen, Jonas Bjerring] Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Kildegaardsvej 28, DK-2900 Hellerup, Denmark; [Fosbol, Emil Loldrup; Lamberts, Morten] Copenhagen Univ Hosp, Rigshosp, Dept Cardiol, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark; [Fosbol, Emil Loldrup; Gislason, Gunnar Hilmar] Danish Heart Assoc, Vognmagergade 7, DK-1120 Copenhagen K, Denmark; [Holm, Ellen A.] Nykobing F Hosp, Dept Internal Med, Fjordvej 15, DK-4800 Nykobing, Denmark; [Gerds, Thomas Alexander; Ozenne, Brice] Univ Copenhagen, Sect Biostat, Dept Publ Hlth, Oster Farimagsgade 5, DK-1353 Copenhagen K, Denmark; [Lip, Gregory Y. H.] Univ Birmingham, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Lip, Gregory Y. H.] Aalborg Univ, Dept Clin Med, Aalborg Thrombosis Res Unit, Fredrik Bajers Vej 5, DK-9100 Aalborg, Denmark; [Torp-Pedersen, Christian] Aalborg Univ Hosp, Dept Cardiol & Clin Epidemiol, Hobrovej 18-22, DK-9100 Aalborg, Denmark; [Torp-Pedersen, Christian] Aalborg Univ, Dept Hlth Sci & Technol, Fredrik Bajers Vej 5, DK-9100 Aalborg, Denmark; [Gislason, Gunnar Hilmar] Univ Copenhagen, Fac Hlth & Med Sci, Blegdamsvej 3B, DK-2200 Copenhagen N, Denmark; [Gislason, Gunnar Hilmar] Univ Southern Denmark, Natl Inst Publ Hlth, Oster Farimagsgade 5, DK-1353 Copenhagen K, Denmark		Staerk, L (corresponding author), Copenhagen Univ Hosp Herlev & Gentofte, Dept Cardiol, Kildegaardsvej 28, DK-2900 Hellerup, Denmark.	lailastaerk@gmail.com	Gislason, Gunnar H/B-7561-2009	Gislason, Gunnar H/0000-0002-0548-402X; Gadsboll, Kasper/0000-0002-1331-3503; Holm, Ellen Astrid/0000-0002-7600-6025; Fosbol, Emil/0000-0002-2048-4167; Gerds, Thomas Alexander/0000-0002-5955-816X; Lamberts, Morten/0000-0002-9827-440X; Bonde, Anders Nissen/0000-0001-6794-8726	Velux FoundationsVelux Fonden; Boehringer-IngelheimBoehringer Ingelheim; Novo Nordisk FoundationNovo Nordisk FoundationNovocure Limited	This work was supported by the Velux Foundations and Boehringer-Ingelheim. The sponsors had no influence on the study design, interpretation of results, or the decision to submit the manuscript for publication. G.H.G. is supported by an unrestricted clinical research scholarship from the Novo Nordisk Foundation.	AALEN OO, 1978, SCAND J STAT, V5, P141; Alamneh EA, 2016, AM J CARDIOVASC DRUG, V16, P183, DOI 10.1007/s40256-016-0161-8; Albrecht JS, 2014, JAMA INTERN MED, V174, P1244, DOI 10.1001/jamainternmed.2014.2534; BENICHOU J, 1990, BIOMETRICS, V46, P813, DOI 10.2307/2532098; de Vries OJ, 2013, AGE AGEING, V42, P764, DOI 10.1093/ageing/aft089; Frost L, 2007, AM J MED, V120, P47, DOI 10.1016/j.amjmed.2005.12.027; Hadjizacharia P, 2011, AM SURGEON, V77, P634; Healey JS, 2016, LANCET, V388, P1161, DOI 10.1016/S0140-6736(16)30968-0; Hundrup YA, 2004, SCAND J PUBLIC HEALT, V32, P136, DOI 10.1080/14034940310017490; Hylek EM, 2006, STROKE, V37, P1075, DOI 10.1161/01.STR.0000209239.71702.ce; Inui TS, 2014, J TRAUMA ACUTE CARE, V76, P642, DOI 10.1097/TA.0000000000000138; Jorgensen TSH, 2014, SCAND J PUBLIC HEALT, V42, P287, DOI 10.1177/1403494813516831; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Liu XG, 2015, J CLIN PHARMACOL, V55, P25, DOI 10.1002/jcph.375; Majdan M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008672; Olesen JB, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d124; Park YJ, 2016, AM J EMERG MED, V34, P515, DOI 10.1016/j.ajem.2015.12.024; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Sabouret P, 2015, ARCH CARDIOVASC DIS, V108, P544, DOI 10.1016/j.acvd.2015.05.005; Sato T, 2003, EPIDEMIOLOGY, V14, P680, DOI 10.1097/01.EDE.0000081989.82616.7d; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schnabel RB, 2015, LANCET, V386, P154, DOI 10.1016/S0140-6736(14)61774-8; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Staerk L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31477; Staerk L, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5876; Stollberger C, 2016, NEUROL NEUROCHIR POL, V50, P200, DOI 10.1016/j.pjnns.2016.01.012; Stollberger C, 2015, J GERIATR CARDIOL, V12, P83, DOI 10.11909/j.issn.1671-5411.2015.01.010; Torstensson M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009522	31	18	18	0	2	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0195-668X	1522-9645		EUR HEART J	Eur. Heart J.	MAY 14	2018	39	19					1698	+		10.1093/eurheartj/ehx598			9	Cardiac & Cardiovascular Systems	Science Citation Index Expanded (SCI-EXPANDED)	Cardiovascular System & Cardiology	GG4ST	WOS:000432687200010	29165556	Bronze			2022-02-06	
J	Michailidou, I; Jongejan, A; Vreijling, JP; Georgakopoulou, T; de Wissel, MB; Wolterman, RA; Ruizendaal, P; Klar-Mohamad, N; Grootemaat, AE; Picavet, DI; Kumar, V; van Kooten, C; Woodruff, TM; Morgan, BP; Van der Wel, NN; Ramaglia, V; Fluiter, K; Baas, F				Michailidou, Iliana; Jongejan, Aldo; Vreijling, Jeroen P.; Georgakopoulou, Theodosia; de Wissel, Marit B.; Wolterman, Ruud A.; Ruizendaal, Patrick; Klar-Mohamad, Ngaisah; Grootemaat, Anita E.; Picavet, Daisy I.; Kumar, Vinod; van Kooten, Cees; Woodruff, Trent M.; Morgan, B. Paul; Van der Wel, Nicole N.; Ramaglia, Valeria; Fluiter, Kees; Baas, Frank			Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitis	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Complement; Inflammasome; Neuroinflammation	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SPINAL-CORD-INJURY; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; TRAUMATIC BRAIN-INJURY; BIOZZI ABH MOUSE; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; INFLAMMASOME ACTIVATION; WALLERIAN DEGENERATION; MENINGOCOCCAL DISEASE	The complement system is a key driver of neuroinflammation. Activation of complement by all pathways, results in the formation of the anaphylatoxin C5a and the membrane attack complex (MAC). Both initiate pro-inflammatory responses which can contribute to neurological disease. In this study, we delineate the specific roles of C5a receptor signaling and MAC formation during the progression of experimental autoimmune encephalomyelitis (EAE)-mediated neuroinflammation. MAC inhibition was achieved by subcutaneous administration of an antisense oligonucleotide specifically targeting murine C6 mRNA (5 mg/kg). The C5a receptor 1 (C5aR1) was inhibited with the C5a receptor antagonist PMX205 (1.5 mg/kg). Both treatments were administered systemically and started after disease onset, at the symptomatic phase when lymphocytes are activated. We found that antisense-mediated knockdown of C6 expression outside the central nervous system prevented relapse of disease by impeding the activation of parenchymal neuroinflammatory responses, including the Nod-like receptor protein 3 (NLRP3) inflammasome. Furthermore, C6 antisense-mediated MAC inhibition protected from relapse-induced axonal and synaptic damage. In contrast, inhibition of C5aR1-mediated inflammation diminished expression of major proinflammatory mediators, but unlike C6 inhibition, it did not stop progression of neurological disability completely. Our study suggests that MAC is a key driver of neuroinflammation in this model, thereby MAC inhibition might be a relevant treatment for chronic neuroinflammatory diseases.	[Michailidou, Iliana; Georgakopoulou, Theodosia; de Wissel, Marit B.; Wolterman, Ruud A.; Ruizendaal, Patrick; Ramaglia, Valeria] Acad Med Ctr, Dept Genome Anal, Amsterdam, Netherlands; [Michailidou, Iliana; Vreijling, Jeroen P.; Fluiter, Kees; Baas, Frank] Leiden Univ, Dept Clin Genet, Med Ctr, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands; [Jongejan, Aldo] Acad Med Ctr, Dept Bioinformat, Amsterdam, Netherlands; [Klar-Mohamad, Ngaisah; van Kooten, Cees] Leiden Univ, Dept Nephrol, Med Ctr, Leiden, Netherlands; [Grootemaat, Anita E.; Picavet, Daisy I.; Van der Wel, Nicole N.] Acad Med Ctr, Electron Microscopy Ctr Amsterdam, Dept Med Biol, Amsterdam, Netherlands; [Kumar, Vinod; Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia; [Morgan, B. Paul] Cardiff Univ, Syst Immun Univ Res Inst, Sch Med, Cardiff, S Glam, Wales; [Ramaglia, Valeria] Univ Toronto, Dept Immunol, Toronto, ON, Canada		Baas, F (corresponding author), Leiden Univ, Dept Clin Genet, Med Ctr, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	F.Baas@lumc.nl	Van Der Wel, Nicole/AAE-7569-2020; Woodruff, Trent M/ABF-1428-2020; Woodruff, Trent/AAS-4629-2020; Kumar, Vinod/AAM-3705-2020; van Kooten, Cees/E-5694-2018; Fluiter, Kees/H-2828-2015; Woodruff, Trent M./B-4861-2009; Baas, Frank/F-9574-2010	Woodruff, Trent M/0000-0003-1382-911X; Woodruff, Trent/0000-0003-1382-911X; Kumar, Vinod/0000-0002-7263-9917; van Kooten, Cees/0000-0002-6257-0899; Fluiter, Kees/0000-0003-0898-7260; Woodruff, Trent M./0000-0003-1382-911X; Michailidou, Iliana/0000-0001-6196-4944; Baas, Frank/0000-0003-3912-5428; Morgan, Paul/0000-0003-4075-7676; van der Wel, Nicole/0000-0001-6392-3417	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG 4775A1/1]	This work was funded by the National Multiple Sclerosis Society grant no. RG 4775A1/1 to F.B. and V.R.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Barnett MH, 2009, ANN NEUROL, V65, P32, DOI 10.1002/ana.21524; Biggins PJC, 2017, J NEUROTRAUM, V34, P2075, DOI 10.1089/neu.2016.4701; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Burger D, 2009, P NATL ACAD SCI USA, V106, P4355, DOI 10.1073/pnas.0812183106; Burm SM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0605-8; Carroll MC, 2008, VACCINE, V26, pI28, DOI 10.1016/j.vaccine.2008.11.022; CHU AC, 1980, BRIT J DERMATOL, V103, P607, DOI 10.1111/j.1365-2133.1980.tb01682.x; Craft JM, 2005, EXPERT OPIN THER TAR, V9, P887, DOI 10.1517/14728222.9.5.887; El Idrissi NB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0538-2; El Idrissi NB, 2015, ACTA NEUROPATHOL, V129, P653, DOI 10.1007/s00401-015-1404-5; Fandel D, 2013, BRAIN RES, V1535, P89, DOI 10.1016/j.brainres.2013.08.022; FIGUEROA J, 1993, IMMUNOL RES, V12, P295, DOI 10.1007/BF02918259; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Folaranmi T, 2015, MMWR-MORBID MORTAL W, V64, P608; Furlan R, 1999, J IMMUNOL, V163, P2403; Gasque P, 1997, AM J PATHOL, V150, P31; Geary RS, 2015, ADV DRUG DELIVER REV, V87, P46, DOI 10.1016/j.addr.2015.01.008; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; HAUSER SL, 1990, NEUROLOGY, V40, P1735, DOI 10.1212/WNL.40.11.1735; Hillmen P, 2006, NEW ENGL J MED, V355, P1233, DOI 10.1056/NEJMoa061648; Hisahara S, 2001, J EXP MED, V193, P111, DOI 10.1084/jem.193.1.111; HOBART MJ, 1977, J EXP MED, V146, P629, DOI 10.1084/jem.146.2.629; Ingram G, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-53; Inoue M, 2016, NAT NEUROSCI, V19, P1599, DOI 10.1038/nn.4421; Inoue M, 2012, P NATL ACAD SCI USA, V109, P10480, DOI 10.1073/pnas.1201836109; Inoue M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002767; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Jackson SJ, 2009, J NEUROPATH EXP NEUR, V68, P616, DOI 10.1097/NEN.0b013e3181a41d23; Jha S, 2010, J NEUROSCI, V30, P15811, DOI 10.1523/JNEUROSCI.4088-10.2010; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kilgore KS, 1997, AM J PATHOL, V150, P2019; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kotimaa J, 2016, MOL IMMUNOL, V76, P13, DOI 10.1016/j.molimm.2016.06.004; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lassmann H, 2007, J NEUROL SCI, V259, P3, DOI 10.1016/j.jns.2006.08.016; Lassmann H, 2017, ACTA NEUROPATHOL, V133, P223, DOI 10.1007/s00401-016-1631-4; Lassmann H, 2015, NEUROINFLAMMATION: NEW INSIGHTS INTO BENEFICIAL AND DETRIMENTAL FUNCTIONS, P3; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lee JD, 2017, BRIT J PHARMACOL, V174, P689, DOI 10.1111/bph.13730; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; MCGEER PL, 1994, TOHOKU J EXP MED, V174, P269, DOI 10.1620/tjem.174.269; Mead RJ, 2002, J IMMUNOL, V168, P458, DOI 10.4049/jimmunol.168.1.458; Mellergard J, 2010, MULT SCLER J, V16, P208, DOI 10.1177/1352458509355068; Mellergard J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044739; Michailidou I, 2017, GLIA, V65, P264, DOI 10.1002/glia.23090; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Morgan BP, 2004, CLIN EXP IMMUNOL, V138, P430, DOI 10.1111/j.1365-2249.2004.02646.x; Niculescu T, 2004, J IMMUNOL, V172, P5702, DOI 10.4049/jimmunol.172.9.5702; PAPADIMITRIOU JC, 1994, CELL CALCIUM, V15, P217, DOI 10.1016/0143-4160(94)90061-2; Peelen E, 2015, MOL IMMUNOL, V63, P521, DOI 10.1016/j.molimm.2014.10.008; Ramaglia V, 2015, CLIN EXP IMMUNOL, V180, P432, DOI 10.1111/cei.12595; Ramaglia V, 2007, J NEUROSCI, V27, P7663, DOI 10.1523/JNEUROSCI.5623-06.2007; Ramaglia V, 2009, MOL IMMUNOL, V46, P1892, DOI 10.1016/j.molimm.2009.01.017; Reiman R, 2005, NEUROSCI LETT, V390, P134, DOI 10.1016/j.neulet.2005.08.022; Reiman R, 2002, EUR J IMMUNOL, V32, P1157, DOI 10.1002/1521-4141(200204)32:4<1157::AID-IMMU1157>3.3.CO;2-D; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ronchi F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11541; Rossi S, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-32; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; Saper CB, 2003, J COMP NEUROL, V465, P161, DOI 10.1002/cne.10858; Schellenberg AE, 2007, MAGN RESON MED, V58, P298, DOI 10.1002/mrm.21289; Seppi D, 2014, J NEUROIMMUNOL, V270, P56, DOI 10.1016/j.jneuroim.2014.02.014; Shaftel SS, 2007, J NEUROSCI, V27, P9301, DOI 10.1523/JNEUROSCI.1418-07.2007; Shaw PJ, 2010, J IMMUNOL, V184, P4610, DOI 10.4049/jimmunol.1000217; Stokowska A, 2017, BRAIN, V140, P353, DOI 10.1093/brain/aww314; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Tran GT, 2002, J IMMUNOL, V168, P4293, DOI 10.4049/jimmunol.168.9.4293; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Triantafilou M, 2016, IMMUNOLOGY, V147, P152, DOI 10.1111/imm.12556; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Ward PA, 2009, J MOL MED, V87, P375, DOI 10.1007/s00109-009-0442-7; Watkins LM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0611-x; Weerth SH, 2003, AM J PATHOL, V163, P1069, DOI 10.1016/S0002-9440(10)63466-9; Wong EKS, 2015, TRANSL RES, V165, P306, DOI 10.1016/j.trsl.2014.10.010; Woodruff TM, 2006, FASEB J, V20, P1407, DOI 10.1096/fj.05-5814com; WURZNER R, 1991, CLIN EXP IMMUNOL, V83, P430; Zhang T, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/8193932	87	18	18	2	4	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	MAY 3	2018	6								36	10.1186/s40478-018-0536-y			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GE8ZT	WOS:000431520400001	29724241	Green Published, gold, Green Accepted			2022-02-06	
J	Bodien, YG; McCrea, M; Dikmen, S; Temkin, N; Boase, K; Machamer, J; Taylor, SR; Sherer, M; Levin, H; Kramer, JH; Corrigan, JD; McAllister, TW; Whyte, J; Manley, GT; Giacino, JT				Bodien, Yelena G.; McCrea, Michael; Dikmen, Sureyya; Temkin, Nancy; Boase, Kim; Machamer, Joan; Taylor, Sabrina R.; Sherer, Mark; Levin, Harvey; Kramer, Joel H.; Corrigan, John D.; McAllister, Thomas W.; Whyte, John; Manley, Geoffrey T.; Giacino, Joseph T.		TRACK-TBI Investigators	Optimizing Outcome Assessment in Multicenter TBI Trials: Perspectives From TRACK-TBI and the TBI Endpoints Development Initiative	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						common data elements; error; longitudinal studies; multicenter study; neuropsychological tests; outcome assessment; self-report; traumatic brain injury; validity	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CLINICAL-TRIALS; ADULT COGNITION; HEAD-INJURY; SCALE; RELIABILITY; TELEPHONE; SEVERITY; CONSCIOUSNESS	Traumatic brain injury (TBI) is a global public health problem that affects the long-term cognitive, physical, and psychological health of patients, while also having a major impact on family and caregivers. In stark contrast to the effective trials that have been conducted in other neurological diseases, nearly 30 studies of interventions employed during acute hospital care for TBI have failed to identify treatments that improve outcome. Many factors may confound the ability to detect true and meaningful treatment effects. One promising area for improving the precision of intervention studies is to optimize the validity of the outcome assessment battery by using well-designed tools and data collection strategies to reduce variability in the outcome data. The Transforming Research and Clinical Knowledge in TBI (TRACK-TBI) study, conducted at 18 sites across the United States, implemented a multidimensional outcome assessment battery with 22 measures aimed at characterizing TBI outcome up to 1 year postinjury. In parallel, through the TBI Endpoints Development (TED) Initiative, federal agencies and investigators have partnered to identify the most valid, reliable, and sensitive outcome assessments for TBI. Here, we present lessons learned from the TRACK-TBI and TED initiatives aimed at optimizing the validity of outcome assessment in TBI.	[Bodien, Yelena G.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 175 Cambridge St, Boston, MA 02114 USA; [Bodien, Yelena G.; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Dikmen, Sureyya; Boase, Kim; Machamer, Joan] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg & Biostat, Seattle, WA 98195 USA; [Taylor, Sabrina R.] Univ Calif San Francisco, Dept Neurol Surg, Brain & Spinal Injury Ctr, San Francisco, CA USA; [Kramer, Joel H.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Sherer, Mark] TIRR Mem Hermann, Houston, TX USA; [Sherer, Mark; Levin, Harvey] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Whyte, John] Moss Rehabil Res Inst, Elkins Pk, PA USA		Bodien, YG (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Neurol, 175 Cambridge St, Boston, MA 02114 USA.	ybodien@mgh.harvard.edu	Corrigan, John D./E-2921-2011; Giacino, Joseph/AAF-1952-2021	Giacino, Joseph/0000-0002-7916-9698; Bodien, Yelena/0000-0003-4858-2903	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U0-1NS086090]; Department of DefenseUnited States Department of Defense [DoD W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090, R21NS086714] Funding Source: NIH RePORTER	This study was supported by the National Institute of Neurological Disorders and Stroke (grant no. U0-1NS086090) and the Department of Defense (grant no. DoD W81XWH-14-2-0176). The TRACK-TBI and TED initiatives also receive key support from One Mind and more than 25 industry and philanthropic partners.	Amtmann D, 2010, PAIN, V150, P173, DOI 10.1016/j.pain.2010.04.025; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Beauchamp MH, 2017, J NEUROTRAUM, V34, P2545, DOI 10.1089/neu.2016.4868; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bogner J, 2010, ARCH PHYS MED REHAB, V91, pS66, DOI 10.1016/j.apmr.2009.11.032; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Centers for Disease Control and Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention, 2015, TRAUM BRAIN INJ US E; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Derogatis LR, 2001, BSI18; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gavett BE, 2013, NEUROREHABILITATION, V32, P253, DOI 10.3233/NRE-130842; Giacino JT, 2009, PROG BRAIN RES, V177, P33, DOI 10.1016/S0079-6123(09)17704-X; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Greenwald BD, 2015, J NEUROTRAUM, V32, P1883, DOI 10.1089/neu.2014.3454; Grimby G, 2012, J REHABIL MED, V44, P97, DOI 10.2340/16501977-0938; Jette AM, 2005, J REHABIL MED, V37, P339, DOI 10.1080/16501970500302793; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lachman ME, 2014, ASSESSMENT, V21, P404, DOI 10.1177/1073191113508807; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Levin H.S., 2014, UNDERSTANDING TRAUMA; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P1603, DOI 10.1016/j.apmr.2012.04.003; Malec JF, 2004, ARCH PHYS MED REHAB, V85, P1989, DOI 10.1016/j.apmr.2004.01.032; Manley GT, 2017, J NEUROTRAUM, V34, P2721, DOI 10.1089/neu.2016.4729; Mathias JL, 2013, BRAIN INJURY, V27, P887, DOI 10.3109/02699052.2013.793398; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Roozenbeek Bob, 2012, Clin Investig (Lond), V2, P153; Ryan J J, 1986, Arch Clin Neuropsychol, V1, P209; SACKETT DL, 1979, J CHRON DIS, V32, P51, DOI 10.1016/0021-9681(79)90012-2; Shapiro D M, 1990, Arch Clin Neuropsychol, V5, P405, DOI 10.1016/0887-6177(90)90018-K; Sherer M, 2005, ARCH PHYS MED REHAB, V86, P896, DOI 10.1016/j.apmr.2004.09.029; Shilon Y, 2012, CHILD CARE HLTH DEV, V38, P366, DOI 10.1111/j.1365-2214.2011.01278.x; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Stancin T, 1998, J TRAUMA, V45, P1031, DOI 10.1097/00005373-199812000-00010; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Tun PA, 2006, AGE AGEING, V35, P629, DOI 10.1093/ageing/afl095; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; VAKIL E, 1993, J CLIN PSYCHOL, V49, P883, DOI 10.1002/1097-4679(199311)49:6<883::AID-JCLP2270490616>3.0.CO;2-6; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilde EA, 2016, J NEUROTRAUM, V33, P2000, DOI 10.1089/neu.2015.4212; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	62	18	18	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2018	33	3					147	157		10.1097/HTR.0000000000000367			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ7HA	WOS:000435555500119	29385010	Green Accepted			2022-02-06	
J	Lynall, RC; Blackburn, JT; Guskiewicz, KM; Marshall, SW; Plummer, P; Mihalik, JP				Lynall, Robert C.; Blackburn, J. Troy; Guskiewicz, Kevin M.; Marshall, Stephen W.; Plummer, Prudence; Mihalik, Jason P.			Reaction Time and Joint Kinematics During Functional Movement in Recently Concussed Individuals	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Mild traumatic brain injury; Rehabilitation	EXTREMITY MUSCULOSKELETAL INJURY; SPORT-RELATED CONCUSSION; GAIT BALANCE CONTROL; FOOTBALL PLAYERS; POSTURAL CONTROL; SYMPTOM-FREE; STABILITY; ADOLESCENTS; TRUNK; RISK	Objective: To compare movement reaction time and joint kinematics between athletes with recent concussion and matched control recreational athletes during 3 functional tasks. Design: Cross-sectional. Setting: Laboratory. Participants: College-aged recreational athletes (N = 30) comprising 2 groups (15 participants each): (1) recent concussion group (median time since concussion, 126d; range, 28-432d) and (2) age- and sex-matched control group with no recent concussions. Interventions: We investigated movement reaction time and joint kinematics during 3 tasks: (1) jump landing, (2) anticipated cut, and (3) unanticipated cut. Main Outcome Measures: Reaction time and reaction time cost (jump landing reaction time cut reaction time/jump landing reaction time x 100%), along with trunk, hip, and knee joint angles in the sagittal and frontal planes at initial ground contact. Results: There were no reaction time between-group differences, but the control group displayed improved reaction time cost (10.7%) during anticipated cutting compared with the concussed group (0.8%; P = .030). The control group displayed less trunk flexion than the concussed group during the nondominant anticipated cut (5.1 difference; P = .022). There were no other kinematic between-group differences (P >=.079). Conclusions: We observed subtle reaction time and kinematic differences between individuals with recent concussion and those without concussion more than a month after return to activity after concussion. The clinical interpretation of these findings remains unclear, but may have future implications for postconcussion management and rehabilitation. (C) 2018 by the American Congress of Rehabilitation Medicine	[Lynall, Robert C.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA; [Lynall, Robert C.; Guskiewicz, Kevin M.; Mihalik, Jason P.] Univ N Carolina, Dept Exercise & Sport Sci, Matthew Gfeller Sport Related Traumat Brain Injur, Chapel Hill, NC USA; [Lynall, Robert C.; Blackburn, J. Troy; Guskiewicz, Kevin M.; Plummer, Prudence; Mihalik, Jason P.] Univ N Carolina, Dept Allied Hlth Sci, Human Movement Sci Curriculum, Chapel Hill, NC USA; [Blackburn, J. Troy] Univ N Carolina, Dept Exercise & Sport Sci, Neuromusc Res Lab, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA; [Marshall, Stephen W.] Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC USA; [Plummer, Prudence] Univ N Carolina, Dept Allied Hlth Sci, Div Phys Therapy, Chapel Hill, NC USA		Lynall, RC (corresponding author), 330 River Rd, Athens, GA 30677 USA.	rlynall@uga.edu	Lynall, Robert/M-2888-2014	Lynall, Robert/0000-0002-0785-6640	University of North Carolina at Chapel Hill Junior Faculty Development Award	Supported by The University of North Carolina at Chapel Hill Junior Faculty Development Award.	Blackburn JT, 2008, CLIN BIOMECH, V23, P313, DOI 10.1016/j.clinbiomech.2007.10.003; Blackburn JT, 2009, J ATHL TRAINING, V44, P174, DOI 10.4085/1062-6050-44.2.174; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brooks MA, 2016, AM J SPORT MED, V44, P742, DOI 10.1177/0363546515622387; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; Cross M, 2016, BRIT J SPORT MED, V50, P926, DOI 10.1136/bjsports-2015-094982; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; Dubose DF, 2017, MED SCI SPORT EXER, V49, P167, DOI 10.1249/MSS.0000000000001067; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2010, NEUROLOGY, V74, pA202; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Fino P.C., 2017, CLIN J SPORT MED; Frank B, 2013, AM J SPORT MED, V41, P2676, DOI 10.1177/0363546513496625; HENRY FM, 1960, RES QUART, V31, P448, DOI 10.1080/10671188.1960.10762052; Herman DC, 2017, SPORTS MED, V47, P1003, DOI 10.1007/s40279-016-0607-9; Howell DR, 2015, AM J SPORT MED, V43, P625, DOI 10.1177/0363546514560994; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Hunter MC, 2001, GAIT POSTURE, V13, P41, DOI 10.1016/S0966-6362(00)00089-8; Lapointe A.P, 2017, INT J PSYCHOPHYSIOL; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McNevin NH, 2002, HUM MOVEMENT SCI, V21, P187, DOI 10.1016/S0167-9457(02)00095-7; Nordstrom A, 2014, BRIT J SPORT MED, V48, P1447, DOI 10.1136/bjsports-2013-093406; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pietrosimone B, 2015, MED SCI SPORT EXER, V47, P2366, DOI 10.1249/MSS.0000000000000684; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; Riemann BL, 2002, J ATHL TRAINING, V37, P71; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Teel EF, 2013, J SCI MED SPORT, V16, P190, DOI 10.1016/j.jsams.2012.09.007	36	18	18	0	12	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2018	99	5					880	886		10.1016/j.apmr.2017.12.011			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	GE7CG	WOS:000431387000008	29337022				2022-02-06	
J	Parri, N; Crosby, BJ; Mills, L; Soucy, Z; Musolino, AM; Da Dalt, L; Cirilli, A; Grisotto, L; Kuppermann, N				Parri, Niccolo; Crosby, Bradley J.; Mills, Lisa; Soucy, Zachary; Musolino, Anna Maria; Da Dalt, Liviana; Cirilli, Angela; Grisotto, Laura; Kuppermann, Nathan			Point-of-Care Ultrasound for the Diagnosis of Skull Fractures in Children Younger Than Two Years of Age	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; COMPUTED-TOMOGRAPHY; PEDIATRIC SKULL; INTRACRANIAL INJURY; HEAD TRAUMA; RADIATION-EXPOSURE; MANAGEMENT; CANCER; RISKS; CT	Objectives To determine the accuracy of skull point-of-care ultrasound (POCUS) for identifying fractures in children younger than 2 years of age with signs of head trauma, and the ability of POCUS to identify the type and depth of fracture depression. Study design This was a multicenter, prospective, observational study of children younger than 2 years of age with nontrivial mechanisms of injury and signs of scalp/skull trauma. Patients were enrolled if they underwent computed tomography (CT). Patients underwent clinical evaluation, in addition to a cranial POCUS in the emergency department (ED). From the POCUS examinations, we documented whether fractures were present or absent, their location, characteristics, and depth. POCUS and CT findings were compared to calculate the diagnostic accuracy. Results We enrolled a convenience sample of 115 of 151 (76.1%) eligible patients. Of the 115 enrolled, 88 (76.5%) had skull fractures. POCUS had a sensitivity of 80 of 88 (90.9%; 95% CI 82.9-96.0) and a specificity of 23 of 27 (85.2%; 95% CI 66.3-95.8) for identifying skull fractures. Agreement between POCUS and CT to identify the type of fracture as linear, depressed, or complex was 84.4% (97 of 115) with a kappa of 0.75 (95% CI 0.70-0.84). Conclusions POCUS performed by emergency physicians may identify the type and depth of fractures in infants with local physical signs of head trauma with substantial accuracy. Emergency physicians should consider POCUS as an adjunct to clinical evaluation and prediction rules for traumatic brain injuries in children younger than 2 years of age.	[Parri, Niccolo] Meyer Childrens Hosp, Dept Pediat Emergency Med, Viale Pieraccini 24, I-50139 Florence, Italy; [Parri, Niccolo] Meyer Childrens Hosp, Trauma Ctr, Viale Pieraccini 24, I-50139 Florence, Italy; [Crosby, Bradley J.] Dixie Reg Med Ctr, Emergency Dept, St George, UT USA; [Mills, Lisa; Soucy, Zachary; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Musolino, Anna Maria] IRCCS Rome, Bambino Gesu Childrens Hosp, Emergency Dept, Rome, Italy; [Da Dalt, Liviana] Univ Padua, Dept Womans & Childs Hlth, Padua, Italy; [Cirilli, Angela] Long Isl Jewish Med Ctr, Dept Emergency Med, New Hyde Pk, NY 11042 USA; [Cirilli, Angela] Cohen Childrens Med Ctr, New Hyde Pk, NY USA; [Grisotto, Laura] Univ Florence, Dept Stat G Parenti, Florence, Italy; [Grisotto, Laura] ISPO Canc Prevent & Res Inst, Florence, Italy; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA		Parri, N (corresponding author), Meyer Childrens Hosp, Dept Pediat Emergency Med, Viale Pieraccini 24, I-50139 Florence, Italy.; Parri, N (corresponding author), Meyer Childrens Hosp, Trauma Ctr, Viale Pieraccini 24, I-50139 Florence, Italy.	niccolo.parri@meyer.it	Musolino, Anna Maria/AAI-1839-2019	Parri, Niccolo/0000-0002-8098-2504; Anna Maria, Musolino/0000-0001-9606-2860			Bin SS, 2010, PEDIATR EMERG CARE, V26, P633, DOI 10.1097/PEC.0b013e3181ef0440; Bonfield CM, 2014, J NEUROSURG-PEDIATR, V14, P205, DOI 10.3171/2014.5.PEDS13414; Bossuyt PM, 2003, CROAT MED J, V44, P635; BOWKER AH, 1948, J AM STAT ASSOC, V43, P572, DOI 10.2307/2280710; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2001, AM J ROENTGENOL, V176, P289, DOI 10.2214/ajr.176.2.1760289; Browning JG, 2005, EMERG MED J, V22, P33, DOI 10.1136/emj.2004.016196; Burke K, 2014, ARCH DIS CHILD, V99, P958, DOI 10.1136/archdischild-2014-306159; Cicchetti D, 2006, J NERV MENT DIS, V194, P557, DOI 10.1097/01.nmd.0000230392.83607.c5; Dayan PS, 2014, ANN EMERG MED, V64, P153, DOI 10.1016/j.annemergmed.2014.02.003; Dunning J, 2004, ARCH DIS CHILD, V89, P653, DOI 10.1136/adc.2003.027722; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; Greenes DS, 1998, ANN EMERG MED, V32, P680, DOI 10.1016/S0196-0644(98)70067-8; Greenes DS, 2001, PEDIATR EMERG CARE, V17, P88, DOI 10.1097/00006565-200104000-00002; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Hennelly KE, 2013, J PEDIATR-US, V162, P392, DOI 10.1016/j.jpeds.2012.07.018; Hofman PAM, 2000, J NEUROL NEUROSUR PS, V68, P416, DOI 10.1136/jnnp.68.4.416; Hunink MGM, 2003, J CLIN INVEST, V111, P1612, DOI 10.1172/JCI200318842; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LENDE RA, 1961, J NEUROSURG, V18, P479, DOI 10.3171/jns.1961.18.4.0479; Liu XS, 2012, J NEUROSURG-PEDIATR, V9, P670, DOI 10.3171/2012.2.PEDS11538; Lloyd DA, 1997, LANCET, V349, P821, DOI 10.1016/S0140-6736(96)09356-7; Mathews JD, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2360; MAXWELL AE, 1970, BRIT J PSYCHIAT, V116, P651, DOI 10.1192/bjp.116.535.651; Medwid Kelly, 2012, Ann Emerg Med, V60, P278, DOI 10.1016/j.annemergmed.2012.01.029; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; MUHONEN MG, 1995, SURG NEUROL, V43, P367, DOI 10.1016/0090-3019(95)80066-P; NELSON EL, 1984, NEUROSURGERY, V15, P318, DOI 10.1227/00006123-198409000-00005; Nigrovic LE, 2011, PEDIATRICS, V127, P1067, DOI 10.1542/peds.2010-3373; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; Parri N, 2013, J EMERG MED, V44, P135, DOI 10.1016/j.jemermed.2012.02.038; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pinto PS, 2012, J NEUROIMAGING, V22, pe1, DOI 10.1111/j.1552-6569.2011.00688.x; Powell EC, 2015, PEDIATRICS, V135, pE851, DOI 10.1542/peds.2014-2858; Quayle KS, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.5.e11; Rabiner JE, 2013, PEDIATRICS, V131, pE1757, DOI 10.1542/peds.2012-3921; Reid SR, 2012, CLIN PEDIATR, V51, P745, DOI 10.1177/0009922812446009; Riera A, 2012, PEDIATR EMERG CARE, V28, P420, DOI 10.1097/PEC.0b013e318252da3b; Schnadower D, 2007, CURR OPIN PEDIATR, V19, P258, DOI 10.1097/MOP.0b013e3281084e85; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; Schutzman SA, 2001, ANN EMERG MED, V37, P65, DOI 10.1067/mem.2001.109440; Sheridan DC, 2017, J NEUROSURG-PEDIATR, V19, P259, DOI 10.3171/2016.7.PEDS16204; Soucy ZP, 2015, J ULTRAS MED, V34, P1473, DOI 10.7863/ultra.34.8.1473; STUART A, 1955, BIOMETRIKA, V42, P412, DOI 10.1093/biomet/42.3-4.412; Vignes JR, 2007, J PEDIATR-US, V151, P316, DOI 10.1016/j.jpeds.2007.04.041; Weinberg ER, 2010, INJURY, V41, P862, DOI 10.1016/j.injury.2010.04.020	48	18	18	0	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	MAY	2018	196						230	+		10.1016/j.jpeds.2017.12.057			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	GG1MY	WOS:000432452300043	29499992				2022-02-06	
J	Patel, NS; Klett, J; Pilarzyk, K; Lee, DI; Kass, D; Menniti, FS; Kelly, MP				Patel, Neema S.; Klett, Jennifer; Pilarzyk, Katy; Lee, Dong Ik; Kass, David; Menniti, Frank S.; Kelly, Michy P.			Identification of new PDE9A isoforms and how their expression and subcellular compartmentalization in the brain change across the life span	NEUROBIOLOGY OF AGING			English	Article						Phosphodiesterase; Hippocampus; Cerebellum; Prefrontal cortex; Striatum; GAPDH; Ponceau; Allen institute for Brain Science; cGMP; Aging; Aging; Development	CGMP-SPECIFIC PHOSPHODIESTERASE; MESSENGER-RNA; RAT-BRAIN; GUANYLYL CYCLASE; INHIBITOR PF-04447943; SYNAPTIC PLASTICITY; ALZHEIMERS-DISEASE; HUMAN STRIATUM; MICE; LOCALIZATION	3',5'-Cyclic nucleotide phosphodiesterases (PDEs) degrade 3',5' cyclic adenonosine monophosphate (cAMP) and 3',5' cyclic guanosine monophosphate (cGMP), with PDE9A having the highest affinity for cGMP. We show PDE9A6 and 3 novel PDE9 isoforms (PDE9X-100, PDE9X-120, and PDE9X-175) are reliably detected in the brain and lung of mice, whereas PDE9A2 and other isoforms are found elsewhere. PDE9A localizes to the membrane in all organs except the bladder, where it is cytosolic. Brain additionally shows PDE9 in the nuclear fraction. PDE9A mRNA expression/localization dramatically changes across neurodevelopment in a manner that is strikingly consistent between mice and humans (i.e., decreased expression in the hippocampus and cortex and inverted-U in the cerebellum). Study of the 4 PDE9 isoforms in the mouse brain from postnatal day 7 through 24 months similarly identifies dramatic effects of age on expression and subcellular compartmentalization that are isoform specific and brain region specific. Finally, PDE9A mRNA is elevated in the aged human hippocampus with dementia when there is a history of traumatic brain injury. Thus, brain PDE9 is localized to preferentially regulate nuclear- and membrane-proximal pools of cGMP, and its function likely changes across the life span. (C) 2018 Elsevier Inc. All rights reserved.	[Patel, Neema S.; Klett, Jennifer; Pilarzyk, Katy; Kelly, Michy P.] Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, 6439 Garners Ferry Rd,VA Bldg 1,3rd Floor,D-12, Columbia, SC 29209 USA; [Lee, Dong Ik; Kass, David] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol,Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Menniti, Frank S.] Univ Rhode Isl, George & Anne Ryan Inst Neurosci, Kingston, RI 02881 USA		Kelly, MP (corresponding author), Univ South Carolina, Sch Med, Dept Pharmacol Physiol & Neurosci, 6439 Garners Ferry Rd,VA Bldg 1,3rd Floor,D-12, Columbia, SC 29209 USA.	Michy.Kelly@uscmed.sc.edu	Kelly, Michy/K-8409-2014	Kelly, Michy/0000-0002-1735-3342; Pilarzyk, Kaitlyn/0000-0001-6312-4412	University of South Carolina Magellan Scholar Program; University of South Carolina Honors College Science Undergraduate Research Fellowship Program; NIMHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1R01MH101130]; PfizerPfizer; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH101130] Funding Source: NIH RePORTER	Research supported by the University of South Carolina Magellan Scholar Program (NSP), the University of South Carolina Honors College Science Undergraduate Research Fellowship Program (NSP), and 1R01MH101130 from NIMH (MPK). NSP, JK, KP, DiL, and MPK have no financial conflicts to disclose. DK received research support from Pfizer and serves as a consultant to Merck and Ironwood Pharmaceuticals. FSM is currently Founder/CSO of MindImmune Therapeutics, Inc, and was previously Founder/CSO of Mnemosyne Pharmaceuticals, Inc (neither entity has interests in PDE9A).	Alexander MS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.174; Andreeva SG, 2001, J NEUROSCI, V21, P9068, DOI 10.1523/JNEUROSCI.21-22-09068.2001; Baltrons MA, 2004, NEUROBIOL DIS, V17, P462, DOI 10.1016/j.nbd.2004.07.022; Baltrons MA, 2002, NEUROBIOL DIS, V10, P139, DOI 10.1006/nbdi.2002.0492; Bingham J, 2006, BIOCHEM BIOPH RES CO, V350, P25, DOI 10.1016/j.bbrc.2006.08.180; Boland K, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2569; BONKALE WL, 1995, NEUROSCI LETT, V187, P5, DOI 10.1016/0304-3940(95)11323-O; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Demilly A, 2011, CEREBELLUM, V10, P409, DOI 10.1007/s12311-010-0156-y; Fisher DA, 1998, J BIOL CHEM, V273, P15559, DOI 10.1074/jbc.273.25.15559; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Hashimoto K, 2009, NEUROSCIENCE, V162, P601, DOI 10.1016/j.neuroscience.2008.12.037; Hegde S, 2016, NEUROPSYCHOPHARMACOL, V41, P2920, DOI 10.1038/npp.2016.106; Hegde S, 2016, NEUROSCIENCE, V335, P151, DOI 10.1016/j.neuroscience.2016.08.019; Houslay MD, 2010, TRENDS BIOCHEM SCI, V35, P91, DOI 10.1016/j.tibs.2009.09.007; Huai Q, 2004, P NATL ACAD SCI USA, V101, P9624, DOI 10.1073/pnas.0401120101; Hutson PH, 2011, NEUROPHARMACOLOGY, V61, P665, DOI 10.1016/j.neuropharm.2011.05.009; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; Kelly MR, 2009, PHARMACOL BIOCHEM BE, V92, P649, DOI 10.1016/j.pbb.2009.03.003; Kelly MP, 2018, CELL SIGNAL, V42, P281, DOI 10.1016/j.cellsig.2017.11.004; Kelly MP, 2014, CELL SIGNAL, V26, P383, DOI 10.1016/j.cellsig.2013.10.007; Kleiman RJ, 2012, J PHARMACOL EXP THER, V341, P396, DOI 10.1124/jpet.111.191353; Kokkonen K, 2017, ANNU REV PHARMACOL, V57, P455, DOI 10.1146/annurev-pharmtox-010716-104756; Kroker KS, 2014, NEUROBIOL AGING, V35, P2072, DOI 10.1016/j.neurobiolaging.2014.03.023; Kroker KS, 2012, NEUROPHARMACOLOGY, V62, P1964, DOI 10.1016/j.neuropharm.2011.12.021; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Lee DI, 2015, NATURE, V519, P472, DOI 10.1038/nature14332; Liddie S, 2012, J PSYCHOPHARMACOL, V26, P1375, DOI 10.1177/0269881112447991; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; MacMullen CM, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.3; MacMullen CM, 2017, GENE, V606, P17, DOI 10.1016/j.gene.2016.12.033; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Miller JA, 2014, NATURE, V508, P199, DOI 10.1038/nature13185; Nagy D, 2015, EXP NEUROL, V263, P122, DOI 10.1016/j.expneurol.2014.10.001; Nicholas T., 2009, ALZHEIMER DEMEN, V5, P330; Pathak G, 2017, MOL PSYCHIATR, V22, P1714, DOI 10.1038/mp.2016.155; Pathak G, 2015, NEUROPHARMACOLOGY, V95, P434, DOI 10.1016/j.neuropharm.2015.04.026; Rentero C, 2003, BIOCHEM BIOPH RES CO, V301, P686, DOI 10.1016/S0006-291X(03)00021-4; Schmidt C. J., 2009, ALZHEIMERS DEMENT, V5, P331; Schwam EM, 2014, CURR ALZHEIMER RES, V11, P413, DOI 10.2174/1567205011666140505100858; Sillitoe RV, 2007, ANNU REV CELL DEV BI, V23, P549, DOI 10.1146/annurev.cellbio.23.090506.123237; Singh N, 2014, LIFE SCI, V106, P1, DOI 10.1016/j.lfs.2014.04.007; STEINER AL, 1972, J BIOL CHEM, V247, P1121; van der Staay FJ, 2008, NEUROPHARMACOLOGY, V55, P908, DOI 10.1016/j.neuropharm.2008.07.005; van Staveren WCG, 2003, J COMP NEUROL, V467, P566, DOI 10.1002/cne.10955; van Staveren WCG, 2002, J NEUROCYTOL, V31, P729, DOI 10.1023/A:1025704031210; van Staveren Wilma C. G., 2005, V307, P75; Vardigan JD, 2011, J NEUROGENET, V25, P120, DOI 10.3109/01677063.2011.630494; Wang P, 2003, GENE, V314, P15, DOI 10.1016/S0378-1119(03)00733-9; Wunderlich G., 2016, ALZHEIMERS DEMENT, V12, pP820; Yang XP, 2016, CELL, V164, P805, DOI 10.1016/j.cell.2016.01.029	52	18	18	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	MAY	2018	65						217	234		10.1016/j.neurobiolaging.2018.01.019			18	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	GA3MO	WOS:000428233700022	29505961	Green Accepted			2022-02-06	
J	Radford, K; Sutton, C; Sach, T; Holmes, J; Watkins, C; Forshaw, D; Jones, T; Hoffman, K; O'Connor, R; Tyerman, R; Merchan-Baeza, JA; Morris, R; McManus, E; Drummond, A; Walker, M; Duley, L; Shakespeare, D; Hammond, A; Phillips, J				Radford, Kate; Sutton, Chris; Sach, Tracey; Holmes, Jain; Watkins, Caroline; Forshaw, Denise; Jones, Trevor; Hoffman, Karen; O'Connor, Rory; Tyerman, Ruth; Antonio Merchan-Baeza, Jose; Morris, Richard; McManus, Emma; Drummond, Avril; Walker, Marion; Duley, Lelia; Shakespeare, David; Hammond, Alison; Phillips, Julie			Early, specialist vocational rehabilitation to facilitate return to work after traumatic brain injury: the FRESH feasibility RCT	HEALTH TECHNOLOGY ASSESSMENT			English	Article							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; COST-EFFECTIVENESS ANALYSIS; ROUTINE FOLLOW-UP; HEAD-INJURY; MILD; EMPLOYMENT; MODERATE; PEOPLE; TBI	Background: Up to 160,000 people incur traumatic brain injury (TBI) each year in the UK. TBI can have profound effects on many areas of human functioning, including participation in work. There is limited evidence of the clinical effectiveness and cost-effectiveness of vocational rehabilitation (VR) after injury to promote early return to work (RTW) following TBI. Objective: To assess the feasibility of a definitive, multicentre, randomised controlled trial (RCT) of the clinical effectiveness and cost-effectiveness of early, specialist VR plus usual care (UC) compared with UC alone on work retention 12 months post TBI. Design: A multicentre, feasibility, parallel-group RCT with a feasibility economic evaluation and an embedded mixed-methods process evaluation. Randomisation was by remote computer-generated allocation. Setting: Three NHS major trauma centres (MTCs) in England. Participants: Adults with TBI admitted for >48 hours and working or studying prior to injury. Interventions: Early specialist TBI VR delivered by occupational therapists (OTs) in the community using a case co-ordination model. Main outcome measures: Self-reported RTW 12 months post randomisation, mood, functional ability, participation, work self-efficacy, quality of life and work ability. Feasibility outcomes included recruitment and retention rates. Follow-up was by postal questionnaires in two centres and face to face in one centre. Those collecting data were blind to treatment allocation. Results: Out of 102 target participants, 78 were recruited (39 randomised to each arm), representing 39% of those eligible and 5% of those screened. Approximately 2.2 patients were recruited per site per month. Of those, 56% had mild injuries, 18% had moderate injuries and 26% had severe injuries. A total of 32 out of 45 nominated carers were recruited. A total of 52 out of 78 (67%) TBI participants responded at 12 months (UC, n = 23; intervention, n = 29), completing 90% of the work questions; 21 out of 23 (91%) UC respondents and 20 out of 29 (69%) intervention participants returned to work at 12 months. Two participants disengaged from the intervention. Face-to-face follow-up was no more effective than postal follow-up. RTW was most strongly related to social participation and work self-efficacy. It is feasible to assess the cost-effectiveness of VR. Intervention was delivered as intended and valued by participants. Factors likely to affect a definitive trial include deploying experienced OTs, no clear TBI definition or TBI registers, and repatriation of more severe TBI from MTCs, affecting recruitment of those most likely to benefit/least likely to drop out. Limitations: Target recruitment was not reached, but mechanisms to achieve this in future studies were identified. Retention was lower than expected, particularly in UC, potentially biasing estimates of the 12-month RTW rate. Conclusions: This study met most feasibility objectives. The intervention was delivered with high fidelity. When objectives were not met, strategies to ensure feasibility of a full trial were identified. Future work should test two-stage recruitment and include resources to recruit from 'spokes'. A broader measure covering work ability, self-efficacy and participation may be a more sensitive outcome.	[Radford, Kate; Holmes, Jain; Jones, Trevor; Morris, Richard; Drummond, Avril; Walker, Marion; Duley, Lelia; Phillips, Julie] Univ Nottingham, Sch Med, Div Rehabil & Ageing, Nottingham, England; [Sutton, Chris; Watkins, Caroline; Forshaw, Denise] Univ Cent Lancashire, Fac Hlth & Wellbeing, Preston, Lancs, England; [Sach, Tracey; McManus, Emma] Univ East Anglia, Norwich Med Sch, Hlth Econ Grp, Norwich, Norfolk, England; [Hoffman, Karen] Queen Mary Univ London, Ctr Trauma Sci, London, England; [O'Connor, Rory] Univ Leeds, Acad Dept Rehabil Med, Sch Med, Leeds, W Yorkshire, England; [Tyerman, Ruth] Buckinghamshire Healthcare NHS Trust, Community Head Injury Serv, Aylesbury, Bucks, England; [Antonio Merchan-Baeza, Jose] Univ Malaga, Dept Physiotherapy, Malaga, Spain; [Shakespeare, David] Lancashire Teaching Hosp Trust, Preston, Lancs, England; [Hammond, Alison] Univ Salford, Hlth Sci Res Ctr, Salford, Lancs, England		Radford, K (corresponding author), Univ Nottingham, Sch Med, Div Rehabil & Ageing, Nottingham, England.	Kate.Radford@nottingham.ac.uk	Holmes, Jain A/K-2125-2016; O'Connor, Rory/AAG-4503-2020; Radford, Kate A/F-8571-2013; Duley, Lelia/E-8107-2015; Watkins, Caroline/E-6898-2013	Holmes, Jain A/0000-0003-2465-102X; O'Connor, Rory/0000-0002-4643-9794; Radford, Kate A/0000-0001-6246-3180; Duley, Lelia/0000-0001-6721-5178; Hammond, Alison/0000-0002-5266-9991; Forshaw, Denise/0000-0001-5725-3736; Hoffman, Karen/0000-0002-3531-3467; Watkins, Caroline/0000-0002-9403-3772; Sutton, Chris/0000-0002-6406-1318; Merchan-Baeza, Jose Antonio/0000-0002-6893-952X; Sach, Tracey/0000-0002-8098-9220	National Institute for Health Research (NIHR) Health Technology Assessment programmeNational Institute for Health Research (NIHR)	This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 33. See the NIHR Journals Library website for further project information.	Abdullah G, 2014, WORLDV EVID-BASED NU, V11, P284, DOI 10.1111/wvn.12060; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; Andersson EE, 2007, ACTA NEUROCHIR, V149, P151, DOI 10.1007/s00701-006-1082-0; Annegers JF, 2000, SEIZURE-EUR J EPILEP, V9, P453, DOI 10.1053/seiz.2000.0458; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Berger E, 1999, RESTOR NEUROL NEUROS, V14, P93; Bjorkdahl A, 2010, BRAIN INJURY, V24, P1061, DOI 10.3109/02699052.2010.494588; Bootes Kylie, 2002, Work, V19, P255; Borglin G, 2016, BMC HLTH SERV RES S1, V16, P101; BrainandSpinalCord.org, 2017, PROGN TBI; BrainLine.org, 2017, BRAIN TRAUM CONC COM; Brasure M, 2013, ARCH PHYS MED REHAB, V94, P1398, DOI 10.1016/j.apmr.2012.12.019; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 1997, HEALTH ECON, V6, P327, DOI 10.1002/(SICI)1099-1050(199707)6:4<327::AID-HEC282>3.0.CO;2-W; British Society of Rehabilitation Medicine, 2010, VOC ASS REH PEOPL LO; British Society of Rehabilitation Medicine, 2003, VOC REH WAY FORW WOR; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS201, DOI 10.1016/j.apmr.2013.10.010; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Centre for Mental Health, 2016, TRAUM BRAIN INJ OFF; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Crowther R, 1800, Cochrane Database Syst Rev, pCD003080, DOI 10.1002/14651858.CD003080; Curtis L., 2013, UNIT COSTS HLTH SOCI; Curtis L, 2010, UNIT COSTS HLTH SOCI; Curtis L., 2015, UNIT COSTS HLTH SOCI; Curtis L., 2014, UNIT COSTS HLTH SOCI; Cuthbert JP, 2015, J HEAD TRAUMA REHAB, V30, P160, DOI 10.1097/HTR.0000000000000090; Daisley A, 2009, HEAD INJURY FACTS; das Nair R, 2015, TRIALS, V16, DOI 10.1186/1745-6215-16-6; Delbecq A.L., 1975, GROUP TECHNIQUES PRO; Department for Transport, 2016, FREE FLOW VEH SPEED; Department for Work and Pensions, 2013, 2010 2015 GOV POL EM; Department of Health and Social Care, 2014, NHS OUTC FRAM 2015 2; Department of Health and Social Care, 2015, NHS REF COSTS 2014 2; Department of Health and Social Care, 2005, RES GOV FRAM HLTH SO; DESHPANDE P, 2004, SURVEY VOCATIONAL RE, P35; Dillman DA., 2000, MAIL INTERNET SURVEY; Doctor JN, 2005, J INT NEUROPSYCH SOC, V11, P747, DOI 10.1017/S1355617705050836; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Eldridge Sandra M, 2016, BMJ, V355, pi5239, DOI 10.1136/bmj.i5239; Escorpizo R, 2011, J OCCUP REHABIL, V21, P147, DOI 10.1007/s10926-010-9276-y; Eva G, 2012, THINKING POSITIVELY; Fadyl JK, 2009, J HEAD TRAUMA REHAB, V24, P195, DOI 10.1097/HTR.0b013e3181a0d458; Faul M, 2010, TRAUMATIC BRAIN INJU; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Frank AO, 2006, INT J THER REHABIL, V13, P126, DOI 10.12968/ijtr.2006.13.3.21364; Franulic A, 2004, BRAIN INJURY, V18, P119, DOI 10.1080/0269905031000149515; Friedland JF, 2001, J NERV MENT DIS, V189, P426, DOI 10.1097/00005053-200107000-00003; Frost D., 2011, HLTH WORK INDEPENDEN; Garfield A, 2013, LOW MOOD MS GROUP AD; Gilworth G, 2008, J REHABIL MED, V40, P334, DOI 10.2340/16501977-0169; Graham CW, 2016, CAMP SYST REV, V6; Grant M., 2014, DEV DELIVERING EVALU; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; Headway The Brain Injury Association, 2015, STATISTICS; Headway The Brain Injury Association, 2017, TYP BRAIN INJ; Headway The Brain Injury Association, 2017, SEV IS BRAIN INJ; Health and Social Care Information Centre, 2015, PRESCR COST AN ENGL; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; International Council for Harmonisation, 1996, EFF GUID E6 R1 GOOD; JENNETT B, 1975, LANCET, V1, P480; Johnson R, 1998, NEUROPSYCHOL REHABIL, V8, P61, DOI 10.1080/713755552; Johnson V, 2009, ASSESSMENT TRAUMATIC; Jourdan C, 2016, J HEAD TRAUMA REHAB, V31, pE42, DOI 10.1097/HTR.0000000000000147; Kendall E, 2006, J VOCAT REHABIL, V25, P149; Kersel DA, 2001, BRAIN INJURY, V15, P683, DOI 10.1080/02699050010013662; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; King NS, 1997, J NEUROL NEUROSUR PS, V62, P38, DOI 10.1136/jnnp.62.1.38; Krellman JW, 2014, ARCH PHYS MED REHAB, V95, P633, DOI 10.1016/j.apmr.2013.10.016; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Kristman VL, 2010, OPEN OCCUP HLTH SAF, V2, P1, DOI [10.2174/1876216601002010001, DOI 10.2174/1876216601002010001]; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langley J, 2010, BRAIN INJURY, V24, P939, DOI 10.3109/02699052.2010.491494; Laureys S, 2005, LANCET NEUROL, V4, P789, DOI 10.1016/S1474-4422(05)70230-1; Logan PA, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18290; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Malec JF, 2000, ARCH PHYS MED REHAB, V81, P1007, DOI 10.1053/apmr.2000.6980; Man DWK, 2013, BRAIN INJURY, V27, P1016, DOI 10.3109/02699052.2013.794969; Manca A, 2005, HEALTH ECON, V14, P487, DOI 10.1002/hec.944; Mansfield E, 2015, BRAIN INJURY, V29, P1362, DOI 10.3109/02699052.2015.1053524; Marshman LAG, 2013, J CLIN NEUROSCI, V20, P1475, DOI 10.1016/j.jocn.2012.11.022; McCormack B, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-107; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; McNamee S, 2009, J REHABIL RES DEV, V46, P893, DOI 10.1682/JRRD.2008.08.0106; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moore GF, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1258; National Institute for Health and Care Excellence (NICE), 2013, GUID METH TECHN APPR; National Institute of Neurological Disorders and Stroke, 2017, TRAUM BRAIN INJ INF; Nouri F. M., 1987, CLIN REHABIL, V1, P301, DOI [DOI 10.1177/026921558700100409, 10.1177/026921558700100409]; O'Callaghan A, 2012, BRAIN INJURY, V26, P1599, DOI 10.3109/02699052.2012.698788; O'Connor MK, 2016, J REHABIL RES DEV, V53, P307, DOI 10.1682/JRRD.2014.10.0231; Office for National Statistics, ANN SURV HOURS EARN; Paniak C, 1998, BRAIN INJURY, V12, P1011, DOI 10.1080/026990598121927; Petzold A, 2010, J CONTIN EDUC HEALTH, V30, P167, DOI 10.1002/chp.20077; Phillips J, 2013, RETURN WORK TRAUMATI; Phillips J, 2010, BRIT J OCCUP THER, V73, P422, DOI 10.4276/030802210X12839367526138; Playford ED, 2011, MAPPING VOCATIONAL R; Polinder S, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0037-1; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2013, NEUROREHABILITATION, V32, P803, DOI 10.3233/NRE-130904; Possl O, 2001, BRAIN INJURY, V15, P15; Powell J, 2002, J NEUROL NEUROSUR PS, V72, P193, DOI 10.1136/jnnp.72.2.193; Pritchard C, 2000, PRODUCTIVITY COSTS P; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Radford K, 2013, BRAIN INJURY, V27, P507, DOI 10.3109/02699052.2013.766929; Ramsey SD, 2015, VALUE HEALTH, V18, P161, DOI 10.1016/j.jval.2015.02.001; Rapport LJ, 2008, ARCH PHYS MED REHAB, V89, P922, DOI 10.1016/j.apmr.2008.01.009; REILLY MC, 1993, PHARMACOECONOMICS, V4, P353, DOI 10.2165/00019053-199304050-00006; Relyea-Chew A, 2009, ARCH PHYS MED REHAB, V90, P413, DOI 10.1016/j.apmr.2008.07.031; Richards D.A., 2015, COMPLEX INTERVENTION; Rickels E, 2010, BRAIN INJURY, V24, P1491, DOI 10.3109/02699052.2010.498006; Ritchie JB, 2013, QUALITATIVE RES PRAC; ROBINSON BC, 1983, J GERONTOL, V38, P344, DOI 10.1093/geronj/38.3.344; Sach Tracey H, 2003, Appl Health Econ Health Policy, V2, P135; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Sculpher MJ, 2015, METHODS EC EVALUATIO; Sendroy-Terrill M, 2010, ARCH PHYS MED REHAB, V91, P489, DOI 10.1016/j.apmr.2009.11.011; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shemilt I, 2010, EVID POLICY, V6, P51, DOI 10.1332/174426410X482999; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Simpson G, 2007, BRAIN INJURY, V21, P1335, DOI 10.1080/02699050701785542; Sinclair E, 2014, DISABIL REHABIL, V36, P409, DOI 10.3109/09638288.2013.793410; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Svendsen HA, 2006, BRAIN INJURY, V20, P1295, DOI 10.1080/02699050601082123; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Trexler LE, 2016, ARCH PHYS MED REHAB, V97, P204, DOI 10.1016/j.apmr.2015.09.016; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Tuomi K, 1993, AGEING AND WORK, P142; Tuominen R, 2012, BRAIN INJURY, V26, P1697, DOI 10.3109/02699052.2012.722256; Turner-Stokes L, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub3; Turner-Strokes, 2003, REHABILITATION FOLLO; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Tyerman A, 2004, VOCATIONAL ASSESSMEN; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; Vanderploeg RD, 2008, ARCH PHYS MED REHAB, V89, P2227, DOI 10.1016/j.apmr.2008.06.015; Vikane E, 2014, BRAIN INJURY, V28, P1374, DOI 10.3109/02699052.2014.919532; Waddell G, 2008, VOCATIONAL REHABILIT; Wade DT, 1997, J NEUROL NEUROSUR PS, V62, P478, DOI 10.1136/jnnp.62.5.478; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Walker MF, 2012, CLIN REHABIL, V26, P675, DOI 10.1177/0269215511431089; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Walsh RS, 2014, HEALTH PSYCHOL REV, V8, P458, DOI 10.1080/17437199.2012.733914; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843; WK Kellogg Foundation, 2004, LOG MOD DEV GUID; Zhu XL, 2007, BRAIN INJURY, V21, P681, DOI 10.1080/02699050701468941; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	156	18	19	1	15	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	MAY	2018	22	33					1	+		10.3310/hta22330			125	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	GH9JM	WOS:000433985700001	29863459	Green Accepted, Green Published, Green Submitted, gold			2022-02-06	
J	Wang, D; Xu, X; Wu, YG; Lyu, L; Zhou, ZW; Zhang, JN				Wang, Dong; Xu, Xin; Wu, Yin-Gang; Lyu, Li; Zhou, Zi-Wei; Zhang, Jian-Ning			Dexmedetomidine attenuates traumatic brain injury: action pathway and mechanisms	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; neuroinflammation; nuclear factor kappa B; NLRP3 inflammasome; brain edema; blood-brain barrier; tight junction proteins; apoptosis; neuroprotection; dexmedetomidine; neural regeneration	ISCHEMIA-REPERFUSION INJURY; NF-KAPPA-B; NLRP3 INFLAMMASOME; SIGNALING PATHWAY; OXIDATIVE STRESS; DISRUPTION; ACTIVATION; PROTECTS; RATS; TEMPERATURE	Traumatic brain injury induces potent inflammatory responses that can exacerbate secondary blood-brain barrier (BBB) disruption, neuronal injury, and neurological dysfunction. Dexmedetomidine is a novel alpha 2-adrenergic receptor agonist that exert protective effects in various central nervous system diseases. The present study was designed to investigate the neuroprotective action of dexmedetomidine in a mouse traumatic brain injury model, and to explore the possible mechanisms. Adult male C57BL/6J mice were subjected to controlled cortical impact. After injury, animals received 3 days of consecutive dexmedetomidine therapy (25 mu g/kg per day). The modified neurological severity score was used to assess neurological deficits. The rotarod test was used to evaluate accurate motor coordination and balance. Immunofluorescence was used to determine expression of ionized calcium binding adapter molecule-1, myeloperoxidase, and zonula occluden-1 at the injury site. An enzyme linked immunosorbent assay was used to measure the concentration of interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha, and IL-6. The dry-wet weight method was used to measure brain water content. The Evans blue dye extravasation assay was used to measure BBB disruption. Western blot assay was used to measure protein expression of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3), caspase-1 p20, IL-1 beta, nuclear factor kappa B (NF-kappa B) p65, occluding, and zonula occluden-1. Flow cytometry was used to measure cellular apoptosis. Results showed that dexmedetomidine treatment attenuated early neurological dysfunction and brain edema. Further, dexmedetomidine attenuated post-traumatic inflammation, up-regulated tight junction protein expression, and reduced secondary BBB damage and apoptosis. These protective effects were accompanied by down-regulation of the NF-kappa B and NLRP3 inflammasome pathways. These findings suggest that dexmedetomidine exhibits neuroprotective effects against acute (3 days) post-traumatic inflammatory responses, potentially via suppression of NF-kappa B and NLRP3 inflammasome activation.	[Wang, Dong; Xu, Xin; Wu, Yin-Gang; Zhou, Zi-Wei; Zhang, Jian-Ning] Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Wang, Dong; Xu, Xin; Wu, Yin-Gang; Zhou, Zi-Wei; Zhang, Jian-Ning] Minist Educ & Tianjin City, Key Lab Postneuroinjury Neurorepair & Regenerat C, Tianjin Neurol Inst, Tianjin, Peoples R China; [Lyu, Li] Tianjin Childrens Hosp, Dept Cardiovasc, Tianjin, Peoples R China		Zhou, ZW; Zhang, JN (corresponding author), Tianjin Med Univ Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.; Zhou, ZW; Zhang, JN (corresponding author), Minist Educ & Tianjin City, Key Lab Postneuroinjury Neurorepair & Regenerat C, Tianjin Neurol Inst, Tianjin, Peoples R China.	ziweizhou2009@hotmail.com; jianningzhang@hotmail.com		Xu, Xin/0000-0003-3395-9923	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81330029, 81671380]; Natural Science Foundation of Tianjin City of ChinaNatural Science Foundation of Tianjin [17JCZDJC35900]	This work was supported by the National Natural Science Foundation of China, No. 81330029, 81671380; and the Natural Science Foundation of Tianjin City of China, No. 17JCZDJC35900.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Akpinar H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37196; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen X, 2017, ISJ-INVERT SURVIV J, V14, P1; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Fang B, 2015, CELL PHYSIOL BIOCHEM, V36, P373, DOI 10.1159/000430107; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hang CH, 2006, BRAIN RES, V1109, P14, DOI 10.1016/j.brainres.2006.06.045; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Ismael S, 2018, J NEUROTRAUM, V35, P1294, DOI 10.1089/neu.2017.5344; Jayakumar AR, 2014, J NEUROTRAUM, V31, P1249, DOI 10.1089/neu.2013.3169; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Liang H, 2017, INFLAMM RES, V66, P399, DOI 10.1007/s00011-017-1023-9; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Luo C, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00197; Ma QY, 2014, ANN NEUROL, V75, P209, DOI 10.1002/ana.24070; Mamik MK, 2017, BRAIN, V140, P2273, DOI 10.1093/brain/awx133; McAdams RM, 2015, PEDIATR RES, V77, P772, DOI 10.1038/pr.2015.45; Mckee CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00556; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Schoeler M, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-20; Shen M, 2017, BIOMED PHARMACOTHER, V95, P885, DOI 10.1016/j.biopha.2017.08.125; Shen ZY, 2013, WORLD J GASTROENTERO, V19, P3583, DOI 10.3748/wjg.v19.i23.3583; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Wang LJ, 2017, BIOMOL THER, V25, P383, DOI 10.4062/biomolther.2015.180; Xu X, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0934-2; Yang SJ, 2018, CELL MOL NEUROBIOL, V38, P595, DOI 10.1007/s10571-017-0526-9; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zhou KR, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/9238290; Zhu HT, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-59	31	18	21	1	9	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2018	13	5					819	826		10.4103/1673-5374.232529			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GI1LE	WOS:000434131200019	29863012	Green Published, gold			2022-02-06	
J	Stewart, WF; Kim, N; Ifrah, C; Sliwinski, M; Zimmerman, ME; Kim, M; Lipton, RB; Lipton, ML				Stewart, Walter F.; Kim, Namhee; Ifrah, Chloe; Sliwinski, Martin; Zimmerman, Molly E.; Kim, Mimi; Lipton, Richard B.; Lipton, Michael L.			Heading Frequency Is More Strongly Related to Cognitive Performance Than Unintentional Head Impacts in Amateur Soccer Players	FRONTIERS IN NEUROLOGY			English	Article						risk factors in epidemiology; brain trauma; heading; sports; soccer	CHRONIC TRAUMATIC ENCEPHALOPATHY; NEUROCOGNITIVE PERFORMANCE; NEUROPSYCHOLOGICAL IMPAIRMENT; BRAIN-INJURY; CONCUSSION; SPORTS; SYMPTOMS; DEMENTIA; ABNORMALITIES; CONSEQUENCES	Objective: Compared to heading, unintentional head impacts (e.g., elbow to head, head to head, head to goalpost) in soccer are more strongly related to risk of moderate to very severe Central Nervous System (CNS) symptoms. But, most head impacts associated with CNS symptoms that occur in soccer are mild and are more strongly related to heading. We tested for a differential relation of heading and unintentional head impacts with neuropsychological (NP) test performance. Method: Active adult amateur soccer players were recruited in New York City and the surrounding areas for this repeated measures longitudinal study of individuals who were enrolled if they had 5+ years of soccer play and were active playing soccer 6+ months/year. All participants completed a baseline validated questionnaire ("HeadCount-2w"), reporting 2-week recall of soccer activity, heading and unintentional head impacts. In addition, participants also completed NP tests of verbal learning, verbal memory, psychomotor speed, attention, and working memory. Most participants also completed one or more identical follow-up protocols (i.e., HeadCount-2w and NP tests) at 3-to 6-month intervals over a 2-year period. Repeated measures General Estimating Equations (GEE) linear models were used to determine if variation in NP tests at each visit was related to variation in either heading or unintentional head impacts in the 2-week period before testing. Results: 308 players (78% male) completed 741 HeadCount-2w. Mean (median) heading/2-weeks was 50 (17) for men and 26 (7) for women. Heading was significantly associated with poorer performance on psychomotor speed (p < 0.001) and attention (p = 0.02) tasks and was borderline significant with poorer performance on the working memory (p = 0.06) task. Unintentional head impacts were not significantly associated with any NP test. Results did not differ after excluding 22 HeadCount-2w with reported concussive or borderline concussive symptoms. Conclusion: Poorer NP test performance was consistently related to frequent heading during soccer practice and competition in the 2 weeks before testing. In contrast, unintentional head impacts incurred during soccer were not related to cognitive performance.	[Stewart, Walter F.] Sutter Hlth Res, Walnut Creek, CA USA; [Kim, Namhee; Ifrah, Chloe; Lipton, Michael L.] Gruss Magnet Resonance Res Ctr, Bronx, NY 10461 USA; [Kim, Namhee; Ifrah, Chloe; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Sliwinski, Martin] Penn State Univ, Dept Human Dev & Family Studies, University Pk, PA 16802 USA; [Zimmerman, Molly E.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA; [Zimmerman, Molly E.] Fordham Univ, Bronx, NY 10458 USA; [Kim, Mimi; Lipton, Richard B.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Lipton, Richard B.; Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA; [Lipton, Michael L.] Montefiore Med Ctr, Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA		Lipton, ML (corresponding author), Gruss Magnet Resonance Res Ctr, Bronx, NY 10461 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Psychiat & Behav Sci, Bronx, NY 10467 USA.; Lipton, ML (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10467 USA.	michael.lipton@einstein.yu.edu	Lipton, Richard Bruce/AAY-2818-2021; Lipton, Richard B/B-5060-2011		NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001073] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS082432] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS082432] Funding Source: NIH RePORTER		Allen B, 2017, NEUROLOGY, V88, pE74, DOI 10.1212/WNL.0000000000003669; Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Comstock RD, 2015, JAMA PEDIATR, V169, P830, DOI 10.1001/jamapediatrics.2015.1062; Downs DS, 2002, J SPORT MED PHYS FIT, V42, P103; FIFA, 2007, FIFA MAGAZINE, P10; Filley CM, 2010, NEUROPSYCHOL REV, V20, P158, DOI 10.1007/s11065-010-9127-9; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gouttebarge V, 2017, PHYSICIAN SPORTSMED, V45, P443, DOI 10.1080/00913847.2017.1376572; Grinberg LT, 2016, J ALZHEIMERS DIS, V54, P169, DOI 10.3233/JAD-160312; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hales C, 2014, NEUROLOGY, V83, P2307, DOI 10.1212/WNL.0000000000001081; Kirkendall DT, 2001, J ATHL TRAINING, V36, P328; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Koutures CG, 2010, PEDIATRICS, V125, P410, DOI 10.1542/peds.2009-3009; Levitch CF, 2018, J INT NEUROPSYCH SOC, V24, P147, DOI 10.1017/S1355617717000790; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lipton ML, 2018, J SCI MED SPORT, V21, P363, DOI 10.1016/j.jsams.2017.08.008; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Maher ME, 2014, BRAIN INJURY, V28, P271, DOI 10.3109/02699052.2013.865269; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Matser JT, 2001, J CLIN EXP NEUROPSYC, V23, P770, DOI 10.1076/jcen.23.6.770.1029; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; Meier TB, 2016, HUM BRAIN MAPP, V37, P833, DOI 10.1002/hbm.23072; Merritt VC, 2018, ARCH CLIN NEUROPSYCH, V33, P36, DOI 10.1093/arclin/acx051; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Rodrigues AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00038; Rutherford A, 2005, J CLIN EXP NEUROPSYC, V27, P299, DOI 10.1080/13803390490515504; Rutherford A, 2009, J CLIN EXP NEUROPSYC, V31, P664, DOI 10.1080/13803390802484755; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Straume-Naesheim TM, 2009, NEUROSURGERY, V64, P719, DOI 10.1227/01.NEU.0000340681.12949.6D; TYSVAER AT, 1991, AM J SPORT MED, V19, P56, DOI 10.1177/036354659101900109; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Witol AD, 2003, ARCH CLIN NEUROPSYCH, V18, P397, DOI 10.1016/S0887-6177(02)00151-8	43	18	18	1	13	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 24	2018	9								240	10.3389/fneur.2018.00240			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	GD8FN	WOS:000430748400001	29740384	gold, Green Published			2022-02-06	
J	Kawata, K; Mitsuhashi, M; Aldret, R				Kawata, Keisuke; Mitsuhashi, Masato; Aldret, Randy			A Preliminary Report on Brain-Derived Extracellular Vesicle as Novel Blood Biomarkers for Sport-Related Concussions	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury; concussion; neurotrauma; ice hockey; subconcussion; microvesicle	SERUM NEUROFILAMENT LIGHT; INTRACRANIAL LESIONS; INJURY; EXOSOMES; MILD; REHABILITATION; PROTEINS; PLAYERS; TAU	The purpose of the study was to test the utility of unique panel of blood biomarkers as a means to reflect one's recovery process after sport-related neurotrauma. We established a panel of biomarkers that reacted positive with CD81 (extracellular vesicle marker) and various neuron-and glia-specific antigens [e.g., neurofilament light polypeptide (NF-L), tau, synaptosome-associated protein 25 (SNAP25), glial fibrillary acidic protein, and myelin basic protein]. We first evaluated test-retest reliabilities of brain-derived exosome markers, followed by an application of these markers in eight professional ice hockey players to detect cumulative neuronal burden from a single ice hockey season. During the season, two players were diagnosed with concussions by team physician based on an exhibition of symptoms as well as abnormality in balance and ocular motor testing. One player reached symptom-free status 7 days after the concussion, while the other player required 36 days for symptoms to completely resolve. Blood samples and clinical assessments including balance error scoring system and near point of convergence throughout recovery process were obtained. Biomarkers indicative of axonal damage, neuronal inflammation, and glial activation showed excellent test-retest reliabilities (intra-class correlation coefficient: 0.713-0.998, p's < 0.01). There was a statistically significant increase in the NF-L marker at post-season follow-up compared to pre-season baseline (Z = -2.100, P = 0.036); however the statistical significance did not withstand Bonferroni correction for multiple comparisons. In concussion cases, neuronal and microglia markers notably increased after concussions, with the unique expression patterns being similar to that of concussion recovery process. These longitudinal data coupled with excellent test-retest reliabilities of novel array of blood biomarkers potentially reflect the damage in neural cell structures and metabolic crisis due to concussion. However, future studies with larger sample size and appropriate control groups to evaluate sensitivity and specificity of these markers are needed. This preliminary case report suggests the potential utility of multimodal blood biomarkers for concussion prognosis and recovery assessment.	[Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA; [Mitsuhashi, Masato] NanoSomiX Inc, Aliso Viejo, CA USA; [Aldret, Randy] Univ Louisiana Lafayette, Sch Kinesiol, Lafayette, LA 70504 USA		Kawata, K (corresponding author), Indiana Univ, Dept Kinesiol, Sch Publ Hlth Bloomington, Bloomington, IN 47405 USA.	kkawata@indiana.edu			Indiana State Department of Health [ISCBIRF 0019939]	The authors would like to thank Dr. Stephanie N. Aldret for her assistance in data collection. This work was partly supported by the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (to K. Kawata: ISCBIRF 0019939). Sponsors had no role in the design or execution of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Andreu Z, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00442; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2007, J ATHL TRAINING, V42, P509; De Beaumont L, 2007, BRAIN INJURY, V21, P631, DOI 10.1080/02699050701426931; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2018, J NEUROTRAUM, V35, P260, DOI 10.1089/neu.2017.5376; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kiechle K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084977; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Li P, 2017, THERANOSTICS, V7, P789, DOI 10.7150/thno.18133; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Nekludov M, 2017, BRAIN INJURY, V31, P1856, DOI 10.1080/02699052.2017.1358395; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Pant S, 2012, BIOCHEM PHARMACOL, V83, P1484, DOI 10.1016/j.bcp.2011.12.037; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Siman R, 2015, J NEUROTRAUM, V32, P1294, DOI 10.1089/neu.2014.3698; Stern RA, 2016, J ALZHEIMERS DIS, V51, P1099, DOI 10.3233/JAD-151028; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Yoshioka Y, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20424; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang H, 2010, EURASIP J ADV SIG PR, V2010, P7, DOI DOI 10.1016/J.NEUR0IMAGE.2010.12.007; Zhang XF, 2015, J INEQUAL APPL, DOI 10.1186/1029-242X-2015-1	40	18	18	0	11	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	APR 12	2018	9								239	10.3389/fneur.2018.00239			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GC5IY	WOS:000429822000001	29706930	Green Published, gold			2022-02-06	
J	Godoy, DA; Lubillo, S; Rabinstein, AA				Agustin Godoy, Daniel; Lubillo, Santiago; Rabinstein, Alejandro A.			Pathophysiology and Management of Intracranial Hypertension and Tissular Brain Hypoxia After Severe Traumatic Brain Injury An Integrative Approach	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Intracranial pressure; Intracranial hypertension; Acute brain injury; Cerebral perfusion pressure; Cerebral oxygenation; Brain hypoxia; Multimodal monitoring; Traumatic brain injury	CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; RANDOMIZED CONTROLLED-TRIALS; HYPERTONIC SODIUM SOLUTIONS; DECOMPRESSIVE CRANIECTOMY; OXYGEN-PRESSURE; THERAPEUTIC HYPOTHERMIA; METABOLIC CRISIS; LUMBAR DRAINAGE; BLOOD-FLOW	Monitoring intracranial pressure in comatose patients with severe traumatic brain injury (TBI) is considered necessary by most experts. Acute intracranial hypertension (IHT), when severe and sustained, is a life-threatening complication that demands emergency treatment. Yet, secondary anoxic-ischemic injury after brain trauma can occur in the absence of IHT. In such cases, adding other monitoring modalities can alert clinicians when the patient is in a state of energy failure. This article reviews the mechanisms, diagnosis, and treatment of IHT and brain hypoxia after TBI, emphasizing the need to develop a physiologically integrative approach to the management of these complex situations.	[Agustin Godoy, Daniel] San Juan Bautista Hosp, Intens Care Unit, Catamarca, Argentina; [Agustin Godoy, Daniel] Sanatorio Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina; [Lubillo, Santiago] Hosp Univ NS Candelaria, Intens Care Unit, Tenerife, Spain; [Rabinstein, Alejandro A.] Mayo Clin, Neurosci Crit Care Unit, Rochester, MN USA		Godoy, DA (corresponding author), Sanatorio Pasteur, Neurointens Care Unit, Chacabuco 675, RA-4700 Catamarca, Argentina.	dagodoytorres@yahoo.com.ar					Abadal-Centellas JM, 2007, J TRAUMA, V62, P282, DOI 10.1097/01.ta.0000199422.01949.78; Albeck MJ, 1998, J NEUROSURG, V89, P275, DOI 10.3171/jns.1998.89.2.0275; ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Aramendi I, 2016, MED INTENSIVA, V40, P113, DOI 10.1016/j.medin.2015.09.002; Artru F, 1998, NEUROL RES, V20, pS48; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Bassin SL, 2008, CRIT CARE, V12, DOI 10.1186/cc7020; Bellemare P, 2007, INTENS CARE MED, V33, P2004, DOI 10.1007/s00134-007-0842-5; Berger-Pelleiter E, 2016, CAN J EMERG MED, V18, P112, DOI 10.1017/cem.2016.12; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Bohman LE, 2011, NEUROCRIT CARE, V14, P361, DOI 10.1007/s12028-011-9526-7; Bor-Seng-Shu E, 2013, NEUROSURG REV, V36, P361, DOI 10.1007/s10143-013-0453-2; Bouzat P, 2014, CURR OPIN CRIT CARE, V20, P133, DOI 10.1097/MCC.0000000000000072; Bouzat P, 2013, ANN INTENSIVE CARE, V3, DOI 10.1186/2110-5820-3-23; Brenner M, 2012, J TRAUMA ACUTE CARE, V72, P1135, DOI 10.1097/TA.0b013e31824af90b; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; CARDOSO ER, 1983, J NEUROSURG, V59, P817, DOI 10.3171/jns.1983.59.5.0817; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Celis-Rodriguez E, 2013, MED INTENSIVA, V37, P519, DOI 10.1016/j.medin.2013.04.001; Chesnut RM, 2015, ANN NY ACAD SCI, V1345, P99, DOI 10.1111/nyas.12483; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Curley G, 2010, CRIT CARE MED, V38, P1348, DOI 10.1097/CCM.0b013e3181d8cf2b; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; Danish SF, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS945; Diringer MN, 2013, CURR OPIN CRIT CARE, V19, P77, DOI 10.1097/MCC.0b013e32835eba30; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Gantner D, 2014, CURR OPIN CRIT CARE, V20, P385, DOI 10.1097/MCC.0000000000000114; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Gillman LM, 2014, CASE REP CRIT CARE, V2014; Godoy DA, 2015, MED INTENSIVA, V39, P445, DOI 10.1016/j.medin.2014.10.009; Godoy DA, 2005, ACTA ANAESTH SCAND, V49, P1577, DOI 10.1111/j.1399-6576.2005.00885_49_10.x; Godoy DA, 2014, NEUROCRIT CARE, V141, P616; Godoy DA, 2014, GREEN BOOK CUIDADOS, P19; Godoy DA, 2016, CURR OPIN CRIT CARE, V22, P120, DOI 10.1097/MCC.0000000000000292; Godoy DA, 2012, NEUROSURGERY, V71, P245, DOI 10.1227/NEU.0b013e318256b9f5; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; GOPINATH SP, 1994, J NEUROL NEUROSUR PS, V57, P717, DOI 10.1136/jnnp.57.6.717; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; GUERCI AD, 1985, CIRC RES, V56, P20, DOI 10.1161/01.RES.56.1.20; Harrigan MR, 1997, J NEUROTRAUM, V14, P637, DOI 10.1089/neu.1997.14.637; Honda M, 2017, NEUROCRIT CARE; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Johnston AJ, 2005, CRIT CARE MED, V33, P189, DOI 10.1097/01.CCM.0000149837.09225.BD; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kerr M E, 1998, Am J Crit Care, V7, P205; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Lang EW, 2007, NEUROSURG REV, V30, P99, DOI 10.1007/s10143-006-0062-4; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Lauerman MH, 2014, CURR OPIN ANESTHESIO, V27, P219, DOI 10.1097/ACO.0000000000000044; Lazaridis C, 2013, CRIT CARE MED, V41, P1353, DOI 10.1097/CCM.0b013e31827ca4b3; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Le Roux P, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0331-2; Lee TT, 1997, SURG NEUROL, V48, P333, DOI 10.1016/S0090-3019(96)00483-1; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Lelubre C, 2016, MINERVA ANESTESIOL, V82, P112; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Li M, 2015, MEDICINE, V94; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Makarenko S, 2016, J CLIN NEUROSCI, V26, P8, DOI 10.1016/j.jocn.2015.05.065; Malbrain MLNG, 2011, AM SURGEON, V77, pS6; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Marin-Caballos AJ, 2008, MED INTENSIVA, V32, P81, DOI 10.1016/S0210-5691(08)70912-4; Marion DW, 2014, CRIT CARE, V18, DOI 10.1186/cc13955; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; Martini RP, 2013, RESP CARE, V58, P162, DOI 10.4187/respcare.01942; Menon DK, 2004, CRIT CARE MED, V32, P1384, DOI 10.1097/01.CCM.0000127777.16609.08; Meyer MJ, 2010, BRAIN INJURY, V24, P706, DOI 10.3109/02699051003692126; Meyer MJ, 2010, BRAIN INJURY, V24, P694, DOI 10.3109/02699051003692118; Meyfroidt G, 2017, LANCET NEUROL, V16, P721, DOI 10.1016/S1474-4422(17)30259-4; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Mirski MA, 2008, SEMIN NEUROL, V28, P611, DOI 10.1055/s-0028-1105970; Monro A., 1823, OBSERVATIONS STRUCTU, P5; Mortazavi MM, 2012, J NEUROSURG, V116, P210, DOI 10.3171/2011.7.JNS102142; Munch EC, 2001, CRIT CARE MED, V29, P976; Murad A, 2008, ACT NEUR S, V102, P89, DOI 10.1007/978-3-211-85578-2_18; Nangunoori R, 2012, NEUROCRIT CARE, V17, P131, DOI 10.1007/s12028-011-9621-9; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Pascual JL, 2011, J TRAUMA, V70, P535, DOI 10.1097/TA.0b013e31820b59de; Perez-Barcena J, 2014, CRIT CARE CLIN, V30, P735, DOI 10.1016/j.ccc.2014.06.005; PICKARD JD, 1993, J NEUROL NEUROSUR PS, V56, P845, DOI 10.1136/jnnp.56.8.845; Poca MA, 2005, NEUROCIRUGIA, V16, P385; Puppo C, 2007, ACTA NEUROCHIR, V149, P139, DOI 10.1007/s00701-006-1074-0; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Rickard AC, 2014, EMERG MED J, V31, P679, DOI 10.1136/emermed-2013-202679; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Roberts R G, 2002, Crit Care Resusc, V4, P271; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Ortega MAR, 2014, MED INTENSIVA, V38, P41, DOI 10.1016/j.medin.2013.03.008; Rosenthal R J, 1998, J Gastrointest Surg, V2, P415, DOI 10.1016/S1091-255X(98)80031-0; Rosner MJ, 1989, INTRACRANIAL PRESSUR, P611; Sader N, 2015, NEUROCRIT CARE, V22, P437, DOI 10.1007/s12028-014-0088-3; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Sahuquillo J, 2002, NEUROCIRUGIA, V13, P78; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Sanfilippo F, 2015, NEUROCRIT CARE, V22, P325, DOI 10.1007/s12028-014-0061-1; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; Scalea TM, 2007, J TRAUMA, V62, P647, DOI 10.1097/TA.0b013e31802ee542; SIGGAARDANDERSEN O, 1995, CRIT CARE MED, V23, P1284, DOI 10.1097/00003246-199507000-00020; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steingrub JS, 2014, CRIT CARE MED, V42, P90, DOI 10.1097/CCM.0b013e31829eb7c9; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 2008, INTENS CARE MED, V34, P461, DOI 10.1007/s00134-007-0948-9; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Stocchetti N, 2013, CRIT CARE, V17, DOI 10.1186/cc11513; Tang JF, 2011, NEUROCRIT CARE, V15, P175, DOI 10.1007/s12028-009-9315-8; Thongrong C, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.02.027; Tuettenberg J, 2009, J NEUROSURG, V110, P1200, DOI 10.3171/2008.10.JNS08293; Valadka AB, 1998, J NEUROTRAUM, V15, P509, DOI 10.1089/neu.1998.15.509; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; vanSantbrink H, 1996, NEUROSURGERY, V38, P21, DOI 10.1097/00006123-199601000-00007; Veenith TV, 2016, JAMA NEUROL, V73, P542, DOI 10.1001/jamaneurol.2016.0091; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; WELCH K, 1980, J NEUROSURG, V52, P693, DOI 10.3171/jns.1980.52.5.0693; Willemse RB, 1998, ACT NEUR S, V71, P37; WOLF AL, 1993, J NEUROSURG, V78, P54, DOI 10.3171/jns.1993.78.1.0054; Zauner A, 2002, NEUROSURGERY, V51, P289, DOI 10.1097/00006123-200208000-00003	132	18	21	0	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2018	29	2					195	+		10.1016/j.nec.2017.12.001			19	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GB6MJ	WOS:000429183000002	29502711				2022-02-06	
J	Calviello, L; Donnelly, J; Cardim, D; Robba, C; Zeiler, FA; Smielewski, P; Czosnyka, M				Calviello, L.; Donnelly, J.; Cardim, D.; Robba, C.; Zeiler, F. A.; Smielewski, P.; Czosnyka, M.			Compensatory-Reserve-Weighted Intracranial Pressure and Its Association with Outcome After Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Intracranial pressure; Brain trauma; Compensatory reserve; Mortality	HEAD-INJURY; NEUROCRITICAL CARE; VOLUME-PRESSURE; PLATEAU WAVES; HYPERTENSION; THRESHOLDS; REACTIVITY; TRIAL; ICP	Objective We introduced 'compensatory-reserve-weighted intracranial pressure (ICP),' named 'weightedICP' for brevity, as a variable that may better describe changes leading to mortality after traumatic brain injury (TBI) over the standard mean ICP. Methods ICP was monitored prospectively in over 1023 sedated and ventilated patients. The RAP coefficient (R-correlation, A-amplitude, and P-pressure) was calculated as the running correlation coefficient between slow changes in the pulse amplitude of ICP and the mean ICP. RAP has a value of 0 on the linear part of the pressure-volume curve and a value of + 1 on the ascending exponential part. Then, RAP decreases towards zero or even becomes negative when ICP increases further-a phenomenon thought to be related to the critical closing of cerebral vessels. In this study, we investigated a derived variable called weightedICP, calculated as ICP*(1 - RAP). Results Mortality after TBI was associated with both elevated ICP and weightedICP. Analysis of variance showed higher values of test statistics for weightedICP (K = 93) than for ICP (K = 64) in outcome categorization. Additionally, receiver operator curve analysis indicated greater area under the curve for weightedICP (0.71) than for ICP (0.67) with respect to associated mortality; however, the difference was not statistically significant (p = 0.12). The best threshold (maximizing sensitivity and specificity) was 19.5 mm Hg for mean ICP, and 8 mm Hg for weightedICP. Mortality rate expressed as a function of mean ICP and weightedICP showed an ascending profile in both cases. Conclusion The proposed variable shows a significant association with mortality following head injury. It is sensitive to both the rising absolute ICP and to the critical deterioration of pressure-volume compensation.	[Calviello, L.; Donnelly, J.; Cardim, D.; Robba, C.; Zeiler, F. A.; Smielewski, P.; Czosnyka, M.] Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge Biomed Campus, Cambridge, England; [Robba, C.] Univ Cambridge, Addenbrookes Hosp, Div Anesthesia, Dept Med, Cambridge, England; [Czosnyka, M.] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Zeiler, F. A.] Univ Cambridge, Dept Anesthesiol, Cambridge, England; [Czosnyka, M.] Cambridge Univ Hosp, Neurosurg Unit, Cambridge Biomed Campus,Box 167, Cambridge CB2 0QQ, England		Czosnyka, M (corresponding author), Univ Cambridge, Div Neurosurg, Dept Clin Neurosci, Brain Phys Lab, Cambridge Biomed Campus, Cambridge, England.; Czosnyka, M (corresponding author), Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland.; Czosnyka, M (corresponding author), Cambridge Univ Hosp, Neurosurg Unit, Cambridge Biomed Campus,Box 167, Cambridge CB2 0QQ, England.	mc141@medschl.cam.ac.uk	Donnelly, Joseph/E-9235-2018; Robba, Chiara/AAS-7421-2020; Cardim, Danilo Augusto/B-8447-2012; Donnelly, Joseph/N-6803-2019	Donnelly, Joseph/0000-0002-6502-8069; Cardim, Danilo Augusto/0000-0002-9261-1321; Donnelly, Joseph/0000-0002-6502-8069; Zeiler, Frederick/0000-0003-1737-0510; czosnyka, marek/0000-0003-2446-8006	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: Medline		ALBERICO AM, 1987, J NEUROSURG, V67, P648, DOI 10.3171/jns.1987.67.5.0648; AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cushing H., 1926, 3 CIRCULATION STUDIE; CZOSNYKA M, 1994, INT J CLIN MONIT COM, V11, P223, DOI 10.1007/BF01139874; Czosnyka M, 2005, ACT NEUR S, V95, P341; Czosnyka M, 1996, ACTA NEUROCHIR, V138, P531, DOI 10.1007/BF01411173; Donnelly J, 2017, J CEREBR BLOOD F MET, V37, P694, DOI 10.1177/0271678X16639060; Eide PK, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-14; Hall A, 2016, ACTA NEUROCHIR, V158, P1997, DOI 10.1007/s00701-016-2932-z; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Hutchinson PJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1000; KUSSKE JA, 1973, J NEUROSURG, V38, P591, DOI 10.3171/jns.1973.38.5.0591; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; LOFGREN J, 1973, ACTA NEUROL SCAND, V49, P557; Lu CW, 2012, BRAIN, V135, P2399, DOI 10.1093/brain/aws155; MARMAROU A, 1978, J NEUROSURG, V48, P332, DOI 10.3171/jns.1978.48.3.0332; MILLER JD, 1974, INJURY, V5, P265, DOI 10.1016/S0020-1383(74)80021-5; Patel HC, 2002, INTENS CARE MED, V28, P547, DOI 10.1007/s00134-002-1235-4; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Smielewski P, 2005, ACT NEUR S, V95, P43; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Varsos GV, 2014, NEUROCRIT CARE, V20, P40, DOI 10.1007/s12028-013-9913-3; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678	27	18	19	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2018	28	2					212	220		10.1007/s12028-017-0475-7			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GF5GM	WOS:000431994700011	29043546				2022-02-06	
J	Foley, KL; Hebela, N; Keenan, MA; Pignolo, RJ				Foley, Kristin L.; Hebela, Nader; Keenan, Mary Ann; Pignolo, Robert J.			Histopathology of periarticular non-hereditary heterotopic ossification	BONE			English	Article						Heterotopic ossification; Injury; Arthropathy; Traumatic brain injury; Cerebrovascular accident; Trauma; Spinal cord injury; Arthroplasty; Aging	TOTAL KNEE ARTHROPLASTY; ECTOPIC BONE-FORMATION; TOTAL HIP-ARTHROPLASTY; SPINAL-CORD-INJURY; HEAD-INJURIES; PROGRESSIVA; RECEPTOR; MICE; MANAGEMENT; INDUCTION	In the mature adult skeleton, new bone formation is normally restricted to regeneration of osseous tissue at sites of fracture. However, heterotopic ossification, or the formation of bone outside the normal skeleton, can occur within muscle, adipose, or fibrous connective tissue. Periarticular non-hereditary heterotopic ossification (NHHO) may occur after musculoskeletal trauma, following CNS injury, with certain arthropathies, or following injury or surgery that is often sustained in the context of age-related pathology. The histological mechanism of bone development in these forms of heterotopic ossification has thus far been uncharacterized. We performed a histological analysis of 90 bone specimens from 18 patients with NHHO secondary to defined precipitating conditions, including traumatic brain injury, spinal cord injury. cerebrovascular accident, trauma without neurologic injury, and total hip or knee arthroplasty. All bone specimens revealed normal endochondral osteogenesis at heterotopic sites. We defined the order of sequence progression in NHHO lesion formation as occurring through six distinct histological stages: (1) perivascular lymphocytic infiltration, (2) lymphocytic migration into soft tissue, (3) reactive fibroproliferation, (4) neovascularity, (5) cartilage formation, and (6) endochondral bone formation. This study provides the first systematic evaluation of the predominant histopathological findings associated with multiple forms of NHHO and shows that they share a common mechanism of lesion formation. (C) 2017 Elsevier Inc All rights reserved.	[Foley, Kristin L.] Boston Osteopath Hlth, Worcester, MA USA; [Foley, Kristin L.] Univ Massachusetts, Med Sch, Worcester, MA USA; [Foley, Kristin L.] Boston Osteopath Hlth, Newton, MA USA; [Foley, Kristin L.] Univ Massachusetts, Med Sch, Newton, MA USA; [Hebela, Nader] Cleveland Clin Abu Dhabi, Neurol Inst, Abu Dhabi, U Arab Emirates; [Keenan, Mary Ann] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Pignolo, Robert J.] Mayo Clin, Sch Med, Dept Med, Rochester, MN USA		Pignolo, RJ (corresponding author), Mayo Clin, Coll Med, Div Geriatr Med & Gerontol, 200 First St SW, Rochester, MN 55905 USA.	klfoleydo@aol.com; Meekanm@comcast.net; Pignolo.Robert@mayo.edu	Keenan, Mary Ann/ABB-1551-2020		Ian Cali Distinguished Clinician-Scientist award at the University of Pennsylvania; Robert and Arlene Professorship in Geriatric Medicine at the Mayo Clinic; Radiant Hope Foundation	This work was supported by the Ian Cali Distinguished Clinician-Scientist award at the University of Pennsylvania, the Robert and Arlene Professorship in Geriatric Medicine at the Mayo Clinic, and the Radiant Hope Foundation.	ACKERMAN LV, 1958, J BONE JOINT SURG AM, V40, P279, DOI 10.2106/00004623-195840020-00004; AUSTIN KS, 1995, J ARTHROPLASTY, V10, P695, DOI 10.1016/S0883-5403(05)80219-0; Barrack RL, 2002, CLIN ORTHOP RELAT R, P208, DOI 10.1097/01.blo.0000030497.43495.3f; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; Burd TA, 2001, J BONE JOINT SURG AM, V83A, P1783, DOI 10.2106/00004623-200112000-00003; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chakkalakal SA, 2016, J BONE MINER RES, V31, P1666, DOI 10.1002/jbmr.2820; Chua KSG, 2003, BRAIN INJURY, V17, P535, DOI 10.1080/0269905021000010104; Dalury DF, 2004, J ARTHROPLASTY, V19, P447, DOI 10.1016/j.arth.2003.12.064; DiCaprio MR, 2004, ORTHOPEDICS, V27, P41; Dua SG, 2011, CLIN NUCL MED, V36, P952, DOI 10.1097/RLU.0b013e31821a28b1; Fukuda T, 2006, GENESIS, V44, P159, DOI 10.1002/dvg.20201; FURIA JP, 1995, J ARTHROPLASTY, V10, P413, DOI 10.1016/S0883-5403(05)80139-1; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Glaser DL, 2003, J BONE JOINT SURG AM, V85A, P2332, DOI 10.2106/00004623-200312000-00010; Hatsell SJ, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4358; Jamil F, 2002, SPINAL CORD, V40, P388, DOI 10.1038/sj.sc.3101305; JEE WSS, 1987, BONE, V8, P171, DOI 10.1016/8756-3282(87)90017-2; Joshi AB, 2002, J ARTHROPLASTY, V17, P427, DOI 10.1054/arth.2002.32170; Kan LX, 2004, AM J PATHOL, V165, P1107, DOI 10.1016/S0002-9440(10)63372-X; KAPLAN FS, 1993, J BONE JOINT SURG AM, V75A, P220, DOI 10.2106/00004623-199302000-00009; Keenan MAE, 1996, J HEAD TRAUMA REHAB, V11, P8, DOI 10.1097/00001199-199608000-00004; MENDELSON L, 1975, SCAND J REHABIL MED, V7, P141; MITAL MA, 1987, J PEDIATR ORTHOPED, V7, P83, DOI 10.1097/01241398-198701000-00017; Mohler ER, 2001, CIRCULATION, V103, P1522, DOI 10.1161/01.cir.103.11.1522; Moore T J, 1993, J Orthop Trauma, V7, P11, DOI 10.1097/00005131-199302000-00003; Neal B, 2002, ANZ J SURG, V72, P808, DOI 10.1046/j.1445-2197.2002.02549.x; Nilsson Olle S., 1999, Current Opinion in Rheumatology, V11, P127, DOI 10.1097/00002281-199903000-00008; ORZEL JA, 1985, J NUCL MED, V26, P125; Pauli S, 2000, ANGIOLOGY, V51, P77, DOI 10.1177/000331970005100112; Pignolo RJ, 2005, CLIN REV BONE MINER, V3, P261, DOI 10.1385/BMM:3:3-4:261; Pignolo RJ, 2005, CLIN REV BONE MINER, V3, P195, DOI 10.1385/BMM:3:3-4:195; Pignolo RJ, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-80; Rader GP, 1997, ACTA ORTHOP SCAND, V68, P46, DOI 10.3109/17453679709003974; Ranganathan K, 2015, J BONE JOINT SURG AM, V97A, P1101, DOI 10.2106/JBJS.N.01056; Schurch B, 1997, ARCH PHYS MED REHAB, V78, P687, DOI 10.1016/S0003-9993(97)90074-5; SCUTT A, 1995, J BONE MINER RES, V10, P474; Shimono K, 2011, NAT MED, V17, P454, DOI 10.1038/nm.2334; Shore EM, 2006, NAT GENET, V38, P525, DOI 10.1038/ng1783; Sterner T, 2005, ARCH ORTHOP TRAUM SU, V125, P188, DOI 10.1007/s00402-005-0797-3; Stoeger T, 2002, GROWTH FACTORS, V20, P197, DOI 10.1080/0897719021000069579; van Kuijk AA, 2002, SPINAL CORD, V40, P313, DOI 10.1038/sj.sc.3101309; Webb L X, 1990, J Orthop Trauma, V4, P376, DOI 10.1097/00005131-199012000-00002	43	18	19	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	APR	2018	109				SI		65	70		10.1016/j.bone.2017.12.006			6	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	GB5DK	WOS:000429082400011	29225159				2022-02-06	
J	Kimbrel, NA; Meyer, EC; DeBeer, BB; Gulliver, SB; Morissette, SB				Kimbrel, Nathan A.; Meyer, Eric C.; DeBeer, Bryann B.; Gulliver, Suzy B.; Morissette, Sandra B.			The Impact of Cannabis Use Disorder on Suicidal and Nonsuicidal Self-Injury in Iraq/Afghanistan-Era Veterans with and without Mental Health Disorders	SUICIDE AND LIFE-THREATENING BEHAVIOR			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WAR VETERANS; PTSD; SCALE; HARM; COMORBIDITY; PREVALENCE; DEPRESSION; PREDICTOR; MARIJUANA	The objective of this study was to assess the association between cannabis use disorder (CUD) and self-injury among veterans. As expected, after adjusting for sex, age, sexual orientation, combat exposure, traumatic life events, traumatic brain injury, posttraumatic stress disorder, depression, alcohol use disorder, and noncannabis drug use disorder, CUD was significantly associated with both suicidal (OR=3.10, p=.045) and nonsuicidal (OR=5.12, p=.009) self-injury. CUD was the only variable significantly associated with self-injury in all three models examined. These findings are consistent with prior research among civilians and suggest that CUD may also increase veterans' risk for self-injurious behavior.	[Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA; [Kimbrel, Nathan A.] VA Mid Atlantic Mental Illness Res Educ & Clin Ct, Durham, NC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Durham, NC USA; [Meyer, Eric C.; DeBeer, Bryann B.] VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX USA; [Meyer, Eric C.; DeBeer, Bryann B.] Cent Texas Vet Hlth Care Syst, Temple, TX USA; [Meyer, Eric C.; DeBeer, Bryann B.] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX USA; [Gulliver, Suzy B.] Baylor Scott & White Healthcare Syst, Warriors Res Inst, Waco, TX USA; [Morissette, Sandra B.] Univ Texas San Antonio, San Antonio, TX USA		Kimbrel, NA (corresponding author), Durham Vet Affairs Med Ctr, 508 Fulton St, Durham, NC 27705 USA.	Nathan.Kimbrel@va.gov	Gulliver, Suzy/X-9776-2019; Kimbrel, Nathan/P-3109-2016	Gulliver, Suzy Bird/0000-0002-6476-9447; Kimbrel, Nathan/0000-0001-7218-1005	Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD) [I01RX000304]; RR&D Service of VA ORD [I01RX000304-04]; Clinical Science Research and Development (CSR&D) Service of VA ORD [I01 CX001486]; CSR&D Service of VA ORD [IK2 CX000525]; VA VISN 17 Center of Excellence for Research on Returning War Veterans; Central Texas Veterans Health Care System; VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center; Research & Development and Mental Health Services of the Durham VA Medical Center; Veterans AffairsUS Department of Veterans Affairs [I01CX001486, IK2CX000525, I01RX000304] Funding Source: NIH RePORTER	This work was supported by Merit Award #I01RX000304 to Dr. Morissette from the Rehabilitation Research and Development (RR&D) Service of the Department of Veterans Affairs (VA) Office of Research and Development (ORD), Merit Award #I01RX000304-04 to Dr. Meyer from the RR&D Service of VA ORD, and Merit Award #I01 CX001486 to Dr. Kimbrel from the Clinical Science Research and Development (CSR&D) Service of VA ORD. Dr. Kimbrel was also supported by a Career Development Award (#IK2 CX000525) from the CSR&D Service of VA ORD. This research was also supported by the VA VISN 17 Center of Excellence for Research on Returning War Veterans, the Central Texas Veterans Health Care System, the VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center, and the Research & Development and Mental Health Services of the Durham VA Medical Center. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the U.S. government.	Belendiuk KA, 2015, ADDICT SCI CLIN PRAC, V10, DOI 10.1186/s13722-015-0032-7; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Boden MT, 2013, AM J ADDICTION, V22, P277, DOI 10.1111/j.1521-0391.2012.12018.x; Bonn-Miller MO, 2007, J TRAUMA STRESS, V20, P577, DOI 10.1002/jts.20243; Bonn-Miller MO, 2012, PSYCHOL SERV, V9, P404, DOI 10.1037/a0027622; Borges G, 2016, J AFFECT DISORDERS, V195, P63, DOI 10.1016/j.jad.2016.02.007; Bremner JD, 1996, AM J PSYCHIAT, V153, P369; Bryan CJ, 2015, COMPR PSYCHIAT, V59, P1, DOI 10.1016/j.comppsych.2014.07.009; BULLMAN TA, 1994, J NERV MENT DIS, V182, P604, DOI 10.1097/00005053-199411000-00002; Chapman AL, 2006, BEHAV RES THER, V44, P371, DOI 10.1016/j.brat.2005.03.005; Cheung JTW, 2010, AM J DRUG ALCOHOL AB, V36, P118, DOI 10.3109/00952991003713784; Curran HV, 2016, NAT REV NEUROSCI, V17, P293, DOI 10.1038/nrn.2016.28; Delforterie MJ, 2015, DRUG ALCOHOL DEPEN, V150, P98, DOI 10.1016/j.drugalcdep.2015.02.019; Few LR, 2016, J STUD ALCOHOL DRUGS, V77, P873, DOI 10.15288/jsad.2016.77.873; First M.B., 1994, STRUCTURAL CLIN INTE, Vsecond; Gentes EL, 2016, PSYCHOL ADDICT BEHAV, V30, P415, DOI 10.1037/adb0000154; Giletta M, 2012, PSYCHIAT RES, V197, P66, DOI 10.1016/j.psychres.2012.02.009; Goldman M, 2010, J ADDICT MED, V4, P47, DOI 10.1097/ADM.0b013e3181b18782; Gratz KL, 2015, ASSESSMENT, V22, P527, DOI 10.1177/1073191114565878; Hall W, 2004, DRUG ALCOHOL REV, V23, P433, DOI 10.1080/09595230412331324554; Hoch E, 2015, DTSCH ARZTEBL INT, V112, P271, DOI 10.3238/arztebl.2015.0271; Joshi M, 2014, CURR OPIN PULM MED, V20, P173, DOI 10.1097/MCP.0000000000000026; Kimbrel NA, 2017, WORLD PSYCHIATRY, V16, P108, DOI 10.1002/wps.20358; Kimbrel NA, 2016, PSYCHIAT RES, V243, P232, DOI 10.1016/j.psychres.2016.06.039; Kimbrel NA, 2016, PSYCHIAT RES, V243, P97, DOI 10.1016/j.psychres.2016.06.011; Kimbrel NA, 2015, PSYCHIAT RES, V227, P360, DOI 10.1016/j.psychres.2015.03.026; Kimbrel NA, 2014, PSYCHIAT RES, V220, P1118, DOI 10.1016/j.psychres.2014.08.053; Kimbrel NA, 2014, PSYCHIAT RES, V220, P397, DOI 10.1016/j.psychres.2014.07.064; Kimbrel NA, 2014, J TRAUMA STRESS, V27, P474, DOI 10.1002/jts.21932; Klonsky ED, 2011, PSYCHOL MED, V41, P1981, DOI 10.1017/S0033291710002497; Kubany ES, 2000, PSYCHOL ASSESSMENT, V12, P210, DOI 10.1037//1040-3590.12.2.210; Moller CI, 2013, ADDICTION, V108, P211, DOI 10.1111/j.1360-0443.2012.04021.x; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; Selby EA, 2015, CLIN PSYCHOL REV, V38, P79, DOI 10.1016/j.cpr.2015.03.003; Selby EA, 2012, PERSONAL DISORD, V3, P167, DOI 10.1037/a0024405; Sherman BJ, 2016, PHARMACOTHERAPY, V36, P511, DOI 10.1002/phar.1747; United Nations Office on Drugs and Crime, 2014, WORLD DRUG REP 2014; van Ours JC, 2013, J HEALTH ECON, V32, P524, DOI 10.1016/j.jhealeco.2013.02.002; Vasterling J. J., 2008, TBI SCREENING UNPUB	39	18	18	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0363-0234	1943-278X		SUICIDE LIFE-THREAT	Suicide Life-Threat. Behav.	APR	2018	48	2					140	148		10.1111/sltb.12345			9	Psychiatry; Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychiatry; Psychology	GC8QX	WOS:000430062400002	28295524	Green Accepted			2022-02-06	
J	Pagulayan, KF; Rau, H; Madathil, R; Werhane, M; Millard, SP; Petrie, EC; Parmenter, B; Peterson, S; Sorg, S; Hendrickson, R; Mayer, C; Meabon, JS; Huber, BR; Raskind, M; Cook, DG; Peskind, ER				Pagulayan, Kathleen F.; Rau, Holly; Madathil, Renee; Werhane, Madeleine; Millard, Steven P.; Petrie, Eric C.; Parmenter, Brett; Peterson, Sarah; Sorg, Scott; Hendrickson, Rebecca; Mayer, Cindy; Meabon, James S.; Huber, Bertrand R.; Raskind, Murray; Cook, David G.; Peskind, Elaine R.			Retrospective and Prospective Memory Among OEF/OIF/OND Veterans With a Self-Reported History of Blast-Related mTBI	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Brain Concussion; Veteran; Iraq War; Memory; PTSD; Cognition	TRAUMATIC BRAIN-INJURY; INTENTIONS SCREENING-TEST; WHITE-MATTER ABNORMALITIES; NEUROPSYCHOLOGICAL OUTCOMES; FUNCTIONAL CONNECTIVITY; EXECUTIVE FUNCTION; OIF/OEF VETERANS; SERVICE MEMBERS; WORKING-MEMORY; HIV-INFECTION	Objectives: To evaluate prospective and retrospective memory abilities in Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) Veterans with and without a self-reported history of blast-related mild traumatic brain injury (mTBI). Methods: Sixty-one OEF/OIF/OND Veterans, including Veterans with a self-reported history of blast-related mTBI (mTBI group; n=42) and Veterans without a self-reported history of TBI (control group; n=19) completed the Memory for Intentions Test, a measure of prospective memory (PM), and two measures of retrospective memory (RM), the California Verbal Learning Test-II and the Brief Visuospatial Memory Test-Revised. Results: Veterans in the mTBI group exhibited significantly lower PM performance than the control group, but the groups did not differ in their performance on RM measures. Further analysis revealed that Veterans in the mTBI group with current PTSD (mTBI/PTSD+) demonstrated significantly lower performance on the PM measure than Veterans in the control group. PM performance by Veterans in the mTBI group without current PTSD (mTBI/PTSD-) was intermediate between the mTBI/PTSD+ and control groups, and results for the mTBI/PTSD- group were not significantly different from either of the other two groups. Conclusions: Results suggest that PM performance may be a sensitive marker of cognitive dysfunction among OEF/OIF/OND Veterans with a history of self-reported blast-related mTBI and comorbid PTSD. Reduced PM may account, in part, for complaints of cognitive difficulties in this Veteran cohort, even years post-injury.	[Pagulayan, Kathleen F.; Rau, Holly; Madathil, Renee; Millard, Steven P.; Petrie, Eric C.; Parmenter, Brett; Peterson, Sarah; Hendrickson, Rebecca; Mayer, Cindy; Meabon, James S.; Raskind, Murray; Peskind, Elaine R.] Vet Affairs Puget Sound Hlth Care Syst, MIRECC, Vet Affairs VA Northwest Network VISN 20, Seattle, WA 98108 USA; [Pagulayan, Kathleen F.; Petrie, Eric C.; Parmenter, Brett; Meabon, James S.; Raskind, Murray; Peskind, Elaine R.] Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Werhane, Madeleine] San Diego State Univ Univ Calif San Diego SDSU UC, San Diego, CA USA; [Werhane, Madeleine; Sorg, Scott] VASDHS, San Diego, CA USA; [Millard, Steven P.; Cook, David G.] Vet Affairs Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98108 USA; [Huber, Bertrand R.] Vet Adm, Jamaica Plain, MA USA; [Huber, Bertrand R.] Boston Univ, Dept Neurol, Boston, MA USA; [Cook, David G.] Univ Washington, Sch Med, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA; [Cook, David G.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA		Pagulayan, KF (corresponding author), VA Puget Sound Hlth Care Syst, Mail Code S-116 MIRECC,1660 South Columbian Way, Seattle, WA 98108 USA.	farkat@u.washington.edu	Pagulayan, Kati/AAR-9225-2020; Madathil, Renee/AAK-5492-2020; Hendrickson, Rebecca/I-4923-2017	Hendrickson, Rebecca/0000-0003-2377-823X; Petrie, Eric/0000-0003-1188-6321	Department of Veterans Affairs VA Clinical Science Research and Development (R&D) Career Development Award [IK2 CX000516, CX001508-02]; Rehabilitation R&D Service Merit Review Award [B77421]; VA Northwest Network MIRECC; Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs, National Institute of Health [T32 AG000258]; Department of Veterans Affairs Office of R&D Medical Research Service; Veterans AffairsUS Department of Veterans Affairs [I01RX000521, I01RX001612] Funding Source: NIH RePORTER	This material is based on work supported by the Department of Veterans Affairs VA Clinical Science Research and Development (R&D) Career Development Award IK2 CX000516 (K.F.P.) and Award CX001508-02 (S.S.); Rehabilitation R&D Service Merit Review Award B77421 (E.R.P.); VA Northwest Network MIRECC (E.R.P., B.R.H., M.A.R., K.F.P., H.R., E.C.P., C.M., J.S.M., B.R.H.); Office of Academic Affiliations, Advanced Fellowship Program in Mental Illness Research and Treatment, Department of Veterans Affairs (B.R.H.), National Institute of Health T32 AG000258 (J.S.M.); Department of Veterans Affairs Office of R&D Medical Research Service (D.G.C., E.R.P.); and an anonymous foundation. The authors have no conflicts of interest to report.	Altgassen M, 2009, COGNITION EMOTION, V23, P1041, DOI 10.1080/02699930802284158; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict R., 1997, BRIEF VISUOSPATIAL M; Blake D. D., 1990, BEHAV THER, V13, P187, DOI DOI 10.1007/BF02105408; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Butcher J.N., 1989, MANUAL RESTANDARDIZE; Carey CL, 2006, J CLIN EXP NEUROPSYC, V28, P536, DOI 10.1080/13803390590949494; Cohen J., 2013, STAT POWER ANAL BEHA; Contardo C, 2009, ARCH CLIN NEUROPSYCH, V24, P547, DOI 10.1093/arclin/acp046; Cooper DB, 2011, BRAIN INJURY, V25, P1, DOI 10.3109/02699052.2010.531692; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Dawson DR, 2009, ARCH PHYS MED REHAB, V90, pS41, DOI 10.1016/j.apmr.2009.07.012; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Drag LL, 2012, J INT NEUROPSYCH SOC, V18, P576, DOI 10.1017/S1355617712000203; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; Etkin Amit, 2013, Dialogues Clin Neurosci, V15, P419; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Fleming JM, 2005, BRAIN INJURY, V19, P1, DOI 10.1080/02699050410001720059; Foa E.B., 2007, PROLONGED EXPOSURE T; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Gonneaud J, 2014, HUM BRAIN MAPP, V35, P3066, DOI 10.1002/hbm.22385; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; Grundgeiger T, 2014, MEMORY, V22, P679, DOI 10.1080/09658211.2013.812220; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOLM S, 1979, SCAND J STAT, V6, P65; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; JOHNSTONE B, 1995, NEUROREHABILITATION, V5, P75, DOI 10.3233/NRE-1995-5107; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Kamat R, 2014, ASSESSMENT, V21, P742, DOI 10.1177/1073191114530774; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P74, DOI [DOI 10.1097/00001199-199309000-00009, 10.1097/00001199-199309000-00009]; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; Kliegel M., 2008, PROSPECTIVE MEMORY; Kliegel M, 2011, NEUROPSYCHOLOGIA, V49, P2166, DOI 10.1016/j.neuropsychologia.2011.01.024; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; LEVIN JR, 1994, PSYCHOL BULL, V115, P153, DOI 10.1037/0033-2909.115.1.153; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Ling J, 2007, PSYCHOSOM MED, V69, P144, DOI 10.1097/PSY.0b013e31802e0f22; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Marshall AM, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00075; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; McCrea M.A., 2008, MILD TRAUAMATIC BRAI; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Meabon J.S., 2016, SCI TRANSL MED, V8, P1; Millard S.P., 2013, ENVSTATS R PACKAGE E; Morey L.C., 2007, PERSONALITY ASSESSME; Nelson NW, 2012, J INT NEUROPSYCH SOC, V18, P845, DOI 10.1017/S1355617712000616; Nelson NW, 2011, BRAIN INJURY, V25, P511, DOI 10.3109/02699052.2011.558040; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Newsome MR, 2016, J INT NEUROPSYCH SOC, V22, P631, DOI 10.1017/S1355617716000448; Newsome MR, 2015, NEUROIMAGE-CLIN, V8, P543, DOI 10.1016/j.nicl.2015.04.024; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Neil ME, 2014, J INT NEUROPSYCH SOC, V20, P249, DOI [10.1017/S1355617714000204, 10.1017/S135561771300146X]; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Paxton J, 2014, J INT NEUROPSYCH SOC, V20, P673, DOI 10.1017/S1355617714000575; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pietrzak RH, 2010, J AFFECT DISORDERS, V123, P102, DOI 10.1016/j.jad.2009.08.001; Poquette AJ, 2013, J INT NEUROPSYCH SOC, V19, P155, DOI 10.1017/S1355617712001051; R Core Team, 2017, R LANG ENV STAT COMP; Raskin S., 2010, MEMORY INTENTIONS TE; Raskin SA, 2012, NEUROPSYCHOL REHABIL, V22, P40, DOI 10.1080/09602011.2011.632908; Raskin SA, 2009, BRAIN IMPAIR, V10, P76, DOI 10.1375/brim.10.1.76; Raskin SA, 2009, BRAIN IMPAIR, V10, P23, DOI 10.1375/brim.10.1.23; Resick P. A., 2008, COGNITIVE PROCESSING; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Scott J.C., 2016, J INT NEUROPSYCH SOC, V22, P1; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Shum D, 2011, J REHABIL MED, V43, P216, DOI 10.2340/16501977-0647; Spencer RJ, 2010, J REHABIL RES DEV, V47, P521, DOI 10.1682/JRRD.2009.11.0181; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Storzbach D, 2017, J HEAD TRAUMA REHAB, V32, P16, DOI 10.1097/HTR.0000000000000228; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Tator CH, 2016, J NEUROSURG, V125, P1206, DOI 10.3171/2015.6.JNS15664; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Vanderploeg RD, 2012, J REHABIL RES DEV, V49, P545, DOI 10.1682/JRRD.2011.04.0069; Vasterling J.J., 2005, NEUROPSYCHOLOGY PTSD, P178; Vedhara K., 2004, PSYCHOL HLTH MED, V9; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Walker WC, 2015, J NEUROTRAUM, V32, P464, DOI 10.1089/neu.2014.3433; Weathers F., 1993, 9 ANN C ISTSS SAN AN; WechslerD, 2001, WECHSLER TEST ADULT; Woods SP, 2008, CLIN NEUROPSYCHOL, V22, P864, DOI 10.1080/13854040701595999; Woods SP, 2011, REHABIL PSYCHOL, V56, P77, DOI 10.1037/a0022753; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zogg JB, 2010, CLIN NEUROPSYCHOL, V24, P945, DOI 10.1080/13854046.2010.501343	99	18	18	2	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	APR	2018	24	4					324	334		10.1017/S1355617717001217			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GA1JR	WOS:000428072200002	29284552				2022-02-06	
J	Russell, RT; McDaniel, JK; Cao, WJ; Shroyer, M; Wagener, BM; Zheng, XL; Pittet, JF				Russell, Robert T.; McDaniel, Jenny K.; Cao, Wenjing; Shroyer, Michelle; Wagener, Brant M.; Zheng, X. Long; Pittet, Jean-Francois			Low Plasma ADAMTS13 Activity Is Associated with Coagulopathy, Endothelial Cell Damage and Mortality after Severe Paediatric Trauma	THROMBOSIS AND HAEMOSTASIS			English	Article						paediatric; trauma; injury; coagulopathy; ADAMTS13; von Willebrand Factor; human neutrophil peptide	VON-WILLEBRAND-FACTOR; HUMAN NEUTROPHIL PEPTIDES; PROTEIN-C PATHWAY; BRAIN-INJURY; GLYCOCALYX DEGRADATION; INFLAMMATORY CYTOKINES; ALPHA-DEFENSINS; ORGAN FAILURE; CLEAVAGE; THROMBOSPONDIN-1	Decrease of plasma activity of ADAMTS13, a metalloenzyme that cleaves von Willebrand factor (VWF) and prevents adhesion and aggregation of platelets, has been reported early after onset of systemic inflammation resulting from infections and after severe trauma. Here, we determined whether trauma-induced systemic (sterile) inflammation would be associated with a reduction of plasma ADAMTS13 activity in paediatric patients and its association with disease severity and outcome. Paediatric patients ( n =106) with severe trauma at a level 1 paediatric trauma centre between 2014 and 2016 were prospectively enrolled. Blood samples were collected upon arrival and at 24 hours and analysed for plasma levels of ADAMTS13 activity, VWF antigen, collagen binding activity, human neutrophil peptides (HNP) 1-3, coagulation abnormalities, endothelial glycocalyx damage and clinical outcome. Plasma samples were also collected for similar measurements from 52 healthy paediatric controls who underwent elective minor surgery. The median age of patients was 9 years with 81% sustaining blunt trauma. The median injury severity score was 22 and the mortality rate was 11%. Plasma levels of ADAMTS13 activity were significantly lower and plasma levels of VWF antigen and HNP 1-3 proteins were significantly higher for paediatric trauma patients on admission and at 24 hours when compared with controls. Finally, the lowest plasma ADAMTS13 activity was found in patients who died from their injuries. We conclude that relative plasma deficiency of ADAMTS13 activity may be associated with more severe traumatic injury, significant endothelial glycocalyx damage, coagulation abnormalities and mortality after severe trauma in paediatric patients.	[Russell, Robert T.; Shroyer, Michelle] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35249 USA; [McDaniel, Jenny K.; Cao, Wenjing; Zheng, X. Long] Univ Alabama Birmingham, Dept Pathol, Div Lab Med, WP230K,619 19th St South, Birmingham, AL 35249 USA; [Wagener, Brant M.; Pittet, Jean-Francois] Univ Alabama Birmingham, Dept Anesthesiol & Perioperat Med, Birmingham, AL 35249 USA		Zheng, XL (corresponding author), Univ Alabama Birmingham, Dept Pathol, Div Lab Med, WP230K,619 19th St South, Birmingham, AL 35249 USA.	xzheng@uabmc.edu	Zheng, X. Long/ABD-7362-2021; Wagener, Brant/AAI-7480-2020	Russell, Robert/0000-0002-8531-4249; Zheng, X. Long/0000-0003-1680-5295	American College of Surgeons C. James Carrico Fellowship [HL115187, R01 HL126724]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL126724, R01HL115187] Funding Source: NIH RePORTER	This study is supported in part by the American College of Surgeons C. James Carrico Fellowship (to R.T.R.), R01 HL126724 (to X.L.Z.) and HL115187 (to X.L.Z).	Albers JM, 2012, CEREBROVASC DIS, V33, P403, DOI 10.1159/000335826; Bandyopadhyay G, 2014, J LEUKOCYTE BIOL, V96, P797, DOI 10.1189/jlb.4MA0214-077R; Bernardo A, 2004, BLOOD, V104, P100, DOI 10.1182/blood-2004-01-0107; Bonnefoy A, 2006, BLOOD, V107, P955, DOI 10.1182/blood-2004-12-4856; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Cao WJ, 2008, J THROMB HAEMOST, V6, P1233, DOI 10.1111/j.1538-7836.2008.02989.x; Cao WJ, 2016, HAEMATOLOGICA, V101, P1319, DOI 10.3324/haematol.2016.149021; Chinen Y, 2013, INT J HEMATOL, V97, P511, DOI 10.1007/s12185-013-1308-x; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Christiaans SC, 2013, AM J PHYSIOL-LUNG C, V305, pL455, DOI 10.1152/ajplung.00093.2013; Christian CW, 2010, PEDIATRICS, V126, P592, DOI 10.1542/peds.2010-2006; Cohan MJ, 2007, J TRAUMA, V63, P1254, DOI 10.1097/TA.0b013e318156ee4c; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Ganter MT, 2007, SHOCK, V28, P29, DOI 10.1097/shk.0b013e3180342439; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; Ganz T, 1999, SCIENCE, V286, P420, DOI 10.1126/science.286.5439.420; Hack CE, 2001, CRIT CARE MED, V29, pS21, DOI 10.1097/00003246-200107001-00011; Hendrickson J E, 2012, J PEDIAT, V160, P204; Horn M, 2012, J THROMB HAEMOST, V10, P647, DOI 10.1111/j.1538-7836.2012.04640.x; Hovinga JAK, 2007, J THROMB HAEMOST, V5, P2284; Hyun J, 2009, THROMB RES, V124, P75, DOI 10.1016/j.thromres.2008.11.020; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Johansson Par I, 2013, J Emerg Trauma Shock, V6, P171, DOI 10.4103/0974-2700.115327; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kokame K, 2005, BRIT J HAEMATOL, V129, P93, DOI 10.1111/j.1365-2141.2005.05420.x; Kozar RA, 2015, J TRAUMA ACUTE CARE, V78, pS83, DOI 10.1097/TA.0000000000000631; Kumar M, 2017, THROMB HAEMOSTASIS, V117, P691, DOI 10.1160/TH16-11-0834; Lao ZQ, 2012, INT J PREVENTIVE MED, V3, P303; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Lehrer RI, 2012, IMMUNOL REV, V245, P84, DOI 10.1111/j.1600-065X.2011.01082.x; Liras IN, 2017, J AM COLL SURGEONS, V224, P625, DOI 10.1016/j.jamcollsurg.2016.12.046; Liu L, 2005, J THROMB HAEMOST, V3, P2536, DOI 10.1111/j.1538-7836.2005.01561.x; Mannucci PM, 2004, BRIT J HAEMATOL, V126, P213, DOI 10.1111/j.1365-2141.2004.05009.x; Martin K, 2007, CRIT CARE MED, V35, P2375, DOI 10.1097/01.CCM.0000284508.05247.B3; Meiring M, 2016, INT J MED SCI, V13, P759, DOI 10.7150/ijms.15688; Mimuro J, 2008, THROMB RES, V122, P91, DOI 10.1016/j.thromres.2007.09.011; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Ostrowski SR, 2012, J TRAUMA ACUTE CARE, V73, P60, DOI 10.1097/TA.0b013e31825b5c10; Pillai VG, 2016, BLOOD, V128, P110, DOI 10.1182/blood-2015-12-688747; Rahbar E, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0481-5; Raife TJ, 2009, BLOOD, V114, P1666, DOI 10.1182/blood-2009-01-195461; Rodriguez EG, 2017, J AM COLL SURGEONS, V225, P419, DOI 10.1016/j.jamcollsurg.2017.05.012; Russell RT, 2018, SHOCK, V49, P44, DOI 10.1097/SHK.0000000000000902; Schrieber M, 2007, J TRAUMA, V63, P1261; Schwameis M, 2015, THROMB HAEMOSTASIS, V113, P708, DOI 10.1160/TH14-09-0731; Shang DZ, 2006, BLOOD, V108, P2207, DOI 10.1182/blood-2006-02-002139; Soares RPS, 2013, CLINICS, V68, P531, DOI 10.6061/clinics/2013(04)15; Suominen P, 1998, INJURY, V29, P425; Tang N, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-70; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb; Xie LJ, 2001, J EXP MED, V193, P1341, DOI 10.1084/jem.193.12.1341	51	18	18	0	5	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0340-6245	2567-689X		THROMB HAEMOSTASIS	Thromb. Haemost.	APR	2018	118	4					676	687		10.1055/s-0038-1636528			12	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	GB5JP	WOS:000429100700007	29618154	Green Accepted			2022-02-06	
J	Clevenger, AC; Kim, H; Salcedo, E; Yonchek, JC; Rodgers, KM; Orfila, JE; Dietz, RM; Quillinan, N; Traystman, RJ; Herson, PS				Clevenger, Amy C.; Kim, Hoon; Salcedo, Ernesto; Yonchek, Joan C.; Rodgers, Krista M.; Orfila, James E.; Dietz, Robert M.; Quillinan, Nidia; Traystman, Richard J.; Herson, Paco S.			Endogenous Sex Steroids Dampen Neuroinflammation and Improve Outcome of Traumatic Brain Injury in Mice	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Traumatic brain injury; sex differences; Sex steroids; Stereology; Neuroinflammation	GENDER-DIFFERENCES; ESTROGEN; MODERATE; PREDICTORS; DIFFERENCE; IMPACT; NEUROPROTECTION; PROGESTERONE; DIMORPHISM; SEVERITY	The role of biological sex in short-term and long-term outcome after traumatic brain injury (TBI) remains controversial. The observation that exogenous female sex steroids (progesterone and estrogen) reduce brain injury coupled with a small number of clinical studies showing smaller injury in women suggest that sex steroids may play a role in outcome from TBI. We used the controlled cortical impact (CCI) model of TBI in mice to test the hypothesis that after CCI, female mice would demonstrate less injury than male mice, related to the protective role of endogenous steroids. Indeed, adult females exhibit histological protection (3.7 +/- 0.5 mm(3)) compared to adult male mice (6.8 +/- 0.6 mm(3)), and females that lacked sex steroids (ovex) showed increased injury compared to intact females. Consistent with histology, sensorimotor deficits measured as reduced contralateral limb use were most pronounced in male mice (31.9 +/- 6.9% reduced limb use) compared to a 12.7 +/- 3.8% reduction in female mice. Ovex mice exhibited behavioral deficits similar to males (31.5 +/- 3.9% reduced limb use). Ovex females demonstrated increased microglial activation relative to intact females in both the peri-injury cortex and the reticular thalamic nucleus. Ovex females also demonstrated increased astrogliosis in comparison to both females and males in the peri-injury cortex. These data indicate that female sex steroids reduce brain sensitivity to TBI and that reduced acute neuroinflammation may contribute to the relative protection observed in females.	[Clevenger, Amy C.; Dietz, Robert M.] Childrens Hosp Colorado, Dept Pediat, Anschutz Med Campus,13121 E 17th Ave, Aurora, CO 80045 USA; [Clevenger, Amy C.; Dietz, Robert M.] Univ Colorado Denver, Anschutz Med Campus,13121 E 17th Ave, Aurora, CO 80045 USA; [Kim, Hoon] Chungbuk Natl Univ Hosp, Dept Emergency Med, Coll Med, Chung Dae Ro1, Cheongju, South Korea; [Salcedo, Ernesto] Univ Colorado Denver, Dept Cell & Dev Biol, Anschutz Med Campus,12801 E 17th Ave, Aurora, CO 80045 USA; [Yonchek, Joan C.; Rodgers, Krista M.; Orfila, James E.; Quillinan, Nidia; Traystman, Richard J.; Herson, Paco S.] Univ Colorado Denver, Dept Anesthesiol, Anschutz Med Campus,12800 E 19th Ave, Aurora, CO 80045 USA		Herson, PS (corresponding author), Univ Colorado Denver, Dept Anesthesiol, Anschutz Med Campus,12800 E 19th Ave, Aurora, CO 80045 USA.	Amy.Clevenger@childrenscolorado.org; nichekh2000@hanmail.net; Ernesto.Salcedo@ucdenver.edu; joan.yonchek@ucdenver.edu; krista.rodgers@ucdenver.edu; james.orfila@ucdenver.edu; Robert.Dietz@childrenscolorado.org; nidia.quillinan@ucdenver.edu; richard.traystman@ucdenver.edu; paco.herson@ucdenver.edu	Rodgers, Krista/AAC-5063-2020	RODGERS, KRISTA/0000-0003-4393-6389	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS046072, R01NS092645]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS046072, R01NS092645] Funding Source: NIH RePORTER	We would like to acknowledge Frank Strnad, who completed a portion of the animal perfusions post-injury. We would also like to acknowledge Myriam Moreno Garcia who managed the animal colonies. Funding provided by National Institutes of Health, R01NS046072 (RJT) and R01NS092645 (PSH).	Acaz-Fonseca E, 2015, GLIA, V63, P1966, DOI 10.1002/glia.22867; Albrecht JS, 2016, J TRAUMA ACUTE CARE, V81, P486, DOI 10.1097/TA.0000000000001118; Allen D, 2011, J CEREBR BLOOD F MET, V31, P2302, DOI 10.1038/jcbfm.2011.90; Baum J, 2016, WORLD NEUROSURG, V90, P525, DOI 10.1016/j.wneu.2015.12.012; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Bland ST, 2000, STROKE, V31, P1144, DOI 10.1161/01.STR.31.5.1144; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Coimbra R, 2003, J TRAUMA, V54, P689, DOI 10.1097/01.TA.0000058314.31655.5F; CUTOLO M, 1995, CLIN EXP RHEUMATOL, V13, P217; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Davis DP, 2006, J NEUROTRAUM, V23, P140, DOI 10.1089/neu.2006.23.140; Deng GY, 2017, CELL REP, V18, P1109, DOI 10.1016/j.celrep.2017.01.011; Devitt R, 2006, DISABIL REHABIL, V28, P547, DOI 10.1080/00222930500219258; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Finkelstein EA., 2007, J EPIDEMIOL COMMUNIT, V61, P926, DOI DOI 10.1136/JECH.2007.059717; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Halassa MM, 2016, TRENDS NEUROSCI, V39, P680, DOI 10.1016/j.tins.2016.08.001; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hurn PD, 2003, STROKE, V34, P338, DOI 10.1161/01.STR.0000054051.88378.25; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Kraus J F, 2000, Neurosurg Focus, V8, pe5; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maghool F, 2013, BRAIN RES, V1497, P61, DOI 10.1016/j.brainres.2012.12.014; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Ng I, 2006, BRIT J NEUROSURG, V20, P73, DOI 10.1080/02688690600682259; Nortje J, 2004, CURR OPIN NEUROL, V17, P711, DOI 10.1097/00019052-200412000-00011; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Ottochian M, 2009, AM J SURG, V197, P155, DOI 10.1016/j.amjsurg.2008.09.008; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Sarajuuri JM, 2005, ARCH PHYS MED REHAB, V86, P2296, DOI 10.1016/j.apmr.2005.06.018; Scholten AC, 2015, INJURY, V46, P616, DOI 10.1016/j.injury.2014.10.064; Semple BD, 2017, BEHAV BRAIN RES, V319, P48, DOI 10.1016/j.bbr.2016.10.045; Shimizu K, 2016, EXP NEUROL, V275, P78, DOI 10.1016/j.expneurol.2015.10.014; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Suzuki T, 2003, EXP NEUROL, V184, P1017, DOI 10.1016/S0014-4886(03)00389-3; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Tucker LB, 2017, J NEUROTRAUM, V34, P890, DOI 10.1089/neu.2016.4508; Tucker LB, 2016, J NEUROTRAUM, V33, P880, DOI 10.1089/neu.2015.3977; Villapol S, 2017, GLIA, V65, P1423, DOI 10.1002/glia.23171; Wagner AK, 2004, BRAIN RES, V998, P113, DOI 10.1016/j.brainres.2003.11.027; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; Xing GQ, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00173; Xiong Y, 2007, BRAIN RES, V1185, P301, DOI 10.1016/j.brainres.2007.09.052	60	18	18	1	5	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	MAR	2018	64	3					410	420		10.1007/s12031-018-1038-x			11	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GA8HD	WOS:000428579400009	29450697	Green Accepted			2022-02-06	
J	Micay, R; Richards, D; Hutchison, MG				Micay, Rachel; Richards, Doug; Hutchison, Michael G.			Feasibility of a postacute structured aerobic exercise intervention following sport concussion in symptomatic adolescents: a randomised controlled study	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Objective The utility of structured exercise for rehabilitation purposes early in the postacute phase (ie, beyond the initial 24-48 hours of advised rest) following sport-related concussion (SRC) remains largely unexplored. This study examined the feasibility of implementing a standardised aerobic exercise (AE) intervention in the postacute stage of SRC recovery in a sample of adolescent students with SRC compared with usual care. Methods Symptomatic adolescents with SRC were randomised to one of two groups: Aerobic Exercise (n=8) or Usual Care (n=7). The AE intervention, beginning on day 6 postinjury, comprised eight sessions with progressive increases in intensity and duration on a cycle ergometer. Usual care consisted of rest followed by physician-advised progressions in activity levels in an unsupervised setting. All participants were evaluated by physician at weeks 1, 2, 3 and 4 postconcussion. Outcome measures included: (1) Intervention feasibility: symptom status pre-post exercise sessions and completion of intervention and (2) Clinical recovery: symptom status at weeks 1, 2, 3 and 4 postinjury and medical clearance date. Results All participants completed the exercise sessions as part of the AE intervention and symptom exacerbation was not associated with any exercise session. The AE group experienced greater symptom resolution compared with the Usual Care Group across the recovery timeline. Conclusion A structured AE protocol appears to be safe and feasible to administer in the postacute stage of SRC recovery in adolescents and should be explored as part of a full Phase III Clinical Trial.	[Micay, Rachel; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada		Micay, R (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.	rachel.micay@mail.utoronto.ca			Steve Moore Foundation (Toronto, ON, Canada) [501044]	This study was funded by the Steve Moore Foundation (Toronto, ON, Canada), grant number 501044.	Albert S, 2012, J NEUROL, V259, P817, DOI 10.1007/s00415-011-6247-y; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Cumming TB, 2008, J REHABIL MED, V40, P609, DOI 10.2340/16501977-0226; Dahm KT, 1996, ADVICE REST BED VERS, P1; Di Battista AP, 2018, BRAIN INJURY, V32, P575, DOI 10.1080/02699052.2018.1432892; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hagen KB, 2005, SPINE, V30, P542, DOI 10.1097/01.brs.0000154625.02586.95; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hutchison MG, 2017, J HEAD TRAUMA REHAB, V32, pE38, DOI 10.1097/HTR.0000000000000252; Itoh T, 2011, J NEURAL TRANSM, V118, P193, DOI 10.1007/s00702-010-0495-3; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Jacotte-Simancas A, 2015, J NEUROTRAUM, V32, P739, DOI 10.1089/neu.2014.3502; Leddy JJ, 2013, CURR SPORT MED REP, V12, P370, DOI 10.1249/JSR.0000000000000008; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/0006-8993(96)00273-9; Ono KE, 2016, AM J SPORT MED, V44, P748, DOI 10.1177/0363546515617746; Schnabel M, 2004, EMERG MED J, V21, P306, DOI 10.1136/emj.2003.010165; Soderlund A, 2000, CLIN REHABIL, V14, P457, DOI 10.1191/0269215500cr348oa; Stern RA, 2017, J NEUROTRAUM, V34, P861, DOI 10.1089/neu.2016.4475; Teasell RW, 2010, PAIN RES MANAG, V15, P313, DOI 10.1155/2010/487279; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Waddell G, 1997, BRIT J GEN PRACT, V47, P647	27	18	19	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000404	10.1136/bmjsem-2018-000404			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200103	30018795	Green Published, gold			2022-02-06	
J	Zhang, J; Wei, XH; Xie, SM; Zhou, Z; Shang, DS; Ji, RJ; Yu, YM; He, FP; Du, Y; Ye, XM; Luo, BY				Zhang, Jie; Wei, Xuehu; Xie, Sangma; Zhou, Zhen; Shang, Desheng; Ji, Renjie; Yu, Yamei; He, Fangping; Du, Yue; Ye, Xiangming; Luo, Benyan			Multifunctional Roles of the Ventral Stream in Language Models: Advanced Segmental Quantification in Post-Stroke Aphasic Patients	FRONTIERS IN NEUROLOGY			English	Article						aphasia; language model; ventral pathway; stroke; diffusion tensor imaging	TRAUMATIC BRAIN-INJURY; CEREBRAL WHITE-MATTER; DIFFUSION-TENSOR MRI; STRUCTURAL CONNECTIVITY; SENTENCE COMPREHENSION; ANATOMIC DISSECTION; UNCINATE FASCICULUS; SPEECH PRODUCTION; STROKE; TRACTOGRAPHY	In the dual-route language model, the dorsal pathway is known for sound-to-motor mapping, but the role of the ventral stream is controversial. With the goal of enhancing our understanding of language models, this study investigated the diffusion characteristics of candidate tracts in aphasic patients. We evaluated 14 subacute aphasic patients post-stroke and 11 healthy controls with language assessment and diffusion magnetic resonance imaging. Voxel-based lesion-symptom mapping found multiple linguistic associations for the ventral stream, while automated fiber quantification (AFQ) showed, via reduced fractional anisotropy (FA) and axial diffusivity with increased radial diffusivity (all corrected p < 0.05), that the integrity of both the left dorsal and ventral streams was compromised. The average diffusion metrics of each fascicle provided by AFQ also confirmed that voxels with significant FA-language correlations were located in the ventral tracts, including the left inferior fronto-occipital fascicle (IFOF) (comprehension: r = 0.839, p = 0.001; repetition: r = 0.845, p = 0.001; naming: r = 0.813, p = 0.002; aphasia quotient: r = 0.847, p = 0.001) and uncinate fascicle (naming: r = 0.948, p = 0.001). Furthermore, point-wise AFQ revealed that the segment of the left IFOF with the strongest correlations was its narrow stem. The temporal segment of the left inferior longitudinal fascicle was also found to correlate significantly with comprehension (r = 0.663, p = 0.03) and repetition (r = 0.742, p = 0.009). This preliminary study suggests that white matter integrity analysis of the ventral stream may have the potential to reveal aphasic severity and guide individualized rehabilitation. The left IFOF, specifically its narrow stem segment, associates with multiple aspects of language, indicating an important role in semantic processing and multimodal linguistic functions.	[Zhang, Jie; Ye, Xiangming] Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Rehabil Med, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jie; Ji, Renjie; Yu, Yamei; He, Fangping; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Jie; Ji, Renjie; Yu, Yamei; He, Fangping; Luo, Benyan] Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Hangzhou, Zhejiang, Peoples R China; [Wei, Xuehu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu, Sichuan, Peoples R China; [Xie, Sangma] Hangzhou Dianzi Univ, Coll Life Informat Sci & Instrument Engn, Hangzhou, Zhejiang, Peoples R China; [Zhou, Zhen] Zhejiang Univ, Dept Comp Sci, Hangzhou, Zhejiang, Peoples R China; [Shang, Desheng] Zhejiang Univ, Affiliated Hosp 1, Dept Radiol, Hangzhou, Zhejiang, Peoples R China; [Du, Yue] Zhejiang Univ, Sch Med, Hangzhou, Zhejiang, Peoples R China		Ye, XM (corresponding author), Hangzhou Med Coll, Peoples Hosp, Zhejiang Prov Peoples Hosp, Dept Rehabil Med, Hangzhou, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Neurol, Hangzhou, Zhejiang, Peoples R China.; Luo, BY (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Brain Med Ctr, Hangzhou, Zhejiang, Peoples R China.	yexmdr@hotmail.com; luobenyan@zju.edu.cn		Ye, Xiangming/0000-0003-2230-6329; Zhang, Jie/0000-0002-1397-5224	Medical Science and Technology Project - Zhejiang Province; Ministry of Health of China [2016152769]; Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [Q13H090002]; Science and Technology Planning Project of Zhejiang Province, China [2017C03011]	This work was supported by the grants from the Medical Science and Technology Project co-founded by Zhejiang Province and the Ministry of Health of China [2016152769], Zhejiang Provincial Natural Science Foundation [Q13H090002], and the Science and Technology Planning Project of Zhejiang Province, China [2017C03011].	Agosta F, 2013, BRAIN LANG, V127, P157, DOI 10.1016/j.bandl.2013.06.003; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BRUST JCM, 1976, STROKE, V7, P167, DOI 10.1161/01.STR.7.2.167; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Chang EF, 2015, J NEUROSURG, V122, P250, DOI 10.3171/2014.10.JNS132647; Corbetta M, 2015, NEURON, V85, P927, DOI 10.1016/j.neuron.2015.02.027; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; Dick AS, 2014, NEUROSCIENTIST, V20, P453, DOI 10.1177/1073858413513502; Dronkers NF, 2007, BRAIN, V130, P1432, DOI 10.1093/brain/awm042; Duffau H, 2005, BRAIN, V128, P797, DOI 10.1093/brain/awh423; Duffau H, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00044; Duffau H, 2009, J NEUROL, V256, P382, DOI 10.1007/s00415-009-0053-9; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Forkel SJ, 2014, BRAIN, V137, P2027, DOI 10.1093/brain/awu113; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friederici AD, 2013, CURR OPIN NEUROBIOL, V23, P250, DOI 10.1016/j.conb.2012.10.002; Friederici AD, 2012, TRENDS COGN SCI, V16, P262, DOI 10.1016/j.tics.2012.04.001; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; Gao S.R., 2006, APHASIA; Geva S, 2015, BRAIN LANG, V150, P117, DOI 10.1016/j.bandl.2015.09.001; Gierhan SME, 2013, BRAIN LANG, V127, P205, DOI 10.1016/j.bandl.2012.11.002; Gleichgerrcht E, 2016, RESTOR NEUROL NEUROS, V34, P19, DOI 10.3233/RNN-150511; Hagoort P, 2014, CURR OPIN NEUROBIOL, V28, P136, DOI 10.1016/j.conb.2014.07.013; Han ZZ, 2016, BRAIN STRUCT FUNCT, V221, P577, DOI 10.1007/s00429-014-0926-2; Harvey DY, 2015, CORTEX, V67, P37, DOI 10.1016/j.cortex.2015.03.004; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Iffland PH, 2014, VASCULAR MECH CNS TR, P29, DOI DOI 10.1007/978-1-4614-8690-9_2; Johansen-Berg H., 2014, DIFFUSION MRI QUANTI; Kier EL, 2004, AM J NEURORADIOL, V25, P677; Kummerer D, 2013, BRAIN, V136, P619, DOI 10.1093/brain/aws354; Mandonnet E, 2007, BRAIN, V130, P623, DOI 10.1093/brain/awl361; Marchina S, 2011, STROKE, V42, P2251, DOI 10.1161/STROKEAHA.110.606103; Martino J, 2010, CORTEX, V46, P691, DOI 10.1016/j.cortex.2009.07.015; Matsuo K, 2008, NEURORADIOLOGY, V50, P605, DOI 10.1007/s00234-008-0379-5; McKinnon ET, 2017, ANN NEUROL, V82, P147, DOI 10.1002/ana.24983; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Nunnari D, 2014, J STROKE CEREBROVASC, V23, pE477, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.047; Papagno C, 2011, BRAIN, V134, P405, DOI 10.1093/brain/awq283; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Rosso C, 2015, NEUROREHAB NEURAL RE, V29, P287, DOI 10.1177/1545968314543926; Sarubbo S, 2013, BRAIN STRUCT FUNCT, V218, P21, DOI 10.1007/s00429-011-0372-3; Sathian K, 2015, NEURON, V85, P887, DOI 10.1016/j.neuron.2015.02.031; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Tak HJ, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-46; Tremblay P, 2016, BRAIN LANG, V162, P60, DOI 10.1016/j.bandl.2016.08.004; WAB, 2007, W APHASIA BATTERY RE, P38; WADE DT, 1986, J NEUROL NEUROSUR PS, V49, P11, DOI 10.1136/jnnp.49.1.11; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wise RJS, 2003, BRIT MED BULL, V65, P95, DOI 10.1093/bmb/65.1.95; Wu YP, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00088; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790	59	18	20	5	14	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	FEB 27	2018	9								89	10.3389/fneur.2018.00089			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FX6QQ	WOS:000426211100001	29535675	Green Published, gold			2022-02-06	
J	Carrie, C; Bentejac, M; Cottenceau, V; Masson, F; Petit, L; Cochard, JF; Sztark, F				Carrie, Cedric; Bentejac, Merry; Cottenceau, Vincent; Masson, Francoise; Petit, Laurent; Cochard, Jean-Francois; Sztark, Francois			Association between augmented renal clearance and clinical failure of antibiotic treatment in brain-injured patients with ventilator-acquired pneumonia: A preliminary study	ANAESTHESIA CRITICAL CARE & PAIN MEDICINE			English	Article						Augmented renal clearance; Traumatic brain injury; Ventilator-acquired pneumonia; Therapeutic failure; beta-lactams	CRITICALLY-ILL PATIENTS; CREATININE CLEARANCE; INTENSIVE-CARE; INFUSION; THERAPY; HYDROCORTISONE; PIPERACILLIN; INTERMITTENT; SUFFICIENT; DURATION	Objectives: This preliminary study aimed to determine whether augmented renal clearance (ARC) impacts negatively on the clinical outcome in traumatic brain-injured patients (TBI) treated for a first episode of ventilator-acquired pneumonia (VAP). Methods: During a 5-year period, all TBI patients who had developed VAP were retrospectively reviewed to assess variables associated with clinical failure in multivariate analysis. Clinical failure was defined as an impaired clinical response with a need for escalating antibiotics during treatment and/or within 15 days after the end-of-treatment. Recurrence was considered if at least one of the initial causative bacterial strains was growing at a significant concentration from a second sample. Augmented renal clearance (ARC) was defined by an enhanced creatinine clearance exceeding 130 mL/min/1.73 m(2) calculated from a urinary sample during the first three days of antimicrobial therapy. Main results: During the study period, 223 TBI patients with VAP were included and 59 (26%) presented a clinical failure. Factors statistically associated with clinical failure were GSC <= 7 (OR = 2.2 [1.1-4.4], P = 0.03), early VAP (OR = 3.9 [1.9-7.8], P = 0.0001), bacteraemia (OR = 11 [2.2-54], P = 0.003) and antimicrobial therapy <= 7 days (OR = 3.7 [1.8-7.4], P = 0.0003). ARC was statistically associated with recurrent infections with an OR of 4.4 [1.2-16], P = 0.03. Conclusion: ARC was associated with recurrent infection after a first episode of VAP in TBI patients. The optimal administration and dosing of the antimicrobial agents in this context remain to be determined. (C) 2017 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.	[Carrie, Cedric; Bentejac, Merry; Cottenceau, Vincent; Masson, Francoise; Petit, Laurent; Cochard, Jean-Francois; Sztark, Francois] CHU Bordeaux, Anaesthesiol & Crit Care Dept 1, Surg Intens Care Unit, F-33000 Bordeaux, France; [Sztark, Francois] Univ Bordeaux Segalen, F-33000 Bordeaux, France		Carrie, C (corresponding author), CHU Bordeaux, Hop Pellegrin, Anaesthesiol & Crit Care Dept 1, Surg Intens Care Unit, Pl Amelie Raba Leon, F-33076 Bordeaux, France.	cedric.carrie@chu-bordeaux.fr					Abdul-Aziz MH, 2016, INTENS CARE MED, V42, P1535, DOI 10.1007/s00134-015-4188-0; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Asehnoune K, 2014, LANCET RESP MED, V2, P706, DOI 10.1016/S2213-2600(14)70144-4; Asin-Prieto E, 2014, J ANTIMICROB CHEMOTH, V69, P180, DOI 10.1093/jac/dkt304; Barletta JF, 2016, J TRAUMA ACUTE CARE, V81, P1115, DOI 10.1097/TA.0000000000001211; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; Combes A, 2003, CRIT CARE MED, V31, P1102, DOI 10.1097/01.CCM.0000059313.31477.2C; Cotta MO, 2015, INFECT DIS-NOR, V47, P739, DOI 10.3109/23744235.2015.1021831; De Cock PAJG, 2015, ANTIMICROB AGENTS CH, V59, P7027, DOI [10.1128/AAC.01368-15, 10.1128/AAC.01368-]; Dimopoulos G, 2013, CHEST, V144, P1759, DOI 10.1378/chest.13-0076; Geeraerts T, 2016, ANESTH REANIM, V2, P431, DOI 10.1016/j.anrea.2016.09.007; Hobbs ALV, 2015, PHARMACOTHERAPY, V35, P1063, DOI 10.1002/phar.1653; Huttner A, 2015, INT J ANTIMICROB AG, V45, P385, DOI 10.1016/j.ijantimicag.2014.12.017; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; KIM KE, 1972, BRIT MED J, V1, P379, DOI 10.1136/bmj.1.5796.379-b; Kollef MH, 2012, CRIT CARE, V16, DOI [10.1186/cc11853, 10.1186/cc11862]; May CC, 2015, NEUROCRIT CARE, V23, P374, DOI 10.1007/s12028-015-0127-8; Reese AM, 2005, INT J ANTIMICROB AG, V26, P114, DOI 10.1016/j.ijantimicag.2005.06.004; Roberts JA, 2007, J ANTIMICROB CHEMOTH, V59, P285, DOI [10.1093/jac/dkl478, 10.1093/jac/dk1478]; Roberts JA, 2016, AM J RESP CRIT CARE, V194, P681, DOI 10.1164/rccm.201601-0024OC; Roberts JA, 2014, CLIN INFECT DIS, V58, P1072, DOI 10.1093/cid/ciu027; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Taccone FS, 2010, CRIT CARE, V14, DOI 10.1186/cc9091; Tsai D, 2015, CURR OPIN CRIT CARE, V21, P412, DOI 10.1097/MCC.0000000000000229; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2017, J NEUROTRAUM, V34, P137, DOI 10.1089/neu.2015.4328; Udy AA, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0750-y; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2013, CRIT CARE, V17, DOI 10.1186/cc12544; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671; Wahl WL, 2009, J BURN CARE RES, V30, P801, DOI 10.1097/BCR.0b013e3181b47ef9; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	34	18	18	1	7	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	2352-5568			ANAESTH CRIT CARE PA	Anaesth. Crit. Care Pain Med.	FEB	2018	37	1					35	41		10.1016/j.accpm.2017.06.006			7	Anesthesiology; Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; General & Internal Medicine	FU5DC	WOS:000423872100010	28756331				2022-02-06	
J	Parthasarathy, AB; Gannon, KP; Baker, WB; Favilla, CG; Balu, R; Kasner, SE; Yodh, AG; Detre, JA; Mullen, MT				Parthasarathy, Ashwin B.; Gannon, Kimberly P.; Baker, Wesley B.; Favilla, Christopher G.; Balu, Ramani; Kasner, Scott E.; Yodh, Arjun G.; Detre, John A.; Mullen, Michael T.			Dynamic autoregulation of cerebral blood flow measured non-invasively with fast diffuse correlation spectroscopy	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Cerebral blood flow; cerebral autoregulation; noninvasive monitoring; intrinsic optical imaging; neurocritical care	ACUTE ISCHEMIC-STROKE; NEAR-INFRARED SPECTROSCOPY; CEREBROVASCULAR PRESSURE REACTIVITY; TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; TIME-DOMAIN; TRANSCRANIAL DOPPLER; PERFUSION; HEMODYNAMICS; INFANTS	Cerebral autoregulation (CA) maintains cerebral blood flow (CBF) in the presence of systemic blood pressure changes. Brain injury can cause loss of CA and resulting dysregulation of CBF, and the degree of CA impairment is a functional indicator of cerebral tissue health. Here, we demonstrate a new approach to noninvasively estimate cerebral autoregulation in healthy adult volunteers. The approach employs pulsatile CBF measurements obtained using high-speed diffuse correlation spectroscopy (DCS). Rapid thigh-cuff deflation initiates a chain of responses that permits estimation of rates of dynamic autoregulation in the cerebral microvasculature. The regulation rate estimated with DCS in the microvasculature (median: 0.26 s(-1), inter quartile range: 0.19 s(-1)) agrees well (R=0.81, slope=0.9) with regulation rates measured by transcranial Doppler ultrasound (TCD) in the proximal vasculature (median: 0.28 s(-1), inter quartile range: 0.10 s(-1)). We also obtained an index of systemic autoregulation in concurrently measured scalp microvasculature. Systemic autoregulation begins later than cerebral autoregulation and exhibited a different rate (0.55 s(-1), inter quartile range: 0.72 s(-1)). Our work demonstrates the potential of diffuse correlation spectroscopy for bedside monitoring of cerebral autoregulation in the microvasculature of patients with brain injury.	[Parthasarathy, Ashwin B.; Yodh, Arjun G.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Parthasarathy, Ashwin B.] Univ S Florida, Dept Elect Engn, Tampa, FL USA; [Gannon, Kimberly P.; Favilla, Christopher G.; Balu, Ramani; Kasner, Scott E.; Detre, John A.; Mullen, Michael T.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Baker, Wesley B.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA		Parthasarathy, AB (corresponding author), 4202 Fowler Ave,ENB 118, Tampa, FL 33647 USA.	ashwinbp@usf.edu	Parthasarathy, Ashwin B/ABH-9098-2020	Parthasarathy, Ashwin B/0000-0003-2024-3432; Baker, Wesley/0000-0002-3025-6061	American Heart AssociationAmerican Heart Association [14POST20460161]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R25-NS065745, R01-NS060653, P41-EB015893]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060653, R25NS065745] Funding Source: NIH RePORTER	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: We gratefully acknowledge support from the American Heart Association (14POST20460161), and the National Institutes of Health (R25-NS065745, R01-NS060653, P41-EB015893).	AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Alexandrov AV, 1999, STROKE, V30, P1604, DOI 10.1161/01.STR.30.8.1604; Aoi MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046794; Atkins ER, 2010, CEREBROVASC DIS, V29, P228, DOI 10.1159/000267845; Baker WB, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.3.035004; Baker WB, 2014, BIOMED OPT EXPRESS, V5, P4053, DOI 10.1364/BOE.5.004053; Boas DA, 1997, J OPT SOC AM A, V14, P192, DOI 10.1364/JOSAA.14.000192; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Brady KM, 2010, STROKE, V41, P1957, DOI 10.1161/STROKEAHA.109.575167; Brady K, 2010, STROKE, V41, P1951, DOI 10.1161/STROKEAHA.109.575159; Buckley EM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.3.037007; Buckley EM, 2009, OPT EXPRESS, V17, P12571, DOI 10.1364/OE.17.012571; Budohoski KP, 2013, NAT REV NEUROL, V9, P152, DOI 10.1038/nrneurol.2013.11; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Christ M, 2007, INTENS CARE MED, V33, P246, DOI 10.1007/s00134-006-0451-8; Cohen J., 2013, STAT POWER ANAL BEHA; Coolican H., 2014, RES METHODS STAT PSY, V6th Edn; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; Dawson SL, 2003, CEREBROVASC DIS, V16, P69, DOI 10.1159/000070118; Diop M, 2011, BIOMED OPT EXPRESS, V2, P2068, DOI 10.1364/BOE.2.002068; Durduran T, 2014, NEUROIMAGE, V85, P51, DOI 10.1016/j.neuroimage.2013.06.017; Durduran T, 2009, OPT EXPRESS, V17, P3884, DOI 10.1364/OE.17.003884; Eriksen VR, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.3.037009; Fantini S, 2014, NEUROIMAGE, V85, P202, DOI 10.1016/j.neuroimage.2013.03.065; Favilla CG, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00045; Favilla CG, 2014, STROKE, V45, P1269, DOI 10.1161/STROKEAHA.113.004116; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Goldstein LB, 2000, DRUG SAFETY, V22, P13, DOI 10.2165/00002018-200022010-00002; Hlatky R, 2006, NEUROCRIT CARE, V4, P127, DOI 10.1385/NCC:4:2:127; Jaeger M, 2007, STROKE, V38, P981, DOI 10.1161/01.STR.0000257964.65743.99; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Jain V, 2014, J CEREBR BLOOD F MET, V34, P380, DOI 10.1038/jcbfm.2013.214; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Kim MN, 2010, NEUROCRIT CARE, V12, P173, DOI 10.1007/s12028-009-9305-x; Mesquita RC, 2011, PHILOS T R SOC A, V369, P4390, DOI 10.1098/rsta.2011.0232; Mullen MT, 2016, STROKE, V47; Nazir FS, 2005, CEREBROVASC DIS, V19, P77, DOI 10.1159/000082783; Nazir FS, 2004, J HYPERTENS, V22, P989, DOI 10.1097/00004872-200405000-00022; Panerai RB, 2015, AM J PHYSIOL-HEART C, V308, pH688, DOI 10.1152/ajpheart.00887.2014; Reinhard M, 2005, STROKE, V36, P1684, DOI 10.1161/01.STR.0000173183.36331.ee; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Roche-Labarbe N, 2010, HUM BRAIN MAPP, V31, P341, DOI 10.1002/hbm.20868; Santos E, 2011, ACTA NEUROCHIR, V153, P2189, DOI 10.1007/s00701-011-1148-5; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; STRANDGAARD S, 1984, STROKE, V15, P413, DOI 10.1161/01.STR.15.3.413; Tgavalekos KT, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.10.101410; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Tsuji M, 2000, PEDIATRICS, V106, P625, DOI 10.1542/peds.106.4.625; Verdecchia K, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.027007; Wang DT, 2016, BIOMED OPT EXPRESS, V7, P776, DOI 10.1364/BOE.7.000776; Yu GQ, 2007, OPT EXPRESS, V15, P1064, DOI 10.1364/OE.15.001064; Zweifel C, 2014, MED ENG PHYS, V36, P638, DOI 10.1016/j.medengphy.2014.03.002; Zweifel C, 2010, STROKE, V41, P1963, DOI 10.1161/STROKEAHA.109.577320	56	18	18	1	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	FEB	2018	38	2					230	240		10.1177/0271678X17747833			11	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	FU7VJ	WOS:000424060500004	29231781	Green Published, Bronze			2022-02-06	
J	Wallace, J; Covassin, T; Moran, R				Wallace, Jessica; Covassin, Tracey; Moran, Ryan			Racial Disparities in Concussion Knowledge and Symptom Recognition in American Adolescent Athletes	JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES			English	Article						Concussion; Symptoms of concussion; African-American; Adolescents	TRAUMATIC BRAIN-INJURY; STATES HIGH-SCHOOL; UNITED-STATES; 2ND-IMPACT SYNDROME; FOOTBALL PLAYERS; CHILDREN; SPORTS; YOUTH; RACE	Background The purpose of this study was to identify if knowledge of concussion differences exists between communities that service underserved, African-American athletes compared to white athletes, and to explore differences in concussion knowledge between African-American and white athletes with and without access to an athletic trainer. Methods Five hundred seventy-seven adolescent athletes ranging in age from 13 to 18 from 14 schools in the USA completed a one-time pencil and paper survey instrument. Data were collected from September 2014 to April 2015. All athletes included in the study received concussion education implemented (i.e., Centers for Disease Control and Prevention (CDC) Heads UP documents) by state concussion law. Knowledge of concussion scores were determined by summing the total correct responses to the 35 questions. Race (white or African-American) and access to an athletic trainer were the independent variables explored. Results White high school athletes have increased concussion knowledge compared to African-American athletes (p < 0.001). African-American athletes less frequently recognized all correct signs and symptoms of concussion compared to white athletes. African-American athletes with access to an athletic trainer have more knowledge than African-American athletes without access to an athletic trainer (p = 0.003). Conclusions White athletes had more concussion knowledge than African-American athletes; however, African-Americans that had access to an athletic trainer at their respective school were more likely to identify the signs and symptoms of concussion compared to African-Americans that did not have access to an athletic trainer. This further accentuates the health disparity that occurs in high school athletics, in regard to the presence of an athletic trainer and their influence on an athlete's health and safety.	[Wallace, Jessica] Youngstown State Univ, 1 Univ Plaza,307L Beeghly Ctr, Youngstown, OH 44512 USA; [Covassin, Tracey] Michigan State Univ, 105 IM Sports Circle, E Lansing, MI 48824 USA; [Moran, Ryan] North Dakota State Univ, Bentson Bunker Fieldhouse,Room 1,Dept 2620, Fargo, ND 58101 USA		Wallace, J (corresponding author), Youngstown State Univ, 1 Univ Plaza,307L Beeghly Ctr, Youngstown, OH 44512 USA.	jwallace02@ysu.edu			Pentacost Foundation; Blue Cross Blue; Shield of Michigan Foundation; Michigan State University Graduate School	This project was supported by grants from the Pentacost Foundation, Blue Cross Blue, Shield of Michigan Foundation, and Michigan State University Graduate School.	Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Bazarian JJ, 2003, ACAD EMERG MED, V10, P1209, DOI 10.1197/S1069-6563(03)00491-3; Bloodgood B, 2013, J ADOLESCENT HEALTH, V53, P34, DOI 10.1016/j.jadohealth.2013.01.022; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Centers for Disease Control and Prevention Web site, 2011, CONC MILD TBI; Coakley J., 2007, SPORT SOC ISSUES CON; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gourley M. M., 2010, AWARENESS RECOGNITIO, P1; Haider AH, 2007, J TRAUMA, V62, P1259, DOI 10.1097/TA.0b013e31803c760e; Jager TE, 2000, ACAD EMERG MED, V7, P134, DOI 10.1111/j.1553-2712.2000.tb00515.x; Kontos AP, 2010, ARCH CLIN NEUROPSYCH, V25, P734, DOI 10.1093/arclin/acq068; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2013, J ATHL TRAINING, V48, P483, DOI 10.4085/1062-6050-48.4.04; National Collegiate Athletic Association, SPORT SPONS PART DEM; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Selassie AW, 2004, AM J EMERG MED, V22, P465, DOI 10.1016/j.ajem.2004.07.024; Vicente R., RACE ETHNICITY 19990; Wallace J., 2017, J ATHL TRAIN; WATSON BC, 1989, J NEGRO EDUC, V58, P309, DOI 10.2307/2295664	25	18	18	0	3	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	2197-3792	2196-8837		J RACIAL ETHN HEALTH	J. Racial Ethn. Health Disparities	FEB	2018	5	1					221	228		10.1007/s40615-017-0361-1			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GC0DL	WOS:000429447000024	28389906				2022-02-06	
J	Lindblad, C; Thelin, EP; Nekludov, M; Frostell, A; Nelson, DW; Svensson, M; Bellander, BM				Lindblad, Caroline; Thelin, Eric Peter; Nekludov, Michael; Frostell, Arvid; Nelson, David W.; Svensson, Mikael; Bellander, Bo-Michael			Assessment of Platelet function in Traumatic Brain Injury-A Retrospective Observational Study in the Neuro-Critical Care Setting	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; progressive hemorrhagic injury; platelet aggregation; platelet aggregation inhibitors; multiple electrode aggregometry; cyclooxygenase inhibitors	TRANSFUSION; DYSFUNCTION; COAGULATION; CLASSIFICATION; HEMORRHAGE; ASPIRIN; UTILITY	Background: Despite seemingly functional coagulation, hemorrhagic lesion progression is a common and devastating condition following traumatic brain injury (TBI), stressing the need for new diagnostic techniques. Multiple electrode aggregometry (MEA) measures platelet function and could aid in coagulopathy assessment following TBI. The aims of this study were to evaluate MEA temporal dynamics, influence of concomitant therapy, and its capabilities to predict lesion progression and clinical outcome in a TBI cohort. Material and methods: Adult TBI patients in a neurointensive care unit that underwent MEA sampling were retrospectively included. MEA was sampled if the patient was treated with antiplatelet therapy, bled heavily during surgery, or had abnormal baseline coagulation values. We assessed platelet activation pathways involving the arachidonic acid receptor (ASPI), P2Y(12) receptor, and thrombin receptor (TRAP). ASPI was the primary focus of analysis. If several samples were obtained, they were included. Retrospective data were extracted from hospital charts. Outcome variables were radiologic hemorrhagic progression and Glasgow Outcome Scale assessed prospectively at 12 months posttrauma. MEA levels were compared between patients on antiplatelet therapy. Linear mixed effect models and uni-/multivariable regression models were used to study longitudinal dynamics, hemorrhagic progression and outcome, respectively. Results: In total, 178 patients were included (48% unfavorable outcome). ASPI levels increased from initially low values in a time-dependent fashion (p < 0.001). Patients on cyclooxygenase inhibitors demonstrated low ASPI levels (p < 0.001), while platelet transfusion increased them (p < 0.001). The first ASPI (p = 0.039) and TRAP (p = 0.009) were significant predictors of outcome, but not lesion progression, in univariate analyses. In multivariable analysis, MEA values were not independently correlated with outcome. Conclusion: A general longitudinal trend of MEA is identified in this TBI cohort, even in patients without known antiplatelet therapies. Values appear also affected by platelet inhibitory treatment and by platelet transfusions. While significant in univariate models to predict outcome, MEA values did not independently correlate to outcome or lesion progression in multivariable analyses. Further prospective studies to monitor coagulation in TBI patients are warranted, in particular the interpretation of pathological MEA values in patients without antiplatelet therapies.	[Lindblad, Caroline; Thelin, Eric Peter; Frostell, Arvid; Svensson, Mikael; Bellander, Bo-Michael] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Thelin, Eric Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Cambridge Biomed Campus, Cambridge, England; [Nekludov, Michael; Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Perioperat Med & Intens Care, Stockholm, Sweden		Bellander, BM (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	bo-michael.bellander@ki.se	Frostell, Arvid/ABG-5167-2021; Thelin, Eric Peter/K-2144-2012; Svensson, Mikael/F-8662-2012; Lindblad, Caroline/AAJ-7911-2021	Thelin, Eric Peter/0000-0002-2338-4364; Svensson, Mikael/0000-0003-1179-7003; Lindblad, Caroline/0000-0003-4952-8597; Nelson, David/0000-0003-2530-8207	NEURO Sweden (Neuroforbundet); ALF (from Stockholms lans landsting) [103000]; Svenska Lakaresallskapet postdoctoral scholarships [SLS-587221]	The authors are grateful to the funding enabling this project, namely, NEURO Sweden (Neuroforbundet), ALF (from Stockholms lans landsting, grant number 103000), and Svenska Lakaresallskapet postdoctoral scholarships (grant number SLS-587221).	Acker JE, 2004, ADV TRAUMA LIFE SUPP; Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Bachelani AM, 2011, SURGERY, V150, P836, DOI 10.1016/j.surg.2011.07.059; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beynon C, 2015, J CLIN NEUROSCI, V22, P252, DOI 10.1016/j.jocn.2014.07.029; Beynon C, 2013, J CLIN NEUROSCI, V20, P1805, DOI 10.1016/j.jocn.2013.02.022; Beynon C, 2013, CLIN NEUROL NEUROSUR, V115, P2003, DOI 10.1016/j.clineuro.2013.06.002; Beynon C, 2012, CRIT CARE, V16, DOI 10.1186/cc11292; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CARDINAL DC, 1980, J PHARMACOL METHOD, V3, P135, DOI 10.1016/0160-5402(80)90024-8; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Cull JD, 2015, AM SURGEON, V81, P128; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Harrell FE, 2015, SPRINGER SER STAT, DOI 10.1007/978-3-319-19425-7; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; JENNETT B, 1975, LANCET, V1, P480; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Kuznetsova A., 2016, LMERTEST TESTS LINEA; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Marshall A, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-7; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCully SP, 2013, SEMIN THROMB HEMOST, V39, P896, DOI 10.1055/s-0033-1357484; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nekludov M, 2014, J NEUROTRAUM, V31, P1927, DOI 10.1089/neu.2013.3168; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Parry PV, 2017, NEUROSURGERY, V80, P92, DOI 10.1227/NEU.0000000000001406; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sillesen M, 2013, J TRAUMA ACUTE CARE, V74, P1252, DOI 10.1097/TA.0b013e31828c7a6b; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Sun YR, 2011, BRIT J NEUROSURG, V25, P363, DOI 10.3109/02688697.2011.552650; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Thelin EP, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002368; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Tierney N, 2015, NEATO VARIOUS USEFUL; van Buuren S, 2011, J STAT SOFTW, V45, P1; Williams Graham J, 2011, DATA MINING RATTLE R	49	18	19	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 26	2018	9								15	10.3389/fneur.2018.00015			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT8GE	WOS:000423390000001	29434566	gold, Green Published			2022-02-06	
J	Hofmeijer, J; van Kaam, CR; van de Werff, B; Vermeer, SE; Tjepkema-Cloostermans, MC; van Putten, MJAM				Hofmeijer, Jeannette; van Kaam, C. R.; van de Werff, Babette; Vermeer, Sarah E.; Tjepkema-Cloostermans, Marleen C.; van Putten, Michel J. A. M.			Detecting Cortical Spreading Depolarization with Full Band Scalp Electroencephalography: An Illusion?	FRONTIERS IN NEUROLOGY			English	Article						cortical spreading depolarization; infraslow activity; acute ischemic stroke; traumatic brain injury; full band electroencephalography	CEREBRAL-CORTEX; SUBARACHNOID HEMORRHAGE; MALIGNANT STROKE; MIGRAINE AURA; BRAIN TRAUMA; DC SHIFTS; DEPRESSION; ISCHEMIA; INJURY; EEG	Introduction: There is strong evidence suggesting detrimental effects of cortical spreading depolarization (CSD) in patients with acute ischemic stroke and severe traumatic brain injury. Previous studies implicated scalp electroencephalography (EEG) features to be correlates of CSD based on retrospective analysis of EEG epochs after having detected "CSD" in time aligned electrocorticography. We studied the feasibility of CSD detection in a prospective cohort study with continuous EEG in 18 patients with acute ischemic stroke and 18 with acute severe traumatic brain injury. Methods: Full band EEG with 21 silver/silver chloride electrodes was started within 48 h since symptom onset. Five additional electrodes were used above the infarct. We visually analyzed all raw EEG data in epochs of 1 h. Inspection was directed at detection of the typical combination of CSD characteristics, i.e., (i) a large slow potential change (SPC) accompanied by a simultaneous amplitude depression of > 1Hz activity, (ii) focal presentation, and (iii) spread reflected as appearance on neighboring electrodes with a delay. Results: In 3,035 one-hour EEG epochs, infraslow activity (ISA) was present in half to three quarters of the registration time. Typically, activity was intermittent with amplitudes of 40-220 mu V, approximately half was oscillatory. There was no specific spatial distribution. Relevant changes of ISA were always visible in multiple electrodes, and not focal, as expected in CSD. ISA appearing as "SPC" was mostly associated with an amplitude increase of faster activities, and never with suppression. In all patients, depressions of spontaneous brain activity occurred. However, these were not accompanied by simultaneous SPC, occurred simultaneously on all channels, and were not focal, let alone spread, as expected in CSD. Conclusion: With full band scalp EEG in patients with cortical ischemic stroke or traumatic brain injury, we observed various ISA, probably modulating cortical excitability. However, we were unable to identify unambiguous characteristics of CSD.	[Hofmeijer, Jeannette; van Kaam, C. R.; van de Werff, Babette; van Putten, Michel J. A. M.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Clin Neurophysiol, Enschede, Netherlands; [Hofmeijer, Jeannette; van Kaam, C. R.; van de Werff, Babette; Vermeer, Sarah E.] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands; [Tjepkema-Cloostermans, Marleen C.; van Putten, Michel J. A. M.] Med Spectrum Twente, Dept Clin Neurophysiol, Enschede, Netherlands		Hofmeijer, J (corresponding author), Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Clin Neurophysiol, Enschede, Netherlands.; Hofmeijer, J (corresponding author), Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands.	jhofmeijer@rijnstate.nl	van Kaam, Ruud/T-9308-2018				ALADJALOVA NA, 1957, NATURE, V179, P957, DOI 10.1038/179957a0; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P1172, DOI 10.1097/01.WCB.0000137057.92786.F3; BESSON JM, 1970, AM J PHYSIOL, V218, P284, DOI 10.1152/ajplegacy.1970.218.1.284; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hartings JA, 2017, BRAIN, V140, P2673, DOI 10.1093/brain/awx214; Hartings JA, 2014, ANN NEUROL, V76, P681, DOI 10.1002/ana.24256; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Helbok R, 2017, J CEREBR BLOOD F MET, V37, P1871, DOI 10.1177/0271678X16651269; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Kemp B, 2010, CLIN NEUROPHYSIOL, V121, P1992, DOI 10.1016/j.clinph.2010.05.006; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; LEAO AAP, 1947, J NEUROPHYSIOL, V10, P409, DOI 10.1152/jn.1947.10.6.409; Lehmenkuhler A, 1999, NEUROSCI LETT, V270, P67, DOI 10.1016/S0304-3940(99)00469-3; NEDERGAARD M, 1988, BRAIN RES, V449, P395, DOI 10.1016/0006-8993(88)91062-1; OLESEN J, 1981, ANN NEUROL, V9, P344, DOI 10.1002/ana.410090406; Palva JM, 2012, NEUROIMAGE, V62, P2201, DOI 10.1016/j.neuroimage.2012.02.060; SHINOHARA M, 1979, SCIENCE, V203, P188, DOI 10.1126/science.758688; Somjen GG, 2004, IONS BRAIN NORMAL FU; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Voipio J, 2003, J NEUROPHYSIOL, V89, P2208, DOI 10.1152/jn.00915.2002; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901; Winkler MKL, 2017, J CEREBR BLOOD F MET, V37, P1841, DOI 10.1177/0271678X16641424; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Zandt BJ, 2015, REV NEUROSCIENCE, V26, P183, DOI 10.1515/revneuro-2014-0069	33	18	18	0	4	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JAN 25	2018	9								17	10.3389/fneur.2018.00017			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FT8FF	WOS:000423387500001	29422883	Green Published, gold			2022-02-06	
J	An, N; Xu, HM; Gao, WQ; Yang, H				An, Na; Xu, Huiming; Gao, Wei-Qiang; Yang, Hao			Direct Conversion of Somatic Cells into Induced Neurons	MOLECULAR NEUROBIOLOGY			English	Article						Cell reprogramming; Somatic cells; Induced neuron; Transdifferentiation	PLURIPOTENT STEM-CELLS; DIRECT LINEAGE CONVERSION; ADULT HUMAN FIBROBLASTS; FUNCTIONAL-NEURONS; TRANSCRIPTION FACTOR; MEDIATED CONVERSION; MOUSE FIBROBLASTS; GLIAL-CELLS; GENERATION; INDUCTION	The progressive loss and degeneration of neurons in the central nervous system (CNS), as a result of traumas or diseases including Alzheimer's, Parkinson's, Huntington's disease, stroke, and traumatic injury to the brain and spinal cord, can usually have devastating effects on quality of life. The current strategies available for treatments are described including drug delivery, surgery, electrical stimulation, and cell-based tissue engineering approaches. However, apart from cell-based therapy, other attempts are limited in improving clinical outcomes. Recently, stem cell and neural stem cell (NSC) in particular therapy has been proposed as an attractive and promising strategy for regenerative medicine due to their unique biological attributes, such as giving rise to neuronal lineage commitment in accordance with the neural development. Nevertheless, stem cell strategy still faces numerous challenges, including ethical issue, tumor formation, and graft rejection. Thus, seeking a more appropriate approach like direct reprogramming or lineage reprogramming is critical. Compared to induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs), direct lineage reprogramming of somatic cells to generate induced neurons (iNs) without undergoing a state of pluripotent still has several advantages such as short induction cycle, high transdifferentiation efficiency, no ethical concerns, and risk of neoplasia. On the basis of these advantages, cell reprogramming will hold great promise for therapeutic cell replacement, disease modeling establishment, drug screening, and personalized medicine. Here, we systematically review recent advances in somatic lineage reprogramming into iNs, including the identification of novel reprogramming factors, the underlying molecular mechanisms and the concerns exist, as well as the major challenges in the future.	[An, Na; Xu, Huiming; Gao, Wei-Qiang; Yang, Hao] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Renji Med Clin Stem Cell Res Ctr 10,State Key Lab, Shanghai 200127, Peoples R China		Gao, WQ; Yang, H (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Renji Med Clin Stem Cell Res Ctr 10,State Key Lab, Shanghai 200127, Peoples R China.	gao.weiqiang@sjtu.edu.cn; yanghao.71_99@yahoo.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81371411, 81571208, YG2014MS45]	This work was supported by the Natural Science Foundation of China (grant nos. 81371411, 81571208, and YG2014MS45). The authors confirm that there has been no financial support for this research that could have influenced its outcome.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; De la Rossa A, 2013, NAT NEUROSCI, V16, P193, DOI 10.1038/nn.3299; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Feng GD, 2014, MOL NEUROBIOL, V50, P997, DOI 10.1007/s12035-014-8649-1; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Hansen KF, 2016, LEARN MEMORY, V23, P61, DOI 10.1101/lm.039578.115; Harada K, 2016, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00499; Heinrich C, 2011, NAT PROTOC, V6, P214, DOI 10.1038/nprot.2010.188; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hu WX, 2015, CELL STEM CELL, V17, P204, DOI 10.1016/j.stem.2015.07.006; Huang YH, 2015, NEUROSCI BULL, V31, P357, DOI 10.1007/s12264-014-1517-1; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jiang HB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10100; Karow M, 2014, JOVE-J VIS EXP, DOI 10.3791/51433; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Li X, 2015, CELL STEM CELL, V17, P195, DOI 10.1016/j.stem.2015.06.003; Li XW, 2016, BIOMATER SCI-UK, V4, P1100, DOI 10.1039/c6bm00140h; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Maguire JA, 2016, STEM CELL RES, V16, P338, DOI 10.1016/j.scr.2016.02.017; Marro S, 2014, METHODS MOL BIOL, V1150, P237, DOI 10.1007/978-1-4939-0512-6_16; Marro S, 2011, CELL STEM CELL, V9, P374, DOI 10.1016/j.stem.2011.09.002; Montana CL, 2013, P NATL ACAD SCI USA, V110, P1732, DOI 10.1073/pnas.1214387110; Niu WZ, 2015, STEM CELL REP, V4, P780, DOI 10.1016/j.stemcr.2015.03.006; Pang ZPP, 2011, NATURE, V476, P220, DOI 10.1038/nature10202; Park H, 2015, BIOMATERIALS, V72, P152, DOI 10.1016/j.biomaterials.2015.09.002; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pfisterer U, 2011, P NATL ACAD SCI USA, V108, P10343, DOI 10.1073/pnas.1105135108; Rouaux C, 2013, NAT CELL BIOL, V15, P214, DOI 10.1038/ncb2660; Shen CN, 2000, NAT CELL BIOL, V2, P879, DOI 10.1038/35046522; Shi ZX, 2016, J BIOL CHEM, V291, P13560, DOI 10.1074/jbc.M115.709808; Son EY, 2011, CELL STEM CELL, V9, P205, DOI 10.1016/j.stem.2011.07.014; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tantirigama MLS, 2016, J COMP NEUROL, V524, P829, DOI 10.1002/cne.23875; Torper O, 2013, P NATL ACAD SCI USA, V110, P7038, DOI 10.1073/pnas.1303829110; Torres-Padilla ME, 2013, DEVELOPMENT, V140, P487, DOI 10.1242/dev.087577; Vadodaria KC, 2016, MOL PSYCHIATR, V21, P49, DOI 10.1038/mp.2015.161; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wapinski OL, 2013, CELL, V155, P621, DOI 10.1016/j.cell.2013.09.028; Xiao B, 2016, J NEUROL NEUROSUR PS, V87, P697, DOI 10.1136/jnnp-2015-312036; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu J, 2015, CELL STEM CELL, V16, P119, DOI 10.1016/j.stem.2015.01.013; Xu Z, 2016, MOL PSYCHIATR, V21, P62, DOI 10.1038/mp.2015.101; Yoo AS, 2011, NATURE, V476, P228, DOI 10.1038/nature10323; Zhang L, 2015, CELL STEM CELL, V17, P735, DOI 10.1016/j.stem.2015.09.012; Zhang SZ, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2452985; Zhang XQ, 2010, CELL STEM CELL, V7, P90, DOI 10.1016/j.stem.2010.04.017; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	55	18	19	1	27	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JAN	2018	55	1					642	651		10.1007/s12035-016-0350-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV6PC	WOS:000424702600057	27981499				2022-02-06	
S	Baldwin, GT; Breiding, MJ; Comstock, RD		Hainline, B; Stern, RA		Baldwin, Grant T.; Breiding, Matthew J.; Comstock, R. Dawn			Epidemiology of sports concussion in the United States	SPORTS NEUROLOGY	Handbook of Clinical Neurology		English	Article; Book Chapter							TRAUMATIC BRAIN-INJURY; HIGH-SCHOOL SPORTS; COLLEGIATE; MANAGEMENT; SYMPTOMS; TRENDS	Sports and recreation-related (SRR) activities are common in the United States. Beyond the benefits to health, SRR activities can create new friendships, give people a sense of belonging, foster teamwork and other leadership skills, and develop sportsmanship and a respect for rules that govern play. Public awareness about the risk of concussion has grown as the long-term consequences of traumatic brain injury (TBI) have become better known, and likely explains the increasing concussion incidence rates. Currently, surveillance systems capture SRR concussions among high school and college athletes participating in sanctioned sports. National estimates of SRR TBI presenting to an emergency department also exist. Persons under the age of 19 sustain a majority of SRR concussions. Concussion risk is greatest for boys in contact/collision sports like football, ice hockey, and lacrosse, and is more likely to occur in competition versus practice settings. Girls have elevated concussion rates in gender-comparable sports. Despite better data, concussions are still underreported, undermanaged, and often not properly identified. This is especially true for concussions occurring outside organized sports, in nonsport recreational activities, and for concussions either not seen or evaluated in nonemergency department settings. A new surveillance system proposed by the Centers for Disease Control and Prevention aims to fill the gap.	[Baldwin, Grant T.; Breiding, Matthew J.] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unint Injury Prevent, 4770 Buford Hwy NE F-62, Atlanta, GA 30341 USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA		Baldwin, GT (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Div Unint Injury Prevent, 4770 Buford Hwy NE F-62, Atlanta, GA 30341 USA.	gfb3@cdc.gov					Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Aspen Institute, 2016, STAT PLAY 2016 TREND; Bell JM, 2017, J SAFETY RES, V62, P253, DOI 10.1016/j.jsr.2017.04.002; Centers for Disease Control and Prevention, 2016, BAS INF TRAUM BRAIN; Centers for Disease Control and Prevention, 2015, CONC PLAY OPP RESH C; Collins MW, 2003, AM J SPORT MED, V31, P168, DOI 10.1177/03635465030310020301; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Dai SF, 2015, J PHYS ACT HEALTH, V12, pS128, DOI 10.1123/jpah.2015-0038; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Ellis MJ, 2016, FRONT NEUROL, V7; Fakhouri Tala H I, 2014, NCHS Data Brief, P1; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Haegerich TM, 2015, AM J PREV MED, V48, P219, DOI 10.1016/j.amepre.2014.08.018; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS REL CONC YOUT; Irick E, 2016, NCAA SPORT SPONSORSH; KB Arbogast, 2017, CLIN PEDIATR; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lumba-Brown A, 2018, JAMA PEDIAT; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; National Council for Youth Sports, 2017, PART ORG YOUTH SPORT; National Federation of State High School Associations, 2015, PART STAT; Patel Dilip R, 2002, Adolesc Med, V13, P569; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Pfister T, 2016, BRIT J SPORT MED, V50, P292, DOI 10.1136/bjsports-2015-094978; Powell JW, 1999, JAMA-J AM MED ASSOC, V282, P958, DOI 10.1001/jama.282.10.958; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Sarmiento K, 2016, INJURY PREV, V22, pA96, DOI 10.1136/injuryprev-2016-042156.263; Sarmiento K, 2014, J SAFETY RES, V50, P143, DOI 10.1016/j.jsr.2014.05.003; Schroeder T, 2001, NATL ELECT INJURY SU; Song M, 2015, J PHYS ACT HEALTH, V12, pS11, DOI 10.1123/jpah.2014-0117; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Tierney RT, 2005, MED SCI SPORT EXER, V37, P272, DOI 10.1249/01.MSS.0000152734.47516.AA; United States Census, 2015, SINGL GRAD ENR HIGH; Wallace J, 2017, J ATHL TRAINING, V52, P682, DOI 10.4085/1062-6050-52.3.06; Watson KB, 2015, J PHYS ACT HEALTH, V12, pS3, DOI 10.1123/jpah.2013-0521; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	46	18	19	0	0	ELSEVIER	AMSTERDAM	Radarweg 29, PO Box 211, AMSTERDAM, NETHERLANDS	0072-9752		978-0-44-463955-4; 978-0-444-63954-7	HAND CLINIC			2018	158						63	74		10.1016/B978-0-444-63954-7.00007-0			12	Clinical Neurology; Sport Sciences	Book Citation Index – Science (BKCI-S)	Neurosciences & Neurology; Sport Sciences	BP1MW	WOS:000540371100009	30482376				2022-02-06	
J	Cecchetto, C; Korb, S; Rumiati, RI; Aiello, M				Cecchetto, Cinzia; Korb, Sebastian; Rumiati, Raffaella Ida; Aiello, Marilena			Emotional reactions in moral decision-making are influenced by empathy and alexithymia	SOCIAL NEUROSCIENCE			English	Article						Moral decision-making; alexithymia; empathy; skin conductance; heart rate variability	VENTROMEDIAL PREFRONTAL DAMAGE; TRAUMATIC BRAIN-INJURY; LINEAR MIXED MODELS; FRONTOTEMPORAL DEMENTIA; AUTONOMIC REACTIVITY; JUDGMENT; CORTEX; ACCEPTABILITY; NEUROSCIENCE; DIMENSIONS	The role of emotional processes in driving moral choices remains debated. In particular, diminished emotional processing and reduced empathy have been associated with unusual high rates of utilitarian responses in moral judgments while, to date, the effects of diminished emotional processing and empathy on moral decision-making have been only partially considered. In this study, we investigated the influence of empathy and alexithymia on behavior and emotional responses while participants performed a moral decision task. Self-report (valence and arousal ratings) and physiological (skin conductance and heart rate) measures were collected during the task. Results showed that empathy and alexithymia shaped emotional reactions to moral decisions but did not bias moral choices. The more empathic the participants, the more dilemmas were perceived as unpleasant and arousing, and the greater the increase in skin conductance. Conversely, alexithymia was characterized by a reduced physiological activation during moral decisions, but normal self-report ratings. Heart rate was not modulated by empathy or alexithymia. These results add new evidence to the field of moral decision showing that empathy and alexithymia modulate emotional reactions to moral decision.	[Cecchetto, Cinzia; Rumiati, Raffaella Ida; Aiello, Marilena] SISSA, Neurosci Area, Trieste, Italy; [Korb, Sebastian] Univ Vienna, Dept Appl Psychol Hlth Dev Enhancement & Interven, Vienna, Austria; [Rumiati, Raffaella Ida] ANVUR, Rome, Italy		Cecchetto, C (corresponding author), SISSA, Insula Lab, Neurosci Area, Via Bonomea 265, Trieste, TS, Italy.	ccecchet@sissa.it	Korb, Sebastian/A-6294-2016; Cecchetto, Cinzia/AAW-1113-2020; aiello, mari/AAA-9215-2020	Korb, Sebastian/0000-0002-3517-3783; Cecchetto, Cinzia/0000-0001-9047-9884; 			Batson C.D., 2014, ALTRUISM QUESTION SO; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bermond B., 1994, BERMOND VORST ALEXIT; Bermond Bob, 2006, Cogn Neuropsychiatry, V11, P332, DOI 10.1080/13546800500368607; Bermond B, 2007, COGNITION EMOTION, V21, P1125, DOI 10.1080/02699930601056989; Bermond B, 2010, INT J PSYCHOPHYSIOL, V75, P227, DOI 10.1016/j.ijpsycho.2009.11.004; Berthoz S, 2011, HDB SOCIAL NEUROSCIE, P906; Bird G, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.61; Blair RJR, 2005, CONSCIOUS COGN, V14, P698, DOI 10.1016/j.concog.2005.06.004; Bloomfield Paul, 2007, MORALITY SELF INTERE; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bressi C, 1996, J PSYCHOSOM RES, V41, P551, DOI 10.1016/S0022-3999(96)00228-0; Brewer R, 2015, J ABNORM PSYCHOL, V124, P589, DOI 10.1037/abn0000076; Cacioppo J.T., 2000, HDB EMOTIONS, V2nd ed, P173; Carrigan B, 2016, BRAIN COGNITION, V108, P88, DOI 10.1016/j.bandc.2016.07.007; Cecchetto C., PROMOTING C IN PRESS; Choe SY, 2011, JUDGM DECIS MAK, V6, P580; Christensen JF, 2012, NEUROSCI BIOBEHAV R, V36, P1249, DOI 10.1016/j.neubiorev.2012.02.008; Christensen JF, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00607; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Crockett MJ, 2015, CURR BIOL, V25, P1852, DOI 10.1016/j.cub.2015.05.021; Crockett MJ, 2010, P NATL ACAD SCI USA, V107, P17433, DOI 10.1073/pnas.1009396107; Davis M.H., 1980, JSAS CATALOG SELECTE, V10, P85; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Decety J, 2014, PERSPECT PSYCHOL SCI, V9, P525, DOI 10.1177/1745691614545130; Decety J, 2014, TRENDS COGN SCI, V18, P337, DOI 10.1016/j.tics.2014.04.008; Decety J, 2009, MORAL BRAIN: ESSAYS ON THE EVOLUTIONARY AND NEUROSCIENTIFIC ASPECTS OF MORALITY, P109, DOI 10.1007/978-1-4020-6287-2_5; Eisenberg N, 2000, ANNU REV PSYCHOL, V51, P665, DOI 10.1146/annurev.psych.51.1.665; Flaisch T, 2008, PSYCHOPHYSIOLOGY, V45, P1, DOI 10.1111/j.1469-8986.2007.00600.x; Foot P., 1967, THEORIES OF ETHICS; Franz M, 2003, J PSYCHOPHYSIOL, V17, P203, DOI 10.1027/0269-8803.17.4.203; Gao Y, 2013, J CRIM JUST, V41, P342, DOI 10.1016/j.jcrimjus.2013.06.012; Gleichgerrcht E, 2015, EUR J NEUROL, V22, P1295, DOI 10.1111/ene.12745; Gleichgerrcht E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060418; Gleichgerrcht E, 2011, SOC NEUROSCI-UK, V6, P113, DOI 10.1080/17470919.2010.506751; Glenn AL, 2010, JUDGM DECIS MAK, V5, P497; Goerlich-Dobre KS, 2015, NEUROIMAGE, V122, P20, DOI 10.1016/j.neuroimage.2015.08.014; Goerlich-Dobre KS, 2015, HUM BRAIN MAPP, V36, P3805, DOI 10.1002/hbm.22879; Goerlich-Dobre KS, 2014, NEUROPSYCHOLOGIA, V53, P284, DOI 10.1016/j.neuropsychologia.2013.12.006; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2008, COGNITION, V107, P1144, DOI 10.1016/j.cognition.2007.11.004; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Guttman H, 2002, COMPR PSYCHIAT, V43, P448, DOI 10.1053/comp.2002.35905; Hauser M, 2007, MIND LANG, V22, P1, DOI 10.1111/j.1468-0017.2006.00297.x; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hoffman, 1994, REACHING OUT CARING, V7, P161; Johnson PCD, 2014, METHODS ECOL EVOL, V5, P944, DOI 10.1111/2041-210X.12225; Judd CM, 2012, J PERS SOC PSYCHOL, V103, P54, DOI 10.1037/a0028347; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koven NS, 2011, EMOTION, V11, P1255, DOI 10.1037/a0025616; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Langdon R, 2012, EMOTIONS IMAGINATION; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Lotto L, 2014, J BEHAV DECIS MAKING, V27, P57, DOI 10.1002/bdm.1782; MAIBOM HL, 2014, EMPATHY AND MORALITY; Martins AT, 2012, JUDGM DECIS MAK, V7, P478; McCulloch CE, 1997, J AM STAT ASSOC, V92, P162, DOI 10.2307/2291460; Mendez MF, 2005, COGN BEHAV NEUROL, V18, P193, DOI 10.1097/01.wnn.0000191292.17964.bb; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Moretto G, 2010, J COGNITIVE NEUROSCI, V22, P1888, DOI 10.1162/jocn.2009.21367; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nemiah J. C., 1976, MODERN TRENDS PSYCHO, V3, P430; Neufeld J, 2016, AUTISM RES, V9, P781, DOI 10.1002/aur.1573; Neumann D, 2014, J HEAD TRAUMA REHAB, V29, pE18, DOI 10.1097/HTR.0b013e31827fb0b5; Neumann SA, 2004, INT J PSYCHOPHYSIOL, V53, P183, DOI 10.1016/j.ijpsycho.2004.03.008; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Orelien JG, 2008, COMPUT STAT DATA AN, V52, P1896, DOI 10.1016/j.csda.2007.06.006; Palomba D, 2000, INT J PSYCHOPHYSIOL, V36, P45, DOI 10.1016/S0167-8760(99)00099-9; Parker J.D.A., 1999, DISORDERS AFFECT REG; Patil I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23637; Patil I, 2014, J COGN PSYCHOL, V26, P597, DOI 10.1080/20445911.2014.929137; Patil I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00501; Peasley-Miklus CE, 2016, EMOTION, V16, P164, DOI 10.1037/emo0000086; Pizarro D, 2000, J THEOR SOC BEHAV, V30, P355, DOI 10.1111/1468-5914.00135; Pollatos O, 2011, J PSYCHOSOM RES, V70, P525, DOI 10.1016/j.jpsychores.2010.12.003; Ranyard R., 2011, HDB PROCESS TRACING; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; Sarlo M, 2014, PHYSIOL BEHAV, V130, P127, DOI 10.1016/j.physbeh.2014.04.002; Sarlo M, 2012, J COGNITIVE NEUROSCI, V24, P1018, DOI 10.1162/jocn_a_00146; Shenhav A, 2014, J NEUROSCI, V34, P4741, DOI 10.1523/JNEUROSCI.3390-13.2014; SIFNEOS PE, 1973, PSYCHOTHER PSYCHOSOM, V22, P255, DOI 10.1159/000286529; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sturm VE, 2011, NEUROCASE, V17, P242, DOI 10.1080/13554794.2010.532503; Szekely RD, 2015, COGNITION EMOTION, V29, P64, DOI 10.1080/02699931.2014.895300; Tassy S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00229; Tassy S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00250; Thomas BC, 2011, J COGNITIVE NEUROSCI, V23, P2186, DOI 10.1162/jocn.2010.21591; Thomson J.A.K., 1976, ARISTOTLE ETHICS; Vorst HCM, 2001, PERS INDIV DIFFER, V30, P413, DOI 10.1016/S0191-8869(00)00033-7; Wood A, 2016, TRENDS COGN SCI, V20, P227, DOI 10.1016/j.tics.2015.12.010; Young L, 2012, J ABNORM PSYCHOL, V121, P659, DOI 10.1037/a0027489	96	18	19	5	51	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1747-0919	1747-0927		SOC NEUROSCI-UK	Soc. Neurosci.		2018	13	2					226	240		10.1080/17470919.2017.1288656			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	GB8ZP	WOS:000429364100007	28129727				2022-02-06	
J	Cheng, XX; Zheng, YY; Bu, P; Qi, XB; Fan, CL; Li, FQ; Kim, DH; Cao, QL				Cheng, Xiaoxin; Zheng, Yiyan; Bu, Ping; Qi, Xiangbei; Fan, Chunling; Li, Fengqiao; Kim, Dong H.; Cao, Qilin			Apolipoprotein E as a novel therapeutic neuroprotection target after traumatic spinal cord injury	EXPERIMENTAL NEUROLOGY			English	Article						Apolipoprotein E; Spinal cord-blood-barrier; Neuroprotection; Treatment; Spinal cord injury	BLOOD-BRAIN-BARRIER; E-DEFICIENT MICE; IMPROVES COGNITIVE PERFORMANCE; GLOBAL CEREBRAL-ISCHEMIA; E-MIMETIC PEPTIDE; APOE GENOTYPE; AXONAL REGENERATION; FUNCTIONAL RECOVERY; MULTIPLE-SCLEROSIS; NEURONAL DAMAGE	Apolipoprotein E (apoE), a plasma lipoprotein well known for its important role in lipid and cholesterol metabolism, has also been implicated in many neurological diseases. In this study, we examined the effect of apoE on the pathophysiology of traumatic spinal cord injury (SCI). ApoE-deficient mutant (apoE(-/-)) and wild-type mice received a T9 moderate contusion SCI and were evaluated using histological and behavioral analyses after injury. At 3 days after injury, the permeability of spinal cord-blood-barrier, measured by extravasation of Evans blue dye, was significantly increased in apoE(-/-) mice compared to wild type. The inflammation and spared white matter was also significantly increased and decreased, respectively, in apoE(-/-) mice compared to the wild type ones. The apoptosis of both neurons and oligodendrocytes was also significantly increased in apoE(-/-) mice. At 42 days after injury, the inflammation was still robust in the injured spinal cord in apoE(-/-) but not wild type mice. CD45 + leukocytes from peripheral blood persisted in the injured spinal cord of apoE(-/-) mice. The spared white matter was significantly decreased in apoE(-/-) mice compared to wild type ones. Locomotor function was significantly decreased in apoE(-/-) mice compared to wild type ones from week 1 to week 8 after contusion. Treatment of exogenous apoE mimetic peptides partially restored the permeability of spinal cord blood-barrier in apoE(-/-) mice after SCI. Importantly, the exogenous apoE peptides decreased inflammation, increased spared white matter and promoted locomotor recovery in apoE(-/-) mice after SCI. Our results indicate that endogenous apoE plays important roles in maintaining the spinal cord-blood-barrier and decreasing inflammation and spinal cord tissue loss after SCI, suggesting its important neuroprotective function after SCI. Our results further suggest that exogenous apoE mimetic peptides could be a novel and promising neuroprotective reagent for SCI.	[Cheng, Xiaoxin; Zheng, Yiyan; Bu, Ping; Qi, Xiangbei; Fan, Chunling; Kim, Dong H.; Cao, Qilin] Univ Texas Hlth Sci Ctr Houston, Vivian L Smith Dept Neurosurg, Houston, TX 77030 USA; [Cheng, Xiaoxin; Zheng, Yiyan; Bu, Ping; Kim, Dong H.; Cao, Qilin] Univ Texas Hlth Sci Ctr Houston, Brown Fdn, Inst Mol Med Prevent Human Dis, Ctr Stem Cell & Regenerat Med, Houston, TX 77030 USA; [Cheng, Xiaoxin] Dalian Med Univ, Dept Cell Biol, 25 Tinxin Rd, Dalian 116033, Liaoning, Peoples R China; [Qi, Xiangbei] Hebei Med Univ, Hosp 3, Dept Orthopaed Trauma Ctr, Shijiazhuang 050051, Hebei, Peoples R China; [Fan, Chunling] Cent S Univ, Xiangya Sch Med, Dept Anat & Neurobiol, Changsha 410011, Hunan, Peoples R China; [Li, Fengqiao] Cognosci Inc, Res Triangle Pk, NC USA		Cao, QL (corresponding author), UT Med Sch Houston, Dept Neurosurg, 1825 Pressler St, Houston, TX 77030 USA.	qi-lin.cao@uth.tmc.edu		Kim, Dong/0000-0002-1523-6396	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS099635]; Staman Ogilvie Fund for Spinal Cord Injury Recovery; Craig H. Neilsen Foundation [385446]; Mission Connect-a project of The TIRR Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS099635] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (R01 NS099635), the Staman Ogilvie Fund for Spinal Cord Injury Recovery, Craig H. Neilsen Foundation (385446), and Mission Connect-a project of The TIRR Foundation.	ALBERTS MJ, 1995, LANCET, V346, P575, DOI 10.1016/S0140-6736(95)91411-0; Aono M, 2003, NEUROSCIENCE, V116, P437, DOI 10.1016/S0306-4522(02)00709-1; Badaut J, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-132; Bart RD, 1998, NEUROREPORT, V9, P2615, DOI 10.1097/00001756-199808030-00035; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Cao QL, 2005, EXP NEUROL, V191, pS3, DOI 10.1016/j.expneurol.2004.08.026; Chapman J, 2001, NEUROLOGY, V56, P312, DOI 10.1212/WNL.56.3.312; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cohen DM, 2009, NMR BIOMED, V22, P332, DOI 10.1002/nbm.1343; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Fan CL, 2014, NEURAL REGEN RES, V9, P119, DOI 10.4103/1673-5374.125339; Fan CL, 2013, INT J BIOL SCI, V9, P78, DOI 10.7150/ijbs.5626; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fazekas F, 2000, J NEUROL NEUROSUR PS, V69, P25, DOI 10.1136/jnnp.69.1.25; Fazekas F, 2001, NEUROLOGY, V57, P853, DOI 10.1212/WNL.57.5.853; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Gordon I, 1996, MOL CHEM NEUROPATHOL, V28, P97, DOI 10.1007/BF02815210; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Gu Zhen, 2013, J Neurol Neurophysiol, V2014, P10; Guptill JT, 2017, J CLIN PHARMACOL, V57, P770, DOI 10.1002/jcph.853; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Han SH, 2000, ANN NY ACAD SCI, V903, P357, DOI 10.1111/j.1749-6632.2000.tb06387.x; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Hill RL, 2009, J NEUROTRAUM, V26, P1, DOI 10.1089/neu.2008.0543; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Huang YWA, 2017, CELL, V168, P427, DOI 10.1016/j.cell.2016.12.044; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Jha A, 2008, J SPINAL CORD MED, V31, P171, DOI 10.1080/10790268.2008.11760708; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kakinuma Y, 1998, NAT MED, V4, P1078, DOI 10.1038/2070; Karussis D, 2003, MULT SCLER, V9, P476, DOI 10.1191/1352458503ms950oa; Kaufman NA, 2010, BEHAV BRAIN RES, V214, P395, DOI 10.1016/j.bbr.2010.06.017; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Laskowitz DT, 2006, ACTA NEUROL SCAND, V114, P15, DOI 10.1111/j.1600-0404.2006.00680.x; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Laskowitz DT, 2012, NEUROCRIT CARE, V16, P316, DOI 10.1007/s12028-011-9641-5; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; Laskowitz DT, 2000, J LIPID RES, V41, P613; Laskowitz DT, 1997, J CEREBR BLOOD F MET, V17, P753; Laskowitz DT, 1997, J NEUROIMMUNOL, V76, P70, DOI 10.1016/S0165-5728(97)00021-0; Laskowitz DT, 2001, EXP NEUROL, V167, P74, DOI 10.1006/exnr.2001.7541; Laskowitz DT, 1998, J CEREBR BLOOD F MET, V18, P465, DOI 10.1097/00004647-199805000-00001; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Li FQ, 2006, J PHARMACOL EXP THER, V318, P956, DOI 10.1124/jpet.106.103671; Li FQ, 2010, J PHARMACOL EXP THER, V334, P106, DOI 10.1124/jpet.110.167882; Lill CM, 2012, J MED GENET, V49, P558, DOI 10.1136/jmedgenet-2012-101175; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; Lomnitski L, 1997, PHARMACOL BIOCHEM BE, V56, P669, DOI 10.1016/S0091-3057(96)00412-1; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; Lynch JR, 2003, J BIOL CHEM, V278, P48529, DOI 10.1074/jbc.M306923200; Lynch JR, 2005, EXP NEUROL, V192, P109, DOI 10.1016/j.expneurol.2004.11.014; Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x; Mahley RW, 2016, J MOL MED, V94, P739, DOI 10.1007/s00109-016-1427-y; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; McCarron MO, 1999, NEUROLOGY, V53, P2176, DOI 10.1212/WNL.53.9.2176; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; MICHEL RP, 1988, J MICROSC-OXFORD, V150, P117, DOI 10.1111/j.1365-2818.1988.tb04603.x; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Oitzl MS, 1997, BRAIN RES, V752, P189, DOI 10.1016/S0006-8993(96)01448-5; Pang JW, 2017, TRANSL STROKE RES, V8, P257, DOI 10.1007/s12975-016-0507-1; Patel CB, 2009, J NEUROTRAUM, V26, P1005, DOI 10.1089/neu.2008.0860; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Sarantseva S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008191; Schmitt Caroline, 2006, Spine J, V6, P113, DOI 10.1016/j.spinee.2005.05.379; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Seitz A, 2003, J NEUROSCI RES, V71, P417, DOI 10.1002/jnr.10482; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sheng HX, 1998, J CEREBR BLOOD F MET, V18, P361, DOI 10.1097/00004647-199804000-00003; Sheng HX, 1999, STROKE, V30, P1118, DOI 10.1161/01.STR.30.5.1118; Shi J, 2011, COGN BEHAV NEUROL, V24, P128, DOI 10.1097/WNN.0b013e31823380b5; Singh K, 2008, J BIOL CHEM, V283, P16752, DOI 10.1074/jbc.M710530200; Tai LM, 2016, ACTA NEUROPATHOL, V131, P709, DOI 10.1007/s00401-016-1547-z; Teng ZP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06932-3; Tenger C, 2003, IMMUNOLOGY, V109, P392, DOI 10.1046/j.1365-2567.2003.01665.x; Tlaskowitz D, 2007, PHARMACOGENOMICS, V8, P959, DOI 10.2217/14E22416.8.8.959; Toops KA, 2016, ADV EXP MED BIOL, V854, P3, DOI 10.1007/978-3-319-17121-0_1; Tu TM, 2017, ANN CLIN TRANSL NEUR, V4, P246, DOI 10.1002/acn3.399; Van Giau V, 2015, NEUROPSYCH DIS TREAT, V11, P1723, DOI 10.2147/NDT.S84266; Wang H, 2007, NEUROSCIENCE, V144, P1324, DOI 10.1016/j.neuroscience.2006.11.017; Wang H, 2013, EXP NEUROL, V241, P67, DOI 10.1016/j.expneurol.2012.11.027; Wang H, 2014, TRENDS ENDOCRIN MET, V25, P8, DOI 10.1016/j.tem.2013.10.003; Wang RH, 2014, J NEUROSCI RES, V92, P884, DOI 10.1002/jnr.23371; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Wei JJ, 2013, NEUROBIOL DIS, V56, P59, DOI 10.1016/j.nbd.2013.04.009; Whetstone WD, 2003, J NEUROSCI RES, V74, P227, DOI 10.1002/jnr.10759; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Yin YW, 2012, GENE, V511, P12, DOI 10.1016/j.gene.2012.09.010; Zhang W, 2010, CLIN DEV IMMUNOL, DOI [10.1155/2010/459143, 10.1155/2010/186813]; Zhong JJ, 2017, NEUROSCIENCE, V343, P434, DOI 10.1016/j.neuroscience.2016.05.033; Zhu L, 2015, P NATL ACAD SCI USA, V112, P11965, DOI 10.1073/pnas.1510011112; Zlokovic BV, 2013, JAMA NEUROL, V70, P440, DOI 10.1001/jamaneurol.2013.2152	98	18	19	1	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.		2018	299		A				97	108		10.1016/j.expneurol.2017.10.014			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR7PD	WOS:000419261500009	29056364	Green Accepted			2022-02-06	
J	Gibson, TJ; Rebelo, CB; Gowers, TA; Chancellor, NM				Gibson, T. J.; Rebelo, C. B.; Gowers, T. A.; Chancellor, N. M.			Electroencephalographic assessment of concussive non-penetrative captive bolt stunning of turkeys	BRITISH POULTRY SCIENCE			English	Article						Animal welfare; behaviour; brainstem reflexes; captive bolt; electroencephalogram (EEG); non-penetrative; stunning; turkey	SOMATOSENSORY-EVOKED POTENTIALS; HALOTHANE-ANESTHETIZED CALVES; CERVICAL DISLOCATION; ON-FARM; BLUNT TRAUMA; WATER BATH; RESPONSES; POULTRY; HEAD; SLAUGHTER	1. The aim of this study was to evaluate the electroencephalographic (EEG) and behavioural responses of turkeys stunned with three different concussive non-penetrative captive-bolt guns prior to slaughter.2. A total of 31 slaughter weight ex-breeding female turkeys (29weeks of age; mean body weight 13.32 SD 0.65kg) were stunned with the Cash Poultry Killer (CPK) (n=10), Turkey Euthanasia Device (TED) (n=10) and Zephyr EXL (n=11).3. Mean peak kinetic energy was highest for the CPK compared to the TED and Zephyr EXL (75.94.5, 28.4 +/- 0.4 and 24.4 +/- 0.7J, respectively).4. A total of 29 (94%) of the turkeys were rendered unconscious following captive bolt stunning, with total power of the EEG (Ptot) significantly reduced from baseline values (reductions of 67% CPK, 84% TED and 76% Zephyr EXL, p<0.01) and waveforms becoming isoelectric after periods of transitional EEG. However, two birds shot with the CPK and Zephyr EXL had periods of behavioural/reflexes (rhythmic respiration, nictitating membrane reflex, neck tension) and EEG activity (43-47 and 36-60+s after the shot, respectively) indicating incomplete concussion and return of consciousness. In one bird, the shot was incorrectly positioned (Zephyr EXL), while the other appeared to be related to a defective cartridge (CPK).5. In conclusion, all three captive bolt gun models were effective in producing unconsciousness in turkeys, provided they were positioned correctly and power loads performed according to their specifications.	[Gibson, T. J.; Rebelo, C. B.; Gowers, T. A.; Chancellor, N. M.] Univ London, Dept Pathobiol & Populat Sci, Royal Vet Coll, Hatfield AL9 7TA, Herts, England		Gibson, TJ (corresponding author), Univ London, Dept Pathobiol & Populat Sci, Royal Vet Coll, Hatfield AL9 7TA, Herts, England.	tgibson@rvc.ac.uk	Gibson, Troy/AAA-8687-2019	Gibson, Troy/0000-0002-1242-2695	Humane Slaughter Association	Carlos Rebelo was supported by a grant from the Humane Slaughter Association.	Authie E, 2014, EFSA J, V12, DOI 10.2903/j.efsa.2014.3745; BAGER F, 1990, MEAT SCI, V27, P211, DOI 10.1016/0309-1740(90)90052-8; Beyssen C, 2004, BRIT POULTRY SCI, V45, P409, DOI 10.1080/00071660410001730923; Beyssen C, 2004, ANIM RES, V53, P155, DOI 10.1051/animres:2004002; Casey-Trott TM, 2013, J ANIM SCI, V91, P5477, DOI 10.2527/jas.2013-6320; DEFRA, 2017, UK POULTR POULTR MEA; Erasmus MA, 2010, VET REC, V167, P850, DOI 10.1136/vr.c5051; Erasmus MA, 2010, POULTRY SCI, V89, P1345, DOI 10.3382/ps.2009-00445; Gibson TJ, 2016, BRIT POULTRY SCI, V57, P295, DOI 10.1080/00071668.2016.1156648; Gibson TJ, 2012, ANIM WELFARE, V21, P35, DOI 10.7120/096272812X13353700593446; Gibson TJ, 2009, NEW ZEAL VET J, V57, P96, DOI 10.1080/00480169.2009.36885; Gibson TJ, 2009, NEW ZEAL VET J, V57, P90, DOI 10.1080/00480169.2009.36884; Gibson TJ, 2015, J APPL ANIM WELF SCI, V18, P222, DOI 10.1080/10888705.2014.980579; Gibson TJ, 2015, MEAT SCI, V100, P227, DOI 10.1016/j.meatsci.2014.10.022; Gregory NG, 2007, MEAT SCI, V77, P499, DOI 10.1016/j.meatsci.2007.04.026; GREGORY NG, 1990, VET REC, V126, P570; Grist A, 2017, ANIM WELFARE, V26, P111, DOI 10.7120/09627286.26.1.111; Hillebrand SJW, 1996, POULTRY SCI, V75, P664, DOI 10.3382/ps.0750664; Hindle VA, 2010, POULTRY SCI, V89, P401, DOI 10.3382/ps.2009-00297; Lines JA, 2011, BRIT POULTRY SCI, V52, P432, DOI 10.1080/00071668.2011.587180; Martin JE, 2016, ANIM WELFARE, V25, P227, DOI 10.7120/09627286.25.2.227; McKeegan DEF, 2013, POULTRY SCI, V92, P1145, DOI 10.3382/ps.2012-02587; McKeegan DEF, 2011, BRIT POULTRY SCI, V52, P645, DOI 10.1080/00071668.2011.640307; Raj ABM, 2006, ANIM WELFARE, V15, P7; Raj ABM, 2004, ANIM WELFARE, V13, P159; Raj ABM, 2001, BRIT POULTRY SCI, V42, P295, DOI 10.1080/00071660120055232; Sparrey J, 2014, WORLD POULTRY SCI J, V70, P737, DOI 10.1017/S0043933914000816; Terlouw C, 2016, MEAT SCI, V118, P147, DOI 10.1016/j.meatsci.2016.03.010	28	18	19	0	17	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0007-1668	1466-1799		BRIT POULTRY SCI	Br. Poult. Sci.		2018	59	1					13	20		10.1080/00071668.2017.1401215			8	Agriculture, Dairy & Animal Science	Science Citation Index Expanded (SCI-EXPANDED)	Agriculture	FW5MU	WOS:000425362300003	29099622	Green Accepted			2022-02-06	
J	Harriss, A; Walton, DM; Dickey, JP				Harriss, Alexandra; Walton, David M.; Dickey, James P.			Direct player observation is needed to accurately quantify heading frequency in youth soccer	RESEARCH IN SPORTS MEDICINE			English	Article						Soccer; concussion; heading; self-report	NEUROCOGNITIVE PERFORMANCE; EXPOSURE; FOOTBALLERS; FEMALE	In soccer, heading may be related to subsequent neurological impairment. Accurate measures of heading exposure are therefore important. This study evaluated whether 12 female youth players accurately recalled their average number of headers over an entire soccer season (20 games total). Their self-reported average number of headers per game was multiplied by the number of games that they participated in, and were compared to actual number of headers extracted from game video. All players overestimated the number of headers compared to game video. Linear regression analysis indicated that self-reported headers overestimated the number of headers by 51%. While self-reports are a convenient way to estimate heading behaviour, they do not accurately represent the number of headers that players perform. Self-reports of heading exposure should be interpreted with caution.	[Harriss, Alexandra; Dickey, James P.] Western Univ, Sch Kinesiol, 1151 Richmond St,3M Ctr, London, ON N6A 3K7, Canada; [Walton, David M.] Western Univ, Sch Phys Therapy, Elborn Coll, London, ON, Canada		Dickey, JP (corresponding author), Western Univ, Sch Kinesiol, 1151 Richmond St,3M Ctr, London, ON N6A 3K7, Canada.	jdickey@uwo.ca	Walton, David M/C-9902-2015; Dickey, James P/K-6776-2013	Walton, David M/0000-0001-9155-3337; Dickey, James P/0000-0002-4101-835X	Ontario Soccer Association; Burlington Youth Soccer Club	We would like to thank the Ontario Soccer Association, and the Burlington Youth Soccer Club for supporting this study. The authors would like to thank Aakash Naik for help in data acquisition.	Catenaccio E, 2016, RES SPORTS MED, V24, P416, DOI 10.1080/15438627.2016.1234472; Chan Y H, 2003, Singapore Med J, V44, P614; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Di Virgilio TG, 2016, EBIOMEDICINE, V13, P66, DOI 10.1016/j.ebiom.2016.10.029; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Kaminski TW, 2007, J CLIN EXP NEUROPSYC, V29, P742, DOI 10.1080/13825580600976911; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kunz M., 2007, FIFA MAGAZINE, V7, P11, DOI DOI 10.1080/13673882.2007.9680857; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Metzl JD, 1998, CLIN SPORT MED, V17, P663, DOI 10.1016/S0278-5919(05)70110-1; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Rutherford A, 2005, APPL COGNITIVE PSYCH, V19, P477, DOI 10.1002/acp.1091; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI70, DOI 10.1136/bjsm.2005.019646; Webbe FM, 2007, J CLIN SPORT PSYCHOL, V1, P379, DOI 10.1123/jcsp.1.4.379	19	18	18	3	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1543-8627	1543-8635		RES SPORTS MED	Res. Sports Med.		2018	26	2					191	198		10.1080/15438627.2018.1431534			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	GA8NL	WOS:000428596900007	29366355				2022-02-06	
J	Hausser, N; Johnson, K; Parsley, MA; Guptarak, J; Spratt, H; Sell, SL				Hausser, Nicole; Johnson, Kathia; Parsley, Margaret A.; Guptarak, Jutatip; Spratt, Heidi; Sell, Stacy L.			Detecting Behavioral Deficits in Rats After Traumatic Brain Injury	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Behavior; Issue 131; Behavior; neuroscore; beam-balance; beam-walk; working memory; brain injury; fluid-percussion injury; Morris water maze; rat		With the increasing incidence of traumatic brain injury (TBI) in both civilian and military populations, TBI is now considered a chronic disease; however, few studies have investigated the long-term effects of injury in rodent models of TBI. Shown here are behavioral measures that are well-established in TBI research for times early after injury, such as two weeks, until two months. Some of these methods have previously been used at later times after injury, up to one year, but by very few laboratories. The methods demonstrated here are a short neurological assessment to test reflexes, a Beam-Balance to test balance, a Beam-Walk to test balance and motor coordination, and a working memory version of the Morris water maze that can be sensitive to deficits in reference memory. Male rats were handled and pre-trained to neurological, balance, and motor coordination tests prior to receiving parasagittal fluid percussion injury (FPI) or sham injury. Rats can be tested on the short neurological assessment (neuroscore), the beam-balance, and the Beam-Walk multiple times, while testing on the water maze can only be done once. This difference is because rats can remember the task, thus confounding the results if repeated testing is attempted in the same animal. When testing from one to three days after injury, significant differences are detected in all three non-cognitive tasks. However, differences in the Beam-Walk task were not detectable at later time points (after 3 months). Deficits were detected at 3 months in the Beam-Balance and at 6 months in the neuroscore. Deficits in working memory were detected out to 12 months after injury, and a deficit in a reference memory first appeared at 12 months. Thus, standard behavioral tests can be useful measures of persistent behavioral deficits after FPI.	[Hausser, Nicole; Johnson, Kathia; Parsley, Margaret A.; Guptarak, Jutatip; Spratt, Heidi; Sell, Stacy L.] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA		Sell, SL (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.	slsell@utmb.edu		Spratt, Heidi/0000-0002-9420-5028	Moody Project for Translational Traumatic Brain Injury Research	We thank Ian Bolding for assistance with surgical preparation of subjects and Elizabeth Sumner for her meticulous editing. These studies were completed as part of a team funded by The Moody Project for Translational Traumatic Brain Injury Research.	Bramlett H. M., 2015, J NEUROTRAUM, V32, P1; DeWitt DS, 1997, J NEUROTRAUM, V14, P223, DOI 10.1089/neu.1997.14.223; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Ferguson S. A., 2003, PHYSIOL BEHAV, V119, P130; Fujimoto S. T., 2004, NEUROSCI BIOBEHAV RE; Gold EM, 2013, REGEN MED, V8, P483, DOI 10.2217/rme.13.41; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; MORRIS RGM, 1986, Q J EXP PSYCHOL-B, V38, P365; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; R Core Team, 2017, R LANG ENV STAT COMP; RUIS JF, 1991, PHYSIOL BEHAV, V50, P1233, DOI 10.1016/0031-9384(91)90588-F; Schallert T, 2003, ILAR J, V44, P130, DOI 10.1093/ilar.44.2.130; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Sell SL, 2008, ANESTHESIOLOGY, V108, P873, DOI 10.1097/ALN.0b013e31816c8a15; Sell SL, 2017, J NEUROTRAUM, V34, P1086, DOI 10.1089/neu.2016.4616; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Verma P, 2010, PHYSIOL BEHAV, V99, P276, DOI 10.1016/j.physbeh.2009.11.002	21	18	18	3	3	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	JAN	2018		131							e56044	10.3791/56044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX5CM	WOS:000426095700016	29443022	Bronze, Green Published, Green Submitted			2022-02-06	
J	Hollund, IMH; Olsen, A; Skranes, J; Brubakk, AM; Haberg, AK; Eikenes, L; Evensen, KAI				Hollund, Ingrid Marie Husby; Olsen, Alexander; Skranes, Jon; Brubakk, Ann-Mari; Haberg, Asta K.; Eikenes, Live; Evensen, Kari Anne I.			White matter alterations and their associations with motor function in young adults born preterm with very low birth weight	NEUROIMAGE-CLINICAL			English	Article						Preterm; Brain; Diffusion tensor imaging; Tractography; Motor function; Young adulthood	TRAUMATIC BRAIN-INJURY; ASSESSMENT-TOOL HIMAT; CORPUS-CALLOSUM; FRACTIONAL ANISOTROPY; SPATIAL STATISTICS; DIFFUSION; CHILDREN; AGE; ADOLESCENTS; INFANTS	Very low birth weight (VLBW: <= 1500 g) individuals have an increased risk of white matter alterations and neurodevelopmental problems, including fine and gross motor problems. In this hospital-based follow-up study, the main aim was to examine white matter microstructure and its relationship to fine and gross motor function in 31 VLBW young adults without cerebral palsy compared with 31 term-born controls, at mean age 22.6 +/- 0.7 years. The participants were examined with tests of fine and gross motor function (Trail Making Test-5: TMT-5, Grooved Pegboard, Triangle from Movement Assessment Battery for Children-2: MABC-2 and High-level Mobility Assessment Tool: HiMAT) and diffusion tensor imaging (DTI). Probabilistic tractography of motor pathways of the corticospinal tract (CST) and corpus callosum (CC) was performed. Fractional anisotropy (FA) was calculated in non-crossing (capsula interna in CST, body of CC) and crossing (centrum semiovale) fibre regions along the tracts and examined for group differences. Associations between motor test scores and FA in the CST and CC were investigated with linear regression. Tract-based spatial statistics (TBSS) was used to examine group differences in DTI metrics in all major white matter tracts. The VLBW group had lower scores on all motor tests compared with controls, however, only statistically significant for TMT-5. Based on tractography, FA in the VLBW group was lower in non-crossing fibre regions and higher in crossing fibre regions of the CST compared with controls. Within the VLBW group, poorer fine motor function was associated with higher FA in crossing fibre regions of the CST, and poorer bimanual coordination was additionally associated with lower FA in crossing fibre regions of the CC. Poorer gross motor function was associated with lower FA in crossing fibre regions of the CST and CC. There were no associations between motor function and FA in non-crossing fibre regions of the CST and CC within the VLBW group. In the TBSS analysis, the VLBW group had lower FA and higher mean diffusivity compared with controls in all major white matter tracts. The findings in this study may indicate that the associations between motor function and FA are caused by other tracts crossing the CST and CC, and/or by alterations in the periventricular white matter in the centrum semiovale. Some of the associations were in the opposite direction than hypothesized, thus higher FA does not always indicate better function. Furthermore, widespread white matter alterations in VLBW individuals persist into young adulthood.	[Hollund, Ingrid Marie Husby; Skranes, Jon; Brubakk, Ann-Mari; Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7491 Trondheim, Norway; [Olsen, Alexander] Norwegian Univ Sci & Technol, Dept Psychol, Trondheim, Norway; [Olsen, Alexander] Trondheim Reg & Univ Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway; [Skranes, Jon] Sorlandet Hosp, Dept Pediat, Arendal, Norway; [Haberg, Asta K.] Norwegian Univ Sci & Technol, Dept Neurosci, Trondheim, Norway; [Haberg, Asta K.] Trondheim Reg & Univ Hosp, St Olavs Hosp, MR Ctr, Dept Radiol & Nucl Med, Trondheim, Norway; [Eikenes, Live] Norwegian Univ Sci & Technol, Dept Circulat & Med Imaging, Trondheim, Norway; [Evensen, Kari Anne I.] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway; [Evensen, Kari Anne I.] Dept Physiotherapy, Trondheim, Norway		Hollund, IMH (corresponding author), Norwegian Univ Sci & Technol, Dept Lab Med Childrens & Womens Hlth, N-7491 Trondheim, Norway.	ingridmhusby@gmail.com	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860; Evensen, Kari Anne I./0000-0002-0129-0164	Research Council of Norway (Researcher program: NEVRONOR) [182663]	The study was funded by the Research Council of Norway (Researcher program: NEVRONOR. Project Number: 182663) and was independent of commercial interest.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; [Anonymous], 2002, GROOV PEG TEST US IN; BAKKETEIG LS, 1993, ACTA OBSTET GYN SCAN, V72, P273, DOI 10.3109/00016349309068037; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Berntsen EM, 2008, NEUROL RES, V30, P968, DOI 10.1179/016164108X323753; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Counsell SJ, 2008, BRAIN, V131, P3201, DOI 10.1093/brain/awn268; de Kieviet JF, 2014, EUR J PAEDIATR NEURO, V18, P126, DOI 10.1016/j.ejpn.2013.09.004; de Kieviet JF, 2009, JAMA-J AM MED ASSOC, V302, P2235, DOI 10.1001/jama.2009.1708; Delis D.C., 2001, EXAMINERS MANUAL; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eikenes L, 2011, NEUROIMAGE, V54, P1774, DOI 10.1016/j.neuroimage.2010.10.037; Groeschel S, 2014, NEUROIMAGE, V87, P209, DOI 10.1016/j.neuroimage.2013.10.034; Henderson S.E., 2007, MOVEMENT ASSESSMENT, V2nd ed.; Hoeft F, 2007, J NEUROSCI, V27, P11960, DOI 10.1523/JNEUROSCI.3591-07.2007; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Holland D, 2010, NEUROIMAGE, V50, P175, DOI 10.1016/j.neuroimage.2009.11.044; Hollingshead A. B., 1957, 2 FACTOR INDEX SOCIA; Husby IM, 2013, EARLY HUM DEV, V89, P747, DOI 10.1016/j.earlhumdev.2013.05.009; Johansen-Berg H, 2007, NEUROIMAGE, V36, pT16, DOI 10.1016/j.neuroimage.2007.03.041; Jurcoane A, 2016, HUM BRAIN MAPP, V37, P289, DOI 10.1002/hbm.23031; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Li K., 2014, DEV MED CHILD NEUROL; Meng C, 2016, BRAIN STRUCT FUNCT, V221, P2109, DOI 10.1007/s00429-015-1032-9; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Pandit AS, 2013, NEURORADIOLOGY, V55, P65, DOI 10.1007/s00234-013-1242-x; Skranes J, 2007, BRAIN, V130, P654, DOI 10.1093/brain/awm001; Skranes JS, 1997, NEUROPEDIATRICS, V28, P149, DOI 10.1055/s-2007-973692; SKRANES JS, 1993, NEUROPEDIATRICS, V24, P256, DOI 10.1055/s-2008-1071553; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sripada K, 2015, NEUROIMAGE, V109, P493, DOI 10.1016/j.neuroimage.2015.01.019; Steele CJ, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00289; van Kooij BJM, 2012, AM J NEURORADIOL, V33, P188, DOI 10.3174/ajnr.A2723; Vangberg TR, 2006, NEUROIMAGE, V32, P1538, DOI 10.1016/j.neuroimage.2006.04.230; Volpe JJ, 2003, PEDIATRICS, V112, P176, DOI 10.1542/peds.112.1.176; Volpe JJ, 2009, LANCET NEUROL, V8, P110, DOI 10.1016/S1474-4422(08)70294-1; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	42	18	18	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	17						241	250		10.1016/j.nicl.2017.10.006			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FX6GA	WOS:000426180300027	29159041	Green Published, gold			2022-02-06	
J	Kreutzer, JS; Marwitz, JH; Sima, AP; Mills, A; Hsu, NH; Lukow, HR				Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Sima, Adam P.; Mills, Ana; Hsu, Nancy H.; Lukow, Herman R.			Efficacy of the resilience and adjustment intervention after traumatic brain injury: a randomized controlled trial	BRAIN INJURY			English	Article						Intervention; resilience; psychological adjustment; psychological distress	CONNOR-DAVIDSON RESILIENCE; COGNITIVE-BEHAVIOR THERAPY; EMOTIONAL ADJUSTMENT; FAMILY INTERVENTION; REHABILITATION; OUTCOMES; METAANALYSIS; PREDICTORS; SCALE; RECOVERY	Objective: Examine a psychoeducational and skill-building intervention's effectiveness for individuals after traumatic brain injury (TBI), using a two-arm, parallel, randomized, controlled trial with wait-listed control.Methods: The Resilience and Adjustment Intervention (RAI) targets adjustment challenges and emphasizes education, skill-building and psychological support. Overall, 160 outpatients were randomly assigned to a treatment or wait-list control (WLC) group. The manualized treatment was delivered in seven 1-h sessions. The Connor-Davidson Resilience Scale (CD-RISC) was the primary outcome measure. Secondary measures included the Mayo Portland Adaptability Inventory-4 (MPAI-4), Brief Symptom Inventory-18 (BSI-18) and 13-Item Stress Test.Results: After adjusting for injury severity, education and time postinjury, the RAI group (N=75) demonstrated a significantly greater increase in resilience (effect size=1.03) compared to the WLC group (N=73). Participants in the RAI group demonstrated more favourable scores on the MPAI-4 Adjustment and Ability Indices, BSI-18 and the 13-item Stress Test. However, only the CD-RISC and BSI-18 demonstrated a clinically significant difference. In addition, RAI participants demonstrated maintenance of gains from pre-treatment to 3-month follow-up; however, only the BSI-18 maintained a clinically significant difference.Conclusions: Investigation provided evidence that a resilience-focused intervention can improve psychological health and adjustment after TBI. Additional research is needed to ascertain the longer term benefits of intervention and the efficacy of alternative delivery methods (e.g., via telephone, Internet).	[Kreutzer, Jeffrey S.; Marwitz, Jennifer H.; Mills, Ana; Hsu, Nancy H.; Lukow, Herman R.] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA; [Sima, Adam P.] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA USA		Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Box 980542, Richmond, VA 23284 USA.	jennifer.marwitz@vcuhealth.org		Sima, Adam/0000-0001-8426-9987	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0033, 90AR5002]	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90DP0033, 90AR5002). NIDILRR is a centre within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.	Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Bell KR, 2017, J NEUROTRAUM, V34, P313, DOI 10.1089/neu.2016.4444; Bell KR, 2011, ARCH PHYS MED REHAB, V92, P1552, DOI 10.1016/j.apmr.2011.05.018; Bergquist TF, 2010, TELEMED J E-HEALTH, V16, P417, DOI 10.1089/tmj.2009.0118; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Campbell-Sills L, 2007, J TRAUMA STRESS, V20, P1019, DOI 10.1002/jts.20271; Campbell-Sills L, 2009, J PSYCHIATR RES, V43, P1007, DOI 10.1016/j.jpsychires.2009.01.013; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Cosco TD, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0418-6; Derogatis L.R., 2000, BRIEF SYMPTOM INVENT; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Ellis A., 1975, NEW GUIDE RATIONAL L; Evans JJ, 2011, BRAIN IMPAIR, V12, P117, DOI 10.1375/brim.12.2.117; Godwin EE, 2013, BRAIN INJURY, V27, P637, DOI 10.3109/02699052.2012.750745; Gordon WA, 2006, AM J PHYS MED REHAB, V85, P343, DOI 10.1097/01.phm.0000202106.01654.61; Hanks RA, 2016, REHABIL PSYCHOL, V61, P269, DOI 10.1037/rep0000069; Hart T, 2014, J NEUROTRAUM, V31, P610, DOI 10.1089/neu.2013.3041; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; HODGSON J, 2005, BRAIN IMPAIR, V6, P169, DOI DOI 10.1375/BRIM.2005.6.3.169; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Hsieh MY, 2012, NEUROPSYCHOL REHABIL, V22, P585, DOI 10.1080/09602011.2012.678860; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; KOBASA SC, 1979, J PERS SOC PSYCHOL, V37, P1, DOI 10.1037/0022-3514.37.1.1; Konigs M, 2016, EUR J NEUROL, V23, P21, DOI 10.1111/ene.12719; Kreutzer J, 2012, GETTING BETTER BETTE; Kreutzer JS, 2016, ARCH PHYS MED REHAB, V97, P708, DOI 10.1016/j.apmr.2015.12.003; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kreutzer JS, 2002, J HEAD TRAUMA REHAB, V17, P349, DOI 10.1097/00001199-200208000-00008; Kreutzer JS, 2014, RESILIENCE ADJUSTMEN; Kreutzer JS, 1999, GETTING BETTER BETTE; Losoi H, 2016, J NEUROTRAUM, V33, P766, DOI 10.1089/neu.2015.4070; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; Losoi H, 2015, J HEAD TRAUMA REHAB, V30, pE24, DOI 10.1097/HTR.0000000000000055; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Malec JF, 2008, MAYO PORTLAND ADAPTA; Mateer CA, 2005, J HEAD TRAUMA REHAB, V20, P62, DOI 10.1097/00001199-200501000-00007; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; Meachen SJ, 2008, ARCH PHYS MED REHAB, V89, P958, DOI 10.1016/j.apmr.2007.12.028; Newman R, 2005, PROF PSYCHOL-RES PR, V36, P227, DOI 10.1037/0735-7028.36.3.227; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Richardson GE, 2002, J CLIN PSYCHOL, V58, P307, DOI 10.1002/jclp.10020; Rohling ML, 2009, NEUROPSYCHOLOGY, V23, P20, DOI 10.1037/a0013659; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; RUTTER M, 1985, BRIT J PSYCHIAT, V147, P598, DOI 10.1192/bjp.147.6.598; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Sullivan KA, 2016, NEUROPSYCHOL REV, V26, P173, DOI 10.1007/s11065-016-9317-1; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Thaut MH, 2009, ANN NY ACAD SCI, V1169, P406, DOI 10.1111/j.1749-6632.2009.04585.x; Thurmond VA, 2010, ARCH PHYS MED REHAB, V91, P1633, DOI 10.1016/j.apmr.2010.06.034; Ungar M, 2013, TRAUMA VIOLENCE ABUS, V14, P255, DOI 10.1177/1524838013487805; Vikane E, 2017, BRAIN INJURY, V31, P1; Whelan-Goodinson R, 2010, J HEAD TRAUMA REHAB, V25, P320, DOI 10.1097/HTR.0b013e3181c8f8e7; White B, 2008, REHABIL PSYCHOL, V53, P9, DOI 10.1037/0090-5550.53.1.9; Whyte J, 2003, AM J PHYS MED REHAB, V82, P639, DOI 10.1097/01.PHM.0000078200.61840.2D; Whyte J, 2012, ARCH PHYS MED REHAB, V93, pS101, DOI 10.1016/j.apmr.2011.11.040; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Williams MW, 2014, REHABIL PSYCHOL, V59, P298, DOI 10.1037/a0037164; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Wood RLL, 2006, J INT NEUROPSYCH SOC, V12, P350, DOI 10.1017/S1355617706060498; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	68	18	18	1	11	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	8			SI		963	971		10.1080/02699052.2018.1468577			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GJ2QK	WOS:000435116400002	29792533				2022-02-06	
J	McAvoy, K; Eagan-Johnson, B; Halstead, M				McAvoy, Karen; Eagan-Johnson, Brenda; Halstead, Mark			Return to learn: Transitioning to school and through ascending levels of academic support for students following a concussion	NEUROREHABILITATION			English	Article						Concussion; return to learn (RTL); return to play (RTP); return to sport (RTS); 504 plan; Individualized Health Plan (IHP); Individualized Education Plan (IEP); Individuals with Disabilities Education Act (IDEA); Traumatic Brain Injury (TBI)		PURPOSE: The purpose of this article is to familiarize healthcare providers and parents with educational language, laws, and processes as they relate to a comprehensive ascending level of academic supports as it pertains to promoting a smooth and supported transition to school following a concussion. BACKGROUND: Returning to learn (RTL) following a concussion is of parallel importance to returning to sport (RTS). A successful RTL is a critical part of concussion management. Many RTL articles advise healthcare providers and parents to request formalized educational supports, also known as Tier 2 or Tier 3 services, for children with concussion as they return to school. FINDINGS: Premature requests for formal (Tier 2 or 3) educational services, rather than allowing for immediate informal educational supports (known as Tier 1), can actually delay academic supports and have the potential to cause adversarial relationships between parents and schools. Additionally, this practice contradicts current research demonstrating the need for fast, flexible, temporary academic supports within the first month post-injury. CONCLUSION: Allowing school districts to direct the application of existing ascending levels of educational support for students with concussion as they return to school can promote robust and positive outcomes.	[McAvoy, Karen] Rocky Mt Hosp Children, Lone Tree, CO USA; [Eagan-Johnson, Brenda] BrainSTEPS Program, New Castle, PA USA; [Halstead, Mark] Washington Univ, Sports Med, St Louis, MO USA		McAvoy, K (corresponding author), 631 Peterson St, Ft Collins, CO 80524 USA.	KarenMcAvoy11@gmail.com					Building the Legacy: IDEA, 2004, BUILD LEG IDEA 2004; Centers for Disease Control and Prevention, 2017, TBI GET THE FACTS; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; McAvoy & Eagan Brown, 2015, GET SCH CONC RET LEA; McCrory P., 2017, BRIT J SPORTS MED; National Association of School Nurses, 2016, CONC ROL SCH NURS; Pennsylvania Department of Education, 2014, SPEC ED TIM; Russell K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165116; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; US Department of Education, OSEP FUND TECHN ASS; Wasserman EB, 2016, AM J PUBLIC HEALTH, V106, P1247, DOI 10.2105/AJPH.2016.303154; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zirkel PA, 2015, J SCH NURS, V31, P99, DOI 10.1177/1059840514521465	13	18	18	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					325	330		10.3233/NRE-172381			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300008	29660962				2022-02-06	
J	Saldert, C; Jensen, LR; Johansson, MB; Simmons-Mackie, N				Saldert, C.; Jensen, L. R.; Johansson, M. Blom; Simmons-Mackie, N.			Complexity in measuring outcomes after communication partner training: alignment between goals of intervention and methods of evaluation	APHASIOLOGY			English	Article						Communication partner training; aphasia; outcome measures; patient-relevant outcome; core outcome set	APHASIA TREATMENT RESEARCH; TRAUMATIC BRAIN-INJURY; ITEM BANK CALIBRATION; SUPPORTED CONVERSATION; PSYCHOMETRIC PROPERTIES; MEDICAL-STUDENTS; NURSES WORKING; HEALTH-CARE; STROKE; PARTICIPATION	Background: Researchers are currently discussing the need for consensus on a core set of outcome measures to assess interventions in aphasia. For indirect, environmental approaches to aphasia intervention, such as communication partner training (CPT), the roadmap to obtaining consensus on core outcome measures seems especially complex. While the purpose of CPT is to improve communication for people with communication disorders, the intervention is aimed at the communication partner. There is also a variety of goals, activities, and possible settings for CPT. This complexity increases the risk of a mismatch between the goals and content of the intervention and measures used to evaluate the outcome. Aims: The purpose of this paper is to describe the complexity of measuring outcomes from CPT. The aim is to enable clinicians and researchers to reflect on the outcomes to be measured and also on how different types of measures may or may not be aligned with the goals and content of a specific CPT intervention. Main contribution: The current proliferation of outcome measures used in CPT is considered in the light of a survey of general factors to be considered in evaluating intervention outcomes. The complexity of measuring outcomes in CPT is illustrated and the importance of alignment of main objectives, intervention tasks, and projected outcomes is exemplified by referencing two common types of CPT approaches. Objectives relating to knowledge of aphasia, interactional behaviour, and feelings and attitudes are considered in relation to specific outcome measurements. It is suggested that both study-specific and more general measures are needed for capturing and comparing outcomes. The measurement of relevant outcome in CPT is discussed along with implications for future research and clinical practice. Conclusions: Different CPT approaches share the same purpose of facilitating communication in aphasia, but their application in research studies or in the clinic, is specific to the particular context. Special care must thus be taken in both clinical practice and research to safeguard the alignment between objectives, tasks, and projected intervention outcomes and the actual measures used. Further, it is concluded that there is a need for the development of new measures based on a consensus on key outcomes to be measured in CPT.	[Saldert, C.] Univ Gothenburg, Speech Language Pathol Unit, Inst Neurosci & Physiol, Gothenburg, Sweden; [Jensen, L. R.] Univ Copenhagen, Dept Nord Studies & Linguist, Copenhagen, Denmark; [Johansson, M. Blom] Uppsala Univ, Dept Neurosci, Speech Language Pathol, Uppsala, Sweden; [Simmons-Mackie, N.] Southeastern Louisiana Univ, Dept Hlth & Human Sci, Hammond, LA USA		Saldert, C (corresponding author), Univ Gothenburg, Speech Language Pathol Unit, Inst Neurosci & Physiol, Gothenburg, Sweden.	charlotta.saldert@neuro.gu.se	Saldert, Charlotta/ABH-1746-2020; Johansson, Monica Blom/AAN-1593-2020; Jensen, Lise Randrup/D-8342-2017	Saldert, Charlotta/0000-0001-8808-3610; Johansson, Monica Blom/0000-0002-6095-6130; Jensen, Lise Randrup/0000-0001-8784-6962			Ahlsen E., APHASIOLOGY; Ali M, 2013, INT J STROKE, V8, P18, DOI 10.1111/j.1747-4949.2012.00973.x; American Speech-Language Hearing Association, PRACT PORT; Baylor C, 2017, APHASIOLOGY, V31, P861, DOI 10.1080/02687038.2016.1225274; Baylor C, 2013, J SPEECH LANG HEAR R, V56, P1190, DOI 10.1044/1092-4388(2012/12-0140); Baylor C, 2011, AM J SPEECH-LANG PAT, V20, P269, DOI 10.1044/1058-0360(2011/10-0084); Baylor CR, 2009, J SPEECH LANG HEAR R, V52, P1302, DOI 10.1044/1092-4388(2009/07-0275); Beeke S., 2013, BETTER CONVERSATIONS; Best W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2076.00562; BLOMERT L, 1994, APHASIOLOGY, V8, P381, DOI 10.1080/02687039408248666; Booth S, 1999, APHASIOLOGY, V13, P283, DOI 10.1080/026870399402109; Brady MC, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000425.pub4; Brady MC, 2014, APHASIOLOGY, V28, P1385, DOI 10.1080/02687038.2014.930261; Brandenburg C, 2015, DISABIL REHABIL, V37, P1113, DOI 10.3109/09638288.2014.955132; Cardillo JE., 1994, GOAL ATTAINMENT SCAL; Cherney LR, 2013, INT J SPEECH-LANG PA, V15, P535, DOI 10.3109/17549507.2013.763289; Correll A, 2010, APHASIOLOGY, V24, P612, DOI 10.1080/02687030902732752; Coster WJ, 2013, AM J OCCUP THER, V67, P162, DOI 10.5014/ajot.2013.006015; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Croteau C, 2018, APHASIOLOGY, V32, P247, DOI 10.1080/02687038.2017.1350629; De Los Reyes A, 2011, CLIN PSYCHOL REV, V31, P829, DOI 10.1016/j.cpr.2011.03.011; Dijkers MP, 2010, ARCH PHYS MED REHAB, V91, pS5, DOI 10.1016/j.apmr.2009.10.036; Dipper L., APHASIOLOGY; Doyle PJ, 2008, APHASIOLOGY, V22, P718, DOI 10.1080/02687030701803093; Eadie TL, 2006, AM J SPEECH-LANG PAT, V15, P307, DOI 10.1044/1058-0360(2006/030); Eriksson K, 2014, J INTERACT RES COM D, V5, P245, DOI 10.1558/jircd.v5i2.245; Eriksson K, 2016, DISABIL REHABIL, V38, P1187, DOI 10.3109/09638288.2015.1089952; Fox S, 2009, APHASIOLOGY, V23, P951, DOI 10.1080/02687030802669526; Friedman LM, 2015, FUNDAMENTALS CLIN TR; Genereux S, 2004, APHASIOLOGY, V18, P1161, DOI 10.1080/02687030444000507; Geroin C, 2013, J REHABIL MED, V45, P987, DOI 10.2340/16501977-1234; Goldberg D., 1972, DETECTION PSYCHIAT I; Hausberg MC, 2012, BMC MED EDUC, V12, DOI 10.1186/1472-6920-12-16; Hays R D, 1992, Qual Life Res, V1, P73, DOI 10.1007/BF00435438; Hebert D, 2016, INT J STROKE, V11, P459, DOI 10.1177/1747493016643553; Hilari K, 2009, CLIN REHABIL, V23, P544, DOI 10.1177/0269215508101729; Hopper T, 2002, APHASIOLOGY, V16, P745, DOI 10.1080/02687030244000059; Horton S., 2014, 16 INT APH REH C HAG; Horton S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011207; Hula WD, 2015, J SPEECH LANG HEAR R, V58, P906, DOI 10.1044/2015_JSLHR-L-14-0235; Hula WD, 2014, APHASIOLOGY, V28, P1396, DOI 10.1080/02687038.2014.930264; Hutchby I., 1998, CONVERSATION ANAL PR; Jensen LR, 2015, APHASIOLOGY, V29, P57, DOI 10.1080/02687038.2014.955708; Johansson MB, 2011, DISABIL REHABIL, V33, P51, DOI 10.3109/09638288.2010.486465; Johansson MB, 2013, APHASIOLOGY, V27, P201, DOI 10.1080/02687038.2012.744808; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan A., 2012, CLIN APH C LAK TAH C; Kagan A., 2011, ASSESSMENT LIVING AP; Kagan A, 2017, ARCH PHYS MED REHAB, V98, P2228, DOI 10.1016/j.apmr.2017.04.017; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; Kerckhofs E, 2010, CLIN REHABIL, V24, P479, DOI 10.1177/0269215509353266; Krasny-Pacini A., 2013, Annals of Physical and Rehabilitation Medicine, V56, P212, DOI 10.1016/j.rehab.2013.02.002; Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Lock S, 2001, SUPPORTING PARTNERS; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Long AF, 2008, CLIN REHABIL, V22, P1083, DOI 10.1177/0269215508090091; Long A, 2009, CLIN REHABIL, V23, P846, DOI 10.1177/0269215509336055; Lyon JG, 1997, APHASIOLOGY, V11, P693, DOI 10.1080/02687039708249416; Mays N, 2000, BMJ-BRIT MED J, V320, P50, DOI 10.1136/bmj.320.7226.50; Mc Menamin R, 2015, APHASIOLOGY, V29, P914, DOI 10.1080/02687038.2015.1006564; McDowell I, 2006, MEASURING HLTH GUIDE; McGilton KS, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-61; Meinert CL, 2013, CLIN TRIALS HDB DESI; Moran P, 2017, J FAM THER, V39, P41, DOI 10.1111/1467-6427.12082; National Institute for Health and Care Excellence (NICE), 2013, STR REH AD CLIN GUID; Nykanen A, 2013, APHASIOLOGY, V27, P1159, DOI 10.1080/02687038.2013.802284; Perkins L., 1997, CONVERSATION ANAL PE; Purdy M, 2005, APHASIOLOGY, V19, P377, DOI 10.1080/02687030444000822; Rautakoski P, 2008, APHASIOLOGY, V22, P1269, DOI 10.1080/02687030802374788; Saldert C, 2016, INT J SPEECH-LANG PA, V18, P571, DOI 10.3109/17549507.2016.1143975; Saldert C, 2013, APHASIOLOGY, V27, P271, DOI 10.1080/02687038.2012.710317; Schegloff E, 1993, RES LANG SOC INTERAC, V26, P99, DOI DOI 10.1207/S15327973RLSI2601_5; SHEWAN CM, 1984, J COMMUN DISORD, V17, P175, DOI 10.1016/0021-9924(84)90010-8; Silverman D., 2001, INTERPRETING QUALITA; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Simmons-Mackie N, 2014, INT J LANG COMM DIS, V49, P511, DOI 10.1111/1460-6984.12097; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Simmons-Mackie NN, 2007, APHASIOLOGY, V21, P39, DOI 10.1080/02687030600798287; Sirman N, 2017, APHASIOLOGY, V31, P465, DOI 10.1080/02687038.2017.1278739; Socialstyrelsen, 2018, NAT RIKTL VARD VID S; Sorin-Peters R, 2010, APHASIOLOGY, V24, P1511, DOI 10.1080/02687038.2010.494829; SORINPETERS R, 1995, APHASIOLOGY, V9, P565, DOI 10.1080/02687039508248715; Staniszewska S, 2012, PATIENT, V5, P79, DOI 10.2165/11597150-000000000-00000; Swinburn K, 2012, INT J STROKE, V7, P30; Tennant A, 2007, DISABIL REHABIL, V29, P1583, DOI 10.1080/09638280701618828; TINSLEY HEA, 1975, J COUNS PSYCHOL, V22, P358, DOI 10.1037/h0076640; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Turner S, 2006, APHASIOLOGY, V20, P483, DOI 10.1080/02687030600589991; Van de Velde D, 2017, CLIN REHABIL, V31, P379, DOI 10.1177/0269215516644310; van der Meulen I, 2010, INT J LANG COMM DIS, V45, P424, DOI 10.3109/13682820903111952; Visch-Brink E., 2017, COLL APH TRIAL C ROT; Wallace S. J., 2016, INT APH REH C LOND U; Wallace SJ, 2017, APHASIOLOGY, V31, P643, DOI 10.1080/02687038.2016.1186265; Wallace SJ, 2017, DISABIL REHABIL, V39, P1364, DOI 10.1080/09638288.2016.1194899; Wallace SJ, 2016, AM J SPEECH-LANG PAT, V25, pS729, DOI 10.1044/2016_AJSLP-15-0150; Wallace SJ, 2014, APHASIOLOGY, V28, P1364, DOI 10.1080/02687038.2014.930262; Wiering B, 2017, HEALTH EXPECT, V20, P11, DOI 10.1111/hex.12442; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilkinson R, 2015, APHASIOLOGY, V29, P257, DOI 10.1080/02687038.2014.974138; Wilkinson R, 2012, ARCH PHYS MED REHAB, V93, pS70, DOI 10.1016/j.apmr.2011.07.206; Wilkinson R, 2011, INT J SPEECH-LANG PA, V13, P74, DOI 10.3109/17549507.2011.551140; WILLIAMS SE, 1986, ARCH PHYS MED REHAB, V67, P250; Worral L., 1999, FCTP FUNCT COMM THER; Wright D.B., 1997, UNDERSTANDING STAT I	105	18	18	0	7	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2018	32	10			SI		1167	1193		10.1080/02687038.2018.1470317			27	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	GT8TR	WOS:000444813200003		Green Published			2022-02-06	
J	Wojtowicz, M; Gardner, AJ; Stanwell, P; Zafonte, R; Dickerson, BC; Iverson, GL				Wojtowicz, Magdalena; Gardner, Andrew J.; Stanwell, Peter; Zafonte, Ross; Dickerson, Bradford C.; Iverson, Grant L.			Cortical thickness and subcortical brain volumes in professional rugby league players	NEUROIMAGE-CLINICAL			English	Article						Volumetric MRI; Cortical thickness; Concussion; Brain morphometry; Athletes; Rugby	ALCOHOL DEPENDENCE; HIGH-SCHOOL; CONCUSSION; COLLEGIATE; SPORTS; HISTORY; CORTEX	Purpose: The purpose of this study was to examine cortical thickness and subcortical volumes in professional rugby players with an extensive history of concussions compared to control subjects. Method: Participants included 24 active and former professional rugby league players [Age M(SD) = 33.3(6.3); Range = 21-44] with an extensive history of concussion and 18 age-and education-matched controls with no history of neurotrauma or participation in contact sports. Participants underwent T1-weighted imaging and completed a neuropsychological battery, including two tests of memory. Whole brain cortical thickness analysis and structural volume analysis was performed using FreeSurfer version 6.0. Results: Professional rugby league players reported greater alcohol consumption (p < .001) and had significantly worse delayed recall of a visually complex design (p = . 04). They did not differ from controls on other clinical outcome measures. There were no differences in cortical thickness between the groups. Professional players had smaller whole brain (p = . 003), bilateral hippocampi (ps = . 03), and left amygdala volumes (p = . 01) compared to healthy controls. Within the players group, there were significant associations between greater alcohol use and smaller bilateral hippocampi and left amygdala volumes. There were no associations between structural volumes and history of concussions or memory performance. Conclusions: The literature examining cortical thickness in athletes with a history of multiple concussions is mixed. We did not observe differences in cortical thickness in professional rugby league players compared to controls. However, smaller subcortical volumes were found in players that were, in part, associated with greater alcohol consumption.	[Wojtowicz, Magdalena] York Univ, Dept Psychol, Behav Hlth Sci Bldg Room 282,4700 Keele St, Toronto, ON M3J 1P, Canada; [Gardner, Andrew J.] Univ Newcastle, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW 2308, Australia; [Stanwell, Peter] Univ Newcastle, Fac Hlth, Sch Hlth Sci, Callaghan, NSW 2308, Australia; [Zafonte, Ross; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zafonte, Ross; Iverson, Grant L.] Home Base, Boston, MA USA; [Dickerson, Bradford C.] Harvard Med Sch, Dept Neurol, Boston, MA 02114 USA; [Iverson, Grant L.] MassGen Hosp Children Sport Concuss Program, Boston, MA 02114 USA		Wojtowicz, M (corresponding author), York Univ, Dept Psychol, Behav Hlth Sci Bldg Room 282,4700 Keele St, Toronto, ON M3J 1P, Canada.	magdawoj@yorku.ca; andrew.gardner@neurogard.com.au; peter.stanwell@newcastle.edu.au; rzafonte@mgh.harvard.edu; bradd@nmr.mgh.harvard.edu; giverson@mgh.harvard.edu	Stanwell, Peter/F-9136-2012	Stanwell, Peter/0000-0002-4780-0393; Iverson, Grant/0000-0001-7348-9570; Gardner, Andrew/0000-0001-5031-5586	New South Wales Sporting Injuries Committee; Brain Foundation Australia	New South Wales Sporting Injuries Committee; Brain Foundation Australia.	Albaugh MD, 2015, J PEDIATR-US, V166, P394, DOI 10.1016/j.jpeds.2014.10.016; BOHN MJ, 1995, J STUD ALCOHOL, V56, P423, DOI 10.15288/jsa.1995.56.423; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Cummins C, 2015, INT J SPORT PHYSIOL, V10, P732, DOI 10.1123/ijspp.2014-0541; Durazzo TC, 2011, ALCOHOL CLIN EXP RES, V35, P1187, DOI 10.1111/j.1530-0277.2011.01452.x; Fein G, 2013, NEUROIMAGE-CLIN, V3, P47, DOI 10.1016/j.nicl.2013.06.018; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Koerte IK, 2016, BRAIN IMAGING BEHAV, V10, P792, DOI 10.1007/s11682-015-9442-0; Kuhn S, 2014, JAMA PSYCHIAT, V71, P806, DOI 10.1001/jamapsychiatry.2014.352; Lee J, 2016, PSYCHIAT RES-NEUROIM, V258, P16, DOI 10.1016/j.pscychresns.2016.10.009; Lovibond SH., 1995, MANUAL DEPRESSION AN, V2nd; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2016, J NEUROTRAUM, V33, P330, DOI 10.1089/neu.2015.3919; Meyers JE., 1995, REY COMPLEX FIGURE T; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Rey A., 1964, EXAMEN CLIN PSYCHOL; Strain J. F., 2015, JAMA NEUROL, V9044, P1; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102	22	18	18	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2018	18						377	381		10.1016/j.nicl.2018.01.005			5	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GH1NG	WOS:000433169000037	29487794	Green Published, gold			2022-02-06	
J	Zhou, Y; Wang, HD; Zhou, XM; Fang, I; Zhu, L; Ding, K				Zhou, Yuan; Wang, Han-dong; Zhou, Xiao-ming; Fang, Iang; Zhu, Lin; Ding, Ke			N-acetylcysteine amide provides neuroprotection via Nrf2-ARE pathway in a mouse model o f traumatic brain injury	DRUG DESIGN DEVELOPMENT AND THERAPY			English	Article						N-acetylcysteine amide; traumatic brain injury; nuclear factor erythroid 2-related factor 2; heme oxygenase-1 (HO-1); NAD(P)H: quinine oxidoreductase-1; oxidative stress	INDUCED OXIDATIVE STRESS; MITOCHONDRIAL BIOENERGETICS; FUNCTIONAL RECOVERY; ANTIOXIDANT; PLASMA; MICE	Background: Increasing evidence demonstrate N-acetylcysteine amide (NACA) provides neuroprotection and attenuated oxidative stress in rats following traumatic brain injury (TBI). The nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element (ARE) signal pathway is activated after TBI and provides a protective effect against TIM. However, the function and mechanism of NACA in mice after TBI remain unknown. This study was to evaluate the neuroprotection of NACA and the potential action of the Nrf2-ARE pathway in a weight-drop mouse model of TBI. Materials and methods: Four groups of animals were randomly divided into sham, TBI, TBI+vehicle, and TBI+NACA (100 mg/kg, administered intraperitoneally). The protein levels of Nrf2, heme oxygenise-1 (HO-1), NAD(P)H: quinine oxidoreductase-1 (NQO1), cleaved caspase-3 and the mRNA levels of HO-1 and NQO1 were detected. The neurobehavior, neuronal degeneration, apoptosis and oxidative stress were also assessed. Results: Treatment with NACA significantly improved neurologic status at days 1 and 3 following TBI. Moreover, NACA promoted Nrf2 activation a day after TBI. The protein and m RNA levels of HO-1 and NQOI were upregulated by NACA. Meanwhile, NACA treatment significantly reduced the level of malondialdehyde (MDA) and enhanced the activity of superoxide dismutase (SOD) and glutathione peroxidase (GPx), which indicated NACA attenuated oxidative stress following TBI. NACA prominently reduced the protein level of cleaved caspase-3 and TUNEL-positive cells, indicating its antiapoptotic effect. Additionally, Fluoro-Jade C staining showed NACA alleviated neuronal degeneration a day after TBI. Conclusions: Our study reveals that NACA potentially provides neuroprotection via the activation of the Nrf2-ARE signaling pathway after TBI in mice.	[Zhou, Yuan; Wang, Han-dong] Nanjing Med Univ, Jinling Hosp, Jinling Sch Clin Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Zhou, Xiao-ming; Fang, Iang; Zhu, Lin; Ding, Ke] Jinling Hosp, Dept Neurosurg, Nanjing, Jiangsu, Peoples R China		Wang, HD (corresponding author), Nanjing Med Univ, Jinling Hosp, Jinling Sch Clin Med, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	njhdwang@hotmail.com			Youth Training Project [16QNP042]; Key Clinical Subjects of "Strengthening Health by Science Education" Project in Jiangsu [ZDXKB2016023]; Jinling Hospital of Nanjing [2016017]	This work was financially supported by the Youth Training Project (grant no 16QNP042), the Key Clinical Subjects of "Strengthening Health by Science Education" Project in Jiangsu (grant no ZDXKB2016023), and the Jinling Hospital of Nanjing (grant no 2016017).	Bhatti J, 2018, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00744; Cao Y, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0251-1; Casili G, 2018, J NEUROTRAUM, V35, P1437, DOI 10.1089/neu.2017.5260; Chandran R, 2018, J CEREBR BLOOD F MET, V38, P1818, DOI 10.1177/0271678X17738701; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Dai W, 2018, BRAIN RES BULL, V140, P65, DOI 10.1016/j.brainresbull.2018.03.020; Ding H, 2017, NEUROCHEM INT, V111, P32, DOI 10.1016/j.neuint.2017.04.016; Ding H, 2017, NEUROCHEM RES, V42, P337, DOI 10.1007/s11064-016-2077-8; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gunther M, 2015, J CLIN NEUROSCI, V22, P1477, DOI 10.1016/j.jocn.2015.03.025; Hagos FT, 2017, XENOBIOTICA, V47, P346, DOI 10.1080/00498254.2016.1187777; Halstrom A, 2017, J CLIN NEUROSCI, V35, P104, DOI 10.1016/j.jocn.2016.09.006; Huang YN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19654-x; Kawoos U, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00219; Khatri N, 2018, CNS NEUROL DISORD-DR, V17, P689, DOI 10.2174/1871527317666180627120501; Li XK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160026; Liu ZW, 2017, NEUROCHEM RES, V42, P1375, DOI 10.1007/s11064-017-2186-z; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Miller DM, 2015, EXP NEUROL, V264, P103, DOI 10.1016/j.expneurol.2014.11.008; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Penugonda S, 2005, BRAIN RES, V1056, P132, DOI 10.1016/j.brainres.2005.07.032; Price TO, 2006, EXP NEUROL, V201, P193, DOI 10.1016/j.expneurol.2006.03.030; Semple BD, 2014, EXP NEUROL, V261, P291, DOI 10.1016/j.expneurol.2014.07.013; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Wu G, 2016, MED SCI MONITOR, V22, P2161, DOI 10.12659/MSM.896568; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Zhang L, 2018, NEUROCHEM INT, V118, P304, DOI 10.1016/j.neuint.2018.05.011; Zhang L, 2017, SCI REP-UK, V7, DOI 10.1038/srep46763; Zhang XS, 2009, BRAIN RES, V1275, P87, DOI 10.1016/j.brainres.2009.04.008	32	18	18	0	2	DOVE MEDICAL PRESS LTD	ALBANY	PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND	1177-8881			DRUG DES DEV THER	Drug Des. Dev. Ther.		2018	12						4117	4127		10.2147/DDDT.S179227			11	Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	HD0FA	WOS:000452182100001	30584276	Green Published, Green Submitted, gold			2022-02-06	
J	Zhao, J; Hylin, MJ; Kobori, N; Hood, KN; Moore, AN; Dash, PK				Zhao, Jing; Hylin, Michael J.; Kobori, Nobuhide; Hood, Kimberly N.; Moore, Anthony N.; Dash, Pramod K.			Post-Injury Administration of Galantamine Reduces Traumatic Brain Injury Pathology and Improves Outcome	JOURNAL OF NEUROTRAUMA			English	Article						blood-brain barrier permeability; cholinergic neurotransmission; GABAergic neurodegeneration; memory impairments; microglial polarization	CHOLINERGIC RECEPTOR-BINDING; ADULT HIPPOCAMPAL NEUROGENESIS; CORTICAL IMPACT INJURY; DENTATE GYRUS; ACETYLCHOLINESTERASE INHIBITORS; COGNITIVE IMPAIRMENT; ALLOSTERIC MODULATOR; PATTERN SEPARATION; ALPHA-7 NACHRS; RAT-BRAIN	Acetylcholine is an excitatory neurotransmitter in the central nervous system that plays a key role in cognitive function, including learning and memory. Previous studies have shown that experimental traumatic brain injury (TBI) reduces cholinergic neurotransmission, decreases evoked release of acetylcholine, and alters cholinergic receptor levels. Galantamine (U.S. Food and Drug Administration approved for the treatment of vascular dementia and Alzheimer's disease) has been shown to inhibit acetylcholinesterase activity and allosterically potentiate nicotinic receptor signaling. We investigated whether acute administration of galantamine can reduce TBI pathology and improve cognitive function tested days after the termination of the drug treatment. Post-injury administration of galantamine was found to decrease TBI-triggered blood-brain barrier (BBB) permeability (tested 24h post-injury), attenuate the loss of both GABAergic and newborn neurons in the ipsilateral hippocampus, and improve hippocampal function (tested 10 days after termination of the drug treatment). Specifically, significant improvements in the Morris water maze, novel object recognition, and context-specific fear memory tasks were observed in injured animals treated with galantamine. Although messenger RNAs for both M1 (Nos2, TLR4, and IL-12 beta ) and M2 (Arg1, CCL17, and Mcr1) microglial phenotypes were elevated post-TBI, galantamine treatment did not alter microglial polarization tested 24h and 6 days post-injury. Taken together, these findings support the further investigation of galantamine as a treatment for TBI.	[Zhao, Jing; Hylin, Michael J.; Kobori, Nobuhide; Hood, Kimberly N.; Moore, Anthony N.; Dash, Pramod K.] Univ Texas McGovern Med Sch, Dept Neurobiol & Anat, Houston, TX USA		Dash, PK (corresponding author), UTHlth McGovern Med Sch, Dept Neurobiol & Anat, POB 20036, Houston, TX 77225 USA.	p.dash@uth.tmc.edu	Hylin, Michael/U-2878-2019	Dash, Pramod/0000-0001-6746-1002	Senator Lloyd and B.A. Bentsen Center for Stroke Research; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS087149, NS088298]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088298] Funding Source: NIH RePORTER	The authors are thankful of the Senator Lloyd and B.A. Bentsen Center for Stroke Research and NIH (NS087149 and NS088298) who provided funding support.	Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Arias E, 2005, J PHARMACOL EXP THER, V315, P1346, DOI 10.1124/jpet.105.090365; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bedi SS, 2013, STEM CELL TRANSL MED, V2, P953, DOI 10.5966/sctm.2013-0100; Belluardo N., 2000, Journal of Neural Transmission Supplement, V60, P227; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bruchfeld A, 2008, MOL MED, V14, P109, DOI 10.2119/2007-00107.Bruchfeld; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Colicos MA, 1996, BRAIN RES, V739, P120, DOI 10.1016/S0006-8993(96)00824-4; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; DASH PK, 1995, J NEUROSCI, V15, P2030, DOI 10.1523/JNEUROSCI.15-03-02030.1995; Dash PK, 2016, J NEUROSCI, V36, P2809, DOI 10.1523/JNEUROSCI.3197-15.2016; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; de la Tremblaye PB, 2017, J NEUROTRAUM, V34, P1610, DOI 10.1089/neu.2016.4790; DEANGELIS MM, 1994, BRAIN RES, V653, P39, DOI 10.1016/0006-8993(94)90369-7; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DRACHMAN DA, 1974, ARCH NEUROL-CHICAGO, V30, P113, DOI 10.1001/archneur.1974.00490320001001; Drew MR, 2010, BEHAV NEUROSCI, V124, P446, DOI 10.1037/a0020081; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; ENNACEUR A, 1988, 1 BEHAVIORAL DATA BE, V31, P47; Evilsizor M.N., 2015, SOURCEBRAIN NEUROTRA; GALEY D, 1994, BEHAV BRAIN RES, V60, P183, DOI 10.1016/0166-4328(94)90146-5; Garthe A, 2014, GENES BRAIN BEHAV, V13, P357, DOI 10.1111/gbb.12130; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; Gorman LK, 1996, J NEUROTRAUM, V13, P457, DOI 10.1089/neu.1996.13.457; HALL ED, 1993, RES P ARNMD, V71, P81; Hall ED, 2016, J BIOENERG BIOMEMBR, V48, P169, DOI 10.1007/s10863-015-9600-5; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAYES RL, 1992, J NEUROTRAUM, V9, pS173; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Ji H, 2014, MUCOSAL IMMUNOL, V7, P335, DOI 10.1038/mi.2013.52; JIANG JY, 1994, BRAIN RES, V651, P123, DOI 10.1016/0006-8993(94)90687-4; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Levine YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104530; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1993, BRAIN RES, V617, P69, DOI 10.1016/0006-8993(93)90614-S; LYETH BG, 1994, BRAIN RES, V640, P240, DOI 10.1016/0006-8993(94)91879-1; LYETH BG, 1992, BRAIN RES, V569, P281, DOI 10.1016/0006-8993(92)90640-U; LYETH BG, 1988, BRAIN RES, V452, P39, DOI 10.1016/0006-8993(88)90006-6; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; Monbaliu J, 2003, ARZNEIMITTEL-FORSCH, V53, P486; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Mortazavian Seyed Mohsen, 2013, Int J Alzheimers Dis, V2013, P121068, DOI 10.1155/2013/121068; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Pavlov VA, 2009, BRAIN BEHAV IMMUN, V23, P41, DOI 10.1016/j.bbi.2008.06.011; PIKE BR, 1995, BRAIN RES, V686, P37, DOI 10.1016/0006-8993(95)00448-Y; Povlishock J T, 1992, Hum Cell, V5, P345; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Samochocki M, 2000, ACTA NEUROL SCAND, V102, P68, DOI 10.1034/j.1600-0404.2000.00310.x; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; SCHMIDT RH, 1995, J NEUROSURG, V83, P496, DOI 10.3171/jns.1995.83.3.0496; Schrattenholz A, 1996, MOL PHARMACOL, V49, P1; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shin SS, 2015, J NEUROTRAUM, V32, P1429, DOI 10.1089/neu.2014.3445; Tenovuo O, 2005, PROG NEURO-PSYCHOPH, V29, P61, DOI 10.1016/j.pnpbp.2004.10.006; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; van Beijsterveldt L, 2004, ARZNEIMITTEL-FORSCH, V54, P85; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; WESTER P, 1995, STROKE, V26, P444, DOI 10.1161/01.STR.26.3.444; Whitlock JA, 1999, J HEAD TRAUMA REHAB, V14, P424, DOI 10.1097/00001199-199908000-00010; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Yu TS, 2008, J NEUROSCI, V28, P12901, DOI 10.1523/JNEUROSCI.4629-08.2008; Zhang BL, 2011, BRAIN RES, V1382, P165, DOI 10.1016/j.brainres.2011.01.065; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007; Zhao YH, 2016, STEM CELLS, V34, P1263, DOI 10.1002/stem.2310	79	18	18	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					362	374		10.1089/neu.2017.5102		DEC 2017	13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000418128700001	29088998	Green Published			2022-02-06	
J	Chorney, SR; Suryadevara, AC; Nicholas, BD				Chorney, Stephen R.; Suryadevara, Amar C.; Nicholas, Brian D.			Audiovestibular symptoms as predictors of prolonged sports-related concussion among NCAA athletes	LARYNGOSCOPE			English	Article; Proceedings Paper	138th Annual Meeting of the American-Laryngological-Association at Combined Otolaryngology Spring Meeting (COSM)	APR 26-30, 2017	San Diego, CA	Amer Laryngol Assoc		Concussion; audiovestibular symptoms; sports-related concussion; NCAA athletes	TRAUMATIC BRAIN-INJURY; FOOTBALL PLAYERS; HIGH-SCHOOL; EPIDEMIOLOGY; DIZZINESS; RECOVERY; TIME	ObjectiveWe looked to determine the rates of audiovestibular symptoms following sports-related concussions among collegiate athletes. Further, we assessed the correlation between these symptoms and the time to return to participation in athletic activity. Study DesignRetrospective analysis of the National Collegiate Athletic Association Injury Surveillance System (NCAA-ISS). MethodsThe NCAA-ISS was queried from 2009 through 2014 for seven men's sports and eight women's sports across divisions 1, 2, and 3. Injuries resulting in concussions were analyzed for audiovestibular symptoms, duration of symptoms, and return to participation times. ResultsFrom 2009 to 2014, there were 1,647 recorded sports-related concussions, with athletes reporting dizziness (68.2%), imbalance (35.8%), disorientation (31.4%), noise sensitivity (29.9%), and tinnitus (8.5%). Concussion symptoms resolved within 1 day (17.1%), within 2 to 7 days (50.0%), within 8 to 30 days (25.9%), or persisted over 1 month (7.0%). Return to participation occurred within 1 week (38.3%), within 1 month (53.0%), or over 1 month (8.7%). Using Mann-Whitney U testing, overall symptom duration and return to competition time were significantly increased when any of these symptoms were present (P < 0.05). Duration of concussion symptom correlated with dizziness (P = 0.043) and noise sensitivity (P = 0.000), whereas return to participation times correlated with imbalance (P = 0.011) and noise sensitivity (P = 0.000). Dizziness and imbalance (odds ratio: 4.15, confidence interval: 3.20-5.38, P < 0.001) were the two symptoms with the strongest association. ConclusionAudiovestibular symptoms are common complaints among collegiate athletes sustaining concussions. Dizziness and noise sensitivity correlated with the duration of concussive symptoms, whereas imbalance and noise sensitivity was correlated with prolonged return to competition time. Level of Evidence4. Laryngoscope, 127:2850-2853, 2017	[Chorney, Stephen R.; Suryadevara, Amar C.; Nicholas, Brian D.] SUNY Upstate Med Univ, Dept Otolaryngol & Commun Sci, Syracuse, NY 13210 USA		Nicholas, BD (corresponding author), SUNY Upstate Med Univ, Dept Otolaryngol & Commun Sci, Syracuse, NY 13210 USA.	nicholab@upstate.edu			NCAA	The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the NCAA. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the Datalys Center or the NCAA. We thank the many athletic trainers who have volunteered their time and efforts to submit data to the NCAA Injury Surveillance Program. Their efforts are greatly appreciated and have had a tremendously positive effect on the safety of collegiate athletes.	Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Cancelliere Carol, 2014, Arch Phys Med Rehabil, V95, pS210, DOI 10.1016/j.apmr.2013.06.035; Corwin DJ, 2015, J PEDIATR-US, V166, P1221, DOI 10.1016/j.jpeds.2015.01.039; Dick R, 2007, J ATHL TRAINING, V42, P173; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McLeod TCV, 2015, BRAIN INJURY, V29, P175, DOI 10.3109/02699052.2014.965206; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; Wasserman EB, 2016, AM J SPORT MED, V44, P226, DOI 10.1177/0363546515610537; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	17	18	18	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	DEC	2017	127	12					2850	2853		10.1002/lary.26564			4	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Research & Experimental Medicine; Otorhinolaryngology	FM6WY	WOS:000415204100034	28349568				2022-02-06	
J	Gerbatin, RD; Cassol, G; Dobrachinski, F; Ferreira, APO; Quines, CB; Della Pace, ID; Busanello, GL; Gutierres, JM; Nogueira, CW; Oliveira, MS; Soares, FA; Morsch, VM; Fighera, MR; Royes, LFF				Gerbatin, Rogerio da Rosa; Cassol, Gustavo; Dobrachinski, Fernando; Ferreira, Ana Paula O.; Quines, Caroline B.; Della Pace, Iuri D.; Busanello, Guilherme L.; Gutierres, Jessie M.; Nogueira, Cristina W.; Oliveira, Mauro S.; Soares, Felix A.; Morsch, Vera M.; Fighera, Michele R.; Royes, Luiz Fernando F.			Guanosine Protects Against Traumatic Brain Injury-Induced Functional Impairments and Neuronal Loss by Modulating Excitotoxicity, Mitochondrial Dysfunction, and Inflammation	MOLECULAR NEUROBIOLOGY			English	Article						Motor deficit; Neurotoxicity; Glutamate; Fluid percussion injury; Nucleoside; Neuroprotection	PENTYLENETETRAZOL-INDUCED SEIZURES; DECREASES GLUTAMATE UPTAKE; OXIDATIVE STRESS; HIPPOCAMPAL SLICES; RATS; SYNTHETASE; RECEPTORS; ACID; NEUROPROTECTION; TRANSPORTERS	Traumatic brain injury (TBI) is one of the most common types of brain injuries that cause death or persistent neurological disturbances in survivors. Most of the promising experimental drugs were not effective in clinical trials; therefore, the development of TBI drugs represents a huge unmet need. Guanosine, an endogenous neuroprotective nucleoside, has not been evaluated in TBI to the best of our knowledge. Therefore, the present study evaluated the effect of guanosine on TBI-induced neurological damage. Our findings showed that a single dose of guanosine (7.5 mg/kg, intraperitoneally (i.p.) injected 40 min after fluid percussion injury (FPI) in rats protected against locomotor and exploratory impairments 8 h after injury. The treatment also protected against neurochemical damage to the ipsilateral cortex, glutamate uptake, Na+/K+-ATPase, glutamine synthetase activity, and alterations in mitochondrial function. The inflammatory response and brain edema were also reduced by this nucleoside. In addition, guanosine protected against neuronal death and caspase 3 activation. Therefore, this study suggests that guanosine plays a neuroprotective role in TBI and can be exploited as a new pharmacological strategy.	[Gerbatin, Rogerio da Rosa; Cassol, Gustavo; Ferreira, Ana Paula O.; Della Pace, Iuri D.; Busanello, Guilherme L.; Fighera, Michele R.; Royes, Luiz Fernando F.] Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, Santa Maria, RS, Brazil; [Dobrachinski, Fernando; Gutierres, Jessie M.; Soares, Felix A.; Morsch, Vera M.] Univ Fed Santa Maria, Dept Bioquim & Biol Mol, Ctr Ciencias Nat & Exatas, Santa Maria, RS, Brazil; [Quines, Caroline B.; Nogueira, Cristina W.] Univ Fed Santa Maria, Ctr Ciencias Nat & Exatas, Lab Sintese Reatividade & Avaliacao Farmacol & To, Santa Maria, RS, Brazil; [Oliveira, Mauro S.] Univ Fed Santa Maria, Ctr Ciencias Saude, Lab Neurotoxicidade & Psicofarmacol, Santa Maria, RS, Brazil; [Fighera, Michele R.] Univ Fed Santa Maria, Dept Neuropsiquiatria, Ctr Ciencias Saude, Santa Maria, RS, Brazil		Gerbatin, RD (corresponding author), Univ Fed Santa Maria, Ctr Educ Fis & Desportos, Lab Bioquim Exercicio, Santa Maria, RS, Brazil.	rogeriogerbatin@hotmail.com	Gutierres, Jessie M/D-6938-2013; Soares, Felix/AAE-6251-2020; Soares, Felix AA/K-7611-2012; Dobrachinski, Fernando/C-4316-2014; Oliveira, Mauro Schneider/G-3437-2012; Nogueira, Cristina W/H-1581-2012; Morsch, Vera M.M./M-6215-2014; Fighera, Michele R/J-9576-2014	Gutierres, Jessie M/0000-0002-9574-4007; Soares, Felix/0000-0002-6453-7902; Soares, Felix AA/0000-0002-6453-7902; Dobrachinski, Fernando/0000-0002-3948-1273; Oliveira, Mauro Schneider/0000-0002-5381-1208; Nogueira, Cristina W/0000-0003-2950-3632; Cassol, Gustavo/0000-0003-1343-7001; Fighera, Michele/0000-0002-3111-7530	Universidade Federal de Santa Maria (UFSM); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e TecnologicoConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS); Programa de Apoio a Nucleos Emergentes (PRONEM) [11/2082-4]	We gratefully acknowledged the Universidade Federal de Santa Maria (UFSM), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS), and Programa de Apoio a Nucleos Emergentes (PRONEM) 11/2082-4 for the financial support.	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Silva LFA, 2013, J NEUROTRAUM, V30, P1278, DOI 10.1089/neu.2012.2577; Bellaver B, 2015, PURINERG SIGNAL, V11, P571, DOI 10.1007/s11302-015-9475-2; Bettio LEB, 2016, PURINERG SIGNAL, V12, P411, DOI 10.1007/s11302-016-9509-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carvalho FB, 2015, J NUTR BIOCHEM, V26, P378, DOI 10.1016/j.jnutbio.2014.11.006; Cittolin-Santos GF, 2017, MOL NEUROBIOL, V54, P3137, DOI 10.1007/s12035-016-9892-4; Cunha GMA, 2006, NEUROSCIENCE, V141, P1775, DOI 10.1016/j.neuroscience.2006.05.024; Dal-Cim T, 2016, NEUROTOX RES, V29, P460, DOI 10.1007/s12640-015-9595-z; Dal-Cim T, 2013, J NEUROCHEM, V126, P437, DOI 10.1111/jnc.12324; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; de Oliveira DL, 2004, BRAIN RES, V1018, P48, DOI 10.1016/j.brainres.2004.05.033; Dobrachinski F, 2014, NEUROTOX RES, V26, P317, DOI 10.1007/s12640-014-9463-2; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fiorin FD, 2016, J NEUROTRAUM, V33, P1317, DOI 10.1089/neu.2015.4068; Folkersma H, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-67; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Funck VR, 2014, EPILEPSY RES, V108, P1705, DOI 10.1016/j.eplepsyres.2014.09.025; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; GRAY EG, 1962, J ANAT, V96, P79; HACHIMORI A, 1975, J BIOCHEM-TOKYO, V78, P1235, DOI 10.1093/oxfordjournals.jbchem.a131021; Hansel G, 2015, MOL NEUROBIOL, V52, P1791, DOI 10.1007/s12035-014-8978-0; Hansel G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090693; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; HOCHSTRATE P, 1994, GLIA, V12, P268; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jiang SC, 2007, PURINERG SIGNAL, V3, P411, DOI 10.1007/s11302-007-9079-6; Jorgensen OS, 1997, EXP NEUROL, V144, P326, DOI 10.1006/exnr.1996.6372; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kabadi SV, 2010, NAT PROTOC, V5, P1552, DOI 10.1038/nprot.2010.112; Kovesdi E, 2007, PROG BRAIN RES, V161, P81, DOI 10.1016/S0079-6123(06)61006-6; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Migues PV, 1999, NEUROREPORT, V10, P67, DOI 10.1097/00001756-199901180-00013; Morel P, 1998, NEUROCHEM INT, V33, P531, DOI 10.1016/S0197-0186(98)00062-X; Moretto MB, 2005, EXP NEUROL, V195, P400, DOI 10.1016/j.expneurol.2005.06.005; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Pandya JD, 2007, J NEUROTRAUM, V24, P798, DOI 10.1089/neu.2006.3673; Paniz LG, 2014, METAB BRAIN DIS, V29, P645, DOI 10.1007/s11011-014-9548-x; PETITO CK, 1992, BRAIN RES, V569, P275, DOI 10.1016/0006-8993(92)90639-Q; Rambo LM, 2013, AMINO ACIDS, V44, P857, DOI 10.1007/s00726-012-1408-6; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Schmidt AP, 2007, PHARMACOL THERAPEUT, V116, P401, DOI 10.1016/j.pharmthera.2007.07.004; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shojo H, 2010, NEUROSCIENCE, V171, P1273, DOI 10.1016/j.neuroscience.2010.10.018; Soares FA, 2004, BRAIN RES, V1005, P182, DOI 10.1016/j.brainres.2004.01.053; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Tavares RG, 2008, NEUROCHEM RES, V33, P97, DOI 10.1007/s11064-007-9421-y; Thomazi AP, 2004, MECH AGEING DEV, V125, P475, DOI 10.1016/j.mad.2004.04.005; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Toklu HZ, 2009, FREE RADICAL RES, V43, P658, DOI 10.1080/10715760902988843; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wehr NB, 2012, ANAL BIOCHEM, V423, P241, DOI 10.1016/j.ab.2012.01.031; Whishaw IQ, 2003, J NEUROSCI METH, V126, P13, DOI 10.1016/S0165-0270(03)00049-9; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001	62	18	18	1	14	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2017	54	10					7585	7596		10.1007/s12035-016-0238-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM8MF	WOS:000415341900003	27830534				2022-02-06	
J	Mei, ZR; Zheng, PY; Tan, XP; Wang, Y; Situ, B				Mei, Zhengrong; Zheng, Peiying; Tan, Xiangping; Wang, Ying; Situ, Bing			Huperzine A alleviates neuroinflammation, oxidative stress and improves cognitive function after repetitive traumatic brain injury	METABOLIC BRAIN DISEASE			English	Article						Traumatic brain injury; Huperzine A; Nueroprotection; Neuroinflammation; Oxidative stress	AMYLOID PRECURSOR PROTEIN; DEFICITS; EXPRESSION; PATHWAY	Traumatic brain injury (TBI) may trigger secondary injury cascades including endoplasmic reticulum stress, oxidative stress, and neuroinflammation. Unfortunately, there are no effective treatments targeting either primary or secondary injuries that result in long-term detrimental consequences. Huperzine A (HupA) is a potent acetylcholinesterase inhibitor (AChEI) that has been used treatment of Alzheimer's disease (AD). This study aimed to explore the neuroprotective effects of HupA in TBI and its possible mechanisms. Repetitive mild closed head injury (CHI) model was used to mimic concussive TBI. Mice were randomly assigned into three groups including sham, vehicle-treated and HupA-treated injured mice. The HupA was given at dose of 1.0 mg/kg/day and was initiated 30 min after the first injury, then administered daily for a total of 30 days. The neuronal functions including motor functions, emotion-like behaviors, learning and memory were tested. Axonal injury, reactive oxygen species (ROS), and neuroinflammation were examined as well. The results showed that injured mice treated with HupA had significant improvement in Morris water maze performance compared with vehicle-treated injured mice. HupA treatment significantly attenuated markers of neuroinflammation and oxidative stress in the injured mice. Taken together, HupA was effective in reducing neuroinflammation, oxidative stress and behavioral recovery after TBI. HupA is a promising candidate for treatment of TBI.	[Mei, Zhengrong; Zheng, Peiying; Tan, Xiangping; Wang, Ying; Situ, Bing] Guangzhou Med Univ, Affiliated Hosp 3, Dept Pharm, Guangzhou 510150, Guangdong, Peoples R China		Situ, B (corresponding author), Guangzhou Med Univ, Affiliated Hosp 3, Dept Pharm, Guangzhou 510150, Guangdong, Peoples R China.	646133313@qq.com			Guangzhou Education Bureau [1201421151]	This work is supported by a grant from Guangzhou Education Bureau (1201421151).	Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Ding K, 2014, FREE RADICAL BIO MED, V73, P1, DOI 10.1016/j.freeradbiomed.2014.04.031; Hayes JP, 2017, BRAIN, V140, P813, DOI 10.1093/brain/aww344; Johnson MW, 2011, J FORENSIC SCI, V56, P1198, DOI 10.1111/j.1556-4029.2011.01814.x; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kobeissy FH, 2016, PLOS ONE, V11; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lee DJ, 2015, J NEUROTRAUM, V32, P1822, DOI 10.1089/neu.2014.3744; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Mannix R, 2017, J NEUROTRAUM, V34, P495, DOI 10.1089/neu.2016.4457; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mao XY, 2016, CELL MOL NEUROBIOL, V36, P915, DOI 10.1007/s10571-015-0276-5; Mei ZR, 2018, BEHAV BRAIN RES, V340, P195, DOI 10.1016/j.bbr.2017.04.017; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Ruan QW, 2013, MECH AGEING DEV, V134, P89, DOI 10.1016/j.mad.2012.12.005; Scherer RW, 2013, PLOS ONE, V8; Schumann J, 2008, J NEUROTRAUM, V25, P945, DOI 10.1089/neu.2008.0521; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tu TM, 2017, ANN CLIN TRANSL NEUR, V4, P246, DOI 10.1002/acn3.399; Velosky AG, 2017, BEHAV BRAIN RES, V324, P115, DOI 10.1016/j.bbr.2017.02.017; Wang CY, 2011, NEUROPSYCHOPHARMACOL, V36, P1073, DOI 10.1038/npp.2010.245; Wang Y, 2012, J NEUROSCI RES, V90, P508, DOI 10.1002/jnr.22775; Wheaton P, 2011, J CLIN PSYCHOPHARM, V31, P745, DOI 10.1097/JCP.0b013e318235f4ac; Yang L, 2017, METAB BRAIN DIS, V32, P1395, DOI 10.1007/s11011-017-9991-6; Zhu D, 2015, PLOS ONE, V10	30	18	19	4	22	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0885-7490	1573-7365		METAB BRAIN DIS	Metab. Brain Dis.	DEC	2017	32	6					1861	1869		10.1007/s11011-017-0075-4			9	Endocrinology & Metabolism; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Neurosciences & Neurology	FM7CC	WOS:000415225800010	28748496				2022-02-06	
J	Shura, RD; Denning, JH; Miskey, HM; Rowland, JA				Shura, Robert D.; Denning, John H.; Miskey, Holly M.; Rowland, Jared A.			Symptom and Performance Validity With Veterans Assessed for Attention-Deficit/Hyperactivity Disorder (ADHD)	PSYCHOLOGICAL ASSESSMENT			English	Article						ADHD; MMPI-2-RF; TOMM; validity; veteran	TRAUMATIC BRAIN-INJURY; SELF-REPORTED SYMPTOMS; RESPONSE BIAS; FEIGNED ADHD; TEST FAILURE; ADULTS; NEUROPSYCHOLOGY; EXAGGERATION; STATEMENT; SOLDIERS	Little is known about attention-deficit/hyperactivity disorder (ADHD) in veterans. Practice standards recommend the use of both symptom and performance validity measures in any assessment, and there are salient external incentives associated with ADHD evaluation (stimulant medication access and academic accommodations). The purpose of this study was to evaluate symptom and performance validity measures in a clinical sample of veterans presenting for specialty ADHD evaluation. Patients without a history of a neurocognitive disorder and tor whom data were av ailable on all measures (n = 114) completed a clinical interview structured on DSM-5 ADHD symptoms, the Minnesota Multiphasic Personality Inventory-2-Restructured Form (MMPI-2-RF), and the Test of Memory Malingering Trial 1 (TOMM1) as part of a standardized ADHD diagnostic evaluation. Veterans meeting criteria for ADIID were not more likely to overreport symptoms on the MMPI-2-RF nor to fail TOMM1 (score <= 41) compared with those who did not meet criteria. Those who overreported symptoms did not endorse significantly more ADHD symptoms; however, hose who failed TOMMJ did report significantly more ADHD symptoms (g = 0.90). In the total sample, 19.3% failed TOMM1, 44.7% overreported on the MMPI-2-RF, and 8.8% produced both an overreported MMPI-2-RF and invalid TOMM1. F-r had the highest correlation to TOMM1 scores (r = -.30). These results underscore the importance of assessing both symptom and performance validity in a clinical ADHD evaluation with veterans. In contrast to certain other conditions (e.g., mild traumatic brain injury). ADHD as a diagnosis is not related to higher rates of invalid report/performance in veterans.	[Shura, Robert D.] WG Bill Hefner Vet Affairs Med Ctr VAMC, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Shura, Robert D.] WG Bill Hefner Vet Affairs Med Ctr VAMC, Midatlantic Mental Illness Res Educ & Clin Ctr MA, Salisbury, NC USA; [Shura, Robert D.; Miskey, Holly M.] Wake Forest Sch Med, Dept Psychiat & Behav Sci, Winston Salem, NC USA; [Denning, John H.] Ralph H Johnson VAMC, Mental Hlth Care Line, Charleston, SC USA; [Denning, John H.] Med Univ South Carolina, Dept Psychiat & Behav Sci, Charleston, SC 29425 USA; [Miskey, Holly M.] WG Bill Hefner VAMC, Mental Hlth & Behav Sci Serv Line, Salisbury, NC USA; [Miskey, Holly M.; Rowland, Jared A.] WG Bill Hefner VAMC, MA MIRECC, Salisbury, NC USA; [Rowland, Jared A.] WG Bill Hefner VAMC, Res & Acad Affairs Serv Line, Salisbury, NC USA; [Rowland, Jared A.] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC USA		Shura, RD (corresponding author), Hefner VAMC, 11M-2 MH&BS,1601 Brenner Ave, Salisbury, NC 28144 USA.	Robert.Shura2@va.gov	Rowland, Jared A./AAN-3030-2021; Shura, Robert D/J-6749-2019	Rowland, Jared A./0000-0002-3655-3411; Miskey, Holly/0000-0002-5139-4586; Shura, Robert/0000-0002-9505-0080	W. G. (Bill) Hefner VAMC; Mid-Atlantic Mental Illness Research Education and Clinical Center	This research was supported by resources of the W. G. (Bill) Hefner VAMC and the Mid-Atlantic Mental Illness Research Education and Clinical Center. These results have not been previously presented in any form. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs, the Department of Defense, or the U.S. government.	American Psychiatric Association, 2013, DAIAGN STAT MAN MENT; Antshel KM, 2010, PSYCHOL MED, V40, P1909, DOI 10.1017/S0033291709992273; Arbisi PA, 2011, PSYCHOL ASSESSMENT, V23, P203, DOI 10.1037/a0021339; Barkley R. A., 2006, ATTENTION DEFICIT HY; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boone K., 2002, THE B TEST; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Department of Veterans Affairs, 2013, DEP VET AFF ED PROGR; Fazio R. L., 2016, CLIN NEUROPSYCHOL, V31, P1; Flory K, 2006, J CLIN CHILD ADOLESC, V35, P571, DOI 10.1207/s15374424jccp3504_8; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Harp JP, 2011, PSYCHOL INJ LAW, V4, P32, DOI 10.1007/s12207-011-9100-9; Heaton R. K., 2004, REVISED COMPREHENSIV; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hervey AS, 2004, NEUROPSYCHOLOGY, V18, P485, DOI 10.1037/0894-4105.18.3.485; Kessler RC, 2014, JAMA PSYCHIAT, V71, P504, DOI 10.1001/jamapsychiatry.2014.28; Klein RG, 2012, ARCH GEN PSYCHIAT, V69, P1295, DOI 10.1001/archgenpsychiatry.2012.271; Kuriyan AB, 2013, J ABNORM CHILD PSYCH, V41, P27, DOI 10.1007/s10802-012-9658-z; Lange RT, 2010, J CLIN EXP NEUROPSYC, V32, P961, DOI 10.1080/13803391003645657; McCormick CL, 2013, ARCH CLIN NEUROPSYCH, V28, P808, DOI 10.1093/arclin/act050; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Musso MW, 2014, J ATTEN DISORD, V18, P186, DOI 10.1177/1087054712441970; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Shura R. D., 2016, MILITARY PSYCHOL; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Sullivan BK, 2007, APPL NEUROPSYCHOL, V14, P189, DOI 10.1080/09084280701509083; Tellegen A., 2011, MINNESOTA MULTIPHASI; Tellegen A., 2011, MINNESOTA MULTIPHASI; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Williamson KD, 2014, CLIN NEUROPSYCHOL, V28, P1182, DOI 10.1080/13854046.2014.956674; Young JC, 2011, ARCH CLIN NEUROPSYCH, V26, P165, DOI 10.1093/arclin/acr013	37	18	18	0	9	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1040-3590	1939-134X		PSYCHOL ASSESSMENT	Psychol. Assess.	DEC	2017	29	12					1458	1465		10.1037/pas0000436			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	FS7JJ	WOS:000419973500005	29227127				2022-02-06	
J	Cavanagh, JF; Napolitano, A; Wu, C; Mueen, A				Cavanagh, James F.; Napolitano, Arthur; Wu, Christopher; Mueen, Abdullah			The Patient Repository for EEG Data plus Computational Tools (PRED plus CT)	FRONTIERS IN NEUROINFORMATICS			English	Article						EEG; open data; pattern classification; databases as topic; clinical neuroscience	TRAUMATIC BRAIN-INJURY; QUANTITATIVE EEG; ELECTRICAL-ACTIVITY; NEUROIMAGING DATA; AMERICAN ACADEMY; IDENTIFICATION; PSYCHIATRY; ENDOPHENOTYPES; DIAGNOSIS; NEUROLOGY	Electroencephalographic (EEG) recordings are thought to reflect the network-wide operations of canonical neural computations, making them a uniquely insightful measure of brain function. As evidence of these virtues, numerous candidate biomarkers of different psychiatric and neurological diseases have been advanced. Presumably, we would only need to apply powerful machine-learning methods to validate these ideas and provide novel clinical tools. Yet, the reality of this advancement is more complex: the scale of data required for robust and reliable identification of a clinical biomarker transcends the ability of any single laboratory. To surmount this logistical hurdle, collective action and transparent methods are required. Here we introduce the Patient Repository of EEG Data + Computational Tools (PRED + CT: predictsite.com). The ultimate goal of this project is to host a multitude of available tasks, patient datasets, and analytic tools, facilitating large-scale data mining. We hope that successful completion of this aim will lead to the development of novel EEG biomarkers for differentiating populations of neurological and psychiatric disorders.	[Cavanagh, James F.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Napolitano, Arthur; Wu, Christopher; Mueen, Abdullah] Univ New Mexico, Dept Comp Sci, Albuquerque, NM 87131 USA		Cavanagh, JF (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	jcavanagh@unm.edu			University of New Mexico Office of the Vice President of Research; NIGMSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [1P20GM109089-01A1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM109089] Funding Source: NIH RePORTER	This work was supported by a grant from the University of New Mexico Office of the Vice President of Research. JC and AM are also supported by NIGMS 1P20GM109089-01A1.	Allen JJB, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00232; Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Arns M, 2013, J ATTEN DISORD, V17, P374, DOI 10.1177/1087054712460087; Ayaz SI, 2015, AM J EMERG MED, V33, P493, DOI 10.1016/j.ajem.2014.11.015; Bigdely-Shamlo N, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00016; Cavanagh JF, 2017, BIOL PSYCHIAT-COGN N, V2, P413, DOI 10.1016/j.bpsc.2017.01.004; Cavanagh JF, 2016, NEUROIMAGE, V133, P1, DOI 10.1016/j.neuroimage.2016.02.075; Cavanagh JF, 2015, J PHYSIOL-PARIS, V109, P3, DOI 10.1016/j.jphysparis.2014.04.003; Chaumon M, 2015, J NEUROSCI METH, V250, P47, DOI 10.1016/j.jneumeth.2015.02.025; Coburn KL, 2006, J NEUROPSYCH CLIN N, V18, P460, DOI 10.1176/appi.neuropsych.18.4.460; Cohen JD., 2006, MULTIVOXEL PATTERN A; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Diaz-Arrastia R, 2009, EPILEPSIA, V50, P14, DOI 10.1111/j.1528-1167.2008.02006.x; Doshi-Velez F., 2017, ARXIV170208608; Dyrholm Mads, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P4249; Eickhoff S, 2016, NEUROIMAGE, V124, P1065, DOI 10.1016/j.neuroimage.2015.10.079; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Food and Drug Administration, 2013, DE NOV CLASS REQ NEU; Ford JM, 1999, PSYCHOPHYSIOLOGY, V36, P667, DOI 10.1111/1469-8986.3660667; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Gillan CM, 2016, NEURON, V91, P19, DOI 10.1016/j.neuron.2016.06.002; Gloss D, 2016, NEUROLOGY, V87, P2375, DOI 10.1212/WNL.0000000000003265; Gorgolewski KJ, 2015, FRONT NEUROINFORM, V9, DOI 10.3389/fninf.2015.00008; Gould TD, 2006, GENES BRAIN BEHAV, V5, P113, DOI 10.1111/j.1601-183X.2005.00186.x; Hanke M, 2009, NEUROINFORMATICS, V7, P37, DOI 10.1007/s12021-008-9041-y; Hanley DF, 2013, J NEUROTRAUM, V30, P2051, DOI 10.1089/neu.2013.3062; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Iyengar S, 2016, P NATL ACAD SCI USA, V113, P7699, DOI 10.1073/pnas.1608146113; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Kaiser DA, 2000, J NEUROTHERAPY, V1530-017X, P57, DOI DOI 10.1300/J184V04N02_07; Kappenman ES, 2012, SCHIZOPHRENIA BULL, V38, P92, DOI 10.1093/schbul/sbr147; Kennedy DN, 2004, NEUROINFORMATICS, V2, P367, DOI 10.1385/NI:2:4:367; Kieffaber PD, 2016, CLIN NEUROPHYSIOL, V127, P2192, DOI 10.1016/j.clinph.2016.01.023; Kraus N, 2016, SCI REP-UK, V6, DOI 10.1038/srep39009; Lainscsek C, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00200; Landis D, 2016, NEUROIMAGE, V124, P1084, DOI 10.1016/j.neuroimage.2015.05.049; Lemm S, 2011, NEUROIMAGE, V56, P387, DOI 10.1016/j.neuroimage.2010.11.004; Mognon A, 2011, PSYCHOPHYSIOLOGY, V48, P229, DOI 10.1111/j.1469-8986.2010.01061.x; Montague PR, 2012, TRENDS COGN SCI, V16, P72, DOI 10.1016/j.tics.2011.11.018; Moser JS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00466; Nair AK, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00001; Naunheim RS, 2010, BRAIN INJURY, V24, P1324, DOI 10.3109/02699052.2010.506862; Nichols TE, 2017, NAT NEUROSCI, V20, P299, DOI 10.1038/nn.4500; Nolan H, 2010, J NEUROSCI METH, V192, P152, DOI 10.1016/j.jneumeth.2010.07.015; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Parra LC, 2005, NEUROIMAGE, V28, P326, DOI 10.1016/j.neuroimage.2005.05.032; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Plis SM, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00365; Poldrack RA, 2017, NAT REV NEUROSCI, V18, P115, DOI 10.1038/nrn.2016.167; Poldrack RA, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00012; Prichep LS, 2005, CLIN EEG NEUROSCI, V36, P82, DOI 10.1177/155005940503600207; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Proudfit GH, 2015, PSYCHOPHYSIOLOGY, V52, P449, DOI 10.1111/psyp.12370; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Saad JF, 2018, J ATTEN DISORD, V22, P815, DOI 10.1177/1087054715578270; Schirrmeister R T, 2017, DEEP LEARNING CONVOL; Siegel M, 2012, NAT REV NEUROSCI, V13, P121, DOI 10.1038/nrn3137; Solis-Vivanco R, 2015, CLIN NEUROPHYSIOL, V126, P2142, DOI 10.1016/j.clinph.2014.12.024; Steele VR, 2014, BIOL PSYCHIAT, V76, P75, DOI 10.1016/j.biopsych.2013.09.030; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Teeters JL, 2008, NEUROINFORMATICS, V6, P47, DOI 10.1007/s12021-008-9009-y; Thatcher RW, 2003, CLIN ELECTROENCEPHAL, V34, P39, DOI 10.1177/155005940303400203; Thatcher RW, 2001, J NEUROPSYCH CLIN N, V13, P77, DOI 10.1176/appi.neuropsych.13.1.77; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Wiener M, 2016, NEURON, V92, P617, DOI 10.1016/j.neuron.2016.10.037; Woo CW, 2017, NAT NEUROSCI, V20, P365, DOI 10.1038/nn.4478	68	18	18	0	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5196			FRONT NEUROINFORM	Front. Neuroinformatics	NOV 21	2017	11								67	10.3389/fninf.2017.00067			9	Mathematical & Computational Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Neurosciences & Neurology	FN2PN	WOS:000415835900002	29209195	Green Published, gold			2022-02-06	
J	Sajja, VSSS; Jablonska, A; Haughey, N; Bulte, JWM; Stevens, RD; Long, JB; Walczak, P; Janowski, M				Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Haughey, Norman; Bulte, Jeff W. M.; Stevens, Robert D.; Long, Joseph B.; Walczak, Piotr; Janowski, Miroslaw			Sphingolipids and microRNA Changes in Blood following Blast Traumatic Brain Injury: An Exploratory Study	JOURNAL OF NEUROTRAUMA			English	Article						blast; ceramides; miRNA; sphingolipids	PLASMA SPHINGOMYELINS; METABOLISM; EXOSOMES; MILD; EXPRESSION; BIOMARKERS; EXPOSURE; REVEALS; PROTEIN; MODEL	At present, accurate and reliable biomarkers to ascertain the presence, severity, or prognosis of blast traumatic brain injury (bTBI) are lacking. There is an urgent need to establish accurate and reliable biomarkers capable of mbTBI detection. Currently, there are no studies that identify changes in miRNA and lipids at varied severities of bTBI. Various biological components such as lipids, circulating mRNA, and miRNA, could potentially be detected using advanced techniques such as next-generation sequencing and mass spectroscopy. Therefore, plasma analysis is an attractive approach with which to diagnose and treat brain injuries. Subacute changes in plasma microRNA (miRNA) and lipid composition for sphingolipids were evaluated in a murine model of mild-to-moderate bTBI using next-generation sequencing and mass spectroscopy respectively. Animals were exposed at 17, 17 x 3, and 20 psi blast intensities using a calibrated blast simulator. Plasma lipid profiling demonstrated decreased C18 fatty acid chains of sphingomyelins and increased ceramide levels when compared with controls. Plasma levels of brain-enriched miRNA, miR-127 were increased in all groups while let-7a, b, and g were reduced in the 17 x 3 and 20 psi groups, but let 7d was increased in the 17 psi group. The majority of the miRs and lipids are highly conserved across different species, making them attractive to explore and potentially employ as diagnostic markers. It is tempting to speculate that sphingolipids, miR-128, and the let-7 family could predict mTBI, while a combination of miR-484, miR-122, miR-148a, miR-130a, and miR-223 could be used to predict the overall status of injury following blast injury.	[Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Bulte, Jeff W. M.; Stevens, Robert D.; Walczak, Piotr; Janowski, Miroslaw] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, Baltimore, MD USA; [Haughey, Norman; Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Neurol & Neurosurg, Richard T Johnson Div Neuroimmunol & Neurol Infec, Baltimore, MD USA; [Haughey, Norman] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Stevens, Robert D.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Bulte, Jeff W. M.; Stevens, Robert D.; Walczak, Piotr; Janowski, Miroslaw] Johns Hopkins Univ, Inst Cell Engn, Cellular Imaging Sect, Baltimore, MD USA; [Sajja, Venkata Siva Sai Sujith; Jablonska, Anna; Bulte, Jeff W. M.; Stevens, Robert D.; Walczak, Piotr; Janowski, Miroslaw] Johns Hopkins Univ, Inst Cell Engn, Vasc Biol Program, Baltimore, MD USA; [Sajja, Venkata Siva Sai Sujith] Johns Hopkins Mil & Vet Hlth Inst, Baltimore, MD USA; [Sajja, Venkata Siva Sai Sujith; Long, Joseph B.] Walter Reed Army Inst Res, Blast Induced Neurotrauma Branch, Ctr Mil Psychiat & Neurosci, Silver Spring, MD USA; [Walczak, Piotr] Univ Warmia & Mazury, Dept Radiol, Fac Med Sci, Olsztyn, Poland; [Janowski, Miroslaw] Polish Acad Sci, NeuroRepair Dept, Mossakowski Med Res Ctr, Warsaw, Poland		Janowski, M (corresponding author), 733 N Broadway, Baltimore, MD 21205 USA.	mjanows1@jhmi.edu	Sajja, Sujith/I-5289-2019	Sajja, Sujith/0000-0002-1992-9501; Walczak, Piotr/0000-0002-3733-3322; Janowski, Miroslaw/0000-0001-5261-7975	Department of DefenseUnited States Department of Defense [W81XWH-13-1-0389]; Russell Military Scholar Program of the Johns Hopkins Military and Veterans Health Institute	This project was partially funded by the Department of Defense (Award no. W81XWH-13-1-0389) and a young investigator award from the Russell Military Scholar Program of the Johns Hopkins Military and Veterans Health Institute.	Adlakha YK, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.46; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Bae M, 2014, J NEUROCHEM, V131, P645, DOI 10.1111/jnc.12834; Balakathiresan N, 2012, J NEUROTRAUM, V29, P1379, DOI 10.1089/neu.2011.2146; Bergman P, 2013, J IMMUNOL, V190, P4066, DOI 10.4049/jimmunol.1200728; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Department of Defense, 2016, JEI; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Ellis B, 2015, J ALZHEIMERS DIS, V46, P313, DOI 10.3233/JAD-141899; Fonteh AN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125597; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Guo BB, 2015, J BIOL CHEM, V290, P3455, DOI 10.1074/jbc.M114.605253; Ha D, 2016, ACTA PHARM SIN B, V6, P287, DOI 10.1016/j.apsb.2016.02.001; Haughey NJ, 2004, ANN NEUROL, V55, P257, DOI 10.1002/ana.10828; Haughey NJ, 2010, NEUROMOL MED, V12, P301, DOI 10.1007/s12017-010-8135-5; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Ji D, 2015, CELL PHYSIOL BIOCHEM, V36, P1026, DOI 10.1159/000430276; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kastelowitz N, 2014, CHEMBIOCHEM, V15, P923, DOI 10.1002/cbic.201400043; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Liu R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077068; Liu SX, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101770; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Luo LL, 2012, J CELL SCI, V125, P3124, DOI 10.1242/jcs.096412; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Mielke MM, 2015, AGING CELL, V14, P112, DOI 10.1111/acel.12275; Mielke MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073094; Mielke MM, 2011, J ALZHEIMERS DIS, V27, P259, DOI 10.3233/JAD-2011-110405; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Pang XM, 2015, J NEUROCHEM, V133, P926, DOI 10.1111/jnc.13094; Polikepahad S, 2013, NUCLEIC ACIDS RES, V41, P1164, DOI 10.1093/nar/gks1098; Rahman M, 2014, J BIOL CHEM, V289, P26406, DOI 10.1074/jbc.M114.573592; Record M, 2014, BBA-MOL CELL BIOL L, V1841, P108, DOI 10.1016/j.bbalip.2013.10.004; Sheinerman KS, 2013, AGING-US, V5, P925, DOI 10.18632/aging.100624; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tan CL, 2013, SCIENCE, V342, P1254, DOI 10.1126/science.1244193; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Wang BY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047053; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.356; Wang K. K. W, 2014, RJIIJ, P83; Wang K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1770; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wheeler D, 2008, BRAIN, V131, P3092, DOI 10.1093/brain/awn190; Woods AS, 2013, ACS CHEM NEUROSCI, V4, P594, DOI 10.1021/cn300216h; Ying HJ, 2015, J IMMUNOL, V194, P1239, DOI 10.4049/jimmunol.1402088; Zhang CZ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-229; Zhang H, 2011, CELL DEATH DIFFER, V18, P1702, DOI 10.1038/cdd.2011.28; Zhang Y, 2013, NAT CELL BIOL, V15, P284, DOI 10.1038/ncb2690; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200	53	18	19	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					353	361		10.1089/neu.2017.5009		NOV 2017	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000417107800001	29020847				2022-02-06	
J	Yamakawa, GR; Lengkeek, C; Salberg, S; Spanswick, SC; Mychasiuk, R				Yamakawa, Glenn R.; Lengkeek, Connor; Salberg, Sabrina; Spanswick, Simon C.; Mychasiuk, Richelle			Behavioral and pathophysiological outcomes associated with caffeine consumption and repetitive mild traumatic brain injury (RmTBI) in adolescent rats	PLOS ONE			English	Article							SEX-DIFFERENCES; HIPPOCAMPAL NEUROGENESIS; RECEPTOR ANTAGONISTS; GENE-EXPRESSION; ENERGY DRINKS; CONCUSSION; CHILDREN; MODEL; IMPAIRMENT; SLEEP	Given that caffeine consumption is exponentially rising in adolescents and they are at increased risk for repetitive mild traumatic brain injury (RmTBI), we sought to examine the pathophysiological outcomes associated with early life caffeine consumption and RmTBI. Adolescent male and female Sprague Dawley rats received either caffeine in the drinking water or normal water and were then randomly assigned to 3 mild injuries using our lateral impact device or 3 sham procedures. Following injury induction, behavioral outcomes were measured with a test battery designed to examine symptoms consistent with clinical manifestation of PCS (balance and motor coordination, anxiety, short-term working memory, and depressive-like behaviours). In addition, pathophysiological outcomes were examined with histological measures of volume and cellular proliferation in the dentate gyrus, as well as microglia activation in the ventromedial hypothalamus. Finally, modifications to expression of 12 genes (Adora2a, App, Aqp4, Bdnf, Bmall, Clock, Cry, Gfap, Orxl, Orx2, Per, Tau), in the prefrontal cortex, hippocampus, and/or the hypothalamus were assessed. We found that chronic caffeine consumption in adolescence altered normal developmental trajectories, as well as recovery from RmTBI. Of particular importance, many of the outcomes exhibited sex-dependent responses whereby the sex of the animal modified response to caffeine, RmTBI, and the combination of the two. These results suggest that caffeine consumption in adolescents at high risk for RmTBI should be monitored.	[Yamakawa, Glenn R.; Lengkeek, Connor; Salberg, Sabrina; Spanswick, Simon C.; Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada		Mychasiuk, R (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.	rmmychas@ucalgary.ca		Yamakawa, Glenn/0000-0003-3079-6532	University of Calgary; Alberta Children's Hospital Research Institute; O'Brien Summer Studentship Foundation	Financial support from the Integrated Concussion Research Program at the University of Calgary, the Alberta Children's Hospital Research Institute, and the O'Brien Summer Studentship Foundation. No Grant Numbers Available.; The authors would like to thank the Integrated Concussion Research Program at the University of Calgary, the Alberta Children's Hospital Research Institute, and the O'Brien Summer Studentship Foundation for their financial support. The authors would also like to thank Melinda Wang and Rose Tobias for their technical support.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053376; Aepli A, 2015, BRAIN SCI, V5, P441, DOI 10.3390/brainsci5040441; Araujo LF, 2016, J ALZHEIMERS DIS, V53, P451, DOI 10.3233/JAD-160116; Ardais A, 2014, NEUROSCIENCE, V270; Ballesteros-Yanez Inmaculada, 2012, J Caffeine Res, V2, P90, DOI 10.1089/jcr.2012.0011; Behrens M, 2015, SCI REP-UK, V5, DOI 10.1038/srep10209; Benedetti MD, 2000, NEUROLOGY, V55, P1350, DOI 10.1212/WNL.55.9.1350; Bloms LP, 2016, J STRENGTH COND RES, V30, P1855, DOI 10.1519/JSC.0000000000001280; Bonefeld BE, 2008, SYNAPSE, V62, P302, DOI 10.1002/syn.20496; Boone DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046204; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broshek D, 2012, J NEUROSURG, V102, P856; Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013; Burke TM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5125; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Cognato GP, 2010, J NEUROCHEM, V112, P453, DOI 10.1111/j.1471-4159.2009.06465.x; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Daisuke I, 1998, MOL BRAIN RES, V57, P1; De Bellis MD, 2001, CEREB CORTEX, V11, P552, DOI 10.1093/cercor/11.6.552; Dunn GA, 2011, HORM BEHAV, V59, P290, DOI 10.1016/j.yhbeh.2010.05.004; Endesfelder S, 2014, FREE RADICAL BIO MED, V67, P221, DOI 10.1016/j.freeradbiomed.2013.09.026; Gabbita SP, 2005, J NEUROTRAUM, V22, P83, DOI 10.1089/neu.2005.22.83; Ghoneim FM, 2015, INT J CLIN EXP PATHO, V8, P7710; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Han ME, 2007, BIOCHEM BIOPH RES CO, V356, P976, DOI 10.1016/j.bbrc.2007.03.086; Han ME, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-110; Harnack L, 1999, J AM DIET ASSOC, V99, P436, DOI 10.1016/S0002-8223(99)00106-6; Hehar H, 2016, NEUROSCIENCE, V332, P61, DOI 10.1016/j.neuroscience.2016.06.039; Howell D, 2013, MED SCI SPORT EXER, V45, P1030, DOI 10.1249/MSS.0b013e3182814595; Huang H, 2006, NEUROIMAGE, V33, P27, DOI 10.1016/j.neuroimage.2006.06.009; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Kamphuis W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042823; Kolb B, 2003, P NATL ACAD SCI USA, V100, P10523, DOI 10.1073/pnas.1834271100; Lakhan SE, 2012, BRAIN BEHAV, V2, P661, DOI 10.1002/brb3.78; Landolt HP, 2004, NEUROPSYCHOPHARMACOL, V29, P1933, DOI 10.1038/sj.npp.1300526; LATINI R, 1980, J PHARM PHARMACOL, V32, P596, DOI 10.1111/j.2042-7158.1980.tb13010.x; Lohsoonthorn V, 2013, SLEEP BREATH, V17, P1017, DOI 10.1007/s11325-012-0792-1; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; McCrory C, 2017, J NUTR EDUC BEHAV, V49, P304, DOI 10.1016/j.jneb.2016.11.013; Metting Z, 2012, NEUROLOGY, V78, P1428, DOI 10.1212/WNL.0b013e318253d5c7; Minen MT, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0697-7; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nowak D, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080768; Oike H, 2011, BIOCHEM BIOPH RES CO, V410, P654, DOI 10.1016/j.bbrc.2011.06.049; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Paus T, 1999, SCIENCE, V283, P1908, DOI 10.1126/science.283.5409.1908; Perlaki G, 2011, BRAIN IMAGING BEHAV, V5, P274, DOI 10.1007/s11682-011-9131-6; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pintor A, 2004, J NEUROCHEM, V89, P152, DOI 10.1111/j.1471-4159.2003.02306.x; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Qin  Y., 2016, BEHAV BRAIN RES; Qosa H, 2012, J ALZHEIMERS DIS, V31, P151, DOI 10.3233/JAD-2012-120319; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Rivera-Oliver M, 2014, LIFE SCI, V101, P1, DOI 10.1016/j.lfs.2014.01.083; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rose SC, 2015, PEDIATR NEUROL, V53, P108, DOI 10.1016/j.pediatrneurol.2015.04.003; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schallert T., 2002, PHARM CEREB ISCHEMIA, V2002, P201; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sherman H, 2011, INT J BIOCHEM CELL B, V43, P829, DOI 10.1016/j.biocel.2011.02.008; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Spanswick SC, 2010, LEARN MEMORY, V17, P241, DOI 10.1101/lm.1746710; Temple JL, 2009, NEUROSCI BIOBEHAV R, V33, P793, DOI 10.1016/j.neubiorev.2009.01.001; Van Batenburg-Eddes T, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00457; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vila-Luna S, 2012, NEUROSCIENCE, V202, P384, DOI 10.1016/j.neuroscience.2011.11.053; Vynorius KC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00188; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; Wright D, NEUROBIOLOGY D UNPUB; Wright D, 2017, ANN CLIN TRANSLATION; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu HT, 2008, J NEUROTRAUM, V25, P130, DOI 10.1089/neu.2007.0369; Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006; Yadid G, 2001, BRAIN RES, V896, P43, DOI 10.1016/S0006-8993(00)03248-0; Yamakawa GR, 2017, EXP NEUROL, V295, P55, DOI 10.1016/j.expneurol.2017.06.001; Zhao J, 2005, J NEUROSCI RES, V82, P499, DOI 10.1002/jnr.20649	82	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2017	12	11							e0187218	10.1371/journal.pone.0187218			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FL7JU	WOS:000414424600019	29108016	gold, Green Published, Green Submitted			2022-02-06	
J	Kennedy, E; Cohen, M; Munafo, M				Kennedy, Eleanor; Cohen, Miriam; Munafo, Marcus			Childhood Traumatic Brain Injury and the Associations With Risk Behavior in Adolescence and Young Adulthood: A Systematic Review	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						antisocial behavior; child; conduct disorder; head injury; pediatric; risk behavior; substance use; systematic review; traumatic brain injury	MILD HEAD-INJURY; POST-CONCUSSIVE SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; CHILDREN; OUTCOMES; PREDICTORS; PRESCHOOL; POSTINJURY; SEQUELAE; PARENTS	Objective: To systematically review the evidence that childhood traumatic brain injury (TBI) is associated with risk behavior in adolescence and young adulthood. Risk behavior included one or more of the following: use of substances, including alcohol, tobacco, and illicit substances; involvement in criminal behavior; and behavioral issues with conduct. Methods: A literature search was conducted using these terms: child, pediatric, traumatic brain injury, head injury, adolescent, psychosocial, antisocial, conduct, substance use. Studies describing original research were included if they reported outcomes over the age of 13 years in participants who sustained a TBI between birth and age 13 years. Results: Six journal articles were reviewed based on 4 separate studies. Three articles indicated a relationship between childhood TBI and increased problematic substance use in adolescence and young adulthood. Three articles supported an association between childhood TBI and later externalizing behavior; however, 2 articles did not support this link. Conclusion: More research is warranted to explore the association between childhood TBI and later risk behavior as the relationship is not currently understood. Future research should build on existing longitudinal research with continued use of medical records for identifying TBI and inclusion of a non-brain-related trauma group to control for general injury effects.	[Kennedy, Eleanor; Munafo, Marcus] Univ Bristol, MRC Integrat Epidemiol Unit, UK Ctr Tobacco & Alcohol Studies, Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England; [Cohen, Miriam] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [Munafo, Marcus] UK Ctr Tobacco & Alcohol Studies, Bristol, Avon, England		Kennedy, E (corresponding author), Univ Bristol, MRC Integrat Epidemiol Unit, UK Ctr Tobacco & Alcohol Studies, Sch Expt Psychol, 12a Priory Rd, Bristol BS8 1TU, Avon, England.	e.kennedy@bristol.ac.uk	Munafo, Marcus/AAE-2306-2020	Munafo, Marcus/0000-0002-4049-993X	University of Bristol [MC_UU_12013/6]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission; British Heart FoundationBritish Heart Foundation; Cancer Research UKCancer Research UK; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC); National Institute for Health Research under the UK Clinical Research Collaboration; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MC_UU_12013/6] Funding Source: UKRI; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [1564726] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MC_UU_12013/6] Funding Source: researchfish	This study was supported in part by the Medical Research Council and the University of Bristol (MC_UU_12013/6).; MM is a member of the UK Centre for Tobacco and Alcohol Studies, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged.	ACHENBACH TM, 1987, PSYCHOL BULL, V101, P213, DOI 10.1037/0033-2909.101.2.213; Anderson V., 1997, J INT NEUROPSYCH SOC, V3, P553; Anderson VA, 2014, DEV MED CHILD NEUROL, V56, P329, DOI 10.1111/dmcn.12387; Andrews TK, 1998, BRAIN INJURY, V12, P133, DOI 10.1080/026990598122755; [Anonymous], 2009, STAT STAT SOFTW COMP; ASARNOW RF, 1991, J PEDIATR PSYCHOL, V16, P543, DOI 10.1093/jpepsy/16.5.543; BABCOCK L, 2013, PEDIATRICS, V167, P156; Babikian T, 2013, J INT NEUROPSYCH SOC, V19, P145, DOI 10.1017/S135561771200104X; Barlow KM, 2016, J CHILD NEUROL, V31, P57, DOI 10.1177/0883073814543305; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Batty RA, 2013, BRAIN IMPAIR, V14, P21, DOI 10.1017/BrImp.2013.10; Bernard C, 2016, J INT NEUROPSYCH SOC, V22, P1; BIJUR PE, 1990, PEDIATRICS, V86, P337; Blinman TA, 2009, J PEDIATR SURG, V44, P1223, DOI 10.1016/j.jpedsurg.2009.02.027; Bracken B.A., 2004, CLIN ASSESSMENT BEHA; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; Brown H., 2015, APPL MIXED MODELS ME; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Gioia GA, 2015, BRAIN INJURY, V29, P195, DOI 10.3109/02699052.2014.965210; Gioia GA, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P151, DOI 10.1007/978-0-387-89545-1_12; Guo S., 2015, PROPENSITY SCORE ANA; Hooper SR, 2004, NEUROREHABILITATION, V19, P175; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kirk RE, 1996, EDUC PSYCHOL MEAS, V56, P746, DOI 10.1177/0013164496056005002; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kolb B, 2012, DEV PSYCHOBIOL, V54, P311, DOI 10.1002/dev.20515; Lagattuta KH, 2012, J EXP CHILD PSYCHOL, V113, P211, DOI 10.1016/j.jecp.2012.04.001; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P3, DOI 10.1111/j.1365-2214.2009.01006.x; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2014, AUST PSYCHOL, V49, P323, DOI 10.1111/ap.12084; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P233, DOI 10.1097/HTR.0b013e3182a2dd7f; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Myers R. H., 1990, CLASSICAL MODERN REG; Ponsford, 2014, UNDERSTANDING TRAUMA, P190; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Satz P, 1997, PSYCHOL BULL, V122, P107, DOI 10.1037/0033-2909.122.2.107; Satz P., 1993, NEUROPSYCHOLOGY, V7, P273, DOI DOI 10.1037/0894-4105.7.3.273; Scott C, 2015, NEUROPSYCHOLOGY, V29, P501, DOI 10.1037/neu0000074; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stevens Penelope K, 2010, J Trauma Nurs, V17, P178, DOI 10.1097/JTN.0b013e3181ff2789; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Tabachnick B.G., 2013, USING MULTIVARIATE S; Taylor H G, 1997, J Int Neuropsychol Soc, V3, P555; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Yeates KO, 2001, J PEDIATR PSYCHOL, V26, P79, DOI 10.1093/jpepsy/26.2.79	59	18	18	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2017	32	6					425	432		10.1097/HTR.0000000000000289			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FQ8BO	WOS:000418588100098	28092286	Green Published			2022-02-06	
J	Zhou, ZW; Li, F; Zheng, ZT; Li, YD; Chen, TH; Gao, WW; Chen, JL; Zhang, JN				Zhou, Zi-wei; Li, Fei; Zheng, Zhi-tong; Li, Ya-dan; Chen, Tong-heng; Gao, Wei-wei; Chen, Jie-li; Zhang, Jian-ning			Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury	BRAIN AND BEHAVIOR			English	Article						erythropoietin; neuroimmune; neuroinflammation; regulatory T cell (Treg); traumatic brain injury	RECOMBINANT-HUMAN-ERYTHROPOIETIN; CEREBRAL-ISCHEMIA; COGNITIVE IMPAIRMENT; RECEPTOR EXPRESSION; NEURONAL APOPTOSIS; BARRIER DISRUPTION; WHITE-MATTER; HEAD-INJURY; T-CELLS; MODEL	IntroductionTraumatic brain injury (TBI) remains a leading cause of disability and death among young people in China. Unfortunately, no specific pharmacological agents to block the progression of secondary brain injury have been approved for clinical treatment. Recently, neuroprotective effects of erythropoietin (EPO) have been demonstrated in addition to its principal function in erythropoiesis, and hence it is viewed as a potential drug for TBI. In this study, we have investigated the neuroprotective effects of EPO associated with immune/inflammatory modulation in a mouse experimental TBI model. MethodsEPO (5000U/kg body weight, i.p.) was injected at 1hr, 1, 2, and 3days after TBI, and its effect on cognitive function, brain edema, immune/inflammatory cells including regulatory T cells (Tregs), neutrophils, CD3(+) T cells, and microglia, cytokines including interleukin-10 (IL-10), transforming growth factor- (TGF-), interleukin-1 (IL-1), and tumor necrosis factor- (TNF-) were evaluated at different time points after treatment. ResultsEPO treatment significantly decreased brain edema and improved cognitive function when compared to Saline-treated mice (p<.05). EPO treatment also significantly increased Tregs level in spleen and injured brain tissue as well as significantly reduced the infiltration and activation of immune/inflammatory cells (neutrophils, CD3(+)T cells, and microglia) in the injured hemisphere compared to Saline-treated control animals (p<.05). In addition, ELISA analysis demonstrated that EPO treatment increased the expression of anti-inflammatory cytokine IL-10, but decreased the expression of proinflammatory cytokine IL-1 and TNF- in the injured brain tissue (p<.05). ConclusionsThese findings suggest that EPO could improve neurological and cognitive functional outcomes as well as regulate immune/inflammatory reaction in TBI.	[Zhou, Zi-wei; Li, Fei; Zheng, Zhi-tong; Gao, Wei-wei; Zhang, Jian-ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Zhou, Zi-wei; Gao, Wei-wei; Zhang, Jian-ning] Tianjin Neurol Inst, Tianjin, Peoples R China; [Zhou, Zi-wei; Gao, Wei-wei; Zhang, Jian-ning] Minist Educ, Key Lab Posttrauma Neurorepair & Regenerat Cent N, Tianjin, Peoples R China; [Zhou, Zi-wei; Gao, Wei-wei; Zhang, Jian-ning] Tianjin Key Lab Injuries Variat & Regenerat Nervo, Tianjin, Peoples R China; [Li, Ya-dan] Tianjin Huanhu Hosp, Intens Care Units, Tianjin, Peoples R China; [Chen, Tong-heng] Tianjin Med Univ, Hosp 2, Dept Neurosurg, Tianjin, Peoples R China; [Chen, Jie-li] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Zhou, ZW; Zhang, JN (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China.	ziweizhou2009@hotmail.com; jianningzhang@hotmail.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81271361, 81330029]; Natural Science Foundations of TianjinNatural Science Foundation of Tianjin [13JCZDJC30800]; Incubation project of Natural Science Foundations of Tianjin Medical University General Hospital [303071901401]	National Natural Science Foundation of China, Grant/Award Number: 81271361 and 81330029; Natural Science Foundations of Tianjin, Grant/Award Number: 13JCZDJC30800; Incubation project of Natural Science Foundations of Tianjin Medical University General Hospital, Grant/Award Number: 303071901401	Acheson A, 2007, PHYSIOL BEHAV, V91, P579, DOI 10.1016/j.physbeh.2007.03.020; Assaraf MI, 2007, J NEUROPATH EXP NEUR, V66, P389, DOI 10.1097/nen.0b013e3180517b28; Atalay B, 2007, BRIT J NEUROSURG, V21, P281, DOI 10.1080/02688690701364781; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barichello T, 2014, TRANSL RES, V163, P503, DOI 10.1016/j.trsl.2013.12.008; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Cianferotti L, 2014, ENDOCRINE, V45, P165, DOI 10.1007/s12020-013-0026-8; Cunningham TL, 2014, J NEUROTRAUM, V31, P505, DOI 10.1089/neu.2013.2965; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Okutan O, 2008, SURG NEUROL, V70, P498, DOI 10.1016/j.surneu.2007.07.061; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roberts DJ, 2013, J NEUROTRAUM, V30, P1727, DOI 10.1089/neu.2012.2842; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Schneider DF, 2007, J BURN CARE RES, V28, P365, DOI 10.1097/BCR.0B013E318053D40B; Tada H, 2006, CARDIOVASC RES, V71, P466, DOI 10.1016/j.cardiores.2006.05.010; TAN CC, 1991, KIDNEY INT, V40, P69, DOI 10.1038/ki.1991.181; Tang ZH, 2013, NEUROPHARMACOLOGY, V67, P8, DOI 10.1016/j.neuropharm.2012.10.017; Teixeira AM, 2010, RENAL FAILURE, V32, P1073, DOI 10.3109/0886022X.2010.509897; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Walsh JT, 2011, TRENDS MOL MED, V17, P541, DOI 10.1016/j.molmed.2011.05.012; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; Wu AG, 2010, NEUROREHAB NEURAL RE, V24, P290, DOI 10.1177/1545968309348318; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xu F, 2012, EXP THER MED, V4, P977, DOI 10.3892/etm.2012.723; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yi CL, 2012, INJURY, V43, P402, DOI 10.1016/j.injury.2010.12.011; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924	42	18	22	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	NOV	2017	7	11							e00827	10.1002/brb3.827			10	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FN5QR	WOS:000416063200004	29201540	Green Published, gold			2022-02-06	
J	van der Horn, HJ; Scheenen, ME; de Koning, ME; Liemburg, EJ; Spikman, JM; van der Naalt, J				van der Horn, Harm J.; Scheenen, Myrthe E.; de Koning, Myrthe E.; Liemburg, Edith J.; Spikman, Jacoba M.; van der Naalt, Joukje			The Default Mode Network as a Biomarker of Persistent Complaints after Mild Traumatic Brain Injury: A Longitudinal Functional MRI Study	JOURNAL OF NEUROTRAUMA			English	Article						brain networks; fMRI; functional connectivity; mTBI; persistent complaints	HEAD-INJURY; INDEPENDENT COMPONENTS; EARLY PREDICTORS; CONNECTIVITY; SYMPTOMS; ANXIETY; FMRI; INFERENCES; UPFRONT; RETURN	The objective of this study was to examine longitudinal functional connectivity of resting-state networks in patients with and without complaints after uncomplicated mild traumatic brain injury (mTBI). Second, we aimed to determine the value of network connectivity in predicting persistent complaints, anxiety, depression and long-term outcome. Thirty mTBI patients with three or more post-traumatic complaints at 2 weeks post-injury, 19 without complaints, and 20 matched healthy controls were selected for this study. Resting-state functional MRI (fMRI) was performed in patients at 1 month and 3 months post-injury, and once in healthy controls. Independent component analysis (ICA) was used to investigate the default mode, executive and salience networks. Persistent post-traumatic complaints, anxiety, and depression were measured at 3 months post-injury, and outcome was determined at 1 year post-injury. Within the group with complaints, higher functional connectivity between the anterior and posterior components of the default mode network at 1 month post-injury was associated with a greater number of complaints at 3 months post-injury (p=0.59, p=0.001). Minor longitudinal changes in functional connectivity were found for patients with and without complaints after mTBI, which were limited to connectivity within the precuneus component of the default mode network. No significant results were found for the executive and salience networks. Current results suggest that the default mode network may serve as a biomarker of persistent complaints in patients with uncomplicated mTBI.	[van der Horn, Harm J.; de Koning, Myrthe E.; van der Naalt, Joukje] Univ Groningen, Dept Neurol, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands; [Liemburg, Edith J.] Univ Med Ctr Groningen, NeuroImaging Ctr, Dept Neurosci, Groningen, Netherlands		van der Horn, HJ (corresponding author), Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, Hanzepl 1,POB 30-001, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl	Leemans, Alexander/A-1784-2011	Leemans, Alexander/0000-0002-9306-6126; van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763	Dutch Brain Foundation [Ps2012-06]	The authors thank Dr. Jan Cees de Groot for his assistance in the assessment of structural MRI scans. The study was funded by the Dutch Brain Foundation (grant no. Ps2012-06).	Allen EA, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00002; Andrews-Hanna JR, 2014, ANN NY ACAD SCI, V1316, P29, DOI 10.1111/nyas.12360; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Cole MW, 2014, NEUROSCIENTIST, V20, P652, DOI 10.1177/1073858414525995; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; DeYoung CG, 2010, PSYCHOL SCI, V21, P820, DOI 10.1177/0956797610370159; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Fisher RA, 1914, BIOMETRIKA, V10, P507; Fox KCR, 2015, NEUROIMAGE, V111, P611, DOI 10.1016/j.neuroimage.2015.02.039; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Li WJ, 2014, HUM BRAIN MAPP, V35, P238, DOI 10.1002/hbm.22168; Li YO, 2007, HUM BRAIN MAPP, V28, P1251, DOI 10.1002/hbm.20359; Linley PA, 2004, J TRAUMA STRESS, V17, P11, DOI 10.1023/B:JOTS.0000014671.27856.7e; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; MCGRAW KO, 1992, PSYCHOL BULL, V111, P361, DOI 10.1037/0033-2909.111.2.361; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mulders PC, 2015, NEUROSCI BIOBEHAV R, V56, P330, DOI 10.1016/j.neubiorev.2015.07.014; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Scheenen M. E., 2017, J NEUROTRAUMA NEU, V2016, P4885; Scheenen ME, 2017, CLIN REHABIL, V31, P1019, DOI 10.1177/0269215516687101; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Servaas MN, 2014, HUM BRAIN MAPP, V35, P4303, DOI 10.1002/hbm.22476; Skup M, 2010, STAT INTERFACE, V3, P235; Sours C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134019; Sours C, 2015, BRAIN IMAGING BEHAV, V9, P190, DOI 10.1007/s11682-014-9295-y; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stulemeijer M, 2007, J PSYCHOSOM RES, V63, P637, DOI 10.1016/j.jpsychores.2007.06.023; Sylvester CM, 2012, TRENDS NEUROSCI, V35, P527, DOI 10.1016/j.tins.2012.04.012; Termenon M, 2016, NEUROIMAGE, V142, P172, DOI 10.1016/j.neuroimage.2016.05.062; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Verhage F, 1964, INTELLIGENCE AGE STU; Whitfield-Gabrieli S, 2012, ANNU REV CLIN PSYCHO, V8, P49, DOI 10.1146/annurev-clinpsy-032511-143049; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	60	18	18	1	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2017	34	23					3262	3269		10.1089/neu.2017.5185		OCT 2017	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FN9HM	WOS:000414459100001	28882089	Green Submitted			2022-02-06	
J	Abosadegh, MM; Rahman, SA; Saddki, N				Abosadegh, Maher M.; Rahman, Shaifulizan Abdul; Saddki, Norkhafizah			Association of traumatic head injuries and maxillofacial fractures: A retrospective study	DENTAL TRAUMATOLOGY			English	Article						facial fracture; maxillofacial fractures; risk factor; traumatic head injuries	FACIAL FRACTURES; COMPUTED-TOMOGRAPHY; BRAIN-INJURIES; IMPACT	Background/AimsThe association of traumatic head injury (THI) with maxillofacial fractures (MFF) is a major health concern worldwide. In spite of the close anatomical proximity of maxillofacial bones to the cranium, the association of THI with MFF is controversial. The aim of this study was to assess the association between THI and MFF. Other factors associated with THI in patients with MFF were also investigated. Materials and MethodsA hospital-based retrospective study was conducted at the OMFS Unit, Hospital USM, Kelantan, Malaysia. From 12 June 2013 to 31 December 2015, 473 patient records with MFF were reviewed to evaluate the association of THI and MFF. ResultsA total of 331 patients (69.98%) presented with concomitant THI. The most common associated THI were cranial bone fractures (68.6%) followed by intracranial injuries and concussion. A significant association existed between the Glasgow coma scale (GCS) score and the presence of THI concomitant MFF with P-value <.001. The univariable logistic regression analysis revealed that age group (31-40years), cause of injury (road traffic accidentRTA), all midface fracture types and most of the mandibular fracture types were statistically associated with the presence of THI. The multivariable logistic regression analysis revealed that the cause of the injury (RTA) and MFF types (nasal bone, zygomatic complex, zygomatic arch, orbital wall, maxillary sinus wall and the alveolar process of mandible fractures) were statistically significantly associated with THI in patients with MFF. ConclusionThere was a high prevalence of THI among patients with MFF (69.98%). RTA, nasal bone, zygomatic complex, zygomatic arch, orbital wall, maxillary sinus wall and mandibular alveolar process fractures were significantly associated with THI in patients who sustained a MFF.	[Abosadegh, Maher M.; Rahman, Shaifulizan Abdul] Univ Sains Malaysia, Sch Dent Sci, Maxillofacial Surg Unit, Kubang Kerian 16150, Kelantan, Malaysia; [Saddki, Norkhafizah] Univ Sains Malaysia, Sch Dent Sci, Dent Publ Hlth Unit, Kubang Kerian 16150, Kelantan, Malaysia		Abosadegh, MM (corresponding author), Univ Sains Malaysia, Sch Dent Sci, Maxillofacial Surg, Kubang Kerian 16150, Kelantan, Malaysia.	maherdental@hotmail.com		Abosadegh, maher/0000-0002-8072-1099			Akheel M, 2014, SCI J PUBLIC HLTH, V2, P29; Alves La-Salete, 2014, Braz. Dent. J., V25, P561, DOI 10.1590/0103-6440201302395; Alvi A, 2003, LARYNGOSCOPE, V113, P102, DOI 10.1097/00005537-200301000-00019; Arslan ED, 2014, WORLD J EMERG SURG, V9, DOI 10.1186/1749-7922-9-13; CHANG CJ, 1994, J TRAUMA, V37, P807, DOI 10.1097/00005373-199411000-00017; DAVIDOFF G, 1988, ANN EMERG MED, V17, P6, DOI 10.1016/S0196-0644(88)80492-X; Goil P, 2016, INDIAN J APPL RES, V6, P528; Grant AL, 2012, J CRANIOFAC SURG, V23, P1324, DOI 10.1097/SCS.0b013e31825e60ae; HAYTER JP, 1991, BRIT J ORAL MAX SURG, V29, P370, DOI 10.1016/0266-4356(91)90003-N; Hohlrieder M, 2004, INT J ORAL MAX SURG, V33, P389, DOI 10.1016/j.ijom.2003.10.011; Holmgren EP, 2004, J ORAL MAXIL SURG, V62, P913, DOI 10.1016/j.joms.2003.12.026; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Isik D, 2012, ULUS TRAVMA ACIL CER, V18, P200, DOI 10.5505/tjtes.2012.01047; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Khalighi Sigaroudi S. A., 2012, J DENT SHIRAZ, V13, P18; Kloss F, 2008, J CRANIO MAXILL SURG, V36, P372, DOI 10.1016/j.jcms.2007.12.002; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; LIM LH, 1993, BRIT J PLAST SURG, V46, P635, DOI 10.1016/0007-1226(93)90191-D; Marincek B, 2007, AM SOC NEURORADIOLOG, V29, P313; Martin RCG, 2002, AM SURGEON, V68, P477; Mulligan RP, 2010, J TRAUMA, V68, P587, DOI 10.1097/TA.0b013e3181b16bc5; Pappachan B, 2006, J ORAL MAXIL SURG, V64, P1023, DOI 10.1016/j.joms.2006.03.021; Ramli R, 2011, DENT TRAUMATOL, V27, P122, DOI 10.1111/j.1600-9657.2010.00968.x; Salentijn EG, 2014, J CRANIO MAXILL SURG, V42, P705, DOI 10.1016/j.jcms.2013.12.008; SCHELLHAS KP, 1988, ARCH OTOLARYNGOL, V114, P438; Smith Hayden, 2012, J Trauma Nurs, V19, P57, DOI 10.1097/JTN.0b013e31823a4c0e; Tung TC, 2000, J TRAUMA, V49, P420, DOI 10.1097/00005373-200009000-00006; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z; Zhou HH, 2015, DENT TRAUMATOL, V31, P209, DOI 10.1111/edt.12165	29	18	19	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	OCT	2017	33	5					369	374		10.1111/edt.12349			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	FH3FX	WOS:000411031700007	28504848				2022-02-06	
J	Bodanapally, UK; Dreizin, D; Issa, G; Archer-Arroyo, KL; Sudini, K; Fleiter, TR				Bodanapally, U. K.; Dreizin, D.; Issa, G.; Archer-Arroyo, K. L.; Sudini, K.; Fleiter, T. R.			Dual-Energy CT in Enhancing Subdural Effusions that Masquerade as Subdural Hematomas: Diagnosis with Virtual High-Monochromatic (190-keV) Images	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTRACRANIAL HYPOTENSION; IODINATED CONTRAST; HEMORRHAGE; ANGIOGRAPHY; ENHANCEMENT	BACKGROUND AND PURPOSE: Extravasation of iodinated contrast into subdural space following contrast-enhanced radiographic studies results in hyperdense subdural effusions, which can be mistaken as acute subdural hematomas on follow-up noncontrast head CTs. Our aim was to identify the factors associated with contrast-enhancing subdural effusion, characterize diffusion and washout kinetics of iodine in enhancing subdural effusion, and assess the utility of dual-energy CT in differentiating enhancing subdural effusion from subdural hematoma. MATERIALS AND METHODS: We retrospectively analyzed follow-up head dual-energy CT studies in 423 patients with polytrauma who had undergone contrast-enhanced whole-body CT. Twenty-four patients with enhancing subdural effusion composed the study group, and 24 randomly selected patients with subdural hematoma were enrolled in the comparison group. Postprocessing with syngo.via was performed to determine the diffusion and washout kinetics of iodine. The sensitivity and specificity of dual-energy CT for the diagnosis of enhancing subdural effusion were determined with 120-kV, virtual monochromatic energy (190-keV) and virtual noncontrast images. RESULTS: Patients with enhancing subdural effusion were significantly older (mean, 69 years; 95% CI, 60-78 years; P < .001) and had a higher incidence of intracranial hemorrhage (P = .001). Peak iodine concentration in enhancing subdural effusions was reached within the first 8 hours of contrast administration with a mean of 0.98 mg/mL (95% CI, 0.81-1.13 mg/mL), and complete washout was achieved at 38 hours. For the presence of a hyperdense subdural collection on 120-kV images with a loss of hyperattenuation on 190-keV and virtual noncontrast images, when considered as a true-positive for enhancing subdural effusion, the sensitivity was 100% (95% CI, 85.75%-100%) and the specificity was 91.67% (95% CI, 73%-99%). CONCLUSIONS: Dual-energy CT has a high sensitivity and specificity in differentiating enhancing subdural effusion from subdural hematoma. Hence, dual-energy CT has a potential to obviate follow-up studies.	[Bodanapally, U. K.; Dreizin, D.; Issa, G.; Archer-Arroyo, K. L.; Fleiter, T. R.] Univ Maryland, Med Ctr, Dept Diagnost Radiol & Nucl Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Sudini, K.] Johns Hopkins Univ, Dept Environm Hlth Sci, Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA		Fleiter, TR (corresponding author), Univ Maryland, Med Ctr, Dept Radiol, Baltimore, MD 21201 USA.	tfleiter@gmail.com		Fleiter, Thorsten/0000-0001-6255-9027			Bodanapally UK, 2015, RADIOL CLIN N AM, V53, P695, DOI 10.1016/j.rcl.2015.02.011; Brightbill TC, 2000, HEADACHE, V40, P292, DOI 10.1046/j.1526-4610.2000.00043.x; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; FISHMAN RA, 1993, NEUROLOGY, V43, P609, DOI 10.1212/WNL.43.3_Part_1.609; Gupta R, 2010, RADIOLOGY, V257, P205, DOI 10.1148/radiol.10091806; Koehler DM, 2011, J TRAUMA, V70, P324, DOI 10.1097/TA.0b013e31820b5d22; Koss SA, 2003, AM J NEURORADIOL, V24, P704; MOKRI B, 1995, NEUROLOGY, V45, P1801, DOI 10.1212/WNL.45.10.1801; Mori K, 2000, SURG NEUROL, V53, P303, DOI 10.1016/S0090-3019(00)00199-3; Norwood SH, 2008, J TRAUMA, V65, P1021, DOI 10.1097/TA.0b013e31818a0e74; Paldino M., 2003, NEUROSURG FOCUS, V15, P1, DOI DOI 10.3171/FOC.2003.15.6.8; PANNULLO SC, 1993, NEUROLOGY, V43, P919, DOI 10.1212/WNL.43.5.919; Phan CM, 2012, AM J NEURORADIOL, V33, P1088, DOI 10.3174/ajnr.A2909; Phelan HA, 2012, J TRAUMA ACUTE CARE, V73, P1434, DOI 10.1097/TA.0b013e31825ac49e; Postma Alida A, 2015, Curr Radiol Rep, V3, P16; Potter CA, 2016, RADIOGRAPHICS, V36, P2186, DOI 10.1148/rg.2016160069; Rennert J, 2010, J COMPUT ASSIST TOMO, V34, P249, DOI 10.1097/RCT.0b013e3181c6e704; SAGE MR, 1983, AM J NEURORADIOL, V4, P897; Shinohara Y, 2014, ACTA RADIOL, V55, P1015, DOI 10.1177/0284185113510492; Tan LA, 2016, J NEUROSURG, V124, P279, DOI 10.3171/2015.5.JNS15953; Willmann JK, 2002, AM J ROENTGENOL, V179, P437, DOI 10.2214/ajr.179.2.1790437; YAMADA H, 1980, SURG NEUROL, V13, P441; Zamora CA, 2015, J NEUROSURG, V123, P1184, DOI 10.3171/2014.10.JNS142172	23	18	18	0	0	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2017	38	10					1946	1952		10.3174/ajnr.A5318			7	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FI4PQ	WOS:000411955100026	28798216	hybrid, Green Published			2022-02-06	
J	Dennis, EL; Babikian, T; Giza, CC; Thompson, PM; Asarnow, RF				Dennis, Emily L.; Babikian, Talin; Giza, Christopher C.; Thompson, Paul M.; Asarnow, Robert F.			Diffusion MRI in pediatric brain injury	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Diffusion MRI; Diffuse axonal injury; Pediatric; Concussion	WHITE-MATTER ABNORMALITIES; HEAD IMPACT EXPOSURE; CORPUS-CALLOSUM; BEHAVIOR RELATIONSHIPS; LONGITUDINAL CHANGES; EARLY-CHILDHOOD; CHILDREN; INTEGRITY; MICROSTRUCTURE; METAANALYSIS	Traumatic brain injury (TBI) is a major public health issue around the world and can be especially devastating in children as TBI can derail cognitive and social development. White matter (WM) is particularly vulnerable to disruption post-TBI, as myelination is ongoing during this period. Diffusion magnetic resonance imaging (dMRI) is a versatile modality for identifying and quantifying WM disruption and can detect diffuse axonal injury (DAI or TAI (traumatic axonal injury)). This review covers dMRI studies of pediatric TBI, including mild to severe injuries, and covering all periods post-injury. While there have been considerable advances in our understanding of pediatric TBI through the use of dMRI, there are still large gaps in our knowledge, which will be filled in by larger studies and more longitudinal studies. Heterogeneity post-injury is an obstacle in all TBI studies, but we expect that larger better-characterized samples will aid in identifying clinically meaningful subgroups within the pediatric TBI patient population.	[Dennis, Emily L.; Thompson, Paul M.] USC, Keck Sch Med, Imaging Genet Ctr, Mark & Mary Stevens Neuroimaging & Informat Inst, Marina Del Rey, CA 90292 USA; [Babikian, Talin; Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Mattel Childrens Hosp, Div Pediat Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Los Angeles, CA USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA USA		Dennis, EL (corresponding author), USC, Keck Sch Med, Imaging Genet Ctr, Mark & Mary Stevens Neuroimaging & Informat Inst, Marina Del Rey, CA 90292 USA.	emily.dennis@ini.usc.edu	Thompson, Paul M/C-4194-2018; Dennis, Emily/AAD-5223-2021	Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99 NS096116]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U54 EB020403, R01 AG040060, R01 NS080655]; UCLA BIRC [R01 NS027544]; NCAA; US Dept of Defense; UCLA Steve Tisch BrainSPORT Program; Easton Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [U54EB020403, P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027544, K99NS096116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060] Funding Source: NIH RePORTER	Researchers were supported by the NICHD (R01 HD061504). ELD is supported by a grant from the NINDS (K99 NS096116). ELD and PT are also supported by NIH grants to PT: U54 EB020403, R01 AG040060, and R01 NS080655. CCG is supported by the UCLA BIRC, R01 NS027544, NCAA, US Dept of Defense, UCLA Steve Tisch BrainSPORT Program, and Easton Foundation.	Adamson C, 2013, BRAIN INJURY, V27, P454, DOI 10.3109/02699052.2012.750756; Babcock L, 2015, J PEDIATR REHAB MED, V8, P285, DOI 10.3233/PRM-150347; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bearden CE, 2017, NEURON, V94, P232, DOI 10.1016/j.neuron.2017.03.033; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Broglio SP, 2017, SPORTS MED, DOI 10.1007/s40279-017-0707-1; Bruce D, 1979, MECH TIME COURSE CLE, P155; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Caeyenberghs K, 2011, J NEUROTRAUM, V28, P897, DOI 10.1089/neu.2010.1721; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dennis E. L., 2015, NEUROIMAGE CLIN; Dennis EL, 2017, NEUROLOGY, V88, P1392, DOI 10.1212/WNL.0000000000003808; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Ewing-Cobbs L, 2016, HUM BRAIN MAPP, V37, P3929, DOI 10.1002/hbm.23286; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Genc S, 2017, J NEUROTRAUM, V34, P798, DOI 10.1089/neu.2016.4584; Hulkower M. B., 2013, AJNR AM J NEURORADIO; Insel T, 2013, DSM 5 RDOC SHARED IN; Jiang Q, 2010, STROKE, V41, pS112, DOI 10.1161/STROKEAHA.110.595629; Johnson CP, 2011, J INT NEUROPSYCH SOC, V17, P663, DOI 10.1017/S1355617711000464; Johnson CP, 2015, NEUROIMAGE-CLIN, V9, P668, DOI 10.1016/j.nicl.2015.10.009; Juranek J, 2012, BRAIN IMAGING BEHAV, V6, P36, DOI 10.1007/s11682-011-9140-5; Konigs M, 2017, BRAIN IMAGING BEHAV; Kurowski B, 2009, J PEDIATR REHAB MED, V2, P273, DOI 10.3233/PRM-2009-0093; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCauley SR, 2011, J NEUROTRAUM, V28, P503, DOI 10.1089/neu.2010.1555; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Thompson PM, 2014, BRAIN IMAGING BEHAV, V8, P153, DOI 10.1007/s11682-013-9269-5; Thompson PM, 2015, NEUROIMAGE; Tlustos SJ, 2015, J PEDIATR REHAB MED, V8, P321, DOI 10.3233/PRM-150350; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Van Beek L, 2015, BRAIN INJURY, V29, P1701, DOI 10.3109/02699052.2015.1075172; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; van der Zijden JP, 2008, EXP NEUROL, V212, P207, DOI 10.1016/j.expneurol.2008.03.027; Vu JA, 2011, EXCEPT CHILDREN, V77, P263, DOI 10.1177/001440291107700301; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006; Yallampalli R, 2013, J NEUROIMAGING, V23, P224, DOI 10.1111/j.1552-6569.2010.00537.x; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Yuan WH, 2017, NEUROREHAB NEURAL RE, V31, P190, DOI 10.1177/1545968316675430; Yuan WH, 2015, HUM BRAIN MAPP, V36, P779, DOI 10.1002/hbm.22664; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216; Zhan L, 2010, NEUROIMAGE, V49, P1357, DOI 10.1016/j.neuroimage.2009.09.057	63	18	19	0	12	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	OCT	2017	33	10					1683	1692		10.1007/s00381-017-3522-y			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	FG1LZ	WOS:000409558900011	29149383	Green Accepted			2022-02-06	
J	Jiang, ZX; Zhang, JN; Cai, YH; Huang, JX; You, LT				Jiang, Zhixian; Zhang, Jinning; Cai, Yonghui; Huang, Jiaxin; You, Lingtong			Catechin attenuates traumatic brain injury-induced blood-brain barrier damage and improves longer-term neurological outcomes in rats	EXPERIMENTAL PHYSIOLOGY			English	Article						blood-brain barrier; catechin; inflammation; neuroprotection; traumatic brain injury	GREEN TEA CATECHINS; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; TIGHT JUNCTION; PROTECTS; INTEGRITY; OCCLUDIN	Traumatic brain injury (TBI) resulting from external force on the head usually leads to long-term deficits in motor and cognitive functions. Catechin has shown neuroprotective effects in neurodegenerative diseases and ischaemia models. We therefore investigated the potential neuroprotective effects of catechin after TBI and explored the underlying mechanisms. Male rats were subjected to controlled cortical impact injury and then treated with catechin. Brain damage, motor and cognitive functions, blood-brain barrier (BBB) integrity and neuro-inflammation were examined. Catechin treatment ameliorated brain damage and motor and cognitive deficits after TBI. Catechin was shown to protect BBB integrity, alleviate the TBI-induced loss of the junction proteins occludin and zonula occludens protein-1 and suppress local inflammatory reactions. Catechin treatment had neuroprotective effects in a rat model of TBI, and these effects might be mediated by intervention in the self-perpetuating process of BBB disruption and excessive inflammatory reaction.	[Jiang, Zhixian; Zhang, Jinning; Cai, Yonghui; Huang, Jiaxin; You, Lingtong] Fujian Med Univ, Quanzhou Hosp 1, Chendong Area, Inpatient Dept, 10th Floor Dist N13, Quanzhou 362000, Peoples R China		Zhang, JN (corresponding author), Fujian Med Univ, Quanzhou Hosp 1, Chendong Area, Inpatient Dept, 10th Floor Dist N13, Quanzhou 362000, Peoples R China.	zjn00131@sina.com					Abd El-Aziz TA, 2012, CLIN EXP MED, V12, P233, DOI 10.1007/s10238-011-0165-2; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Ashafaq M, 2012, NEUROCHEM RES, V37, P1747, DOI 10.1007/s11064-012-0786-1; Bolton SJ, 1998, NEUROSCIENCE, V86, P1245, DOI 10.1016/S0306-4522(98)00058-X; Brown GC, 2010, MOL NEUROBIOL, V41, P242, DOI 10.1007/s12035-010-8105-9; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Haque AM, 2008, J NUTR BIOCHEM, V19, P619, DOI 10.1016/j.jnutbio.2007.08.008; Hirao K, 2010, LIFE SCI, V86, P654, DOI 10.1016/j.lfs.2010.02.017; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Kago T, 2006, BIOCHEM BIOPH RES CO, V339, P1197, DOI 10.1016/j.bbrc.2005.11.133; Li Q, 2009, NEUROSCIENCE, V163, P741, DOI 10.1016/j.neuroscience.2009.07.014; Liu WY, 2012, CNS NEUROSCI THER, V18, P609, DOI 10.1111/j.1755-5949.2012.00340.x; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Mandel SA, 2005, NEUROSIGNALS, V14, P46, DOI 10.1159/000085385; Mandel SA, 2008, CNS NEUROSCI THER, V14, P352, DOI 10.1111/j.1755-5949.2008.00060.x; Metz GA, 2002, J NEUROSCI METH, V115, P169, DOI 10.1016/S0165-0270(02)00012-2; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Neuwelt E, 2008, LANCET NEUROL, V7, P84, DOI 10.1016/S1474-4422(07)70326-5; Shi H, 2015, CNS NEUROSCI THER, V21, P374, DOI 10.1111/cns.12366; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Uzun FG, 2013, FOOD CHEM TOXICOL, V55, P549, DOI 10.1016/j.fct.2013.01.056; Wang YL, 2014, J NEUROCHEM, V129, P827, DOI 10.1111/jnc.12695; Yuan J, 2016, BRAIN RES BULL, V127, P171, DOI 10.1016/j.brainresbull.2016.09.010	25	18	18	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0958-0670	1469-445X		EXP PHYSIOL	Exp. Physiol.	OCT 1	2017	102	10					1269	1277		10.1113/EP086520			9	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	FI5ZM	WOS:000412067400003	28678393	Bronze			2022-02-06	
J	Maclean, FL; Wang, Y; Walker, R; Horne, MK; Williams, RJ; Nisbet, DR				Maclean, Francesca L.; Wang, Yi; Walker, Rohan; Horne, Malcolm K.; Williams, Richard J.; Nisbet, David R.			Reducing Astrocytic Scarring after Traumatic Brain Injury with a Multifaceted Anti-Inflammatory Hydrogel System	ACS BIOMATERIALS SCIENCE & ENGINEERING			English	Article						hydrogels; fucoidan; astrocyte; phenotype; central nervous system	SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; GLIAL SCAR; ELECTROSPUN SCAFFOLDS; EXTRACELLULAR-MATRIX; REACTIVE ASTROCYTES; STEM-CELLS; DUAL ROLE; REGENERATION; REPAIR	Traumatic brain injury results in devastating long-term functional damage due to the growth inhibition of the inflammatory response, and in particular, the complex response of astrocytes. Sustained, nonsteroidal anti-inflammatory approaches that can attenuate this response are of interest to improve therapeutic outcomes, particularly when combined with a tissue engineering construct that recapitulates the physiological microenvironment to facilitate functional repair. Here, we present a multifaceted, therapeutic extracellular-matrix mimic consisting of a coassembled scaffold with a laminin-inspired self-assembling peptide hydrogel, Fmoc-DIKVAV, and the anti-inflammatory macromolecule, fucoidan. At 7 days post-injury, our novel multicomponent hydrogel system presenting biologically relevant nanofibers and the anti-inflammatory fucoidan attenuated the primary glial scar to half that of a stab (control) injury. Further, the presentation of fucoidan increased the organization of astrocytes within the glial scar, while also significantly changing the morphology of astrocytes distal from the administered hydrogel and further into the parenchyma. This demonstrates that the anti-inflammatory fucoidan, present on the surface of the Fmoc-DIKVAV nanofibers, causes a change in astrocyte phenotype post-injury attenuating "reactive" astrocytosis. For the first time, we present a multicomponent tissue engineering construct to promote a growth-permissive environment in vivo and, thus, increase the potential for repair and regeneration after traumatic brain injury.	[Maclean, Francesca L.; Wang, Yi; Nisbet, David R.] Australian Natl Univ, Res Sch Engn, Lab Adv Biomat, Canberra, ACT, Australia; [Walker, Rohan] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Walker, Rohan] Hunter Med Res Inst, Ctr Brain & Mental Hlth Res, New Lambton Hts, Australia; [Horne, Malcolm K.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Horne, Malcolm K.] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic, Australia; [Williams, Richard J.] RMIT Univ, Sch Engn, Melbourne, Vic, Australia; [Williams, Richard J.] St Vincents Hosp, BioFab3D, Fitzroy, Vic, Australia		Nisbet, DR (corresponding author), Australian Natl Univ, Res Sch Engn, Lab Adv Biomat, Canberra, ACT, Australia.; Williams, RJ (corresponding author), RMIT Univ, Sch Engn, Melbourne, Vic, Australia.; Williams, RJ (corresponding author), St Vincents Hosp, BioFab3D, Fitzroy, Vic, Australia.	richard.williams@rmit.edu.au; david.nisbet@anu.edu.au	Williams, Richard/AAS-2568-2021; Horne, Malcolm/AAL-5214-2020	Williams, Richard/0000-0003-3831-8738; Horne, Malcolm/0000-0001-9427-2100; Nisbet, David/0000-0002-1343-0769	NHMRCNational Health and Medical Research Council of Australia [APP1020332, APP1020401, APP1050684]; Australian Postgraduate AwardAustralian Government; Alfred Deakin Research Fellowship; Australian Microscopy and Microanalysis Research Facility (AMMRF)	This research was supported by funding from an NHMRC project grant (APP1020332). F.L.M. was supported by an Australian Postgraduate Award. M.K.H. was supported by an NHMRC Research Fellowship APP1020401. R.J.W. was supported by an Alfred Deakin Research Fellowship. D.R.N. was supported by an NHMRC Career Development Fellowship (APP1050684). Access to the facilities of the Australian National University Centre for Advanced Microscopy (CAM) with funding through the Australian Microscopy and Microanalysis Research Facility (AMMRF) is gratefully acknowledged, as is A/Prof Colin Jackson for the HPLC. The Florey Institute of Neuroscience and Mental Health receives infrastructure support from the Victorian State Government (Australia).	Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Baiguera S, 2014, BIOMATERIALS, V35, P1205, DOI 10.1016/j.biomaterials.2013.10.060; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cregg JM, 2014, EXP NEUROL, V253, P197, DOI 10.1016/j.expneurol.2013.12.024; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; FLACH CR, 1994, BIOPHYS J, V67, P402, DOI 10.1016/S0006-3495(94)80495-3; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014; Kwon BK, 2002, P NATL ACAD SCI USA, V99, P3246, DOI 10.1073/pnas.052308899; Lau CL, 2014, J NEUROCHEM, V130, P215, DOI 10.1111/jnc.12702; Li R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04643-3; Li R, 2016, NANOMED-NANOTECHNOL, V12, P1397, DOI 10.1016/j.nano.2016.01.009; Li R, 2015, RSC ADV, V5, P301, DOI 10.1039/c4ra13266a; Maclean FL, 2016, STEM CELLS DEV, V25, P214, DOI 10.1089/scd.2015.0314; Moshayedi P, 2014, BIOMATERIALS, V35, P3919, DOI 10.1016/j.biomaterials.2014.01.038; Muccigrosso MM, 2016, BRAIN BEHAV IMMUN, V54, P95, DOI 10.1016/j.bbi.2016.01.009; Nisbet DR, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-011-0002-x; O'Shea RD, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00050; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Park HY, 2011, FOOD CHEM TOXICOL, V49, P1745, DOI 10.1016/j.fct.2011.04.020; Pekny M, 2014, NEUROSCI LETT, V565, P30, DOI 10.1016/j.neulet.2013.12.071; Ramon y Cajal S., 1928, DEGENERATION REGENER; Rodriguez AL, 2014, J MATER CHEM B, V2, P7771, DOI 10.1039/c4tb01391c; Rodriguez AL, 2016, NANO RES, V9, P674, DOI 10.1007/s12274-015-0946-0; Rodriguez AL, 2013, SOFT MATTER, V9, P3915, DOI 10.1039/c3sm27758e; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Shi W, 2016, ACTA BIOMATER, V45, P247, DOI 10.1016/j.actbio.2016.09.001; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Tom VJ, 2004, J NEUROSCI, V24, P6531, DOI 10.1523/JNEUROSCI.0994-04.2004; Wang TY, 2012, BIOMATERIALS, V33, P9188, DOI 10.1016/j.biomaterials.2012.09.013; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013	32	18	18	1	29	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2373-9878			ACS BIOMATER SCI ENG	ACS Biomater. Sci. Eng.	OCT	2017	3	10					2542	2549		10.1021/acsbiomaterials.7b00524			8	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	FJ6KO	WOS:000412866900034	33465910				2022-02-06	
J	Zhao, W; Kuo, C; Wu, L; Camarillo, DB; Ji, SB				Zhao, Wei; Kuo, Calvin; Wu, Lyndia; Camarillo, David B.; Ji, Songbai			Performance Evaluation of a Pre-computed Brain Response Atlas in Dummy Head Impacts	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Concussion; Contact sports; Pre-computation; Finite element model; Worcester head injury model	MAXIMUM PRINCIPAL STRAIN; HIGH-SCHOOL FOOTBALL; WHITE-MATTER; CONCUSSION; INJURY; ACCELERATIONS; SPORTS; PREDICTORS; KINEMATICS; MOUTHGUARD	A pre-computed brain response atlas (pcBRA) may have the potential to accelerate the investigation of the biomechanical mechanisms of traumatic brain injury on a large-scale. In this study, we further enhance the technique and evaluate its performance using six degree-of-freedom angular velocity profiles from dummy head impacts. Using the pcBRA to simplify profiles into acceleration-only shapes, sufficiently accurate strain estimates were obtained for impacts with a major dominating velocity peak. However, they were largely under-estimated when substantial deceleration occurred that reversed the direction of the angular velocity. For these impacts, estimation accuracy was substantially improved with a biphasic profile simplification (average correlation coefficient and linear regression slope of 0.92 +/- 0.03 and 0.95 +/- 0.07 for biphasic shapes, respectively, vs. 0.80 +/- 0.06 and 0.80 +/- 0.08 for acceleration-only shapes). Peak maximum principal strain (E > (p)) and cumulative strain damage measure (CSDM) from the estimated strains consistently correlated stronger than kinematic metrics with respect to the baseline E > (p) and CSDM from the directly simulated responses, regardless of the brain region, and by a large margin (e.g., correlation of 0.93 vs. 0.75 compared to Brain Injury Criterion (BrIC) for E > (p) in the whole-brain, and 0.91 vs. 0.47 compared to BrIC for CSDM in the corpus callosum). These findings further support the pre-computation technique for accurate, real-time strain estimation, which could be important to accelerate model-based brain injury studies in the future.	[Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01506 USA; [Kuo, Calvin; Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Wu, Lyndia; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Ji, Songbai] Dartmouth Coll, Thayer Sch Engn, Hanover, NH 03755 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, 60 Prescott St, Worcester, MA 01506 USA.	sji@wpi.edu	Wu, Lyndia/AAQ-1106-2020; Kuo, Calvin/AAH-1933-2019	Wu, Lyndia/0000-0002-8236-032X; Kuo, Calvin/0000-0001-8401-9136; Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088781, R01NS092853] Funding Source: NIH RePORTER	Funding is provided by the NIH Grants R01 NS092853 and R21 NS088781.	Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bigler ED, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00055; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Cai Y., 2017, CONCUSSION CLASSIFIC; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; CDC, 2015, C TRAUM BRAIN INJ US, DOI [10.1161/HYPERTENSIONAHA.111.186106, DOI 10.1161/HYPERTENSIONAHA.111.186106]; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Franklyn Melanie, 2005, Stapp Car Crash J, V49, P1; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Garimella HT, 2017, INT J NUMER METH BIO, V33, DOI 10.1002/cnm.2823; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Graham R, 2014, SPORTS RELATED CONCU; Hernandez F, 2016, ANN BIOMED ENG, V44, P828, DOI 10.1007/s10439-015-1487-0; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Ji SB, 2007, J BIOMECH, V40, P92, DOI 10.1016/j.jbiomech.2005.11.009; Ji SB, 2015, ANN BIOMED ENG, V43, P1877, DOI 10.1007/s10439-014-1193-3; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, BIOMECH MODEL MECHAN, V13, P1121, DOI 10.1007/s10237-014-0562-z; Kang YS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4005427; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kuo C, 2016, J BIOMECH, V49, P1845, DOI 10.1016/j.jbiomech.2016.04.017; Marjoux D, 2008, ACCIDENT ANAL PREV, V40, P1135, DOI 10.1016/j.aap.2007.12.006; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Rapp PE, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00011; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Ward C., 1980, INTRACRANIAL PRESSUR, DOI [10.4271/801304, DOI 10.4271/801304]; Yanaoka T., 2015, INVESTIGATION INJURY, DOI [10.4271/2015-01-1439, DOI 10.4271/2015-01-1439]; Zhang JY, 2006, BIOMED SCI INSTRUM, V42, P501; Zhao W., 2015, IRCOBI C; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	48	18	18	0	15	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	OCT	2017	45	10					2437	2450		10.1007/s10439-017-1888-3			14	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FI4XU	WOS:000411984300017	28710533	Green Accepted			2022-02-06	
J	Moller, MC; Nordin, LE; Bartfai, A; Julin, P; Li, TQ				Moller, Marika C.; Nordin, Love Engstrom; Bartfai, Aniko; Julin, Per; Li, Tie-Qiang			Fatigue and cognitive Fatigability in Mild Traumatic Brain injury are correlated with altered neural activity during Vigilance Test Performance	FRONTIERS IN NEUROLOGY			English	Article						functional magnetic resonance imaging; mild traumatic brain injury; fatigue; pseudo-continuous arterial spin labeling; cerebral blood flow	POSITRON-EMISSION-TOMOGRAPHY; INFERIOR FRONTAL GYRUS; MULTIPLE-SCLEROSIS; SUSTAINED ATTENTION; MENTAL FATIGUE; FUNCTIONAL CONNECTIVITY; OBJECTIVE MEASUREMENT; PERFUSION FMRI; BASAL GANGLIA; ASL PERFUSION	Introduction: Fatigue is the most frequently reported persistent symptom following a mild traumatic brain injury (mTBI), but the explanations for the persisting fatigue symptoms in mTBI remain controversial. In this study, we investigated the change of cerebral blood flow during the performance of a psychomotor vigilance task (PVT) by using pseudo-continuous arterial spin labeling (PCASL) MRI technique to better understand the relationship between fatigability and brain activity in mTBI. Material and methods: Ten patients (mean age: 37.5 +-/ 11.2 years) with persistent complaints of fatigue after mTBI and 10 healthy controls (mean age 36.9 +-/ 11.0 years) were studied. Both groups completed a 20-min long PVT inside a clinical MRI scanner during simultaneous measurements of reaction time and regional cerebral blood flow (rCBF) with PCASL technique. Cognitive fatigability and neural activity during PVT were analyzed by dividing the performance and rCBF data into quintiles in addition to the assessment of self-rated fatigue before and after the PVT. Results: The patients showed significant fatigability during the PVT while the controls had a stable performance. The variability in performance was also significantly higher among the patients, indicating monitoring difficulty. A three-way ANOVA, modeling of the rCBF data demonstrated that there was a significant interaction effect between the subject group and performance time during PVT in a mainly frontal/thalamic network, indicating that the pattern of rCBF change for the mTBI patients differed significantly from that of healthy controls. In the mTBI patients, fatigability at the end of the PVT was related to increased rCBF in the right middle frontal gyrus, while self-rated fatigue was related to increased rCBF in left medial frontal and anterior cingulate gyri and decreases of rCBF in a frontal/thalamic network during this period. Discussion: This study demonstrates that PCASL is a useful technique to investigate neural correlates of fatigability and fatigue in mTBI patients. Patients suffering from fatigue after mTBI used different brain networks compared to healthy controls during a vigilance task and in mTBI, there was a distinction between rCBF changes related to fatigability vs. perceived fatigue. Whether networks for fatigability and self-rated fatigue are different, needs to be investigated in future studies.	[Moller, Marika C.; Bartfai, Aniko] Univ Dept Rehabil Med, Danderyd Hosp, Stockholm, Sweden; [Moller, Marika C.; Bartfai, Aniko] Karolinska Inst, Div Rehabil Med, Dept Clin Sci, Stockholm, Sweden; [Moller, Marika C.] Uppsala Univ, Ctr Clin Res, Uppsala, Sweden; [Nordin, Love Engstrom; Li, Tie-Qiang] Karolinska Univ Hosp Huddinge, Dept Diagnost Med Phys, Stockholm, Sweden; [Nordin, Love Engstrom; Julin, Per] Karolinska Inst, Div Clin Geriatr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden; [Li, Tie-Qiang] Karolinska Inst, Div Med Imaging & Technol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden		Moller, MC (corresponding author), Univ Dept Rehabil Med, Danderyd Hosp, Stockholm, Sweden.; Moller, MC (corresponding author), Karolinska Inst, Div Rehabil Med, Dept Clin Sci, Stockholm, Sweden.; Moller, MC (corresponding author), Uppsala Univ, Ctr Clin Res, Uppsala, Sweden.	marika.moller@sll.se	Moller, Marika/S-5427-2019; MAller, Marika C/N-8782-2016	Moller, Marika/0000-0001-8700-5186; MAller, Marika C/0000-0001-8700-5186	Swedish Research Council, ALF Medicine in Stockholm, Centre for Clinical Research Sormland [DLL-302171]; Promobilia [15044]	This study was supported by research grants from the Swedish Research Council, ALF Medicine in Stockholm, Centre for Clinical Research Sormland (grant no.: DLL-302171), and Promobilia (grant no.: 15044).	Ackerman PL, 2010, COGNITIVE FATIGUE MU, P3; Ackerman PL., 2010, COGNITIVE FATIGUE MU, P11; Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990; Alahmadi AAS, 2015, HUM BRAIN MAPP, V36, P5079, DOI 10.1002/hbm.22997; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P33, DOI 10.1097/01.HTR.0000308719.70288.22; Aslan S, 2010, MAGN RESON IMAGING, V28, P928, DOI 10.1016/j.mri.2010.03.037; Boissoneault J, 2016, MAGN RESON IMAGING, V34, P603, DOI 10.1016/j.mri.2015.12.008; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Bryant D, 2004, REHABIL PSYCHOL, V49, P114, DOI 10.1037/0090-5550.49.2.114; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Chaudhuri A, 2000, J NEUROL SCI, V179, P34, DOI 10.1016/S0022-510X(00)00411-1; Davis Mellar P, 2010, J Support Oncol, V8, P164; DeLuca J, 2005, ISS CLIN COGN NEUROP, P319; Depue BE, 2010, PSYCHIAT RES-NEUROIM, V182, P231, DOI 10.1016/j.pscychresns.2010.01.012; Dittner AJ, 2004, J PSYCHOSOM RES, V56, P157, DOI 10.1016/S0022-3999(03)00371-4; Dobryakova E, 2013, J INT NEUROPSYCH SOC, V19, P849, DOI 10.1017/S1355617713000684; Drummond SPA, 2005, SLEEP, V28, P1059; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Kaufmann T, 2016, NEUROIMAGE, V127, P324, DOI 10.1016/j.neuroimage.2015.12.028; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim J, 2006, NEUROIMAGE, V31, P376, DOI 10.1016/j.neuroimage.2005.11.035; Kluger BM, 2013, NEUROLOGY, V80, P409, DOI 10.1212/WNL.0b013e31827f07be; Kohl AD, 2009, BRAIN INJURY, V23, P420, DOI 10.1080/02699050902788519; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lim J, 2010, NEUROIMAGE, V49, P3426, DOI 10.1016/j.neuroimage.2009.11.020; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Moller MC, 2014, J CLIN EXP NEUROPSYC, V36, P716, DOI 10.1080/13803395.2014.933779; Nordin LE, 2016, SCI REP-UK, V6, DOI 10.1038/srep21183; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Pellicano C, 2010, ARCH NEUROL-CHICAGO, V67, P447, DOI 10.1001/archneurol.2010.48; Roelcke U, 1997, NEUROLOGY, V48, P1566, DOI 10.1212/WNL.48.6.1566; Schwid SR, 2003, MULT SCLER, V9, P503, DOI 10.1191/1352458503ms946oa; Schwid SR, 2002, J REHABIL RES DEV, V39, P211; SEITZ RJ, 1992, EUR J NEUROSCI, V4, P154, DOI 10.1111/j.1460-9568.1992.tb00862.x; Shallice T, 2008, CORTEX, V44, P794, DOI 10.1016/j.cortex.2007.04.002; Shigihara Y, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-2; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Vellucci R, 2012, CLIN DRUG INVEST, V32, P3, DOI 10.2165/11630030-000000000-00000; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437; Wang Z, 2008, MAGN RESON IMAGING, V26, P261, DOI 10.1016/j.mri.2007.07.003; Xie L, 2016, NEUROIMAGE-CLIN, V11, P388, DOI 10.1016/j.nicl.2016.03.002; Zwarts MJ, 2008, CLIN NEUROPHYSIOL, V119, P2, DOI 10.1016/j.clinph.2007.09.126	50	18	18	0	13	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 21	2017	8								496	10.3389/fneur.2017.00496			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FH6CB	WOS:000411258800001	28983280	Green Published, gold			2022-02-06	
J	Yu, YH; Cao, F; Ran, QS; Wang, F				Yu, Yunhu; Cao, Fang; Ran, Qishan; Wang, Fei			Long non-coding RNA Gm4419 promotes trauma-induced astrocyte apoptosis by targeting tumor necrosis factor alpha	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						LncRNA; Gm4419; Traumatic brain injury; Tumor necrosis factor alpha; Apoptosis	INJURY; NEUROINFLAMMATION; NEUROPROTECTION; INFLAMMATION; PLAYERS; CELLS	Traumatic brain injury (TBI) remains a life-threatening disease. Accumulating evidences have showed that neuroinflammatory response is a critical biological event in the progression of TBI induced astrocyte damage. However, the exact mechanisms are not well understood. In this study, we demonstrated that long non-coding RNA (lncRNA) Gm4419 promoted trauma-induced astrocyte apoptosis by up-regulating the expression of inflammatory cytokine tumor necrosis factor alpha (TNF-alpha). We observed that Gm4419 was aberrantly induced after injury on astroglial cells in vitro. Overexpression of Gm4419 in injury-treated astrocytes increased protein expressions of TNF-alpha, Bax, cleaved caspase-3 and cleaved caspase-9, decreased levels of Bcl-2 and CyclinD1, and significantly led to cellular apoptosis. Mechanically, Gm4419 transcript could function as a sponge for miR-466l and miR-466l could target TNF-alpha 3' UTR for degradation and translation inhibition. Therefore, Gm4419 could up-regulate TNF-alpha expression by competitively binding miR-466l and then contribute to inflammatory damage as well as astrocyte apoptosis during TBI. Generally speaking, our findings provide better understandings of the mechanism underlying Gm4419 in trauma-induced neuroinflammation and neurological deficits. Thus, the present study would expand the insight into the novel approaches for TBI therapy. (C) 2017 Elsevier Inc. All rights reserved.	[Yu, Yunhu; Wang, Fei] Zunyi Med Coll, Dept Neurosurg, Affiliated Hosp 3, 98 Fenghuang North Rd, Zunyi 563000, Peoples R China; [Cao, Fang; Ran, Qishan] Zunyi Med Coll, Dept Cerebrovasc, Affiliated Hosp 1, Zunyi, Peoples R China		Yu, YH (corresponding author), Zunyi Med Coll, Dept Neurosurg, Affiliated Hosp 3, 98 Fenghuang North Rd, Zunyi 563000, Peoples R China.	yunhuyu1616@163.com			GuiZhou Province Scientific Award for Society Development [SY[2012] 3118]	This work was supported by GuiZhou Province Scientific Award for Society Development SY[2012] 3118.	Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Berman S, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7060059; Briggs JA, 2015, NEURON, V88, P861, DOI 10.1016/j.neuron.2015.09.045; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Ghosal S, 2013, STEM CELLS DEV, V22, P2240, DOI 10.1089/scd.2013.0014; Gu DM, 2015, BIOCHEM BIOPH RES CO, V457, P391, DOI 10.1016/j.bbrc.2015.01.002; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jensen CJ, 2013, J NEUROIMMUNE PHARM, V8, P824, DOI 10.1007/s11481-013-9480-6; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Petraglia Anthony L, 2014, Neurosurgery, V75 Suppl 4, pS34, DOI 10.1227/NEU.0000000000000472; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ramos AD, 2013, CELL STEM CELL, V12, P616, DOI 10.1016/j.stem.2013.03.003; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Sen R., 2014, THESCIENTIFICWORLDJO, V2014, DOI DOI 10.1155/2014/896206; Varfolomeev EE, 2004, CELL, V116, P491, DOI 10.1016/S0092-8674(04)00166-7; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wen YC, 2017, BIOCHEM BIOPH RES CO, V487, P923, DOI 10.1016/j.bbrc.2017.05.005; Yi H, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.451; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zhang MK, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0358-z	25	18	22	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	SEP 16	2017	491	2					478	485		10.1016/j.bbrc.2017.07.021			8	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics	FE5ZZ	WOS:000408291100036	28688761				2022-02-06	
J	Bell, JM; Breiding, MJ; DePadilla, L				Bell, Jeneita M.; Breiding, Matthew J.; DePadilla, Lara			CDC's efforts to improve traumatic brain injury surveillance	JOURNAL OF SAFETY RESEARCH			English	Article						Traumatic; Brain; Injury; Sports; Survey	LONG-TERM DISABILITY; UNITED-STATES; POPULATION; PREVALENCE	Introduction: Youth sports concussion has become a prominent public health issue due to growing concern about the risk of long-term health effects. Method: A broad spectrum of stakeholders has convened to propose solutions, including a committee of the National Academy of Sciences (NAS) who systematically examined the issue and, in a 2014 report, made a series of recommendations to better address this public health problem. Results: Among these recommendations, the NAS committee called for CDC to develop a plan for a comprehensive surveillance system to better quantify the incidence and outcomes of youth sports concussion among children 5 to 21 years of age. Since the release of the NAS report, CDC has taken action to address this recommendation and, in the process, develop strategies to improve traumatic brain injury (TBI) surveillance more broadly. The challenges outlined by the NAS committee with respect to producing comprehensive incidence estimates of youth sports concussion are not exclusive to youth sports concussion, but also apply to TBI surveillance overall. In this commentary, we will discuss these challenges, the process CDC has undertaken to address them and describe our plan for improving TBI and youth sports concussion surveillance.	[Bell, Jeneita M.; Breiding, Matthew J.; DePadilla, Lara] Ctr Dis Control & Prevent, Natl Ctr Injury Prevent & Control, Atlanta, GA USA; [Breiding, Matthew J.; DePadilla, Lara] Ctr Dis Control & Prevent, 4770 Buford Highway,MS-F62, Atlanta, GA 30341 USA		Bell, JM (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS-A24, Atlanta, GA 30329 USA.	jbell2@cdc.gov; mbreiding@cdc.gov; ldepadilla@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline		Cantor JB, 2004, ARCH PHYS MED REHAB, V85, pS54, DOI 10.1016/j.apmr.2003.08.113; Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Centers for Disease Control and Prevention, 2015, BRFSS COMB LANDL CEL; Centers for Disease Control and Prevention, 2011, MATR E COD GROUP; Comstock RD, SUMMARY REPORT NATL; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Courtney-Long EA, 2015, MMWR-MORBID MORTAL W, V64, P777, DOI 10.15585/mmwr.MM6429a2; Dick R, 2007, J ATHL TRAINING, V42, P173; Gaskell GD, 2000, PUBLIC OPIN QUART, V64, P77, DOI 10.1086/316761; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Greby S. M., 2012, ADDING HOUSEHOLDS CE; Groves RM, 2006, PUBLIC OPIN QUART, V70, P646, DOI 10.1093/poq/nfl033; Institute of Medicine (IOM) and National Research Council (NRC), 2014, SPORTS RELATED CONCU; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Rowhani-Rahbar A., 2015, J NEUROTRAUM, P784; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Schroeder T., 2001, NEISS SAMPLE DESIGN; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	19	18	18	1	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-4375	1879-1247		J SAFETY RES	J. Saf. Res.	SEP	2017	62						253	256		10.1016/j.jsr.2017.04.002			4	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	FH9PF	WOS:000411543500027	28882274	Green Accepted			2022-02-06	
J	Leal-Noval, SR; Arellano-Orden, V; Munoz-Gomez, M; Cayuela, A; Marin-Caballos, A; Rincon-Ferrari, MD; Garcia-Alfaro, C; Amaya-Villar, R; Casado-Mendez, M; Dusseck, R; Murillo-Cabezas, F				Leal-Noval, Santiago R.; Arellano-Orden, Victoria; Munoz-Gomez, Manuel; Cayuela, Aurelio; Marin-Caballos, Antonio; Rincon-Ferrari, Maria D.; Garcia-Alfaro, Claudio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Dusseck, Reginal; Murillo-Cabezas, Francisco			Red Blood Cell Transfusion Guided by Near Infrared Spectroscopy in Neurocritically Ill Patients with Moderate or Severe Anemia: A Randomized, Controlled Trial	JOURNAL OF NEUROTRAUMA			English	Article						anemia; intracerebral hemorrhage; neurocritically ill; NIRS; RBCT; subarachnoid hemorrhage; transcranial oxygen saturation; rSO(2); traumatic brain injury	TRAUMATIC BRAIN-INJURY; TISSUE OXYGEN-SATURATION; CEREBRAL OXYGENATION; HEMOGLOBIN CONCENTRATION; SUBARACHNOID HEMORRHAGE; GUIDELINES; MANAGEMENT; MORTALITY; STROKE; IMPACT	In neurocritically ill patients (NCPs), the use of hemoglobin level as the sole indicator for red blood cell transfusion (RBCT) can result in under-or over-transfusion. This randomized controlled trial was conducted to ascertain whether a transcranial oxygen saturation (rSO(2)) threshold, as measured by near-infrared spectroscopy, reduces RBCT requirements in anemic NCPs (closed traumatic brain injury, subarachnoid, or intracerebral hemorrhage), compared with a hemoglobin threshold alone. Patients with hemoglobin 70-100 g/L received RBCTs to attain an rSO(2) > 60% (rSO(2) arm) or to maintain hemoglobin between 85 and 100 g/L (hemoglobin arm). A total of 102NCPs (51 in each group) were included in the intention-to-treat analysis, and 97 were included in the per-protocol analysis (51 and 46, respectively). Compared with those from the hemoglobin arm, patients in rSO(2) arm received fewer RBC units (1.0 +/- 0.1 vs. 1.5 +/- 1.4 units/patient; p < 0.05) and showed lower hemoglobin levels while in protocol. There were no differences between the study arms regarding the percentage of transfused patents (59% vs. 71%; relative risk 0.83 [95% CI 0.62-1.11]), stay on neurocritical care unit (21 vs. 20 days), unfavorable Glasgow Outcome Scale scores on hospital discharge (57% vs. 71%), in-hospital mortality (6% vs. 10%), or 1 year mortality (24% vs. 24%). Among NCPs with hemoglobin concentrations of 70-85 g/L, withholding transfusion until rSO(2) is < 60% may result in reduced RBCs requirements compared with routinely transfusing to attain a hemoglobin level > 85 g/L. Further studies are required to confirm this finding and its possible impact on clinically significant outcomes.	[Leal-Noval, Santiago R.; Arellano-Orden, Victoria; Marin-Caballos, Antonio; Rincon-Ferrari, Maria D.; Garcia-Alfaro, Claudio; Amaya-Villar, Rosario; Casado-Mendez, Manuel; Dusseck, Reginal; Murillo-Cabezas, Francisco] Univ Hosp Virgen del Rocio, Neurocrit Care Unit, Avda Manuel Siurot S-N, Seville 41013, Spain; [Munoz-Gomez, Manuel] Univ Malaga, Sch Med, Perioperat Transfus Med, Malaga, Spain; [Cayuela, Aurelio] Univ Hosp Virgen del Valme, Dept Publ Hlth, Stat & Design Div, Seville, Spain		Leal-Noval, SR (corresponding author), Univ Hosp Virgen del Rocio, Neurocrit Care Unit, Avda Manuel Siurot S-N, Seville 41013, Spain.	srlealnoval@gmail.com	Cayuela, Aurelio/AAZ-1294-2020; Murillo-Cabezas, Francisco/AAO-3348-2021; Cayuela, Aurelio/C-6698-2012; Noval, Santiago/K-4515-2019	Cayuela, Aurelio/0000-0002-4936-9402; 	Fondo de Investigacion Sanitaria (FIS)Instituto de Salud Carlos III [PI 08/1069, PI 15/00512]; Instituto de Salud Carlos IIIInstituto de Salud Carlos IIIEuropean Commission; Government of SpainSpanish Government; European Regional Development Fund (FEDER Funds)European Commission	This study was supported by Fondo de Investigacion Sanitaria (FIS) PI 08/1069 and PI 15/00512, Instituto de Salud Carlos III, Health Minister, Government of Spain, and by the European Regional Development Fund (FEDER Funds).	Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Carson JL, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002042.pub4; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Davies DJ, 2015, J NEUROTRAUM, V32, P933, DOI 10.1089/neu.2014.3748; Dhabangi A, 2015, JAMA-J AM MED ASSOC, V314, P2514, DOI 10.1001/jama.2015.13977; Dunham CM, 2002, J TRAUMA, V52, P40, DOI 10.1097/00005373-200201000-00009; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Leal-Noval SR, 2008, CURR OPIN CRIT CARE, V14, P156, DOI 10.1097/MCC.0b013e3282f57577; Leal-Noval SR, 2016, NEUROCRIT CARE, V24, P371, DOI 10.1007/s12028-015-0220-z; Leal-Noval SR, 2013, BLOOD TRANSFUS-ITALY, V11, P585, DOI 10.2450/2013.0029-13; Leal-Noval SR, 2010, INTENS CARE MED, V36, P1309, DOI 10.1007/s00134-010-1920-7; Leal-Noval SR, 2006, INTENS CARE MED, V32, P1733, DOI 10.1007/s00134-006-0376-2; Lelubre C, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1321-6; Llau JV, 2015, MED INTENSIVA, V39, P483, DOI [10.1016/j.medine.2015.10.001, 10.1016/j.medin.2015.05.002]; McCredie VA, 2017, NEUROCRIT CARE, V26, P247, DOI 10.1007/s12028-016-0310-6; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Naidech AM, 2010, NEUROCRIT CARE, V13, P313, DOI 10.1007/s12028-010-9424-4; Leal-Noval SR, 2008, CRIT CARE MED, V36, P1290, DOI 10.1097/CCM.0b013e3181692dfc; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sheth KN, 2011, NEUROSURGERY, V68, P1286, DOI 10.1227/NEU.0b013e31820cccb2; Smith J, 2008, AM SURGEON, V74, P1006; Spahn DR, 2006, ANESTHESIOLOGY, V104, P905, DOI 10.1097/00000542-200605000-00002; Stein M, 2015, J CLIN NEUROSCI, V22, P530, DOI 10.1016/j.jocn.2014.08.026; Torella F, 2003, J SURG RES, V110, P217, DOI 10.1016/S0022-4804(03)00037-4; Vlaar APJ, 2013, LANCET, V382, P984, DOI 10.1016/S0140-6736(12)62197-7; Vretzakis G, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-145; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	30	18	18	1	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2553	2559		10.1089/neu.2016.4794			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200008	28486023				2022-02-06	
J	Wade, SL; Narad, ME; Kingery, KM; Taylor, HG; Stancin, T; Kirkwood, MW; Yeates, KO				Wade, Shari L.; Narad, Megan E.; Kingery, Kathleen M.; Taylor, H. Gerry; Stancin, Terry; Kirkwood, Michael W.; Yeates, Keith O.			Teen Online Problem Solving for Teens With Traumatic Brain Injury: Rationale, Methods, and Preliminary Feasibility of a Teen Only Intervention	REHABILITATION PSYCHOLOGY			English	Article						problem solving intervention; traumatic brain injury; telehealth	COGNITIVE PREDICTORS; PRELIMINARY EFFICACY; FAMILY INTERVENTION; ADOLESCENTS; CHILDHOOD; CHILDREN; BEHAVIOR; OUTCOMES; THERAPY; SKILLS	Purpose/Objective: To describe the Teen Online Problem Solving-Teen Only (TOPS-TO) intervention relative to the original Teen Online Problem Solving-Family (TOPS-F) intervention, to describe a randomized controlled trial to assess intervention efficacy, and to report feasibility and acceptability of the TOPS-TO intervention. Research method and design: This is a multisite randomized controlled trial, including 152 teens (49 TOPS-F, 51 TOPS-TO, 52 IRC) between the ages of 11-18 who were hospitalized for a moderate to severe traumatic brain injury in the previous 18 months. Assessments were completed at baseline, 6-months post baseline, and 12-months post baseline. Data discussed include adherence and satisfaction data collected at the 6-month assessment (treatment completion) for TOPS-F and TOPS-TO. Results: Adherence measures (sessions completed, dropout rates, duration of treatment engagement, and rates of program completion) were similar across treatment groups. Overall, teen and parent reported satisfaction was high and similar across groups. Teens spent a similar amount of time on the TOPS website across groups, and parents in the TOPS-F spent more time on the TOPS website than those in the TOPS-TO group (p = .002). Parents in the TOPS-F group rated the TOPS website as more helpful than those in the TOPS-TO group (p = .05). Conclusions/Implications: TOPS-TO intervention is a feasible and acceptable intervention approach. Parents may perceive greater benefit from the family based intervention. Further examination is required to understand the comparative efficacy in improving child and family outcomes, and who is likely to benefit from each approach.	[Wade, Shari L.; Narad, Megan E.; Kingery, Kathleen M.] Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave MLC 3015, Cincinnati, OH 45229 USA; [Kingery, Kathleen M.] Univ Cincinnati, Dept Psychol, Cincinnati, OH 45221 USA; [Taylor, H. Gerry] Case Western Reserve Univ, Dept Pediat, Div Dev & Behav Pediat & Psychol, Cleveland, OH 44106 USA; [Taylor, H. Gerry] Univ Hosp Case Med Ctr, Rainbow Babies & Childrens Hosp, Cleveland, OH USA; [Stancin, Terry] MetroHlth Med Ctr, Dept Pediat, Div Pediat Psychol, Cleveland, OH USA; [Stancin, Terry] Case Western Reserve Univ, Dept Pediat, Div Pediat Psychol, Cleveland, OH 44106 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Dept Phys Med & Rehabil, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Boulder, CO 80309 USA; [Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp Res Inst, Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada		Narad, ME (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Phys Med & Rehabil, 3333 Burnet Ave MLC 3015, Cincinnati, OH 45229 USA.	M@cchmc.org	Stancin, Terry/L-7993-2019; Yeates, Keith/AAJ-4223-2020	Yeates, Keith/0000-0001-7680-2892	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133B090010]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [F32HD088011] Funding Source: NIH RePORTER	This project was supported by the National Institute on Disability, Independent Living, and Rehabilitation Research (grant H133B090010).	Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Arnett AB, 2013, J INT NEUROPSYCH SOC, V19, P881, DOI 10.1017/S1355617713000635; DZurilla TJ, 2010, HDB COGNITIVE BEHAV, P197, DOI 10.1891/0889-8391.2.4.283a; Faul M, 2010, TRAUMATIC BRAIN INJU; Folkman S., 1984, STRESS; Fulton JB, 2012, NEUROPSYCHOLOGY, V26, P314, DOI 10.1037/a0027973; Ganesalingam K, 2006, J INT NEUROPSYCH SOC, V12, P609, DOI 10.1017/S1355617706060796; Jacobs R, 2002, CHILD NEUROPSYCHOL, V8, P93, DOI 10.1076/chin.8.2.93.8726; Janusz JA, 2002, CHILD NEUROPSYCHOL, V8, P179, DOI 10.1076/chin.8.3.179.13499; KAZDIN AE, 1992, J CONSULT CLIN PSYCH, V60, P733, DOI 10.1037/0022-006X.60.5.733; Kennedy Mary R. T, 2005, Seminars in Speech and Language, V26, P242, DOI 10.1055/s-2005-922103; Kurowski BG, 2013, PEDIATRICS, V132, pE158, DOI 10.1542/peds.2012-4040; Mai N, 1991, NEUROPSYCHOL REHABIL, V1, P45, DOI DOI 10.1080/09602019108401379; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; NEZU AM, 1986, J CONSULT CLIN PSYCH, V54, P196, DOI 10.1037/0022-006X.54.2.196; NEZU AM, 1989, J CONSULT CLIN PSYCH, V57, P408, DOI 10.1037/0022-006X.57.3.408; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Puskar Kathryn, 2003, J Child Adolesc Psychiatr Nurs, V16, P71, DOI 10.1111/j.1744-6171.2003.tb00350.x; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Robinson KE, 2014, J NEUROTRAUM, V31, P1835, DOI 10.1089/neu.2014.3422; Spence SH, 2003, J CONSULT CLIN PSYCH, V71, P3, DOI 10.1037/0022-006X.71.1.3; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Wade SL, 2006, J CONSULT CLIN PSYCH, V74, P445, DOI 10.1037/0022-006X.74.3.445; Wade SL, 2006, REHABIL PSYCHOL, V51, P179, DOI 10.1037/0090-5550.51.3.179; Wade SL, 2014, J HEAD TRAUMA REHAB, V29, P198, DOI 10.1097/HTR.0b013e31828f9fe8; Wade SL, 2011, PEDIATRICS, V128, pE947, DOI 10.1542/peds.2010-3721; Wade SL, 2010, J HEAD TRAUMA REHAB, V25, P409, DOI 10.1097/HTR.0b013e3181fb900d; Wade SL, 2008, J HEAD TRAUMA REHAB, V23, P369, DOI 10.1097/01.HTR.0000341432.67251.48; Wade SL, 2006, J HEAD TRAUMA REHAB, V21, P57, DOI 10.1097/00001199-200601000-00006	31	18	18	0	3	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	AUG	2017	62	3					290	299		10.1037/rep0000160			10	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	FT3KV	WOS:000423046900008	28836809	Green Accepted, Bronze			2022-02-06	
J	Zhang, LM; Li, R; Zhao, XC; Zhang, Q; Luo, XL				Zhang, Li-Min; Li, Rui; Zhao, Xiao-Chun; Zhang, Qian; Luo, Xing-Liao			Increased Transfusion of Fresh Frozen Plasma is Associated with Mortality or Worse Functional Outcomes After Severe Traumatic Brain Injury: A Retrospective Study	WORLD NEUROSURGERY			English	Article						Fresh frozen plasma; Glasgow Outcome Scale; Traumatic brain injury	POSTTRAUMATIC CEREBRAL INFARCTION; RISK-FACTORS; RESUSCITATION; RECOVERY; MODERATE	BACKGROUND: The fresh frozen plasma (FFP) transfusion threshold and timing for traumatic brain injury (TBI)-associated coagulopathy are controversial. Thus, a multicenter retrospective study was conducted to determine whether or not FFP transfusion is associated with poor outcomes after severe TBI. METHODS: Data from decompressive craniotomy after blunt force trauma that took place between December 2013 and June 2016 were collected in a multicenter chart. The primary outcomes were mortality and survival, as well as worse outcomes (defined as a Glasgow Outcome Scale [GOS] score <= 3) and better outcomes (GOS score >= 4). Secondary outcomes included 90-day survival rates in all patients with or without FFP transfusion, as well as length of hospital stay in patients with a better prognosis (GOS score >= 4). Univariate analysis, bivariate logistic regression, Spearman rank correlation, and Kaplan-Meier analysis were performed to account for the association between perioperative FFP transfusion and different outcomes. RESULTS: Bivariate logistic analysis showed that mortality and worse outcomes were correlated with FFP transfusion and Glasgow Coma Scale score (P < 0.05). Kaplan-Meier analysis suggested that mortality was statistically higher in the FFP transfusion groups compared with the no FFP transfusion groups, regardless of the severity of TBI (P < 0.05). The overall complications, acute respiratory distress syndrome, and pneumonia rate were significantly higher for patients receiving FFP transfusion (P < 0.05). CONCLUSIONS: Increased perioperative FFP infusion was independently associated with mortality or worse outcomes across a spectrum of surgical risk profiles.	[Zhang, Li-Min; Li, Rui] Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Zhao, Xiao-Chun] Shengjing Hosp, Dept Anesthesiol, Shenyang, Liaoning, Peoples R China; [Zhang, Qian] Cangzhou Second People Hosp, Dept Anesthesiol, Cangzhou, Peoples R China; [Luo, Xing-Liao] Huabei Petr Adm Bur, Gen Hosp, Dept Anesthesiol, Renqiu, Peoples R China		Zhang, LM (corresponding author), Cangzhou Cent Hosp, Dept Anesthesiol, Cangzhou, Peoples R China.	azai2010@126.com					Anglin CO, 2013, J NEUROSURG, V118, P676, DOI 10.3171/2012.11.JNS12622; Baker AJ, 2008, J TRAUMA, V64, P348, DOI 10.1097/01.ta.0000245973.71929.db; Beattie GW, 2014, INTERACT CARDIOV TH, V18, P117, DOI 10.1093/icvts/ivt327; Bochicchio GV, 2008, WORLD J SURG, V32, P2185, DOI 10.1007/s00268-008-9655-0; Carr KR, 2016, NEUROCRIT CARE, V25, P185, DOI 10.1007/s12028-016-0273-7; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Haagh W A J J M, 2006, Ned Tijdschr Geneeskd, V150, P2530; Halaweish I, 2015, J AM COLL SURGEONS, V220, P809, DOI 10.1016/j.jamcollsurg.2015.01.057; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Khajavikhan J, 2016, J CLIN DIAGN RES, V10, pPC16, DOI 10.7860/JCDR/2016/16390.7294; Kumar MA, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0391-y; Liu SW, 2015, ACTA NEUROCHIR, V157, P1697, DOI 10.1007/s00701-015-2559-5; Marshall A, 2015, J THROMB, V14, P324; Myburgh J, 2007, NEW ENGL J MED, V357, P874; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Peiniger S, 2011, CRIT CARE, V15, DOI 10.1186/cc10048; Sandsmark DK, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0654-5; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5	18	18	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	AUG	2017	104						381	389		10.1016/j.wneu.2017.04.140			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FD7NP	WOS:000407713100053	28465266				2022-02-06	
J	Bertisch, H; Rivara, FP; Kisala, PA; Wang, J; Yeates, KO; Durbin, D; Zonfrillo, MR; Bell, MJ; Temkin, N; Tulsky, DS				Bertisch, Hilary; Rivara, Frederick P.; Kisala, Pamela A.; Wang, Jin; Yeates, Keith Owen; Durbin, Dennis; Zonfrillo, Mark R.; Bell, Michael J.; Temkin, Nancy; Tulsky, David S.			Psychometric evaluation of the pediatric and parent-proxy Patient-Reported Outcomes Measurement Information System and the Neurology and Traumatic Brain Injury Quality of Life measurement item banks in pediatric traumatic brain injury	QUALITY OF LIFE RESEARCH			English	Article						Brain Injuries; Child; Adolescent; Outcome assessment (Health Care); Patient-centered outcomes research	PROMISA(R) PHYSICAL FUNCTION; RESPONSE THEORY ANALYSIS; GENERIC CORE SCALES; DIFFICULTIES QUESTIONNAIRE; CHRONIC PAIN; SELF-REPORT; POSTCONCUSSIVE SYMPTOMS; SEDENTARY BEHAVIOR; ORTHOPEDIC FOOT; STRENGTH IMPACT	The primary objective is to provide evidence of convergent and discriminant validity for the pediatric and parent-proxy versions of the Patient-Reported Outcomes Measurement Information System (PROMIS) Anxiety, Depression, Anger, Peer Relations, Mobility, Pain Interference, and Fatigue item banks, the Neurology Quality of Life measurement system (Neuro-QOL) Cognition-General Concerns and Stigma item banks, and the Traumatic Brain Injury Quality of Life (TBI-QOL) Executive Function and Headache item banks in a pediatric traumatic brain injury (TBI) sample. Participants were 134 parent-child (ages 8-18 years) days. Children all sustained TBI and the dyads completed outcome ratings 6 months after injury at one of six medical centers across the United States. Ratings included PROMIS, Neuro-QOL, and TBI-QOL item banks, as well as the Pediatric Quality of Life inventory (PedsQL), the Health Behavior Inventory (HBI), and the Strengths and Difficulties Questionnaire (SDQ) as legacy criterion measures against which these item banks were validated. The PROMIS, Neuro-QOL, and TBI-QOL item banks demonstrated good convergent validity, as evidenced by moderate to strong correlations with comparable scales on the legacy measures. PROMIS, Neuro-QOL, and TBI-QOL item banks showed weaker correlations with ratings of unrelated constructs on legacy measures, providing evidence of discriminant validity. Our results indicate that the constructs measured by the PROMIS, Neuro-QOL, and TBI-QOL item banks are valid in our pediatric TBI sample and that it is appropriate to use these standardized scores for our primary study analyses.	[Bertisch, Hilary] NYU, Sch Med, NYU Rusk Rehabil, 240 East 38th St,Suite 17-72, New York, NY 10016 USA; [Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle Childrens Res Inst, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rivara, Frederick P.] Univ Washington, Dept Epidemiol, Seattle Childrens Res Inst, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Kisala, Pamela A.] Univ Delaware, Dept Phys Therapy, Ctr Assessment Res & Translat, Newark, DE USA; [Wang, Jin] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Yeates, Keith Owen] Univ Calgary, Hotchkiss Brain Inst, Dept Psychol, Calgary, AB, Canada; [Yeates, Keith Owen] Univ Calgary, Alberta Childrens Hosp, Res Inst, Calgary, AB, Canada; [Durbin, Dennis] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Zonfrillo, Mark R.] Brown Univ, Alpert Med Sch, Hasbro Childrens Hosp, Dept Emergency Med, Providence, RI 02912 USA; [Bell, Michael J.] Univ Pittsburgh, Crit Care Med, Neurol Surg & Pediat, Pittsburgh, PA USA; [Temkin, Nancy] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Dept Phys Therapy, Newark, DE USA; [Tulsky, David S.] Univ Delaware, Ctr Assessment Res & Translat, Dept Psychol & Brain Sci, Newark, DE USA; [Tulsky, David S.] Kessler Fdn, W Orange, NJ USA		Bertisch, H (corresponding author), NYU, Sch Med, NYU Rusk Rehabil, 240 East 38th St,Suite 17-72, New York, NY 10016 USA.	Hilary.bertisch@nyumc.org	Durbin, Dennis/AAD-7829-2022; Zonfrillo, Mark R./H-9403-2017; Yeates, Keith/AAJ-4223-2020	Zonfrillo, Mark R./0000-0002-0610-9563; Tulsky, David/0000-0002-4335-4509; Yeates, Keith/0000-0001-7680-2892	United States Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196]; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROLUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U01CE002196] Funding Source: NIH RePORTER	This project was funded by the United States Centers for Disease Control and Prevention, Grant Number U01CE002196. The authors would like to thank Marni Levy and Natalie Jenkins for their dedicated efforts in acquiring the data described in this manuscript.	Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bevans KB, 2013, J PEDIATR PSYCHOL, V38, P173, DOI 10.1093/jpepsy/jss107; Broderick Joan E, 2013, EGEMS (Wash DC), V1, P1015, DOI 10.13063/2327-9214.1015; Brooks BL, 2014, ARCH CLIN NEUROPSYCH, V29, P186, DOI 10.1093/arclin/act083; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carle AC, 2011, EXPERT REV PHARM OUT, V11, P677, DOI [10.1586/ERP.11.74, 10.1586/erp.11.74]; Carlsson M, 2008, DEV MED CHILD NEUROL, V50, P784, DOI 10.1111/j.1469-8749.2008.03090.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cella D, 2010, INVERSTIGATORS N Q; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; Cella D, 2011, ARCH PHYS MED REHAB, V92, pS28, DOI 10.1016/j.apmr.2011.01.025; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Centers for Disease Control and Prevention, 2016, INJ PREV CONTR TRAUM; Centers for Disease Control and Prevention, 1999, TBI US REP C; Clover A., 2006, MBMC PUBLIC HLTH, V6, P105; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; de Kloet AJ, 2015, J DEV BEHAV PEDIATR, V36, P342, DOI 10.1097/DBP.0000000000000169; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; DeWalt DA, 2015, QUAL LIFE RES, V24, P2195, DOI 10.1007/s11136-015-0953-3; DeWalt DA, 2013, HEALTH PSYCHOL, V32, P1093, DOI 10.1037/a0032670; DeWitt EM, 2011, J CLIN EPIDEMIOL, V64, P794, DOI 10.1016/j.jclinepi.2010.10.012; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2010, J INT NEUROPSYCH SOC, V16, P94, DOI 10.1017/S1355617709991007; Fries JF, 2005, CLIN EXP RHEUMATOL, V23, pS53; Gershon R, 2010, QUAL LIFE RES, V19, P677, DOI 10.1007/s11136-010-9634-4; Gershon Richard C, 2005, J Appl Meas, V6, P109; Gershon Richard C, 2010, J Appl Meas, V11, P304; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Gipson DS, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-30; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Green L, 2012, DEV NEUROREHABIL, V15, P105, DOI 10.3109/17518423.2011.638331; Hinds PS, 2013, PEDIATR BLOOD CANCER, V60, P402, DOI 10.1002/pbc.24233; Ho B, 2016, FOOT ANKLE INT, V37, P911, DOI 10.1177/1071100716665113; Howell CR, 2016, QUAL LIFE RES, V25, P1815, DOI 10.1007/s11136-016-1237-2; Hung M, 2014, FOOT ANKLE INT, V35, P592, DOI 10.1177/1071100714528492; Hung M, 2013, CLIN ORTHOP RELAT R, V471, P3466, DOI 10.1007/s11999-013-3097-1; Hunt KJ, 2014, FOOT ANKLE INT, V35, P847, DOI 10.1177/1071100714544157; Irwin DE, 2012, QUAL LIFE RES, V21, P697, DOI 10.1007/s11136-011-9969-5; Irwin DE, 2010, QUAL LIFE RES, V19, P595, DOI 10.1007/s11136-010-9619-3; Irwin DE, 2010, QUAL LIFE RES, V19, P585, DOI 10.1007/s11136-010-9618-4; Iverson GL, 2010, CLIN NEUROPSYCHOL, V24, P17, DOI 10.1080/13854040903190797; Jacobson CJ, 2013, J PEDIATR PSYCHOL, V38, P82, DOI 10.1093/jpepsy/jss099; Jacobson CJ, 2015, J PAIN, V16, P1243, DOI 10.1016/j.jpain.2015.08.007; Johnson H, 2005, DEV MED CHILD NEUROL, V47, P237, DOI 10.1017/S0012162205000460; Kashikar-Zuck S, 2015, PAIN; Kratz AL, 2013, QUAL LIFE RES, V22, P2865, DOI 10.1007/s11136-013-0397-6; Lai JS, 2015, EPILEPSY BEHAV, V46, P209, DOI 10.1016/j.yebeh.2015.02.038; Lai JS, 2013, QUAL LIFE RES, V22, P2417, DOI 10.1007/s11136-013-0357-1; Lai JS, 2012, NEUROREHAB NEURAL RE, V26, P36, DOI 10.1177/1545968311412054; Lange RT, 2009, BRAIN INJURY, V23, P83, DOI 10.1080/02699050802635281; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; Liu YY, 2015, QUAL LIFE RES, V24, P1491, DOI 10.1007/s11136-014-0870-x; Mano KEJ, 2011, J PEDIATR PSYCHOL, V36, P517, DOI 10.1093/jpepsy/jsp099; Marr A., 2004, CENTRAL NERVOUS SYST; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Mulcahey MJ, 2016, J PEDIATR ORTHOPED, V36, P749, DOI 10.1097/BPO.0000000000000533; (NINDS) NIoNDaS, 2015, MAN QUAL LIF NEUR DI; Olsson GM, 2008, NORD J PSYCHIAT, V62, P66, DOI 10.1080/08039480801979586; Organization PH, PROMIS DOM FRAM; Papuga MO, 2016, SPINE, V41, P1153, DOI 10.1097/BRS.0000000000001518; Quinn H, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/s12955-014-0160-x; Ravens-Sieberer U, 2014, J CLIN EPIDEMIOL, V67, P207, DOI 10.1016/j.jclinepi.2013.08.018; Reeve BB, 2015, QUALITY LIFE RES INT; Rivara FP, 2012, AM J PUBLIC HEALTH, V102, P2074, DOI 10.2105/AJPH.2012.300696; Rivara FP, 2012, J NEUROTRAUM, V29, P2499, DOI 10.1089/neu.2012.2434; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Schalet BD, 2015, J GEN INTERN MED, V30, P1517, DOI 10.1007/s11606-015-3360-0; Selewski DT, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-29; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Stroke NIoNDa, 2014, NINDS COMM DAT EL PR; Swanson JO, 2012, PEDIATR RADIOL, V42, P974, DOI 10.1007/s00247-012-2372-8; Thissen D, 2016, QUAL LIFE RES, V25, P13, DOI 10.1007/s11136-015-1058-8; Thissen D, 2011, QUAL LIFE RES, V20, P1497, DOI 10.1007/s11136-011-9874-y; Tucker CA, 2014, PEDIATR PHYS THER, V26, P385, DOI 10.1097/PEP.0000000000000074; Tucker CA, 2014, PEDIATR PHYS THER, V26, P376, DOI 10.1097/PEP.0000000000000073; Tulsky DS, 2016, J HEAD TRAUMA REHAB, V31, P40, DOI 10.1097/HTR.0000000000000131; van de Looij-Jansen PM, 2011, BRIT J CLIN PSYCHOL, V50, P127, DOI 10.1348/014466510X498174; Varni James W, 2004, Health Qual Life Outcomes, V2, P55, DOI 10.1186/1477-7525-2-55; Varni JW, 2014, QUAL LIFE RES, V23, P1233, DOI 10.1007/s11136-013-0544-0; Varni JW, 2010, J PAIN, V11, P1109, DOI 10.1016/j.jpain.2010.02.005; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, J BEHAV MED, V25, P175, DOI 10.1023/A:1014836921812; Wagner LI, 2015, CANCER-AM CANCER SOC, V121, P927, DOI 10.1002/cncr.29104; Weaver B, 2013, BEHAV RES METHODS, V45, P880, DOI 10.3758/s13428-012-0289-7; Whyte J, 2010, ARCH PHYS MED REHAB, V91, P1692, DOI 10.1016/j.apmr.2010.06.031; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Yeatts KB, 2010, J ASTHMA, V47, P295, DOI 10.3109/02770900903426997; Zonfrillo MR, 2014, J NEUROTRAUM, V31, P722, DOI 10.1089/neu.2013.3088	92	18	18	0	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	JUL	2017	26	7					1887	1899		10.1007/s11136-017-1524-6			13	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	EY4MS	WOS:000403952800023	28271316				2022-02-06	
J	Kim, H; Yu, T; Cam-Etoz, B; van Groen, T; Hubbard, WJ; Chaudry, IH				Kim, Harrison; Yu, Tao; Cam-Etoz, Betul; van Groen, Thomas; Hubbard, William J.; Chaudry, Irshad H.			Treatment of traumatic brain injury with 17 alpha-ethinylestradiol-3-sulfate in a rat model	JOURNAL OF NEUROSURGERY			English	Article						TBI; traumatic brain injury; intracranial pressure; T2 mapping; diffusion tensor imaging; positron emission tomography; behavioral test	ORGANS THERAPEUTIC APPROACH; DIFFUSE AXONAL INJURY; ETHINYL ESTRADIOL; ORAL-CONTRACEPTIVES; MU-G; ESTROGEN; PHARMACOKINETICS; PARAMETERS; NEUROPROTECTION; HIPPOCAMPUS	OBJECTIVE 17 alpha-ethynylestradiol-3-sulfate (EE-3-SO4) is a highly water-soluble synthetic estrogen that has an extended half-life (10 hours) over that of naturally occurring estrogen (similar to 10 minutes). In this study, EE-3-SO4 was evaluated in a lateral fluid percussion induced traumatic brain injury (TBI) model in rats. METHODS A total of 9 groups of Sprague-Dawley rats underwent craniectomy. Twenty-four hours later, lateral fluid percussion was applied to 6 groups of animals to induce TBI; the remaining 3 groups served as sham control groups. EE-3-SO4 (1 mg/kg body weight in 0.4 ml/kg body weight) or saline (vehicle control) was injected intravenously 1 hour after TBI; saline was injected in all sham animals. One day after EE-3-SO4/saline injection, intracranial pressure (ICP), cerebral perfusion pressure (CPP), and partial brain oxygen pressure (PbtO(2)) were measured in Groups 1-3 (2 TBI groups and 1 sham group), and brain edema, diffusion axonal injury, and cerebral glycolysis were assessed in Groups 4-6 using MRI T2 mapping, diffusion tensor imaging (DTI), and FDG-PET imaging, respectively. Four days after dosing, the open-field anxiety of animals was assessed in Groups 7-9 by measuring the duration that each animal spent in the center area of an open chamber during 4 minutes of monitoring. RESULTS EE-3-SO4 significantly lowered ICP while raising CPP and PbtO(2), compared with vehicle treatment in TBI-induced animals (p < 0.05). The mean size of cerebral edema of TBI animals treated with EE-3-SO4 was 25 3 mm(3) (mean SE), which was significantly smaller than that of vehicle-treated animals (67 +/- 6 mm(3), p < 0.001). Also, EE-3-SO4 treatment significantly increased the fractional anisotropy of the white matter in the ipsilateral side (p = 0.003) and cerebral glycolysis (p = 0.014). The mean duration that EE-3-SO4 treated animals spent in the center area was 12 +/- 2 seconds, which was significantly longer than that of vehicle-treated animals (4 1 seconds; p = 0.008) but not different from that of sham animals (11 +/- 3 seconds; p > 0.05). CONCLUSIONS These data support the clinical use of EE-3-SO4 for early TBI treatment.	[Kim, Harrison] Univ Alabama Birmingham, Dept Radiol, Birmingham, AL USA; [Yu, Tao; Hubbard, William J.; Chaudry, Irshad H.] Univ Alabama Birmingham, Dept Surg, VH G094,1670 Univ Blvd, Birmingham, AL 35294 USA; [van Groen, Thomas] Univ Alabama Birmingham, Dept Dev & Integrat Biol, Birmingham, AL USA; [Cam-Etoz, Betul] Uludag Univ, Dept Physiol, Bursa, Turkey		Chaudry, IH (corresponding author), Univ Alabama Birmingham, Dept Surg, VH G094,1670 Univ Blvd, Birmingham, AL 35294 USA.	ichaudry@uab.edu			US Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program of the Department of Defense [W81XWH-08-2-0153]	We thank Dr Ahmar Ayub for inducing TBI in the rats and Dr. Guihua Zhai and Sharon Samuel for data collection and analyses. This study was supported by the US Army Medical Research and Material Command, Office of Congressional Directed Medical Research Program in W81XWH-08-2-0153 of the Department of Defense to I.H.C.	Abrams LS, 2001, J CLIN PHARMACOL, V41, P1301, DOI 10.1177/00912700122012887; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; BACK DJ, 1980, CONTRACEPTION, V21, P145, DOI 10.1016/0010-7824(80)90126-2; Bodanapally UK, 2013, NEURORADIOLOGY, V55, P771, DOI 10.1007/s00234-013-1166-5; Bowman RE, 2002, NEUROSCIENCE, V113, P401, DOI 10.1016/S0306-4522(02)00156-2; Carpenter KLH, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00026; Charlier TD, 2013, J EXP NEUROSCI, V7, P31, DOI 10.4137/JEN.S11268; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; DeWitt D S, 1995, New Horiz, V3, P376; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; GOLDZIEHER JW, 1990, AM J OBSTET GYNECOL, V163, P2114, DOI 10.1016/0002-9378(90)90550-Q; GUENGERICH FP, 1990, AM J OBSTET GYNECOL, V163, P2159, DOI 10.1016/0002-9378(90)90557-N; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hubbard W, 2015, J SURG RES, V193, P355, DOI 10.1016/j.jss.2014.06.047; Jick SS, 2006, CONTRACEPTION, V73, P223, DOI 10.1016/j.contraception.2006.01.001; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; JONES GE, 1976, ACTA ENDOCRINOL-COP, V82, P706, DOI 10.1530/acta.0.0820706; JUNGHOFFMANN C, 1991, HORM RES, V36, P238, DOI 10.1159/000182172; Kawasaki T, 2012, J ANESTH, V26, P883, DOI 10.1007/s00540-012-1425-3; Kharatishvili I, 2009, EXP NEUROL, V217, P154, DOI 10.1016/j.expneurol.2009.01.026; Kim H, 2015, J NEUROTRAUM, V32, P1210, DOI 10.1089/neu.2014.3771; LINDBERG UB, 1988, MATURITAS, V10, P343, DOI 10.1016/0378-5122(88)90069-2; LINDBERG UB, 1989, THROMB HAEMOSTASIS, V61, P65; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Manthey D, 2006, NEUROSCIENCE, V138, P845, DOI 10.1016/j.neuroscience.2005.10.058; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Miller M, 2014, J TRAUMA ACUTE CARE, V76, P1409, DOI 10.1097/TA.0000000000000237; Morales T, 2011, J NEUROENDOCRINOL, V23, P994, DOI 10.1111/j.1365-2826.2011.02141.x; Murakami Y, 2012, J NEUROSCI METH, V203, P115, DOI 10.1016/j.jneumeth.2011.09.025; Neter J., 1996, APPL LINEAR STAT MOD, V4; O'Connor CA, 2003, J NEUROTRAUM, V20, P533, DOI 10.1089/089771503767168465; Obach RS, 2008, DRUG METAB DISPOS, V36, P1385, DOI 10.1124/dmd.108.020479; ORTIZDEMONTELLANO PR, 1980, J BIOL CHEM, V255, P5578; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Ryan NP, 2016, SOC COGN AFFECT NEUR, V11, P683, DOI 10.1093/scan/nsw007; Santollo J, 2015, FRONT SYST NEUROSCI, V9, DOI [10.3369/fusys.2015.00025, 10.3389/fnsys.2015.00025]; Schindler AE, 2013, INT J ENDOCRINOL MET, V11, P41, DOI 10.5812/ijem.4158; Selwyn R, 2013, J NEUROTRAUM, V30, P1943, DOI 10.1089/neu.2013.2928; Seo JP, 2012, NEUROREHABILITATION, V30, P323, DOI 10.3233/NRE-2012-0762; Shah N, 2012, MOL IMAGING BIOL, V14, P237, DOI 10.1007/s11307-011-0491-5; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Stocchetti N, 2007, J NEUROTRAUM, V24, P1339, DOI 10.1089/neu.2007.0300; Tofts P, 2003, QUANTITATIVE MRI OF THE BRAIN: MEASURING CHANGES CAUSED BY DISEASE, P1; TOFTS PS, 1990, NEURORADIOLOGY, V32, P407, DOI 10.1007/BF00588474; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Walf AA, 2006, NEUROPSYCHOPHARMACOL, V31, P1097, DOI 10.1038/sj.npp.1301067; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	51	18	19	0	10	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUL	2017	127	1					23	31		10.3171/2016.7.JNS161263			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EY6JB	WOS:000404087500004	27662529				2022-02-06	
J	Klein, P; Tyrlikova, I				Klein, Pavel; Tyrlikova, Ivana			Prevention of epilepsy: Should we be avoiding clinical trials?	EPILEPSY & BEHAVIOR			English	Article						Epilepsy; Seizures; Traumatic brain injury; Post-traumatic epilepsy; Epileptogenesis	TRAUMATIC BRAIN-INJURY; HIGH-FREQUENCY OSCILLATIONS; POSTTRAUMATIC EPILEPSY; STATUS EPILEPTICUS; GENETIC-VARIATION; KINDLING MODEL; EPILEPTOGENESIS; SEIZURES; LEVETIRACETAM; INFLAMMATION	Epilepsy prevention is one of the great unmet needs in epilepsy. Approximately 15% of all epilepsy is caused by an acute acquired CNS insult such as traumatic brain injury (TBI), stroke or encephalitis. There is a latent period between the insult and epilepsy onset that presents an opportunity to intervene with preventive treatment that is unique in neurology. Yet no phase 3 epilepsy prevention studies, and only 2 phase 2 studies have been initiated in the last 16 years. Current prevailing opinion is that the research community is not ready for clinical preventive epilepsy studies, and that animal models should first be refined and biomarkers of epileptogenesis and of epilepsy discovered before clinical studies are embarked upon. We review data to suggest that there is basis to do epilepsy prevention studies now with the current knowledge and available drugs, and that those studies are feasible with currently available tools. We suggest that a different approach is needed from the past in order to maximize chances of success, minimize the cost, and set up platform for future preventive treatment development. That approach should include close coordination of preclinical and clinical development programs in a combined PTE prevention strategy, consideration of polytherapy, and simultaneous, combined clinical development of preventive treatment and of biomarker discovery. We argue that the currently favored approach of eschewing clinical studies until biomarkers are available will delay the discovery of epilepsy prevention treatment by at least 10 years and significantly increase the cost of such discovery. (C) 2017 Elsevier Inc. All rights reserved.	[Klein, Pavel; Tyrlikova, Ivana] Midatlantic Epilepsy & Sleep Ctr, 6410 Rockledge Dr,Suite 410, Bethesda, MD 20817 USA		Klein, P (corresponding author), Midatlantic Epilepsy & Sleep Ctr, 6410 Rockledge Dr,Suite 410, Bethesda, MD 20817 USA.	kleinp@epilepsydc.com; tyrlikovai@epilepsydc.com			Esai; LundbeckLundbeck Corporation; Acorda, Inc.; Marinus; SK Life Sciences; UCB PharmaUCB Pharma SA; Upsher Smith	Dr. Klein has served on advisory boards of Lundbeck, Sunovion and UCB Pharma, has acted as a consultant to Eisai, Lundbeck, Sunovion and UCB Pharma, is on Speaker's Bureau of Eisai, Sunovion and UCB Pharma, has received research support from Esai and Lundbeck, and has participated in clinical trials sponsored by Acorda, Inc., Marinus, SK Life Sciences, UCB Pharma, and Upsher Smith.	Alves OL, 2003, ANN NY ACAD SCI, V993, P34; Amhaoul H, 2015, NEUROBIOL DIS, V82, P526, DOI 10.1016/j.nbd.2015.09.004; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; [Anonymous], 2015, NAT NEUROSCI, V18, P317, DOI 10.1038/nn.3964; Bar-Klein G, 2014, ANN NEUROL, V75, P864, DOI 10.1002/ana.24147; Beghi E, 2003, EPILEPSIA, V44, P21, DOI 10.1046/j.1528-1157.44.s10.1.x; Benardo LS, 2003, EPILEPSIA, V44, P27, DOI 10.1046/j.1528-1157.44.s10.2.x; Brooks-Kayal AR, 2013, EPILEPSIA, V54, P44, DOI 10.1111/epi.12298; Chu K, 2008, EPILEPSIA, V49, P1723, DOI 10.1111/j.1528-1167.2008.01644.x; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; Dedeurwaerdere S, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-60; Diamond ML, 2015, EPILEPSIA, V56, P1198, DOI 10.1111/epi.13044; Diamond ML, 2014, EPILEPSIA, V55, P1109, DOI 10.1111/epi.12628; Drexel M, 2015, NEUROPHARMACOLOGY, V88, P122, DOI 10.1016/j.neuropharm.2014.08.023; Dudek F.E., 2012, TIME COURSE CIRCUIT; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Engel J, 2013, EPILEPSIA, V54, P61, DOI 10.1111/epi.12299; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; EPITARGET, TARG BIOM ANT; Finnema SJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6667; Galanopoulou AS, 2012, EPILEPSIA, V53, P571, DOI 10.1111/j.1528-1167.2011.03391.x; Gao F, 2012, PHARMACOL BIOCHEM BE, V103, P187, DOI 10.1016/j.pbb.2012.08.025; Gershen LD, 2015, JAMA NEUROL, V72, P882, DOI 10.1001/jamaneurol.2015.0941; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Guo J, 2015, NEUROLOGY, V85, P701, DOI 10.1212/WNL.0000000000001814; Gusakov I V, PATOL FIZIOL EKSP TE, P4; Hauser WA, 2003, EPILEPSIA, V44, P1, DOI 10.1046/j.1528-1157.44.s10.7.x; Hauser WA, PREVALENCE EPILEPSY, V32, P429; Herman ST, 2002, NEUROLOGY, V59, pS21, DOI 10.1212/WNL.59.9_suppl_5.S21; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Irlbacher K, 2002, ANN NEUROL, V52, P119, DOI 10.1002/ana.10229; Ivens S, 2007, BRAIN, V130, P535, DOI 10.1093/brain/awl317; Jones RT, 2015, EPILEPSIA, V56, P1879, DOI 10.1111/epi.13218; Jung KH, 2006, NEUROBIOL DIS, V23, P237, DOI 10.1016/j.nbd.2006.02.016; Jung KH, 2011, EPILEPSIA, V52, P541, DOI 10.1111/j.1528-1167.2010.02916.x; Kaminski RM, 2014, NEUROTHERAPEUTICS, V11, P385, DOI 10.1007/s13311-014-0266-1; Klein P, 2012, ARCH NEUROL-CHICAGO, V69, P1290, DOI 10.1001/archneurol.2012.445; Kobow K, 2012, EPILEPSIA, V53, P1868, DOI 10.1111/j.1528-1167.2012.03716.x; Komatsu M, 2000, EPILEPSIA, V41, P1091, DOI 10.1111/j.1528-1157.2000.tb00312.x; Kron MM., 2012, NEUROGENESIS EPILEPS; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Ling D, 2009, LEVETIRACETAM PREVEN; Liu GM, 2013, NEURON, V79, P31, DOI 10.1016/j.neuron.2013.04.027; Loane D.J., 2015, NEUROPROTECTION TRAU, V127; Loscher W, 2015, EPILEPSY BEHAV, V49, P20, DOI 10.1016/j.yebeh.2015.02.027; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loscher W, 1998, J PHARMACOL EXP THER, V284, P474; Loscher W, 2010, JASPERS BASIC MECH E, V51; Mani R, 2011, NEUROSCI LETT, V497, P251, DOI 10.1016/j.neulet.2011.03.010; Mazarati AM, 2004, EPILEPSY RES, V58, P167, DOI 10.1016/j.eplepsyres.2004.02.002; McDaniel SS, 2011, NEUROSCI LETT, V497, P231, DOI 10.1016/j.neulet.2011.02.037; Mishra M, 2013, EPILEPSY RES, V106, P83, DOI 10.1016/j.eplepsyres.2013.06.008; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Pitkanen A., 2012, HEAD TRAUMA EPILEPSY; Pitkanen A, 2016, LANCET NEUROL, V15, P843, DOI 10.1016/S1474-4422(16)00112-5; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P231, DOI 10.1007/s13311-014-0257-2; Pitkanen A, 2013, EPILEPSIA, V54, P35, DOI 10.1111/epi.12297; Prince D. A., 2012, TRAUMATIC BRAIN INJU; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; Salazar Andres M, 2015, Handb Clin Neurol, V128, P525, DOI 10.1016/B978-0-444-63521-1.00033-9; Sandsmark DK, 2007, HISTOL HISTOPATHOL, V22, P895, DOI 10.14670/HH-22.895; Shafi MM, 2015, ANN NEUROL, V77, P487, DOI 10.1002/ana.24343; Shetty AK, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00172; SILVER JM, 1991, ANN NEUROL, V29, P356, DOI 10.1002/ana.410290404; Simonato M, 2014, LANCET NEUROL, V13, P949, DOI 10.1016/S1474-4422(14)70076-6; Simonato M, 2012, EPILEPSIA, V53, P1860, DOI 10.1111/j.1528-1167.2012.03541.x; SUTULA T, 1992, J NEUROSCI, V12, P4173; Suzer T, 2000, RES EXP MED, V199, P223; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Thompson K, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009900.pub2; Tomkins O, 2007, NEUROBIOL DIS, V25, P367, DOI 10.1016/j.nbd.2006.10.006; Tosetti P, 2013, J NEUROTRAUM, V30, P1211, DOI 10.1089/neu.2013.2896; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; Weiss SA, 2016, EPILEPSIA, V57, P111, DOI 10.1111/epi.13251; White A, 2010, EPILEPSIA, V51, P371, DOI 10.1111/j.1528-1167.2009.02339.x; White HS, 2014, NEUROTHERAPEUTICS, V11, P373, DOI 10.1007/s13311-013-0250-1; Willmore LJ, 2009, NEUROCHEM RES, V34, P688, DOI 10.1007/s11064-008-9841-3; Willmore LJ, 2012, EPILEPSY CURR, V12, P87, DOI 10.5698/1535-7511-12.3.87; WILLMORE LJ, 1990, EPILEPSIA, V31, pS67, DOI 10.1111/j.1528-1157.1990.tb05861.x; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zeng YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140624; Zou HC, 2013, NEUROREHAB NEURAL RE, V27, P878, DOI 10.1177/1545968313491007	88	18	19	2	105	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	JUL	2017	72						188	194		10.1016/j.yebeh.2017.05.024			7	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	FB7LE	WOS:000406321300032	28647441				2022-02-06	
J	Mammadova, N; Ghaisas, S; Zenitsky, G; Sakaguchi, DS; Kanthasamy, AG; Greenlee, JJ; Greenlee, MHW				Mammadova, Najiba; Ghaisas, Shivani; Zenitsky, Gary; Sakaguchi, Donald S.; Kanthasamy, Anumantha G.; Greenlee, Justin J.; Greenlee, M. Heather West			Lasting Retinal Injury in a Mouse Model of Blast-Induced Trauma	AMERICAN JOURNAL OF PATHOLOGY			English	Article							INDUCED OCULAR TRAUMA; PRIMARY OVERPRESSURE BLAST; CLOSED-HEAD MODEL; MULLER GLIAL-CELL; UP-REGULATION; TAU; MICROGLIA; PATHOPHYSIOLOGY; DEGENERATION; ACTIVATION	Traumatic brain injury due to blast exposure is currently the most prevalent of war injuries. Although secondary ocular blast injuries due to flying debris are more common, primary ocular blast exposure resulting from blast wave pressure has been reported among survivors of explosions, but with Limited understanding of the resulting retinal pathologies. Using a compressed air-driven shock tube system, adult male and female C57BL/6 mice were exposed to blast wave pressure of 300 kPa (43.5 psi) per day for 3 successive days, and euthanized 30 days after injury. We assessed retinal tissues using immunofluorescence for Oa fibrilLary acidic protein, microglia-specific proteins Iba1 and CD68, and phosphorylated tau (AT-270 pThr181 and AT-180 pThr231). Primary blast wave pressure resulted in activation of Muller glia, Loss of photoreceptor cells, and an increase in phosphorylated tau in retinal neurons and glia. We found that 300-kPa blasts yielded no detectable cognitive or motor deficits, and no neurochemical or biochemical evidence of injury in the striatum or prefrontal cortex, respectively. These changes were detected 30 days after blast exposure, suggesting the possibility of long-lasting retinal injury and neuronal inflammation after primary blast exposure.	[Mammadova, Najiba; Sakaguchi, Donald S.] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Mammadova, Najiba; Ghaisas, Shivani; Greenlee, M. Heather West] Iowa State Univ, Immunobiol Grad Program, Ames, IA 50011 USA; [Mammadova, Najiba; Sakaguchi, Donald S.; Greenlee, M. Heather West] Iowa State Univ, Neurosci Grad Program, Ames, IA 50011 USA; [Ghaisas, Shivani; Zenitsky, Gary; Kanthasamy, Anumantha G.; Greenlee, M. Heather West] Iowa State Univ, Coll Vet Med, Dept Biomed Sci, 1800 Christensen Dr,Room 2008, Ames, IA 50011 USA; [Greenlee, Justin J.] ARS, Virus & Prion Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA		Greenlee, MHW (corresponding author), Iowa State Univ, Coll Vet Med, Dept Biomed Sci, 1800 Christensen Dr,Room 2008, Ames, IA 50011 USA.	mheather@iastate.edu	Ghaisas, Shivani/AAO-7105-2020; Greenlee, Justin/Y-5732-2019; West Greenlee, Heather/B-5342-2016	Ghaisas, Shivani/0000-0001-7827-8190; Greenlee, Justin/0000-0003-2202-3054; Kanthasamy, Anumantha/0000-0002-6454-4264; West Greenlee, Heather/0000-0002-6622-0044; Zenitsky, Gary/0000-0003-1214-3247; Sakaguchi, Donald/0000-0003-4537-0972	US Army Medical Research and Materiel Command grantU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-11-1-0700]; Stem Cell Research Fund; Departfrients of Genetics, Development, and Cell Biology; Department of Biomedical Sciences at Iowa State University	Supported by a US Army Medical Research and Materiel Command grant under contract W81XWH-11-1-0700 (A.G.K.); the Stem Cell Research Fund (D.S.S.); and the Departfrients of Genetics, Development, and Cell Biology (N.M.) and Department of Biomedical Sciences at Iowa State University (M.H.W.G.).	BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Bricker-Anthony C, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0192-5; Bringmann A, 2001, FRONT BIOSCI-LANDMRK, V6, pE77, DOI 10.2741/Bringman; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Choi JH, 2015, CLIN EXP OPHTHALMOL, V43, P239, DOI 10.1111/ceo.12407; Committee for the Update of the Guide for the Care and Use of Laboratory Animals Institute to Laboratory Animal Research, 2011, GUIDE CARE USE LAB A; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Garcia M, 2003, HISTOL HISTOPATHOL, V18, P1205, DOI 10.14670/HH-18.1205; Ghosh A, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M112.444224; Ghoshal N, 2001, J NEUROCHEM, V77, P1372, DOI 10.1046/j.1471-4159.2001.00346.x; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Gulinello M, 2009, BEHAV BRAIN RES, V196, P220, DOI 10.1016/j.bbr.2008.09.002; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gupta N, 2008, CAN J OPHTHALMOL, V43, P53, DOI 10.3129/i07-185; Harischandra DS, 2015, TOXICOL SCI, V143, P454, DOI 10.1093/toxsci/kfu247; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jackman SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001057; Karlstetter M, 2015, PROG RETIN EYE RES, V45, P30, DOI 10.1016/j.preteyeres.2014.11.004; Komori T, 1999, BRAIN PATHOL, V9, P663; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; Magone MT, 2014, J REHABIL RES DEV, V51, P71, DOI 10.1682/JRRD.2013.01.0008; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mohan K, 2013, INVEST OPHTH VIS SCI, V54, P3440, DOI 10.1167/iovs.12-11522; ODAWARA T, 1995, NEUROSCI LETT, V192, P145, DOI 10.1016/0304-3940(95)11595-N; Pekny M, 2014, PHYSIOL REV, V94, P1077, DOI 10.1152/physrev.00041.2013; Reichenbach A, 1997, OPHTHALMIC RES, V29, P326, DOI 10.1159/000268031; Shah MA, 2011, BIOMED SCI INSTRUM, V48, P393; Sonntag S, 2012, J NEUROSCI, V32, P10713, DOI 10.1523/JNEUROSCI.0442-12.2012; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Tynan RJ, 2013, ACTA NEUROPATHOL, V126, P75, DOI 10.1007/s00401-013-1102-0; Wang HCH, 2014, MIL MED, V179, P34, DOI 10.7205/MILMED-D-13-00504; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Zou YY, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-79	40	18	18	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0002-9440	1525-2191		AM J PATHOL	Am. J. Pathol.	JUL	2017	187	7					1459	1472		10.1016/j.ajpath.2017.03.005			14	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	EY9LQ	WOS:000404320500004	28606756	Green Published, Bronze			2022-02-06	
J	Yin, C; Huang, GF; Sun, XC; Guo, ZD; Zhang, JH				Yin, Cheng; Huang, Guang-fu; Sun, Xiao-chuan; Guo, Zongduo; Zhang, John H.			DLK silencing attenuated neuron apoptosis through JIP3/MA2K7/JNK pathway in early brain injury after SAH in rats	NEUROBIOLOGY OF DISEASE			English	Article						Subarachnoid hemorrhage; Early brain injury; DLK; Neuron; Apoptosis	LEUCINE-ZIPPER KINASE; ANEURYSMAL SUBARACHNOID HEMORRHAGE; SIGNALING PATHWAY; BARRIER INTEGRITY; CELL-DEATH; MODEL; REGENERATION; ACTIVATION; MIGRATION; ISCHEMIA	Objective: Dual leucine zipper kinase (DLK/MA3K12) has been reported involved in apoptosis and neuronal degeneration during neural development and traumatic brain injury. This study was designed to investigate the role of DIX with its adaptor protein JNK interacting protein-3 (JIP3), and its downstream MA2K7/JNK signaling pathway in early brain injury (EBI) after subarachnoid hemorrhage (SAH) in a rat model. Design: Controlled in vivo laboratory study. Setting: Animal research laboratory. Subjects: Two hundred and twenty-three adult male Sprague-Dawley rats weighing 280-320 g. Interventions: SAH was induced by endovascular perforation in rats. The SAH grade, neurological score, and brain water content were measured at 24 and 72 h after SAH. Immunofluorescence staining was used to detect the cells that expressed DLK. The terminal deoxynucleotid transferase-deoxyuridine triphosphate (dUTP) nick end labeling (TUNEL) was used to detect the neuronal apoptosis. In mechanism research, the expression of DLK, JIP3, phosphorylated-JNK (p-JNK)/INK, and cleaved caspase-3 (CC-3) were analyzed by western blot at 24 h after SAH. The DLK small interfering RNA (siRNA), JIP3 siRNA, MA2K7 siRNA and recombinant DLK protein which injected intracerebroventricularly were given as the interventions. Measurements and main results: The DLK expression was increased in the left cortex neurons and peaked at 24 h after SAH. DLK siRNA attenuated brain edema, reduced neuronal apoptosis, and improved the neurobehavioral functions after SAH, but the recombinant DLK protein deteriorated neurobehavioral functions and brain edema. DLK siRNA decreased and recombinant DLK protein increased the expression of MA2K7/p-INK/CC-3 at 24 h after SAH. The JIP3 siRNA reduced the level of JIP3/MA2K7/p-JNK/CC-3, combined DLK siRNA and JIP3 siRNA further decreased the expression of DLK/MA2K7/p-JNK/CC-3, and MA2K7 siRNA lowered the amount of MA2K7/p-JNK/CC-3 at 24 h after SAH. Conclusions: As a negative role, DLK was involved in EBI after SAH, possibly mediated by its adaptor protein JIP3 and MA2K7/JNK signaling pathways. To reduce the level of DLK may be a new target as intervention for SAH. (C) 2017 Elsevier Inc. All rights reserved.	[Yin, Cheng; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Anesthesiol, Loma Linda, CA USA; [Yin, Cheng; Zhang, John H.] Loma Linda Univ, Sch Med, Dept Physiol, Loma Linda, CA 92350 USA; [Yin, Cheng; Huang, Guang-fu] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Affiliated Hosp, Dept Neurosurg, Chengdu, Peoples R China; [Sun, Xiao-chuan; Guo, Zongduo] Chongqing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Chongqing, Peoples R China		Zhang, JH (corresponding author), Loma Linda Univ, Sch Med, Dept Physiol & Pharmacol, 11041 Campus St,Risley Hall,Room 219, Loma Linda, CA 92354 USA.	jhzhang@llu.edu		sun, xiao chuan/0000-0001-6992-332X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS081740, NS084921]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS081740, R01NS084921, P01NS082184] Funding Source: NIH RePORTER	This study is partially supported by the National Institutes of Health grants NS081740 and NS084921 to JHZ.	Ayer R, 2010, TURK NEUROSURG, V20, P159, DOI 10.5137/1019-5149.JTN.2714-09.0; Bederson JB, 1998, NEUROSURGERY, V42, P352, DOI 10.1097/00006123-199802000-00091; BEDERSON JB, 1995, STROKE, V26, P1086, DOI 10.1161/01.STR.26.6.1086; Bloom AJ, 2007, GENE DEV, V21, P2593, DOI 10.1101/gad.1592107; Broad KD, 2016, NEUROBIOL DIS, V87, P29, DOI 10.1016/j.nbd.2015.12.001; Cahill WJ, 2006, J CEREBR BLOOD F MET, V26, P1341, DOI 10.1038/sj.jcbfm.9600283; Chen QW, 2015, TRANSL STROKE RES, V6, P125, DOI 10.1007/s12975-014-0367-5; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Chen S, 2013, CRIT CARE MED, V41, pE466, DOI 10.1097/CCM.0b013e31829a8246; Chen XQ, 2008, J NEUROSCI, V28, P672, DOI 10.1523/JNEUROSCI.2132-07.2008; Etminan N, 2015, TRANSL STROKE RES, V6, P167, DOI 10.1007/s12975-015-0398-6; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Ghosh AS, 2011, J CELL BIOL, V194, P751, DOI 10.1083/jcb.201103153; Grunwald IQ, 2014, J INVASIVE CARDIOL, V26, P30; Gupta S, 1996, EMBO J, V15, P2760, DOI 10.1002/j.1460-2075.1996.tb00636.x; Hasegawa Y, 2015, TRANSL STROKE RES, V6, P458, DOI 10.1007/s12975-015-0423-9; Hirai S, 2002, DEVELOPMENT, V129, P4483; Hirai S, 2006, J NEUROSCI, V26, P11992, DOI 10.1523/JNEUROSCI.2272-06.2006; Hirai S, 2011, J NEUROSCI, V31, P6468, DOI 10.1523/JNEUROSCI.5038-10.2011; Itoh A, 2011, J NEUROSCI, V31, P7223, DOI 10.1523/JNEUROSCI.5947-10.2011; Itoh T, 2014, J NEUROSCI, V34, P10729, DOI 10.1523/JNEUROSCI.0539-14.2014; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Li HY, 2014, TRANSL STROKE RES, V5, P618, DOI 10.1007/s12975-014-0354-x; Liu F, 2014, STROKE, V45, P3691, DOI 10.1161/STROKEAHA.114.006635; Marbacher S, 2012, J NEUROSCI METH, V208, P138, DOI 10.1016/j.jneumeth.2012.05.010; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; Merritt SE, 1999, J BIOL CHEM, V274, P10195, DOI 10.1074/jbc.274.15.10195; Nix P, 2012, NEURON, V74, P961, DOI 10.1016/j.neuron.2012.06.005; Robitaille K, 2008, CELL DEATH DIFFER, V15, P1522, DOI 10.1038/cdd.2008.77; Sherchan P, 2016, NEUROBIOL DIS, V85, P164, DOI 10.1016/j.nbd.2015.11.003; Song JP, 2015, TRANSL STROKE RES, V6, P290, DOI 10.1007/s12975-015-0396-8; Sugawara T, 2008, J NEUROSCI METH, V167, P327, DOI 10.1016/j.jneumeth.2007.08.004; Suwatcharangkoon S, 2016, JAMA NEUROL, V73, P28, DOI 10.1001/jamaneurol.2015.3188; Tang JJ, 2015, NEUROBIOL DIS, V78, P126, DOI 10.1016/j.nbd.2015.01.009; Tedeschi A, 2013, EMBO REP, V14, P605, DOI 10.1038/embor.2013.64; Thatipamula S, 2015, NEUROBIOL DIS, V75, P15, DOI 10.1016/j.nbd.2014.12.016; Topkoru BC, 2013, STROKE, V44, P3189, DOI 10.1161/STROKEAHA.113.001574; Valakh V, 2015, NEUROBIOL DIS, V77, P13, DOI 10.1016/j.nbd.2015.02.014; Watkins TA, 2013, P NATL ACAD SCI USA, V110, P4039, DOI 10.1073/pnas.1211074110; Welsbie DS, 2013, P NATL ACAD SCI USA, V110, P4045, DOI 10.1073/pnas.1211284110; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yasuda J, 1999, MOL CELL BIOL, V19, P7245; Yin C, 2016, NEUROPHARMACOLOGY, V108, P316, DOI 10.1016/j.neuropharm.2016.04.013; Zhan Y, 2015, J NEUROSCI RES, V93, P94, DOI 10.1002/jnr.23475	44	18	20	0	10	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUL	2017	103						133	143		10.1016/j.nbd.2017.04.006			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV3TY	WOS:000401683200013	28396258	Green Accepted			2022-02-06	
J	Badenes, R; Oddo, M; Suarez, JI; Antonelli, M; Lipman, J; Citerio, G; Taccone, FS				Badenes, Rafael; Oddo, Mauro; Suarez, Jose I.; Antonelli, Massimo; Lipman, Jeffrey; Citerio, Giuseppe; Taccone, Fabio Silvio			Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: an international survey	CRITICAL CARE			English	Article						Hemoglobin; Transfusion; Threshold; Brain injury; Outcome	BLOOD-CELL TRANSFUSION; ANEURYSMAL SUBARACHNOID HEMORRHAGE; CEREBRAL OXYGEN DELIVERY; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE; CLINICAL-TRIAL; SEVERE SEPSIS; ANEMIA; STRATEGIES; MANAGEMENT	Background: The optimal hemoglobin (Hb) threshold at which to initiate red blood cell (RBC) transfusion in patients with acute brain injury is unknown. The aim of this survey was to investigate RBC transfusion practices used with these patients. Methods: We conducted a web-based survey within various societies of critical care medicine for intensive care unit (ICU) physicians who currently manage patients with primary acute brain injury. Results: A total of 868 responses were obtained from around the world, half of which (n = 485) were from European centers; 204 (24%) respondents had a specific certificate in neurocritical care, and most were specialists in anesthesiology or intensive care and had less than 15 years of practice experience. Four hundred sixty-six respondents (54%) said they used an Hb threshold of 7-8 g/dl to initiate RBC transfusion after acute brain injury, although half of these respondents used a different threshold (closer to 9 g/dl) in patients with traumatic brain injury, subarachnoid hemorrhage, or ischemic stroke. Systemic and cerebral factors were reported as influencing the need for higher Hb thresholds. Most respondents agreed that a randomized clinical trial was needed to compare two different Hb thresholds for RBC transfusion, particularly in patients with traumatic brain injury, subarachnoid hemorrhage, and ischemic stroke. Conclusions: The Hb threshold used for RBC transfusion after acute brain injury was less than 8 g/dl in half of the ICU clinicians who responded to our survey. However, more than 50% of these physicians used higher Hb thresholds in certain conditions.	[Badenes, Rafael] Hosp Clin Univ, Dept Anesthesiol & Surg Intens Care, Valencia, Spain; [Oddo, Mauro] Lausanne Univ Hosp, CHUV, Dept Intens Care Med, CH-1011 Lausanne, Switzerland; [Suarez, Jose I.] Baylor Coll Med, Dept Neurol, CHI Baylor St Lukes Baylor St Lukes Med Ctr, Div Vasc Neurol & Neurocrit Care, Houston, TX 77030 USA; [Antonelli, Massimo] Catholic Univ, Fdn Policlin Agostino Gemelli Univ Hosp, Dept Anesthesiol & Intens Care Med, Rome, Italy; [Lipman, Jeffrey] Royal Brisbane & Womens Hosp, Intens Care Serv, Herston, Qld, Australia; [Lipman, Jeffrey] Univ Queensland, Burns Trauma Crit Care Res Ctr, Herston, Qld, Australia; [Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Citerio, Giuseppe] ASST Monza, San Gerardo Hosp, Neurointens Care, Monza, Italy; [Taccone, Fabio Silvio] Free Univ Brussels ULB, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium		Taccone, FS (corresponding author), Free Univ Brussels ULB, Erasme Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	ftaccone@ulb.ac.be	Badenes, Rafael/K-6628-2019; Citerio, Giuseppe/B-1839-2015; Lipman, Jeffrey/G-2211-2010	Badenes, Rafael/0000-0001-7017-0150; Citerio, Giuseppe/0000-0002-5374-3161; Lipman, Jeffrey/0000-0002-5965-9876			Amer Soc Anesthesiologists, 2015, ANESTHESIOLOGY, V122, P241, DOI 10.1097/ALN.0000000000000463; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Carson JL, 2016, JAMA-J AM MED ASSOC, V316, P2025, DOI 10.1001/jama.2016.9185; Dhar R, 2012, J NEUROSURG, V116, P648, DOI 10.3171/2011.9.JNS11691; Dhar R, 2009, STROKE, V40, P3039, DOI 10.1161/STROKEAHA.109.556159; Frank SM, 2012, ANESTHESIOLOGY, V117, P99, DOI 10.1097/ALN.0b013e318255e550; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Hare GMT, 2013, BEST PRAC RES-CL ANA, V27, P85, DOI 10.1016/j.bpa.2012.12.002; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Hofmann A, 2012, CURR OPIN ANESTHESIO, V25, P66, DOI 10.1097/ACO.0b013e32834eb726; Kramer AH, 2008, CRIT CARE MED, V36, P2070, DOI 10.1097/CCM.0b013e31817c1095; Kramer AH, 2011, CRIT CARE, V15, DOI 10.1186/cc9977; Kramer AH, 2009, NEUROCRIT CARE, V10, P157, DOI 10.1007/s12028-008-9171-y; Kulier A, 2007, CIRCULATION, V116, P471, DOI 10.1161/CIRCULATIONAHA.106.653501; Kurtz P, 2016, NEUROCRIT CARE, V24, P118, DOI 10.1007/s12028-015-0180-3; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; Meier J, 2016, BRIT J ANAESTH, V116, P255, DOI 10.1093/bja/aev456; Napolitano LM, 2010, CRIT CARE MED, V38, P1621, DOI 10.1097/CCM.0b013e3181e922ba; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Pendem S, 2006, NEUROCRIT CARE, V4, P63, DOI 10.1385/NCC:4:1:063; Retter A, 2013, BRIT J HAEMATOL, V160, P445, DOI 10.1111/bjh.12143; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sadaka F, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-46; Safaeian N, 2013, J CEREBR BLOOD F MET, V33, P1633, DOI 10.1038/jcbfm.2013.119; Sakr Y, 2007, CRIT CARE MED, V35, P1639, DOI 10.1097/01.CCM.0000269936.73788.32; Schneider WH, 2013, TRANSFUS MED REV, V27, P21, DOI 10.1016/j.tmrv.2012.08.001; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Smith MJ, 2005, CRIT CARE MED, V33, P1104, DOI 10.1097/01.CCM.0000162685.60609.49; Theusinger OM, 2012, CURR OPIN ANESTHESIO, V25, P59, DOI 10.1097/ACO.0b013e32834dec98; Walsh TS, 2006, INTENS CARE MED, V32, P100, DOI 10.1007/s00134-005-2855-2; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Weiskopf RB, 2005, CLIN NEUROPHYSIOL, V116, P1028, DOI 10.1016/j.clinph.2004.12.009; Wu WC, 2007, JAMA-J AM MED ASSOC, V297, P2481, DOI 10.1001/jama.297.22.2481; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	37	18	19	0	3	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JUN 17	2017	21								159	10.1186/s13054-017-1748-4			10	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FH0KN	WOS:000410829100001	28623949	Green Published, gold			2022-02-06	
J	Cardim, D; Schmidt, B; Robba, C; Donnelly, J; Puppo, C; Czosnyka, M; Smielewski, P				Cardim, Danilo; Schmidt, Bernhard; Robba, Chiara; Donnelly, Joseph; Puppo, Corina; Czosnyka, Marek; Smielewski, Peter			Transcranial Doppler Monitoring of Intracranial Pressure Plateau Waves	NEUROCRITICAL CARE			English	Article						Transcranial Doppler; Noninvasive ICP; Traumatic brain injury; ICP plateau waves	HEAD-INJURED PATIENTS; CEREBRAL PERFUSION-PRESSURE; BLOOD-FLOW; NONINVASIVE ASSESSMENT; ULTRASONOGRAPHY; HYDROCEPHALUS; HYPERTENSION; INFUSION; VOLUME; BRAIN	Background Transcranial Doppler (TCD) has been used to estimate ICP noninvasively (nICP); however, its accuracy varies depending on different types of intracranial hypertension. Given the high specificity of TCD to detect cerebrovascular events, this study aimed to compare four TCD-based nICP methods during plateau waves of ICP. Methods A total of 36 plateau waves were identified in 27 patients (traumatic brain injury) with TCD, ICP, and ABP simultaneous recordings. The nICP methods were based on: (1) interaction between flow velocity (FV) and ABP using a "black-box" mathematical model (nICP_BB); (2) diastolic FV (nICP_FV (d) ); (3) critical closing pressure (nICP_CrCP), and (4) pulsatility index (nICP_PI). Analyses focused on relative changes in time domain between ICP and noninvasive estimators during plateau waves and the magnitude of changes (a dagger between baseline and plateau) in real ICP and its estimators. A ROC analysis for an ICP threshold of 35 mmHg was performed. Results In time domain, nICP_PI, nICP_BB, and nICP_CrCP presented similar correlations: 0.80 +/- 0.24, 0.78 +/- 0.15, and 0.78 +/- 0.30, respectively. nICP_FV (d) presented a weaker correlation (R = 0.62 +/- 0.46). Correlations between a dagger ICP and a dagger nICP were better represented by nICP_CrCP and BB, R = 0.48, 0.44 (p < 0.05), respectively. nICP_FV (d) and PI presented nonsignificant a dagger correlations. ROC analysis showed moderate to good areas under the curve for all methods: nICP_BB, 0.82; nICP_FV (d) , 0.77; nICP_CrCP, 0.79; and nICP_PI, 0.81. Conclusion Changes of ICP in time domain during plateau waves were replicated by nICP methods with strong correlations. In addition, the methods presented high performance for detection of intracranial hypertension. However, absolute accuracy for noninvasive ICP assessment using TCD is still low and requires further improvement.	[Cardim, Danilo; Robba, Chiara; Donnelly, Joseph; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Schmidt, Bernhard] Univ Hosp Chemnitz, Dept Neurol, Chemnitz, Germany; [Robba, Chiara] Cambridge Univ NHS Fdn Trust, Addenbrookes Hosp, Neurosci Crit Care Unit, Cambridge, England; [Puppo, Corina] Univ Republica, Sch Med Hosp, Montevideo, Uruguay; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Cardim, D (corresponding author), Univ Cambridge, Dept Clin Neurosci, Div Neurosurg, Brain Phys Lab, Cambridge, England.	dac69@cam.ac.uk	Donnelly, Joseph/N-6803-2019; Donnelly, Joseph/E-9235-2018; Cardim, Danilo Augusto/B-8447-2012; Robba, Chiara/AAS-7421-2020	Donnelly, Joseph/0000-0002-6502-8069; Donnelly, Joseph/0000-0002-6502-8069; Cardim, Danilo Augusto/0000-0002-9261-1321; Smielewski, Peter/0000-0001-5096-3938	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G0600986] Funding Source: Medline; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986] Funding Source: UKRI		AVEZAAT CJJ, 1979, J NEUROL NEUROSUR PS, V42, P687, DOI 10.1136/jnnp.42.8.687; Budohoski Karol P, 1800, Acta Neurochir Suppl, V114, P121, DOI 10.1007/978-3-7091-0956-4_22; Cardim D, 2016, ACTA NEUROCHIR, V158, P279, DOI 10.1007/s00701-015-2661-8; Cardim D, 2016, NEUROCRIT CARE, V25, P473, DOI 10.1007/s12028-016-0258-6; Cardim D, 2016, J NEUROTRAUM, V33, P792, DOI 10.1089/neu.2015.4134; Castellani G, 2009, NEUROCRIT CARE, V11, P143, DOI 10.1007/s12028-009-9235-7; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Czosnyka M, 1999, J NEUROSURG, V91, P11, DOI 10.3171/jns.1999.91.1.0011; Czosnyka M, 1998, J NEUROSURG, V88, P802, DOI 10.3171/jns.1998.88.5.0802; Czosnyka Marek, 1800, Neurosurg Focus, V22, pE10; DAHL A, 1992, STROKE, V23, P15, DOI 10.1161/01.STR.23.1.15; Eide PK, 2010, ACTA NEUROL SCAND, V122, P262, DOI 10.1111/j.1600-0404.2009.01304.x; HAYASHI M, 1987, J NEUROSURG, V67, P97, DOI 10.3171/jns.1987.67.1.0097; HAYASHI M, 1991, BRAIN, V114, P2681, DOI 10.1093/brain/114.6.2681; HAYASHI M, 1984, J NEUROSURG, V61, P30, DOI 10.3171/jns.1984.61.1.0030; Hosmer D, 1989, APPL LOGISTIC REGRES; Ibaraki M, 2007, J CEREBR BLOOD F MET, V27, P404, DOI 10.1038/sj.jcbfm.9600337; Kasprowicz Magdalena, 1800, Acta Neurochir Suppl, V114, P17, DOI 10.1007/978-3-7091-0956-4_4; KASUGA Y, 1987, J NEUROSURG, V66, P907, DOI 10.3171/jns.1987.66.6.0907; Kim DJ, 2009, PHYSIOL MEAS, V30, P647, DOI 10.1088/0967-3334/30/7/009; Koskinen LOD, 2005, NEUROSURGERY, V56, P693, DOI 10.1227/01.NEU.0000156609.95596.24; LUNDBERG N, 1960, Acta Psychiatr Scand Suppl, V36, P1; Marmarelis P., 1978, ANAL PHYSL SYSTEMS; RENIER D, 1982, J NEUROSURG, V57, P370, DOI 10.3171/jns.1982.57.3.0370; Robin AX, 2013, PACKAGE PROC; ROSNER MJ, 1984, J NEUROSURG, V60, P312, DOI 10.3171/jns.1984.60.2.0312; Schmidt B, 1997, STROKE, V28, P2465, DOI 10.1161/01.STR.28.12.2465; Schmidt B, 1999, J CEREBR BLOOD F MET, V19, P990, DOI 10.1097/00004647-199909000-00006; Schmidt B, 2000, J NEUROSURG, V92, P793, DOI 10.3171/jns.2000.92.5.0793; Sloan MA, 2004, NEUROLOGY, V62, P1468, DOI 10.1212/WNL.62.9.1468; URSINO M, 1991, ANN BIOMED ENG, V19, P15, DOI 10.1007/BF02368459; Varsos GV, 2015, J NEUROSURG, V123, P638, DOI 10.3171/2014.10.JNS14613; Zacchetti L, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1137-9; [No title captured]	35	18	18	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2017	26	3					330	338		10.1007/s12028-016-0356-5			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EV9JA	WOS:000402101100003	28000131	Green Published, hybrid			2022-02-06	
J	Mayer, AR; Ling, JM; Dodd, AB; Meier, TB; Hanlon, FM; Klimaj, SD				Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Meier, Timothy B.; Hanlon, Faith M.; Klimaj, Stefan D.			A prospective microstructure imaging study in mixed-martial artists using geometric measures and diffusion tensor imaging: methods and findings	BRAIN IMAGING AND BEHAVIOR			English	Article						Diffusion tensor imaging; NODDI; Concussion; Repetitive injury; Edema; Water fractions	TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; VOXEL-BASED MORPHOMETRY; WHITE-MATTER INTEGRITY; SPATIAL STATISTICS; WATER DIFFUSION; ARTS FIGHTERS; WISE ANALYSIS; DATA SETS; MRI DATA	Although diffusion magnetic resonance imaging (dMRI) has been widely used to characterize the effects of repetitive mild traumatic brain injury (rmTBI), to date no studies have investigated how novel geometric models of microstructure relate to more typical diffusion tensor imaging (DTI) sequences. Moreover, few studies have evaluated the sensitivity of different registration pipelines (non-linear, linear and tract-based spatial statistics) for detecting dMRI abnormalities in clinical populations. Results from single-subject analyses in healthy controls (HC) indicated a strong negative relationship between fractional anisotropy (FA) and orientation dispersion index (ODI) in both white and gray matter. Equally important, only moderate relationships existed between all other estimates of free/intracellular water volume fractions and more traditional DTI metrics (FA, mean, axial and radial diffusivity). These findings suggest that geometric measures provide differential information about the cellular microstructure relative to traditional DTI measures. Results also suggest greater sensitivity for non-linear registration pipelines that maximize the anatomical information available in T-1-weighted images. Clinically, rmTBI resulted in a pattern of decreased FA and increased ODI, largely overlapping in space, in conjunction with increased intracellular and free water fractions, highlighting the potential role of edema following repeated head trauma. In summary, current results suggest that geometric models of diffusion can provide relatively unique information regarding potential mechanisms of pathology that contribute to long-term neurological damage.	[Mayer, Andrew R.; Ling, Josef M.; Dodd, Andrew B.; Meier, Timothy B.; Hanlon, Faith M.; Klimaj, Stefan D.] Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA		Mayer, AR (corresponding author), Mind Res Network, Lovelace Biomed & Environm Res Inst, Albuquerque, NM 87106 USA.; Mayer, AR (corresponding author), Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA.; Mayer, AR (corresponding author), Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA.	amayer@mrn.org	Klimaj, Stefan/AAV-4060-2020		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS098494] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098494] Funding Source: NIH RePORTER		Adluru G, 2014, IEEE ENG MED BIO, P742, DOI 10.1109/EMBC.2014.6943697; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Borich M, 2013, J NEUROTRAUM, V30, P1243, DOI 10.1089/neu.2012.2818; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chung SW, 2008, NEUROIMAGE, V39, P1693, DOI 10.1016/j.neuroimage.2007.10.039; Cox R., 2006, P INT SOC MAGN RES M; Daducci A, 2015, NEUROIMAGE, V105, P32, DOI 10.1016/j.neuroimage.2014.10.026; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Didehbani N, 2013, ARCH CLIN NEUROPSYCH, V28, P418, DOI 10.1093/arclin/act028; Dietrich O, 2007, J MAGN RESON IMAGING, V26, P375, DOI 10.1002/jmri.20969; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; GENTRY LR, 1994, RADIOLOGY, V191, P1; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Harel O, 2009, J APPL STAT, V36, P1109, DOI 10.1080/02664760802553000; Hart J, 2013, JAMA NEUROL, V70, P326, DOI 10.1001/2013.jamaneurol.340; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Holbourn AHS, 1943, LANCET, V2, P438; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jansons KM, 2003, INVERSE PROBL, V19, P1031, DOI 10.1088/0266-5611/19/5/303; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jones DK, 2002, NEUROIMAGE, V17, P592, DOI 10.1006/nimg.2002.1148; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Koay C. G., 2015, 151002934 ARXIV; Koerte IK, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12303; Ling J, 2012, HUM BRAIN MAPP, V33, P50, DOI 10.1002/hbm.21192; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Mayer AR, 2007, J INT NEUROPSYCH SOC, V13, P839, DOI 10.1017/S1355617707071081; Mayer AR, 2015, J NEUROTRAUM, V32, P1759, DOI 10.1089/neu.2014.3833; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Schlaffke L, 2014, NEUROSCIENCE, V259, P35, DOI 10.1016/j.neuroscience.2013.11.046; Schwarz CG, 2014, NEUROIMAGE, V94, P65, DOI 10.1016/j.neuroimage.2014.03.026; Sepehrband F, 2015, HUM BRAIN MAPP, V36, P3687, DOI 10.1002/hbm.22872; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Skare S, 2000, J MAGN RESON, V147, P340, DOI 10.1006/jmre.2000.2209; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song, 2009, INSIGHT J, V2, P1; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Storey P, 2007, MAGN RESON MED, V57, P614, DOI 10.1002/mrm.21132; Tustison NJ, 2014, HUM BRAIN MAPP, V35, P745, DOI 10.1002/hbm.22211; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3; Zhang L, 2006, AM J NEURORADIOL, V27, P2000; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	66	18	18	0	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2017	11	3					698	711		10.1007/s11682-016-9546-1			14	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY0VE	WOS:000403676400009	27071950	Green Accepted			2022-02-06	
J	Mollayeva, T; Colantonio, A; Cassidy, JD; Vernich, L; Moineddin, R; Shapiro, CM				Mollayeva, Tatyana; Colantonio, Angela; Cassidy, J. David; Vernich, Lee; Moineddin, Rahim; Shapiro, Colin M.			Sleep stage distribution in persons with mild traumatic brain injury: a polysomnographic study according to American Academy of Sleep Medicine standards	SLEEP MEDICINE			English	Article						Nocturnal wakefulness; REM sleep; Non-REM sleep; Slow-wave sleep; Sex differences; Normative data	EYE-MOVEMENT SLEEP; HEAD TRAUMA; CONCUSSION; ARCHITECTURE; DEPRIVATION; DISTURBANCE; DISORDER; INSOMNIA; SYNCOPE; SPORT	Objective and background: Sleep stage disruption in persons with mild traumatic brain injury (mTBI) has received little research attention. We examined deviations in sleep stage distribution in persons with mTBI relative to population age- and sex-specific normative data and the relationships between such deviations and brain injury-related, medical/psychiatric, and extrinsic factors. Patients and methods: We conducted a cross-sectional polysomnographic investigation in 40 participants diagnosed with mTBI (mean age 47.54 11.30 years; 56% males). Measurements: At the time of investigation, participants underwent comprehensive clinical and neuroimaging examinations and one full-night polysomnographic study. We used the 2012 American Academy of Sleep Medicine recommendations for recording, scoring, and summarizing sleep stages. We compared participants' sleep stage data with normative data stratified by age and sex to yield z-scores for deviations from available population norms and then employed stepwise multiple regression analyses to determine the factors associated with the identified significant deviations. Results: In patients with mTBI, the mean duration of nocturnal wakefulness was higher and consolidated sleep stage N2 and REM were lower than normal (p < 0.0001, p = 0.018, and p = 0.010, respectively). In multivariate regression analysis, several covariates accounted for the variance in the relative changes in sleep stage duration. No sex differences were observed in the mean proportion of non-REM or REM sleep. Conclusions: We observed longer relative nocturnal wakefulness and shorter relative N2 and REM sleep in patients with mTBI, and these outcomes were associated with potentially modifiable variables. Addressing disruptions in sleep architecture in patients with mTBI could improve their health status. (C) 2017 Elsevier B.V.All rights reserved.	[Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Fac Med, Rehabil Sci Inst, Toronto, ON, Canada; [Mollayeva, Tatyana] Univ Toronto, Collaborat Program Neurosci, Toronto, ON, Canada; [Mollayeva, Tatyana] Toronto Rehab Univ Hlth Network, Toronto, ON, Canada; [Shapiro, Colin M.] Univ Toronto, Fac Arts & Sci, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Acquired Brain Injury Res Lab, Toronto, ON, Canada; [Shapiro, Colin M.] Univ Hlth Network, Toronto Western Hosp, Toronto, ON, Canada; [Shapiro, Colin M.] Youthdale Child & Adolescent Sleep Clin, Toronto, ON, Canada; [Cassidy, J. David] Univ Hlth Network, Krembil Res Inst, Div Hlth Care & Outcomes Res, Toronto, ON, Canada; [Cassidy, J. David; Vernich, Lee; Moineddin, Rahim] Univ Toronto, Dalla Lana Sch Publ Hlth, Inst Hlth Policy Management & Evaluat, Div Epidemiol, Toronto, ON, Canada; [Colantonio, Angela] Univ Toronto, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Mollayeva, T (corresponding author), Univ Toronto, Toronto Rehabil Inst, Univ Hlth Network, Rehabil Sci Inst, 550 Univ Ave,Room 11-183, Toronto, ON MSG 2A2, Canada.	tatyana.mollayeva@utoronto.ca	, Mollayeva/A-4522-2018	Moineddin, Rahim/0000-0002-5506-084X; Colantonio, Angela/0000-0003-2094-4765; Mollayeva, Tatyana/0000-0002-2787-1848	Neurotrauma Foundation Summer Scholarship; Mitacs Accelerate Graduate Internship; Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [290950]; Alzheimer's AssociationAlzheimer's Association [AARF-16-442937]; Canadian Institutes for Health Research Grant Institute for Gender and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; University of TorontoUniversity of Toronto	Our study had no external funding source. The first author was supported by the 2011 Neurotrauma Foundation Summer Scholarship, the 2011/2012 Mitacs Accelerate Graduate Internship, the 2013/2015 Frederick Banting and Charles Best Doctoral Research Award from the Canadian Institutes of Health Research (#290950), and the postdoctoral research fellowship from the University of Toronto and the Alzheimer's Association (AARF-16-442937). Angela Colantonio was supported by the Canadian Institutes for Health Research Grant Institute for Gender and Health (#CGW-126580). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Association of Workers' Compensation Boards of Canada (AWCBC), 2011, NAT RES WORK COMP; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Berry RB, 2012, AASM MANUAL SCORING; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bjurstrom MF, 2016, SLEEP MED REV, V26, P74, DOI 10.1016/j.smrv.2015.03.004; Borzage M, 2014, BRAIN STRUCT FUNCT, V219, P141, DOI 10.1007/s00429-012-0490-6; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; DeMartinis Nicholas A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P17, DOI 10.2174/187152707779940835; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dorffner G, 2015, ADV EXP MED BIOL, V821, P93, DOI 10.1007/978-3-319-08939-3_13; ETEVENON P, 1986, NEUROPSYCHOBIOLOGY, V16, P146, DOI 10.1159/000118316; Fogel SM, 2011, NEUROSCI BIOBEHAV R, V35, P1154, DOI 10.1016/j.neubiorev.2010.12.003; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Government of Ontario, 2016, AB ONT; HERSCOVITCH J, 1981, SLEEP, V4, P83, DOI 10.1093/sleep/4.1.83; Hughes SW, 2005, NEUROSCIENTIST, V11, P357, DOI 10.1177/1073858405277450; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; International Statistical Classification of Diseases and Related Health Problems, 2010, SYMPT SIGNS ABN CLIN; Jackson J, 2014, NAT NEUROSCI, V17, P1362, DOI 10.1038/nn.3803; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Leddy JJ, 2016, PHYS MED REH CLIN N, V27, P437, DOI 10.1016/j.pmr.2015.12.003; Lippel K, 2012, AM J IND MED, V55, P519, DOI 10.1002/ajim.22022; Lu W, 2015, BRAIN INJURY, V29, P1342, DOI 10.3109/02699052.2015.1043947; Madigan MF, 1997, PERCEPT MOTOR SKILL, V85, P1451, DOI 10.2466/pms.1997.85.3f.1451; Maestri M, 2015, SLEEP MED, V16, P1139, DOI 10.1016/j.sleep.2015.04.027; Mancebo-Sosa V, 2016, SLEEP SCI, V9, P84, DOI 10.1016/j.slsci.2016.06.002; Maquet P, 2000, J SLEEP RES, V9, P207; MAQUET P, 1992, BRAIN RES, V571, P149, DOI 10.1016/0006-8993(92)90522-B; Maroon JC, 2014, PROG NEUROL SURG, V28, P1, DOI 10.1159/000358746; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McEwen BS, 2006, METABOLISM, V55, pS20, DOI 10.1016/j.metabol.2006.07.008; Merica H, 2003, CEREB CORTEX, V13, P1044, DOI 10.1093/cercor/13.10.1044; Mitterling T, 2015, SLEEP, V38, P867, DOI 10.5665/sleep.4730; Mollayeva T, 2013, ENCY SLEEP; Mollayeva T, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0657-2; Mollayeva T, 2013, SLEEP MED, V14, P1235, DOI 10.1016/j.sleep.2013.07.009; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Nofzinger EA, 2004, ARCH GEN PSYCHIAT, V61, P695, DOI 10.1001/archpsyc.61.7.695; Oosterhuis HEM, 2017, PSYCHOMETRIKA, V82, P559, DOI 10.1007/s11336-016-9535-8; Ouellet MC, 2006, SLEEP MED, V7, P486, DOI 10.1016/j.sleep.2006.03.017; Parcell DL, 2008, ARCH PHYS MED REHAB, V89, P843, DOI 10.1016/j.apmr.2007.09.057; Parsons LC, 1997, J NEUROTRAUM, V14, P549, DOI 10.1089/neu.1997.14.549; Popat RA, 2010, SLEEP MED, V11, P154, DOI 10.1016/j.sleep.2009.01.012; Puel V, 2013, INT J CARDIOL, V168, P1666, DOI 10.1016/j.ijcard.2013.03.061; RON S, 1980, ELECTROEN CLIN NEURO, V48, P432, DOI 10.1016/0013-4694(80)90135-2; Ryu WHA, 2009, CAN J NEUROL SCI, V36, P429, DOI 10.1017/S0317167100007745; Schreiber S, 2008, SLEEP MED, V9, P481, DOI 10.1016/j.sleep.2007.04.014; Sheehan A, 2012, EMERG MED J, V29, P899, DOI 10.1136/emermed-2011-200155; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Stone AA, 2002, ANN BEHAV MED, V24, P236, DOI 10.1207/S15324796ABM2403_09; Sturzenegger C, 2004, J SLEEP RES, V13, P395, DOI 10.1111/j.1365-2869.2004.00422.x; Thase Michael E, 2006, Dialogues Clin Neurosci, V8, P217; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; van der Helm E, 2011, CURR BIOL, V21, P2029, DOI 10.1016/j.cub.2011.10.052; Varga AW, 2016, SLEEP, V39, P2041, DOI 10.5665/sleep.6240; Vitiello M V, 1989, Clin Geriatr Med, V5, P289; Williams BR, 2008, CLIN NEUROPHYSIOL, V119, P429, DOI 10.1016/j.clinph.2007.11.003; WILLIAMS RL, 1974, ELECTROENCEPHALOGRAP, P49; Wolf H, 2014, J NEUROSURG, V120, P447, DOI 10.3171/2013.10.JNS13726; World Health Organization, 2010, NEUR DIS PUBL HLTH C; Xiong C, 2016, DISABIL HEALTH J, V9, P439, DOI 10.1016/j.dhjo.2015.12.002; Zysko D, 2014, CARDIOL J, V21, P674, DOI 10.5603/CJ.2014.0099	69	18	18	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	JUN	2017	34						179	192		10.1016/j.sleep.2017.02.021			14	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EW2VF	WOS:000402353400028	28522089				2022-02-06	
J	Wang, CM; Wei, ZJ; Jiang, GH; Liu, HJ				wang, Changming; Wei, Zhijie; Jiang, Guohong; Liu, Haijun			Neuroprotective mechanisms of miR-124 activating PI3K/Akt signaling pathway in ischemic stroke	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						miR-124; phosphoinositide 3-kinase/Akt signaling pathway; ischemic stroke; oxygen-glucose deprivation model; apoptosis rate; Bax; Bcl-2; caspase-3	TRAUMATIC BRAIN-INJURY; MICRORNAS; APOPTOSIS; AUTOPHAGY	The neuroprotective mechanisms of miR-124 activating phosphoinositide 3-kinase (PI3K)/Akt signaling pathway in ischemic stroke were investigated. The oxygen-glucose deprivation model of nerve cells induced by PC12 cells was established in vitro, then miR-124 mimics or inhibitor was transfected and synthesized by liposome. Cells were divided into the blank control, model, mimics and inhibitor groups, and the apoptotic rate was determined using flow cytometry. Additionally, the expression levels of PI3K, Akt, Bax, Bcl-2, caspase-3 mRNA and protein were tested by quantitative PCR and western blot analysis at 0, 3, 6, 12 and 24 h, respectively. The apoptotic rate at each time-point in the blank control group was not significantly different. The apoptotic rate of the model and inhibitor groups increased over time, whereas the mimics group decreased (P<0.05). The apoptotic rate at each time-point in the mimics group was significantly lower than that of the model and inhibitor groups, and the rate of the inhibitor group was higher than that of the model group (P<0.05). PI3K, Akt and Bcl-2 mRNA and protein expression levels at the different time-points in the mimics group were significantly higher than those of the remaining groups (P<0.05). The expression levels of Bax and caspase-3 mRNA and protein in the inhibitor group were the highest, followed by the model and mimics groups, while that of the blank control group was the lowest (P<0.05). The results suggest that miR-124 participates in the neural protection of ischemic stroke by activating the PI3K/Akt signaling pathway.	[wang, Changming; Wei, Zhijie; Jiang, Guohong; Liu, Haijun] Zunyi Med Coll, Affiliated Hosp, Dept Neurol, 149 Dalian Rd, Zunyi 563003, Guizhou, Peoples R China		Jiang, GH (corresponding author), Zunyi Med Coll, Affiliated Hosp, Dept Neurol, 149 Dalian Rd, Zunyi 563003, Guizhou, Peoples R China.	gzzyyxywcm@sina.com			Zunyi Science and Technology Plan, Compliance with Zunyi City Branch [(2014) 78]	The present study was supported by the Zunyi Science and Technology Plan, Compliance with Zunyi City Branch (2014) 78. We thank all partners and staff who helped us in the process of this study.	Akerblom M, 2012, J NEUROSCI, V32, P8879, DOI 10.1523/JNEUROSCI.0558-12.2012; Bergmann A, 2007, CELL, V131, P1032, DOI 10.1016/j.cell.2007.11.027; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Gu X, 2014, J MOL NEUROSCI, V52, P156, DOI 10.1007/s12031-013-0190-6; Kilic E, 2005, FASEB J, V19, P2026, DOI 10.1096/fj.05-3941fje; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lang QB, 2012, BIOCHEM BIOPH RES CO, V426, P247, DOI 10.1016/j.bbrc.2012.08.075; Liu Xinling, 2011, FAILURE ANAL PREVENT, V6, P124, DOI DOI 10.1371/J0URNAL.P0NE.0023461; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Wang Z, 2015, MICROSYST TECHNOL, V21, P1; Weiss JBW, 2012, AM J CARDIOVASC DIS, V2, P237; Zhang Lijuan, 2016, Zhongguo Zhen Jiu, V36, P131; Zhao SF, 2012, NEUROL RES, V34, P400, DOI 10.1179/1743132812Y.0000000025	17	18	21	0	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	JUN	2017	13	6					3315	3318		10.3892/etm.2017.4424			4	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	EU5NW	WOS:000401080000103	28587406	Green Published, gold, Green Submitted			2022-02-06	
J	Yang, DB; Yu, WH; Dong, XQ; Zhang, ZY; Du, Q; Zhu, Q; Che, ZH; Wang, H; Shen, YF; Jiang, L				Yang, Ding-Bo; Yu, Wen-Hua; Dong, Xiao-Qiao; Zhang, Zu-Yong; Du, Quan; Zhu, Qiang; Che, Zhi-Hao; Wang, Hao; Shen, Yong-Feng; Jiang, Li			Serum macrophage migration inhibitory factor concentrations correlate with prognosis of traumatic brain injury	CLINICA CHIMICA ACTA			English	Article						Traumatic brain injury; Macrophage migration inhibitory factor; Prognosis	POSTTRAUMATIC CEREBRAL INFARCTION; FACTOR MIF; COAGULOPATHY; MODERATE; PATHOPHYSIOLOGY; PROGRESSION; HEMORRHAGE; EXPRESSION; REGULATOR; CT	Background: Macrophage migration inhibitory factor (MIF) is a well-known pro-inflammatory cytokine. Serum MIF concentrations are associated with the severity and prognosis of ischemic stroke. Methods: In this prospective, observational study, white blood cell (WBC) count and serum concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and MIF among 108 severe traumatic brain injury (TBI) patients and 108 controls were measured. We determined whether serum MIF concentrations are associated with inflammation, severity, in-hospital major adverse events (IMAEs) (i.e., in hospital mortality, acute lung injury, acute traumatic coagulopathy, progressive hemorrhagic injury and posttraumatic cerebral infarction) and long-term clinical outcome (i.e., 6-month functional outcome) after TBI. Results: As compared to the controls, serum CRP, IL-6, TNF-a and MIF concentrations were significantly increased. MIF concentrations correlated with WBC count, CRP, IL-6 and TNF-alpha concentrations and Glasgow coma scale (GCS) scores. MIF in serum was independently associated with IMAEs and long-term clinical outcome. Area under receiver operating characteristic curve of MIF concentrations was similar to GCS scores'. Moreover, MIF concentrations markedly improved the predictive value of GCS scores for 6-month unfavorable outcome. Conclusion: Increased serum MIF concentrations have close relation to inflammation, trauma severity and clinical outcomes, substantializing MIF as a good prognostic biomarker after TBI.	[Yang, Ding-Bo] Tumor Hosp Hangzhou City, Dept Neurosurg, 34 Yanguan Lane, Hangzhou 310002, Zhejiang, Peoples R China; [Yu, Wen-Hua; Dong, Xiao-Qiao; Du, Quan; Zhu, Qiang; Che, Zhi-Hao; Wang, Hao; Shen, Yong-Feng; Jiang, Li] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China; [Zhang, Zu-Yong] Hangzhou Hosp Tradit Chinese Med, Dept Neurosurg, 453 Tiyuchang Rd, Hangzhou 310007, Zhejiang, Peoples R China		Dong, XQ (corresponding author), Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Neurosurg, 261 Huansha Rd, Hangzhou 310006, Zhejiang, Peoples R China.	dxqhyy@163.com			Zhejiang Province Medical and Health Project [2014KYA177, 2016RCB016]; Hangzhou Medical Research Fund Project [2014Z06, 2016Z10]	The authors thank the staffs in Department of Neurosurgery, The Hangzhou First People's Hospital (Hangzhou, China) for their technical support. This study was supported financially by Zhejiang Province Medical and Health Project (No. 2014KYA177, 2016RCB016) and Hangzhou Medical Research Fund Project (No. 2014Z06, 2016Z10).	Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Assis DN, 2014, HEPATOLOGY, V59, P580, DOI 10.1002/hep.26664; BERNARD GR, 1994, INTENS CARE MED, V20, P225, DOI 10.1007/BF01704707; Bernhagen Juergen, 1994, Trends in Microbiology, V2, P198, DOI 10.1016/0966-842X(94)90111-H; Calandra T, 1997, CRIT REV IMMUNOL, V17, P77, DOI 10.1615/CritRevImmunol.v17.i1.30; Capone-Neto A, 2009, CURR OPIN CRIT CARE, V15, P290, DOI 10.1097/MCC.0b013e32832e383e; Chuang CC, 2004, CRIT CARE MED, V32, P734, DOI 10.1097/01.CCM.0000117170.13320.F4; Chuang TY, 2014, INT J INFECT DIS, V20, P13, DOI 10.1016/j.ijid.2013.12.006; Cohen MJ, 2014, THROMB RES, V133, pS25, DOI 10.1016/j.thromres.2014.03.013; Dong XQ, 2010, CRIT CARE, V14, DOI 10.1186/cc9307; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Franschman G, 2012, J NEUROTRAUM, V29, P128, DOI 10.1089/neu.2011.2044; Frattalone AR, 2013, NEUROSURG CLIN N AM, V24, P309, DOI 10.1016/j.nec.2013.03.006; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harris T, 2012, POSTGRAD MED J, V88, P595, DOI 10.1136/postgradmedj-2011-130285; Hemmila MR, 2017, CRIT CARE CLIN, V33, P193, DOI 10.1016/j.ccc.2016.08.010; Inacio AR, 2011, J CEREBR BLOOD F MET, V31, P1093, DOI 10.1038/jcbfm.2010.194; Kim KW, 2016, KOREAN J INTERN MED, V31, P634, DOI 10.3904/kjim.2016.098; Koda M, 2004, ACTA NEUROPATHOL, V108, P31, DOI 10.1007/s00401-004-0853-z; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Latronico N, 2009, J TRAUMA, V66, P1745, DOI 10.1097/TA.0b013e3181a56c8b; Li Y, 2016, ADV MATER TECHNOL-US, V1, DOI 10.1002/admt.201600102; Lolis E, 1996, P ASSOC AM PHYSICIAN, V108, P415; Lv W, 2016, CANCER LETT, V375, P245, DOI 10.1016/j.canlet.2016.02.005; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MIRVIS SE, 1990, AM J ROENTGENOL, V154, P1293, DOI 10.2214/ajr.154.6.2110744; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Shen YF, 2016, CLIN CHIM ACTA, V456, P75, DOI 10.1016/j.cca.2016.02.029; Sheriff FG, 2015, SEMIN NEUROL, V35, P42, DOI 10.1055/s-0035-1544238; Sillesen M, 2014, J TRAUMA ACUTE CARE, V76, P12, DOI 10.1097/TA.0b013e3182aaa675; Su YH, 2016, ONCOTARGET; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Turtzo LC, 2013, NEUROBIOL DIS, V54, P421, DOI 10.1016/j.nbd.2013.01.016; Wang KY, 2012, CLIN CHIM ACTA, V413, P1737, DOI 10.1016/j.cca.2012.07.002; Wu GQ, 2016, CLIN CHIM ACTA, V458, P124, DOI 10.1016/j.cca.2016.05.001; Zammit Christopher, 2013, Emerg Med Pract, V15, P1; Zis O, 2015, MOL NEUROBIOL, V51, P155, DOI 10.1007/s12035-014-8727-4	38	18	21	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-8981	1873-3492		CLIN CHIM ACTA	Clin. Chim. Acta	JUN	2017	469						99	104		10.1016/j.cca.2017.03.030			6	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED)	Medical Laboratory Technology	EV6KU	WOS:000401879100016	28366792				2022-02-06	
J	Zuckerman, SL; Zalneraitis, BH; Totten, DJ; Rubel, KE; Kuhn, AW; Yengo-Kahn, AM; Bonfield, CM; Sills, AK; Solomon, GS				Zuckerman, Scott L.; Zalneraitis, Brian Holt; Totten, Douglas J.; Rubel, Kolin E.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Sills, Allen K.; Solomon, Gary S.			Socioeconomic status and outcomes after sport-related concussion: a preliminary investigation	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						socioeconomic status; sports-related concussion; traumatic brain injury; football; basketball; soccer; athletics; postconcussion syndrome; trauma	TRAUMATIC BRAIN-INJURY; RISK-FACTORS; PROLONGED RECOVERY; HIGH-SCHOOL; SHORT-TERM; PREDICTORS; HEALTH; PREVALENCE; SYMPTOMS; CHILDREN	OBJECTIVE. A significant proportion of patients experience long-term symptoms after sport-related concussion (SRC), and several factors have been associated with this protracted recovery. Limited data exist on the role of socioeconomic status (SES) on SRC outcomes. The objective in this study was to conduct a preliminary investigation to determine the effect of SES on outcomes after SRC in student-athletes treated at a regional sports concussion center. METHODS. A retrospective cohort study of 282 middle school, high school, and collegiate student-athletes was conducted. An attempt was made to contact all patients seen at a comprehensive SRC center between January 2012 and May 2015 for, in-depth interviews. Subsequent demographic data were collected. The SES was defined as follows: cost of living percentile, median income percentile, percentage of college graduates, percentage of homeowners, county type, and insurance status. Outcomes after SRC were defined as follows: days of symptom duration, days of missed school, and days of missed practice. Statistically controlled covariates included sex, race, age, body mass index, concussion history, neuropsychiatric history, and type of sport. RESULTS. A total of 282 student-athletes consented and were studied. The median age was 15.8 years (range 11.6-22.2 years) and 61.4% of student-athletes were male. A previous concussion was incurred by 34.0% of student-athletes. Football was the most common sport (32.3%), followed by soccer (16.3%), and basketball (15.6%). The median symptom duration was 21 days (range 1-365 days); the median missed school days was 2 (range 0-90 days); and median for days of missed practice was 10 (range 0-150 days). After multivariate Cox regression analysis, no relationship between any of the 6 SES variables and symptom duration or missed practice was seen. However, individuals with private insurance had more missed days of school than those with public insurance (hazard ratio 0.46, 95% CI 0.26-0.83, p = 0.009). CONCLUSIONS. In a preliminary study of middle school, high school, and collegiate student-athletes,. SES had no impact on the outcomes of symptom duration and missed practice. However, for individuals with private insurance, the return to school was slower than for those with public insurance. This pilot study reveals the complex relationship between SES and SRC recovery, which demands further study with more accurate and validated assessments of SES.	[Zuckerman, Scott L.; Zalneraitis, Brian Holt; Totten, Douglas J.; Kuhn, Andrew W.; Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Zuckerman, Scott L.; Yengo-Kahn, Aaron M.; Bonfield, Christopher M.; Sills, Allen K.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Rubel, Kolin E.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA		Zuckerman, SL (corresponding author), Vanderbilt Univ, Sch Med, Dept Neurol Surg, Med Ctr, North T-4224, Nashville, TN 37212 USA.	scott.zuckerman@vanderbilt.edu	Kuhn, Andrew W/AAM-4820-2020; Solomon, Gary/K-9011-2019; Yengo-Kahn, Aaron/AAV-7647-2020	Kuhn, Andrew W/0000-0003-1836-7575; Yengo-Kahn, Aaron/0000-0002-5989-3064; Totten, Douglas/0000-0002-0665-9653	Tennessee Titans (National Football League [NFL]); Nashville Predators (National Hockey League); athletic departments for several universities (University of Tennessee, Tennessee Tech)	Dr. Solomon receives consulting fees from the Tennessee Titans (National Football League [NFL]), the Nashville Predators (National Hockey League), and the athletic departments for several universities (University of Tennessee, Tennessee Tech fees paid to institution). In addition he is a member of the ImPACT Scientific Advisory Board and receives reimbursement for expenses to board meetings. Dr. Sills is a consulting physician to the Nashville Predators (uncompensated) and also serves as an unaffiliated neurotrauma consultant for the NFL. Dr. Bonfield serves as an unaffiliated neurotrauma consultant for the NFL. Dr. Zuckerman, Mr. Totten. Mr. Rubel, Mr. Kuhn, Mr. Zalneraitis, and Dr. Yengo-Kahn report no conflicts.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; Carson JD, 2014, CAN FAM PHYSICIAN, V60, pE310; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Doocy Shannon, 2006, World Health Popul, V8, P32; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hart T, 2016, ARCH PHYS MED REHAB, V97, P701, DOI 10.1016/j.apmr.2015.08.436; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Ingram DD., 2014, 2013 NCHS URBAN RURA; Kasamatsu T, 2016, J ATHL TRAINING, V51, P153, DOI 10.4085/1062-6050-51.4.02; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu W. M., 2001, INTERSECTION RACE CL; Marcin JP, 2003, AM J PUBLIC HEALTH, V93, P461, DOI 10.2105/AJPH.93.3.461; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1032, DOI 10.1097/01.chi.0000173293.05817.b1; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Oakes JM, 2003, SOC SCI MED, V56, P769, DOI 10.1016/S0277-9536(02)00073-4; Olsson KA, 2013, BRAIN INJURY, V27, P145, DOI 10.3109/02699052.2012.729286; Penson DF, 2001, J CLIN EPIDEMIOL, V54, P350, DOI 10.1016/S0895-4356(00)00312-7; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Upchurch C, 2015, CLIN J SPORT MED, V25, P297, DOI 10.1097/JSM.0000000000000123; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; Wijtzes AI, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/s12966-014-0155-3; WINKLEBY MA, 1992, AM J PUBLIC HEALTH, V82, P816, DOI 10.2105/AJPH.82.6.816; Yeates KO, 2004, J INT NEUROPSYCH SOC, V10, P412, DOI 10.1017/S1355617704103093; Zuckerman SL, NEUROSURG FOCUS, V40, pE13	33	18	18	1	12	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2017	19	6					652	661		10.3171/2017.1.PEDS16611			10	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Pediatrics; Surgery	EV6OW	WOS:000401889700006	28338445	Bronze			2022-02-06	
J	Sussman, D; da Costa, L; Chakrayarty, MM; Pang, EW; Taylor, MJ; Dunkley, BT				Sussman, Dafna; da Costa, Leodante; Chakrayarty, Mallar M.; Pang, Elizabeth W.; Taylor, Margot J.; Dunkley, Benjamin T.			Concussion induces focal and widespread neuromorphological changes	NEUROSCIENCE LETTERS			English	Article						Concussion; MRI; Cortical thickness; Cortical volume; Cerebellum	TRAUMATIC BRAIN-INJURY; MILD; MRI; SEGMENTATION; CONNECTIVITY; HIPPOCAMPUS; CORTEX	Concussion induces transient, and oftentimes chronic, lingering impairment to mental functioning, which must be driven by some underlying neurobiological perturbation - however, the physical changes related to sequelae are difficult to detect. Previous imaging studies on concussion have focused on alterations to cortical anatomy, but few have examined the cerebrum, subcortex, and cerebellum. Here, we present an analysis of these structures in a single cohort (all males, 21 patients, 22 controls) using MRI and diagnosed with a single-concussive episode in the acute and sub-acute stages of injury. Structural images were segmented into 78 cortical brain regions and 81,924 vertices using the CIVET algorithm. Sub cortical volumetric analyses of the cerebellum, thalamus, globus pallidus, caudate and putamen were conducted following segmentation. Participants with concussion were found to have reduced white and grey matter volume, total cortical volume, as well as cortical thinning, primarily in left frontal areas. No differences were observed in the cerebellum or subcortical structures. In conclusion, just a single concussive episode induces measurable changes in brain structure manifesting as diffuse and local patterns of altered neuromorphometry. Crown Copyright (C) 2017 Published by Elsevier Ireland Ltd.	[Sussman, Dafna] Hosp Sick Children, Physiol & Expt Med, Toronto, ON, Canada; [da Costa, Leodante] Sunnybrook Med Ctr, Div Neurosurg, Toronto, ON, Canada; [Chakrayarty, Mallar M.] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Montreal, PQ, Canada; [Chakrayarty, Mallar M.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chakrayarty, Mallar M.] McGill Univ, Dept Biol & Biomed Engn, Montreal, PQ, Canada; [Pang, Elizabeth W.] Hosp Sick Children, Neurol, Toronto, ON, Canada; [Taylor, Margot J.; Dunkley, Benjamin T.] Hosp Sick Children, Diagnost Imaging, Toronto, ON, Canada; [Dunkley, Benjamin T.] Univ Toronto, Dept Med Imaging, Toronto, ON, Canada		Dunkley, BT (corresponding author), Hosp Sick Chidlren, Dept Diagnost Imaging, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	ben.dunkley@sickkids.ca		Dunkley, Ben/0000-0001-6173-1171	Defence Research and Development Canada [W7719-135182/001/TOR]	This study was supported by a Defence Research and Development Canada contract (W7719-135182/001/TOR) to MJT and EWP.	Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benjamini Y, 2001, ANN STAT, V29, P1165; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Chakravarty MM, 2006, LECT NOTES COMPUT SC, V4191, P389; Chakravarty MM, 2013, HUM BRAIN MAPP, V34, P2635, DOI 10.1002/hbm.22092; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Collins DL, 2010, NEUROIMAGE, V52, P1355, DOI 10.1016/j.neuroimage.2010.04.193; Costa L. da, 2014, J NEUROL NEUROSUR PS, P1; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Evaluation S., 2009, BRIT J SPORT MED, V43, P1; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hamberger A, 2009, NEUROSURGERY, V64, P1174, DOI 10.1227/01.NEU.0000316855.40986.2A; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hovda D.A., 2016, CONCUSSION, V2012, P28; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Kabani N, 2001, NEUROIMAGE, V13, P375, DOI 10.1006/nimg.2000.0652; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; Lewen A, 1999, ACTA NEUROCHIR, V141, P193, DOI 10.1007/s007010050286; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Meabon JS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaa9585; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Misic B, 2016, J NEUROSCI, V36, P419, DOI 10.1523/JNEUROSCI.1506-15.2016; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Oh A, 2014, BRAIN COGNITION, V86, P90, DOI 10.1016/j.bandc.2014.02.006; Pang E.W., 2015, ANN CLIN TRANSL NEUR; Park MTM, 2014, NEUROIMAGE, V95, P217, DOI 10.1016/j.neuroimage.2014.03.037; Pipitone J, 2014, NEUROIMAGE, V101, P494, DOI 10.1016/j.neuroimage.2014.04.054; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; RUTHERFORD WH, 1977, LANCET, V1, P1; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Sponheim SR, 2011, NEUROIMAGE, V54, pS21, DOI 10.1016/j.neuroimage.2010.09.007; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; TEASDALE G, 1974, LANCET, V2, P81; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wechsler D., 2011, WECHSLER ABBREVIATED; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	55	18	19	1	17	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	MAY 22	2017	650						52	59		10.1016/j.neulet.2017.04.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EW2XK	WOS:000402359100009	28428014	hybrid			2022-02-06	
J	Yap, YC; King, AE; Guijt, RM; Jiang, TC; Blizzard, CA; Breadmore, MC; Dickson, TC				Yap, Yiing C.; King, Anna E.; Guijt, Rosanne M.; Jiang, Tongcui; Blizzard, Catherine A.; Breadmore, Michael C.; Dickson, Tracey C.			Mild and repetitive very mild axonal stretch injury triggers cystoskeletal mislocalization and growth cone collapse	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; TRANSGENIC MOUSE MODEL; COGNITIVE IMPAIRMENT; MICROTUBULES; DEGENERATION; TRANSPORT; NEUROFILAMENTS; VULNERABILITY; CYTOSKELETAL; REGENERATION	Diffuse axonal injury is a hallmark pathological consequence of non-penetrative traumatic brain injury (TBI) and yet the axonal responses to stretch injury are not fully understood at the cellular level. Here, we investigated the effects of mild (5%), very mild (0.5%) and repetitive very mild (2x0.5%) axonal stretch injury on primary cortical neurons using a recently developed compartmentalized in vitro model. We found that very mild and mild levels of stretch injury resulted in the formation of smaller growth cones at the tips of axons and a significantly higher number of collapsed structures compared to those present in uninjured cultures, when measured at both 24 h and 72 h post injury. Immunocytochemistry studies revealed that at 72 h following mild injury the axonal growth cones had a significantly higher colocalization of ss III tubulin and F-actin and higher percentage of collapsed morphology than those present following a very mild injury. Interestingly, cultures that received a second very mild stretch injury, 24 h after the first insult, had a further increased proportion of growth cone collapse and increased ss III tubulin and F-actin colocalization, compared with a single very mild injury at 72 h PI. In addition, our results demonstrated that microtubule stabilization of axons using brain penetrant Epothilone D (EpoD) (100 nM) resulted in a significant reduction in the number of fragmented axons following mild injury. Collectively, these results suggest that mild and very mild stretch injury to a very localized region of the cortical axon is able to trigger a degenerative response characterized by growth cone collapse and significant abnormal cytoskeletal rearrangement. Furthermore, repetitive very mild stretch injury significantly exacerbated this response. Results suggest that axonal degeneration following stretch injury involves destabilization of the microtubule cytoskeleton and hence treatment with EpoD reduced fragmentation. Together, these results contribute a better understanding of the pathogenesis of mild and repetitive TBI and highlight the therapeutic effect of microtubule targeted drugs on distal part of neurons using a compartmentalized culturing model.	[Yap, Yiing C.; Jiang, Tongcui; Blizzard, Catherine A.; Dickson, Tracey C.] Univ Tasmania, Menzies Inst Med Res, Hobart, Australia; [Yap, Yiing C.; King, Anna E.] Univ Tasmania, Wicking Dementia Res & Educ Ctr, Hobart, Australia; [Yap, Yiing C.; Guijt, Rosanne M.] Univ Tasmania, Pharm Sch Med, Australian Ctr Res Separat Sci ACROSS, Hobart, Australia; [Yap, Yiing C.; Breadmore, Michael C.] Univ Tasmania, Sch Phys Sci, ACROSS, Hobart, Australia		Dickson, TC (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Australia.	Tracey.Dickson@utas.edu.au	Breadmore, Michael/J-7628-2014; Guijt, Rosanne Marieke/R-2428-2017; King, Anna/J-7927-2014	Breadmore, Michael/0000-0001-5591-4326; Guijt, Rosanne Marieke/0000-0003-0011-5708; King, Anna/0000-0003-1792-0965; Blizzard, Catherine/0000-0002-8683-2937; Dickson, Tracey/0000-0002-9196-1661	Select Foundation; Wicking Dementia Research and Education Centre; Australian Research CouncilAustralian Research Council; ARC Discovery ProjectAustralian Research Council [DP150100998]; UTAS Pro Vice Chancellor for Research; UTAS Cross Theme Grant; NHMRC project grantNational Health and Medical Research Council of Australia [APP1042556]; NHMRC project grantNational Health and Medical Research Council of Australia	This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant (APP1042556) to TD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Mr Graeme McCormark, Miss Clara Lee, Mr Justin Dittman and Mr John Davis for their technical assistance in completing this work. This research is supported by Select Foundation (Fellowship to TD), the Wicking Dementia Research and Education Centre (Fellowship to AK), Australian Research Council (Future Fellowship to MCB), ARC Discovery Project Grant (DP150100998), UTAS Pro Vice Chancellor for Research and UTAS Cross Theme Grant and NHMRC project grant to TD.	Adlard PA, 2000, ACTA NEUROPATHOL, V100, P183, DOI 10.1007/s004019900160; Andrieux A, 2006, BIOL PSYCHIAT, V60, P1224, DOI 10.1016/j.biopsych.2006.03.048; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Bradke F, 2012, NAT REV NEUROSCI, V13, P183, DOI 10.1038/nrn3176; Brizuela M, 2015, MOL CELL NEUROSCI, V66, P129, DOI 10.1016/j.mcn.2015.02.006; Brunden KR, 2010, J NEUROSCI, V30, P13861, DOI 10.1523/JNEUROSCI.3059-10.2010; Childs WR, 2005, LANGMUIR, V21, P10096, DOI 10.1021/la050011b; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; Chuckowree JA, 2003, J NEUROSCI, V23, P3715; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Farkas O, 2007, PROGR BRAIN RES, V161, P43; Finn JT, 2000, J NEUROSCI, V20, P1333; Folkerts MM, 1998, J NEUROTRAUM, V15, P349, DOI 10.1089/neu.1998.15.349; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Hill CE, 2001, EXP NEUROL, V171, P153, DOI 10.1006/exnr.2001.7734; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Jang EH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/5056418; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; King CE, 2000, CLIN EXP PHARMACOL P, V27, P548, DOI 10.1046/j.1440-1681.2000.03292.x; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; Maxwell WL, 1997, J NEUROTRAUM, V14, P603, DOI 10.1089/neu.1997.14.603; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller CCJ, 2002, CELL MOL LIFE SCI, V59, P323, DOI 10.1007/s00018-002-8425-7; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Mueller BK, 2009, BRIT J PHARMACOL, V157, P675, DOI 10.1111/j.1476-5381.2009.00220.x; Osterloh JM, 2012, SCIENCE, V337, P481, DOI 10.1126/science.1223899; Peyrin JM, 2011, LAB CHIP, V11, P3663, DOI 10.1039/c1lc20014c; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Richter M, 2007, J NEUROSCI, V27, P14205, DOI 10.1523/JNEUROSCI.2746-07.2007; Saatman KE, 1998, J NEUROTRAUM, V15, P1047, DOI 10.1089/neu.1998.15.1047; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor AM, 2003, LANGMUIR, V19, P1551, DOI 10.1021/la026417v; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Vickers JC, 2009, BRAIN RES BULL, V80, P217, DOI 10.1016/j.brainresbull.2009.08.004; Weber JT, 2007, PROG BRAIN RES, V161, P253, DOI 10.1016/S0079-6123(06)61018-2; Yap YC, 2014, BIOMICROFLUIDICS, V8, DOI 10.1063/1.4891098; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161	54	18	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 4	2017	12	5							e0176997	10.1371/journal.pone.0176997			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET9SP	WOS:000400648500112	28472086	Green Published, Green Accepted, gold, Green Submitted			2022-02-06	
J	Cnossen, MC; Lingsma, HF; Tenovuo, O; Maas, AIR; Menon, D; Steyerberg, EW; Ribbers, GM; Polinder, S				Cnossen, Maryse C.; Lingsma, Hester F.; Tenovuo, Olli; Maas, Andrew I. R.; Menon, David; Steyerberg, Ewout. W.; Ribbers, Gerard M.; Polinder, Suzanne		CENTER-TBI Investigators	REHABILITATION AFTER TRAUMATIC BRAIN INJURY: A SURVEY IN 70 EUROPEAN NEUROTRAUMA CENTRES PARTICIPATING IN THE CENTER-TBI STUDY	JOURNAL OF REHABILITATION MEDICINE			English	Article						brain injuries; rehabilitation; health services research; survey; Europe	INPATIENT REHABILITATION; OUTCOMES; DISPARITIES; CHALLENGES; GUIDELINES; DISCHARGE; CARE	Objective: To describe variation in structural and process characteristics of acute in-hospital rehabilitation and referral to post-acute care for patients with traumatic brain injury across Europe. Design: Survey study, of neurotrauma centres. Methods: A 14-item survey about in-hospital rehabilitation and referral to post-acute care was sent to 71 neurotrauma centres participating in a European multicentre study (CENTER-TBI). The questionnaire was developed based on literature and expert opinion and was pilot-tested before sending out to the centres. Results: Seventy (99%) centres in 20 countries completed the survey. The included centres were predominately academic level I trauma centres. Among the 70 centres, a multidisciplinary rehabilitation team can be consulted at 41% (n = 29) of the intensive care units and 49% (n = 34) of the wards. Only 13 (19%) centres used rehabilitation guidelines in patients with traumatic brain injury. Age was reported as a major determinant of referral decisions in 32 (46%) centres, with younger patients usually referred to specialized rehabilitation centres, and patients = 65 years also referred to nursing homes or local hospitals. Conclusion: Substantial variation exists in structural and process characteristics of in-hospital acute rehabilitation and referral to post-acute rehabilitation facilities among neurotrauma centres across Europe.	[Cnossen, Maryse C.; Lingsma, Hester F.; Steyerberg, Ewout. W.; Polinder, Suzanne] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, NL-3015CN Rotterdam, Netherlands; [Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Dept Rehabil & Brain Trauma, Turku, Finland; [Tenovuo, Olli] Univ Turku, Dept Neurol, Turku, Finland; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Menon, David] Univ Cambridge, Div Anaesthesia, Addenbrookes Hosp, Cambridge, England; [Ribbers, Gerard M.] Erasmus MC, Rijndam Rehabil Ctr, Rotterdam, Netherlands; [Ribbers, Gerard M.] Erasmus MC, Dept Rehabil Med, Rotterdam, Netherlands		Cnossen, MC (corresponding author), Erasmus MC, Dept Publ Hlth, Ctr Med Decis Sci, NL-3015CN Rotterdam, Netherlands.	m.c.cnossen@erasmusmc.nl	Ribbers, Gerard/N-3623-2019; Maas, Andrew IR/C-5584-2013; Badenes, Rafael/K-6628-2019; Ribbers, Gerard M/C-1454-2014	Maas, Andrew IR/0000-0003-1612-1264; Badenes, Rafael/0000-0001-7017-0150; Ribbers, Gerard M/0000-0002-6114-349X	European Commission 7th Framework program [602150]	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Commission 7th Framework program (602150).	Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Asemota AO, 2013, J NEUROTRAUM, V30, P2057, DOI 10.1089/neu.2013.3091; Borg J, 2011, AM J PHYS MED REHAB, V90, P65, DOI 10.1097/PHM.0b013e3181fc80e7; Brown AW, 2015, PM&R, V7, P3, DOI 10.1016/j.pmrj.2014.06.016; Carney N, 2016, NEUROSURGERY; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Checkley W, 2014, CRIT CARE MED, V42, P344, DOI 10.1097/CCM.0b013e3182a275d7; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Cnossen MC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161367; Cnossen MC, 2015, J NEUROTRAUMA; Dijkers M, 2013, NEUROREHABILITATION, V32, P233, DOI 10.3233/NRE-130841; Englum BR, 2011, J AM COLL SURGEONS, V213, P699, DOI 10.1016/j.jamcollsurg.2011.08.017; European Comission, 2007, REM RES PUBL PRIV SE; Francisco GE, 2007, BRAIN INJURY, V21, P1007, DOI 10.1080/02699050701559558; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS66, DOI 10.1016/j.apmr.2013.03.033; Hasenbein U, 2003, DISABIL REHABIL, V25, P136, DOI 10.1080/0963828021000024889; Heffernan DS, 2011, J TRAUMA, V70, P527, DOI 10.1097/TA.0b013e31820d0ed7; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Meagher AD, 2015, J NEUROSURG, V122, P595, DOI 10.3171/2014.10.JNS14187; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Pisa FE, 2015, BRAIN INJURY, V29, P508, DOI 10.3109/02699052.2014.992474; Ribbers GM, 2007, J HEAD TRAUMA REHAB, V22, P234, DOI 10.1097/01.HTR.0000281839.07968.32; Servadei F, 2016, WORLD NEUROSURG, V90, P657, DOI 10.1016/j.wneu.2016.02.013; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265	25	18	19	0	11	FOUNDATION REHABILITATION INFORMATION	UPPSALA	TRADGARDSGATAN 14, UPPSALA, SE-753 09, SWEDEN	1650-1977	1651-2081		J REHABIL MED	J. Rehabil. Med.	MAY	2017	49	5					395	401		10.2340/16501977-2216			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EV7YI	WOS:000401997100004	28440841	Green Published, gold, Green Submitted			2022-02-06	
J	Dams-O'Connor, K; Mellick, D; Dreer, LE; Hammond, FM; Hoffman, J; Landau, A; Zafonte, R; Pretz, C				Dams-O'Connor, Kristen; Mellick, Dave; Dreer, Laura E.; Hammond, Flora M.; Hoffman, Jeanne; Landau, Alexandra; Zafonte, Ross; Pretz, Christopher			Rehospitalization Over 10 Years Among Survivors of TBI: A National Institute on Disability, Independent Living, and Rehabilitation Research Traumatic Brain Injury Model Systems Study	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						chronic health; longitudinal outcomes; rehospitalization; traumatic brain injury	INPATIENT REHABILITATION; MULTICENTER ANALYSIS; AFTER-DISCHARGE; INDIVIDUALS; MORTALITY; DISEASE	Objective: To describe the rates and causes for rehospitalization over 10 years after moderate-severe traumatic brain injury (TBI), and to characterize longitudinal trajectories of the probability of rehospitalization using generalized linear mixed models and individual growth curve models conditioned on factors that help explain individual variability in rehospitalization risk over time. Design: Secondary analysis of data from a multicenter longitudinal cohort study. Setting: Acute inpatient rehabilitation facilities and community follow-up. Participants: Individuals 16 years and older with a primary diagnosis of TBI. Main Outcome Measures: Rehospitalization (and reason for rehospitalization) as reported by participants or proxy during follow-up telephone interviews at 1, 2, 5, and 10 years postinjury. Results: The greatest number of rehospitalizations occurred in the first year postinjury (27.8% of the sample), and the rates of rehospitalization remained largely stable (22.1%-23.4%) at 2, 5, and 10 years. Reasons for rehospitalization varied over time: Orthopedic and reconstructive surgery rehospitalizations were most common in year 1, whereas general health maintenance was most common by year 2 with rates increasing at each follow-up. Longitudinal models indicate that multiple demographic and injury-related factors are associated with the probability of rehospitalization over time. Conclusions: These findings can inform the content and timing of interventions to improve health and longevity after TBI.	[Dams-O'Connor, Kristen; Landau, Alexandra] Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA; [Mellick, Dave; Pretz, Christopher] Craig Hosp, Res Dept, Englewood, CO USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, Laura E.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL 35294 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Hoffman, Jeanne] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Zafonte, Ross] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Gen Hosp, Spaulding Rehabil Hosp,Dept Phys Med & Rehabil, Boston, MA USA		Dams-O'Connor, K (corresponding author), Icahn Sch Med Mt Sinai, Dept Rehabil Med, One Gustave Levy Pl,Box 1163, New York, NY 10029 USA.	mrlin@tmu.edu.tw			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [90DP0010-01-00]; New York TBI Model System [90DP0038-02-00]; Indiana University/Rehabilitation Hospital of Indiana TBI Model System [90DP0036-01-00]; University of Washington Traumatic Brain Injury Model System [90DP0031-01-00]; Spaulding-Harvard TBI Model System [2012P002490]; University of Alabama at Birmingham Traumatic Brain Injury Care System [90DP0044-01-00]; National Institutes of Health, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K01HD074651-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R43DP000010, U48DP000031, U48DP000036] Funding Source: NIH RePORTER	This work was funded by grants from the National Institute on Disability, Independent Living, and Rehabilitation Research to the Traumatic Brain Injury Model Systems National Data and Statistical Center (Grant Number is 90DP0010-01-00), the New York TBI Model System (Grant Number 90DP0038-02-00), Indiana University/Rehabilitation Hospital of Indiana TBI Model System (Grant Number 90DP0036-01-00), University of Washington Traumatic Brain Injury Model System (Grant Number 90DP0031-01-00), Spaulding-Harvard TBI Model System (Grant Number 2012P002490), University of Alabama at Birmingham Traumatic Brain Injury Care System (Grant Number 90DP0044-01-00), and by a grant from the National Institutes of Health, The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (Grant Number K01HD074651-01A1).	Ashley J, 2012, 2 ANN SANT CLAR VALL; Biester RC, 2016, PROF CASE MANAG, V21, P22, DOI 10.1097/NCM.0000000000000121; Boaz TL, 2015, AGING MENT HEALTH, P1; Carlson KF, 2012, J HEAD TRAUMA REHAB, V27, P14, DOI 10.1097/HTR.0b013e318236bd86; Centers for Medicare & Medicaid Services, 2013, SPEC ALL CAUS UNPL R; Cifu DX, 1999, ARCH PHYS MED REHAB, V80, P85, DOI 10.1016/S0003-9993(99)90312-X; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Davydow DS, 2014, J GEN INTERN MED, V29, P1362, DOI 10.1007/s11606-014-2916-8; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Granger CV, 2010, AM J PHYS MED REHAB, V89, P781, DOI 10.1097/PHM.0b013e3181f1c83a; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Harrison-Felix C, 2006, J HEAD TRAUMA REHAB, V21, P22, DOI 10.1097/00001199-200601000-00003; IBM SPSS Statistics for Windows, 2010, IBM SPSS STAT WIND C; Institute of Medicine, 2009, GULF WAR AND HLTH, V7; Kozlowski AJ, 2013, ARCH PHYS MED REHAB, V94, P589, DOI 10.1016/j.apmr.2012.08.199; Marwitz JH, 2001, J HEAD TRAUMA REHAB, V16, P307, DOI 10.1097/00001199-200108000-00002; Masel BE, 2015, J NEUROTRAUM, V32, P1833, DOI 10.1089/neu.2015.29004.bm; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1884, DOI 10.1016/j.apmr.2012.11.054; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Pretz CR, 2014, J HEAD TRAUMA REHAB, V29, pE65, DOI 10.1097/HTR.0000000000000025; Pretz CR, 2013, ARCH PHYS MED REHAB, V94, P579, DOI 10.1016/j.apmr.2012.08.197; Pretz CR, 2015, JOINT STAT M SEATTL; SAS, 2013, SAS COMP PROGR VERS; Saverino C, 2016, ARCH PHYS MED REHAB, V97, pS19, DOI 10.1016/j.apmr.2015.04.016; Selassie AW, 2005, J HEAD TRAUMA REHAB, V20, P257, DOI 10.1097/00001199-200505000-00008; Ventura T, 2010, ARCH PHYS MED REHAB, V91, P20, DOI 10.1016/j.apmr.2009.08.151; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569	29	18	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2017	32	3					147	157		10.1097/HTR.0000000000000263			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV4GM	WOS:000401716900001	28476056	Green Accepted			2022-02-06	
J	Helbok, R; Schiefecker, AJ; Friberg, C; Beer, R; Kofler, M; Rhomberg, P; Unterberger, I; Gizewski, E; Hauerberg, J; Moller, K; Lackner, P; Broessner, G; Pfausler, B; Ortler, M; Thome, C; Schmutzhard, E; Fabricius, M				Helbok, Raimund; Schiefecker, Alois Josef; Friberg, Christian; Beer, Ronny; Kofler, Mario; Rhomberg, Paul; Unterberger, Iris; Gizewski, Elke; Hauerberg, John; Moller, Kirsten; Lackner, Peter; Broessner, Gregor; Pfausler, Bettina; Ortler, Martin; Thome, Claudius; Schmutzhard, Erich; Fabricius, Martin			Spreading depolarizations in patients with spontaneous intracerebral hemorrhage: Association with perihematomal edema progression	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						Spreading depolarization; electrocorticography; intracerebral hemorrhage; perihematomal edema; secondary brain damage	ISCHEMIC NEUROLOGICAL DEFICITS; HEALTH-CARE PROFESSIONALS; EXTRACELLULAR POTASSIUM; SUBARACHNOID HEMORRHAGE; NATURAL-HISTORY; BRAIN; DEPRESSION; STROKE; MANAGEMENT; GUIDELINES	Pathophysiologic mechanisms of secondary brain injury after intracerebral hemorrhage and in particular mechanisms of perihematomal-edema progression remain incompletely understood. Recently, the role of spreading depolarizations in secondary brain injury was established in ischemic stroke, subarachnoid hemorrhage and traumatic brain injury patients. Its role in intracerebral hemorrhage patients and in particular the association with perihematomal-edema is not known. A total of 27 comatose intracerebral hemorrhage patients in whom hematoma evacuation and subdural electrocorticography was performed were studied prospectively. Hematoma evacuation and subdural strip electrode placement was performed within the first 24 h in 18 patients (67%). Electrocorticography recordings started 3 h after surgery (IQR, 3-5 h) and lasted 157 h (median) per patient and 4876 h in all 27 patients. In 18 patients (67%), a total of 650 spreading depolarizations were observed. Spreading depolarizations were more common in the initial days with a peak incidence on day 2. Median electrocorticography depression time was longer than previously reported (14.7 min, IQR, 9-22min). Postoperative perihematomal-edema progression (85% of patients) was significantly associated with occurrence of isolated and clustered spreading depolarizations. Monitoring of spreading depolarizations may help to better understand pathophysiologic mechanisms of secondary insults after intracerebral hemorrhage. Whether they may serve as target in the treatment of intracerebral hemorrhage deserves further research.	[Helbok, Raimund; Schiefecker, Alois Josef; Beer, Ronny; Kofler, Mario; Unterberger, Iris; Lackner, Peter; Broessner, Gregor; Pfausler, Bettina; Schmutzhard, Erich] Med Univ Innsbruck, Dept Neurol, Neurocrit Care Unit, Innsbruck, Austria; [Friberg, Christian; Fabricius, Martin] Rigshosp, Dept Clin Neurophysiol, Copenhagen, Denmark; [Rhomberg, Paul; Gizewski, Elke] Med Univ Innsbruck, Dept Neuroradiol, Innsbruck, Austria; [Hauerberg, John] Rigshosp, Dept Neurosurg, Copenhagen, Denmark; [Moller, Kirsten] Rigshosp, Dept Neuroanesthesiol, Copenhagen, Denmark; [Ortler, Martin; Thome, Claudius] Med Univ Innsbruck, Dept Neurosurg, Innsbruck, Austria		Helbok, R (corresponding author), Med Univ Innsbruck, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	raimund.helbok@tirol-kliniken.at	Moller, Kirsten/A-4751-2009; Helbok, Raimund/AAA-8361-2021	Moller, Kirsten/0000-0003-3058-1072; Gizewski, Elke Ruth/0000-0001-6859-8377	Austrian National Bank [OeNB-Nr.: 14082]; NovoNordisk FoundationNovo Nordisk Foundation; Toyota-Fonden	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by a grant of the Austrian National Bank (OeNB-Nr.: 14082), the NovoNordisk Foundation and the Toyota-Fonden.	Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Antunes AP, 2014, CRIT CARE, V18, DOI 10.1186/cc13916; Bereczki D, 2008, HEADACHE, V48, P1226, DOI 10.1111/j.1526-4610.2008.01183.x; Butcher KS, 2004, STROKE, V35, P1879, DOI 10.1161/01.STR.0000131807.54742.1a; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; de Crespigny AJ, 1999, STROKE, V30, P2212, DOI 10.1161/01.STR.30.10.2212; DOCZI T, 1985, ACTA NEUROCHIR, V77, P110, DOI 10.1007/BF01476215; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2017, J CEREBR BLOOD F MET, V37, P1595, DOI 10.1177/0271678X16654496; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2012, BRAIN, V135, P259, DOI 10.1093/brain/awr303; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; Dreier JP, 1998, J CEREBR BLOOD F MET, V18, P978, DOI 10.1097/00004647-199809000-00007; Dreier JP, 2000, J NEUROSURG, V93, P658, DOI 10.3171/jns.2000.93.4.0658; Drenckhahn C, 2012, BRAIN, V135, P853, DOI 10.1093/brain/aws010; Elijovich L, 2008, SEMIN NEUROL, V28, P657, DOI 10.1055/s-0028-1105974; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Gingrich MB, 2000, J NEUROSCI, V20, P4582, DOI 10.1523/JNEUROSCI.20-12-04582.2000; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Gursoy-Ozdemir Y, 2004, J CLIN INVEST, V113, P1447, DOI 10.1172/JCI200421227; Hartings JA, 2016, J CEREBR BL IN PRESS; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Herweh C, 2010, J NEUROIMAGING, V20, P350, DOI 10.1111/j.1552-6569.2009.00408.x; HUBSCHMANN OR, 1983, J NEUROSURG, V59, P289, DOI 10.3171/jns.1983.59.2.0289; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kempski O, 2000, ACT NEUR S, V76, P251; Kollmar R, 2012, INT J STROKE, V7, P168, DOI 10.1111/j.1747-4949.2011.00707.x; Kothari U, 1996, STROKE, V27, P1304, DOI 10.1161/01.STR.27.8.1304; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Leira R, 2004, NEUROLOGY, V63, P461, DOI 10.1212/01.WNL.0000133204.81153.AC; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Mun-Bryce S, 2001, BRAIN RES, V888, P248, DOI 10.1016/S0006-8993(00)03068-7; OBRENOVITCH TP, 1995, J NEUROPHYSIOL, V73, P2107, DOI 10.1152/jn.1995.73.5.2107; Ohta O., 1983, VASCULAR NEUROEFFECT, P353; Oliveira-Ferreira AI, 2010, J CEREBR BLOOD F MET, V30, P1504, DOI 10.1038/jcbfm.2010.40; Orakcioglu Berk, 2012, Acta Neurochir Suppl, V114, P369, DOI 10.1007/978-3-7091-0956-4_71; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Reinert M, 2000, Neurosurg Focus, V8, pe10; Rincon F, 2014, INT J STROKE, V9, P646, DOI 10.1111/ijs.12220; Risher WC, 2010, J NEUROSCI, V30, P9859, DOI 10.1523/JNEUROSCI.1917-10.2010; ROPPER AH, 1986, NEW ENGL J MED, V314, P953, DOI 10.1056/NEJM198604103141504; Sakowitz OW, 2013, STROKE, V44, P220, DOI 10.1161/STROKEAHA.112.672352; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Schiefecker AJ, 2015, NEUROCRIT CARE, V22, P293, DOI 10.1007/s12028-014-0050-4; Seule M, 2015, NEUROCRIT CARE, V23, P108, DOI 10.1007/s12028-015-0111-3; Steiner T, 2014, INT J STROKE, V9, P840, DOI 10.1111/ijs.12309; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; The Brain Trauma Foundation. The American Association of Neurological Surgeons. The Joint Section on Neurotrauma and Critical Care, 2000, J NEUROTRAUM, V17, P597; Venkatasubramanian C, 2011, STROKE, V42, P73, DOI 10.1161/STROKEAHA.110.590646; Zazulia AR, 1999, STROKE, V30, P1167, DOI 10.1161/01.STR.30.6.1167; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	58	18	18	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	MAY	2017	37	5					1871	1882		10.1177/0271678X16651269			12	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	ET8CG	WOS:000400525200023	27207168	Green Published, Bronze			2022-02-06	
J	Seo, JS; Lee, S; Shin, JY; Hwang, YJ; Cho, H; Yoo, SK; Kim, Y; Lim, S; Kim, YK; Hwang, EM; Kim, SH; Kim, CH; Hyeon, SJ; Yun, JY; Kim, J; Kim, Y; Alvarez, VE; Stein, TD; Lee, J; Kim, DJ; Kim, JI; Kowall, NW; Ryu, H; McKee, AC				Seo, Jeong-Sun; Lee, Seungbok; Shin, Jong-Yeon; Hwang, Yu Jin; Cho, Hyesun; Yoo, Seong-Keun; Kim, Yunha; Lim, Sungsu; Kim, Yun Kyung; Hwang, Eun Mi; Kim, Su Hyun; Kim, Chong-Hyun; Hyeon, Seung Jae; Yun, Ji-Young; Kim, Jihye; Kim, Yona; Alvarez, Victor E.; Stein, Thor D.; Lee, Junghee; Kim, Dong Jin; Kim, Jong-Il; Kowall, Neil W.; Ryu, Hoon; McKee, Ann C.			Transcriptome analyses of chronic traumatic encephalopathy show alterations in protein phosphatase expression associated with tauopathy	EXPERIMENTAL AND MOLECULAR MEDICINE			English	Article							DISEASE; EPIDEMIOLOGY; CALCINEURIN	Chronic traumatic encephalopathy (CTE) is a progressive neurodegenerative disorder that is associated with repetitive head injury and has distinctive neuropathological features that differentiate this disease from other neurodegenerative diseases. Intraneuronal tau aggregates, although they occur in different patterns, are diagnostic neuropathological features of CTE, but the precise mechanism of tauopathy is not known in CTE. We performed whole RNA sequencing analysis of post-mortem brain tissue from patients with CTE and compared the results to normal controls to determine the transcriptome signature changes associated with CTE. The results showed that the genes related to the MAP kinase and calcium-signaling pathways were significantly downregulated in CTE. The altered expression of protein phosphatases (PPs) in these networks further suggested that the tauopathy observed in CTE involves common pathological mechanisms similar to Alzheimer's disease (AD). Using cell lines and animal models, we also showed that reduced PPP3CA/PP2B phosphatase activity is directly associated with increases in phosphorylated (p)-tau proteins. These findings provide important insights into PP-dependent neurodegeneration and may lead to novel therapeutic approaches to reduce the tauopathy associated with CTE.	[Seo, Jeong-Sun; Lee, Seungbok; Shin, Jong-Yeon; Cho, Hyesun; Yoo, Seong-Keun; Yun, Ji-Young; Kim, Jihye; Kim, Jong-Il] Seoul Natl Univ, Genom Med Inst, Med Res Ctr, Med Sci Bldg 405,28 Yongon Dong, Seoul 110799, South Korea; [Seo, Jeong-Sun; Cho, Hyesun; Kim, Jong-Il] Seoul Natl Univ, Dept Biochem & Mol Biol, Coll Med, Seoul, South Korea; [Seo, Jeong-Sun; Cho, Hyesun; Kim, Jong-Il] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Seo, Jeong-Sun; Shin, Jong-Yeon; Yun, Ji-Young; Kim, Jihye] Macrogen Inc, Seoul, South Korea; [Hwang, Yu Jin; Kim, Yunha; Lim, Sungsu; Kim, Yun Kyung; Hyeon, Seung Jae; Kim, Dong Jin; Ryu, Hoon] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neuromed, Seoul, South Korea; [Yoo, Seong-Keun] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul, South Korea; [Hwang, Eun Mi] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Funct Connect, Seoul, South Korea; [Kim, Su Hyun; Kim, Chong-Hyun] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul, South Korea; [Hwang, Eun Mi; Kim, Su Hyun] Univ Sci & Technol, Dept Neurosci, Daejeon, South Korea; [Kim, Yona] Seoul Natl Univ, Canc Res Inst, Coll Med, Dept Neurosurg, Seoul, South Korea; [Alvarez, Victor E.; Stein, Thor D.; McKee, Ann C.] Boston Univ, Sch Med, Ctr Study Traumat Encephalopathy, Boston, MA 02118 USA; [Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; Ryu, Hoon; McKee, Ann C.] VA Boston Healthcare Syst, Boston, MA USA; [Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; Ryu, Hoon; McKee, Ann C.] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Stein, Thor D.; Lee, Junghee; Kowall, Neil W.; Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA		Seo, JS (corresponding author), Seoul Natl Univ, Genom Med Inst, Med Res Ctr, Med Sci Bldg 405,28 Yongon Dong, Seoul 110799, South Korea.; Ryu, H; McKee, AC (corresponding author), Boston Univ, Sch Med, Dept Neurol, VA Boston Healthcare Syst, Res Bldg 1A,150 S Huntington Ave, Boston, MA 02130 USA.	jeongsun@snu.ac.kr; hoonryu@bu.edu; amckee@bu.edu	Kowall, Neil/M-5378-2019; KIM, Yunha/J-4698-2019; KIM, JONG-IL/D-1019-2011; Seo, Jeong-Sun/J-2763-2012	Kowall, Neil/0000-0002-6624-0213; KIM, JONG-IL/0000-0002-7240-3744; Yoo, Seong-Keun/0000-0002-8749-7050; Stein, Thor/0000-0001-6954-4477	Macrogen Inc. [MGR14-02]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS067283]; Brain Science Flagship Grant [2E26200, 2N41600]; Korea Institute of Science and TechnologyKorea Institute of Science & Technology (KIST) [2E26640 CHK]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1U01NS086659-01]; Department of Veterans Affairs, Veterans Affairs BiorepositoryUS Department of Veterans Affairs [CSP 501]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; National Institute of Aging Boston University Framingham Heart Study [R01AG1649]; Concussion Legacy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067283, U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG013846] Funding Source: NIH RePORTER	We thank Thomas Bleazard at Faculty of Medical and Human Sciences, University of Manchester for discussion and assistance with manuscript preparation. This work was financially supported by grants from Macrogen Inc. (grant no. MGR14-02), NIH R01 NS067283 (HR), Brain Science Flagship Grant (2E26200 and 2N41600 HR) and an intramural grant (2E26640 CHK) from the Korea Institute of Science and Technology. The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA). This work was financially supported by grants from the National Institute of Neurological Disorders and Stroke (1U01NS086659-01, Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501), the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5), the National Institute of Aging Boston University Framingham Heart Study (R01AG1649), and the Concussion Legacy Foundation. This work was also financially supported by unrestricted gifts from the Andlinger Foundation, the World Wrestling Entertainment and the National Football League.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Braithwaite SP, 2012, PROG MOL BIOL TRANSL, V106, P343, DOI 10.1016/B978-0-12-396456-4.00012-2; Chiocco MJ, 2010, SUBST USE MISUSE, V45, P1809, DOI 10.3109/10826084.2010.482449; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gandy S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-37; Gratuze M, 2015, HUM MOL GENET, V24, P86, DOI 10.1093/hmg/ddu456; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee J, 2013, ACTA NEUROPATHOL, V125, P727, DOI 10.1007/s00401-013-1103-z; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mychasiuk R, 2014, JOVE-J VIS EXP, DOI 10.3791/51820; Nowinski C, 2006, HEAD GAMES FOOTBALLS; Rahman A, 2006, J NEURAL TRANSM, V113, P219, DOI 10.1007/s00702-005-0313-5; Rahman A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006344; RUDELLI R, 1982, ARCH NEUROL-CHICAGO, V39, P570, DOI 10.1001/archneur.1982.00510210040009; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; STILLER JW, 1985, PSYCHIAT CLIN N AM, V8, P339; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tak H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081682; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	31	18	18	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1226-3613	2092-6413		EXP MOL MED	Exp. Mol. Med.	MAY	2017	49								e333	10.1038/emm.2017.56			12	Biochemistry & Molecular Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Research & Experimental Medicine	EY7HD	WOS:000404159600007	28524178	Green Published, gold			2022-02-06	
J	Struzyna, LA; Adewole, DO; Gordian-Velez, WJ; Grovola, MR; Burrell, JC; Katiyar, KS; Petrov, D; Harris, JP; Cullen, DK				Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.; Grovola, Michael R.; Burrell, Justin C.; Katiyar, Kritika S.; Petrov, Dmitriy; Harris, James P.; Cullen, D. Kacy			Anatomically Inspired Three-dimensional Micro-tissue Engineered Neural Networks for Nervous System Reconstruction, Modulation, and Modeling	JOVE-JOURNAL OF VISUALIZED EXPERIMENTS			English	Article						Neuroscience; Issue 123; Neural tissue engineering; biomaterials; living scaffolds; neurotrauma; neuroregeneration; neuromodulation; axonal pathways; synapses	STEM-CELL TRANSPLANTATION; AXON REGENERATION; LIVING SCAFFOLDS; RAT-BRAIN; CONSTRUCTS; STRATEGIES; GROWTH; INJURY; REPAIR; CNS	Functional recovery rarely occurs following injury or disease-induced degeneration within the central nervous system (CNS) due to the inhibitory environment and the limited capacity for neurogenesis. We are developing a strategy to simultaneously address neuronal and axonal pathway loss within the damaged CNS. This manuscript presents the fabrication protocol for micro-tissue engineered neural networks (micro-TENNs), implantable constructs consisting of neurons and aligned axonal tracts spanning the extracellular matrix (ECM) lumen of a preformed hydrogel cylinder hundreds of microns in diameter that may extend centimeters in length. Neuronal aggregates are delimited to the extremes of the three-dimensional encasement and are spanned by axonal projections. Micro-TENNs are uniquely poised as a strategy for CNS reconstruction, emulating aspects of brain connectome cytoarchitecture and potentially providing means for network replacement. The neuronal aggregates may synapse with host tissue to form new functional relays to restore and/or modulate missing or damaged circuitry. These constructs may also act as pro-regenerative "living scaffolds" capable of exploiting developmental mechanisms for cell migration and axonal pathfinding, providing synergistic structural and soluble cues based on the state of regeneration. Micro-TENNs are fabricated by pouring liquid hydrogel into a cylindrical mold containing a longitudinally centered needle. Once the hydrogel has gelled, the needle is removed, leaving a hollow micro-column. An ECM solution is added to the lumen to provide an environment suitable for neuronal adhesion and axonal outgrowth. Dissociated neurons are mechanically aggregated for precise seeding within one or both ends of the micro-column. This methodology reliably produces self-contained miniature constructs with long-projecting axonal tracts that may recapitulate features of brain neuroanatomy. Synaptic immunolabeling and genetically encoded calcium indicators suggest that micro-TENNs possess extensive synaptic distribution and intrinsic electrical activity. Consequently, micro-TENNs represent a promising strategy for targeted neurosurgical reconstruction of brain pathways and may also be applied as biofidelic models to study neurobiological phenomena in vitro.	[Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.] Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA 19104 USA; [Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.; Grovola, Michael R.; Burrell, Justin C.; Katiyar, Kritika S.; Petrov, Dmitriy; Harris, James P.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Struzyna, Laura A.; Adewole, Dayo O.; Gordian-Velez, Wisberty J.; Grovola, Michael R.; Burrell, Justin C.; Katiyar, Kritika S.; Petrov, Dmitriy; Harris, James P.; Cullen, D. Kacy] Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA; [Katiyar, Kritika S.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA		Cullen, DK (corresponding author), Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA.; Cullen, DK (corresponding author), Michael J Crescenz Vet Affairs Med Ctr, Ctr Neurotrauma Neurodegenerat & Restorat, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu	Burrell, Justin C./AAW-2310-2020	Burrell, Justin C./0000-0002-5361-9224; Grovola, Michael/0000-0003-4125-9329; Harris, James/0000-0002-8458-5434; Adewole, Dayo/0000-0003-4685-6974	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01-NS094340, T32-NS043126, F31-NS090746]; Michael J. Fox Foundation [9998]; Penn Medicine Neuroscience Center; National Science FoundationNational Science Foundation (NSF) [DGE-1321851]; Department of Veterans Affairs (RRD Merit Review)US Department of Veterans Affairs [B1097-I]; American Association of Neurological Surgeons and Congress of Neurological Surgeons; U.S. Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-207004, W81XWH-15-1-0466]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS090746, T32NS043126, U01NS094340] Funding Source: NIH RePORTER	Financial support was provided by the National Institutes of Health U01-NS094340 (Cullen), T32-NS043126 (Harris), and F31-NS090746 (Katiyar)), the Michael J. Fox Foundation (Therapeutic Pipeline Program #9998 (Cullen)), the Penn Medicine Neuroscience Center Pilot Award (Cullen), the National Science Foundation (Graduate Research Fellowships DGE-1321851 (Struzyna and Adewole)), the Department of Veterans Affairs (RR&D Merit Review #B1097-I (Cullen)), the American Association of Neurological Surgeons and Congress of Neurological Surgeons (2015-2016 Codman Fellowship in Neurotrauma and Critical Care (Petrov)), and the U.S. Army Medical Research and Materiel Command (#W81XWH-13-207004 (Cullen) and W81XWH-15-1-0466 (Cullen)).	Adewole Dayo O., 2016, Critical Reviews in Biomedical Engineering, V44, P123, DOI 10.1615/CritRevBiomedEng.2016017198; BENFEY M, 1982, NATURE, V296, P150, DOI 10.1038/296150a0; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Chen BK, 2009, J NEUROTRAUM, V26, P1759, DOI [10.1089/neu.2008.0610, 10.1089/neu.2008-0610]; Chen HI, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00001; Cheng HC, 2010, ANN NEUROL, V67, P715, DOI 10.1002/ana.21995; Chwalek K, 2015, NAT PROTOC, V10, P1362, DOI 10.1038/nprot.2015.091; Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434; Cullen DK, 2007, ANN BIOMED ENG, V35, P835, DOI 10.1007/s10439-007-9292-z; Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P241; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Cullen DK, 2008, J NEURAL ENG, V5, P374, DOI 10.1088/1741-2560/5/4/002; Curinga G, 2008, EXP NEUROL, V209, P333, DOI 10.1016/j.expneurol.2007.06.026; Dahotre N. B., 2008, LASER FABRICATION MA; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Denham M, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00011; Donaghue IE, 2014, J CONTROL RELEASE, V190, P219, DOI 10.1016/j.jconrel.2014.05.040; FAWCETT JW, 1995, EXP BRAIN RES, V106, P275; Ganguly K, 2013, NEURON, V80, P729, DOI 10.1016/j.neuron.2013.10.028; Gao YD, 2016, REGEN BIOMATER, V3, P115, DOI 10.1093/rb/rbw004; Han QQ, 2010, BIOMATERIALS, V31, P9212, DOI 10.1016/j.biomaterials.2010.08.040; Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019; Hinman JD, 2014, CURR OPIN NEUROL, V27, P615, DOI 10.1097/WCO.0000000000000149; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Howard MA, 2016, J NEUROPHYSIOL, V116, P472, DOI 10.1152/jn.00321.2016; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Huebner EA, 2009, RESULTS PROBL CELL D, V48, P339, DOI 10.1007/400_2009_19; Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006; Jain A, 2006, BIOMATERIALS, V27, P497, DOI 10.1016/j.biomaterials.2005.07.008; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Katiyar K. S., 2016, J TISSUE ENG REGEN M; Kutter J. P., 2004, J MICROMECHANICS MIC, V14; LaPlaca M. C., 2010, METHODS BIOENG 3D TI; Li XW, 2012, PROG POLYM SCI, V37, P1105, DOI 10.1016/j.progpolymsci.2012.02.004; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lu P, 2008, EXP NEUROL, V209, P313, DOI 10.1016/j.expneurol.2007.08.004; Mehta ST, 2016, EXP NEUROL, V280, P115, DOI 10.1016/j.expneurol.2016.03.004; Mine Y, 2013, NEUROBIOL DIS, V52, P191, DOI 10.1016/j.nbd.2012.12.006; Montani L, 2014, J NEUROSCI, V34, P4443, DOI 10.1523/JNEUROSCI.0320-14.2014; Moore MJ, 2006, BIOMATERIALS, V27, P419, DOI 10.1016/j.biomaterials.2005.07.045; Morrison B, 2011, STUD MECHANOBIOL TIS, V3, P247, DOI 10.1007/8415_2011_79; Pacifici M, 2012, JOVE-J VIS EXP, DOI 10.3791/3965; Ren HM, 2013, INT J CLIN EXP PATHO, V6, P230; Shoichet Molly S., 2008, P221; Silva NA, 2010, TISSUE ENG PT A, V16, P45, DOI [10.1089/ten.tea.2008.0559, 10.1089/ten.TEA.2008.0559]; Sinclair SR, 1999, EUR J NEUROSCI, V11, P4341, DOI 10.1046/j.1460-9568.1999.00867.x; Spicar-Mihalic P, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/6/067003; Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]; Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943; Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004; Suzuki H, 2015, MED MOL MORPHOL, V48, P214, DOI 10.1007/s00795-015-0104-5; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Tam RY, 2014, NEUROPSYCHOPHARMACOL, V39, P169, DOI 10.1038/npp.2013.237; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Tate MC, 2002, CELL TRANSPLANT, V11, P283; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; Vukasinovic J, 2009, BIOMED MICRODEVICES, V11, P1155, DOI 10.1007/s10544-009-9332-6; Wernig M, 2004, J NEUROSCI, V24, P5258, DOI 10.1523/JNEUROSCI.0428-04.200; Winter CC, 2016, ACTA BIOMATER, V38, P44, DOI 10.1016/j.actbio.2016.04.021; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yoo Sang Jin, 2011, Exp Neurobiol, V20, P110, DOI 10.5607/en.2011.20.2.110	65	18	19	1	13	JOURNAL OF VISUALIZED EXPERIMENTS	CAMBRIDGE	1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA	1940-087X			JOVE-J VIS EXP	J. Vis. Exp.	MAY	2017		123							e55609	10.3791/55609			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FB5WV	WOS:000406213900057	28605376	Green Published			2022-02-06	
J	Suzuki, Y; Khoury, S; El-Khatib, H; Chauny, JM; Paquet, J; Giguere, JF; Denis, R; Gosselin, N; Lavigne, GJ; Arbour, C				Suzuki, Yoshitaka; Khoury, Samar; El-Khatib, Hejar; Chauny, Jean-Marc; Paquet, Jean; Giguere, Jean-Francois; Denis, Ronald; Gosselin, Nadia; Lavigne, Gilles J.; Arbour, Caroline			Individuals with pain need more sleep in the early stage of mild traumatic brain injury	SLEEP MEDICINE			English	Article						Traumatic brain injury; Pain; Sleep; Actigraphy	PSYCHOMETRIC PROPERTIES; HEALTH SURVEY; QUALITY; HYPERSOMNIA; PREVALENCE; INVENTORY; SYMPTOMS; HEADACHE	Objective: Hypersomnia is frequently reported after mild traumatic brain injury (mTBI), but its cause(s) remain elusive. This study examined sleep/wake activity after mTBI and its association with pain, a comorbidity often associated with insomnia. Methods: Actigraphy recording was performed for 7 2 consecutive days in 56 individuals at one month post-mTBI (64% male; 38 +/- 12 years), 24 individuals at one year post-mTBI (58% male; 44 +/- 11years), and in 20 controls (50% male; 37 12 years). Pain intensity and its effect on quality of life was assessed with a visual analogue scale and the Short Form Health Survey (SF-36) bodily pain subscale. Results: Overall, few differences in sleep/wake patterns were found between mTBI patients and controls. However, higher percentages of mTBI individuals with moderate-to-severe pain were found to require more than eight hours of sleep per day (37% vs11%; p = 0.04) and to be frequent nappers (defined as those who took three or more naps per week) (42% vs 22%; p = 0.04) compared to those with mild or no pain at one month postinjury. Correcting for age and depression, The SF-36 score was found to be a significant predictor of sleep duration exceeding eight hours per day at one month (odds ratio = 0.95; 95% confidence interval = 0.92-0.99; p = 0.01), but not at one year post-mTBI. Pain and increased sleep need (in terms of hours per day or napping frequency) were found to co-exist in as much as 29% of mTBI patients at one month postinjury. Conclusion: Pain could be associated with more pronounced sleep need in about one-third of mTBI patients during early recovery. Unalleviated pain, found in more than 60% of mTBI patients, should therefore be looked for in all mTBI patients reporting new onset of sleep disorder, not only in those with insomnia. (C) 2016 Elsevier B.V. All rights reserved.	[Suzuki, Yoshitaka; El-Khatib, Hejar; Chauny, Jean-Marc; Paquet, Jean; Giguere, Jean-Francois; Denis, Ronald; Gosselin, Nadia; Lavigne, Gilles J.; Arbour, Caroline] Hop Sacre Coeur Montreal, Montreal, PQ, Canada; [Suzuki, Yoshitaka; Lavigne, Gilles J.] Univ Montreal, Fac Dent Med, Montreal, PQ, Canada; [Khoury, Samar] McGill Univ, Fac Dent, Montreal, PQ, Canada; [El-Khatib, Hejar; Gosselin, Nadia] Univ Montreal, Dept Psychol, Montreal, PQ, Canada; [Arbour, Caroline] Univ Montreal, Fac Nursing, Montreal, PQ, Canada		Arbour, C (corresponding author), Hop Sacre Coeur Montreal, Montreal, PQ, Canada.; Arbour, C (corresponding author), Univ Montreal, Fac Nursing, Montreal, PQ, Canada.	caroline.arbour@umontreal.ca			Quebec Pain Research Network of the Fonds de Recherche du Quebec-Sante (FRQ-S); trauma fund (R. Denis Foundation); Canadian Institutes of Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [115172]; Canada Research Chair on Pain, Sleep, and Traumatic Injuries	The authors would like to thank J.F.G. for his work on confirming mTBI diagnoses. This study was funded by the Quebec Pain Research Network of the Fonds de Recherche du Quebec-Sante (FRQ-S), a trauma fund (R. Denis Foundation), and our Hospital's Research Centre. Part of this study was also supported by the Canadian Institutes of Health Research (CIHR grant 115172) to N.G. G.L. holds a Canada Research Chair on Pain, Sleep, and Traumatic Injuries.	American Academy of Sleep Medicine, 2014, ICSD 3 INT CLASS SLE, V3rd; Ancoli-Israel S., 2011, PRINCIPLES PRACTICE, P1668, DOI 10.1016/B978-1-4160-6645-3.00147-X; Barloese M, 2015, CEPHALALGIA, V35, P869, DOI 10.1177/0333102414562971; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1988, CLIN PSYCHOL REV, V8, P77, DOI 10.1016/0272-7358(88)90050-5; Boivin DB, 2004, SLEEP, V27, P417, DOI 10.1093/sleep/27.3.417; Boyne K, 2013, SLEEP BREATH, V17, P411, DOI 10.1007/s11325-012-0709-z; Buchanan DT, 2014, J CLIN SLEEP MED, V10, P1003, DOI 10.5664/jcsm.4038; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Carney N, 2014, NEUROSURGERY, V75, pS1, DOI 10.1227/NEU.0000000000000434; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Dauvilliers Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-78; Dauvilliers Yves, 2005, Dialogues Clin Neurosci, V7, P347; Doan L, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/504691; Faul M, 2010, TRAUMATIC BRAIN INJU; GARLAND DE, 1980, J BONE JOINT SURG AM, V62, P1143, DOI 10.2106/00004623-198062070-00012; Guilfoyle MR, 2010, J NEUROTRAUM, V27, P2173, DOI 10.1089/neu.2010.1353; Haydel Micelle, 2012, Emerg Med Pract, V14, P1; HODDES E, 1972, PSYCHOPHYSIOLOGY, V9, P150; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Ju YES, 2013, JAMA NEUROL, V70, P587, DOI 10.1001/jamaneurol.2013.2334; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Khoury S, 2013, J NEUROTRAUM, V30, P633, DOI 10.1089/neu.2012.2519; Kosinski M, 1999, MED CARE, V37, pMS10, DOI 10.1097/00005650-199905001-00002; Lavigne G, 2015, PAIN, V156, pS75, DOI 10.1097/j.pain.0000000000000111; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; National Sleep Foundation (NSF), 2005, AD SLEEP HAB; Orlando JA, 1986, PAVLOVIAN J BIOL SCI, V21, P50; Pollak C. P., 2009, ENCY SLEEP SLEEP DIS; Quinto C, 2000, NEUROLOGY, V54, P250, DOI 10.1212/WNL.54.1.250; Sommerauer M, 2013, J SLEEP RES, V22, P634, DOI 10.1111/jsr.12068; Watson NF, 2007, J CLIN SLEEP MED, V3, P363; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	39	18	18	1	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	MAY	2017	33						36	42		10.1016/j.sleep.2016.06.033			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EV3SS	WOS:000401680000007	28449903				2022-02-06	
J	Vilcinis, R; Bunevicius, A; Tamasauskas, A				Vilcinis, Rimantas; Bunevicius, Adomas; Tamasauskas, Arimantas			The Association of Surgical Method with Outcomes of Acute Subdural Hematoma Patients: Experience with 643 Consecutive Patients	WORLD NEUROSURGERY			English	Article						Coma; Decompressive craniectomy; Outcome; Prognosis; Subdural hematoma	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; CLINICAL ARTICLE; CRANIOTOMY; MANAGEMENT; EVACUATION; TRIAL	OBJECTIVE: We investigated the association of decompressive craniectomy (DC) and osteoplastic craniotomy (OC) with outcomes in consecutive patients undergoing surgical evacuation of acute subdural hematoma (ASDH) and analyzed prognostic indicators to determine optimal surgical management strategy for patients with ASDH. METHODS: We performed a prospective review of all adult patients with ASDH operated on by craniotomy from January 2009 to January 2016. Mortality and discharge outcomes (Glasgow Outcome Scale) were analyzed as a function of surgical method adjusting for age, admission Glasgow Coma Scale score, ASDH thickness and midline shift. RESULTS: OC was performed in 394 (61%) patients, and DC was performed in 249 (39%) patients. Patients undergoing DC were younger, with lower Glasgow Coma Scale score, greater ASDH thickness, and greater midline shift (P < 0.001). Mortality rate (54% vs. 20%; P < 0.001) and proportion of patients with poor discharge outcomes (85% and 45%; P < 0.001) were greater in DC patients versus OC patients. Glasgow Outcome Scale score was lower and mortality rate was greater (P <= 0.048) in DC patients versus OC patients across all patient subgroups. Outcomes were similar between the 2 groups in patients with Glasgow Coma Scale score of 3 and midline shift of >= 2 cm. Adjusting for disease severity, DC remained associated with greater risk for in-hospital mortality (odds ratio = 3.442 [95% confidence interval 2.196-5.396], P < 0.001) and unfavorable discharge outcome (odds ratio [5.277 [95% confidence interval 3.030-9.191], P < 0.001). CONCLUSIONS: DC was performed more often in younger and more severely injured patients. DC is associated with greater mortality and handicap rates independent of disease severity. Clinical trials investigating optimal surgical management strategy of patients with ASDH are needed.	[Vilcinis, Rimantas; Bunevicius, Adomas; Tamasauskas, Arimantas] Hosp Lithuanian Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania; [Bunevicius, Adomas; Tamasauskas, Arimantas] Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania		Bunevicius, A (corresponding author), Hosp Lithuanian Univ Hlth Sci, Dept Neurosurg, Kaunas, Lithuania.; Bunevicius, A (corresponding author), Lithuanian Univ Hlth Sci, Neurosci Inst, Kaunas, Lithuania.	a.bunevicius@yahoo.com	Bunevicius, Adomas/I-3394-2019	Bunevicius, Adomas/0000-0003-0446-6898			Bunevicius A, 2013, J NEUROSURG, V118, P1279, DOI 10.3171/2013.1.JNS121696; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chen SH, 2011, J TRAUMA, V71, P1632, DOI 10.1097/TA.0b013e3182367b3c; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Hanif S, 2009, Ir Med J, V102, P255; Hartings JA, 2014, J NEUROSURG, V120, P434, DOI 10.3171/2013.9.JNS13581; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JENNETT B, 1975, LANCET, V1, P480; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kinoshita T, 2016, WORLD NEUROSURG, V89, P187, DOI 10.1016/j.wneu.2016.01.071; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Li XG, 2013, J CLIN NEUROSCI, V20, P509, DOI 10.1016/j.jocn.2012.04.019; Lund-Johansen M, 2011, WORLD NEUROSURG, V75, P454, DOI 10.1016/j.wneu.2011.01.020; Nguyen R, 2016, CAN J NEUROL SCI, V27, P1; Paci GM, 2009, J TRAUMA, V67, P531, DOI 10.1097/TA.0b013e3181b840e8; Tanrikulu L, 2015, CLIN NEUROL NEUROSUR, V135, P15, DOI 10.1016/j.clineuro.2015.04.019; Walcott BP, 2013, WORLD NEUROSURG, V79, P80, DOI 10.1016/j.wneu.2012.11.014; Wang JW, 2016, J CLIN NEUROSCI, V27, P1, DOI 10.1016/j.jocn.2015.06.037	22	18	18	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAY	2017	101						335	342		10.1016/j.wneu.2017.02.010			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EV7CR	WOS:000401932500044	28216211				2022-02-06	
J	Robertsen, A; Forde, R; Skaga, NO; Helseth, E				Robertsen, Annette; Forde, Reidun; Skaga, Nils Oddvar; Helseth, Eirik			Treatment-limiting decisions in patients with severe traumatic brain injury in a Norwegian regional trauma center	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Withholding treatment; Futility; Potentially inappropriate treatment; Traumatic brain injury; Decision-making	INTENSIVE-CARE UNITS; OF-LIFE DECISIONS; POTENTIALLY INAPPROPRIATE TREATMENTS; NO ESCALATION; CANADIAN INTENSIVISTS; NEUROSURGICAL UNIT; POLICY STATEMENT; ROUTINE STRATEGY; WITHDRAWAL; END	Background: Treatment-limiting decisions (TLD) for severe traumatic brain injury (sTBI) have been sparsely studied. This study determine prevalence, main reason for, categories and timing of TLDs in a Norwegian regional trauma setting. Methods: A retrospective study of a 2-year cohort of 579 sTBI patients admitted to Oslo University Hospital (OUH). Prospectively collected data in the OUH Trauma Registry were combined with retrospective data from a chart review regarding TLDs. Results: TLDs were documented for 101/579 sTBI patients (17%). The situation was evaluated as futile in 59 cases and as potentially inappropriate in 42 cases. The three most frequent types of TLDs were withholding of neurosurgery, do not resuscitate orders and withdrawing of organ support. In 70% of cases, the first TLD was made within 2 days after injury, while in 14%, the first TLD was made later than day 7. Twenty percent (20/101) of the first TLDs were later adjusted, revoked in 4 patients and broadening of TLDs in 16 patients. The median time from the decision to death was 2 days (range 1-652). TLDs were documented in 93% of in-hospital death cases (n = 79). In-hospital deaths occurred in 73% of TLD group cases and 1% of non-TLD group cases. Family interaction and multi-team discussions were documented in > 88% of cases, but no advanced directives were found, and notifications of patients' preferences were found in only 7% of cases. Discussion: Clinicians should consider limiting treatment if continued treatment is not in the patients best interest. A range of different types of TLDs were applied for patients after sTBI in the trauma hospital setting. Conclusion: TLDs were found in 17% of sTBI patients. Value considerations behind TLDs in this care context need to be further explored.	[Robertsen, Annette; Skaga, Nils Oddvar] Oslo Univ Hosp, Dept Anesthesiol & Crit Care, POB 4950Nydalen, N-0424 Oslo, Norway; [Robertsen, Annette; Helseth, Eirik] Univ Oslo, Dept Clin Med, Oslo, Norway; [Forde, Reidun] Univ Oslo, Ctr Med Eth, POB 1130Blindern, N-0318 Oslo, Norway; [Helseth, Eirik] Oslo Univ Hosp, Dept Neurosurg, POB 4950Nydalen, N-0424 Oslo, Norway; [Skaga, Nils Oddvar] Oslo Univ Hosp, Trauma Registry, Oslo, Norway		Robertsen, A (corresponding author), Oslo Univ Hosp, Dept Anesthesiol & Crit Care, POB 4950Nydalen, N-0424 Oslo, Norway.; Robertsen, A (corresponding author), Univ Oslo, Dept Clin Med, Oslo, Norway.	anerob@ous-hf.no	Helseth, Eirik/AAH-2466-2020		Division of Critical Care at OUH	Thanks to OUH-TR for providing some of the data, Division of Critical Care at OUH for supporting the study and Manuela Zucknick for statistical support.	ACCORD EU, 2015, ACH COMPR COORD ORG; Association of Official Agricultural Chemists, 1998, AOAC PEER VER METH P, P1; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BARLOW P, 1991, SCOT MED J, V36, P109, DOI 10.1177/003693309103600404; Bell D, 2012, ANAESTHESIA, V67, P1405, DOI 10.1111/anae.12080; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Cai XM, 2015, NEUROCRIT CARE, V23, P131, DOI 10.1007/s12028-015-0149-2; Cape D, 2016, J MED ETHICS, V42, P180, DOI 10.1136/medethics-2015-102856; Cochrane TI, 2009, AM J BIOETHICS, V9, P47, DOI 10.1080/15265160902718857; Cote N, 2013, NEUROCRIT CARE, V18, P154, DOI 10.1007/s12028-012-9787-9; Curtis JR, 2014, INTENS CARE MED, V40, P1374, DOI 10.1007/s00134-014-3421-6; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Frontera JA, 2015, CRIT CARE MED, V43, P1964, DOI 10.1097/CCM.0000000000001131; Geurts M, 2014, LANCET NEUROL, V13, P515, DOI 10.1016/S1474-4422(14)70030-4; Hemphill JC, 2009, EMERG MED CLIN N AM, V27, P27, DOI 10.1016/j.emc.2008.08.009; Izzy S, 2013, NEUROCRIT CARE, V19, P347, DOI 10.1007/s12028-013-9925-z; JENNETT B, 1992, BRIT J HOSP MED, V47, P354; Kitzinger C, 2014, TIMELINE ADM WITHHOL; Kon AA, 2016, CRIT CARE MED, V44, P1769, DOI 10.1097/CCM.0000000000001965; Long AC, 2016, INTENS CARE MED, V42, P1043, DOI 10.1007/s00134-016-4336-1; Manara Alex R, 2016, J Intensive Care Soc, V17, P295, DOI 10.1177/1751143716647980; Manara AR, 1998, ANAESTHESIA, V53, P523, DOI 10.1046/j.1365-2044.1998.t01-1-00407.x; Mayor SA, 1999, NEUROLOGY, V52, P1602, DOI 10.1212/WNL.52.8.1602; Morgan CK, 2014, CRIT CARE MED, V42, P357, DOI 10.1097/CCM.0b013e3182a276c9; Norwegian Directorate of Health, 2013, NAT GUID DEC MAK PRO; Osler T, 1997, J TRAUMA, V43, P922, DOI 10.1097/00005373-199712000-00009; Rubin MA, 2016, AM J RESP CRIT CARE, V193, P466, DOI 10.1164/rccm.201510-2086LE; Schaller C, 2006, J MED ETHICS, V32, P65, DOI 10.1136/jme.2005.011767; Schenker Y, 2013, J CRIT CARE, V28, P862, DOI 10.1016/j.jcrc.2013.04.015; Smith AK, 2013, NEW ENGL J MED, V368, P2448, DOI 10.1056/NEJMp1303295; Smith M, 2012, ANAESTHESIA, V67, P941, DOI 10.1111/j.1365-2044.2012.07304.x; Souter MJ, 2015, NEUROCRIT CARE, V23, P4, DOI 10.1007/s12028-015-0137-6; Sovik S, 2014, INJURY, V45, P1722, DOI 10.1016/j.injury.2014.05.038; Sprung CL, 2008, INTENS CARE MED, V34, P271, DOI 10.1007/s00134-007-0927-1; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Thompson DR, 2014, INTENS CARE MED, V40, P1372, DOI 10.1007/s00134-014-3422-5; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Turgeon AF, 2011, CAN MED ASSOC J, V183, P1581, DOI 10.1503/cmaj.101786; Turnbull AE, 2014, CRIT CARE MED, V42, P1455, DOI 10.1097/CCM.0000000000000227; Verkade MA, 2012, NEUROCRIT CARE, V16, P130, DOI 10.1007/s12028-011-9567-y; Wilson WT, 2017, BRIT J NEUROSURG, V31, P254, DOI 10.1080/02688697.2016.1226259; Wunsch H, 2005, INTENS CARE MED, V31, P823, DOI 10.1007/s00134-005-2644-y; Yee AH, 2010, NEUROLOGY, V74, P1380, DOI 10.1212/WNL.0b013e3181dad5f0	43	18	19	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	APR 26	2017	25								44	10.1186/s13049-017-0385-x			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	ET6SQ	WOS:000400423100001	28441973	Green Published, gold			2022-02-06	
J	Farina, B; Di Sorbo, G; Chambery, A; Caporale, A; Leoni, G; Russo, R; Mascanzoni, F; Raimondo, D; Fattorusso, R; Ruvo, M; Doti, N				Farina, Biancamaria; Di Sorbo, Gianluigi; Chambery, Angela; Caporale, Andrea; Leoni, Guido; Russo, Rosita; Mascanzoni, Fabiola; Raimondo, Domenico; Fattorusso, Roberto; Ruvo, Menotti; Doti, Nunzianna			Structural and biochemical insights of CypA and AIF interaction	SCIENTIFIC REPORTS			English	Article							APOPTOSIS-INDUCING FACTOR; CELL-DEATH; CYCLOPHILIN; PROTEIN; BINDING; CATALYSIS; NETWORK	The Cyclophilin A (CypA)/Apoptosis Inducing Factor (AIF) complex is implicated in the DNA degradation in response to various cellular stress conditions, such as oxidative stress, cerebral hypoxia-ischemia and traumatic brain injury. The pro-apoptotic form of AIF (AIF(Delta 1-121)) mainly interacts with CypA through the amino acid region 370-394. The AIF(370-394) synthetic peptide inhibits complex formation in vitro by binding to CypA and exerts neuroprotection in a model of glutamate-mediated oxidative stress. Here, the binding site of AIF(Delta 1-121) and AIF(370-394) on CypA has been mapped by NMR spectroscopy and biochemical studies, and a molecular model of the complex has been proposed. We show that AIF(370-394) interacts with CypA on the same surface recognized by AIF(Delta 1-121) protein and that the region is very close to the CypA catalytic pocket. Such region partially overlaps with the binding site of cyclosporin A (CsA), the strongest catalytic inhibitor of CypA. Our data point toward distinct CypA structural determinants governing the inhibitor selectivity and the differential biological effects of AIF and CsA, and provide new structural insights for designing CypA/AIF selective inhibitors with therapeutic relevance in neurodegenerative diseases.	[Farina, Biancamaria; Di Sorbo, Gianluigi; Caporale, Andrea; Mascanzoni, Fabiola; Ruvo, Menotti; Doti, Nunzianna] CNR, Ist Biostrutture & Bioimmagini, Via Mezzocannone 16, I-80134 Naples, Italy; [Farina, Biancamaria; Di Sorbo, Gianluigi; Caporale, Andrea; Mascanzoni, Fabiola; Ruvo, Menotti; Doti, Nunzianna] CIRPEB, Via Mezzocannone 16, I-80134 Naples, Italy; [Di Sorbo, Gianluigi; Chambery, Angela; Russo, Rosita; Fattorusso, Roberto] Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Via Vivaldi 46, I-81100 Caserta, Italy; [Leoni, Guido] Nouscom Srl, Via Castel Romano 100, I-00128 Rome, Italy; [Raimondo, Domenico] Sapienza Univ Roma, Viale Regina Elena 324, I-00161 Rome, Italy		Doti, N (corresponding author), CNR, Ist Biostrutture & Bioimmagini, Via Mezzocannone 16, I-80134 Naples, Italy.; Doti, N (corresponding author), CIRPEB, Via Mezzocannone 16, I-80134 Naples, Italy.	nunzianna.doti@cnr.it	Leoni, Guido/AAX-6544-2020; Caporale, Andrea/ABA-8445-2021; Doti, Nunzianna/ABC-9948-2020	Leoni, Guido/0000-0003-0502-1962; Caporale, Andrea/0000-0002-7827-3960; Russo, Rosita/0000-0002-2235-6302; raimondo, domenico/0000-0002-1780-7295	European Grid Initiative (EGI) through the national GRID Initiative of Belgium [261572]; European Grid Initiative (EGI) through the national GRID Initiative of France [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Italy [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Germany [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Netherlands [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Poland [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Portugal [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Spain [261572]; European Grid Initiative (EGI) through the national GRID Initiative of UK [261572]; European Grid Initiative (EGI) through the national GRID Initiative of South Africa [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Malaysia [261572]; European Grid Initiative (EGI) through the national GRID Initiative of Taiwan [261572]; Latin America GRID infrastructure via the Gisela project	The authors thank Leopoldo Zona, Maurizio Amendola, Giouse Sorrentino and Luca De Luca for the technical assistance. We also thanks the group of Dr. Valentina Bonetto of the "Department of Molecular Biochemistry and Pharmacology" IRCCS "Mario Negri", Milano, Italy, that kindly provided the construct pCMV6-AC-Myc-CypA<SUP>R55A</SUP> used as template for the amplification of cypA<SUP>R55A</SUP> gene. The WeNMR project (European FP7 eInfrastructure grant, contract no. 261572, www.wenmr.eu), supported by the European Grid Initiative (EGI) through the national GRID Initiatives of Belgium, France, Italy, Germany, the Netherlands, Poland, Portugal, Spain, UK, South Africa, Malaysia, Taiwan, the Latin America GRID infrastructure via the Gisela project and the US Open Science Grid (OSG) are acknowledged for the use of web portals, computing and storage facilities.	Artus C, 2010, EMBO J, V29, P1585, DOI 10.1038/emboj.2010.43; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Caporale A, 2017, J PEPT SCI, V23, P272, DOI 10.1002/psc.2977; Caporale A, 2016, J BIOMOL SCREEN, V21, P701, DOI 10.1177/1087057116650402; Doshi U, 2016, P NATL ACAD SCI USA, V113, P4735, DOI 10.1073/pnas.1523573113; Doti N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.518; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fanghanel J, 2003, BIOPHYS CHEM, V100, P351, DOI 10.1016/S0301-4622(02)00292-2; Farina B, 2013, BBA-PROTEINS PROTEOM, V1834, P1572, DOI 10.1016/j.bbapap.2013.04.012; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Hangen E, 2015, MOL CELL, V58, P1001, DOI 10.1016/j.molcel.2015.04.020; Houry WA, 1998, P NATL ACAD SCI USA, V95, P4299, DOI 10.1073/pnas.95.8.4299; Keller R. L. J., 2004, COMPUTER AIDED RESON; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozakov D, 2015, NAT PROTOC, V10, P733, DOI 10.1038/nprot.2015.043; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Leone M, 2004, BIOCHEMISTRY-US, V43, P6043, DOI 10.1021/bi036261d; Li GH, 2003, J AM CHEM SOC, V125, P15028, DOI 10.1021/ja0367851; McInnes C, 2000, PROTEIN ENG, V13, P143, DOI 10.1093/protein/13.3.143; Mckee CJ, 2009, METHODS, V47, P304, DOI 10.1016/j.ymeth.2008.10.023; NERI P, 1991, FEBS LETT, V290, P195, DOI 10.1016/0014-5793(91)81258-A; Nigro P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.410; Oppermann S, 2014, J PHARMACOL EXP THER, V350, P273, DOI 10.1124/jpet.114.213777; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Ow YLP, 2008, NAT REV MOL CELL BIO, V9, P532, DOI 10.1038/nrm2434; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Piao CS, 2012, NEUROBIOL DIS, V46, P745, DOI 10.1016/j.nbd.2012.03.018; Polster BM, 2013, NEUROCHEM INT, V62, P695, DOI 10.1016/j.neuint.2012.12.002; Saelens X, 2004, ONCOGENE, V23, P2861, DOI 10.1038/sj.onc.1207523; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Severino V, 2011, J PROTEOME RES, V10, P3212, DOI 10.1021/pr200244f; Thal SE, 2011, NEUROSCI LETT, V499, P1, DOI 10.1016/j.neulet.2011.05.016; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang YF, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2000902; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193	42	18	21	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	APR 25	2017	7								1138	10.1038/s41598-017-01337-8			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET2LL	WOS:000400104200027	28442737	gold, Green Published			2022-02-06	
J	Andrade, P; Nissinen, J; Pitkanen, A				Andrade, Pedro; Nissinen, Jari; Pitkanen, Asla			Generalized Seizures after Experimental Traumatic Brain Injury Occur at the Transition from Slow-Wave to Rapid Eye Movement Sleep	JOURNAL OF NEUROTRAUMA			English	Article						epilepsy; lateral fluid percussion; paradoxical sleep; post-traumatic epilepsy; rat	EPILEPSY; DISORDERS; DISTURBANCES; NEUROGENESIS; DEPRIVATION; SPINDLES; INSOMNIA	Sleep disturbances commonly occur after traumatic brain injury (TBI) and may predispose patients to epileptic seizures. We hypothesized that unprovoked seizure occurrence post-TBI depends on the sleep-wake cycle, and that the electrographic characteristics of a given sleep stage provide biomarkers for post-traumatic epilepsy (PTE). We show, in a rat lateral fluid percussion model, that 92% of spontaneous generalized seizures occur during the transition from stage III to rapid eye movement sleep. Moreover, a reduction in spindle duration and dominant frequency during the transition stage present as specific and sensitive noninvasive biomarkers for experimentally induced PTE with generalized electrographic seizures.	[Andrade, Pedro; Nissinen, Jari; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Dept Neurobiol, POB 1627, FI-70211 Kuopio, Finland.	asla.pitkanen@uef.fi	Andrade, Pedro/N-8410-2018	Andrade, Pedro/0000-0001-9118-8341	Academy of Finland, CURE (Citizens United for Research in Epilepsy), FP7-HEALTH project [602102]	This study was supported by the Academy of Finland, CURE (Citizens United for Research in Epilepsy), FP7-HEALTH project 602102 (EPITARGET). The authors thank Mr. Jarmo Hartikainen and Mrs. Merja Lukkari for their excellent technical assistance.	Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Baumann CR, 2016, SLEEP MED CLIN, V11, P19, DOI 10.1016/j.jsmc.2015.10.004; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Brites D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00476; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Feige B, 2013, INT J PSYCHOPHYSIOL, V89, P171, DOI 10.1016/j.ijpsycho.2013.04.002; Gelinas JN, 2016, NAT MED, V22, P641, DOI 10.1038/nm.4084; Gottesmann C, 1996, NEUROSCI BIOBEHAV R, V20, P367, DOI 10.1016/0149-7634(95)00055-0; Halasz P, 2013, EPILEPSY RES, V107, P9, DOI 10.1016/j.eplepsyres.2013.06.021; Halasz Peter, 2012, Handb Clin Neurol, V107, P305, DOI 10.1016/B978-0-444-52898-8.00019-7; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iber C., 2007, AASM MANUAL SCORING, P7; Imbach LL, 2016, NEUROLOGY, V86, P1945, DOI 10.1212/WNL.0000000000002697; Kalia M, 2006, METABOLISM, V55, pS2, DOI 10.1016/j.metabol.2006.07.005; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kreutzmann JC, 2015, NEUROSCIENCE, V309, P173, DOI 10.1016/j.neuroscience.2015.04.053; Luthi A, 2014, NEUROSCIENTIST, V20, P243, DOI 10.1177/1073858413500854; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Ng M., 2013, EPILEPSY RES TREAT; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Pace-Schott EF, 2002, NEUROPSYCHOPHARMACOL, P1859; Pitkanen A, 2002, LANCET NEUROL, V1, P173, DOI 10.1016/S1474-4422(02)00073-X; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raymont V, 2010, NEUROLOGY, V75, P224, DOI 10.1212/WNL.0b013e3181e8e6d0; Schmitt B, 2015, NEUROPEDIATRICS, V46, P171, DOI 10.1055/s-0035-1551574; Valko PO, 2016, SLEEP, V39, P1249, DOI 10.5665/sleep.5844	34	18	18	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1482	1487		10.1089/neu.2016.4675			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600018	27707084				2022-02-06	
J	Armstead, WM; Riley, J; Vavilala, MS				Armstead, William M.; Riley, John; Vavilala, Monica S.			Sex and Age Differences in Epinephrine Mechanisms and Outcomes after Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						age; brain injury; cerebral autoregulation; histopathology; sex; signal transduction; vasopressor	ACTIVATED PROTEIN-KINASE; CEREBRAL AUTOREGULATION; UP-REGULATION; ERK MAPK; HIPPOCAMPAL NECROSIS; JUVENILE PIGS; INHIBITION; CEREBROVASODILATION; HYPOTENSION; JNK	Traumatic brain injury (TBI) is the leading cause of injury-related death in children, with boys and children < 4 years of age having particularly poor outcomes. Cerebral autoregulation is often impaired after TBI, contributing to poor outcome. Cerebral perfusion pressure can be normalized by use of vasoactive agents. The c-Jun-terminal kinase (JNK) isoform of mitogen activated protein kinase (MAPK) produces hemodynamic impairment after TBI, but less is known about its role in histopathology. We investigated whether epinephrine (EPI), age, and sex dependently protected cerebral autoregulation and limited histopathology after TBI, and sought to determine the role of JNK in that outcome. Lateral fluid percussion injury (FPI) was produced in anesthetized pigs. Pial artery reactivity was measured via a closed cranial window. Phosphorylated JNK MAPK was quantified by enzyme-linked immunosorbent assay (ELISA). Results show that EPI preserves autoregulation, prevents histopathology, and blocks phosphorylated JNK upregulation in newborn males and females and juvenile females but not juvenile males after TBI. These data indicate that EPI preserves cerebral autoregulation and limits histopathology after TBI through blockade of JNK in an age-and sex-dependent manner.	[Armstead, William M.; Riley, John] Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA; [Armstead, William M.] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol Pediat & Neurol Surg, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA		Armstead, WM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, 3620 Hamilton Walk,JM3, Philadelphia, PA 19104 USA.	armsteaw@uphs.upenn.edu		Riley, John/0000-0002-7932-8935	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS090998]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090998] Funding Source: NIH RePORTER	This work was supported by NIH R01 NS090998.	Armstead WM, 2008, BRAIN RES, V1231, P121, DOI 10.1016/j.brainres.2008.06.115; Armstead WM, 2007, J CEREBR BLOOD F MET, V27, P1702, DOI 10.1038/sj.jcbfm.9600473; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Armstead WM, 2016, PEDIATR CRIT CARE ME, V17, pe130, DOI 10.1097/PCC.0000000000000603; Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Armstead WM, 2012, NEUROL RES, V34, P530, DOI 10.1179/1743132812Y.0000000039; Armstead WM, 2011, NEUROL RES, V33, P726, DOI 10.1179/016164110X12807570509853; Armstead WM, 2010, CRIT CARE MED, V38, P1868, DOI 10.1097/CCM.0b013e3181e8ac1a; Armstead WM, 2010, J NEUROTRAUM, V27, P391, DOI 10.1089/neu.2009.1094; Armstead WM, 2000, MICROCIRCULATION, V7, P225, DOI 10.1080/713773978; Bell MJ, 2013, PEDIATR CRIT CARE ME, V14, P811, DOI 10.1097/PCC.0b013e3182975e2f; Dai YX, 2014, NEUROCHEM RES, V39, P1603, DOI 10.1007/s11064-014-1355-6; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dobbing J., 1981, SCI F PAEDIATRICS, P744; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hlatky R, 2005, NEUROSURGERY, V57, P917, DOI 10.1227/01.NEU.0000180025.43747.fc; Ishikawa S, 2009, ANESTH ANALG, V108, P1631, DOI 10.1213/ane.0b013e31819d94e3; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Newacheck PW, 2004, PEDIATRICS, V114, P79, DOI 10.1542/peds.114.1.79; Ortolano F, 2009, J NEUROPATH EXP NEUR, V68, P964, DOI 10.1097/NEN.0b013e3181b20670; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Ross J, 2005, BRAIN RES, V1054, P95, DOI 10.1016/j.brainres.2005.06.065; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Tran HT, 2012, J NEUROPATH EXP NEUR, V71, P116, DOI 10.1097/NEN.0b013e3182456aed	28	18	18	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1666	1675		10.1089/neu.2016.4770			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500018	27912253	Green Published			2022-02-06	
J	McCutcheon, V; Park, E; Liu, E; Sobhebidari, P; Tavakkoli, J; Wen, XY; Baker, AJ				McCutcheon, Victoria; Park, Eugene; Liu, Elaine; Sobhebidari, Pooya; Tavakkoli, Jahan; Wen, Xiao-Yan; Baker, Andrew J.			A Novel Model of Traumatic Brain Injury in Adult Zebrafish Demonstrates Response to Injury and Treatment Comparable with Mammalian Models	JOURNAL OF NEUROTRAUMA			English	Article						animal model; behavior; concussion; high intensity ultrasound; traumatic brain injury; zebrafish	DANIO-RERIO; ANIMAL-MODELS; NEUROSCIENCE RESEARCH; SOCIAL-BEHAVIOR; NERVOUS-SYSTEM; AXONAL INJURY; HEAD-INJURY; QUANTIFICATION; HYPOTHERMIA; NICOTINE	Traumatic brain injury (TBI) is a leading cause of death and morbidity in industrialized countries with considerable associated health care costs. The cost and time associated with pre-clinical development of TBI therapeutics is lengthy and expensive with a poor track record of successful translation to the clinic. The zebrafish is an emerging model organism in research with unique technical and genomic strengths in the study of disease and development. Its high degree of genetic homology and cell signaling pathways relative to mammalian species and amenability to high and medium throughput assays has potential to accelerate the rate of therapeutic drug identification. Accordingly, we developed a novel closed-head model of TBI in adult zebrafish using a targeted, pulsed, high-intensity focused ultrasound (pHIFU) to induce mechanical injury of the brain. Western blot results indicated altered microtubule and neurofilament expression as well as increased expression of cleaved caspase-3 and beta APP (beta-APP; p < 0.05). We used automated behavioral tracking software to evaluate locomotor deficits 24 and 48 h post-injury. Significant behavioral impairment included decreased swim distance and velocity (p < 0.05), as well as heightened anxiety and altered group social dynamics. Responses to injury were pHIFU dose-dependent and modifiable with MK-801, MDL-28170, or temperature modulation. Together, results indicate that the zebrafish exhibits responses to injury and intervention similar to mammalian TBI pathophysiology and suggest the potential for use to rapidly evaluate therapeutic compounds with high efficiency.	[McCutcheon, Victoria; Baker, Andrew J.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Wen, Xiao-Yan] Univ Toronto, Dept Med, Toronto, ON, Canada; [Wen, Xiao-Yan] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Baker, Andrew J.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Park, Eugene; Liu, Elaine; Tavakkoli, Jahan; Wen, Xiao-Yan; Baker, Andrew J.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Sobhebidari, Pooya; Tavakkoli, Jahan] Ryerson Univ, Dept Phys, Toronto, ON, Canada		Park, E (corresponding author), St Michaels Hosp, Li Ka Shing Knowledge Inst, 209 Victoria St,LKSKI W Room 6-656, Toronto, ON M5B 1T8, Canada.	parke@smh.ca	Tavakkoli, Jahan/W-5715-2019	Wen, Xiao-Yan/0000-0001-6728-0025; Peterson, Victoria/0000-0003-1627-0526	Ontario Research Fund-Research Excellence (ORF-RE) grant; Brain Canada Foundation; Ontario Centres of Excellence (OCE)-CQDM; Canada Foundation for InnovationCanada Foundation for InnovationCGIAR	We would like to thank Arthur Worthington from the Advanced Biomedical Ultrasound Imaging and Therapy Laboratory, Department of Physics, Ryerson University, for his technical help in developing and testing of the pHIFU equipment. Partial funding for pHIFU equipment development was provided by an Ontario Research Fund-Research Excellence (ORF-RE) grant that was awarded to J. Tavakkoli. The authors acknowledge funding from the Brain Canada Foundation (Dr. Wen), Ontario Centres of Excellence (OCE)-CQDM (Dr. Wen), and the Canada Foundation for Innovation (Dr. Wen).	Ablain J, 2013, TRENDS CELL BIOL, V23, P584, DOI 10.1016/j.tcb.2013.09.009; Albert-Weissenberger C., 2010, EXP TRANSL STROKE ME, V4, P1; Alhamami M, 2014, MED PHYS, V41, DOI 10.1118/1.4871621; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Best J D, 2008, Neuropsychiatr Dis Treat, V4, P567; Blaser RE, 2010, BEHAV BRAIN RES, V208, P56, DOI 10.1016/j.bbr.2009.11.009; Blaser R, 2006, BEHAV RES METHODS, V38, P456, DOI 10.3758/BF03192800; Blaser RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036931; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buske C, 2011, PROG NEURO-PSYCHOPH, V35, P1409, DOI 10.1016/j.pnpbp.2010.09.003; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen John, 2010, Int J Comp Psychol, V23, P82; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Faul M, 2010, TRAUMATIC BRAIN INJU; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Gerlai Robert, 2012, Curr Top Behav Neurosci, V12, P3, DOI 10.1007/7854_2011_180; Green J, 2012, J NEUROSCI METH, V210, P266, DOI 10.1016/j.jneumeth.2012.07.017; Grossman L, 2010, BEHAV BRAIN RES, V214, P277, DOI 10.1016/j.bbr.2010.05.039; Han RZ, 2009, NEUROSCI BULL, V25, P367, DOI 10.1007/s12264-009-0608-x; Hoppmann V, 2008, DEV DYNAM, V237, P788, DOI 10.1002/dvdy.21447; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kalueff AV, 2014, PROG NEURO-PSYCHOPH, V55, P1, DOI 10.1016/j.pnpbp.2014.01.022; Kalueff AV, 2014, TRENDS PHARMACOL SCI, V35, P63, DOI 10.1016/j.tips.2013.12.002; Kennedy JE, 2003, BRIT J RADIOL, V76, P590, DOI 10.1259/bjr/17150274; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Laird AS, 2011, METHODS MOL BIOL, V793, P167, DOI 10.1007/978-1-61779-328-8_11; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Maaswinkel H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075955; Maaswinkel H, 2013, PHARMACOL BIOCHEM BE, V108, P16, DOI 10.1016/j.pbb.2013.04.009; Marz M, 2011, DEV DYNAM, V240, P2221, DOI 10.1002/dvdy.22710; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Miller N, 2013, BEHAV BRAIN RES, V240, P192, DOI 10.1016/j.bbr.2012.11.033; Miracle A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004491; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; O'Neill B.E., 2012, PULSED HIGH INTENSIT, P2181; Pagnussat N, 2013, ZEBRAFISH, V10, P338, DOI 10.1089/zeb.2013.0867; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Park E, 2007, EXP NEUROL, V204, P49, DOI 10.1016/j.expneurol.2006.09.012; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Pugach Emily K, 2009, J Vis Exp, DOI 10.3791/1645; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Sahuquillo J, 2007, CURR PHARM DESIGN, V13, P2310; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sherman AL, 2014, PHYS MED REH CLIN N, V25, P519, DOI 10.1016/j.pmr.2014.04.003; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Spence R, 2008, BIOL REV, V83, P13, DOI 10.1111/j.1469-185X.2007.00030.x; Stewart AM, 2015, BEHAV BRAIN RES, V276, P28, DOI 10.1016/j.bbr.2013.12.024; Stewart AM, 2014, TRENDS NEUROSCI, V37, P264, DOI 10.1016/j.tins.2014.02.011; Tavakkoli J, 2011, THERAPEUTIC ULTRASOU, P137; Van Dam D, 2006, NAT REV DRUG DISCOV, V5, P956, DOI 10.1038/nrd2075; van der Staay FJ, 2006, BRAIN RES REV, V52, P131, DOI 10.1016/j.brainresrev.2006.01.006; Varga OE, 2010, ATLA-ALTERN LAB ANIM, V38, P245, DOI 10.1177/026119291003800309; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	63	18	18	0	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1382	1393		10.1089/neu.2016.4497			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600008	27650063				2022-02-06	
J	Schmidt, JD; Hoffman, NL; Ranchet, M; Miller, LS; Tomporowski, PD; Akinwuntan, AE; Devos, H				Schmidt, Julianne D.; Hoffman, Nicole L.; Ranchet, Maud; Miller, L. Stephen; Tomporowski, Phillip D.; Akinwuntan, Abiodun E.; Devos, Hannes			Driving after Concussion: Is It Safe To Drive after Symptoms Resolve?	JOURNAL OF NEUROTRAUMA			English	Article						driving safety; mild traumatic brain injury; post-concussion	TRAUMATIC BRAIN-INJURY; NEUROPSYCHOLOGICAL DEFICITS; ON-ROAD; PERFORMANCE; PARKINSONS; SPORT; ASSOCIATION; IMPAIRMENTS; CONCURRENT; STATEMENT	Post-concussion impairments may result in unsafe driving performance, but little research is available to guide consensus on when concussed individuals should return to driving. The purpose of this study was to compare driving performance between individuals with and without a concussion and to explore relationships between neuropsychological and driving performance. Fourteen participants with concussion (age 20.2 +/- 0.9 years old) and 14 non-concussed age-and driving experience-matched controls (age 20.4 +/- 1.1 years old) completed a graded symptom checklist, a brief neuropsychological exam, and a 20.5 km driving simulation task. Participants with a concussion completed driving simulation within 48 h of becoming asymptomatic (15.9 +/- 9.0 days post-concussion). One-way analyses of variance were used to compare total number of crashes, tickets, and lane excursions, as well as standard deviation of lateral position (SDLP) and standard deviation of speed. Pearson's correlations were conducted to explore the relationship between the neuropsychological and driving performance separately by group (a = 0.05). Participants with a concussion committed more frequent lane excursions (concussed 10.9 +/- 4.5; controls 7.4 +/- 2.4; p = 0.017) and exhibited greater SDLP, compared with controls, during the first curve (concussed 45.7 +/- 21.3 cm, controls 27.4 +/- 6.1 cm; p = 0.030) and final curve (concussed 39.6 +/- 24.4 cm; controls 33.5 +/- 21.3 cm; p = 0.036). Poorer performance on symbol digit modalities (r = -0.54), Rey Osterrieth Complex Figure (r = -0.53), verbal memory (r = -0.77), and motor speed (r = -0.54) were correlated with more frequent lane excursions in the concussed group, but not in the control group. Despite being asymptomatic, concussed participants exhibited poorer vehicle control, especially when navigating curves. Driving impairments may persist beyond when individuals with a concussion have returned to driving. Our study provides preliminary guidance regarding which neuropsychological functions may best indicate driving impairment following concussion.	[Schmidt, Julianne D.; Hoffman, Nicole L.; Tomporowski, Phillip D.] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Miller, L. Stephen] Univ Georgia, Dept Psychol, Athens, GA 30602 USA; [Ranchet, Maud; Devos, Hannes] Augusta Univ, Coll Allied Hlth Sci, Dept Phys Therapy, Augusta, GA USA; [Ranchet, Maud] Lab Ergon & Cognit Sci Appl Transport, Lyon, France; [Akinwuntan, Abiodun E.; Devos, Hannes] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA		Schmidt, JD (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	schmidtj@uga.edu	Devos, Hannes/I-6852-2019; Maud, Ranchet/AAF-2672-2019; Akinwuntan, Abiodun/G-6029-2019	Devos, Hannes/0000-0002-8853-6840; Maud, Ranchet/0000-0002-5325-064X; Akinwuntan, Abiodun/0000-0002-0167-685X	Office of the Vice President of Research at the University of Georgia	This study was funded by the Office of the Vice President of Research at the University of Georgia.	Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Brouwer W, 2011, HDB DRIVING SIMULATI; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cullen N, 2014, BRAIN INJURY, V28, P38, DOI 10.3109/02699052.2013.849005; Dawson JD, 2010, J AM GERIATR SOC, V58, P1090, DOI 10.1111/j.1532-5415.2010.02872.x; Devos H, 2013, MOVEMENT DISORD, V28, P1949, DOI 10.1002/mds.25701; Devos H, 2013, DISABIL REHABIL, V35, P1387, DOI 10.3109/09638288.2012.731468; Dovoedo YH, 2015, COMMUN STAT-SIMUL C, V44, P1492, DOI 10.1080/03610918.2013.813037; Fisk GD, 1998, BRAIN INJURY, V12, P683; Grace J, 2005, J INT NEUROPSYCH SOC, V11, P766, DOI 10.1017/S135561770505848; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Gunstad J, 2001, J INT NEUROPSYCH SOC, V7, P323, DOI 10.1017/S1355617701733061; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Kennedy RS, 1993, INT J AVIAT PSYCHOL, V3, P203, DOI [10.1207/s15327108ijap0303_3, DOI 10.1207/S15327108IJAP0303_3]; Krantz J. H., 2014, MENTAL ROTATION EXPT; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Marcotte TA, 2008, ARCH PHYS MED REHAB, V89, P1753, DOI 10.1016/j.apmr.2007.12.049; Mayhew DR, 2011, J SAFETY RES, V42, P267, DOI 10.1016/j.jsr.2011.06.004; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moore Catherine, 2004, N Z Med J, V117, pU1046; Neyens DM, 2015, HUM FACTORS, V57, P1472, DOI 10.1177/0018720815594057; Owens Katherine, 2009, P43, DOI 10.1007/978-3-7643-9923-8_3; Preece M.H.W., 2016, BRAIN INJURY, V3, P1; Preece MHW, 2013, BRAIN INJURY, V27, P83, DOI 10.3109/02699052.2012.722260; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Reed MP, 1999, ERGONOMICS, V42, P1015, DOI 10.1080/001401399185117; Reger MA, 2004, NEUROPSYCHOLOGY, V18, P85, DOI 10.1037/0894-4105.18.1.85; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Schneider JJ, 2005, APPL NEUROPSYCHOL, V12, P138, DOI 10.1207/S15324826AN1203_3; Stolwyk RJ, 2005, MOVEMENT DISORD, V20, P846, DOI 10.1002/mds.20420; Uc EY, 2009, NEUROLOGY, V73, P2112, DOI 10.1212/WNL.0b013e3181c67b77; Uc EY, 2009, NEUROLOGY, V73, P1103, DOI 10.1212/WNL.0b013e3181bacf6e; Verster JC, 2014, HUM PSYCHOPHARM CLIN, V29, P322, DOI 10.1002/hup.2406	39	18	18	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	8					1571	1578		10.1089/neu.2016.4668			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	ES1ZM	WOS:000399325500009	27959745	Green Submitted			2022-02-06	
J	Hsu, LJ; Hong, QY; Chen, ST; Kuo, HL; Schultz, L; Heath, J; Lin, SR; Lee, MH; Li, DZ; Li, ZL; Cheng, HC; Armand, G; Chang, NS				Hsu, Li-Jin; Hong, Qunying; Chen, Shur-Tzu; Kuo, Hsiang-Lin; Schultz, Lori; Heath, John; Lin, Sing-Ru; Lee, Ming-Hui; Li, Dong-Zhang; Li, Zih-Ling; Cheng, Hui-Ching; Armand, Gerard; Chang, Nan-Shan			Hyaluronan activates Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed	ONCOTARGET			English	Article						hyaluronan; hyaluronidase; Hyal-2; Smad; WWOX	DOMAIN-CONTAINING OXIDOREDUCTASE; CANDIDATE TUMOR-SUPPRESSOR; HUMAN-PROSTATE-CANCER; NECROSIS-FACTOR CYTOTOXICITY; IN-VIVO; ANGIOGENIC OLIGOSACCHARIDES; L929 FIBROBLASTS; DOWN-REGULATION; POTENTIAL ROLE; WWOX	Malignant cancer cells frequently secrete significant amounts of transforming growth factor beta (TGF-beta), hyaluronan (HA) and hyaluronidases to facilitate metastasizing to target organs. In a non-canonical signaling, TGF-beta binds membrane hyaluronidase Hyal-2 for recruiting tumor suppressors WWOX and Smad4, and the resulting Hyal-2/WWOX/Smad4 complex is accumulated in the nucleus to enhance SMAD-promoter dependent transcriptional activity. Yeast two-hybrid analysis showed that WWOX acts as a bridge to bind both Hyal-2 and Smad4. When WWOX-expressing cells were stimulated with high molecular weight HA, an increased formation of endogenous Hyal-2/WWOX/Smad4 complex occurred rapidly, followed by relocating to the nuclei in 20-40 min. In WWOX-deficient cells, HA failed to induce Smad2/3/4 relocation to the nucleus. To prove the signaling event, we designed a real time trimolecular FRET analysis and revealed that HA induces the signaling pathway from ectopic Smad4 to WWOX and finally to p53, as well as from Smad4 to Hyal-2 and then to WWOX. An increased binding of the Smad4/Hyal-2/WWOX complex occurs with time in the nucleus that leads to bubbling cell death. In contrast, HA increases the binding of Smad4/WWOX/p53, which causes membrane blebbing but without cell death. In traumatic brain injury-induced neuronal death, the Hyal-2/WWOX complex was accumulated in the apoptotic nuclei of neurons in the rat brains in 24 hr post injury, as determined by immunoelectron microscopy. Together, HA activates the Hyal-2/WWOX/Smad4 signaling and causes bubbling cell death when the signaling complex is overexpressed.	[Hsu, Li-Jin; Hong, Qunying; Chen, Shur-Tzu; Schultz, Lori; Heath, John; Chang, Nan-Shan] Guthrie Res Inst, Lab Mol Immunol, Sayre, PA 18840 USA; [Kuo, Hsiang-Lin; Lin, Sing-Ru; Lee, Ming-Hui; Li, Dong-Zhang; Li, Zih-Ling; Chang, Nan-Shan] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan; [Hsu, Li-Jin; Cheng, Hui-Ching] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan, Taiwan; [Chen, Shur-Tzu] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan, Taiwan; [Chang, Nan-Shan] Natl Cheng Kung Univ, Adv Optoelectron Technol Ctr, Tainan, Taiwan; [Chang, Nan-Shan] China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung, Taiwan; [Armand, Gerard] GlycoMed Res Inc, Hastings On Hudson, NY USA		Chang, NS (corresponding author), Guthrie Res Inst, Lab Mol Immunol, Sayre, PA 18840 USA.; Chang, NS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan, Taiwan.; Chang, NS (corresponding author), Natl Cheng Kung Univ, Adv Optoelectron Technol Ctr, Tainan, Taiwan.; Chang, NS (corresponding author), China Med Univ, Grad Inst Biomed Sci, Coll Med, Taichung, Taiwan.	nschang13827@gmail.com	Hsu, Li-Jin/G-7822-2011		Guthrie Foundation for Education and Research; American Heart AssociationAmerican Heart Association; Department of Defense USAUnited States Department of Defense [W81XWH-08-1-0682]; Ministry of Science and Technology, Taiwan, ROCMinistry of Science and Technology, Taiwan [105-2320-B-006-046, 105-2320-B-006-036]	This work was supported, in part, by the Guthrie Foundation for Education and Research, the American Heart Association, the Department of Defense USA (W81XWH-08-1-0682), and the Ministry of Science and Technology, Taiwan, ROC (105-2320-B-006-046 and 105-2320-B-006-036). This article is in our memory of Professor Shur-Tzu Chen with deepest respect and great love. Dr. Chen passed away on February 28, 2015 with lymphoma.	Abu-Remaileh M, 2015, J BIOL CHEM, V290, P30728, DOI 10.1074/jbc.R115.676346; Aldaz CM, 2014, BBA-REV CANCER, V1846, P188, DOI 10.1016/j.bbcan.2014.06.001; Alkhateeb AM, 2016, METAB BRAIN DIS, V31, P901, DOI 10.1007/s11011-016-9827-9; Bednarek AK, 2000, CANCER RES, V60, P2140; Beech DJ, 2002, J SURG RES, V103, P203, DOI 10.1006/jsre.2002.6351; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Chang HT, 2014, ONCOTARGET, V5, P11792, DOI 10.18632/oncotarget.2961; Chang JY, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.3; Chang JY, 2015, ONCOTARGET, V6, P3578, DOI 10.18632/oncotarget.2876; Chang JY, 2010, EXP BIOL MED, V235, P796, DOI 10.1258/ebm.2010.009351; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 2016, EXP BIOL MED, V241, P1306, DOI 10.1177/1535370216644531; Chang NS, 2015, EXP BIOL MED, V240, P281, DOI 10.1177/1535370215574226; Chang NS, 1997, AM J PHYSIOL-CELL PH, V273, pC1987; Chang NS, 1998, CANCER LETT, V131, P45, DOI 10.1016/S0304-3835(98)00200-6; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-8; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen ST, 2005, NEUROSCIENCE, V130, P397, DOI 10.1016/j.neuroscience.2004.07.054; Chen ST, 2004, NEUROSCIENCE, V124, P831, DOI 10.1016/j.neuroscience.2003.12.036; Chen SJ, 2015, ONCOTARGET, V6, P8007, DOI 10.18632/oncotarget.3153; COEZY E, 1982, CANCER RES, V42, P317; Csoka TB, 1998, GENOMICS, V48, P63, DOI 10.1006/geno.1997.5158; Duterme C, 2009, J BIOL CHEM, V284, P33495, DOI 10.1074/jbc.M109.044362; Ferguson BW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-593; Franzmann EJ, 2003, INT J CANCER, V106, P438, DOI 10.1002/ijc.11252; Frost GI, 2000, ONCOGENE, V19, P870, DOI 10.1038/sj.onc.1203317; Hsu LJ, 2009, J BIOL CHEM, V284, P16049, DOI 10.1074/jbc.M806688200; Huang SS, 2016, J BIOL CHEM, V291, P17319, DOI 10.1074/jbc.M116.716167; Husanie H, 2016, CANC RES IN PRESS; ISAACS WB, 1991, CANCER RES, V51, P4716; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Kultti Anne, 2012, Cancers (Basel), V4, P873, DOI 10.3390/cancers4030873; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6; Lee MH, 2015, ONCOTARGET, V6, P3737, DOI 10.18632/oncotarget.2895; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Li MY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007820; Lin Hsin-Ping, 2011, Genes Cancer, V2, P550, DOI 10.1177/1947601911418498; Lo JY, 2015, EXP BIOL MED, V240, P383, DOI 10.1177/1535370214566747; McAtee CO, 2014, ADV CANCER RES, V123, P1, DOI 10.1016/B978-0-12-800092-2.00001-0; Nikitovic D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/929531; O'Keefe LV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136356; OTSUKA N, 1991, BRAIN RES, V568, P335, DOI 10.1016/0006-8993(91)91422-W; Park BJ, 2000, CANCER RES, V60, P3031; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Richards RI, 2015, EXP BIOL MED, V240, P338, DOI 10.1177/1535370214565990; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Schmaus A, 2014, CANCER METAST REV, V33, P1059, DOI 10.1007/s10555-014-9532-2; Schrock MS, 2015, EXP BIOL MED, V240, P296, DOI 10.1177/1535370214561590; Sherman Larry S, 2015, Int J Cell Biol, V2015, P368584, DOI 10.1155/2015/368584; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; Slevin M, 1998, LAB INVEST, V78, P987; Stern R, 2004, EUR J CELL BIOL, V83, P317, DOI 10.1078/0171-9335-00392; Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112; Sze CI, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.251; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Tsai CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.308; Wang J, 2015, NEUROCHEM RES, V40, P98, DOI 10.1007/s11064-014-1470-4; WOLLIN M, 1989, RADIOTHER ONCOL, V15, P285, DOI 10.1016/0167-8140(89)90097-2	65	18	19	1	4	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	MAR 21	2017	8	12					19137	19155		10.18632/oncotarget.13268			19	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	EO7OE	WOS:000396879200044	27845895	gold, Green Published, Green Submitted			2022-02-06	
J	Meyers, MC				Meyers, Michael C.			Incidence, Mechanisms, and Severity of Match-Related Collegiate Men's Soccer Injuries on FieldTurf and Natural Grass Surfaces: A 6-Year Prospective Study	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						artificial surface; knee; head; trauma	SCHOOL FOOTBALL INJURIES; ARTIFICIAL TURF; PLAYING SURFACE; DATA-COLLECTION; RISK-FACTORS; PLAYERS; EPIDEMIOLOGY; SPORT; PREVENTION; CONCUSSION	Background: Numerous injuries have been attributed to playing on artificial turf. More recently, newer generations of artificial turf have been developed to duplicate the playing characteristics of natural grass. Although artificial turf has been deemed safer than natural grass in some studies, few long-term studies have been conducted comparing match-related collegiate soccer injuries between the 2 playing surfaces. Hypothesis: Collegiate male soccer athletes do not experience any difference in the incidence, mechanisms, or severity of match-related injuries between FieldTurf and natural grass. Study Design: Cohort study; Level of evidence, 2. Methods: Male soccer athletes from 11 universities were evaluated over 6 seasons. Demographic features and predictors included player position, cleat design, player weight, turf age, and environmental factors. Outcomes of interest included injury incidence, injury category, time loss, injury mechanism and situation, type of injury, injury grade and anatomic location, injury severity, head and lower extremity trauma, and elective medical procedures. All match-related injuries were evaluated by the attending head athletic trainer and team physicians on site and subsequently in the physician's office when further follow-up and treatment were deemed necessary. In sum, 765 collegiate games were evaluated for match-related soccer injuries sustained on FieldTurf or natural grass during 6 seasons. Results: Overall, 380 team games (49.7%) were played on FieldTurf versus 385 team games (50.3%) played on natural grass. A total of 722 injuries were documented, with 268 (37.1%) occurring on FieldTurf and 454 (62.9%) on natural grass. Multivariate analysis per 10 team games indicated a significant playing surface effect: F-2,F-720 = 7.260, P = .001. A significantly lower total injury incidence rate (IIR) of 7.1 (95% CI, 6.6-7.5) versus 11.8 (95% CI, 11.3-12.2; P < .0001) and lower rate of substantial injuries, 0.7 (95% CI, 0.5-1.0) versus 1.9 (95% CI, 1.5-2.3; P < .03), were documented on FieldTurf versus natural grass, respectively. Analyses also indicated significantly less trauma on FieldTurf when comparing injury category, time loss, player position, injury mechanism and situation, injuries under various environmental conditions, cleat design, turf age, anatomic location, and elective medical procedures. No significant difference (F-11,F-710 = 0.822, P = .618) between surfaces by knee injury was observed, with the majority of knee injuries involving patellar tendinopathies/syndromes followed by medial collateral ligament injuries on both surfaces. Conclusion: Although similarities existed between FieldTurf and natural grass during competitive match play, FieldTurf is, in many cases, safer than natural grass when comparing injuries in collegiate men's soccer. The findings of this study, however, may not be generalizable to other levels of competition or to other artificial surfaces.	[Meyers, Michael C.] Idaho State Univ, Pocatello, ID 83209 USA		Meyers, MC (corresponding author), Idaho State Univ, Dept Sport Sci & Phys Educ, Human Performance Lab, 921 South 8th Ave, Pocatello, ID 83209 USA.	meyersgroupinc@gmail.com	FACSM, Michael C Meyers PhD/AAH-9728-2019	FACSM, Michael C Meyers PhD/0000-0003-3108-7279	FieldTurf USA	This research was partially funded by FieldTurf USA. M.C.M. has received reimbursement for attending a symposium as well as fees for speaking or organizing an educational program, conducting research, and consulting from FieldTurf USA.	Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Bergfeld JA., 2001, PRINCIPLES PRACTICE, P477; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Dick R, 2007, J ATHL TRAINING, V42, P278; Dvorak J, 2000, AM J SPORT MED, V28, pS69; Ekstrand J, 2006, BRIT J SPORT MED, V40, P975, DOI 10.1136/bjsm.2006.027623; Ekstrand J, 2011, SCAND J MED SCI SPOR, V21, P824, DOI 10.1111/j.1600-0838.2010.01118.x; Faude O, 2005, AM J SPORT MED, V33, P1694, DOI 10.1177/0363546505275011; Ford KR, 2006, J SCI MED SPORT, V9, P433, DOI 10.1016/j.jsams.2006.03.019; Fuller CW, 2007, BRIT J SPORT MED, V41, pI20, DOI 10.1136/bjsm.2007.037267; Giza E, 2005, BRIT J SPORT MED, V39, P212, DOI 10.1136/bjsm.2004.011973; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hagglund M, 2011, AM J SPORT MED, V39, P1906, DOI 10.1177/0363546511408877; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Junge A, 2000, AM J SPORT MED, V28, pS40; Knapik JJ, 2007, SPORTS MED, V37, P117, DOI 10.2165/00007256-200737020-00003; Knowles SB, 2009, EPIDEMIOLOGY, V20, P302, DOI 10.1097/EDE.0b013e318193107c; Krosshaug T, 2005, BRIT J SPORT MED, V39, P330, DOI 10.1136/bjsm.2005.018358; Lankhorst NE, 2012, J ORTHOP SPORT PHYS, V42, P81, DOI 10.2519/jospt.2012.3803; Lee AJ, 2001, BRIT J SPORT MED, V35, P412, DOI 10.1136/bjsm.35.6.412; LEVY IM, 1990, AM J SPORT MED, V18, P406, DOI 10.1177/036354659001800413; Lindenfeld T N, 1988, Am J Sports Med, V16 Suppl 1, pS69; Livesay GA, 2006, AM J SPORT MED, V34, P415, DOI 10.1177/0363546505284182; Luthje P, 1996, SCAND J MED SCI SPOR, V6, P180; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Meeuwisse WH., 1994, CLIN J SPORT MED, V4, P166, DOI [10.1097/00042752-199407000-00004, DOI 10.1097/00042752-199407000-00004]; Meyers MC, 2004, AM J SPORT MED, V32, P1626, DOI 10.1177/0363546504266978; Meyers MC, 2001, INT J SPORT PSYCHOL, V32, P29; Meyers MC, 2013, AM J SPORT MED, V41, P2409, DOI 10.1177/0363546513498994; Meyers MC, 2010, AM J SPORT MED, V38, P687, DOI 10.1177/0363546509352464; Milne C, 2011, BRIT J SPORT MED, V45, P945, DOI 10.1136/bjsm.2010.076943; National Collegiate Athletic Association, 2010, 1981 1982 2009 2010; National Federation of State High School Associations, 2011, 2010 2011 HIGH SCH A; Navarro RR, 2011, CURR SPORT MED REP, V10, P27, DOI 10.1249/JSR.0b013e318205e072; Noyes F R, 1988, Am J Sports Med, V16 Suppl 1, pS65; Orchard J, 2002, SPORTS MED, V32, P419, DOI 10.2165/00007256-200232070-00002; Orchard JW, 2003, MED SCI SPORT EXER, V35, P1118, DOI 10.1249/01.MSS.0000074563.61975.9B; Peterson L, 2000, AM J SPORT MED, V28, pS51; PRAGER BI, 1989, AM J SPORT MED, V17, P681, DOI 10.1177/036354658901700516; Rudicel S, 1988, Am J Sports Med, V16 Suppl 1, pS48; Sassi A, 2011, J STRENGTH COND RES, V25, P606, DOI 10.1519/JSC.0b013e3181c7baf9; Sigward SM, 2012, MED SCI SPORT EXER, V44, P1497, DOI 10.1249/MSS.0b013e31824e8813; Small K, 2010, J SCI MED SPORT, V13, P120, DOI 10.1016/j.jsams.2008.08.005; Steffen K, 2007, BRIT J SPORT MED, V41, pI33, DOI 10.1136/bjsm.2007.036665; Stiles VH, 2009, SPORTS MED, V39, P65, DOI 10.2165/00007256-200939010-00005; Swenson DM, 2010, CLIN J SPORT MED, V20, P293, DOI 10.1097/JSM.0b013e3181e8fae8; Swenson DM, 2009, AM J SPORT MED, V37, P1586, DOI 10.1177/0363546509332500; Tabachnick B. G., 1989, USING MULTIVARIATE S; Theobald P, 2010, SPORT BIOMECH, V9, P29, DOI 10.1080/14763141003690245; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Villwock MR, 2009, AM J SPORT MED, V37, P518, DOI 10.1177/0363546508328108; von Porat A, 2004, ANN RHEUM DIS, V63, P269, DOI 10.1136/ard.2003.008136; Wallace R B, 1988, Am J Sports Med, V16 Suppl 1, pS22; Williams S, 2011, SPORTS MED, V41, P903, DOI 10.2165/11593190-000000000-00000; Wong P, 2005, BRIT J SPORT MED, V39, P473, DOI 10.1136/bjsm.2004.015511	55	18	18	0	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	MAR	2017	45	3					708	718		10.1177/0363546516671715			11	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	EN7RI	WOS:000396199500030	27872124				2022-02-06	
J	Ray, B; Richardson, NJ				Ray, Bradley; Richardson, Nicholas J.			TRAUMATIC BRAIN INJURY AND RECIDIVISM AMONG RETURNING INMATES	CRIMINAL JUSTICE AND BEHAVIOR			English	Article						recidivism; traumatic brain injury; mental illness; returning inmate; TBI	TBI IDENTIFICATION METHOD; FRONTAL-LOBE INJURIES; HEAD-INJURY; PSYCHIATRIC-DISORDERS; SUBSTANCE-ABUSE; MENTAL-ILLNESS; NEIGHBORHOOD CONTEXT; VIOLENT BEHAVIOR; NORTHERN FINLAND; DECISION-MAKING	In recent years, there has been a surge in research that examines the relationship between traumatic brain injury (TBI) and involvement in the criminal justice system. However, the bulk of this research has been largely retrospective and descriptive, comparing rates of TBI in the offending population with the rates of TBI in the general population. Although findings from these studies indicate a higher prevalence of TBI in the offending population, virtually no studies have examined whether those with TBI are more likely to recidivate. To address this gap, the present study examined rearrest post release from prison among a cohort sample of Indiana inmates who were screened using the Ohio State University Traumatic Brain Injury Identification (OSU-TBI-ID) instrument. Findings indicate that, net of control variables, those with TBI were more likely to recidivate sooner than those without TBI. Policy implications and directions for future research are discussed.	[Ray, Bradley] Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Business SPEA Bldg,801 West Michigan St, Indianapolis, IN 46202 USA; [Richardson, Nicholas J.] RTI Int, Res Triangle Pk, NC USA		Ray, B (corresponding author), Indiana Univ Purdue Univ, Sch Publ & Environm Affairs, Business SPEA Bldg,801 West Michigan St, Indianapolis, IN 46202 USA.	bradray@iupui.edu	; Ray, Bradley/C-1843-2017	Richardson, Nicholas/0000-0001-8378-4557; Ray, Bradley/0000-0003-3643-775X			BARKLEY RA, 1992, J ABNORM CHILD PSYCH, V20, P163, DOI 10.1007/BF00916547; Barnfield TV, 1998, BRAIN INJURY, V12, P455, DOI 10.1080/026990598122421; Bechara A, 2005, CURR OPIN NEUROL, V18, P734, DOI 10.1097/01.wco.0000194141.56429.3c; Beck A, 1989, RECIDIVISM PRISONERS; BLAKE PY, 1995, NEUROLOGY, V45, P1641, DOI 10.1212/WNL.45.9.1641; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Box-Steffensmeier JM., 2004, EVENT HIST MODELING; Bufkin JL, 2005, TRAUMA VIOLENCE ABUS, V6, P176, DOI 10.1177/1524838005275089; Chayer C, 2001, Curr Neurol Neurosci Rep, V1, P547, DOI 10.1007/s11910-001-0060-4; Cole WR, 2008, BRAIN INJURY, V22, P932, DOI 10.1080/02699050802454808; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P315, DOI 10.1097/01.HTR.0000300226.67748.3e; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; DelBello MP, 1999, PSYCHIAT RES, V89, P281, DOI 10.1016/S0165-1781(99)00112-2; Diamond PM, 2007, J HEAD TRAUMA REHAB, V22, P330, DOI 10.1097/01.HTR.0000300228.05867.5c; Dinn WM, 2009, CRIM JUSTICE BEHAV, V36, P117, DOI 10.1177/0093854808327507; Eghwrudjakpor PO, 2008, LIBYAN J MED, V3, P192, DOI 10.4176/080908; Fabian JM, 2010, AGGRESS VIOLENT BEH, V15, P209, DOI 10.1016/j.avb.2009.12.004; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Faul M, 2010, TRAUMATIC BRAIN INJU; Fazel S, 2002, LANCET, V359, P545, DOI 10.1016/S0140-6736(02)07740-1; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fisher WH, 2014, CRIME DELINQUENCY, V60, P811, DOI 10.1177/0011128714541204; Freedman D, 2000, SOC SCI MED, V50, P1757, DOI 10.1016/S0277-9536(99)00417-7; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Gendreau P, 1996, CRIMINOLOGY, V34, P575, DOI 10.1111/j.1745-9125.1996.tb01220.x; Gerring JP, 2009, BRAIN INJURY, V23, P944, DOI 10.3109/02699050903285531; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; Gottfredson M. R., 1990, GEN THEORY CRIME; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Hartwell SW, 2004, PSYCHIAT SERV, V55, P145, DOI 10.1176/appi.ps.55.2.145; Hawley CA, 2003, BRAIN INJURY, V17, P743, DOI 10.1080/0269905031000089341; Hesdorffer DC, 2009, J HEAD TRAUMA REHAB, V24, P452, DOI 10.1097/HTR.0b013e3181c133fd; Hirschi T., 1969, CAUSES DELINQUENCY; Huebner BM, 2011, JUSTICE Q, V28, P146, DOI 10.1080/07418820903365213; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kaufman JM, 2005, JUSTICE Q, V22, P224, DOI 10.1080/07418820500088986; Kolakowsky-Hayner S, 2002, BRAIN INJURY, V16, P583, DOI 10.1080/02699050110119475; Koponen S, 2005, EUR PSYCHIAT, V20, pS203; Kubrin CE, 2006, CRIMINOLOGY, V44, P165, DOI 10.1111/j.1745-9125.2006.00046.x; Kurlychek MC, 2007, CRIME DELINQUENCY, V53, P64, DOI 10.1177/0011128706294439; Langan PatrickA., 2002, RECIDIVISM PRISONERS; Langevin R, 2006, BRAIN COGNITION, V60, P206; Leon-Carrion J, 2003, BRAIN INJURY, V17, P207, DOI 10.1080/0269905021000010249; LEWIS DO, 1986, AM J PSYCHIAT, V143, P838; Luukkainen S, 2012, PSYCHIAT RES, V200, P767, DOI 10.1016/j.psychres.2012.04.018; Martell D. A., 1996, EXPLORATIONS CRIMINA, P66; MARTELL DA, 1992, J FORENSIC SCI, V37, P878; Max JE, 1998, J AM ACAD CHILD PSY, V37, P297, DOI 10.1097/00004583-199803000-00015; Max JE, 2001, J NEUROPSYCH CLIN N, V13, P161, DOI 10.1176/appi.neuropsych.13.2.161; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; National Data and Statistical Center, 2016, TRAUM BRAIN INJ MOD; National Institute of Neurological Disorders and Stroke Common Data Elements, 2016, COMM DAT EL; Pardini M, 2011, NEUROLOGY, V76, P1038, DOI 10.1212/WNL.0b013e318211c33e; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Pickelsimer E. E., 2014, INT J OFFENDER THER, V60, P65; Raine A, 2002, J ABNORM CHILD PSYCH, V30, P311, DOI 10.1023/A:1015754122318; Raine A, 2014, ANATOMY VIOLENCE BIO; RANTAKALLIO P, 1992, ARCH DIS CHILD, V67, P1459, DOI 10.1136/adc.67.12.1459; Ray B, 2014, J FORENSIC SCI, V59, P1248, DOI 10.1111/1556-4029.12466; Reisig MD, 2007, JUSTICE Q, V24, P408, DOI 10.1080/07418820701485387; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Sampson R.J., 1993, CRIME MAKING PATHWAY; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Turkstra L, 2003, BRAIN INJURY, V17, P39, DOI 10.1080/0269905021000010122; Ulmer JT, 2001, SOCIOL INQ, V71, P164, DOI 10.1111/j.1475-682X.2001.tb01107.x; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; Vickery CD, 2008, ARCH PHYS MED REHAB, V89, P48, DOI 10.1016/j.apmr.2007.07.047; Visher CA, 2003, ANNU REV SOCIOL, V29, P89, DOI 10.1146/annurev.soc.29.010202.095931; Walker R, 2003, J PSYCHOACTIVE DRUGS, V35, P343, DOI 10.1080/02791072.2003.10400017; Walker R, 2001, SUBST USE MISUSE, V36, P757, DOI 10.1081/JA-100104089; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	80	18	18	0	11	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0093-8548	1552-3594		CRIM JUSTICE BEHAV	Crim. Justice Behav.	MAR	2017	44	3					472	486		10.1177/0093854816686631			15	Psychology, Clinical; Criminology & Penology	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology	EL7GV	WOS:000394790000008		Green Submitted			2022-02-06	
J	Polimanti, R; Chen, CY; Ursano, RJ; Heeringa, SG; Jain, S; Kessler, RC; Nock, MK; Smoller, JW; Sun, XY; Gelernter, J; Stein, MB				Polimanti, Renato; Chen, Chia-Yen; Ursano, Robert J.; Heeringa, Steven G.; Jain, Sonia; Kessler, Ronald C.; Nock, Matthew K.; Smoller, Jordan W.; Sun, Xiaoying; Gelernter, Joel; Stein, Murray B.		Army STARRS Collaborators	Cross-Phenotype Polygenic Risk Score Analysis of Persistent Post-Concussive Symptoms in US Army Soldiers with Deployment-Acquired Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; concussion; genetic correlation; military personnel; US Army	GENOME-WIDE ASSOCIATION; MILITARY SERVICE MEMBERS; METAANALYSIS; INDIVIDUALS; DISEASE; BLAST; SCHIZOPHRENIA; VARIANTS; ALLELE; LOCI	Traumatic brain injury (TBI) contributes to the increased rates of suicide and post-traumatic stress disorder in military personnel and veterans, and it is also associated with the risk for neurodegenerative and psychiatric disorders. A cross-phenotype high-resolution polygenic risk score (PRS) analysis of persistent post-concussive symptoms (PCS) was conducted in 845 U.S. Army soldiers who sustained TBI during their deployment. We used a prospective longitudinal survey of three brigade combat teams to assess deployment-acquired TBI and persistent physical, cognitive, and emotional PCS. PRS was derived from summary statistics of large genome-wide association studies of Alzheimer's disease, Parkinson's disease, schizophrenia, bipolar disorder, and major depressive disorder (MDD); and for years of schooling, college completion, childhood intelligence, infant head circumference (IHC), and adult intracranial volume. Although our study had more than 95% of statistical power to detect moderate-to-large effect sizes, no association was observed with neurodegenerative and psychiatric disorders, suggesting that persistent PCS does not share genetic components with these traits to a moderate-to-large degree. We observed a significant finding: subjects with high IHC PRS recovered better from cognitive/emotional persistent PCS than the other individuals (R-2 = 1.11%; p = 3.37 x 10(-3)). Enrichment analysis identified two significant Gene Ontology (GO) terms related to this result: GO: 0050839 similar to Cell adhesion molecule binding (p = 8.9 x 10(-6)) and GO: 0050905 similar to Neuromuscular process (p = 9.8 x 10(-5)). In summary, our study indicated that the genetic predisposition to persistent PCS after TBI does not have substantial overlap with neurodegenerative and psychiatric diseases, but mechanisms related to early brain growth may be involved.	[Polimanti, Renato] Yale Sch Med, Dept Psychiat, West Haven, CT USA; [Gelernter, Joel] Yale Sch Med, Dept Psychiat, West Haven, CT USA; [Gelernter, Joel] Yale Sch Med, Dept Genet, West Haven, CT USA; [Gelernter, Joel] Yale Sch Med, Dept Neurosci, West Haven, CT USA; [Gelernter, Joel] VA CT Healthcare Ctr, West Haven, CT USA; [Chen, Chia-Yen; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Chen, Chia-Yen; Smoller, Jordan W.] Harvard Med Sch, Boston, MA USA; [Chen, Chia-Yen; Smoller, Jordan W.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA; [Heeringa, Steven G.] Univ Michigan, Inst Social Res, Ann Arbor, MI USA; [Jain, Sonia; Sun, Xiaoying] Univ Calif La Jolla, Dept Family Med & Publ Hlth, La Jolla, CA USA; [Stein, Murray B.] Univ Calif La Jolla, Dept Psychiat, La Jolla, CA USA; [Kessler, Ronald C.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [Nock, Matthew K.] Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA; [Stein, Murray B.] VA San Diego Healthcare Syst, San Diego, CA USA		Stein, MB (corresponding author), Univ Calif San Diego, Dept Psychiat, 9500 Gilman Dr,Mailcode 0855, La Jolla, CA 92093 USA.	mstein@ucsd.edu	Nock, Matthew/AAE-8330-2019; Ursano, Robert/ABE-6533-2020	Chen, Chia-Yen/0000-0001-9548-5597; Ursano, Robert/0000-0002-1861-9173; Gelernter, Joel/0000-0002-4067-1859; Polimanti, Renato/0000-0003-0745-6046	GWAS consortia IGAP (International Genomics of Alzheimer's Project); PDGene, PGC (Psychiatric Genomics Consortium); SSGAC (Social Science Genetic Association Consortium); CHIC (Childhood Intelligence Consortium); EGG (Early Growth Genetics); ENIGMA (Enhancing Neuro Imaging Genetics through Meta-Analysis); French National Foundation on Alzheimer's Disease and Related Disorders; LABEX (Laboratory Of Excellence Program Investment for the Future) DISTALZ grant; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [503480]; Alzheimer's Research UKAlzheimer's Research UK (ARUK) [503176]; Wellcome TrustWellcome TrustEuropean Commission [082604/2/07/Z]; German Federal Ministry of Education and Research (BMBF) Competence Network Dementia (CND)Federal Ministry of Education & Research (BMBF) [01GI0102, 01GI0711, 01GI0420]; NIH/NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG033193, AG081220, U01 AG032984, U24 AG021886, U01 AG016976]; AGES [N01-AG-12100]; NHLBIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01 HL105756]; Icelandic Heart Association; Erasmus Medical Center; Erasmus University; Alzheimer's AssociationAlzheimer's Association [ADGC 10 196728]; Department of the Army; U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/ NIMH) [U01MH087981]; National Institutes of Health, National Institute of Alcoholism and Alcohol Abuse (NIH/NIAAA) [R21 AA024404]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U01MH087981, K24MH094614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA024404] Funding Source: NIH RePORTER	We thank the GWAS consortia IGAP (International Genomics of Alzheimer's Project), PDGene, PGC (Psychiatric Genomics Consortium), SSGAC (Social Science Genetic Association Consortium), CHIC (Childhood Intelligence Consortium), EGG (Early Growth Genetics), and ENIGMA (Enhancing Neuro Imaging Genetics through Meta-Analysis) and their funding agencies for providing summary results data for these analyses. The investigators who contributed to the design and implementation of these previous GWAS did not participate in analysis or writing of this report. IGAP and its participants were supported by the French National Foundation on Alzheimer's Disease and Related Disorders, LABEX (Laboratory Of Excellence Program Investment for the Future) DISTALZ grant, Medical Research Council (Grant no. 503480), Alzheimer's Research UK (Grant no. 503176), Wellcome Trust (Grant no. 082604/2/07/Z), German Federal Ministry of Education and Research (BMBF) Competence Network Dementia (CND) (Grant no. 01GI0102, 01GI0711, 01GI0420), NIH/NIA Grants (R01 AG033193, AG081220, U01 AG032984, U24 AG021886, U01 AG016976) and AGES contract N01-AG-12100, NHLBI Grant R01 HL105756, Icelandic Heart Association, Erasmus Medical Center and Erasmus University, and Alzheimer's Association Grant ADGC 10 196728.; Army STARRS was sponsored by the Department of the Army and funded under cooperative agreement number U01MH087981 with the U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Mental Health (NIH/ NIMH). Additional support was provided by the grant R21 AA024404 from the National Institutes of Health, National Institute of Alcoholism and Alcohol Abuse (NIH/NIAAA). The contents are solely the responsibility of the authors and do not necessarily represent the views of the Department of Health and Human Services, NIMH, Veterans Administration, Department of the Army, or Department of Defense.	Agerbo E, 2015, JAMA PSYCHIAT, V72, P635, DOI 10.1001/jamapsychiatry.2015.0346; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bailey ZS, 2015, NEUROSCI LETT, V604, P119, DOI 10.1016/j.neulet.2015.07.035; Benyamin B, 2014, MOL PSYCHIATR, V19, P253, DOI 10.1038/mp.2012.184; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Chiang CC, 2016, QUAL LIFE RES, V25, P2009, DOI 10.1007/s11136-015-1215-0; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Delaneau O, 2012, NAT METHODS, V9, P179, DOI [10.1038/NMETH.1785, 10.1038/nmeth.1785]; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; Dretsch MN, 2015, J NEUROTRAUM, V32, P1217, DOI 10.1089/neu.2014.3637; Escott-Price V, 2015, ANN NEUROL, V77, P582, DOI 10.1002/ana.24335; Euesden J, 2015, BIOINFORMATICS, V31, P1466, DOI 10.1093/bioinformatics/btu848; French LM, 2014, J NEUROTRAUM, V31, P1607, DOI 10.1089/neu.2014.3401; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Kiss JZ, 2014, CURR OPIN NEUROL, V27, P133, DOI 10.1097/WCO.0000000000000068; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Lill CM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002548; Loh PR, 2015, NAT GENET, V47, P1385, DOI 10.1038/ng.3431; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Mychasiuk R, 2015, NEUROSCIENCE, V288, P145, DOI 10.1016/j.neuroscience.2014.12.034; Nalls MA, 2014, NAT GENET, V46, P989, DOI 10.1038/ng.3043; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Polimanti R., 2016, NEUROPSYCHOPHARMACOL; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Simonti CN, 2016, SCIENCE, V351, P737, DOI 10.1126/science.aad2149; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Smyth K, 2014, DEV MED CHILD NEUROL, V56, P73, DOI 10.1111/dmcn.12263; Stein M. B., 2016, J NEUROTRAUMA; Stein MB, 2016, JAMA PSYCHIAT, V73, P695, DOI 10.1001/jamapsychiatry.2016.0350; Sullivan PF, 2013, MOL PSYCHIATR, V18, P497, DOI 10.1038/mp.2012.21; Taal HR, 2012, NAT GENET, V44, P532, DOI 10.1038/ng.2238; Ursano RJ, 2014, PSYCHIATRY, V77, P107, DOI 10.1521/psyc.2014.77.2.107; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Wolfsgruber S., 2016, ALZHEIMERS DEMENT; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zheng J., 2016, LD HUB CENTRALIZED D	50	18	18	0	18	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2017	34	4					781	789		10.1089/neu.2016.4550			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EL0XD	WOS:000394344200004	27439997	Green Published			2022-02-06	
J	Daley, MJ; Enright, Z; Nguyen, J; Ali, S; Clark, A; Aydelotte, JD; Teixeira, PG; Coopwood, TB; Brown, CVR				Daley, M. J.; Enright, Z.; Nguyen, J.; Ali, S.; Clark, A.; Aydelotte, J. D.; Teixeira, P. G.; Coopwood, T. B.; Brown, C. V. R.			Adenosine diphosphate platelet dysfunction on thromboelastogram is independently associated with increased morality in traumatic brain injury	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Thromboelastogram; TEG; Platelet dysfunction; Traumatic brain injury	MILD HEAD-INJURY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL HEMORRHAGE; ANTIPLATELET AGENTS; COAGULOPATHY; TRANSFUSION; COAGULATION; MANAGEMENT; MORTALITY; HEMATOMA	The purpose of this study is to determine if adenosine diphosphate (ADP) platelet dysfunction on thromboelastogram (TEG) is associated with increased in-hospital mortality in patients with head trauma. The hypothesis is that ADP dysfunction is associated with increased mortality. This retrospective review evaluated trauma patients admitted to a level 1 trauma center from February 2011 to October 2013 who received a TEG. Patients were included if the TEG was drawn within the first 24 h of admission and the head abbreviated injury score was greater than or equal to three. Patients were categorized as severe ADP dysfunction if the degree of ADP inhibition on TEG exceeded 60 %. A total of 90 patients were included (no ADP dysfunction n = 37; ADP dysfunction n = 53). Initial Glasgow Coma Scale [GCS (12 +/- 4 vs. 11 +/- 5; p = 0.26)] and use of pre-injury antiplatelet agents (30 vs. 28 %; p = 0.88) were similar. Patients with ADP dysfunction on TEG had a higher in-hospital mortality rate (8 vs. 32 %; p < 0.01). ADP dysfunction was independently associated with in-hospital mortality upon fixed logistic regression (OR 6.2; 95 % CI 1.2-33) while controlling for age, gender, hypotension, pre-injury antiplatelet agents, GCS and Injury Severity Score. ADP dysfunction on TEG is associated with increased mortality in patients with traumatic brain injury.	[Daley, M. J.; Enright, Z.; Nguyen, J.] Univ Med Ctr Brackenridge, Dept Pharmaceut Serv, 601 E 15th St, Austin, TX 78701 USA; [Daley, M. J.; Enright, Z.; Nguyen, J.] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Ali, S.; Clark, A.; Aydelotte, J. D.; Teixeira, P. G.; Coopwood, T. B.; Brown, C. V. R.] Univ Med Ctr Brackenridge, Dept Trauma Serv, 601 E 15th St, Austin, TX 78701 USA; [Aydelotte, J. D.; Teixeira, P. G.; Coopwood, T. B.; Brown, C. V. R.] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA		Daley, MJ (corresponding author), Univ Med Ctr Brackenridge, Dept Pharmaceut Serv, 601 E 15th St, Austin, TX 78701 USA.; Daley, MJ (corresponding author), Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA.	mjdaley@seton.org; Sali@seton.org; Sali@seton.org; jdaydelotte@seton.org; pgteixeira@seton.org; tbcoopwoodjr@seton.org; cvrbrown@seton.org					Batchelor JS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000588; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; BRODERICK JP, 1993, STROKE, V24, P987, DOI 10.1161/01.STR.24.7.987; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chen LQ, 2004, J THORAC CARDIOV SUR, V128, P425, DOI 10.1016/j.jtcvs.2004.02.019; de Gans K, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-19; Downey DM, 2009, AM SURGEON, V75, P1100; Ducruet AF, 2010, NEUROL RES, V32, P706, DOI 10.1179/174313209X459129; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; FRANKE CL, 1992, J NEUROL NEUROSUR PS, V55, P653, DOI 10.1136/jnnp.55.8.653; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P417, DOI 10.1097/TA.0000000000000372; Kashuk JL, 2010, ANN SURG, V251, P604, DOI 10.1097/SLA.0b013e3181d3599c; Leon C, 2004, BLOOD, V103, P594, DOI 10.1182/blood-2003-05-1385; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Major J, 2009, EMERG MED J, V26, P871, DOI 10.1136/emj.2008.068643; Marini JJ, 2015, JAMA-J AM MED ASSOC, V313, P893, DOI 10.1001/jama.2014.18484; Naidech AM, 2012, NEUROCRIT CARE, V16, P82, DOI 10.1007/s12028-011-9619-3; PARETI FI, 1980, AM J MED, V69, P235, DOI 10.1016/0002-9343(80)90383-6; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	29	18	18	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	FEB	2017	43	1					105	111		10.1007/s00068-016-0643-z			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EL0MG	WOS:000394315900015	26888580				2022-02-06	
J	Fogang, Y; Legros, B; Depondt, C; Mavroudakis, N; Gaspard, N				Fogang, Yannick; Legros, Benjamin; Depondt, Chantal; Mavroudakis, Nicolas; Gaspard, Nicolas			Yield of repeated intermittent EEG for seizure detection in critically ill adults	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			English	Article						Non-convulsive seizures; Continuous EEG monitoring; Critical care EEG; Electroencephalography; Health resources	NONCONVULSIVE STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; ELECTROGRAPHIC SEIZURES; CONSENSUS STATEMENT; RECOMMENDATIONS; CHILDREN	Introduction. - Seizures are common in critically ill patients and prevalence can exceed 30% in the neuro-intensive care unit (ICU). Continuous EEG monitoring (cEEG) is the gold standard for seizure detection in critically ill patients. Objectives. - To determine the yield of intermittent EEG (iEEG) to detect critically ill adult patients with seizures and to identify the factors that affect this yield. Methods. - We retrospectively analyzed cEEG data and medical records from 977 consecutive critically ill patients undergoing cEEG. We included those presenting at least one electrographic seizure during the first 24 hours of cEEG. Patients with hypoxic-ischemic encephalopathy were excluded. For seizure detection, we reviewed six 30-minute epochs on cEEG selected at H0, H3, H6, H12, H18 and H24. Results. - Seizures occurred in 10.75% (105/977) of patients. Level of consciousness was impaired in 79 (75%) of patients, with 42 (40%) in coma. Review of the HO epoch on cEEG permitted to detect seizures in 61 (58%) patients. These figures increased to 70 (67%), 75 (71%), 91 (87%) and 97 (92%) patients for a sampling every 24, 12, 6 and 3 hours, respectively (P = 0.02). Frequency of seizures on cEEG was the only factor significantly affecting the probability of seizure detection. Sampling every 6 hours revealed seizures in all patients with more than six seizures per 24 hours. Conclusions. - iEEG repeated every 6 hours can accurately detect patients presenting seizures, especially when seizure frequency is greater than six per 24 hours. These findings have practical implications for electrographic seizure detection in critically ill patients in settings lacking cEEG. (C) 2016 Elsevier Masson SAS. All rights reserved.	[Fogang, Yannick; Legros, Benjamin; Depondt, Chantal; Mavroudakis, Nicolas; Gaspard, Nicolas] Univ Libre Bruxelles, Hop Erasme, Neurol Dept, Route Lennik 808, B-1070 Brussels, Belgium; [Fogang, Yannick] Cheikh Anta Diop Univ, Fann Teaching Hosp, Neurol Dept, Dakar, Senegal; [Gaspard, Nicolas] Yale Univ, Neurol Dept, New Haven, CT USA		Gaspard, N (corresponding author), Univ Libre Bruxelles, Hop Erasme, Neurol Dept, Route Lennik 808, B-1070 Brussels, Belgium.	Nicolas.Gaspard@erasme.ulb.ac.be			Fonds Erasme pour la Recherche Medicate	NG is a Master Clinician Scientist of the Belgian Fund for Scientific Research (FNRS); receives research funding from the Fonds Erasme pour la Recherche Medicate.	Aarli JA, 2007, NEUROLOGY, V69, P1715, DOI 10.1212/01.wnl.0000285102.47543.02; Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Alvarez V, 2013, CRIT CARE, V17, DOI 10.1186/cc12879; Andre-Obadia N, 2015, NEUROPHYSIOL CLIN, V45, P39, DOI 10.1016/j.neucli.2014.11.003; Andre-Obadia N, 2015, NEUROPHYSIOL CLIN, V45, P1, DOI 10.1016/j.neucli.2014.11.002; Andre-Obadia N, 2014, NEUROPHYSIOL CLIN, V44, P515, DOI 10.1016/j.neucli.2014.10.001; BLECK TP, 1993, CRIT CARE MED, V21, P98, DOI 10.1097/00003246-199301000-00019; Carrera E, 2008, ARCH NEUROL-CHICAGO, V65, P1612, DOI 10.1001/archneur.65.12.1612; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Gaspard N, 2014, EPILEPSIA, V55, P1366, DOI 10.1111/epi.12653; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P96, DOI 10.1097/WNP.0000000000000165; Hirsch LJ, 2013, J CLIN NEUROPHYSIOL, V30, P1, DOI 10.1097/WNP.0b013e3182784729; Husain AM, 2003, J NEUROL NEUROSUR PS, V74, P189, DOI 10.1136/jnnp.74.2.189; Jordan KG, 1999, J CLIN NEUROPHYSIOL, P1614; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Shafi MM, 2012, NEUROLOGY, V79, P1796, DOI 10.1212/WNL.0b013e3182703fbc; Shneker BF, 2003, NEUROLOGY, V61, P1066, DOI 10.1212/01.WNL.0000082653.40257.0B; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Trinka E, 2015, EPILEPSIA, V56, P1515, DOI 10.1111/epi.13121; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Wittman JJ, 2005, NEUROCRIT CARE, V2, P330, DOI 10.1385/NCC:2:3:330; Young GB, 1996, NEUROLOGY, V47, P83	31	18	18	0	3	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0987-7053	1769-7131		NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	FEB	2017	47	1					5	12		10.1016/j.neucli.2016.09.001			8	Clinical Neurology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	ET0NT	WOS:000399959800002	27771198				2022-02-06	
J	Khaing, ZZ; Cates, LN; Fischedick, AE; McClintic, AM; Mourad, PD; Hofstetter, CP				Khaing, Zin Z.; Cates, Lindsay N.; Fischedick, Amanda E.; McClintic, Abbi M.; Mourad, Pierre D.; Hofstetter, Christoph P.			Temporal and Spatial Evolution of Raised Intraspinal Pressure after Traumatic Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						intraspinal pressure; spinal cord injury	INTRACRANIAL-PRESSURE; PERFUSION-PRESSURE; ANIMAL-MODEL; DECOMPRESSION; COMPRESSION; MYELOPATHY	Traumatic spinal cord injury (SCI) often leads to permanent neurological impairment. Currently, the only clinically effective intervention for patients with acute SCI is surgical decompression by removal of impinging bone fragments within 24 h after injury. Recent clinical studies suggest that elevated intraparenchymal spinal pressure (ISP) limits functional recovery following SCI. Here, we report on the temporal and spatial patterns of elevated ISP following a moderate rodent contusion SCI. Compared with physiological ISP in the intact cord (2.7+/-0.5mm Hg), pressures increase threefold 30 min following injury (8.9+/-1.1mm Hg, p < 0.001) and remain elevated for up to 7 days (4.3+/-0.8mm Hg). Measurements of rostrocaudal ISP distribution reveal peak pressures in the injury center and in segments rostral to the injury during the acute phase(<= 24 h). During the subacute phase(>= 72 h), peak ISP decreases while a 7.5 mm long segment of moderately elevated ISP remains, centered on the initial contusion site. Interestingly, the contribution of the dural and pial compartments toward increased ISP changes with time after injury: Dural and pial linings contribute almost equally to increased ISP during the acute phase, whereas the dural lining is primarily responsible for elevated ISP during the subacute phase (78.9%). Our findings suggest that a rat contusion SCI model in combination with novel micro-catheters allows for direct measurement of ISP after SCI. Similarly to traumatic brain injury, raised tissue pressure is likely to have detrimental effects on spontaneous recovery following SCI.	[Khaing, Zin Z.; Cates, Lindsay N.; Fischedick, Amanda E.; McClintic, Abbi M.; Mourad, Pierre D.; Hofstetter, Christoph P.] Univ Washington, Dept Neurol Surg, Campus Box 356470,Room RR734 1959 NE Pacific St, Seattle, WA 98195 USA		Hofstetter, CP (corresponding author), Univ Washington, Dept Neurol Surg, Campus Box 356470,Room RR734 1959 NE Pacific St, Seattle, WA 98195 USA.	chh9045@uw.edu		Khaing, Zin/0000-0001-5652-5891	Department of Neurological Surgery; University of WashingtonUniversity of Washington [65-3210]	This work was supported by the start-up funds from the Department of Neurological Surgery and the Royalty Research Fund from the University of Washington (65-3210) to CPH. The authors would also like to thank Dr. Nikolai C. Dembrow for help with writing a custom code in Igor Pro.	BALENTINE JD, 1978, LAB INVEST, V39, P254; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cao Y., 2011, TOPICS SPINAL CORD I, V16, P10, DOI DOI 10.1310/SCI1604-10; Frankel HL, 1998, SPINAL CORD, V36, P266, DOI 10.1038/sj.sc.3100638; Gaudet AD, 2014, EXP NEUROL, V258, P24, DOI 10.1016/j.expneurol.2013.11.020; GELLAD F, 1983, AM J NEURORADIOL, V4, P614; Hurlbert R John, 2015, Neurosurgery, V76 Suppl 1, pS71, DOI 10.1227/01.neu.0000462080.04196.f7; Jones CF, 2012, SPINE, V37, pE1422, DOI 10.1097/BRS.0b013e31826ba7cd; Jones CF, 2012, SPINE, V37, pE890, DOI 10.1097/BRS.0b013e3182553d1d; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; Martirosyan NL, 2015, NEUROSURGERY, V76, P461, DOI 10.1227/NEU.0000000000000638; Meagher TM, 2012, SPINAL CORD, V50, P638, DOI 10.1038/sc.2011.133; MENDELOW AD, 1983, J NEUROSURG, V58, P45, DOI 10.3171/jns.1983.58.1.0045; MILLEN JW, 1961, BRAIN, V84, P514, DOI 10.1093/brain/84.3.514; Miller BA, 2016, WORLD NEUROSURG, V88, DOI 10.1016/j.wneu.2015.11.058; MILLER JD, 1986, NEUROSURGERY, V19, P253, DOI 10.1227/00006123-198608000-00012; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; Noussitou FL, 2015, VET SURG, V44, P944, DOI 10.1111/vsu.12399; Okada S, 2014, SPINE J, V14, pE9, DOI 10.1016/j.spinee.2014.08.449; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; Ozawa H, 2004, J NEUROSURG-SPINE, V1, P122, DOI 10.3171/spi.2004.1.1.0122; Phang I, 2015, J NEUROTRAUM, V32, P865, DOI 10.1089/neu.2014.3668; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sakka L., 2015, NEUROSURGERY; SCIMS, 2015, SPIN CORD INJ SCI FA; SHAPIRO K, 1977, SURG NEUROL, V7, P275; SOMERSON SK, 1987, EXP NEUROL, V96, P82, DOI 10.1016/0014-4886(87)90170-1; Soubeyrand M, 2012, SPINE, V37, pE1376, DOI 10.1097/BRS.0b013e318269790f; Surkin J, 2000, SPINE, V25, P716, DOI 10.1097/00007632-200003150-00011; Ulbrich EJ, 2014, RADIOLOGY, V271, P172, DOI 10.1148/radiol.13120370; van Asbeck FWA, 2000, SPINAL CORD, V38, P420, DOI 10.1038/sj.sc.3101003; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028; YU YL, 1983, AM J NEURORADIOL, V4, P839	36	18	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2017	34	3					645	651		10.1089/neu.2016.4490			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EI9GJ	WOS:000392815600012	27503121				2022-02-06	
J	Nam, SJ; Park, EY				Nam, Su-Jung; Park, Eun-Young			Relationship between caregiving burden and depression in caregivers of individuals with intellectual disabilities in Korea	JOURNAL OF MENTAL HEALTH			English	Article						Caregiving burden; caregiver depression; individuals with intellectual disabilities	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; CES-D; PSYCHOLOGICAL DISTRESS; INFORMAL CAREGIVERS; DEMENTIA; CHILDREN; PARENTS; HEALTH; SCALE	Background: Individuals with intellectual disabilities (IWID) need intensive long-term care. Consequently, caregivers experience not only economic burdens but also tension, depression, insecurity, etc.Aim: This study aimed to provide basic data and materials for preparing policy alternatives to improve caregiver quality of life of by examining relationships between IWID caregiving burden and depression.Methods: This study involved secondary analysis of data from the 2011 Survey on the Actual Conditions of Individuals with Developmental Disabilities, conducted by the Ministry of Health and Welfare of Korea. Effects of caregivers' characteristics, caregiving time and cost, and perceptions of time and cost, on depression were analyzed.Results: All components of caregiving burden and depression were significantly higher in the 1st grade, designating the most severe disabilities. Overall, caregiving burden tended to be higher in female caregivers, the unemployed, parents, co-residents, and people with health problems. Caregivers' characteristics such as spouse relationship, having health problems, and perception of caregiving time and cost were associated with depression.Conclusion: Caregiving burden and depression vary depending on the characteristics of IWID and their caregivers. Services for decreasing caregiving burden may be optimized by focusing on these characteristics.	[Nam, Su-Jung] Jeonju Univ, Coll Educ, Dept Home Econ Educ, Jeonju, Jeollabuk Do, South Korea; [Park, Eun-Young] Jeonju Univ, Coll Educ, Dept Secondary Special Educ, 45 Baengma Gil, Jeonju, Jeollabuk Do, South Korea		Park, EY (corresponding author), Jeonju Univ, Coll Educ, Dept Secondary Special Educ, 45 Baengma Gil, Jeonju, Jeollabuk Do, South Korea.	eunyoung@jj.ac.kr					AGRELL B, 1989, STROKE, V20, P1190, DOI 10.1161/01.STR.20.9.1190; Blacher J, 1997, FAM RELAT, V46, P325, DOI 10.2307/585093; Buhse M, 2008, J NEUROSCI NURS, V40, P25, DOI 10.1097/01376517-200802000-00005; Bull M, 1990, WESTERN J NURS RES, V23, P756; Burgener S, 2002, ALZ DIS ASSOC DIS, V16, P88, DOI 10.1097/00002093-200204000-00006; Carretero S, 2009, ARCH GERONTOL GERIAT, V49, P74, DOI 10.1016/j.archger.2008.05.004; Cho NO, 1996, THESIS; Clyburn LD, 2000, J GERONTOL B-PSYCHOL, V55, pS2, DOI 10.1093/geronb/55.1.s2; Davis NO, 2008, J AUTISM DEV DISORD, V38, P1278, DOI 10.1007/s10803-007-0512-z; Etters L, 2008, J AM ACAD NURSE PRAC, V20, P423, DOI 10.1111/j.1745-7599.2008.00342.x; Gellis ZD, 2010, J GERONTOL SOC WORK, V53, P289, DOI 10.1080/01634371003741417; Grayson DA, 2000, J GERONTOL B-PSYCHOL, V55, pP273, DOI 10.1093/geronb/55.5.P273; Grzywacz JG, 2006, HISPANIC J BEHAV SCI, V28, P404, DOI 10.1177/0739986306290645; Hann D, 1999, J PSYCHOSOM RES, V46, P437, DOI 10.1016/S0022-3999(99)00004-5; Ingersoll D, 1996, GERONTOLOGIST, V44, P318; Kim H, 1996, KOREA J RES GERONTOL, V5, P107; 이영휘, 2008, [The Journal of Fundamentals of Nursing, 기본간호학회지], V15, P274; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; KOSBERG JI, 1986, GERONTOLOGIST, V26, P273, DOI 10.1093/geront/26.3.273; Kwon JD, 1995, THESIS; Lai DWL, 2012, SAGE OPEN, V2, DOI 10.1177/2158244012470467; Lee AS, 2003, HLTH SOC SCI, V13, P29; Lee HS, 2012, J KOREAN ACAD NURS, V42, P236, DOI 10.4040/jkan.2012.42.2.236; Lee S., 1994, THESIS; Lee Y-W, 2007, J NURS QUERY, V16, P135; Lehmann V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-109; Magana SM, 2007, PSYCHIAT SERV, V58, P378, DOI 10.1176/appi.ps.58.3.378; Mannse Hoe，, 2015, [Mental Health & Social Work, 정신건강과 사회복지], V43, P313; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Meyers J L, 2001, Oncol Nurs Forum, V28, P73; Molyneux GJ, 2008, INT PSYCHOGERIATR, V20, P1193, DOI 10.1017/S1041610208007515; MONTGOMERY RJV, 1985, FAM RELAT, V34, P19, DOI 10.2307/583753; MORRIS LW, 1988, BRIT J MED PSYCHOL, V61, P231, DOI 10.1111/j.2044-8341.1988.tb02784.x; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; Papastavrou E, 2007, J ADV NURS, V58, P446, DOI 10.1111/j.1365-2648.2007.04250.x; Park C, 2003, J WELFARE AGED, V20, P179; Parks SM, 2000, AM FAM PHYSICIAN, V62, P2613; Phipps S, 2005, J PEDIATR PSYCHOL, V30, P139, DOI 10.1093/jpepsy/jsi002; Pinquart M, 2003, PSYCHOL AGING, V18, P250, DOI 10.1037/0882-7974.18.2.250; Pinquart M, 2007, J GERONTOL B-PSYCHOL, V62, pP126, DOI 10.1093/geronb/62.2.P126; Raina Parminder, 2004, BMC Pediatr, V4, P1, DOI 10.1186/1471-2431-4-1; Sawyer MG, 2011, DEV MED CHILD NEUROL, V53, P338, DOI 10.1111/j.1469-8749.2010.03848.x; SCHULZ R, 1995, GERONTOLOGIST, V35, P771, DOI 10.1093/geront/35.6.771; Serrano-Aguilar PG, 2006, NEUROEPIDEMIOLOGY, V27, P136, DOI 10.1159/000095760; Silver EJ, 1998, J PEDIATR PSYCHOL, V23, P5, DOI 10.1093/jpepsy/23.1.5; SLOPER P, 1993, J CHILD PSYCHOL PSYC, V34, P167, DOI 10.1111/j.1469-7610.1993.tb00978.x; Thompson A, 2008, INT J GERIATR PSYCH, V23, P511, DOI 10.1002/gps.1929; Wada K, 2007, AM J IND MED, V50, P8, DOI 10.1002/ajim.20403; Wade SL, 1998, PEDIATRICS, V102, P110, DOI 10.1542/peds.102.1.110; Yoo SH, 2004, J WELFARE AGED I, V26, P191; Yoon Hyun-sook, 2007, [Journal of the Korea Gerontological Society, 한국노년학], V27, P195; Yun E., 2010, J WELFARE AGED, V47, P289; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649; 백용운, 2010, [Korean Journal of Gerontological Social Welfare, 노인복지연구], V49, P215	54	18	19	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0963-8237	1360-0567		J MENT HEALTH	J. Ment. Heal.	FEB	2017	26	1					50	56		10.1080/09638237.2016.1276538			7	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	EM3EY	WOS:000395198500009	28084102				2022-02-06	
J	Tanaka, Y; Tsugawa, T; Maeda, Y				Tanaka, Yuto; Tsugawa, Tsuyoshi; Maeda, Yoshinobu			Effect of mouthguards on impact to the craniomandibular complex	DENTAL TRAUMATOLOGY			English	Article						mouthguard; teeth-clenching; temporomandibular joint; craniomandibular complex; concussion	COLLEGIATE FOOTBALL PLAYERS; SOLEUS H-REFLEX; HEAD IMPACTS; MANDIBULAR CONDYLE; DENTAL INJURIES; FRACTURES; CONCUSSION; ACCELERATION; MODULATION; FIXATION	BackgroundThe aim of this study was to investigate the effect of wearing a mouthguard and teeth-clenching on impact to the head and temporomandibular joint (TMJ) during a blow to the jaw. Material and MethodsA custom-made mouthguard was fabricated for five participants. A 4.1-N impact load was applied to the chin with a pendulum. Two acceleration sensors were attached to the forehead and left TMJ. The amplitudes and durations of the accelerations were obtained under five conditions: mouth-open without mouthguard; light teeth-clenching without mouthguard; maximum voluntary clenching (MVC) without mouthguard; mouth-open with mouthguard and MVC with mouthguard. ResultsWearing a mouthguard led to significant decreases in the amplitude (mouth-open with mouthguard vs mouth-open without mouthguard, P = 0.035 at forehead, P = 0.022 at TMJ) and duration (mouth-open with mouthguard vs mouth-open without mouthguard, P = 0.043 at forehead, not significant at TMJ). Similarly, teeth-clenching caused significant decreases in the amplitude (mouth-open without mouthguard vs MVC without mouthguard, P = 0.024 at forehead, P = 0.025 at TMJ) and duration (mouth-open without mouthguard vs MVC without mouthguard, P = 0.033 at forehead, not significant at TMJ). Furthermore, wearing a mouthguard in itself provided an impact reduction effect similar to the combination of teeth-clenching and wearing a mouthguard. ConclusionsWearing a mouthguard and/or teeth-clenching reduced the impact to the head and TMJ during a blow to the jaw. However, it should be noted that the findings are the results from a small impact load to the jaw.	[Tanaka, Yuto; Tsugawa, Tsuyoshi; Maeda, Yoshinobu] Osaka Univ, Dept Prosthodont Gerodontol & Oral Rehabil, Grad Sch Dent, 1-8 Yamadaoka Suita, Suita, Osaka 5650871, Japan		Tanaka, Y (corresponding author), Osaka Univ, Dept Prosthodont Gerodontol & Oral Rehabil, Grad Sch Dent, 1-8 Yamadaoka Suita, Suita, Osaka 5650871, Japan.	yutotanaka.0106@gmail.com	Tanaka, Yuto/I-1786-2019	Tanaka, Yuto/0000-0001-5859-5519	Japan Society for the Promotion of ScienceMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science [23249086]	We are grateful to Satoshi Fukuzawa (Assistant Professor at Tokyo Women's Medical University) for professional advice regarding oral surgery. This research was supported by a Grant-in-Aid for Scientific Research (number 23249086) from the Japan Society for the Promotion of Science.	Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Beyer JA, 2012, ANN BIOMED ENG, V40, P150, DOI 10.1007/s10439-011-0412-4; Fredericson Michael, 2006, Top Magn Reson Imaging, V17, P309; Gandhi S, 2011, DENT TRAUMATOL, V27, P257, DOI 10.1111/j.1600-9657.2011.00996.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Glendor U, 2009, DENT TRAUMATOL, V25, P19, DOI 10.1111/j.1600-9657.2008.00694.x; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hasegawa K, 2014, DENT TRAUMATOL, V30, P259, DOI 10.1111/edt.12082; HICKEY JC, 1967, J AM DENT ASSOC, V74, P735, DOI 10.14219/jada.archive.1967.0145; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Kumar GBA, 2015, J MAXILLOFAC ORAL SU, V14, P138, DOI 10.1007/s12663-013-0583-7; Labella CR, 2002, MED SCI SPORT EXER, V34, P41, DOI 10.1097/00005768-200201000-00007; Lim D, 2005, CLIN J SPORT MED, V15, P313, DOI 10.1097/01.jsm.0000180019.22018.3c; Maeda Y, 2006, BRIT J SPORT MED, V40, P1006, DOI 10.1136/bjsm.2006.030874; Maeda Y, 2009, DENT TRAUMATOL, V25, P556, DOI 10.1111/j.1600-9657.2009.00822.x; Maxen M, 2011, DENT TRAUMATOL, V27, P95, DOI 10.1111/j.1600-9657.2010.00960.x; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Miyahara T, 1996, J NEUROPHYSIOL, V76, P2033, DOI 10.1152/jn.1996.76.3.2033; Nogami S, 2014, J ORAL REHABIL, V41, P141, DOI 10.1111/joor.12124; Nogami S, 2012, J CRANIOFAC SURG, V23, P1815, DOI 10.1097/SCS.0b013e3182710393; Nowinski Chris, 2013, Cerebrum, V2013, P2; Nozaki K, 2013, DENT TRAUMATOL, V29, P139, DOI 10.1111/j.1600-9657.2012.01140.x; Takada Y, 2000, J NEUROPHYSIOL, V83, P2063, DOI 10.1152/jn.2000.83.4.2063; Takeda T, 2004, DENT TRAUMATOL, V20, P150, DOI 10.1111/j.1600-4469.2004.00247.x; Takeda T, 2014, DENT TRAUMATOL, V30, P76, DOI 10.1111/edt.12050; Tanaka Y, 2015, INT J SPORTS MED, V36, P684, DOI 10.1055/s-0034-1398655; Tanaka Y, 2015, INT J SPORTS MED, V36, P254, DOI 10.1055/s-0034-1390498; Tuna EB, 2014, SPORTS MED, V44, P777, DOI 10.1007/s40279-014-0167-9; Tuncer M, 2007, ARCH ORAL BIOL, V52, P374, DOI 10.1016/j.archoralbio.2006.12.011; Zachariades N, 2006, J CRANIO MAXILL SURG, V34, P421, DOI 10.1016/j.jcms.2006.07.854	31	18	19	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-4469	1600-9657		DENT TRAUMATOL	Dent. Traumatol.	FEB	2017	33	1					51	56		10.1111/edt.12283			6	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	EK0GR	WOS:000393605300009	27207582				2022-02-06	
J	Verhelst, H; Vander Linden, C; Vingerhoets, G; Caeyenberghs, K				Verhelst, Helena; Vander Linden, Catharine; Vingerhoets, Guy; Caeyenberghs, Karen			How to Train an Injured Brain? A Pilot Feasibility Study of Home-Based Computerized Cognitive Training	GAMES FOR HEALTH JOURNAL			English	Article						Cognitive training; Attention; Working memory; Brain injury; Neuroplasticity; Feasibility	WORKING-MEMORY; CONTROLLED-TRIAL; ATTENTION; REHABILITATION; METAANALYSIS; CHILDREN; INFORMATION; TASK; ADHD	Objective: Computerized cognitive training programs have previously shown to be effective in improving cognitive abilities in patients suffering from traumatic brain injury (TBI). These studies often focused on a single cognitive function or required expensive hardware, making it difficult to be used in a home-based environment. This pilot feasibility study aimed to evaluate the feasibility of a newly developed, home-based, computerized cognitive training program for adolescents who suffered from TBI. Additionally, feasibility of study design, procedures, and measurements were examined. Design: Case series, longitudinal, pilot, feasibility intervention study with one baseline and two follow-up assessments. Materials and Methods: Nine feasibility outcome measures and criteria for success were defined, including accessibility, training motivation/user experience, technical smoothness, training compliance, participation willingness, participation rates, loss to follow-up, assessment timescale, and assessment procedures. Five adolescent patients (four boys, mean age=16 years 7 months, standard deviation=9 months) with moderate to severe TBI in the chronic stage were recruited and received 8 weeks of cognitive training with BrainGames. Effect sizes (Cohen's d) were calculated to determine possible training-related effects. Results: The new cognitive training intervention, BrainGames, and study design and procedures proved to be feasible; all nine feasibility outcome criteria were met during this pilot feasibility study. Estimates of effect sizes showed small to very large effects on cognitive measures and questionnaires, which were retained after 6 months. Conclusion: Our pilot study shows that a longitudinal intervention study comprising our novel, computerized cognitive training program and two follow-up assessments is feasible in adolescents suffering from TBI in the chronic stage. Future studies with larger sample sizes will evaluate training-related effects on cognitive functions and underlying brain structures.	[Verhelst, Helena; Vingerhoets, Guy] Univ Ghent, Fac Psychol & Educ Sci, Dept Expt Psychol, Ghent, Belgium; [Vander Linden, Catharine] Ghent Univ Hosp, Dept Phys Med & Rehabil, Child Rehabil Ctr, Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Sydney, NSW 2059, Australia		Verhelst, H (corresponding author), Univ Ghent, Dept Expt Psychol, Henri Dunantlaan 2, B-9000 Ghent, Belgium.	helena.verhelst@ugent.be		Caeyenberghs, Karen/0000-0001-7009-6843; Verhelst, Helena/0000-0002-6861-0249	Special Research Fund (BOF) [01N00214]	Helena Verhelst is currently receiving a grant (#01N00214) from the Special Research Fund (BOF). The authors are very grateful to the participants and their parents and the staff from the Child Rehabilitation Centre of the Ghent University Hospital and Pulderbos.	[Anonymous], 2005, CAMBRIDGE NEUROPSYCH; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Ballard K, 2012, TRAINING RELATED IMP; Beatty EL, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00086; Bjorkdahl A, 2013, BRAIN INJURY, V27, P1658, DOI 10.3109/02699052.2013.830196; Bogdanova Y, 2016, J HEAD TRAUMA REHAB, V31, P419, DOI 10.1097/HTR.0000000000000203; Byars AW, 2002, J CHILD NEUROL, V17, P885, DOI 10.1177/08830738020170122201; Cantagallo, 2003, Z NEUROPSYCHOL, V14, P283, DOI [10.1024/1016-264X.14.4.283, DOI 10.1024/1016-264X.14.4.283]; Corsi PM, 1972, HUMAN MEMORY MEDIAL; Cumming G, 2012, UNDERSTANDING NEW ST, P2012; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Finn M, 2011, BRAIN IMPAIR, V12, P187; Geusgens CAV, 2007, J REHABIL MED, V39, P425, DOI 10.2340/16501977-0092; Hauke J, 2011, NEUROPSYCHOL REHABIL, V21, P164, DOI 10.1080/09602011.2010.541792; Hellgren L., 2015, OPEN J THERAPY REHAB, V3, P46, DOI [DOI 10.4236/OJTR.2015.32007, 10.4236/ojtr.2015.32007]; Huizinga M., 2009, BRIEF VRAGENLIJST EX; Jaeggi SM, 2011, P NATL ACAD SCI USA, V108, P10081, DOI 10.1073/pnas.1103228108; Jaeggi SM, 2010, INTELLIGENCE, V38, P625, DOI 10.1016/j.intell.2010.09.001; Klingberg T, 2005, J AM ACAD CHILD PSY, V44, P177, DOI 10.1097/00004583-200502000-00010; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kort W, 2005, WISC III NL WECHSLER; Kraus JF, 1996, NEUROL CLIN, V14, P435, DOI 10.1016/S0733-8619(05)70266-8; Leon AC, 2011, J PSYCHIATR RES, V45, P626, DOI 10.1016/j.jpsychires.2010.10.008; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; MCAULEY E, 1989, RES Q EXERCISE SPORT, V60, P48, DOI 10.1080/02701367.1989.10607413; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson K, 2015, CHILD NEUROPSYCHOL, P1; Park NW, 2001, NEUROPSYCHOLOGY, V15, P199, DOI 10.1037/0894-4105.15.2.199; Phillips NL, 2017, CHILD NEUROPSYCHOL, V23, P26, DOI 10.1080/09297049.2015.1085500; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RYAN RM, 1982, J PERS SOC PSYCHOL, V43, P450, DOI 10.1037/0022-3514.43.3.450; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shipstead Z, 2012, J APPL RES MEM COGN, V1, P185, DOI 10.1016/j.jarmac.2012.06.003; Sitzer DI, 2006, ACTA PSYCHIAT SCAND, V114, P75, DOI 10.1111/j.1600-0447.2006.00789.x; Sonuga-Barke E, 2014, CHILD ADOL PSYCH CL, V23, P807, DOI 10.1016/j.chc.2014.05.009; Tayal F, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00044; Thabane L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-1; Verbruggen F, 2008, J EXP PSYCHOL GEN, V137, P649, DOI 10.1037/a0013170; YNTEMA DB, 1963, HUM FACTORS, V5, P7, DOI 10.1177/001872086300500102; Zickefoose S, 2013, BRAIN INJURY, V27, P707, DOI 10.3109/02699052.2013.775484	44	18	19	1	16	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2161-783X	2161-7856		GAMES HEALTH J	Games Health J.	FEB	2017	6	1					28	38		10.1089/g4h.2016.0043			11	Health Policy & Services; Public, Environmental & Occupational Health; Rehabilitation	Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Rehabilitation	EM5ZQ	WOS:000395393000004	27991840				2022-02-06	
J	Folweiler, KA; Bondi, CO; Ogunsanya, EA; LaPorte, MJ; Leary, JB; Radabaugh, HL; Monaco, CM; Kline, AE				Folweiler, Kaitlin A.; Bondi, Corina O.; Ogunsanya, Elizabeth A.; LaPorte, Megan J.; Leary, Jacob B.; Radabaugh, Hannah L.; Monaco, Christina M.; Kline, Anthony E.			Combining the Antipsychotic Drug Haloperidol and Environmental Enrichment after Traumatic Brain Injury Is a Double-Edged Sword	JOURNAL OF NEUROTRAUMA			English	Article						antipsychotic drugs; behavioral outcome; controlled cortical impact; environmental enrichment; functional recovery; learning and memory; Morris water maze; traumatic brain injury	CONTROLLED CORTICAL IMPACT; WATER MAZE PERFORMANCE; RAT CEREBRAL-CORTEX; COGNITIVE FUNCTION; ATYPICAL ANTIPSYCHOTICS; LIPID-PEROXIDATION; WORKING-MEMORY; UNITED-STATES; IN-VIVO; RECOVERY	Environmental enrichment (EE) confers significant benefits after experimental traumatic brain injury (TBI). In contrast, the antipsychotic drug (APD) haloperidol (HAL) exerts deleterious effects on neurobehavioral and cognitive recovery. Neurorehabilitation and management of agitation, however, are integral components of the treatment strategy for patients with TBI. Hence, the goal of this study was to determine how the two therapeutic approaches interact and influence motor and cognitive recovery. Anesthetized adult male rats received a controlled cortical impact (2.8mmtissue deformation at 4 m/sec) or sham injury and then were provided HAL (0.5 mg/kg; intraperitoneally [IP]) or vehicle (VEH; 1 mL/kg; IP) commencing 24 h after surgery and once daily for 19 days while housed in EE or standard (STD) conditions. Beam balance/walk and Morris water maze performance were assessed on post-injury days 1-5 and 14-19, respectively, followed immediately by quantification of cortical lesion volumes. The data revealed both expected and unexpected findings. It was not surprising that the TBI groups receiving EE performed significantly better than those in STD housing and that the TBI + STD + HAL group performed worse than the TBI + STD + VEH group (p < 0.05). What was surprising was that the therapeutic effects of EE were greatly reduced by concomitant administration of HAL. No differences in cortical lesion volumes were observed among the groups (p > 0.05). The potential clinical implications of these findings suggest that administering HAL to patients undergoing neurorehabilitation may be a double-edged sword because agitation must be controlled before rehabilitation can be safely initiated and executed, but its use may compromise therapeutic efficacy.	[Folweiler, Kaitlin A.; Bondi, Corina O.; Ogunsanya, Elizabeth A.; LaPorte, Megan J.; Leary, Jacob B.; Radabaugh, Hannah L.; Monaco, Christina M.; Kline, Anthony E.] Univ Pittsburgh, Phys Med & Rehabil, Pittsburgh, PA USA; [Folweiler, Kaitlin A.; Bondi, Corina O.; Ogunsanya, Elizabeth A.; LaPorte, Megan J.; Leary, Jacob B.; Radabaugh, Hannah L.; Monaco, Christina M.; Kline, Anthony E.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Bondi, Corina O.] Univ Pittsburgh, Neurobiol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Psychol, Pittsburgh, PA USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15260 USA; [Kline, Anthony E.] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA; [Folweiler, Kaitlin A.] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; [Folweiler, Kaitlin A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Leary, Jacob B.] NIH, Dept Rehabil Med, Ctr Clin, Bethesda, MD 20892 USA; [Monaco, Christina M.] Philadelphia Coll Osteopath Med, Philadelphia, PA USA		Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Phys Med & Rehabil, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Crit Care Med, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.; Kline, AE (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Dept Psychol, 3471 Fifth Ave,Suite 201, Pittsburgh, PA 15213 USA.	klineae@upmc.edu		Bondi, Corina/0000-0002-5733-4912	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS060005, R01HD069620, HD069620-S1, R01NS084967]; University of Pittsburgh Physicians / UPMC Academic Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS084967] Funding Source: NIH RePORTER	This work was supported, in part, by the National Institutes of Health grants R01NS060005, R01HD069620, HD069620-S1, R01NS084967 (AEK) and the University of Pittsburgh Physicians / UPMC Academic Foundation (COB).	Abadi AHA, 2016, BEHAV PHARMACOL, V27, P270, DOI 10.1097/FBP.0000000000000197; BENES FM, 1985, BRAIN RES, V329, P265, DOI 10.1016/0006-8993(85)90532-3; Besret L, 2000, EUR J PHARMACOL, V408, P35, DOI 10.1016/S0014-2999(00)00747-0; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Briones TL, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-57; Briones TL, 2011, J NEUROTRAUM, V28, P2485, DOI 10.1089/neu.2011.1842; CADET JL, 1994, NEUROSCI BIOBEHAV R, V18, P457, DOI 10.1016/0149-7634(94)90001-9; CAMPBELL A, 1985, PSYCHOPHARMACOLOGY, V87, P161, DOI 10.1007/BF00431801; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Cristofori Irene, 2015, Handb Clin Neurol, V128, P579, DOI 10.1016/B978-0-444-63521-1.00037-6; Crofton EJ, 2015, NEUROSCI BIOBEHAV R, V49, P19, DOI 10.1016/j.neubiorev.2014.11.017; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIAMOND MC, 1966, J COMP NEUROL, V128, P117, DOI 10.1002/cne.901280110; DIAMOND MC, 1964, J COMP NEUROL, V123, P111, DOI 10.1002/cne.901230110; DIAMOND MC, 1976, J NEUROBIOL, V7, P75, DOI 10.1002/neu.480070108; Dixon CE, 1999, RESTOR NEUROL NEUROS, V14, P285; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Elovic EP, 2008, J HEAD TRAUMA REHAB, V23, P132, DOI 10.1097/01.HTR.0000314532.07530.e5; Faul M, 2010, TRAUMATIC BRAIN INJU; FEENEY DM, 1982, SCIENCE, V217, P855, DOI 10.1126/science.7100929; Galili-Mosberg R, 2000, J NEURAL TRANSM, V107, P479, DOI 10.1007/s007020070089; Hajheidari S, 2015, NEUROSCI LETT, V605, P39, DOI 10.1016/j.neulet.2015.08.010; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; Hicks RR, 2002, NEUROSCIENCE, V112, P631, DOI 10.1016/S0306-4522(02)00104-5; Hoffman AN, 2008, LIFE SCI, V83, P602, DOI 10.1016/j.lfs.2008.08.007; HOVDA DA, 1985, P W PHARMACOL SOC, V28, P209; Hutchings EJ, 2013, J PHARMACOL EXP THER, V347, P547, DOI 10.1124/jpet.113.209031; KAPETANOVIC IM, 1982, J PHARMACOL EXP THER, V221, P434; Karl T, 2006, BEHAV BRAIN RES, V171, P286, DOI 10.1016/j.bbr.2006.04.004; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kline AE, 2002, J NEUROTRAUM, V19, P415, DOI 10.1089/08977150252932370; Kline AE, 2004, J NEUROTRAUM, V21, P1712, DOI 10.1089/0897715042664849; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2007, CRIT CARE MED, V35, P919, DOI 10.1097/01.CCM.0000256722.88854.C0; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kline AE, 2008, NEUROSCI LETT, V448, P263, DOI 10.1016/j.neulet.2008.10.076; Klitenick MA, 1996, NEUROPSYCHOPHARMACOL, V15, P424, DOI 10.1016/0893-133X(96)00017-6; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leary L. B., 2016, J NEUROTRAUMA; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Li XJ, 2015, NEUROSCI LETT, V599, P92, DOI 10.1016/j.neulet.2015.05.035; Lombard LA, 2005, AM J PHYS MED REHAB, V84, P797, DOI 10.1097/01.phm.0000179438.22235.08; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Matter AM, 2011, NEUROREHAB NEURAL RE, V25, P558, DOI 10.1177/1545968310397206; Mazaux JM, 1997, ARCH PHYS MED REHAB, V78, P1316, DOI 10.1016/S0003-9993(97)90303-8; McNett M, 2012, BRAIN INJURY, V26, P1155, DOI 10.3109/02699052.2012.667587; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Monaco CM, 2014, J NEUROTRAUM, V31, P1934, DOI 10.1089/neu.2014.3541; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Naidu PS, 2002, BRIT J PHARMACOL, V136, P193, DOI 10.1038/sj.bjp.0704717; Nott MT, 2010, BRAIN INJURY, V24, P1214, DOI 10.3109/02699052.2010.506858; Papadia S, 2008, NAT NEUROSCI, V11, P476, DOI 10.1038/nn2071; Park SW, 2013, SYNAPSE, V67, P224, DOI 10.1002/syn.21634; Passineau MJ, 2001, EXP NEUROL, V168, P373, DOI 10.1006/exnr.2000.7623; PAYLOR R, 1992, BEHAV BRAIN RES, V52, P49, DOI 10.1016/S0166-4328(05)80324-9; Peck JA, 2015, PHARMACOL BIOCHEM BE, V138, P20, DOI 10.1016/j.pbb.2015.09.009; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Pillai A, 2007, J PSYCHIATR RES, V41, P372, DOI 10.1016/j.jpsychires.2006.01.011; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rao V, 2015, SEMIN NEUROL, V35, P64, DOI 10.1055/s-0035-1544241; Roemer RA, 1996, J PSYCHIATR NEUROSCI, V21, P325; Rosengarten H, 2002, PROG NEURO-PSYCHOPH, V26, P1047, DOI 10.1016/S0278-5846(02)00221-X; Saout V., 2011, Annals of Physical and Rehabilitation Medicine, V54, P259, DOI 10.1016/j.rehab.2011.04.003; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Seo MK, 2015, PSYCHIAT RES, V229, P968, DOI 10.1016/j.psychres.2015.05.098; Sozda CN, 2010, J NEUROTRAUM, V27, P1047, DOI 10.1089/neu.2010.1313; Stanislav SW, 1997, BRAIN INJURY, V11, P335, DOI 10.1080/026990597123494; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ukai W, 2004, J NEURAL TRANSM, V111, P667, DOI 10.1007/s00702-004-0109-z; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Weeks J. J., 2016, BEHAV BRAIN RES; Will B, 2004, PROG NEUROBIOL, V72, P167, DOI 10.1016/j.pneurobio.2004.03.001; Wilson MS, 2003, AM J PHYS MED REHAB, V82, P871, DOI 10.1097/01.PHM.0000091982.33232.CB; Wolf AP, 1996, BRAIN INJURY, V10, P241, DOI 10.1080/026990596124412; Zhu J, 2000, EXP NEUROL, V166, P136, DOI 10.1006/exnr.2000.7484	83	18	18	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					451	+		10.1089/neu.2016.4417			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800021	26975872	Green Published			2022-02-06	
J	Silverberg, ND; Crane, PK; Dams-O'Connor, K; Holdnack, J; Ivins, BJ; Lange, RT; Manley, GT; McCrea, M; Iverson, GL				Silverberg, Noah D.; Crane, Paul K.; Dams-O'Connor, Kristen; Holdnack, James; Ivins, Brian J.; Lange, Rael T.; Manley, Geoffrey T.; McCrea, Michael; Iverson, Grant L.			Developing a Cognition Endpoint for Traumatic Brain Injury Clinical Trials	JOURNAL OF NEUROTRAUMA			English	Article						clinical trials; cognition; craniocerebral trauma; neuropsychological tests; outcome assessment; psychometrics	NEUROPSYCHOLOGICAL TEST-PERFORMANCE; NEUROIMAGING INITIATIVE ADNI; PATIENT-REPORTED OUTCOMES; MINOR HEAD-INJURY; PREDICTIVE-VALIDITY; RANDOMIZED-TRIAL; COMPOSITE SCORE; NIH TOOLBOX; MILD; REHABILITATION	Cognitive impairment is a core clinical feature of traumatic brain injury (TBI). After TBI, cognition is a key determinant of post-injury productivity, outcome, and quality of life. As a final common pathway of diverse molecular and microstructural TBI mechanisms, cognition is an ideal endpoint in clinical trials involving many candidate drugs and nonpharmacological interventions. Cognition can be reliably measured with performance-based neuropsychological tests that have greater granularity than crude rating scales, such as the Glasgow Outcome Scale-Extended, which remain the standard for clinical trials. Remarkably, however, there is no well-defined, widely accepted, and validated cognition endpoint for TBI clinical trials. A single cognition endpoint that has excellent measurement precision across a wide functional range and is sensitive to the detection of small improvements (and declines) in cognitive functioning would enhance the power and precision of TBI clinical trials and accelerate drug development research. We outline methodologies for deriving a cognition composite score and a research program for validation. Finally, we discuss regulatory issues and the limitations of a cognition endpoint.	[Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Dept Med, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC, Canada; [Silverberg, Noah D.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Silverberg, Noah D.; Iverson, Grant L.] Red Sox Fdn, Boston, MA USA; [Silverberg, Noah D.; Iverson, Grant L.] Massachusetts Gen Hosp, Home Base Program, Boston, MA 02114 USA; [Crane, Paul K.] Univ Washington, Dept Med, Seattle, WA USA; [Dams-O'Connor, Kristen] Icahn Sch Med Mt Sinai, Dept Rehabil Med, New York, NY 10029 USA; [Holdnack, James] Univ Delaware, Dept Phys Therapy, Newark, DE USA; [Ivins, Brian J.] DVBIC, Silver Spring, MD USA; [Lange, Rael T.] Walter Reed Natl Mil Med Ctr, DVBIC, Bethesda, MD USA; [Lange, Rael T.] Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, MassGen Hosp Children, Sports Concuss Program,Dept Phys Med & Rehabil, Boston, MA USA; [Iverson, Grant L.] Natl Intrepid Ctr Excellence, Def & Vet Brain Injury Ctr, Bethesda, MD USA		Silverberg, ND (corresponding author), Rehabil Res Program, 4255 Laurel St, Vancouver, BC V5Z 2G9, Canada.	noah.silverberg@vch.ca		Iverson, Grant/0000-0001-7348-9570	Vancouver Coastal Health Research Institute Clinician-Scientist Career Development Award; INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium - Department of Defense Psychological Health/Traumatic Brain Injury Research Program [X81XWH-07-CC-CSDoD]; Harvard Integrated Program to Protect and Improve the Health of NFLPA Members; Mooney-Reed Charitable Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01 NS086090-01]; DOD USAMRAAUnited States Department of Defense [W81XWH-13-1-0441]; DODUnited States Department of Defense [W81XWH-14-2-0176]; One Mind; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K01HD074651] Funding Source: NIH RePORTER	NDS receives salary support from a Vancouver Coastal Health Research Institute Clinician-Scientist Career Development Award. GLI acknowledges support from the INTRuST Posttraumatic Stress Disorder and Traumatic Brain Injury Clinical Consortium funded by the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (X81XWH-07-CC-CSDoD), Harvard Integrated Program to Protect and Improve the Health of NFLPA Members, and the Mooney-Reed Charitable Foundation. GTM acknowledges support from NIH U01 NS086090-01, DOD USAMRAA W81XWH-13-1-0441, DOD W81XWH-14-2-0176, and One Mind. This work is related to the TBI Endpoints Development Initiative and a grant entitled Development and Validation of a Cognition Endpoint for Traumatic Brain Injury Clinical Trials.	Alali AS, 2015, J NEUROTRAUM, V32, P581, DOI 10.1089/neu.2014.3495; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bigler ED, 2013, NEUROPSYCHOLOGY, V27, P438, DOI 10.1037/a0032837; Binder LM, 2009, ARCH CLIN NEUROPSYCH, V24, P31, DOI 10.1093/arclin/acn001; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Brooks BL, 2011, ASSESSMENT, V18, P156, DOI 10.1177/1073191110385316; Carey CL, 2004, J CLIN EXP NEUROPSYC, V26, P307, DOI 10.1080/13803390490510031; Carter CS, 2007, SCHIZOPHRENIA BULL, V33, P1131, DOI 10.1093/schbul/sbm081; Chaytor N, 2007, J INT NEUROPSYCH SOC, V13, P377, DOI 10.1017/S1355617707070592; Chiaravalloti N. D., 2015, NEUROREHABIL NEURAL; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; CLIFTON GL, 1992, NEUROSURGERY, V31, P975, DOI 10.1227/00006123-199211000-00028; Cordoba G, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3920; Crane PK, 2008, J INT NEUROPSYCH SOC, V14, P746, DOI 10.1017/S1355617708081162; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; Crane PK, 2012, BRAIN IMAGING BEHAV, V6, P502, DOI 10.1007/s11682-012-9186-z; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; DIKMEN S, 1986, J NEUROL NEUROSUR PS, V49, P1227, DOI 10.1136/jnnp.49.11.1227; Dikmen SS, 2000, NEUROLOGY, V54, P895, DOI 10.1212/WNL.54.4.895; Donders J, 2007, BRAIN INJURY, V21, P319, DOI 10.1080/02699050701253129; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gershon RC, 2013, NEUROLOGY, V80, pS2, DOI 10.1212/WNL.0b013e3182872e5f; Giacino JT, 2014, NAT REV NEUROL, V10, P99, DOI 10.1038/nrneurol.2013.279; Gibbons LE, 2012, BRAIN IMAGING BEHAV, V6, P517, DOI 10.1007/s11682-012-9176-1; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS51, DOI 10.1016/j.apmr.2008.09.552; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Hanks RA, 1999, ARCH PHYS MED REHAB, V80, P1030, DOI 10.1016/S0003-9993(99)90056-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hannay HJ, 1996, J HEAD TRAUMA REHAB, V11, P41, DOI 10.1097/00001199-199612000-00007; Hernandez AV, 2005, NEUROSURGERY, V57, P1244, DOI 10.1227/01.NEU.0000186039.57548.96; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Iverson GL, 2010, BRAIN INJURY, V24, P1246, DOI 10.3109/02699052.2010.490513; Iverson GL, 2009, APPL NEUROPSYCHOL, V16, P254, DOI 10.1080/09084280903297594; Ivins BJ, 2015, ARCH CLIN NEUROPSYCH, V30, P26, DOI 10.1093/arclin/acu072; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Lu J, 2012, BRAIN INJURY, V26, P1523, DOI 10.3109/02699052.2012.722257; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Manly JJ, 2008, NEUROPSYCHOL REV, V18, P179, DOI 10.1007/s11065-008-9068-8; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2015, NAT REV NEUROL, V11, P71, DOI 10.1038/nrneurol.2014.261; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Novack TA, 2001, ARCH PHYS MED REHAB, V82, P300, DOI 10.1053/apmr.2001.18222; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Perel P, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16130; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Poon W, 2015, J NEUROTRAUM, V32, P571, DOI 10.1089/neu.2014.3558; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P567, DOI 10.1080/13803390500434466; Reeve BB, 2007, MED CARE, V45, pS22, DOI 10.1097/01.mlr.0000250483.85507.04; Reise SP, 2007, QUAL LIFE RES, V16, P19, DOI 10.1007/s11136-007-9183-7; Revicki D, 2008, J CLIN EPIDEMIOL, V61, P102, DOI 10.1016/j.jclinepi.2007.03.012; Rohling ML, 2015, ARCH CLIN NEUROPSYCH, V30, P611, DOI 10.1093/arclin/acv039; Rohling ML, 2003, CLIN NEUROPSYCHOL, V17, P289, DOI 10.1076/clin.17.3.289.18086; Rosenbaum SB, 2012, BRAIN IMAGING BEHAV, V6, P255, DOI 10.1007/s11682-012-9162-7; Ross S R, 1997, Appl Neuropsychol, V4, P165, DOI 10.1207/s15324826an0403_4; Russell E. W., 2011, SCI FDN NEUROPSYCHOL; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sherer M, 2002, CLIN NEUROPSYCHOL, V16, P157, DOI 10.1076/clin.16.2.157.13238; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Strauss E, 2006, ADM NORMS COMMENTARY, P1216; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Testa SM, 2009, J INT NEUROPSYCH SOC, V15, P1012, DOI 10.1017/S1355617709990713; Vacha-Haase T, 2004, J COUNS PSYCHOL, V51, P473, DOI 10.1037/0022-0167.51.4.473; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Weintraub S, 2013, NEUROLOGY, V80, pS54, DOI 10.1212/WNL.0b013e3182872ded; Wheaton P, 2011, J PSYCHOPHARMACOL, V25, P1581, DOI 10.1177/0269881110388331; Whyte J, 2014, ARCH PHYS MED REHAB, V95, pS17, DOI 10.1016/j.apmr.2013.02.029; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Yue JK, 2015, NEUROGENETICS, V16, P169, DOI 10.1007/s10048-015-0437-1; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	92	18	18	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					363	371		10.1089/neu.2016.4443			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800011	27188248	Green Published			2022-02-06	
J	Wilke, S; List, J; Mekle, R; Lindenberg, R; Bukowski, M; Ott, S; Schubert, F; Ittermann, B; Floel, A				Wilke, Skadi; List, Jonathan; Mekle, Ralf; Lindenberg, Robert; Bukowski, Martin; Ott, Stefanie; Schubert, Florian; Ittermann, Bernd; Floeel, Agnes			No Effect of Anodal Transcranial Direct Current Stimulation on Gamma-Aminobutyric Acid Levels in Patients with Recurrent Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						concussion; GABA; MR spectroscopy; transcranial magnetic stimulation	SPORTS-RELATED CONCUSSION; MOTOR CORTEX; IN-VIVO; LONG-TERM; MAGNETIC STIMULATION; PROFESSIONAL FOOTBALL; COGNITIVE FUNCTION; MR SPECTROSCOPY; RESISTANT RULES; SYMPTOMS	In patients in the chronic phase after recurrent mild traumatic brain injury (mTBI), alterations in gamma-aminobutyric acid (GABA) concentration and receptor activity have been reported, possibly mediating subtle but persistent cognitive deficits and increased rate of dementia in older age. We evaluated whether anodal transcranial direct current stimulation (atDCS) over the primary motor cortex reduces GABA concentration and GABA(B) receptor activity in patients with recurrent mTBI. Seventeen patients (mean age 25, two women) in the chronic phase after recurrent mTBI and 22 healthy control subjects (mean age 26, two women) were included. All participants received comprehensive cognitive testing and detailed questionnaires on post-concussive symptoms at baseline. Subsequently, they participated in four experimental sessions, consisting of either magnetic resonance spectroscopy (MRS)/atDCS/MRS, transcranial magnetic stimulation (TMS)/atDCS/TMS, MRS/sham/MRS, or TMS/sham/TMS to determine GABA concentration (from MRS) and GABAB receptor activity (from TMS) after atDCS and after sham stimulation. Patients with mTBI scored significantly lower on verbal fluency tasks compared with healthy control subjects. GABA concentration at baseline was associated with the number of mTBI, although no group differences in GABA concentration and GABAB receptor activity were found. Moreover, no effects of atDCS on GABA concentration and receptor activity were seen in patients with mTBI or healthy control subjects. GABA concentration may increase with the number of mTBI, but atDCS did not modulate GABA concentration and receptor activity, as has been reported previously. Specifics of experimental design and analysis, but also characteristics of the respective samples, may account for these differential findings, and should be addressed in future larger studies.	[Wilke, Skadi; List, Jonathan; Lindenberg, Robert; Bukowski, Martin; Ott, Stefanie; Floeel, Agnes] Charite, Dept Neurol, CharitePl 1, D-10117 Berlin, Germany; [Floeel, Agnes] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Floeel, Agnes] Charite, NeuroCure Cluster Excellence, Berlin, Germany; [Mekle, Ralf; Schubert, Florian; Ittermann, Bernd] PTB, Berlin, Germany		Wilke, S; Floel, A (corresponding author), Charite, Dept Neurol, CharitePl 1, D-10117 Berlin, Germany.	skadi.wilke@charite.de; agnes.floeel@charite.de	Floel, Agnes/A-9426-2017; Mekle, Ralf/S-6542-2019	Wilke, Skadi/0000-0002-1424-516X; Mekle, Ralf/0000-0001-6821-7722	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [AF: 379-10/1, 379-11/1, DFG-Exc-257]; Bundesministerium fur Bildung und ForschungFederal Ministry of Education & Research (BMBF) [01EO0801, 01GQ1424A, 01GQ1420B]; Charite Universitatsmedizin Berlin; Berlin Institute of Health	This work was supported by grants from the Deutsche Forschungsgemeinschaft (AF: 379-10/1; 379-11/1; DFG-Exc-257), Bundesministerium fur Bildung und Forschung (AF: 01EO0801, 01GQ1424A, 01GQ1420B). JL is participant in the Charite Clinical Scientist Program funded by the Charite Universitatsmedizin Berlin and the Berlin Institute of Health.	Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Bachtiar V, 2015, ELIFE, V4, DOI 10.7554/eLife.08789; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Broglio SP, 2011, J NEUROTRAUM, V28, P2061, DOI 10.1089/neu.2011.1905; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Chamard E, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12305; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chollet F., 2013, NEUROSCIENCE, V15, P67, DOI DOI 10.31887/DCNS.2013.15.1/FCH0LLET; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cousijn H, 2014, P NATL ACAD SCI USA, V111, P9301, DOI 10.1073/pnas.1321072111; Das S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00550; De Beaumont L, 2007, NEUROSURGERY, V61, P329, DOI 10.1227/01.NEU.0000280000.03578.B6; De Beaumont L, 2012, CEREB CORTEX, V22, P112, DOI 10.1093/cercor/bhr096; De Beaumont L, 2011, J ATHL TRAINING, V46, P234; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dinsmore J, 2013, BJA EDUC, V13, P189, DOI 10.1093/bjaceaccp/mkt010; Edden RAE, 2012, J MAGN RESON IMAGING, V35, P229, DOI 10.1002/jmri.22865; Floel A, 2014, NEUROIMAGE, V85, P934, DOI 10.1016/j.neuroimage.2013.05.098; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fregni F, 2006, BIPOLAR DISORD, V8, P203, DOI 10.1111/j.1399-5618.2006.00291.x; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gasparovic C, 2009, J NEUROTRAUM, V26, P1635, DOI [10.1089/neu.2009.0896, 10.1089/neu.2009-0896]; Giza CC, 2001, J ATHL TRAINING, V36, P228; GRUETTER R, 1993, MAGNET RESON MED, V29, P804, DOI 10.1002/mrm.1910290613; Gruetter R, 2000, MAGNET RESON MED, V43, P319, DOI 10.1002/(SICI)1522-2594(200002)43:2<319::AID-MRM22>3.0.CO;2-1; Guerriero RM, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0545-1; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Hautzinger M, 2006, BECK DEPRESSION INVE; Helmstaedter C., 2001, VLMT VERBALER LERN M; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; HOAGLIN DC, 1986, J AM STAT ASSOC, V81, P991, DOI 10.2307/2289073; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Hotting K, 2013, NEUROSCI BIOBEHAV R, V37, P2243, DOI 10.1016/j.neubiorev.2013.04.005; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2010, NEUROBIOL AGING, V31, P2160, DOI 10.1016/j.neurobiolaging.2008.12.008; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Keightley ML, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00139; Kidgell DJ, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/603502; Kim S, 2014, NEUROIMAGE, V99, P237, DOI 10.1016/j.neuroimage.2014.05.070; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Lindenberg R, 2013, J NEUROSCI, V33, P9176, DOI 10.1523/JNEUROSCI.0055-13.2013; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; List J, 2015, NEUROLOGY, V84, P626, DOI 10.1212/WNL.0000000000001230; Lopez-Alonso V, 2014, BRAIN STIMUL, V7, P372, DOI 10.1016/j.brs.2014.02.004; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maroon JC, 2000, NEUROSURGERY, V47, P659, DOI 10.1097/00006123-200009000-00027; Matser EJT, 1999, JAMA-J AM MED ASSOC, V282, P971, DOI 10.1001/jama.282.10.971; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; Meinzer M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00253; Meinzer M, 2013, J NEUROSCI, V33, P12470, DOI 10.1523/JNEUROSCI.5743-12.2013; Mekle R, 2009, MAGN RESON MED, V61, P1279, DOI 10.1002/mrm.21961; Mescher M, 1998, NMR BIOMED, V11, P266, DOI 10.1002/(SICI)1099-1492(199810)11:6<266::AID-NBM530>3.0.CO;2-J; Meyers JE, 1998, ASSESSMENT, V5, P303, DOI 10.1177/107319119800500309; Mlynarik V, 2006, MAGN RESON MED, V56, P965, DOI 10.1002/mrm.21043; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Near J, 2013, NMR BIOMED, V26, P1353, DOI 10.1002/nbm.2960; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Pape TLB, 2006, J HEAD TRAUMA REHAB, V21, P437, DOI 10.1097/00001199-200609000-00063; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pellman EJ, 2004, NEUROSURGERY, V55, P1290, DOI 10.1227/01.NEU.0000149244.97560.91; Powers KC, 2014, BRAIN INJURY, V28, P465, DOI 10.3109/02699052.2014.888759; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Puts NAJ, 2013, J MAGN RESON IMAGING, V37, P999, DOI 10.1002/jmri.23817; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Stagg Charlotte J, 2011, Commun Integr Biol, V4, P573, DOI 10.4161/cib.4.5.16213; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Stagg CJ, 2009, J NEUROSCI, V29, P5202, DOI 10.1523/JNEUROSCI.4432-08.2009; Suzuki K, 2012, INT J NEUROSCI, V122, P675, DOI 10.3109/00207454.2012.707715; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tang CY, 2012, TRANSL NEUROSCI, V3, P9, DOI 10.2478/s13380-012-0003-3; Tkac I, 1999, MAGNET RESON MED, V41, P649, DOI 10.1002/(SICI)1522-2594(199904)41:4<649::AID-MRM2>3.0.CO;2-G; Tremblay S, 2014, CLIN NEUROPHYSIOL, V125, P1371, DOI 10.1016/j.clinph.2013.11.040; Tremblay S, 2013, NEUROREPORT, V24, P46, DOI 10.1097/WNR.0b013e32835c36b8; Tremblay S, 2011, J NEUROTRAUM, V28, P493, DOI 10.1089/neu.2010.1615; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Ulm L, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00550; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wiethoff S, 2014, BRAIN STIMUL, V7, P468, DOI 10.1016/j.brs.2014.02.003; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilke S, 2017, J NEUROTRAUM, V34, P281, DOI 10.1089/neu.2016.4399; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006	108	18	20	2	28	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					281	+		10.1089/neu.2016.4399			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800003	27393381				2022-02-06	
J	Tanaka, M; Moran, S; Wen, J; Affram, K; Chen, TH; Symes, AJ; Zhang, YM				Tanaka, Mikiei; Moran, Sean; Wen, Jie; Affram, Kwame; Chen, Tinghua; Symes, Aviva J.; Zhang, Yumin			WWL70 attenuates PGE(2) production derived from 2-arachidonoylglycerol in microglia by ABHD6-independent mechanism	JOURNAL OF NEUROINFLAMMATION			English	Article						Endocannabinoid; 2-AG; Arachidonic acid; ABHD6; COX-2; PGE(2); PGE(2)-glyceryl ester; PGE synthase; BV2 cells; Microglia	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; CONTAINING 6 ABHD6; CANNABINOID RECEPTORS; MULTIPLE-SCLEROSIS; THERAPEUTIC TARGET; MASS-SPECTROMETRY; PROSTAGLANDIN E-2; RAT-BRAIN; INHIBITION	Background: alpha/beta-Hydrolase domain 6 (ABHD6) is one of the major enzymes for endocannabinoid 2-arachidonoylglycerol (2-AG) hydrolysis in microglia cells. Our recent studies have shown that a selective ABHD6 inhibitor WWL70 has anti-inflammatory and neuroprotective effects in animal models of traumatic brain injury and multiple sclerosis. However, the role of ABHD6 in the neuroinflammatory response and the mechanisms by which WWL70 suppresses inflammation has not yet been elucidated in reactive microglia. Methods: The hydrolytic activity and the levels of 2-AG in BV2 cells were measured by radioactivity assay and liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The expression of cyclooxygenase-2 (COX-2) and prostaglandin E-2 (PGE(2)) synthases in microglia treated with lipopolysaccharide (LPS) with/without WWL70 was determined by western blot and quantitative RT-PCR. The conversion of 2-AG to PGE(2) or PGE(2)-glyceryl ester (PGE(2)-G) was assessed by enzyme-linked immunoassay (EIA) or LC-MS/MS. The involvement of ABHD6 in PGE(2) production was assessed using pharmacological inhibitors and small interfering RNA (siRNA). The effect of WWL70 on PGE(2) biosynthesis activity in the microsome fraction from BV2 cells and experimental autoimmune encephalopathy (EAE) mouse brain was also examined. Results: We found that WWL70 suppressed PGE2 production in LPS-activated microglia via cannabinoid receptor-independent mechanisms, although intracellular levels of 2-AG were elevated by WWL70 treatment. This reduction was not attributable to WWL70 inhibition of ABHD6, given the fact that downregulation of ABHD6 by siRNA or use of KT182, an alternative ABHD6 inhibitor failed to suppress PGE2 production. WWL70 attenuated the expression of COX-2 and PGES-1/2 leading to the downregulation of the biosynthetic pathways of PGE(2) and PGE(2)-G. Moreover, PGE(2) production from arachidonic acid was reduced in the microsome fraction, indicating that WWL70 also targets PGE(2) biosynthetic enzymes, which are likely to contribute to the therapeutic mechanisms of WWL70 in the EAE mouse model. Conclusions: WWL70 is an anti-inflammatory therapeutic agent capable of inhibiting PGE(2) and PGE(2)-G production, primarily due to its reduction of COX-2 and microsomal PGES-1/2 expression and their PGE(2) biosynthesis activity in microglia cells, as well as in the EAE mouse brain.	[Tanaka, Mikiei; Wen, Jie; Chen, Tinghua; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Moran, Sean] Uniformed Serv Univ Hlth Sci, Biomed Instrumentat Ctr, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Affram, Kwame; Symes, Aviva J.] Uniformed Serv Univ Hlth Sci, Dept Pharmacol & Mol Therapeut, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Affram, Kwame; Symes, Aviva J.; Zhang, Yumin] Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA		Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Anat Physiol & Genet, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Zhang, YM (corresponding author), Uniformed Serv Univ Hlth Sci, Neurosci Program, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	yumin.zhang@usuhs.edu	Symes, Aviva J/S-7471-2016	Symes, Aviva J/0000-0003-2557-9939	National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [RG3741]; Defense Medical Research and Development Program [0130-10-00003-00002]; Military Center of Excellence Research Award [306514-1.00-63671]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [308049-14.01-60855]	This work was supported by grants from the National Multiple Sclerosis Society (RG3741), the Defense Medical Research and Development Program (0130-10-00003-00002), the Military Center of Excellence Research Award (306514-1.00-63671), and the Center for Neuroscience and Regenerative Medicine (308049-14.01-60855).	Alhouayek M, 2013, P NATL ACAD SCI USA, V110, P17558, DOI 10.1073/pnas.1314017110; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Buczynski MW, 2009, J LIPID RES, V50, P1015, DOI 10.1194/jlr.R900004-JLR200; Cabral G. A., 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P159, DOI 10.2174/187153008785700118; Chen RQ, 2012, CELL REP, V2, P1329, DOI 10.1016/j.celrep.2012.09.030; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Gong JP, 2006, BRAIN RES, V1071, P10, DOI 10.1016/j.brainres.2005.11.035; Hoover HS, 2008, BIOORG MED CHEM LETT, V18, P5838, DOI 10.1016/j.bmcl.2008.06.091; Hsu KL, 2013, J MED CHEM, V56, P8270, DOI 10.1021/jm400899c; Hu SSJ, 2008, BRIT J PHARMACOL, V153, P1538, DOI 10.1038/bjp.2008.33; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Kingsley PJ, 2005, ANAL BIOCHEM, V343, P203, DOI 10.1016/j.ab.2005.05.005; Kinsey SG, 2009, J PHARMACOL EXP THER, V330, P902, DOI 10.1124/jpet.109.155465; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Laine K, 2002, INVEST OPHTH VIS SCI, V43, P3216; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Marrs WR, 2010, NAT NEUROSCI, V13, P951, DOI 10.1038/nn.2601; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Navia-Paldanius D, 2012, J LIPID RES, V53, P2413, DOI 10.1194/jlr.M030411; Naydenov AV, 2014, NEURON, V83, P361, DOI 10.1016/j.neuron.2014.06.030; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Nomura DK, 2011, SCIENCE, V334, P809, DOI 10.1126/science.1209200; Pryce G, 2007, BRIT J PHARMACOL, V150, P519, DOI 10.1038/sj.bjp.0707003; Sakata D, 2010, J PHARMACOL SCI, V112, P1, DOI 10.1254/jphs.09R03CP; Sang N, 2007, J NEUROCHEM, V102, P1966, DOI 10.1111/j.1471-4159.2007.04668.x; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Tchantchou F, 2013, J NEUROTRAUM, V30, P565, DOI 10.1089/neu.2012.2647; Valdeolivas S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.387; van der Stelt M, 2001, J NEUROSCI, V21, P6475, DOI 10.1523/JNEUROSCI.21-17-06475.2001; Wen J, 2015, NEUROPHARMACOLOGY, V99, P196, DOI 10.1016/j.neuropharm.2015.07.010; Zhang MY, 2010, J MASS SPECTROM, V45, P167, DOI 10.1002/jms.1701	38	18	18	0	12	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JAN 10	2017	14								7	10.1186/s12974-016-0783-4			15	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	EH6PH	WOS:000391895200001	28086912	Green Published, gold			2022-02-06	
J	Cernak, I; Stein, DG; Elder, GA; Ahlers, S; Curley, K; DePalma, RG; Duda, J; Ikonomovic, M; Iverson, GL; Kobeissy, F; Koliatsos, VE; Leggieri, MJ; Pacifico, AM; Smith, DH; Swanson, R; Thompson, FJ; Tortella, FC				Cernak, Ibolja; Stein, Donald G.; Elder, Gregory A.; Ahlers, Stephn; Curley, Kenneth; DePalma, Ralph G.; Duda, John; Ikonomovic, Milos; Iverson, Grant L.; Kobeissy, Firas; Koliatsos, Vassilis E.; Leggieri, Michael J., Jr.; Pacifico, Anthony M.; Smith, Douglas H.; Swanson, Raymond; Thompson, Floyd J.; Tortella, Frank C.			Preclinical modelling of militarily relevant traumatic brain injuries: Challenges and recommendations for future directions	BRAIN INJURY			English	Article						United States Department of Veterans Affairs; conference; traumatic brain injury; blast-induced neurotrauma; preclinical research; experimental models	LONG-TERM CONSEQUENCES; COMMON DATA ELEMENTS; MITOCHONDRIAL DYSFUNCTION; CONCUSSION; PERSONNEL; UPDATE; PATHOPHYSIOLOGY; PROGESTERONE; EPIDEMIOLOGY; INFLAMMATION	As a follow-up to the 2008 state-of-the-art (SQTA) conference on traumatic brain injuries (TBIs); the 2015 event organized by the United States Department of Veterans Affairs (VA) Office of Research and Development (ORD) analysed the knowledge gained Over the last 7 years as it relates to basic scientific methods, experimental findings, diagnosis. therapy, and rehabilitation of TBIs and blast-induced neurotraumas (BINTs). The current article summarizes the discussions and recommendations of the scientific panel attending the Preclinical Modeling and Therapeutic Development Workshop of the conference; with special emphasis on factors slowing research,progress and recommendations for ways of addressing the most significant pitfalls.	[Cernak, Ibolja] Univ Alberta, Fac Rehabil Med, Mil & Vet Clin Rehabil Res, Edmonton, AB, Canada; [Stein, Donald G.] Emory Sch Med, Dept Emergency Med, Brain Res Lab, Atlanta, GA USA; [Elder, Gregory A.] James J Peters VA Med Ctr, Bronx, NY USA; [Elder, Gregory A.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Ahlers, Stephn] Naval Med Res Ctr, Operat & Undersea Med, Silver Spring, MD USA; [Curley, Kenneth] Latrikos Res & Dev Strategies LLC, Tampa, FL USA; [Curley, Kenneth] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA; [DePalma, Ralph G.] Uniformed Serv Univ Hlth Sci, Off Res & Dev, VA ORD, Washington, DC USA; [DePalma, Ralph G.] Uniformed Serv Univ Hlth Sci, Off Res & Dev, Dept Surg, Washington, DC USA; [Duda, John] Univ Penn, Parkinsons Dis Res Educ & Clin Ctr, Philadelphia VA Med Ctr, Philadelphia, PA 19104 USA; [Duda, John] Univ Penn, Perelman Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Ikonomovic, Milos] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Neuropsychol Outcome Assessment Lab, Boston, MA USA; [Kobeissy, Firas] Univ Florida, Evelyn F & William L McKnight Brain Inst, Dept Psychiat, Psychoprote & Nanotechnol Res Ctr, Gainesville, FL USA; [Koliatsos, Vassilis E.] Johns Hopkins Sch Med, Dept Pathol Neuropathol & Neurol, Baltimore, MD USA; [Leggieri, Michael J., Jr.] US Army, Med Res & Mat Command, DoD Blast Injury Res Program Coordinating Off, Ft Detrick, MD USA; [Pacifico, Anthony M.] Alzheimers & Epilepsy Res Programs, Congressionally Directed Med Res Programs, Ft Detrick, MD USA; [Pacifico, Anthony M.] US Dept Hlth & Human Serv, Telemed & Adv Technol Res Ctr, Ft Detrick, MD USA; [Smith, Douglas H.] Univ Penn, PENNs Ctr Brain Injury & Repair, Robert A Groff Prof Neurosurg Res & Educ, Dept Neurosurg, Philadelphia, PA 19104 USA; [Swanson, Raymond] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Swanson, Raymond] SFVAMC, Neurol Serv, San Francisco, CA USA; [Thompson, Floyd J.] Univ Florida, Malcom Randall VAMC, Brain Rehabil Res Ctr, Gainesville, FL USA; [Thompson, Floyd J.] Univ Florida, Neurosci, Gainesville, FL USA; [Tortella, Frank C.] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Branch Brain Trauma Neuroprotect & Neurorestorat, Silver Spring, MD USA		Cernak, I (corresponding author), Univ Alberta, Fac Rehabil Med, Corbett Hall 3-48, Edmonton, AB T6M 2J9, Canada.	cernak@ualberta.ca	Kobeissy, Firas/E-7042-2017; DePalma, Ralph/P-1733-2019; Stein, Donald/AAJ-5139-2020	Kobeissy, Firas/0000-0002-5008-6944; Ibolja, Cernak/0000-0003-3214-698X; Iverson, Grant/0000-0001-7348-9570	Veterans AffairsUS Department of Veterans Affairs [I01RX000996] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS092398] Funding Source: Medline; RRD VA [I01 RX000996] Funding Source: Medline		Ahmed F, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00114; Arun P, 2013, J NEUROTRAUM, V30, P1645, DOI 10.1089/neu.2012.2834; Barkhoudarian G, 2016, PHYS MED REH CLIN N, V27, P373, DOI 10.1016/j.pmr.2016.01.003; Bazarian JJ, 2009, J HEAD TRAUMA REHAB, V24, P439, DOI 10.1097/HTR.0b013e3181c15600; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Faden AI, 2016, BRIT J PHARMACOL, V173, P681, DOI 10.1111/bph.13179; Giannotti M, 2010, INJURY, V41, P907, DOI 10.1016/j.injury.2009.09.040; Gilmer LK, 2009, J NEUROTRAUM, V26, P1271, DOI 10.1089/neu.2008.0857; Gubata ME, 2014, J HEAD TRAUMA REHAB, V29, P65, DOI 10.1097/HTR.0b013e318295f590; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hellewell S, 2016, BRAIN RES, V1640, P36, DOI 10.1016/j.brainres.2015.12.024; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Holtkamp MD, 2016, CURR PAIN HEADACHE R, V20, DOI 10.1007/s11916-016-0572-x; Howard RB, 2017, J NEUROTRAUM, V34, P1915, DOI 10.1089/neu.2015.4179; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; MacGregor AJ, 2011, J REHABIL RES DEV, V48, P1269, DOI 10.1682/JRRD.2011.01.0013; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; Nelson C, 2011, MIL MED, V176, P156, DOI 10.7205/MILMED-D-10-00252; Nimmo AJ, 2004, NEUROPEPTIDES, V38, P40, DOI 10.1016/j.npep.2003.12.003; Pandya JD, 2009, EXP NEUROL, V218, P381, DOI 10.1016/j.expneurol.2009.05.023; Patel HDL, 2012, J TRAUMA ACUTE CARE, V73, P276, DOI 10.1097/TA.0b013e318256dd80; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Pryor James, 2016, J Lifestyle Med, V6, P7, DOI 10.15280/jlm.2016.6.1.7; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; Smith DH, 2015, J NEUROTRAUM, V32, P1725, DOI 10.1089/neu.2014.3861; Stein DG, 2011, NEUROSCIENCE, V191, P101, DOI 10.1016/j.neuroscience.2011.04.013; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Voss JD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0506-z; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002	40	18	19	0	2	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	9			SI		1168	1176		10.1080/02699052.2016.1274779			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FK0NN	WOS:000413176600002	28981339	hybrid			2022-02-06	
J	Chiu, LS; Anderton, RS; Cross, JL; Clark, VW; Edwards, AB; Knuckey, NW; Meloni, BP				Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Edwards, Adam B.; Knuckey, Neville W.; Meloni, Bruno P.			ASSESSMENT OF R18, COG1410, AND APP96-110 IN EXCITOTOXICITY AND TRAUMATIC BRAIN INJURY	TRANSLATIONAL NEUROSCIENCE			English	Article						TBI; cationic arginine-rich peptides (CARPs); R18; APP96-110; COG1410; axonal injury; neuroprotection	ARGININE-RICH PEPTIDES; IMPROVES COGNITIVE PERFORMANCE; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; NEUROPROTECTIVE EFFICACY; POLY-ARGININE; MIMETIC PEPTIDE; CELLULAR UPTAKE; GLUTAMIC-ACID; MODEL	Cationic arginine-rich and poly-arginine peptides (referred to as CARPs) have potent neuroprotective properties in in vitro excitotoxicity and in vivo models of stroke. Traumatic brain injury (TBI) shares many pathophysiological processes as stroke, including excitotoxicity. Therefore, we evaluated our lead peptide, poly-arginine R18, with the COG1410 and APP96-110 peptides, which have neuroprotective actions following TBI. In an in vitro cortical neuronal glutamic acid excitotoxicity injury model, R18 was highly neuroprotective and reduced neuronal calcium influx, while COG1410 and APP96-110 displayed modest neuroprotection and were less effective at reducing calcium influx. In an impact-acceleration closed-head injury model (Marmarou model), R18, COG1410, and APP96-110 were administered intravenously (300 nmol/kg) at 30 minutes after injury in male Sprague-Dawley rats. When compared to vehicle, no peptide significantly improved functional outcomes, however the R18 and COG1410 treatment groups displayed positive trends in the adhesive tape test and rotarod assessments. Similarly, no peptide had a significant effect on hippocampal neuronal loss, however a significant reduction in axonal injury was observed for R18 and COG1410. In conclusion, this study has demonstrated that R18 is significantly more effective than COG1410 and APP96-110 at reducing neuronal injury and calcium influx following excitotoxicity, and that both R18 and COG1410 reduce axonal injury following TBI. Additional dose response and treatment time course studies are required to further assess the efficacy of R18 in TBI.	[Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Edwards, Adam B.; Knuckey, Neville W.; Meloni, Bruno P.] Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia; [Chiu, Li Shan; Anderton, Ryan S.; Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; [Cross, Jane L.; Clark, Vince W.; Knuckey, Neville W.; Meloni, Bruno P.] Sir Charles Gairdner Hosp, QEII Med Ctr, Dept Neurosurg, Nedlands, WA 6009, Australia; [Anderton, Ryan S.; Edwards, Adam B.] Univ Notre Dame Australia, Sch Heath Sci, Fremantle, WA 6160, Australia; [Anderton, Ryan S.] Univ Notre Dame Australia, Inst Hlth Res, Fremantle, WA 6160, Australia		Meloni, BP (corresponding author), Perron Inst Neurol & Translat Sci, Nedlands, WA 6009, Australia.; Meloni, BP (corresponding author), Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia.; Meloni, BP (corresponding author), Sir Charles Gairdner Hosp, QEII Med Ctr, Dept Neurosurg, Nedlands, WA 6009, Australia.	bruno.meloni@perron.uwa.edu.au	Chiu, Li Shan/AAQ-5330-2020; Edwards, Adam/U-3386-2019	Chiu, Li Shan/0000-0002-5601-7739; Edwards, Adam/0000-0002-7503-3232; Anderton, Ryan/0000-0003-0568-9794	Neurotrauma Research Program of Western Australia; Brain Foundation (Australia); Perron Institute for Neurological and Translational Science; Department of Neurosurgery at Sir Charles Gairdner Hospital	This study was supported by grants from the Neurotrauma Research Program of Western Australia and Brain Foundation (Australia), and financial support was also provided by the Perron Institute for Neurological and Translational Science and the Department of Neurosurgery at Sir Charles Gairdner Hospital. We also thank Jim Litis for providing a student PhD scholarship for Li Shan Chiu, Argeo Siliquini for constructing the weight-drop device, and Professor Frank Mastaglia for his assistance in the preparation of this manuscript.	Alwis DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052169; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Bouet V, 2009, NAT PROTOC, V4, P1560, DOI 10.1038/nprot.2009.125; Buki A, 2000, J NEUROSCI, V20, P2825; Cao F, 2016, J NEUROTRAUM, V33, P175, DOI 10.1089/neu.2015.3887; Chiu LS, 2016, EXPERT REV NEUROTHER, V16, P361, DOI 10.1586/14737175.2016.1150180; Chiu LS, 2016, MOL NEUROBIOL; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; Dahdah MN, 2016, ARCH PHYS MED REHAB, V97, P1821, DOI 10.1016/j.apmr.2016.05.005; Davceva N, 2015, AM J FOREN MED PATH, P1; Edwards AB, 2017, MOL CELL BIOCHEM, V426, P75, DOI 10.1007/s11010-016-2882-z; Haberg AK, 2014, J NEUROSCI RES, P1126; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Jiang Y, 2012, J NEUROTRAUM, V29, P2332, DOI 10.1089/neu.2012.2362; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kaufman NA, 2010, BEHAV BRAIN RES, V214, P395, DOI 10.1016/j.bbr.2010.06.017; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2017, SCI REP-UK, V7, DOI 10.1038/srep46461; Lei BL, 2016, SCI REP-UK, V6, DOI 10.1038/srep34834; Leupold E, 2008, BBA-BIOMEMBRANES, V1778, P2781, DOI 10.1016/j.bbamem.2008.09.008; MacDougall G, 2016, J MOL NEUROSCI, V12, P1; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meloni BP, 2017, NEUROMOL MED, P1; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Meloni BP, 2014, CELL MOL NEUROBIOL, V34, P173, DOI 10.1007/s10571-013-9999-3; Milani D, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/2372710; Milani D, 2017, NEUROSCI RES, V114, P9, DOI 10.1016/j.neures.2016.09.002; Milani D, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0253-z; Misra UK, 2001, J LEUKOCYTE BIOL, V70, P677; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Qin X, 2016, J NEUROTRAUM, V2016, P4485; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Tu TM, 2017, ANN CLIN TRANSL NEUR, V4, P246, DOI 10.1002/acn3.399; Tukhovskaya EA, 2009, J NEUROSCI RES, V87, P677, DOI 10.1002/jnr.21874; Wang XS, 1997, J CELL PHYSIOL, V173, P73, DOI 10.1002/(SICI)1097-4652(199710)173:1<73::AID-JCP9>3.0.CO;2-G; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	42	18	18	1	3	DE GRUYTER POLAND SP ZOO	WARSAW	BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND	2081-3856	2081-6936		TRANSL NEUROSCI	Transl. Neurosci.	JAN	2017	8	1					147	157		10.1515/tnsci-2017-0021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM9LP	WOS:000415591200001	29177102	Green Published, gold			2022-02-06	
J	Cook, NE; Huang, DS; Silverberg, ND; Brooks, BL; Maxwell, B; Zafonte, R; Berkner, PD; Iverson, GL				Cook, Nathan E.; Huang, Donna S.; Silverberg, Noah D.; Brooks, Brian L.; Maxwell, Bruce; Zafonte, Ross; Berkner, Paul D.; Iverson, Grant L.			Baseline cognitive test performance and concussion-like symptoms among adolescent athletes with ADHD: examining differences based on medication use	CLINICAL NEUROPSYCHOLOGIST			English	Article						Attention-deficit; hyperactivity disorder (ADHD); concussion; mild traumatic brain injury; adolescents	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; HIGH-SCHOOL; CHILDREN; METAANALYSIS; DISABILITY; SPORTS; SCORES	Objective: Youth with attention deficit hyperactivity disorder (ADHD) perform more poorly on preseason cognitive testing and report more baseline concussion-like symptoms but prior studies have not examined the influence of medication use on test performance or symptom reporting. This study investigated whether medication use is relevant when interpreting baseline ImPACT (R) results from student athletes with ADHD. Method: Participants were 39,247 adolescent athletes, ages 13-18 (mean age=15.5years, SD=1.3), who completed baseline cognitive testing with ImPACT (R). The sample included slightly more boys (54.4%) than girls. Differences in ImPACT (R) composite scores and concussion-like symptom reporting (between ADHD/No medication, ADHD/Medication, No ADHD/Medication, and Control groups) were examined with ANOVAs, conducted separately by gender. Results: In this large, state-wide data-set, youth with ADHD had greater rates of invalid ImPACT results compared to control subjects (ADHD/No Medication: girls=10.9%, boys=10%; ADHD/Medication: girls=8.1%, boys=9.1%; Controls: girls=5.2%, boys=6.7%). Groups differed across all ImPACT (R) composites (invalid profiles were removed), in the following order (from worse to better performance): ADHD/No Medication, ADHD/Medication, and Control participants. Pairwise effect sizes indicated that the largest differences were on the Visual Motor Speed composite, with the ADHD/No medication group performing worse than the ADHD/Medication group and the Controls. The ADHD/Medication group did not differ meaningfully from Controls on any composite, for either sex (d=0 to .19). The ADHD groups did not differ on total symptom scores but both ADHD groups endorsed significantly more symptoms compared to Controls. Conclusions: Contrary to our hypothesis, we found medication use had only a subtle effect on cognitive performance and no significant effect on concussion-like symptom reporting. Student athletes reporting medication use for ADHD performed comparably to student athletes with no ADHD on baseline testing.	[Cook, Nathan E.] Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA; [Cook, Nathan E.] Massachusetts Gen Hosp, Dept Psychiat, Learning & Emot Assessment Program, Boston, MA 02114 USA; [Cook, Nathan E.; Silverberg, Noah D.; Iverson, Grant L.] MassGeneral Hosp, Children Sport Concuss Program, Boston, MA 02114 USA; [Huang, Donna S.; Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Huang, Donna S.; Silverberg, Noah D.; Zafonte, Ross; Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] GF Strong Rehab Ctr, Vancouver, BC, Canada; [Silverberg, Noah D.; Zafonte, Ross; Iverson, Grant L.] Home Base, Boston, MA USA; [Silverberg, Noah D.; Zafonte, Ross; Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Brooks, Brian L.] Alberta Childrens Prov Gen Hosp, Neurosci & Vi Riddell Childrens Pain & Rehabil Pr, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Paediat, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Brooks, Brian L.] Univ Calgary, Alberta Childrens Hosp Res Inst, Calgary, AB, Canada; [Maxwell, Bruce] Colby Coll, Dept Comp Sci, Waterville, ME 04901 USA; [Zafonte, Ross] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Zafonte, Ross] Massachusetts Gen Hosp, Dept Phys Med & Rehabil, Boston, MA 02114 USA; [Zafonte, Ross] Brigham & Womens Hosp, Dept Phys Med & Rehabil, 75 Francis St, Boston, MA 02115 USA; [Berkner, Paul D.] Colby Coll, Hlth Serv, Waterville, ME 04901 USA; [Berkner, Paul D.] Colby Coll, Dept Biol, Waterville, ME 04901 USA		Cook, NE (corresponding author), Harvard Med Sch, Dept Psychiat, Boston, MA 02115 USA.; Cook, NE (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Learning & Emot Assessment Program, Boston, MA 02114 USA.	necook@mgh.harvard.edu		Iverson, Grant/0000-0001-7348-9570; Huang, Donna/0000-0001-8620-639X	Goldfarb Center for Public Policy and Civic Engagement at Colby College; Bill and Joan Alfond Foundation	This work was supported in part by the Goldfarb Center for Public Policy and Civic Engagement at Colby College, and the Bill and Joan Alfond Foundation.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Brooks BL, 2016, APPL NEUROPSYCH-CHIL, V5, P119, DOI 10.1080/21622965.2014.1003066; Chinn S, 2000, STAT MED, V19, P3127, DOI 10.1002/1097-0258(20001130)19:22<3127::AID-SIM784>3.3.CO;2-D; Coghill DR, 2014, BIOL PSYCHIAT, V76, P603, DOI 10.1016/j.biopsych.2013.10.005; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Ellis P. D, 2009, EFFECT SIZE CALCULAT; Faraone SV, 2010, EUR CHILD ADOLES PSY, V19, P353, DOI 10.1007/s00787-009-0054-3; Goth-Owens TL, 2010, CHILD NEUROPSYCHOL, V16, P577, DOI 10.1080/09297049.2010.485126; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; ImPACT Applications Inc, 2011, IMM POSTC ASS COGN T; Iverson G. L., 2014, J NEUROTRAUM, V33, P2077, DOI [10.1089/neu.2014.3424, DOI 10.1089/NEU.2014.3424.]; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Nelson LD, 2015, AM J SPORT MED, V43, P2018, DOI 10.1177/0363546515587714; Shanahan MA, 2006, J ABNORM CHILD PSYCH, V34, P585, DOI 10.1007/s10802-006-9037-8; Sussman W. I., 2014, AM J PHYS MED REHABI, V93, pa94; Visser SN, 2014, J AM ACAD CHILD PSY, V53, P34, DOI 10.1016/j.jaac.2013.09.001; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	24	18	18	0	6	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1385-4046	1744-4144		CLIN NEUROPSYCHOL	Clin. Neuropsychol.		2017	31	8					1341	1352		10.1080/13854046.2017.1317031			12	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	FM2JR	WOS:000414811500006	28429656				2022-02-06	
J	Das, J; Singh, R; Sharma, D				Das, Jharana; Singh, Rameshwar; Sharma, Deepak			Antiepileptic effect of fisetin in iron-induced experimental model of traumatic epilepsy in rats in the light of electrophysiological, biochemical, and behavioral observations	NUTRITIONAL NEUROSCIENCE			English	Article						Fisetin; Epilepsy; Oxidative stress; Na+; K+-ATPase; Lipid peroxidation; Morris water maze; Open-field test	OXIDATIVE STRESS; ANTIOXIDANT; FLAVONOIDS; SEIZURES; MICE; INVOLVEMENT; ACTIVATION; MECHANISMS; DISEASE; PROTEIN	Background: Traumatic epilepsy is defined by episodes of recurring seizures secondary to severe brain injury. Though drugs are found effective to control seizures, their long-term use have been observed to increase reactive oxygen species in animals. Flavonoid fisetin, a natural bioactive phytonutrient reported to exert anticonvulsive effect in experimental seizure models. But, trauma-induced seizures could not be prevented by anticonvulsants was reported in some clinical studies. Objective: To study the effect of fisetin on epileptiform electrographic activity in iron-induced traumatic epilepsy and also the probable reason behind the effect in rats. Methods: Fisetin pretreatment (20mg/kg body wt., p.o.) of rats for 12 weeks were chosen followed by injecting iron (5 mu l, 100mM) stereotaxically to generate iron-induced epilepsy. Experimental design include electrophysiological study (electroencephalograph in correlation with multiple unit activity (MUA) in the cortex and CA1 subfield of the hippocampus; spectral analysis of seizure and seizure-associated behavioral study (Morris water maze for spatial learning, open-field test for anxiety) and biochemical study (lipid peroxidation, Na+,K+-ATPase activity) in both the cortex and the hippocampus. Results: Fisetin pretreatment was found to prevent the development of iron-induced electrical seizure and decrease the corresponding MUA in the cortex (*P < 0.05) as well as in the hippocampus (***P < 0.001). Fisetin pretreatment decreased the lipid peroxides (*P < 0.05) and retained the Na+,K+-ATPase activity (*P < 0.05) which was found altered in the epileptic animals and also found to attenuate the seizure-associated cognitive dysfunctions. Conclusion: This study demonstrated the antiepileptic action of fisetin in iron-induced model of epileptic rats by inhibiting oxidative stress.	[Das, Jharana; Singh, Rameshwar; Sharma, Deepak] Jawaharlal Nehru Univ, Sch Life Sci, Lab Neurobiol, New Delhi 110067, India		Sharma, D (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	deepak57in@yahoo.co.in		Das, Jharana/0000-0001-7212-9215	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, IndiaDepartment of Biotechnology (DBT) India [BT/PR4993/MED/30/914/2012]	Department of Biotechnology, Ministry of Science and Technology, Government of India, New Delhi, India (BT/PR4993/MED/30/914/2012).	Silva LFA, 2011, J NEUROL SCI, V308, P35, DOI 10.1016/j.jns.2011.06.030; Arakawa H, 2003, DEV PSYCHOBIOL, V43, P11, DOI 10.1002/dev.10120; Beltowski J, 2003, ACTA BIOCHIM POL, V50, P103; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Cesnik E, 2013, NEUROL NEUROPHYSIO S, VS2, P1; Constantin RP, 2011, J BIOCHEM MOL TOXIC, V25, P117, DOI 10.1002/jbt.20367; Currais A, 2014, AGING CELL, V13, P379, DOI 10.1111/acel.12185; Diniz TC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/171756; Fiske CH, 1925, J BIOL CHEM, V66, P375; HOLMES GL, 1990, ANN NEUROL, V27, P24, DOI 10.1002/ana.410270106; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Javed H, 2015, J NEUROL SCI, V348, P51, DOI 10.1016/j.jns.2014.10.044; Junker H, 2005, EPILEPSIA, V46, P339, DOI 10.1111/j.0013-9580.2005.46904.x; Kang KA, 2014, IN VITRO CELL DEV-AN, V50, P66, DOI 10.1007/s11626-013-9681-6; Khan N, 2013, ANTIOXID REDOX SIGN, V19, P151, DOI 10.1089/ars.2012.4901; Kovacs Z, 2011, J NEUROSCI METH, V197, P133, DOI 10.1016/j.jneumeth.2011.02.005; Maher P, 2007, BRAIN RES, V1173, P117, DOI 10.1016/j.brainres.2007.07.061; Maher P, 2011, HUM MOL GENET, V20, P261, DOI 10.1093/hmg/ddq460; Maher P, 2009, GENES NUTR, V4, P297, DOI 10.1007/s12263-009-0142-5; Markovic JMD, 2014, RSC ADV, V4, P32228, DOI 10.1039/c4ra02577f; Markovic JMD, 2011, DALTON T, V40, P4560, DOI 10.1039/c0dt01834a; Mishra M, 2010, EPILEPSY BEHAV, V19, P264, DOI 10.1016/j.yebeh.2010.06.048; Miteva MA, 2006, NUCLEIC ACIDS RES, V34, pW738, DOI 10.1093/nar/gkl065; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Moseley AE, 2007, J NEUROSCI, V27, P616, DOI 10.1523/JNEUROSCI.4464-06.2007; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Piao MJ, 2013, BIOMOL THER, V21, P210, DOI 10.4062/biomolther.2013.017; Raygude KS, 2012, BIOMED PREV NUTR, V2, P215, DOI DOI 10.1016/J.BIONUT.2012.04.005; Rezin GT, 2014, REV BRAS PSIQUIATR, V36, P138, DOI 10.1590/1516-4446-2012-0956; Saenz JCB, 2006, BEHAV BRAIN RES, V169, P57, DOI 10.1016/j.bbr.2005.12.001; Sagara Y, 2004, J NEUROCHEM, V90, P1144, DOI 10.1111/j.1471-4159.2004.02563.x; Shin EJ, 2011, NEUROCHEM INT, V59, P122, DOI 10.1016/j.neuint.2011.03.025; WILLMORE LJ, 1981, NEUROLOGY, V31, P63, DOI 10.1212/WNL.31.1.63; Zhao X, 2015, SCI REP-UK, V5, DOI 10.1038/srep09043; Zhen LL, 2012, BEHAV BRAIN RES, V228, P359, DOI 10.1016/j.bbr.2011.12.017	36	18	18	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1028-415X	1476-8305		NUTR NEUROSCI	Nutr. Neurosci.		2017	20	4					255	264		10.1080/1028415X.2016.1183342			10	Neurosciences; Nutrition & Dietetics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Nutrition & Dietetics	ES6QF	WOS:000399673200006	27198489				2022-02-06	
J	Dretsch, MN; Williams, K; Staver, T; Grammer, G; Bleiberg, J; DeGraba, T; Lange, RT				Dretsch, Michael N.; Williams, Kathy; Staver, Tara; Grammer, Geoffrey; Bleiberg, Joseph; DeGraba, Thomas; Lange, Rael T.			Evaluating the clinical utility of the Validity-10 for detecting amplified symptom reporting for patients with mild traumatic brain injury and comorbid psychological health conditions	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Mild traumatic brain injury; neurobehavioral symptom inventory; post-concussive symptoms; Validity-10	MILITARY SERVICE MEMBERS; POSTCONCUSSION SYNDROME; INVENTORY; EXAGGERATION; SCALE	The objective of this study was to compare the Validity-10 scale with the PAI Negative Impression Management Scale (PAI-NIM) for detecting exaggerated symptom reporting in active-duty military service members (SMs) admitted with unremitting mild TBI symptoms and comorbid psychological health conditions (mTBI/PH). Data were analyzed from 254 SMs who completed the Neurobehavioral Symptom Inventory (NSI) and Personality Assessment Inventory (PAI) as a part of a larger battery of self-report symptom scales upon admission to the intensive-outpatient TBI treatment program at a military medical center. Symptom exaggeration was operationalized using the PAI Negative Impression Management Scale (PAI-NIM). A PAI-NIM score of 73 was categorized as positive for symptom exaggeration (SVTpos), while a lower score was categorized as negative for symptom exaggeration (SVTneg). SMs in the SVTpos group (n=34) had significantly higher scores (p.004) on the PAI clinical scales as well as on the NSI total score (range: d=0.59-1.91) compared to those who were SVTneg (n=220). The optimal cut-score for the NSI Val-10 scale to identify possible symptom exaggeration was 26 (sensitivity=.29, specificity=.95, PPP=.74, NPP=.71). In patients suffering from mTBI/PH, the Validity-10 requires a higher cut-score than previously reported to be useful as a metric of exaggerated symptom reporting.	[Dretsch, Michael N.; Williams, Kathy; Staver, Tara; Grammer, Geoffrey; Bleiberg, Joseph; DeGraba, Thomas; Lange, Rael T.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Dretsch, Michael N.] Headquarters US Army Training & Doctrine Command, Human Dimens Div, Ft Eustis, VA USA; [Lange, Rael T.] Def & Vet Brain Injury Ctr, Bethesda, MD USA		Dretsch, MN (corresponding author), HQ TRADOC, Human Dimens Div, 950 Jefferson Ave, Ft Eustis, VA 23604 USA.	dretschphd@gmail.com		Bleiberg, Joseph/0000-0003-0867-5494			CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P23, DOI 10.1097/HTR.0b013e3181b4b6ab; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Lalkhen AG, 2008, BJA EDUC, V8, P221, DOI 10.1093/bjaceaccp/mkn041; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P853, DOI 10.1080/13803395.2015.1064864; Lange RT, 2015, J CLIN EXP NEUROPSYC, V37, P325, DOI 10.1080/13803395.2015.1013021; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Morey, 1991, PERSONALITY ASSESSME; Morey L.C., 2007, PERSONALITY ASSESSME; Rohling Martin L, 2002, CNS Spectr, V7, P387; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e	14	18	18	0	0	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2017	24	4					376	380		10.1080/23279095.2016.1220947			5	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	EW6FW	WOS:000402605300009	27556139				2022-02-06	
J	Main, KL; Soman, S; Pestilli, F; Furst, A; Noda, A; Hernandez, B; Kong, J; Cheng, JT; Fairchild, JK; Taylor, J; Yesavage, J; Ashford, JW; Kraemer, H; Adamson, MM				Main, Keith L.; Soman, Salil; Pestilli, Franco; Furst, Ansgar; Noda, Art; Hernandez, Beatriz; Kong, Jennifer; Cheng, Jauhtai; Fairchild, Jennifer K.; Taylor, Joy; Yesavage, Jerome; Ashford, J. Wesson; Kraemer, Helena; Adamson, Maheen M.			DTI measures identify mild and moderate TBI cases among patients with complex health problems: A receiver operating characteristic analysis of US veterans	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; Concussion; Imaging; Axon degeneration; Neurodegeneration	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; DIFFUSE AXONAL INJURY; WHITE-MATTER INTEGRITY; POST-CONCUSSION SYNDROME; TENSOR IMAGING FINDINGS; HEAD-INJURY; FIBER TRACTOGRAPHY; POSTCONCUSSION SYNDROME; EXTERNAL VALIDATION	Standard MRI methods are often inadequate for identifying mild traumatic brain injury (TBI). Advances in diffusion tensor imaging now provide potential biomarkers of TBI among white matter fascicles (tracts). However, it is still unclear which tracts are most pertinent to TBI diagnosis. This study ranked fiber tracts on their ability to discriminate patients with and without TBI. We acquired diffusion tensor imaging data from military veterans admitted to a polytrauma clinic (Overall n = 109; Age: M = 47.2, SD= 11.3; Male: 88%; TBI: 67%). TBI diagnosis was based on self-report and neurological examination. Fiber tractography analysis produced 20 fiber tracts per patient. Each tract yielded four clinically relevant measures (fractional anisotropy, mean diffusivity, radial diffusivity, and axial diffusivity). We applied receiver operating characteristic (ROC) analyses to identify the most diagnostic tract for each measure. The analyses produced an optimal cutpoint for each tract. We then used kappa coefficients to rate the agreement of each cutpoint with the neurologist's diagnosis. The tract with the highest kappa was most diagnostic. As a check on the ROC results, we performed a stepwise logistic regression on each measure using all 20 tracts as predictors. We also bootstrapped the ROC analyses to compute the 95% confidence intervals for sensitivity, specificity, and the highest kappa coefficients. The ROC analyses identified two fiber tracts as most diagnostic of TBI: the left cingulum (LCG) and the left inferior fronto-occipital fasciculus (LIF). Like ROC, logistic regression identified LCG as most predictive for the FA measure but identified the right anterior thalamic tract (RAT) for the MD, RD, and AD measures. These findings are potentially relevant to the development of TBI biomarkers. Our methods also demonstrate how ROC analysis may be used to identify clinically relevant variables in the TBI population.	[Main, Keith L.; Soman, Salil; Furst, Ansgar; Kong, Jennifer; Cheng, Jauhtai; Yesavage, Jerome; Ashford, J. Wesson] VAPAHCS, War Related Illness & Injury Study Ctr, Palo Alto, CA USA; [Main, Keith L.] DVBIC, 1335 East West Highway,Suite 4-100, Silver Spring, MD 20910 USA; [Main, Keith L.] GDHS, Fairfax, VA USA; [Soman, Salil; Furst, Ansgar; Noda, Art; Hernandez, Beatriz; Fairchild, Jennifer K.; Taylor, Joy; Yesavage, Jerome; Ashford, J. Wesson; Kraemer, Helena; Adamson, Maheen M.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA; [Soman, Salil] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Radiol, Boston, MA USA; [Pestilli, Franco] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA; [Furst, Ansgar] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Adamson, Maheen M.] Stanford Sch Med, Dept Neurosurg, Stanford, CA USA; [Adamson, Maheen M.] VAPAHCS, DVBIC, Palo Alto, CA USA		Main, KL (corresponding author), VAPAHCS, War Related Illness & Injury Study Ctr, Palo Alto, CA USA.; Main, KL (corresponding author), DVBIC, 1335 East West Highway,Suite 4-100, Silver Spring, MD 20910 USA.	keith.l.main3.ctr@mail.mil	Ashford, J. Wesson/D-3929-2009	Soman, Salil/0000-0002-5887-0717; Adamson, Maheen/0000-0002-1534-4063; Pestilli, Franco/0000-0002-2469-0494	ar Related Illness and Injury Study Center; NSFNational Science Foundation (NSF) [IIS 1636893]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [ULTTR001108]	This research was funded by the ar Related Illness and Injury Study Center. F.P. is supported by NSF IIS 1636893 and NIH ULTTR001108.	Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Alemayehu D, 2012, ACAD RADIOL, V19, P1457, DOI 10.1016/j.acra.2012.09.006; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2010, BRAIN IMAGING BEHAV, V4, P270, DOI 10.1007/s11682-010-9105-0; Bigler ED, 2010, NEUROLOGY, V74, P626, DOI 10.1212/WNL.0b013e3181d3e43a; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Bozzali M, 2005, BRAIN, V128, P1595, DOI 10.1093/brain/awh493; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; BROWN JW, 1975, NEUROPSYCHOLOGIA, V13, P107, DOI 10.1016/0028-3932(75)90054-8; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Catani M, 2007, BRAIN, V130, P602, DOI 10.1093/brain/awm008; Centers for Disease Control and Prevention, 2013, REP C TRAUM BRAIN IN; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Creelman, 2005, DETECTION THEORY USE; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Daniels JK, 2016, EBIOMEDICINE, V4, P20, DOI 10.1016/j.ebiom.2016.02.002; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; de la Plata CDM, 2011, J INT NEUROPSYCH SOC, V17, P24, DOI 10.1017/S1355617710001189; Defense and Veterans Brain Injury Center, 2012, DOD WORLDW NUMB TBI; Delaney JS, 2006, CLIN J SPORT MED, V16, P162, DOI 10.1097/00042752-200603000-00013; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dong Q, 2004, J MAGN RESON IMAGING, V19, P6, DOI 10.1002/jmri.10424; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Fairchild JK, 2013, INT PSYCHOGERIATR, V25, P607, DOI 10.1017/S1041610212002049; Fani N, 2012, NEUROPSYCHOPHARMACOL, V37, P2740, DOI 10.1038/npp.2012.146; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fleiss J.L., 1981, STAT METHODS RATES P; Galanaud D, 2012, ANESTHESIOLOGY, V117, P1300, DOI 10.1097/ALN.0b013e3182755558; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gass A, 2001, J NEUROL SCI, V186, pS15, DOI 10.1016/S0022-510X(01)00487-7; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Goggio AF, 1941, J NEUROL PSYCHIATRY, V4, P11, DOI 10.1136/jnnp.4.1.11; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Gwet KL, 2014, HDB INTERRATER RELIA; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Han ZZ, 2013, BRAIN, V136, P2952, DOI 10.1093/brain/awt205; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hoblyn J, 2006, J PSYCHIATR RES, V40, P160, DOI 10.1016/j.jpsychires.2005.06.004; HODGSON VR, 1983, P 27 STAPP CAR CRASH; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Honeybul S, 2014, J NEUROSURG, V120, P1131, DOI 10.3171/2014.1.JNS131559; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunter JV, 2012, J NEUROTRAUM, V29, P654, DOI 10.1089/neu.2011.1906; Huster RJ, 2009, HUM BRAIN MAPP, V30, P383, DOI 10.1002/hbm.20509; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Isaac L, 2015, BIOL PSYCHOL, V105, P20, DOI 10.1016/j.biopsycho.2014.12.011; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kiernan M, 2001, PSYCHOL METHODS, V6, P35, DOI 10.1037//1082-989X.6.1.35; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kinoshita LM, 2012, SLEEP BREATH, V16, P1201, DOI 10.1007/s11325-011-0632-8; Klingberg T, 1999, NEUROREPORT, V10, P2817, DOI 10.1097/00001756-199909090-00022; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraemer H. C., 2005, TUTORIALS BIOSTATIST, V1; Kraemer HC, 1992, EVALUATING MED TESTS; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange G, 2013, MIL MED, V178, P705, DOI 10.7205/MILMED-D-13-00053; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Lo C, 2009, J COMPUT ASSIST TOMO, V33, P293, DOI 10.1097/RCT.0b013e31817579d1; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Matsuo K, 2008, NEURORADIOLOGY, V50, P605, DOI 10.1007/s00234-008-0379-5; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; METZ CE, 1986, INVEST RADIOL, V21, P720, DOI 10.1097/00004424-198609000-00009; Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866; Mittenberg W, 2000, J HEAD TRAUMA REHAB, V15, P783, DOI 10.1097/00001199-200004000-00003; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Nelles M, 2008, AM J NEURORADIOL, V29, P488, DOI 10.3174/ajnr.A0855; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Noda A, 2006, AM J GERIAT PSYCHIAT, V14, P931, DOI 10.1097/01.JGP.0000230660.39635.68; O'Hara R, 2002, J GERIATR PSYCH NEUR, V15, P233, DOI 10.1177/089198870201500409; O'Hara Ruth, 2002, Ann Gen Hosp Psychiatry, V1, P1, DOI 10.1186/1475-2832-1-1; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; PEERLESS SJ, 1967, CAN MED ASSOC J, V96, P577; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Periyakoil VS, 2005, INT J METH PSYCH RES, V14, P202, DOI 10.1002/mpr.8; Periyakoil VS, 2012, J PALLIAT MED, V15, P1350, DOI 10.1089/jpm.2012.0280; Perlbarg V, 2009, HUM BRAIN MAPP, V30, P3924, DOI 10.1002/hbm.20817; Pestilli F, 2014, NAT METHODS, V11, P1058, DOI 10.1038/nmeth.3098; Pettus EH, 1996, BRAIN RES, V722, P1, DOI 10.1016/0006-8993(96)00113-8; Pierpaoli C, 2001, NEUROIMAGE, V13, P1174, DOI 10.1006/nimg.2001.0765; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Porto L, 2011, EUR J PAEDIATR NEURO, V15, P493, DOI 10.1016/j.ejpn.2011.06.004; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Povlishock JT, 1996, ACT NEUR S, V66, P81; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Provenzale JM, 2010, AM J ROENTGENOL, V194, P16, DOI 10.2214/AJR.09.3687; Rayhan RU, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058493, 10.1371/journal.pone.0063903]; Ressel V., 2016, BRAIN IMAGING BEHAV; Rodrigo S, 2007, AM J NEURORADIOL, V28, P1526, DOI 10.3174/ajnr.A0584; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Salmond CH, 2006, NEUROIMAGE, V29, P117, DOI 10.1016/j.neuroimage.2005.07.012; Sanjuan PM, 2013, PSYCHIAT RES-NEUROIM, V214, P260, DOI 10.1016/j.pscychresns.2013.09.002; Sekiguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083967; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shen C., 2008, J DATA SCI, V6, P189; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; SHULTZ EK, 1995, CLIN CHEM, V41, P1248; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Sorg SF, 2016, J HEAD TRAUMA REHAB, V31, P297, DOI 10.1097/HTR.0000000000000189; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; SU JQ, 1993, J AM STAT ASSOC, V88, P1350; Sugiyama K, 2009, J NEUROTRAUM, V26, P1879, DOI [10.1089/neu.2008.0839, 10.1089/neu.2008-0839]; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tanielian T., 2008, INVISIBLE WOUNDS OF; Taoka T, 2006, AM J NEURORADIOL, V27, P1040; TEASDALE G, 1974, LANCET, V2, P81; Thanassi W, 2012, PULM MED, V2012, DOI 10.1155/2012/291294; Thiebaut de Schotten M, 2011, NEUROIMAGE, V54, P49, DOI 10.1016/j.neuroimage.2010.07.055; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tinklenberg JR, 2015, AM J GERIAT PSYCHIAT, V23, P384, DOI 10.1016/j.jagp.2014.09.007; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2010, DEV NEUROPSYCHOL, V35, P333, DOI 10.1080/87565641003696940; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Wu X, 2013, IEEE ACM T COMPUT BI, V10, P173, DOI 10.1109/TCBB.2012.141; Xu J, 2007, J NEUROTRAUM, V24, P753, DOI 10.1089/neu.2006.0208; Yamada K, 2003, STROKE, V34, DOI 10.1161/01.STR.0000085827.54986.89; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165; Yeatman JD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5932; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yesavage JA, 2003, J PSYCHIAT RES, V37, P535, DOI 10.1016/S0022-3956(03)00053-0; Yesavage JA, 2011, J GERONTOL B-PSYCHOL, V66, P444, DOI 10.1093/geronb/gbr031; Yin XT, 2013, HUM BRAIN MAPP, V34, P796, DOI 10.1002/hbm.21477; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zhang WH, 2008, NEUROIMAGE, V42, P771, DOI 10.1016/j.neuroimage.2008.04.241; ZWEIG MH, 1993, CLIN CHEM, V39, P561	213	18	21	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	16						1	16		10.1016/j.nicl.2017.06.031			16	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FK1IU	WOS:000413235100001	28725550	gold, Green Published			2022-02-06	
J	Nakhjavan-Shahraki, B; Yousefifard, M; Oraii, A; Sarveazad, A; Hosseini, M				Nakhjavan-Shahraki, Babak; Yousefifard, Mahmoud; Oraii, Alireza; Sarveazad, Arash; Hosseini, Mostafa			META-ANALYSIS OF NEURON SPECIFIC ENOLASE IN PREDICTING PEDIATRIC BRAIN INJURY OUTCOMES	EXCLI JOURNAL			English	Article						biomarker; pediatric; traumatic brain injury	ACUTE KIDNEY INJURY; GELATINASE-ASSOCIATED LIPOCALIN; CELL TRANSPLANTATION; CEREBROSPINAL-FLUID; BIOCHEMICAL MARKERS; TREATMENT RESPONSE; DIAGNOSTIC-VALUE; HEAD TRAUMA; SERUM; BIOMARKERS	A reliable biomarker has not been identified to predict the outcome of traumatic brain injury (TBI) in children. Therefore, the present systematic review and meta-analysis aimed to assess the association between neuron specific enolase (NSE) and traumatic brain injury (TBI) in children. Two independent reviewers searched electronic databases of EMBASE, Cochrane library, Medline and Scopus and then they summarized the results and did a quality control check. At the end, standardized mean difference (SMD) with 95 % confidence interval (CI) and performance of NSE were assessed. 10 studies were included in the present meta-analysis. Average serum (SMD=1.3; 95 % CI: 0.5 to 2.1; p=0.001) and CSF levels (SMD=2.45; 95 % CI: 1.04 to 3.8; p<0.0001) of NSE biomarker were significantly higher in children with TBI with unfavorable outcome compared with other children. Serum NSE had an area under the curve, sensitivity and specificity of 0.75 (95 % CI: 0.72 to 0.79), 0.74 (95 % CI: 0.64 to 0.82) and 0.69 (95 % CI: 0.59 to 0.77), respectively in prediction outcome of TBI. Positive likelihood ratio, negative likelihood ratio and diagnostic odds ratio of serum NSE were 2.4 (95 % CI: 1.7 to 3.3), 0.38 (95 % CI: 0.26 to 0.55) and 6.0 (95 % CI: 3.0 to 12.0), respectively. The results show that the performance of NSE is in a moderate level in prediction of unfavorable outcome in children with TBI. However, data in this aspect is not sufficient and more studies are needed.	[Nakhjavan-Shahraki, Babak] Univ Tehran Med Sci, Sina Trauma & Surg Res Ctr, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Fac Med, Physiol Res Ctr, Tehran, Iran; [Yousefifard, Mahmoud] Iran Univ Med Sci, Fac Med, Dept Physiol, Tehran, Iran; [Oraii, Alireza] Univ Tehran Med Sci, Sch Med, Dept Med, Tehran, Iran; [Sarveazad, Arash] Iran Univ Med Sci, Colorectal Res Ctr, Tehran, Iran; [Hosseini, Mostafa] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran		Hosseini, M (corresponding author), Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Poursina Ave, Tehran, Iran.	babaknakhjavanshahraki@yahoo.com; yousefifard20@gmail.com; alirezaoraii@gmail.com; arashsarveazad@gmail.com; mhossein110@yahoo.com	Yousefifard, Mahmoud/P-1621-2018; Oraii, Alireza/AAX-6455-2021; Sarveazad, Arash/L-2064-2018	Yousefifard, Mahmoud/0000-0001-5181-4985; Sarveazad, Arash/0000-0001-9273-1940; Oraii, Alireza/0000-0002-2422-2930; hosseini, mostafa/0000-0002-1334-246X			Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Berger RP, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e31; Cheng F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106680; Chiaretti A, 2009, NEUROLOGY, V72, P609, DOI 10.1212/01.wnl.0000342462.51073.06; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; Dayan PS, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2709; DeFazio MV, 2014, WORLD NEUROSURG, V81, P151, DOI 10.1016/j.wneu.2013.01.015; Ebrahimi Ali, 2014, Tanaffos, V13, P29; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; ELSON LM, 1994, SEMIN NEUROL, V14, P8, DOI 10.1055/s-2008-1041053; Fridriksson T, 2000, ACAD EMERG MED, V7, P816, DOI 10.1111/j.1553-2712.2000.tb02276.x; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Ghelichkhani P, 2016, INT J PEDIATR-MASSHA, V4, P3503, DOI 10.22038/ijp.2016.7409; Haque A, 2016, METAB BRAIN DIS, V31, P487, DOI 10.1007/s11011-016-9801-6; Hassanzadeh-Rad A, 2016, J GASTROEN HEPATOL, V31, P929, DOI 10.1111/jgh.13247; Hedt BL, 2011, STAT MED, V30, P560, DOI 10.1002/sim.3920; Higgins JPT, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9780470712184; Hosseini M, 2016, J CHEM NEUROANAT, V78, P102, DOI 10.1016/j.jchemneu.2016.09.002; Hosseini M, 2015, EMERGENCY, V3, P127; Hosseini M, 2015, BIOL BLOOD MARROW TR, V21, P1537, DOI 10.1016/j.bbmt.2015.05.008; Hozo SP, 2005, BMC MED RES METHODOL, V5, DOI DOI 10.1186/1471-2288-5-13; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P1272, DOI 10.1093/ije/dyu115; Izadi A, 2016, INT J PEDIATR-MASSHA, V4, P3875, DOI 10.22038/ijp.2016.7783; Izadi A, 2016, INT J PEDIATR-MASSHA, V4, P3815, DOI 10.22038/ijp.2016.7782; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Lo TYM, 2010, J NEUROTRAUM, V27, P2139, DOI 10.1089/neu.2010.1387; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Menascu S, 2010, PEDIATR NEUROSURG, V46, P82, DOI 10.1159/000319004; Mercier E, 2012, CRITICAL CARE, V16, pS112; Mercier Eric, 2016, CMAJ Open, V4, pE371; Nakhjavan-Shahraki B, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0539-0; Papa L, 2015, NEUROCRIT CARE, V22, P52, DOI 10.1007/s12028-014-0028-2; Rahimi-Movaghar V, 2016, EMERGENCY, V4, P116; Rodriguez-Rodriguez A, 2016, NEUROL RES, V38, P130, DOI 10.1080/01616412.2016.1144410; Safari S, 2016, CLIN EXP NEPHROL, V20, P153, DOI 10.1007/s10157-015-1204-1; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Shore PM, 2007, J NEUROTRAUM, V24, P75, DOI 10.1089/neu.2006.0062; Sistrom CL, 2000, AM J ROENTGENOL, V174, P1241, DOI 10.2214/ajr.174.5.1741241; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Wilkinson AA, 2016, PEDIATR CRIT CARE ME, V17, P638, DOI 10.1097/PCC.0000000000000752; Yousefifard M, 2016, NEUROSCIENCE, V322, P377, DOI 10.1016/j.neuroscience.2016.02.034; Yousefifard M, 2016, EMERGENCY IN PRESS, V5, pe37; Yousefifard M, 2016, EMERGENCY, V4, P55; Yousefifard M, 2016, EMERGENCY, V4, P1; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	50	18	18	1	3	EXCLI JOURNAL MANAGING OFFICE	DORTMUND	LEIBNIZ RESEARCH CENTRE WORKING ENVIRONMENT & HUMAN FACTORS EXCLI JOURNAL, ARDEYSTR 67, DORTMUND, D-44139, GERMANY	1611-2156			EXCLI J	EXCLI J.		2017	16						995	1008		10.17179/excli2017-405			14	Biology	Science Citation Index Expanded (SCI-EXPANDED)	Life Sciences & Biomedicine - Other Topics	FB6SG	WOS:000406272100028	28900380				2022-02-06	
J	Parsons, TD; Barnett, M				Parsons, Thomas D.; Barnett, Michael			Validity of a Newly Developed Measure of Memory: Feasibility Study of the Virtual Environment Grocery Store	JOURNAL OF ALZHEIMERS DISEASE			English	Article						Aging; episodic memory; neuropsychological tests; prospective memory; validation studies; virtual reality	TRAUMATIC BRAIN-INJURY; ECOLOGICAL VALIDITY; EXECUTIVE FUNCTION; EPISODIC MEMORY; OLDER-ADULTS; INDIVIDUAL-DIFFERENCES; REALITY; PERFORMANCE; YOUNG; TASK	Virtual reality-based neuropsychological assessments proffer the potential to address the limited ecological validity of pen-and-paper measures of memory. To investigate the construct validity of a newly developed virtual reality measure of memory, the Virtual Environment Grocery Store (VEGS), traditional neuropsychological measures of memory and executive functioning were administered to 48 older adults and 55 young adults. Performances on the VEGS memory tasks and the traditional neuropsychological assessments of memory were positively correlated, indicating that memory for VEGS content was similar to memory for traditional paper-and-pencil measures. The older adults performed significantly worse than young adults on the VEG Sand the California Verbal Learning Test, but the DKEFS Color-Word Interference failed to differentiate the groups. Furthermore, significant differences were found between groups for the VEGS memory and multitasking measures. The VEGS has the advantage over traditional measures of providing objective measurement of individual components of memory in simulations of everyday activities.	[Parsons, Thomas D.; Barnett, Michael] Univ North Texas, Dept Psychol, Denton, TX 76203 USA		Parsons, TD (corresponding author), Univ North Texas, Dept Psychol, Psychol, 1155 Union Circle 311280, Denton, TX 76203 USA.; Parsons, TD (corresponding author), Univ North Texas, Dept Psychol, Computat Neuropsychol & Simulat CNS Lab, 1155 Union Circle 311280, Denton, TX 76203 USA.; Parsons, TD (corresponding author), Univ North Texas, Dept Psychol, Natl Acad Neuropsychol, 1155 Union Circle 311280, Denton, TX 76203 USA.	Thomas.Parsons@unt.edu		Parsons, Thomas/0000-0003-0331-5019			Adolfsdottir S, 2017, J INT NEUROPSYCH SOC, V23, P90, DOI 10.1017/S1355617716000898; Alderman N, 2003, J INT NEUROPSYCH SOC, V9, P31, DOI 10.1017/S1355617703910046; Allain P, 2014, J INT NEUROPSYCH SOC, V20, P468, DOI 10.1017/S1355617714000344; Benoit M, 2015, NEUROPSYCH DIS TREAT, V11, P557, DOI 10.2147/NDT.S73179; Besnard J, 2016, APPL NEUROPSYCH-ADUL, V23, P223, DOI 10.1080/23279095.2015.1048514; Bier N, 2016, J ALZHEIMERS DIS, V52, P1361, DOI 10.3233/JAD-150957; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Canty AL, 2014, NEUROPSYCHOL REHABIL, V24, P238, DOI 10.1080/09602011.2014.881746; Cargin JW, 2007, J CLIN EXP NEUROPSYC, V29, P706, DOI 10.1080/13825580600954256; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Cohen AL, 2005, APPL COGNITIVE PSYCH, V19, P1177, DOI 10.1002/acp.1154; Cole SN, 2013, Q J EXP PSYCHOL, V66, P1687, DOI 10.1080/17470218.2012.758157; Davis HP, 2003, CORTEX, V39, P1063, DOI 10.1016/S0010-9452(08)70878-5; Delis D.C., 2000, CVLT 2 CALIFORNIA VE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Einstein, 2002, PSYCHOL BEITR, V44, P303, DOI [10.1037/0012-1649.44.2.612, DOI 10.1037/0012-1649.44.2.612]; GRAF P, 1995, J CLIN EXP NEUROPSYC, V17, P390, DOI 10.1080/01688639508405132; Grewe P, 2014, EPILEPSY BEHAV, V31, P57, DOI 10.1016/j.yebeh.2013.11.014; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Holdnack H.A., 2001, WECHSLER TEST ADULT; HUPPERT FA, 1993, J CLIN EXP NEUROPSYC, V15, P805, DOI 10.1080/01688639308402597; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P171, DOI 10.1080/09084282.2011.643955; Logie RH, 2011, MEM COGNITION, V39, P1561, DOI 10.3758/s13421-011-0120-1; Manchester D, 2004, BRAIN INJURY, V18, P1067, DOI 10.1080/02699050410001672387; Matheis RJ, 2007, CLIN NEUROPSYCHOL, V21, P146, DOI 10.1080/13854040601100668; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel Mark A, 2015, Front Hum Neurosci, V9, P392, DOI 10.3389/fnhum.2015.00392; Mueller C, 2012, J NEUROSCI METH, V209, P290, DOI 10.1016/j.jneumeth.2012.06.025; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Parsons T.D., 2008, GERONTECHNOLOGY, V7, P187; Parsons TD, 2013, P 17 IEEE VIRT REAL, P1; Parsons TD, 2008, CYBERPSYCHOL BEHAV, V11, P17, DOI 10.1089/cpb.2007.9934; Parsons TD, 2017, NEUROPSYCHOL REHABIL, V27, P777, DOI 10.1080/09602011.2015.1109524; Parsons TD, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00660; Plancher G, 2012, NEUROPSYCHOLOGIA, V50, P592, DOI 10.1016/j.neuropsychologia.2011.12.013; Plancher G, 2010, NEUROPSYCHOLOGY, V24, P379, DOI 10.1037/a0018680; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Rose NS, 2010, PSYCHOL AGING, V25, P595, DOI 10.1037/a0019771; Sauzeon H, 2012, EXP PSYCHOL, V59, P99, DOI 10.1027/1618-3169/a000131; Schnitzspahn KM, 2013, DEV PSYCHOL, V49, P1544, DOI 10.1037/a0030579; Shilling VM, 2002, NEUROPSYCHOLOGIA, V40, P605, DOI 10.1016/S0028-3932(01)00157-9; Wilson B, 1989, RIVERMEAD BEHAV MEMO; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263	47	18	18	2	9	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2017	59	4					1227	1235		10.3233/JAD-170295			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FD8BJ	WOS:000407749900007	28759971				2022-02-06	
J	Peeters, S; Blaine, C; Vycheth, I; Nang, S; Vuthy, D; Park, KB				Peeters, Sophie; Blaine, Caitlin; Vycheth, Iv; Nang, Sam; Vuthy, Din; Park, Kee B.			Epidemiology of Traumatic Brain Injuries at a Major Government Hospital in Cambodia	WORLD NEUROSURGERY			English	Article						Cambodia; Helmet; Low-income countries; Neurosurgery; Road traffic accidents; Traumatic brain injury	MOTORCYCLE HELMET USE; HEAD-INJURIES; VIETNAM; HEMATOMAS; DISEASE; IMPACT; LAW	BACKGROUND: Traumatic brain injury (TBI) is a critical public health problem worldwide with a significant socioeconomic burden. Although improved safety regulations in high-income countries have resulted in a decline in traffic-related TBI, the incidence of TBI in low-income countries is on the rise. We illustrate the trends and factors involved in TBI in a large Cambodian governmental hospital in Phnom Penh. In addition, suggestions for improvement of the country's road traffic safety are discussed. METHODS: This is a cross-sectional study of all patients who presented with traumatic brain injury to Department of Neurosurgery at Preah Kossamak Hospital in Phnom Penh, Cambodia between November 2013 and March 2016. RESULTS: TBIs in Cambodia are on the rise; 34% occur during rush hour, 5-9 PM, and 40% during the weekend. The vast majority (74%) occur as the result of road traffic accidents, of which 81% are motorcycle related. Helmet wear remains low at 13%, and recent alcohol use was reported as 38%. The most common diagnosis is skull fracture. The subdural to epidural hematoma ratio was 1:1.05. Lastly, in both subdural and epidural hematomas the frontal lobe was most commonly involved, with 60% of epidural hematomas associated with a lucid interval. CONCLUSIONS: Our study suggests prevention and management of TBIs can have a measurable public health impact in Cambodia. Initiative examples include helmet safety awareness campaigns, stricter penalties, improvement of prehospital care, and more efficient triage. A high proportion of unhelmeted motorcycle accidents correlates with an increase in epidural hematomas.	[Peeters, Sophie] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA; [Peeters, Sophie; Blaine, Caitlin; Vycheth, Iv; Nang, Sam; Vuthy, Din; Park, Kee B.] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia; [Park, Kee B.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA USA		Peeters, S (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.; Peeters, S (corresponding author), Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia.	Sophie.Peeters@UTsouthwestern.edu		Peeters, Sophie/0000-0002-9548-644X	Foundation of the World Federation of Neurosurgical Societies; Korean American Medical Foundation	This research received partial funding support from the Foundation of the World Federation of Neurosurgical Societies and the Korean American Medical Foundation.	Adeolu A. A., 2005, INTERNET J EPIDEMIOL, V2, P2; [Anonymous], 2010, ANN REPORT; Bachani AM, 2013, INJURY, V44, pS31, DOI [10.1016/S0020-1383(13)70210-9, 10.1016/S0020-1383(13)70209-2]; Chiu WT, 2000, AM J PUBLIC HEALTH, V90, P793, DOI 10.2105/AJPH.90.5.793; Enserink M, 2014, SCIENCE, V345, P1261, DOI 10.1126/science.345.6202.1261; Eze K C, 2011, West Afr J Med, V30, P404; Georgoff P, 2010, WORLD NEUROSURG, V74, P331, DOI 10.1016/j.wneu.2010.03.025; Hung DV, 2008, ACCIDENT ANAL PREV, V40, P1627, DOI 10.1016/j.aap.2008.05.002; Jeng TC, 2008, MALAYS J MED SCI, V15, P56; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Letourneau-Guillon L, 2013, AM J NEURORADIOL, V34, P773, DOI 10.3174/ajnr.A3309; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Olson Z, 2016, INJURY PREV, V22, P233, DOI 10.1136/injuryprev-2015-041650; Passmore J, 2010, TRAFFIC INJ PREV, V11, P202, DOI 10.1080/15389580903497121; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petroni G, 2010, J TRAUMA, V68, P564, DOI 10.1097/TA.0b013e3181ce1eed; Rastogi Devarshi, 2014, Int J Crit Illn Inj Sci, V4, P298, DOI 10.4103/2229-5151.147523; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sitsapesan HA, 2013, WORLD NEUROSURG, V79, P568, DOI 10.1016/j.wneu.2012.09.018; Tallon JM, 2008, CAN J SURG, V51, P339; Tran TM, 2015, WORLD NEUROSURG, V83, P269, DOI 10.1016/j.wneu.2014.12.028; Umerani MS, 2014, TURK NEUROSURG, V24, P19, DOI 10.5137/1019-5149.JTN.7080-12.1; World Health Organization, 2013, GLOB STAT REP ROAD S; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5	25	18	18	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						580	589		10.1016/j.wneu.2016.09.127			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400079	27773857				2022-02-06	
J	Shah, SA; Goldi, Y; Conte, MM; Goldfine, AM; Mohamadpour, M; Fidali, BC; Cicerone, K; Schiff, ND				Shah, Sudhin A.; Goldi, Yelena; Conte, Mary M.; Goldfine, Andrew M.; Mohamadpour, Maliheh; Fidali, Brian C.; Cicerone, Keith; Schiff, Nicholas D.			Executive attention deficits after traumatic brain injury reflect impaired recruitment of resources	NEUROIMAGE-CLINICAL			English	Article						EEG; Traumatic brain injury; Attention network test; Executive attention; Frontal lobe; Medial frontal theta	ANTERIOR CINGULATE CORTEX; BETA-BAND OSCILLATIONS; POSITRON-EMISSION-TOMOGRAPHY; STATISTICAL IMAGE-ANALYSIS; HUMAN THETA-OSCILLATIONS; FRONTAL MIDLINE THETA; SPECTRAL-ANALYSIS; WORKING-MEMORY; AROUSAL REGULATION; REACTION-TIME	Deficits in attention are a common and devastating consequence of traumatic brain injury (TBI), leading to functional impairments, rehabilitation barriers, and long-term disability. While such deficits are well documented, little is known about their underlying pathophysiology hindering development of effective and targeted interventions. Here we evaluate the integrity of brain systems specific to attentional functions using quantitative assessments of electroencephalography recorded during performance of the Attention Network Test (ANT), a behavioral paradigm that separates alerting, orienting, and executive components of attention. We studied 13 patients, at least 6months post-TBI with cognitive impairments, and 24 control subjects. Based on performance on the ANT, TBI subjects showed selective impairment in executive attention. In TBI subjects, principal component analysis combined with spectral analysis of the EEG after target appearance extracted a pattern of increased frontal midline theta power (2.5-7.5 Hz) and suppression of frontal beta power ( 12.5-22.5 Hz). Individual expression of this pattern correlated (r=-0.67, p < 0.001) with executive attention impairment. The grading of this pattern of spatiotemporal dynamics with executive attention deficits reflects impaired recruitment of anterior forebrain resources following TBI; specifically, deafferentation and variable disfacilitation of medial frontal neuronal populations is proposed as the basis of our findings. (C) 2017 The Authors. Published by Elsevier Inc.	[Shah, Sudhin A.; Conte, Mary M.; Fidali, Brian C.; Schiff, Nicholas D.] Weill Cornell Med Coll, Brain & Mind Res Inst, Dept Neurosci, New York, NY 0065 USA; [Goldi, Yelena; Cicerone, Keith] JFK Johnson Rehabil Inst, Cognit Rehabil Dept, Edison, NJ 08820 USA; [Goldi, Yelena; Cicerone, Keith] JFK Johnson Rehabil Inst, Dept Phys Med & Rehabil, Edison, NJ 08820 USA; [Goldfine, Andrew M.] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA; [Mohamadpour, Maliheh] Suny Downstate Med Ctr, Brooklyn, NY 11203 USA		Shah, SA (corresponding author), Weill Cornell Med Coll, 1300 York Ave,Room F610, New York, NY 10065 USA.	sut2006@med.cornell.edu	Mohamadpour, Maliheh/I-8041-2019		Jerold B Katz Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD079556] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000457] Funding Source: NIH RePORTER	The Jerold B Katz Foundation supported this work.	Ashman TA, 2006, MT SINAI J MED, V73, P999; Azouvi P, 2000, CURR OPIN NEUROL, V13, P665, DOI 10.1097/00019052-200012000-00009; Babadi B, 2014, IEEE T BIO-MED ENG, V61, P1555, DOI 10.1109/TBME.2014.2311996; Baker JL, 2016, J NEUROPHYSIOL, V116, P2383, DOI 10.1152/jn.01129.2015; BARBAS H, 1991, J COMP NEUROL, V313, P65, DOI 10.1002/cne.903130106; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brinkman L, 2014, J NEUROSCI, V34, P14783, DOI 10.1523/JNEUROSCI.2039-14.2014; Caplan JB, 2003, J NEUROSCI, V23, P4726; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Cazalis F, 2006, BRAIN INJURY, V20, P1019, DOI 10.1080/02699050600664384; Cicerone K., 2014, HDB NEUROPSYCHOLOGY, P191, DOI [10.1007/978-1-4939-0784-7_10, DOI 10.1007/978-1-4939-0784-7_10]; Cimenser A, 2011, P NATL ACAD SCI USA, V108, P8832, DOI 10.1073/pnas.1017041108; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Cohen MX, 2013, J NEUROPHYSIOL, V110, P2752, DOI 10.1152/jn.00479.2013; Deiber MP, 2013, NEUROIMAGE, V82, P531, DOI 10.1016/j.neuroimage.2013.06.037; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Dockree PM, 2011, INT J PSYCHOPHYSIOL, V82, P53, DOI 10.1016/j.ijpsycho.2011.01.004; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fan J, 2007, J NEUROSCI, V27, P6197, DOI 10.1523/JNEUROSCI.1833-07.2007; Floden D, 2011, J COGNITIVE NEUROSCI, V23, P867, DOI 10.1162/jocn.2010.21492; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Gola M, 2012, INT J PSYCHOPHYSIOL, V85, P62, DOI 10.1016/j.ijpsycho.2011.09.001; Goldfine AM, 2011, CLIN NEUROPHYSIOL, V122, P2157, DOI 10.1016/j.clinph.2011.03.022; Goldstein G, 2010, BRAIN INJURY, V24, P625, DOI 10.3109/02699051003670882; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hanif A, 2012, ACTA PSYCHOL, V139, P104, DOI 10.1016/j.actpsy.2011.09.010; Hartikainen KM, 2010, J CLIN EXP NEUROPSYC, V32, P767, DOI 10.1080/13803390903521000; HJORTH B, 1975, ELECTROEN CLIN NEURO, V39, P526, DOI 10.1016/0013-4694(75)90056-5; Hsieh LT, 2014, NEUROIMAGE, V85, P721, DOI 10.1016/j.neuroimage.2013.08.003; Hu PP, 2013, NEUROSCI LETT, V534, P177, DOI 10.1016/j.neulet.2012.12.038; Jolliffe I.T., 2002, PRINCIPAL COMPONENT; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Kubat-Silman AK, 2002, BRAIN COGNITION, V50, P178, DOI 10.1016/S0278-2626(02)00502-X; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Leon-Carrion J, 2012, J REHABIL MED, V44, P505, DOI 10.2340/16501977-0982; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu J, 2015, ELIFE, V4, DOI 10.7554/eLife.09215; Luu P, 2004, CLIN NEUROPHYSIOL, V115, P1821, DOI 10.1016/j.clinph.2004.03.031; Mattia M, 2012, Front Neuroeng, V5, P12, DOI 10.3389/fneng.2012.00012; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; Mitra P, 2007, OBSERVED BRAIN DYNAM; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Percival D.B., 1993, SPECTRAL ANAL PHYS A; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Rodriguez-Bailon M, 2012, SPAN J PSYCHOL, V15, P967, DOI 10.5209/rev_SJOP.2012.v15.n3.39388; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schiff ND, 2013, J NEUROPHYSIOL, V109, P1152, DOI 10.1152/jn.00317.2011; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Slobounov SM, 2000, COGNITIVE BRAIN RES, V9, P287, DOI 10.1016/S0926-6410(00)00009-4; Stierwalt Julie A. G., 2002, Seminars in Speech and Language, V23, P129, DOI 10.1055/s-2002-24989; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; TREXLER LE, 1988, BRAIN COGNITION, V8, P291, DOI 10.1016/0278-2626(88)90056-5; Tsujimoto T, 2010, J NEUROPHYSIOL, V103, P827, DOI 10.1152/jn.00358.2009; TUCKER DM, 1993, ELECTROEN CLIN NEURO, V87, P154, DOI 10.1016/0013-4694(93)90121-B; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; van Donkelaar P, 2005, BRAIN INJURY, V19, P1031, DOI 10.1080/02699050500110363; van Vugt MK, 2007, J NEUROSCI METH, V162, P49, DOI 10.1016/j.jneumeth.2006.12.004; Wang CM, 2005, J NEUROSCI, V25, P604, DOI 10.1523/JNEUROSCI.4151-04.2005; Willmott C, 2009, NEUROPSYCHOLOGY, V23, P424, DOI 10.1037/a0015058; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	71	18	18	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	14						233	241		10.1016/j.nicl.2017.01.010			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FB2OY	WOS:000405984300025	28180082	Green Published, gold			2022-02-06	
J	Stein, DM; Feather, CB; Napolitano, LM				Stein, Deborah M.; Feather, Cristina B.; Napolitano, Lena M.			Traumatic Brain Injury Advances	CRITICAL CARE CLINICS			English	Article						Traumatic brain injury; Antiseizure prophylaxis; Hyperosmolar therapy; Targeted temperature modulation; Intracranial pressure monitoring; Decompressive craniectomy	INTRACRANIAL-PRESSURE; THERAPEUTIC HYPOTHERMIA; DECOMPRESSIVE CRANIECTOMY; PROPHYLACTIC HYPOTHERMIA; HYPERTONIC SALINE; CONTROLLED-TRIAL; CLINICAL-TRIAL; PROGESTERONE; MANAGEMENT; PHENYTOIN	There have been many recent advances in the management of traumatic brain injury (TBI). Research regarding established and novel therapies is ongoing. Future research must not only focus on development of new strategies but determine the long-term benefits or disadvantages of current strategies. In addition, the impact of these adyances on varying severities of brain injury must not be ignored. It is hoped that future research strategies in TBI will prioritize large-scale trials using common data elements to develop large registries and databases, and leverage international collaborations.	[Stein, Deborah M.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Neurotrauma Crit Care,Sect Trauma Crit Care, 22 South Greene St, Baltimore, MD 21201 USA; [Feather, Cristina B.] Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Surg Crit Care, 22 South Greene St, Baltimore, MD 21201 USA; [Napolitano, Lena M.] Univ Michigan Hlth Syst, Dept Surg Trauma & Surg Crit Care, Div Acute Care Surg Trauma Burns Surg Crit Care E, Room 1C340-UH,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA		Stein, DM (corresponding author), Univ Maryland, Med Ctr, R Adams Cowley Shock Trauma Ctr, Neurotrauma Crit Care,Sect Trauma Crit Care, 22 South Greene St, Baltimore, MD 21201 USA.	dstein@umm.edu	Napolitano, Lena/AAZ-8651-2021	Stein, Deborah/0000-0003-3683-3963			Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Andrews PJD, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-277; Badri S, 2012, INTENS CARE MED, V38, P1800, DOI 10.1007/s00134-012-2655-4; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Burgess S, 2016, ANN PHARMACOTHER, V50, P291, DOI 10.1177/1060028016628893; Cardim D, 2016, NEUROCRIT CARE; Carney N, 2016, NEUROSURGERY; Carney N, 2012, J NEUROTRAUM, V29, P2022, DOI 10.1089/neu.2011.2019; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cottenceau V, 2011, J NEUROTRAUM, V28, P2003, DOI 10.1089/neu.2011.1929; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Dawes AJ, 2015, JAMA SURG, V150, P965, DOI 10.1001/jamasurg.2015.1678; Deutsch ER, 2013, BRAIN RES, V1530, P82, DOI 10.1016/j.brainres.2013.07.014; Dietrich WD, 2016, BRAIN RES, V1640, P94, DOI 10.1016/j.brainres.2015.12.034; Ditillo M, 2011, J TRAUMA, V71, P373; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Forsyth RJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002043.pub3; Fox JL, 2010, CAN J EMERG MED, V12, P355; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Gruenbaum SE, 2016, CNS DRUGS, V30, P791, DOI 10.1007/s40263-016-0355-2; Honeybul S, 2016, J CLIN NEUROSCI, V28, P12, DOI 10.1016/j.jocn.2016.01.002; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Kamel H, 2011, CRIT CARE MED, V39, P554, DOI 10.1097/CCM.0b013e318206b9be; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kruer RM, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.11.020; Liu WC, 2017, J NEUROSURG, V127, P8, DOI 10.3171/2016.4.JNS152909; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Nichol A, 2015, CRIT CARE RESUSC, V17, P92; O'Phelan Kristine H, 2015, World J Crit Care Med, V4, P296, DOI 10.5492/wjccm.v4.i4.296; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Stein DM, 2011, J TRAUMA, V71, P364, DOI 10.1097/TA.0b013e31822820da; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Wakai A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001049.pub5; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Wright DW, 2014, NEW ENGL J MED, V371, P2457, DOI 10.1056/NEJMoa1404304; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	52	18	23	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0749-0704	1557-8232		CRIT CARE CLIN	Crit. Care Clin.	JAN	2017	33	1					1	13		10.1016/j.ccc.2016.08.008			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG3ZW	WOS:000390984200002	27894490				2022-02-06	
J	Vien, L; DalPorto, C; Yang, D				Vien, Lee; DalPorto, Christina; Yang, David			Retrograde Degeneration of Retinal Ganglion Cells Secondary to Head Trauma	OPTOMETRY AND VISION SCIENCE			English	Article						transsynaptic retrograde degeneration; traumatic brain injury; retinal nerve fiber layer; optical coherence tomography; post-geniculate lesion	OPTICAL COHERENCE TOMOGRAPHY; TRANSSYNAPTIC DEGENERATION; HOMONYMOUS HEMIANOPIA; MULTIPLE-SCLEROSIS; VISUAL PATHWAY; LAYER; INFARCTION; TRACT; HUMANS; SYSTEM	Purpose. To discuss the clinical case of a patient with transsynaptic retrograde degeneration (TRD) demonstrated by progressive retinal nerve fiber layer loss documented by serial spectral domain optical coherence tomography secondary to traumatic brain injury after 2 months post-trauma. Case Report. A 25-year-old Caucasian male patient presented to a polytrauma rehabilitation center (PRC) for evaluation and treatment secondary to a severe traumatic brain injury (TBI) from a motorcycle accident 2 months before. Spectral-domain optical coherence tomography (SD-OCT) was completed at intervals that ranged between 8 and 42 days for a duration of 119 days. A comparison to the pre-trauma SD-OCT 10 months before revealed progressive thinning of the retinal nerve fiber layer (RNFL) in both eyes over multiple follow-ups post-trauma. Humphrey visual field (HVF) testing revealed an incomplete congruous right homonymous hemianopsia that gradually improved over the follow-ups. Analysis of the macular ganglion cell-inner plexiform layer (GCIPL) thickness displayed loss that corresponded to the pattern of visual field defect. Conclusions. TRD can occur as soon as 2 months after severe TBI with damage posterior to the lateral geniculate nucleus. Progressive RNFL loss can be tracked with SD-OCT, and the rate of thinning may slowly stabilize over time. Visual field defects can improve months after the trauma but may not correspond to the progressive RNFL loss detected by SD-OCT.	[Vien, Lee; DalPorto, Christina; Yang, David] Vet Affairs Palo Alto Healthcare Syst, 3801 Miranda Ave,112 OPTOM, Palo Alto, CA 94304 USA; [Vien, Lee; Yang, David] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA		Vien, L (corresponding author), Vet Affairs Palo Alto Healthcare Syst, 3801 Miranda Ave,112 OPTOM, Palo Alto, CA 94304 USA.	Lee.vien@va.gov					Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Bai HQ, 2009, EUR J OPHTHALMOL, V19, P201, DOI 10.1177/112067210901900205; BEATTY RM, 1982, J NEUROL NEUROSUR PS, V45, P143, DOI 10.1136/jnnp.45.2.143; Bermel RA, 2014, NEUROLOGY, V82, P2152, DOI 10.1212/WNL.0000000000000532; Bridge H, 2011, INVEST OPHTH VIS SCI, V52, P382, DOI 10.1167/iovs.10-5708; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Cowey A, 2011, BRAIN, V134, P2149, DOI 10.1093/brain/awr125; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; Huang-Link YM, 2014, J NEUROL, V261, P2453, DOI 10.1007/s00415-014-7538-x; Jindahra P, 2012, BRAIN, V135, P534, DOI 10.1093/brain/awr324; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Keller J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097444; Lawlor M, 2014, OPHTHALMOLOGY, V121, pE15, DOI 10.1016/j.ophtha.2013.11.016; Meier PG, 2015, J NEURO-OPHTHALMOL, V35, P112, DOI 10.1097/WNO.0000000000000182; Miliaras G, 2013, J NEUROL SURG PART A, V74, P168, DOI 10.1055/s-0032-1330115; Park HYL, 2013, OPHTHALMOLOGY, V120, P1292, DOI 10.1016/j.ophtha.2012.11.021; Romero RS, 2012, J NEURO-OPHTHALMOL, V32, P150, DOI 10.1097/WNO.0b013e3182504688; Shin HY, 2014, GRAEF ARCH CLIN EXP, V252, P1501, DOI 10.1007/s00417-014-2706-3; Sriram P, 2012, INVEST OPHTH VIS SCI, V53, P1271, DOI 10.1167/iovs.11-8732; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; TIEL K, 1991, NEURO-OPHTHALMOLOGY, V11, P33, DOI 10.3109/01658109109009640; VANBUREN JM, 1963, J NEUROL NEUROSUR PS, V26, P402; Zhang X, 2006, NEUROLOGY, V66, P901, DOI 10.1212/01.wnl.0000203338.54323.22	24	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					125	134		10.1097/OPX.0000000000000899			10	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EM5ZZ	WOS:000395393900018	27273271				2022-02-06	
J	Sharfi, K; Rosenblum, S				Sharfi, Kineret; Rosenblum, Sara			Executive Functions, Time Organization and Quality of Life among Adults with Learning Disabilities	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; ACADEMIC-ACHIEVEMENT; CHILDREN; PERFORMANCE; HEALTH; COMPREHENSION; ADOLESCENTS; DEFINITION	Purpose This study compared the executive functions, organization in time and perceived quality of life (QoL) of 55 adults with learning disabilities (LD) with those of 55 matched controls (mean age 30 years). Furthermore, relationships and predictive relationships between these variables among the group with LD were examined. Methods All participants completed the Behavioral Rating Inventory of Executive Functions (BRIEFA), the Time Organization and Participation (TOPS, A-C) and the World Health Organization Quality of Life (WHOQOL) questionnaires. Chi-square tests, independent t-tests and MANOVA were used to examine group differences in each of the subscales scores and ratings of each instrument. Pearson correlations and regression predictive models were used to examine the relationships between the variables in the group with LD. Results Adults with LD had significantly poorer executive functions (BRIEF-A), deficient organization in time abilities (TOPS A-B), accompanied with negative emotional response (TOPS-C), and lower perceived QoL (physical, psychological, social and environmental) in comparison to adults without LD. Regression analysis revealed that Initiation (BRIEF-A) significantly predicted approximately 15% of the participants' organization in time abilities (TOPS A, B scores) beyond group membership. Furthermore, initiation, emotional control (BRIEF-A subscales) and emotional responses following unsuccessful organization of time (TOPS-C) together accounted for 39% of the variance of psychological QoL beyond the contribution of group membership. Conclusions Deficits in initiation and emotional executive functions as well as organization in time abilities and emotional responses to impairments in organizing time affect the QoL of adults with LD and thus should be considered in further research as well as in clinical applications.	[Sharfi, Kineret; Rosenblum, Sara] Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, Haifa, Israel		Sharfi, K (corresponding author), Univ Haifa, Lab Complex Human Act & Participat, Dept Occupat Therapy, Haifa, Israel.	kineretsharfi@gmail.com			Israeli Ministry of Science and TechnologyMinistry of Science, Technology and Space (MOST), Israel [3-8634]	This study was funded by the Israeli Ministry of Science and Technology, grant number 3-8634. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank all those who participated for their cooperation and interest in the study and to the Israeli Ministry of Science and Technology for their support. The ethics committee for human subject research in the faculty of social welfare and health sciences at Haifa University approved this study in October 2010 (confirmation No. 170/10). An informed consent was signed by each participant and afterwards the subjects' personal identifiers were kept separately from the data.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Bailey CE, 2007, ANN NY ACAD SCI, V1118, P122, DOI 10.1196/annals.1412.011; Barkley RA, 1994, ADHD REPORT, V2, P1; Barkley RA, 2011, J PSYCHOPATHOL BEHAV, V33, P137, DOI 10.1007/s10862-011-9217-x; Blair C, 2007, CHILD DEV, V78, P647, DOI 10.1111/j.1467-8624.2007.01019.x; Borella E, 2010, J LEARN DISABIL-US, V43, P541, DOI 10.1177/0022219410371676; Braun U, 2015, P NATL ACAD SCI USA, V112, P11678, DOI 10.1073/pnas.1422487112; Brod M, 2006, QUAL LIFE RES, V15, P117, DOI 10.1007/s11136-005-8325-z; Brosnan M, 2002, NEUROPSYCHOLOGIA, V40, P2144, DOI 10.1016/S0028-3932(02)00046-5; Brown TE, 2010, POSTGRAD MED, V122, P42, DOI 10.3810/pgm.2010.09.2200; Bryan T, 2004, LEARN DISABILITY Q, V27, P45, DOI 10.2307/1593631; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Cavendish W, 2013, J LEARN DISABIL-US, V46, P52, DOI 10.1177/0022219412464352; Christopher ME, 2012, J EXP PSYCHOL GEN, V141, P470, DOI 10.1037/a0027375; Cortiella C., 2014, STATE LEARNING DISAB; Duncan GJ, 2007, DEV PSYCHOL, V43, P1428, DOI 10.1037/0012-1649.43.6.1428; Farnworth L., 2003, J OCCUP SCI, V10, P150, DOI [10.1080/, DOI 10.1080/14427591.2003.9686523]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Felce D., 1997, QUALITY LIFE SCOPE T, V2nd, P56; Funahashi S, 2001, NEUROSCI RES, V39, P147, DOI 10.1016/S0168-0102(00)00224-8; Gathercole SE, 2004, APPL COGNITIVE PSYCH, V18, P1, DOI 10.1002/acp.934; Gioia GA, 2002, CHILD NEUROPSYCHOL, V8, P121, DOI 10.1076/chin.8.2.121.8727; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Godard J, 2011, PSYCHIAT RES, V190, P244, DOI 10.1016/j.psychres.2011.06.014; Greenhill LL., 2000, LEARNING DISABILITIE; Grinblat N, 2012, THESIS; Hooper SR, 2002, J LEARN DISABIL-US, V35, P57, DOI 10.1177/002221940203500105; Kane MJ, 2007, PSYCHOL SCI, V18, P614, DOI 10.1111/j.1467-9280.2007.01948.x; Karande S, 2009, J TROP PEDIATRICS, V55, P160, DOI 10.1093/tropej/fmn099; Katz N., 2011, COGNITION OCCUPATION, V3rd ed., P13; Kavale KA, 2000, J LEARN DISABIL-US, V33, P239, DOI 10.1177/002221940003300303; Kavale KA, 1996, J LEARN DISABIL, V29, P226, DOI 10.1177/002221949602900301; Kavale KA, 2009, LEARN DISABILITY Q, V32, P39, DOI 10.2307/25474661; Koven NS, 2010, PERS INDIV DIFFER, V49, P24, DOI 10.1016/j.paid.2010.02.034; KUYKEN W, 1994, INT J MENT HEALTH, V23, P24, DOI 10.1080/00207411.1994.11449286; LACHMAN ME, 1993, INT J BEHAV DEV, V16, P131, DOI 10.1177/016502549301600203; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; McDougall J, 2011, DEV NEUROREHABIL, V14, P41, DOI 10.3109/17518423.2010.521795; McDougall J, 2010, DEV NEUROREHABIL, V13, P204, DOI 10.3109/17518421003620525; Morrison F.J., 2010, CHILD DEV INTERSECTI, P203, DOI [DOI 10.1037/12059-011, 10.1037/12059-011]; Peleg O, 2009, LEARN DISABILITY Q, V32, P11, DOI 10.2307/25474659; Pyne JM, 1997, PSYCHOPHARMACOL BULL, V33, P23; Rosenblum S, 2013, RES DEV DISABIL, V34, P218, DOI 10.1016/j.ridd.2012.07.011; Rosenblum S, 2012, NEUROPSYCHOL REHABIL, V22, P65, DOI 10.1080/09602011.2011.640465; Rosenblum S, 2010, RES DEV DISABIL, V31, P502, DOI 10.1016/j.ridd.2009.10.016; Rotenberg-Shpigelman S, 2008, ISRAELI J OCCUP THER, V17, pH77; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Scanlon D, 2013, J LEARN DISABIL-US, V46, P26, DOI 10.1177/0022219412464342; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Sharfi K, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106657, 10.1371/journal.pone.0108691]; Sharma K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125693; Skevington SM, 2004, QUAL LIFE RES, V13, P299, DOI 10.1023/B:QURE.0000018486.91360.00; Stern A, 2013, J ATTEN DISORD, P1; SWANSON HL, 1994, J LEARN DISABIL-US, V27, P34, DOI 10.1177/002221949402700107; Taylor HG, 2004, DEV NEUROPSYCHOL, V25, P199, DOI 10.1207/s15326942dn2501&2_11; Theofilou P, 2013, EUR J PSYCHOL, V9, P150, DOI 10.5964/ejop.v9i1.337; Toll SWM, 2011, J LEARN DISABIL-US, V44, P521, DOI 10.1177/0022219410387302; Vasic N, 2008, NEUROPSYCHOLOGIA, V46, P640, DOI 10.1016/j.neuropsychologia.2007.09.002; Vriezen ER, 2002, CHILD NEUROPSYCHOL, V8, P296, DOI 10.1076/chin.8.4.296.13505; Wilson AM, 2009, J LEARN DISABIL-US, V42, P24, DOI 10.1177/0022219408326216; World Health Organization, 2007, INT CLASS FUNCT DIS; World Health Organization (WHO), 2004, WHO QUAL LIF QUEST W	62	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2016	11	12							e0166939	10.1371/journal.pone.0166939			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EI8JY	WOS:000392753900006	27959913	Green Published, gold, Green Submitted			2022-02-06	
J	Yumoto, T; Mitsuhashi, T; Yamakawa, Y; Iida, A; Nosaka, N; Tsukahara, K; Naito, H; Nakao, A				Yumoto, Tetsuya; Mitsuhashi, Toshiharu; Yamakawa, Yasuaki; Iida, Atsuyoshi; Nosaka, Nobuyuki; Tsukahara, Kohei; Naito, Hiromichi; Nakao, Atsunori			Impact of Cushing's sign in the prehospital setting on predicting the need for immediate neurosurgical intervention in trauma patients: a nationwide retrospective observational study	SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE			English	Article						Traumatic brain injury; Hypertension; Bradycardia; Cushing's sign; Prehospital	GLASGOW COMA SCALE; BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MORTALITY; HYPERTENSION; MANAGEMENT; REFLEX	Background: Cushing's reflex usually results from intracranial hypertension. Although Cushing's sign can implicate severe traumatic brain injury (TBI) in injured patients, no major investigations have been made. The purpose of this study was to assess the predictability of life-threatening brain injury requiring immediate neurosurgical intervention (LT-BI) among trauma patients with Cushing's sign in the prehospital setting. Methods: This was a retrospective study using data from the Japan Trauma Data Bank from the period of 2010 to 2014. Patients 16 years old or older with blunt mechanisms of injury who were transported directly from the scene and Glasgow Coma Scale for eye opening of one in the prehospital setting were included. LT-BI was defined as patients requiring burr hole evacuation or craniotomy within 24 h of hospital arrival and patients who were non-survivors due to isolated severe TBI. Prehospital systolic blood pressure (pSBP) and heart rate (pHR) were assessed using area under the receiver operating characteristic curve (AUROC) and multiple logistic regression analysis to predict LT-BI. Results: Of 6332 eligible patients, 1859 (29%) exhibited LT-BI. AUROC of LT-BI using pSBP and pHR was 0.666 (95% confidence interval (CI); 0.652-0.681, P < 0.001), and 0.578 (95% CI; 0.563-0.594, P < 0.001), respectively. AUROC of pSBP was the highest among the 60 <= pHR <= 99 subgroup, of which AUROC was 0.680 (95% CI; 0.662-0.699, P < 0.001). Multiple logistic regression analysis showed that the higher the pSBP and the lower the pHR, the more likely that the patients had LT-BI. In a group with pSBP >= 180 mmHg and pHR <= 59 beats/min, the odds ratio and 95% CI of LT-BI after adjusting for age, sex, and severity of injuries to other body regions was 4. 77 (2.85-7.97), P < 0.001 was compared with the reference group, which was defined as patients with normal vital signs. Discussion: Our study has found that the combination of hypertension and bradycardia, which are the components of Cushing's sign without eye opening in the prehospital setting was a weak but a significant predictor of LT-BI, or death due to possible isolated severe TBI. Conclusions: Prehospital Cushing's sign with disturbed level of consciousness in trauma patients was a weak but significant predictor of the need for immediate neurosurgical intervention.	[Yumoto, Tetsuya; Yamakawa, Yasuaki; Iida, Atsuyoshi; Nosaka, Nobuyuki; Tsukahara, Kohei; Naito, Hiromichi; Nakao, Atsunori] Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, 2-5-1 Kita Ku,Shikata Cho, Okayama, Okayama 7008558, Japan; [Mitsuhashi, Toshiharu] Okayama Univ Hosp, Ctr Innovat Clin Med, 2-5-1 Kita Ku,Shikata Cho, Okayama, Okayama 7008558, Japan		Yumoto, T (corresponding author), Okayama Univ Hosp, Adv Emergency & Crit Care Med Ctr, 2-5-1 Kita Ku,Shikata Cho, Okayama, Okayama 7008558, Japan.	tyumoto@cc.okayama-u.ac.jp		Nosaka, Nobuyuki/0000-0002-7722-0701; Naito, Hiromichi/0000-0002-7308-1716			Abe T, 2014, CRIT CARE, V18, DOI 10.1186/cc13981; Barmparas G, 2014, J TRAUMA ACUTE CARE, V77, P592, DOI 10.1097/TA.0000000000000382; Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Brazinova A, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0133-z; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fodstad H, 2006, NEUROSURGERY, V59, P1132, DOI 10.1227/01.NEU.0000245582.08532.7C; Inokuchi R, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003354; Japan Trauma Care and Research, JAP TRAUM DAT BANK A; Kalmar AF, 2005, BRIT J ANAESTH, V94, P791, DOI 10.1093/bja/aei121; Krishnamoorthy V, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-015-0113-4; Lump D, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0494-0; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Matsushima K, 2015, J TRAUMA ACUTE CARE, V79, P838, DOI 10.1097/TA.0000000000000719; Qiu WS, 2009, CRIT CARE, V13, DOI 10.1186/cc8178; Rangel-Castillo L, 2008, NEUROL CLIN, V26, P521, DOI 10.1016/j.ncl.2008.02.003; Reisner A, 2014, J NEUROTRAUM, V31, P906, DOI 10.1089/neu.2013.3128; Shimoda K, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.08.014; Tohira H, 2012, INJURY, V43, P1924, DOI 10.1016/j.injury.2012.08.024	19	18	18	0	2	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1757-7241			SCAND J TRAUMA RESUS	Scand. J. Trauma Resusc. Emerg. Med.	DEC 9	2016	24								147	10.1186/s13049-016-0341-1			7	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EG6GA	WOS:000391141400003	27938387	gold, Green Published			2022-02-06	
J	Middleton, A; Graham, JE; Lin, YL; Goodwin, JS; Bettger, JP; Deutsch, A; Ottenbacher, KJ				Middleton, Addie; Graham, James E.; Lin, Yu-Li; Goodwin, James S.; Bettger, Janet Prvu; Deutsch, Anne; Ottenbacher, Kenneth J.			Motor and Cognitive Functional Status Are Associated with 30-day Unplanned Rehospitalization Following Post-Acute Care in Medicare Fee-for-Service Beneficiaries	JOURNAL OF GENERAL INTERNAL MEDICINE			English	Article						rehabilitation; functional status; health care reform; health services research; medicare	TRAUMATIC BRAIN-INJURY; INPATIENT REHABILITATION; HOSPITAL READMISSION; INDEPENDENCE MEASURE; IMPAIRMENT; RELIABILITY; DISCHARGE	The Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014 stipulates that standardized functional status (self-care and mobility) and cognitive function data will be used for quality reporting in post-acute care settings. Thirty-day post-discharge unplanned rehospitalization is an established quality metric that has recently been extended to post-acute settings. The relationships between the functional domains in the IMPACT Act and 30-day unplanned rehospitalization are poorly understood. To determine the degree to which discharge mobility, self-care, and cognitive function are associated with 30-day unplanned rehospitalization following discharge from post-acute care. This was a retrospective cohort study. Inpatient rehabilitation facilities submitting claims and assessment data to the Centers for Medicare and Medicaid Services in 2012-2013. Medicare fee-for-service enrollees discharged from post-acute rehabilitation in 2012-2013. The sample included community-dwelling adults admitted for rehabilitation following an acute care stay who survived for 32 days following discharge (N = 252,406). Not applicable. Thirty-day unplanned rehospitalization following post-acute rehabilitation. The unadjusted 30-day unplanned rehospitalization rate was 12.0 % (n = 30,179). Overall, patients dependent at discharge for mobility had a 50 % increased odds of rehospitalization (OR = 1.50, 95 % CI: 1.42-1.59), patients dependent for self-care a 36 % increased odds (OR = 1.36, 95 % CI: 1.27-1.47), and patients dependent for cognition a 19 % increased odds (OR = 1.19, 95 % CI: 1.09-1.29). Patients dependent for both self-care and mobility at discharge (n = 8312, 3.3 %) had a 16.1 % (95 % CI: 15.3-17.0 %) adjusted rehospitalization rate versus 8.5 % (95 % CI: 8.3-8.8 %) for those independent for both (n = 74,641; 29.6 %). The functional domains identified in the IMPACT Act were associated with 30-day unplanned rehospitalization following post-acute care in this large national sample. Further research is needed to better understand and improve the functional measures, and to determine if their association with rehospitalizations varies across post-acute settings, patient populations, or episodes of care.	[Middleton, Addie; Graham, James E.; Ottenbacher, Kenneth J.] Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA; [Lin, Yu-Li] Univ Texas Med Branch, Off Biostat, Galveston, TX 77555 USA; [Goodwin, James S.] Univ Texas Med Branch, Div Geriatr Med, Dept Internal Med, Galveston, TX 77555 USA; [Bettger, Janet Prvu] Duke Univ Med Ctr, Duke Clin Res Inst, Dept Orthopaed Surg, Durham, NC USA; [Deutsch, Anne] RTI Int & Rehabil Inst Chicago, Chicago, IL USA		Middleton, A (corresponding author), Univ Texas Med Branch, Div Rehabil Sci, 301 Univ Blvd, Galveston, TX 77555 USA.	jamiddle@utmb.edu	Deutsch, Anne/B-7530-2017	Deutsch, Anne/0000-0003-2290-7757; Middleton, Addie/0000-0001-8970-3703; Ottenbacher, Kenneth/0000-0001-5990-3982	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R24-HD065702, R01-HD069443, 5K12HD055929-09]; National Institute for Disability, Independent Living, and Rehabilitation Research [H133G140127]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD069443, K12HD055929, P2CHD065702] Funding Source: NIH RePORTER	The study was supported by the National Institutes of Health (R24-HD065702, R01-HD069443 and 5K12HD055929-09, PI, K. Ottenbacher) and the National Institute for Disability, Independent Living, and Rehabilitation Research (H133G140127, PI, K. Ottenbacher).	[Anonymous], 2014, FED REG, V79; Barnett ML, 2015, JAMA INT MED; Burwell SM, 2015, NEW ENGL J MED, V372, P897, DOI 10.1056/NEJMp1500445; Centers for Medicare and Medicaid Services, 2014, BUNDL PAYM CAR IMPR; Chen C, 2014, JAMA-J AM MED ASSOC, V311, P673, DOI 10.1001/jama.2014.11; Cutler DM, 2015, JAMA-J AM MED ASSOC, V313, P1606, DOI 10.1001/jama.2015.1926; Deutsch A, 2012, ANAL CROSSCUTTING ME; Faulk CE, 2013, PM&R, V5, P757, DOI 10.1016/j.pmrj.2013.06.002; Granger CV, 2007, AM J PHYS MED REHAB, V86, P883, DOI 10.1097/PHM.0b013e318152058a; Greysen SR, 2015, JAMA INTERN MED, V175, P559, DOI 10.1001/jamainternmed.2014.7756; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS293, DOI 10.1016/j.apmr.2014.08.026; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS330, DOI 10.1016/j.apmr.2014.09.041; Hoyer EH, 2014, J HOSP MED, V9, P277, DOI 10.1002/jhm.2152; Hoyer EH, 2013, ARCH PHYS MED REHAB, V94, P1951, DOI 10.1016/j.apmr.2013.05.028; Leppin AL, 2014, JAMA INTERN MED, V174, P1095, DOI 10.1001/jamainternmed.2014.1608; Lum HD, 2012, J GEN INTERN MED, V27, P1467, DOI 10.1007/s11606-012-2116-3; Medicare Payment Advisory Commission (MedPAC), 2015, C MED PAYM POL MAR; Morandi A, 2013, J AM MED DIR ASSOC, V14, P761, DOI 10.1016/j.jamda.2013.03.013; Neuman MD, 2014, JAMA-J AM MED ASSOC, V312, P1542, DOI 10.1001/jama.2014.13513; Ottenbacher KJ, 2012, J GERONTOL A-BIOL, V67, P875, DOI 10.1093/gerona/glr247; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Ottenbacher KJ, 2001, ARCH PHYS MED REHAB, V82, P1367, DOI 10.1053/apmr.2001.26088; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Shih SL, 2015, J GEN INTERN MED; Stineman MG, 2003, ARCH PHYS MED REHAB, V84, P29, DOI 10.1053/apmr.2003.50061; Stineman MG, 1996, ARCH PHYS MED REHAB, V77, P1101, DOI 10.1016/S0003-9993(96)90130-6; UB Foundation Activities, 2012, INP REH FAC PAT ASS; van Walraven C, 2012, J CLIN EPIDEMIOL, V65, P126, DOI 10.1016/j.jclinepi.2011.08.002; Yale New Haven Health Services Corporation/Center for Outcomes Research & Evaluation, 2014, 2014 MEAS UPD SPEC R	29	18	18	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0884-8734	1525-1497		J GEN INTERN MED	J. Gen. Intern. Med.	DEC	2016	31	12					1427	1434		10.1007/s11606-016-3704-4			8	Health Care Sciences & Services; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services; General & Internal Medicine	EE5DX	WOS:000389626600007	27439979	Green Published, Bronze			2022-02-06	
J	Thomsen, GM; Ma, AM; Ko, A; Harada, MY; Wyss, L; Haro, PS; Vit, JP; Shelest, O; Rhee, P; Svendsen, CN; Ley, EJ				Thomsen, Gretchen M.; Ma, Annie M.; Ko, Ara; Harada, Megan Y.; Wyss, Livia; Haro, Patricia S.; Vit, Jean-Philippe; Shelest, Oksana; Rhee, Peter; Svendsen, Clive N.; Ley, Eric J.			A model of recurrent concussion that leads to long-term motor deficits, CTE-like tauopathy and exacerbation of an ALS phenotype	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	46th Annual Meeting of the Western-Trauma-Association	FEB 28-MAR 04, 2016	CA	Western Trauma Assoc		Traumatic brain injury; concussion; rat model; amyotrophic lateral sclerosis	TRAUMATIC BRAIN-INJURY; AMYOTROPHIC-LATERAL-SCLEROSIS; RAT MODEL; HEAD-INJURY; NEURON DEGENERATION; ALZHEIMERS-DISEASE; MUTANT SOD1; MOUSE MODEL; IN-VIVO; ENCEPHALOPATHY	BACKGROUND: Concussion injury is the most common form of traumatic brain injury (TBI). How recurrent concussions alter long-term outcomes is poorly understood, especially as related to the development of neurodegenerative disease. We evaluated the functional and pathological consequences of repeated TBI over time in wild type (WT) rats as well as rats harboring the human SOD1(G93A) mutation ("SOD1"), a model of familial amyotrophic lateral sclerosis (ALS). METHODS: A total of 42 rats, 26 WT and 16 SOD1, were examined over a study period of 25 weeks (or endpoint). At postnatal day 60, 20 WT and 7 SOD1 rats were exposed to mild, bilateral TBI once per week for either 2 weeks (2 x TBI) or 5 weeks (5 x TBI) using a controlled cortical impact device. Six WT and nine SOD1 rats underwent sham injury with anesthesia alone. Twenty WT rats were euthanized at 12 weeks after first injury and six WT rats were euthanized at 25 weeks after first injury. SOD1 rats were euthanized when they reached ALS disease endpoint. Weekly body weights and behavioral assessments were performed. Tauopathy in brain tissue was analyzed using immunohistochemistry. RESULTS: 2XTBI injured rats initially demonstrated recovery of motor function but failed to recover to baseline within the 12-week study period. Relative to both 2XTBI and sham controls, 5XTBI rats demonstrated significant deficits that persisted over the 12-week period. SOD1 5XTBI rats reached a peak body weight earlier than sham SOD1 rats, indicating earlier onset of the ALS phenotype. Histologic examination of brain tissue revealed that, in contrast with sham controls, SOD1 and WT TBI rats demonstrated cortical and corpus collosum thinning and tauopathy, which increased over time. CONCLUSIONS: Unlike previous models of repeat brain injury, which demonstrate only transient deficits in motor function, our concussion model of repeat, mild, bilateral TBI induced long-lasting deficits in motor function, decreased cortical thickness, shrinkage of the corpus callosum, increased brain tauopathy, and earlier onset of ALS symptoms in SOD1 rats. This model may allow for a greater understanding of the complex relationship between TBI and neurodegenerative diseases and provides a potential method for testing novel therapeutic strategies. Copyright (C) 2016 Wolters Kluwer Health, Inc. All rights reserved.	[Thomsen, Gretchen M.; Ma, Annie M.; Wyss, Livia; Haro, Patricia S.; Shelest, Oksana; Svendsen, Clive N.] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Vit, Jean-Philippe; Svendsen, Clive N.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Vit, Jean-Philippe] Cedars Sinai Med Ctr, Biobehav Res Core, Los Angeles, CA 90048 USA; [Ko, Ara; Harada, Megan Y.; Ley, Eric J.] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA; [Rhee, Peter] Univ Arizona, Med Ctr, Div Trauma Crit Care Burn & Emergency Surg, Tucson, AZ USA		Ley, EJ (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8700 Beverly Blvd,Suite 8215 N, Los Angeles, CA 90048 USA.	Eric.Ley@cshs.org	vit, jean-philippe/Q-7286-2019	Vit, Jean-Philippe/0000-0001-5057-8554			Bae JS, 2013, J CLIN NEUROL, V9, P65, DOI 10.3988/jcn.2013.9.2.65; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Gerson J. E., 2016, J NEUROTRAUMA; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Graham R., 2014, SPORTS RELATED CONCU; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Nordstrom P, 2014, ANN NEUROL, V75, P374, DOI 10.1002/ana.24101; Omalu B, 2014, PROG NEUROL SURG, V28, P38, DOI 10.1159/000358761; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Sabbagh JJ, 2016, J NEUROTRAUMA; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Sundman MH, 2014, J ALZHEIMERS PARKINS, V4, P137; Suzuki M, 2010, EXP NEUROL, V221, P346, DOI 10.1016/j.expneurol.2009.12.004; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Thomsen GM, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0059-14.2015; Thomsen GM, 2014, J NEUROSCI, V34, P15587, DOI 10.1523/JNEUROSCI.2037-14.2014; Turner BJ, 2008, PROG NEUROBIOL, V85, P94, DOI 10.1016/j.pneurobio.2008.01.001; Vucic S, 2008, BRAIN, V131, P1540, DOI 10.1093/brain/awn071; Yamada K, 2014, J EXP MED, V211, P387, DOI 10.1084/jem.20131685; Yanamandra K, 2013, NEURON, V80, P402, DOI 10.1016/j.neuron.2013.07.046; Yoshiyama Y, 2005, J NEUROTRAUM, V22, P1134, DOI 10.1089/neu.2005.22.1134	49	18	18	0	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2016	81	6					1070	1079		10.1097/TA.0000000000001248			10	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	EE0BH	WOS:000389237900011	27602892				2022-02-06	
J	Li, XY; Zhu, H; Sun, XC; Zuo, FX; Lei, JF; Wang, ZJ; Bao, XJ; Wang, RZ				Li, Xueyuan; Zhu, Hua; Sun, Xicai; Zuo, Fuxing; Lei, Jianfeng; Wang, Zhanjing; Bao, Xinjie; Wang, Renzhi			Human Neural Stem Cell Transplantation Rescues Cognitive Defects in APP/PS1 Model of Alzheimer's Disease by Enhancing Neuronal Connectivity and Metabolic Activity	FRONTIERS IN AGING NEUROSCIENCE			English	Article						APP/PS1 mice; neuronal connectivity; metabolic activity; cognition; human neural stem cell; Alzheimer's disease	PROTON MR SPECTROSCOPY; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; IMPROVE COGNITION; TRANSGENIC MODEL; AMYLOID-BETA; MOUSE MODELS; MEMORY; IMPAIRMENT; PATHOLOGY	Alzheimer's disease (AD), the most frequent type of dementia, is featured by A beta pathology, neural degeneration and cognitive decline. To date, there is no cure for this disease. Neural stem cell (NSC) transplantation provides new promise for treating AD. Many studies report that intra-hippocampal transplantation of murine NSCs improved cognition in rodents with AD by alleviating neurodegeneration via neuronal complement or replacement. However, few reports examined the potential of human NSC transplantation for AD. In this study, we implanted human brain-derived NSCs (hNSCs) into bilateral hippocampus of an amyloid precursor protein (APP)/presenilin 1 (PS1) transgenic (Tg) mouse model of AD to test the effects of hNSC transplantation on Alzheimer's behavior and neuropathology. Six weeks later, transplanted hNSCs engrafted into the brains of AD mice, migrated dispersedly in broad brain regions, and some of them differentiated into neural cell types of central nervous system (CNS). The hNSC transplantation restored the recognition, learning and memory deficits but not anxiety tasks in AD mice. Although A beta plaques were not significantly reduced, the neuronal, synaptic and nerve fiber density was significantly increased in the frontal cortex and hippocampus of hNSC-treated AD mice, suggesting of improved neuronal connectivity in AD brains after hNSC transplantation. Ultrastructural analysis confirmed that synapses and nerve fibers maintained relatively well-structured shapes in these mice. Furthermore, in vivo magnetic resonance spectroscopy (MRS) showed that hNSC treated mice had notably increased levels of N-acetylaspartate (NAA) and Glu in the frontal cortex and hippocampus, suggesting that neuronal metabolic activity was improved in AD brains after hNSC transplantation. These results suggest that transplanted hNSCs rescued Alzheimer's cognition by enhancing neuronal connectivity and metabolic activity through a compensation mechanism in APP/PS1 mice. This study provides preclinical evidence that hNSC transplantation can be a possible and feasible strategy for treating patients with AD.	[Li, Xueyuan; Zuo, Fuxing; Bao, Xinjie; Wang, Renzhi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China; [Li, Xueyuan; Zuo, Fuxing; Bao, Xinjie; Wang, Renzhi] Peking Union Med Coll, Beijing, Peoples R China; [Zhu, Hua] Chinese Acad Med Sci, Peking Union Med Coll, Comparat Med Ctr, Dept Pathol, Beijing, Peoples R China; [Zhu, Hua] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Sun, Xicai; Wang, Zhanjing] Tsinghua Univ, Sch Med, Ctr Stem Cell Biol & Regenerat Med, Ctr Life Sci, Beijing, Peoples R China; [Lei, Jianfeng] Capital Med Univ, Ctr Med Expt & Testing, Beijing, Peoples R China		Bao, XJ; Wang, RZ (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing, Peoples R China.; Bao, XJ; Wang, RZ (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.	xinjieabao@163.com; wangrz@126.com			National High Technology Research and Development Program of ChinaNational High Technology Research and Development Program of China [2014CB541603, 2013AA020106]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301061, 81671272]	This work was supported by National High Technology Research and Development Program of China (2014CB541603, 2013AA020106) and National Natural Science Foundation of China (81301061, 81671272).	Ackl N, 2005, NEUROSCI LETT, V384, P23, DOI 10.1016/j.neulet.2005.04.035; Ager RR, 2015, HIPPOCAMPUS, V25, P813, DOI 10.1002/hipo.22405; Alvarez EO, 2004, BEHAV BRAIN RES, V152, P209, DOI 10.1016/j.bbr.2003.10.012; Arturo A., 2004, VITAE ACAD BIOMEDICA, V24, pN226; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; Chen SJ, 2012, RECONFIGURABLE NETWORKS-ON-CHIP, P1, DOI 10.1007/978-1-4419-9341-0; Fereshtehnejad SM, 2014, DRUGS AGING, V2014, P2014, DOI DOI 10.1007/S40266-014-0154-8; Fu TT, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/2412958; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; Jessen F, 2006, NEUROLOGY, V67, P528, DOI 10.1212/01.wnl.0000228218.68451.31; Kim JA, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.138; Lee IS, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0035-6; Lee SR, 2015, CELL TRANSPLANT, V24, P191, DOI 10.3727/096368914X678526; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Li XY, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101707; Li XY, 2015, J NEUROSCI RES, V93, P1313, DOI 10.1002/jnr.23555; Li XY, 2016, INT J MOL MED, V37, P271, DOI 10.3892/ijmm.2015.2428; Lo AC, 2013, J ALZHEIMERS DIS, V37, P109, DOI 10.3233/JAD-122296; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Pen AE, 2017, ACTA NEUROL SCAND, V135, P57, DOI 10.1111/ane.12545; Prince M, 2015, ALZHEIMERS DIS INT W; Rockenstein E, 2015, STEM CELL RES, V15, P54, DOI 10.1016/j.scr.2015.04.008; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shihabuddin LS, 2010, NEUROPHARMACOLOGY, V58, P845, DOI 10.1016/j.neuropharm.2009.12.015; Takamatsu K, 2014, STEM CELL RES, V13, P442, DOI 10.1016/j.scr.2014.10.001; Vadodaria KC, 2014, CELL, V156, DOI 10.1016/j.cell.2014.02.029; Yao ZG, 2013, EVID-BASED COMPL ALT, V2013, DOI DOI 10.1155/2013/518421; Zhang L, 2014, J ALZHEIMERS DIS, V41, P1193, DOI 10.3233/JAD-140066; Zhang N, 2014, CURR ALZHEIMER RES, V11, P367, DOI 10.2174/1567205011666140302200312; Zou CY, 2015, ACTA NEUROPATHOL, V129, P909, DOI 10.1007/s00401-015-1421-4; Zuo FX, 2015, INT J MOL SCI, V16, P26473, DOI 10.3390/ijms161125966	34	18	18	1	29	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	NOV 23	2016	8								282	10.3389/fnagi.2016.00282			14	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	EC8UB	WOS:000388417200002	27932977	Green Published, gold			2022-02-06	
J	Yan, FF; Zhang, MM; Meng, Y; Li, HJ; Yu, L; Fu, XJ; Tang, YC; Jiang, C				Yan, Fangfang; Zhang, Meimei; Meng, Yan; Li, Huijuan; Yu, Lie; Fu, Xiaojie; Tang, Youcai; Jiang, Chao			Erythropoietin improves hypoxic-ischemic encephalopathy in neonatal rats after short-term anoxia by enhancing angiogenesis	BRAIN RESEARCH			English	Article						Erythropoietin; Anoxia; Angiogenesis; VEGF; Neonatal Rats	ENDOTHELIAL GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; DOSE RECOMBINANT ERYTHROPOIETIN; INCREASES NEUROGENESIS; RECEPTOR; VEGF; MODEL; EXPRESSION; PROMOTES; OUTCOMES	Erythropoietin (EPO) is important for angiogenesis after hypoxia/ischemia. In this study, we investigated whether recombinant human erythropoietin (rhEPO) can enhance angiogenesis, and promote cognitive function through vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) signaling pathway in a rat model of hypoxic-ischemic encephalopathy (HIE). RhEPO, selective VEGFR2 inhibitor (SU5416) or vehicle was administrated by intraperitoneal injection. The assessment for cognitive function begins on day 60 after anoxia. Vascular density in hippocampus and white matter damage within corpus callosum were examined on day 28 after anoxia. The expression of erythropoietin receptor (EPOR), VEGF, rapidly accelerated fibrosarcoma 1 (Raf1), and extracellular-signal-regulated kinases 1 and 2 (ERK1/2) in hippocampus were evaluated on day 7 after anoxia. RhEPO-treated anoxia rats had better cognitive recovery, higher vascular density, and less white matter damage than in the vehicle anoxia rats. These protective effects associated with increased expression of EPOR, VEGF; and increased phosphorylation of Raf1 and ERK1/2. While this up-regulation, and changes in the histopathologic and functional outcomes were abolished by SU5416. Our data indicate that rhEPO can enhance angiogenesis, reduce white matter damage, and promote cognitive recovery through VEGF/VEGFR2 signaling pathway in anoxia rats. (C) 2016 Elsevier B.V. All rights reserved.	[Yan, Fangfang; Li, Huijuan; Yu, Lie; Fu, Xiaojie; Tang, Youcai; Jiang, Chao] Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [Zhang, Meimei; Meng, Yan] Zhengzhou Univ, Affiliated Hosp 5, Dept Pediat Neurol, Zhengzhou 450052, Henan, Peoples R China		Jiang, C (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China.; Zhang, MM (corresponding author), Zhengzhou Univ, Affiliated Hosp 5, Dept Pediat Neurol, Zhengzhou 450052, Henan, Peoples R China.	mmzhangzzu@163.com; chaojzzu@126.com		Tang, Youcai/0000-0003-2087-6029	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81301006]; Education Department of Henan Province [13A320633]	This work was supported by grants from the National Natural Science Foundation of China (81301006), and the Education Department of Henan Province (13A320633).	Adamczak J, 2015, STROKE, V46, pE103, DOI 10.1161/STROKEAHA.114.007642; BACIC M, 1995, GROWTH FACTORS, V12, P11, DOI 10.3109/08977199509003209; Bouzat P, 2013, CRIT CARE MED, V41, P1316, DOI 10.1097/CCM.0b013e31827ca64e; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Byts Nadiya, 2009, Exp Transl Stroke Med, V1, P4, DOI 10.1186/2040-7378-1-4; Cechetti F, 2010, BRAZ J MED BIOL RES, V43, P1178, DOI 10.1590/S0100-879X2010007500124; Chun PT, 2015, DEV NEUROSCI-BASEL, V37, P161, DOI 10.1159/000370147; DIGICAYLIOGLU M, 1995, P NATL ACAD SCI USA, V92, P3717, DOI 10.1073/pnas.92.9.3717; Dixon BJ, 2015, INT J MOL SCI, V16, P22368, DOI 10.3390/ijms160922368; DOBBING J, 1971, PSYCHIAT NEUROL NEUR, V74, P433; Fan XY, 2011, PEDIATR RES, V69, P56, DOI 10.1203/PDR.0b013e3181fcbef3; Freitag MT, 2015, J NEUROIMAGING, V25, P582, DOI 10.1111/jon.12202; Gonzalez FF, 2013, STROKE, V44, P753, DOI 10.1161/STROKEAHA.111.000104; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grojean S, 2003, NEUROBIOL DIS, V14, P265, DOI 10.1016/S0969-9961(03)00082-2; Harrigan MR, 2002, NEUROSURGERY, V50, P589, DOI 10.1097/00006123-200203000-00030; Itokawa T, 2002, MOL CANCER THER, V1, P295; Iwai M, 2007, STROKE, V38, P2795, DOI 10.1161/STROKEAHA.107.483008; Juul SE, 2004, BIOL NEONATE, V85, P138, DOI 10.1159/000074970; Kaji T, 2006, BBA-GEN SUBJECTS, V1760, P1465, DOI 10.1016/j.bbagen.2006.06.010; Kellert BA, 2007, PEDIATR RES, V61, P451, DOI 10.1203/pdr.0b013e3180332cec; Kertesz N, 2004, DEV BIOL, V276, P101, DOI 10.1016/j.ydbio.2004.08.025; Kertmen H, 2015, ARCH MED SCI, V11, P1119, DOI 10.5114/aoms.2015.54869; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lee MS, 2015, CELL SIGNAL, V27, P1439, DOI 10.1016/j.cellsig.2015.04.001; Li WL, 2011, EXP BRAIN RES, V214, P503, DOI 10.1007/s00221-011-2849-y; Ma QY, 2015, PROG NEUROBIOL, V124, P28, DOI 10.1016/j.pneurobio.2014.11.001; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Minnerup J, 2009, STROKE, V40, P3113, DOI 10.1161/STROKEAHA.109.555789; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller Aaron J, 2014, Neoreviews, V15, pe177; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Nakano M, 2007, CIRC RES, V100, P662, DOI 10.1161/01.RES.0000260179.43672.fe; Nyakas C, 1996, PROG NEUROBIOL, V49, P1; Ogunshola Omolara O, 2013, Methods Mol Biol, V982, P13, DOI 10.1007/978-1-62703-308-4_2; Okazaki T, 2008, NEOPLASIA, V10, P932, DOI 10.1593/neo.08140; Pan CH, 2015, TOXICOL APPL PHARM, V282, P215, DOI 10.1016/j.taap.2014.11.009; Paris D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055392; Pulera MR, 1998, STROKE, V29, P2622, DOI 10.1161/01.STR.29.12.2622; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; RICE JE, 1981, ANN NEUROL, V9, P131, DOI 10.1002/ana.410090206; Robertson RT, 2015, HISTOCHEM CELL BIOL, V143, P225, DOI 10.1007/s00418-014-1301-3; Shea KL, 2015, CURR OPIN ANESTHESIO, V28, P261, DOI 10.1097/ACO.0000000000000184; Spandou E, 2004, BRAIN RES, V1021, P167, DOI 10.1016/j.brainres.2004.06.057; Statler PA, 2007, PEDIATR RES, V61, P671, DOI 10.1203/pdr.0b013e31805341dc; Sugawa M, 2002, NEUROSCI RES, V44, P391, DOI 10.1016/S0168-0102(02)00161-X; Tang YH, 2016, AGING DIS, V7, P326, DOI 10.14336/AD.2015.1125; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Torun YA, 2014, BRAIN DEV-JPN, V36, P864, DOI 10.1016/j.braindev.2014.01.005; Traudt CM, 2013, DEV NEUROSCI-BASEL, V35, P491, DOI 10.1159/000355460; Trincavelli ML, 2013, INT J MOL SCI, V14, P2258, DOI 10.3390/ijms14022258; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tsui AKY, 2014, AM J PHYSIOL-REG I, V307, pR13, DOI 10.1152/ajpregu.00411.2013; Tufro A, 2015, J AM SOC NEPHROL, V26, P997, DOI 10.1681/ASN.2014101004; Wang J., 2015, MOL NEUROBIOL; Wang JP, 2014, BEHAV BRAIN RES, V265, P171, DOI 10.1016/j.bbr.2014.02.033; Wang L, 2008, J CEREBR BLOOD F MET, V28, P1361, DOI 10.1038/jcbfm.2008.32; Westenbrink BD, 2010, CARDIOVASC RES, V87, P30, DOI 10.1093/cvr/cvq041; Wu H, 2012, NEUROBIOL DIS, V45, P388, DOI 10.1016/j.nbd.2011.08.028; Wu YW, 2015, DEV MED CHILD NEUROL, V57, P34, DOI 10.1111/dmcn.12730; Wu YW, 2012, PEDIATRICS, V130, P683, DOI 10.1542/peds.2012-0498; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, J NEUROSURG, V113, P598, DOI 10.3171/2009.9.JNS09844; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yang ZH, 2014, AM J PATHOL, V184, P1230, DOI 10.1016/j.ajpath.2013.12.023; Yeganeh F, 2013, J MOL NEUROSCI, V50, P551, DOI 10.1007/s12031-013-9996-5; Zacharias R, 2010, BRAIN RES, V1343, P14, DOI 10.1016/j.brainres.2010.04.081; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhao J, 2013, INT J DEV NEUROSCI, V31, P543, DOI 10.1016/j.ijdevneu.2013.06.008; Zhu CL, 2009, PEDIATRICS, V124, pE218, DOI 10.1542/peds.2008-3553	72	18	22	3	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	NOV 15	2016	1651						104	113		10.1016/j.brainres.2016.09.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EB6WU	WOS:000387527100012	27659964				2022-02-06	
J	Kim, SC; Ro, YS; Shin, SD; Kim, JY				Kim, Sang Chul; Ro, Young Sun; Shin, Sang Do; Kim, Joo Yeong			Preventive Effects of Safety Helmets on Traumatic Brain Injury after Work-Related Falls	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						occupational injuries; accidental falls; traumatic brain injury	OCCUPATIONAL INJURIES; PROGNOSTIC-FACTORS; UNITED-STATES; CONSTRUCTION; MORTALITY; EFFICACY	Introduction: Work-related traumatic brain injury (TBI) caused by falls is a catastrophic event that leads to disabilities and high socio-medical costs. This study aimed to measure the magnitude of the preventive effect of safety helmets on clinical outcomes and to compare the effect across different heights of fall. Methods: We collected a nationwide, prospective database of work-related injury patients who visited the 10 emergency departments between July 2010 and October 2012. All of the adult patients who experienced work-related fall injuries were eligible, excluding cases with unknown safety helmet use and height of fall. Primary and secondary endpoints were intracranial injury and in-hospital mortality. We calculated adjusted odds ratios (AORs) of safety helmet use and height of fall for study outcomes, and adjusted for any potential confounders. Results: A total of 1298 patients who suffered from work-related fall injuries were enrolled. The industrial or construction area was the most common place of fall injury occurrence, and 45.0% were wearing safety helmets at the time of fall injuries. The safety helmet group was less likely to have intracranial injury comparing with the no safety helmet group (the adjusted odds ratios (ORs) (95% confidence interval (CI)): 0.42 (0.24-0.73)), however, there was no statistical difference of in-hospital mortality between two groups (the adjusted ORs (95% CI): 0.83 (0.34-2.03). In the interaction analysis, preventive effects of safety helmet on intracranial injury were significant within 4 m height of fall. Conclusions: A safety helmet is associated with prevention of intracranial injury resulting from work-related fall and the effect is preserved within 4 m height of fall. Therefore, wearing a safety helmet can be an intervention for protecting fall-related intracranial injury in the workplace.	[Kim, Sang Chul] Konkuk Univ, Sch Med, Dept Emergency Med, Chungju 27376, South Korea; [Kim, Sang Chul] Chungju Hosp, Chungju 27376, South Korea; [Kim, Sang Chul; Ro, Young Sun; Shin, Sang Do; Kim, Joo Yeong] Seoul Natl Univ, Hosp Biomed Res, Lab Emergency Med Serv, Seoul 03080, South Korea; [Shin, Sang Do] Seoul Natl Univ, Coll Med, Dept Emergency Med, Seoul 03080, South Korea; [Kim, Joo Yeong] Korea Univ, Dept Emergency Med, Ansan Hosp, Ansan 15355, South Korea		Ro, YS (corresponding author), Seoul Natl Univ, Hosp Biomed Res, Lab Emergency Med Serv, Seoul 03080, South Korea.	arahan@kku.ac.kr; Ro.youngsun@gmail.com; shinsangdo@gmail.com; blj01he@gmail.com	Lee, Jae Hyuk/W-5616-2018	Lee, Jae Hyuk/0000-0003-2429-4085	Konkuk University	This paper was supported by the Konkuk University.	Attewell RG, 2001, ACCIDENT ANAL PREV, V33, P345, DOI 10.1016/S0001-4575(00)00048-8; Baron SL, 2013, MMWR-MORBID MORTAL W, V62, P35; BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Bureau of Labor Statistics, 2014, CENS FAT OCC INJ CFO; Cattledge GH, 1996, ACCIDENT ANAL PREV, V28, P655, DOI 10.1016/0001-4575(96)00026-7; Chi CF, 2005, APPL ERGON, V36, P391, DOI 10.1016/j.apergo.2004.09.011; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Dembe AE, 2001, AM J IND MED, V40, P403, DOI 10.1002/ajim.1113; El Sayed I., 2016, NEUROSURG R IN PRESS; Haider AH, 2012, J TRAUMA ACUTE CARE, V73, P1340, DOI 10.1097/TA.0b013e318270bbca; Health and Safety Executive, 2015, PERS PROT EQUIPM WOR; Icer M, 2013, ULUS TRAVMA ACIL CER, V19, P529, DOI 10.5505/tjtes.2013.77535; Konda S, 2016, AM J IND MED, V59, P212, DOI 10.1002/ajim.22557; Lapostolle F, 2005, CRIT CARE MED, V33, P1239, DOI 10.1097/01.CCM.0000164564.11989.C3; Liberty Mutual Research Institute for Safety, 2015, 2015 ANN REP SCI ACT; Liu B., 2008, COCHRANE DATABASE SY, V1; Liu CC, 2009, INJURY, V40, P595, DOI 10.1016/j.injury.2008.11.014; Mangharam J., 2016, ERGONOMICS; McCurley L., 2013, FALLS HEIGHT GUIDE R, P95; McMillan TM, 2012, J NEUROL NEUROSUR PS, V83, P1086, DOI 10.1136/jnnp-2012-302746; Occupational Safety and Branch Labour Department, 2004, GUID NOT SEL US MAIN; SafetyWork Manitoba, 2008, FALL PROT GUID WORKP; Sise RG, 2014, J TRAUMA ACUTE CARE, V76, P913, DOI 10.1097/TA.0000000000000169; Smedley J., 2013, OXFORD HDB OCCUPATIO, P138; Smith G S, 2001, Inj Prev, V7 Suppl 1, pi3, DOI 10.1136/ip.7.suppl_1.i3; Socias C. M., 2014, MMWR-MORBID MORTAL W, V63, P341; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5; Waehrer GM, 2007, ACCIDENT ANAL PREV, V39, P1258, DOI 10.1016/j.aap.2007.03.012; Yoon HY, 2006, INT J IND ERGONOM, V36, P83, DOI 10.1016/j.ergon.2005.08.005	29	18	18	1	10	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2016	13	11							1063	10.3390/ijerph13111063			15	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	EE4KR	WOS:000389571300022		Green Submitted, Green Published, gold			2022-02-06	
J	Tornas, S; Lovstad, M; Solbakk, AK; Schanke, AK; Stubberud, J				Tornas, Sveinung; Lovstad, Marianne; Solbakk, Anne-Kristin; Schanke, Anne-Kristine; Stubberud, Jan			Goal Management Training Combined With External Cuing as a Means to Improve Emotional Regulation, Psychological Functioning, and Quality of Life in Patients With Acquired Brain Injury: A Randomized Controlled Trial	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Clinical trial; Cognition; Emotions; Executive function; Rehabilitation	BEHAVIOR RATING INVENTORY; FUNCTION-ADULT VERSION; EXECUTIVE DYSFUNCTION; COGNITIVE REHABILITATION; SPINA-BIFIDA; ECOLOGICAL VALIDITY; ATTENTION SYSTEM; SELF-REGULATION; AWARENESS; DEFICITS	Objective: To investigate whether goal management training (GMT) expanded to include external cuing and an emotional regulation module is associated with improved emotional regulation, psychological functioning, and quality of life (QOL) after chronic acquired brain injury (ABI). Design: Randomized controlled trial with blinded outcome assessment at baseline, posttraining, and 6-month follow-up. Setting: Outpatient. Participants: Persons with ABI and executive dysfunction (N=70; 64% traumatic brain injury; 52% men; mean age +/- SD, 43 +/- 13y; mean time since injury +/- SD, 8.1 +/- 9.4y). Intervention: Eight sessions of GMT in groups, including a new module addressing emotional regulation, and external cuing. A psychoeducative control condition (Brain Health Workshop) was matched on amount of training, therapist contact, and homework. Main Outcome Measures: Emotional regulation was assessed with the Brain Injury Rehabilitation Trust Regulation of Emotions Questionnaire, the Emotional Control subscale and the Emotion Regulation factor (Behavior Rating Inventory of Executive Function Adult Version), and the Positive and Negative Affect subscales from the Dysexecutive Questionnaire. Secondary outcome measures included psychological distress (Hopkins Symptom Checklist-25) and QOL (Quality of Life After Brain Injury Scale). Results: Findings indicated beneficial effects of GMT on emotional regulation skills in everyday life and in QOL 6 months posttreatment. No intervention effects on measures of psychological distress were registered. Conclusions: GMT is a promising intervention for improving emotional regulation after ABI, even in the chronic phase. More research using objective measures of emotional regulation is needed to investigate the efficacy of this type of training. (C) 2016 by the American Congress of Rehabilitation Medicine	[Tornas, Sveinung; Lovstad, Marianne; Schanke, Anne-Kristine; Stubberud, Jan] Sunnaas Rehabil Hosp, Nesodden, Norway; [Lovstad, Marianne; Solbakk, Anne-Kristin; Schanke, Anne-Kristine] Univ Oslo, Dept Psychol, Oslo, Norway; [Solbakk, Anne-Kristin] Oslo Univ Hosp, Rikshosp, Dept Neurosurg, Div Surg & Clin Neurosci, Oslo, Norway; [Solbakk, Anne-Kristin] Helgeland Hosp, Dept Neuropsychol, Mosjoen, Norway		Tornas, S (corresponding author), Sunnaas Rehabil Hosp, N-1450 Bjornemyrveien, Nesoddtangen, Norway.	Sveinung.tornaas@sunnaas.no	Stubberud, Jan/ABE-6922-2021		Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds [2011/2/0204]	Supported by the Norwegian Extra Foundation for Health and Rehabilitation through EXTRA funds (grant no. 2011/2/0204).	Arnemann KL, 2015, NEUROLOGY, V84, P1568, DOI 10.1212/WNL.0000000000001476; Baycrest Centre for Geriatric Care, 2012, GOAL MAN TRAIN TRAIN; Beck AT, 2009, DEPRESSION: CAUSES AND TREATMENT, SECOND EDITION, P1; Becker F, 2014, NEUROREHABILITATION, V34, P87, DOI 10.3233/NRE-131015; Benedict R., 1997, BRIEF VISUOSPATIAL M; Bennett PC, 2005, J INT NEUROPSYCH SOC, V11, P376, DOI 10.1017/S1355617705050423; Benson D.F., 1986, FRONTAL LOBES; Bertens D, 2015, J INT NEUROPSYCH SOC, V21, P639, DOI 10.1017/S1355617715000764; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Burgess PW., 1996, BEHAV ASSESSMENT DYS; Cantor J, 2014, ARCH PHYS MED REHAB, V95, P1, DOI 10.1016/j.apmr.2013.08.005; Cattran C, 2011, J CLIN EXP NEUROPSYC, V33, P672, DOI 10.1080/13803395.2010.550603; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Chaytor N, 2006, ARCH CLIN NEUROPSYCH, V21, P217, DOI 10.1016/j.acn.2005.12.002; Chen AJW, 2011, BRAIN, V134, P1541, DOI 10.1093/brain/awr067; Chiesa A, 2011, CLIN PSYCHOL REV, V31, P449, DOI 10.1016/j.cpr.2010.11.003; Cicerone KD, 2004, ARCH PHYS MED REHAB, V85, P943, DOI 10.1016/j.apmr.2003.07.019; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Cicerone KD, 2012, ARCH PHYS MED REHAB, V93, P188, DOI 10.1016/j.apmr.2011.12.003; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cicerone KD, 2008, ARCH PHYS MED REHAB, V89, P2239, DOI 10.1016/j.apmr.2008.06.017; Cisler JM, 2010, J PSYCHOPATHOL BEHAV, V32, P68, DOI 10.1007/s10862-009-9161-1; Cohen J., 2013, STAT POWER ANAL BEHA; Cole P.M., 1994, MONOGR SOC RES CHILD, V59, P73, DOI [10.1111/j.1540-5834.1994.tb01278.x, DOI 10.2307/1166139]; Conners C. K., 2000, CONNORS CPT 2 CONTIN; D'Zurilla TJ, 2001, HANDBOOK OF COGNITIVE-BEHAVIORAL THERAPIES, SECOND EDITION, P211; Damasio A, 2013, NAT REV NEUROSCI, V14, P143, DOI 10.1038/nrn3403; Dams-O'Connor K, 2013, BRAIN IMPAIR, V14, P51, DOI 10.1017/BrImp.2013.9; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Diller, 2011, HDB HOLISTIC NEUROPS; Donders J, 2016, ARCH CLIN NEUROPSYCH, V31, P29, DOI 10.1093/arclin/acv048; Draper K, 2008, NEUROPSYCHOLOGY, V22, P618, DOI 10.1037/0894-4105.22.5.618; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; DZURILLA TJ, 1971, J ABNORM PSYCHOL, V78, P107, DOI 10.1037/h0031360; FASOTTI L, 2002, COGNITIVE REHABILITA, P107; Finnanger TG, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/329241; Fischer S, 2004, J INT NEUROPSYCH SOC, V10, P190, DOI 10.1017/S1355617704102051; Fish J, 2007, NEUROPSYCHOLOGIA, V45, P1318, DOI 10.1016/j.neuropsychologia.2006.09.015; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Gioia GA, 2005, PSYCHOL ASSESS RESOU; Gioia GA IP, 2000, BEHAV RATING INVENTO; Grant M, 2012, NEUROPSYCHOL REHABIL, V22, P852, DOI 10.1080/09602011.2012.693455; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2015, CONTEMP CLIN TRIALS, V40, P180, DOI 10.1016/j.cct.2014.12.005; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kennedy MRT, 2008, NEUROPSYCHOL REHABIL, V18, P257, DOI 10.1080/09602010701748644; Knight R. T., 2002, PRINCIPLES FRONTAL L, P573; Koole S, 2009, COGNITION EMOTION, V23, P4, DOI 10.1080/02699930802619031; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Logan DE, 2008, PAIN, V136, P366, DOI 10.1016/j.pain.2007.07.015; Maki-Marttunen V, 2015, J NEUROTRAUM, V32, P272, DOI 10.1089/neu.2014.3557; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; McCambridge J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039116; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Medd J, 2000, NEUROPSYCHOL REHABIL, V10, P185, DOI 10.1080/096020100389246; Miotto EC, 2009, NEUROPSYCHOL REHABIL, V19, P517, DOI 10.1080/09602010802332108; Novakovic-Agopian T, 2011, J HEAD TRAUMA REHAB, V26, P325, DOI 10.1097/HTR.0b013e3181f1ead2; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Posner MI., 1994, IMAGES MIND; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Rath JF, 2003, NEUROPSYCHOL REHABIL, V13, P461, DOI 10.1080/09602010343000039; Ravndal E, 2010, DRUG ALCOHOL DEPEN, V108, P65, DOI 10.1016/j.drugalcdep.2009.11.008; ROBERTSON IH, 2000, NEW COGNITIVE NEUROS, P563; Robertson IH, 2013, PRINCIPLES FRONTAL L, P742; Roth RM, 2013, ARCH CLIN NEUROPSYCH, V28, P425, DOI 10.1093/arclin/act031; Rueda M. R., 2004, HDB SELF REGULATION, P283; Ruff H. A., 1996, ATTENTION EARLY DEV; Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332; Simblett SK, 2012, NEUROPSYCHOL REHABIL, V22, P874, DOI 10.1080/09602011.2012.703956; Simblett SK, 2011, NEUROPSYCHOL REHABIL, V21, P1, DOI [10.1080/09602011.2010.531216, 10.1080/09602011.2011.592099]; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2010, J INT NEUROPSYCH SOC, V16, P118, DOI 10.1017/S1355617709991020; Stubberud J, 2015, REHABIL PSYCHOL, V60, P1, DOI 10.1037/rep0000018; Stubberud J, 2014, NEUROPSYCHOL REHABIL, V24, P26, DOI 10.1080/09602011.2013.847847; Stubberud J, 2013, J INT NEUROPSYCH SOC, V19, P672, DOI 10.1017/S1355617713000209; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Tornas S, 2016, J INT NEUROPSYCH SOC, V21, P1; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; van der Horn HJ, 2016, J NEUROTRAUM, V33, P1, DOI 10.1089/neu.2015.3905; van Hooren SAH, 2007, PATIENT EDUC COUNS, V65, P205, DOI 10.1016/j.pec.2006.07.010; von Steinbuechel N, 2005, CURR OPIN NEUROL, V18, P681, DOI 10.1097/01.wco.0000194140.56429.75; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; VONCRAMON DY, 1994, NEUROPSYCHOL REHABIL, V4, P399, DOI 10.1080/09602019408401608; Wechsler D., 1999, MANUAL WECHSLER ABBR; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; Zald DH, 2010, NEUROPSYCHOLOGIA, V48, P3377, DOI 10.1016/j.neuropsychologia.2010.08.012; Zeman J, 2006, J DEV BEHAV PEDIATR, V27, P155, DOI 10.1097/00004703-200604000-00014	100	18	18	1	27	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2016	97	11					1841	1852		10.1016/j.apmr.2016.06.014			12	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	EB8IK	WOS:000387634500003	27424292				2022-02-06	
J	Waldum, ER; Dufault, CL; McDaniel, MA				Waldum, Emily R.; Dufault, Carolyn L.; McDaniel, Mark A.			Prospective Memory Training: Outlining a New Approach	JOURNAL OF APPLIED GERONTOLOGY			English	Article						aging; event-based; time-based; intervention; prospective memory	AGE-RELATED DIFFERENCES; ATTENTIONAL CONTROL; OLDER-ADULTS; IMPLEMENTATION INTENTIONS; IMPROVING MEMORY; SELF-EFFICACY; PERFORMANCE; TASK; IMPACT; INTERVENTION	Prospective memory (PM) tasks are those that must be performed in the future (e.g., attend an appointment). While these everyday tasks can be especially relevant for older adults (i.e., medication adherence), and have been associated with age-related decline, PM has been virtually overlooked in the cognitive training domain. This article describes the first comprehensive PM training intervention. Older adults (age 55 to 75) who received training completed 8 weekly PM training sessions that consisted of variable PM training tasks, strategy-focused discussion, and homework assignments. Those assigned to a control group completed only the first and last training task. On both a real-world proxy PM transfer task and the training tasks detailed here, there was a positive impact of PM training, suggesting practical benefits of the current training package for older adults. Benefits may also extend to other special populations who experience PM impairments (e.g., traumatic brain injury [TBI], Parkinson's).	[Waldum, Emily R.; Dufault, Carolyn L.; McDaniel, Mark A.] Washington Univ, St Louis, MO 63130 USA		Waldum, ER (corresponding author), Washington Univ, Dept Psychol, Campus Box 1125,One Brookings Dr, St Louis, MO 63130 USA.	ewaldum@artsci.wustl.edu			National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034581, 5T32AG000030]; Harvey A. Friedman Center for Aging; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG034581, T32AG000030] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by Grant R01AG034581 from the National Institute on Aging and by the Harvey A. Friedman Center for Aging. Emily Waldum was supported by National Institute on Aging grant 5T32AG000030.	Bagwell DK, 2008, CLIN INTERV AGING, V3, P371; Bherer L, 2005, PSYCHOL AGING, V20, P695, DOI 10.1037/0882-7974.20.4.695; Breneiser J., 2007, THESIS; Craik F.I.M., 2008, HDB AGING COGNITION; Duchek JM, 2006, NEUROPSYCHOLOGY, V20, P633, DOI 10.1037/0894-4105.20.6.633; Einstein, 2007, PROSPECTIVE MEMORY O; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1995, J EXP PSYCHOL LEARN, V21, P996, DOI 10.1037/0278-7393.21.4.996; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Jennings JM, 2003, NEUROPSYCHOL REHABIL, V13, P417, DOI 10.1080/09602010244000390; KRAMER AF, 1995, J EXP PSYCHOL-APPL, V1, P50, DOI 10.1037/1076-898X.1.1.50; Liu LL, 2004, PSYCHOL AGING, V19, P318, DOI 10.1037/0882-7974.19.2.318; MacKay-Brandt A, 2011, AGING NEUROPSYCHOL C, V18, P432, DOI 10.1080/13825585.2011.568046; MAYLOR EA, 1993, PSYCHOL AGING, V8, P420, DOI 10.1037/0882-7974.8.3.420; Maylor EA, 1996, PSYCHOL AGING, V11, P74, DOI 10.1037/0882-7974.11.1.74; McDaniel MA, 2008, MEM COGNITION, V36, P716, DOI 10.3758/MC.36.4.716; McDaniel MA, 2014, PSYCHOL AGING, V29, P717, DOI 10.1037/a0037363; McDaniel MA, 2010, MEM COGNITION, V38, P221, DOI 10.3758/MC.38.2.221; Park DC, 1997, PSYCHOL AGING, V12, P314, DOI 10.1037/0882-7974.12.2.314; REBOK GW, 1989, DEV PSYCHOL, V25, P714, DOI 10.1037/0012-1649.25.5.714; Redick TS, 2013, J EXP PSYCHOL GEN, V142, P359, DOI 10.1037/a0029082; Rendell PG, 2007, AGING NEUROPSYCHOL C, V14, P236, DOI 10.1080/13825580600579186; Rendell PG, 2000, APPL COGNITIVE PSYCH, V14, pS43, DOI 10.1002/acp.770; Rose N. S., 2012, ANN M PSYCH SOC MINN; Salthouse T.A., 2000, HDB AGING COGNITION; Schmidt IW, 2001, EDUC GERONTOL, V27, P455, DOI 10.1080/036012701316894162; Schnitzspahn KM, 2009, EUR J AGEING, V6, P147, DOI 10.1007/s10433-009-0116-x; Smith GE, 2009, J AM GERIATR SOC, V57, P594, DOI 10.1111/j.1532-5415.2008.02167.x; Stine-Morrow EAL, 2007, J GERONTOL B-PSYCHOL, V62, P62, DOI 10.1093/geronb/62.special_issue_1.62; Toglia JP, 2012, CAN J OCCUP THER, V79, P225, DOI 10.2182/cjot.2012.79.4.4; VERHAEGHEN P, 1992, PSYCHOL AGING, V7, P242, DOI 10.1037/0882-7974.7.2.242; West RL, 2008, AGING NEUROPSYCHOL C, V15, P302, DOI 10.1080/13825580701440510	32	18	19	2	20	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0733-4648	1552-4523		J APPL GERONTOL	J. Appl. Gerontol.	NOV	2016	35	11					1211	1234		10.1177/0733464814559418			24	Gerontology	Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DZ6GP	WOS:000385960000005	25480795	Green Accepted			2022-02-06	
J	Ahmed, AI; Bullock, MR; Dietrich, WD				Ahmed, Aminul I.; Bullock, M. Ross; Dietrich, W. Dalton			Hypothermia in Traumatic Brain Injury	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Hypothermia; Traumatic brain injury; Neuroprotection; Intracranial pressure	TERM MILD HYPOTHERMIA; RANDOMIZED CONTROLLED-TRIAL; HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; INTRACRANIAL HYPERTENSION; MODERATE HYPOTHERMIA; FLUID PRESSURE; FEVER CONTROL; HYPERTHERMIA; TEMPERATURE	For over 50 years, clinicians have used hypothermia to manage traumatic brain injury (TBI). In the last two decades, numerous trials have assessed whether hypothermia is of benefit in patients. Mild to moderate hypothermia reduces the intracranial pressure (ICP). Randomized control trials for short-term hypothermia indicate no benefit in outcome after severe TBI, whereas longer-term hypothermia could be of benefit by reducing ICP. This article summarises current evidence and gives recommendations based upon the conclusions.	[Ahmed, Aminul I.; Bullock, M. Ross; Dietrich, W. Dalton] Univ Miami, Lois Pope Life Ctr, Miami Project Cure Paralysis, 1095 Northwest,14th Terrace, Miami, FL 33136 USA		Ahmed, AI (corresponding author), Univ Southampton, Southampton Univ Hosp, Clin Expt Sci, LD83,South Acad Block,Tremona Rd, Southampton SO16 6YD, Hants, England.	a.ahmed@soton.ac.uk		Ahmed, Aminul/0000-0001-6670-0438			Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Alderson P, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001048.pub2, DOI 10.1002/14651858.CD001048.PUB2]; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Atkins CM, 2010, EUR J NEUROSCI, V32, P1912, DOI 10.1111/j.1460-9568.2010.07467.x; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; CLIFTON GL, 1991, J CEREBR BLOOD F MET, V11, P114, DOI 10.1038/jcbfm.1991.13; Clifton GL, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0009; Crossley S, 2014, CRIT CARE, V18, DOI 10.1186/cc13835; Dietrich WD, 2007, PROG BRAIN RES, V162, P201, DOI 10.1016/S0079-6123(06)62011-6; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dietrich WD, 1996, NEUROSURGERY, V38, P533, DOI 10.1097/00006123-199603000-00023; DIETRICH WD, 1994, ACTA NEUROPATHOL, V87, P250, DOI 10.1007/BF00296740; DIETRICH WD, 1992, J NEUROTRAUM, V9, pS475; FAY T, 1959, J NEUROSURG, V16, P239, DOI 10.3171/jns.1959.16.3.0239; Finkelstein Robert A, 2010, J Intensive Care Med, V25, P205, DOI 10.1177/0885066610366919; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; Fox JL, 2010, CAN J EMERG MED, V12, P355; Gebauer CM, 2006, PEDIATRICS, V117, P843, DOI 10.1542/peds.2004-1587; Gupta AK, 2002, BRIT J ANAESTH, V88, P188, DOI 10.1093/bja/88.2.188; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Inamasu J, 2010, WORLD NEUROSURG, V74, P120, DOI 10.1016/j.wneu.2010.02.065; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; Jiang JY, 2006, J CEREBR BLOOD F MET, V26, P771, DOI 10.1038/sj.jcbfm.9600253; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kramer C, 2012, NEUROLOGIST, V18, P173, DOI 10.1097/NRL.0b013e318253f8ef; Lei J, 2015, CONTEMP CLIN TRIALS, V40, P9, DOI 10.1016/j.cct.2014.11.008; LUND LO, 1965, ANESTHESIOLOGY, V26, P45, DOI 10.1097/00000542-196501000-00008; LUNDBERG N, 1965, J NEUROSURG, V22, P581, DOI 10.3171/jns.1965.22.6.0581; Maekawa T, 2015, J NEUROTRAUM, V32, P422, DOI 10.1089/neu.2013.3197; Marion D, 2009, J NEUROTRAUM, V26, P455, DOI 10.1089/neu.2008.0582; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1993, J NEUROSURG, V79, P354, DOI 10.3171/jns.1993.79.3.0354; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, pS186, DOI 10.1097/CCM.0b013e3181aa5241; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Puccio AM, 2009, NEUROCRIT CARE, V11, P82, DOI 10.1007/s12028-009-9213-0; Qiu W, 2007, J CRIT CARE, V22, P229, DOI 10.1016/j.jcrc.2006.06.011; ROSOMOFF HL, 1959, J NEUROSURG, V16, P177, DOI 10.3171/jns.1959.16.2.0177; Sadaka F, 2012, BRAIN INJURY, V26, P899, DOI 10.3109/02699052.2012.661120; Sakurai A, 2012, J NEUROTRAUM, V29, P313, DOI 10.1089/neu.2011.2152; Sandestig A, 2014, THER HYPOTHERMIA TEM, V4, P10, DOI 10.1089/ther.2013.0024; Saxena M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006811.pub2; Schreckinger M, 2009, NEUROCRIT CARE, V11, P427, DOI 10.1007/s12028-009-9256-2; SEDZIMIR CB, 1959, J NEUROSURG, V16, P407, DOI 10.3171/jns.1959.16.4.0407; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Shiozaki T, 2001, J NEUROSURG, V94, P50, DOI 10.3171/jns.2001.94.1.0050; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; SYDENHAM E, 2009, COCHRANE DATABASE SY; Thompson Hilaire J, 2010, J Trauma Nurs, V17, P173, DOI 10.1097/JTN.0b013e3181ff272e; Tokutomi T, 2003, NEUROSURGERY, V52, P102, DOI 10.1097/00006123-200301000-00013; Urbano LA, 2012, CURR NEUROL NEUROSCI, V12, P580, DOI 10.1007/s11910-012-0304-5	61	18	19	2	16	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	OCT	2016	27	4					489	+		10.1016/j.nec.2016.05.004			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DY9SQ	WOS:000385475800010	27637398				2022-02-06	
J	Kroll, MW; Adamec, J; Wetli, CV; Williams, HE				Kroll, Mark W.; Adamec, Jiri; Wetli, Charles V.; Williams, Howard E.			Fatal traumatic brain injury with electrical weapon falls	JOURNAL OF FORENSIC AND LEGAL MEDICINE			English	Article						TASER; Arrest-related-death; Traumatic brain injury; Falls; Electrical weapons; CEW; ECD	SUDDEN CARDIAC-ARREST; POLICE USE; VENTRICULAR-FIBRILLATION; DEATH; TASER; RESTRAINT; DEVICES; BIOMECHANICS; CUSTODY; SAFETY	Introduction: While generally reducing morbidity and mortality, electrical weapons have risks associated with their usage, including eye injuries and falls. With sufficient probe spread, an uncontrolled fall to the ground typically occurs along with the possibility of a fatal brain injury. Methods: We analyzed possible risk factors including running and elevated surfaces with established head-injury criteria to estimate the risk of brain injury. We searched for cases of arrest-related or incustody death, with TASER (R) electrical weapon usage where fall-induced injuries might have contributed to the death. We found 24 cases meeting our initial inclusion criteria of a fatal fall involving electronic control. We then excluded 5 cases as intentional jumps, leaving 19 cases of forced falls. Autopsy reports and other records were analyzed to determine which of these deaths were from brain injury caused by the fall. Results: We found 16 probable cases of fatal brain injuries induced by electronic control from electrical weapons. Out of 3 million field uses, this gives a risk of 5.3 +/- 2.6 PPM which is higher than the theoretical risk of electrocution. The mean age was 46 +/- 14 years which is significantly greater that the age of the typical ARD (36 +/- 10). Probe shots to the subject's back may present a higher risk of a fatal fall. Conclusions: The use of electronic control presents a small but real risk of death from fatal traumatic brain injury. Increased age represents an independent risk factor for such fatalities. (C) 2016 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.	[Kroll, Mark W.] Univ Minnesota, Calif Polytech Inst, Dept Biomed Engn, Minneapolis, MN 55455 USA; [Adamec, Jiri] LMU, Inst Legal Med, Munich, Germany; [Williams, Howard E.] Texas State Univ, Sch Criminal Justice, San Marcos, TX USA		Kroll, MW (corresponding author), Box 23, Crystal Bay, MN 55323 USA.	mark@kroll.name; Jiri.Adamec@med.uni-muenchen.de; charlesvwetli@gmail.com; howardewilliams@msn.com		Kroll, Mark/0000-0001-7716-1716	TASER corporate and scientific advisory board	MWK & CVW have been expert witnesses in law-enforcement litigation. MWK is a member of the TASER corporate and scientific advisory board who partially funded this work. HEW is a retired Police Chief.	Adler A., 2013, MODERN INSTRUMENTATI, V2, P7; Advani S, 1975, P INT C BIOM SER TRA, P153; Allsop DL, 1991, 01487191 SAE; [Anonymous], 2006, 60335276 IEC; Bozeman WP, 2009, ANN EMERG MED, V53, P480, DOI 10.1016/j.annemergmed.2008.11.021; Brewer JKM, 2009, TASER CONDUCTED ELEC; C Mumola, 2011, BUREAU JUSTICE STAT; Cormier Joseph, 2010, Ann Adv Automot Med, V54, P3; Criscione JC, 2014, FORENSIC SCI MED PAT, V10, P203, DOI 10.1007/s12024-014-9551-x; Eastman AL, 2008, J TRAUMA, V64, P1567, DOI 10.1097/TA.0b013e31817113b9; Ferdik FV, 2014, POLICE Q, V17, P328, DOI 10.1177/1098611114548098; Fox AW, 2012, FORENSIC SCI INT, V223, P261, DOI 10.1016/j.forsciint.2012.09.016; Freeman MD, 2014, J FORENSIC LEG MED, V21, P64, DOI 10.1016/j.jflm.2013.08.005; Hajiaghamemar M, 2015, ANN BIOMED ENG, P1; Hall C, 2015, J FORENSIC LEG MED, V31, P29, DOI 10.1016/j.jflm.2014.12.007; Hamel A, 2013, INT J LEGAL MED, V127, P111, DOI 10.1007/s00414-011-0627-9; Hickman M.J., 2008, CRIMINOL PUBLIC POL, V7, P563, DOI DOI 10.1111/J.1745-9133.2008.00528.X; Ho J, 2012, FORENSIC SCI MED PAT, V8, P358, DOI 10.1007/s12024-012-9346-x; Ho JD, 2009, WEST J EMERG MED, V10, P68; Ideker RE, 2007, AM J FOREN MED PATH, V28, P195, DOI 10.1097/PAF.0b013e31803179a9; IEEE, 2011, IEEE ENG MED BIO, P255, DOI 10.1109/IEMBS.2011.6090049; Kim PJ, 2005, NEW ENGL J MED, V353, P958, DOI 10.1056/NEJMc051625; Kroll MW, 2014, CIRCULATION, V129, P93, DOI 10.1161/CIRCULATIONAHA.113.004401; Kroll MW, 2011, IEEE ENG MED BIO, P271, DOI 10.1109/IEMBS.2011.6090053; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; MacDonald JM, 2009, AM J PUBLIC HEALTH, V99, P2268, DOI 10.2105/AJPH.2009.159616; Mallory Ann, 2010, Ann Adv Automot Med, V54, P51; Mangus BE, 2008, AM SURGEON, V74, P862; Meyer G., 2009, POLICEONE        NOV, P9; Nahum A. M., 1968, SAE TECHNICAL PAPER; Naunheim RS, 2010, EMERG MED J, V27, P645, DOI 10.1136/emj.2009.088468; Nimunkar AJ, 2009, PHYSIOL MEAS, V30, P101, DOI 10.1088/0967-3334/30/1/007; Nyquist G.W, 1986, SAE TECHNICAL PAPER; Panescu D, 2013, IEEE ENG MED BIO, P5342, DOI 10.1109/EMBC.2013.6610756; Pollanen MS, 1998, CAN MED ASSOC J, V158, P1603; Schneider DC., 1972, SAE TECHNICAL PAPER; Schwarz ES, 2009, AM J EMERG MED, V27; Southall Pamela, 2008, J Forensic Leg Med, V15, P227, DOI 10.1016/j.jflm.2007.10.005; STRATTON SJ, 1995, ANN EMERG MED, V25, P710, DOI 10.1016/S0196-0644(95)70187-7; Strote J, 2006, PREHOSP EMERG CARE, V10, P447, DOI 10.1080/10903120600884863; Swerdlow CD, 2009, ACAD EMERG MED, V16, P726, DOI 10.1111/j.1553-2712.2009.00432.x; Taylor B, 2010, POLICE Q, V13, P260, DOI 10.1177/1098611110373994; Thierauf A, 2010, FORENSIC SCI INT, V198, P92, DOI 10.1016/j.forsciint.2010.01.010; YOGANANDAN N, 1995, J NEUROTRAUM, V12, P659, DOI 10.1089/neu.1995.12.659; Yoganandan N, 2004, CLIN BIOMECH, V19, P225, DOI 10.1016/j.clinbiomech.2003.12.014; Zipes DP, 2012, CIRCULATION, V125, P2417, DOI 10.1161/CIRCULATIONAHA.112.097584	46	18	18	0	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1752-928X	1532-2009		J FORENSIC LEG MED	J. Forensic Leg. Med.	OCT	2016	43						12	19		10.1016/j.jflm.2016.07.001			8	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	EE3SB	WOS:000389516900003	27423132				2022-02-06	
J	Salas, CE; Castro, O; Yuen, KSL; Radovic, D; d'Avossa, G; Turnbull, OH				Salas, Christian E.; Castro, Osvaldo; Yuen, Kenneth S. L.; Radovic, Darinka; d'Avossa, Giovanni; Turnbull, Oliver H.			'Just can't hide it': a behavioral and lesion study on emotional response modulation after right prefrontal damage	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						response modulation; suppression; emotion; emotion regulation; prefrontal cortex; insula; brain injury	TRAUMATIC BRAIN-INJURY; EXECUTIVE FUNCTIONS; INDIVIDUAL-DIFFERENCES; COGNITIVE CONTROL; DECISION-MAKING; DUCHENNE SMILE; FRONTAL LOBES; NEURAL BASIS; INHIBITION; CORTEX	Introduction: Historically, emotion regulation problems have been reported as a common consequence of right prefrontal cortex (rPFC) damage. It has been proposed that the rPFC, particularly the rIFG, has a key role inhibiting prepotent reflexive actions, thus contributing to emotion regulation and self-regulation. This study is the first to directly explore this hypothesis, by testing whether damage to the rIFG compromises the voluntary modulation of emotional responses, and whether performance on inhibition tasks is associated with emotion regulation. Method: 10 individuals with unilateral right prefrontal damage and 15 matched healthy controls were compared on a well-known response modulation task. During the task participants had to amplify and suppress their facial emotional expressions, while watching film clips eliciting amusement. Measures of executive control, emotion regulation strategies usage and symptomatology were also collected. Results: As a group, individuals with rPFC damage presented a significantly reduced range of response modulation compared with controls. In addition, performance in the suppression task was associated with measures of cognitive inhibition and suppression usage. Interestingly, these effects were driven primarily by a subgroup of individuals with rPFC damage, all of whom also had damage to the right posterior insula, and who presented a marked impairment in suppressing facial emotional expressions	[Salas, Christian E.] Univ Diego Portales, Fac Psicol, Lab Neurociencia Cognit & Social LaNCyS, Vergara 275, Santiago, Chile; [Salas, Christian E.; d'Avossa, Giovanni; Turnbull, Oliver H.] Bangor Univ, Sch Psychol, Brigantia Bldg, Bangor LL57 2AS, Gwynedd, Wales; [Castro, Osvaldo] Univ Autonoma Chile, Escuela Terapia Ocupac, San Miguel 3369, Santiago, Chile; [Yuen, Kenneth S. L.] Johannes Gutenberg Univ Mainz, Med Ctr, Neuroimaging Ctr, EG, Langenbeckstr 1 Geb 701,R 0-035, D-55131 Mainz, Germany; [Radovic, Darinka] Univ Manchester, Manchester M13 9PL, Lancs, England		Salas, CE (corresponding author), Withington Methodist Church, Head Forward Ctr, 439 Wimslow Rd, Manchester M20 4AN, Withington, England.	salasriquelme@gmail.com			CONICYT -Chile-Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT); NEUROPSYCHOANALYSIS FOUNDATION	This research has been funded by CONICYT -Chile- and the NEUROPSYCHOANALYSIS FOUNDATION.	Abreau B. C., 2009, LIFE BALANCE MULTIDI, P223; Ambadar Z, 2009, J NONVERBAL BEHAV, V33, P17, DOI 10.1007/s10919-008-0059-5; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Aron AR, 2004, BRAIN, V127, P1561, DOI 10.1093/brain/awh169; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barrash J., 2011, J CLIN EXPT NEUROPSY, V33, P1; Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Beer J. S., 2007, HDB EMOTION REGULATI; Benson D.F., 1986, FRONTAL LOBES; Bowen C., 2010, RELATIONAL APPROACH; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2007, J NEUROPHYSIOL, V98, P3638, DOI 10.1152/jn.00685.2007; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Coan J. A., 2007, HDB EMOTION ELICITAT, P267; Craig AD., 2008, HDB EMOTION, P272; Cummings JL, 1997, BRAIN LANG, V57, P22, DOI 10.1006/brln.1997.1832; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demaree HA, 2004, COGNITION EMOTION, V18, P1079, DOI 10.1080/02699930441000085; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Dillon DG, 2007, APPL PREV PSYCHOL, V12, P99, DOI 10.1016/j.appsy.2007.09.004; DREWE E A, 1975, Cortex, V11, P8; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; EKMAN P, 1982, J NONVERBAL BEHAV, V6, P238, DOI 10.1007/BF00987191; EKMAN P, 1990, J PERS SOC PSYCHOL, V58, P342, DOI 10.1037/0022-3514.58.2.342; Ekman P., 2002, FACIAL ACTION CODING; Feinberg TE, 2011, CONSCIOUS COGN, V20, P75, DOI 10.1016/j.concog.2010.09.017; Feinberg TE, 2010, J NEUROL NEUROSUR PS, V81, P276, DOI 10.1136/jnnp.2009.188946; Forstmann BU, 2008, J NEUROSCI, V28, P9790, DOI 10.1523/JNEUROSCI.1465-08.2008; FRANK MG, 1993, J PERS SOC PSYCHOL, V64, P83, DOI 10.1037/0022-3514.64.1.83; Gable SL, 2004, J PERS SOC PSYCHOL, V87, P228, DOI 10.1037/0022-3514.87.2.228; Giuliani NR, 2011, NEUROIMAGE, V58, P10, DOI 10.1016/j.neuroimage.2011.06.028; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goodkind MS, 2010, PSYCHOL AGING, V25, P30, DOI 10.1037/a0018519; Gross J. J., 2014, HDB EMOTION REGULATI; Gross JJ, 1999, COGNITION EMOTION, V13, P551, DOI 10.1080/026999399379186; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Gross JJ, 1997, J ABNORM PSYCHOL, V106, P95, DOI 10.1037/0021-843X.106.1.95; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Gross JJ., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Gyurak A, 2009, COGN AFFECT BEHAV NE, V9, P144, DOI 10.3758/CABN.9.2.144; Hayes JP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00230; Henry JD, 2009, PSYCHOL AGING, V24, P252, DOI 10.1037/a0014001; Hewig J, 2005, COGNITION EMOTION, V19, P1095, DOI 10.1080/02699930541000084; Hilz MJ, 2006, BRAIN, V129, P3343, DOI 10.1093/brain/awl299; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; KELTNER D, 1995, J PERS SOC PSYCHOL, V68, P441, DOI 10.1037/0022-3514.68.3.441; Kuhn S., 2011, PLOS ONE, V6, P4; Lee TW, 2008, CEREB CORTEX, V18, P104, DOI 10.1093/cercor/bhm035; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; Levy BJ, 2011, ANN NY ACAD SCI, V1224, P40, DOI 10.1111/j.1749-6632.2011.05958.x; Lewis MD, 2006, J COGNITIVE NEUROSCI, V18, P430, DOI 10.1162/jocn.2006.18.3.430; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Manes F, 2002, BRAIN, V125, P624, DOI 10.1093/brain/awf049; McDonald S, 2010, J CLIN EXP NEUROPSYC, V32, P855, DOI 10.1080/13803391003596405; Niven K, 2009, EMOTION, V9, P498, DOI 10.1037/a0015962; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Quirk G. J., 2007, HDB EMOTION REGULATI, P27; Robertson I., 1994, TEST EVERYDAY ATTENT; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rottenberg J, 2002, EMOTION, V2, P135, DOI 10.1037//1528-3542.2.2.135; ROVNER BW, 1987, HOSP PRACT, V22, P99; Royzman EB, 2006, EMOTION, V6, P82, DOI 10.1037/1528-3542.6.1.82; Rubia K, 2003, NEUROIMAGE, V20, P351, DOI 10.1016/S1053-8119(03)00275-1; Salas C. E., 2012, NEUROPSYCHOANALYSIS, V14, P77, DOI DOI 10.1080/15294145.2012.10773691; Salas CE, 2014, REV CHIL NEUROPSICOL, V9, P38, DOI 10.5839/rcnp.2014.0901E.07; Salas CE, 2014, B MENNINGER CLIN, V78, P301, DOI 10.1521/bumc.2014.78.4.301; Salas CE, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00242; Salas CE, 2013, NEUROPSYCHOL REHABIL, V23, P467, DOI 10.1080/09602011.2013.784709; Salas CE, 2012, EMOTION, V12, P568, DOI 10.1037/a0025811; Shallice T., 1988, NEUROPSYCHOLOGY MENT; Simmons WK, 2013, HUM BRAIN MAPP, V34, P2944, DOI 10.1002/hbm.22113; Simons G, 2003, COGNITION EMOTION, V17, P759, DOI 10.1080/02699930302280; Smith RH, 1996, PERS SOC PSYCHOL B, V22, P158, DOI 10.1177/0146167296222005; Soussignan R, 2002, EMOTION, V2, P52, DOI 10.1037/1528-3542.2.1.52; STERN RA, 1994, CLIN NEUROPSYCHOL, V8, P309, DOI 10.1080/13854049408404137; Stuss DT, 2000, AFFECTIVE MINDS, P13; Stuss DT, 2000, MEMORY, CONSCIOUSNESS, AND THE BRAIN, P215; Stuss DT, 2000, PSYCHOL RES-PSYCH FO, V63, P289, DOI 10.1007/s004269900007; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Thayer JF, 2000, J AFFECT DISORDERS, V61, P201, DOI 10.1016/S0165-0327(00)00338-4; Tranel D, 2002, CORTEX, V38, P589, DOI 10.1016/S0010-9452(08)70024-8; van Dijk WW, 2011, COGNITION EMOTION, V25, P360, DOI 10.1080/02699931.2010.487365; Watson D., 1994, PANAS X MANUAL POSIT; WESCHLER D, 1981, WESCHLER ADULT INTEL; Weschler D. A., 1987, WECHSLER MEMORY SCAL; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	94	18	19	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	OCT	2016	11	10					1528	1540		10.1093/scan/nsw075			13	Neurosciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	ED6BR	WOS:000388939700003	27317928	Green Submitted, Green Published, hybrid			2022-02-06	
J	Abboud, A; Mi, Q; Puccio, A; Okonkwo, D; Bulige, M; Constantine, G; Vodovotz, Y				Abboud, Andrew; Mi, Qi; Puccio, Ava; Okonkwo, David; Bulige, Marius; Constantine, Gregory; Vodovotz, Yoram			Inflammation Following Traumatic Brain Injury in Humans: Insights from Data-Driven and Mechanistic Models into Survival and Death	FRONTIERS IN PHARMACOLOGY			English	Article						inflammation; TBI outcome; mathematical modeling; data-driven modeling; mortality; inflammatory mediators in CNS	REDUCED MATHEMATICAL-MODEL; IN-SILICO; CEREBROSPINAL-FLUID; SYSTEMS BIOLOGY; BLUNT TRAUMA; VIVO; INTERLEUKIN-10; DYNAMICS; STATES; MICE	Inflammation induced by traumatic brain injury (TBI) is a complex mediator of morbidity and mortality. We have previously demonstrated the utility of both data-driven and mechanistic models in settings of traumatic injury. We hypothesized that differential dynamic inflammation programs characterize TBI survivors vs. non-survivors, and sought to leverage computational modeling to derive novel insights into this life/death bifurcation. Thirteen inflammatory cytokines and chemokines were determined using Luminex (TM) in serial cerebrospinal fluid (CSF) samples from 31 TBI patients over 5 days. In this cohort, 5 were non-survivors (Glasgow Outcome Scale EGOS] score = 1) and 26 were survivors (GOS > 1). A Pearson correlation analysis of initial injury (Glasgow Coma Scale [GCS]) vs. GOS suggested that survivors and non survivors had distinct clinical response trajectories to injury. Statistically significant differences in interleukin (IL)-4, IL-5, IL-6, IL-8, IL-13, and tumor necrosis factor-alpha (INF-alpha) were observed between TBI survivors vs. non-survivors over 5 days. Principal Component Analysis and Dynamic Bayesian Network inference suggested differential roles of chemokines, INF-alpha, IL-6, and IL-10, based upon which an ordinary differential equation model of TBI was generated. This model was calibrated separately to the time course data of TBI survivors vs. non-survivors as a function of initial GCS. Analysis of parameter values in ensembles of simulations from these models suggested differences in microglial and damage responses in TBI survivors vs. non-survivors. These studies suggest the utility of combined data-driven and mechanistic models in the context of human TBI.	[Abboud, Andrew; Vodovotz, Yoram] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA; [Mi, Qi] Univ Pittsburgh, Dept Sports Med & Nutr, Pittsburgh, PA USA; [Mi, Qi; Constantine, Gregory; Vodovotz, Yoram] Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA; [Puccio, Ava; Okonkwo, David] Univ Pittsburgh, Dept Neurol Surg, Pittsburgh, PA 15260 USA; [Bulige, Marius] Univ Pittsburgh, Dept Math, Bradford, PA USA; [Constantine, Gregory] Univ Pittsburgh, Dept Math, Pittsburgh, PA USA; [Constantine, Gregory] Univ Pittsburgh, Dept Stat, Pittsburgh, PA USA		Vodovotz, Y (corresponding author), Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15260 USA.; Vodovotz, Y (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Inflammat & Regenerat Modeling, Pittsburgh, PA 15260 USA.	vodovotzy@upmc.edu		Abboud, Andrew/0000-0003-1527-1535	Commonwealth of Pennsylvania grant SAP [4100068505]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50GM53789]; Walter Copeland Fund of the Pittsburgh Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P50GM053789] Funding Source: NIH RePORTER	This work was supported in part by Commonwealth of Pennsylvania grant SAP#4100068505 and by National Institutes of Health grant P50GM53789 to YV, and the Walter Copeland Fund of the Pittsburgh Foundation to AP.	Abboud A, 2016, CRIT CARE MED, V44, pE1074, DOI 10.1097/CCM.0000000000001951; Almahmoud K, 2015, SHOCK, V44, P101, DOI 10.1097/SHK.0000000000000395; Almahmoud K, 2015, CRIT CARE MED, V43, P1395, DOI 10.1097/CCM.0000000000000964; An G, 2012, INT J BURNS TRAUMA, V2, P1; Azhar N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078202; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Brown D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3636; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Daun S, 2008, J THEOR BIOL, V253, P843, DOI 10.1016/j.jtbi.2008.04.033; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Day J, 2006, J THEOR BIOL, V242, P237, DOI 10.1016/j.jtbi.2006.02.015; Eungdamrong NJ, 2004, BIOL CELL, V96, P355, DOI 10.1016/j.biolcel.2004.03.004; Ferrell JE, 2013, CURR OPIN CELL BIOL, V25, P676, DOI 10.1016/j.ceb.2013.07.007; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Kumar R, 2004, J THEOR BIOL, V230, P145, DOI 10.1016/j.jtbi.2004.04.044; Kumar R, 2008, SHOCK, V29, P104, DOI 10.1097/SHK.0b013e318067da56; Li NYK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002789; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; Mi Q, 2007, WOUND REPAIR REGEN, V15, P671, DOI 10.1111/j.1524-475X.2007.00271.x; Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; Namas RA, 2016, J CRIT CARE, V36, P146, DOI 10.1016/j.jcrc.2016.07.002; Namas RA, 2015, ANTIOXID REDOX SIGN, V23, P1370, DOI 10.1089/ars.2015.6398; Namas RA, 2016, ANN SURG, V263, P191, DOI 10.1097/SLA.0000000000001001; Namas RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067419; Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106; Nieman G, 2012, CRIT CARE MED, V40, P1052, DOI 10.1097/CCM.0b013e31823e986a; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Prince JM, 2006, MOL MED, V12, P88, DOI 10.2119/2006-00012.Prince; Reynolds A, 2006, J THEOR BIOL, V242, P220, DOI 10.1016/j.jtbi.2006.02.016; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Starzl R, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00587; Torres A, 2009, SHOCK, V32, P172, DOI 10.1097/SHK.0b013e318193cc2b; Vasudeva K, 2015, J NEUROIMMUNOL, V283, P43, DOI 10.1016/j.jneuroim.2015.04.012; Vodovotz, 2014, TRANSLATIONAL SYSTEM; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zaaqoq AM, 2014, CRIT CARE MED, V42, P1487, DOI 10.1097/CCM.0000000000000248	40	18	18	0	3	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1663-9812			FRONT PHARMACOL	Front. Pharmacol.	SEP 27	2016	7								342	10.3389/fphar.2016.00342			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DX3FG	WOS:000384258300001	27729864	Green Published, gold			2022-02-06	
J	Breedlove, KM; Breedlove, EL; Bowman, TG; Nauman, EA				Breedlove, Katherine M.; Breedlove, Evan L.; Bowman, Thomas G.; Nauman, Eric A.			Impact attenuation capabilities of football and lacrosse helmets	JOURNAL OF BIOMECHANICS			English	Article						Protective equipment; Gadd severity index; Head impact; Drop test; Helmet evaluation	AMERICAN FOOTBALL; HEAD IMPACT; CONCUSSION; PLAYERS; ACCELERATION; EPIDEMIOLOGY; BIOMECHANICS; INJURIES; BOYS; MASS	Although the National Operating Committee on Standards for Athletic Equipment (NOCSAE) standards are similar for football and lacrosse helmets, it remains unknown how helmets for each sport compare on drop tests. Due to the increased concern over head injury in sport and the rapid growth in lacrosse participation, it is useful to compare the performance of various football and lacrosse helmets. Therefore, the goal of this study was to document the impact attenuation properties of football and lacrosse helmets and to identify the relative performance between helmets for the two sports. Six models of football and six models of lacrosse helmets were tested using a drop tower at three prescribed velocities and six locations on the helmets. A repeated measures ANOVA was conducted to determine the effect of sport on Gadd Severity Index (GSI) scores and linear accelerations. The interaction between location and sport was significant at the low (F-2.64,F-89.71=7.68, P<.001, eta(2)=.025), medium (F-2.85,F-98.85=16.78, P<.001, eta(2)=.085), and high (F-2.96,F-100.69=16.67, P<.001, eta(2)=.093) velocities for GSI scores. When comparing peak acceleration results, we found a significant interaction between location and sport for the medium (F-3.40,F-115.616=5.57, P=.001, omega(2)=.031) and high (F-3.46,F-117.50=6.42, P<.001, omega(2)=.047) velocities. Features of football helmet design provide superior protection compared to lacrosse helmets. Further investigation of helmet design features across sports will yield insight into how design features influence helmet performance during laboratory testing. (C) 2016 Elsevier Ltd. All rights reserved.	[Breedlove, Katherine M.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA; [Bowman, Thomas G.] Lynchburg Coll, Dept Athlet Training, Lynchburg, VA 24501 USA; [Nauman, Eric A.] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Nauman, Eric A.] Purdue Univ, Dept Basic Med Sci, W Lafayette, IN 47907 USA		Nauman, EA (corresponding author), Purdue Univ, Sch Mech Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.	enauman@purdue.edu	Bowman, Thomas/AAA-3036-2020; Bowman, Tom/AAU-6473-2020	Bowman, Thomas/0000-0002-0034-2946; 	Indiana State Department of Health Spinal Cord and Brain Injury Research Fund; Indiana Clinical and Translational Sciences Institute, Purdue's Office of the Vice President for Research; Lynchburg College; National Science Foundation Graduate Research FellowshipNational Science Foundation (NSF) [DGE-1333468]	This work was supported in part by grants from the Indiana State Department of Health Spinal Cord and Brain Injury Research Fund, a Core Facility Grant from the Indiana Clinical and Translational Sciences Institute, Purdue's Office of the Vice President for Research, and a faculty development grant from Lynchburg College. This material is also based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1333468. Xenith helmets were provided by Xenith, Inc. We would like to thank the Lynchburg College men's lacrosse program for donating the used helmets tested in the current study. In addition, we thank Jay Hertel, Ph.D., ATC, FNATA, FACSM for his assistance with the statistical approach to data analysis.	Bachynski KE, 2014, J LAW MED ETHICS, V42, P323, DOI 10.1111/jlme.12149; Bartsch A, 2012, J NEUROSURG, V116, P222, DOI 10.3171/2011.9.JNS111059; BISHOP PJ, 1984, AM J SPORT MED, V12, P233, DOI 10.1177/036354658401200313; Bower D.T., 2016, J ATHL TRAI IN PRESS; Bowman TG, 2015, J BIOMECH, V48, P3782, DOI 10.1016/j.jbiomech.2015.08.026; Breedlove E.L., 2013, FAILED CASCADE HELME; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Caswell SV, 2002, J ATHL TRAINING, V37, P164; Dick R, 2007, J ATHL TRAINING, V42, P255; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gadd C. W., 1966, P 10 STAPP CAR CRASH; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Higgins M.J., 2015, J ATHL TRAINING, V50, pS; Hillman K, 2005, INTRO ATHLETIC TRAIN; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hutchinson TP, 2014, EUR J SPORT SCI, V14, pS377, DOI 10.1080/17461391.2012.705334; Koehling E.M., 2015, J ATHL TRAINING, V50, pS; Levy ML, 2004, NEUROSURGERY, V55, P656, DOI 10.1227/01.NEU.0000134599.01917.AA; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; MARTIN RB, 1994, J BIOMECH, V27, P361, DOI 10.1016/0021-9290(94)90011-6; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; NCAA,, 2013, NCAA SPORTS SPONS PA; Newman J.A., 2015, DESIGN TESTING SPORT, P755; NOCSAE, 2013, DOCND00213M13 NOCSAE; NOCSAE, 2013, DOCND00111M13 NOCSAE; NOCSAE,, 2011, DOCND04204M11A NOCSA; NOCSAE, 2006, DOCND80104M04 NOCSAE; NOCSAE, 2012, DOCND04111M12 NOCSAE; O'Day K.M., 2015, J ATHL TRAINING, V50, pS242; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Post A, 2013, MATER DESIGN, V45, P653, DOI 10.1016/j.matdes.2012.09.017; Rowson S, 2011, ANN BIOMED ENG, V39, P2130, DOI 10.1007/s10439-011-0322-5; Scher I., 2008, J ASTM INT, V5, P1; STX, RES REC NOCSAE STAND; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Vollavanh L.R., 2015, J ATHL TRAINING, V50, pS	38	18	18	0	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	SEP 6	2016	49	13					2838	2844		10.1016/j.jbiomech.2016.06.030			7	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DY9RH	WOS:000385472300037	27416777	Bronze			2022-02-06	
J	Myers, RB; Lazaridis, C; Jermaine, CM; Robertson, CS; Rusin, CG				Myers, Risa B.; Lazaridis, Christos; Jermaine, Christopher M.; Robertson, Claudia S.; Rusin, Craig G.			Predicting Intracranial Pressure and Brain Tissue Oxygen Crises in Patients With Severe Traumatic Brain Injury	CRITICAL CARE MEDICINE			English	Article						brain tissue hypoxia; forecasting; data mining; intracranial pressure; neuromonitoring; prediction algorithm; traumatic brain injury	CARE	Objectives: To develop computer algorithms that can recognize physiologic patterns in traumatic brain injury patients that occur in advance of intracranial pressure and partial brain tissue oxygenation crises. The automated early detection of crisis precursors can provide clinicians with time to intervene in order to prevent or mitigate secondary brain injury. Design: A retrospective study was conducted from prospectively collected physiologic data. intracranial pressure, and partial brain tissue oxygenation crisis events were defined as intracranial pressure of greater than or equal to 20 mm Hg lasting at least 15 minutes and partial brain tissue oxygenation value of less than 10 mm Hg for at least 10 minutes, respectively. The physiologic data preceding each crisis event were used to identify precursors associated with crisis onset. Multivariate classification models were applied to recorded data in 30-minute epochs of time to predict crises between 15 and 360 minutes in the future. Setting: The neurosurgical unit of Ben Taub Hospital (Houston, TX). Subjects: Our cohort consisted of 817 subjects with severe traumatic brain injury. Measurements and Main Results: Our algorithm can predict the onset of intracranial pressure crises with 30-minute advance warning with an area under the receiver operating characteristic curve of 0.86 using only intracranial pressure measurements and time since last crisis. An analogous algorithm can predict the start of partial brain tissue oxygenation crises with 30-minute advanced warning with an area under the receiver operating characteristic curve of 0.91. Conclusions: Our algorithms provide accurate and timely predictions of intracranial hypertension and tissue hypoxia crises in patients with severe traumatic brain injury. Almost all of the information needed to predict the onset of these events is contained within the signal of interest and the time since last crisis.	[Myers, Risa B.; Jermaine, Christopher M.] Rice Univ, Dept Comp Sci, Houston, TX USA; [Lazaridis, Christos] Baylor Coll Med, Dept Neurol, Div Neurocrit Care, Houston, TX 77030 USA; [Robertson, Claudia S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Rusin, Craig G.] Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA		Rusin, CG (corresponding author), Baylor Coll Med, Dept Pediat, Cardiol Sect, Houston, TX 77030 USA.	crusin@bcm.edu		Rusin, Craig/0000-0003-3812-8133	Keck Center of the Gulf Coast Consortia, on Rice University's NLM Training Program in Biomedical Informatics [T15LM007093]; NSFNational Science Foundation (NSF) [0964526]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Science FoundationNational Science Foundation (NSF); NIH, National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM); US National Science FoundationNational Science Foundation (NSF); NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [T15LM007093] Funding Source: NIH RePORTER	Supported, in part, by a training fellowship from the Keck Center of the Gulf Coast Consortia, on Rice University's NLM Training Program in Biomedical Informatics (grant number T15LM007093) and by the NSF under grant number 0964526.; Dr. Myers received support for article research from the National Institutes of Health (NIH) and the National Science Foundation. Her institution received funding from the NIH, National Library of Medicine, and from the National Science Foundation. She received supported, in part, by the Keck Center of the Gulf Coast Consortia, on Rice University's NLM Training Program in Biomedical Informatics (grant T15LM007093) and by the NSF (grant 0964526). Dr. Jermaine received support for article research from the US National Science Foundation. His institution received funding from the US National Science Foundation. Dr. Rusin is a co-founder of Medical Informatics; however, MIC has no interests in this work. All other authors report no conflicts of interest. The remaining authors have disclosed that they do not have any potential conflicts of interest.	ALLEN R, 1983, J BIOMED ENG, V5, P103, DOI 10.1016/0141-5425(83)90027-4; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Buchman TG, 2009, CRIT CARE MED, V37, P1167, DOI 10.1097/CCM.0b013e3181987bbc; Efron B., 1994, INTRO BOOTSTRAP; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Hemphill JC, 2011, NAT REV NEUROL, V7, P451, DOI 10.1038/nrneurol.2011.101; JENNETT B, 1975, LANCET, V1, P480; Koknar-Tezel S, 2009, DAT MIN 2009 ICDM 09, P59; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Lewis D.D., 1995, P 18 ANN INT ACM SIG; Mladenic D, 1999, ICML 99 P 16 NEUR CR; Myers R. B., 2015, SOC IND APPL MATH SI; Narotam PK, 2014, J NEUROTRAUM, V31, P630, DOI 10.1089/neu.2013.3104; Stocchetti N, 2014, ACTA NEUROCHIR, V156, P1615, DOI 10.1007/s00701-014-2127-4; Swiercz M, 2000, ACTA NEUROCHIR, V142, P401, DOI 10.1007/s007010050449; Van Rijsbergen CJ., 1979, INFORM RETRIEVAL; Wakeland W, 2009, CRIT CARE MED, V37, P1079, DOI 10.1097/CCM.0b013e31819b629d; Weiss G. M., 2004, SIGKDD EXPLORE, V6, P7, DOI DOI 10.1145/1007730.1007734	19	18	18	2	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	SEP	2016	44	9					1754	1761		10.1097/CCM.0000000000001838			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT8CZ	WOS:000381718000015	27315192	Green Accepted			2022-02-06	
J	Leung, A; Shukla, S; Yang, E; Canlas, B; Kadokana, M; Heald, J; Davani, A; Song, D; Lin, L; Polston, G; Tsai, A; Lee, R				Leung, Albert; Shukla, Shivshil; Yang, Eric; Canlas, Bryan; Kadokana, Mawj; Heald, Jason; Davani, Ariea; Song, David; Lin, Lisa; Polston, Greg; Tsai, Alice; Lee, Roland			Diminished supraspinal pain modulation in patients with mild traumatic brain injury	MOLECULAR PAIN			English	Article						Traumatic brain injury; chronic posttraumatic headaches; pain; functional magnetic resonance imaging; supraspinal pain processing; mild traumatic brain injury; resting state functional connectivity	TRANSCRANIAL MAGNETIC STIMULATION; POSTTRAUMATIC-STRESS-DISORDER; NEEDLE COMBINATION; THERMAL PAIN; MILITARY; HEADACHE; BLAST; MECHANISMS; VETERANS; ELECTROACUPUNCTURE	Background: Chronic pain conditions are highly prevalent in patients with mild traumatic brain injury. Supraspinal diffuse axonal injury is known to dissociate brain functional connectivity in these patients. The effect of this dissociated state on supraspinal pain network is largely unknown. A functional magnetic resonance imaging study was conducted to compare the supraspinal pain network in patients with mild traumatic brain injury to the gender and age-matched healthy controls with the hypothesis that the functional connectivities of the medial prefrontal cortices, a supraspinal pain modulatory region to other pain-related sensory discriminatory and affective regions in the mild traumatic brain injury subjects are significantly reduced in comparison to healthy controls. Results: The mild traumatic brain injury group (N = 15) demonstrated significantly (P < 0.01, cluster threshold > 150 voxels) less activities in the thalamus, pons, anterior cingulate cortex, insula, dorsolateral prefrontal cortex, and medial prefrontal cortices than the healthy control group (N = 15). Granger Causality Analyses (GCA) indicated while the left medial prefrontal cortices of the healthy control group cast a noticeable degree of outward (to affect) causality inference to multiple pain processing related regions, this outward inference pattern was not observed in the mild traumatic brain injury group. On the other hand, only patients' bilateral anterior cingulate cortex received multiple inward (to be affected) causality inferences from regions including the primary and secondary somatosensory cortices and the inferior parietal lobe. Resting state functional connectivity analyses indicated that the medial prefrontal cortices of the mild traumatic brain injury group demonstrated a significantly (P < 0.01, F = 3.6, cluster size > 150 voxels) higher degree of functional connectivity to the inferior parietal lobe, premotor and secondary somatosensory cortex than the controls. Conversely, the anterior cingulate cortex of the healthy group demonstrated significantly (P < 0.01, F = 3.84, cluster size > 150 voxels) less degree of functional connectivities to the inferior parietal lobe and secondary somatosensory cortex than their mild traumatic brain injury counterparts. Conclusions: In short, the current study demonstrates that patients with mild traumatic brain injury and headaches appear to have an altered state of supraspinal modulatory and affective functions related to pain perception.	[Leung, Albert; Shukla, Shivshil; Polston, Greg] Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92161 USA; [Leung, Albert; Shukla, Shivshil; Song, David; Lin, Lisa; Polston, Greg; Tsai, Alice; Lee, Roland] Veteran Adm San Diego Healthcare Syst, San Diego, CA USA; [Yang, Eric; Canlas, Bryan; Kadokana, Mawj] Univ Calif San Diego, San Diego, CA 92103 USA; [Heald, Jason] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA; [Davani, Ariea] St Louis Sch Med, St Louis, MO USA; [Song, David] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Lee, Roland] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA		Leung, A (corresponding author), Univ Calif San Diego, Dept Anesthesiol, San Diego, CA 92161 USA.	ayleung@ucsd.edu			VA Rehabilitation and Research Development Award	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors thank the funding support of VA Rehabilitation and Research Development Award.	Abler B, 2006, MAGN RESON IMAGING, V24, P181, DOI 10.1016/j.mri.2005.10.022; Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2009, J INT NEUROPSYCH SOC, V15, P1, DOI 10.1017/S1355617708090036; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; Bouwense SAW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055460; Caeyenberghs K, 2011, NEUROREHAB NEURAL RE, V25, P492, DOI 10.1177/1545968310394870; Costanzo ME, 2014, NEUROSCI LETT, V577, P11, DOI 10.1016/j.neulet.2014.05.054; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Esposito F, 2005, NEUROIMAGE, V25, P193, DOI 10.1016/j.neuroimage.2004.10.042; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; George MS, 2013, CURR OPIN PSYCHIATR, V26, P13, DOI 10.1097/YCO.0b013e32835ab46d; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Gosselin N, 2012, J NEUROTRAUM, V29, P2625, DOI 10.1089/neu.2012.2312; Hehar H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139842; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Joubert Jacques, 2005, Aust Fam Physician, V34, P621; Koski L, 2015, J NEUROTRAUM, V32, P38, DOI 10.1089/neu.2014.3449; Kriegeskorte N, 2001, NEUROIMAGE, V14, P329, DOI 10.1006/nimg.2001.0831; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lange RT, 2012, J INT NEUROPSYCH SOC, V18, P595, DOI 10.1017/S1355617712000239; Leung A, 2005, J ALTERN COMPLEM MED, V11, P653, DOI 10.1089/acm.2005.11.653; Leung A, 2014, HEADACHE, V54, P57; Leung A, 2001, PAIN, V91, P177, DOI 10.1016/S0304-3959(00)00433-4; Leung A., 2006, NEUROIMAGE, V31, P504; Leung A, 2016, NEUROMODULATION, V19, P133, DOI 10.1111/ner.12364; Leung A, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-23; Leung A, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-18; Leung A, 2007, MED ACUPUNCT, V19, P191, DOI 10.1089/acu.2007.0564; Leung AY, 2008, BMC COMPLEM ALTERN M, V8, DOI 10.1186/1472-6882-8-18; Leung AY, 2005, PAIN, V116, P26, DOI 10.1016/j.pain.2005.03.026; Levin HS, 2011, DEV NEUROPSYCHOL, V36, P273, DOI 10.1080/87565641.2010.549885; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Matos SC, 2015, J NEUROSCI, V35, P13244, DOI 10.1523/JNEUROSCI.0799-15.2015; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Moulton EA, 2012, J NEUROSCI, V32, P6024, DOI 10.1523/JNEUROSCI.0006-12.2012; Neugebauer V, 2009, BRAIN RES REV, V60, P226, DOI 10.1016/j.brainresrev.2008.12.014; Oshiro Y, 2007, J NEUROSCI, V27, P3388, DOI 10.1523/JNEUROSCI.5128-06.2007; Pal D, 2012, CLIN NEUROL NEUROSUR, V114, P564, DOI 10.1016/j.clineuro.2011.12.002; Palacios EM, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-24; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Schmidt-Wilcke T, 2014, NEUROIMAGE-CLIN, V6, P252, DOI 10.1016/j.nicl.2014.09.007; Schmidt-Wilcke T, 2014, PAIN MED, V15, P1346, DOI 10.1111/pme.12460; Seifert F, 2010, NEUROSCIENCE, V170, P670, DOI 10.1016/j.neuroscience.2010.07.024; Shukla S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-45; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Tallus J, 2012, ACTA NEUROL SCAND, V126, P178, DOI 10.1111/j.1600-0404.2011.01623.x; Theeler BJ, 2012, HEADACHE, V52, P732, DOI 10.1111/j.1526-4610.2012.02112.x; Theeler BJ, 2012, CURR TREAT OPTION NE, V14, P36, DOI 10.1007/s11940-011-0157-2; Tracey I, 2005, CURR OPIN NEUROBIOL, V15, P478, DOI 10.1016/j.conb.2005.06.010; Tracey Irene, 2007, Curr Opin Support Palliat Care, V1, P109, DOI 10.1097/SPC.0b013e3282efc58b; Wang S., 2012, NONGCUN JISHU JINGJI, V6, P4, DOI DOI 10.1186/1752-1505-6-4; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc	65	18	18	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA		1744-8069		MOL PAIN	Mol. Pain	AUG 16	2016	12								1744806916662661	10.1177/1744806916662661			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EA2SJ	WOS:000386444700001	27531671	gold, Green Published			2022-02-06	
J	Chatelle, C; Bodien, YG; Carlowicz, C; Wannez, S; Charland-Verville, V; Gosseries, O; Laureys, S; Seel, RT; Giacino, JT				Chatelle, Camille; Bodien, Yelena G.; Carlowicz, Cecilia; Wannez, Sarah; Charland-Verville, Vanessa; Gosseries, Olivia; Laureys, Steven; Seel, Ron T.; Giacino, Joseph T.			Detection and Interpretation of Impossible and Improbable Coma Recovery Scale-Revised Scores	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Brain injuries; Consciousness disorders; Outcome assessment (health care); Rehabilitation	MINIMALLY CONSCIOUS STATE; VEGETATIVE STATE; LEVEL	Objective: To determine the frequency with which specific Coma Recovery Scale-Revised (CRS-R) subscale scores co-occur as a means of providing clinicians and researchers with an empirical method of assessing CRS-R data quality. Design: We retrospectively analyzed CRS-R subscale scores in hospital inpatients diagnosed with disorders of consciousness (DOCs) to identify impossible and improbable subscore combinations as a means of detecting inaccurate and unusual scores. Impossible subscore combinations were based on violations of CRS-R scoring guidelines. To determine improbable subscore combinations, we relied on the Mahalanobis distance, which detects outliers within a distribution of scores. Subscore pairs that were not observed at all in the database (ie, frequency of occurrence = 0%) were also considered improbable. Setting: Specialized DOC program and university hospital. Participants: Patients diagnosed with DOCs (N=1190; coma: n=76, vegetative state: n=464, minimally conscious state: n=586, emerged from minimally conscious state: n=64; 794 men; mean age, 43 +/- 20y; traumatic etiology: n=747; time postinjury, 162 +/- 568d). Interventions: Not applicable. Main Outcome Measure: Impossible and improbable CRS-R subscore combinations. Results: Of the 1190 CRS-R profiles analyzed, 4.7% were excluded because they met scoring criteria for impossible co-occurrence. Among the 1137 remaining profiles, 12.2% (41/336) of possible subscore combinations were classified as improbable. Conclusions: Clinicians and researchers should take steps to ensure the accuracy of CRS-R scores. To minimize the risk of diagnostic error and erroneous research findings, we have identified 9 impossible and 36 improbable CRS-R subscore combinations. The presence of any one of these subscore combinations should trigger additional data quality review. (C) 2016 by the American Congress of Rehabilitation Medicine	[Chatelle, Camille; Bodien, Yelena G.; Carlowicz, Cecilia; Giacino, Joseph T.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Chatelle, Camille; Bodien, Yelena G.; Carlowicz, Cecilia; Giacino, Joseph T.] Harvard Med Sch, Boston, MA USA; [Chatelle, Camille] Massachusetts Gen Hosp, Lab NeuroImaging Coma & Consciousness, 175 Cambridge St,Ste 300, Boston, MA 02114 USA; [Chatelle, Camille; Wannez, Sarah; Charland-Verville, Vanessa; Gosseries, Olivia; Laureys, Steven] Univ Hosp Liege, GIGA Res Ctr, Coma Sci Grp, Liege, Belgium; [Gosseries, Olivia] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA; [Gosseries, Olivia] Univ Wisconsin, Dept Psychiat, Madison, WI 53706 USA; [Seel, Ron T.] Shepherd Ctr, Crawford Res Inst, Atlanta, GA USA		Chatelle, C (corresponding author), Massachusetts Gen Hosp, Lab NeuroImaging Coma & Consciousness, 175 Cambridge St,Ste 300, Boston, MA 02114 USA.	cchatelle@partners.org	Laureys, Steven/A-3349-2011; Giacino, Joseph/AAF-1952-2021; Laureys, Steven/AAN-2097-2021; Gosseries, Olivia/AAB-6469-2020	Giacino, Joseph/0000-0002-7916-9698; Laureys, Steven/0000-0002-3096-3807; Gosseries, Olivia/0000-0001-9011-7496; Chatelle, Camille/0000-0002-7526-2107; Bodien, Yelena/0000-0003-4858-2903	National Institute on Disability, Independent Living, and Rehabilitation Research, Department of Health and Human Services, Administration for Community Living [90DP0039-01-00]; James S. McDonnell Foundation; Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources); Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]; Harvard University and its affiliated academic health care centers; Belgian American Educational Foundation; Wallonie Bruxelles International Concerted Research Action; Belgian Funds for Scientific Research, European CommissionFonds de la Recherche Scientifique - FNRS; European Foundation for Biomedical Research; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMOUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [U48DP000039] Funding Source: NIH RePORTER	Supported by the National Institute on Disability, Independent Living, and Rehabilitation Research, Department of Health and Human Services, Administration for Community Living (grant no. 90DP0039-01-00); The James S. McDonnell Foundation; Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health award no. UL1 TR001102); financial contributions from Harvard University and its affiliated academic health care centers; The Belgian American Educational Foundation; Wallonie Bruxelles International Concerted Research Action; Belgian Funds for Scientific Research, European Commission; and the European Foundation for Biomedical Research.	ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Bodien YG, 2016, ARCH PHYS MED REHAB, V97, P490, DOI 10.1016/j.apmr.2015.08.422; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; La Porta F, 2013, ARCH PHYS MED REHAB, V94, P527, DOI 10.1016/j.apmr.2012.09.035; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lovstad M, 2010, J HEAD TRAUMA REHAB, V25, P349, DOI 10.1097/HTR.0b013e3181cec841; Mahalanobis PC., 1936, P NATL I SCI INDIA, V2, P49; Schnakers C, 2008, BRAIN INJURY, V22, P786, DOI 10.1080/02699050802403557; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seel RT, 2010, ARCH PHYS MED REHAB, V91, P1795, DOI 10.1016/j.apmr.2010.07.218; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169	13	18	20	1	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	AUG	2016	97	8					1295	1300		10.1016/j.apmr.2016.02.009			6	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DT1LM	WOS:000381244200011	26944708	Green Accepted			2022-02-06	
J	Chiang, CC; Guo, SE; Huang, KC; Lee, BO; Fan, JY				Chiang, Chia-Chen; Guo, Su-Er; Huang, Kuo-Chang; Lee, Bih-O; Fan, Jun-Yu			Trajectories and associated factors of quality of life, global outcome, and post-concussion symptoms in the first year following mild traumatic brain injury	QUALITY OF LIFE RESEARCH			English	Article						Quality of life; Global outcome; Post-concussion symptoms; Mild traumatic brain injury; Trajectory	ANALYZING DEVELOPMENTAL TRAJECTORIES; POSTCONCUSSIVE SYMPTOMS; STRUCTURED INTERVIEWS; SCALE; QOLIBRI; WORK; RELIABILITY; PREDICTORS; RETURN	To investigate the associated factors and change trajectories of quality of life (QoL), global outcome, and post-concussion symptoms (PCS) over the first year following mild traumatic brain injury (mTBI). This was a prospective longitudinal study of 100 participants with mTBI from neurosurgical outpatient departments in Chiayi County District Hospitals in Taiwan. The checklist of post-concussion syndromes (CPCS) was used to assess PCS at enrollment and at 1, 3, and 12 months after mTBI; the glasgow outcome scale extended (GOSE), the quality of life after brain injured (QOLIBRI), Chinese version, and the Short Form 36 Health Survey (SF-36), Taiwan version, were used to assess mTBI global outcome and QoL at 1, 3, and 12 months after mTBI. Latent class growth models (LCGMs) indicated the change trajectories of QOLIBRI, PCS SF-36, MCS SF-36, GOSE, and PCS. Classes of trajectory were associated with age a parts per thousand yen40 years, unemployment at 1 month after injury, and educational level a parts per thousand currency sign12 years. Univariate analysis revealed that employment status at 1 month post-injury was correlated with the trajectories of QOLIBRI, PCS SF-36, MCS SF-36, and GOSE, but not PCS. Employment status was the most crucial associated factor for QoL in individuals with mTBI at the 1-year follow-up. Future studies should explore the benefits of employment on QoL of individuals with mTBI.	[Chiang, Chia-Chen] Sinying Hosp, Dept Nursing, Minist Hlth & Welf, Tainan, Taiwan; [Guo, Su-Er; Lee, Bih-O] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Dept Nursing, Chiayi, Taiwan; [Guo, Su-Er; Lee, Bih-O] Chang Gung Univ Sci & Technol, Chron Dis & Hlth Promot Res Ctr, Grad Inst Nursing, Chiayi, Taiwan; [Lee, Bih-O] Ditmanson Med Fdn Chiayi Christian Hosp, Sect Neurosurg, Dept Surg, Chiayi, Taiwan; [Fan, Jun-Yu] Chang Gung Univ Sci & Technol, Dept Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan; [Fan, Jun-Yu] Chang Gung Univ Sci & Technol, Grad Inst Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan		Fan, JY (corresponding author), Chang Gung Univ Sci & Technol, Dept Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan.; Fan, JY (corresponding author), Chang Gung Univ Sci & Technol, Grad Inst Nursing, 261,Wen Hua 1st Rd, Taoyuan 33303, Taiwan.	joyful5230@gmail.com; seguo@gw.cgust.edu.tw; 05780@cych.org.tw; bih-olee@gw.cgust.edu.tw; jyfan@gw.cgust.edu.tw	Lee, Bih-O/ABA-8451-2021	Lee, Bih-O/0000-0003-1903-8378	Administration Center of the Medical Research Department, Chang Gung Memorial Hospital, Taiwan [BMRPB80]	The authors wish to acknowledge all 100 participants for their time and effort contributed to this study. This research was supported by a Grant from the Administration Center of the Medical Research Department, Chang Gung Memorial Hospital, Taiwan (BMRPB80), to the corresponding author.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Anderson V, 2011, NEUROPSYCHOLOGY, V25, P176, DOI 10.1037/a0021217; Andersson EE, 2011, J REHABIL MED, V43, P323, DOI 10.2340/16501977-0666; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Beseoglu K, 2013, BRIT J NEUROSURG, V27, P202, DOI 10.3109/02688697.2012.717984; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Centers for Disease Control and Prevention, 2017, INJ PREV CONTR TRAUM; Dixon CE, 1993, J HEAD TRAUMA REHAB, V8, P1; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Jakola AS, 2007, ACTA NEUROL SCAND, V115, P398, DOI 10.1111/j.1600-0404.2007.00827.x; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Lin YN, 2014, J HEAD TRAUMA REHAB, V29, pE37, DOI 10.1097/HTR.0b013e3182816363; Lu J.F., 2003, TAIWAN J PUBLIC HLTH, V22, P501, DOI DOI 10.6288/TJPH2003-22-06-09; Maestas KL, 2014, J HEAD TRAUMA REHAB, V29, P407, DOI 10.1097/HTR.0b013e31828654b4; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Nagin DS, 1999, PSYCHOL METHODS, V4, P139, DOI 10.1037/1082-989X.4.2.139; Nagin DS, 2001, PSYCHOL METHODS, V6, P18, DOI 10.1037/1082-989X.6.1.18; Oppermann JD, 2004, BRAIN INJURY, V18, P941, DOI 10.1080/02699050410001671919; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Pettigrew LEL, 2003, J HEAD TRAUMA REHAB, V18, P252, DOI 10.1097/00001199-200305000-00003; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Steadman-Pare D, 2001, J HEAD TRAUMA REHAB, V16, P330, DOI 10.1097/00001199-200108000-00004; Tsaousides T, 2009, REHABIL PSYCHOL, V54, P299, DOI 10.1037/a0016807; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; von Steinbuechel N, 2005, ACTA NEUROCHIR SUPPL, V93, P43; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1167, DOI 10.1089/neu.2009.1076; von Steinbuchel N, 2010, J NEUROTRAUM, V27, P1157, DOI 10.1089/neu.2009.1077; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Yang CC, 2007, J TRAUMA, V62, P657, DOI 10.1097/01.ta.0000203577.68764.b8; Yang CC, 2009, BRAIN INJURY, V23, P299, DOI 10.1080/02699050902788543; Zumstein MA, 2011, J TRAUMA, V71, P120, DOI 10.1097/TA.0b013e3181f2d670	44	18	18	1	18	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0962-9343	1573-2649		QUAL LIFE RES	Qual. Life Res.	AUG	2016	25	8					2009	2019		10.1007/s11136-015-1215-0			11	Health Care Sciences & Services; Health Policy & Services; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health	DR6IP	WOS:000380005900015	26706751				2022-02-06	
J	Kroshus, E; Garnett, BR; Baugh, CM; Calzo, JP				Kroshus, Emily; Garnett, Bernice R.; Baugh, Christine M.; Calzo, Jerel P.			Engaging Teammates in the Promotion of Concussion Help Seeking	HEALTH EDUCATION & BEHAVIOR			English	Article						bystander; concussion; education; norms; sport	SPORT-RELATED CONCUSSION; HIGH-SCHOOL; ICE HOCKEY; FOOTBALL PLAYERS; PLANNED BEHAVIOR; EDUCATION; RISK; KNOWLEDGE; OUTCOMES; INJURY	Concussion underreporting contributes to the substantial public health burden of concussions from sport. Teammates may be able to play an important role in encouraging injury identification and help seeking. This study assessed whether there was an association between beliefs about the consequences of continued play with a concussion and intentions to engage as a proactive bystander in facilitating or encouraging teammate help seeking for a possible concussion. Participants were 328 (male and female) members of 19 U.S. collegiate contact or collision sports teams. Athletes who believed that there were negative health or performance consequences of continued play with a concussion were significantly more likely than their peers to intend to encourage teammate help seeking, but not more likely to alert a coach or medical personnel. Additionally, athletes who believed that their teammates were more supportive of concussion safety were more likely to intend to engage as proactive bystanders in encouraging teammate help seeking. Exploring how to encourage bystander promotion of concussion safety is an important direction for future programming and evaluation research and may provide an opportunity to improve the effectiveness of concussion education.	[Kroshus, Emily] Univ Washington, Dept Pediat, 2001 Eighth Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Garnett, Bernice R.] Univ Vermont, Coll Educ & Social Serv, Burlington, VT USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.; Calzo, Jerel P.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Calzo, Jerel P.] Harvard Med Sch, Dept Pediat, Cambridge, MA USA; [Calzo, Jerel P.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Boston, MA USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 Eighth Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu	Baugh, Christine/AAG-2324-2020	Baugh, Christine/0000-0002-9340-6338; Calzo, Jerel/0000-0002-4656-1052			AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bailey R, 2006, J SCHOOL HEALTH, V76, P397, DOI 10.1111/j.1746-1561.2006.00132.x; Banyard VL, 2011, PSYCHOL VIOLENCE, V1, P287, DOI 10.1037/a0023544; Benabou R., 2005, 11535 NAT BUR EC RES; Benson BW, 2013, BRIT J SPORT MED, V47, P321, DOI 10.1136/bjsports-2013-092216; Chekroun P, 2002, EUR J SOC PSYCHOL, V32, P853, DOI 10.1002/ejsp.126; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, BRAIN INJURY, V27, P1, DOI 10.3109/02699052.2012.722251; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Cusimano MD, 2014, BRIT J SPORT MED, V48, P141, DOI 10.1136/bjsports-2012-091660; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Delaney JS, 2015, CLIN J SPORT MED, V25, P113, DOI 10.1097/JSM.0000000000000112; Dovidio J. F., 2006, SOCIAL PSYCHOL PROSO; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10210; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Figner B, 2009, J EXP PSYCHOL LEARN, V35, P709, DOI 10.1037/a0014983; Fredricks JA, 2006, DEV PSYCHOL, V42, P698, DOI 10.1037/0012-1649.42.4.698; Frings D, 2010, GROUP DYN-THEOR RES, V14, P80, DOI 10.1037/a0016092; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Hootman JM, 2007, J ATHL TRAINING, V42, P311; IVERSON GL, 2012, REHABIL RES PRACT, V2012, DOI DOI 10.1155/2012/316575; Kerr Zachary Y, 2014, Inj Epidemiol, V1, P28; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kroshus E, 2015, HEALTH EDUC BEHAV, V42, P153, DOI 10.1177/1090198114543011; Kroshus E, 2015, ANN BEHAV MED, V49, P95, DOI 10.1007/s12160-014-9636-5; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Latane B., 1970, UNRESPONSIVE BYSTAND; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Long J. B. V., 2012, U VIRGINIAS STEP UP; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, NEUROSURGERY, V65, P876, DOI 10.1227/01.NEU.0000350155.89800.00; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; National Collegiate Athletic Association, 2013, 198182201213 NCAA; National Collegiate Athletic Association, 2014, DIV STEER COMM GOV R; National Federation of High School Sports, 2014, HIGH SCH SPORT PART; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Reyna VF, 2006, PSYCHOL SCI, P1, DOI 10.1111/j.1529-1006.2006.00026.x; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; The National Collegiate Athletic Association, 2014, 2014 2015 NCAA SPORT; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Tracey J, 2003, J APPL SPORT PSYCHOL, V15, P279, DOI 10.1080/714044197; Vast RL, 2010, AUST PSYCHOL, V45, P132, DOI 10.1080/00050060903261538; Zemper ED, 2003, AM J PHYS MED REHAB, V82, P653, DOI 10.1097/01.PHM.0000083666.74494.BA	53	18	18	0	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	AUG	2016	43	4					442	451		10.1177/1090198115602676			10	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	DS7KG	WOS:000380961800008	27405801				2022-02-06	
J	Rezai, AR; Sederberg, PB; Bogner, J; Nielson, DM; Zhang, J; Mysiw, WJ; Knopp, MV; Corrigan, JD				Rezai, Ali R.; Sederberg, Per B.; Bogner, Jennifer; Nielson, Dylan M.; Zhang, Jun; Mysiw, W. Jerry; Knopp, Michael V.; Corrigan, John D.			Improved Function After Deep Brain Stimulation for Chronic, Severe Traumatic Brain Injury	NEUROSURGERY			English	Article						Adult brain injury; Deep brain stimulation; Nucleus accumbens; Traumatic brain injury	DISABILITY	BACKGROUND: Severe traumatic brain injury (TBI) damages the frontal lobes and connecting networks, which impairs executive functions, including the ability to self-regulate. Despite significant disabling effects, there are few treatment options in the chronic phase after injury. OBJECTIVE: To investigate the safety and potential effectiveness of deep brain stimulation (DBS) for individuals with chronic, disabling TBI and problems of behavioral and emotional self-regulation. METHODS: This study was an open-label, prospective design with serial assessments of behavioral outcomes and positron emission tomography 2 years after DBS implantation. Four participants 6 to 21 years after severe TBIs from automobile crashes were included. Although alert and volitional, all experienced significant executive impairments, including either impulsivity or reduced initiation. DBS implants were placed bilaterally in the nucleus accumbens and anterior limb of the internal capsule to modulate the prefrontal cortex. RESULTS: The procedure was safe, and all participants had improved functional outcomes. Two years after implantation, 3 met a priori criteria for improvement on the Mayo-Portland Adaptability Inventory-4. Improvement was due largely to better emotional adjustment, although 1 participant showed marked increases in multiple domains. Significant improvement in a composite score of functional capacity indicated improved independence in self-care and activities of daily living. The pattern of change in cognition corresponded with changes in activation of the prefrontal cortex observed in serial scanning. CONCLUSION: This first study of DBS to this target for severe TBI supports its safety and suggests potential effectiveness to improve function years after injury. The primary impact was on behavioral and emotional adjustment, which in turn improved functional independence.	[Rezai, Ali R.] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Rezai, Ali R.] Ohio State Univ, Ctr Neuromodulat, Columbus, OH 43210 USA; [Sederberg, Per B.] Ohio State Univ, Dept Psychol, Columbus, OH USA; [Bogner, Jennifer; Nielson, Dylan M.; Mysiw, W. Jerry; Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH USA; [Zhang, Jun; Knopp, Michael V.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA		Corrigan, JD (corresponding author), 2145 Dodd Hall,480 Med Ctr Dr, Columbus, OH 43210 USA.	corrigan.1@osu.edu	Nielson, Dylan/ABD-1615-2021	Nielson, Dylan/0000-0003-4613-6643; zhang, jun/0000-0002-6515-601X	Ohio State University Wexner Medical Center; Wright Center of Innovation in Biomedical Imaging [OTF TECH 11-044]	Funding was provided by The Ohio State University Wexner Medical Center and Wright Center of Innovation in Biomedical Imaging, OTF TECH 11-044. Dr Rezai is a Member of the Board of Directors and an equity shareholder for Autonomic Technologies, Inc. The authors have no personal, financial, or institutional interest in any of the drugs, materials, or devices described in this article.	Baker KB, 2007, NEUROSURGERY, V61, P367, DOI 10.1227/01.neu.0000303995.66902.36; Bauer R, 2008, FORTSCHR NEUROL PSYC, V76, P396, DOI 10.1055/s-2008-1038217; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Brasure M, 2013, AHRQ PUBLICATION, V13-ehc047-ef; Corrigan JD, 2004, J HEAD TRAUMA REHAB, V19, P205, DOI 10.1097/00001199-200405000-00002; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Dougherty DD, 2015, BIOL PSYCHIAT, V78, P240, DOI 10.1016/j.biopsych.2014.11.023; Faul M, 2010, TRAUMATIC BRAIN INJU; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Granger C. V., 1986, TOP GERIATR REHABIL, V1, P59, DOI DOI 10.1097/00013614-198604000-00007; Greenberg BD, 2010, MOL PSYCHIATR, V15, P64, DOI 10.1038/mp.2008.55; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; HEINEMANN AW, 1993, ARCH PHYS MED REHAB, V74, P566, DOI 10.1016/0003-9993(93)90153-2; Kuhn J, 2009, EUR ADDICT RES, V15, P196, DOI 10.1159/000228930; Lane SD, 2004, PSYCHOPHARMACOLOGY, V172, P68, DOI 10.1007/s00213-003-1628-2; Malec JF, 2012, ARCH PHYS MED REHAB, V93, P2271, DOI 10.1016/j.apmr.2012.06.013; Nuttin B, 1999, LANCET, V354, P1526, DOI 10.1016/S0140-6736(99)02376-4; Psychological Corporation, 1997, WAIS 3 WMS 3 TECHNIC; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Rauch SL, 2006, J NEUROSURG, V104, P558, DOI 10.3171/jns.2006.104.4.558; Salgado S, 2015, STEREOT FUNCT NEUROS, V93, P75, DOI 10.1159/000368279; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Volkow ND, 2015, CELL, V162, P712, DOI 10.1016/j.cell.2015.07.046; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wright DW, 2013, MMWR-MORBID MORTAL W, V62, P549; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	27	18	21	0	8	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	AUG	2016	79	2					204	210		10.1227/NEU.0000000000001190			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DU6OS	WOS:000382335100021	26702839				2022-02-06	
J	Meier, TB; Savitz, J; Singh, R; Teague, TK; Bellgowan, PSF				Meier, Timothy B.; Savitz, Jonathan; Singh, Rashmi; Teague, T. Kent; Bellgowan, Patrick S. F.			Smaller Dentate Gyrus and CA2 and CA3 Volumes Are Associated with Kynurenine Metabolites in Collegiate Football Athletes	JOURNAL OF NEUROTRAUMA			English	Article						concussion; football; hippocampus; kynurenine pathway; mTBI	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSIVE DISORDER; QUINOLINIC ACID; HIPPOCAMPAL SUBFIELDS; OXIDATIVE STRESS; IN-VIVO; PATHWAY; RAT; 3-HYDROXYKYNURENINE	An imbalance in kynurenine pathway metabolism is hypothesized to be associated with dysregulated glutamatergic neurotransmission, which has been proposed as a mechanism underlying the hippocampal volume loss observed in a variety of neurological disorders. Pre-clinical models suggest that the CA2-3 and dentate gyrus hippocampal subfields are particularly susceptible to excitotoxicity after experimental traumatic brain injury. We tested the hypothesis that smaller hippocampal volumes in collegiate football athletes with (n = 25) and without (n = 24) a concussion history would be most evident in the dentate gyrus and CA2-3 subfields relative to nonfootball healthy controls (n = 27). Further, we investigated whether the concentration of peripheral levels of kynurenine metabolites are altered in football athletes. Football athletes with and without a self-reported concussion history had smaller dentate gyrus (p < 0.05, p < 0.10) and CA2-3 volumes (p's < 0.05) relative to healthy controls. Football athletes with and without a concussion history had a trend toward lower (p < 0.10) and significantly lower (p < 0.05) kynurenine levels compared with healthy controls, while athletes with a concussion history had greater levels of quinolinic acid compared with athletes without a concussion history (p < 0.05). Finally, plasma levels of 3-hydroxykynurenine inversely correlated with bilateral hippocampal volumes in football athletes with a concussion history (p < 0.01), and left hippocampal volume was correlated with the ratio of kynurenic acid to quinolinic acid in football athletes without a concussion history (p < 0.05). Our results raise the possibility that abnormalities of the kynurenine metabolic pathway constitute a mechanism for hippocampal volume differences in the context of sports-related brain injury.	[Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Meier, Timothy B.; Savitz, Jonathan; Singh, Rashmi] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Bellgowan, Patrick S. F.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Meier, TB (corresponding author), Med Coll Wisconsin, Neurosci Res Ctr, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu	Savitz, Jonathan/C-3088-2009; Teague, T. Kent/A-2527-2008	Savitz, Jonathan/0000-0001-8143-182X; Teague, T. Kent/0000-0002-4680-5440			Agudelo LZ, 2014, CELL, V159, P33, DOI 10.1016/j.cell.2014.07.051; Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Baldwin SA, 1997, J NEUROTRAUM, V14, P385, DOI 10.1089/neu.1997.14.385; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; BLIGHT AR, 1993, BRAIN RES, V632, P314, DOI 10.1016/0006-8993(93)91167-Q; Boen E, 2014, J PSYCHIATR NEUROSCI, V39, P127, DOI 10.1503/jpn.130070; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Gabbay V, 2010, PROG NEURO-PSYCHOPH, V34, P37, DOI 10.1016/j.pnpbp.2009.09.015; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Guidetti P, 1999, EUR J NEUROSCI, V11, P3857, DOI 10.1046/j.1460-9568.1999.00806.x; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kraemer WJ, 2005, J STRENGTH COND RES, V19, P485; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Lugo-Huitron R, 2011, NEUROTOXICOL TERATOL, V33, P538, DOI 10.1016/j.ntt.2011.07.002; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Meier T. B., 2015, J NEUROTRAUMA; Ode JJ, 2007, MED SCI SPORT EXER, V39, P403, DOI 10.1249/01.mss.0000247008.19127.3e; Okuda S, 1998, J NEUROCHEM, V70, P299; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Sandhir R, 2008, EXP NEUROL, V213, P372, DOI 10.1016/j.expneurol.2008.06.013; Savitz J, 2015, PSYCHONEUROENDOCRINO, V62, P54, DOI 10.1016/j.psyneuen.2015.07.609; Savitz J, 2015, PSYCHONEUROENDOCRINO, V52, P200, DOI 10.1016/j.psyneuen.2014.11.015; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Schwarz MJ, 2013, EUR ARCH PSY CLIN N, V263, P345, DOI 10.1007/s00406-012-0384-x; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Singh R., 2015, J NEUROL NEUROSURG P; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Stein MB, 1997, PSYCHOL MED, V27, P951, DOI 10.1017/S0033291797005242; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Stone TW, 2013, BRIT J PHARMACOL, V169, P1211, DOI 10.1111/bph.12230; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Van Leemput K, 2009, HIPPOCAMPUS, V19, P549, DOI 10.1002/hipo.20615; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wierenga L, 2014, NEUROIMAGE, V96, P67, DOI 10.1016/j.neuroimage.2014.03.072; Zierhut KC, 2013, BRAIN, V136, P804, DOI 10.1093/brain/aws335	51	18	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2016	33	14					1349	1357		10.1089/neu.2015.4118			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DQ5CX	WOS:000379223100006	26493952	Green Published			2022-02-06	
J	Zhang, HS; Li, H; Zhang, DD; Yan, HY; Zhang, ZH; Zhou, CH; Ye, ZN; Chen, Q; Jiang, TW; Liu, JP; Hang, CH				Zhang, Hua-Sheng; Li, Hua; Zhang, Ding-Ding; Yan, Hui-Ying; Zhang, Zi-Huan; Zhou, Chen-Hui; Ye, Zhen-Nan; Chen, Qiang; Jiang, Tian-Wei; Liu, Jing-Peng; Hang, Chun-Hua			Inhibition of myeloid differentiation factor 88(MyD88) by ST2825 provides neuroprotection after experimental traumatic brain injury in mice	BRAIN RESEARCH			English	Article						Myeloid differentiation factor 88; Traumatic brain injury; Apoptosis; ST2825	CLOSED-HEAD INJURY; PROTEIN 88 MYD88; FACTOR-KAPPA-B; SIGNALING PATHWAYS; RATS; EXPRESSION; INFLAMMATION; RECRUITMENT; ACTIVATION; RECEPTORS	Myeloid differentiation factor 88(MyD88) is an endogenous adaptor protein that plays an important role in coordinating intracellular inflammatory responses induced by agonists of the Toll-like receptor and interleukin-1 receptor families. MyD88 has been reported to be essential for neuronal death in animal models and may represent a therapeutic target for pharmacologic inhibition following traumatic brain injury (TBI). The purpose of the current study was to investigate the neuroprotective effect of MyD88 specific inhibitor ST2825 in an experimental mouse model of TBI. Intracerebroventricular (ICV) injection of high concentration (20 mu g/mu L) ST2825 (15 min post TBI) attenuated the development of TBI in mice, markedly improved neurological function and reduced brain edema. Decreased neural apoptosis and increased neuronal survival were also observed. Biochemically, the high concentration of ST2825 significantly reduced the levels of MyD88, further decreased TAK1, p-TAK1, nuclear p65 and increased I kappa B-alpha. Additionally, ST2825 significantly reduced the levels of Iba-1 and inflammatory factors TNF-alpha and IL-1 beta. These data provide an experimental rationale for evaluation of MyD88 as a drug target and highlight the potential therapeutic implications of ST2825 in TBI. (c) 2016 Elsevier B.V. All rights reserved.	[Zhang, Hua-Sheng; Zhang, Ding-Ding; Yan, Hui-Ying; Zhou, Chen-Hui; Jiang, Tian-Wei; Hang, Chun-Hua] Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China; [Li, Hua] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430030, Hubei Province, Peoples R China; [Zhang, Zi-Huan] Zhongdu Hosp, Dept Neurosurg, Bengbu, Anhui, Peoples R China; [Ye, Zhen-Nan; Chen, Qiang; Liu, Jing-Peng; Hang, Chun-Hua] Southern Univ Guangzhou, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Neurosurg, 305 East Zhongshan Rd, Nanjing 210002, Jiangsu, Peoples R China.	hang_neurosurgery@163.com		Li, Hua/0000-0001-5893-535X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171170, 81371294, 81401029]; Natural Science Foundation of Jiangsu Province, ChinaNatural Science Foundation of Jiangsu Province [BK2010459]	This work is supported by Grants from National Natural Science Foundation of China (No. 81171170, 81371294, 81401029), Natural Science Foundation of Jiangsu Province, China (BK2010459).	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Adeleye A, 2010, EUR J PHARMACOL, V629, P25, DOI 10.1016/j.ejphar.2009.11.066; Ajibade AA, 2013, TRENDS IMMUNOL, V34, P307, DOI 10.1016/j.it.2013.03.007; Babcock AA, 2008, J IMMUNOL, V181, P6481, DOI 10.4049/jimmunol.181.9.6481; Biegon A, 2004, P NATL ACAD SCI USA, V101, P5117, DOI 10.1073/pnas.0305741101; Bjorkbacka H, 2004, NAT MED, V10, P416, DOI 10.1038/nm1008; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Ding K, 2015, NEUROCHEM INT, V91, P46, DOI 10.1016/j.neuint.2015.10.008; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Fan D, 2011, CELL MOL NEUROBIOL, V31, P1213, DOI 10.1007/s10571-011-9723-0; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hardiman G, 1996, ONCOGENE, V13, P2467; Hu YC, 2014, INFLAMM RES, V63, P109, DOI 10.1007/s00011-013-0677-1; Hue CD, 2015, J CEREBR BLOOD F MET, V35, P1191, DOI 10.1038/jcbfm.2015.38; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Joosten LAB, 2003, J IMMUNOL, V171, P6145, DOI 10.4049/jimmunol.171.11.6145; Jungner M., 2015, MINERVA ANESTESIOL; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Li W, 2014, MOL NEUROBIOL, V49, P187, DOI 10.1007/s12035-013-8509-4; Li W, 2013, J SURG RES, V180, P133, DOI 10.1016/j.jss.2012.10.928; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mao SS, 2012, J NEUROTRAUM, V29, P1941, DOI 10.1089/neu.2011.2244; Mayeux JP, 2015, BEHAV BRAIN RES, V279, P22, DOI 10.1016/j.bbr.2014.10.053; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Prinz M, 2006, J CLIN INVEST, V116, P456, DOI 10.1172/JCI26078; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; Sette Claudio, 2007, J Leukoc Biol, V82, P811; Soltani Z., 2015, J PHYSL BIOCH; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Van Tassell BW, 2010, J CARDIOVASC PHARM, V55, P385, DOI 10.1097/FJC.0b013e3181d3da24; Wang T., 2015, FA YI XUE ZA ZHI, V31, P92; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhang DD, 2014, NEUROCHEM INT, V75, P11, DOI 10.1016/j.neuint.2014.05.003; Zhou ML, 2007, J CEREBR BLOOD F MET, V27, P1583, DOI 10.1038/sj.jcbfm.9600456	43	18	20	0	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 15	2016	1643						130	139		10.1016/j.brainres.2016.05.003			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DP4EE	WOS:000378448200014	27155455				2022-02-06	
J	Buchele, F; Morawska, MM; Schreglmann, SR; Penner, M; Muser, M; Baumann, CR; Noain, D				Buchele, Fabian; Morawska, Marta M.; Schreglmann, Sebastian R.; Penner, Marco; Muser, Markus; Baumann, Christian R.; Noain, Daniela			Novel Rat Model of Weight Drop-Induced Closed Diffuse Traumatic Brain Injury Compatible with Electrophysiological Recordings of Vigilance States	JOURNAL OF NEUROTRAUMA			English	Article						rat model; sleep recording; TBI; traumatic axonal injury; weight drop	AMYLOID PRECURSOR PROTEIN; AXONAL INJURY; HEAD-INJURY; COGNITIVE DEFICITS; SLEEP; MICE; IMPACT; MEMORY; MILD; BETA	Traumatic brain injury (TBI) is a major cause of persistent disabilities such as sleep-wake disorders (SWD). Rodent studies of SWD after TBI are scarce, however, because of lack of appropriate TBI models reproducing acceleration deceleration forces and compatible with electroencephalography/myography (EEG/EMG)-based recordings of vigilance states. We therefore adapted the Marmarou impact acceleration model to allow for compatibility with EEG-headset implantation. After implantation of EEG/EMG electrodes, we induced closed TBI by a frontal, angular hit with a weight drop device (56 rats, weight 2500 g, fall height 25 cm). Subsequently, we tested our model's usefulness for long-term studies on a behavioral, electrophysiological, and histological level. Neurological, motor, and memory deficits were assessed with the neurological severity score, open field, and novel object recognition tests, respectively. EEG/EMG recordings were performed in both Sham (n = 7) and TBI (n = 7) rats before and 1, 7, and 28 days after trauma to evaluate sleep-wake proportions and post-traumatic implant stability. Histological assessments included hematoxylin and eosin staining for parenchymal damage and hemorrhage and amyloid precursor protein staining for diffuse axonal damage. All rats survived TBI without major neurological or motor deficits. Memory function was impaired after TBI at weeks 1, 2, and 3 and recovered at week 4. EEG implants were stable for at least 1 month and enabled qualitative and quantitative sleep analyses. Histological assessments revealed no major bleedings or necrosis but intense diffuse axonal damage after TBI. This approach fulfills major pre-conditions for experimental TBI models and offers a possibility to electrophysiologically study behavioral states before and after trauma.	[Buchele, Fabian; Morawska, Marta M.; Schreglmann, Sebastian R.; Penner, Marco; Baumann, Christian R.; Noain, Daniela] Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland; [Morawska, Marta M.] Univ Zurich, Neurosci Ctr Zurich ZNZ, Zurich, Switzerland; [Muser, Markus] Swiss Fed Inst Technol, Working Grp Accid Mech, Zurich, Switzerland		Noain, D (corresponding author), Univ Zurich Hosp, Dept Neurol, Frauenklin Str 26, CH-8091 Zurich, Switzerland.	daniela.noain@usz.ch		Noain, Daniela/0000-0001-5482-7933; Buechele, Fabian/0000-0001-7091-1676; Morawska, Marta/0000-0003-1612-6786; Baumann, Christian/0000-0003-3417-1978; Schreglmann, Sebastian/0000-0002-4129-5808			Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2006, SLEEP, V29, P1339, DOI 10.1093/sleep/29.10.1339; Baumann CR, 2009, ANN NEUROL, V66, P555, DOI 10.1002/ana.21836; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Cam E, 2013, EXP NEUROL, V247, P673, DOI 10.1016/j.expneurol.2013.03.003; Carre E, 2004, J NEUROSCI METH, V140, P23, DOI 10.1016/j.jneumeth.2004.04.037; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fabian Buchele, 2016, J NEUROTRAUM, V33, P1171; FODA MAA, 1994, J NEUROSURG, V80, P301, DOI 10.3171/jns.1994.80.2.0301; Geeraerts T, 2006, J NEUROTRAUM, V23, P1059, DOI 10.1089/neu.2006.23.1059; GENNARELLI TA, 1994, J NEUROTRAUM, V11, P357, DOI 10.1089/neu.1994.11.357; Hamm RJ, 1996, J NEUROTRAUM, V13, P317, DOI 10.1089/neu.1996.13.317; Hodor A, 2015, NEUROSCIENCE, V284, P18, DOI 10.1016/j.neuroscience.2014.08.061; Hodor A, 2014, ANN CLIN TRANSL NEUR, V1, P765, DOI 10.1002/acn3.115; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Imbach LL, 2015, BRAIN, V138, P726, DOI 10.1093/brain/awu391; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Itoh T, 2009, NEUROL RES, V31, P103, DOI 10.1179/016164108X323771; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kang JE, 2009, SCIENCE, V326, P1005, DOI 10.1126/science.1180962; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li SH, 2006, NEUROSCI LETT, V409, P182, DOI 10.1016/j.neulet.2006.09.054; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; O'Connor WT, 2011, PHARMACOL THERAPEUT, V130, P106, DOI 10.1016/j.pharmthera.2011.01.001; Pierce JES, 1996, J NEUROSCI, V16, P1083; Piper IR, 1996, J NEUROSCI METH, V69, P171, DOI 10.1016/S0165-0270(96)00046-5; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Rowe RK, 2014, BRAIN INJURY, V28, P504, DOI 10.3109/02699052.2014.888768; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Schwarzbold ML, 2010, J NEUROTRAUM, V27, P1883, DOI 10.1089/neu.2010.1318; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Thomasy Hannah E., 2016, NEUROBIOLOGY SLEEP C; Vaishnavi S, 2009, PSYCHOSOMATICS, V50, P198, DOI 10.1176/appi.psy.50.3.198; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	58	18	19	1	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2016	33	13					1171	+		10.1089/neu.2015.4001			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DP2QY	WOS:000378336200383	26414556				2022-02-06	
J	Rumrill, P; Wehman, P; Cimera, R; Kaya, C; Dillard, C; Chan, F				Rumrill, Phillip; Wehman, Paul; Cimera, Robert; Kaya, Cahit; Dillard, Chad; Chan, Fong			Vocational Rehabilitation Services and Outcomes for Transition-Age Youth With Traumatic Brain Injuries	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						transition-age youth; traumatic brain injuries; vocational rehabilitation	EMPLOYMENT OUTCOMES; PREDICTORS; ADULTS; WORK	Objective: This study examined data provided by the US Department of Education's Rehabilitation Services Administration (RSA) in an effort to evaluate the relationship between (a) demographic variables and vocational rehabilitation (VR) services and (b) the employment outcomes of transition-age youth with traumatic brain injuries. Setting: Not applicable. Participants: Data for 1546 transition-age youth (ie, 16-25 years of age) with traumatic brain injuries were examined. Design: Purposeful selection of multivariate logistic regression was employed to analyze the data. Main Measures: Not applicable. Results: Receipt of more VR services at higher expenditure levels over shorter periods of time was related to case closure in successful competitive employment status. Also, higher levels of education at the time of enrollment in the VR program (ie, bachelor's degrees or higher); nonreceipt of social security disability benefits at the time of enrollment in the VR program; and receipt of VR services such as occupational/vocational training, job search, job placement, on-the-job support, maintenance, and information/referral were associated with competitive employment outcomes. Conclusion: Client demographic and VR service-related variables significantly predict competitive employment outcomes for transition-age youth with traumatic brain injuries. Vocational rehabilitation services should focus on the specific interventions that are most closely associated with successful rehabilitation.	[Rumrill, Phillip; Cimera, Robert] Kent State Univ, Ctr Disabil Studies, 413 White Hall,150 Terrace Dr, Kent, OH 44242 USA; [Wehman, Paul; Dillard, Chad] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA 23284 USA; [Kaya, Cahit; Chan, Fong] Univ Wisconsin, Dept Rehabil Psychol & Special Educ, Madison, WI 53706 USA		Rumrill, P (corresponding author), Kent State Univ, Dept Rehabil Counseling, 413 White Hall,150 Terrace Dr, Kent, OH 44242 USA.	prumrill@kent.edu	kaya, cahit/Q-6568-2018	kaya, cahit/0000-0003-0757-320X	United States Department of EducationUS Department of Education; NIDRR [H133A130066, H133A100007]	The contents of this article were developed under 2 grants from the United States Department of Education, NIDRR grant #H133A130066 and NIDRR grant #H133A100007. However, those contents do not necessarily represent the policy of the Department of Education, and readers should not assume endorsement by the Federal Government.	Ashman TA, 2006, MT SINAI J MED, V73, P999; Brown J, 2013, IOWA NOW; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Carter EW, 2011, INTELLECT DEV DISAB, V49, P233, DOI 10.1352/1934-9556-49.4.233; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Chiu CY, 2013, MULT SCLER J, V19, P1655, DOI 10.1177/1352458513482372; Cimera RE, 2013, RES PRACT PERS SEV D, V38, P88, DOI 10.2511/027494813807714474; Ditchman N., 2013, CAREER DEV EMPLOYMEN, P343; Faul M, 2010, TRAUMATIC BRAIN INJU; Gamble D, 2003, J VOCATIONAL REHABIL, V19, P19; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Graham CW, 2014, CAMPBELL SYSTEMATIC; JOHNSTONE B, 1994, J CLIN PSYCHOL MED S, V1, P375, DOI 10.1007/BF01991080; Kennedy MRT, 2008, NEUROREHABILITATION, V23, P511; Marini Irmo, 2003, Work, V21, P37; National Association of State Head Injury Administrators, 2006, TRAUM BRAIN INJ FACT; Rumrill P., 2014, AM PSYCHOL ASS HDB C, P139; Siperstein GN, 2014, J VOCAT REHABIL, V41, P165, DOI 10.3233/JVR-140711; Stock S., 2006, EMPLOYMENT PERSONS B; Strauser D. R., 2013, CAREER DEV EMPLOYMEN; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; SUPER DE, 1980, J VOCAT BEHAV, V16, P282, DOI 10.1016/0001-8791(80)90056-1; SykesHorn W, 1997, ARCH PHYS MED REHAB, V78, P1327, DOI 10.1016/S0003-9993(97)90305-1; Todis B, 2008, J HEAD TRAUMA REHAB, V23, P252, DOI 10.1097/01.HTR.0000327257.84622.bc; Todis B, 2011, J HEAD TRAUMA REHAB, V26, P138, DOI 10.1097/HTR.0b013e3181e5a87a; Toriello P., 2012, NEW DIRECTIONS REHAB; Wehman P, 2005, J HEAD TRAUMA REHAB, V20, P115, DOI 10.1097/00001199-200503000-00001; Wehman P, 2003, ARCH PHYS MED REHAB, V84, P192, DOI 10.1053/apmr.2003.50027; Wehman P., 2013, LIFE CLASSROOM; Wehman P., J POSTSECON IN PRESS; Wehman P, 2015, J OCCUP REHABIL, V25, P323, DOI 10.1007/s10926-014-9541-6; Wehman P, 2014, NEUROREHABILITATION, V34, P365, DOI 10.3233/NRE-131029	32	18	18	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					288	295		10.1097/HTR.0000000000000186			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000014	26360004				2022-02-06	
J	Salter, KL; McClure, JA; Foley, NC; Sequeira, K; Teasell, RW				Salter, Katherine L.; McClure, J. Andrew; Foley, Norine C.; Sequeira, Keith; Teasell, Robert W.			Pharmacotherapy for Depression Posttraumatic Brain Injury: A Meta-analysis	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depression; meta-analysis; pharmacotherapy; traumatic brain injury	PSYCHIATRIC-DISORDERS; HEAD-INJURY; ANTIDEPRESSANTS; SERTRALINE; REHABILITATION; DISABILITY; SEQUELAE; QUALITY; TRIALS	Objective: To examine the effectiveness of pharmacotherapy for the treatment of depression following traumatic brain injury (TBI). Design: Systematic review and meta-analysis. Multiple electronic databases were searched to identify relevant studies examining effectiveness of pharmacotherapy for depression post-TBI. Clinical trials evaluating the use of pharmacotherapy in individuals with depression at baseline and using standardized assessments of depression were included. Data abstracted included sample size, antidepressant used, treatment timing/duration, method of assessment, and results pertaining to impact of treatment. Study quality was assessed using a modified Jadad scale. Results: Nine studies met criteria for inclusion. Pooled analyses based on reported means (standard deviations) from repeated assessments of depression showed that, over time, antidepressant treatment was associated with a significant effect in favor of treatment (Hedges g = 1.169; 95% confidence interval, 0.849-1.489; P < .001). Similarly, when limited to placebo-controlled trials, treatment was associated with a significant reduction in symptoms (standardized mean difference = 0.84; 95% confidence interval, 0.314-1.366; P = .002). Conclusion: Pharmacotherapy after TBI may be associated with a reduction in depressive symptomatology. Given limitations within the available literature, further well-powered, placebo-controlled trials should be conducted to confirm the effectiveness of antidepressant therapy in this population.	[Salter, Katherine L.; McClure, J. Andrew; Foley, Norine C.; Sequeira, Keith; Teasell, Robert W.] Lawson Hlth Res Inst, Aging Rehabil & Geriatr Care Program, Parkwood Hosp Site, London, ON, Canada; [Salter, Katherine L.] Western Univ, Grad Program, Hlth & Rehabil Sci, London, ON, Canada; [Sequeira, Keith; Teasell, Robert W.] Univ Western Ontario, Schulich Sch Med, Dept Phys Med & Rehabil, London, ON, Canada		Salter, KL (corresponding author), Western Univ, Fac Hlth Sci, Lab Knowledge Translat & Exchange, Room HSB 403,Hlth Sci Bldg, London, ON N6A 5B9, Canada.	katesalt1@gmail.com		McClure, Andrew/0000-0001-5595-730X			Alderfer BS, 2005, J HEAD TRAUMA REHAB, V20, P544, DOI 10.1097/00001199-200511000-00006; Arroll B, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007954; Ashman TA, 2009, ARCH PHYS MED REHAB, V90, P733, DOI 10.1016/j.apmr.2008.11.005; Bae KY, 2011, PSYCHIAT INVEST, V8, P234, DOI 10.4306/pi.2011.8.3.234; Biostat Inc, 2005, COMPREHENSIVE METAAN; Borenstein M., 2009, INTRO META ANAL; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Cohen J, 1977, STAT POWER ANAL BEHA; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2009, J HEAD TRAUMA REHAB, V24, P272, DOI 10.1097/HTR.0b013e3181a66342; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Fann JR, 2000, J NEUROPSYCH CLIN N, V12, P226, DOI 10.1176/appi.neuropsych.12.2.226; Gill D, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001312.pub2; GomezHernandez R, 1997, ARCH PHYS MED REHAB, V78, P1321, DOI 10.1016/S0003-9993(97)90304-X; Guaiana G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004186.pub2; Hackett ML, 2008, COCHRANE DB SYST REV; Hart T, 2011, ARCH PHYS MED REHAB, V92, P1211, DOI 10.1016/j.apmr.2011.03.005; Hibbard MR, 2004, ARCH PHYS MED REHAB, V85, pS43, DOI 10.1016/j.apmr.2003.08.116; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Huggins JM, 2011, AM J HEALTH-SYST PH, V68, P254, DOI 10.2146/ajhp090629; Hurley Robin A., 2002, Curr Treat Options Neurol, V4, P59, DOI 10.1007/s11940-002-0005-5; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kanetani Kouichi, 2003, Journal of Nippon Medical School, V70, P313; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Lee H, 2005, HUM PSYCHOPHARM CLIN, V20, P97, DOI 10.1002/hup.668; Lipsey M.W., 2001, PRACTICAL META ANAL; Macdonald GM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub2; McDowell I., 1996, MEASURING HLTH GUIDE; Newburn G, 1999, BRAIN INJURY, V13, P637; Olivo SA, 2008, PHYS THER REHABIL J, V88, P156, DOI 10.2522/ptj.20070147; Price A, 2011, J NEUROL NEUROSUR PS, V82, P914, DOI 10.1136/jnnp.2010.230862; Rapoport MJ, 2008, J PSYCHOPHARMACOL, V22, P860, DOI 10.1177/0269881107083845; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rayner L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007503.pub2; Salter K, 2007, TOP STROKE REHABIL, V14, P1, DOI 10.1310/tsr1403-1; SARAN A, 1988, INT J PSYCHIAT MED, V18, P75, DOI 10.2190/15AH-JB7Q-U94T-JEAF; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; Turner-Stokes L, 2002, CLIN REHABIL, V16, P261, DOI 10.1191/0269215502cr489oa; van Reekum R, 2000, J NEUROPSYCH CLIN N, V12, P316, DOI 10.1176/appi.neuropsych.12.3.316; Warden DL, 2006, J NEUROTRAUM, V23, P1468, DOI 10.1089/neu.2006.23.1468; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Wroblewski BA, 1996, J CLIN PSYCHIAT, V57, P582, DOI 10.4088/JCP.v57n1206	47	18	18	1	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JUL-AUG	2016	31	4					E21	E32		10.1097/HTR.0000000000000193			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DR3FW	WOS:000379789000003	26479398				2022-02-06	
J	Schiff, ND				Schiff, Nicholas D.			Central thalamic deep brain stimulation to support anterior forebrain mesocircuit function in the severely injured brain	JOURNAL OF NEURAL TRANSMISSION			English	Article						Mesocircuit; Severe-to-moderate traumatic brain injury; Consciousness; Intralaminar nuclei; Executive function impairment	STATISTICAL IMAGE-ANALYSIS; ELECTRICAL-STIMULATION; AROUSAL REGULATION; MECHANISMS; CONSCIOUSNESS; ORGANIZATION; SYSTEM; NUCLEI; STATE; NEUROMODULATION	This integrative review frames a general rationale for the use of central thalamic deep brain stimulation (CT-DBS) to support arousal regulation mechanisms in the severely injured brain. The organizing role of the anterior forebrain mesocircuit in recovery mechanisms following widespread deafferentation produced by multi-focal structural brain injuries is emphasized. The mesocircuit model provides the conceptual foundation for the key role of the central thalamus as a privileged node for neuromodulation to support forebrain arousal regulation. In this context, cellular mechanisms arising at the neocortical, striatal, and thalamic population level are considered in the assessment of an individual patient's capacity for harboring underlying reserve that could be recruited for further recovery. Recent preclinical studies and pilot clinical results are compared to frame the detailed rationale for CT-DBS. Application of CT-DBS across the range of outcomes following severe-to-moderate brain injuries is discussed with the aim of improving consciousness and cognition in patients with non-progressive brain injuries.	[Schiff, Nicholas D.] Weill Cornell Med Coll, Lab Cognit Neuromodulat, Neurol & Neurosci, 1300 York Ave, New York, NY 10065 USA		Schiff, ND (corresponding author), Weill Cornell Med Coll, Lab Cognit Neuromodulat, Neurol & Neurosci, 1300 York Ave, New York, NY 10065 USA.	nds2001@med.cornell.edu					Baker JL, 2012, SOC NEUR ABSTR, V597, P14; Baker JL, 2011, SOC NEUR ABSTR, V197, P26; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Chatelle C, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00917; COHADON F, 1985, NEUROSTIMULATION OVE; Cruikshank SJ, 2012, J NEUROSCI, V32, P17813, DOI 10.1523/JNEUROSCI.3231-12.2012; DELIAC P, 1993, NEUROCHIRURGIE, V39, P293; Deschenes M, 1996, NEUROSCIENCE, V72, P679, DOI 10.1016/0306-4522(96)00001-2; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Ellender TJ, 2013, J PHYSIOL-LONDON, V591, P257, DOI 10.1113/jphysiol.2012.245233; Forgacs PB, 2014, ANN NEUROL, V76, P869, DOI 10.1002/ana.24283; Fridman EA, 2014, CURR OPIN NEUROBIOL, V29, P172, DOI 10.1016/j.conb.2014.09.008; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Giacino J, 2012, NEUROMODULATION, V15, P339, DOI 10.1111/j.1525-1403.2012.00458.x; Gold L, 2002, P NATL ACAD SCI USA, V99, P7699, DOI 10.1073/pnas.112012499; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; HASSLER R, 1969, ELECTROEN CLIN NEURO, V27, P306, DOI 10.1016/0013-4694(69)90060-1; Hosobuchi Y, 1993, Adv Neurol, V63, P247; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Kato T, 2007, J NEUROTRAUM, V24, P919, DOI 10.1089/neu.2006.0203; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512; Knight RT., 2013, PRINCIPLES FRONTAL L; Levin HS, 2013, J NEUROTRAUM, V30, P625, DOI 10.1089/neu.2012.2627; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; Liu J, 2015, ELIFE, V4, DOI 10.7554/eLife.09215; Mair RG, 2011, DOSE-RESPONSE, V9, P313, DOI 10.2203/dose-response.10-017.Mair; Mair RG, 2008, J NEUROSCI, V28, P14293, DOI 10.1523/JNEUROSCI.3301-08.2008; Maxwell WL, 2006, J NEUROPATH EXP NEUR, V65, P478, DOI 10.1097/01.jnen.0000229241.28619.75; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; McLardy T, 1968, Trans Am Neurol Assoc, V93, P25; Narayanan NS, 2013, NAT NEUROSCI, V16, P1888, DOI 10.1038/nn.3549; Narayanan NS, 2009, J NEUROPHYSIOL, V101, P2859, DOI 10.1152/jn.90615.2008; Parvizi J, 2001, COGNITION, V79, P135, DOI 10.1016/S0010-0277(00)00127-X; Paus T, 1997, J COGNITIVE NEUROSCI, V9, P392, DOI 10.1162/jocn.1997.9.3.392; Quinkert AW, 2012, BEHAV BRAIN RES, V229, P349, DOI 10.1016/j.bbr.2012.01.025; Quinkert AW, 2010, BEHAV BRAIN RES, V214, P377, DOI 10.1016/j.bbr.2010.06.009; Scannell JW, 1999, CEREB CORTEX, V9, P277, DOI 10.1093/cercor/9.3.277; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schiff ND, 2013, J NEUROPHYSIOL, V109, P1152, DOI 10.1152/jn.00317.2011; Schiff ND, 2016, BRAIN FUNCTION RESPO, DOI [10.1007/978-3-319-21425-2_15, DOI 10.1007/978-3-319-21425-2_15]; Schiff ND, 2008, ANN NY ACAD SCI, V1129, P105, DOI 10.1196/annals.1417.029; Schiff ND, 2012, ANN NY ACAD SCI, V1265, P56, DOI 10.1111/j.1749-6632.2012.06712.x; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Shah SA, 2010, EUR J NEUROSCI, V32, P1135, DOI 10.1111/j.1460-9568.2010.07420.x; Shirvalkar P, 2006, P NATL ACAD SCI USA, V103, P17007, DOI 10.1073/pnas.0604811103; Smith AC, 2009, J NEUROSCI METH, V183, P267, DOI 10.1016/j.jneumeth.2009.06.028; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Steriade M, 1997, THALAMUS; STURM V, 1979, ACTA NEUROCHIR, V47, P235, DOI 10.1007/BF01406406; Tabansky I, 2014, BEHAV BRAIN RES, V273, P123, DOI 10.1016/j.bbr.2014.07.026; Thibaut A, 2014, NEUROLOGY, V82, P1112, DOI 10.1212/WNL.0000000000000260; Tsubokawa T, 1990, Brain Inj, V4, P315; Williams ST, 2013, ELIFE, V2, DOI 10.7554/eLife.01157; Yamamoto T, 2005, NEUROPSYCHOL REHABIL, V15, P406, DOI 10.1080/09602010443000353	57	18	20	0	4	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	JUL	2016	123	7			SI		797	806		10.1007/s00702-016-1547-0			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ1XA	WOS:000378992700013	27113938				2022-02-06	
J	Hirst, JJ; Cumberland, AL; Shaw, JC; Bennett, GA; Kelleher, MA; Walker, DW; Palliser, HK				Hirst, Jonathan J.; Cumberland, Angela L.; Shaw, Julia C.; Bennett, Greer A.; Kelleher, Meredith A.; Walker, David W.; Palliser, Hannah K.			Loss of neurosteroid-mediated protection following stress during fetal life	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article; Proceedings Paper	8th International Meeting on Steroids and Nervous System	2015	Torino, ITALY			Preterm birth; Pregnancy compromise; Perinatal brain injury; Allopregnanolone; Fetus; Neonate; Placenta	PITUITARY-ADRENAL AXIS; TRAUMATIC BRAIN-INJURY; GABA(A) RECEPTORS; PRENATAL STRESS; PRETERM BIRTH; GUINEA-PIG; RAT-BRAIN; 5-ALPHA-PREGNANE STEROIDS; NEUROACTIVE STEROIDS; GROWTH RESTRICTION	Elevated levels of neurosteroids during late gestation protect the fetal brain from hypoxia/ischaemia and promote neurodevelopment. Suppression of allopregnanolone production during pregnancy leads to the onset of seizure-like activity and potentiates hypoxia-induced brain injury. Markers of myelination are reduced and astrocyte activation is increased. The placenta has a key role in maintaining allopregnanolone concentrations in the fetal circulation and brain during gestation and levels decline markedly after both normal and preterm birth. This leads to the preterm neonate developing in a neurosteroid deficient environment between delivery and term equivalence. The expression of 5 alpha-reductases is also lower in the fetus prior to term. These deficiencies in neurosteroid exposure may contribute to the increase in incidence of the adverse patterns of behaviour seen in children that are born preterm. Repeated exposure to glucocorticoid stimulation suppresses 5 alpha-reductase expression and allopregnanolone levels in the fetus and results in reduced myelination. Both fetal growth restriction and prenatal maternal stress lead to increased cortisol concentrations in the maternal and fetal circulation. Prenatal stress results in reduced expression of key GABA(A) receptor subunits that normally heighten neurosteroid sensitivity. These stressors also result in altered placental allopregnanolone metabolism pathways. These findings suggest that reduced neurosteroid production and action in the perinatal period may contribute to some of the adverse neurodevelopmental and behavioural outcomes that result from these pregnancy compromises. Studies examining perinatal steroid supplementation therapy with non-metabolisable neurosteroid analogues to improve these outcomes are warranted. (C) 2015 Elsevier Ltd. All rights reserved.	[Hirst, Jonathan J.; Cumberland, Angela L.; Shaw, Julia C.; Bennett, Greer A.; Palliser, Hannah K.] Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia; [Kelleher, Meredith A.] Oregon Natl Primate Res Ctr, Beaverton, OR 97006 USA; [Walker, David W.] Monash Univ, Dept Obstet & Gynaecol, Ritchie Ctr Baby Hlth Res, Clayton, Vic 3800, Australia		Hirst, JJ (corresponding author), Univ Newcastle, Sch Biomed Sci, Callaghan, NSW 2308, Australia.	Jon.Hirst@newcastle.edu.au	Kelleher, Meredith Anne/L-2317-2019; Cumberland, Angela/AAM-3052-2020; HIRST, JONATHAN JAMES/G-7822-2013; Hirst, Jonathan/ABC-3250-2021	Kelleher, Meredith Anne/0000-0002-5313-004X; HIRST, JONATHAN JAMES/0000-0002-9362-5303; Hirst, Jonathan/0000-0002-9362-5303; Palliser, Hannah/0000-0001-5783-9737; Cumberland, Angela/0000-0003-4463-9378			Aneja S, 2013, INDIAN PEDIATR, V50, P1033, DOI 10.1007/s13312-013-0284-9; Austin MP, 2005, EARLY HUM DEV, V81, P917, DOI 10.1016/j.earlhumdev.2005.07.005; Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005; Baram TZ, 2003, ANN NEUROL, V54, P701, DOI 10.1002/ana.10833; Belelli D, 2005, J NEUROSCI, V25, P11513, DOI 10.1523/JNEUROSCI.2679-05.2005; Ben-Ari Y, 2006, LANCET NEUROL, V5, P1055, DOI 10.1016/S1474-4422(06)70626-3; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Ben-Ari Y, 2011, EPILEPSIA, V52, P1544, DOI 10.1111/j.1528-1167.2011.03132.x; Bennett GA, 2013, DEV NEUROSCI-BASEL, V35, P416, DOI 10.1159/000354176; Bennett P.H., 2014, J PAEDIATR CHILD H, V50, pA339; Billiards S.S., 2002, FETAL NEONATAL PHYSL, V29, pA32; Coleman H., 2013, FETAL NEONATAL PHYSL, P40; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Crossley KJ, 2000, NEUROPHARMACOLOGY, V39, P1514, DOI 10.1016/S0028-3908(99)00222-1; Cumberland A.L., 2015, 8 INT C STER NERV SY, V8, pA24; Dalziel SR, 2005, BMJ-BRIT MED J, V331, P665, DOI 10.1136/bmj.38576.494363.E0; Dean JM, 2006, NEUROPHARMACOLOGY, V50, P491, DOI 10.1016/j.neuropharm.2005.10.017; DOLLING M, 1979, Journal of Developmental Physiology (Eynsham), V1, P399; Dzhala VI, 2008, ANN NEUROL, V63, P222, DOI 10.1002/ana.21229; Elgen S.K., 2014, EUR CHILD ADOLES PSY, V24, P263; Grassi S, 2007, EUR J NEUROSCI, V26, P23, DOI 10.1111/j.1460-9568.2007.05645.x; HARRISON NL, 1987, J PHARMACOL EXP THER, V241, P346; Hart AR, 2008, DEV MED CHILD NEUROL, V50, P655, DOI 10.1111/j.1469-8749.2008.03050.x; Hill M, 2007, J STEROID BIOCHEM, V105, P166, DOI 10.1016/j.jsbmb.2006.10.010; Hill M, 2010, J STEROID BIOCHEM, V122, P114, DOI 10.1016/j.jsbmb.2010.05.007; Ibanez C, 2004, NEUROPATH APPL NEURO, V30, P80, DOI 10.1046/j.0305-1846.2003.00515.x; Kapoor A, 2005, J PHYSIOL-LONDON, V566, P967, DOI 10.1113/jphysiol.2005.090191; Kaur KH, 2009, J BIOL CHEM, V284, P7889, DOI 10.1074/jbc.M806484200; Keirse MJNC, 2004, BIRTH-ISS PERINAT C, V31, P230, DOI 10.1111/j.0730-7659.2004.00315.x; Kelleher MA, 2013, REPROD SCI, V20, P1365, DOI 10.1177/1933719113485295; Kelleher MA, 2011, J ENDOCRINOL, V208, P301, DOI 10.1677/JOE-10-0248; King S, 2005, STRESS, V8, P35, DOI 10.1080/10253890500108391; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lindstrom K, 2011, PEDIATRICS, V127, P858, DOI 10.1542/peds.2010-1279; Linnet KM, 2006, ARCH DIS CHILD, V91, P655, DOI 10.1136/adc.2005.088872; Matthews SG, 2007, J NEUROENDOCRINOL, V19, P73, DOI 10.1111/j.1365-2826.2006.01504.x; McKendry AA, 2010, J NEUROENDOCRINOL, V22, P166, DOI 10.1111/j.1365-2826.2009.01949.x; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Murphy KE, 2008, LANCET, V372, P2143, DOI 10.1016/S0140-6736(08)61929-7; Nappi RE, 2001, OBSTET GYNECOL, V97, P77, DOI 10.1016/S0029-7844(00)01112-1; Newnham JP, 2008, LANCET, V372, P2094, DOI 10.1016/S0140-6736(08)61903-0; Newnham JP, 2009, SEMIN FETAL NEONAT M, V14, P157, DOI 10.1016/j.siny.2008.11.005; Nguyen PN, 2004, J PHYSIOL-LONDON, V560, P593, DOI 10.1113/jphysiol.2004.069336; Nguyen PN, 2003, PEDIATR RES, V54, P840, DOI 10.1203/01.PDR.0000088066.47755.36; Nguyen PN, 2003, PEDIATR RES, V53, P956, DOI 10.1203/01.PDR.0000064905.64688.10; Nicol MB, 2001, NEUROSCI LETT, V306, P13, DOI 10.1016/S0304-3940(01)01861-4; Nicol MB, 1999, NEUROPHARMACOLOGY, V38, P49, DOI 10.1016/S0028-3908(98)00166-X; NORMAN TR, 1991, FERTIL STERIL, V56, P1034; Norwitz Errol R, 2011, Rev Obstet Gynecol, V4, P60; Palliser HK, 2015, J DEV ORIG HLTH DIS, V6, P350, DOI 10.1017/S2040174415001075; Petrini JR, 2009, J PEDIATR-US, V154, P169, DOI 10.1016/j.jpeds.2008.08.020; Poletti A, 1998, ENDOCRINOLOGY, V139, P2171, DOI 10.1210/en.139.4.2171; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Roberts G, 2009, J PEDIATR-US, V154, P829, DOI 10.1016/j.jpeds.2008.12.036; Schule C, 2014, PROG NEUROBIOL, V113, P79, DOI 10.1016/j.pneurobio.2013.09.003; Shaw JC, 2015, J DEV ORIG HLTH DIS, V6, P250, DOI 10.1017/S2040174415000069; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Smith SS, 2007, PHARMACOL THERAPEUT, V116, P58, DOI 10.1016/j.pharmthera.2007.03.008; Smith SS, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00135; Snead OC, 1998, ANN NEUROL, V44, P688, DOI 10.1002/ana.410440417; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Trotter A, 2000, ANN MED, V32, P608, DOI 10.3109/07853890009002031; Turner AJ, 2009, PLACENTA, V30, P236, DOI 10.1016/j.placenta.2008.11.023; Tyzio R, 2008, EUR J NEUROSCI, V27, P2515, DOI 10.1111/j.1460-9568.2008.06234.x; Van den Bergh BRH, 2004, CHILD DEV, V75, P1085, DOI 10.1111/j.1467-8624.2004.00727.x; Volpe JJ, 2009, SEMIN PEDIATR NEUROL, V16, P167, DOI 10.1016/j.spen.2009.09.005; Vu TT, 2009, REPROD FERT DEVELOP, V21, P599, DOI 10.1071/RD08224; Wang JM, 2008, BRAIN RES REV, V57, P398, DOI 10.1016/j.brainresrev.2007.08.010; Williams MT, 1999, NEUROTOXICOL TERATOL, V21, P403, DOI 10.1016/S0892-0362(98)00060-9; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang SY, 2007, MOL GENET METAB, V92, P36, DOI 10.1016/j.ymgme.2007.06.001; Yawno T, 2007, NEUROSCIENCE, V146, P1726, DOI 10.1016/j.neuroscience.2007.03.023; Yawno T, 2011, STRESS, V14, P13, DOI 10.3109/10253890.2010.504789; Zimmerberg B, 1998, PHARMACOL BIOCHEM BE, V59, P819, DOI 10.1016/S0091-3057(97)00540-6; Zwain IH, 1999, ENDOCRINOLOGY, V140, P3843, DOI 10.1210/en.140.8.3843	77	18	18	1	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	JUN	2016	160				SI		181	188		10.1016/j.jsbmb.2015.09.012			8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Endocrinology & Metabolism	DN1QM	WOS:000376840500022	26365557				2022-02-06	
J	Horswill, MS				Horswill, Mark S.			Improving Fitness to Drive: The Case for Hazard Perception Training	AUSTRALIAN PSYCHOLOGIST			English	Article						driving skill; hazard perception; rehabilitation; road safety; training	TRAUMATIC BRAIN-INJURY; OLDER DRIVERS; NOVICE DRIVERS; RISK AWARENESS; WILL REDUCE; PERFORMANCE; ROAD; ABILITY; INTERVENTION; SIMULATOR	On one hand, individuals who are unfit to drive should not be allowed behind the wheel. On the other hand, being unable to drive can have significant negative consequences for some individuals, including an increased mortality risk. One potential solution to this dilemma is to use training interventions to improve fitness-to-drive. The problem is that, in general, post-licensing driver training and education has a disappointing track record in terms of improving road safety. However, one type of intervention that may have the potential to buck this trend is hazard perception training. Hazard perception, which is the driver's ability to anticipate dangerous situations on the road ahead, has been found to predict both crash risk and on-road driving performance, and can account for variance in both of these criteria that other key fitness-to-drive measures cannot. Crucially, there is evidence that hazard perception competence can be improved by brief computer-based interventions, even for driver groups who are more likely to face fitness-to-drive challenges, such as individuals aged over 65 years or adults with attention deficit hyperactivity disorder. This article puts the case for potentially using such interventions to help individuals with fitness-to-drive difficulties.	[Horswill, Mark S.] Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia		Horswill, MS (corresponding author), Univ Queensland, Sch Psychol, St Lucia, Qld 4072, Australia.	m.horswill@psy.uq.edu.au	Horswill, Mark/J-9029-2019	Horswill, Mark/0000-0002-0286-6292			Anstey K. J., 2009, AUSTR ROAD SAF RES P; Austroads, 2012, ASS FITN DRIV; Baker A, 2015, BRIT J OCCUP THER, V78, P73, DOI 10.1177/0308022614562405; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Beanland V, 2013, SAFETY SCI, V51, P127, DOI 10.1016/j.ssci.2012.06.021; Borowsky A., 2009, TRANSPORTATION RES F; Borowsky A., 2014, P HUM FACT ERG SOC A; Borowsky A, 2015, TRAFFIC INJ PREV, V16, P133, DOI 10.1080/15389588.2014.909593; Borowsky A, 2010, ACCIDENT ANAL PREV, V42, P1240, DOI 10.1016/j.aap.2010.02.001; Boufous S, 2011, TRAFFIC INJ PREV, V12, P475, DOI 10.1080/15389588.2011.591856; Brown P.C., 2014, MAKE IT STICK; Cantwell S., 2013, AUSTR ROAD SAF RES P; Chapman P., 2002, TRANSP RES F, V5, P157, DOI DOI 10.1016/S1369-8478(02)00014-1; Chatham RE, 2009, DEVELOPMENT OF PROFESSIONAL EXPERTISE: TOWARD MEASUREMENT OF EXPERT PERFORMANCE AND DESIGN OF OPTIMAL LEARNING ENVIRONMENTS, P27, DOI 10.1017/CBO9780511609817.003; Cheng ASK, 2011, ACCIDENT ANAL PREV, V43, P1464, DOI 10.1016/j.aap.2011.02.024; Clay OJ, 2005, OPTOMETRY VISION SCI, V82, P724, DOI 10.1097/01.opx.0000175009.08626.65; Congdon P., 1999, VICROADS HAZARD PERC; Crundall D, 2010, ACCIDENT ANAL PREV, V42, P2117, DOI 10.1016/j.aap.2010.07.001; Darby P, 2009, SAFETY SCI, V47, P436, DOI 10.1016/j.ssci.2008.05.004; Deery HA, 1996, ADDICTION, V91, P815, DOI 10.1046/j.1360-0443.1996.9168158.x; Devos H, 2010, NEUROREHAB NEURAL RE, V24, P843, DOI 10.1177/1545968310368687; Devos H, 2009, NEUROREHAB NEURAL RE, V23, P699, DOI 10.1177/1545968309334208; Dickerson AE, 2014, OCCUP THER HEALTH CA, V28, P82, DOI 10.3109/07380577.2014.904535; Dogan E, 2012, ACCIDENT ANAL PREV, V45, P522, DOI 10.1016/j.aap.2011.09.004; Edwards JD, 2009, J GERONTOL A-BIOL, V64, P1290, DOI 10.1093/gerona/glp114; Edwards JD, 2009, GERONTOLOGIST, V49, P485, DOI 10.1093/geront/gnp042; Ericsson KA, 2007, CURR DIR PSYCHOL SCI, V16, P346, DOI 10.1111/j.1467-8721.2007.00533.x; Evans L., 1991, TRAFFIC SAFETY DRIVE; Fisher DL, 2006, INJURY PREV, V12, P25, DOI 10.1136/ip.2006.012021; Fisher DL, 2002, HUM FACTORS, V44, P287, DOI 10.1518/0018720024497853; Grayson G, 2003, RISK HAZARD PERCEPTI; Groeger JA, 2007, ERGONOMICS, V50, P1250, DOI 10.1080/00140130701318723; Hamid M., 2014, TRANSP RES BOARD 93; Horswill M. S., 2004, COGNITIVE APPROACH S, P155; Horswill MS, 2008, J GERONTOL B-PSYCHOL, V63, pP212, DOI 10.1093/geronb/63.4.P212; Horswill MS, 2015, PSYCHOL AGING, V30, P62, DOI 10.1037/a0038671; Horswill MS, 2013, ACCIDENT ANAL PREV, V52, P100, DOI 10.1016/j.aap.2012.12.014; Horswill MS, 2013, ACCIDENT ANAL PREV, V50, P130, DOI 10.1016/j.aap.2012.04.001; Horswill MS, 2011, ACCIDENT ANAL PREV, V43, P2121, DOI 10.1016/j.aap.2011.05.035; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Horswill MS, 2010, PSYCHOL AGING, V25, P464, DOI 10.1037/a0017306; Horswill MS, 2004, J APPL SOC PSYCHOL, V34, P177, DOI 10.1111/j.1559-1816.2004.tb02543.x; Horswill MS, 1999, BRIT J PSYCHOL, V90, P189, DOI 10.1348/000712699161341; Isler RB, 2011, ACCIDENT ANAL PREV, V43, P1818, DOI 10.1016/j.aap.2011.04.017; Isler RB, 2009, ACCIDENT ANAL PREV, V41, P445, DOI 10.1016/j.aap.2008.12.016; JACOBY LL, 1978, J VERB LEARN VERB BE, V17, P649, DOI 10.1016/S0022-5371(78)90393-6; Korner-Bitensky N, 2009, J SAFETY RES, V40, P105, DOI 10.1016/j.jsr.2009.02.002; Liddle J, 2012, AUST OCCUP THER J, V59, P384, DOI 10.1111/j.1440-1630.2011.00956.x; Marottoli RA, 2007, J GEN INTERN MED, V22, P590, DOI 10.1007/s11606-007-0134-3; Mayhew DR, 1998, J PUBLIC HEALTH POL, V19, P51, DOI 10.2307/3343089; McKenna F, 1997, DEV HAZARD PERCEPTIO; McKenna F.P., 1999, J INT ASS TRAFFIC SA, V23, P26; McKenna F.P., 1991, HAZARD PERCEPTION DR; McKenna FP, 2006, J EXP PSYCHOL-APPL, V12, P1, DOI 10.1037/1076-898X.12.1.1; Meir A., 2010, 3 INT C APPL HUM FAC; Meir A, 2014, TRAFFIC INJ PREV, V15, P172, DOI 10.1080/15389588.2013.802775; Nasvadi GE, 2007, ACCIDENT ANAL PREV, V39, P1073, DOI 10.1016/j.aap.2007.02.005; Pelz D.C., 1974, ACCIDENT ANAL PREV, V6, P45, DOI [10.1016/0001-4575(74)90015-3., DOI 10.1016/0001-4575(74)90015-3]; Petzoldt T, 2013, ACCIDENT ANAL PREV, V50, P1185, DOI 10.1016/j.aap.2012.09.016; Pollatsek A, 2006, HUM FACTORS, V48, P447, DOI 10.1518/001872006778606787; Poulsen AA, 2010, AUST NZ J PSYCHIAT, V44, P528, DOI 10.3109/00048671003596048; Pradhan AK, 2009, ERGONOMICS, V52, P657, DOI 10.1080/00140130802550232; Preece MHW, 2011, J NEUROL NEUROSUR PS, V82, P447, DOI 10.1136/jnnp.2010.215228; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Quimby A., 1981, HUMAN FACTORS DRIVIN; QUIMBY AR, 1986, PERCEPTUAL ABILITIES; Ragland DR, 2005, J GERONTOL A-BIOL, V60, P399, DOI 10.1093/gerona/60.3.399; Regan MA, 2000, ROAD SAF RES POL ED; Roenker DL, 2003, HUM FACTORS, V45, P218, DOI 10.1518/hfes.45.2.218.27241; Rosenbloom T, 2011, ACCIDENT ANAL PREV, V43, P601, DOI 10.1016/j.aap.2010.08.005; Ross R. W, 2013, 7 INT DRIV S HUM FAC; Savage SW, 2013, TRANSPORT RES F-TRAF, V17, P52, DOI 10.1016/j.trf.2012.10.002; Schmidt R, 2005, MOTOR CONTROL LEARNI, V4th; Scialfa CT, 2012, ACCIDENT ANAL PREV, V45, P547, DOI 10.1016/j.aap.2011.09.005; Scialfa CT, 2011, ACCIDENT ANAL PREV, V43, P204, DOI 10.1016/j.aap.2010.08.010; Shinar D., 2007, TRAFFIC SAFETY HUMAN; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Taylor T, 2013, ACCIDENT ANAL PREV, V58, P175, DOI 10.1016/j.aap.2013.02.008; Taylor T. G., 2011, P INT DRIV S HUM FAC; Transport and Road Research Laboratory, 1979, HAZ PERC TEST DRIV; Vlakveld W, 2011, TRANSPORT RES REC, P153, DOI 10.3141/2265-17; Wallis TSA, 2007, ACCIDENT ANAL PREV, V39, P1177, DOI 10.1016/j.aap.2007.03.003; Wang YB, 2010, TRAFFIC INJ PREV, V11, P483, DOI 10.1080/15389588.2010.489242; Waylen AE, 2004, TRANSPORT RES F-TRAF, V7, P323, DOI 10.1016/j.trf.2004.09.009; Wells P, 2008, COHORT 2 STUDY LEARN; WEST R, 1993, ADDICTION, V88, P527, DOI 10.1111/j.1360-0443.1993.tb02059.x; Wetton MA, 2010, ACCIDENT ANAL PREV, V42, P1232, DOI 10.1016/j.aap.2010.01.017; Wetton MA, 2013, ACCIDENT ANAL PREV, V54, P57, DOI 10.1016/j.aap.2013.02.013; Wetton MA, 2011, ACCIDENT ANAL PREV, V43, P1759, DOI 10.1016/j.aap.2011.04.007; Wood JM, 2013, ACCIDENT ANAL PREV, V50, P1161, DOI 10.1016/j.aap.2012.09.009; Zafian T., 2014, TRANSP RES BOARD 93	91	18	19	0	15	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0005-0067	1742-9544		AUST PSYCHOL	Aust. Psychol.	JUN	2016	51	3					173	181		10.1111/ap.12132			9	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	DR6XF	WOS:000380043900001					2022-02-06	
J	Jang, SH; Park, SM; Kwon, HG				Jang, Sung Ho; Park, So Min; Kwon, Hyeok Gyu			Relation between injury of the periaqueductal gray and central pain in patients with mild traumatic brain injury: Observational study	MEDICINE			English	Article						central pain; diffusion tensor imaging; mild traumatic brain injury; periaqueductal gray	CENTRAL POSTSTROKE PAIN; NEUROPATHIC PAIN; SENSORY ABNORMALITIES; AXONAL INJURY; MECHANISMS; TRACTOGRAPHY; STIMULATION; MANAGEMENT; MIDBRAIN; MATTER	The periaqueductal gray (PAG) plays a pivotal role in pain modulation. We attempted to examine the relation between injury of the PAG and central pain in patients with mild traumatic brain injury (TBI).Sixty-one patients with mild TBI with central pain and 31 healthy control subjects were recruited for this study. Visual analog scale (VAS) was used for evaluation of central pain. The region of interest was defined for the PAG and the fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were measured.The FA value was significantly lower in the patient group than in the control group (P<0.05). However, no significant difference in the ADC value was observed between the patient and control groups (P>0.05). VAS score of the patient group showed significant moderate negative correlation with the FA (r = -0.38), while no significant correlation was observed between VAS score and the ADC value (P<0.05).We demonstrated injury of the PAG in patients with central pain following mild TBI and the degree of injury of the PAG was closely related to the degree of central pain.	[Jang, Sung Ho; Park, So Min; Kwon, Hyeok Gyu] Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Daegu 705717, South Korea		Kwon, HG (corresponding author), Yeungnam Univ, Dept Phys Med & Rehabil, Coll Med, 317-1 Daemyung Dong, Daegu 705717, South Korea.	khg0715@hanmail.net			Medical Research Center Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2015R1A5A2009124]	This work was supported by the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Ab Aziz CB, 2006, MALAYS J MED SCI, V13, P11; ALEXANDER MP, 1995, NEUROLOGY, V45, P1253, DOI 10.1212/WNL.45.7.1253; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; Barad M., 2009, CONTINUUM MINNEAP MI, V15, P30, DOI 10.1212/01.con.0000348853.20265.b7; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BLUMBERGS PC, 1989, J NEUROL NEUROSUR PS, V52, P838, DOI 10.1136/jnnp.52.7.838; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Borsook D, 2012, BRAIN, V135, P320, DOI 10.1093/brain/awr271; CESARO P, 1991, PAIN, V47, P329, DOI 10.1016/0304-3959(91)90224-L; DaSilva AFM, 2007, NEUROREPORT, V18, P301, DOI 10.1097/WNR.0b013e32801776bb; de Kruijk JR, 2001, BRAIN INJURY, V15, P99, DOI 10.1080/026990501458335; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Ezra M, 2015, HUM BRAIN MAPP, V36, P3459, DOI 10.1002/hbm.22855; Hoskin KL, 2001, J ANAT, V198, P29, DOI 10.1046/j.1469-7580.2001.19810029.x; Ito K, 2016, NEURORADIOLOGY, V58, P115, DOI 10.1007/s00234-015-1603-8; Jang SH, 2016, BRAIN INJ; Jiang HY, 2006, COMPUT METH PROG BIO, V81, P106, DOI 10.1016/j.cmpb.2005.08.004; Kim JH, 2015, J HEAD TRAUMA REHAB, V30, pE40, DOI 10.1097/HTR.0000000000000121; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kwon HG, 2014, BRAIN INJURY, V28, P511, DOI 10.3109/02699052.2014.887228; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lee SK, 2005, RADIOGRAPHICS, V25, P68; Lee SK, 2005, RADIOGRAPHICS, V25, P53, DOI 10.1148/rg.251045085; Linnman C, 2012, NEUROIMAGE, V60, P505, DOI 10.1016/j.neuroimage.2011.11.095; Lorenz J, 2003, BRAIN, V126, P1079, DOI 10.1093/brain/awg102; Maarrawi J, 2007, PAIN, V127, P183, DOI 10.1016/j.pain.2006.10.013; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Merskey H, 1994, CLASSIFICATION CHRON; Miller M D, 1993, Fam Pract Res J, V13, P15; NASHOLD BS, 1969, J NEUROSURG, V30, P14, DOI 10.3171/jns.1969.30.1.0014; Neugebauer V, 2004, NEUROSCIENTIST, V10, P221, DOI 10.1177/1073858403261077; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Owen SLF, 2006, PAIN, V120, P202, DOI 10.1016/j.pain.2005.09.035; Petrovic P, 1999, PAIN, V83, P459, DOI 10.1016/S0304-3959(99)00150-5; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Satpute AB, 2013, P NATL ACAD SCI USA, V110, P17101, DOI 10.1073/pnas.1306095110; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Topolovec JC, 2004, J COMP NEUROL, V471, P446, DOI 10.1002/cne.20033; VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0	45	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0025-7974	1536-5964		MEDICINE	Medicine (Baltimore)	JUN	2016	95	26							e4017	10.1097/MD.0000000000004017			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS1PV	WOS:000380369300046	27368020	Green Published, gold			2022-02-06	
J	Kallet, RH; Branson, RD				Kallet, Richard H.; Branson, Richard D.			Should Oxygen Therapy Be Tightly Regulated to Minimize Hyperoxia in Critically Ill Patients?	RESPIRATORY CARE			English	Article; Proceedings Paper	54th Respiratory Care Journal Conference on Respiratory Care Controversies III	JUN 05-06, 2015	St Petersburg, FL			hyperoxia; hyperoxic acute lung injury; lung protective ventilation; oxygen toxicity; reactive oxygen species; ventilator-induced lung injury	ACUTE RESPIRATORY-DISTRESS; MECHANICALLY VENTILATED PATIENTS; INDUCED LUNG INJURY; OBSTRUCTIVE PULMONARY-DISEASE; TRAUMATIC BRAIN-INJURY; HIGH TIDAL VOLUME; ARTERIAL HYPEROXIA; OXIDATIVE STRESS; CARDIAC-ARREST; NORMOBARIC HYPEROXIA	Oxygen is both lifesaving and toxic. Appropriate use of oxygen aims to provide a balance between the two effects. Although local oxygen toxicity to the lung is well accepted, recent evidence has called into question the negative consequences of hyperoxemia in other organ beds. Hyperoxia following cardiac arrest, traumatic brain injury, and stroke has been shown to worsen outcomes. The role of hyperoxemia in mechanically ventilated patients, in the face of non-toxic inspired oxygen concentrations, is less clear. This paper will review the data for and against the use of conservative oxygen targets and the avoidance of hyperoxemia in mechanically ventilated patients. (C) 2016 Daedalus Enterprises	[Kallet, Richard H.] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia, NH GA-2,1001 Potrero Ave, San Francisco, CA 94110 USA; [Branson, Richard D.] Univ Cincinnati, Dept Surg, 231 Bethesda Ave, Cincinnati, OH 45267 USA		Kallet, RH (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia, NH GA-2,1001 Potrero Ave, San Francisco, CA 94110 USA.		Branson, Richard/K-4567-2019; Branson, Richard/ABD-7229-2020	Branson, Richard/0000-0002-0912-3360			Abdelsalam M, 2010, RESP CARE, V55, P1483; Aboab J, 2006, INTENS CARE MED, V32, P1979, DOI 10.1007/s00134-006-0382-4; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; Andrade PV, 2014, INFLAMMATION, V37, P486, DOI 10.1007/s10753-013-9762-4; ASHBAUGH DG, 1967, LANCET, V2, P319; Austin MA, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5462; Bailey TC, 2003, J APPL PHYSIOL, V94, P975, DOI 10.1152/japplphysiol.00619.2002; Barbaro MPF, 2005, FREE RADICAL RES, V39, P1111, DOI 10.1080/10715760500250257; Bellani G, 2009, CRIT CARE MED, V37, P2216, DOI 10.1097/CCM.0b013e3181aab31f; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; BLAISDELL FW, 1970, SURG GYNECOL OBSTETR, V130, P15; Boissier F, 2013, INTENS CARE MED, V39, P1725, DOI 10.1007/s00134-013-2941-9; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Buczynski BW, 2013, SEMIN PERINATOL, V37, P69, DOI 10.1053/j.semperi.2013.01.002; Bull TM, 2010, AM J RESP CRIT CARE, V182, P1123, DOI 10.1164/rccm.201002-0250OC; Cameron L, 2012, POSTGRAD MED J, V88, P684, DOI 10.1136/postgradmedj-2012-130809; Carlo WA, 2010, NEW ENGL J MED, V362, P1959, DOI 10.1056/NEJMoa0911781; Chiang CH, 2008, RESUSCITATION, V79, P147, DOI 10.1016/j.resuscitation.2008.02.028; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; CLARK JM, 1971, PHARMACOL REV, V23, P37; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; DAVIS JM, 1989, J APPL PHYSIOL, V67, P1007, DOI 10.1152/jappl.1989.67.3.1007; de Graaff AE, 2011, INTENS CARE MED, V37, P46, DOI 10.1007/s00134-010-2025-z; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; DREYFUSS D, 1985, AM REV RESPIR DIS, V132, P880; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Eastwood GM, 2016, RESUSCITATION, V101, P108, DOI 10.1016/j.resuscitation.2015.11.026; Eastwood GM, 2014, AUST CRIT CARE, V27, P120, DOI 10.1016/j.aucc.2013.11.004; Eastwood GM, 2014, CURR OPIN CRIT CARE, V20, P266, DOI 10.1097/MCC.0000000000000084; Ehlert CA, 2006, BIOL NEONATE, V90, P89, DOI 10.1159/000092005; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; FAIRLEY HB, 1964, CAN MED ASSOC J, V90, P1394; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FINCH CA, 1972, NEW ENGL J MED, V286, P407, DOI 10.1056/NEJM197202242860806; Fisher AO, 2012, PEDIATR PULM, V47, P979, DOI 10.1002/ppul.22517; Fisher AB, 2008, AM J PHYSIOL-LUNG C, V295, pL1066, DOI 10.1152/ajplung.90486.2008; Fluck M, 2007, INTEGR COMP BIOL, V47, P524, DOI 10.1093/icb/icm080; GANZ W, 1972, CIRCULATION, V45, P763, DOI 10.1161/01.CIR.45.4.763; Gattinoni L, 2005, INTENS CARE MED, V31, P776, DOI 10.1007/s00134-005-2627-z; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; GERSCHMAN R, 1954, SCIENCE, V119, P623, DOI 10.1126/science.119.3097.623; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Helmerhorst HJF, 2016, CRIT CARE MED, V44, P554, DOI 10.1097/CCM.0000000000001461; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0996-4; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; HESS ML, 1984, J MOL CELL CARDIOL, V16, P969, DOI 10.1016/S0022-2828(84)80011-5; Hlatky R, 2008, J NEUROSURG, V108, P53, DOI 10.3171/JNS/2008/108/01/0053; Hubmayr RD, 2012, AM J PHYSIOL-LUNG C, V302, pL1233, DOI 10.1152/ajplung.00121.2012; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; Kielan-Jaworowska Z., 2004, MAMMALS AGE DINOSAUR; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kirkham PA, 2013, CHEST, V144, P266, DOI 10.1378/chest.12-2664; Kuipers MT, 2011, CRIT CARE, V15, DOI 10.1186/cc10437; LENFANT C, 1965, ANN NY ACAD SCI, V121, P797, DOI 10.1111/j.1749-6632.1965.tb14249.x; Leverve XM, 2008, CRIT CARE MED, V36, P637, DOI 10.1097/CCM.0B013E31816296AD; Li LF, 2007, CRIT CARE, V11, DOI 10.1186/cc5704; Linton R C, 1965, Can Anaesth Soc J, V12, P451; Liu YY, 2009, TRANSL RES, V154, P228, DOI 10.1016/j.trsl.2009.06.006; Lopez-Rodriguez E, 2014, BBA-BIOMEMBRANES, V1838, P1568, DOI 10.1016/j.bbamem.2014.01.028; LUND T, 1984, CRIT CARE MED, V12, P75, DOI 10.1097/00003246-198401000-00020; Mak S, 2001, CHEST, V120, P467, DOI 10.1378/chest.120.2.467; Makena PS, 2011, J APPL PHYSIOL, V111, P1467, DOI 10.1152/japplphysiol.00539.2011; Makena PS, 2010, AM J PHYSIOL-LUNG C, V299, pL711, DOI 10.1152/ajplung.00072.2010; Malley WJ, 2005, CLIN BLOOD GASES ASS, P170; Martin DS, 2013, CRIT CARE MED, V41, P423, DOI 10.1097/CCM.0b013e31826a44f6; McNulty PH, 2005, AM J PHYSIOL-HEART C, V288, pH1057, DOI 10.1152/ajpheart.00625.2004; Meyhoff CS, 2012, CURR OPIN ANESTHESIO, V25, P363, DOI 10.1097/ACO.0b013e328352b402; Morita K, 2012, GEN THORAC CARDIOVAS, V60, P549, DOI 10.1007/s11748-012-0115-2; Nastos C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/906965; Nieuwenhuizen L, 2009, EUR J HAEMATOL, V82, P413, DOI 10.1111/j.1600-0609.2009.01238.x; Nitzan M, 2014, MED DEVICES-EVID RES, V7, P231, DOI 10.2147/MDER.S47319; Panwar R, 2016, AM J RESP CRIT CARE, V193, P43, DOI 10.1164/rccm.201505-1019OC; PETTY TL, 1971, ANN INTERN MED, V75, P361, DOI 10.7326/0003-4819-75-3-361; Pilcher J, 2012, RESUSCITATION, V83, P417, DOI 10.1016/j.resuscitation.2011.12.021; Pontoppidan H, 1967, JAMA, V201, P89, DOI 10.1001/jama.201.1.89; PONTOPPIDAN H, 1972, NEW ENGL J MED, V287, P690, DOI 10.1056/NEJM197210052871404; POWERS SR, 1972, J TRAUM, V12, P1, DOI 10.1097/00005373-197201000-00001; PRATT PC, 1958, AM J PATHOL, V34, P1033; Quinn DA, 2002, J APPL PHYSIOL, V93, P517, DOI 10.1152/japplphysiol.00570.2001; Rachmale S, 2012, RESP CARE, V57, P1887, DOI 10.4187/respcare.01696; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Risom L, 2005, MUTAT RES-FUND MOL M, V592, P119, DOI 10.1016/j.mrfmmm.2005.06.012; Roan E, 2012, AM J PHYSIOL-LUNG C, V302, pL1235, DOI 10.1152/ajplung.00223.2011; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rousseau A, 2005, ACTA PHYSIOL SCAND, V183, P231, DOI 10.1111/j.1365-201X.2005.01405.x; Sandroni C, 2014, MINERVA ANESTESIOL, V80, P1105; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Severinghaus J W, 1986, J Clin Monit, V2, P125, DOI 10.1007/BF01637680; Sinclair SE, 2004, CRIT CARE MED, V32, P2496, DOI 10.1097/01.CCM.0000148231.04642.8D; Sjoberg F, 2013, J INTERN MED, V274, P505, DOI 10.1111/joim.12139; Soler-Cataluna JJ, 2005, THORAX, V60, P925, DOI 10.1136/thx.2005.040527; Stenson BJ, 2013, NEW ENGL J MED, V368, P2094, DOI 10.1056/NEJMoa1302298; Suzuki S, 2015, J CRIT CARE, V30, P1232, DOI 10.1016/j.jcrc.2015.07.033; Suzuki S, 2014, CRIT CARE MED, V42, P1414, DOI 10.1097/CCM.0000000000000219; Tao F, 2003, FREE RADICAL BIO MED, V35, P327, DOI 10.1016/S0891-5849(03)00280-6; Terragni PP, 2007, AM J RESP CRIT CARE, V175, P160, DOI 10.1164/rccm.200607-915OC; Tiwari YV, 2016, BRAIN RES, V1635, P121, DOI 10.1016/j.brainres.2016.01.030; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Wang Y, 2015, NEUROREPORT, V26, P131, DOI 10.1097/WNR.0000000000000314; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; West JB, 2012, RESP PHYSL ESSENTIAL, P80; Wu O, 2012, J CEREBR BLOOD F MET, V32, P1800, DOI 10.1038/jcbfm.2012.87; Zangl Q, 2014, ANESTHESIOLOGY, V121, P1217, DOI 10.1097/ALN.0000000000000447; Zhao S, 2015, CRIT CARE MED, V43, pE560, DOI 10.1097/CCM.0000000000001297	113	18	19	0	7	DAEDALUS ENTERPRISES INC	IRVING	9425 N MAC ARTHUR BLVD, STE 100, IRVING, TX 75063-4706 USA	0020-1324	1943-3654		RESP CARE	Respir. Care	JUN	2016	61	6			SI		801	815		10.4187/respcare.04933			15	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Respiratory System	DN7CU	WOS:000377233700014	27235315	Bronze			2022-02-06	
J	Litofsky, NS; Martin, S; Diaz, J; Ge, B; Petroski, G; Miller, DC; Barnes, SL				Litofsky, N. Scott; Martin, Simon; Diaz, Jenna; Ge, Bin; Petroski, Greg; Miller, Douglas C.; Barnes, Stephen L.			The Negative Impact of Anemia in Outcome from Traumatic Brain Injury	WORLD NEUROSURGERY			English	Article						Anemia; Glasgow Outcome Score; Hemoglobin; Injury Severity Score; Traumatic brain injury	BLOOD-CELL TRANSFUSION; GENDER-DIFFERENCES; HEAD-INJURY; MODERATE; OXYGENATION; MORTALITY; WORSE	BACKGROUND: Whether anemia complicating traumatic brain injury (TBI) has an impact on patient outcomes is controversial; therefore, recommendations for blood transfusions for such patients are inconsistent. We hypothesized that patient outcome after TBI would be worse in patients with lower hemoglobin levels. METHODS: We retrospectively reviewed records of patients with TBI and head Abbreviated Injury Scale >3 with abnormal head computed tomography findings and neurologic injury. The relationships between initial hemoglobin and lowest hemoglobin during hospitalization at threshold values of <= 7, <= 8, <= 9, and <= 10 g/dL were investigated relative to Glasgow Outcome Score at last follow-up not exceeding 1 year. RESULTS: Of 939 patients meeting inclusion criteria, initial and lowest hemoglobin concentrations were significant predictors of poor outcome (P < 0.0001). For each 1 g/dL higher hemoglobin value, the likelihood of a good outcome increased by 33%. More severe levels of initial anemia were associated with lower Glasgow Coma Scale, greater head Abbreviated Injury Scale, and greater Injury Severity Score (P < 0.0001). Female patients had worse outcome than male patients only for initial hemoglobin between 7 and 8 g/dL (P < 0.05). Blood transfusion was associated with poorer outcome at hemoglobin levels <= 9 and <= 10 g/dL (P < 0.05), but not at lower hemoglobin thresholds. CONCLUSIONS: Patient outcome after TBI is worse in patients with lower hemoglobin. Initial hemoglobin and lowest hemoglobin after admission are independently associated with poor outcome. Our data support consideration of blood transfusion when hemoglobin is <= 8 g/dl.	[Litofsky, N. Scott; Martin, Simon; Diaz, Jenna] Univ Missouri, Sch Med, Div Neurol Surg, Columbia, MO 65211 USA; [Ge, Bin; Petroski, Greg] Univ Missouri, Sch Med, Off Med Res, Columbia, MO USA; [Miller, Douglas C.] Univ Missouri, Sch Med, Dept Pathol, Columbia, MO 65212 USA; [Barnes, Stephen L.] Univ Missouri, Sch Med, Div Acute Care Surg, Columbia, MO USA		Litofsky, NS (corresponding author), Univ Missouri, Sch Med, Div Neurol Surg, Columbia, MO 65211 USA.	litofskyn@health.missouri.edu		Barnes, Stephen/0000-0001-6186-1435; Diaz, Jenna/0000-0002-2514-9739	Division of Neurological Surgery of the University of Missouri School of Medicine; Medical Student Summer Research Fellowship from the University of Missouri School of Medicine	Supported by research funds from Division of Neurological Surgery of the University of Missouri School of Medicine and a Medical Student Summer Research Fellowship from the University of Missouri School of Medicine for S.M.	Ariza M, 2004, J NEUROTRAUM, V21, P864, DOI 10.1089/0897715041526203; Bellapart J, 2012, J TRAUMA ACUTE CARE, V73, P997, DOI 10.1097/TA.0b013e318265cede; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; Blissitt PA, 2012, AACN ADV CRIT CARE, V23, P186, DOI 10.1097/NCI.0b013e31824db4f3; Boutin A, 2016, TRANSFUS MED REV, V30, P15, DOI 10.1016/j.tmrv.2015.08.004; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carlson AP, 2006, J TRAUMA, V61, P567, DOI 10.1097/01.ta.0000231768.44727.a2; Dexter F, 2007, BRIT J ANAESTH, V79, P346; Duane TM, 2008, J SURG RES, V147, P163, DOI 10.1016/j.jss.2008.02.044; Ekegren CL, 2016, INJURY, V47, P130, DOI 10.1016/j.injury.2015.08.002; Elterman J, 2013, J TRAUMA ACUTE CARE, V75, P8, DOI 10.1097/TA.0b013e318298492e; Ely EW, 1999, NEW ENGL J MED, V340, P467, DOI 10.1056/NEJM199902113400610; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; George ME, 2008, NEUROCRIT CARE, V8, P337, DOI 10.1007/s12028-008-9066-y; Goodnough LT, 2003, CRIT CARE MED, V31, pS678, DOI 10.1097/01.CCM.0000100124.50579.D9; Gruenbaum SE, 2014, CURR OPIN ANESTHESIO, V27, P470, DOI 10.1097/ACO.0000000000000109; Hare GMT, 2007, J APPL PHYSIOL, V103, P1021, DOI 10.1152/japplphysiol.01315.2006; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Kim YJ, 2011, J CLIN NURS, V20, P1518, DOI 10.1111/j.1365-2702.2010.03618.x; Kramer AH, 2012, CURR TREAT OPTION NE, V14, P150, DOI 10.1007/s11940-012-0167-8; Kramer AH, 2009, CRIT CARE, V13, DOI 10.1186/cc7916; Kumar MA, 2012, NEUROTHERAPEUTICS, V9, P56, DOI 10.1007/s13311-011-0094-5; Lei C, 2012, ANESTHESIOLOGY, V117, P1190, DOI 10.1097/ALN.0b013e318272d866; LeRoux P, 2013, CURR OPIN CRIT CARE, V19, P83, DOI 10.1097/MCC.0b013e32835eba43; McCrossan L, 2012, BRIT J ANAESTH, V88, P6; McIntyre LA, 2006, NEUROCRIT CARE, V5, P4, DOI 10.1385/NCC:5:1:4; Oddo M, 2012, INTENS CARE MED, V38, P1497, DOI 10.1007/s00134-012-2593-1; Ponsford JL, 2008, INJURY, V39, P67, DOI 10.1016/j.injury.2007.08.028; Reddy GD, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0379-9; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Salim A, 2008, J AM COLL SURGEONS, V207, P398, DOI 10.1016/j.jamcollsurg.2008.03.013; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schirmer-Mikalsen K, 2012, ACTA ANAESTH SCAND, V57, P46; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sena MJ, 2009, INTENS CARE MED, V35, P480, DOI 10.1007/s00134-008-1289-z; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Tango HK, 2009, J TRAUMA, V66, P720, DOI 10.1097/TA.0b013e3181719b35; Utter GH, 2011, J NEUROTRAUM, V28, P155, DOI 10.1089/neu.2010.1451; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Walsh TS, 2004, CRIT CARE MED, V32, P364, DOI 10.1097/01.CCM.0000108878.23703.E0; Warner MA, 2010, J NEUROSURG, V113, P539, DOI 10.3171/2009.12.JNS091337; Winn HR, 2004, CRITICAL CARE MANAGE, P3411; Yang C-J, 2011, J TRAUMA, V71, P132; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	45	18	20	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JUN	2016	90						82	90		10.1016/j.wneu.2016.02.076			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DS1MS	WOS:000380360500012	26921698				2022-02-06	
J	Schmidt, B; Reinhard, M; Lezaic, V; McLeod, DD; Weinhold, M; Mattes, H; Klingelhofer, J				Schmidt, Bernhard; Reinhard, Matthias; Lezaic, Vesna; McLeod, Damian D.; Weinhold, Marco; Mattes, Heinz; Klingelhoefer, Juergen			Autoregulation monitoring and outcome prediction in neurocritical care patients: Does one index fit all?	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Cerebral autoregulation; Cerebrovascular pressure reactivity; Modified Rankin Scale; Cerebral blood flow; Traumatic brain injury; Stroke	CEREBRAL PERFUSION-PRESSURE; TRAUMATIC BRAIN-INJURY; VOLUME INDEX; HEAD-INJURY; CEREBROVASCULAR REACTIVITY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL-PRESSURE; BLOOD-FLOW; CRANIECTOMY; VELOCITY	Indexes PRx and Mx have been formerly introduced to assess cerebral autoregulation and have been shown to be associated with 3-month clinical outcome. In a mixed cohort of neurocritical care patients, we retrospectively investigated the impact of selected clinical characteristics on this association. Forty-one patients (18-77 years) with severe traumatic (TBI, N = 20) and non-traumatic (N = 21) brain injuries were studied. Cerebral blood flow velocity, arterial blood pressure and intracranial pressure were repeatedly recorded during 1-h periods. Calculated PRx and Mx were correlated with 3-month clinical outcome score of modified Rankin Scale (mRS) in different subgroups with specific clinical characteristics. Both PRx and Mx correlated significantly with outcome (PRx: r = 0.38, p < 0.05; AUC = 0.64, n.s./Mx: r = 0.48, p < 0.005; AUC = 0.80, p < 0.005) in the overall group, and in patients with hemicraniectomy (N = 17; PRx: r = 0.73, p < 0.001; AUC = 0.89, p < 0.01/Mx: r = 0.69, p < 0.005; AUC = 0.87, p < 0.05). Mx, not PRx, correlated significantly with mRS in patients with heart failure (N = 17; r = 0.69, p < 0.005; AUC = 0.92, p < 0.005), and in non-traumatic patients (r = 0.49, p < 0.05; AUC = 0.79, p < 0.05). PRx, not Mx, correlated significantly with mRS in TBI patients (r = 0.63, p < 0.01; AUC = 0.89, p < 0.01). Both indexes did not correlate with mRS in diabetes patients (N = 15), PRx failed in hypocapnic patients (N = 26). Both PRx and Mx were significantly associated with 3-month clinical outcome, even in patients with hemicraniectomy. PRx was more appropriate for TBI patients, while Mx was better suited for non-traumatic patients and patients with heart failure. Prognostic values of indexes were affected by diabetes (both Mx and PRx) and hypocapnia (PRx only).	[Schmidt, Bernhard; Lezaic, Vesna; Weinhold, Marco; Klingelhoefer, Juergen] Chemnitz Med Ctr, Dept Neurol, Dresdner Str 178, D-09131 Chemnitz, Germany; [Reinhard, Matthias] Univ Freiburg, Dept Neurol, Breisacher Str 64, D-79106 Freiburg, Germany; [McLeod, Damian D.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW 2308, Australia; [Mattes, Heinz] Univ Erlangen Nurnberg, Dept Elect Elect & Commun Engn, D-91052 Erlangen, Germany		Schmidt, B (corresponding author), Chemnitz Med Ctr, Dept Neurol, Dresdner Str 178, D-09131 Chemnitz, Germany.	B.Schmidt@skc.de	MCLEOD, DAMIAN/G-7704-2013	MCLEOD, DAMIAN/0000-0002-1297-8984			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Barth M, 2010, NEUROCRIT CARE, V12, P234, DOI 10.1007/s12028-009-9287-8; Brady KM, 2012, J APPL PHYSIOL, V113, P1362, DOI 10.1152/japplphysiol.00853.2012; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Budohoski KP, 2012, NEUROCRIT CARE, V17, P211, DOI 10.1007/s12028-011-9572-1; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Diedler J, 2014, CRIT CARE, V18, DOI 10.1186/cc13796; Diedler J, 2009, STROKE, V40, P815, DOI 10.1161/STROKEAHA.108.531020; ENEVOLDSEN EM, 1978, J NEUROSURG, V48, P689, DOI 10.3171/jns.1978.48.5.0689; GRAY WJ, 1987, J NEUROSURG, V67, P369, DOI 10.3171/jns.1987.67.3.0369; GRAY WJ, 1987, J NEUROSURG, V67, P377, DOI 10.3171/jns.1987.67.3.0377; LASSEN NA, 1974, CIRC RES, V34, P749, DOI 10.1161/01.RES.34.6.749; Lazaridis C, 2013, NEUROL RES, V35, P138, DOI 10.1179/1743132812Y.0000000150; MASET AL, 1987, J NEUROSURG, V67, P832, DOI 10.3171/jns.1987.67.6.0832; MUDHOLKAR GS, 1992, BIOMETRIKA, V79, P850, DOI 10.2307/2337243; NEWELL DW, 1994, STROKE, V25, P793, DOI 10.1161/01.STR.25.4.793; Reinhard M, 2010, INTENS CARE MED, V36, P264, DOI 10.1007/s00134-009-1698-7; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; Schmidt B, 2003, STROKE, V34, P84, DOI 10.1161/01.STR.0000047849.01376.AE; Schmidt B, 2014, IJCNMH S1, V1, pS18; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Sorrentino E, 2011, NEUROCRIT CARE, V14, P188, DOI 10.1007/s12028-010-9492-5; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wang EC, 2006, BRIT J NEUROSURG, V20, P24, DOI 10.1080/02688690600598257	29	18	18	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307	1573-2614		J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	JUN	2016	30	3					367	375		10.1007/s10877-015-9726-3			9	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	DL6YV	WOS:000375786900014	26085437	Green Published, hybrid			2022-02-06	
J	Besnard, J; Richard, P; Banville, F; Nolin, P; Aubin, G; Le Gall, D; Richard, I; Allain, P				Besnard, Jeremy; Richard, Paul; Banville, Frederic; Nolin, Pierre; Aubin, Ghislaine; Le Gall, Didier; Richard, Isabelle; Allain, Phillippe			Virtual reality and neuropsychological assessment: The reliability of a virtual kitchen to assess daily-life activities in victims of traumatic brain injury	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						instrumental activities of daily living (IADL); executive functions; ecological validity; virtual reality; activities of daily living (ADL); neuropsychological assessment; Action; traumatic brain injury	EXECUTIVE FUNCTION; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; HEAD-INJURY; REHABILITATION; DEFICITS; VALIDITY; TASK; ENVIRONMENTS; DYSFUNCTION	Traumatic brain injury (TBI) causes impairments affecting instrumental activities of daily living (IADL). However, few studies have considered virtual reality as an ecologically valid tool for the assessment of IADL in patients who have sustained a TBI. The main objective of the present study was to examine the use of the Nonimmersive Virtual Coffee Task (NI-VCT) for IADL assessment in patients with TBI. We analyzed the performance of 19 adults suffering from TBI and 19 healthy controls (HCs) in the real and virtual tasks of making coffee with a coffee machine, as well as in global IQ and executive functions. Patients performed worse than HCs on both real and virtual tasks and on all tests of executive functions. Correlation analyses revealed that NI-VCT scores were related to scores on the real task. Moreover, regression analyses demonstrated that performance on NI-VCT matched real-task performance. Our results support the idea that the virtual kitchen is a valid tool for IADL assessment in patients who have sustained a TBI.	[Besnard, Jeremy] Univ Angers, Lab Psychol Pays Loire EA 4638, LUNAM Univ, Angers, France; [Richard, Paul] Univ Angers, Lab Angevin Rech Ingn Syst EA 7315, LUNAM Univ, Angers, France; [Banville, Frederic] Univ Quebec Rimousky, Dept Nursing, Rimousky, PQ, Canada; [Nolin, Pierre] Univ Quebec Trois Rivieres, Dept Psychol, Trois Rivieres, PQ GA9 5H7, Canada; [Aubin, Ghislaine; Richard, Isabelle] Reg Ctr Funct Rehabil, Angers, France; [Le Gall, Didier; Allain, Phillippe] Univ Angers, Lab Psychol Pays Loire EA 4638, LUNAM Univ, Angers, France; [Le Gall, Didier; Allain, Phillippe] Univ Hosp Angers, Dept Neurol, Neuropsychol Unit, 4 Rue Larrey, F-49033 Angers 01, France		Allain, P (corresponding author), Univ Hosp Angers, Dept Neurol, Neuropsychol Unit, 4 Rue Larrey, F-49033 Angers 01, France.	philippe.allain@univ-angers.fr		ALLAIN, Philiooe/0000-0003-0668-0986; Besnard, Jeremy/0000-0001-7127-7558			Allain P, 2004, REV NEUROPSYCHOL, V14, P285; Allain P, 2014, J INT NEUROPSYCH SOC, V20, P468, DOI 10.1017/S1355617714000344; Allain P, 2012, CORTEX, V48, P1155, DOI 10.1016/j.cortex.2011.05.016; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; Boelen DHE, 2011, J NEUROPSYCHOL, V5, P73, DOI 10.1348/174866410X516434; Bohil CJ, 2011, NAT REV NEUROSCI, V12, P752, DOI 10.1038/nrn3122; Botvinick M, 2004, PSYCHOL REV, V111, P395, DOI 10.1037/0033-295X.111.2.395; Botvinick M, 2015, ANNU REV PSYCHOL, V66, P83, DOI 10.1146/annurev-psych-010814-015044; Burgess P, 1996, BEHAV ASSESSMENT DYS; Burgess PW, 2009, RESTOR NEUROL NEUROS, V27, P493, DOI 10.3233/RNN-2009-0511; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Canty AL, 2014, NEUROPSYCHOL REHABIL, V24, P238, DOI 10.1080/09602011.2014.881746; Chaytor N, 2003, NEUROPSYCHOL REV, V13, P181, DOI 10.1023/B:NERV.0000009483.91468.fb; Chevignard M, 2000, CORTEX, V36, P649, DOI 10.1016/S0010-9452(08)70543-4; Christiansen C, 1998, ARCH PHYS MED REHAB, V79, P888, DOI 10.1016/S0003-9993(98)90083-1; Cooper R, 2000, COGN NEUROPSYCHOL, V17, P297, DOI 10.1080/026432900380427; CREPEAU F, 1993, NEUROPSYCHOL REHABIL, V3, P5; Cushman LA, 2008, NEUROLOGY, V71, P888, DOI 10.1212/01.wnl.0000326262.67613.fe; Dickinson A, 2007, BEHAV INFORM TECHNOL, V26, P343, DOI 10.1080/01449290601176948; Edwards J, 2014, APPL NEUROPSYCH-ADUL, V21, P220, DOI 10.1080/09084282.2013.796554; Flanagan Steven R, 2008, Neuropsychiatr Dis Treat, V4, P877; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fortin S, 2003, CORTEX, V39, P273, DOI 10.1016/S0010-9452(08)70109-6; Giovannetti T, 2008, DEMENT GERIATR COGN, V25, P359, DOI 10.1159/000121005; Giovannetti T, 2008, NEUROPSYCHOLOGY, V22, P235, DOI 10.1037/0894-4105.22.2.235; Giovannetti T, 2007, J CLIN EXP NEUROPSYC, V29, P690, DOI 10.1080/13803390600932286; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Grafman J., 1989, INTEGRATING THEORY P, P93; Harris Kristen, 2005, Can J Occup Ther, V72, P21; Jacoby M, 2013, IEEE T NEUR SYS REH, V21, P182, DOI 10.1109/TNSRE.2012.2235184; Josman N, 2008, INT J DISABIL HUM DE, V7, P49; Jovanovski D, 2012, APPL NEUROPSYCH-ADUL, V19, P171, DOI 10.1080/09084282.2011.643955; Lee JH, 2003, CYBERPSYCHOL BEHAV, V6, P383, DOI 10.1089/109493103322278763; McGeorge P, 2001, PRESENCE-TELEOP VIRT, V10, P375, DOI 10.1162/1054746011470235; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Rand D, 2007, DISABIL REHABIL, V29, P1710, DOI 10.1080/09638280601107450; Rand D, 2009, NEUROPSYCHOL REHABIL, V19, P583, DOI 10.1080/09602010802469074; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Renison B, 2012, J INT NEUROPSYCH SOC, V18, P440, DOI 10.1017/S1355617711001883; Rizzo AA, 2004, NEUROPSYCHOL REHABIL, V14, P207, DOI 10.1080/09602010343000183; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schwartz MF, 1998, NEUROPSYCHOLOGY, V12, P13, DOI 10.1037/0894-4105.12.1.13; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Ward T., 1994, TEST EVERYDAY ATTENT; Westbrook A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068210; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; Withaar FK, 2000, J INT NEUROPSYCH SOC, V6, P480, DOI 10.1017/S1355617700644065; Wood E, 2005, J APPL GERONTOL, V24, P419, DOI 10.1177/0733464805278378; Zhang L, 2003, ARCH PHYS MED REHAB, V84, P1118, DOI 10.1016/S0003-9993(03)00203-X; Zhang L, 2001, AM J PHYS MED REHAB, V80, P597, DOI 10.1097/00002060-200108000-00010	53	18	21	1	40	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult	MAY 3	2016	23	3					223	235		10.1080/23279095.2015.1048514			13	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	DH6KJ	WOS:000372899100010	26569498				2022-02-06	
J	Ackland, HM; Pilcher, DV; Roodenburg, OS; McLellan, SA; Cameron, PA; Cooper, DJ				Ackland, Helen M.; Pilcher, David V.; Roodenburg, Owen S.; McLellan, Susan A.; Cameron, Peter A.; Cooper, D. James			Danger at every rung: Epidemiology and outcomes of ICU-admitted ladder-related trauma	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Ladder; Ladder falls; Ladder-related trauma; Ladder injuries; High falls; Traumatic brain injury; Intensive care	FALL INJURIES; BRAIN-INJURY; ACCIDENTS; PATTERNS; SCALE; RISK	Introduction: The incidence of ladder-related falls is increasing, and this represents a disturbing trend, particularly in the context of increased life expectancy and the impending retirement of the populous 'baby-boomer' generation. To date, there have been no critical illness-focused studies reporting on the incidence, severity and outcomes of severe ladder-related injuries requiring ICU management. Methods: Major trauma patients admitted to ICU over a 5 year period to June 2011 after ladder falls > 1 m were identified from prospectively collected trauma data at a Level 1 trauma service. Demographic and ICU clinical management data were collected and non-parametric statistical analyses were used to explore the relationships between variables in hospital mortality/survival. Results: There were 584 ladder fall admissions, including 194 major trauma cases, of whom 29.9% (n = 58) fell > 1 m and were admitted to ICU. Hospital mortality was 26%, and fatal cases were almost entirely older males in domestic falls of <= 3 m who died as a result of traumatic brain injury. Non-survivors had lower GCS at the scene (p = 0.02), higher AIS head code (p = 0.01), higher heart rate and lower mean arterial pressure (p < 0.01) in the initial 24 h period in ICU, and were >= 55 years of age (p = 0.05). Only 46% of patients available for follow-up were living at home at 12 months without requiring additional care. Conclusions: The incidence of ladder falls requiring ICU management is increasing, and severe traumatic brain injury was responsible for the majority of deaths and for poor outcomes in survivors. In-hospital costs attributable to the care of these patients are high, and fewer than half were living independently at home at 12 months post-fall. A concerted public health campaign is required to alert the community to the potential consequences of this mechanism of injury. The use of helmets for ladder users in domestic settings, where occupational health and safety regulations are less likely to be applied, is strongly recommended to mitigate the risk of severe brain injury. The benefits of this simple strategy far outweigh any mild inconvenience for the wearer, and may prevent catastrophic injury. Crown Copyright (C) 2016 Published by Elsevier Ltd. All rights reserved.	[Ackland, Helen M.; Pilcher, David V.; Roodenburg, Owen S.; Cooper, D. James] Alfred Hosp, Dept Intens Care, Melbourne, Vic 3004, Australia; [Ackland, Helen M.; Pilcher, David V.; McLellan, Susan A.; Cameron, Peter A.; Cooper, D. James] Monash Univ, Crit Care Res Div, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Ackland, Helen M.] Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia; [Cameron, Peter A.] Alfred Hosp, Emergency & Trauma Ctr, Melbourne, Vic 3004, Australia		Ackland, HM (corresponding author), Alfred Hosp, Natl Trauma Res Inst, Melbourne, Vic 3004, Australia.	h.ackland@alfred.org.au	Cooper, D. James/G-7961-2013	Cooper, D. James/0000-0002-5872-9051; Pilcher, David/0000-0002-8939-7985; Cameron, Peter/0000-0002-1443-557X	Department of Health and Human Services; State Government of Victoria and Transport Accident Commission	The Victorian State Trauma Registry (VSTR) is jointly funded by the Department of Health and Human Services, State Government of Victoria and Transport Accident Commission - we also gratefully acknowledge the Victorian State Trauma Outcome Registry and Monitoring (VSTORM) group for the provision of VSTR data.	American Academy of Orthopedic Surgeons, 2012, LADD SAF GUID; Australian and New Zealand Intensive Care Society, 2013, ANZICS CTR OUTC RES; Australian and New Zealand Intensive Care Society, 2014, 201213 ANZICS CORE; Australian Competition and Consumer Commission, 2015, PROD SAF AUSTR LADD; Australian Government Department of Health and Ageing, 2011, AUSTR HOSP PAT COST; Bedi HS, 2008, J TRAUMA, V64, P1608, DOI 10.1097/TA.0b013e31804aa444; BJORNSTIG U, 1992, J SAFETY RES, V23, P9, DOI 10.1016/0022-4375(92)90035-8; Bradley C., 2007, LADDER RELATED FALL; Lopez MAC, 2011, J SAFETY RES, V42, P391, DOI 10.1016/j.jsr.2011.08.003; Cassell E, 2006, INJURY RELATED USE L, P1; Con J, 2014, J SURG RES, V191, P262, DOI 10.1016/j.jss.2014.05.072; D'Souza AL, 2007, AM J PREV MED, V32, P413, DOI 10.1016/j.amepre.2007.01.012; Department of Health Victoria, 2014, VICT STAT TRAUM REG; Diggs BS, 2005, ACAD EMERG MED, V12, P267, DOI 10.1197/j.aem.2004.10.028; Faergemann C, 2000, ACCIDENT ANAL PREV, V32, P745, DOI 10.1016/S0001-4575(99)00124-4; Inui TS, 2014, J TRAUMA ACUTE CARE, V76, P642, DOI 10.1097/TA.0000000000000138; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Kent Alison, 2006, Emerg Med Australas, V18, P23, DOI 10.1111/j.1742-6723.2006.00800.x; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mitra B, 2007, MED J AUSTRALIA, V186, P31, DOI 10.5694/j.1326-5377.2007.tb00785.x; MUIR L, 1993, INJURY, V24, P485, DOI 10.1016/0020-1383(93)90156-Z; O'Sullivan J, 2004, INJURY, V35, P429, DOI 10.1016/S0020-1383(03)00265-1; Oxley J, 2014, REPORT REDUCTION MAJ; Partridge RA, 1998, ACAD EMERG MED, V5, P31, DOI 10.1111/j.1553-2712.1998.tb02571.x; Pliner EM, 2014, ERGONOMICS, P1; *SAF WORK AUSTR, 2013, WORK REL INJ FAT INV; Seluga Kristopher J, 2007, Int J Inj Contr Saf Promot, V14, P215, DOI 10.1080/17457300701722601; Simeonov P, 2013, APPL ERGON, V44, P496, DOI 10.1016/j.apergo.2012.10.017; Smith GS, 2006, ACCIDENT ANAL PREV, V38, P973, DOI 10.1016/j.aap.2006.04.008; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tsipouras S, 2001, MED J AUSTRALIA, V174, P516, DOI 10.5694/j.1326-5377.2001.tb143403.x; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Warren LR, 2015, ANZ J SURG S1, V85, P132; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; WorkSafe Victoria, 2005, PREV FALLS LADD	35	18	18	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	MAY	2016	47	5					1109	1117		10.1016/j.injury.2015.12.016			9	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	DK6TA	WOS:000375057000023	26783012				2022-02-06	
J	Chan, V; Mollayeva, T; Ottenbacher, KJ; Colantonio, A				Chan, Vincy; Mollayeva, Tatyana; Ottenbacher, Kenneth J.; Colantonio, Angela			Sex-Specific Predictors of Inpatient Rehabilitation Outcomes After Traumatic Brain Injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							GENDER-DIFFERENCES; OLDER-ADULTS; MODERATE; NEUROTRAUMA; DISCHARGE; SYMPTOMS; ONTARIO; WORK; MEN; AGE	Objective: To identify sex-specific predictors of inpatient rehabilitation outcomes among patients with a traumatic brain injury (TBI) from a population-based perspective. Design: Retrospective cohort study. Setting: Inpatient rehabilitation. Participants: Patients in inpatient rehabilitation for a TBI within 1 year of acute care discharge between 2008/2009 and 2011/2012 (N=1730, 70% men, 30% women). Interventions: None. Main Outcome Measures: Inpatient rehabilitation length of stay, total FIM score, and motor and cognitive FIM ratings at discharge. Results: Sex, as a covariate in multivariable linear regression models, was not a significant predictor of rehabilitation outcomes. Although many of the predictors examined were similar across men and women, sex-specific multivariable models identified some predictors of rehabilitation outcome that are specific for men and women; mechanism of injury (P<.0001) was a significant predictor of functional outcome only among women, whereas comorbidities (P<.0001) was a significant predictor for men only. Conclusions: Predictors of outcomes after inpatient rehabilitation differed by sex, providing evidence for a sex-specific approach in planning and resource allocation for inpatient rehabilitation services for patients with TBI. (C) 2016 by the American Congress of Rehabilitation Medicine	[Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Chan, Vincy; Mollayeva, Tatyana; Colantonio, Angela] Univ Toronto, Rehabil Sci Inst, Toronto, ON, Canada; [Ottenbacher, Kenneth J.] Univ Texas Med Branch, Rehabil Sci, Galveston, TX 77555 USA		Chan, V (corresponding author), 550 Univ Ave, Toronto, ON M5G 2A2, Canada.	vincy.chan@uhn.ca	, Mollayeva/A-4522-2018; Chan, Vincy/AAA-7813-2020	Chan, Vincy/0000-0002-6884-044X; Ottenbacher, Kenneth/0000-0001-5990-3982; Colantonio, Angela/0000-0003-2094-4765	Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; Ontario Institute for Cancer Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R24HD065702]; Canadian Institutes of Health Research (CIHR) Chair in Gender, Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Frederick Banting and Charles Best Canada Gradate Scholarships Doctoral AwardCanadian Institutes of Health Research (CIHR); Pediatric Oncology Group of Ontario for a Doctoral Research Award, Brain Canada; Canadian Imperial Bank of Commerce for a Brain Cancer Training Award; Jane Gillett Pediatric Acquired Brain Injury Studentship from the Ontario Neurotrauma Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P2CHD065702, R24HD065702] Funding Source: NIH RePORTER	Supported by the provision of data by the Institute for Clinical Evaluative Sciences (ICES) and Cancer Care Ontario; funding support to the ICES from an annual grant by the Ministry of Health and Long-Term Care and the Ontario Institute for Cancer Research; the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (award no. R24HD065702); the Canadian Institutes of Health Research (CIHR) Chair in Gender, Work and Health (grant no. CGW-126580) and Frederick Banting and Charles Best Canada Gradate Scholarships Doctoral Award; the Pediatric Oncology Group of Ontario for a Doctoral Research Award, Brain Canada; the Canadian Imperial Bank of Commerce for a Brain Cancer Training Award; and the Jane Gillett Pediatric Acquired Brain Injury Studentship from the Ontario Neurotrauma Foundation.	Babitsch B, 2012, PSYCHOSOC MED, V9, P1, DOI DOI 10.3205/PSM000089; Baker DW, 1998, MED CARE, V36, P1461, DOI 10.1097/00005650-199810000-00004; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Canadian Institute for Health Information, 2015, REHABILITATION; Canadian Institute for Health Information, 2009, NRS MIN DAT SET MAN; Canadian Institute for Health Information, 2015, AC CAR; Canadian Institutes of Health Research, 2015, SEX GEND HLTH RES GU; Centers for Disease Control and Prevention, 2015, ICD INJ MATR; Centers for Disease Control and Prevention, 2015, SEV TBI; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chan V, 2013, CAN J AGING, V32, P278, DOI 10.1017/S0714980813000317; Chang PFJ, 2008, ARCH PHYS MED REHAB, V89, P231, DOI 10.1016/j.apmr.2007.08.143; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Chen A, 2014, J REHABIL MED, V46, P144, DOI 10.2340/16501977-1243; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Colantonio A, 2010, CAN J NEUROL SCI, V37, P783, DOI 10.1017/S0317167100051441; Colantonio A, 2010, J REHABIL MED, V42, P773, DOI 10.2340/16501977-0582; Colantonio A, 2010, J WOMENS HEALTH, V19, P1109, DOI 10.1089/jwh.2009.1740; Commission on Accreditation of Rehabilitation Facilities (CARF), 2015, CARF CCAC STAND MAN; Corrigan JD, 2007, ARCH PHYS MED REHAB, V88, P1400, DOI 10.1016/j.apmr.2007.08.006; Covassin T, 2012, J NEUROSCI NURS, V44, P124, DOI 10.1097/JNN.0b013e318252737d; Cullen N, 2014, EFFICACY MODELS CARE; Farace E, 2000, Neurosurg Focus, V8, pe6; Faul M, 2010, TRAUAMTIC BRAIN INJU; Flaskerud Jacquelyn H, 2012, Issues Ment Health Nurs, V33, P494, DOI 10.3109/01612840.2012.662581; Freeman JD, 2008, MED CARE, V46, P1023, DOI 10.1097/MLR.0b013e318185c913; Gendered Innovations in Science Health & Medicine Enginerring and Environment, 2011, WHAT IS GEND INN; Glazier RH., 2012, COMP PRIMARY CARE MO; Government of Canada, 2015, FACTS FIG 2014 IMM O; Graham JE, 2010, ARCH PHYS MED REHAB, V91, P43, DOI 10.1016/j.apmr.2009.09.017; Granger CV, 2010, AM J PHYS MED REHAB, V89, P265, DOI 10.1097/PHM.0b013e3181d3eb20; Haag HL, 2016, ARCH PHYS MED REHAB, V97, pS64, DOI 10.1016/j.apmr.2014.12.018; Health Canada, 2010, HEALTH PORTFOLIO SEX; Health Services Research & Development Center, 2009, J HOPK ACG SYST; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; John-Baptiste A, 2004, J GEN INTERN MED, V19, P221, DOI 10.1111/j.1525-1497.2004.21205.x; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Lucassen PJ, 2014, ACTA NEUROPATHOL, V127, P109, DOI 10.1007/s00401-013-1223-5; Malmusi D, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23189; Markovits EK, 2014, PERSPECT POLIT, V12, P81, DOI 10.1017/S1537592713003721; Mikkonen J, 2010, SOCIAL DETERMINANTS; Ministry of Finance, 2014, ONT POP PROJ; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Neysmith SM, 2010, CAN REV SOCIOL, V47, P149, DOI 10.1111/j.1755-618X.2010.01228.x; Niemeier JP, 2007, NEUROPSYCHOL REHABIL, V17, P293, DOI 10.1080/09602010600814729; Ontario Ministry of Health and Long-Term Care, 2015, ALT LEV CAR ALC PAT; Parsons Daria, 2012, BMC Res Notes, V5, P584, DOI 10.1186/1756-0500-5-584; Public Health Agency of Canada National Population Health Study of Neurological Conditions (Canada)., 2014, MAPP CONN UND NEUR C; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Sarver J, 2000, J GEN INTERN MED, V15, P256, DOI 10.1046/j.1525-1497.2000.015004256.x; Slewa-Younan S, 2004, ARCH PHYS MED REHAB, V85, P376, DOI 10.1016/j.apmr.2003.05.007; Slewa-Younan S, 2008, BRAIN INJURY, V22, P183, DOI 10.1080/02699050801888808; Statistics Canada, 2015, LING CHAR CAN; Whiteneck G, 2004, ARCH PHYS MED REHAB, V85, pS73, DOI 10.1016/j.apmr.2003.08.107; World Health Organization, 2009, EX SUMM WOM HLTH TOD; Wright DW, 2014, ACAD EMERG MED, V21, P1414, DOI 10.1111/acem.12532	59	18	18	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	MAY	2016	97	5					772	780		10.1016/j.apmr.2016.01.011			9	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DL4UM	WOS:000375633300016	26836952	Green Accepted			2022-02-06	
J	Pugh, MJ; Jaramillo, CA; Leung, KW; Faverio, P; Fleming, N; Mortensen, E; Amuan, ME; Wang, CP; Eapen, B; Restrepo, M; Morris, MJ				Pugh, Mary Jo; Jaramillo, Carlos A.; Leung, Kar-wei; Faverio, Paola; Fleming, Nicholas; Mortensen, Eric; Amuan, Megan E.; Wang, Chen-Pin; Eapen, Blessen; Restrepo, Marcos; Morris, Michael J.			Increasing Prevalence of Chronic Lung Disease in Veterans of the Wars in Iraq and Afghanistan	MILITARY MEDICINE			English	Article							RESPIRATORY SYMPTOMS; PARTICULATE MATTER; HEALTH; DEPLOYMENT; SOLDIERS; EXPLOSIONS; PNEUMONIA; INJURIES; EXPOSURE; FREEDOM	Research from the wars in Afghanistan and Iraq have focused on traumatic brain injury (TBI) and mental health conditions; however, it is becoming clear that other health concerns, such as respiratory illnesses, warrant further scientific inquiry. Early reports from theater and postdeployment health assessments suggested an association with deployment-related exposures (e.g., sand, burn pits, chemical, etc.) and new-onset respiratory symptoms. We used data from Veterans Affairs medical encounters between fiscal years 2003 and 2011 to identify trends in chronic obstructive pulmonary disease, asthma, and interstitial lung disease in veterans. We used data from Veterans Affairs and Department of Defense sources to identify sociodemographic (age, sex, race), military (e.g., service branch, multiple deployments) and clinical characteristics (TBI, smoking) of individuals with and without chronic lung diseases. Generalized estimating equations found significant increases over time for chronic obstructive pulmonary disease and asthma in both unadjusted and adjusted analyses. Trends for interstitial lung disease were significant only in adjusted analyses. Age, smoking, and TBI were also significantly associated with chronic lung diseases; however, multiple deployments were not associated. Research is needed to identify which characteristics of deployment-related exposures are linked with chronic lung disease.	[Pugh, Mary Jo; Jaramillo, Carlos A.; Eapen, Blessen; Restrepo, Marcos] South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA; [Pugh, Mary Jo; Jaramillo, Carlos A.; Leung, Kar-wei; Fleming, Nicholas; Wang, Chen-Pin; Eapen, Blessen; Restrepo, Marcos] Univ Texas Hlth Sci Ctr San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Faverio, Paola] Univ Milano Bicocca, AO San Gerardo, Clin Pneumol, Dept Hlth Sci, Via Pergolesi 22, Monza, Italy; [Mortensen, Eric] North Texas Vet Hlth Care Syst, 4500 South Lancaster Rd, Dallas, TX 75216 USA; [Amuan, Megan E.] Edith Nourse Rogers VA Med Ctr, 200 Springs Rd, Bedford, MA 01730 USA; [Morris, Michael J.] Uniformed Serv Univ Hlth Sci, Brooke Army Med Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA		Pugh, MJ (corresponding author), South Texas Vet Hlth Care Syst, 7400 Merton Minter Blvd, San Antonio, TX 78229 USA.; Pugh, MJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.		Pugh, Mary Jo/K-5336-2019; Faverio, Paola/A-3660-2019; Mortensen, Eric/AAF-2713-2020	Pugh, Mary Jo/0000-0003-4196-7763; faverio, paola/0000-0002-0360-1237; Mortensen, Eric/0000-0002-3880-5563	VA Health Services Research and Development ServiceUS Department of Veterans Affairs [DHI 09-237]	Data were obtained with the assistance of the VA Office of Environmental Epidemiology for the Operation Enduring Freedom/Operation Iraqi Freedom Roster file. This study was funded by the VA Health Services Research and Development Service (DHI 09-237). The content, of this article is solely the responsibility of the authors and does not necessarily reflect the official views of the Veterans' Health Administration or the Department of Defense. The funding organizations had no role in the design and conduct of die study; the collection, management, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript. This retrospective data study received approval including a waiver of informed consent and Health Insurance Portability and Accountability Act authorization by the institutional review boards of the University of Texas Health Science Center San Antonio and the Edith Nourse Rogers Memorial VA Hospital.	Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P733, DOI 10.1097/JOM.0b013e318253356c; Abraham JH, 2012, J OCCUP ENVIRON MED, V54, P740, DOI 10.1097/JOM.0b013e318252969a; American Lung Association, 2012, TRENDS ASTHM MORB MO; Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Barth SK, 2014, MIL MED, V179, P241, DOI 10.7205/MILMED-D-13-00338; Committee on Gulf War and Health, 2014, LONG TERM EFFECTS BL, V9; DelVecchio SP, 2014, J ASTHMA, V52, P263; Finlay SE, 2012, PREHOSP DISASTER MED, V27, P385, DOI 10.1017/S1049023X12000891; Government Accountability Office, 2010, AFGH IR DOD SHOULD I; Green Michael E, 2015, CMAJ Open, V3, pE15, DOI 10.9778/cmajo.20140040; King MS, 2011, NEW ENGL J MED, V365, P222, DOI 10.1056/NEJMoa1101388; Martin EM, 2008, AM J NURS, V108, P40, DOI 10.1097/01.NAJ.0000315260.92070.3f; Matthews T, 2014, MIL MED, V179, P1273, DOI 10.7205/MILMED-D-14-00066; Mortensen EM, 2012, CLIN INFECT DIS, V55, P1466, DOI 10.1093/cid/cis733; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Roop SA, 2007, MIL MED, V172, P1264, DOI 10.7205/MILMED.172.12.1264; Shorr AF, 2004, JAMA-J AM MED ASSOC, V292, P2997, DOI 10.1001/jama.292.24.2997; Sine C, 2011, CHEST, V140, p675A; Singleton JAG, 2013, J TRAUMA ACUTE CARE, V75, pS269, DOI 10.1097/TA.0b013e318299d93e; Skabelund A, 2013, CHEST, V144, DOI 10.1378/chest.1704368; Smith B, 2008, AM J PREV MED, V35, P539, DOI 10.1016/j.amepre.2008.07.009; Smith B, 2012, J OCCUP ENVIRON MED, V54, P708, DOI 10.1097/JOM.0b013e31825107f9; Smith B, 2009, AM J EPIDEMIOL, V170, P1433, DOI 10.1093/aje/kwp287; Szema AM, 2011, J OCCUP ENVIRON MED, V53, P961, DOI 10.1097/JOM.0b013e31822c9f05; Szema AM, 2010, ALLERGY ASTHMA PROC, V31, pE67, DOI 10.2500/aap.2010.31.3383; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Weese CB, 2009, INHAL TOXICOL, V21, P291, DOI [10.1080/08958370802672891, 10.1080/08958370802672891 ]	27	18	18	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAY	2016	181	5					476	481		10.7205/MILMED-D-15-00035			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN5MZ	WOS:000377114400015	27136656	Bronze			2022-02-06	
J	Basrai, HS; Christie, KJ; Turbic, A; Bye, N; Turnley, AM				Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.			Suppressor of Cytokine Signaling-2 (SOCS2) Regulates the Microglial Response and Improves Functional Outcome after Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; CD40 GENE-EXPRESSION; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; ERYTHROPOIETIN; NEUROGENESIS; PROLIFERATION; CELLS; DIFFERENTIATION; RECOVERY	Traumatic brain injury (TBI) is frequently characterized by neuronal, axonal and myelin loss, reactive gliosis and neuroinflammation, often associated with functional deficits. Endogenous repair mechanisms include production of new neurons from precursor cells, but usually the new neurons fail to integrate and survive more than a few weeks. This is in part mediated by the toxic and inflammatory environment present in the injured brain which activates precursor cells to proliferate and differentiate but limits survival of the newborn progeny. Therefore, an understanding of mechanisms that regulate production and survival of newborn neurons and the neuroinflammatory response after brain injury may lead to therapeutic options to improve outcomes. Suppressor of Cytokine Signaling 2 (SOCS2) promotes hippocampal neurogenesis and survival of newborn neurons in the adult brain and regulates anti-inflammatory responses in the periphery, suggesting it may be a useful candidate to improve outcomes of TBI. In this study the functional and cellular responses of SOCS2 over-expressing transgenic (SOCS2Tg) mice were compared to wildtype litter-mates following mild or moderately severe TBI. Unlike wildtype controls, SOCS2Tg mice showed functional improvement on a ladder test, with a smaller lesion volume at 7d post injury and increased numbers of proliferative CD11b(+) microglia/macrophages at 35d post-injury in the mild injury paradigm. At 7d post-moderately severe injury there was an increase in the area covered by cells expressing an anti-inflammatory M2 phenotype marker (CD206(+)) but no difference in cells with a pro-inflammatory M1 phenotype marker (CD16/32(+)). No effect of SOCS2 overexpression was observed in production or survival of newborn neurons, even in the presence of the neuroprotective agent erythropoietin (EPO). Therefore, SOCS2 may improve outcome of TBI in mice by regulating aspects of the neuroinflammatory response, promoting a more anti-inflammatory environment, although this was not sufficient to enhance survival of newborn cortical neurons.	[Basrai, Harleen S.; Christie, Kimberly J.; Turbic, Alisa; Bye, Nicole; Turnley, Ann M.] Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia		Turnley, AM (corresponding author), Univ Melbourne, Dept Anat & Neurosci, Parkville, Vic 3052, Australia.	turnley@unimelb.edu.au			National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia [1045125, 628344]; Stem Cells Australia	This work was supported by funding from the National Health and Medical Research Council of Australia (www.nhmrc.gov.au): Project grant 1045125 to AMT and Fellowship 628344 to AMT, as well as support from Stem Cells Australia (www.stemcellsaustralia.edu.au) to HSB and AMT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Baciu I, 2000, Rom J Physiol, V37, P3; Baker BJ, 2009, TRENDS IMMUNOL, V30, P392, DOI 10.1016/j.it.2009.07.001; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Bye N, 2007, EXP NEUROL, V204, P220, DOI 10.1016/j.expneurol.2006.10.013; Chehrehasa F, 2009, J NEUROSCI METH, V177, P122, DOI 10.1016/j.jneumeth.2008.10.006; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Choi JS, 2009, J NEUROTRAUM, V26, P2097, DOI [10.1089/neu.2008.0793, 10.1089/neu.2008-0793]; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Christie KJ, 2013, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00070; Costine BA, 2015, DEV NEUROSCI-BASEL, V37, P115, DOI 10.1159/000369091; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Esper L, 2012, AM J PATHOL, V181, P130, DOI 10.1016/j.ajpath.2012.03.042; Faul M, 2010, TRAUMATIC BRAIN INJU; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Goldshmit Y, 2004, EUR J NEUROSCI, V20, P2260, DOI 10.1111/j.1460-9568.2004.03698.x; Greenhalgh CJ, 2002, J BIOL CHEM, V277, P40181, DOI 10.1074/jbc.C200450200; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; HU XM, 2012, STROKE, V43, P3063, DOI DOI 10.1161/STR0KEAHA.112.659656; Iverson GL, 2005, CURRENT OPINION PSYC, DOI [10.1097/00001504-200505000-00013, DOI 10.1097/00001504-200505000-00013]; Jia XX, 2012, J TRAUMA ACUTE CARE, V73, P1168, DOI 10.1097/TA.0b013e318246eaf4; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Kim YH, 2010, STEM CELLS, V28, P1816, DOI 10.1002/stem.511; Koketsu D, 2006, EXP NEUROL, V199, P92, DOI 10.1016/j.expneurol.2006.03.012; Krantz S B, 1988, Contrib Nephrol, V66, P25; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; LONGIN A, 1993, J HISTOCHEM CYTOCHEM, V41, P1833, DOI 10.1177/41.12.8245431; Lu DY, 2005, J NEUROTRAUM, V22, P1011, DOI 10.1089/neu.2005.22.1011; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Metcalf D, 2000, NATURE, V405, P1069, DOI 10.1038/35016611; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Ng SY, 2012, J NEUROTRAUM, V29, P1410, DOI 10.1089/neu.2011.2188; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Qin HW, 2006, J IMMUNOL, V177, P7761, DOI 10.4049/jimmunol.177.11.7761; Qin HW, 2006, FASEB J, V20, P985, DOI 10.1096/fj.05-5493fje; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Ransome MI, 2008, HIPPOCAMPUS, V18, P1034, DOI 10.1002/hipo.20463; Ransome MI, 2007, J NEUROCHEM, V102, P1953, DOI 10.1111/j.1471-4159.2007.04684.x; Ransome MI, 2005, NEUROSCIENCE, V132, P673, DOI 10.1016/j.neuroscience.2004.12.041; Rico-Bautista E, 2006, CYTOKINE GROWTH F R, V17, P431, DOI 10.1016/j.cytogfr.2006.09.008; Rolls A, 2009, NAT REV NEUROSCI, V10, P235, DOI 10.1038/nrn2591; Saha B, 2013, STEM CELL RES, V11, P965, DOI 10.1016/j.scr.2013.06.006; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Turnley AM, 2002, NAT NEUROSCI, V5, P1155, DOI 10.1038/nn954; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Uren RT, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00039, 10.3389/fnmo1.2014.00039]; Uren RT, 2014, J NEUROCHEM, V129, P614, DOI 10.1111/jnc.12671; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Wang L, 2004, NEUROREPORT, V15, P1225, DOI 10.1097/01.wnr.0000127636.15181.c1; Wei ZX, 2015, NEUROSCI LETT, V606, P48, DOI 10.1016/j.neulet.2015.08.032; Xiong Y, 2011, TRANSL STROKE RES, V2, P619, DOI 10.1007/s12975-011-0120-2; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yu XB, 2002, DEVELOPMENT, V129, P505; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	64	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2016	11	4							e0153418	10.1371/journal.pone.0153418			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ0NI	WOS:000373900700065	27071013	gold, Green Submitted, Green Published			2022-02-06	
J	Hernandez, RV; Puro, AC; Manos, JC; Huitron-Resendiz, S; Reyes, KC; Liu, K; Vo, K; Roberts, AJ; Gruol, DL				Hernandez, Ruben V.; Puro, Alana C.; Manos, Jessica C.; Huitron-Resendiz, Salvador; Reyes, Kenneth C.; Liu, Kevin; Vo, Khanh; Roberts, Amanda J.; Gruol, Donna L.			Transgenic mice with increased astrocyte expression of IL-6 show altered effects of acute ethanol on synaptic function	NEUROPHARMACOLOGY			English	Article						Synaptic plasticity; EEG; Gamma frequency; Glia; Ethanol withdrawal hyperexcitability; Neuroimmune; STAT3; Long-term potentiation	LONG-TERM POTENTIATION; CHRONIC INTERMITTENT ETHANOL; RAT HIPPOCAMPAL SLICES; CONTAINING GABA(A) RECEPTORS; HANDLING-INDUCED CONVULSIONS; REGION-SPECIFIC CHANGES; TRAUMATIC BRAIN-INJURY; GLIAL TNF-ALPHA; NMDA-RECEPTOR; WITHDRAWAL SEVERITY	A growing body of evidence has revealed that resident cells of the central nervous system (CNS), and particularly the glial cells, comprise a neuroimmune system that serves a number of functions in the normal CNS and during adverse conditions. Cells of the neuroimmune system regulate CNS functions through the production of signaling factors, referred to as neuroimmune factors. Recent studies show that ethanol can activate cells of the neuroimmune system, resulting in the elevated production of neuroimmune factors, including the cytokine interleukin-6 (IL-6). Here we analyzed the consequences of this CNS action of ethanol using transgenic mice that express elevated levels of IL-6 through increased astrocyte expression (IL-6-tg) to model the increased IL-6 expression that occurs with ethanol use. Results show that increased IL-6 expression induces neuroadaptive changes that alter the effects of ethanol. In hippocampal slices from non-transgenic (non-tg) littermate control mice, synaptically evoked dendritic field excitatory postsynaptic potential (fEPSP) and somatic population spike (PS) at the Schaffer collateral to CM pyramidal neuron synapse were reduced by acute ethanol (20 or 60 mM). In contrast, acute ethanol enhanced the fEPSP and PS in hippocampal slices from IL-6 tg mice. Long-term synaptic plasticity of the fEPSP (i.e., LTP) showed the expected dose-dependent reduction by acute ethanol in non-tg hippocampal slices, whereas LW in the IL-6 tg hippocampal slices was resistant to this depressive effect of acute ethanol. Consistent with altered effects of acute ethanol on synaptic function in the IL-6 tg mice, EEG recordings showed a higher level of CNS activity in the IL-6 tg mice than in the non-tg mice during the period of withdrawal from an acute high dose of ethanol. These results suggest a potential role for neuroadaptive effects of ethanol-induced astrocyte production of IL-6 as a mediator or modulator of the actions of ethanol on the CNS, including persistent changes in CNS function that contribute to cognitive dysfunction and the development of alcohol dependence. (C) 2015 Elsevier Ltd. All rights reserved.	[Hernandez, Ruben V.; Puro, Alana C.; Manos, Jessica C.; Huitron-Resendiz, Salvador; Reyes, Kenneth C.; Liu, Kevin; Vo, Khanh; Roberts, Amanda J.; Gruol, Donna L.] Scripps Res Inst, Mol & Cellular Neurosci Dept, SP30-1522,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA		Gruol, DL (corresponding author), Scripps Res Inst, Mol & Cellular Neurosci Dept, SP30-1522,10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	gruol@scripps.edu			NIAAA GrantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA019261]; Integrated Neuroscience Initiative on Alcoholism (INAI)-West grant [AA020893]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [U01AA020893, RC1AA019261] Funding Source: NIH RePORTER	Supported by NIAAA Grant AA019261 and the Integrated Neuroscience Initiative on Alcoholism (INAI)-West grant AA020893.	Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Bachtell RK, 2002, J PHARMACOL EXP THER, V302, P516, DOI 10.1124/jpet.102.036046; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Becker HC, 2000, ALCOHOL RES HEALTH, V24, P105; Becker Howard C, 2014, Handb Clin Neurol, V125, P133, DOI 10.1016/B978-0-444-62619-6.00009-4; BELLINGER FP, 1993, BRAIN RES, V628, P227, DOI 10.1016/0006-8993(93)90959-Q; Blanco AM, 2005, J IMMUNOL, V175, P6893, DOI 10.4049/jimmunol.175.10.6893; Blednov YA, 2005, BEHAV BRAIN RES, V165, P110, DOI 10.1016/j.bbr.2005.06.026; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; BLITZER RD, 1990, BRAIN RES, V537, P203, DOI 10.1016/0006-8993(90)90359-J; Boyadjieva NI, 2010, ALCOHOL CLIN EXP RES, V34, P1835, DOI 10.1111/j.1530-0277.2010.01271.x; Bray JG, 2013, NEUROPHARMACOLOGY, V67, P115, DOI 10.1016/j.neuropharm.2012.11.007; Briere FN, 2014, COMPR PSYCHIAT, V55, P526, DOI 10.1016/j.comppsych.2013.10.007; Buzsaki G, 2012, ANNU REV NEUROSCI, V35, P203, DOI 10.1146/annurev-neuro-062111-150444; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; Chandler LJ, 2005, ALCOHOL CLIN EXP RES, V29, P672, DOI 10.1097/01.ALC.0000158935.53360.5F; Cheaha D, 2014, NEUROPHARMACOLOGY, V77, P49, DOI 10.1016/j.neuropharm.2013.09.020; Chen JP, 1999, FEBS LETT, V457, P162, DOI 10.1016/S0014-5793(99)01031-5; CHIANG CS, 1994, DEV NEUROSCI-BASEL, V16, P212, DOI 10.1159/000112109; Coogan A, 1997, NEUROREPORT, V8, P2107, DOI 10.1097/00001756-199707070-00004; Crabbe J C, 1980, Subst Alcohol Actions Misuse, V1, P159; Crabbe JC, 1998, J PHARMACOL EXP THER, V286, P263; CRABBE JC, 1991, J PHARMACOL EXP THER, V257, P663; CRABBE JC, 1983, PHARMACOL BIOCHEM BE, V18, P541, DOI 10.1016/0091-3057(83)90233-2; Doremus-Fitzwater TL, 2015, PHYSIOL BEHAV, V148, P131, DOI 10.1016/j.physbeh.2015.02.032; Doremus-Fitzwater TL, 2014, ALCOHOL CLIN EXP RES, V38, P2186, DOI 10.1111/acer.12481; Erickson MA, 2010, J COGNITIVE NEUROSCI, V22, P2530, DOI 10.1162/jocn.2009.21375; Farook JM, 2008, PHYSIOL BEHAV, V95, P267, DOI 10.1016/j.physbeh.2008.05.020; Ferando I, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00144; Finn DA, 2007, ALCOHOL CLIN EXP RES, V31, P939, DOI 10.1111/j.1530-0277.2007.00379.x; Foltran F, 2011, NUTR REV, V69, P642, DOI 10.1111/j.1753-4887.2011.00417.x; Franklin K.B., 1997, MOUSE BRAIN STEREOTA; Fujii S, 2008, BRAIN RES, V1211, P13, DOI 10.1016/j.brainres.2008.02.052; Fujita N, 2003, INT J OBESITY, V27, P55, DOI 10.1038/sj.ijo.0802194; GADIENT RA, 1994, BRAIN RES, V637, P10, DOI 10.1016/0006-8993(94)91211-4; Ghozland S, 2005, NEUROPHARMACOLOGY, V49, P493, DOI 10.1016/j.neuropharm.2005.04.006; Gilpin NW, 2009, ALCOHOL CLIN EXP RES, V33, P2113, DOI 10.1111/j.1530-0277.2009.01051.x; Giralt M, 2013, GLIA, V61, P587, DOI 10.1002/glia.22457; GOLDSTEI.DB, 1971, SCIENCE, V172, P288, DOI 10.1126/science.172.3980.288; Gruol DL, 2011, J NEUROIMMUNOL, V239, P28, DOI 10.1016/j.jneuroim.2011.08.009; Gruol DL, 1997, MOL NEUROBIOL, V15, P307, DOI 10.1007/BF02740665; Gruol DL, 2015, NEUROPHARMACOLOGY, V96, P42, DOI 10.1016/j.neuropharm.2014.10.023; Gruol DL, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ricel.2014.00234, 10.3389/fncel.2014.00234]; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Heilig M, 2010, ADDICT BIOL, V15, P169, DOI 10.1111/j.1369-1600.2009.00194.x; Hendricson AW, 2007, J PHARMACOL EXP THER, V321, P60, DOI 10.1124/jpet.106.111419; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Hingson RW, 2006, PEDIATRICS, V118, pE755, DOI 10.1542/peds.2006-0223; Huang DR, 2002, J NEUROSCI, V22, P10633; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; Ikegaya Y, 2003, SYNAPSE, V47, P54, DOI 10.1002/syn.10154; Izumi Y, 2005, NEUROSCIENCE, V136, P509, DOI 10.1016/j.neuroscience.2005.08.002; Jankowsky JL, 2000, LEARN MEMORY, V7, P400, DOI 10.1101/lm.32600; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kachadourian LK, 2014, J PSYCHIATR RES, V55, P35, DOI 10.1016/j.jpsychires.2014.04.018; Kalluri HSG, 2003, NEUROCHEM RES, V28, P765, DOI 10.1023/A:1022822119560; Kalluri HSG, 2002, EUR J PHARMACOL, V439, P53, DOI 10.1016/S0014-2999(01)01599-0; Kane CJM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-66; Kane CJM, 2014, ALCOHOL CLIN EXP RES, V38, P384, DOI 10.1111/acer.12244; KATSUKI H, 1990, EUR J PHARMACOL, V181, P323, DOI 10.1016/0014-2999(90)90099-R; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Li AJ, 1997, BRAIN RES, V748, P30, DOI 10.1016/S0006-8993(96)01283-8; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Lippai D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070945; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Long JM, 1998, NEUROBIOL AGING, V19, P497, DOI 10.1016/S0197-4580(98)00088-8; LOVINGER DM, 1990, J NEUROSCI, V10, P1372; Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153; Mann EO, 2010, NAT NEUROSCI, V13, P205, DOI 10.1038/nn.2464; Marshall SA, 2013, NEUROBIOL DIS, V54, P239, DOI 10.1016/j.nbd.2012.12.016; McCool BA, 2011, NEUROPHARMACOLOGY, V61, P1097, DOI 10.1016/j.neuropharm.2010.12.028; MCQUARRIE DG, 1958, J PHARMACOL EXP THER, V124, P264; Medvedev A, 2000, BRAIN RES BULL, V52, P89, DOI 10.1016/S0361-9230(00)00239-2; Metten P, 2010, ALCOHOL CLIN EXP RES, V34, P1552, DOI 10.1111/j.1530-0277.2010.01240.x; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Mulholland PJ, 2015, PSYCHOPHARMACOLOGY, V232, P1995, DOI 10.1007/s00213-014-3835-4; Mulholland PJ, 2009, ALCOHOL CLIN EXP RES, V33, P1125, DOI 10.1111/j.1530-0277.2009.00936.x; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; Nelson TE, 2012, BRAIN BEHAV IMMUN, V26, P959, DOI 10.1016/j.bbi.2012.05.005; Nelson TE, 2005, BRAIN RES, V1048, P69, DOI 10.1016/j.brainres.2005.04.041; Neupane SP, 2014, CNS NEUROSCI THER, V20, P898, DOI 10.1111/cns.12303; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Norkina O, 2008, ALCOHOL CLIN EXP RES, V32, P1565, DOI 10.1111/j.1530-0277.2008.00726.x; O'Connor JJ, 1999, EXP PHYSIOL, V84, P601, DOI 10.1111/j.1469-445X.1999.01892.x; Olive MF, 2008, ALCOHOL, V42, P191, DOI 10.1016/j.alcohol.2008.01.007; Papatheodoropoulos C, 2002, BRAIN RES, V948, P117, DOI 10.1016/S0006-8993(02)02958-X; Peng S, 2011, MOL BIOL REP, V38, P453, DOI 10.1007/s11033-010-0128-9; Peris Joanna, 1997, Frontiers in Bioscience (online), V2, pD309; PERPER JA, 1986, J FORENSIC SCI, V31, P212; Petrides T, 2007, EXP BRAIN RES, V177, P370, DOI 10.1007/s00221-006-0681-6; Piana JP, 2008, BRAIN RES, V1194, P28, DOI 10.1016/j.brainres.2007.11.057; Pribiag H, 2013, J NEUROSCI, V33, P15879, DOI 10.1523/JNEUROSCI.0530-13.2013; Qin LY, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-130; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Ramachandran B, 2015, HIPPOCAMPUS, V25, P106, DOI 10.1002/hipo.22356; Rizzo SJS, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.120; Roberto M, 2003, EUR J NEUROSCI, V17, P1646, DOI 10.1046/j.1460-9568.2003.02614.x; ROBERTS AJ, 1992, BRAIN RES, V579, P296, DOI 10.1016/0006-8993(92)90064-G; Sallmann S, 2000, J NEUROSCI, V20, P8637; Samland H, 2003, J NEUROSCI RES, V73, P176, DOI 10.1002/jnr.10635; Sanz E, 2008, GLIA, V56, P190, DOI 10.1002/glia.20602; Sarc L, 2011, HUM EXP TOXICOL, V30, P1256, DOI 10.1177/0960327110388533; Savchenko VL, 2000, NEUROSCIENCE, V96, P195, DOI 10.1016/S0306-4522(99)00538-2; SCHOBITZ B, 1993, EUR J NEUROSCI, V5, P1426, DOI 10.1111/j.1460-9568.1993.tb00210.x; Schumann G, 1999, J NEUROCHEM, V73, P2009; Schummers J, 1997, ALCOHOL CLIN EXP RES, V21, P404; Schwieler L, 2015, J PSYCHIATR NEUROSCI, V40, P126, DOI 10.1503/jpn.140126; Shield KD, 2013, ALCOHOL RES-CURR REV, V35, P155; Shu MF, 2011, MOL ONCOL, V5, P265, DOI 10.1016/j.molonc.2011.03.003; Silverstein PS, 2014, CURR HIV RES, V12, P282, DOI 10.2174/1570162X12666140721122956; SINCLAIR JG, 1986, GEN PHARMACOL, V17, P231, DOI 10.1016/0306-3623(86)90144-8; Smiley JF, 2015, ALCOHOL, V49, P571, DOI 10.1016/j.alcohol.2015.04.008; SMOLEN TN, 1989, ALCOHOL, V6, P33, DOI 10.1016/0741-8329(89)90070-0; Spanos M, 2012, BEHAV BRAIN RES, V230, P158, DOI 10.1016/j.bbr.2012.02.010; STEFFENSEN SC, 1994, BRAIN RES, V652, P149, DOI 10.1016/0006-8993(94)90329-8; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tancredi V, 2000, J NEUROCHEM, V75, P634, DOI 10.1046/j.1471-4159.2000.0750634.x; TANCREDI V, 1992, NEUROSCI LETT, V146, P176, DOI 10.1016/0304-3940(92)90071-E; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Tipps ME, 2014, NEUROBIOL LEARN MEM, V112, P87, DOI 10.1016/j.nlm.2013.12.002; Tiwari V, 2009, BEHAV BRAIN RES, V203, P296, DOI 10.1016/j.bbr.2009.05.016; Trapero I, 2014, METAB BRAIN DIS, V29, P593, DOI 10.1007/s11011-014-9551-2; Udomuksorn W, 2011, ACTA HISTOCHEM, V113, P283, DOI 10.1016/j.acthis.2009.11.001; Valles SL, 2004, BRAIN PATHOL, V14, P365; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Vollenweider F, 2003, NEUROSCI LETT, V341, P49, DOI 10.1016/S0304-3940(03)00136-8; Vongvatcharanon U, 2010, ACTA HISTOCHEM, V112, P392, DOI 10.1016/j.acthis.2009.04.001; Ward RJ, 2014, ALCOHOL ALCOHOLISM, V49, P193, DOI 10.1093/alcalc/agu002; Ward RJ, 2009, J NEUROCHEM, V111, P1119, DOI 10.1111/j.1471-4159.2009.06389.x; Wei H, 2013, NEUROSCIENCE, V252, P320, DOI 10.1016/j.neuroscience.2013.08.025; Wei WZ, 2004, J NEUROSCI, V24, P8379, DOI 10.1523/JNEUROSCI.2040-04.2004; Weiner JL, 2006, PHARMACOL THERAPEUT, V111, P533, DOI 10.1016/j.pharmthera.2005.11.002; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; White AM, 2004, ANN NY ACAD SCI, V1021, P206, DOI 10.1196/annals.1308.026; White AM, 2003, ALCOHOL RES HEALTH, V27, P186; Wirkner K, 1999, NEUROCHEM INT, V35, P153, DOI 10.1016/S0197-0186(99)00057-1; Yang S, 2005, BRAIN RES, V1034, P172, DOI 10.1016/j.brainres.2004.11.018; Young JJ, 2014, J AFFECT DISORDERS, V169, P15, DOI 10.1016/j.jad.2014.07.032; Zhang RY, 2010, NEUROBIOL DIS, V38, P68, DOI 10.1016/j.nbd.2009.12.028; Zhang Y, 2014, BIOCHEM BIOPH RES CO, V452, P450, DOI 10.1016/j.bbrc.2014.08.092; Zhao YN, 2013, BEHAV BRAIN RES, V236, P270, DOI 10.1016/j.bbr.2012.08.052; Zhu B, 2012, NEUROBIOL DIS, V48, P348, DOI 10.1016/j.nbd.2012.06.022; Zorumski CF, 2014, ALCOHOL, V48, P1, DOI 10.1016/j.alcohol.2013.09.045; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	152	18	19	1	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	APR	2016	103						27	43		10.1016/j.neuropharm.2015.12.015			17	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DF1KO	WOS:000371098800003	26707655	Green Accepted			2022-02-06	
J	Kolev, OI; Sergeeva, M				Kolev, Ognyan I.; Sergeeva, Michaela			Vestibular disorders following different types of head and neck trauma	FUNCTIONAL NEUROLOGY			English	Article						concussion; dizziness; imbalance; traumatic brain injury; vertigo; vestibular	SALT WASTING SYNDROME; BRAIN-INJURY; WHIPLASH INJURY; PERILYMPHATIC FISTULA; POSTURAL VERTIGO; CONCUSSION; HYPONATREMIA; CLASSIFICATION; CONSEQUENCES; DYSFUNCTION	This review focuses on the published literature on vestibular disorders following different types of head and neck trauma. Current knowledge of the different causes and underlying mechanisms of vestibular disorders, as well as the sites of organic damage, is presented. Non-organic mechanisms are also surveyed. The frequency of occurrence of vestibular symptoms, and of other accompanying subjective complaints, associated with different types of trauma is presented and related to the specific causes. Hypotheses about the pathogenesis of traumatic vestibular disorders are presented, and the knowledge derived from animal experiments is also discussed. We believe this to be a very important topic, since vestibular complaints in traumatic patients often remain undiagnosed or underestimated in clinical practice. This review article aims to suggest directions for additional research and to provide guidance to both the scientific and clinical practice communities.	[Kolev, Ognyan I.; Sergeeva, Michaela] Med Univ Sofia, Univ Hosp Neurol & Psychiat, Sofia, Bulgaria; [Kolev, Ognyan I.] Bulgarian Acad Sci, Inst Neurobiol, Sofia, Bulgaria		Kolev, OI (corresponding author), Med Univ Sofia, Univ Hosp Neurol & Psychiat, Sofia, Bulgaria.; Kolev, OI (corresponding author), Bulgarian Acad Sci, Inst Neurobiol, Sofia, Bulgaria.	kolev_ogi@yahoo.com					Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Akin FW, 2011, OTOLARYNG CLIN N AM, V44, P323, DOI 10.1016/j.otc.2011.01.005; Alhilali LM, 2014, RADIOLOGY, V272, P224, DOI 10.1148/radiol.14132670; Allison L, 2000, NEUROLOGICAL REHABIL, V116, P616; Armstrong LE, 2004, J SPORT SCI, V22, P144; Awwad HO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00132; Brandt T, 1996, NEUROLOGY, V46, P1515, DOI 10.1212/WNL.46.6.1515; Brandt T, 2001, J NEUROL NEUROSUR PS, V71, P8, DOI 10.1136/jnnp.71.1.8; CARTLIDGE NEF, 1978, SCOT MED J, V23, P103, DOI 10.1177/003693307802300146; Daroff RB, 2005, HARRISONS PRINCIPLES, P100; DAVIES RA, 1995, J NEUROL, V242, P222, DOI 10.1007/BF00919595; de Jong P T, 1977, Ann Neurol, V1, P240, DOI 10.1002/ana.410010307; DIETERICH M, 1993, CEPHALALGIA, V13, P285, DOI 10.1046/j.1468-2982.1993.1304285.x; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; FISCHER AJEM, 1995, J NEUROL SCI, V132, P35, DOI 10.1016/0022-510X(95)00118-L; FISHER CM, 1966, NEUROLOGY, V16, P826, DOI 10.1212/WNL.16.8.826; Fitzgerald DC, 1997, ANN OTO RHINOL LARYN, V106, P830, DOI 10.1177/000348949710601005; Franke LM, 2012, J REHABIL RES DEV, V49, P985, DOI 10.1682/JRRD.2011.12.0250; Friedland D, 2015, ACNR, V15, P24; GANNON RP, 1978, ARCH OTOLARYNGOL, V104, P404; Gdowski GT, 2000, EXP BRAIN RES, V135, P511, DOI 10.1007/s002210000542; GRAY L P, 1956, J Laryngol Otol, V70, P352, DOI 10.1017/S0022215100053032; GRIMM RJ, 1989, ACTA OTO-LARYNGOL, P1, DOI 10.3109/00016488909138632; HALMAGYI GM, 1994, OTOLARYNG HEAD NECK, V111, P571, DOI 10.1016/S0194-5998(94)70523-2; Harrigan MR, 1996, NEUROSURGERY, V38, P152, DOI 10.1097/00006123-199601000-00035; HEALY GB, 1982, NEW ENGL J MED, V306, P1029, DOI 10.1056/NEJM198204293061705; Hinoki M., 1984, ACTA OTO-LARYNGOL, V419, P9; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; HUGENHOLTZ H, 1988, NEUROSURGERY, V22, P853, DOI 10.1227/00006123-198805000-00006; Huppert D, 1994, J AUDIOLOGICAL MED, V4, P97; ILDIZ F, 1994, AVIAT SPACE ENVIR MD, V65, P67; JAFFE BF, 1979, NEW ENGL J MED, V301, P1385, DOI 10.1056/NEJM197912203012507; Jellinger K, 1967, Wien Z Nervenheilkd Grenzgeb, V25, P223; KARNATH HO, 1994, EXP BRAIN RES, V101, P140; Kelders WPA, 2005, J NEUROTRAUM, V22, P133, DOI 10.1089/neu.2005.22.133; Kim SH, 2001, INT J PEDIATR OTORHI, V60, P147, DOI 10.1016/S0165-5876(01)00485-2; KORTSCHOT HW, 1994, ORTHOPADE, V23, P275; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Luxon L. M., 1996, DISORDERS VESTIBULAR, P381; MELAMED Y, 1992, NEW ENGL J MED, V326, P30; Nacci A, 2011, ACTA OTORHINOLARYNGO, V31, P378; OOSTERVELD WJ, 1991, ACTA OTO-LARYNGOL, V111, P201, DOI 10.3109/00016489109137375; PULLEN FW, 1992, AM J OTOL, V13, P270; Rajan GP, 2003, ANN OTO RHINOL LARYN, V112, P221, DOI 10.1177/000348940311200305; RUBIN W, 1990, NEUROL CLIN, V8, P225, DOI 10.1016/S0733-8619(18)30352-9; RUTHERFORD WH, 1977, LANCET, V1, P1; SANDSTROM J, 1962, Acta Otolaryngol, V54, P207, DOI 10.3109/00016486209126940; Scherer MR, 2011, EXP BRAIN RES, V208, P399, DOI 10.1007/s00221-010-2490-1; Scherer MR, 2009, PHYS THER, V89, P980, DOI 10.2522/ptj.20080353; Schessel D. A., 2005, OTOLARYNGOLOGY HEAD; Schumway-Cook A, 2000, VESTIBULAR REHABILIT, P476; Shepard NT, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P779; SHEPARD NT, 1990, NEUROL CLIN, V8, P459, DOI 10.1016/S0733-8619(18)30367-0; TAYLOR SL, 1995, NEUROSURGERY, V37, P649, DOI 10.1227/00006123-199510000-00007; Tranter RMD, 2009, J FORENSIC LEG MED, V16, P53, DOI 10.1016/j.jflm.2008.09.001; Tuohimaa P, 1978, Acta Otolaryngol Suppl, V359, P3; WEEKS VD, 1955, J PEDIATR-US, V47, P315, DOI 10.1016/S0022-3476(55)80006-6; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Zafonte RD, 1997, ARCH PHYS MED REHAB, V78, P540, DOI 10.1016/S0003-9993(97)90173-8; Zee DS, 2006, NEUROLOGY EYE MOVEME; Zhou D, 1994, Zhonghua Er Bi Yan Hou Ke Za Zhi, V29, P350	61	18	19	0	8	C I C-EDIZIONI INT SRL	ROME	CORSO TRIESTE, 42, 00198 ROME, ITALY	0393-5264	1971-3274		FUNCT NEUROL	Funct. Neurol.	APR-JUN	2016	31	2					75	80					6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	DR5RH	WOS:000379959600003	27358219	Green Published			2022-02-06	
J	Jesus, TS; Silva, IL				Silva Jesus, Tiago; Lopes Silva, Isabel			Toward an evidence-based patient-provider communication in rehabilitation: linking communication elements to better rehabilitation outcomes	CLINICAL REHABILITATION			English	Article						Patient-physician communication; patient-physician relations; engagement; psychological adaptation; rehabilitation outcomes	SPINAL-CORD-INJURY; QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; HEALTH-RELATED QUALITY; LOW-BACK-PAIN; THERAPEUTIC WORKING ALLIANCE; LOWER-LIMB AMPUTATION; INPATIENT REHABILITATION; PSYCHOSOCIAL ADAPTATION; PHYSICAL-ACTIVITY	Background: There is a growing interest in linking aspects of patient-provider communication to rehabilitation outcomes. However, the field lacks a conceptual understanding on: (a) how' rehabilitation outcomes can be improved by communication; and (b) through which' elements in particular. This article elaborates on the conceptual developments toward informing further practice and research. Methods: Existing models of communication in healthcare were adapted to rehabilitation, and its outcomes through a comprehensive literature review. Results: After depicting mediating mechanisms and variables (e.g. therapeutic engagement, adjustment toward disability), this article presents the 4 Rehab Communication Elements' deemed likely to underpin rehabilitation outcomes. The four elements are: (a) knowing the person and building a supportive relationship; (b) effective information exchange and education; (c) shared goal-setting and action planning; and (d) fostering a more positive, yet realistic, cognitive and self-reframing. Discussion: This article describes an unprecedented, outcomes-oriented approach toward the design of rehabilitation communication, which has resulted in the development of a new intervention model: the 4 Rehab Communication Elements'. Further trials are needed to evaluate the impact of this whole intervention model on rehabilitation outcomes.	[Silva Jesus, Tiago] Univ Miguel Hernandez, Hlth Psychol Dept, Sch Med, Elche, Spain; [Silva Jesus, Tiago; Lopes Silva, Isabel] Univ Fernando Pessoa, Oporto, Portugal		Jesus, TS (corresponding author), Univ Miguel Hernandez, Hlth Psychol Dept, Sch Med, Elche, Spain.; Jesus, TS (corresponding author), Univ Fernando Pessoa, Oporto, Portugal.; Jesus, TS (corresponding author), Rua Fogaceiras, P-4520322 Fornos, Santa Maria Da, Portugal.	jesus-ts@outlook.com		Silva Jesus, Tiago/0000-0003-1300-6308; Silva, Isabel/0000-0002-6259-2182			Ahalt C, 2012, J GEN INTERN MED, V27, P568, DOI 10.1007/s11606-011-1933-0; Ahlund K, 2013, J REHABIL MED, V45, P1028, DOI 10.2340/16501977-1219; Alexanders J, 2015, PHYSIOTHERAPY, V101, P95, DOI 10.1016/j.physio.2014.03.008; Amtmann D, 2012, ARCH PHYS MED REHAB, V93, P1757, DOI 10.1016/j.apmr.2012.05.001; Anderson DR, 2014, HEALTH PSYCHOL, V33, P1614, DOI 10.1037/hea0000017; Anderson LM, 2013, J CLIN EPIDEMIOL, V66, P1223, DOI 10.1016/j.jclinepi.2013.06.014; Anson K, 2006, J HEAD TRAUMA REHAB, V21, P248, DOI 10.1097/00001199-200605000-00005; Arbour-Nicitopoulos KP, 2009, ARCH PHYS MED REHAB, V90, P2003, DOI 10.1016/j.apmr.2009.06.019; Balcazar FE, 2009, DISABIL REHABIL, V31, P1153, DOI 10.1080/09638280902773752; Barclay-Goddard R, 2011, ARCH PHYS MED REHAB, V92, P1762, DOI 10.1016/j.apmr.2011.06.013; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P352, DOI 10.1177/0269215508101741; Brands I, 2015, CLIN REHABIL, V29, P611, DOI 10.1177/0269215514549484; Brands I, 2014, ARCH PHYS MED REHAB, V95, P2327, DOI 10.1016/j.apmr.2014.06.006; Brands IMH, 2012, CLIN REHABIL, V26, P840, DOI 10.1177/0269215511432018; Bravata DM, 2005, ANN INTERN MED, V142, P1056, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00005; Bryant C, 2014, PHYS THER, V94, P1443, DOI 10.2522/ptj.20130444; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Chan DK, 2009, ARCH PHYS MED REHAB, V90, P1977, DOI 10.1016/j.apmr.2009.05.024; Chewning B, 2012, PATIENT EDUC COUNS, V86, P9, DOI 10.1016/j.pec.2011.02.004; Chow EOW, 2015, CLIN REHABIL, V29, P315, DOI 10.1177/0269215514544039; Clark AM, 2013, SOC SCI MED, V93, P185, DOI 10.1016/j.socscimed.2012.03.035; Coffey L, 2014, ARCH PHYS MED REHAB, V95, P1895, DOI 10.1016/j.apmr.2014.05.012; Coffey L, 2014, ARCH PHYS MED REHAB, V95, P244, DOI 10.1016/j.apmr.2013.08.011; Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010; Darlington ASE, 2009, J REHABIL MED, V41, P237, DOI 10.2340/16501977-0313; de Haes H, 2009, PATIENT EDUC COUNS, V74, P287, DOI 10.1016/j.pec.2008.12.006; Dibbelt S, 2009, PATIENT EDUC COUNS, V76, P328, DOI 10.1016/j.pec.2009.07.031; Dijkers MP, 2013, ARCH PHYS MED REHAB, V94, pS115, DOI 10.1016/j.apmr.2012.11.047; Doering BK, 2011, NEUROPSYCHOL REHABIL, V21, P515, DOI 10.1080/09602011.2011.583500; Ehde DM, 2013, ARCH PHYS MED REHAB, V94, pS30, DOI 10.1016/j.apmr.2012.10.025; Del Bano-Aledo ME, 2014, PHYSIOTHERAPY, V100, P73, DOI 10.1016/j.physio.2013.05.001; Epstein, 2007, PATIENT CTR COMMUNIC; Epstein RM, 2011, ANN FAM MED, V9, P454, DOI 10.1370/afm.1301; Escolar-Reina P, 2009, ARCH PHYS MED REHAB, V90, P1734, DOI 10.1016/j.apmr.2009.05.012; Evans CC, 2008, J HEAD TRAUMA REHAB, V23, P329, DOI 10.1097/01.HTR.0000336845.06704.bc; Eyssen ICJM, 2014, J REHABIL MED, V46, P527, DOI 10.2340/16501977-1797; Fadyl JK, 2011, BMJ QUAL SAF, V20, P87, DOI 10.1136/bmjqs.2010.042812; Farin E, 2013, J BEHAV MED, V36, P246, DOI 10.1007/s10865-012-9419-z; Ferreira PH, 2013, PHYS THER, V93, P470, DOI 10.2522/ptj.20120137; Forster A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001919.pub3; Fuentes J, 2014, PHYS THER REHABIL J, V94, P477, DOI 10.2522/ptj.20130118; Glattacker M, 2013, J REHABIL MED, V45, P268, DOI 10.2340/16501977-1104; Greenhalgh T, 2005, BRIT MED J, V331, P1064, DOI 10.1136/bmj.38636.593461.68; Gregorio GW, 2011, J REHABIL MED, V43, P190, DOI 10.2340/16501977-0633; Hafsteinsdottir TB, 2011, PATIENT EDUC COUNS, V85, P14, DOI 10.1016/j.pec.2010.07.046; Haggman S, 2004, PHYS THER, V84, P1157, DOI 10.1093/ptj/84.12.1157; Hall AM, 2010, PHYS THER, V90, P1099, DOI 10.2522/ptj.20090245; Hammond FM, 2013, ARCH PHYS MED REHAB, V94, pS106, DOI 10.1016/j.apmr.2012.12.023; Hanks RA, 2014, ARCH PHYS MED REHAB, V95, P2096, DOI 10.1016/j.apmr.2014.06.017; Hart T, 2006, J HEAD TRAUMA REHAB, V21, P142, DOI 10.1097/00001199-200603000-00007; Hart T, 2014, ARCH PHYS MED REHAB, V95, pS33, DOI 10.1016/j.apmr.2013.05.032; Hart T, 2013, DISABIL REHABIL, V35, P1668, DOI 10.3109/09638288.2012.751131; Hart T, 2012, ARCH PHYS MED REHAB, V93, pS117, DOI 10.1016/j.apmr.2011.11.039; Heinemann AW, 2013, ARCH PHYS MED REHAB, V94, P2157, DOI 10.1016/j.apmr.2013.05.017; Hemsley B, 2014, AUGMENT ALTERN COMM, V30, P329, DOI 10.3109/07434618.2014.955614; Henry SG, 2012, PATIENT EDUC COUNS, V86, P297, DOI 10.1016/j.pec.2011.07.006; Hill AM, 2011, ARCH PHYS MED REHAB, V92, P1395, DOI 10.1016/j.apmr.2011.04.009; Hunt MR, 2013, AM J PHYS MED REHAB, V92, P818, DOI 10.1097/PHM.0b013e318292309b; Jensen MP, 2011, ARCH PHYS MED REHAB, V92, P146, DOI 10.1016/j.apmr.2010.09.021; Kortte KB, 2007, ARCH PHYS MED REHAB, V88, P877, DOI 10.1016/j.apmr.2007.03.030; Kortte KB, 2012, REHABIL PSYCHOL, V57, P248, DOI 10.1037/a0029004; Kortte KB, 2010, REHABIL PSYCHOL, V55, P40, DOI 10.1037/a0018624; Kruithof WJ, 2013, PATIENT EDUC COUNS, V93, P169, DOI 10.1016/j.pec.2013.06.003; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P1599, DOI 10.1016/j.apmr.2004.03.027; Lenze EJ, 2004, ARCH PHYS MED REHAB, V85, P380, DOI 10.1016/j.apmr.2003.06.001; Lequerica AH, 2010, AM J PHYS MED REHAB, V89, P415, DOI 10.1097/PHM.0b013e3181d8ceb2; Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Levasseur M, 2010, CLIN REHABIL, V24, P756, DOI 10.1177/0269215509360752; Livneh H, 2014, REHABIL PSYCHOL, V59, P329, DOI 10.1037/a0036733; Makoul G, 2007, PATIENT EDUC COUNS, V67, P333, DOI 10.1016/j.pec.2007.05.005; Martz E, 2005, ARCH PHYS MED REHAB, V86, P1182, DOI 10.1016/j.apmr.2004.11.036; Mays Nicholas, 2005, J Health Serv Res Policy, V10 Suppl 1, P6, DOI 10.1258/1355819054308576; Medley AR, 2010, NEUROPSYCHOL REHABIL, V20, P481, DOI 10.1080/09602010903529610; Morris JH, 2014, ARCH PHYS MED REHAB, V95, P956, DOI 10.1016/j.apmr.2013.12.016; Morris MA, 2015, DISABIL HEALTH J, V8, P208, DOI 10.1016/j.dhjo.2014.09.007; Muller R, 2012, SPINAL CORD, V50, P94, DOI 10.1038/sc.2011.116; Muller R, 2015, ARCH PHYS MED REHAB, V96, P447, DOI 10.1016/j.apmr.2014.09.006; Murray A, 2015, ARCH PHYS MED REHAB, V96, P809, DOI 10.1016/j.apmr.2014.11.007; Neumann M, 2010, PATIENT EDUC COUNS, V80, P307, DOI 10.1016/j.pec.2010.07.020; Nielsen M, 2014, PHYS THER, V94, P197, DOI 10.2522/ptj.20130047; O'Halloran PD, 2014, CLIN REHABIL, V28, P1159, DOI 10.1177/0269215514536210; Oliveira VC, 2012, J PHYSIOTHER, V58, P215, DOI 10.1016/S1836-9553(12)70123-6; Parry RH, 2009, PHYSIOTHERAPY, V95, P294, DOI 10.1016/j.physio.2009.05.003; Pawson Ray, 2005, J Health Serv Res Policy, V10 Suppl 1, P21, DOI 10.1258/1355819054308530; Peiris CL, 2012, J PHYSIOTHER, V58, P261, DOI 10.1016/S1836-9553(12)70128-5; Peter C, 2012, SPINAL CORD, V50, P188, DOI 10.1038/sc.2011.125; Peter C, 2014, QUAL LIFE RES, V23, P2693, DOI 10.1007/s11136-014-0721-9; Peter C, 2014, ARCH PHYS MED REHAB, V95, P1662, DOI 10.1016/j.apmr.2014.04.012; Pinto RZ, 2012, J PHYSIOTHER, V58, P77, DOI 10.1016/S1836-9553(12)70087-5; Playford ED, 2009, CLIN REHABIL, V23, P334, DOI 10.1177/0269215509103506; Portegijs E, 2012, ARCH PHYS MED REHAB, V93, P2340, DOI 10.1016/j.apmr.2012.05.022; Rosewilliam S, 2011, CLIN REHABIL, V25, P501, DOI 10.1177/0269215510394467; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Satink T, 2013, ARCH PHYS MED REHAB, V94, P1171, DOI 10.1016/j.apmr.2013.01.011; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P1101, DOI 10.1016/j.apmr.2012.01.020; Schmid AA, 2012, ARCH PHYS MED REHAB, V93, P978, DOI 10.1016/j.apmr.2011.12.012; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schmitz MA, 2010, TOP STROKE REHABIL, V17, P204, DOI 10.1310/tsr1703-204; Schonberger M, 2007, BRAIN INJURY, V21, P825, DOI 10.1080/02699050701499433; Schoenthaler A, 2014, PATIENT EDUC COUNS, V96, P3, DOI 10.1016/j.pec.2014.04.006; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; Schwartz CE, 2010, ARCH PHYS MED REHAB, V91, pS38, DOI 10.1016/j.apmr.2009.11.029; Schwarzer R, 2008, HEALTH PSYCHOL, V27, pS54, DOI 10.1037/0278-6133.27.1(Suppl.).S54; Schwarzer R, 2011, REHABIL PSYCHOL, V56, P161, DOI 10.1037/a0024509; Scobbie L, 2011, CLIN REHABIL, V25, P468, DOI 10.1177/0269215510389198; Sharpe L, 2006, SOC SCI MED, V62, P1153, DOI 10.1016/j.socscimed.2005.07.010; Jesus TS, 2015, ARCH PHYS MED REHAB, V96, P960, DOI 10.1016/j.apmr.2014.12.007; Silverman J, 2009, PATIENT EDUC COUNS, V76, P361, DOI 10.1016/j.pec.2009.06.011; Skidmore ER, 2010, ARCH PHYS MED REHAB, V91, P203, DOI 10.1016/j.apmr.2009.10.026; Smedema SM, 2010, DISABIL REHABIL, V32, P1311, DOI 10.3109/09638280903514721; Street RL, 2009, PATIENT EDUC COUNS, V74, P295, DOI 10.1016/j.pec.2008.11.015; Tate DG, 2015, ARCH PHYS MED REHAB, V96, P340, DOI 10.1016/j.apmr.2014.09.036; Tielemans NS, 2014, CLIN REHABIL, V28, P530, DOI 10.1177/0269215513514460; Tielemans NS, 2014, ARCH PHYS MED REHAB, V95, P670, DOI 10.1016/j.apmr.2013.11.010; van Leeuwen CMC, 2012, SPINAL CORD, V50, P174, DOI 10.1038/sc.2011.120; van Leeuwen CMC, 2012, QUAL LIFE RES, V21, P1499, DOI 10.1007/s11136-011-0073-7; van Mierlo ML, 2014, INT J STROKE, V9, P341, DOI 10.1111/ijs.12149; van Til JA, 2010, J REHABIL MED, V42, P598, DOI 10.2340/16501977-0549; Venetis MK, 2009, PATIENT EDUC COUNS, V77, P379, DOI 10.1016/j.pec.2009.09.015; Wanyonyi KL, 2011, PATIENT EDUC COUNS, V85, P348, DOI 10.1016/j.pec.2011.02.006; Watkins CL, 2011, STROKE, V42, P1956, DOI 10.1161/STROKEAHA.110.602227; Whittemore R, 2005, J ADV NURS, V52, P546, DOI 10.1111/j.1365-2648.2005.03621.x; Wiles R, 2004, SOC SCI MED, V59, P1263, DOI 10.1016/j.socscimed.2003.12.022; Wiles R, 2008, J ADV NURS, V64, P564, DOI 10.1111/j.1365-2648.2008.04815.x; Wright BJ, 2014, J REHABIL MED, V46, P153, DOI 10.2340/16501977-1241; Zimmermann L, 2014, PATIENT EDUC COUNS, V96, P98, DOI 10.1016/j.pec.2014.04.015	128	18	18	1	31	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	APR	2016	30	4					315	328		10.1177/0269215515585133			14	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DH0LD	WOS:000372474800002	25952588				2022-02-06	
J	Konstantinou, N; Pettemeridou, E; Seimenis, I; Eracleous, E; Papacostas, SS; Papanicolaou, AC; Constantinidou, F				Konstantinou, Nikos; Pettemeridou, Eva; Seimenis, Ioannis; Eracleous, Eleni; Papacostas, Savvas S.; Papanicolaou, Andrew C.; Constantinidou, Fofi			Assessing the Relationship between Neurocognitive Performance and Brain Volume in Chronic Moderate-Severe Traumatic Brain Injury	FRONTIERS IN NEUROLOGY			English	Article						TBI; VBM; grey matter; white matter; neurocognitive/neuropsychological assessment; brain atrophy	VOXEL-BASED MORPHOMETRY; SHORT-TERM-MEMORY; WHITE-MATTER; HEAD-INJURY; ALZHEIMERS-DISEASE; DIFFUSION-TENSOR; LONGITUDINAL CHANGES; COGNITIVE CONTROL; AXONAL INJURY; CELL-DEATH	Objectives: Characterize the scale and pattern of long-term atrophy in gray matter (GM), white matter (WM), and cerebrospinal fluid (CSF) in chronic moderate-severe traumatic brain injury (TBI) and its relationship to neurocognitive outcomes. Participants: The TBI group consisted of 17 males with primary diagnosis of moderate-severe closed head injury. Participants had not received any systematic, postacute rehabilitation and were recruited on average 8.36 years post- injury. The control group consisted of 15 males matched on age and education. Main measures: Neurocognitive battery included widely used tests of verbal memory, visual memory, executive functioning, and attention/organization. GM, WM, and CSF volumes were calculated from segmented T1-weighted anatomical MR images. Voxelbased morphometry was employed to identify brain regions with differences in GM and WM between TBI and control groups. Results: Chronic TBI results in significant neurocognitive impairments, and significant loss of GM and WM volume, and significant increase in CSF volume. Brain atrophy is not widespread, but it is rather distributed in a fronto-thalamic network. The extent of volume loss is predictive of performance on the neurocognitive tests. Conclusion: Significant brain atrophy and associated neurocognitive impairments during the chronic stages of TBI support the notion that TBI results in a chronic condition with lifelong implications.	[Konstantinou, Nikos; Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Ctr Appl Neurosci, CY-1678 Nicosia, Cyprus; [Konstantinou, Nikos; Pettemeridou, Eva; Constantinidou, Fofi] Univ Cyprus, Dept Psychol, CY-1678 Nicosia, Cyprus; [Seimenis, Ioannis] Democritus Univ Thrace, Sch Med, Dept Med Phys, Alexandroupolis, Greece; [Eracleous, Eleni] Med Diagnost Ctr Ayios Therissos, Nicosia, Cyprus; [Papacostas, Savvas S.] Cyprus Inst Neurol & Genet, Cyprus Sch Mol Med, Neurol Clin B, Nicosia, Cyprus; [Papanicolaou, Andrew C.] Univ Tennessee, Hlth Sci Ctr, Div Clin Neurosci, Dept Pediat,Le Bonheur Neurosci Inst, Memphis, TN USA; [Papanicolaou, Andrew C.] Univ Tennessee, Hlth Sci Ctr, Div Clin Neurosci, Dept Neurobiol & Anat,Le Bonheur Neurosci Inst, Memphis, TN USA		Konstantinou, N (corresponding author), Univ Cyprus, Ctr Appl Neurosci, CY-1678 Nicosia, Cyprus.; Konstantinou, N (corresponding author), Univ Cyprus, Dept Psychol, CY-1678 Nicosia, Cyprus.	nkonstantinou@gmail.com	Seimenis, Ioannis/AAF-4406-2021	Seimenis, Ioannis/0000-0003-3665-5271; Konstantinou, Nikos/0000-0003-4531-3636; Papacostas, Savvas/0000-0003-3845-7439; Constantinidou, Fofi/0000-0002-7928-8363; PETTEMERIDOU, EVA/0000-0001-5081-0042	Cyprus Research Promotion Foundation; Cyprus Government; European Regional Development FundEuropean Commission [NEW INFRASTRUCTURE/STRATEGIC/0309/37]	This work was supported by the Cyprus Research Promotion Foundation through a grant co-funded by the Cyprus Government and the European Regional Development Fund (FC, PI; NEW INFRASTRUCTURE/STRATEGIC/0309/37).	Adnan A, 2013, BRAIN INJURY, V27, P1415, DOI 10.3109/02699052.2013.823659; Aleman-Gomez Y. M-GL, 2006, 12 ANN M ORG HUM BRA; Alvarez GA, 2004, PSYCHOL SCI, V15, P106, DOI 10.1111/j.0963-7214.2004.01502006.x; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Areza-Fegyveres R, 2007, ARQ NEURO-PSIQUIAT, V65, P830, DOI 10.1590/S0004-282X2007000500019; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 1997, AM J NEURORADIOL, V18, P24; Bigler ED, 2013, BRAIN, V136, P9, DOI 10.1093/brain/aws342; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Braitenberg V, 1977, TEXTURE BRAINS INTRO; Bramlett HM, 1997, J NEUROPATH EXP NEUR, V56, P1132, DOI 10.1097/00005072-199710000-00007; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Constantinidou F, 2011, CHILD NEUROPSYCHOL, V2011, P37; Constantinidou F, 2008, J HEAD TRAUMA REHAB, V23, P312, DOI 10.1097/01.HTR.0000336844.99079.2c; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Courtney SM, 1996, CEREB CORTEX, V6, P39, DOI 10.1093/cercor/6.1.39; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Dietrich WD, 1998, NEUROSURGERY, V43, P585, DOI 10.1097/00006123-199809000-00105; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Djebaili M, 2004, NEUROSCIENCE, V123, P349, DOI 10.1016/j.neuroscience.2003.09.023; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Farbota KD, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00160; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Frisoni GB, 2010, ALZHEIMERS DEMENT, V6, P280, DOI 10.1016/j.jalz.2010.03.005; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Green REA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00067; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; Hammoud DA, 2002, NEUROIMAG CLIN N AM, V12, P205, DOI 10.1016/S1052-5149(02)00011-4; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Kiraly MA, 2007, THESCIENTIFICWORLDJO, V7, P1768, DOI 10.1100/tsw.2007.269; Klauer KC, 2004, J EXP PSYCHOL GEN, V133, P355, DOI 10.1037/0096-3445.133.3.355; Konstantinou N, 2013, J VIS, V13, P6, DOI [10.1167/13.9.6, DOI 10.1167/13.9.6]; Konstantinou N, 2014, ATTEN PERCEPT PSYCHO, V76, P1985, DOI 10.3758/s13414-014-0742-z; Kosmidis MH, 2004, J INT NEUROPSYCH SOC, V10, P164, DOI 10.1017/S1355617704102014; Leunissen I, 2014, HUM BRAIN MAPP, V35, P2459, DOI 10.1002/hbm.22341; Leunissen I, 2013, HUM BRAIN MAPP, V34, P1254, DOI 10.1002/hbm.21508; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Lye TC, 2000, NEUROPSYCHOL REV, V10, P115, DOI 10.1023/A:1009068804787; MacKenzie JD, 2002, AM J NEURORADIOL, V23, P1509; Marcoux J, 2008, CRIT CARE MED, V36, P2871, DOI 10.1097/CCM.0b013e318186a4a0; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MAWDSLEY C, 1963, LANCET, V2, P795; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Rey A., 1993, CLIN NEUROPSYCHOL, V7, P4; ROOF RL, 1994, EXP NEUROL, V129, P64, DOI 10.1006/exnr.1994.1147; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; STRICH SJ, 1961, LANCET, V2, P443; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Till C, 2008, ARCH PHYS MED REHAB, V89, pS25, DOI 10.1016/j.apmr.2008.07.004; Tomaiuolo F, 2005, J NEUROTRAUM, V22, P76, DOI 10.1089/neu.2005.22.76; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D, 1997, WAIS 3 WECHSLER ADUL; Wilson JTL, 2007, NEUROSURGERY, V61, P123, DOI 10.1227/01.neu.0000279732.21145.9e; XU Y, 2009, J CEREB BLOOD FLOW M, V30, P883, DOI DOI 10.1038/JCBFM.2009.263; Zalonis I, 2008, CLIN NEUROPSYCHOL, V22, P842, DOI 10.1080/13854040701629301; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197	81	18	18	0	12	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	MAR 10	2016	7								29	10.3389/fneur.2016.00029			13	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DF9DI	WOS:000371660100001	27014183	gold, Green Published			2022-02-06	
J	Holcomb, EM; Towns, S; Kamper, JE; Barnett, SD; Sherer, M; Evans, C; Nakase-Richardson, R				Holcomb, Erin M.; Towns, Stephanie; Kamper, Joel E.; Barnett, Scott D.; Sherer, Mark; Evans, Clea; Nakase-Richardson, Risa			The Relationship Between Sleep-Wake Cycle Disturbance and Trajectory of Cognitive Recovery During Acute Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						rehabilitation; brain injury; cognition; sleep	DEPRIVATION; PERFORMANCE; DISORDERS; DELIRIUM; CONSEQUENCES; PREVALENCE; VALIDATION; STATE	Objective: Following traumatic brain injury, both sleep dysfunction and cognitive impairment are common. Unfortunately, little is known regarding the potential associations between these 2 symptoms during acute recovery. This study sought to prospectively examine the relationship between ratings of sleep dysfunction and serial cognitive assessments among traumatic brain injury acute neurorehabilitation admissions. Methods: Participants were consecutive admissions to a free-standing rehabilitation hospital following moderate to severe traumatic brain injury (Median Emergency Department Glasgow Coma Scale = 7). Participants were assessed for sleep-wake cycle disturbance (SWCD) and cognitive functioning at admission and with subsequent weekly examinations. Participants were grouped on the basis of presence (SWCD+) or absence (SWCD-) of sleep dysfunction for each examination; groups were equivalent on demographic and injury variables. Individual Growth Curve modeling was used to examine course of Cognitive Test for Delirium performance across examinations. Results: Individual Growth Curve modeling revealed a significant interaction between examination number (ie, time) and SWCD group (beta = -4.03, P < .001) on total Cognitive Test for Delirium score. The SWCD+ ratings on later examinations were predicted to result in lower Cognitive Test for Delirium scores and greater cognitive impairment over time. Conclusions: This study has implications for improving neurorehabilitation treatment, as targeting sleep dysfunction for early intervention may facilitate cognitive recovery.	[Holcomb, Erin M.; Sherer, Mark] TIRR Mem Hermann, 1333 Moursund St, Houston, TX 77030 USA; [Kamper, Joel E.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Mental Hlth & Behav Sci, Tampa, FL USA; [Barnett, Scott D.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Ctr Innovat Disabil Rehabil & Res CINDRR, Tampa, FL USA; [Nakase-Richardson, Risa] James A Haley Vet Hosp, Def & Vet Brain Injury Ctr, Tampa, FL USA; [Nakase-Richardson, Risa] Univ S Florida, Dept Med, Tampa, FL USA; [Towns, Stephanie] Geisel Sch Med Dartmouth, Dartmouth Hitchcock Med Ctr, Lebanon, NH USA; [Evans, Clea] Methodist Rehabil Ctr, Jackson, MS USA		Holcomb, EM (corresponding author), TIRR Mem Hermann, 1333 Moursund St, Houston, TX 77030 USA.	holcomberin@gmail.com	Kamper, Joel/V-2450-2019; Towns, Stephanie/AAF-2035-2020; Towns, Stephanie/AAS-5118-2021	Kamper, Joel/0000-0001-5098-5176; 	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research; VHA Central Office VA TBI Model System Program of Research; General Dynamics Health Solutions from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U. S. Department of Veterans Affairs [W91YTZ-13-C-0015, 1 I50 HX001233-01, W81XWH-13-2-0095]; General Dynamics Health Solutions from the U. S. Department of Defense Congressionally Directed Medical Research Programs	The Polytrauma Rehabilitation Center Traumatic Brain Injury (TBI) Model System collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability, Independent Living, and Rehabilitation Research. This research is sponsored by VHA Central Office VA TBI Model System Program of Research, and Subcontract from General Dynamics Health Solutions (W91YTZ-13-C-0015) from the Defense and Veterans Brain Injury Center, US Army Medical Research and Material Command (USAMRMC), U. S. Department of Veterans Affairs grants (1 I50 HX001233-01, W81XWH-13-2-0095), and U. S. Department of Defense Congressionally Directed Medical Research Programs. The contents of this article were developed under grants from the National Institute on Disability and Rehabilitation Research, Department of Education H133A120020 (Texas TBIModel System of TIRR). The views, opinions, and/ or findings contained in this article are those of the authors and should not be construed as an official Department of Defense, Department of Veterans Affairs, or Department of Education position or any other federal agency, policy, or decision unless so designated by other official documentation.	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bourne RS, 2007, CRIT CARE, V11, DOI 10.1186/cc5966; Castriotta RJ, 2007, J CLIN SLEEP MED, V3, P349; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Castriotta RJ, 2001, ARCH PHYS MED REHAB, V82, P1403, DOI 10.1053/apmr.2001.26081; Chuah YML, 2006, J NEUROSCI, V26, P7156, DOI 10.1523/JNEUROSCI.0906-06.2006; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Dinges DF, 1997, SLEEP, V20, P267; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Fitzmaurice G.M., 2012, APPL LONGITUDINAL AN, V998; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grover S, 2011, J PSYCHOSOM RES, V70, P473, DOI 10.1016/j.jpsychores.2010.11.007; Hairston IS, 2004, NATURE, V430, P27, DOI 10.1038/430027a; Hart RP, 1996, PSYCHOSOMATICS, V37, P533, DOI 10.1016/S0033-3182(96)71517-7; HORNE JA, 1985, ANN CLIN RES, V17, P199; KATZ DI, 1994, ARCH NEUROL-CHICAGO, V51, P661, DOI 10.1001/archneur.1994.00540190041013; Kennedy RE, 2003, PSYCHOSOMATICS, V44, P283, DOI 10.1176/appi.psy.44.4.283; KESSLER RC, 1991, LINEAR PANEL ANAL MO; Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Makley MJ, 2009, NEUROREHAB NEURAL RE, V23, P320, DOI 10.1177/1545968308325268; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McDermott CM, 2003, J NEUROSCI, V23, P9687; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P875, DOI 10.1016/j.apmr.2013.01.001; Nakase-Thompson R, 2004, BRAIN INJURY, V18, P131, DOI 10.1080/0269905031000149542; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Pilcher JJ, 1996, SLEEP, V19, P318, DOI 10.1093/sleep/19.4.318; ROGOSA D, 1982, PSYCHOL BULL, V92, P726, DOI 10.1037/0033-2909.92.3.726; ROGOSA DR, 1985, PSYCHOMETRIKA, V50, P203, DOI 10.1007/BF02294247; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sherer M, 2009, ARCH PHYS MED REHAB, V90, P1749, DOI 10.1016/j.apmr.2009.05.011; Silva MA, 2012, AM J PHYS MED REHAB, V91, P890, DOI 10.1097/PHM.0b013e31825a1648; Trzepacz PT, 2001, J NEUROPSYCH CLIN N, V13, P229, DOI 10.1176/appi.neuropsych.13.2.229; Van Someren EJW, 2007, SLEEP MED REV, V11, P465, DOI 10.1016/j.smrv.2007.07.003; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zepelin H., 2005, PRINCIPLES PRACTICE, V4th ed., P91, DOI DOI 10.1016/B0-72-160797-7/50015-X; Zohar D, 2005, SLEEP, V28, P47, DOI 10.1093/sleep/28.1.47; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	40	18	18	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2016	31	2			SI		108	116		10.1097/HTR.0000000000000206			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DH7NO	WOS:000372981100004	26709584				2022-02-06	
J	Lo Giudice, D; Smith, K; Fenner, S; Hyde, Z; Atkinson, D; Skeaf, L; Malay, R; Flicker, L				Lo Giudice, Dina; Smith, Kate; Fenner, Stephen; Hyde, Zoe; Atkinson, David; Skeaf, Linda; Malay, Roslyn; Flicker, Leon			Incidence and predictors of cognitive impairment and dementia in Aboriginal Australians: A follow-up study of 5 years	ALZHEIMERS & DEMENTIA			English	Article						Indigenous; Dementia; Cognition; Cohort study; Older people	STRAIT ISLANDER PEOPLES; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; VASCULAR DEMENTIA; RISK-FACTORS; PREVALENCE; BURDEN; OLDER; TRENDS; PAIN	Introduction: Aboriginal Australians are reported to develop dementia earlier than the general population. The causes remain unknown. Methods: This was a longitudinal study of 363 participants aged >= 45 years. Consensus diagnoses were established for cognitive impairment or dementia. Results: At follow-up, 189 people (mean +/- standard deviation age, 65.4 +/- 10.3 years) participated, as 109 (30%) had died and 65 (18%) were unavailable. The incidence of cognitive impairment or dementia was 52.6 (95% confidence interval 33.9, 81.5) per 1000 person-years (380.3 total person-years) and for dementia was 21.0 (10.5, 42.1) per 1000 person-years (380.3 person-years total) over the age 60 years. Longitudinal risk factors associated with a decline from normal cognition to impairment were age and head injury. Other associations with cognitive decline were stroke, head injury, nonaspirin analgesics, lower BMI, and higher systolic BP. Discussion: Dementia incidence in Aboriginal Australians is among the highest in the world, and is associated with age and head injury. (C) 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.	[Lo Giudice, Dina] Melbourne Hlth, Aged Care, Melbourne, Vic, Australia; [Lo Giudice, Dina; Smith, Kate; Hyde, Zoe; Skeaf, Linda; Malay, Roslyn; Flicker, Leon] WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia; [Fenner, Stephen] Royal Perth Hosp, Dept Psychiat, Perth, WA 6001, Australia; [Hyde, Zoe; Flicker, Leon] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Atkinson, David] Univ Western Australia, Rural Clin Sch WA, Perth, WA 6009, Australia; [Atkinson, David] Kimberley Aboriginal Med Serv, Broome, Australia; [Flicker, Leon] Royal Perth Hosp, Dept Geriatr Med, Perth, WA 6001, Australia		Lo Giudice, D (corresponding author), Melbourne Hlth, Aged Care, Melbourne, Vic, Australia.; Lo Giudice, D (corresponding author), WA Ctr Hlth & Ageing, Med Res Ctr, Perth, WA, Australia.	dina.logiudice@mhorg.au	Smith, Kate/ABF-3402-2021; Hyde, Zoe/B-6411-2009; LoGiudice, Dina/ABD-2618-2021	Smith, Kate/0000-0003-4077-1996; Hyde, Zoe/0000-0002-5985-1729; Flicker, Leon/0000-0002-3650-0475; Atkinson, David/0000-0001-7069-5555	National Health and Medical Research Council (NHMRC)National Health and Medical Research Council of Australia [634486]	This research was supported by National Health and Medical Research Council (NHMRC) Project Grant ID 634486.	Avila-Funes JA, 2012, J AM GERIATR SOC, V60, P1708, DOI 10.1111/j.1532-5415.2012.04142.x; Australian Institute of Health and Welfare, 2011, HLTH WELF AUSTR AB T; Australian Institute of Health and Welfare, 2011, LIF EXP MORT AB TORR; Bowirrat A, 2002, J NEUROL SCI, V203, P73, DOI 10.1016/S0022-510X(02)00269-1; Catindig JAS, 2012, J NEUROL SCI, V321, P11, DOI 10.1016/j.jns.2012.07.023; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Flicker L, 2010, CLIN GERIATR MED, V26, P17, DOI 10.1016/j.cger.2009.12.005; Gardner RC, 2014, ANN NEUROL, V75, P339, DOI 10.1002/ana.24121; Hendrie H C, 1993, Int Psychogeriatr, V5, P5, DOI 10.1017/S1041610293001358; Jacklin KM, 2013, CAN J PUBLIC HEALTH, V104, pE39, DOI 10.1007/BF03405652; JORM AF, 1987, ACTA PSYCHIAT SCAND, V76, P465, DOI 10.1111/j.1600-0447.1987.tb02906.x; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Li SQ, 2014, MED J AUSTRALIA, V200, P465, DOI 10.5694/mja13.11052; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; LoGiudice DC, 2012, INTERN MED J, V42, pE102, DOI 10.1111/j.1445-5994.2010.02332.x; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ott A, 1998, AM J EPIDEMIOL, V147, P574; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Radford K, 2015, ALZHEIMERS DEMENT, V11, P271, DOI 10.1016/j.jalz.2014.03.007; Rocca WA, 2011, ALZHEIMERS DEMENT, V7, P80, DOI 10.1016/j.jalz.2010.11.002; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Russ TC, 2012, INT J EPIDEMIOL, V41, P1012, DOI 10.1093/ije/dys103; Smith K, 2008, NEUROLOGY, V71, P1470, DOI 10.1212/01.wnl.0000320508.11013.4f; Smith K, 2010, AUST NZ J PSYCHIAT, V44, P888, DOI 10.3109/00048674.2010.491816; Thrift AG, 2007, INT J STROKE, V2, P57, DOI 10.1111/j.1747-4949.2007.00090.x; Vindigni Dein, 2003, Aust J Rural Health, V11, P187, DOI 10.1046/j.1440-1584.2003.00503.x; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Wang ZM, 2006, EUR J CARDIOV PREV R, V13, P438, DOI 10.1097/00149831-200606000-00021; Yaffe K, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7051	30	18	18	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	MAR	2016	12	3					252	261		10.1016/j.jalz.2015.01.009			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DH3VP	WOS:000372715200006	25998515				2022-02-06	
J	Williams, DSB; Murray, NG; Powell, DW				Williams, D. S. Blaise, III; Murray, Nicholas G.; Powell, Douglas W.			Athletes who train on unstable compared to stable surfaces exhibit unique postural control strategies in response to balance perturbations	JOURNAL OF SPORT AND HEALTH SCIENCE			English	Article						Athletes; Balance; Negative feedback; Postural stability; Training	DYNAMIC BALANCE; CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; RHYTHMIC GYMNASTICS; HEALTHY-YOUNG; BODY SWAY; ADULTS; EQUILIBRIUM; DIRECTIONS; BASKETBALL	Background: Athletes have been shown to exhibit better balance compared to non-athletes (NON). However, few studies have investigated how the surface on which athletes train affects the strategies adopted to maintain balance. Two distinct athlete groups who experience different types of sport-specific balance training are stable surface athletes (SSA) such as basketball players and those who train on unstable surfaces (USA) such as surfers. The purpose of this study was to investigate the effects of training surface on dynamic balance in athletes compared to NON. Methods: Eight NON, eight SSA, and eight USA performed five 20-s trials in each of five experimental conditions including a static condition and four dynamic conditions in which the support surface translated in the anteroposterior (AP) or mediolateral (ML) planes using positive or negative feedback paradigms. Approximate entropy (ApEn) and root mean square distance (RMS) of the center of pressure (CoP) were calculated for the AP and ML directions. Four 3 x 5 (group x condition) repeated measures ANOVAs were used to determine significant effects of group and condition on variables of interest. Results: USA exhibited smaller ApEn values than SSA in the AP signals while no significant differences were observed in the ML CoP signals. Generally, the negative feedback conditions were associated with significantly greater RMS values than the positive feedback conditions. Conclusion: USA exhibit unique postural strategies compared to SSA. These unique strategies seemingly exhibit a direction-specific attribute and may be associated with divergent motor control strategies. (C) 2016 Production and hosting by Elsevier B.V. on behalf of Shanghai University of Sport.	[Williams, D. S. Blaise, III] Virginia Commonwealth Univ, Dept Phys Therapy, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Murray, Nicholas G.] Georgia So Univ, Dept Hlth Sci & Kinesiol, Statesboro, GA 30458 USA; [Powell, Douglas W.] Campbell Univ, Coll Pharm & Hlth Sci, Dept Phys Therapy, Buies Creek, NC 27506 USA; [Powell, Douglas W.] Campbell Univ, Sch Osteopath Med, Dept Physiol, Buies Creek, NC 27506 USA		Powell, DW (corresponding author), Campbell Univ, Coll Pharm & Hlth Sci, Dept Phys Therapy, Buies Creek, NC 27506 USA.; Powell, DW (corresponding author), Campbell Univ, Sch Osteopath Med, Dept Physiol, Buies Creek, NC 27506 USA.	dwp0817@gmail.com					[Anonymous], 1995, GAIT POSTURE; Bressel E, 2007, J ATHL TRAINING, V42, P42; Calavalle AR, 2008, EUR J APPL PHYSIOL, V104, P643, DOI 10.1007/s00421-008-0815-6; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Chen Wei-ting, 2006, J Zhejiang Univ Sci B, V7, P844, DOI 10.1631/jzus.2006.B0844; Davlin CD, 2004, PERCEPT MOTOR SKILL, V98, P1171, DOI 10.2466/pms.98.3c.1171-1176; Demura SI, 2008, PERCEPT MOTOR SKILL, V107, P89, DOI 10.2466/PMS.107.1.89-98; Gerbino PG, 2007, GAIT POSTURE, V26, P501, DOI 10.1016/j.gaitpost.2006.11.205; Golomer E, 1999, NEUROSCI LETT, V267, P189, DOI 10.1016/S0304-3940(99)00356-0; Guillou E, 2007, CLIN NEUROPHYSIOL, V118, P317, DOI 10.1016/j.clinph.2006.10.001; Hansen MS, 2000, KNEE SURG SPORT TR A, V8, P180, DOI 10.1007/s001670050211; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1987, PHYS THER, V67, P1881, DOI 10.1093/ptj/67.12.1881; Kiers H, 2013, SPORTS MED, V43, P1171, DOI 10.1007/s40279-013-0082-5; Kioumourtzoglou E, 1998, PERCEPT MOTOR SKILL, V86, P771, DOI 10.2466/pms.1998.86.3.771; Kioumourtzoglou E, 1997, PERCEPT MOTOR SKILL, V84, P1363, DOI 10.2466/pms.1997.84.3c.1363; Klous M, 2011, J NEUROPHYSIOL, V105, P2275, DOI 10.1152/jn.00665.2010; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; Perrin P, 2002, GAIT POSTURE, V15, P187, DOI 10.1016/S0966-6362(01)00149-7; Powell DW, 2015, HUM MOVEMENT SCI, V44, P73, DOI 10.1016/j.humov.2015.08.013; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; RILEY PO, 1990, J BIOMECH, V23, P503, DOI 10.1016/0021-9290(90)90306-N; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Sforza C, 2003, PERCEPT MOTOR SKILL, V96, P127, DOI 10.2466/PMS.96.1.127-136; Stergiou Nicholas, 2006, J Neurol Phys Ther, V30, P120; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Thompson W R, 2010, ACSMS GUIDELINES EXE; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	31	18	18	1	23	SHANGHAI UNIV SPORT	SHANGHAI	EDITORIAL BOARD, 650 QINGYUANHUAN RD, SHANGHAI, 200438, PEOPLES R CHINA	2095-2546	2213-2961		J SPORT HEALTH SCI	J. Sport Health Sci.	MAR	2016	5	1					70	76		10.1016/j.jshs.2016.01.010			7	Hospitality, Leisure, Sport & Tourism; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Sport Sciences	DI8AH	WOS:000373722600009	30356520	Green Published, gold			2022-02-06	
J	Yellinek, S; Cohen, A; Merkin, V; Shelef, I; Benifla, M				Yellinek, Shlomi; Cohen, Avi; Merkin, Vladimir; Shelef, Ilan; Benifla, Mony			Clinical significance of skull base fracture in patients after traumatic brain injury	JOURNAL OF CLINICAL NEUROSCIENCE			English	Article						Brain injury; CSF leak; Skull base fractures	CEREBROSPINAL-FLUID FISTULA; TEMPORAL BONE-FRACTURES; HEAD-INJURY; MANAGEMENT; MENINGITIS; METAANALYSIS; GUIDELINES; LEAKAGE	About 4% of all head injuries include skull base fractures. Most of these fractures (90%) are secondary to closed head trauma; the remainder are due to penetrating trauma. We reviewed the records from January 2006 through December 2008 of all patients older than 18 years of age who arrived at Soroka Medical Center in Be'er-Sheva, Israel, with skull base fractures following a traumatic brain injury (TBI). We identified 107 patients with a mean age of 42 years at the time of TBI. Glasgow Coma score on arrival predicted the clinical outcome. We observed temporal fractures in 30% of these patients, occipital fractures in 20%, pyramidal fractures in 19%, anterior skull base fractures in 17%, and multiple fractures in 14%. Cerebrospinal fluid (CSF) leak was observed in 16 patients (15%). Of the patients experiencing CSF leaks, otorrhea occurred in 10 (62%) and rhinorrhea occurred in six (37%). Three patients required surgical intervention to repair the leak. Meningitis occurred in four patients with clinically evident CSF leak. Multiple skull base fractures are associated with poor neurological outcome. The low rate of meningitis in this patient sample implies that there is no indication to administer prophylactic antibiotics to patients with skull base fractures. (C) 2015 Elsevier Ltd. All rights reserved.	[Yellinek, Shlomi; Cohen, Avi; Merkin, Vladimir] Soroka Med Ctr, Dept Neurosurg, IL-84101 Beer Sheva, Israel; [Yellinek, Shlomi; Cohen, Avi; Merkin, Vladimir; Shelef, Ilan] Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel; [Shelef, Ilan] Soroka Med Ctr, Neuroradiol Div, IL-84101 Beer Sheva, Israel; [Benifla, Mony] Hadassah Med Ctr, Dept Neurosurg, Kiryat Haddasah, IL-91120 Jerusalem, Israel		Benifla, M (corresponding author), Hadassah Med Ctr, Dept Neurosurg, Kiryat Haddasah, IL-91120 Jerusalem, Israel.	Benifla@hadassah.org.il		shelef, ilan/0000-0002-8398-6455			Abuabara Allan, 2007, Med Oral Patol Oral Cir Bucal, V12, pE397; APPELBAUM E, 1960, JAMA-J AM MED ASSOC, V173, P1818, DOI 10.1001/jama.1960.03020340036010; BALTAS I, 1994, NEUROSURGERY, V35, P422, DOI 10.1227/00006123-199409000-00009; Brodie HA, 1997, ARCH OTOLARYNGOL, V123, P749; Brodie HA, 1997, AM J OTOL, V18, P188; CHEE CP, 1991, AUST NZ J SURG, V61, P597, DOI 10.1111/j.1445-2197.1991.tb00299.x; Connor SEJ, 2005, CLIN RADIOL, V60, P878, DOI 10.1016/j.crad.2005.04.003; Dalgic A, 2008, MINIM INVAS NEUROSUR, V51, P154, DOI 10.1055/s-2008-1042437; Feiz-Erfan I, 2007, J NEUROSURG, V107, P364, DOI 10.3171/JNS-07/08/0364; Friedman J A, 2000, Neurosurg Focus, V9, pe1, DOI 10.3171/foc.2000.9.1.1; GLARNER H, 1994, J TRAUMA, V36, P198, DOI 10.1097/00005373-199402000-00009; Iacob G, 2007, Rev Med Chir Soc Med Nat Iasi, V111, P643; Ibanez J, 2004, J NEUROSURG, V100, P825, DOI 10.3171/jns.2004.100.5.0825; Joosse P, 2009, J CLIN NEUROSCI, V16, P925, DOI 10.1016/j.jocn.2008.06.014; Katzen JT, 2003, J TRAUMA, V54, P1026, DOI 10.1097/01.TA.0000066180.14666.8B; Kerman M, 2002, NEUROSURG QUART, V12, P23, DOI 10.1097/00013414-200203000-00003; LEECH PJ, 1973, LANCET, V1, P1013; Legros B, 2000, J TRAUMA, V48, P342, DOI 10.1097/00005373-200002000-00031; Liu CC, 2009, INJURY, V40, P595, DOI 10.1016/j.injury.2008.11.014; Mandrioli S, 2008, J CRANIOFAC SURG, V19, P713, DOI 10.1097/SCS.0b013e31816aac44; MCGUIRT WF, 1995, LARYNGOSCOPE, V105, P359, DOI 10.1288/00005537-199504000-00003; Rocchi G, 2005, SURG NEUROL, V63, P559, DOI 10.1016/j.surneu.2004.07.047; Samii M, 2002, NEUROL RES, V24, P147, DOI 10.1179/016164102101199693; Schuknecht B, 2005, EUR RADIOL, V15, P560, DOI 10.1007/s00330-004-2631-7; Servais L, 2005, CHILD NERV SYST, V21, P339, DOI 10.1007/s00381-004-1022-3; Shohet MR, 2008, FACIAL PLAST SURG, V24, P129, DOI 10.1055/s-2008-1037454; Tasdemiroglu E, 2002, NEUROSURG QUART, V12, P42; Villalobos T, 1998, CLIN INFECT DIS, V27, P364, DOI 10.1086/514666; Yidirim A, 2005, PEDIATR EMERG CARE, V21, P440, DOI 10.1097/01.pec.0000169435.36938.6d; Yilmazlar S, 2006, NEUROSURG REV, V29, P64, DOI 10.1007/s10143-005-0396-3	30	18	20	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0967-5868	1532-2653		J CLIN NEUROSCI	J. Clin. Neurosci.	MAR	2016	25						111	115		10.1016/j.jocn.2015.10.012			5	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DE0HA	WOS:000370304500021	26724846				2022-02-06	
J	Sung, CW; Chen, KY; Chiang, YH; Chiu, WT; Ou, JC; Lee, HC; Tsai, SH; Lin, JW; Yang, CM; Tsai, YR; Liao, KH; Chen, GS; Li, WJ; Wang, JY				Sung, Chih-Wei; Chen, Kai-Yun; Chiang, Yung-Hsiao; Chiu, Wen-Ta; Ou, Ju-Chi; Lee, Hsin-Chien; Tsai, Shin-Han; Lin, Jia-Wei; Yang, Che-Ming; Tsai, Yan-Rou; Liao, Kuo-Hsing; Chen, Gunng-Shinng; Li, Wei-Jiun; Wang, Jia-Yi			Heart rate variability and serum level of insulin-like growth factor-1 are correlated with symptoms of emotional disorders in patients suffering a mild traumatic brain injury	CLINICAL NEUROPHYSIOLOGY			English	Article						Mild traumatic brain injury (mTBI); Autonomic nervous system (ANS); Heart rate variability (HRV); Insulin-like growth factor-1 (IGF-1); Emotional disorder	MAJOR DEPRESSIVE DISORDER; COGNITIVE DYSFUNCTION; CIRCADIAN-RHYTHM; INVENTORY-II; CORTISOL; RISK; ANXIETY; BIOMARKER; MELATONIN; RELEASE	Objective: Patients who have experienced a mild traumatic brain injury (mTBI) are susceptible to symptoms of anxiety or depression. To explore the potential biomarkers for emotional disorders in mTBI patients, we analyzed the frequency domain of heart rate variability (HRV) and serum concentrations of four neurohormones. Methods: We assessed mTBI patients on their first visit and follow-up. Symptoms were evaluated by the Beck Anxiety Inventory and the Beck Depression Inventory, respectively. Serum levels of adrenocorticotropic hormone (ACTH), melatonin, cortisol, and insulin-like growth factor (IGF)-1 and HRV follow-ups were measured and compared. Results: mTBI patients were more vulnerable to symptoms of anxiety or depression than healthy controls. Reduced HRV was noted in mTBI patients compared to healthy controls. The mTBI patients demonstrated higher serum levels of ACTH, lower IGF-1 compared to healthy controls. In correlation analysis, only IGF-1 was positively correlated with HRV in mTBI patients. Both HRV and IGF-1 were correlated with symptom of depression while only HRV was correlated with symptom of anxiety in mTBI patients. Conclusions: We infer that HRV may be more significantly correlated with emotional disorders than is IGF-1 in mTBI patients. Significance: The study is relevant for specific diagnostic markers in mTBI patients. (C) 2015 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.	[Sung, Chih-Wei; Chen, Gunng-Shinng; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei 110, Taiwan; [Sung, Chih-Wei; Li, Wei-Jiun; Wang, Jia-Yi] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, Taipei 110, Taiwan; [Chen, Kai-Yun; Chiang, Yung-Hsiao; Tsai, Yan-Rou] Taipei Med Univ, Grad Program Neuroregenerat, Taipei 110, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Neurosurg, Taipei 110, Taiwan; [Chiu, Wen-Ta; Tsai, Shin-Han] Taipei Med Univ, Grad Inst Injury & Prevent, Coll Publ Hlth, Taipei 110, Taiwan; [Ou, Ju-Chi] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency, New Taipei 235, Taiwan; [Lee, Hsin-Chien] Taipei Med Univ, Shuang Ho Hosp, Dept Psychiat, New Taipei 235, Taiwan; [Lin, Jia-Wei] Taipei Med Univ, Shuang Ho Hosp, Dept Neurosurg, New Taipei 235, Taiwan; [Yang, Che-Ming] Taipei Med Univ, Shuang Ho Hosp, Dept Nucl Med, New Taipei 235, Taiwan; [Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Neurosurg, Taipei 116, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Coll Med, 250 Wu Xing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw		lee, hsin-chien/0000-0002-7557-8259; Sung, Chih-Wei/0000-0003-3312-2752; Wang, Jia-Yi/0000-0002-9106-3351	Ministry of Science and Technology [MOST-103-2321-B-038-002, MOST-104-2320-B-038-057-MY3, MOST-103-2815-C-038-016-B]; National Science CouncilMinistry of Science and Technology, Taiwan [NSC 98-2321-B-038-003-MY3]	This work was supported in part by grants from the Ministry of Science and Technology (MOST-103-2321-B-038-002 and MOST-104-2320-B-038-057-MY3) to JYW; and from National Science Council (NSC 98-2321-B-038-003-MY3) to WTC; and from the Ministry of Science and Technology (MOST-103-2815-C-038-016-B) to CWS, Taiwan.	Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Akdemir A, 2001, COMPR PSYCHIAT, V42, P161, DOI 10.1053/comp.2001.19756; Altrocchi PH, 1996, NEUROLOGY, V46, P278; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BECK AT, 1991, AM J PSYCHIAT, V148, P1195; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boyce WT, 2001, BRIT J PSYCHIAT, V179, P144, DOI 10.1192/bjp.179.2.144; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Camm AJ, 1996, EUR HEART J, V17, P354; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cernak I, 1999, BRAIN INJURY, V13, P1005; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Cox BJ, 1996, BEHAV RES THER, V34, P949, DOI 10.1016/S0005-7967(96)00037-X; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; Evans S, 2013, J PAIN RES, V6, P449, DOI 10.2147/JPR.S43849; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Fernandez-Rodriguez E, 2015, ENDOCRIN METAB CLIN, V44, P151, DOI 10.1016/j.ecl.2014.10.012; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Goldstein B, 1998, AM J PHYSIOL-REG I, V275, pR1287, DOI 10.1152/ajpregu.1998.275.4.R1287; GOLDSTEIN B, 1993, CRIT CARE MED, V21, P228, DOI 10.1097/00003246-199302000-00014; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hansen MV, 2014, BREAST CANCER RES TR, V145, P683, DOI 10.1007/s10549-014-2962-2; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Laborde S, 2015, PHYSIOL BEHAV, V139, P430, DOI 10.1016/j.physbeh.2014.11.036; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Lemoine P, 2007, J SLEEP RES, V16, P372, DOI 10.1111/j.1365-2869.2007.00613.x; Lemoine P, 2012, EXPERT OPIN PHARMACO, V13, P895, DOI 10.1517/14656566.2012.667076; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Lerma C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3513; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; LINN RT, 1994, BRAIN INJURY, V8, P135, DOI 10.3109/02699059409150965; Llompart-Pou JA, 2010, J ENDOCRINOL INVEST, V33, P368, DOI 10.1007/BF03346605; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Ma HP, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004205; Malhi GS, 2013, ACTA PSYCHIAT SCAND, V128, P2, DOI 10.1111/acps.12173; Mirzaie B, 2013, ARCH MED SCI, V9, P68, DOI 10.5114/aoms.2012.30833; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Osman A, 1997, J CLIN PSYCHOL, V53, P7, DOI 10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pandi-Perumal SR, 2009, PROG NEUROBIOL, V88, P264, DOI 10.1016/j.pneurobio.2009.04.007; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Popovic Vera, 2005, Pituitary, V8, P239, DOI 10.1007/s11102-006-6047-z; Posener JA, 2000, ARCH GEN PSYCHIAT, V57, P755, DOI 10.1001/archpsyc.57.8.755; RABINS PV, 1985, J AFFECT DISORDERS, V9, P165, DOI 10.1016/0165-0327(85)90096-5; Rubovitch V, 2010, NEUROBIOL DIS, V38, P299, DOI 10.1016/j.nbd.2010.01.021; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P1621, DOI 10.1053/S0003-9993(03)00270-3; Serra-Nedelec AD, 2012, P NATL ACAD SCI USA, V109, P4257, DOI 10.1073/pnas.1119803109; Sharma R, 2012, CURR NEUROL NEUROSCI, V12, P560, DOI 10.1007/s11910-012-0301-8; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Siman R, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00190; Sojka P, 2006, BRAIN INJURY, V20, P613, DOI 10.1080/02699050600676982; Sosin DM, 1996, BRAIN INJURY, V10, P47; Srinivasan V, 2009, PSYCHIAT RES, V165, P201, DOI 10.1016/j.psychres.2007.11.020; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Tang SC, 2015, J NEUROL NEUROSUR PS, V86, P95, DOI 10.1136/jnnp-2014-308389; Tanriverdi F, 2013, J NEUROTRAUM, V30, P1426, DOI 10.1089/neu.2012.2752; TEASDALE G, 1974, LANCET, V2, P81; Vogele C, 2009, PHYSIOL BEHAV, V98, P229, DOI 10.1016/j.physbeh.2009.05.018; Vreeburg SA, 2009, ARCH GEN PSYCHIAT, V66, P617, DOI 10.1001/archgenpsychiatry.2009.50; Wagner J, 2010, J NEUROTRAUM, V27, P1007, DOI 10.1089/neu.2009.1092; WEITZMAN ED, 1971, J CLIN ENDOCR METAB, V33, P14, DOI 10.1210/jcem-33-1-14; Wojcik SM, 2014, BRAIN INJURY, V28, P422, DOI 10.3109/02699052.2014.884241; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171; Zebrowski JJ, 2015, PHYSIOL MEAS, V36, P163, DOI 10.1088/0967-3334/36/1/163; Zheng A, 2008, J NUTR SCI VITAMINOL, V54, P148, DOI 10.3177/jnsv.54.148	80	18	18	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	1388-2457	1872-8952		CLIN NEUROPHYSIOL	Clin. Neurophysiol.	FEB	2016	127	2					1629	1638		10.1016/j.clinph.2015.08.006			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DB3UW	WOS:000368439100087	26350409				2022-02-06	
J	Adams, RS; Larson, MJ; Corrigan, JD; Ritter, GA; Horgan, CM; Bray, RM; Williams, TV				Adams, Rachel Sayko; Larson, Mary Jo; Corrigan, John D.; Ritter, Grant A.; Horgan, Constance M.; Bray, Robert M.; Williams, Thomas V.			Combat-Acquired Traumatic Brain Injury, Posttraumatic Stress Disorder, and Their Relative Associations With Postdeployment Binge Drinking	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						alcohol drinking; combat; military personnel; path analysis; posttraumatic stress disorder; traumatic brain injury	PERSISTENT POSTCONCUSSIVE SYMPTOMS; ALCOHOL-RELATED PROBLEMS; DUTY MILITARY PERSONNEL; SUBSTANCE USE DISORDERS; WAR VETERANS; DEPLOYMENT RISK; MILD TBI; AFGHANISTAN; IRAQ; SOLDIERS	Objective: To examine whether experiencing a traumatic brain injury (TBI) on a recent combat deployment was associated with postdeployment binge drinking, independent of posttraumatic stress disorder (PTSD). Methods: Using the 2008 Department of Defense Survey of Health Related Behaviors among Active Duty Military Personnel, an anonymous survey completed by 28 546 personnel, the study sample included 6824 personnel who had a combat deployment in the past year. Path analysis was used to examine whether PTSD accounted for the total association between TBI and binge drinking. Main Measures: The dependent variable, binge drinking days, was an ordinal measure capturing the number of times personnel drank 5+ drinks on one occasion (4+ for women) in the past month. Traumatic brain injury level captured the severity of TBI after a combat injury event exposure: TBI-AC (altered consciousness only), TBI-LOC of 20 or less (loss of consciousness up to 20 minutes), and TBI-LOC of more than 20 (loss of consciousness >20 minutes). A PTSD-positive screen relied on the standard diagnostic cutoff of 50+ on the PTSD Checklist-Civilian. Results: The final path model found that while the direct effect of TBI (0.097) on binge drinking was smaller than that of PTSD (0.156), both were significant. Almost 70% of the total effect of TBI on binge drinking was from the direct effect; only 30% represented the indirect effect through PTSD. Conclusion: Further research is needed to replicate these findings and to understand the underlying mechanisms that explain the relationship between TBI and increased postdeployment drinking.	[Adams, Rachel Sayko; Larson, Mary Jo; Horgan, Constance M.] Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02453 USA; [Ritter, Grant A.] Brandeis Univ, Schneider Inst Hlth Policy, Waltham, MA 02453 USA; [Corrigan, John D.] Ohio State Univ, Dept Phys Med & Rehabil, Columbus, OH 43210 USA; [Bray, Robert M.] RTI Int, Res Triangle Pk, NC USA; [Williams, Thomas V.] Def Hlth Agcy, Def Hlth Cost Assessment & Program Evaluat, Dept Def, Falls Church, VA USA		Adams, RS (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Inst Behav Hlth, 415 South St,MS 035, Waltham, MA 02453 USA.	radams@brandeis.edu	Adams, Rachel/AAH-4653-2020		NIAAAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31AA021030, T32AA007567]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [T32AA007567, F31AA021030] Funding Source: NIH RePORTER	Funding for this study was provided by NIAAA grant F31AA021030 and NIAAA institutional training grant T32AA007567.	Adams RS, 2012, J SOC WORK PRACT ADD, V12, P28, DOI 10.1080/1533256X.2012.647580; Adams RS, 2013, SUBST USE MISUSE, V48, P821, DOI 10.3109/10826084.2013.797995; Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Ames G, 2004, ALCOHOL RES HEALTH, V28, P252; Babor T.F., 2001, AUDIT THE ALCOHOL US; Barry AE, 2012, J AM COLL HEALTH, V60, P562, DOI 10.1080/07448481.2012.721427; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Bliese PD, 2011, DEPLOYMENT PSYCHOL E, P175; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Bray RM., 2009, 2008 DEP DEFENSE SUR; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Brenner LA, 2010, J HEAD TRAUMA REHAB, V25, P307, DOI 10.1097/HTR.0b013e3181cada03; Brown JM, 2006, 0209842 RTI INT; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Centers for Disease Control and Prevention, 2003, C MILD TRAUM BRAIN I; Centers for Disease Control and Prevention, 2008, DOD VA COD PROP FIN; Colder CR, 2001, PSYCHOL ADDICT BEHAV, V15, P237, DOI 10.1037/0893-164X.15.3.237; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Corrigan JD, 2013, AM J PSYCHIAT, V170, P351, DOI 10.1176/appi.ajp.2012.12121602; Corrigan JD, 2012, BRAIN INJURY, V26, P139, DOI 10.3109/02699052.2011.648705; Department of Defense, 2012, DOD POL GUID MAN MIL; Department of Defense Task Force on Mental Health, 2007, ACH VIS REP DEP DEF; Deployment Health Clinical Center, 2011, TRAUMATIC BRAIN INJU; DOD Deployment Health Clinical Center, 2010, ENH POSTD HLTH ASS P; Dolan CA, 2008, MIL PSYCHOL, V20, P151, DOI 10.1080/08995600802115987; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Foran HM, 2011, J CONSULT CLIN PSYCH, V79, P521, DOI 10.1037/a0024110; Halbauer JD, 2009, J REHABIL RES DEV, V46, P757, DOI 10.1682/JRRD.2008.08.0119; Hatch SL, 2013, SOCIOL HEALTH ILL, V35, P1045, DOI 10.1111/1467-9566.12022; Helmick K, 2012, MIL MED, V177, P86, DOI 10.7205/MILMED-D-12-00174; Hill JJ, 2009, AM J PHYS MED REHAB, V88, P605, DOI 10.1097/PHM.0b013e3181ae0f83; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Institute of Medicine, 2012, SUBST US DIS US ARM; Institute of Medicine, 2012, TREATM POSTTR STRESS; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Ivins BJ, 2009, J HEAD TRAUMA REHAB, V24, P24, DOI 10.1097/HTR.0b013e3181957042; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keith T.Z., 2006, MULTIPLE REGRESSION; Kelley AM, 2012, J PSYCHIATR RES, V46, P582, DOI 10.1016/j.jpsychires.2012.01.017; Kennedy CH, 2012, ARCH CLIN NEUROPSYCH, V27, P817, DOI 10.1093/arclin/acs092; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Lande RG, 2008, J ADDICT DIS, V27, P115, DOI 10.1080/10550880802122711; Lang KP, 2014, J HEAD TRAUMA REHAB, V29, P44, DOI 10.1097/HTR.0b013e31829c85d0; Larson MJ, 2012, J SOC WORK PRACT ADD, V12, P6, DOI 10.1080/1533256X.2012.647586; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; MacGregor AJ, 2013, J HEAD TRAUMA REHAB, V28, P59, DOI 10.1097/HTR.0b013e3182596382; Mattiko MJ, 2011, ADDICT BEHAV, V36, P608, DOI 10.1016/j.addbeh.2011.01.023; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; Miller KJ, 2013, J HEAD TRAUMA REHAB, V28, P31, DOI 10.1097/HTR.0b013e318255ceae; Miller SC, 2013, AM J PSYCHIAT, V170, P383, DOI 10.1176/appi.ajp.2012.12010126; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; National Institute on Alcohol Abuse and Alcoholism, 2005, NIH PUBLICATION, V05-3769; Pietrzak RH, 2011, J PSYCHIATR RES, V45, P1579, DOI 10.1016/j.jpsychires.2011.07.010; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ramchand R, 2011, MIL PSYCHOL, V23, P6, DOI 10.1080/08995605.2011.534407; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Santiago PN, 2010, PSYCHIAT SERV, V61, P575, DOI 10.1176/ps.2010.61.6.575; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Smith TC, 2008, BMJ-BRIT MED J, V336, P366, DOI 10.1136/bmj.39430.638241.AE; Spera C, 2011, J STUD ALCOHOL DRUGS, V72, P5, DOI 10.15288/jsad.2011.72.5; Stahre MA, 2009, AM J PREV MED, V36, P208, DOI 10.1016/j.amepre.2008.10.017; StataCorp, 2011, STAT STAT SOFTW REL; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Vanderploeg RD, 2009, ARCH PHYS MED REHAB, V90, P1084, DOI 10.1016/j.apmr.2009.01.023; Vasterling J. J., 2012, PTSD MILD TRAUMATIC, P3; Warner CH, 2011, ARCH GEN PSYCHIAT, V68, P1065, DOI 10.1001/archgenpsychiatry.2011.112; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Williams JL, 2012, MIL MED, V177, P789, DOI 10.7205/MILMED-D-12-00019; Zatzick D, 2014, ADDICTION, V109, P754, DOI 10.1111/add.12492	86	18	18	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					13	22		10.1097/HTR.0000000000000082			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000009	25310293	Green Accepted			2022-02-06	
J	Carlson, SW; Yan, H; Ma, M; Li, YM; Henchir, J; Dixon, CE				Carlson, Shaun W.; Yan, Hong; Ma, Michelle; Li, Youming; Henchir, Jeremy; Dixon, C. Edward			Traumatic Brain Injury Impairs Soluble N-Ethylmaleimide-Sensitive Factor Attachment Protein Receptor Complex Formation and Alters Synaptic Vesicle Distribution in the Hippocampus	JOURNAL OF NEUROTRAUMA			English	Article						hippocampus; SNARE; synapse; traumatic brain injury; vesicle docking	CONTROLLED CORTICAL IMPACT; REDUCED EVOKED RELEASE; SNARE-COMPLEX; KNOCKOUT MICE; NEUROTRANSMITTER RELEASE; CSP-ALPHA; IN-VITRO; EXPRESSION; RATS; NEURODEGENERATION	Traumatic brain injury (TBI) impairs neuronal function and can culminate in lasting cognitive impairment. While impaired neurotransmitter release has been well established after experimental TBI, little is understood about the mechanisms underlying this consequence. In the synapse, vesicular docking and neurotransmitter release requires the formation of the soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex. Impairments in vesicle docking, and alterations in SNARE complex formation are associated with impaired neurotransmitter release. We hypothesized that TBI reduces SNARE complex formation and disrupts synaptic vesicle distribution in the hippocampus. To examine the effect of TBI on the SNARE complex, rats were subjected to controlled cortical impact (CCI) or sham injury, and the brains were assessed at 6h, 1 d, one week, two weeks, or four weeks post-injury. Immunoblotting of hippocampal homogenates revealed significantly reduced SNARE complex formation at one week and two weeks post-injury. To assess synaptic vesicles distribution, rats received CCI or sham injury and the brains were processed for transmission electron microscopy at one week post-injury. Synapses in the hippocampus were imaged at 100k magnification, and vesicle distribution was assessed in pre-synaptic terminals at the active zone. CCI resulted in a significant reduction in vesicle number within 150nm of the active zone. These findings provide the first evidence of TBI-induced impairments in synaptic vesicle docking, and suggest that reductions in the pool of readily releasable vesicles and impaired SNARE complex formation are two novel mechanisms contributing to impaired neurotransmission after TBI.	[Carlson, Shaun W.; Yan, Hong; Ma, Michelle; Li, Youming; Henchir, Jeremy; Dixon, C. Edward] Univ Pittsburgh, Dept Neurosurg, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Dixon, CE (corresponding author), Pittsburgh VA Healthcare Syst, Safar Ctr Resuscitat Res, Dept Neurosurg, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixonec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1NS079061, 5T32HD040686-14]; Veteran's Affairs grantUS Department of Veterans Affairs [RX001127]; Pittsburgh Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD040686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS091062, F32NS090748, R01NS079061] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grants 1RO1NS079061 and 5T32HD040686-14, Veteran's Affairs grant RX001127, and The Pittsburgh Foundation. We would like to thank Larry Jenkins, PhD, for his assistance during the development of the ultrastructural study. We would like to thank Jonathan Franks, M.S., and Donna Stolz, PhD, in the Center for Biologic Imaging at the University of Pittsburgh, for their assistance with tissue processing and consultation on quantification of electron micrographs.	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Bigler ED, 1997, AM J NEURORADIOL, V18, P11; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024; DICKINSONNELSON A, 1983, J NEUROSCI, V3, P42; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1997, EXP NEUROL, V146, P479, DOI 10.1006/exnr.1997.6557; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Han YY, 2011, NEURON, V69, P304, DOI 10.1016/j.neuron.2010.12.014; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Latham CF, 2007, J NEUROCHEM, V100, P1543, DOI 10.1111/j.1471-4159.2006.04286.x; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nemani VM, 2010, NEURON, V65, P66, DOI 10.1016/j.neuron.2009.12.023; Paxinos G, 2009, RAT BRAIN STEREOTAXI; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rao VLR, 2003, J NEUROSCI RES, V71, P208, DOI 10.1002/jnr.10486; Reist NE, 1998, J NEUROSCI, V18, P7662; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Serra-Grabulosa JM, 2005, J NEUROL NEUROSUR PS, V76, P129, DOI 10.1136/jnnp.2004.027631; Sharma M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004028; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shin SS, 2012, J NEUROTRAUM, V29, P843, DOI 10.1089/neu.2011.1966; Shin SS, 2011, NEUROSCI LETT, V496, P168, DOI 10.1016/j.neulet.2011.04.009; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; Thompson SN, 2006, EXP NEUROL, V201, P253, DOI 10.1016/j.expneurol.2006.04.013; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Yi JH, 2006, J NEUROTRAUM, V23, P86, DOI 10.1089/neu.2006.23.86	48	18	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2016	33	1					113	121		10.1089/neu.2014.3839			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CZ4EW	WOS:000367057200014	25923735	Green Published			2022-02-06	
J	D'Cruz, K; Howie, L; Lentin, P				D'Cruz, Kate; Howie, Linsey; Lentin, Primrose			Client-centred practice: Perspectives of persons with a traumatic brain injury	SCANDINAVIAN JOURNAL OF OCCUPATIONAL THERAPY			English	Article						Acquired brain injury; brain injury; consumer perspectives; person-centred practice; therapeutic alliance; therapeutic relationship	OCCUPATIONAL THERAPISTS; REHABILITATION; PEOPLE; PARTICIPATION; INDIVIDUALS	Background: Client-centred practice is well established as a core foundation of occupational therapy; however, there is little research evidence concerning the client experience. Objectives: To understand client-centred practice from the perspective of adults with a traumatic brain injury (TBI) participating in community-based occupational therapy. Methods: Six adults with a moderate-severe TBI participated in two semi-structured, qualitative interviews each. In total 12 interview transcripts and additional data were coded using constructivist grounded theory methods. Results: Data analysis produced three main themes and sub-themes: (i) Experiencing the client-therapist relationship: Seeing me as the person I was; Getting to know me in the now; Making a positive connection; (ii) Actively participating in therapy: Valuing the therapist; Being partners in therapy; and (iii) Finding my place in life: Adjusting to who I am now and Sharing my journey. Conclusion: The results present a framework for understanding client-centred practice as a person-centred process of engagement between the client and the therapist, as informed from the client perspective. Significance: Occupational therapists are encouraged to value and invest in the development of relationships with clients whilst the importance of seeking and integrating the client perspective into practice and research is affirmed for the profession.	[D'Cruz, Kate; Howie, Linsey] La Trobe Univ, Bundoora, Vic 3083, Australia; [Lentin, Primrose] Monash Univ, Frankston, Australia		D'Cruz, K (corresponding author), La Trobe Univ, Dept Community & Clin Allied Hlth, Bundoora, Vic 3083, Australia.	k.dcruz@latrobe.edu.au	D'Cruz, Kate/ABC-7970-2021; Lentin, Primrose/ABE-5778-2020	D'Cruz, Kate/0000-0002-5155-1350; Howie, Luke/0000-0002-6906-8498			Abreu BC, 2002, BRAIN INJURY, V16, P691, DOI 10.1080/02699050210128942; Biderman D, 2006, INT J PSYCHOL, V41, P355, DOI 10.1080/00207590500345963; Blank A., 2004, BRIT J OCCUPATIONAL, V67, P118, DOI DOI 10.1177/030802260406700304; Charmaz K., 2014, BROKERAGE CLOSURE IN; Conneeley A. L., 2004, BR J OCCUP THER, V67, P248, DOI DOI 10.1177/030802260406700603; Corring D J, 1999, Can J Occup Ther, V66, P71; Cott CA, 2004, DISABIL REHABIL, V26, P1411, DOI 10.1080/09638280400000237; Curtin M, 2007, AUST OCCUP THER J, V54, P88, DOI 10.1111/j.1440-1630.2007.00661.x; Docherty S, 1999, RES NURS HEALTH, V22, P177, DOI 10.1002/(SICI)1098-240X(199904)22:2<177::AID-NUR9>3.3.CO;2-8; Doig E, 2009, AM J OCCUP THER, V63, P559, DOI 10.5014/ajot.63.5.559; Douglas JM, 2013, BRAIN INJURY, V27, P60, DOI 10.3109/02699052.2012.722254; Duggan Ruth, 2005, Can J Occup Ther, V72, P103; Hammell KRW, 2013, SCAND J OCCUP THER, V20, P174, DOI 10.3109/11038128.2012.752032; Kielhofner G., 2008, MODEL HUMAN OCCUPATI; Kontos PC, 2012, QUAL HEALTH RES, V22, P1612, DOI 10.1177/1049732312458370; Lefebvre H, 2005, BRAIN INJURY, V19, P585, DOI 10.1080/02699050400025026; Levack WMM, 2010, DISABIL REHABIL, V32, P986, DOI 10.3109/09638281003775394; Liamput tong P., 2007, RES VULNERABLE GUIDE; Maitra KK, 2006, AM J OCCUP THER, V60, P298, DOI 10.5014/ajot.60.3.298; Padilla R, 2003, AM J OCCUP THER, V57, P413, DOI 10.5014/ajot.57.4.413; Palmadottir G., 2006, BR J OCCUP THER, V69, P394, DOI DOI 10.1177/030802260606900902; Paterson B, 2002, QUAL HEALTH RES, V12, P399, DOI 10.1177/104973202129119973; Petrella L, 2005, BRAIN INJURY, V19, P643, DOI 10.1080/02699050410001671874; Rebeiro K L, 2000, Can J Occup Ther, V67, P7; Rosa SA, 2005, AM J OCCUP THER, V59, P198, DOI 10.5014/ajot.59.2.198; Schipper K, 2011, BRAIN INJURY, V25, P832, DOI 10.3109/02699052.2011.589796; Schonberger M, 2006, BRAIN INJURY, V20, P445, DOI 10.1080/02699050600664772; Sloan S, 2009, BRAIN IMPAIR, V10, P282, DOI 10.1375/brim.10.3.282; Sumison T, 2004, BRIT J OCCUPATIONAL, V67, P2; Sumsion T, 2000, Can J Occup Ther, V67, P15; Sumsion Thelma, 2005, Can J Occup Ther, V72, P13; Taylor RR, 2008, INTENTIONAL RELATION; Townsend E. A., 2007, ENABLING OCCUPATION; Turner B, 2009, AM J OCCUP THER, V63, P609, DOI 10.5014/ajot.63.5.609; Wilkins S, 2001, CAN J OCCUP THER, V68, P88; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]	36	18	18	0	12	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1103-8128	1651-2014		SCAND J OCCUP THER	Scand. J. Occup. Ther.		2016	23	1					30	38		10.3109/11038128.2015.1057521			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	DK4LP	WOS:000374890100004	26094733				2022-02-06	
J	Djordjevic, J; Sabbir, MG; Albensi, BC				Djordjevic, Jelena; Sabbir, Mohammad Golam; Albensi, Benedict C.			Traumatic Brain Injury as a Risk Factor for Alzheimer's Disease: Is Inflammatory Signaling a Key Player?	CURRENT ALZHEIMER RESEARCH			English	Article						Alzheimer's disease; inflammation; mitochondria; NF-kappa B; Traumatic brain injury	NF-KAPPA-B; ABNORMAL MITOCHONDRIAL DYNAMICS; AMYLOID-BETA; MOUSE MODEL; MICROGLIAL PHENOTYPE; HEAD TRAUMA; A-BETA; TREM2; ASSOCIATION; DYSFUNCTION	Traumatic brain injury (TBI) has become a significant medical and social concern within the last 30 years. TBI has acute devastating effects, and in many cases, seems to initiate long-term neurodegeneration. With advances in medical technology, many people are now surviving severe brain injuries and their long term consequences. Post trauma effects include communication problems, sensory deficits, emotional and behavioral problems, physical complications and pain, increased suicide risk, dementia, and an increased risk for chronic CNS diseases, such as Alzheimer's disease (AD). In this review, we provide an introduction to TBI and hypothesize how it may lead to neurodegenerative disease in general and AD in particular. In addition, we discuss the evidence that supports the hypothesis that TBI may lead to AD. In particular, we focus on inflammatory responses as key processes in TBI-induced secondary injury, with emphasis on nuclear factor kappa B (NF-kappa B) signaling.	[Djordjevic, Jelena; Sabbir, Mohammad Golam; Albensi, Benedict C.] St Boniface Hosp Res Winnipeg, Div Neurodegenerat Disorders, Winnipeg, MB, Canada; [Djordjevic, Jelena; Albensi, Benedict C.] Univ Manitoba, Dept Pharmacol & Therapeut, Fac Hlth Sci, Coll Med, Winnipeg, MB R2H 2A6, Canada		Albensi, BC (corresponding author), St Boniface Hosp Res Winnipeg, Div Neurodegenerat Disorders, Winnipeg, MB, Canada.	balbensi@sbrc.ca	Albensi, Benedict Charles/AAJ-2359-2021; Sabbir, Mohammad/AAG-6238-2019	Albensi, Benedict Charles/0000-0002-7884-9261; Djordjevic, Jelena/0000-0001-9769-6857	National Sciences and Engineering Research CouncilNatural Sciences and Engineering Research Council of Canada (NSERC); Everett Endowment Fund; St. Boniface General Hospital Research Foundation; Alzheimer's Society of Manitoba; Research Manitoba	This work was funded in part by the National Sciences and Engineering Research Council (to B.C.A.), the Everett Endowment Fund (to B.C.A.), the St. Boniface General Hospital Research Foundation (to B.C.A.) the Alzheimer's Society of Manitoba (to B.C.A.), and Research Manitoba (J.D. and B.C.A.). B.C.A. is a Research Affiliate at the University of Manitoba's Centre on Aging and holds the Honourable Douglas Everett, Patricia Everett and the Royal Canadian Properties Endowment Fund Chair and the Manitoba Dementia Research Chair.	Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; Albensi BC, 2000, SYNAPSE, V35, P151; Albert MS, 1996, P NATL ACAD SCI USA, V93, P13547, DOI 10.1073/pnas.93.24.13547; Aragona CJD, 2012, NEUROREHABILITATION, V30, P55, DOI 10.3233/NRE-2011-0727; Bachstetter AD, 2012, J NEUROSCI, V32, P10201, DOI 10.1523/JNEUROSCI.1496-12.2012; Balistreri CR, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-24; BARGER SW, 1995, P NATL ACAD SCI USA, V92, P9328, DOI 10.1073/pnas.92.20.9328; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002; Bourne KZ, 2007, J NEUROSCI RES, V85, P1194, DOI 10.1002/jnr.21252; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; BREITNER JCS, 1994, NEUROLOGY, V44, P227, DOI 10.1212/WNL.44.2.227; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Campbell SJ, 2008, J NEUROPATH EXP NEUR, V67, P223, DOI 10.1097/NEN.0b013e3181654957; Carreiras MC, 2013, CURR TOP MED CHEM, V13, P1745, DOI 10.2174/15680266113139990135; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chami L, 2012, J BIOL CHEM, V287, P24573, DOI 10.1074/jbc.M111.333054; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Chhor V, 2013, BRAIN BEHAV IMMUN, V32, P70, DOI 10.1016/j.bbi.2013.02.005; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Cunningham C, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0117-2; Das HK, 2008, FRONT BIOSCI-LANDMRK, V13, DOI 10.2741/2723; Famakin BM, 2014, AGING DIS, V5, P307, DOI 10.14336/AD.2014.0500307; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Gonzalez H, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0201-8; Gordon SN, 2011, CLIN NEUROPSYCHOL, V25, P337, DOI 10.1080/13854046.2010.550634; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Granic I, 2009, J ALZHEIMERS DIS, V16, P809, DOI 10.3233/JAD-2009-0976; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Heneka MT, 2015, NAT IMMUNOL, V16, P229, DOI 10.1038/ni.3102; Hickman SE, 2014, BIOCHEM PHARMACOL, V88, P495, DOI 10.1016/j.bcp.2013.11.021; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; ISHII T, 1976, ACTA NEUROPATHOL, V36, P243, DOI 10.1007/BF00685368; Jarvis B, 2003, DRUG AGING, V20, P465, DOI 10.2165/00002512-200320060-00005; Jarvis B, 2003, DRUGS AGING, V20, P77; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaltschmidt B, 1997, P NATL ACAD SCI USA, V94, P2642, DOI 10.1073/pnas.94.6.2642; Kaltschmidt B, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001271; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Lawrence T, 2007, INT J EXP PATHOL, V88, P85, DOI 10.1111/j.1365-2613.2006.00507.x; Lee Sarah, 2013, J Alzheimers Dis Parkinsonism, V3, P128; Leinenga G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2512; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Liao B, 2012, EXP NEUROL, V237, P147, DOI 10.1016/j.expneurol.2012.06.011; Lourbopoulos A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00054; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martin BK, 2008, ARCH NEUROL-CHICAGO, V65, P896, DOI 10.1001/archneur.2008.65.7.nct70006; Mattson MP, 2005, NEUROCHEM RES, V30, P883, DOI 10.1007/s11064-005-6961-x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; McGeer PL, 2007, NEUROBIOL AGING, V28, P639, DOI 10.1016/j.neurobiolaging.2006.03.013; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Mullane K, 2013, BIOCHEM PHARMACOL, V85, P289, DOI 10.1016/j.bcp.2012.11.014; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Pagani Lucia, 2011, Int J Alzheimers Dis, V2011, P925050, DOI 10.4061/2011/925050; Park HJ, 2004, NEUROSCI LETT, V357, P63, DOI 10.1016/j.neulet.2003.11.068; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pinto T, 2011, AGEING RES REV, V10, P404, DOI 10.1016/j.arr.2011.01.003; Porta C, 2009, P NATL ACAD SCI USA, V106, P14978, DOI 10.1073/pnas.0809784106; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P1766, DOI 10.1089/ars.2013.5745; Sarnico I, 2009, J NEUROCHEM, V108, P475, DOI 10.1111/j.1471-4159.2008.05783.x; Schwartz M, 2006, TRENDS NEUROSCI, V29, P68, DOI 10.1016/j.tins.2005.12.005; Sieber MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052982; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Swerdlow RH, 2010, J ALZHEIMERS DIS, V20, pS265, DOI 10.3233/JAD-2010-100339; Tillement L, 2011, NEURODEGENER DIS, V8, P331, DOI 10.1159/000323264; Tosto G, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0381-0; Tremblay ME, 2011, NEURON GLIA BIOL, V7, P67, DOI 10.1017/S1740925X12000038; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; UZZELL BP, 1987, NEUROSURGERY, V20, P396, DOI 10.1227/00006123-198703000-00007; Wang XL, 2008, P NATL ACAD SCI USA, V105, P19318, DOI 10.1073/pnas.0804871105; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Ward SM, 2012, BIOCHEM SOC T, V40, P667, DOI 10.1042/BST20120134; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Weitz Tara M, 2012, Int J Alzheimers Dis, V2012, P314185, DOI 10.1155/2012/314185; Wilkins HM, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00311; Yu HM, 2012, NEUROIMMUNOMODULAT, V19, P131, DOI 10.1159/000330254; Zhang X, 2004, CNS NEUROL DISORD-DR, V3, P137, DOI 10.2174/1568007043482499; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zubko N, 2011, BEHAV HEALTHC, V31, P8; Zubko Nick, 2011, Behav Healthc, V31, P28	96	18	19	0	12	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1567-2050	1875-5828		CURR ALZHEIMER RES	Curr. Alzheimer Res.		2016	13	7					730	738		10.2174/1567205013666160222110320			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DM9NP	WOS:000376693300002	26899581				2022-02-06	
J	Dretsch, M; Bleiberg, J; Williams, K; Caban, J; Kelly, J; Grammer, G; DeGraba, T				Dretsch, Michael; Bleiberg, Joseph; Williams, Kathy; Caban, Jesus; Kelly, James; Grammer, Geoffrey; DeGraba, Thomas			Three Scoring Approaches to the Neurobehavioral Symptom Inventory for Measuring Clinical Change in Service Members Receiving Intensive Treatment for Combat-Related mTBI	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mild traumatic brain injury; neurobehavioral symptom inventory; postconcussive syndrome; neurorehabilitation; rehabilitation outcome assessment	TRAUMATIC BRAIN-INJURY; POSTCONCUSSIVE SYMPTOMS; SAMPLES	Objective: To examine the use of the Neurobehavioral Symptom Inventory to measure clinical changes over time in a population of US service members undergoing treatment of mild traumatic brain injury and comorbid psychological health conditions. Setting: A 4-week, 8-hour per day, intensive, outpatient, interdisciplinary, comprehensive treatment program at the National Intrepid Center of Excellence in Bethesda, Maryland. Participants: Three hundred fourteen active-duty service members being treated for combat-related comorbid mild traumatic brain injury and psychological health conditions. Design: Repeated-measures, retrospective analysis of a single-group using a pretest-posttest treatment design. Main Measures: Three Neurobehavioral Symptom Inventory scoring methods: (1) a total summated score, (2) the 3-factor method, and (3) the 4-factor method (with and without orphan items). Results: All 3 scoring methods yielded statistically significant within-subject changes between admission and discharge. The evaluation of effect sizes indicated that the 3 different Neurobehavioral Symptom Inventory scoring methods were comparable. Conclusion: Findings indicate that the different scoring methods all have potential for assessing clinical changes in symptoms for groups of patients undergoing treatment, with no clear advantage with any one method.	[Dretsch, Michael; Bleiberg, Joseph; Williams, Kathy; Caban, Jesus; Kelly, James; Grammer, Geoffrey; DeGraba, Thomas] Walter Reed Natl Mil Med Ctr, Dept Res, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA		Dretsch, M (corresponding author), Walter Reed Natl Mil Med Ctr, Dept Res, Natl Intrepid Ctr Excellence, 4860 South Palmer Rd, Bethesda, MD 20889 USA.	Michael.n.dretsch.mil@mail.mil		Bleiberg, Joseph/0000-0003-0867-5494			[Anonymous], 2008, INVISIBLE WOUNDS WAR; [Anonymous], 2014, NEUR SYMPT INV NSI R; Caplan LJ, 2010, J HEAD TRAUMA REHAB, V25, P447, DOI 10.1097/HTR.0b013e3181d5bdbd; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; Meterko M, 2012, J HEAD TRAUMA REHAB, V27, P55, DOI 10.1097/HTR.0b013e318230fb17; Soble JR, 2014, CLIN NEUROPSYCHOL, V28, P614, DOI 10.1080/13854046.2014.894576; Sullivan KW, 2012, STUD HEALTH TECHNOL, V181, P71, DOI 10.3233/978-1-61499-121-2-71; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, P1, DOI 10.1097/HTR.0000000000000009; Vanderploeg RD, 2014, J HEAD TRAUMA REHAB, V29, P1, DOI 10.1097/HTR.0b013e318281966e; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033	12	18	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2016	31	1					23	29		10.1097/HTR.0000000000000109			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DK9CN	WOS:000375228000010	25699618				2022-02-06	
J	Ehrhart, J; Darlington, D; Kuzmin-Nichols, N; Sanberg, CD; Sawmiller, DR; Sanberg, PR; Tan, J				Ehrhart, Jared; Darlington, Donna; Kuzmin-Nichols, Nicole; Sanberg, Cyndy D.; Sawmiller, Darrell R.; Sanberg, Paul R.; Tan, Jun			Biodistribution of Infused Human Umbilical Cord Blood Cells in Alzheimer's Disease-Like Murine Model	CELL TRANSPLANTATION			English	Article						Human umbilical cord blood cells (HUCBCs); Biodistribution; Polymerase chain reaction (PCR); Mice; Rats; Neurodegenerative diseases	TRANSPLANTATION; THERAPY; STROKE	Human umbilical cord blood cells (HUCBCs), a prolific source of non-embryonic or adult stem cells, have emerged as effective and relatively safe immunomodulators and neuroprotectors, reducing behavioral impairment in animal models of Alzheimer's disease (AD), Parkinson's disease, amyotrophic lateral sclerosis, traumatic brain injury, spinal cord injury, and stroke. In this report, we followed the bioavailability of HUCBCs in AD-like transgenic PSAPP mice and nontransgenic Sprague Dawley rats. HUCBCs were injected into tail veins of mice or rats at a single dose of 1 x 10(6) or 2.2 x 10(6) cells, respectively, prior to harvesting of tissues at 24 h, 7 days, and 30 days after injection. For determination of HUCBC distribution, tissues from both species were subjected to total DNA isolation and polymerase chain reaction (PCR) amplification of the gene for human glycerol-3-phosphate dehydrogenase. Our results show a relatively similar biodistribution and retention of HUCBCs in both mouse and rat organs. HUCBCs were broadly detected both in the brain and several peripheral organs, including the liver, kidney, and bone marrow, of both species, starting within 7 days and continuing up to 30 days posttransplantation. No HUCBCs were recovered in the peripheral circulation, even at 24 h posttransplantation. Therefore, HUCBCs reach several tissues including the brain following a single intravenous treatment, suggesting that this route can be a viable method of administration of these cells for the treatment of neurodegenerative diseases.	[Ehrhart, Jared; Kuzmin-Nichols, Nicole; Sanberg, Cyndy D.] Saneron CCEL Therapeut Inc, 13014 N Dale Mabry Highway,Suite 266, Tampa, FL 33618 USA; [Darlington, Donna; Sawmiller, Darrell R.; Tan, Jun] Univ S Florida, Dept Psychiat & Behav Neurosci, Morsani Coll Med, Rashid Lab Dev Neurobiol,Silver Child Dev Ctr, Tampa, FL USA; [Sanberg, Paul R.; Tan, Jun] Univ S Florida, Dept Neurosurg & Brain Repair, Morsani Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL USA		Ehrhart, J (corresponding author), Saneron CCEL Therapeut Inc, 13014 N Dale Mabry Highway,Suite 266, Tampa, FL 33618 USA.	jce@saneron-ccel.com	Sawmiller, Darrell/AAQ-9722-2021	Sawmiller, Darrell/0000-0003-3599-6859	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R42 AG031586-03]; Florida Hi Tech Corridor Matching Grant Program [FHT 11-12, FHT 12-01, FHT 13-07]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R42AG031586, R01AG032432] Funding Source: NIH RePORTER	This research was supported by an NIH grant (No. 5R42 AG031586-03) and the Florida Hi Tech Corridor Matching Grant Program (FHT 11-12, FHT 12-01, and FHT 13-07). J.T. is a consultant for Saneron CCEL Therapeutics, Inc. and is an inventor on a patent application submitted by USE. P.R.S. is a cofounder of Saneron CCEL Therapeutics, Inc.	Broxmeyer HE, 1995, ANN NY ACAD SCI, V770, P105, DOI 10.1111/j.1749-6632.1995.tb31048.x; Cairns Kevin, 2003, Phys Med Rehabil Clin N Am, V14, pS135, DOI 10.1016/S1047-9651(02)00059-1; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Darlington D, 2013, STEM CELLS DEV, V22, P412, DOI 10.1089/scd.2012.0345; El-Badri NS, 2006, STEM CELLS DEV, V15, P497, DOI 10.1089/scd.2006.15.497; ENDE N, 1995, CLIN IMMUNOL IMMUNOP, V75, P190, DOI 10.1006/clin.1995.1070; Ende N, 2004, BIOCHEM BIOPH RES CO, V321, P168, DOI 10.1016/j.bbrc.2004.06.121; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P173; Ende Norman, 2002, Journal of Medicine (Westbury), V33, P181; Ende Norman, 2001, Journal of Medicine (Westbury), V32, P241; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garbuzova-Davis S, 2006, PROG BRAIN RES, V157, P207, DOI 10.1016/S0079-6123(06)57014-1; Giunta B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-51; Henning RJ, 2006, CELL TRANSPLANT, V15, P647, DOI 10.3727/000000006783981611; Lee JK, 2010, CURR ALZHEIMER RES, V7, P540; Lemere CA, 2003, NEUROCHEM RES, V28, P1017, DOI 10.1023/A:1023203122036; Lewis ID, 2002, INTERN MED J, V32, P601, DOI 10.1046/j.1445-5994.2002.00276.x; Lu DY, 2002, CELL TRANSPLANT, V11, P275; Newman MB, 2003, NEUROTOX RES, V5, P355, DOI 10.1007/BF03033155; Nikolic WV, 2008, STEM CELLS DEV, V17, P423, DOI 10.1089/scd.2008.0018; PATTERSON MB, 1992, ALZ DIS ASSOC DIS, V6, P145, DOI 10.1097/00002093-199206030-00003; Potkin SG, 2002, INT PSYCHOGERIATR, V14, P7, DOI 10.1017/S1041610203008640; Sanberg P. R., 2005, ANN NY ACAD SCI, V10, P855; Sinha S, 1999, P NATL ACAD SCI USA, V96, P11049, DOI 10.1073/pnas.96.20.11049; Steiner H, 1999, BIOCHEM SOC T, V27, P234, DOI 10.1042/bst0270234; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; van de Ven C, 2007, EXP HEMATOL, V35, P1753, DOI 10.1016/j.exphem.2007.08.017; Vendrame M, 2004, STROKE, V35, P2390, DOI 10.1161/01.STR.0000141681.06735.9b; Vendrame M, 2005, STEM CELLS DEV, V14, P595, DOI 10.1089/scd.2005.14.595; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhu YY, 2011, J NEUROSCI, V31, P1355, DOI 10.1523/JNEUROSCI.3268-10.2011	31	18	18	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2016	25	1					195	199		10.3727/096368915X689604			5	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	DC9QV	WOS:000369557000013	26414627	Bronze, Green Accepted			2022-02-06	
J	Furness, Z				Furness, Zack			Reframing concussions, masculinity, and NFL mythology in League of Denial	POPULAR COMMUNICATION			English	Article							MALE BODY; FOOTBALL; MEDIA; IMAGES; WAR	This article explores how the PBS Frontline documentary League of Denial reframes the "concussion crisis" in three ways that contest the rationalization of injury and the normalization of violence in the hegemonic masculine discourses (visual, written, oral) produced about professional football. First, the film problematizes the notion of head injury as merely "part of the game" and a risk that players ostensibly understand when they enter the National Football League. Second, the film's depiction of Mike Webster's "unruly" body further de-naturalizes concussions and contests the masculine ideal of bodily sacrifice in pro football. Third, the film explicitly critiques the role of sports media in constructing a mythology and spectacle of pro football that contributed to the cultural context in which the concussion crisis has emerged.	[Furness, Zack] Penn State Univ, Mckeesport, PA 15132 USA		Furness, Z (corresponding author), Penn State Univ, Dept Commun, 4000 Univ Dr, Mckeesport, PA 15132 USA.	zackfurness@psu.edu					Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; Baker A., 2014, NFL CRITICAL CULTURA, P160; Butterworth M.L., 2014, NFL CRITICAL CULTURA, P205; Butterworth ML, 2014, SPORT SOC, V17, P867, DOI 10.1080/17430437.2013.806033; Butterworth ML, 2008, COMMUN STUD, V59, P259, DOI 10.1080/10510970802257705; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Couturie B., 1985, DISPOSABLE HEROES OT; DeLuca K. M., 1999, ARGUMENTATION ADVOCA, V36, P9, DOI 10.1080/00028533.1999.11951634; Donner R., 1999, ANY GIVEN SUNDAY; Fainaru-Wada Mark, 2013, LEAGUE OF DENIAL; Fischer M, 2014, J SPORT SOC ISSUES, V38, P199, DOI 10.1177/0193723513515889; Gilmore J., 2013, FRONTLINE INTERVIEWS; Grano D. A., 2014, NFL CRITICAL CULTURA, P13; JANSEN SC, 1994, SOCIOL SPORT J, V11, P1, DOI 10.1123/ssj.11.1.1; Jhally Sut, 1984, CRIT SOCIOL, V12, P41; King P., 2011, SPORTS ILLUSTRATED, V115, P74; King S, 2014, J SPORT SOC ISSUES, V38, P184, DOI 10.1177/0193723513515890; Kirk M., 2013, LEAGUE DENIAL NFLS C; Kirk M., 2013, FRONTLINE INTERVIEWS; Kusz Kyle W, 2014, NFL CRITICAL CULTURA, P226; Levy D., 2012, BLEACHER REPORT 0120; Lipsyte R, 2013, ESPN OMBUDSMAN  1015; McGannon KR, 2013, PSYCHOL SPORT EXERC, V14, P891, DOI 10.1016/j.psychsport.2013.08.003; McLeod C, 2014, J SPORT SOC ISSUES, V38, P222, DOI 10.1177/0193723514520997; Messner M. A., 1990, International Review for the Sociology of Sport, V25, P203, DOI 10.1177/101269029002500303; Oates T., 2007, COMMUNICATION CRITIC, V4, P74, DOI [10.1080/14791420601138351, DOI 10.1080/14791420601138351]; Oates TP, 2009, SOCIOL SPORT J, V26, P31, DOI 10.1123/ssj.26.1.31; Oates TP, 2004, PATTERNS PREJUDICE, V38, P301, DOI 10.1080/0031322042000250475; ORIARD M, 1981, J AM CULTURE, V4, P27, DOI 10.1111/j.1542-734X.1981.0403_27.x; ORIARD M, 2007, BRAND NFL MAKING SEL; (Producer) Yablans F., 1979, N DALLAS 40; Real M. R., 1975, MASS MEDIATED CULTUR, P170; Rodgers K., 2014, NFL CRITICAL CULTURA, P142; Sabo Donald F., 1990, SPORT MEN GENDER ORD; Sanderson J., 2014, COMMUNICATION S 0528; Sharp A., 2013, GRANTLAND      1009; Silcock BW, 2008, J MASS MEDIA ETHICS, V23, P36, DOI 10.1080/08900520701753205; TRUJILLO N, 1995, SOCIOL SPORT J, V12, P403, DOI 10.1123/ssj.12.4.403; Veri MJ, 2013, J SPORT SOC ISSUES, V37, P227, DOI 10.1177/0193723512472897; VOGAN T, 2014, KEEP FLAM NFL FILMS, P1; Young, 2004, SPORTING BODIES DAMA, P59; Zirin D, 2013, GAME POLITICS HAS TU	42	18	18	1	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1540-5702	1540-5710		POP COMMUN	Pop. Commun.		2016	14	1			SI		49	57		10.1080/15405702.2015.1084628			9	Communication	Emerging Sources Citation Index (ESCI)	Communication	DN5MB	WOS:000377111200007					2022-02-06	
J	LeVaillant, CJ; Sharma, A; Muhling, J; Wheeler, LPG; Cozens, GS; Hellstrom, M; Rodger, J; Harvey, AR				LeVaillant, Chrisna J.; Sharma, Anil; Muhling, Jill; Wheeler, Lachlan P. G.; Cozens, Greg S.; Hellstroem, Mats; Rodger, Jennifer; Harvey, Alan R.			Significant changes in endogenous retinal gene expression assessed 1 year after a single intraocular injection of AAV-CNTF or AAV-BDNF	MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT			English	Article							NERVE GROWTH-FACTOR; NEUROTROPHIC FACTOR; AXONAL REGENERATION; MEDIATED EXPRESSION; CLINICAL-TRIAL; MESSENGER-RNA; ADULT RATS; THERAPY; VECTOR; SYSTEM	Use of viral vectors to deliver therapeutic genes to the central nervous system holds promise for the treatment of neurodegenerative diseases and neurotrauma. Adeno-associated viral (AAV) vectors encoding brain-derived neurotrophic factor (BDNF) or ciliary derived neurotrophic factor (CNTF) promote the viability and regeneration of injured adult rat retinal ganglion cells. However, these growth-inducing transgenes are driven by a constitutively active promoter, thus we examined whether long-term AAV-mediated secretion of BDNF or CNTF affected endogenous retinal gene expression. One year after the intravitreal injection of AAV-green fluorescent protein (GFP), bi-cistronic AAV-BDNF-GFP or AAV-CNTF-GFP, mRNA was extracted and analyzed using custom 96 well polymerase chain reaction arrays. Of 93 test genes, 56% showed significantly altered expression in AAV-BDNF-GFP and/or AAVCNTF-GFP retinas compared with AAV-GFP controls. Of these genes, 73% showed differential expression in AAV-BDNF versus AAVCNTF injected eyes. To focus on retinal ganglion cell changes, quantitative polymerase chain reaction was undertaken on mRNA (16 genes) obtained from fixed retinal sections in which the ganglion cell layer was enriched. The sign and extent of fold changes in ganglion cell layer gene expression differed markedly from whole retinal samples. Sustained and global alteration in endogenous mRNA expression after gene therapy should be factored into any interpretation of experimental/clinical outcomes, particularly when introducing factors into the central nervous system that require secretion to evoke functionality.	[LeVaillant, Chrisna J.; Sharma, Anil; Muhling, Jill; Wheeler, Lachlan P. G.; Cozens, Greg S.; Hellstroem, Mats; Harvey, Alan R.] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA, Australia; [Rodger, Jennifer] Univ Western Australia, Sch Anim Biol, Nedlands, WA, Australia; [Sharma, Anil] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Muhling, Jill] Childrens Med Res Inst, Westmead, NSW, Australia; [Hellstroem, Mats] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Lab Transplantat & Regenerat Med, Gothenburg, Sweden; [Rodger, Jennifer; Harvey, Alan R.] Western Australian Neurosci Res Inst, Nedlands, WA, Australia		Harvey, AR (corresponding author), Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA, Australia.; Harvey, AR (corresponding author), Western Australian Neurosci Res Inst, Nedlands, WA, Australia.	alan.harvey@uwa.edu.au	; Rodger, Jennifer/H-5735-2014	, Alan/0000-0002-2590-831X; Rodger, Jennifer/0000-0003-3413-4229	WA Neurotrauma Research Program	This work was supported a grant from the WA Neurotrauma Research Program. We thank Marissa Penrose for assistance with preparation of the figures.	Bartus RT, 2014, MOL THER, V22, P487, DOI 10.1038/mt.2013.281; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Buch PK, 2006, MOL THER, V14, P700, DOI 10.1016/j.ymthe.2006.05.019; Chen H, 2004, BRAIN RES, V1011, P99, DOI 10.1016/j.brainres.2004.03.024; de Winter F, 2013, EUR J PHARMACOL, V719, P145, DOI 10.1016/j.ejphar.2013.04.057; Douglas MR, 2009, BRAIN, V132, P3102, DOI 10.1093/brain/awp240; Godinho MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069987; Harvey AR, 2012, INT REV NEUROBIOL, V106, P1, DOI 10.1016/B978-0-12-407178-0.00002-8; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hellstrom M, 2011, MOL CELL NEUROSCI, V46, P507, DOI 10.1016/j.mcn.2010.12.003; Hellstrom M, 2011, J NEUROTRAUM, V28, P2475, DOI 10.1089/neu.2011.1928; Hellstrom M, 2011, CURR GENE THER, V11, P116, DOI 10.2174/156652311794940746; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Klein RL, 1999, NEUROSCIENCE, V90, P815, DOI 10.1016/S0306-4522(98)00537-5; Koilkonda RD, 2014, JAMA OPHTHALMOL, V132, P409, DOI 10.1001/jamaophthalmol.2013.7630; Kurimoto T, 2010, J NEUROSCI, V30, P15654, DOI 10.1523/JNEUROSCI.4340-10.2010; Leaver SG, 2006, GENE THER, V13, P1328, DOI 10.1038/sj.gt.3302791; Leaver SG, 2006, EUR J NEUROSCI, V24, P3323, DOI 10.1111/j.1460-9568.2006.05230.x; Lipinski DM, 2013, PROG RETIN EYE RES, V32, P22, DOI 10.1016/j.preteyeres.2012.09.001; Maguire C, 2014, NEUROTHERAPEUTICS, V11, P817, DOI 10.1007/s13311-014-0299-5; Marks WJ, 2016, HUM GENE THER, V27, P522, DOI 10.1089/hum.2015.134; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; Mizuguchi H, 2000, MOL THER, V1, P376, DOI 10.1006/mthe.2000.0050; Moore DL, 2011, MOL CELL NEUROSCI, V47, P233, DOI 10.1016/j.mcn.2011.05.005; Nagai J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08269; Navarro-Yepes J, 2014, PHARMACOL THERAPEUT, V142, P206, DOI 10.1016/j.pharmthera.2013.12.007; O'Connor DM, 2015, TRENDS MOL MED, V21, P504, DOI 10.1016/j.molmed.2015.06.001; Park KK, 2009, MOL CELL NEUROSCI, V41, P313, DOI 10.1016/j.mcn.2009.04.002; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031061; Ruitenberg MJ, 2004, NEUROBIOL DIS, V15, P394, DOI 10.1016/j.nbd.2003.11.018; Scarrott JM, 2015, EXPERT OPIN BIOL TH, V15, P935, DOI 10.1517/14712598.2015.1044894; Sharma A, 2012, INVEST OPHTH VIS SCI, V53, P8367, DOI 10.1167/iovs.12-10799; Smith PD, 2009, NEURON, V64, P617, DOI 10.1016/j.neuron.2009.11.021; Sun Y, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa8695; Trapani I, 2015, HUM GENE THER, V26, P193, DOI 10.1089/hum.2015.030; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Uchida K, 2014, THER DELIV, V5, P591, DOI [10.4155/TDE.14.20, 10.4155/tde.14.20]; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wollmann G, 2012, CANCER J, V18, P69, DOI 10.1097/PPO.0b013e31824671c9; Wu K, 2003, HUM GENE THER, V14, P1463, DOI 10.1089/104303403769211673; You SW, 2016, EXP NEUROL, V279, P197, DOI 10.1016/j.expneurol.2016.03.006; Zein WM, 2014, INVEST OPHTH VIS SCI, V55, P6301, DOI 10.1167/iovs.14-14860	46	18	18	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA		2329-0501		MOL THER-METH CLIN D	Mol.Ther.-Methods Clin. Dev.		2016	3								16078	10.1038/mtm.2016.78			10	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	VI6FQ	WOS:000503191500025	27933306	Green Published, gold			2022-02-06	
J	Meulenbroek, P; Bowers, B; Turkstra, LS				Meulenbroek, Peter; Bowers, Barbara; Turkstra, Lyn S.			Characterizing common workplace communication skills for disorders associated with traumatic brain injury: A qualitative study	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Traumatic brain injury; employment; vocational rehabilitation; social reintegration; communication disorders	HEAD-INJURY; PREDICTING RETURN; WORK; EMPLOYMENT; OUTCOMES; IMPAIRMENTS; PERFORMANCE; STABILITY; ABILITIES; MEMORY	BACKGROUND: Interpersonal skill deficits are the primary reason for workplace separation after traumatic brain injury (TBI). Communication is integral to interpersonal skills, but workplace communication demands are inadequately described in the rehabilitation literature. OBJECTIVE: This study describes inter-stakeholder examples of workplace communication behaviors for a level of employment to which people with TBI commonly attempt to return. METHODS: Setting: Mid-level workplaces. Design: Semi-structured interviews were audio recorded, transcribed verbatim, then analyzed using thematic content analysis. Findings were linked to common communication deficits in persons with TBI. Participants: A volunteer sample of twenty healthy individuals employed in the mid-level workplaces, ten employees and ten supervisors. Main Outcome Measure(s): Taxonomy of communication skill deficits common in persons with TBI and associated with mid-level workplaces. RESULTS: Interviews revealed seven communication-related skills associated with mid-level employment: 1) spoken language processing; 2) verbal memory; 3) reading and writing; 4) verbal reasoning; 5) expressive pragmatics; 6) multi-tasking; and 7) social cognition. CONCLUSION: Workers and supervisors from an assortment of mid-level jobs with differing job contents all identified similarly common and important cross-occupational communication-related skills. Findings provide a preliminary guide to assess and treat communication skills for patients who have work re-entry as a goal.	[Meulenbroek, Peter] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Meulenbroek, Peter] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Bowers, Barbara] Univ Wisconsin, Sch Nursing, Madison, WI USA; [Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI USA		Meulenbroek, P (corresponding author), Northwestern Univ, Dept Phys Med & Rehabil, Rehabil Inst Chicago, 345 E Super St,Rm 1328, Chicago, IL 60611 USA.	peter.meulenbroek@northwestern.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921; Meulenbroek, Peter/0000-0003-4233-9910; Bowers, Barbara/0000-0002-3226-0718	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [F31 DC011462] Funding Source: Medline		Ashcraft KL, 2003, COMMUN THEOR, V13, P5, DOI 10.1093/ct/13.1.5; Bailey T., 1997, WORKFORCE READINESS, P27; BAYLESS JD, 1989, J CLIN EXP NEUROPSYC, V11, P913, DOI 10.1080/01688638908400944; Beukelman D.R., 1991, COMMUNICATION DISCOU; Bowers D., 1991, FLORIDA AFFECT BATTE; Brenneman FD, 1997, J TRAUMA, V42, P778, DOI 10.1097/00005373-199705000-00004; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bryen DN, 2007, AUGMENT ALTERN COMM, V23, P126, DOI 10.1080/07434610600991175; Burnard P, 1991, Nurse Educ Today, V11, P461, DOI 10.1016/0260-6917(91)90009-Y; Byom LJ, 2012, INT J LANG COMM DIS, V47, P310, DOI 10.1111/j.1460-6984.2011.00102.x; Campbell D.T., 2001, EXPT QUASIEXPERIMENT; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; DeKay SH, 2012, BUS PROF COMMUN Q, V75, P449, DOI 10.1177/1080569912458966; DiCicco-Bloom B, 2006, MED EDUC, V40, P314, DOI 10.1111/j.1365-2929.2006.02418.x; Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Downing J.R., 2011, J BUS COMMUN, V48, P409; Drew Paul., 1992, TALK WORK INTERACTIO; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; EZRACHI O, 1991, J HEAD TRAUMA REHAB, V0006, P00071, DOI DOI 10.1097/00001199-199109000-00010; FRASER R, 1988, REHABIL COUNS BULL, V31, P276; Frith U, 2010, PHILOS T R SOC B, V365, P165, DOI 10.1098/rstb.2009.0160; Godfrey HPD, 2000, APHASIOLOGY, V14, P433, DOI 10.1080/026870300401441; GREENSPAN S, 1981, APPL RES MENT RETARD, V2, P23, DOI 10.1016/0270-3092(81)90004-7; Guilmette TJ, 2005, HANDBOOK OF COMPLEX OCCUPATIONAL DISABILITY CLAIMS: EARLY RISK IDENTIFICATIONS, INTERVENTION, AND PREVENTION, P303, DOI 10.1007/0-387-28919-4_16; HANLEYMAXWELL C, 1986, J ASSOC PERS SEVERE, V11, P45, DOI 10.1177/154079698601100106; Hartley L. L, 1995, COGNITIVE COMMUNICAT; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hooson JM, 2013, NEUROPSYCHOL REHABIL, V23, P19, DOI 10.1080/09602011.2012.713314; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; Isaki E, 2000, BRAIN INJURY, V14, P441; Johansson U, 2001, DISABIL REHABIL, V23, P474; Johnson R, 1987, Int Disabil Stud, V9, P49; Keyser-Marcus LA, 2002, ARCH PHYS MED REHAB, V83, P635, DOI 10.1053/apmr.2002.31605; Keyton J., 2013, J BUS COMMUN, V50, P152, DOI [10.1177/0021943612474990, DOI 10.1177/0021943612474990]; Koester, 2006, INVESTIGATING WORKPL; Konig CJ, 2005, HUM PERFORM, V18, P243, DOI 10.1207/s15327043hup1803_3; Kreutzer JS, 2003, J HEAD TRAUMA REHAB, V18, P128, DOI 10.1097/00001199-200303000-00004; Krippendorff K., 2018, CONTENT ANAL INTRO I; Levinson Stephen., 1983, PRAGMATICS; Lew H., 2004, ARCH PHYS MED REHAB, V83, P5; Lillie R., 2010, NEUROPSYCHOLOGY EVER, P302; MacDonald S., 2005, FAVRES FUNCTIONAL AS; Machamer J, 2005, J INT NEUROPSYCH SOC, V11, P807, DOI 10.1017/S135561770505099X; MACKENZIE EJ, 1987, AM J PUBLIC HEALTH, V77, P329, DOI 10.2105/AJPH.77.3.329; Madigan NK, 2000, J HEAD TRAUMA REHAB, V15, P943, DOI 10.1097/00001199-200006000-00007; Maxwell J., 1997, HDB APPL SOCIAL RES, P69; McConnell MM, 2000, AM ECON REV, V90, P1464, DOI 10.1257/aer.90.5.1464; McDonald S., 2012, DEV SOCIAL NEUROSCIE, P325; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Meadows LM, 2001, NATURE QUALITATIVE E, P187; Meulenbroek P., 2012, 9 WORLD C BRAIN INJ; Meulenbroek P., 2015, COMMUNICATION UNPUB; Meulenbroek P., 2011, ASHA CONV SAN DIEG C; Mikelson K.S., 2003, VIRGINIAS WORKFORCE; Miles M. B., 1994, QUALITATIVE DATA ANA, V2nd; MUCHMORE J, 1983, COMMUN EDUC, V32, P207, DOI 10.1080/03634528309378531; Myers KK, 2010, J BUS PSYCHOL, V25, P225, DOI 10.1007/s10869-010-9172-7; *NAT RES COUNC, 1999, CHANG NAT WORK IMPL; National Center for O*NET Development, 2014, O NET ONLINE HELP JO; NEUENDORF K.A., 2017, CONTENT ANAL GUIDEBO; Norman D, 2000, COGNITIVE NEUROSCIEN, P376; O'Neill J, 1998, J HEAD TRAUMA REHAB, V13, P68, DOI 10.1097/00001199-199808000-00007; Ownsworth T, 2004, DISABIL REHABIL, V26, P765, DOI 10.1080/09638280410001696700; Penn C, 2000, NEUROGENIC COMMUNICA, P103; Rietdijk R, 2013, BRAIN INJURY, V27, P812, DOI 10.3109/02699052.2013.775491; Robles MM, 2012, BUS PROF COMMUN Q, V75, P453, DOI 10.1177/1080569912460400; Saltychev M, 2013, BRAIN INJURY, V27, P1516, DOI 10.3109/02699052.2013.831131; SALZBERG CL, 1986, APPL RES MENT RETARD, V7, P299, DOI 10.1016/S0270-3092(86)80003-0; Schmitter-Edgecombe M, 2005, BRAIN LANG, V94, P331, DOI 10.1016/j.bandl.2005.01.007; Schnurr S., 2013, EXPLORING PROFESSION; SCHWAB K, 1993, NEUROLOGY, V43, P95, DOI 10.1212/WNL.43.1_Part_1.95; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Stephens R.D., 1997, J ASS COMMUNICATION, V3, P170; Stronach ST, 2008, APHASIOLOGY, V22, P1054, DOI 10.1080/02687030701632187; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Sullivan MP, 2014, J SPEECH LANG HEAR R, V57, P1731, DOI 10.1044/2014_JSLHR-L-13-0238; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Togher L, 2011, HANDBOOK OF PSYCHOLINGUISTIC AND COGNITIVE PROCESSES: PERSPECTIVES IN COMMUNICATION DISORDERS, P603; Trabasso T, 1996, DISCOURSE PROCESS, V21, P255, DOI 10.1080/01638539609544959; Turner T, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P841; Walker WC, 2006, ARCH PHYS MED REHAB, V87, P1576, DOI 10.1016/j.apmr.2006.08.335; Weber R. P., 1990, SAGE U PAPERS SERIES; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; Ylvisaker M., 2001, LANGUAGE INTERVENTIO, P745	87	18	18	0	13	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2016	44	1					15	31		10.3233/JVR-150777			17	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EB7MV	WOS:000387572700002	31105415	Green Accepted			2022-02-06	
J	Portbury, SD; Hare, DJ; Sgambelloni, C; Finkelstein, DI; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Sgambelloni, Charlotte; Finkelstein, David I.; Adlard, Paul A.			A time-course analysis of changes in cerebral metal levels following a controlled cortical impact	METALLOMICS			English	Article							TRAUMATIC BRAIN-INJURY; INDUCED OXIDATIVE STRESS; ALZHEIMERS-DISEASE; TAU PHOSPHORYLATION; SYNAPTIC PROTEINS; DELICATE BALANCE; HEAD-INJURY; RAT MODEL; ZINC; IRON	Traumatic brain injury (TBI) is complicated by a sudden and dramatic change in brain metal levels, including iron (Fe), copper (Cu) and zinc (Zn). Specific 'metallo-pathological' features of TBI include increased non-heme bound Fe and the liberation of free Zn ions, both of which may contribute to the pathogenesis of TBI. To further characterise the metal dyshomeostasis that occurs following brain trauma, we performed a quantitative time-course survey of spatial Fe, Cu and Zn distribution in mice receiving a controlled cortical impact TBI. Images of brain metal levels produced using laser ablation-inductively coupled plasma-mass spectrometry (LA-ICP-MS) in the upper quadrant of the ipsilateral hemisphere were compared to the corresponding contralateral hemisphere, together with regional areas radiating toward the center of the brain from the site of lesion. Significant regional and time point specific elevations in Fe, Zn and Cu were detected immediately and up to 28 days after TBI. The magnitude and timeframe of many of these changes suggest that TBI results in a pronounced and sustained alteration in normal metal levels within the brain. Such alterations are likely to play a role in both the short-and long-term consequences of head trauma and suggest that pharmacological modulation to normalize these metal levels may be efficacious in improving functional outcome.	[Portbury, Stuart D.; Hare, Dominic J.; Sgambelloni, Charlotte; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3052, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging Facil, Thomas St, Broadway, NSW 2007, Australia		Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Kenneth Myer Bldg,30 Royal Parade, Parkville, Vic 3052, Australia.	paul.adlard@florey.edu.au	Hare, Dominic/H-2481-2011; Finkelstein, David/B-9617-2009	Hare, Dominic/0000-0002-5922-7643; Finkelstein, David/0000-0002-8167-4917; Portbury, Stuart/0000-0002-5470-6100	Australian Research CouncilAustralian Research Council [FT120100030, LP140100095]; Victorian Government; Operational Infrastructure Support Grant	P. A. A. is supported by an Australian Research Council Future Fellowship (FT120100030). D. J. H. is supported by an Australian Research Council Linkage Project with Agilent Technologies (LP140100095). In addition, the Florey Institute of Neuroscience and Mental Health acknowledge the strong support from the Victorian Government and in particular the funding from the Operational Infrastructure Support Grant. The Elemental Bio-imaging Facility receives material support from Agilent Technologies.	Adlard PA, 2015, NEUROBIOL DIS, V81, P196, DOI 10.1016/j.nbd.2014.12.012; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Ayton S, 2014, FREE RADICAL BIO MED, V69, P331, DOI 10.1016/j.freeradbiomed.2014.01.041; Barnham KJ, 2014, CHEM SOC REV, V43, P6727, DOI 10.1039/c4cs00138a; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Bolognin S, 2009, NEUROMOL MED, V11, P223, DOI 10.1007/s12017-009-8102-1; Bouras C, 1997, EUR NEUROL, V38, P53, DOI 10.1159/000112903; Caliaperumal J, 2012, EXP NEUROL, V237, P363, DOI 10.1016/j.expneurol.2012.07.001; Carbonell T, 2007, CURR MED CHEM, V14, P857, DOI 10.2174/092986707780363014; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Creed JA, 2011, J NEUROTRAUM, V28, P547, DOI 10.1089/neu.2010.1729; Egana JT, 2003, BIOMETALS, V16, P215, DOI 10.1023/A:1020727218493; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; FREDERICKSON CJ, 1989, BRAIN RES, V480, P317, DOI 10.1016/0006-8993(89)90199-6; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hare D, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00034; Hare DJ, 2015, CHEM SOC REV, V44, P5941, DOI 10.1039/c5cs00055f; Hare DJ, 2014, J ANAL ATOM SPECTROM, V29, P1726; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Huang YP, 2014, CELL REP, V8, P831, DOI 10.1016/j.celrep.2014.06.047; Klevay LM, 2013, MED HYPOTHESES, V81, P995, DOI 10.1016/j.mehy.2013.09.011; Lear J, 2012, ANAL CHEM, V84, P6707, DOI 10.1021/ac301156f; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Long DA, 1996, BRAIN RES, V717, P109, DOI 10.1016/0006-8993(95)01500-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Miller G, 2012, SCIENCE, V336, P790, DOI 10.1126/science.336.6083.790; Montenigro PH, 2015, ANNU REV CLIN PSYCHO, V11, P309, DOI 10.1146/annurev-clinpsy-032814-112814; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Pena MMO, 1999, J NUTR, V129, P1251, DOI 10.1093/jn/129.7.1251; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Raven EP, 2013, J ALZHEIMERS DIS, V37, P127, DOI 10.3233/JAD-130209; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Rivera-Mancia S, 2010, CHEM-BIOL INTERACT, V186, P184, DOI 10.1016/j.cbi.2010.04.010; Roberts BR, 2015, METALLOMICS, V7, P124, DOI 10.1039/c4mt00258j; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Sun XY, 2012, J BIOL CHEM, V287, P11174, DOI 10.1074/jbc.M111.309070; Szewczyk B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00033; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Voss K, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-24; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Weinreb O, 2013, FREE RADICAL BIO MED, V62, P52, DOI 10.1016/j.freeradbiomed.2013.01.017; Wojnarowicz M. W., 2012, SCI TRANSL MED, V4; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504; ZIMMERMAN AW, 1976, ARCH NEUROL-CHICAGO, V33, P111, DOI 10.1001/archneur.1976.00500020039007	68	18	18	0	6	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	1756-5901	1756-591X		METALLOMICS	Metallomics		2016	8	2					193	200		10.1039/c5mt00234f			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE9PV	WOS:000370971200006	26689359	Green Published, hybrid			2022-02-06	
J	Wilson, CL; Hayward, SL; Kidambi, S				Wilson, Christina L.; Hayward, Stephen L.; Kidambi, Srivatsan			Astrogliosis in a dish: substrate stiffness induces astrogliosis in primary rat astrocytes	RSC ADVANCES			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; TRAUMATIC BRAIN-INJURY; REACTIVE ASTROCYTES; AUTOIMMUNE ENCEPHALOMYELITIS; OXIDATIVE STRESS; IN-VIVO; TISSUE; MATRIX; ELASTICITY; DISEASE	Astrogliosis due to brain injury or disease can lead to varying molecular and morphological changes in astrocytes. Magnetic resonance elastography and ultrasound have demonstrated that brain stiffness varies with age and disease state. However, there is a lack in understanding the role of varied stiffness on the progression of astrogliosis highlighting a critical need to engineer in vitro models that mimic disease stages. Such models need to incorporate the dynamic changes in the brain microenvironment including the stiffness changes. In this study we developed a polydimethyl siloxane (PDMS) based platform that modeled the physiologically relevant stiffness of brain in both a healthy (200 Pa) and diseased (8000 Pa) state to investigate the effect of stiffness on astrocyte function. We observed that astrocytes grown on soft substrates displayed a consistently more quiescent phenotype while those on stiff substrates displayed an astrogliosis-like morphology. In addition to morphological changes, astrocytes cultured on stiff substrates demonstrated significant increase in other astrogliosis hallmarks - cellular proliferation and glial fibrillary acidic protein (GFAP) protein expression. Furthermore, culturing astrocytes on a stiff surface resulted in increased reactive oxygen species (ROS) production, increased super oxide dismutase activity and decreased glutamate uptake. Our platform lends itself for study of potential therapeutic strategies for brain injury focusing on the intricate brain microenvironment-astrocytes signaling pathways.	[Wilson, Christina L.; Hayward, Stephen L.; Kidambi, Srivatsan] Univ Nebraska, Dept Chem & Biomol Engn, 820 N 16th St,207 Othmer Hall, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska, Nebraska Ctr Mat & Nanosci, 855 N 16th St, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska, Nebraska Ctr Prevent Obes Dis, 316C Leverton Hall,1700 35th St, Lincoln, NE 68588 USA; [Kidambi, Srivatsan] Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, 42nd & Emile St, Omaha, NE USA; [Kidambi, Srivatsan] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA		Kidambi, S (corresponding author), Univ Nebraska, Dept Chem & Biomol Engn, 820 N 16th St,207 Othmer Hall, Lincoln, NE 68588 USA.; Kidambi, S (corresponding author), Univ Nebraska, Nebraska Ctr Mat & Nanosci, 855 N 16th St, Lincoln, NE 68588 USA.; Kidambi, S (corresponding author), Univ Nebraska, Nebraska Ctr Prevent Obes Dis, 316C Leverton Hall,1700 35th St, Lincoln, NE 68588 USA.; Kidambi, S (corresponding author), Univ Nebraska Med Ctr, Mary & Dick Holland Regenerat Med Program, 42nd & Emile St, Omaha, NE USA.; Kidambi, S (corresponding author), Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA.	skidambi2@unl.edu	Kidambi, Srivatsan/A-5689-2015	Kidambi, Srivatsan/0000-0002-0282-0411	start up funds from UNL's Layman Award; MRSEC Seed Grant; Nebraska Center for the Prevention of Obesity Diseases Pilot grant; UNL Interdisciplinary Award; UNL's MolecularMechanisms of Diseases T32 Graduate Fellowship	We thank Dr You Zhou of the UNL Center for Biotechnology Microscopy Core Facilities for his stimulating conversations about the brain microenvironment. We thank Dr Oleh Khalimonchuk and Dr Iryna Bohovych for assistance with flow cytometer experimental set up. This work was funded by the start up funds from UNL's Layman Award, MRSEC Seed Grant, Nebraska Center for the Prevention of Obesity Diseases Pilot grant, UNL Interdisciplinary Award (to S. K.) and UNL'sMolecularMechanisms of Diseases T32 Graduate Fellowship (to C. L. W.).	Arani A, 2015, NEUROIMAGE, V111, P59, DOI 10.1016/j.neuroimage.2015.02.016; Araque A, 2014, NEURON, V81, P728, DOI 10.1016/j.neuron.2014.02.007; Araque A, 2010, PHILOS T R SOC B, V365, P2375, DOI 10.1098/rstb.2009.0313; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beaudoin GMJ, 2012, NAT PROTOC, V7, P1741, DOI 10.1038/nprot.2012.099; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Brambilla R, 2009, J IMMUNOL, V182, P2628, DOI 10.4049/jimmunol.0802954; Buxboim A, 2014, CURR BIOL, V24, P1909, DOI 10.1016/j.cub.2014.07.001; Cole R, 2001, PROTOCOLS NEURAL CEL, P117, DOI [10.1385/1-59259-207-4:117, DOI 10.1385/1-59259-207-4:117]; Correa-Cerro LS, 2007, J NEUROPATH EXP NEUR, V66, P169, DOI 10.1097/01.jnen.0000248555.53079.d5; Dambach H, 2014, EPILEPSIA, V55, P184, DOI 10.1111/epi.12473; Dasbiswas K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7085; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Eliasson C, 1999, J BIOL CHEM, V274, P23996, DOI 10.1074/jbc.274.34.23996; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; ENG LF, 1992, PROG BRAIN RES, V94, P353; Engler A. J., 2007, Journal of Musculoskeletal & Neuronal Interactions, V7, P335; Gefen A, 2003, J NEUROTRAUM, V20, P1163, DOI 10.1089/089771503770802853; Georges PC, 2006, BIOPHYS J, V90, P3012, DOI 10.1529/biophysj.105.073114; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Hamby ME, 2006, GLIA, V54, P566, DOI 10.1002/glia.20411; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOU YJ, 1995, J NEUROSCI RES, V40, P359, DOI 10.1002/jnr.490400310; JIANG X, 2007, OPEN NEUROSCI J, V1, P7; Kidambi S, 2008, ADV FUNCT MATER, V18, P294, DOI 10.1002/adfm.200601237; Kolokoltsova OA, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-126; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Lu YB, 2011, FASEB J, V25, P624, DOI 10.1096/fj.10-163790; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; Medeiros R, 2013, EXP NEUROL, V239, P133, DOI 10.1016/j.expneurol.2012.10.007; Miller K, 2000, J BIOMECH, V33, P1369, DOI 10.1016/S0021-9290(00)00120-2; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Moshayedi P, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194114; Murphy MC, 2011, J MAGN RESON IMAGING, V34, P494, DOI 10.1002/jmri.22707; Natarajan V, 2015, RSC ADV, V5, P80956, DOI [10.1039/C5RA15208A, 10.1039/c5ra15208a]; Natarajan V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134541; Nimmerjahn A, 2009, J PHYSIOL-LONDON, V587, P1639, DOI 10.1113/jphysiol.2008.167171; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Oberheim NA, 2008, J NEUROSCI, V28, P3264, DOI 10.1523/JNEUROSCI.4980-07.2008; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 2001, Prog Brain Res, V132, P23; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; Pirooznia SK, 2014, NEURON, V81, P961, DOI 10.1016/j.neuron.2014.02.024; Placone AL, 2015, BIOMATERIALS, V42, P134, DOI 10.1016/j.biomaterials.2014.11.046; Prager-Khoutorsky M, 2011, NAT CELL BIOL, V13, P1457, DOI 10.1038/ncb2370; Prauzner-Bechcicki S, 2015, J MECH BEHAV BIOMED, V41, P13, DOI 10.1016/j.jmbbm.2014.09.020; Previtera ML, 2010, J BIOSCI BIOENG, V110, P459, DOI 10.1016/j.jbiosc.2010.04.004; Qu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067094; Raab M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt38; Ribbers G. M., 2010, INT ENCY REHABILITAT; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Sack I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023451; Shanker G, 2003, MOL BRAIN RES, V110, P85, DOI 10.1016/S0169-328X(02)00642-3; Sidoryk-Wegrzynowicz M, 2011, TOXICOL PATHOL, V39, P115, DOI 10.1177/0192623310385254; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Streitberger KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029888; Swanson RA, 2004, CURR MOL MED, V4, P193, DOI 10.2174/1566524043479185; Swift J, 2014, J CELL SCI, V127, P3005, DOI 10.1242/jcs.149203; Tamashiro TT, 2012, JOVE-J VIS EXP, DOI 10.3791/3814; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Weydert CJ, 2010, NAT PROTOC, V5, P51, DOI 10.1038/nprot.2009.197; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wilson CL, 2015, NANOSCALE, V7, P18477, DOI 10.1039/c5nr03646a; Wu XF, 2010, BIOCHEM BIOPH RES CO, V393, P514, DOI 10.1016/j.bbrc.2010.02.038; Xu ZNS, 2013, J ULTRAS MED, V32, P485, DOI 10.7863/jum.2013.32.3.485; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Yu ACH, 2004, NEUROCHEM RES, V29, P2171, DOI 10.1007/s11064-004-6891-z; Yu PP, 2012, METHODS MOL BIOL, V814, P327, DOI 10.1007/978-1-61779-452-0_21	73	18	18	2	13	ROYAL SOC CHEMISTRY	CAMBRIDGE	THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS, ENGLAND	2046-2069			RSC ADV	RSC Adv.		2016	6	41					34447	34457		10.1039/c5ra25916a			11	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	DJ2QI	WOS:000374049700043	32742641	Green Published, Green Accepted			2022-02-06	
J	Ruestow, PS; Duke, TJ; Finley, BL; Pierce, JS				Ruestow, Peter S.; Duke, Tina J.; Finley, Brent L.; Pierce, Jennifer S.			Effects of the NFL's Amendments to the Free Kick Rule on Injuries during the 2010 and 2011 Seasons	JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HYGIENE			English	Article						injury prevention; National Football League; occupational injuries	NATIONAL FOOTBALL LEAGUE; LOWER-EXTREMITY INJURY; RISK-FACTORS; PROFESSIONAL FOOTBALL; PLAYING SURFACE; CONCUSSION; SPORTS; ASSOCIATION; PREVENTION	Recognizing the chronic health effects associated with playing football, the National Football League (NFL) has enacted policies and rules aimed at improving player health and safety. Prior to the 2011 season, amendments to the Free Kick rule were implemented, whereby the restraining line was moved from the 30- to the 35-yard line and all kicking team players other than the kicker were required to line up no more than 5 yards behind their restraining line. The objective of this analysis was to evaluate the effects of these rule changes on injury rates.Data for injuries occurring on special teams plays during the 2010 and 2011 NFL seasons were obtained from publically available NFL gamebooks and injury reports. Injury rates for kickoff plays across seasons were statistically compared using incidence rate ratios (RR) and 95% confidence intervals. To evaluate whether injury rate changes could be attributable to the rule amendments, comparisons were made with punt injury rates (presumably unaffected by the Free Kick rule changes) and distributions of potential confounders were assessed across seasons.Incidence of injuries occurring on kickoff plays fell from 2010 to 2011 (RR: 0.45, 95% CI: 0.28-0.73), although on kickoff plays where the ball was returned, this decrease became non-significant (RR: 0.67, 95% CI: 0.41-1.08). While the incidence of head injuries decreased by approximately 3-fold during kickoff plays, this change was not statistically significant (RR: 0.33, 95% CI: 0.09-1.21). No difference was observed in injury incidence during punts between the two seasons, and the distribution of confounding factors was largely uniform across seasons.The observed decrease in injuries occurring during kickoffs was likely directly attributable to the Free Kick rule amendments, principally from the increased frequency of touchbacks. The absence of a significant change in head injuries during kickoffs was unexpected, but may be attributable to small sample size. Despite the injury rate reductions, the rule changes likely had little effect on player safety during active gameplay.	[Ruestow, Peter S.; Duke, Tina J.; Pierce, Jennifer S.] Cardno ChemRisk, Chicago, IL 60612 USA; [Finley, Brent L.] Cardno ChemRisk, New York, NY USA		Ruestow, PS (corresponding author), Cardno ChemRisk, 30 North LaSalle St,Suite 3910, Chicago, IL 60612 USA.	peter.ruestow@cardno.com					Albergotti R., 2011, WALL STREET J; Alentorn-Geli E, 2014, KNEE SURG SPORT TR A, V22, P3, DOI 10.1007/s00167-013-2725-3; Andrews Wilson, 2013, WASHINGTON POST; Baron S. L., 1994, HLTH HAZARD EVALUATI; Battista J., 2011, NY TIMES; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Cottler LB, 2011, DRUG ALCOHOL DEPEN, V116, P188, DOI 10.1016/j.drugalcdep.2010.12.003; Domb BG, 2014, AM J SPORT MED, V42, P1704, DOI 10.1177/0363546514531551; Dragoo JL, 2013, KNEE, V20, P191, DOI 10.1016/j.knee.2012.07.006; Dragoo JL, 2010, SPORTS MED, V40, P981, DOI 10.2165/11535910-000000000-00000; Ellenbogen RG, 2010, WORLD NEUROSURG, V74, P560, DOI 10.1016/j.wneu.2010.11.016; Golightly YM, 2009, J PHYS ACT HEALTH, V6, P638, DOI 10.1123/jpah.6.5.638; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hershman EB, 2012, AM J SPORT MED, V40, P2200, DOI 10.1177/0363546512458888; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Knowles SB, 2006, AM J EPIDEMIOL, V164, P1209, DOI 10.1093/aje/kwj337; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mechelen E. V. A. W. V., 2009, SPORTS INJURY RES; Murphy DF, 2003, BRIT J SPORT MED, V37, P13, DOI 10.1136/bjsm.37.1.13; NFL E. A. T., 2013, OFF 2013 NFL REC FAC; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman EJ, 2003, NEUROSURGERY, V53, P797, DOI 10.1093/neurosurgery/53.3.797; POWELL J W, 1987, Athletic Training, V22, P202; Powell JW, 1999, J ATHL TRAINING, V34, P277; Robeson R, 2014, J LAW MED ETHICS, V42, P334, DOI 10.1111/jlme.12150; Rothman K.J., 2008, Modern epidemiology, V3rd; Turbeville SD, 2003, AM J SPORT MED, V31, P974, DOI 10.1177/03635465030310063801; Tyler TF, 2006, AM J SPORT MED, V34, P471, DOI 10.1177/0363546505280429	29	18	18	0	31	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1545-9624	1545-9632		J OCCUP ENVIRON HYG	J. Occup. Environ. Hyg.	DEC 2	2015	12	12					875	882		10.1080/15459624.2015.1072632			8	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	CV1SZ	WOS:000364039700003	26267168				2022-02-06	
J	Alsalaheen, B; Haines, J; Yorke, A; Broglio, SP				Alsalaheen, Bara; Haines, Jamie; Yorke, Amy; Broglio, Steven P.			Reliability and Construct Validity of Limits of Stability Test in Adolescents Using a Portable Forceplate System	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Ankle; Rehabilitation; Sports	EVALUATING POSTURAL CONTROL; ERROR SCORING SYSTEM; MILD HEAD-INJURY; DYNAMIC BALANCE; ANKLE INSTABILITY; GENERALIZABILITY; CONCUSSION; ADULTS; SPORT; PERTURBATION	Objective: To examine the reliability, convergent, and discriminant validity of the limits of stability (LOS) test to assess dynamic postural stability in adolescents using a portable forceplate system. Design: Cross-sectional reliability observational study. Setting: School setting. Participants: Adolescents (N=36) completed all measures during the first session. To examine the reliability of the LOS test, a subset of 15 participants repeated the LOS test after 1 week. Interventions: Not applicable. Main Outcome Measures: Outcome measurements included the LOS test, Balance Error Scoring System, Instrumented Balance Error Scoring System, and Modified Clinical Test for Sensory Interaction on Balance. Results: A significant relation was observed among LOS composite scores (r=.36.87, P<.05). However, no relation was observed between LOS and static balance outcome measurements. The reliability of the LOS composite scores ranged from moderate to good (intraclass correlation coefficient model 2,1=.73-.96). Conclusions: The results suggest that the LOS composite scores provide unique information about dynamic postural stability, and the LOS test completed at 100% of the theoretical limit appeared to be a reliable test of dynamic postural stability in adolescents. Clinicians should use dynamic balance measurement as part of their balance assessment and should not use static balance testing (eg, Balance Error Scoring System) to make inferences about dynamic balance, especially when balance assessment is used to determine rehabilitation outcomes, or when making return to play decisions after injury. (C) 2015 by the American Congress of Rehabilitation Medicine	[Alsalaheen, Bara; Haines, Jamie; Yorke, Amy] Univ Michigan, Dept Phys Therapy, Flint, MI 48502 USA; [Broglio, Steven P.] Univ Michigan, NeuroSport Res Lab, Ann Arbor, MI 48109 USA		Alsalaheen, B (corresponding author), Univ Michigan, Dept Phys Therapy, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umich.edu	Yorke, Amy/Q-4091-2019	Yorke, Amy/0000-0003-4998-0313	Dr. Ben F. Bryer Foundation Medical Research Fund; University of Michigan-Flint's Research and Creative Activity Award	Supported by the Dr. Ben F. Bryer Foundation Medical Research Fund and the University of Michigan-Flint's Research and Creative Activity Award.	Alsalaheen BA, 2015, PHYSICIAN SPORTSMED, V43, P221, DOI 10.1080/00913847.2015.1040717; Arnold BL, 2009, MED SCI SPORT EXER, V41, P1048, DOI 10.1249/MSS.0b013e318192d044; Balter SGT, 2004, NEUROSCI LETT, V366, P71, DOI 10.1016/j.neulet.2004.05.015; Baumgartner T. A., 1999, MEASUREMENT EVALUATI; Beckerman H, 2001, QUAL LIFE RES, V10, P571, DOI 10.1023/A:1013138911638; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Brouwer B, 1998, SCAND J REHABIL MED, V30, P131; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Clark S, 1997, ARCH PHYS MED REHAB, V78, P1078, DOI 10.1016/S0003-9993(97)90131-3; Clark S, 2001, ARCH PHYS MED REHAB, V82, P468, DOI 10.1053/apmr.2001.21859; COHEN H, 1993, PHYS THER, V73, P346, DOI 10.1093/ptj/73.6.346; Davlin CD, 2004, PERCEPT MOTOR SKILL, V98, P1171, DOI 10.2466/pms.98.3c.1171-1176; FURMAN JM, 1994, BAILLIERE CLIN NEUR, V3, P501; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; GOLDIE PA, 1989, ARCH PHYS MED REHAB, V70, P510; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hatzitaki V, 2002, J MOTOR BEHAV, V34, P161, DOI 10.1080/00222890209601938; Hertel J, 2006, J APPL BIOMECH, V22, P67, DOI 10.1123/jab.22.1.67; Hertel J, 2001, J ATHL TRAINING, V36, P363; Hoffman MA, 1997, ARCH PHYS MED REHAB, V78, P290, DOI 10.1016/S0003-9993(97)90036-8; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Hrysomallis C, 2006, J SCI MED SPORT, V9, P288, DOI 10.1016/j.jsams.2006.05.021; Hubbard TJ, 2007, FOOT ANKLE INT, V28, P343, DOI 10.3113/FAI.2007.0343; Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0; Liston RAL, 1996, ARCH PHYS MED REHAB, V77, P425, DOI 10.1016/S0003-9993(96)90028-3; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; National Federation of State High School Associations, 2013, ANN HIGH SCH ATHL PA; Newstead Ann H, 2005, J Neurol Phys Ther, V29, P18; Olsen BL, 2013, J ATHL TRAINING, V48, pS; Parker TM, 2007, BRIT J SPORT MED, V41, P868, DOI 10.1136/bjsm.2006.033761; Paterno MV, 2010, AM J SPORT MED, V38, P1968, DOI 10.1177/0363546510376053; Pickerill ML, 2011, J ATHL TRAINING, V46, P600; Portney L.G., 2009, FDN CLIN RES APPL PR, V3rd ed.; Quatman-Yates CC, 2013, INT J SPORTS PHYS TH, V8, P741; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Sell TC, 2012, PHYS THER SPORT, V13, P80, DOI 10.1016/j.ptsp.2011.06.006; Shultz SJ, 2000, J ELECTROMYOGR KINES, V10, P159, DOI 10.1016/S1050-6411(00)00002-X; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Wikstrom EA, 2005, J ATHL TRAINING, V40, P305; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906	46	18	18	1	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	DEC	2015	96	12					2194	2200		10.1016/j.apmr.2015.08.418			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	CY6SZ	WOS:000366540400015	26325240				2022-02-06	
J	Drijkoningen, D; Leunissen, I; Caeyenberghs, K; Hoogkamer, W; Sunaert, S; Duysens, J; Swinnen, SP				Drijkoningen, David; Leunissen, Inge; Caeyenberghs, Karen; Hoogkamer, Wouter; Sunaert, Stefan; Duysens, Jacques; Swinnen, Stephan P.			Regional Volumes in Brain Stem and Cerebellum Are Associated With Postural Impairments in Young Brain-Injured Patients	HUMAN BRAIN MAPPING			English	Article						traumatic brain injury; voxel-based morphometry; cerebellum; brain stem; postural control; grey matter; white matter; spatially unbiased infratentorial template; volumetric analysis	DIFFUSE AXONAL INJURY; VOXEL-BASED MORPHOMETRY; TRAUMATIC HEAD-INJURY; DECEREBRATE CAT; WHITE-MATTER; 1ST TRIAL; TELL US; BALANCE; CHILDREN; GAIT	Many patients with traumatic brain injury (TBI) suffer from postural control impairments that can profoundly affect daily life. The cerebellum and brain stem are crucial for the neural control of posture and have been shown to be vulnerable to primary and secondary structural consequences of TBI. The aim of this study was to investigate whether morphometric differences in the brain stem and cerebellum can account for impairments in static and dynamic postural control in TBI. TBI patients (n=18) and healthy controls (n=30) completed three challenging postural control tasks on the EquiTestV (R) system (Neurocom). Infratentorial grey matter (GM) and white matter (WM) volumes were analyzed with cerebellum-optimized voxel-based morphometry using the spatially unbiased infratentorial toolbox. Volume loss in TBI patients was revealed in global cerebellar GM, global infratentorial WM, middle cerebellar peduncles, pons and midbrain. In the TBI group and across both groups, lower postural control performance was associated with reduced GM volume in the vermal/paravermal regions of lobules I-IV, V and VI. Moreover, across all participants, worse postural control performance was associated with lower WM volume in the pons, medulla, midbrain, superior and middle cerebellar peduncles and cerebellum. This is the first study in TBI patients to demonstrate an association between postural impairments and reduced volume in specific infratentorial brain areas. Volumetric measures of the brain stem and cerebellum may be valuable prognostic markers of the chronic neural pathology, which complicates rehabilitation of postural control in TBI. (C) 2015 Wiley Periodicals, Inc.	[Drijkoningen, David; Leunissen, Inge; Hoogkamer, Wouter; Duysens, Jacques; Swinnen, Stephan P.] Katholieke Univ Leuven, Movement Control & Neuroplast Res Grp, Grp Biomed Sci, Leuven, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia; [Sunaert, Stefan] Katholieke Univ Leuven, Univ Hosp, Dept Radiol, Leuven, Belgium; [Swinnen, Stephan P.] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, Leuven, Belgium		Swinnen, SP (corresponding author), Movement Control & Neuroplast Res Grp, Tervuursevest 101, B-3001 Leuven, Belgium.	stephan.swinnen@faber.kuleuven.be	Hoogkamer, Wouter/I-8670-2019	Hoogkamer, Wouter/0000-0003-0524-0196; Caeyenberghs, Karen/0000-0001-7009-6843; Duysens, Jacques/0000-0002-0043-8817; Leunissen, Inge/0000-0002-3977-3620	Research Program of the Research Foundation - Flanders (FWO)FWO [G.A114.11, G.0721.12, G.0708.14]; Research Fund KU LeuvenKU Leuven [OT/11/071]; Interuniversity Attraction Poles program of the Belgian Federal GovernmentBelgian Federal Science Policy Office [P7/11]	Contract grant sponsor: Research Program of the Research Foundation - Flanders (FWO); Contract grant numbers: G.A114.11, G.0721.12, G.0708.14; Contract grant sponsor: Research Fund KU Leuven; Contract grant number: OT/11/071; Contract grant sponsor: Interuniversity Attraction Poles program of the Belgian Federal Government; Contract grant number: P7/11	Ai JL, 2007, EXP BRAIN RES, V177, P95, DOI 10.1007/s00221-006-0654-9; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2010, NEUROIMAGE, V50, P1017, DOI 10.1016/j.neuroimage.2010.01.003; Blackman JA, 2003, J HEAD TRAUMA REHAB, V18, P493, DOI 10.1097/00001199-200311000-00003; Brandauer B, 2008, CLIN NEUROPHYSIOL, V119, P2528, DOI 10.1016/j.clinph.2008.07.280; Bruininks, 2005, BOT2 BRUININKS OSERE; Buckner RL, 2011, J NEUROPHYSIOL, V106, P2322, DOI 10.1152/jn.00339.2011; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2014, BRAIN CONNECT, DOI [10.1089/brain.2014.0293, DOI 10.1089/BRAIN.2014.0293]; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Campbell AD, 2013, J NEUROPHYSIOL, V110, P2236, DOI 10.1152/jn.00766.2012; Choi JH, 2008, J TRAUMA, V65, P1028, DOI 10.1097/TA.0b013e31815eba9b; Dahl E, 2013, J REHABIL MED, V45, P729, DOI 10.2340/16501977-1188; Debaere F, 2004, NEUROIMAGE, V21, P1416, DOI 10.1016/j.neuroimage.2003.12.011; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Diedrichsen J, 2006, NEUROIMAGE, V33, P127, DOI 10.1016/j.neuroimage.2006.05.056; Drijkoningen D, 2015, J NEUROTRAUM, V32, P1324, DOI 10.1089/neu.2014.3787; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Duysens J, 2015, CLIN NEUROPHYSIOL, V126, P5, DOI 10.1016/j.clinph.2014.05.024; Fearing MA, 2008, J CHILD NEUROL, V23, P729, DOI 10.1177/0883073808314159; Ferraye MU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091183; Firsching R, 2002, NEUROL RES, V24, P145, DOI 10.1179/016164102101199684; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Habas C, 2007, NEURORADIOLOGY, V49, P849, DOI 10.1007/s00234-007-0267-4; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Honeycutt CF, 2010, J NEUROPHYSIOL, V103, P3266, DOI 10.1152/jn.00764.2009; Honeycutt CF, 2009, J NEUROPHYSIOL, V101, P2751, DOI 10.1152/jn.91040.2008; Hong JH, 2009, BRAIN RES BULL, V80, P30, DOI 10.1016/j.brainresbull.2009.05.021; Hoogkamer W, 2015, GAIT POSTURE, V41, P592, DOI 10.1016/j.gaitpost.2015.01.004; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Igarashi T, 2007, EXP NEUROL, V203, P258, DOI 10.1016/j.expneurol.2006.08.030; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Ilg W, 2013, MOVEMENT DISORD, V28, P1566, DOI 10.1002/mds.25558; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Konczak J, 2005, BRAIN, V128, P1428, DOI 10.1093/brain/awh385; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; Mori S, 2005, MRI ATLAS HUMAN WHIT; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Nijhuis LBO, 2010, J NEUROPHYSIOL, V104, P2704, DOI 10.1152/jn.01080.2009; Nonnekes J, 2015, NEUROSCI BIOBEHAV R, V53, P131, DOI 10.1016/j.neubiorev.2015.04.002; Ouchi Y, 1999, BRAIN, V122, P329, DOI 10.1093/brain/122.2.329; Parizel PM, 1998, EUR RADIOL, V8, P960, DOI 10.1007/s003300050496; Park E, 2007, PROG BRAIN RES, V161, P327, DOI 10.1016/S0079-6123(06)61023-6; Park E, 2006, J NEUROPATH EXP NEUR, V65, P226, DOI 10.1097/01.jnen.0000202888.29705.93; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Prosperini L, 2013, RADIOLOGY, V268, P181, DOI 10.1148/radiol.13121695; Reuter M, 2015, NEUROIMAGE, V107, P107, DOI 10.1016/j.neuroimage.2014.12.006; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Roberts RM, 2014, DEV NEUROPSYCHOL, V39, P600, DOI 10.1080/87565641.2014.973958; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Rossi C, 1996, ARCH PHYS MED REHAB, V77, P1062, DOI 10.1016/S0003-9993(96)90069-6; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Salmi J, 2010, J COGNITIVE NEUROSCI, V22, P2663, DOI 10.1162/jocn.2009.21382; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schoch B, 2010, CEREBELLUM, V9, P324, DOI 10.1007/s12311-010-0165-x; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Slobounov S, 2006, MOTOR CONTROL, V10, P69, DOI 10.1123/mcj.10.1.69; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Spraker MB, 2012, NEUROIMAGE, V59, P1647, DOI 10.1016/j.neuroimage.2011.09.019; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P94, DOI 10.1136/jnnp.74.1.94; Stoodley CJ, 2012, NEUROIMAGE, V59, P1560, DOI 10.1016/j.neuroimage.2011.08.065; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Talairach J., 1988, COPLANAR STEREOTAXIC; Taube W, 2015, CORTEX, V64, P102, DOI 10.1016/j.cortex.2014.09.022; Taylor DL, 2006, BRAIN PATHOL, V16, P195, DOI 10.1111/j.1750-3639.2006.00017.x; Timmann D, 2008, CEREBELLUM, V7, P602, DOI 10.1007/s12311-008-0066-4; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; Vasudevan EVL, 2014, J NEUROL PHYS THER, V38, P172, DOI 10.1097/NPT.0000000000000049; Wade LD, 1997, ARCH PHYS MED REHAB, V78, P1107, DOI 10.1016/S0003-9993(97)90136-2; Wen L, 2014, NEURAL REGEN RES, V9, P1902, DOI 10.4103/1673-5374.145358	87	18	18	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	DEC	2015	36	12					4897	4909		10.1002/hbm.22958			13	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	DB1QF	WOS:000368283100012	26441014	Green Published			2022-02-06	
J	Hwang, HF; Cheng, CH; Chien, DK; Yu, WY; Lin, MR				Hwang, Hei-Fen; Cheng, Chui-Hsuan; Chien, Ding-Kuo; Yu, Wen-Yu; Lin, Mau-Roung			Risk Factors for Traumatic Brain Injuries During Falls in Older Persons	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						fall mechanism; falls; older people; risk factor; traumatic brain injury	UNITED-STATES; IMPACT SEVERITY; HIP-FRACTURES; ADULTS; PEOPLE; MORTALITY; POPULATION; DISCHARGE; DESCENT; DEATHS	Objective: To identify risk factors for traumatic brain injuries (TBIs) during falls in older Taiwanese people. Participants: Case patients consisted of 113 patients aged 60 years or older with a moderate/severe TBI due to a fall. Two control groups: (1) 339 older patients with a soft-tissue injury; and (2) 113 with a mild-TBI due to a fall. Proxies were required to provide information for a considerable number of patients. Design: Matched case-control study. Settings: The emergency departments of 3 general hospitals. Measures: Sociodemographic, lifestyle behavior, chronic condition, medication use, functional abilities, and fall-related characteristics. Results: When patients with a soft-tissue injury were assigned to the control group, men were 2.06-fold more likely to have a moderate/severe TBI than women. Subjects who took antiarrhythmics within 4 hours of a fall were 2.59-fold more likely to have a moderate/severe TBI than those who took none. Subjects who were negotiating stairs and getting in/out of the bed/chair were 3.12-fold and 2.97-fold, respectively, more likely to have a moderate/severe TBI than those who fell while walking. Falling backward and sideways was 4.07-fold and 2.30-fold, respectively, more likely to cause a moderate/severe TBI than falling forward. When patients with a mild-TBI were assigned to the control group, results were similar, with the exception that the effect of antiarrhythmic use became nonsignificant and subjects who took 2 or more medications were 3.07-fold more likely to have a moderate/severe TBI than those who took none. Conclusion: Avoiding a head impact during a backward or sideways fall, reducing unnecessary use of polypharmacy and antiarrhythmics, and maintaining safety during stair negotiation and bed/chair transfer may protect an elderly person from a severe brain injury.	[Hwang, Hei-Fen] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan; [Hwang, Hei-Fen; Lin, Mau-Roung] Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan; [Cheng, Chui-Hsuan] Tzu Chi Gen Hosp, Taichung Branch, Dept Emergency Med, Taichung, Taiwan; [Chien, Ding-Kuo] Mackay Memorial Hosp, Dept Emergency Med, Taipei, Taiwan; [Yu, Wen-Yu] Taipei Med Univ Hosp, Dept Emergency Med, Taipei, Taiwan		Lin, MR (corresponding author), Taipei Med Univ, Coll Publ Hlth & Nutr, Inst Injury Prevent & Control, 250 Wu Hsing St, Taipei 110, Taiwan.	mrlin@tmu.edu.tw	Cheng, Chui-Hsuan/AAY-4057-2020	Chien, Ding-Kuo/0000-0001-5283-9850	National Health Research InstituteNational Health Research Institutes - Taiwan [NHRI-EX103-10317PI]; National Science Council, TaiwanMinistry of Science and Technology, Taiwan [NSC102-2314-B-038-033]	This work was funded by the National Health Research Institute (NHRI-EX103-10317PI) and National Science Council (NSC102-2314-B-038-033), Taiwan.	*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P276; Chen Y.C., 1997, CHIN J PUBLIC HLTH, V16, P119; Cifu DX, 1996, ARCH PHYS MED REHAB, V77, P883, DOI 10.1016/S0003-9993(96)90274-9; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; CUMMING RG, 1994, J AM GERIATR SOC, V42, P774, DOI 10.1111/j.1532-5415.1994.tb06540.x; CUMMING RG, 1991, AGE AGEING, V20, P455, DOI 10.1093/ageing/20.6.455; CUMMINGS SR, 1989, J GERONTOL, V44, pM107; Davies AJ, 1996, AGE AGEING, V25, P362, DOI 10.1093/ageing/25.5.362; Faul M, 2010, TRAUMATIC BRAIN INJU; FILLENBAUM GG, 1981, J GERONTOL, V36, P428, DOI 10.1093/geronj/36.4.428; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Guo N.W., 1988, J REHABIL MED ASS, V16, P52, DOI DOI 10.1007/978-94-011-7973-7_3; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; HAYES WC, 1993, CALCIFIED TISSUE INT, V52, P192, DOI 10.1007/BF00298717; Jamieson LM, 2007, INJURY PREV, V13, P243, DOI 10.1136/ip.2007.015354; Lamb SE, 2005, J AM GERIATR SOC, V53, P1618, DOI 10.1111/j.1532-5415.2005.53455.x; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40, DOI 10.1111/j.1532-5415.1999.tb01899.x; Liao Y. C., 1995, MED J CHANGHUA CHRIS, V1, P11; LUUKINEN H, 1995, J AM GERIATR SOC, V43, P871, DOI 10.1111/j.1532-5415.1995.tb05529.x; MARCUS FI, 1983, AM HEART J, V106, P924, DOI 10.1016/0002-8703(83)90017-0; MICKEY RM, 1989, AM J EPIDEMIOL, V129, P125, DOI 10.1093/oxfordjournals.aje.a115101; Nagata H, 2007, IND HEALTH, V45, P462, DOI 10.2486/indhealth.45.462; Nagurney J T, 1998, J Emerg Med, V16, P709, DOI 10.1016/S0736-4679(98)00083-3; NEVITT MC, 1993, J AM GERIATR SOC, V41, P1226, DOI 10.1111/j.1532-5415.1993.tb07307.x; O'Mahony D, 1998, J GERONTOL A-BIOL, V53, pM435, DOI 10.1093/gerona/53A.6.M435; Ojha HA, 2009, PHYS THER, V89, P1080, DOI 10.2522/ptj.20080187; Palvanen M, 2000, OSTEOPOROSIS INT, V11, P822, DOI 10.1007/s001980070040; Ramanathan DM, 2012, J NEUROTRAUM, V29, P1371, DOI 10.1089/neu.2011.2197; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Reid SM, 2011, GAIT POSTURE, V34, P529, DOI 10.1016/j.gaitpost.2011.07.008; Robinovitch SN, 2000, J BIOMECH, V33, P863, DOI 10.1016/S0021-9290(00)00025-7; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sandler R, 2001, J BIOMECH ENG-T ASME, V123, P590, DOI 10.1115/1.1408940; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Srivastava A, 2006, BRAIN INJURY, V20, P1377, DOI 10.1080/02699050601111385; Startzell JK, 2000, J AM GERIATR SOC, V48, P567, DOI 10.1111/j.1532-5415.2000.tb05006.x; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Stevens JA, 2001, JAMA-J AM MED ASSOC, V286, P2665, DOI 10.1001/jama.286.21.2665; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thomas KE, 2008, J SAFETY RES, V39, P269, DOI 10.1016/j.jsr.2008.05.001; Tinetti M, 1988, NEW ENGL J MED, V319, P927; TOPPER AK, 1993, J AM GERIATR SOC, V41, P479, DOI 10.1111/j.1532-5415.1993.tb01881.x; US Census Bureau, 2008, AM DIS 2005; Verghese J, 2008, ARCH PHYS MED REHAB, V89, P100, DOI 10.1016/j.apmr.2007.08.129; WHO/IASO/IOTF, 2000, AS PAC PERSP RED OB; Yu WY, 2013, ACCIDENT ANAL PREV, V50, P887, DOI 10.1016/j.aap.2012.07.015	49	18	18	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					E9	E17		10.1097/HTR.0000000000000093			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300002	25629257				2022-02-06	
J	Munoz-Bendix, C; Beseoglu, K; Kram, R				Munoz-Bendix, Christopher; Beseoglu, Kerim; Kram, Rainer			Extracorporeal decarboxylation in patients with severe traumatic brain injury and ARDS enables effective control of intracranial pressure	CRITICAL CARE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; CEREBRAL AUTOREGULATION; VENTILATION; ASSIST; PERFUSION; REMOVAL	Introduction: Acute respiratory distress syndrome (ARDS) with concomitant impairment of oxygenation and decarboxylation represents a complex problem in patients with increased intracranial pressure (ICP). Permissive hypercapnia is not an option to obtain and maintain lung-protective ventilation in the presence of elevated ICP. Pumpless extracorporeal lung assist (pECLA) devices (iLA Membrane Ventilator; Novalung, Heilbronn, Germany) can improve decarboxylation without aggravation associated with invasive ventilation. In this pilot series, we analyzed the safety and efficacy of pECLA in patients with ARDS and elevated ICP after severe traumatic brain injury (TBI). Methods: The medical records of ten patients (eight male, two female) with severe ARDS and severe TBI concurrently managed with external ventricular drainage in the neurointensive care unit (NICU) were retrospectively analyzed. The effect of pECLA on enabling lung-protective ventilation was evaluated using the difference between plateau pressure and positive end-expiratory pressure, defined as driving pressure (Delta P), during the 3 days preceding the implant of pECLA devices until 3 days afterward. The ICP threshold was set at 20 mmHg. To evaluate effects on ICP, the volume of daily cerebrospinal fluid (CSF) drainage needed to maintain the set ICP threshold was compared pre- and postimplant. Results: The Delta P values after pECLA implantation decreased from a mean 17.1 +/- 0.7 cm/H2O to 11.9 +/- 0.5 cm/H2O (p = 0.011). In spite of this improved lung-protective ventilation, carbon dioxide pressure decreased from 46.6 +/- 3.9 mmHg to 39.7 +/- 3.5 mmHg (p = 0.005). The volume of daily CSF drainage needed to maintain ICP at 20 mmHg decreased significantly from 141.5 +/- 103.5 ml to 62.2 +/- 68.1 ml (p = 0.037). Conclusions: For selected patients with concomitant severe TBI and ARDS, the application of pECLA is safe and effective. pECLA devices improve decarboxylation, thus enabling lung-protective ventilation. At the same time, potentially detrimental hypercapnia that may increase ICP is avoided. Larger prospective trials are warranted to further elucidate application of pECLA devices in NICU patients.	[Munoz-Bendix, Christopher; Beseoglu, Kerim] Univ Dusseldorf, Fac Med, Dept Neurosurg, D-40225 Dusseldorf, Germany; [Kram, Rainer] Univ Dusseldorf, Fac Med, Dept Anesthesiol, D-40225 Dusseldorf, Germany		Kram, R (corresponding author), Univ Dusseldorf, Fac Med, Dept Anesthesiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	kram@med.uni-duesseldorf.de	Munoz-Bendix, Christopher/A-1943-2014	Munoz-Bendix, Christopher/0000-0002-2414-2463			Amato MBP, 2015, NEW ENGL J MED, V372, P747, DOI 10.1056/NEJMsa1410639; [Anonymous], 1971, JAMA, V215, P277; Bein T, 2006, CRIT CARE MED, V34, P1372, DOI 10.1097/01.CCM.0000215111.85483.BD; Bein T, 2002, INTENS CARE MED, V28, P554, DOI 10.1007/s00134-002-1273-y; Bein T, 2005, J TRAUMA, V58, P1294, DOI 10.1097/01.TA.0000173275.06947.5C; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Fanelli V, 2013, J THORAC DIS, V5, P326, DOI 10.3978/j.issn.2072-1439.2013.04.05; Haitsma JJ, 2006, MINERVA ANESTESIOL, V72, P117; HARPER AM, 1966, J NEUROL NEUROSUR PS, V29, P398, DOI 10.1136/jnnp.29.5.398; HICKLING KG, 1990, INTENS CARE MED, V16, P372, DOI 10.1007/BF01735174; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Huynh T, 2002, J TRAUMA, V53, P488, DOI 10.1097/00005373-200209000-00016; Kreyer S, 2013, J NEUROSURG ANESTH, V25, P324, DOI 10.1097/ANA.0b013e3182905e6a; Liebold A, 2000, EUR J CARDIO-THORAC, V17, P608, DOI 10.1016/S1010-7940(00)00389-4; Mallick A, 2007, ANAESTHESIA, V62, P72, DOI 10.1111/j.1365-2044.2006.04863.X; Meng LZ, 2015, ANESTHESIOLOGY, V122, P196, DOI 10.1097/ALN.0000000000000506; Muellenbach RM, 2012, J TRAUMA ACUTE CARE, V72, P1444, DOI 10.1097/TA.0b013e31824d68e3; Petrucci N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003844.pub4; Putensen C, 2009, ANN INTERN MED, V151, P566, DOI 10.7326/0003-4819-151-8-200910200-00011; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rincon F, 2012, NEUROSURGERY, V71, P795, DOI 10.1227/NEU.0b013e3182672ae5; Severdija EE, 2015, MED BIOL ENG COMPUT, V53, P195, DOI 10.1007/s11517-014-1225-z; Slutsky AS, 2013, NEW ENGL J MED, V369, P2126, DOI 10.1056/NEJMra1208707; Villar J, 2006, CRIT CARE MED, V34, P1311, DOI 10.1097/01.CCM.0000215598.84885.01; Vincent JL, 2002, CHEST, V121, P1602, DOI 10.1378/chest.121.5.1602; Wheeler AP, 2007, LANCET, V369, P1553, DOI 10.1016/S0140-6736(07)60604-7	28	18	21	0	3	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	OCT 30	2015	19								381	10.1186/s13054-015-1088-1			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU7WT	WOS:000363753200001	26518584	Green Published, gold			2022-02-06	
J	Frieler, RA; Nadimpalli, S; Boland, LK; Xie, A; Kooistra, LJ; Song, JR; Chung, YT; Cho, KW; Lumeng, CN; Wang, MM; Mortensen, RM				Frieler, Ryan A.; Nadimpalli, Sameera; Boland, Lauren K.; Xie, Angela; Kooistra, Laura J.; Song, Jianrui; Chung, Yutein; Cho, Kae W.; Lumeng, Carey N.; Wang, Michael M.; Mortensen, Richard M.			Depletion of macrophages in CD11b diphtheria toxin receptor mice induces brain inflammation and enhances inflammatory signaling during traumatic brain injury	BRAIN RESEARCH			English	Article						Macrophage depletion; CD11b-DTR; Traumatic brain injury; Inflammation	TISSUE LOSS; RECOVERY; ACTIVATION; MECHANISMS; ABLATION; DISTINCT; REPAIR; EDEMA; CELLS; STATE	Immune cells have important roles during disease and are known to contribute to secondary, inflammation-induced injury after traumatic brain injury. To delineate the functional role of macrophages during traumatic brain injury, we depleted macrophages using transgenic CD11b-DTR mice and subjected them to controlled cortical impact. We found that macrophage depletion had no effect on lesion size assessed by T2-weighted MRI scans 28 days after injury. Macrophage depletion resulted in a robust increase in proinflammatory gene expression in both the ipsilateral and contralateral hemispheres after controlled cortical impact. Interestingly, this sizeable increase in inflammation did not affect lesion development. We also showed that macrophage depletion resulted in increased proinflammatory gene expression in the brain and kidney in the absence of injury. These data demonstrate that depletion of macrophages in CD11b-DTR mice can significantly modulate the inflammatory response during brain injury without affecting lesion formation. These data also reveal a potentially confounding inflammatory effect in CD11b-DTR mice that must be considered when interpreting the effects of macrophage depletion in disease models. (C) 2015 Elsevier B.V. All rights reserved.	[Frieler, Ryan A.; Nadimpalli, Sameera; Boland, Lauren K.; Xie, Angela; Kooistra, Laura J.; Song, Jianrui; Chung, Yutein; Lumeng, Carey N.; Wang, Michael M.; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Med Sci 2 7708, Ann Arbor, MI 48109 USA; [Frieler, Ryan A.; Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Cho, Kae W.; Lumeng, Carey N.] Univ Michigan, Sch Med, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Univ Michigan, Sch Med, Dept Neurol, Ann Arbor, MI 48109 USA; [Wang, Michael M.] Vet Adm Ann Arbor Healthcare Syst, Dept Neurol, Ann Arbor, MI 48105 USA; [Mortensen, Richard M.] Univ Michigan, Sch Med, Dept Internal Med, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA		Mortensen, RM (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Med Sci 2 7708, 1137 E Catherine St, Ann Arbor, MI 48109 USA.	rmort@umich.edu		Frieler, Ryan/0000-0003-2780-3244; Boland, Lauren/0000-0003-1324-5827	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL112610, NS077780]; American Heart AssociationAmerican Heart Association [12GRNT11890006]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL112610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS077780] Funding Source: NIH RePORTER	This study was supported by National Institutes of Health Grant HL112610 and American Heart Association Grant-in-Aid 12GRNT11890006 to R.M.M., and National Institutes of Health fellowship NS077780 to R.A.F.	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Bennett R.E., 2014, J NEUROTRAUMA; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Cailhier JF, 2005, J IMMUNOL, V174, P2336, DOI 10.4049/jimmunol.174.4.2336; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ferreira L.C.B., 2014, BRAIN INJURY, P1; Gliem M, 2012, ANN NEUROL, V71, P743, DOI 10.1002/ana.23529; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hsieh C. L., 2014, J NEUROTRAUMA; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Lu L, 2012, AM J NEPHROL, V35, P181, DOI 10.1159/000335582; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Ponomarev ED, 2007, J NEUROSCI, V27, P10714, DOI 10.1523/JNEUROSCI.1922-07.2007; Popovich PG, 1999, EXP NEUROL, V158, P351, DOI 10.1006/exnr.1999.7118; Quintana A, 2007, J NEUROSCI RES, V85, P2668, DOI 10.1002/jnr.21126; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Skardelly M, 2011, J NEUROTRAUM, V28, P401, DOI 10.1089/neu.2010.1526; Tehranian R, 2002, J NEUROTRAUM, V19, P939, DOI 10.1089/089771502320317096; Tittel AP, 2012, NAT METHODS, V9, P385, DOI [10.1038/NMETH.1905, 10.1038/nmeth.1905]; Ueno M, 2013, NAT NEUROSCI, V16, P543, DOI 10.1038/nn.3358; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Zandbergen HR, 2009, J CARDIOVASC PHARM T, V14, P68, DOI 10.1177/1074248408329860	30	18	18	0	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 22	2015	1624						103	112		10.1016/j.brainres.2015.07.011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CW5PY	WOS:000365050100011	26208897	Green Accepted			2022-02-06	
J	Sebastiani, A; Golz, C; Werner, C; Schafer, MKE; Engelhard, K; Thal, SC				Sebastiani, Anne; Goelz, Christina; Werner, Christian; Schaefer, Michael K. E.; Engelhard, Kristin; Thal, Serge C.			Proneurotrophin Binding to P75 Neurotrophin Receptor (P75ntr) Is Essential for Brain Lesion Formation and Functional Impairment after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						BDNF; CCI; neurotrophins; NGF; p75NTR; TBI; traumatic brain injury	FOCAL CEREBRAL-ISCHEMIA; IN-VIVO; PROTEIN TRANSDUCTION; NEURONAL APOPTOSIS; NERVOUS-SYSTEM; CELL-SURVIVAL; SPINAL-CORD; P75(NTR); DEATH; MICE	Traumatic brain injury (TBI) initiates an excessive mediator release of e.g. neurotrophins, which promote neuronal survival, differentiation, and modulate synaptic plasticity. Paradoxically, mature forms of neurotrophins promote neuronal survival, whereas unprocessed forms of neurotrophins induce cell death through p75 neurotrophin receptor (p75NTR) signaling. p75NTR is widely expressed during synaptogenesis and is subsequently downregulated in adulthood. Repair mechanisms after acute cerebral insults can reactivate its expression. Therefore, the influence of p75NTR on secondary brain damage was addressed. mRNA levels of p75NTR and its ligands were quantified in brain tissue up to 7 days after experimental TBI (controlled cortical impact; CCI). Brain damage, motor function and inflammatory marker gene expression were determined in mice lacking the proneurotrophin-binding site of the p75NTR protein (NGFR(-/-)) and wild type littermates (NGFR(+/+)) 24h and 5 days after CCI. In addition, the effect of TAT-Pep5 (pharmacological inhibitor of the intracellular p75NTR death domain) on lesion volume was evaluated 24h after insult. p75NTR mRNA levels were induced nine-fold by TBI. In NGFR(-/-) mice, lesion volume was reduced by 29% at 24h and by 21% 5 days after CCI. Motor coordination was significantly improved 24h after trauma compared with the wild type. Pharmacological inhibition of the p75NTR signaling reduced lesion volume by 18%. The present study presents first time evidence that genetic mutation of the neurotrophin interaction site of p75NTR strongly limits post-traumatic cell death. In addition, we revealed pharmacological targeting of the intracellular p75NTR cell death domain as a promising approach to limit acute brain damage.	[Sebastiani, Anne; Goelz, Christina; Werner, Christian; Schaefer, Michael K. E.; Engelhard, Kristin; Thal, Serge C.] Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, D-55131 Mainz, Germany		Thal, SC (corresponding author), Johannes Gutenberg Univ Mainz, Dept Anesthesiol, Univ Med Ctr, Langenbeckstr 1, D-55131 Mainz, Germany.	thal@uni-mainz.de	Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Schafer, Michael K.E./0000-0001-6055-6244	Federal Ministry of Education and ResearchFederal Ministry of Education & Research (BMBF) [BMBF 01EO1003]; German Research Foundation (DFG)German Research Foundation (DFG) [TH1430/3-1, CRC1080/A9]; Focus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University; Johannes Gutenberg-University	This work was supported by the Federal Ministry of Education and Research (BMBF 01EO1003) to SCT, by the German Research Foundation (DFG) to SCT (TH1430/3-1) and KE (CRC1080/A9), by the Focus Program Translational Neurosciences (FTN) of the Johannes Gutenberg-University and Stage 1 funding of the Johannes Gutenberg-University to AS, MKES and SCT. Some data presented in this article are part of the doctoral thesis presented by CG to the Faculty of Veterinary Medicine of the Justus-Liebig-University Giessen, Germany.	Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Dietz GPH, 2002, MOL CELL NEUROSCI, V21, P29, DOI 10.1006/mcne.2002.1165; Ettinger K, 2012, CELL SIGNAL, V24, P2378, DOI 10.1016/j.cellsig.2012.08.008; Giehl KM, 2001, J NEUROSCI, V21, P3492, DOI 10.1523/JNEUROSCI.21-10-03492.2001; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Heese K, 1998, J NEUROCHEM, V70, P699; Ilag LL, 1999, BIOCHEM BIOPH RES CO, V255, P104, DOI 10.1006/bbrc.1999.0101; Irmady K, 2014, J NEUROSCI, V34, P3419, DOI 10.1523/JNEUROSCI.1982-13.2014; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Kilic E, 2002, ANN NEUROL, V52, P617, DOI 10.1002/ana.10356; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Knowles JK, 2009, J NEUROSCI, V29, P10627, DOI 10.1523/JNEUROSCI.0620-09.2009; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lebrun-Julien F, 2010, P NATL ACAD SCI USA, V107, P3817, DOI 10.1073/pnas.0909276107; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; Luh C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019948; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mysona BA, 2013, DIABETOLOGIA, V56, P2329, DOI 10.1007/s00125-013-2998-6; Nakamura M, 1999, J CEREBR BLOOD F MET, V19, P762, DOI 10.1097/00004647-199907000-00006; Nguyen TVV, 2014, J ALZHEIMERS DIS, V42, P459, DOI 10.3233/JAD-140036; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Ohlmann C. R., 2010, J NEUROCHEM, V112, P1015; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Otten U, 2000, ANN NY ACAD SCI, V917, P322; Park KJ, 2010, NAT NEUROSCI, V13, P559, DOI 10.1038/nn.2513; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Roux PP, 1999, J NEUROSCI, V19, P6887, DOI 10.1523/JNEUROSCI.19-16-06887.1999; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shi J, 2013, STEM CELLS, V31, P2561, DOI 10.1002/stem.1516; Shulga A, 2013, NEUROSCIENCE, V239, P241, DOI 10.1016/j.neuroscience.2012.12.007; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Shulga A, 2012, J NEUROSCI, V32, P1757, DOI 10.1523/JNEUROSCI.3282-11.2012; Singh KK, 2008, NAT NEUROSCI, V11, P649, DOI 10.1038/nn.2114; Skeldal S, 2012, J BIOL CHEM, V287, P43798, DOI 10.1074/jbc.M112.374710; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Thal SC, 2013, CRIT CARE MED, V41, P1305, DOI 10.1097/CCM.0b013e31827ca494; Timaru-Kast R, 2012, CRIT CARE MED, V40, P935, DOI 10.1097/CCM.0b013e31822f08b9; Uesugi N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.83; Underwood CK, 2008, INT J BIOCHEM CELL B, V40, P1664, DOI 10.1016/j.biocel.2007.06.010; Volosin M, 2008, J NEUROSCI, V28, P9870, DOI 10.1523/JNEUROSCI.2841-08.2008; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Widenfalk J, 2001, J NEUROSCI, V21, P3457, DOI 10.1523/JNEUROSCI.21-10-03457.2001; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	50	18	19	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1599	1607		10.1089/neu.2014.3751			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500008	25879397				2022-02-06	
J	Van Beek, L; Ghesquiere, P; Lagae, L; De Smedt, B				Van Beek, Leen; Ghesquiere, Pol; Lagae, Lieven; De Smedt, Bert			Mathematical Difficulties and White Matter Abnormalities in Subacute Pediatric Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						corpus callosum; diffusion tensor imaging; mathematical difficulties; mild traumatic brain injury; pediatrics	TENSOR IMAGING DETECTS; DIFFUSE AXONAL INJURY; WORKING-MEMORY; CORPUS-CALLOSUM; INDIVIDUAL-DIFFERENCES; SHORT-TERM; COGNITIVE DYSFUNCTION; ACADEMIC-ACHIEVEMENT; EXECUTIVE FUNCTIONS; WATER DIFFUSION	Mathematical difficulties have been documented following pediatric mild traumatic brain injury (mTBI), yet a precise characterization of these impairments and their neural correlates is currently unavailable. We aimed to characterize these impairments by comparing behavioral and neuroimaging (i.e., diffusion tensor imaging [DTI]) outcomes from children with subacute mTBI to typically-developing controls. Twenty subacute pediatric mTBI patients and 20 well-matched controls underwent cognitive assessment and DTI examination. DTI tractography was used to detect white matter abnormalities in the corpus callosum (CC) and superior and inferior longitudinal fasciculi; these tracts are involved in mathematical performance and they are often damaged after mTBI. Behavioral results revealed that children with mTBI performed significantly more poorly on rapid apprehension of small numbers of objects (or subitizing), processing of non-symbolic numerosities, and procedural problem solving. These group differences were explained by differences in visuospatial working memory, which suggests that the observed mathematical difficulties may be a consequence of impairments in visuospatial abilities. DTI analysis revealed subtle group differences in the CC genu and splenium (i.e., higher fractional anisotropy and lower mean and radial diffusivity in children with mTBI) but the observed white matter abnormalities of the CC were not significantly associated with the observed mathematical difficulties in the mTBI patients.	[Van Beek, Leen; Ghesquiere, Pol; De Smedt, Bert] Univ Leuven, Parenting & Special Educ Res Unit, Leuven, Belgium; [Lagae, Lieven] Univ Leuven, Dept Dev & Regenerat, Leuven, Belgium		De Smedt, B (corresponding author), Parenting & Special Educ Res Unit, Leopold Vanderkelenstr 32,Box 3765, B-3000 Leuven, Belgium.	Bert.DeSmedt@ppw.kuleuven.be	De Smedt, Bert/U-6124-2019; Ghesquiere, Pol/B-9226-2009; De Smedt, Bert/G-4729-2010; De Smedt, Bert/Q-7020-2019	De Smedt, Bert/0000-0002-3313-3278; Ghesquiere, Pol/0000-0001-9056-7550; De Smedt, Bert/0000-0002-3313-3278; 	"Research Foundation Flanders" FWOFWO [G.0359.10]	This research was supported by the "Research Foundation Flanders" FWO (grant number G.0359.10). We thank the children and their families for their time and contribution to this study.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2009, BRAIN, V132, P45, DOI 10.1093/brain/awn293; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, PEDIATR NEUROL, V41, P406, DOI 10.1016/j.pediatrneurol.2009.06.002; Barnea-Goraly N, 2005, COGNITIVE BRAIN RES, V25, P735, DOI 10.1016/j.cogbrainres.2005.09.013; Barnes M. A., 2010, PEDIAT NEUROPSYCHOLO, P297; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Berch DB, 2005, J LEARN DISABIL-US, V38, P333, DOI 10.1177/00222194050380040901; BERGERGROSS P, 1985, PERCEPT MOTOR SKILL, V61, P254, DOI 10.2466/pms.1985.61.1.254; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bohnert AM, 1997, DEV NEUROPSYCHOL, V13, P477, DOI 10.1080/87565649709540688; Booth RDL., 2000, J MATH BEHAV, V18, P169, DOI [10.1016/S0732-3123(99)00027-9, DOI 10.1016/S0732-3123(99)00027-9]; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; Cantlon JF, 2011, LEARN INDIVID DIFFER, V21, P672, DOI 10.1016/j.lindif.2011.09.003; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Cohen J., 2013, STAT POWER ANAL BEHA; Concha L., 2008, P 16 ANN M INT SOC M, P566; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; De Smedt B, 2013, TRENDS NEUROSCI EDUC, V2, P48, DOI 10.1016/j.tine.2013.06.001; De Smedt B, 2009, DEV DISABIL RES REV, V15, P4, DOI 10.1002/ddrr.44; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P186, DOI 10.1016/j.jecp.2009.01.004; Dowker A, 2008, DEVELOPMENTAL SCI, V11, P650, DOI 10.1111/j.1467-7687.2008.00713.x; Dudal P., 2000, LEERLINGVOLGSYSTEEM; Dumontheil I, 2012, CEREB CORTEX, V22, P1078, DOI 10.1093/cercor/bhr175; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Galloway NR, 2008, J NEUROTRAUM, V25, P1153, DOI 10.1089/neu.2007.0494; Gathercole, 2003, ED CHILD PSYCHOL, V20 (3), P123; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Geary DC, 2007, CHILD DEV, V78, P1343, DOI 10.1111/j.1467-8624.2007.01069.x; Gerardi K, 2013, P NATL ACAD SCI USA, V110, P11267, DOI 10.1073/pnas.1220568110; Gorman S, 2012, J INT NEUROPSYCH SOC, V18, P29, DOI 10.1017/S1355617711001251; Gray SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094428; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hanten G, 2008, NEUROPSYCHOLOGY, V22, P357, DOI 10.1037/0894-4105.22.3.357; Hellgren K, 2013, DEV MED CHILD NEUROL, V55, P1109, DOI 10.1111/dmcn.12206; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hubber PJ, 2014, Q J EXP PSYCHOL, V67, P936, DOI 10.1080/17470218.2013.838590; Huisman TAGM, 2001, RADIOLOGE, V41, P1038, DOI 10.1007/s001170170003; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Johnson AR, 2009, DEV DISABIL RES REV, V15, P124, DOI 10.1002/ddrr.63; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kort W., 2005, WISC 3 NL WECHSLER I; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2010, ALCOHOL CLIN EXP RES, V34, P354, DOI 10.1111/j.1530-0277.2009.01097.x; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; LeFevre JA, 1996, J EXP PSYCHOL GEN, V125, P284, DOI 10.1037/0096-3445.125.3.284; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2009, RADIOLOGY, V252, P816, DOI 10.1148/radiol.2523081584; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Matejko AA, 2013, NEUROIMAGE, V66, P604, DOI 10.1016/j.neuroimage.2012.10.045; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; Miles L, 2008, BRAIN INJURY, V22, P115, DOI 10.1080/02699050801888816; Mori S., 2007, INTRO DIFFUSION TENS; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Hearn K, 2011, VIS COGN, V19, P289, DOI 10.1080/13506285.2010.535994; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Parizel PM, 2005, EUR RADIOL, V15, P569, DOI 10.1007/s00330-004-2558-z; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pickering S., 2001, WORKING MEMORY BATTE; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rasmussen C, 2005, J EXP CHILD PSYCHOL, V91, P137, DOI 10.1016/j.jecp.2005.01.004; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; REUHKALA M, 2001, EDUC PSYCHOL-US, V21, P387, DOI DOI 10.1080/01443410120090786; Reyna VF, 2009, PSYCHOL BULL, V135, P943, DOI 10.1037/a0017327; Rosenblum WI, 2007, J NEUROPATH EXP NEUR, V66, P771, DOI 10.1097/nen.0b013e3181461965; Rotzer S, 2008, NEUROIMAGE, V39, P417, DOI 10.1016/j.neuroimage.2007.08.045; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Rykhlevskaia E, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.051.2009; Salmond CH, 2006, NEUROPSYCHOLOGIA, V44, P1995, DOI 10.1016/j.neuropsychologia.2006.03.013; Sattler J.M., 2001, ASSESSMENT CHILDREN; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Schwartz ED, 2005, NEUROREPORT, V16, P73, DOI 10.1097/00001756-200501190-00017; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Short SJ, 2013, NEUROIMAGE, V64, P156, DOI 10.1016/j.neuroimage.2012.09.021; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Spain A, 2010, J NEUROTRAUM, V27, P1429, DOI 10.1089/neu.2010.1288; Staal JA, 2011, J NEUROTRAUM, V28, P841, DOI 10.1089/neu.2010.1658; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Takahashi M, 2002, P NATL ACAD SCI USA, V99, P16192, DOI 10.1073/pnas.252249999; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Till C, 2011, NEUROREPORT, V22, P1005, DOI 10.1097/WNR.0b013e32834dc301; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Treit S, 2014, NEUROSCIENCE, V276, P87, DOI 10.1016/j.neuroscience.2013.12.019; Trick LM, 2008, PERCEPT PSYCHOPHYS, V70, P743, DOI 10.3758/PP.70.5.743; Tsang JM, 2009, P NATL ACAD SCI USA, V106, P22546, DOI 10.1073/pnas.0906094106; van Dijck JP, 2009, COGNITION, V113, P248, DOI 10.1016/j.cognition.2009.08.005; van Eimeren L, 2010, NEUROIMAGE, V52, P358, DOI 10.1016/j.neuroimage.2010.04.001; van Eimeren L, 2008, NEUROREPORT, V19, P1117, DOI 10.1097/WNR.0b013e328307f5c1; Vandermosten M, 2013, NEUROPSYCHOLOGIA, V51, P2087, DOI 10.1016/j.neuropsychologia.2013.07.008; Vandermosten M, 2012, BRAIN, V135, P935, DOI 10.1093/brain/awr363; Vos SB, 2012, NEUROIMAGE, V59, P2208, DOI 10.1016/j.neuroimage.2011.09.086; Vos SB, 2011, NEUROIMAGE, V55, P1566, DOI 10.1016/j.neuroimage.2011.01.048; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P319, DOI 10.1007/s11682-012-9174-3; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu QZ, 2007, NEUROIMAGE, V37, P1138, DOI 10.1016/j.neuroimage.2007.06.029; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2003, HDB REY OSTERRIETH C, P83; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; [No title captured]	148	18	18	0	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1567	1578		10.1089/neu.2014.3809			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500004	25915107				2022-02-06	
J	Taylor, JM; Montgomery, MH; Gregory, EJ; Berman, NEJ				Taylor, Jordan M.; Montgomery, Mitchell H.; Gregory, Eugene J.; Berman, Nancy E. J.			Exercise preconditioning improves traumatic brain injury outcomes	BRAIN RESEARCH			English	Article						Exercise; Traumatic brain injury; Sensorimotor function; Cognitive function; Vascular endothelial growth factor; Erythropoietin	REAL-TIME PCR; HEME OXYGENASE-1; MOUSE MODEL; HIPPOCAMPAL NEUROGENESIS; HUNTINGTONS-DISEASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; PHYSICAL-ACTIVITY; TRANSGENIC MICE; OLDER-ADULTS	Purpose: To determine whether 6 weeks of exercise performed prior to traumatic brain injury (TBI) could improve post-TBI behavioral outcomes in mice, and if exercise increases neuroprotective molecules (vascular endothelial growth factor-A [VEGF-A], erythropoietin [EPO], and heme oxygenase-1 [HO-1]) in brain regions responsible for movement (sensorimotor cortex) and memory (hippocampus). Methods: 120 mice were randomly assigned to one of four groups: (1) no exercise+no TBI (NOEX-NOTBI [n=301]), (2) no exercise+TBI (NOEX-TBI [n=30]), (3) exercise+no TBI (EX-NOTBI [n=30]), and (4) exercise+TBI (EX-TBI [n=301). The gridwalk task and radial arm water maze were used to evaluate sensorimotor and cognitive function, respectively. Quantitative real time polymerase chain reaction and immunostaining were performed to investigate VEGF-A, EPO, and HO-1 mRNA and protein expression in the right cerebral cortex and ipsilateral hippocampus. Results: EX-TBI mice displayed reduced post-TBI.sensorimotor and cognitive deficits when compared to NOEX-TBI mice. EX-NOTBI and EX-TBI mice showed elevated VEGF-A and EPO mRNA in the cortex and hippocampus, and increased VEGF-A and EPO staining of sensorimotor cortex neurons 1 day post-TBI and/or post-exercise. EX-TBI mice also exhibited increased VEGF-A staining of hippocampal neurons 1 day post-TBI/post-exercise. NOEX-TBI mice demonstrated increased HO-1 mRNA in the cortex (3 days post-TBI) and hippocampus (3 and 7 days post-TBI), but HO-1 was not increased in mice that exercised. Conclusions: Improved TBI outcomes following exercise preconditioning are associated with increased expression of specific neuroprotective genes and proteins (VEGF-A and EPO, but not HO-1) in the brain. (C) 2015 Elsevier B.V. All rights reserved.	[Taylor, Jordan M.; Montgomery, Mitchell H.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66160 USA; [Gregory, Eugene J.; Berman, Nancy E. J.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA		Berman, NEJ (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Mailstop 3038,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	NBERMAN@kumc.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 AG31140, P20 GM103418]; University of Kansas Alzheimer's Disease Center [P30 AG035982]; Landon Center on Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P30HD002528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG031140, P30AG035982] Funding Source: NIH RePORTER	This project was supported by the National Institutes of Health under grant numbers (RO1 AG31140) and (P20 GM103418). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. This work was also supported by an award from the University of Kansas Alzheimer's Disease Center (P30 AG035982) and the Landon Center on Aging. The authors acknowledge the assistance of Lisa Stehno-Bittel (manuscript editing), Stanton Fernald (graphical design), and Jo Wick (statistical support).	Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Alamed J, 2006, NAT PROTOC, V1, P1671, DOI 10.1038/nprot.2006.275; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Anderson J, 2009, J NEUROTRAUM, V26, P1557, DOI 10.1089/neu.2008-0765; Aztatzi-Santillan Emmanuel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P310; Bae JW, 2010, NEUROL SCI, V31, P307, DOI 10.1007/s10072-010-0216-6; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Burns JM, 2008, ALZ DIS ASSOC DIS, V22, P39, DOI 10.1097/WAD.0b013e31815a9ddc; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Cotman CW, 2002, TRENDS NEUROSCI, V25, P295, DOI 10.1016/S0166-2236(02)02143-4; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; FUKUDA K, 1995, NEUROSCI LETT, V199, P127, DOI 10.1016/0304-3940(95)12042-3; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gonzalez FF, 2007, DEV NEUROSCI-BASEL, V29, P321, DOI 10.1159/000105473; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Hildebrandt AL, 2003, AM J PHYSIOL-ENDOC M, V285, pE1021, DOI 10.1152/ajpendo.00234.2003; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Krum JM, 2003, EXP NEUROL, V181, P241, DOI 10.1016/S0014-4886(03)00039-6; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Lin TK, 2014, INT J MOL SCI, V15, P1625, DOI 10.3390/ijms15011625; Lista I, 2010, CELL MOL NEUROBIOL, V30, P493, DOI 10.1007/s10571-009-9488-x; Ma YW, 2013, INT J MOL SCI, V14, P8570, DOI 10.3390/ijms14048570; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mota BC, 2012, NEUROTOX RES, V21, P175, DOI 10.1007/s12640-011-9257-8; Neubauer JA, 2012, RESP PHYSIOL NEUROBI, V184, P178, DOI 10.1016/j.resp.2012.06.027; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Nichol KE, 2007, BEHAV BRAIN RES, V184, P124, DOI 10.1016/j.bbr.2007.06.027; Olenich SA, 2013, J PHYSIOL-LONDON, V591, P5157, DOI 10.1113/jphysiol.2013.254979; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Onyszchuk G, 2007, J NEUROSCI METH, V160, P187, DOI 10.1016/j.jneumeth.2006.09.007; Pang TYC, 2006, NEUROSCIENCE, V141, P569, DOI 10.1016/j.neuroscience.2006.04.013; Parachikova A, 2008, NEUROBIOL DIS, V30, P121, DOI 10.1016/j.nbd.2007.12.008; Petzinger GM, 2007, J NEUROSCI, V27, P5291, DOI 10.1523/JNEUROSCI.1069-07.2007; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Ponce Lucido L, 2013, Pathophysiology, V20, P31, DOI 10.1016/j.pathophys.2012.02.005; Querido JS, 2007, SPORTS MED, V37, P765, DOI 10.2165/00007256-200737090-00002; Saaksjarvi K, 2014, EUR J EPIDEMIOL, V29, P285, DOI 10.1007/s10654-014-9887-2; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Skold MK, 2006, EUR J NEUROSCI, V23, P21, DOI 10.1111/j.1460-9568.2005.04527.x; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Thompson D, 2005, FREE RADICAL RES, V39, P63, DOI 10.1080/10715760400022327; Tillerson JL, 2003, NEUROSCIENCE, V119, P899, DOI 10.1016/S0306-4522(03)00096-4; van Dellen A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-34; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Viboolvorakul S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/230791; Wahl P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096024; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Zhao J, 2007, J NEUROSCI, V27, P10240, DOI 10.1523/JNEUROSCI.1683-07.2007	60	18	19	5	32	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	OCT 5	2015	1622						414	429		10.1016/j.brainres.2015.07.009			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CS4OC	WOS:000362054100040	26165153	Green Accepted			2022-02-06	
J	Moss, JA; Moore, RL; Selleck, CS				Moss, Jacqueline A.; Moore, Randy L.; Selleck, Cynthia S.			Veteran Competencies for Undergraduate Nursing Education	ADVANCES IN NURSING SCIENCE			English	Article						competencies; curricula; Nursing Education; Veterans; Veterans Health		Military Veterans comprise approximately 10% of the US population. Most Veterans do not receive their health care through Veterans Affairs facilities, are seen across the health care system, and their prior military service and associated health issues often go unrecognized. In this study, a modified Delphi design was used to develop a set of 10 Veteran Care Competencies and associated knowledge, skills, and attitudes for Undergraduate Nursing Education: Military and Veteran Culture, Post Traumatic Stress Disorder, Amputation and Assistive Devices, Environmental/Chemical Exposures, Substance Use Disorder, Military Sexual Trauma, Traumatic Brain Injury, Suicide, Homelessness, and Serious Illness Especially at the End of Life.	[Moss, Jacqueline A.] Dept Acute Chron & Continuing Care, Birmingham, AL USA; [Moore, Randy L.] Univ Alabama Birmingham, Sch Nursing, 1720 2nd Ave S, Birmingham, AL 35294 USA; [Moore, Randy L.] Birmingham Vet Affairs Med Ctr, VA Nursing Acad Partnership, Birmingham, AL USA; [Selleck, Cynthia S.] Univ Alabama Birmingham, Sch Nursing, Clin & Global Partnerships, Birmingham, AL 35294 USA		Moss, JA (corresponding author), Univ Alabama Birmingham, Sch Nursing, 1720 2nd Ave S, Birmingham, AL 35294 USA.	mossja@uab.edu			Office of Academic Affiliations through the Veterans Affairs Nursing Academy	This publication was supported in part by the Office of Academic Affiliations through the Veterans Affairs Nursing Academy, a partnership between the Birmingham Veterans Affairs Medical Center and the University of Alabama at Birmingham School of Nursing.	American-Nurses-Association, 2010, NURS SCOP STAND PRAC; Brown R, 2010, TEACH LEARN NURS, V5, P115, DOI 10.1016/j.teln.2010.02.005; Charan R, 2007, 6 PERSONALITY TRAITS; Cronenwett L, 2007, NURS OUTLOOK, V55, P122, DOI 10.1016/j.outlook.2007.02.006; Institute of Medicine, 2003, HLTH PROFESSIONS ED; Jackson JJ, 2012, PSYCHOL SCI, V23, P270, DOI 10.1177/0956797611423545; National Council of State Boards of Nursing, 1996, ASS COMP REG RESP; Pijl-Zieber EM, 2014, NURS EDUC TODAY, V34, P676, DOI 10.1016/j.nedt.2013.09.007; US Department of Veterans Affairs, TRENDS UT VA PROGR S; US Department of Veterans Affairs Office of the Actuary, PROJ VET POP 2013 20	10	18	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0161-9268	1550-5014		ADV NURS SCI	Adv. Nurs. Sci.	OCT-DEC	2015	38	4					306	316		10.1097/ANS.0000000000000092			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	DD2AT	WOS:000369725500008	26517342				2022-02-06	
J	Swan, AR; Nichols, S; Drake, A; Angeles, A; Diwakar, M; Song, T; Lee, RR; Huang, MX				Swan, Ashley Robb; Nichols, Sharon; Drake, Angela; Angeles, AnneMarie; Diwakar, Mithun; Song, Tao; Lee, Roland R.; Huang, Ming-Xiong			Magnetoencephalography Slow-Wave Detection in Patients with Mild Traumatic Brain Injury and Ongoing Symptoms Correlated with Long-Term Neuropsychological Outcome	JOURNAL OF NEUROTRAUMA			English	Article						executive functioning; magnetoencephalography (MEG); mild traumatic brain injury (mTBI); neuropsychological testing; postconcussive syndrome (PCS)	SIGNAL SPACE SEPARATION; MINOR HEAD-INJURY; POSTCONCUSSIVE SYMPTOMS; NEUROCOGNITIVE PERFORMANCE; CLINICAL NEUROPSYCHOLOGY; IMAGING APPROACH; MEG; CONCUSSION; ATTENTION; SYSTEM	Mild traumatic brain injury (mTBI) is common in the United States, accounting for as many as 75-80% of all TBIs. It is recognized as a significant public health concern, but there are ongoing controversies regarding the etiology of persistent symptoms post-mTBI. This constellation of nonspecific symptoms is referred to as postconcussive syndrome (PCS). The present study combined results from magnetoencephalography (MEG) and cognitive assessment to examine group differences and relationships between brain activity and cognitive performance in 31 military and civilian individuals with a history of mTBI+PCS and 33 matched healthy control subjects. An operator-free analysis was used for MEG data to increase reliability of the technique. Subjects completed a comprehensive neuropsychological assessment, and measures of abnormal slow-wave activity from MEG were collected. Results demonstrated significant group differences on measures of executive functioning and processing speed. In addition, significant correlations between slow-wave activity on MEG and patterns of cognitive functioning were found in cortical areas, consistent with cognitive impairments on exams. Results provide more objective evidence that there may be subtle changes to the neurobiological integrity of the brain that can be detected by MEG. Further, these findings suggest that these abnormalities are associated with cognitive outcomes and may account, at least in part, for long-term PCS in those who have sustained an mTBI.	[Swan, Ashley Robb; Angeles, AnneMarie; Lee, Roland R.; Huang, Ming-Xiong] VA San Diego Healthcare Syst, Res Serv, San Diego, CA USA; [Lee, Roland R.; Huang, Ming-Xiong] VA San Diego Healthcare Syst, Serv Radiol, San Diego, CA USA; [Swan, Ashley Robb; Angeles, AnneMarie; Diwakar, Mithun; Song, Tao; Lee, Roland R.; Huang, Ming-Xiong] Univ Calif San Diego, Dept Radiol, San Diego, CA 92103 USA; [Nichols, Sharon] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA; [Drake, Angela] Natl Univ, Dept Community Hlth, San Diego, CA USA		Huang, MX (corresponding author), Univ Calif San Diego, Radiol Imaging Lab, 3510 Dunhill St, San Diego, CA 92121 USA.	mxhuang@ucsd.edu			Merit Review Grants from the Department of Veterans Affairs [I01-CX000499, NURC-022-10F, NEUC-044-06S]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM007198] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX000499] Funding Source: NIH RePORTER	This work was supported by Merit Review Grants from the Department of Veterans Affairs (to M.X.H.; I01-CX000499, NURC-022-10F, and NEUC-044-06S). The authors thank Dr. Rebecca Theilmann for her efforts in preparing the MRI protocol and Terry Curry (RN) for his effort in recruiting TBI participants. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, or the U.S. government.	Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; Belanger HG, 2009, J HEAD TRAUMA REHAB, V24, P4, DOI 10.1097/HTR.0b013e3181957032; Benedict R., 1997, BRIEF VISUOSPATIAL M; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchini KJ, 2006, CLIN NEUROPSYCHOL, V20, P831, DOI 10.1080/13854040600875203; Bigler ED, 2001, ARCH CLIN NEUROPSYCH, V16, P95; Bigler ED, 2013, CLIN NEUROPSYCHOL, V27, P176, DOI 10.1080/13854046.2012.693950; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Broglio SP, 2006, BRIT J SPORT MED, V40, P802, DOI 10.1136/bjsm.2006.028019; Broglio SP, 2012, EXERC SPORT SCI REV, V40, P138, DOI 10.1097/JES.0b013e3182524273; Broglio SP, 2009, J NEUROTRAUM, V26, P1463, DOI [10.1089/neu.2008.0766, 10.1089/neu.2008-0766]; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Cohen D., 2002, P BIOMAG; Conners, 2004, CONNERS CONTINUOUS P; CRAMER EM, 1966, REV EDUC RES, V36, P604, DOI 10.2307/1169484; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P850, DOI 10.1080/13854046.2012.686631; Deb S, 1999, BRIT J PSYCHIAT, V174, P360, DOI 10.1192/bjp.174.4.360; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Faul M, 2010, TRAUMATIC BRAIN INJU; Frazier JA, 2005, AM J PSYCHIAT, V162, P1256, DOI 10.1176/appi.ajp.162.7.1256; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Goldstein JM, 2007, BIOL PSYCHIAT, V61, P935, DOI 10.1016/j.biopsych.2006.06.027; Guskiewicz KM, 2002, AM J SPORT MED, V30, P157, DOI 10.1177/03635465020300020201; Heaton R. K., 2004, REVISED COMPREHENSIV; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Huang MX, 2007, NEUROIMAGE, V37, P731, DOI 10.1016/j.neuroimage.2007.06.002; Huang MX, 2014, NEUROIMAGE, V84, P585, DOI 10.1016/j.neuroimage.2013.09.022; Huang MX, 2012, NEUROIMAGE, V61, P1067, DOI 10.1016/j.neuroimage.2012.04.029; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huang MX, 2006, NEUROIMAGE, V31, P1025, DOI 10.1016/j.neuroimage.2006.01.029; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lees-Haley PR, 2003, ARCH CLIN NEUROPSYCH, V18, P585; Lees-Haley PR, 2001, ARCH CLIN NEUROPSYCH, V16, P689, DOI 10.1016/S0887-6177(00)00092-5; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Lishman WA, 1998, ORGANIC PSYCHIAT; Makris N, 2006, SCHIZOPHR RES, V83, P155, DOI 10.1016/j.schres.2005.11.020; Meyers L. S., 2006, APPL MULTIVARIATE RE; Morey L. C., 2005, PERSONALITY ASSESSME; Mosher JC, 1999, IEEE T BIO-MED ENG, V46, P245, DOI 10.1109/10.748978; Niedermeyer E., 2005, ELECTROENCEPHALOGRAP; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Posner MI, 2007, ANNU REV PSYCHOL, V58, P1, DOI 10.1146/annurev.psych.58.110405.085516; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; Risse GL, 2006, EPILEPSIA, V47, P87, DOI 10.1111/j.1528-1167.2006.00699.x; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Saalmann YB, 2007, SCIENCE, V316, P1612, DOI 10.1126/science.1139140; Song T, 2008, MED BIOL ENG COMPUT, V46, P923, DOI 10.1007/s11517-007-0290-y; Song T, 2009, J CLIN NEUROPHYSIOL, V26, P392, DOI 10.1097/WNP.0b013e3181c29896; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; Taulu S, 2004, Neurol Clin Neurophysiol, V2004, P35; TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Trites R. L., 1977, NEUROPSYCHOLOGICAL T; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Ward B. D., 2000, SIMULTANEOUS INTERFE; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; WechslerD, 2001, WECHSLER TEST ADULT; Yin XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050590	78	18	18	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2015	32	19					1510	1521		10.1089/neu.2014.3654			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CR8NC	WOS:000361609500009	25808909	Green Published			2022-02-06	
J	Grubenhoff', JA; Deakyne, SJ; Comstock, RD; Kirkwood, MW; Bajaj, L				Grubenhoff', Joseph A.; Deakyne, Sara J.; Comstock, R. Dawn; Kirkwood, Michael W.; Bajaj, Lalit			Outpatient follow-up and return to school after emergency department evaluation among children with persistent post-concussion symptoms	BRAIN INJURY			English	Article						Acute brain injury; brain concussion; emergency medicine; post-concussion symptoms; post-concussion syndrome; traumatic brain injury	TRAUMATIC BRAIN-INJURY; POSTCONCUSSION SYNDROME; NEUROCOGNITIVE OUTCOMES; ADOLESCENTS; PARENTS; IMPACT; NEEDS	Objective: To describe differences in outpatient follow-up and academic accommodations received by children with and without persistent post-concussion symptoms (PPCS) after emergency department (ED) evaluation. It was hypothesized that children with PPCS would have more outpatient visits and receive academic accommodations more often than children without PPCS and that follow-up would be positively associated with receiving accommodations. Methods: Children aged 8-18 years with acute (<= 6hours) concussion at time of presentation to a paediatric ED were enrolled in an observational study. Outcomes were assessed through a telephone survey 30 days after injury. Results: Of 234 enrolled participants, 179 (76%) completed follow-up. PPCS occurred in 21%. Only 45% of subjects had follow-up visits after ED discharge. Follow-up visit rates were similar for those with and without PPCS (58% vs. 41%, respectively; p=0.07). Children with PPCS missed twice as many school days as those without (3 vs. 1.5; p<0.001), but did not differ in receiving academic accommodations (36% vs. 53%; p=0.082). Outpatient follow-up was associated with receiving academic accommodations (RR=2.2; 95% Cl=1.4-3.5). Conclusions: Outpatient follow-up is not routine for concussed children. Despite missing more school days, children with PPCS do not receive academic accommodations more often. Outpatient follow-up may facilitate academic accommodations.	[Grubenhoff', Joseph A.; Comstock, R. Dawn; Bajaj, Lalit] Univ Colorado, Dept Pediat, Boulder, CO 80309 USA; [Grubenhoff', Joseph A.; Bajaj, Lalit] Childrens Hosp Colorado, Emergency Dept, Aurora, CO 80045 USA; [Deakyne, Sara J.] Childrens Hosp Colorado, Dept Res Informat, Aurora, CO 80045 USA; [Comstock, R. Dawn] Colorado Sch Publ Hlth, Aurora, CO USA; [Kirkwood, Michael W.] Univ Colorado, Dept Phys Med & Rehabil, Boulder, CO 80309 USA; [Kirkwood, Michael W.] Childrens Hosp Colorado, Rehabil Med, Aurora, CO 80045 USA		Grubenhoff', JA (corresponding author), Childrens Hosp Colorado, 13123 E 16th Ave,B-251, Aurora, CO 80045 USA.	joe.grubenhoff@childrenscolorado.org	Grubenhoff, Joseph A/H-9994-2019	Grubenhoff, Joseph A/0000-0001-5072-4064	Thrasher Research Fund Early Career Award [9202]; NTH/NCATS Colorado CTSI [UL1 TR000154]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000154, UL1TR001082] Funding Source: NIH RePORTER	Support for this study was provided by a Thrasher Research Fund Early Career Award (9202) to Dr Grubenhoff. Use of the REDCap research database was supported by NTH/NCATS Colorado CTSI Grant Number UL1 TR000154.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Berman S, 2005, PEDIATRICS, V116, P1474, DOI 10.1542/peds.2005-0923; BIJUR PE, 1990, PEDIATRICS, V86, P337; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Brown NJ, 2014, PEDIATRICS, V133, pE299, DOI 10.1542/peds.2013-2125; Centers for Disease Control and Prevention, CONC FACT SHEET SCH; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Ganesalingam K, 2008, J PEDIATR PSYCHOL, V33, P621, DOI 10.1093/jpepsy/jsm133; Haboush-Deloye A, 2014, MATERN CHILD HLTH J, V18, P1753, DOI 10.1007/s10995-013-1420-9; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hawley CA, 2004, ARCH DIS CHILD, V89, P136, DOI 10.1136/adc.2002.025577; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Lipkin PH, 2007, PEDIATRICS, V119, P1218, DOI 10.1542/peds.2007-0885; Maillard-Wermelinger A, 2009, DEV NEUROREHABIL, V12, P330, DOI 10.3109/17518420903087251; Master CL, 2012, PEDIATR ANN, V41, pE180, DOI 10.3928/00904481-20120827-09; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Meehan WP, 2009, PEDIATRICS, V123, P114, DOI 10.1542/peds.2008-0309; Moran LM, 2011, J HEAD TRAUMA REHAB, V26, P348, DOI 10.1097/HTR.0b013e3181f8d32e; Popoli DM, 2014, CLIN PEDIATR, V53, P217, DOI 10.1177/0009922813499070; Randolph C, 2009, ARCH CLIN NEUROPSYCH, V24, P219, DOI 10.1093/arclin/acp025; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056; Zemek R, 2013, ACAD EMERG MED, V20, P1041, DOI 10.1111/acem.12220; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431; Zuckerbraun NS, 2014, PEDIATRICS, V133, P635, DOI 10.1542/peds.2013-2600	38	18	18	0	14	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2015	29	10					1186	1191		10.3109/02699052.2015.1035325			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CR3UK	WOS:000361258400007	26004755	Green Accepted			2022-02-06	
J	Kreif, N; Grieve, R; Diaz, I; Harrison, D				Kreif, Noemi; Grieve, Richard; Diaz, Ivan; Harrison, David			Evaluation of the Effect of a Continuous Treatment: A Machine Learning Approach with an Application to Treatment for Traumatic Brain Injury	HEALTH ECONOMICS			English	Article; Proceedings Paper	23rd European Workshop on Econometrics and Health Economics	SEP 04-06, 2014	Starnberg, GERMANY	Univ Munich, Dept Econ, Munich Centre Econ Aging		programme evaluation; generalised propensity score; machine learning	PROPENSITY SCORE; CAUSAL INFERENCE; REGRESSION; PREDICTION; ROBUSTNESS; ADJUSTMENT	For a continuous treatment, the generalised propensity score (GPS) is defined as the conditional density of the treatment, given covariates. GPS adjustment may be implemented by including it as a covariate in an outcome regression. Here, the unbiased estimation of the dose-response function assumes correct specification of both the GPS and the outcome-treatment relationship. This paper introduces a machine learning method, the Super Learner', to address model selection in this context. In the two-stage estimation approach proposed, the Super Learner selects a GPS and then a dose-response function conditional on the GPS, as the convex combination of candidate prediction algorithms. We compare this approach with parametric implementations of the GPS and to regression methods. We contrast the methods in the Risk Adjustment in Neurocritical care cohort study, in which we estimate the marginal effects of increasing transfer time from emergency departments to specialised neuroscience centres, for patients with acute traumatic brain injury. With parametric models for the outcome, we find that dose-response curves differ according to choice of specification. With the Super Learner approach to both regression and the GPS, we find that transfer time does not have a statistically significant marginal effect on the outcomes. (c) 2015 The Authors. Health Economics Published by John Wiley & Sons Ltd.	[Kreif, Noemi; Grieve, Richard] London Sch Hyg & Trop Med, Dept Hlth, Serv Res & Policy, London WC1, England; [Diaz, Ivan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Harrison, David] Intens Care Natl Audit & Res Ctr, London, England		Kreif, N (corresponding author), London Sch Hyg & Trop Med, Dept Hlth, Serv Res & Policy, London WC1, England.	noemi.kreif@lshtm.ac.uk	Harrison, David A/O-4355-2018; Diaz, Ivan/ABG-1090-2021	Harrison, David A/0000-0002-9002-9098; Diaz, Ivan/0000-0001-9056-2047; Grieve, Richard/0000-0001-8899-1301	Policy Research Programme in the Department of Health [SRF-2013-06-016]; National Institute for Health ResearchNational Institute for Health Research (NIHR) [SRF-2013-06-016]; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L012332/1]; Economic and Social Research CouncilUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G00188X/1] Funding Source: researchfish; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G106/1173] Funding Source: researchfish; National Institute for Health ResearchNational Institute for Health Research (NIHR) [07/37/29] Funding Source: researchfish; ESRCUK Research & Innovation (UKRI)Economic & Social Research Council (ESRC) [ES/G00188X/1] Funding Source: UKRI; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G106/1173, MR/L012332/1] Funding Source: UKRI	This is an independent report jointly funded by the Policy Research Programme in the Department of Health to the Policy Innovation Research Unit (PIRU) at LSHTM, the National Institute for Health Research (Senior Research Fellowship, Dr Richard Grieve, SRF-2013-06-016), and the Medical Research Council (Eearly Career Fellowship in the Economics of Health, Dr Noemi Kreif MR/L012332/1). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the National Institute for Health Research, the Department of Health or the Medical Research Council. The authors are grateful to Prof. Kathy Rowan (ICNARC) for data access, Zia Sadique (LSHTM) and Manuel Gomes (LSHTM) for advice on data analysis and to Prof. David Menon (University of Cambridge) and Prof. Martin Smith (UCLH) for clinical advice on the empirical study. We are grateful to Eric Polley for help in using the Super Learner and to Mark van der Laan for helpful comments. We thank seminar participants from the Health, Econometrics and Data Group (University of York) and attendants of the 23rd European Workshop on Econometrics and Health Economics for helpful suggestions.	Austin PC, 2012, MULTIVAR BEHAV RES, V47, P115, DOI 10.1080/00273171.2012.640600; Bia M, 2011, CEPS INSTEAD WORKING; Bia M, 2008, STATA J, V8, P354, DOI 10.1177/1536867X0800800303; Bullock AR, 2006, NEUROSURGERY, V58, pVI; Buuren S., 2011, J STAT SOFTWARE, V45; Diaz I, 2013, J CAUSAL INFERENCE, V1, P171, DOI 10.1515/jci-2012-0005; Eliseeva E, 2013, APPL MACHINE LEARNIN; Flores CA, 2012, REV ECON STAT, V94, P153, DOI 10.1162/REST_a_00177; Gelman A. G., 2013, ARM DATA ANAL USING; GHALANOS A., 2012, RSOLNP GEN NONLINEAR; Harrison D, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17030; Hastie T, 2013, GAM GEN ADDITIVE MOD; Imai K, 2004, J AM STAT ASSOC, V99, P854, DOI 10.1198/016214504000001187; Imai K, 2014, J R STAT SOC B, V76, P243, DOI 10.1111/rssb.12027; Imbens G.W., 2004, APPL BAYESIAN MODELI, V226164, P73; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Kang JDY, 2007, STAT SCI, V22, P523, DOI 10.1214/07-STS227; Kluve J, 2012, J R STAT SOC A STAT, V175, P587, DOI 10.1111/j.1467-985X.2011.01000.x; Kreif N, 2016, STAT METHODS MED RES, V25, P2315, DOI 10.1177/0962280214521341; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; Neugebauer R, 2014, STAT MED, V33, P2480, DOI 10.1002/sim.6099; Petersen ML, 2008, AIDS, V22, P2097, DOI 10.1097/QAD.0b013e32830f97e2; Pirracchio R, 2015, AM J EPIDEMIOL, V181, P108, DOI 10.1093/aje/kwu253; Pirracchio R, 2015, LANCET RESP MED, V3, P42, DOI 10.1016/S2213-2600(14)70239-5; Polley E, 2013, SUPERLEARNER SUPER L SUPERLEARNER SUPER L; Porter KE, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1308; R Development Core Team, 2012, R LANG ENV STAT COMP; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Rose S, 2013, AM J EPIDEMIOL, V177, P443, DOI 10.1093/aje/kws241; ROSENBAUM PR, 1987, BIOMETRIKA, V74, P13, DOI 10.2307/2336017; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; ROYSTON P, 1994, J R STAT SOC C-APPL, V43, P429, DOI 10.2307/2986270; Rubin DB, 2005, J AM STAT ASSOC, V100, P322, DOI 10.1198/016214504000001880; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; van der Laan M.J., 2010, UC BERKELEY DIVISION; van der Laan MJ, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1260; van dersLaan MJ, 2004, STAT APPL GENETICS M, V3; van dersLaan MJ, 2003, UC BERKELEY DIVISION; van dersLaan MJ, 2014, UC BERKELEY DIVISION; van dersLaan MJ, 2011, SPRINGER SER STAT; van dersLaan MJ, 2007, UC BERKELEY DIVISION; Vansteelandt S, 2014, STAT MED, V33, P4053, DOI 10.1002/sim.6207; Wyss R, 2014, AM J EPIDEMIOL, V180, P645, DOI 10.1093/aje/kwu181; Yang S, 2014, 2014 ATL CAUS INF C; Zhu YY, 2015, J CAUSAL INFERENCE, V3, P25, DOI 10.1515/jci-2014-0022	48	18	18	4	28	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1057-9230	1099-1050		HEALTH ECON	Health Econ.	SEP	2015	24	9					1213	1228		10.1002/hec.3189			16	Economics; Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S); Conference Proceedings Citation Index - Social Science &amp; Humanities (CPCI-SSH)	Business & Economics; Health Care Sciences & Services	CO3PH	WOS:000359070000012	26059721	Green Published, hybrid, Green Accepted			2022-02-06	
J	Loosemore, M; Lightfoot, J; Palmer-Green, D; Gatt, I; Bilzon, J; Beardsley, C				Loosemore, Michael; Lightfoot, Joseph; Palmer-Green, Deborah; Gatt, Ian; Bilzon, James; Beardsley, Chris			Boxing injury epidemiology in the Great Britain team: a 5-year surveillance study of medically diagnosed injury incidence and outcome	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							AMATEUR; FOOTBALL; BOXERS; LEAGUE; RISK	Objectives There has been no comprehensive injury report of elite-level amateur boxers in competition and training. We reviewed injuries in training and competition in the Great Britain (GB) amateur boxing squad between 2005 and 2009. Methods Longitudinal, prospective injury surveillance over 5 years of the GB boxing squad from 2005 to 2009. 66 boxers passed through the squad. The location, region affected, description, and the duration of each injury were recorded by the team doctor and team physiotherapist. We recorded whether the injury occurred during competition or training, and also whether it was a new or a recurrent injury. The injury rate during competition was calculated as the number of injuries per 1000 h. Results More injuries affected the hand than any other body location. This was the case overall, in training and competition individually, and for both new and recurrent injuries. More injuries occurred during training than during competition, and most injuries were new rather than recurrent. Total injury rate during competition was 828 per 1000 h and hand injury rate in competition was 302 injuries per 1000 h. Hand injury rate in competition was significantly higher than at the other locations. The incidence of concussion is comparatively low. Conclusions Injury prevention should aim to protect the hands and wrists of elite amateur boxers.	[Loosemore, Michael; Lightfoot, Joseph] UCL, Inst Sport Exercise & Hlth, London W1T 7HA, England; [Palmer-Green, Deborah] Univ Nottingham, Div Orthopaed & Accid Surg, Nottingham NG7 2RD, England; [Gatt, Ian] English Inst Sport, Physiotherapy Dept, Sheffield, S Yorkshire, England; [Bilzon, James] Univ Bath, Dept Hlth, Bath BA2 7AY, Avon, England; [Beardsley, Chris] Strength & Conditioning Res Ltd, London, England		Loosemore, M (corresponding author), UCL, Inst Sport Exercise & Hlth, First Floor,170 Tottenham Court Rd, London W1T 7HA, England.	mike.loosemore@eis2win.co.uk		Bilzon, James/0000-0002-6701-7603			Bartsch AJ, 2012, J NEUROSURG, V116, P1070, DOI 10.3171/2011.12.JNS111478; Bianco M, 2005, BRIT J SPORT MED, V39, P532, DOI 10.1136/bjsm.2004.014365; Bianco M, 2013, BRIT J SPORT MED, V47, P452, DOI 10.1136/bjsports-2012-091771; Bledsoe GH, 2005, SOUTH MED J, V98, P994, DOI 10.1097/01.smj.0000182498.19288.e2; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gilchrist J, 2008, AM J SPORT MED, V36, P1476, DOI 10.1177/0363546508318188; Hagglund M, 2005, SCAND J MED SCI SPOR, V15, P21, DOI 10.1111/j.1600-0838.2004.00395.x; Joch W, 1981, BIOMECHANICS A, P343; Loosemore Mike, 2008, Br J Sports Med, V42, P564; Massimiliano B, 2011, BRIT J SPORT MED, V45, P563, DOI 10.1136/bjsm.2009.061135; Porter M, 1996, CLIN J SPORT MED, V6, P97, DOI 10.1097/00042752-199604000-00006; R Core Team, 2014, LANG ENV STAT COMP; Rae K, 2007, CLIN J SPORT MED, V17, P201, DOI 10.1097/JSM.0b013e318059b536; Smith MS, 2006, J SPORT SCI MED, V5, P74; Smith MS, 2000, J SPORT SCI, V18, P445, DOI 10.1080/02640410050074377; Stephensen S, 1996, BRIT J SPORT MED, V30, P331, DOI 10.1136/bjsm.30.4.331; Timm Kent E., 1993, Journal of Athletic Training, V28, P330; Walden M, 2005, BRIT J SPORT MED, V39, P542, DOI 10.1136/bjsm.2004.014571; Zazryn T, 2006, BRIT J SPORT MED, V40, P670, DOI 10.1136/bjsm.2006.025924; Zazryn TR, 2009, CLIN J SPORT MED, V19, P20, DOI 10.1097/JSM.0b013e31818f1582	22	18	19	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	SEP	2015	49	17					1100	1107		10.1136/bjsports-2015-094755			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	CP3AW	WOS:000359750200004	26192194	Green Accepted			2022-02-06	
J	Painter, TJ; Rickerds, J; Alban, RF				Painter, Thomas J.; Rickerds, Jennifer; Alban, Rodrigo F.			Immune enhancing nutrition in traumatic brain injury - A preliminary study	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Immune-enhancing nutrition; Infection rates; Pre-albumin; Traumatic brain injury	CRITICALLY-ILL PATIENTS; CLOSED-HEAD INJURY; ENTERAL NUTRITION; SEVERE SEPSIS; IMMUNONUTRITION; SUPPORT; GUIDELINES; MANAGEMENT; METABOLISM; GLUTAMINE	Traumatic brain injury (TBI) is a major cause of death and disability worldwide. Certain patients appear to benefit when they receive immune enhancing additives, such as glutamine, arginine, and omega-3 fatty acids. We hypothesized that TBI patients given enteral feedings containing these supplements may have improved nutrition measures and infection rates when compared to standard tube feedings. This is a retrospective review of patients from a Level-One trauma center from July 2009 to July 2013. A total of 240 TBI patients received either an immune enhancing nutrition (LEN) formula (n = 126), or a standard formula (SF) (n = 114) based on the attending surgeon's preference. Data collected included demographic information, infection information and outcome measures. Patients were similar in terms of age, ISS, head AIS, and initial prealbumin level. Patients receiving LEN were found to have lower rates of blood stream infections (10.3% vs 19.3%, p <0.05), whereas pneumonia and UTI rates were similar between groups. In addition, both groups had similar rates of all-cause mortality and hospital length of stay, however LEN patients spent longer in the ICU and on ventilators. In TBI patients receiving LEN, prealbumin levels were higher at the second, third, and fourth week of admission (week 2 - 22.2 vs 17.4, p = 0.006; week 3 - 24.6 vs 20.1, p = 0.04; week 4 26.3 vs 22.1, p = 0.19; week 5 - 25.8 vs 20.3, p = 0.21). This study suggests that patients with traumatic brain injury who receive LEN are more likely to have increased prealbumin levels perhaps reflecting improved nutrition throughout their hospital stay and may show some benefit in rates of infections, particularly in bacteremia. (C) 2015 US Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Alban, Rodrigo F.] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA; [Painter, Thomas J.] Orlando Hlth, Dept Surg Educ, Orlando, FL 32806 USA		Alban, RF (corresponding author), Cedars Sinai Med Ctr, Dept Surg, 8635 W 3rd St,Suite 650-W, Los Angeles, CA 90048 USA.	tjpainter11@gmail.com; jrickerds@gmail.com; Rodrigo.alban@cshs.org					Balk RA, 2000, CRIT CARE CLIN, V16, P337, DOI 10.1016/S0749-0704(05)70113-5; Bertolini G, 2003, INTENS CARE MED, V29, P834, DOI 10.1007/s00134-003-1711-5; BORZOTTA AP, 1994, J TRAUMA, V37, P459, DOI 10.1097/00005373-199409000-00022; CERRA FB, 1987, SURGERY, V101, P1; Chastre J, 2003, JAMA-J AM MED ASSOC, V290, P2588, DOI 10.1001/jama.290.19.2588; DALY JM, 1992, SURGERY, V112, P56; Darbar A, 2001, NUTRITION, V17, P71, DOI 10.1016/S0899-9007(00)00476-7; DEUTSCHMAN CS, 1987, J NEUROSURG, V66, P388, DOI 10.3171/jns.1987.66.3.0388; Galban C, 2000, CRIT CARE MED, V28, P643, DOI 10.1097/00003246-200003000-00007; Griffiths RD, 1997, NUTRITION, V13, P752, DOI 10.1016/S0899-9007(97)83039-0; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Heyland DK, 2003, INTENS CARE MED, V29, P669, DOI 10.1007/s00134-003-1710-6; Heyland DK, 2001, JAMA-J AM MED ASSOC, V286, P944, DOI 10.1001/jama.286.8.944; Jones C, 1999, NUTRITION, V15, P108, DOI 10.1016/S0899-9007(98)00172-5; Kazamias P, 1998, WORLD J SURG, V22, P6, DOI 10.1007/s002689900341; Krakau K, 2006, BRAIN INJURY, V20, P345, DOI 10.1080/02699050500487571; Kudsk K, 1996, ANN SURG, V224, P540; Marik PE, 2008, INTENS CARE MED, V34, P1980, DOI 10.1007/s00134-008-1213-6; McClave SA, 2009, JPEN-PARENTER ENTER, V33, P277, DOI 10.1177/0148607109335234; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Wilson RF, 2001, NEUROL RES, V23, P121, DOI 10.1179/016164101101198451	21	18	24	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	SEP	2015	21						70	74		10.1016/j.ijsu.2015.07.008			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CR0FL	WOS:000360993700014	26209585	Bronze			2022-02-06	
J	Ward, A; Iocono, JA; Brown, S; Ashley, P; Draus, JM				Ward, Austin; Iocono, Joseph A.; Brown, Samuel; Ashley, Phillip; Draus, John M., Jr.			Non-accidental Trauma Injury Patterns and Outcomes: A Single Institutional Experience	AMERICAN SURGEON			English	Article							CHILD MALTREATMENT; UNITED-STATES	Non-accidental trauma (NAT) victims account for a significant percentage of our pediatric trauma population. We sought to better understand the injury patterns and outcomes of NAT victims who were treated at our level I pediatric trauma center. Trauma registry data were used to identify NAT victims between January 2008 and December 2012. Demographic data, injury severity, hospital course, and outcomes were evaluated. One hundred and eighty-eight cases of suspected NAT were identified. Children were mostly male and white. The median age was 1.1 years; the median Injury Severity Score was 9. Traumatic brain injuries, lower extremity fractures, and skull fractures were the most common injuries. Twenty-seven per cent required medical procedures; most were performed by orthopedic surgery. Twenty-four per cent required admission to the pediatric intensive care unit. The median length of stay was two days. The mortality rate was 9.6 per cent. We generated a hot spot map of our catchment area and identified areas of our state where NAT occurs at increased rates. NAT victims sustain significant morbidity and mortality. Due to the severity of injuries, pediatric trauma surgeons should be involved in the evaluation and management of these children. Much work is needed to prevent the death and disability incurred by victims of child abuse.	[Ward, Austin] Univ Kentucky, Grad Med Educ, Gen Surg Residency Program, Lexington, KY 40536 USA; [Iocono, Joseph A.; Draus, John M., Jr.] Univ Kentucky, Dept Surg, Div Pediat Surg, Lexington, KY 40536 USA; [Brown, Samuel] Univ Kentucky, Coll Med, Lexington, KY 40536 USA; [Ashley, Phillip] Univ Kentucky, Grad Med Educ, Orthoped Surg Residency Program, Lexington, KY 40536 USA		Draus, JM (corresponding author), Univ Kentucky, Albert B Chandler Med Ctr, MN-102, Lexington, KY 40536 USA.	jmdr226@uky.edu					[Anonymous], 2009, 2009 2013 AM COMM SU; Eckenrode J, 2014, PEDIATRICS, V133, P454, DOI 10.1542/peds.2013-1707; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Lane WG, 2011, PEDIATRICS, V127, pE1400, DOI 10.1542/peds.2010-2096; Larimer EL, 2013, J PEDIATR SURG, V48, P1357, DOI 10.1016/j.jpedsurg.2013.03.035; Leventhal JM, 2012, PEDIATRICS, V129, P458, DOI 10.1542/peds.2011-1277; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; U. S. Department of Health and Human Services, 2010, 4 NATL INCIDENCE STU; US Department of Health and Human Services, 2013, CHILD MALTREATMENT	9	18	18	0	4	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	SEP	2015	81	9					835	838					4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CQ4GK	WOS:000360562300012	26350656				2022-02-06	
J	Zander, NE; Piehler, T; Boggs, ME; Banton, R; Benjamin, R				Zander, Nicole E.; Piehler, Thuvan; Boggs, Mary E.; Banton, Rohan; Benjamin, Richard			In vitro studies of primary explosive blast loading on neurons	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						primary blast; traumatic brain injury; in vitro model; dissociated cultures; explosives	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; MODEL; DYSFUNCTION; RECOVERY; DAMAGE	In a military setting, traumatic brain injury (TBI) is frequently caused by blast waves that can trigger a series of neuronal biochemical changes. Although many animal models have been used to study the effects of primary blast waves, elucidating the mechanisms of damage in a whole-animal model is extremely complex. In vitro models of primary blast, which allow for the deconvolution of mechanisms, are relatively scarce. It is largely unknown how structural damage at the cellular level impacts the functional activity at variable time scales after the TBI event. A novel in vitro system was developed to probe the effects of explosive blast (ranging from approximate to 25 to 40 psi) on dissociated neurons. PC12 neurons were cultured on laminin-coated substrates, submerged underwater, and subjected to single and multiple blasts in a controlled environment. Changes in cell membrane permeability, viability, and cell morphology were evaluated. Significant increases in axonal beading were observed in the injured cells. In addition, although cell death was minimal after a single insult, cell viability decreased significantly following repeated blast exposure. (c) 2015 Wiley Periodicals, Inc.	[Zander, Nicole E.; Piehler, Thuvan; Banton, Rohan; Benjamin, Richard] US Army Res Lab, Weap & Mat Res Directorate, Aberdeen Proving Ground, MD USA; [Boggs, Mary E.] Univ Delaware, Dept Biol, Newark, DE USA		Zander, NE (corresponding author), US Army Res Lab, Dept Army, RDRL WMM G, Bldg 4600, Aberdeen, MD 21005 USA.	nicole.e.zander.civ@mail.mil			United States Army Research Laboratory's Director's Science Initiative	Contract grant sponsor: United States Army Research Laboratory's Director's Science Initiative.	Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Barthel J, 2008, 26 ARM SCI C ORL FL; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Chen Y, 2013, FRONT NEUROL, V4, P1; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Chew SY, 2005, BIOMACROMOLECULES, V6, P2017, DOI 10.1021/bm0501149; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Department of the Army, 1984, DEP ARM TECHN MAN TM; Edwards MA, 2007, NEUROTOXICOLOGY, V28, P876, DOI 10.1016/j.neuro.2007.04.006; Effgen G. B., 2012, FRONT NEUROL, V3, P1; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Fernandez P, 2010, BIOPHYS J, V99, P3571, DOI 10.1016/j.bpj.2010.10.027; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; HINSHAW DB, 1993, BRAIN RES, V615, P13, DOI 10.1016/0006-8993(93)91110-E; Howard D, 1997, ULTRASOUND MED BIOL, V23, P1107, DOI 10.1016/S0301-5629(97)00081-1; Hue CD, 2014, J NEUROTRAUM, V31, P951, DOI 10.1089/neu.2013.3149; Hue CD, 2013, J NEUROTRAUM, V30, P1652, DOI 10.1089/neu.2012.2773; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Koh HS, 2008, BIOMATERIALS, V29, P3574, DOI 10.1016/j.biomaterials.2008.05.014; LaPlaca MC, 2009, IEEE ENG MED BIO, P1113, DOI 10.1109/IEMBS.2009.5334457; Lee JY, 2009, BIOMATERIALS, V30, P4325, DOI 10.1016/j.biomaterials.2009.04.042; Liu Y, 2003, J CELL MOL MED, V7, P49, DOI 10.1111/j.1582-4934.2003.tb00202.x; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; Moochhala SM, 2004, J TRAUMA, V56, P393, DOI 10.1097/01.TA.0000066181.50879.7A; Moore DF, 2010, NEUROREHABILITATION, V26, P179, DOI 10.3233/NRE-2010-0553; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; Pera M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074344; Ravin R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039421; Serbest G, 2005, J NEUROTRAUM, V22, P119, DOI 10.1089/neu.2005.22.119; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Svetlov SI, 2009, J NEUROTRAUM, V26, P913, DOI 10.1089/neu.2008.0609; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; VandeVord PJ, 2012, ANN BIOMED ENG, V40, P227, DOI 10.1007/s10439-011-0420-4; Weinberger S, 2011, NATURE, V477, P390, DOI 10.1038/477390a; Williamson V., 2009, INVISIBLE WOUNDS PSY	42	18	19	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	SEP	2015	93	9					1353	1363		10.1002/jnr.23594			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CM9HP	WOS:000358019100005	25914380				2022-02-06	
J	Tan, AM; Waxman, SG				Tan, Andrew M.; Waxman, Stephen G.			Dendritic spine dysgenesis in neuropathic pain	NEUROSCIENCE LETTERS			English	Article						Neuropathic pain; Dendritic spine; SCI; Rac1; Diabetes; Nerve injury; Plasticity; Nociception; Spinal cord	LONG-TERM POTENTIATION; PERIPHERAL-NERVE INJURY; SODIUM-CHANNEL EXPRESSION; SUPERFICIAL DORSAL-HORN; CORD-INJURY; BURN INJURY; REMODELING CONTRIBUTES; MECHANICAL ALLODYNIA; DIABETIC-NEUROPATHY; SIGNALING PATHWAYS	Neuropathic pain is a significant unmet medical need in patients with variety of injury or disease insults to the nervous system. Neuropathic pain often presents as a painful sensation described as electrical, burning, or tingling. Currently available treatments have limited effectiveness and narrow therapeutic windows for safety. More powerful analgesics, e.g., opioids, carry a high risk for chemical dependence. Thus, a major challenge for pain research is the elucidation of the mechanisms that underlie neuropathic pain and developing targeted strategies to alleviate pathological pain. The mechanistic link between dendritic spine structure and circuit function could explain why neuropathic pain is difficult to treat, since nociceptive processing pathways are adversely "hard-wired" through the reorganization of dendritic spines. Several studies in animal models of neuropathic pain have begun to reveal the functional contribution of dendritic spine dysgenesis in neuropathic pain. Previous reports have demonstrated three primary changes in dendritic spine structure on nociceptive dorsal horn neurons following injury or disease, which accompany chronic intractable pain: (I) increased density of dendritic spines, particularly mature mushroom-spine spines, (II) redistribution of spines toward dendritic branch locations close to the cell body, and (III) enlargement of the spine head diameter, which generally presents as a mushroom-shaped spine. Given the important functional implications of spine distribution, density, and shape for synaptic and neuronal function, the study of dendritic spine abnormality may provide a new perspective for investigating pain, and the identification of specific molecular players that regulate spine morphology may guide the development of more effective and long-lasting therapies. Published by Elsevier Ireland Ltd.	[Tan, Andrew M.; Waxman, Stephen G.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Tan, Andrew M.; Waxman, Stephen G.] Yale Univ, Sch Med, Ctr Neurosci & Regenerat Res, New Haven, CT 06510 USA; [Tan, Andrew M.; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Dept Neurol, New Haven, CT 06516 USA; [Tan, Andrew M.; Waxman, Stephen G.] Vet Affairs Connecticut Healthcare Syst, Rehabil Res Ctr, New Haven, CT 06516 USA		Tan, AM (corresponding author), Ctr Neurosci & Regenerat Res 127A, 950 Campbell Ave,Bldg 34, West Haven, CT 06516 USA.	andrew.tan@yale.edu	Waxman, Stephen/Z-2507-2019	Waxman, Stephen/0000-0001-5718-7177; Tan, Andrew/0000-0002-0099-8814	Paralyzed Veterans of America (PVA); Department of Veterans Affairs (VA) Medical Research Service and Rehabilitation Research Service; PVA Research Foundation; VA Career Development Award [1 IK2 RX001123-01A2]; Veterans AffairsUS Department of Veterans Affairs [IK2RX001123, I01BX000605] Funding Source: NIH RePORTER	The work presented is supported by grants from the Paralyzed Veterans of America (PVA) and the Department of Veterans Affairs (VA) Medical Research Service and Rehabilitation Research Service. Andrew M. Tan is funded by the PVA Research Foundation and a VA Career Development Award (1 IK2 RX001123-01A2). We thank Lakshmi Bangalore for her excellent editorial and intellectual contribution.	Ackermann M, 2003, NAT NEUROSCI, V6, P1194, DOI 10.1038/nn1135; Allen JW, 2004, METH MOLEC MED, P25; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Apkarian AV, 2009, PROG NEUROBIOL, V87, P81, DOI 10.1016/j.pneurobio.2008.09.018; Baron R, 2000, CLIN J PAIN, V16, pS12, DOI 10.1097/00002508-200006001-00004; Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bramham CR, 2008, CURR OPIN NEUROBIOL, V18, P524, DOI 10.1016/j.conb.2008.09.013; Carp JS, 2006, J NEUROPHYSIOL, V96, P1718, DOI 10.1152/jn.00470.2006; Chang YW, 2010, J PAIN, V11, P1146, DOI 10.1016/j.jpain.2010.02.010; Chang YW, 2010, J PAIN, V11, P119, DOI 10.1016/j.jpain.2009.06.009; Corbetta S, 2009, FASEB J, V23, P1347, DOI 10.1096/fj.08-121574; Cramer SW, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-36; Craner MJ, 2002, ANN NEUROL, V52, P786, DOI 10.1002/ana.10364; Deumens R, 2013, NEUROSCIENCE, V229, P155, DOI 10.1016/j.neuroscience.2012.10.036; Drdla R, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-18; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Erschbamer MK, 2005, J COMP NEUROL, V484, P224, DOI 10.1002/cne.20471; FIFKOVA E, 1985, CELL MOL NEUROBIOL, V5, P47, DOI 10.1007/BF00711085; Fischer TZ, 2012, J REHABIL RES DEV, V49, P515, DOI 10.1682/JRRD.2011.04.0071; Fischer TZ, 2010, NAT REV NEUROL, V6, P462, DOI 10.1038/nrneurol.2010.90; Francis JT, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/310737; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gazzaley A, 2002, NEUROSCIENCE, V111, P853, DOI 10.1016/S0306-4522(02)00021-0; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; Hains BC, 2006, J NEUROSCI, V26, P4308, DOI 10.1523/JNEUROSCI.0003-06.2006; Hains BC, 2004, J NEUROSCI, V24, P4832, DOI 10.1523/JNEUROSCI.0300-04.2004; Hasbargen T, 2010, ANN NY ACAD SCI, V1198, P168, DOI 10.1111/j.1749-6632.2010.05462.x; Heppenstall P A, 2000, Curr Opin Anaesthesiol, V13, P573, DOI 10.1097/00001503-200010000-00015; Ikeda H, 2006, SCIENCE, V312, P1659, DOI 10.1126/science.1127233; Ikeda H, 2009, NEUROSCI RES, V64, P133, DOI 10.1016/j.neures.2009.03.004; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Kerr BJ, 1999, J NEUROSCI, V19, P5138; Kim SK, 2011, J NEUROSCI, V31, P5477, DOI 10.1523/JNEUROSCI.0328-11.2011; Knerlich-Lukoschus F, 2008, J NEUROTRAUM, V25, P427, DOI 10.1089/neu.2007.0431; LATARJET J, 1995, BURNS, V21, P344, DOI 10.1016/0305-4179(95)00003-8; Lee-Kubli CAG, 2014, PAIN, V155, P250, DOI 10.1016/j.pain.2013.10.001; Li YR, 2003, J NEUROPHYSIOL, V90, P857, DOI 10.1152/jn.00236.2003; Li YR, 2004, J NEUROPHYSIOL, V91, P767, DOI 10.1152/jn.00788.2003; Lu VB, 2009, J PHYSIOL-LONDON, V587, P1013, DOI 10.1113/jphysiol.2008.166306; Malenka RC, 2003, NAT REV NEUROSCI, V4, P923, DOI 10.1038/nrn1258; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Meisner JG, 2010, J NEUROTRAUM, V27, P729, DOI 10.1089/neu.2009.1166; Melemedjian OK, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-12; MENDELL LM, 1966, EXP NEUROL, V16, P316, DOI 10.1016/0014-4886(66)90068-9; Morrow T.J., 2004, CURR PROTOC NEUROSCI, V18; Nakayama AY, 2000, HIPPOCAMPUS, V10, P582, DOI 10.1002/1098-1063(2000)10:5<582::AID-HIPO8>3.0.CO;2-K; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; O'Callaghan JP, 2010, METABOLISM, V59, pS21, DOI 10.1016/j.metabol.2010.07.011; Ohsawa K, 2000, J CELL SCI, V113, P3073; Ohsawa M, 2011, PAIN, V152, P114, DOI 10.1016/j.pain.2010.10.005; Pabreja K, 2011, EUR J PHARMACOL, V661, P15, DOI 10.1016/j.ejphar.2011.04.014; PONGRACZ F, 1985, NEUROSCIENCE, V15, P933, DOI 10.1016/0306-4522(85)90244-1; Price TJ, 2009, BRAIN RES REV, V60, P149, DOI 10.1016/j.brainresrev.2008.12.015; Rail W., 1967, J NEUROPHYSIOL, V30, P1169; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Saab CY, 2009, TRENDS NEUROSCI, V32, P110, DOI 10.1016/j.tins.2008.11.004; Sandkuhler J, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-9; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Scholz J, 2002, NAT NEUROSCI, V5, P1062, DOI 10.1038/nn942; Scholz J, 2007, NAT NEUROSCI, V10, P1361, DOI 10.1038/nn1992; Schwechter Brandon, 2013, Commun Integr Biol, V6, pe27343, DOI 10.4161/cib.27343; Segev I, 1998, TRENDS NEUROSCI, V21, P453, DOI 10.1016/S0166-2236(98)01327-7; Smith BH, 2012, CURR PAIN HEADACHE R, V16, P191, DOI 10.1007/s11916-012-0256-0; Svendsen F, 1997, NEUROREPORT, V8, P3427, DOI 10.1097/00001756-199711100-00002; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Talbot S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-36; Tan AM, 2013, EXP NEUROL, V248, P509, DOI 10.1016/j.expneurol.2013.07.017; Tan AM, 2012, J NEUROSCI, V32, P6795, DOI 10.1523/JNEUROSCI.1017-12.2012; Tan AM, 2012, EXP NEUROL, V235, P142, DOI 10.1016/j.expneurol.2011.08.026; Tan AM, 2011, EXP NEUROL, V232, P222, DOI 10.1016/j.expneurol.2011.08.028; Tan AM, 2009, J NEUROPHYSIOL, V102, P2396, DOI 10.1152/jn.00095.2009; Tan AM, 2009, J REHABIL RES DEV, V46, P123, DOI 10.1682/JRRD.2008.03.0048; Tan AM, 2008, J NEUROSCI, V28, P13173, DOI 10.1523/JNEUROSCI.3142-08.2008; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Tesfaye S, 2012, DIABETES-METAB RES, V28, P8, DOI 10.1002/dmrr.2239; Thacker MA, 2009, EUR J PAIN, V13, P263, DOI 10.1016/j.ejpain.2008.04.017; Treede RD, 2008, NEUROLOGY, V70, P1630, DOI 10.1212/01.wnl.0000282763.29778.59; Tsay D, 2004, TRENDS NEUROSCI, V27, P77, DOI 10.1016/j.tins.2003.11.008; Vinay L, 2008, BRAIN RES REV, V57, P103, DOI 10.1016/j.brainresrev.2007.09.003; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; Wang SX, 2011, PAIN MED, V12, P87, DOI 10.1111/j.1526-4637.2010.01021.x; Wang XL, 2007, J PHYSIOL-LONDON, V579, P849, DOI 10.1113/jphysiol.2006.126102; Wang Y, 2006, EUR J NEUROSCI, V23, P141, DOI 10.1111/j.1460-9568.2005.04547.x; Watkins LR, 2001, TRENDS NEUROSCI, V24, P450, DOI 10.1016/S0166-2236(00)01854-3; Waxman SG, 2006, TRENDS NEUROSCI, V29, P207, DOI 10.1016/j.tins.2006.02.003; Wolpaw JR, 1997, TRENDS NEUROSCI, V20, P588, DOI 10.1016/S0166-2236(97)01133-8; WOOLF CJ, 1991, TRENDS NEUROSCI, V14, P74, DOI 10.1016/0166-2236(91)90024-O; WOOLF CJ, 1986, J COMP NEUROL, V251, P517, DOI 10.1002/cne.902510407; WOOLF CJ, 1987, J COMP NEUROL, V261, P105, DOI 10.1002/cne.902610109; Yang YL, 2009, NEUROSCIENTIST, V15, P464, DOI 10.1177/1073858409340800; Yowtak J, 2013, PAIN, V154, P2469, DOI 10.1016/j.pain.2013.07.024; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zeilhofer HU, 2008, NEUROSCI LETT, V437, P170, DOI 10.1016/j.neulet.2008.03.056; Zeilhofer HU, 2008, INT IMMUNOPHARMACOL, V8, P182, DOI 10.1016/j.intimp.2007.07.009; Zhao P, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-27; Zhao P, 2007, J NEUROSCI, V27, P8893, DOI 10.1523/JNEUROSCI.2209-07.2007; Zhao P, 2007, J NEUROSCI, V27, P2357, DOI 10.1523/JNEUROSCI.0138-07.2007	102	18	19	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	AUG 5	2015	601						54	60		10.1016/j.neulet.2014.11.024			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CN5HR	WOS:000358460900008	25445354				2022-02-06	
J	Dismuke, CE; Gebregziabher, M; Yeager, D; Egede, LE				Dismuke, Clara E.; Gebregziabher, Mulugeta; Yeager, Derik; Egede, Leonard E.			Racial/Ethnic Differences in Combat- and Non-Combat-Associated Traumatic Brain Injury Severity in the Veterans Health Administration: 2004-2010	AMERICAN JOURNAL OF PUBLIC HEALTH			English	Article							FUNCTIONAL OUTCOMES; ETHNIC DISPARITIES; MILITARY SERVICE; REHABILITATION; IRAQ; DISORDERS; RISK	Objectives. We examined the association between traumatic brain injury (TBI) severity and combat exposure by race/ethnicity. Methods. We estimated logit models of the fully adjusted association of combat exposure with TBI severity in separate race/ethnicity models for a national cohort of 132 995 veterans with TBI between 2004 and 2010. Results. Of veterans with TBI, 25.8% had served in a combat zone. Mild TBI increased from 11.5% to 40.3%, whereas moderate or severe TBI decreased from 88.5% to 59.7%. Moderate or severe TBI was higher in non-Hispanic Blacks (80.0%) and Hispanics (89.4%) than in non-Hispanic Whites (71.9%). In the fully adjusted all-race/ethnicity model, non-Hispanic Blacks (1.44; 95% confidence interval [CI] = 1.37, 1.52) and Hispanics (1.47; 95% CI = 1.26, 1.72) had higher odds of moderate or severe TBI than did non-Hispanic Whites. However, combat exposure was associated with higher odds of mild TBI in non-Hispanic Blacks (2.48; 95% CI = 2.22, 2.76) and Hispanics (3.42; 95% CI = 1.84, 6.35) than in non-Hispanic Whites (2.17; 95% CI = 2.09, 2.26). Conclusions. Research is needed to understand racial differences in the effect of combat exposure on mild TBI and on interventions to prevent TBI across severity levels.	[Dismuke, Clara E.; Gebregziabher, Mulugeta; Yeager, Derik; Egede, Leonard E.] Ralph H Johnson Vet Affairs Med Ctr, Hlth Equ & Rural Outreach Innovat Ctr, Charleston, SC USA; [Dismuke, Clara E.; Egede, Leonard E.] Med Univ S Carolina, Ctr Hlth Dispar Res, Charleston, SC 29425 USA; [Dismuke, Clara E.; Egede, Leonard E.] Med Univ S Carolina, Div Gen Internal Med & Geriatr, Charleston, SC 29425 USA; [Gebregziabher, Mulugeta] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA		Egede, LE (corresponding author), Med Univ S Carolina, Ctr Hlth Dispar Res, 135 Rutledge Ave,Room 280H,POB 250593, Charleston, SC 29425 USA.	egedel@musc.edu		Gebregziabher, Mulugeta/0000-0002-4826-481X			Arango-Lasprilla JC, 2007, BRAIN INJURY, V21, P701, DOI 10.1080/02699050701481597; Arango-Lasprilla JC, 2007, ARCH PHYS MED REHAB, V88, P11, DOI 10.1016/j.apmr.2006.10.029; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Catalano D, 2006, NEUROREHABILITATION, V21, P279; Catalano D, 2007, NEUROREHABILITATION, V22, P157; Centers for Disease Control and Prevention (CDC), 1997, MMWR Morb Mortal Wkly Rep, V46, P224; Defense and Veterans Brain Injury Center, DEP DEF ICD 9 COD GU; Egede LE, 2012, AM J PUBLIC HEALTH, V102, pS266, DOI 10.2105/AJPH.2011.300176; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Faul M, 2010, TRAUMATIC BRAIN INJU; Gebregziabher M, 2012, J BIOMET BIOSTAT, V3, P1; Gebregziabher M, 2010, J STAT PLAN INFER, V140, P3252, DOI 10.1016/j.jspi.2010.04.020; Gifford B, 2005, ARMED FORCES SOC, V31, P201, DOI 10.1177/0095327X0503100203; Lange RT, 2013, J NEUROTRAUM, V30, P237, DOI 10.1089/neu.2012.2685; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; MacLean A, 2011, SOC SCI RES, V40, P336, DOI 10.1016/j.ssresearch.2010.04.006; Nakase-Richardson R, 2013, ARCH PHYS MED REHAB, V94, P1861, DOI 10.1016/j.apmr.2013.05.027; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Norman RS, 2013, BRAIN INJURY, V27, P1623, DOI 10.3109/02699052.2013.834380; Sander AM, 2009, NEUROREHABILITATION, V24, P15, DOI 10.3233/NRE-2009-0450; Schafer JL, 1997, ANAL INCOMPLETE MULT; Scholten JD, 2012, BRAIN INJURY, V26, P1177, DOI 10.3109/02699052.2012.661914; Shafi S, 2007, J TRAUMA, V63, P1138, DOI 10.1097/TA.0b013e3181568cd4; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; VA Information Resource Center, 2006, VIREC RES US GUID FY; World Health Organization, 1980, INT CLASS DIS	27	18	18	0	2	AMER PUBLIC HEALTH ASSOC INC	WASHINGTON	800 I STREET, NW, WASHINGTON, DC 20001-3710 USA	0090-0036	1541-0048		AM J PUBLIC HEALTH	Am. J. Public Health	AUG	2015	105	8					1696	1702		10.2105/AJPH.2014.302545			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	CT6VL	WOS:000362950400059	26066928	Green Published			2022-02-06	
J	Marcolini, EG; Keegan, J				Marcolini, Evie G.; Keegan, Joshua			Blunt Cardiac Injury	EMERGENCY MEDICINE CLINICS OF NORTH AMERICA			English	Article						Blunt cardiac injury; Cardiac contusion; Cardiac concussion; Commotio cordis; Contusio cordis	COMPLETE HEART-BLOCK; MYOCARDIAL CONTUSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CLINICAL-SIGNIFICANCE; EASTERN ASSOCIATION; TROPONIN-I; TRAUMA; MANAGEMENT; ELECTROCARDIOGRAPHY; ELEVATION	Blunt cardiac injury encompasses multiple different injuries, including contusion, chamber rupture, and acute valvular disorders. Blunt cardiac injury is common and may cause significant morbidity and mortality; a high index of suspicion is needed for accurate diagnosis. Diagnostic work-up should always include electrocardiogram and cardiac enzymes, and may include echocardiography if specific disorders (ie, tamponade or valvular disorders) are suspected. Patients with myocardial contusion should be observed for 24 to 48 hours for arrhythmias. Many other significant forms of blunt cardiac injury require surgical intervention.	[Marcolini, Evie G.] Yale Univ, Sch Med, Dept Emergency Med & Neurol, Div Neurocrit Care & Emergency Neurol, New Haven, CT 06519 USA; [Marcolini, Evie G.] Yale Univ, Sch Med, Div Neurocrit Care & Emergency Neurol, Dept Neurol, New Haven, CT 06520 USA; [Keegan, Joshua] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT 06519 USA		Marcolini, EG (corresponding author), Yale Univ, Sch Med, Dept Emergency Med & Neurol, Div Neurocrit Care & Emergency Neurol, 464 Congress St,Suite 260, New Haven, CT 06519 USA.	emarcolini@gmail.com					Adams JE, 1996, AM HEART J, V131, P308, DOI 10.1016/S0002-8703(96)90359-2; [Anonymous], AM SURG; Baum VC, 2000, J CARDIOTHOR VASC AN, V14, P71, DOI 10.1016/S1053-0770(00)90062-4; Benitez RM, 1999, PACE, V22, P816, DOI 10.1111/j.1540-8159.1999.tb00549.x; Bertinchant JP, 2000, J TRAUMA, V48, P924, DOI 10.1097/00005373-200005000-00018; Bock JS, 2012, CARDIOL CLIN, V30, P545, DOI 10.1016/j.ccl.2012.07.001; BURCHELL HB, 1954, CIRCULATION, V10, P574, DOI 10.1161/01.CIR.10.4.574; Chirillo F, 1996, HEART, V75, P301, DOI 10.1136/hrt.75.3.301; Clancy K, 2012, J TRAUMA ACUTE CARE, V73, pS301, DOI 10.1097/TA.0b013e318270193a; El-Chami MF, 2008, J EMERG MED, V35, P127, DOI 10.1016/j.jemermed.2007.03.018; El-Menyaru A, 2012, ANN CARD ANAESTH, V15, P287, DOI 10.4103/0971-9784.101875; Fulda GJ, 1997, J TRAUMA, V43, P304, DOI 10.1097/00005373-199708000-00016; Garcia-Fernandez MA, 1998, AM HEART J, V135, P476, DOI 10.1016/S0002-8703(98)70324-2; Gibel W, 1988, Z Arztl Fortbild (Jena), V82, P213; Kaye P, 2002, EMERG MED J, V19, P8, DOI 10.1136/emj.19.1.8; Lazaros GA, 2004, INJURY, V35, P1300, DOI 10.1016/j.injury.2003.10.018; LIEDTKE AJ, 1973, AM HEART J, V86, P687, DOI 10.1016/0002-8703(73)90349-9; Lindstaedt M, 2002, J TRAUMA, V52, P479, DOI 10.1097/00005373-200203000-00011; Link MS, 2003, J AM COLL CARDIOL, V41, P99, DOI 10.1016/S0735-1097(02)02669-4; Maenza RL, 1996, AM J EMERG MED, V14, P237, DOI 10.1016/S0735-6757(96)90165-5; Maron BJ, 2009, CIRCULATION, V119, P1085, DOI 10.1161/CIRCULATIONAHA.108.804617; Marshall DT, 2008, AM J FOREN MED PATH, V29, P1, DOI 10.1097/PAF.0b013e31815b4d37; MATTOX KL, 1992, J TRAUMA, V33, P649; McGillicuddy D, 2007, EMERG MED CLIN N AM, V25, P695, DOI 10.1016/j.emc.2007.06.004; PARMLEY LF, 1958, CIRCULATION, V18, P371, DOI 10.1161/01.CIR.18.3.371; Pasquale M, 1998, J TRAUMA, V44, P941, DOI 10.1097/00005373-199806000-00001; PATTON AS, 1981, AM J SURG, V141, P465, DOI 10.1016/0002-9610(81)90141-0; Plautz CU, 2005, AM J EMERG MED, V23, P510, DOI 10.1016/j.ajem.2004.03.014; Press GM, 2013, J EMERG MED, V44, P9, DOI 10.1016/j.jemermed.2012.03.027; Schultz JM, 2004, CRIT CARE CLIN, V20, P57, DOI 10.1016/S0749-0704(03)00092-7; Simon RJ, 2003, J TRAUMA, V54, P50; Stanford GG, 1997, J TRAUMA, V43, P310; TENZER ML, 1985, J TRAUMA, V25, P620, DOI 10.1097/00005373-198507000-00008; Velmahos GC, 2003, J TRAUMA, V54, P45, DOI 10.1097/00005373-200301000-00006; Wolfson AB, 2005, HARWOOD NUSS CLIN PR	35	18	21	0	7	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0733-8627	1558-0539		EMERG MED CLIN N AM	Emerg. Med. Clin. N. Am.	AUG	2015	33	3					519	+		10.1016/j.emc.2015.04.003			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	CP9XW	WOS:000360250200005	26226863				2022-02-06	
J	McCutcheon, BA; Chang, DC; Marcus, L; Gonda, DD; Noorbakhsh, A; Chen, CC; Talamini, MA; Carter, BS				McCutcheon, Brandon A.; Chang, David C.; Marcus, Logan; Gonda, David D.; Noorbakhsh, Abraham; Chen, Clark C.; Talamini, Mark A.; Carter, Bob S.			Treatment biases in traumatic neurosurgical care: a retrospective study of the Nationwide Inpatient Sample from 1998 to 2009	JOURNAL OF NEUROSURGERY			English	Article						extraaxial intracranial hematoma; spinal vertebral fracture; surgical outcomes research; socioeconomic; trauma	INSURANCE STATUS; SOCIOECONOMIC DISPARITIES; INTRACRANIAL ANEURYSMS; MORTALITY; SURGERY; DATABASES; OUTCOMES	OBJECT This study was designed to assess the relationship between insurance status and likelihood of receiving a neurosurgical procedure following admission for either extraaxial intracranial hemorrhage or spinal vertebral fracture. METHODS A retrospective analysis of the Nationwide Inpatient Sample (NIS; 1998-2009) was performed. Cases of traumatic extraaxial intracranial hematoma and spinal vertebral fracture were identified using International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes. Within this cohort, those patients receiving a craniotomy or spinal fusion and/or decompression in the context of an admission for traumatic brain or spine injury, respectively, were identified using the appropriate ICD-9 procedure codes. RESULTS A total of 190,412 patients with extraaxial intracranial hematoma were identified between 1998 and 2009. Within this cohort, 37,434 patients (19.7%) received a craniotomy. A total of 477,110 patients with spinal vertebral fracture were identified. Of these, 37,302 (7.8%) received a spinal decompression and/or fusion. On multivariate analysis controlling for patient demographics, severity of injuries, comorbidities, hospital volume, and hospital characteristics, uninsured patients had a reduced likelihood of receiving a craniotomy (odds ratio [OR] 0.76, 95% confidence interval [CI] 0.71-0.82) and spinal fusion (OR 0.67, 95% CI 0.64-0.71) relative to insured patients. This statistically significant trend persisted when uninsured and insured patients were matched on the basis of mortality propensity score. Uninsured patients demonstrated an elevated risk-adjusted mortality rate relative to insured patients in cases of extraaxial intracranial hematoma. Among patients with spinal injury, mortality rates were similar between patients with and without insurance. CONCLUSIONS In this study, uninsured patients were consistently less likely to receive a craniotomy or spinal fusion for traumatic intracranial extraaxial hemorrhage and spinal vertebral fracture, respectively. This difference persisted after accounting for overall injury severity and patient access to high-or low-volume treatment centers, and potentially reflects a resource allocation bias against uninsured patients within the hospital setting. This information adds to the growing literature detailing the benefits of health reform initiatives seeking to expand access for the uninsured.	[McCutcheon, Brandon A.; Chang, David C.; Marcus, Logan; Noorbakhsh, Abraham; Talamini, Mark A.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Gonda, David D.; Chen, Clark C.; Carter, Bob S.] Univ Calif San Diego, Div Neurosurg, San Diego, CA 92103 USA		McCutcheon, BA (corresponding author), Univ Calif San Diego, Dept Surg, 200 W Arbor Dr, San Diego, CA 92103 USA.	bmccutch@ucsd.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR000098] Funding Source: NIH RePORTER; NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR00098] Funding Source: Medline		Amaranto DJ, 2009, J VASC SURG, V50, P1340, DOI 10.1016/j.jvs.2009.07.089; Brinjikji W, 2012, STROKE, V43, P3200, DOI 10.1161/STROKEAHA.112.671214; Cucchiara BL, 2004, CRIT CARE MED, V32, P241, DOI 10.1097/01.CCM.0000104113.36384.81; Curry WT, 2010, NEUROSURGERY, V66, P427, DOI 10.1227/01.NEU.0000365265.10141.8E; Curry WT, 2009, J NEURO-ONCOL, V93, P25, DOI 10.1007/s11060-009-9840-5; Farber NJ, 2010, MED CARE, V48, P498, DOI 10.1097/MLR.0b013e3181dbe932; Green AR, 2007, J GEN INTERN MED, V22, P1231, DOI 10.1007/s11606-007-0258-5; Greene WR, 2010, AM J SURG, V199, P554, DOI 10.1016/j.amjsurg.2009.11.005; HAAS JS, 1994, AM J PUBLIC HEALTH, V84, P1605, DOI 10.2105/AJPH.84.10.1605; Kelz RR, 2004, CANCER-AM CANCER SOC, V101, P2187, DOI 10.1002/cncr.20624; Leuven E., 2003, PSMATCH2 STATA MODUL; Marion DW, 2006, NEUROSURGERY, V58, P655; Peterson CY, 2011, J SURG RES, V170, pE23, DOI 10.1016/j.jss.2011.04.017; Rincon F, 2007, CURR OPIN CRIT CARE, V13, P115, DOI 10.1097/MCC.0b013e32808255c6; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sanches Jose Eduardo Arantes, 2012, Open Orthop J, V6, P590, DOI 10.2174/1874325001206010590; Segev DL, 2009, J AM SOC NEPHROL, V20, P621, DOI 10.1681/ASN.2008060591; Stephenson SCR, 2002, J TRAUMA, V53, P326, DOI 10.1097/00005373-200208000-00023; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Varela JE, 2011, SURG ENDOSC, V25, P1209, DOI 10.1007/s00464-010-1345-y; Woodworth GF, 2009, NEUROSURGERY, V65, P251, DOI 10.1227/01.NEU.0000347003.35690.7A	21	18	18	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	AUG	2015	123	2					406	414		10.3171/2015.3.JNS131356			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CS6OV	WOS:000362200800018	25955874	Bronze			2022-02-06	
J	Seule, M; Brunner, T; Mack, A; Hildebrandt, G; Fournier, JY				Seule, Martin; Brunner, Thomas; Mack, Alexander; Hildebrandt, Gerhard; Fournier, Jean-Yves			Neurosurgical and Intensive Care Management of Traumatic Brain Injury	FACIAL PLASTIC SURGERY			English	Article						traumatic brain injury; neurosurgery; neurocritical care	FRONTAL-SINUS FRACTURES; CEREBRAL BLOOD-FLOW; INTRACRANIAL-PRESSURE; HEAD-INJURY; FACIAL FRACTURES; HYPERVENTILATION; HYPOTHERMIA; DISSECTION; DIAGNOSIS; OUTCOMES	Optimal management of patients with traumatic brain injury (TBI) remains a challenge, despite significant improvements in pathophysiologic understanding and treatment strategies in recent decades. Because primary brain injury sustained at the time of trauma is irreversible, the TBI management mainly aims for early detection and treatment of secondary brain injury such as space-occupying intracerebral hematomas and brain edema. Prevention of secondary brain injury requires a high standard of care and understanding of both medical and surgical treatment modalities. This review focuses on practical recommendations for neurosurgical and intensive care management in patients with severe TBI.	[Seule, Martin; Mack, Alexander; Hildebrandt, Gerhard; Fournier, Jean-Yves] Kantonsspital St Gallen, Dept Neurosurg, CH-9007 St Gallen, Switzerland; [Brunner, Thomas] Kantonsspital St Gallen, Surg Intens Care Unit, CH-9007 St Gallen, Switzerland		Seule, M (corresponding author), Kantonsspital St Gallen, Dept Neurosurg, Rorschacherstr 95, CH-9007 St Gallen, Switzerland.	martin.seule@kssg.ch					Ali J, 1996, WORLD J SURG, V20, P1121, DOI 10.1007/s002689900171; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bouzat P, 2015, CRIT CARE MED, V43, P445, DOI 10.1097/CCM.0000000000000720; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS55; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock M Ross, 2006, Neurosurgery, V58, pS7; BULLOCK MR, 2006, NEUROSURGERY S, V58; Castro B, 2012, NEUROSURG FOCUS, V32, DOI 10.3171/2012.3.FOCUS1266; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Eastman AL, 2006, J TRAUMA, V60, P925, DOI 10.1097/01.ta.0000197479.28714.62; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Erstad BL, 1999, AM J HEALTH-SYST PH, V56, P347; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Finfer S, 2012, NEW ENGL J MED, V367, P1108, DOI 10.1056/NEJMoa1204942; Gautschi OP, 2013, CLIN NEUROL NEUROSUR, V115, P2482, DOI 10.1016/j.clineuro.2013.09.038; Grande P O, 1997, Acta Anaesthesiol Scand Suppl, V110, P36; HSIANG JK, 1994, CRIT CARE MED, V22, P1471, DOI 10.1097/00003246-199409000-00019; KASSELL NF, 1980, NEUROSURGERY, V7, P598, DOI 10.1227/00006123-198012000-00011; Kennan HT, 1999, ARCH SURG-CHICAGO, V134, P14, DOI 10.1001/archsurg.134.1.14; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; LEE KF, 1987, J NEUROSURG, V66, P542, DOI 10.3171/jns.1987.66.4.0542; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marion DW, 2006, NEUROSURGERY, V58, P655; Markus HS, 2015, LANCET NEUROL, V14, P361, DOI 10.1016/S1474-4422(15)70018-9; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Martin RCG, 2002, AM SURGEON, V68, P477; Maxeiner H, 2007, NEUROSURGERY S, V61, P272; Maxelner H, 2007, NEUROSURGERY, V61, P267, DOI 10.1227/01.neu.0000279222.76375.d4; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Nedeltchev K, 2005, J NEUROL NEUROSUR PS, V76, P191, DOI 10.1136/jnnp.2004.040543; Nelson JA, 2011, ACAD EMERG MED, V18, P78, DOI 10.1111/j.1553-2712.2010.00949.x; Norwood SH, 2002, ARCH SURG-CHICAGO, V137, P696, DOI 10.1001/archsurg.137.6.696; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; Prabhakar Hemanshu, 2014, J Anaesthesiol Clin Pharmacol, V30, P318, DOI 10.4103/0970-9185.137260; Purins K, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00064; Raichle ME, 1972, STROKE, V3, P566, DOI 10.1161/01.STR.3.5.566; Ropper Allan H, 2014, Pract Neurol, V14, P152, DOI 10.1136/practneurol-2014-000811; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Seule M A, 2009, Praxis (Bern 1994), V98, P1021, DOI 10.1024/1661-8157.98.18.1021; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; Strong EB, 2009, CRANIOMAX TRAUM REC, V2, P161, DOI 10.1055/s-0029-1234020; TEASDALE G, 1974, LANCET, V2, P81; Tominaga GT, 2002, ARCH SURG-CHICAGO, V137, P701; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Zandi M, 2013, ORAL MAXILLOFAC SURG, V17, P201, DOI 10.1007/s10006-012-0368-z	54	18	19	0	4	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0736-6825	1098-8793		FACIAL PLAST SURG	Facial Plast. Surg.	AUG	2015	31	4					325	331		10.1055/s-0035-1562884			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CR5UV	WOS:000361410800003	26372706	Green Published			2022-02-06	
J	Kang, WH; Cao, WZ; Graudejus, O; Patel, TP; Wagner, S; Meaney, DF; Morrison, B				Kang, Woo Hyeun; Cao, Wenzhe; Graudejus, Oliver; Patel, Tapan P.; Wagner, Sigurd; Meaney, David F.; Morrison, Barclay, III			Alterations in Hippocampal Network Activity after In Vitro Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						electrophysiology; hippocampus; network synchronization; traumatic brain injury	WORKING-MEMORY; MICROELECTRODE ARRAY; SLICE CULTURES; MODEL; RECORDINGS; HEAD; DYSFUNCTION; DEFORMATION; CONCUSSION; TOPOLOGY	Traumatic brain injury (TBI) alters function and behavior, which can be characterized by changes in electrophysiological function in vitro. A common cognitive deficit after mild-to-moderate TBI is disruption of persistent working memory, of which the in vitro correlate is long-lasting, neuronal network synchronization that can be induced pharmacologically by the gamma-aminobutyric acid A antagonist, bicuculline. We utilized a novel in vitro platform for TBI research, the stretchable microelectrode array (SMEA), to investigate the effects of TBI on bicuculline-induced, long-lasting network synchronization in the hippocampus. Mechanical stimulation significantly disrupted bicuculline-induced, long-lasting network synchronization 24h after injury, despite the continued ability of the injured neurons to fire, as revealed by a significant increase in the normalized spontaneous event rate in the dentate gyrus (DG) and CA1. A second challenge with bicuculline 24h after the first challenge significantly decreased the normalized spontaneous event rate in the DG. In addition, we illustrate the utility of the SMEA for TBI research by combining multiple experimental paradigms in one platform, which has the potential to enable novel investigations into the mechanisms responsible for functional consequences of TBI and speed the rate of drug discovery.	[Kang, Woo Hyeun; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Cao, Wenzhe; Graudejus, Oliver; Wagner, Sigurd] Princeton Univ, Dept Elect Engn, Princeton, NJ 08544 USA; [Graudejus, Oliver] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA; [Patel, Tapan P.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904,1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122; Patel, Tapan/0000-0001-8959-6645	National Highway Traffic Safety Administration [DTNH22-08-C-00088]; New Jersey Commission on Brain Injury Research [08-3209-BIR-E-1]; Multidisciplinary University Research Initiative from the Army Research Office [W911MF-10-1-0526]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176] Funding Source: NIH RePORTER	This work was supported, in part, by the National Highway Traffic Safety Administration (DTNH22-08-C-00088), the New Jersey Commission on Brain Injury Research (08-3209-BIR-E-1), and by a Multidisciplinary University Research Initiative from the Army Research Office (W911MF-10-1-0526). The authors grate-fully acknowledge the pioneering efforts of Stephanie P. Lacour (EPFL) in the early development of the SMEA.	Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Bonislawski DP, 2007, NEUROBIOL DIS, V25, P163, DOI 10.1016/j.nbd.2006.09.002; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Choi JH, 2006, IEEE T BIO-MED ENG, V53, P738, DOI 10.1109/TBME.2006.870239; Christidi F, 2011, J NEUROTRAUM, V28, P711, DOI 10.1089/neu.2010.1644; DECURTIS M, 1994, J NEUROPHYSIOL, V71, P2463, DOI 10.1152/jn.1994.71.6.2463; Doetsch GS, 2000, PHYSIOL BEHAV, V69, P187, DOI 10.1016/S0031-9384(00)00201-8; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Egert U, 2005, PRACTICAL METHODS IN CARDIOVASCULAR RESEARCH, P432, DOI 10.1007/3-540-26574-0_22; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gean AD, 2010, NEUROIMAG CLIN N AM, V20, P527, DOI 10.1016/j.nic.2010.08.001; Graudejus O, 2009, J ELECTROCHEM SOC, V156, pP85, DOI 10.1149/1.3115465; Graudejus O, 2012, ADV FUNCT MATER, V22, P640, DOI 10.1002/adfm.201102290; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kralik JD, 2001, METHODS, V25, P121, DOI 10.1006/meth.2001.1231; Lacour SP, 2003, APPL PHYS LETT, V82, P2404, DOI 10.1063/1.1565683; Leinekugel X, 1999, Adv Neurol, V79, P189; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Li XN, 2007, BIOSENS BIOELECTRON, V22, P1538, DOI 10.1016/j.bios.2006.05.030; Li XL, 2007, J NEUROPHYSIOL, V98, P3341, DOI 10.1152/jn.00977.2007; Li XL, 2010, BIOPHYS J, V98, P1733, DOI 10.1016/j.bpj.2010.01.013; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Matsuyama S, 2008, NEUROREPORT, V19, P1809, DOI 10.1097/WNR.0b013e328319ab94; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; NOVAK JL, 1988, J NEUROSCI METH, V23, P149, DOI 10.1016/0165-0270(88)90187-2; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Patel TP, 2012, ANN BIOMED ENG, V40, P23, DOI 10.1007/s10439-011-0390-6; Pimashkin A, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00046; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; SLOVITER RS, 1994, HIPPOCAMPUS, V4, P250, DOI 10.1002/hipo.450040304; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Tsay C, 2005, IEEE SENSOR, P1169; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang W, 2006, NEUROSCI LETT, V406, P11, DOI 10.1016/j.neulet.2006.06.064; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Yu Z, 2010, J NEUROPHYSIOL, V103, P499, DOI 10.1152/jn.00775.2009; Yu Z, 2009, J NEUROTRAUM, V26, P1135, DOI 10.1089/neu.2008.0810	58	18	18	1	15	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 1	2015	32	13					1011	1019		10.1089/neu.2014.3667			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0SU	WOS:000363964200010	25517970	Green Published			2022-02-06	
J	Kim, JY; Lee, YW; Kim, JH; Lee, WT; Park, KA; Lee, JE				Kim, Jae Young; Lee, Yong Woo; Kim, Jae Hwan; Lee, Won Taek; Park, Kyung Ah; Lee, Jong Eun			Agmatine Attenuates Brain Edema and Apoptotic Cell Death after Traumatic Brain Injury	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Agmatine; Traumatic Brain Injury; Brain Edema; Blood-Brain Barrier; Aquaporins; Mitogen-Activated Protein Kinases	FOCAL CEREBRAL-ISCHEMIA; FACTOR-KAPPA-B; CLONIDINE-DISPLACING SUBSTANCE; PROTEIN-KINASE PATHWAYS; COLD-INJURY; IN-VITRO; EXPRESSION; RATS; AQUAPORIN-4; ASTROCYTES	Traumatic brain injury (TBI) is associated with poor neurological outcome, including necrosis and brain edema. In this study, we investigated whether agmatine treatment reduces edema and apoptotic cell death after TBI. TBI was produced by cold injury to the cerebral primary motor cortex of rats. Agmatine was administered 30 min after injury and once daily until the end of the experiment. Animals were sacrificed for analysis at 1, 2, or 7 days after the injury. Various neurological analyses were performed to investigate disruption of the blood-brain barrier (BBB) and neurological dysfunction after TBI. To examine the extent of brain edema after TBI, the expression of aquaporins (AQPs), phosphorylation of mitogen-activated protein kinases (MAPKs), and nuclear translocation of nuclear factor-kappa B (NF-kappa B) were investigated. Our findings demonstrated that agmatine treatment significantly reduces brain edema after TBI by suppressing the expression of AQP1, 4, and 9. In addition, agmatine treatment significantly reduced apoptotic cell death by suppressing the phosphorylation of MAPKs and by increasing the nuclear translocation of NF-kappa B after TBI. These results suggest that agmatine treatment may have therapeutic potential for brain edema and neural cell death in various central nervous system diseases.	[Kim, Jae Young; Lee, Yong Woo; Kim, Jae Hwan; Lee, Won Taek; Park, Kyung Ah; Lee, Jong Eun] Yonsei Univ, Dept Anat, Coll Med, Seoul 120752, South Korea; [Kim, Jae Young; Lee, Jong Eun] Yonsei Univ, PLUS Project Med Sci BK21, Coll Med, Seoul 120752, South Korea; [Lee, Jong Eun] Yonsei Univ, Brain Res Inst, Coll Med, Seoul 120752, South Korea		Lee, JE (corresponding author), Yonsei Univ, Dept Anat, Coll Med, 50 Yonsei Ro, Seoul 120752, South Korea.	jelee@yuhs.ac		Lee, Won Taek/0000-0001-7348-9562; Lee, Jong Eun/0000-0001-6203-7413; Kim, Jae Young/0000-0001-5315-6015	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [2014R1A2A2A01006556]	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (2014R1A2A2A01006556).	Ahmed KM, 2006, MOL CANCER RES, V4, P945, DOI 10.1158/1541-7786.MCR-06-0291; Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Arndt MA, 2009, AM J PHYSIOL-CELL PH, V296, pC1411, DOI 10.1152/ajpcell.00529.2008; Badaut T, 2002, J CEREBR BLOOD F MET, V22, P367, DOI 10.1097/00004647-200204000-00001; Condello S, 2011, J NEUROCHEM, V116, P67, DOI 10.1111/j.1471-4159.2010.07085.x; deVries HE, 1996, J NEUROIMMUNOL, V64, P37, DOI 10.1016/0165-5728(95)00148-4; Feng YZ, 2002, PEDIATR RES, V52, P606, DOI 10.1203/01.PDR.0000028057.79132.1F; GILAD GM, 1995, LIFE SCI, V58, pPL41, DOI 10.1016/0024-3205(95)02274-0; Gilad GM, 2000, NEUROSCI LETT, V296, P97, DOI 10.1016/S0304-3940(00)01625-6; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Halaris A, 2007, CNS DRUGS, V21, P885, DOI 10.2165/00023210-200721110-00002; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1089, DOI 10.1097/00004647-200007000-00008; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kim JH, 2010, J CEREBR BLOOD F MET, V30, P943, DOI 10.1038/jcbfm.2009.260; Kim JH, 2004, EXP NEUROL, V189, P122, DOI 10.1016/j.expneurol.2004.05.029; Kuo JR, 2007, RESUSCITATION, V75, P506, DOI 10.1016/j.resuscitation.2007.05.011; Kuo JR, 2011, J TRAUMA, V71, pE87, DOI 10.1097/TA.0b013e31820932e2; Lee WT, 2009, BRAIN RES, V1281, P64, DOI 10.1016/j.brainres.2009.05.046; LI G, 1994, SCIENCE, V263, P966, DOI 10.1126/science.7906055; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mattson MP, 2000, J NEUROCHEM, V74, P443, DOI 10.1046/j.1471-4159.2000.740443.x; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Murakami K, 1999, PROG NEUROBIOL, V57, P289, DOI 10.1016/S0301-0082(98)00047-1; Nag S, 1996, J NEUROPATH EXP NEUR, V55, P880, DOI 10.1097/00005072-199608000-00003; Nito C, 2012, J NEUROTRAUM, V29, P2404, DOI 10.1089/neu.2012.2430; Olmos G, 1999, BRIT J PHARMACOL, V127, P1317, DOI 10.1038/sj.bjp.0702679; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; PILETZ JE, 1995, J PHARMACOL EXP THER, V272, P581; Puurunen K, 2001, EXP NEUROL, V167, P348, DOI 10.1006/exnr.2000.7563; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Sugino T, 2000, NEUROSCI LETT, V278, P101, DOI 10.1016/S0304-3940(99)00906-4; Wang Che-Chuan, 2010, BMC Pharmacology, V10, P11, DOI 10.1186/1471-2210-10-11; Yang XC, 1999, J PHARMACOL EXP THER, V288, P544	39	18	19	0	2	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUL	2015	30	7					943	952		10.3346/jkms.2015.30.7.943			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CR4OA	WOS:000361312000018	26130959	Green Submitted, Green Published, gold			2022-02-06	
J	Ramanathan, R; Gu, ZR; Limkemann, AJ; Chandrasekhar, S; Rensing, E; Mays, C; Duane, TM				Ramanathan, Rajesh; Gu, Zirui; Limkemann, Ashley J.; Chandrasekhar, Shillika; Rensing, Edna; Mays, Cathy; Duane, Therese M.			Association between Interruptions in Chemical Prophylaxis and VTE Formation	AMERICAN SURGEON			English	Article							DEEP-VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM PROPHYLAXIS; TRAUMATIC BRAIN-INJURY; MAJOR TRAUMA; SURGERY; PREVENTION; PATIENT; HEPARIN; RISK; MECHANISMS	Venous thromboembolisms (VTE) are considered preventable events with appropriate mechanical or chemical prophylaxis. However, chemical prophylaxis is frequently delayed or interrupted during hospitalization. We investigated the impact of delayed initiation and interruption of chemical prophylaxis on VTE rates. The incidence of VTE at an urban academic medical center was measured in patients hospitalized for >2 days between November 2013 and May 2014. Patients receiving prophylaxis were grouped as complete (started within 24 hours of admission and no interruptions), delayed (started >24 hours and no interruptions), and interrupted (interruption for >24 hours with or without delay). There were 9961 hospital admissions and 33 VTE (3.3 per 1000 admissions). 25.2 per cent had complete, 16.4 per cent had delayed, and 11.8 per cent had interrupted prophylaxis. 36.8 per cent received no prophylaxis. Interrupted prophylaxis was associated with more VTE than complete (10.2 vs 2.0 per 1000, P < 0.01) and 5.2 greater odds. Admission to a surgical service and prolonged hospital stay were independently associated with increased likelihood of VTE. There was a lower likelihood of getting complete prophylaxis among patients admitted to orthopedic, transplant, cardiac, plastic, and vascular surgery. Surgical patients are at higher risk for VTE and interruptions in VTE prophylaxis significantly increase the risk of VTE.	[Ramanathan, Rajesh; Limkemann, Ashley J.] VCU Med Ctr, Dept Surg, Richmond, VA USA; [Gu, Zirui; Rensing, Edna; Mays, Cathy] VCU Med Ctr, Performance Improvement, Richmond, VA USA; [Chandrasekhar, Shillika] Virginia Commonwealth Univ, Richmond, VA USA; [Duane, Therese M.] JPS Hlth Network, Dept Surg, Ft Worth, TX USA		Duane, TM (corresponding author), 1500 S Main St Suite 303, Ft Worth, TX 76104 USA.	tduane@jpshealth.org					Agency for Healthcare Research and Quality, 2003, AHRQ QUAL IND GUID P; Barrera LM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008303.pub2; Bick RL, 2005, HEMATOL ONCOL CLIN N, V19, P1, DOI 10.1016/j.hoc.2004.09.003; BOISCLAIR MD, 1993, BLOOD, V82, P3350; DENNIS JW, 1993, J TRAUMA, V35, P132, DOI 10.1097/00005373-199307000-00021; Falck-Ytter Y, 2012, CHEST, V141, pE278S, DOI 10.1378/chest.11-2404; Francis CW, 2013, J THROMB THROMBOLYS, V35, P359, DOI 10.1007/s11239-013-0889-9; GEERTS WH, 1994, NEW ENGL J MED, V331, P1601, DOI 10.1056/NEJM199412153312401; Guyatt GH, 2012, CHEST, V141, p48S, DOI 10.1378/chest.11-2286; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hill J, 2007, BMJ-BRIT MED J, V334, P1053, DOI 10.1136/bmj.39174.678032.AD; KAKKAR VV, 1972, LANCET, V2, P101; Knudson MM, 1996, J TRAUMA, V41, P446, DOI 10.1097/00005373-199609000-00010; Leonardi MJ, 2006, ARCH SURG-CHICAGO, V141, P790, DOI 10.1001/archsurg.141.8.790; Louis SG, 2014, JAMA SURG, V149, P365, DOI 10.1001/jamasurg.2013.3963; Lyman GH, 2013, J CLIN ONCOL, V31, P2189, DOI 10.1200/JCO.2013.49.1118; Mahan CE, 2011, THROMB HAEMOSTASIS, V106, P405, DOI 10.1160/TH11-02-0132; Malhotra AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106793; Muntz JE, 2010, AM J SURG, V199, pS11, DOI 10.1016/j.amjsurg.2009.10.007; Nathens AB, 2007, J TRAUMA, V62, P557, DOI 10.1097/TA.0b013e318031b5f5; Ramanathan R, 2013, AM SURGEON, V79, P578; Reiff DA, 2009, J TRAUMA, V66, P1436, DOI 10.1097/TA.0b013e31817fdf1c; Rogers SO, 2007, J TRAUMA, V62, P562; Salottolo K, 2011, J TRAUMA, V70, P19, DOI 10.1097/TA.0b013e318207c54d	24	18	18	0	7	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	JUL	2015	81	7					732	737					6	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CN2FN	WOS:000358236300025	26140896				2022-02-06	
J	Scott, GG; Coats, B				Scott, Gregory G.; Coats, Brittany			Microstructural Characterization of the Pia-Arachnoid Complex Using Optical Coherence Tomography	IEEE TRANSACTIONS ON MEDICAL IMAGING			English	Article						Arachnoid; biomedical image processing; in situ imaging; manual image segmentation; meninges; optical coherence tomography (OCT); pig animal model; traumatic brain injury	BRAIN-INJURY; HEAD ROTATIONS; ANATOMY; MICROSCOPY; MORPHOLOGY; RESPONSES; NERVE	Traumatic brain injury (TBI) is one of the leading causes of death and disability in the world, and is often identified by the presence of subdural and/or subarachnoid hemorrhages that develop from ruptured cortical vessels during brain-skull displacement. The pia-arachnoid complex (PAC), also known as the leptomeninges, is the major mechanical connection between the brain and skull, and influences cortical vessel deformation and rupture following brain trauma. This complex consists of cerebrospinal fluid, arachnoid trabeculae, and subarachnoid vasculature sandwiched between the arachnoid and pia mater membranes. Remarkably, studies of the tissues in the PAC are largely qualitative and do not provide numerical metrics of population density and variability of the arachnoid trabeculae and subarachnoid vasculature. In this study, microstructural imaging was performed on the PAC to numerically quantify these metrics. Five porcine brains were perfusion-fixed and imaged in situ using optical coherence tomography with micrometer resolution. Image processing was performed to estimate the volume fraction (VF) of the arachnoid trabeculae and subarachnoid vasculature in 12 regions of the brain. High regional variability was found within each brain, with individual brains exhibiting up to a 38.4 percentage-point range in VF. Regions with high VF were often next to regions with low VF. This suggests that some areas of the brain may be mechanically weaker, increasing their susceptibility to hemorrhage during TBI events. This study provides the first quantifiable data of arachnoid trabeculae and subarachnoid vasculature distribution within the PAC and will be valuable to understanding brain biomechanics during head trauma.	[Scott, Gregory G.; Coats, Brittany] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA		Coats, B (corresponding author), Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA.	greg.scott.me@gmail.com; bcoats@mech.utah.edu	Coats, Brittany/A-4523-2009		Primary Children's Medical Center Foundation Early Career Grant	This work was supported in part by the Primary Children's Medical Center Foundation Early Career Grant.	ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; ARMSTEAD WM, 1994, J NEUROTRAUM, V11, P487, DOI 10.1089/neu.1994.11.487; Assayag O, 2013, NEUROIMAGE-CLIN, V2, P549, DOI 10.1016/j.nicl.2013.04.005; Bizheva K, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1851513; Bizheva K, 2004, J BIOMED OPT, V9, P719, DOI 10.1117/1.1756920; Boppart SA, 2003, PSYCHOPHYSIOLOGY, V40, P529, DOI 10.1111/1469-8986.00055; Brezinski ME, 1997, HEART, V77, P397, DOI 10.1136/hrt.77.5.397; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Damestani Y, 2013, NANOMED-NANOTECHNOL, V9, P1135, DOI 10.1016/j.nano.2013.08.002; Dickerson J. W. T., 1966, Proceedings of the Royal Society, V166B, P384; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Duhaime AC, 2003, J NEUROSURG, V99, P542, DOI 10.3171/jns.2003.99.3.0542; Duhaime AC, 2000, J NEUROSURG, V93, P455, DOI 10.3171/jns.2000.93.3.0455; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Eucker S. A., 2009, THESIS U PENNSYLVANI; Finke M, 2012, INT J MED ROBOT COMP, V8, P327, DOI 10.1002/rcs.1425; FLYNN TJ, 1984, NEUROCHEM RES, V9, P935, DOI 10.1007/BF00964525; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Girard MJA, 2011, INVEST OPHTH VIS SCI, V52, P7738, DOI 10.1167/iovs.10-6925; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Izatt JA, 1996, IEEE J SEL TOP QUANT, V2, P1017, DOI 10.1109/2944.577331; Jeon SW, 2006, J NEUROSCI METH, V154, P96, DOI 10.1016/j.jneumeth.2005.12.008; Killer HE, 2003, BRIT J OPHTHALMOL, V87, P777, DOI 10.1136/bjo.87.6.777; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Nahas A, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121514; NICHOLAS DS, 1988, J NEUROSURG, V69, P276, DOI 10.3171/jns.1988.69.2.0276; OKA K, 1985, NEUROSURGERY, V17, P711, DOI 10.1227/00006123-198511000-00003; Petroni S, 2003, CELLS TISSUES ORGANS, V173, P122, DOI 10.1159/000068943; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; SCHMITT JM, 1995, DERMATOLOGY, V191, P93, DOI 10.1159/000246523; Sci. Comput. Imag. Inst, SEG3D VOL IM SEGM VI; Shaver EG, 1996, PEDIATR NEUROSURG, V25, P123, DOI 10.1159/000121109; Srinivasan VJ, 2011, J CEREBR BLOOD F MET, V31, P1339, DOI 10.1038/jcbfm.2011.19; Srinivasan VJ, 2010, OPT LETT, V35, P43, DOI 10.1364/OL.35.000043; Szu JI, 2012, JOVE-J VIS EXP, DOI 10.3791/50053; Wang H, 2011, NEUROIMAGE, V58, P984, DOI 10.1016/j.neuroimage.2011.07.005; Weller R. O., 2005, Morphologie, V89, P22, DOI 10.1016/S1286-0115(05)83235-7	40	18	18	1	7	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0278-0062	1558-254X		IEEE T MED IMAGING	IEEE Trans. Med. Imaging	JUL	2015	34	7					1452	1459		10.1109/TMI.2015.2396527			8	Computer Science, Interdisciplinary Applications; Engineering, Biomedical; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering; Imaging Science & Photographic Technology; Radiology, Nuclear Medicine & Medical Imaging	CM3VX	WOS:000357614300004	25643401				2022-02-06	
J	Ozkan, H; Ekinci, S; Uysal, B; Akyildiz, F; Turkkan, S; Ersen, O; Koca, K; Seven, MM				Ozkan, Huseyin; Ekinci, Safak; Uysal, Bulent; Akyildiz, Faruk; Turkkan, Selim; Ersen, Omer; Koca, Kenan; Seven, Mehmet Murat			Evaluation and comparison of the effect of hypothermia and ozone on ischemia-reperfusion injury of skeletal muscle in rats	JOURNAL OF SURGICAL RESEARCH			English	Article						IR injury; Hypothermia; Ozone; SOD; GSH-Px MDA; NOx; IL-1B; iNOS	POSTISCHEMIC HYPOTHERMIA; HYPERBARIC-OXYGEN; CARDIAC-ARREST; FREE-RADICALS; ISCHEMIA/REPERFUSION; TOURNIQUET; PROTECTS; DAMAGE; BRAIN; ASSAY	Background: Tourniquet-induced ischemia-reperfusion, which affects local and distant organs, is very common in orthopedic surgery. Hypothermia is used in traumatic tissue during ischemic period commonly. Ozone (O-3) has been recommended as a novel therapeutic agent in various medical conditions. The objective of the study was to evaluate and compare the effect of hypothermia (H) and O-3 on ischemia-reperfusion injury of skeletal muscle in rats by measuring oxidative parameters and inducible nitric oxide synthase (iNOS) levels. Materials and methods: Eighteen rats (Wistar albino) were separated into five groups randomly (sham, IR, IR + H, IR + O-3, IR + H + O-3; n = 6). The lower right extremity of all rats was subjected to 2 h of ischemia and 22 h of reperfusion clamping the common iliac artery and using the rubber-band technique at the level of the lesser trochanter under general anesthesia. Two hours of hypothermia were applied during the first 2 h of reperfusion in two groups. O-3 was applied in two groups. All rats were sacrificed after the IR period with high dose of anesthesia. The tibialis anterior muscle and blood were saved. Levels of superoxide dismutase, glutathione peroxidase, MDA, NOx, and interleukin-1 beta were measured in the muscle. Creatinine kinase, lactate dehydrogenase, aspartate aminotransferase, urea, creatinine, and electrolytes were measured in serum. Immunohistochemical iNOS staining was performed on muscle samples. Results: The levels of MDA, NOx, and interleukin-1 beta in muscle were raised in the IR group compared with those in the sham group. The same parameters were lower in the groups of IR + H, IR + O-3, and IR + H + O-3 compared with those in the IR group. Superoxide dismutase and glutathione peroxidase activities in muscle were lower in the IR group compared with those in the sham group; however, same parameters were higher in the groups of IR + H, IR + O-3, and IR + H + O-3 compared with those in the IR group. Score and intensity of iNOS staining in skeletal muscle in the IR group was increased compared with that in the sham group and decreased in the groups of IR + H, IR + O-3, and IR + H + O-3 compared with that in the IR group. Levels of creatinine kinase, aspartate aminotransferase, and K in the three treatment groups decreased compared with those in the IR group. Conclusions: These findings showed that hypothermia, which has more affect, and O-3 decreased the tourniquet-induced IR injury in the rat's muscle-skeletal system by reducing the levels of oxidative and nitrosative stress parameters and enhancing antioxidant enzymes. Hypothermia and O-3 had no synergistic effect. Hypothermic reperfusion and O-3 preconditioning might be beneficial in skeletal muscle IR injury-associated tourniquet. (C) 2015 Elsevier Inc. All rights reserved.	[Ozkan, Huseyin; Turkkan, Selim; Koca, Kenan] Gulhane Mil Med Fac, Dept Orthoped Surg, Ankara, Turkey; [Ekinci, Safak] Agri Mil Hosp, Dept Orthoped Surg, Agri, Turkey; [Uysal, Bulent] Gulhane Mil Med Fac, Dept Physiol, Ankara, Turkey; [Akyildiz, Faruk] Malatya Mil Hosp, Dept Orthoped Surg, Malatya, Turkey; [Ersen, Omer] Erzurum Mil Hosp, Dept Orthoped Surg, Erzurum, Turkey; [Seven, Mehmet Murat] Gulhane Mil, Dept Sport Med, Fac Med, Ankara, Turkey		Ekinci, S (corresponding author), Agri Mil Hosp, Dept Orthoped Surg, Agri, Turkey.	safakekinci@yahoo.com	Ozkan, Huseyin/E-3000-2016; Ozkan, Huseyin/Y-4005-2019	Ozkan, Huseyin/0000-0001-9708-0112; Ersen, Omer/0000-0001-7351-6305; Uysal, Bulent/0000-0003-1254-9749			Al-Dalain SM, 2001, PHARMACOL RES, V44, P391; ARMSTEAD WM, 1988, AM J PHYSIOL, V255, pH401, DOI 10.1152/ajpheart.1988.255.2.H401; Canevari L, 1999, BRAIN RES, V817, P241, DOI 10.1016/S0006-8993(98)01278-5; Chen H, 2008, J SURG RES, V149, P287, DOI 10.1016/j.jss.2007.12.756; Koca K, 2010, ACTA ORTHOP TRAUMATO, V44, P476, DOI 10.3944/AOTT.2010.2327; Koca K, 2010, J SURG RES, V164, pE83, DOI 10.1016/j.jss.2010.06.030; KORTHUIS RJ, 1985, CIRC RES, V57, P599, DOI 10.1161/01.RES.57.4.599; LEI BP, 1994, STROKE, V25, P147, DOI 10.1161/01.STR.25.1.147; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NAGANO K, 1990, AM J PHYSIOL, V258, pG910, DOI 10.1152/ajpgi.1990.258.6.G910; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Scarfiotti C, 1997, EUR J CANCER PREV, V6, pS31, DOI 10.1097/00008469-199703001-00007; SUN Y, 1988, CLIN CHEM, V34, P497; Tunc T, 2009, J GASTROEN HEPATOL, V24, P681, DOI 10.1111/j.1440-1746.2008.05673.x; Santos ELW, 2013, ACTA CIR BRAS, V28, P582, DOI 10.1590/S0102-86502013000800005; WEINRAUCH V, 1992, STROKE, V23, P1454, DOI 10.1161/01.STR.23.10.1454; WRIGHT JG, 1989, J SURG RES, V47, P389; WRIGHT JG, 1988, J TRAUMA, V28, P1026, DOI 10.1097/00005373-198807000-00019	19	18	20	0	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 15	2015	196	2					313	319		10.1016/j.jss.2015.01.053			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	CI9QC	WOS:000355103700016	25840486				2022-02-06	
J	Pilipovic, K; Zupan, Z; Dolenec, P; Mrsic-Pelcic, J; Zupan, G				Pilipovic, Kristina; Zupan, Zeljko; Dolenec, Petra; Mrsic-Pelcic, Jasenka; Zupan, Gordana			A single dose of PPAR gamma agonist pioglitazone reduces cortical oxidative damage and microglial reaction following lateral fluid percussion brain injury in rats	PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY			English	Article						Inflammation; Oxidative stress; Pioglitazone; Rat; Traumatic brain injury	PROLIFERATOR-ACTIVATED RECEPTORS; TRANSIENT FOCAL ISCHEMIA; NECROSIS-FACTOR-ALPHA; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INDUCED STATUS EPILEPTICUS; NF-KAPPA-B; GLUTATHIONE-PEROXIDASE; NEURONAL INJURY; HEAD-INJURY; PROVIDES NEUROPROTECTION	Neuroprotective actions of the peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists have been observed in various animal models of the brain injuries. In this study we examined the effects of a single dose of pioglitazone on oxidative and inflammatory parameters as well as on neurodegeneration and the edema formation in the rat parietal cortex following traumatic brain injury (TBI) induced by the lateral fluid percussion injury (LFPI) method. Pioglitazone was administered in a dose of 1 mg/kg at 10 min after the brain trauma. The animals of the control group were sham-operated and injected by vehicle. The rats were decapitated 24 h after LFPI and their parietal cortices were analyzed by biochemical and histological methods. Cortical edema was evaluated in rats sacrificed 48 h following TBI. Brain trauma caused statistically significant oxidative damage of lipids and proteins, an increase of glutathione peroxidase (GSH-Px) activity, the cyclooxygenase-2 (COX-2) overexpression, reactive astrocytosis, the microglia activation, neurodegeneration, and edema, but it did not influence the superoxide dismutase activity and the expressions of interleukin-1 beta, interleukin-6 and tumor necrosis factor-alpha in the rat parietal cortex. Pioglitazone significantly decreased the cortical lipid and protein oxidative damage, increased the GSH-Px activity and reduced microglial reaction. Although a certain degree of the TBI-induced COX-2 overexpression, neurodegeneration and edema decrease was detected in pioglitazone treated rats, it was not significant. In the injured animals, cortical reactive astrocytosis was unchanged by the tested PPAR gamma agonist. These findings demonstrate that pioglitazone, administered only in a single dose, early following LFPI, reduced cortical oxidative damage, increased antioxidant defense and had limited anti-inflammatory effect, suggesting the need for further studies of this drug in the treatment of TBI. (C) 2015 Elsevier Inc. All rights reserved.	[Pilipovic, Kristina; Dolenec, Petra; Mrsic-Pelcic, Jasenka; Zupan, Gordana] Univ Rijeka, Sch Med, Dept Pharmacol, Rijeka 51000, Croatia; [Zupan, Zeljko] Univ Rijeka, Sch Med, Dept Anesthesiol Reanimatol & Intens Care Med, Rijeka 51000, Croatia; [Zupan, Zeljko] Clin Hosp Ctr Rijeka, Anesthesiol Clin, Rijeka, Croatia; [Zupan, Zeljko] Clin Hosp Ctr Rijeka, Clin Intens Care Med, Rijeka, Croatia		Zupan, G (corresponding author), Univ Rijeka, Sch Med, Dept Pharmacol, Brace Branchetta 20, Rijeka 51000, Croatia.	gordana.zupan@medri.uniri.hr	Zupan, Zeljko/AAO-1749-2021; Zupan, Gordana/AAO-7057-2021; Pilipovic, Kristina/Q-5974-2018; Zupan, Gordana/AAO-7020-2021; Dolenec, Petra/AAV-1118-2021; Zupan, Zeljko/S-2786-2018; Dolenec, Petra/S-3997-2018; Zupan, Gordana/R-4927-2018; Mrsic-Pelcic, Jasenka/R-2972-2018	Zupan, Zeljko/0000-0003-4576-7961; Zupan, Gordana/0000-0002-4422-9021; Pilipovic, Kristina/0000-0002-7129-1621; Dolenec, Petra/0000-0002-9960-0385; Zupan, Zeljko/0000-0003-4576-7961; Dolenec, Petra/0000-0002-9960-0385; Zupan, Gordana/0000-0002-4422-9021; Mrsic-Pelcic, Jasenka/0000-0002-6313-9232	Ministry of Science, Education and Sports of the Republic of CroatiaMinistry of Science, Education and Sports, Republic of Croatia [062-0620529-0519]; University of Rijeka [13.06.1.1.09]	The authors thank Marina Jakovac, eng.med.lab.diagn., and Maja Rukavina, univ.bacc.biotech et pharm.inv. from the Department of Pharmacology, School of Medicine, University of Rijeka, Rijeka, Croatia for then much appreciated technical assistance. This work has been supported in parts by Grant 062-0620529-0519 to G.Z. from The Ministry of Science, Education and Sports of the Republic of Croatia and by the University of Rijeka under the project number 13.06.1.1.09 to G.Z.	Abdallah DM, 2010, BRAIN RES, V1351, P246, DOI 10.1016/j.brainres.2010.06.034; Abdelrahman M, 2005, CARDIOVASC RES, V65, P772, DOI 10.1016/j.cardiores.2004.12.008; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Aoun P, 2003, EUR J PHARMACOL, V472, P65, DOI 10.1016/S0014-2999(03)01867-3; BAZAN NG, 1989, ANN NY ACAD SCI, V559, P1; Bernardo A, 2006, CURR PHARM DESIGN, V12, P93, DOI 10.2174/138161206780574579; Bordt EA, 2014, FREE RADICAL BIO MED, V76, P34, DOI 10.1016/j.freeradbiomed.2014.07.033; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Breidert T, 2002, J NEUROCHEM, V82, P615, DOI 10.1046/j.1471-4159.2002.00990.x; Callaway JK, 1998, J PHARMACOL TOXICOL, V39, P155, DOI 10.1016/S1056-8719(98)00022-7; Cernak I, 2001, CLIN EXP PHARMACOL P, V28, P922, DOI 10.1046/j.1440-1681.2001.03549.x; Cernak I, 2002, EXP BRAIN RES, V147, P193, DOI 10.1007/s00221-002-1245-z; Chatzipanteli K, 2012, THER HYPOTHERMIA TEM, V2, P167, DOI 10.1089/ther.2012.0016; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheney JA, 2001, J CEREBR BLOOD F MET, V21, P396, DOI 10.1097/00004647-200104000-00008; Collino M, 2006, EUR J PHARMACOL, V530, P70, DOI 10.1016/j.ejphar.2005.11.049; Culman J, 2007, TRENDS PHARMACOL SCI, V28, P244, DOI 10.1016/j.tips.2007.03.004; Cuzzocrea S, 2004, VASC PHARMACOL, V41, P187, DOI 10.1016/j.vph.2004.10.004; Dash PK, 2000, J NEUROTRAUM, V17, P69, DOI 10.1089/neu.2000.17.69; Davis D, 2013, NEURAL IMMUNE INTERA, P3, DOI DOI 10.1007/978-1-4614-4729-0_; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Dehmer T, 2004, J NEUROCHEM, V88, P494, DOI 10.1046/j.1471-4159.2003.02210.x; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Diab A, 2002, J IMMUNOL, V168, P2508, DOI 10.4049/jimmunol.168.5.2508; Eng LF, 2000, NEUROCHEM RES, V25, P1439, DOI 10.1023/A:1007677003387; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; FAN L, 1995, MOL BRAIN RES, V30, P125; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Feinstein DL, 2002, ANN NEUROL, V51, P694, DOI 10.1002/ana.10206; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Frank-Cannon TC, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-47; Freire MAM, 2012, W INDIAN MED J, V61, P751; Gamboa J, 2010, NEUROSCIENCE, V170, P846, DOI 10.1016/j.neuroscience.2010.07.063; Gopez JJ, 2005, NEUROSURGERY, V56, P590, DOI 10.1227/01.NEU.0000154060.14900.8F; Goss JR, 1997, EXP NEUROL, V146, P291, DOI 10.1006/exnr.1997.6515; Gurley C, 2008, PPAR RES, V2008, DOI 10.1155/2008/453120; Hakan T, 2010, NEUROL RES, V32, P629, DOI 10.1179/016164109X12464612122731; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; Heneka MT, 2007, BBA-MOL CELL BIOL L, V1771, P1031, DOI 10.1016/j.bbalip.2007.04.016; Heneka MT, 2005, BRAIN, V128, P1442, DOI 10.1093/brain/awh452; Hickey RW, 2007, PEDIATR RES, V62, P271, DOI 10.1203/PDR.0b013e3180db2902; Hicks R, 1996, ACTA NEUROPATHOL, V91, P236, DOI 10.1007/s004010050421; Hyong A, 2008, BRAIN RES, V1215, P218, DOI 10.1016/j.brainres.2008.04.025; Imai Y, 1996, BIOCHEM BIOPH RES CO, V224, P855, DOI 10.1006/bbrc.1996.1112; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kiaei M, 2005, NEURODEGENER DIS, V2, P246, DOI 10.1159/000090364; Kielian T, 2004, J NEUROCHEM, V90, P1163, DOI 10.1111/j.1471-4159.2004.02579.x; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Kolias Angelos G, 2013, Pract Neurol, V13, P228, DOI 10.1136/practneurol-2012-000268; Kolker S, 2001, EUR J NEUROSCI, V13, P2115, DOI 10.1046/j.0953-816x.2001.01595.x; Kunz T, 2002, J NEUROTRAUM, V19, P1051, DOI 10.1089/089771502760341965; Lawler JM, 2002, BIOCHEM BIOPH RES CO, V294, P1093, DOI 10.1016/S0006-291X(02)00602-2; Lee KJ, 2008, EUR J NEUROSCI, V27, P334, DOI 10.1111/j.1460-9568.2007.06007.x; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Liu F, 2014, MOL MED REP, V9, P1225, DOI 10.3892/mmr.2014.1967; Liu GW, 2007, AUTOIMMUNITY, V40, P95, DOI 10.1080/08916930601083946; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McTigue DM, 2007, EXP NEUROL, V205, P396, DOI 10.1016/j.expneurol.2007.02.009; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Moraga-Amaro R, 2014, J PHYSIOL-PARIS, V108, P240, DOI 10.1016/j.jphysparis.2014.08.005; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nagano S, 2004, J BIOL CHEM, V279, P14673, DOI 10.1074/jbc.M313003200; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Okada K, 2006, BRAIN RES, V1102, P175, DOI 10.1016/j.brainres.2006.04.108; Okimura Y, 1996, J NEUROTRAUM, V13, P385, DOI 10.1089/neu.1996.13.385; Ooigawa H, 2006, ACTA NEUROPATHOL, V112, P471, DOI 10.1007/s00401-006-0108-2; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Phulwani NK, 2006, J NEUROCHEM, V99, P1389, DOI 10.1111/j.1471-4159.2006.04183.x; Pilipovic K, 2011, NEUROCHEM RES, V36, P913, DOI 10.1007/s11064-011-0424-3; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sakamoto J, 2000, BIOCHEM BIOPH RES CO, V278, P704, DOI 10.1006/bbrc.2000.3868; Salminen A, 2011, EUR J NEUROSCI, V34, P3, DOI 10.1111/j.1460-9568.2011.07738.x; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Schmerbach K, 2008, BRAIN RES, V1208, P225, DOI 10.1016/j.brainres.2008.02.032; Schutz B, 2005, J NEUROSCI, V25, P7805, DOI 10.1523/JNEUROSCI.2038-05.2005; Shimazu T, 2005, STROKE, V36, P353, DOI 10.1161/01.STR.0000152271.21943.a2; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SHOHAMI E, 1991, Journal of Basic and Clinical Physiology and Pharmacology, V2, P103; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; SOARES HD, 1992, J NEUROCHEM, V58, P1845, DOI 10.1111/j.1471-4159.1992.tb10061.x; Spaethling JM, 2008, J NEUROTRAUM, V25, P1207, DOI 10.1089/neu.2008.0532; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Storer PD, 2005, J NEUROIMMUNOL, V161, P113, DOI 10.1016/j.jneuroim.2004.12.015; Strauss KI, 2008, BRAIN BEHAV IMMUN, V22, P285, DOI 10.1016/j.bbi.2007.09.011; Strauss KI, 2000, J NEUROTRAUM, V17, P695, DOI 10.1089/089771500415436; Strauss KI, 2002, J NEUROTRAUM, V19, P627, DOI 10.1089/089771502753754091; Su Y, 2014, NEUROSCIENCE, V266, P56, DOI 10.1016/j.neuroscience.2014.02.006; Sun H, 2008, INT J DEV NEUROSCI, V26, P505, DOI 10.1016/j.ijdevneu.2008.01.009; Sundararajan S, 2005, NEUROSCIENCE, V130, P685, DOI 10.1016/j.neuroscience.2004.10.021; Sundararajan S, 2006, NEUROCHEM INT, V49, P136, DOI 10.1016/j.neuint.2006.03.020; Susarla BTS, 2014, ASN NEURO, V6, DOI 10.1042/AN20130034; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Teng SX, 2014, J NEUROTRAUM, V31, P378, DOI 10.1089/neu.2013.3093; Thal SC, 2011, J NEUROTRAUM, V28, P983, DOI 10.1089/neu.2010.1685; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Tureyen K, 2007, J NEUROCHEM, V101, P41, DOI 10.1111/j.1471-4159.2006.04376.x; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vink R, 2009, NEUROTHERAPEUTICS, V6, P28, DOI 10.1016/j.nurt.2008.10.036; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Wolach B, 2001, J NEUROSURG, V94, P706, DOI 10.3171/jns.2001.94.5.0706; Yi JH, 2008, BRAIN RES, V1244, P164, DOI 10.1016/j.brainres.2008.09.074; Yi JH, 2006, NEUROCHEM INT, V48, P394, DOI 10.1016/j.neuint.2005.12.001; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu X, 2008, BRAIN RES, V1200, P146, DOI 10.1016/j.brainres.2008.01.047; Zhang DQ, 1999, NEUROSCI LETT, V272, P57, DOI 10.1016/S0304-3940(99)00455-3; Zhao Y, 2005, EUR J NEUROSCI, V22, P278, DOI 10.1111/j.1460-9568.2005.04200.x; Zhu Tao, 2004, Chin J Traumatol, V7, P32; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016; Zupan Z, 2011, PROG NEURO-PSYCHOPH, V35, P1846, DOI 10.1016/j.pnpbp.2011.08.005	140	18	19	0	44	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0278-5846	1878-4216		PROG NEURO-PSYCHOPH	Prog. Neuro-Psychopharmacol. Biol. Psychiatry	JUN 3	2015	59						8	20		10.1016/j.pnpbp.2015.01.003			13	Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	CB9WP	WOS:000349984900002	25579788				2022-02-06	
J	Eckner, JT; Richardson, JK; Kim, H; Joshi, MS; Oh, YK; Ashton-Miller, JA				Eckner, James T.; Richardson, James K.; Kim, Hogene; Joshi, Monica S.; Oh, Youkeun K.; Ashton-Miller, James A.			RELIABILITY AND CRITERION VALIDITY OF A NOVEL CLINICAL TEST OF SIMPLE AND COMPLEX REACTION TIME IN ATHLETES	PERCEPTUAL AND MOTOR SKILLS			English	Article							TEST-RETEST RELIABILITY; NEUROPSYCHOLOGICAL TEST PROTOCOL; BRAIN-INJURY; CONCUSSION; SPORT; BATTERY; IMPACT; RECOVERY; PERFORMANCE; POPULATION	Slowed reaction time (RT) represents both a risk factor for and a consequence of sport concussion. The purpose of this study was to determine the reliability and criterion validity of a novel clinical test of simple and complex RT, called RTdin, in contact sport athletes. Both tasks were adapted from the well-known ruler drop test of RT and involve manually grasping a falling vertical shaft upon its release, with the complex task employing a go/no-go paradigm based on a light cue. In 46 healthy contact sport athletes (24 men; M = 16.3 yr., SD = 5.0; 22 women: M age = 15.0 yr., SD = 4.0) whose sports included soccer, ice hockey, American football, martial arts, wrestling, and lacrosse, the latency and accuracy of simple and complex RTdin had acceptable test-retest and inter-rater reliabilities and correlated with a computerized criterion standard, the Axon Computerized Cognitive Assessment Tool. Medium to large effect sizes were found. The novel RTdin tests have acceptable reliability and criterion validity for clinical use and hold promise as concussion assessment tools.	[Eckner, James T.; Richardson, James K.; Ashton-Miller, James A.] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48108 USA; [Eckner, James T.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48108 USA; [Kim, Hogene; Joshi, Monica S.; Oh, Youkeun K.; Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48108 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48108 USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			Rehabilitation Medicine Scientist Training Program [5K12HD001097]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097] Funding Source: NIH RePORTER	This project was supported by the Rehabilitation Medicine Scientist Training Program (5K12HD001097). The authors wish to thank Ms. Lea Franco for her editorial assistance in reviewing and submitting this manuscript. We would also like to thank Dr. Jason Cromer for his assistance in addressing our questions about the Axon CCAT.	ANASTASI A, 1998, PSYCHOL TESTING; Bailey CM, 2006, J INT NEUROPSYCH SOC, V12, P475, DOI 10.1017/S1355617706060619; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Broglio SP, 2007, J ATHL TRAINING, V42, P504; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; CHUDLER E. H., 2009, NEUROSCIENCE KIDS; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; DUERSON D., CLIN J SPORT MED; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Eckner JT, 2012, PSYCHOL ASSESSMENT, V24, P249, DOI 10.1037/a0025042; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2011, MED SCI SPORT EXER, V43, P382, DOI 10.1249/MSS.0b013e3181f1cc51; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; Erlanger D, 2003, ARCH CLIN NEUROPSYCH, V18, P293, DOI 10.1016/S0887-6177(02)00138-5; Erlanger D, 2001, J ATHL TRAINING, V36, P280; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Gualtieri CT, 2006, ARCH CLIN NEUROPSYCH, V21, P623, DOI 10.1016/j.acn.2006.05.007; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Lau B, 2009, CLIN J SPORT MED, V19, P216, DOI 10.1097/JSM.0b013e31819d6edb; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; MacDonald J, 2015, CLIN J SPORT MED, V25, P43, DOI 10.1097/JSM.0000000000000096; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Montare A, 2009, PERCEPT MOTOR SKILL, V108, P161, DOI 10.2466/PMS.108.1.161-172; Randolph C, 2005, J ATHL TRAINING, V40, P139; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Segalowitz SJ, 2007, NEUROREHABILITATION, V22, P243; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; WICKELGREN WA, 1977, ACTA PSYCHOL, V41, P67, DOI 10.1016/0001-6918(77)90012-9	40	18	18	2	31	AMMONS SCIENTIFIC, LTD	MISSOULA	PO BOX 9229, MISSOULA, MT 59807-9229 USA	0031-5125			PERCEPT MOTOR SKILL	Percept. Mot. Skills	JUN	2015	120	3					841	859		10.2466/25.15.PMS.120v19x6			19	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	CL3UD	WOS:000356875200013	26106803	Green Accepted			2022-02-06	
J	Peterson, TC; Hoane, MR; McConomy, KS; Farin, FM; Bammler, TK; MacDonald, JW; Kantor, ED; Anderson, GD				Peterson, Todd C.; Hoane, Michael R.; McConomy, Keith S.; Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.; Kantor, Eric D.; Anderson, Gail D.			A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						controlled cortical impact; nicotinamide; polytherapy; progesterone; recovery of function; traumatic brain injury	CORTICAL CONTUSION INJURY; FLUID PERCUSSION INJURY; CELL-DEATH; MALE RATS; POLY(ADP-RIBOSE) POLYMERASE; BARRIER BREAKDOWN; GENE-EXPRESSION; NEURONAL DEATH; EDEMA; NEUROPROTECTION	Neuroprotection, recovery of function, and gene expression were evaluated in an animal model of traumatic brain injury (TBI) after a combination treatment of nicotinamide (NAM) and progesterone (Prog). Animals received a cortical contusion injury over the sensorimotor cortex, and were treated with either Vehicle, NAM, Prog, or a NAM/Prog combination for 72h and compared with a craniotomy only (Sham) group. Animals were assessed in a battery of behavioral, sensory, and both fine and gross motor tasks, and given histological assessments at 24h post-injury to determine lesion cavity size, degenerating neurons, and reactive astrocytes. Microarray-based transcriptional profiling was used to determine treatment-specific changes on gene expression. Our results confirm the beneficial effects of treatment with either NAM or Prog, demonstrating significant improvements in recovery of function and a reduction in lesion cavitation, degenerating neurons, and reactive astrocytes 24h post-injury. The combination treatment of NAM and Prog led to a significant improvement in both neuroprotection at 24h post-injury and recovery of function in sensorimotor related tasks when compared with individual treatments. The NAM/Prog-treated group was the only treatment group to show a significant reduction of cortical loss 24h post-injury. The combination appears to affect inflammatory and immune processes, reducing expression of a significant number of genes in both pathways. Further preclinical trials using NAM and Prog as a combination treatment should be conducted to identify the window of opportunity, determine the optimal duration of treatment, and evaluate the combination in other pre-clinical models of TBI.	[Peterson, Todd C.; Hoane, Michael R.; McConomy, Keith S.] So Illinois Univ, Dept Psychol, Carbondale, IL 62901 USA; [Farin, Fred M.; Bammler, Theo K.; MacDonald, James W.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Kantor, Eric D.; Anderson, Gail D.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Life Sci 2,MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Hoane, Michael/0000-0001-7779-2657	NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD061944-01] Funding Source: Medline; NIEHS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30 ES007033, P30ES007033] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [P30ES007033] Funding Source: NIH RePORTER		Aminmansour Bahram, 2012, Adv Biomed Res, V1, P58, DOI 10.4103/2277-9175.100176; Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Anderson GD, 2011, J NEUROTRAUM, V28, P1827, DOI 10.1089/neu.2011.1911; Asbury ET, 1998, BEHAV BRAIN RES, V97, P99, DOI 10.1016/S0166-4328(98)00031-X; Atif F, 2009, MOL MED, V15, P328, DOI 10.2119/molmed.2009.00016; ATTELLA MJ, 1987, BEHAV NEURAL BIOL, V48, P352, DOI 10.1016/S0163-1047(87)90918-6; Baker AB, 2012, J AM COLL CARDIOL, V59, P1551, DOI 10.1016/j.jacc.2011.11.057; Barbre AB, 2006, BRAIN RES BULL, V69, P639, DOI 10.1016/j.brainresbull.2006.03.009; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Bernier J, 1998, RADIOTHER ONCOL, V48, P123, DOI 10.1016/S0167-8140(98)00048-6; Besson VC, 2003, BRAIN RES, V989, P58, DOI 10.1016/S0006-8993(03)03362-6; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Cekic M, 2011, NEUROBIOL AGING, V32, P864, DOI 10.1016/j.neurobiolaging.2009.04.017; Cekic M, 2009, FRONT NEUROENDOCRIN, V30, P158, DOI 10.1016/j.yfrne.2009.04.002; Chauhan NB, 2010, BRAIN RES, V1360, P177, DOI 10.1016/j.brainres.2010.09.010; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Clark RSB, 2007, J NEUROTRAUM, V24, P1399, DOI 10.1089/neu.2007.0305; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cutler SM, 2007, J NEUROTRAUM, V24, P1475, DOI 10.1089/neu.2007.0294; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Cutler SM, 2005, EXP NEUROL, V195, P423, DOI 10.1016/j.expneurol.2005.06.003; Djebaili M, 2005, J NEUROTRAUM, V22, P106, DOI 10.1089/neu.2005.22.106; DUVDEVANI R, 1995, J NEUROTRAUM, V12, P65, DOI 10.1089/neu.1995.12.65; Endres M, 1997, J CEREBR BLOOD F MET, V17, P1143, DOI 10.1097/00004647-199711000-00002; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; FASS B, 1980, PHYSIOL BEHAV, V25, P683, DOI 10.1016/0031-9384(80)90370-4; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; GANTER S, 1992, J NEUROSCI RES, V33, P218, DOI 10.1002/jnr.490330205; Garcia-Estrada J, 1999, INT J DEV NEUROSCI, V17, P145, DOI 10.1016/S0736-5748(98)00065-3; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GREGERSEN N, 1986, ACTA PAEDIATR SCAND, V75, P676, DOI 10.1111/j.1651-2227.1986.tb10272.x; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2007, J NEUROTRAUM, V24, P1108, DOI 10.1089/neu.2006.0254; Hoane MR, 2006, BRAIN RES, V1125, P185, DOI 10.1016/j.brainres.2006.10.019; Hoane MR, 2006, NEUROSCI LETT, V408, P35, DOI 10.1016/j.neulet.2006.07.011; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2008, OXID MED CELL LONGEV, V1, P46, DOI 10.4161/oxim.1.1.6694; Hoane MR, 2009, J NEUROTRAUM, V26, P121, DOI 10.1089/neu.2008.0565; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; Hoane MR, 1997, RESTOR NEUROL NEUROS, V11, P71, DOI 10.3233/RNN-1997-111208; Holland MA, 2008, J NEUROTRAUM, V25, P140, DOI 10.1089/neu.2007.0312; HORSMAN MR, 1993, RADIOTHER ONCOL, V27, P131, DOI 10.1016/0167-8140(93)90133-S; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Jullienne A, 2014, J CEREBR BLOOD F MET, V34, P1637, DOI 10.1038/jcbfm.2014.124; Kolthur-Seetharam U, 2006, CELL CYCLE, V5, P873, DOI 10.4161/cc.5.8.2690; LaPlaca MC, 2001, J NEUROTRAUM, V18, P369, DOI 10.1089/089771501750170912; Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6; Meffre D, 2005, J NEUROCHEM, V93, P1314, DOI 10.1111/j.1471-4159.2005.03127.x; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Papadopoulos MC, 2007, PEDIATR NEPHROL, V22, P778, DOI 10.1007/s00467-006-0411-0; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Quigley A, 2009, BRAIN RES, V1304, P138, DOI 10.1016/j.brainres.2009.09.062; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Roof RL, 1996, EXP NEUROL, V138, P246, DOI 10.1006/exnr.1996.0063; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Schouten JW, 2007, CURR OPIN CRIT CARE, V13, P134, DOI 10.1097/MCC.0b013e3280895d5c; Shear DA, 2002, EXP NEUROL, V178, P59, DOI 10.1006/exnr.2002.8020; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stein Donald G, 2011, Dialogues Clin Neurosci, V13, P352; Stratford MRL, 1996, ACTA ONCOL, V35, P213, DOI 10.3109/02841869609098504; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Vink R, 2004, EXPERT OPIN INV DRUG, V13, P1263, DOI 10.1517/13543784.13.10.1263; Wali B, 2011, RESTOR NEUROL NEUROS, V29, P61, DOI 10.3233/RNN-2011-0579; Woodlee MT, 2005, EXP NEUROL, V191, P310, DOI 10.1016/j.expneurol.2004.09.005; Wright DW, 2005, J CLIN PHARMACOL, V45, P640, DOI 10.1177/0091270005276201; Wright DW, 2001, J NEUROTRAUM, V18, P901, DOI 10.1089/089771501750451820; Ying WH, 2008, ANTIOXID REDOX SIGN, V10, P179, DOI 10.1089/ars.2007.1672	70	18	19	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2015	32	11					765	779		10.1089/neu.2014.3530			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV0YU	WOS:000363980700002	25313690	Green Published			2022-02-06	
J	Schwarzmaier, SM; Terpolilli, NA; Dienel, A; Gallozzi, M; Schinzel, R; Tegtmeier, F; Plesnila, N				Schwarzmaier, Susanne M.; Terpolilli, Nicole A.; Dienel, Ari; Gallozzi, Micaela; Schinzel, Reinhard; Tegtmeier, Frank; Plesnila, Nikolaus			Endothelial Nitric Oxide Synthase Mediates Arteriolar Vasodilatation after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article						eNOS; brain trauma; intracranial hypertension; vessel diameter; mice	CONTROLLED CORTICAL IMPACT; CEREBRAL-BLOOD-FLOW; L-ARGININE; HEAD-INJURY; SELECTIVE-INHIBITION; TEMPORAL PROFILE; L-NAME; RAT; MICROCIRCULATION; CONTUSION	Brain edema and increased cerebral blood volume (CBV) contribute to intracranial hypertension and hence to unfavorable outcome after traumatic brain injury (TBI). The increased post-traumatic CBV may be caused in part by arterial vasodilatation. The aim of the current study was to uncover the largely unknown mechanisms of post-traumatic arteriolar vasodilatation. The diameter of pial arterioles and venules was monitored by intravital fluorescence microscopy before (baseline) and for 30 min after controlled cortical impact in C57BL/6 and endothelial nitric oxide synthase (eNOS)-/- mice (n=5-6/group) and in C57BL/6 mice (n=6/group) receiving vehicle (phosphate-buffered saline [PBS]) or 4-amino-tetrahydro-L-biopterine (VAS203), a NOS inhibitor previously shown to reduce post-traumatic intracranial hypertension. Temperature, end-tidal partial pressure of carbon dioxide (pCO(2)), and mean arterial blood pressure were kept within the physiological range throughout the experiments. Arteriolar diameters were stable during baseline monitoring but increased significantly in C57BL/6 mice after controlled cortical impact (136 +/- 7% of baseline; p<0.001 vs. baseline). This response was reduced by 78% in eNOS-/- mice (108 +/- 3% of baseline; p<0.005 vs. wild-type). Application of VAS203, a NOS inhibitor, or PBS did not affect vessels diameter before TBI. After trauma, however, administration of VAS203 reduced arteriolar diameter to 92 +/- 2% of baseline (p<0.05). The diameter of pial veins was not affected. Our results suggest that arteriolar vasodilatation after TBI is largely mediated by excess production of endothelial nitric oxide. Accordingly, our data may explain the beneficial effects of the NOS inhibitor VAS203 in the early phase after TBI and suggest that inhibition of excess endothelial nitric oxide production may represent a novel therapeutic strategy following TBI.	[Schwarzmaier, Susanne M.; Terpolilli, Nicole A.; Dienel, Ari; Plesnila, Nikolaus] Univ Munich, Med Ctr, Lab Expt Neurosurg, D-81377 Munich, Germany; [Schwarzmaier, Susanne M.] Univ Munich, Med Ctr, Dept Anesthesiol, D-81377 Munich, Germany; [Terpolilli, Nicole A.; Dienel, Ari] Univ Munich, Med Ctr, Dept Neurosurg, D-81377 Munich, Germany; [Plesnila, Nikolaus] Univ Munich, Med Ctr, Inst Stroke & Dementia Res, D-81377 Munich, Germany; [Schinzel, Reinhard; Tegtmeier, Frank] Vasopharm GmbH, Wurzburg, Germany; [Schwarzmaier, Susanne M.; Gallozzi, Micaela; Plesnila, Nikolaus] Royal Coll Surgeons Ireland, Dept Neurodegenerat, Dublin 2, Ireland; [Plesnila, Nikolaus] Munich Cluster Syst Neurol, Munich, Germany		Plesnila, N (corresponding author), Univ Munich, Med Ctr, Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Plesnila, Nikolaus/T-7522-2019; Terpolilli, Nicole/AAG-3598-2021				BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Cherian L, 2004, J NEUROTRAUM, V21, P1196; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; DEWITT DS, 1986, J NEUROSURG, V64, P787, DOI 10.3171/jns.1986.64.5.0787; Friedrich B, 2012, J CEREBR BLOOD F MET, V32, P447, DOI 10.1038/jcbfm.2011.154; Gahm C, 2005, NEUROSURGERY, V57, P1272, DOI 10.1227/01.NEU.0000187317.32529.06; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hall ED, 2012, EXP NEUROL, V238, P176, DOI 10.1016/j.expneurol.2012.08.024; Hartl R, 1997, J CEREBR BLOOD F MET, V17, P1210; Hlatky R, 2003, J NEUROTRAUM, V20, P995, DOI 10.1089/089771503770195849; Hua J, 2014, MOVEMENT DISORD, V29, P396, DOI 10.1002/mds.25591; Ito H, 2005, ANN NUCL MED, V19, P65, DOI 10.1007/BF03027383; Khan M, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-32; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kontos H A, 1981, Trans Am Clin Climatol Assoc, V92, P111; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Lundblad C, 2007, MICROVASC RES, V74, P1, DOI 10.1016/j.mvr.2007.03.001; Lundblad C, 2009, J NEUROTRAUM, V26, P1953, DOI 10.1089/neu.2009.0955; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACDONALD RL, 1991, STROKE, V22, P971, DOI 10.1161/01.STR.22.8.971; MACPHERS.P, 1973, J NEUROL NEUROSUR PS, V36, P1069, DOI 10.1136/jnnp.36.6.1069; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mendez DR, 2004, J TRAUMA, V57, P244, DOI 10.1097/01.TA.0000103983.22362.67; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; Sahuquillo J, 2001, CURR PHARM DESIGN, V7, P1475, DOI 10.2174/1381612013397311; Schwarzmaier SM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-32; Schwarzmaier SM, 2010, J NEUROTRAUM, V27, P121, DOI 10.1089/neu.2009.1114; Stoffel M, 2000, ACTA NEUROCHIR SUPPL, V76, P357; Stoffel M, 2001, J NEUROTRAUM, V18, P425, DOI 10.1089/089771501750171010; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Thal SC, 2007, J NEUROSCI METH, V159, P261, DOI 10.1016/j.jneumeth.2006.07.016; Thomale UW, 2002, J NEUROTRAUM, V19, P403, DOI 10.1089/08977150252932361; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Werner ER, 1996, BIOCHEM J, V320, P193, DOI 10.1042/bj3200193; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083; Zwienenberg M, 2001, NEUROL RES, V23, P167, DOI 10.1179/016164101101198505	48	18	18	1	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2015	32	10					731	738		10.1089/neu.2014.3650			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CH3ZP	WOS:000353970200008	25363688				2022-02-06	
J	Godbolt, AK; Stenberg, M; Lindgren, M; Ulfarsson, T; Lannsjo, M; Stalnacke, BM; Borg, J; DeBoussard, CN				Godbolt, Alison K.; Stenberg, Maud; Lindgren, Marie; Ulfarsson, Trandur; Lannsjo, Marianne; Stalnacke, Britt-Marie; Borg, Jorgen; DeBoussard, Catharina Nygren			Associations Between Care Pathways and Outcome 1 Year After Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						health facility planning; outcome; rehabilitation; severe traumatic brain injury	REACTION LEVEL SCALE; GLASGOW COMA SCALE; INPATIENT REHABILITATION; PARIS-TBI; GUIDELINES; ADMISSIONS; COHORT; RLS85	Objective: To assess associations between real-world care pathways for working-age patients in the first year after severe traumatic brain injury and outcomes at 1 year. Setting and Design: Prospective, observational study with recruitment from 6 neurosurgical centers in Sweden and Iceland. Follow-up to 1 year, independently of care pathways, by rehabilitation physicians and paramedical professionals. Participants: Patients with severe traumatic brain injury, lowest (nonsedated) Glasgow Coma Scale score 3 to 8 during the first 24 hours and requiring neurosurgical intensive care, age 18 to 65 years, and alive 3 weeks after injury. Main Measures: Length of stay in intensive care, time between intensive care discharge and rehabilitation admission, outcome at 1 year (Glasgow Outcome Scale Extended score), acute markers of injury severity, preexisting medical conditions, and post-acute complications. Logistic regression analyses were performed. Results: A multivariate model found variables significantly associated with outcome (odds ratio for good outcome [confidence interval], P value) to be as follows: length of stay in intensive care (0.92 [0.87-0.98], 0.014), time between intensive care discharge and admission to inpatient rehabilitation (0.97 [0.94-0.99], 0.017), and post-acute complications (0.058 [0.006-0.60], 0.017). Conclusions: Delays in rehabilitation admission were negatively associated with outcome. Measures to ensure timely rehabilitation admission may improve outcome. Further research is needed to evaluate possible causation.	[Godbolt, Alison K.; Borg, Jorgen; DeBoussard, Catharina Nygren] Karolinska Inst, Dept Clin Sci, SE-18288 Stockholm, Sweden; [Godbolt, Alison K.; Borg, Jorgen; DeBoussard, Catharina Nygren] Danderyd Hosp, Univ Dept Rehabil Med Stockholm, Stockholm, Sweden; [Stenberg, Maud; Stalnacke, Britt-Marie] Umea Univ, Dept Community Med & Rehabil, Rehabil Med, Umea, Sweden; [Lindgren, Marie] Cty Council, Dept Clin Rehabil Med, Linkoping, Sweden; [Ulfarsson, Trandur] Sahlgrens Univ Hosp, Dept Rehabil Med, Gothenburg, Sweden; [Lannsjo, Marianne] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Lannsjo, Marianne] Gavle & Sandviken Hosp, Dept Rehabil Med, Sandviken, Sweden; [Godbolt, Alison K.] Univ Hosptial Uppsala, Dept Rehabil Med, Uppsala, Sweden; [Godbolt, Alison K.] Uppsala Univ, Uppsala, Sweden		Godbolt, AK (corresponding author), Karolinska Inst, Dept Clin Sci, Hus 39,Plan 3, SE-18288 Stockholm, Sweden.	alison.godbolt@ki.se	Stenberg, Maud/AAX-4366-2021	Borg, Jorgen/0000-0002-2372-7478; Godbolt, Alison/0000-0003-4511-6181			Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Chen HW, 2010, PM&R, V2, pS306, DOI 10.1016/j.pmrj.2010.10.006; Engberg AW, 2006, ACTA NEUROL SCAND, V113, P178, DOI 10.1111/j.1600-0404.2005.00570.x; Grande PO, 2011, J NEUROSURG ANESTH, V23, P358, DOI 10.1097/01.ana.0000405612.20356.84; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P1305, DOI 10.1016/j.apmr.2012.04.030; Jourdan C, 2013, BRAIN INJURY, V27, P1000, DOI 10.3109/02699052.2013.794971; Jourdan C, 2013, NEUROREHAB NEURAL RE, V27, P35, DOI 10.1177/1545968312440744; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Krakau K, 2007, NUTRITION, V23, P308, DOI 10.1016/j.nut.2007.01.010; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Olivecrona M, 2013, J CLIN NEUROSCI, V20, P996, DOI 10.1016/j.jocn.2012.09.015; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Petticrew, 2008, DEV EVALUATING COMPL; Polinder S, 2005, J TRAUMA, V59, P1283, DOI 10.1097/01.ta.0000195998.11304.5b; Socialstyrelsen, REH PERS TRAUM HJARN; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; STARMARK JE, 1988, ACTA NEUROCHIR, V91, P12, DOI 10.1007/BF01400521; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TESSERIS J, 1991, ACTA NEUROCHIR, V110, P65, DOI 10.1007/BF01402050; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Walther SM, 2003, INTENS CARE MED, V29, P933, DOI 10.1007/s00134-003-1757-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	24	18	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E41	E51		10.1097/HTR.0000000000000050			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100005	24901323				2022-02-06	
J	Losoi, H; Waljas, M; Turunen, S; Brander, A; Helminen, M; Luoto, TM; Rosti-Otajarvi, E; Julkunen, J; Ohman, J				Losoi, Heidi; Waljas, Minna; Turunen, Senni; Brander, Antti; Helminen, Mika; Luoto, Teemu M.; Rosti-Otajarvi, Eija; Julkunen, Juhani; Ohman, Juha			Resilience Is Associated With Fatigue After Mild Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						depressive symptoms; fatigue; head injury; insomnia; pain; resilience; traumatic brain injury	SLEEP DISTURBANCE; CHRONIC PAIN; SEVERITY; RELIABILITY; GUIDELINES; RECOVERY; SCALE	Objective: To examine resilience as a predictor of change in self-reported fatigue after mild traumatic brain injury (MTBI). Participants: A consecutive series of 67 patients with MTBI and 34 orthopedic controls. Design: Prospective longitudinal study. Main Measures: Resilience Scale, Beck Depression Inventory-Second Edition, and Pain subscale from Ruff Neurobehavioral Inventory 1 month after injury and Barrow Neurological Institute Fatigue Scale 1 and 6 months after injury. Results: Insomnia, pain, and depressive symptoms were significantly correlated with fatigue, but even when these variables were controlled for, resilience significantly predicted the change in fatigue from 1 to 6 months after MTBI. In patients with MTBI, the correlation between resilience and fatigue strengthened during follow-up. In controls, significant associations between resilience and fatigue were not found. Conclusion: Resilience is a significant predictor of decrease in self-reported fatigue following MTBI. Resilience seems to be a relevant factor to consider in the management of fatigue after MTBI along with the previously established associated factors (insomnia, pain, and depressive symptoms).	[Losoi, Heidi; Waljas, Minna; Turunen, Senni; Luoto, Teemu M.; Rosti-Otajarvi, Eija; Ohman, Juha] Tampere Univ Hosp, Dept Neurosci & Rehabil, FI-33521 Tampere, Finland; [Brander, Antti] Tampere Univ Hosp, Dept Radiol, Med Imaging Ctr, FI-33521 Tampere, Finland; [Losoi, Heidi; Julkunen, Juhani] Univ Helsinki, Inst Behav Sci, Helsinki, Finland; [Helminen, Mika] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland; [Helminen, Mika] Pirkanmaa Hosp Dist, Ctr Sci, Tampere, Finland		Losoi, H (corresponding author), Tampere Univ Hosp, POB 2000, FI-33521 Tampere, Finland.	heidi.losoi@pshp.fi	Luoto, Teemu/W-6468-2018; Helminen, Mika T/I-3900-2016	Luoto, Teemu/0000-0002-7329-3284; Helminen, Mika T/0000-0001-5695-2084; Ohman, Juha/0000-0002-6592-1367			Abiola Tajudeen, 2011, BMC Res Notes, V4, P509, DOI 10.1186/1756-0500-4-509; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bay E, 2009, WESTERN J NURS RES, V31, P731, DOI 10.1177/0193945909334856; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Borgaro SR, 2004, BRAIN INJURY, V18, P685, DOI 10.1080/02699050310001646080; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Clinchot DM, 1998, AM J PHYS MED REHAB, V77, P291, DOI 10.1097/00002060-199807000-00006; Earvolino-Ramirez M, 2007, NURS FORUM, V42, P73, DOI 10.1111/j.1744-6198.2007.00070.x; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Heilemann MarySue V, 2003, J Nurs Meas, V11, P61, DOI 10.1891/106137403780954976; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Humphreys Janice, 2003, Issues Ment Health Nurs, V24, P137, DOI 10.1080/01612840305293; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Iverson GL, 1997, BRAIN INJURY, V11, P783, DOI 10.1080/026990597122990; Losoi H., 2013, PCH, V2, P1, DOI [10.5964/pch.v2i1.40, DOI 10.5964/PCH.V2I1.40]; Luoto TM, 2013, J NEUROTRAUM, V30, P11, DOI 10.1089/neu.2012.2611; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Maestas KL, J HEAD TRAUMA REHABI, DOI 10.1097/HTR.0b013e31828654b4; Mak WWS, 2011, J COUNS PSYCHOL, V58, P610, DOI 10.1037/a0025195; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Morin CM, 1993, INSOMNIA PSYCHOL ASS; Nishi Daisuke, 2010, BMC Res Notes, V3, P310, DOI 10.1186/1756-0500-3-310; Norrie J, 2010, BRAIN INJURY, V24, P1528, DOI 10.3109/02699052.2010.531687; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Ouellet MC, 2004, NEUROREHAB NEURAL RE, V18, P187, DOI 10.1177/1545968304271405; Ponsford JL, 2012, J HEAD TRAUMA REHAB, V27, P224, DOI 10.1097/HTR.0b013e31824ee1a8; Rao V, 2011, J NEUROPSYCH CLIN N, V23, P201, DOI 10.1176/appi.neuropsych.23.2.201; Robottom BJ, 2012, PARKINSONISM RELAT D, V18, P174, DOI 10.1016/j.parkreldis.2011.09.021; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Ruff R. M., 2003, RUFF NEUROBEHAVIORAL; Sherman Kristen Brewer, 2006, Phys Med Rehabil Clin N Am, V17, P473, DOI 10.1016/j.pmr.2005.11.007; Snell DL, 2011, BRAIN INJURY, V25, P1126, DOI 10.3109/02699052.2011.607786; Stalnacke BM, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/528265; Strauss B, 2007, J CANCER RES CLIN, V133, P511, DOI 10.1007/s00432-007-0195-z; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; UOMOTO JM, 1993, ARCH PHYS MED REHAB, V74, P61; Wagnild G M, 1993, J Nurs Meas, V1, P165; Wagnild G. M., 2009, RESILIENCE SCALE USE; Wagnild Gail, 2003, J Gerontol Nurs, V29, P42; Waljas M, 2012, BRAIN INJURY, V26, P972, DOI 10.3109/02699052.2012.660511; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; Ziino C, 2005, J INT NEUROPSYCH SOC, V11, P416, DOI 10.1017/S1355617705050472	47	18	19	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2015	30	3					E24	E32		10.1097/HTR.0000000000000055			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CH8PJ	WOS:000354298100003	24842587				2022-02-06	
J	Upchurch, C; Morgan, CD; Umfress, A; Yang, G; Riederer, MF				Upchurch, Cameron; Morgan, Clinton D.; Umfress, Allison; Yang, George; Riederer, Mark F.			Discharge Instructions for Youth Sports-Related Concussions in the Emergency Department, 2004 to 2012	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						youth sports; concussion; discharge instructions	UNITED-STATES	Objective: To evaluate the effect of the Centers for Disease Control and Prevention (CDC) Heads-Up concussion campaign on appropriateness of discharge instructions for youth sports-related concussion (SRC) patients presenting to a pediatric emergency department (ED). Design: Retrospective cohort study. Setting: Pediatric ED. Patients: Children up to 18 years. Assessment of Risk Factors: A retrospective chart review was conducted on patients evaluated from 2004 to 2012. Patients were selected by ICD-9 code for having a concussion during a sporting activity. Main Outcome Measures: Discharge instructions were reviewed for recommendations for cognitive rest, physical rest, primary care physician follow-up, and referral to a concussion specialist or center. Results: There were 497 youth SRCs from 392 908 total ED visits. Overall, only 66% had appropriate discharge recommendations. This improved to 75% after 2010, which was not statistically significant (odds ratio = 1.02, P = 0.179). Only 4% of patients received a recommendation of cognitive rest, which only increased to 12% of the patients seen after 2010. Finally, referrals to a sports concussion specialist or center dramatically increased from an average of 8% to 43% after 2010. Conclusions: Even with the CDC Heads-Up campaign on concussion education, there is still need to improve appropriateness of discharge instructions for youth SRCs. There have been dramatic increases in referrals to sports concussion specialists and centers after 2010.	[Upchurch, Cameron; Morgan, Clinton D.; Umfress, Allison; Yang, George] Vanderbilt Univ Sch Med, Nashville, TN USA; [Riederer, Mark F.] Univ Michigan, CS Mott Childrens Hosp, Dept Pediat Orthopaed Surg, Ann Arbor, MI 48109 USA		Riederer, MF (corresponding author), Univ Michigan, CS Mott Childrens Hosp, Dept Pediat Orthopaed Surg, 1540 E Hosp Dr, Ann Arbor, MI 48109 USA.	mriedere@med.umich.edu		Morgan, Clinton/0000-0002-7511-0488; Upchurch, Cameron/0000-0002-8003-0749			Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Centers for Disease Control and Prevention, 2010, HEADS SCH KNOW YOUR; Centers for Disease Control National Football League and CDC Foundation, 2011, HEADS CLIN ADDR CONC; Faul M, 2010, TRAUMATIC BRAIN INJU; GENUARDI FJ, 1995, PEDIATRICS, V95, P216; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; U.S. Department of Health and Human Services and Centers for Disease Control and Prevention, 2007, HEADS FACTS PHYS MIL	10	18	18	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2015	25	3					297	299		10.1097/JSM.0000000000000123			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	CH3EX	WOS:000353911700016	24977953				2022-02-06	
J	Alali, AS; Vavrek, D; Barber, J; Dikmen, S; Nathens, AB; Temkin, NR				Alali, Aziz S.; Vavrek, Darcy; Barber, Jason; Dikmen, Sureyya; Nathens, Avery B.; Temkin, Nancy R.			Comparative Study of Outcome Measures and Analysis Methods for Traumatic Brain Injury Trials	JOURNAL OF NEUROTRAUMA			English	Article						research design; outcome measures; traumatic brain injury; Glasgow Outcome Scale; statistical data analysis	SEVERE HEAD-INJURY; CLINICAL-TRIALS; SCALE; MODERATE; VALIDITY; IMPACT; DESIGN; ODDS	Batteries of functional and cognitive measures have been proposed as alternatives to the Extended Glasgow Outcome Scale (GOSE) as the primary outcome for traumatic brain injury (TBI) trials. We evaluated several approaches to analyzing GOSE and a battery of four functional and cognitive measures. Using data from a randomized trial, we created a "super" dataset of 16,550 subjects from patients with complete data (n=331) and then simulated multiple treatment effects across multiple outcome measures. Patients were sampled with replacement (bootstrapping) to generate 10,000 samples for each treatment effect (n=400 patients/group). The percentage of samples where the null hypothesis was rejected estimates the power. All analytic techniques had appropriate rates of type I error (<= 5%). Accounting for baseline prognosis either by using sliding dichotomy for GOSE or using regression-based methods substantially increased the power over the corresponding analysis without accounting for prognosis. Analyzing GOSE using multivariate proportional odds regression or analyzing the four-outcome battery with regression-based adjustments had the highest power, assuming equal treatment effect across all components. Analyzing GOSE using a fixed dichotomy provided the lowest power for both unadjusted and regression-adjusted analyses. We assumed an equal treatment effect for all measures. This may not be true in an actual clinical trial. Accounting for baseline prognosis is critical to attaining high power in Phase III TBI trials. The choice of primary outcome for future trials should be guided by power, the domain of brain function that an intervention is likely to impact, and the feasibility of collecting outcome data.	[Alali, Aziz S.; Nathens, Avery B.] Univ Toronto, Inst Hlth Policy, Toronto, ON, Canada; [Nathens, Avery B.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Alali, Aziz S.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Alali, Aziz S.] Univ Ottawa, Div Neurosurg, Ottawa, ON, Canada; [Vavrek, Darcy] Univ Western States, Ctr Outcome Studies, Portland, OR USA; [Temkin, Nancy R.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Barber, Jason; Dikmen, Sureyya; Temkin, Nancy R.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Dikmen, Sureyya; Temkin, Nancy R.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA		Temkin, NR (corresponding author), Univ Washington, Dept Neurol Surg & Biostat, Box 359924, Seattle, WA 98104 USA.	temkin@uw.edu			Canada Research Chair Program in Systems of Trauma Care; DoDUnited States Department of Defense [W81XWH-08-2-0159]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS19643]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019643] Funding Source: NIH RePORTER	This work was supported in part by a Canada Research Chair Program in Systems of Trauma Care (to A.B.N.) and by DoD grant W81XWH-08-2-0159 (to N.T). Clinical trial data were collected under NIH grant R01 NS19643.	Agresti A., 2010, ANAL ORDINAL CATEGOR, V2nd; Bagiella E, 2010, J HEAD TRAUMA REHAB, V25, P375, DOI 10.1097/HTR.0b013e3181d27fe3; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; Bell KR, 2005, ARCH PHYS MED REHAB, V86, P851, DOI 10.1016/j.apmr.2004.09.015; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; BROOKS DN, 1986, J NEUROL NEUROSUR PS, V49, P549, DOI 10.1136/jnnp.49.5.549; BUSCHKE H, 1973, J VERB LEARN VERB BE, V12, P543, DOI 10.1016/S0022-5371(73)80034-9; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Edwards P, 2005, LANCET, V365, P1957; Efron B, 1998, INTRO BOOTSTRAP, V2nd; Faul M, 2010, TRAUMATIC BRAIN INJU; Finkelstein E., 2006, INCIDENCE EC BURDEN; Freemantle N, 2003, JAMA-J AM MED ASSOC, V289, P2554, DOI 10.1001/jama.289.19.2554; Grimes DA, 2008, OBSTET GYNECOL, V111, P423, DOI 10.1097/01.AOG.0000297304.32187.5d; Haynes R. B., 2006, CLIN EPIDEMIOLOGY DO; Jennings D. A., 2005, COMP ANAL STRATEGIES; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Moher D, 2010, BMJ-BRIT MED J, V340, DOI [10.1136/bmj.c869, 10.1016/j.ijsu.2011.10.001, 10.1016/j.jclinepi.2010.03.004]; Montori VM, 2005, BMJ-BRIT MED J, V330, P594, DOI 10.1136/bmj.330.7491.594; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Ragnarsson KT, 2006, J HEAD TRAUMA REHAB, V21, P379, DOI 10.1097/00001199-200609000-00002; Roozenbeek B, 2011, CRIT CARE, V15, DOI 10.1186/cc10240; Stanley K, 2007, CIRCULATION, V115, P1164, DOI 10.1161/CIRCULATIONAHA.105.594945; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wolfson, 1993, HALSTEAD REITAN NEUR; Zafonte RD, 2012, JAMA-J AM MED ASSOC, V308, P1993, DOI 10.1001/jama.2012.13256	46	18	18	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2015	32	8					581	589		10.1089/neu.2014.3495			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CF2BS	WOS:000352352900008	25317951	Green Published			2022-02-06	
J	Llorens, R; Noe, E; Ferri, J; Alcaniz, M				Llorens, Roberto; Noe, Enrique; Ferri, Joan; Alcaniz, Mariano			Videogame-based group therapy to improve self-awareness and social skills after traumatic brain injury	Journal of NeuroEngineering and Rehabilitation			English	Article						Self-awareness; Social skills; Traumatic brain injury; Rehabilitation; Neuropsychology; Virtual reality	RANDOMIZED CONTROLLED-TRIAL; IMPAIRED AWARENESS; INTERVENTIONS; MANAGEMENT; FEEDBACK; DEFICITS; COMPETENCE; KNOWLEDGE; PROGRAM; PEOPLE	Background: This study determines the feasibility of different approaches to integrative videogame-based group therapy for improving self-awareness, social skills, and behaviors among traumatic brain injury (TBI) victims and retrieves participant feedback. Methods: Forty-two adult TBI survivors were included in a longitudinal study with a pre- and post-assessments. The experimental intervention involved weekly one-hour sessions conducted over six months. Participants were assessed using the Self-Awareness Deficits Interview (SADI), Patient Competency Rating Scale (PCRS), the Social Skills Scale (SSS), the Frontal Systems Behavior Scale (FrSBe), the System Usability Scale (SUS). Pearson's chi-squared test (chi(2)) was applied to determine the percentage of participants who had changed their clinical classification in these tests. Feedback of the intervention was collected through the Intrinsic Motivation Inventory (IMI). Results: SADI results showed an improvement in participant perceptions of deficits (chi(2) = 5.25, p < 0.05), of their implications (chi(2) = 4.71, p < 0.05), and of long-term planning (chi(2) = 7.86, p < 0.01). PCRS results confirm these findings (chi(2) = 5.79, p < 0.05). SSS results were also positive with respect to social skills outcomes (chi(2) = 17.52, p < 0.01), and FrSBe results showed behavioral improvements (chi(2) = 34.12, p < 0.01). Participants deemed the system accessible (80.43 +/- 8.01 out of 100) and regarded the intervention as interesting and useful (5.74 +/- 0.69 out of 7). Conclusions: Integrative videogame-based group therapy can improve self-awareness, social skills, and behaviors among individuals with chronic TBI, and the approach is considered effective and motivating.	[Llorens, Roberto; Alcaniz, Mariano] Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, E-46022 Valencia, Spain; [Llorens, Roberto; Noe, Enrique; Ferri, Joan] Fdn Hosp NISA, Serv Neurorrehabil, Valencia 46011, Spain; [Llorens, Roberto; Noe, Enrique; Ferri, Joan] Fdn Hosp NISA, Dano Cerebral Hosp NISA, Valencia 46011, Spain; [Alcaniz, Mariano] Univ Jaume 1, Inst Salud Carlos III, Ciber Fisiopatol Obesidad & Nutr, Castellon de La Plana 12071, Spain		Llorens, R (corresponding author), Univ Politecn Valencia, Inst Interuniv Invest Bioingn & Tecnol Orientada, Camino Vera S-N, E-46022 Valencia, Spain.	rllorens@labhuman.com	Alcaniz, Mariano L./I-9659-2016; Llorens, Roberto/AAL-2604-2021	Alcaniz, Mariano L./0000-0001-9207-0636; Llorens, Roberto/0000-0002-8677-8707; Noe Sebastian, Enrique/0000-0002-2547-8727	Ministerio de Economia y Competitividad of SpainSpanish Government [IDI-20110844, TIN2013-44741-R]; Ministerio de Educacion y Ciencia of SpainSpanish GovernmentEuropean Commission [SEJ2006-14301/PSIC]; Excellence Research Program PROMETEO [2008-157]	This study was funded in part by Ministerio de Economia y Competitividad of Spain (Project TEREHA, IDI-20110844; and NeuroVR, TIN2013-44741-R), by Ministerio de Educacion y Ciencia of Spain (Projects Consolider-C, SEJ2006-14301/PSIC; and "CIBER of Physiopathology of Obesity and Nutrition, an initiative of ISCIII"), and by the Excellence Research Program PROMETEO (Generalitat Valenciana. Conselleria de Educacion, 2008-157).	Alexy WD, 1983, COGNITIVE REHABILITA, V1, P8; Bach LJ, 2006, NEUROPSYCHOL REHABIL, V16, P397, DOI 10.1080/09602010500412830; Bennett T L, 1997, Appl Neuropsychol, V4, P55, DOI 10.1207/s15324826an0401_7; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Brooke J., 1996, USABILITY EVALUATION; Carbery H, 1983, COGNITIVE REHABILITA, V1, P5; Cheng SKW, 2006, BRAIN INJURY, V20, P621, DOI 10.1080/02699050600677196; Chittum WR, 1996, BRAIN INJURY, V10, P763; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Delmonico RL, 1998, J HEAD TRAUMA REHAB, V13, P10, DOI 10.1097/00001199-199812000-00004; Fleming JM, 2006, NEUROPSYCHOL REHABIL, V16, P474, DOI 10.1080/09602010500505518; Fleming Jennifer M, 2006, Can J Occup Ther, V73, P44; Fleming JM, 1996, BRAIN INJURY, V10, P1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gismero E., 2000, ESCALA HABILIDADES S; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Katz Noomi, 2002, Can J Occup Ther, V69, P281; Lucas SE, 2005, AUSTR OCCUPATIONAL T, V52, P160, DOI DOI 10.1111/J.1440-1630.2005.00485.X; Lundqvist A, 2010, BRAIN INJURY, V24, P823, DOI 10.3109/02699051003724986; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McGraw-Hunter M, 2006, BRAIN INJURY, V20, P1061, DOI 10.1080/02699050600912163; Nakase-Thompson R, 2005, BRAIN INJURY, V19, P685, DOI 10.1080/02699050400025331; Ownsworth T, 2006, J INT NEUROPSYCH SOC, V12, P54, DOI 10.1017/S135561770606005X; Ownsworth T, 2008, J REHABIL MED, V40, P81, DOI 10.2340/16501977-0124; Ownsworth T, 2010, NEUROPSYCHOL REHABIL, V20, P59, DOI 10.1080/09602010902949223; Ownsworth TL, 2000, NEUROPSYCHOL REHABIL, V10, P465, DOI 10.1080/09602010050143559; PLANT RW, 1985, J PERS, V53, P435, DOI 10.1111/j.1467-6494.1985.tb00375.x; Pollens RD, 1988, COGNITIVE REHABILITA, V6, P26; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; RANSEEN JD, 1990, INT J CLIN NEUROPSYC, V12, P29; Reid-Arndt SA, 2007, BRAIN INJURY, V21, P1361, DOI 10.1080/02699050701785062; Sasse N, 2013, J HEAD TRAUMA REHAB, V28, P464, DOI 10.1097/HTR.0b013e318263977d; Schefft BK, 1997, CLIN NEUROPSYCHOLOGY, P237; Schmidt J, 2013, NEUROREHAB NEURAL RE, V27, P316, DOI 10.1177/1545968312469838; Schmidt J, 2011, J REHABIL MED, V43, P673, DOI 10.2340/16501977-0846; Schrijnemaekers AC, 2014, J HEAD TRAUMA REHAB, V29, pE9, DOI 10.1097/01.HTR.0000438117.63852.b4; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Simmond M., 2003, OCCUP THER J RES, V66, P447, DOI [10.1177/030802260306601003, DOI 10.1177/030802260306601003]; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; Tate R, 2014, J HEAD TRAUMA REHAB, V29, P338, DOI 10.1097/HTR.0000000000000068; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Zhou J, 1996, J HEAD TRAUMA REHAB, V11, P51, DOI 10.1097/00001199-199602000-00007	50	18	18	0	27	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1743-0003			J NEUROENG REHABIL	J. NeuroEng. Rehabil.	APR 11	2015	12								37	10.1186/s12984-015-0029-1			8	Engineering, Biomedical; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Engineering; Neurosciences & Neurology; Rehabilitation	CG5IW	WOS:000353325700001	25889914	Green Published, gold			2022-02-06	
J	Dias, C; Gaio, AR; Monteiro, E; Barbosa, S; Cerejo, A; Donnelly, J; Felgueiras, O; Smielewski, P; Paiva, JA; Czosnyka, M				Dias, Celeste; Rita Gaio, A.; Monteiro, Elisabete; Barbosa, Silvina; Cerejo, Antonio; Donnelly, Joseph; Felgueiras, Oscar; Smielewski, Peter; Paiva, Jose-Artur; Czosnyka, Marek			Kidney-Brain Link in Traumatic Brain Injury Patients? A preliminary report	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Cerebrovascular pressure reactivity index; Creatinine; Renal clearance; Outcome	AUGMENTED RENAL CLEARANCE; CEREBRAL PERFUSION-PRESSURE; CRITICALLY-ILL PATIENTS; CREATININE CLEARANCE; GLOMERULAR-FILTRATION; SERUM CREATININE; BLOOD-FLOW; AUTOREGULATION; REACTIVITY; DISEASE	Kidney hyperfiltration with augmented renal clearance is frequently observed in patients with traumatic brain injury. The aim of this study is to report preliminary findings about the relationship between brain autoregulation impairment, estimated kidney glomerular filtration rate and outcome in critically ill patients after severe traumatic brain injury. Data collected from a cohort of 18 consecutive patients with severe traumatic brain injury managed with ICP monitoring in a Neurocritical Care Unit, were retrospectively analyzed. Early morning blood tests were performed for routine chemistry assessments and we analyzed creatinine and estimated creatinine clearance, osmolarity, and sodium. Daily norepinephrine dose, protein intake, and water balance were documented. Time average of brain monitoring data (intracranial pressure, cerebral perfusion pressure, and cerebrovascular reactivity pressure index-PRx) were calculated for 6 h before blood sample tests. Patient outcome was evaluated using Glasgow outcome scale at 6-month follow-up, considering nonfatal outcome if GOS a parts per thousand yen3 and fatal outcome if GOS < 3. Multiple linear regression models were used to study the crude and adjusted effects of the above variables on PRx throughout time. A total of 199 complete daily observations from 18 adult consecutive multiple trauma patients with severe traumatic brain injury were analyzed. At hospital admission, the median post-resuscitation Glasgow coma score was 6 (range 3-12), mean SAPSII score was 44.65 with predicted mortality of 36 %. Hospital mortality rate was 27 % and median GOS at 6 month after discharge was 3. Creatinine clearance (CrCl) was found to have a negative correlation with PRx (Pearson correlation-0.82), with statistically significant crude (p < 0.001) and adjusted (p = 0.001) effects. For each increase of 10 ml/min in CrCl (estimated either by the Cockcroft-Gault or by Modification of Diet in Renal Disease Study equations) a mean decrease in PRx of approximately 0.01 was expected. Amongst possible confounders only norepinephrine was shown to have a significant effect. Mean PRx value for outcome fatal status was greater than mean PRx for nonfatal status (p < 0.05), regardless of the model used for the CrCl estimation. Better cerebral autoregulation evaluated with cerebrovascular PRx is significantly correlated with augmented renal clearance in TBI patients and associates with better outcome.	[Dias, Celeste; Rita Gaio, A.; Monteiro, Elisabete; Barbosa, Silvina; Cerejo, Antonio; Donnelly, Joseph; Felgueiras, Oscar; Smielewski, Peter; Paiva, Jose-Artur; Czosnyka, Marek] Hosp Sao Joao, Dept Intens Care, Neurocrit Care Unit, Oporto, Portugal		Dias, C (corresponding author), Hosp Sao Joao, Dept Intens Care, Neurocrit Care Unit, Oporto, Portugal.	mceleste.dias@gmail.com	Donnelly, Joseph/N-6803-2019; Dias, Celeste/AAD-8711-2019; Dias, Celeste/L-9901-2014; Paiva, Jose-Artur/AAO-9730-2021; Donnelly, Joseph/E-9235-2018; Dias, Celeste/AAV-3820-2020	Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; Donnelly, Joseph/0000-0002-6502-8069; Dias, Celeste/0000-0003-0340-9808; Gaio, Rita/0000-0003-3906-0775; Smielewski, Peter/0000-0001-5096-3938; czosnyka, marek/0000-0003-2446-8006; Paiva, Jose-Artur/0000-0003-4323-0220; Felgueiras, Oscar/0000-0001-9010-2075	European Regional Development Fund through the program COMPETE; Portuguese Government through the FCT-Fundacao para a Ciencia e a Tecnologia [PEst-C/MAT/UI0144/2013]; Woolf Fisher Scholarship; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [G9439390, G0600986] Funding Source: researchfish; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0600986, G9439390] Funding Source: UKRI	The software for brain monitoring ICM + (www.neurosurg.cam.ac.uk/imcplus) is licensed by the University of Cambridge (Cambridge Enterprise). Peter Smielewski and Marek Czosnyka have financial interests in a part of the licensing fee. Rita Gaio and Oscar Felgueiras were partially funded by the European Regional Development Fund through the program COMPETE and by the Portuguese Government through the FCT-Fundacao para a Ciencia e a Tecnologia under the project PEst-C/MAT/UI0144/2013. Joseph Donnelly is supported by a Woolf Fisher Scholarship.	Albanese J, 2004, CHEST, V126, P534, DOI 10.1378/chest.126.2.534; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Baptista JP, 2011, CRIT CARE, V15, DOI 10.1186/cc10262; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Davenport A, 2008, BLOOD PURIFICAT, V26, P526, DOI 10.1159/000167800; Delanaye P, 2010, ANN BIOL CLIN-PARIS, V68, P531, DOI 10.1684/abc.2010.0479; Gao J, 2014, CLIN SCI, V127, P135, DOI 10.1042/CS20130396; Ito S, 2009, HYPERTENS RES, V32, P115, DOI 10.1038/hr.2008.27; JENNETT B, 1975, LANCET, V1, P480; Jones GR, 2003, CLIN BIOCHEM REV, V24, P95; Just A, 2007, AM J PHYSIOL-REG I, V292, pR1, DOI 10.1152/ajpregu.00332.2006; LASSEN NA, 1964, CIRC RES, V15, P201; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Loutzenhiser R, 2006, AM J PHYSIOL-REG I, V290, pR1153, DOI 10.1152/ajpregu.00402.2005; Minkute R, 2013, J CLIN PHARM THER, V38, P462, DOI 10.1111/jcpt.12088; Minville V, 2011, CRIT CARE, V15, DOI 10.1186/cc10013; Mogi M, 2011, CARDIOL RES PRACT, V2011, DOI DOI 10.4061/2011/306189; Nishimura Y, 2000, BRAIN RES, V871, P29, DOI 10.1016/S0006-8993(00)02377-5; Nongnuch A, 2014, CRIT CARE, V18, DOI 10.1186/cc13907; O'Rourke MF, 2005, HYPERTENSION, V46, P200, DOI 10.1161/01.HYP.0000168052.00426.65; Ohshima K, 2013, CURR HYPERTENS REV, V9, P99, DOI 10.2174/15734021113099990004; Ono M, 2013, CRIT CARE MED, V41, P464, DOI 10.1097/CCM.0b013e31826ab3a1; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; Pedersen TF, 2003, AM J PHYSIOL-HEART C, V285, pH1097, DOI 10.1152/ajpheart.00098.2003; Rao V, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-78; Rhee CJ, 2012, J APPL PHYSIOL, V113, P307, DOI 10.1152/japplphysiol.00024.2012; Schiller A, 2010, NEPHROL DIAL TRANSPL, V25, P1370, DOI 10.1093/ndt/gfq068; Shorr AF, 2014, CRIT CARE MED, V42, P728, DOI 10.1097/CCM.0000000000000081; Sigurdsson ST, 2014, J CEREBR BLOOD F MET, V34, P467, DOI 10.1038/jcbfm.2013.219; Smielewski P, 2005, ACT NEUR S, V95, P43; TEAM 2009, 2012, R LANG ENV STAT COMP; Udy A, 2010, ANESTH ANALG, V111, P1505, DOI 10.1213/ANE.0b013e3181f7107d; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2011, NAT REV NEPHROL, V7, P539, DOI 10.1038/nrneph.2011.92; Udy AA, 2010, CLIN PHARMACOKINET, V49, P1, DOI 10.2165/11318140-000000000-00000	40	18	19	0	7	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2015	22	2					192	201		10.1007/s12028-014-0045-1			10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CD9VK	WOS:000351447100004	25273515				2022-02-06	
J	Garcia, SF; Hahn, EA; Magasi, S; Lai, JS; Semik, P; Hammel, J; Heinemann, AW				Garcia, Sofia F.; Hahn, Elizabeth A.; Magasi, Susan; Lai, Jin-Shei; Semik, Patrick; Hammel, Joy; Heinemann, Allen W.			Development of Self-Report Measures of Social Attitudes That Act As Environmental Barriers and Facilitators for People With Disabilities	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Environment; International classification of functioning, disability and health; Qualitative research; Questionnaires; Rehabilitation; Social environment; Social participation	ITEM; PARTICIPATION; ISSUES	Objective: To describe the development of new self-report measures of social attitudes that act as environmental facilitators or barriers to the participation of people with disabilities in society. Design: A mixed-methods approach included a literature review; item classification, selection, and writing; cognitive interviews and field testing of participants with spinal cord injury (SCI), traumatic brain injury (TBI), or stroke; and rating scale analysis to evaluate initial psychometric properties. Setting: General community. Participants: Individuals with SCI, TBI, or stroke participated in cognitive interviews (n=9); community residents with those same conditions participated in field testing (n=305). Interventions: None. Main Outcome Measure: Self-report item pool of social attitudes that act as facilitators or barriers to people with disabilities participating in society. Results: An interdisciplinary team of experts classified 710 existing social environment items into content areas and wrote 32 new items. Additional qualitative item review included item refinement and winnowing of the pool prior to cognitive interviews and field testing of 82 items. Field test data indicated that the pool satisfies a 1-parameter item response theory measurement model and would be appropriate for development into a calibrated item bank. Conclusions: Our qualitative item review process supported a social environment conceptual framework that includes both social support and social attitudes. We developed a new social attitudes self-report item pool. Calibration testing of that pool is underway with a larger sample to develop a social attitudes item bank for persons with disabilities. (C) 2015 by the American Congress of Rehabilitation Medicine	[Garcia, Sofia F.; Hahn, Elizabeth A.; Lai, Jin-Shei; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Garcia, Sofia F.] Northwestern Univ, Feinberg Sch Med, Dept Psychiat & Behav Sci, Chicago, IL 60611 USA; [Garcia, Sofia F.; Hahn, Elizabeth A.; Lai, Jin-Shei; Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Inst Publ Hlth & Med, Chicago, IL 60611 USA; [Magasi, Susan; Hammel, Joy] Univ Illinois, Dept Occupat Therapy, Chicago, IL USA; [Semik, Patrick; Heinemann, Allen W.] Rehabil Inst Chicago, Chicago, IL 60611 USA; [Heinemann, Allen W.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Garcia, SF (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, 625 N Michigan Ave,Ste 2700, Chicago, IL 60611 USA.	sofia-garcia@northwestern.edu	Heinemann, Allen W./AAI-2790-2021	Heinemann, Allen W./0000-0003-2782-7326	National Institute on Disability and Rehabilitation Research [H133B090024]; National Center for Complementary and Alternative MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine; National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U54AR057951-S1]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) [U54AR057951] Funding Source: NIH RePORTER	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133B090024). A portion of Dr. Garcia's time toward this publication was supported by the National Center for Complementary and Alternative Medicine and the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (award no. U54AR057951-S1).	ANDRICH D, 1978, EDUC PSYCHOL MEAS, V38, P665, DOI 10.1177/001316447803800308; Bode RK, 2003, ARCH PHYS MED REHAB, V84, pS52, DOI 10.1053/apmr.2003.50247; Cella D, 2000, MED CARE, V38, P66; Daruwalla P, 2005, ANN TOURISM RES, V32, P549, DOI 10.1016/j.annals.2004.10.008; Daruwalla PS, 1999, ATTITUDES DISABILITY; DeWalt DA, 2007, MED CARE, V45, pS12, DOI 10.1097/01.mlr.0000254567.79743.e2; Dunn DS, 2013, REHABIL PSYCHOL, V58, P148, DOI 10.1037/a0031691; Field M.J., 2007, FUTURE DISABILITY AM; Fougeyrollas P., 1988, QUEBEC CLASSIFICATIO; Fougeyrollas P, 1999, MEASURE QUALITY ENV; Gill Carol J., 1997, J VOCATIONAL REHABIL, V9, P39, DOI DOI 10.1016/S1052-2263(97)00020-2; Hahn EA, 2006, MED CARE, V44, pS189, DOI 10.1097/01.mlr.0000245145.21869.5b; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hammel J, 2015, ARCH PHYS MED REHAB, V96, P578, DOI 10.1016/j.apmr.2014.12.008; Hays RD, 2000, MED CARE, V38, P28; Heinemann AW, 2015, ARCH PHYS MED REHAB, V96, P589, DOI 10.1016/j.apmr.2013.11.024; Keller C, 2010, J APPL SOC PSYCHOL, V40, P389, DOI 10.1111/j.1559-1816.2009.00579.x; Kimberlin SE, 2009, J HUM BEHAV SOC ENVI, V19, P26, DOI 10.1080/10911350802619870; Kincaid Jr JP, 1975, 875 US NAV AIR STAT; Lennon C., LEXILE FRAMEWORK APP; Linacre J, 1994, RASCH MEAS T, V7, P328; Oliver M., 1990, POLITICS DISABLEMENT; Olkin R, 2003, AM PSYCHOL, V58, P296, DOI 10.1037/0003-066X.58.4.296; Rao D, 2009, QUAL LIFE RES, V18, P585, DOI 10.1007/s11136-009-9475-1; Rasch Georg, 1980, PROBABILISTIC MODELS; Solar O, 2010, 2 WHO; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; United Nations, 2006, **NON-TRADITIONAL**; Whiteneck G, 2009, ARCH PHYS MED REHAB, V90, pS22, DOI 10.1016/j.apmr.2009.06.009; Whiteneck GG, 2004, ARCH PHYS MED REHAB, V85, P1324, DOI 10.1016/j.apmr.2003.09.027; WHO, 2008, COMMISSION SOCIAL DE; World Health Organization, 2002, COMM LANG FUNCT DIS; World Health Organization, 2007, INT CLASS FUNCT DIS; Wright BD, 1985, RATING SCALE ANAL RA	34	18	19	0	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2015	96	4					596	603		10.1016/j.apmr.2014.06.019			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	CE9RC	WOS:000352180100004	25045803	Green Accepted			2022-02-06	
J	Siebenrock, KA; Kienle, KP; Steppacher, SD; Tannast, M; Mamisch, TC; von Rechenberg, B				Siebenrock, Klaus A.; Kienle, Karl-Philipp; Steppacher, Simon D.; Tannast, Moritz; Mamisch, Tallal C.; von Rechenberg, Brigitte			Biochemical MRI Predicts Hip Osteoarthritis in an Experimental Ovine Femoroacetabular Impingement Model	CLINICAL ORTHOPAEDICS AND RELATED RESEARCH			English	Article; Proceedings Paper	Bernese Hip Symposium	FEB 06-08, 2014	Berne, SWITZERLAND	Univ Berne, Inselspital			ARTICULAR-CARTILAGE; JOINT CARTILAGE; MORPHOLOGY; SEQUENCE; INJURY	Cam-type femoroacetabular impingement (FAI) resulting from an abnormal nonspherical femoral head shape leads to chondrolabral damage and is considered a cause of early osteoarthritis. A previously developed experimental ovine FAI model induces a cam-type impingement that results in localized chondrolabral damage, replicating the patterns found in the human hip. Biochemical MRI modalities such as T2 and T2* may allow for evaluation of the cartilage biochemistry long before cartilage loss occurs and, for that reason, may be a worthwhile avenue of inquiry. We asked: (1) Does the histological grading of degenerated cartilage correlate with T2 or T2* values in this ovine FAI model? (2) How accurately can zones of degenerated cartilage be predicted with T2 or T2* MRI in this model? A cam-type FAI was induced in eight Swiss alpine sheep by performing a closing wedge intertrochanteric varus osteotomy. After ambulation of 10 to 14 weeks, the sheep were euthanized and a 3-T MRI of the hip was performed. T2 and T2* values were measured at six locations on the acetabulum and compared with the histological damage pattern using the Mankin score. This is an established histological scoring system to quantify cartilage degeneration. Both T2 and T2* values are determined by cartilage water content and its collagen fiber network. Of those, the T2* mapping is a more modern sequence with technical advantages (eg, shorter acquisition time). Correlation of the Mankin score and the T2 and T2* values, respectively, was evaluated using the Spearman's rank correlation coefficient. We used a hierarchical cluster analysis to calculate the positive and negative predictive values of T2 and T2* to predict advanced cartilage degeneration (Mankin a parts per thousand yen 3). We found a negative correlation between the Mankin score and both the T2 (p < 0.001, r = -0.79) and T2* values (p < 0.001, r = -0.90). For the T2 MRI technique, we found a positive predictive value of 100% (95% confidence interval [CI], 79%-100%) and a negative predictive value of 84% (95% CI, 67%-95%). For the T2* technique, we found a positive predictive value of 100% (95% CI, 79%-100%) and a negative predictive value of 94% (95% CI, 79%-99%). T2 and T2* MRI modalities can reliably detect early cartilage degeneration in the experimental ovine FAI model. T2 and T2* MRI modalities have the potential to allow for monitoring the natural course of osteoarthrosis noninvasively and to evaluate the results of surgical treatments targeted to joint preservation.	[Siebenrock, Klaus A.; Kienle, Karl-Philipp; Steppacher, Simon D.; Tannast, Moritz; Mamisch, Tallal C.] Univ Bern, Inselspital, Dept Orthopaed Surg, CH-3010 Bern, Switzerland; [Tannast, Moritz; von Rechenberg, Brigitte] Univ Bern, Musculoskeletal Res Unit, CH-3010 Bern, Switzerland		Siebenrock, KA (corresponding author), Univ Bern, Inselspital, Dept Orthopaed Surg, Freiburgstr, CH-3010 Bern, Switzerland.	klaus.siebenrock@insel.ch	Tannast, Moritz/ABB-9548-2020	Tannast, Moritz/0000-0002-2761-565X; Siebenrock, Klaus Arno/0000-0003-3627-4313			Beck M, 2005, J BONE JOINT SURG BR, V87B, P1012, DOI 10.1302/0301-620X.87B7.15203; Bittersohl B, 2012, OSTEOARTHR CARTILAGE, V20, P653, DOI 10.1016/j.joca.2012.03.011; Bittersohl B, 2009, MAGN RESON MED, V62, P896, DOI 10.1002/mrm.22096; Ganz R, 2003, CLIN ORTHOP RELAT R, P112, DOI 10.1097/01.blo.0000096804.78689.c2; Gold SL, 2012, CLIN ORTHOP RELAT R, V470, P3321, DOI 10.1007/s11999-012-2403-7; Hesper T, 2014, SKELETAL RADIOL; Jazrawi LM, 2011, J AM ACAD ORTHOP SUR, V19, P420, DOI 10.5435/00124635-201107000-00005; Kijowski R, 2013, RADIOLOGY, V267, P503, DOI 10.1148/radiol.12121413; Kim YJ, 2013, MAGN RESON IMAGING C, V21, P35, DOI 10.1016/j.mric.2012.09.003; Koff MF, 2009, RADIOL CLIN N AM, V47, P495, DOI 10.1016/j.rcl.2009.01.004; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1285, DOI 10.1056/NEJM197412122912406; MANKIN HJ, 1974, NEW ENGL J MED, V291, P1335, DOI 10.1056/NEJM197412192912507; Miese FR, 2011, ACTA RADIOL, V52, P106, DOI 10.3109/02841851.2010.516015; Nishii T, 2010, RADIOLOGY, V256, P955, DOI 10.1148/radiol.10091928; Phillips T W, 1987, J Arthroplasty, V2, P111, DOI 10.1016/S0883-5403(87)80017-7; Siebenrock KA, 2013, J ORTHOP RES, V31, P580, DOI 10.1002/jor.22273; Steppacher SD, 2013, CLIN ORTHOP RELAT R, V472, P337; VANDERSLUIJS JA, 1992, J ORTHOPAED RES, V10, P58, DOI 10.1002/jor.1100100107; Wagner S, 2003, OSTEOARTHR CARTILAGE, V11, P508, DOI 10.1016/S1063-4584(03)00075-X; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	20	18	19	0	8	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-921X	1528-1132		CLIN ORTHOP RELAT R	Clin. Orthop. Rel. Res.	APR	2015	473	4					1318	1324		10.1007/s11999-014-3849-6			7	Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Orthopedics; Surgery	CD2DY	WOS:000350885600022	25183216	Green Published			2022-02-06	
J	Evald, L				Evald, Lars			Prospective memory rehabilitation using smartphones in patients with TBI: What do participants report?	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Smartphones; Assistive technology; Memory disorders; Rehabilitation; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; COGNITIVE REHABILITATION; PEOPLE; AIDS	Use of assistive devices has been shown to be beneficial as a compensatory memory strategy among brain injury survivors, but little is known about possible advantages and disadvantages of the technology. As part of an intervention study participants were interviewed about their experiences with the use of low-cost, off-the-shelf, unmodified smartphones combined with Internet calendars as a compensatory memory strategy. Thirteen community-dwelling patients with traumatic brain injury (TBI) received a 6-week group-based instruction in the systematic use of a smartphone as a memory compensatory aid followed by a brief structured open-ended interview regarding satisfaction with and advantages and disadvantages of the compensatory strategy. Ten of 13 participants continued to use a smartphone as their primary compensatory strategy. Audible and visual reminders were the most frequently mentioned advantages of the smartphone, and, second, the capability as an all-in-one memory device. In contrast, battery life was the most often mentioned disadvantage, followed by concerns about loss or failure of the device. Use of a smartphone seems to be a satisfactory compensatory memory strategy to many patients with TBI and smartphones come with features that are advantageous to other compensatory strategies. However, some benefits come hand-in-hand with drawbacks, such as the feeling of dependency. These aspects should be taken into account when choosing assistive technology as a memory compensatory strategy.	[Evald, Lars] Aarhus Univ, Dept Psychol & Behav Sci, Aarhus, Denmark; [Evald, Lars] Aarhus Univ, MINDLAB, CFIN, CNRU, Aarhus, Denmark; [Evald, Lars] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark		Evald, L (corresponding author), Hammel Neurorehabil & Res Ctr, Voldbyvej 15, DK-8450 Hammel, Denmark.	lars.evald@rm.dk	Evald, Lars/Q-4384-2019	Evald, Lars/0000-0001-6255-2562			Cappa SF, 2005, EUR J NEUROL, V12, P665; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; De Joode EA, 2013, NEUROPSYCHOL REHABIL, V23, P133, DOI 10.1080/09602011.2012.726632; Evald L., 2014, PROSPECTIVE ME UNPUB; Hart T, 2004, J HEAD TRAUMA REHAB, V19, P351, DOI 10.1097/00001199-200409000-00001; Hart T, 2002, J HEAD TRAUMA REHAB, V17, P556, DOI 10.1097/00001199-200212000-00007; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; McDonald A, 2011, NEUROPSYCHOL REHABIL, V21, P784, DOI 10.1080/09602011.2011.598405; Scherer MJ, 2014, DISABIL REHABIL-ASSI, V9, P1, DOI 10.3109/17483107.2013.870239; Scherer MJ, 2002, DISABIL REHABIL, V24, P1, DOI 10.1080/09638280110066262; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Sundhedsstyrelsen s, 2011, MED TEKNOLOGIVURDERI, V13; Svoboda E, 2012, NEUROPSYCHOL REHABIL, V22, P408, DOI 10.1080/09602011.2011.652498; Wade TK, 2001, BRAIN INJURY, V15, P305, DOI 10.1080/026990501750111256; Waldron B., 2012, IRISH J PSYCHOL, V33, P29, DOI [10.1080/03033910.2012.659044, DOI 10.1080/03033910.2012.659044]; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wright P, 2001, BRAIN INJURY, V15, P787, DOI 10.1080/02699050110045161	17	18	18	1	32	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	MAR 4	2015	25	2					283	297		10.1080/09602011.2014.970557			15	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	AZ6BY	WOS:000348304600006	25333304				2022-02-06	
J	Albrecht, JS; Liu, XG; Smith, GS; Baumgarten, M; Rattinger, GB; Gambert, SR; Langenberg, P; Zuckerman, IH				Albrecht, Jennifer S.; Liu, Xinggang; Smith, Gordon S.; Baumgarten, Mona; Rattinger, Gail B.; Gambert, Steven R.; Langenberg, Patricia; Zuckerman, Ilene H.			Stroke Incidence Following Traumatic Brain Injury in Older Adults	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						hemorrhagic stroke; ischemic stroke; older adults; traumatic brain injury	LONG-TERM DISABILITY; UNITED-STATES; MULTICENTER; POPULATION; MORTALITY; RISK	Objective: Following traumatic brain injury (TBI), older adults are at an increased risk of hemorrhagic and thromboembolic events, but it is unclear whether the increased risk continues after hospital discharge. We estimated incidence rates of hemorrhagic and ischemic stroke following hospital discharge for TBI among adults 65 years or older and compared them with pre-TBI rates. Participants: A total of 16 936 Medicare beneficiaries 65 years or older with a diagnosis of TBI in any position on an inpatient claim between June 1, 2006, and December 31, 2009, who survived to hospital discharge. Design: Retrospective analysis of a random 5% sample of Medicare claims data. Main Measures: Hemorrhagic stroke was defined as ICD-9 (International Classification of Diseases, Ninth Revision) codes 430.xx-432.xx. Ischemic stroke was defined as ICD-9 codes 433.xx-435.xx, 437.0x, and 437.1x. Results: There was a 6-fold increase in the rate of hemorrhagic stroke following TBI compared with the pre-TBI period (adjusted rate ratio, 6.5; 95% confidence interval, 5.3-7.8), controlling for age and sex. A smaller increase in the rate of ischemic stroke was observed (adjusted rate ratio, 1.3; 95% CI, 1.2-1.4). Conclusion: Future studies should investigate causes of increased stroke risk post-TBI as well as effective treatment options to reduce stroke risk and improve outcomes post-TBI among older adults.	[Albrecht, Jennifer S.; Liu, Xinggang; Zuckerman, Ilene H.] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA; [Smith, Gordon S.; Baumgarten, Mona; Langenberg, Patricia; Zuckerman, Ilene H.] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Gambert, Steven R.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Smith, Gordon S.] Univ Maryland, Natl Study Ctr Trauma & Emergency Med Serv, Shock Trauma & Anesthesiol Res STAR Organized Res, Baltimore, MD 21201 USA; [Rattinger, Gail B.] Fairleigh Dickinson Univ, Sch Pharm, Pharm Practice Div, Florham Pk, NJ USA		Zuckerman, IH (corresponding author), IMPAQ Int LLC, 10420 Little Patuxent Pkwy,Suite 300, Columbia, MD 21044 USA.	izuckerman@impaqint.com		Albrecht, Jennifer/0000-0003-4838-2274; Smith, Gordon/0000-0002-2911-3071	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R21 AG042768-01, T32AG000262-14]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG042768, T32AG000262] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health grant R21 AG042768-01 (Dr Zuckerman, PI). Dr Albrecht is supported by National Institutes of Health grant T32AG000262-14 (Magaziner, PI).	Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Faul M, 2010, TRAUMATIC BRAIN INJU; Gubler KD, 1997, ARCH SURG-CHICAGO, V132, P1010; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Knudson MM, 2004, ANN SURG, V240, P490, DOI 10.1097/01.sla.0000137138.40116.6c; Livingston DH, 2005, J TRAUMA, V59, P1298, DOI 10.1097/01.ta.0000196002.03681.18; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Subaiya S, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-17; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Yeh CC, 2013, J NEUROL NEUROSUR PS, V84, P441, DOI 10.1136/jnnp-2012-302547; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	19	18	18	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					E62	E67		10.1097/HTR.0000000000000035			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300007	24816156	Green Accepted			2022-02-06	
J	Chitsabesan, P; Lennox, C; Williams, H; Tariq, O; Shaw, J				Chitsabesan, Prathiba; Lennox, Charlotte; Williams, Huw; Tariq, Omar; Shaw, Jenny			Traumatic Brain Injury in Juvenile Offenders: Findings From the Comprehensive Health Assessment Tool Study and the Development of a Specialist Linkworker Service	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						mental health needs; neurodevelopmental disorders; self-harm; service provision; traumatic brain injury	CONCUSSION SYMPTOMS QUESTIONNAIRE; MENTAL-DISORDERS; YOUNG OFFENDERS; PREVALENCE; PREDICTORS; DETENTION; CHILDREN; CUSTODY; YOUTH; NEEDS	Background: Young people in contact with the youth juvenile justice system have well-documented vulnerabilities including high rates of mental health and neurodevelopmental disorders. Studies have suggested that they may also be at increased risk of traumatic brain injury (TBI). Objective: (1) To describe the profile of a cohort of juvenile offenders with TBI and associated comorbidity with other neurodevelopmental disorders, mental health needs, and offending behavior. (2) To describe the development of a specialist brain injury service for juvenile offenders with TBI within custody. Methods: Ninety-three male participants aged 15 to 18 years were consecutively admitted to a custodial secure facility. They were evaluated using a range of different neurocognitive and mental health measures including the Rivermead Post-Concussion Symptoms Questionnaire and the Comprehensive Health Assessment Tool. Results: Eight-two percent of those interviewed reported experiencing at least 1 TBI, and 44% reported ongoing neuropsychological symptoms. Eighteen percent of those sustaining a TBI reported moderate-severe postconcussion symptoms. Conclusions: There is a high prevalence of TBI in juvenile offenders in custody, with many experiencing multiple episodes. This study highlights the need for further research in this area. An example of a specialist brain injury linkworker service is described as one example of a model of service delivery for this group.	[Chitsabesan, Prathiba; Lennox, Charlotte; Tariq, Omar; Shaw, Jenny] Univ Manchester, Manchester Acad Hlth Sci Ctr, Ctr Mental Hlth & Risk, Manchester, Lancs, England; [Chitsabesan, Prathiba] Pennine Care NHS Fdn Trust, Manchester M33 6RG, Lancs, England; [Williams, Huw] Univ Exeter, Ctr Clin Neuropsychol Res, Exeter, Devon, England		Chitsabesan, P (corresponding author), Pennine Care NHS Fdn Trust, Stepping Hill Hosp, Child & Family Serv, Tree House, Manchester M33 6RG, Lancs, England.	pchitsabesan@yahoo.com		Lennox, Charlotte/0000-0001-9014-9965; shaw, jennifer/0000-0003-2569-7687	Department of Health (England); Barrow Cadbury Trust; Disabilities Trust Foundation	Evaluation of the comprehensive health assessment tool was funded through a research grant from the Department of Health (England) and evaluation of the specialist brain injury linkworker service by a research grant from the Barrow Cadbury Trust. The linkworker service is a 2-year project primarily funded by the Disabilities Trust Foundation. The authors acknowledge the contribution of Deborah Fortescue, Professor Michael Oddy, Kate French, and Tansy Warrilow from the Disabilities Trust Foundation in developing the specialist brain injury linkworker service described.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Centre for Mental Health, 2010, YOU JUST GET DO IT H; Chitsabesan P, 2006, BRIT J PSYCHIAT, V188, P534, DOI 10.1192/bjp.bp.105.010116; Chitsabesan P, 2014, J FORENSIC PSYCHI PS, V25, P1, DOI 10.1080/14789949.2014.882387; Chitsabesan P, 2007, J CHILD SERV, V2, P4, DOI 10.1108/17466660200700032; Coughlan A. K., 2007, BIRT MEMORY INFORM P; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; FARRINGTON DP, 2002, OXFORD HDB CRIMINOLO, P657; Fazel S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001150; Fazel S, 2008, J AM ACAD CHILD PSY, V47, P1010, DOI [10.1097/CHI.ObO13e31817eecf3, 10.1097/CHI.0b013e31817eeef3]; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Giola G, 2013, BEHAV RATING INVENTO; Golzari M, 2006, J ADOLESCENT HEALTH, V38, P776, DOI 10.1016/j.jadohealth.2005.06.008; Harrington R., 2005, MENTAL HLTH NEEDS EF; Hollows S. E., 1985, ADULT MEMORY INFORM; Hughes N, 2015, J HEAD TRAUMA REHAB, V30, P94, DOI 10.1097/HTR.0000000000000124; Hux D, 1998, BRAIN INJURY, V12, P667; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; Keenan HT, 2008, BMJ-BRIT MED J, V337, P1208; KIERNAN RJ, 1987, ANN INTERN MED, V107, P481, DOI 10.7326/0003-4819-107-4-481; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Lader D., 2000, PSYCHIAT MORBIDITY Y; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meltzer H, 2002, MENTAL HLTH YOUNG PE; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Mounce L., 2012, NOBODY MADE CONNECTI; Offender Health Research Network, 2013, COMPR HLTH ASS TOOL; Office of the Children's Commissioner, 2011, I THINK I MUST HAV B; Pitman I, 2015, NEUROPSYCHOL REHABIL, V25, P763, DOI 10.1080/09602011.2014.973887; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Putnins AL, 2005, INT J OFFENDER THER, V49, P143, DOI 10.1177/0306624X04269412; Royal College of Paediatrics and Child Health, 2013, HEALTHC STAND CHILDR; Ruchkin VV, 2003, J CHILD PSYCHOL PSYC, V44, P1058, DOI 10.1111/1469-7610.00190; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; The Disabilities Foundation, PRIS LINKW SERV; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2011, BRAIN INJURY, V25, P870, DOI 10.3109/02699052.2011.581641; Vizard E, 2012, PARL SEM NEUR CHILDR; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wiig E. H., 1989, TEST LANGUAGE COMPET; Williams H., 2012, REPAIRING SHATTERED; Williams WH, 2010, NEUROPSYCHOL REHABIL, V20, P801, DOI 10.1080/09602011.2010.519613	44	18	18	0	15	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2015	30	2					106	115		10.1097/HTR.0000000000000129			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CF1MG	WOS:000352309300013	25734841				2022-02-06	
J	Daniels, DJ; Clarke, MJ; Puffer, R; Luo, TD; McIntosh, AL; Wetjen, NM				Daniels, David J.; Clarke, Michelle J.; Puffer, Ross; Luo, T. David; McIntosh, Amy L.; Wetjen, Nicolas M.			High occurrence of head and spine injuries in the pediatric population following motocross accidents	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						motocross; motorcycle; pediatric; sports injury; trauma	TRAUMATIC BRAIN-INJURIES; UNITED-STATES; EPIDEMIOLOGY; SPORTS; IMPACT; CONCUSSION; CHILDREN; TRENDS; COST	OBJECT Off-road motorcycling is a very popular sport practiced by countless people worldwide. Despite its popularity, not much has been published on the severity and distribution of central nervous system related injuries associated with this activity in the pediatric population. The purpose of this study was to confirm, characterize, and document the rate of head and spine injuries associated with off-road motorcycling in this population. METHODS All patients aged 18 years or less who were treated for a motorbike injury at the authors' institution (a Level 1 regional trauma center) between 2000 and 2007 were identified through in-house surgical and trauma registries. Type, mechanism, and severity of CNS-related injuries were assessed, including: incidence of traumatic brain injury (TBI), loss of consciousness (LOC), Glasgow Coma Scale (GCS) score, head CT findings, neurological deficits, spinal fractures, cervical strain, and use of protective gear, including helmet. RESULTS During the 8-year period of study, 298 accidents were evaluated in 248 patients. The patients' mean age at the time of injury was 14.2 +/- 2.7 years. Head injury or TBI was identified in 60 (20.1%) of 298 cases (involving 58 of 248 patients). Fifty-seven cases were associated with LOC, and abnormalities were identified on head CT in 10 patients; these abnormalities included skull fractures and epidural, subdural, subarachnoid, and intraparenchymal hemorrhages. The GCS score was abnormal in 11 cases and ranged from 3 to 15, with an overall mean of 14.5. No patients required cranial surgery. Helmet use was confirmed in 43(71.6%) of the cases involving TBI. Spine fractures were identified in 13 patients (4.3%) and 5 required surgical fixation for their injury. CONCLUSIONS The authors found a high occurrence of head injuries following pediatric off-road motorcycle riding or motocross accidents despite the use of helmets. Additionally, this study severely underestimates the rate of mild TBIs in this patient population. Our data indicate that motocross is a high-risk sport despite the use of protective gear. Riders and parents should be counseled accordingly about the risks prior to participation.	[Daniels, David J.; Clarke, Michelle J.; Puffer, Ross; Wetjen, Nicolas M.] Mayo Clin, Coll Med, Dept Neurosurg, Rochester, MN 55905 USA; [Luo, T. David; McIntosh, Amy L.] Mayo Clin, Coll Med, Dept Orthopaed Surg, Rochester, MN 55905 USA		Clarke, MJ (corresponding author), Mayo Clin, Dept Neurol Surg, 200 First St SW, Rochester, MN 55905 USA.	clarke.michelle@mayo.edu		McIntosh, Amy/0000-0002-3660-4901			American Academy of Pediatrics Committee on Accident and Poison Prevention, 1987, PEDIATRICS, V79, P306; American Motorcyclist Association, 2008 RUL GOV PROAM S; Brandt MM, 2002, J TRAUMA, V53, P469, DOI 10.1097/00005373-200209000-00012; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Conn J. M., 2006, Morbidity and Mortality Weekly Report, V55, P621; Consumer Product Safety Commission, 2010, 2008 ANN REP ATV REL; Cordell H. K., 2005, OFF HIGHWAY VEHICLE; Daniels DJ, 2015, J NEUROSURG-PEDIATR, V15, P266, DOI 10.3171/2014.9.PEDS14153; Faul M, 2010, TRAUMATIC BRAIN INJU; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gobbi A, 2004, KNEE SURG SPORT TR A, V12, P574, DOI 10.1007/s00167-004-0510-z; Gorski TF, 2003, AM SURGEON, V69, P895; Grange JT, 2009, CURR SPORT MED REP, V8, P125, DOI 10.1249/JSR.0b013e3181a61e95; Guerriero RM, 2012, CURR OPIN PEDIATR, V24, P696, DOI 10.1097/MOP.0b013e3283595175; Hooten Kristopher G, 2012, Clin Neurosurg, V59, P126; Kennedy RD, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001848; Killingsworth JB, 2005, PEDIATRICS, V115, pE316, DOI 10.1542/peds.2004-1585; Lace JK, 2005, PEDIATRICS, V115, P1085, DOI 10.1542/peds.2005-0181; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larson AN, 2009, J PEDIATR ORTHOPED, V29, P847, DOI 10.1097/BPO.0b013e3181c1e2fa; Levy ML, 2012, WORLD NEUROSURG, V78, P535, DOI 10.1016/j.wneu.2011.10.032; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; Luo TD, 2015, J NEUROSURG-PEDIATR, V15, P255, DOI 10.3171/2014.11.PEDS14127; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mattei TA, 2012, J NEUROSURG-PEDIATR, V10, P490, DOI 10.3171/2012.8.PEDS12116; Max W, 1998, J TRAUMA, V45, P550, DOI 10.1097/00005373-199809000-00023; Missouri Center for Health Information Management and Epidemiology, 1993, CRASH OUTC DAT EV SY; Pomerantz WJ, 2005, PEDIATRICS, V115, P704, DOI 10.1542/peds.2004-1304; Schulz MR, 2004, AM J EPIDEMIOL, V160, P937, DOI 10.1093/aje/kwh304; Sills AK, 2013, NEUROSURGERY, V73, pE1091, DOI 10.1227/NEU.0000000000000152; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; Thurman DJ, 1998, J HEAD TRAUMA REHAB, V13, P1, DOI 10.1097/00001199-199804000-00003; Vane DW, 2005, PEDIATRICS, V115, P1087, DOI 10.1542/peds.2005-0061	34	18	19	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	MAR	2015	15	3					261	265		10.3171/2014.9.PEDS14149			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	CC3RL	WOS:000350266900006	25555116	Bronze			2022-02-06	
J	Keller, MW; Han, PP; Galarneau, MR; Gaball, CW				Keller, Matthew W.; Han, Peggy P.; Galarneau, Michael R.; Gaball, Curtis W.			Characteristics of Maxillofacial Injuries and Safety of In-Theater Facial Fracture Repair in Severe Combat Trauma	MILITARY MEDICINE			English	Article							OPERATION-IRAQI-FREEDOM; FRONTAL-SINUS FRACTURES; ENDURING FREEDOM; NECK TRAUMA; AFGHANISTAN; CASUALTIES; WAR; BATTLEFIELD; EXPERIENCE; PERSONNEL	The study objectives were to characterize maxillofacial injuries and assess the safety of in-theater facial fracture repair in U.S. military personnel with severe combat trauma from Iraq and Afghanistan. We performed a retrospective chart review of the Expeditionary Medical Encounter Database from 2004 to 2010. 1,345 military personnel with combat-related maxillofacial injuries were identified. Injury severity was quantified with the Abbreviated Injury Scale and Injury Severity Score. Service members with maxillofacial injury and severe combat trauma (Injury Severity Score 3 16) were included. The distribution of facial fractures, types, and outcomes of surgical repairs, incidence of traumatic brain injury, concomitant head and neck injuries, burn rate/severity, and rates of Acinetobacter baumannii colonization and surgical site infection were analyzed. The prevalence of maxillofacial injury in the Expeditionary Medical Encounter Database was 22.7%. The most common mechanism of injury was improvised explosive device (65.7%). Midface trauma and facial burns were common. Approximately 64% of the study sample sustained traumatic brain injury. Overall, 45.6% (109/239) had at least one facial bone fracture. Of those with facial fractures, 64.2% (n = 70) underwent surgical repair. None of the service members who underwent in-theater facial fracture repair developed A. baumannii facial wound infection or implant extrusion.	[Keller, Matthew W.; Gaball, Curtis W.] Naval Med Ctr San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92134 USA; [Han, Peggy P.; Galarneau, Michael R.] Naval Hlth Res Ctr, Med Modeling Simulat & Mission Support Dept, San Diego, CA 92106 USA		Keller, MW (corresponding author), Naval Med Ctr San Diego, Dept Otolaryngol Head & Neck Surg, San Diego, CA 92134 USA.				U.S. Navy Bureau of Medicine and Surgery under the Wounded, III; Injured/Psychological Health/Traumatic Brain Injury Program [60808]	Dr. Matthew Keller had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Mary Clouser critically revised the article for important intellectual content (Medical Modeling, Simulation, and Mission Support Department, Naval Health Research Center) and Amber Dougherty (Medical Modeling, Simulation, and Mission Support Department, Naval Health Research Center) performed scientific and technical editorial reviews of the article. This work was supported by the U.S. Navy Bureau of Medicine and Surgery under the Wounded, III, and Injured/Psychological Health/Traumatic Brain Injury Program under work unit no. 60808.	AC Hart, 2008, ICD 9 CM PROFESSIONA; Ansell M J, 2010, J R Army Med Corps, V156, P106; BAKER SP, 1976, J TRAUMA, V16, P882, DOI 10.1097/00005373-197611000-00006; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BEEBE GW, 1952, BATTLE CASUALTIES, P165; Breeze J, 2013, J ROY ARMY MED CORPS, V159, P59, DOI 10.1136/jramc-2013-000014; Breeze J, 2012, INJURY, V43, P1856, DOI 10.1016/j.injury.2011.07.001; Breeze J, 2012, J ROY ARMY MED CORPS, V158, P79, DOI 10.1136/jramc-158-02-02; Breeze J, 2010, J R Army Med Corps, V156, P137; Breeze J, 2011, J TRAUMA, V71, P108, DOI 10.1097/TA.0b013e318203304a; Brennan J, 2006, OTOLARYNG HEAD NECK, V134, P100, DOI 10.1016/j.otohns.2005.10.008; Brennan J, 2013, LARYNGOSCOPE, V123, P2411, DOI 10.1002/lary.24096; Brennan J, 2011, OTOLARYNG HEAD NECK, V144, P180, DOI 10.1177/0194599810391628; Centers for Disease Control and Prevention, 2004, MMWR MORB MORTAL WKL, V53, P1063; Chambers LW, 2006, J TRAUMA, V60, P1155, DOI 10.1097/01.ta.0000220340.91356.7e; Chan RK, 2012, J TRAUMA ACUTE CARE, V73, pS453, DOI 10.1097/TA.0b013e3182754868; Chen KT, 2006, PLAST RECONSTR SURG, V118, P457, DOI 10.1097/01.prs.0000227738.42077.2d; Davis KA, 2005, EMERG INFECT DIS, V11, P1218, DOI 10.3201/1108.050103; DOBSON JE, 1989, BRIT J ORAL MAX SURG, V27, P441, DOI 10.1016/S0266-4356(89)80001-4; Feldt BA, 2013, OTOLARYNG HEAD NECK, V148, P403, DOI 10.1177/0194599812472874; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gennarelli TA, 2005, ABBREVIATED INJURY S; Goldberg MS, 2010, MIL MED, V175, P220, DOI 10.7205/MILMED-D-09-00130; HARDAWAY RM, 1978, J TRAUMA, V18, P635, DOI 10.1097/00005373-197809000-00004; Hart AC, 2008, INT CLASSIFICATION D, V1; Hospenthal DR, 2011, J TRAUMA, V71, pS52, DOI 10.1097/TA.0b013e31822118fb; Levin L, 2008, J ORAL MAXIL SURG, V66, P1630, DOI 10.1016/j.joms.2007.11.028; Lew TA, 2010, J ORAL MAXIL SURG, V68, P3, DOI 10.1016/j.joms.2009.06.006; Lopez MA, 2007, ARCH FACIAL PLAST S, V9, P400, DOI 10.1001/archfaci.9.6.400; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; Nessen Shawn Christian, 2008, WAR SURG AFGHANISTAN; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Reister F, 2008, BATTLE CASUALITES ME; Salinas NL, 2011, OTOLARYNG HEAD NECK, V144, P703, DOI 10.1177/0194599811400575; Salinas NL, 2010, J CRANIOFAC SURG, V21, P967, DOI 10.1097/SCS.0b013e3181e17ab5; Sheppard FR, 2010, AM J SURG, V200, P489, DOI 10.1016/j.amjsurg.2010.03.001; Sise MJ, 2006, J TRAUMA, V60, P1162; Strong EB, 2006, OTOLARYNG HEAD NECK, V135, P774, DOI 10.1016/j.otohns.2006.03.043; Wade AL, 2007, J TRAUMA, V63, P836, DOI 10.1097/01.ta.0000251453.54663.66; WALLIS A, 1988, LARYNGOSCOPE, V98, P593; Zapor MJ, 2005, CURR OPIN INFECT DIS, V18, P395, DOI 10.1097/01.qco.0000182102.50430.2c	41	18	18	0	5	ASSOC MILITARY SURG US	BETHESDA	9320 OLD GEORGETOWN RD, BETHESDA, MD 20814 USA	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2015	180	3					315	320		10.7205/MILMED-D-14-00345			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CD3OI	WOS:000350987700018	25735023				2022-02-06	
J	Ross, DE; Ochs, AL; DeSmit, ME; Seabaugh, JM; Havranek, MD				Ross, David E.; Ochs, Alfred L.; DeSmit, Megan E.; Seabaugh, Jan M.; Havranek, Michael D.		Alzheimer's Disease Neuroimaging	Man Versus Machine Part 2: Comparison of Radiologists' Interpretations and NeuroQuant Measures of Brain Asymmetry and Progressive Atrophy in Patients With Traumatic Brain Injury	JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES			English	Article							NEUROIMAGING INITIATIVE ADNI; MRI; VOLUMETRY	This study is an expanded version of an earlier study, which compared NeuroQuant measures of MRI brain volume with the radiologist's traditional approach in outpatients with mild or moderate traumatic brain injury. NeuroQuant volumetric analyses were compared with the radiologists' interpretations. NeuroQuant found significantly higher rates of atrophy (50.0%), abnormal asymmetry (83.3%), and progressive atrophy (70.0%) than the radiologists (12.5%, 0% and 0%, respectively). Overall, NeuroQuant wasmore sensitive for detecting at least one sign of atrophy, abnormal asymmetry, or progressive atrophy (95.8%) than the traditional radiologist's approach (12.5%).	[Ross, David E.; Ochs, Alfred L.; DeSmit, Megan E.; Seabaugh, Jan M.] Virginia Inst Neuropsychiat, Midlothian, VA 23114 USA; [Ross, David E.; Ochs, Alfred L.] Virginia Commonwealth Univ, Richmond, VA USA; [Havranek, Michael D.] Amicus Visual Solut, Richmond, VA USA		Ross, DE (corresponding author), Virginia Inst Neuropsychiat, Midlothian, VA 23114 USA.	DRoss@VaNeuropsychiatry.org		Ochs, Alfred/0000-0003-3932-876X	Virginia Institute of Neuropsychiatry; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01 AG024904]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); National Institute of Biomedical Imaging and BioengineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30 AG010129, K01 AG030514]; Dana Foundation; AbbottAbbott Laboratories; AstraZeneca ABAstraZeneca; Bayer Schering Pharma AGBayer AG; Bristol-Myers SquibbBristol-Myers Squibb; Eisai Global Clinical DevelopmentEisai Co Ltd; Elan Corporation; GenentechRoche HoldingGenentech; GE HealthcareGeneral ElectricGE Healthcare; GlaxoSmithKlineGlaxoSmithKline; Innogenetics; Johnson and JohnsonJohnson & JohnsonJohnson & Johnson USA; Eli Lilly and Co.Eli Lilly; Medpace, Inc.; Merck and Co., Inc.Merck & Company; Novartis AG; Pfizer IncPfizer; F. Hoffman-La Roche; Schering-PloughMerck & CompanySchering Plough Corporation; Synarc, Inc.; Alzheimer's AssociationAlzheimer's Association; Alzheimer's Drug Discovery Foundation; Northern California Institute for Research and Education; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [U01AG024904] Funding Source: NIH RePORTER	Supported internally by the Virginia Institute of Neuropsychiatry.; Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, GlaxoSmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., as well as non-profit partners the Alzheimer's Association and Alzheimer's Drug Discovery Foundation, with participation from the U.S. Food and Drug Administration. Private sector contributions to ADNI are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129, K01 AG030514, and the Dana Foundation.	Brewer JB, 2009, BEHAV NEUROL, V21, P21, DOI [10.1155/2009/616581, 10.3233/BEN-2009-0226]; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miyahira Yoshinao, 2004, Seishin Shinkeigaku Zasshi, V106, P138; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Raz N, 2007, ANN NY ACAD SCI, V1097, P84, DOI 10.1196/annals.1379.018; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Ross DE, 2013, BRAIN INJURY, V27, P634, DOI 10.3109/02699052.2013.767939; Ross DE, 2013, J NEUROPSYCH CLIN N, V25, P32, DOI 10.1176/appi.neuropsych.11120377; Ross DE, 2012, BRAIN INJURY, V26, P1500, DOI 10.3109/02699052.2012.694570; Ross DE, 2011, BRAIN INJURY, V25, P1271, DOI 10.3109/02699052.2011.624568; Talairach J., 1988, COPLANAR STEREOTAXIC; Weiner MW, 2010, ALZHEIMERS DEMENT, V6, P202, DOI 10.1016/j.jalz.2010.03.007	14	18	18	0	2	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	0895-0172	1545-7222		J NEUROPSYCH CLIN N	J. Neuropsychiatr. Clin. Neurosci.	SPR	2015	27	2					147	152		10.1176/appi.neuropsych.13040088			6	Clinical Neurology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry	CJ1NM	WOS:000355250300111	25923853				2022-02-06	
J	Yousefzadeh-Chabok, S; Moghaddam, AD; Kazemnejad-Leili, E; Saneei, Z; Hosseinpour, M; Kouchakinejad-Eramsadati, L; Razzaghi, A; Mohtasham-Amiri, Z				Yousefzadeh-Chabok, Sharhokh; Moghaddam, Anoush Dehnadi; Kazemnejad-Leili, Ehsan; Saneei, Zahra; Hosseinpour, Marieh; Kouchakinejad-Eramsadati, Leila; Razzaghi, Alireza; Mohtasham-Amiri, Zahra			The Relationship Between Serum Levels of Interleukins 6, 8, 10 and Clinical Outcome in Patients With Severe Traumatic Brain Injury	ARCHIVES OF TRAUMA RESEARCH			English	Article						Head Injury; Interleukin; Brain	EXCITATORY AMINO-ACIDS; CEREBROSPINAL-FLUID; HEAD-INJURY; CHILDREN; CYTOKINES; PLASMA; IL-6	Background: Clinical outcome in patients with severe traumatic brain injury (TBI) depends on both primary and secondary brain injuries. Neuroinflammation is an important secondary mechanism, which occurs by releasing interleukins (ILs). Increased levels of ILs may affect clinical outcome following TBI. Objectives: This study aimed to determine the relationship between the serum levels of interleukins 6, 8 and 10 and clinical outcome in patients with severe TBI 6 months after injury. Patients and Methods: In a descriptive-analytical study, 44 patients with GCS <= 8 (Glasgow coma scale) and age >= 14 years were included. Their blood samples were collected at first 6 hours after injury. Clinical outcome was determined based on GOS (Glasgow Outcome Scale) at 6 months after head injury. Serum levels of interleukins 6, 8 and 10 were measured using the ELISA method. Spearman's rho, independent T-Test, and Mann-Whitney Test were used for data analysis. Results: Comparing the serum levels of interleukins in two groups with favorable and unfavorable clinical outcomes showed that the mean serum levels of interleukins 6 and 8 in group with favorable outcome was 85.2 +/- 51.6 and 52.2 +/- 31.9, respectively lower than those of group with unfavorable outcome with 162.3 +/- 141.1 and 173.6 +/- 257.3 (P < 0.03) and (P < 0.01). Conclusions: Increased serum levels of interleukins 6 and 8 as a predictive marker might be associated with unfavorable clinical outcome in patients with severe TBI.	[Yousefzadeh-Chabok, Sharhokh] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Neurosurg Dept, Rasht, Iran; [Moghaddam, Anoush Dehnadi] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Anesthesiol Dept, Rasht, Iran; [Kazemnejad-Leili, Ehsan] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Biostat Dept, Rasht, Iran; [Saneei, Zahra; Hosseinpour, Marieh; Razzaghi, Alireza; Mohtasham-Amiri, Zahra] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran; [Kouchakinejad-Eramsadati, Leila] Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Human Resource Management, Rasht, Iran		Mohtasham-Amiri, Z (corresponding author), Guilan Univ Med Sci, Guilan Rd Trauma Res Ctr, Rasht, Iran.	mohtasham@gums.ac.ir	Kazemnezhad Leyli, Ehsan/S-2292-2017; Razzaghi, Alireza/E-6855-2018; Mogha, Anoush Dehnadi/E-4722-2019; Mohtasham-Amiri, Zahra/C-4469-2012	Kazemnezhad Leyli, Ehsan/0000-0002-9195-9094; Razzaghi, Alireza/0000-0003-1874-6364; Mohtasham-Amiri, Zahra/0000-0002-4896-6248; Dehnadi Moghadam, Anoush/0000-0002-8408-2909			Antunes Alessandra Armstrong, 2010, Asian J Neurosurg, V5, P68; Chiaretti A, 2005, CHILD NERV SYST, V21, P185, DOI 10.1007/s00381-004-1032-1; Chiaretti A, 2008, J NEUROTRAUM, V25, P225, DOI 10.1089/neu.2007.0405; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P437, DOI 10.1007/978-3-211-85578-2_85; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Kalabalikis P, 1999, INTENS CARE MED, V25, P288, DOI 10.1007/s001340050837; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Maier B, 2001, SHOCK, V15, P421, DOI 10.1097/00024382-200115060-00002; McIntosh TK, 1996, LAB INVEST, V74, P315; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Oda S, 2005, CYTOKINE, V29, P169, DOI 10.1016/j.cyto.2004.10.010; ROUMEN RMH, 1993, ANN SURG, V218, P769, DOI 10.1097/00000658-199312000-00011; Shiozaki T, 2005, SHOCK, V23, P406, DOI 10.1097/01.shk.0000161385.62758.24; Singhal A, 2002, J NEUROTRAUM, V19, P929, DOI 10.1089/089771502320317087; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Winter CD, 2004, BRAIN, V127, P315, DOI 10.1093/brain/awh039; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	25	18	18	0	4	KASHAN UNIV MEDICAL SCIENCES	KASHAN	PO BOX 87159-88141, KASHAN, REPUBLIC ISLAMIC 00000, IRAN	2251-953X	2251-9599		ARCH TRAUMA RES	Arch. Trauma Res.	MAR	2015	4	1							e18357	10.5812/atr.18357			4	Orthopedics	Emerging Sources Citation Index (ESCI)	Orthopedics	CP9GI	WOS:000360201400002	26064865	Green Submitted, Green Published, Bronze			2022-02-06	
J	Perera, CJ; Duffy, SS; Lees, JG; Kim, CF; Cameron, B; Apostolopoulos, V; Moalem-Taylor, G				Perera, Chamini J.; Duffy, Samuel S.; Lees, Justin G.; Kim, Cristina F.; Cameron, Barbara; Apostolopoulos, Vasso; Moalem-Taylor, Gila			Active immunization with myelin-derived altered peptide ligand reduces mechanical pain hypersensitivity following peripheral nerve injury	JOURNAL OF NEUROINFLAMMATION			English	Article						Neuropathic pain; Myelin basic protein; Altered peptide ligand; Mechanical allodynia; Pro-inflammatory cytokines; Anti-inflammatory cytokines; M1 and M2 macrophages	PROINFLAMMATORY CYTOKINE EXPRESSION; TRAUMATIC BRAIN-INJURY; BASIC-PROTEIN EPITOPE; DORSAL-ROOT GANGLIA; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RAT SCIATIC-NERVE; NEUROPATHIC PAIN; SPINAL-CORD; IMMUNE-RESPONSES	Background: T cells have been implicated in neuropathic pain that is caused by peripheral nerve injury. Immunogenic myelin basic protein (MBP) peptides have been shown to initiate mechanical allodynia in a T cell-dependent manner. Antagonistic altered peptide ligands (APLs) are peptides with substitutions in amino acid residues at T cell receptor contact sites and can inhibit T cell function and modulate inflammatory responses. In the present study, we studied the effects of immunization with MBP-derived APL on pain behavior and neuroinflammation in an animal model of peripheral nerve injury. Methods: Lewis rats were immunized subcutaneously at the base of the tail with either a weakly encephalitogenic peptide of MBP (cyclo-MBP87-99) or APL (cyclo-(87-99)[A(91),A(96)]MBP87-99) in complete Freund's adjuvant (CFA) or CFA only (control), following chronic constriction injury (CCI) of the left sciatic nerve. Pain hypersensitivity was tested by measurements of paw withdrawal threshold to mechanical stimuli, regulatory T cells in spleen and lymph nodes were analyzed by flow cytometry, and immune cell infiltration into the nervous system was assessed by immunohistochemistry (days 10 and 30 post-CCI). Cytokines were measured in serum and nervous tissue of nerve-injured rats (day 10 post-CCI). Results: Rats immunized with the APL cyclo-(87-99)[A(91),A(96)]MBP87-99 had significantly reduced mechanical pain hypersensitivity in the ipsilateral hindpaw compared to cyclo-MBP87-99-treated and control rats. This was associated with significantly decreased infiltration of T cells and ED1+ macrophages in the injured nerve of APL-treated animals. The percentage of anti-inflammatory (M2) macrophages was significantly upregulated in the APL-treated rats on day 30 post-CCI. Compared to the control rats, microglial activation in the ipsilateral lumbar spinal cord was significantly increased in the MBP-treated rats, but was not altered in the rats immunized with the MBP-derived APL. In addition, immunization with the APL significantly increased splenic regulatory T cells. Several cytokines were significantly altered after CCI, but no significant difference was observed between the APL-treated and control rats. Conclusions: These results suggest that immune deviation by active immunization with a non-encephalitogenic MBP-derived APL mediates an analgesic effect in animals with peripheral nerve injury. Thus, T cell immunomodulation warrants further investigation as a possible therapeutic strategy for the treatment of peripheral neuropathic pain.	[Perera, Chamini J.; Duffy, Samuel S.; Lees, Justin G.; Kim, Cristina F.; Moalem-Taylor, Gila] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia; [Cameron, Barbara] Univ New S Wales, Sch Med Sci, Ctr Infect & Inflammat Res, Sydney, NSW 2052, Australia; [Apostolopoulos, Vasso] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, Melbourne, Vic 8001, Australia		Moalem-Taylor, G (corresponding author), Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia.	gila@unsw.edu.au	Moalem-Taylor, Gila/C-3116-2008; Apostolopoulos, Vasso/Q-4525-2019	Moalem-Taylor, Gila/0000-0003-3828-9527; Lees, Justin/0000-0002-0874-2856; Apostolopoulos, Vasso/0000-0001-6788-2771	National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	This study was supported by a grant from the National Health and Medical Research Council of Australia to Gila Moalem-Taylor. We would like to thank Ms Shima Zahrooni for technical assistance in immunohistochemistry and acknowledge the assistance of Mr Christopher Brownlee and the BRIL Flow Cytometry Facility at the University of New South Wales, Australia.	Austin PJ, 2012, PAIN, V153, P1916, DOI 10.1016/j.pain.2012.06.005; Austin PJ, 2010, J NEUROIMMUNOL, V229, P26, DOI 10.1016/j.jneuroim.2010.08.013; Barclay J, 2007, PAIN, V130, P225, DOI 10.1016/j.pain.2006.11.017; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bileviciute-Ljungar I, 2001, NEUROSCI LETT, V311, P157, DOI 10.1016/S0304-3940(01)02154-1; Cao L, 2008, EUR J IMMUNOL, V38, P448, DOI 10.1002/eji.200737485; Cao XF, 2007, IMMUNITY, V27, P635, DOI 10.1016/j.immuni.2007.08.014; Clark AK, 2007, EUR J PAIN, V11, P223, DOI 10.1016/j.ejpain.2006.02.003; Colburn RW, 1997, J NEUROIMMUNOL, V79, P163, DOI 10.1016/S0165-5728(97)00119-7; Costigan M, 2009, J NEUROSCI, V29, P14415, DOI 10.1523/JNEUROSCI.4569-09.2009; Cui JG, 2000, PAIN, V88, P239, DOI 10.1016/S0304-3959(00)00331-6; Draleau Ks, 2014, J Pain Relief, VSuppl 3, P003; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Gao YJ, 2010, PHARMACOL THERAPEUT, V126, P56, DOI 10.1016/j.pharmthera.2010.01.002; Gaur A, 1997, J NEUROIMMUNOL, V74, P149, DOI 10.1016/S0165-5728(96)00220-2; Gillen C, 1998, J NEUROSCI RES, V51, P489, DOI 10.1002/(SICI)1097-4547(19980215)51:4<489::AID-JNR8>3.3.CO;2-5; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GOULD KE, 1993, J NEUROIMMUNOL, V46, P193, DOI 10.1016/0165-5728(93)90249-X; Gritsch S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6472; Hauben E, 2001, J CLIN INVEST, V108, P591, DOI 10.1172/JCI200112837; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Hu P, 2002, NEUROSCIENCE, V112, P23, DOI 10.1016/S0306-4522(02)00065-9; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Ibarra A, 2013, NEUROSCI LETT, V554, P59, DOI 10.1016/j.neulet.2013.08.048; Kalergis AM, 2000, J IMMUNOL, V165, P280, DOI 10.4049/jimmunol.165.1.280; KARIN N, 1994, J EXP MED, V180, P2227, DOI 10.1084/jem.180.6.2227; Katsara M, 2008, EXPERT OPIN BIOL TH, V8, P1873, DOI [10.1517/14712590802494501, 10.1517/14712590802494501 ]; Katsara M, 2008, MOL IMMUNOL, V45, P3661, DOI 10.1016/j.molimm.2008.04.024; Katsara M, 2009, IMMUNOLOGY, V128, P521, DOI 10.1111/j.1365-2567.2009.03137.x; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Kim CF, 2011, BRAIN RES, V1405, P95, DOI 10.1016/j.brainres.2011.06.022; Kleinschnitz C, 2005, MOL BRAIN RES, V136, P23, DOI 10.1016/j.molbrainres.2004.12.015; Kobayashi H, 2008, MOL CELL NEUROSCI, V39, P619, DOI 10.1016/j.mcn.2008.08.008; Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2; Ledeboer A, 2005, PAIN, V115, P71, DOI 10.1016/j.pain.2005.02.009; Ledeboer A, 2007, BRAIN BEHAV IMMUN, V21, P686, DOI 10.1016/j.bbi.2006.10.012; Lewitus GM, 2009, BIOL PSYCHIAT, V65, P283, DOI 10.1016/j.biopsych.2008.07.014; Liu HQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-119; Liu LJ, 2006, J NEUROPHYSIOL, V95, P1478, DOI 10.1152/jn.00509.2005; Liu T, 2000, PAIN, V86, P25, DOI 10.1016/S0304-3959(99)00306-1; Mantzourani ED, 2006, J MED CHEM, V49, P6683, DOI 10.1021/jm060040z; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon S, 2007, EUR J NEUROSCI, V26, P403, DOI 10.1111/j.1460-9568.2007.05650.x; Matsoukas J, 2005, J MED CHEM, V48, P1470, DOI 10.1021/jm040849g; McGuirk P, 2002, TRENDS IMMUNOL, V23, P450, DOI 10.1016/S1471-4906(02)02288-3; Mert T, 2009, N-S ARCH PHARMACOL, V379, P445, DOI 10.1007/s00210-008-0387-3; Mika J, 2008, PAIN, V138, P587, DOI 10.1016/j.pain.2008.02.015; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Moalem-Taylor G, 2007, BRAIN BEHAV IMMUN, V21, P699, DOI 10.1016/j.bbi.2006.07.007; Moalem-Taylor G, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-1; Myers RR, 2006, DRUG DISCOV TODAY, V11, P8, DOI 10.1016/S1359-6446(05)03637-8; Nicholson LB, 1997, P NATL ACAD SCI USA, V94, P9279, DOI 10.1073/pnas.94.17.9279; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Parkitny L, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/890706; Qin HW, 2012, P NATL ACAD SCI USA, V109, P5004, DOI 10.1073/pnas.1117218109; Raghavendra V, 2004, EUR J NEUROSCI, V20, P467, DOI 10.1111/j.1460-9568.2004.03514.x; Reeve AJ, 2000, EUR J PAIN-LONDON, V4, P247, DOI 10.1053/eujp.2000.0177; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; SLOANLANCASTER J, 1994, CELL, V79, P913, DOI 10.1016/0092-8674(94)90080-9; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Tian DH, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00168; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; von Herrath MG, 2003, NAT REV IMMUNOL, V3, P223, DOI 10.1038/nri1029; Wang GH, 2013, J CEREBR BLOOD F MET, V33, P1864, DOI 10.1038/jcbfm.2013.146; Weber MS, 2007, NAT MED, V13, P935, DOI 10.1038/nm1620; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Young DA, 2000, J IMMUNOL, V164, P3563, DOI 10.4049/jimmunol.164.7.3563; Zhang RX, 2008, PAIN, V135, P232, DOI 10.1016/j.pain.2007.05.023; Zhang XW, 2014, J NEUROSCI, V34, P3013, DOI 10.1523/JNEUROSCI.3681-13.2014; Zheng FY, 2011, NEUROSCIENCE, V176, P447, DOI 10.1016/j.neuroscience.2010.12.052	74	18	18	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	FEB 13	2015	12								28	10.1186/s12974-015-0253-4			19	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	CC5GE	WOS:000350386300001	25885812	gold, Green Published, Green Accepted			2022-02-06	
J	Boldsen, JL; Milner, GR; Weise, S				Boldsen, Jesper L.; Milner, George R.; Weise, Svenja			Cranial vault trauma and selective mortality in medieval to early modern Denmark	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article						selective mortality; cranial trauma survival|; violence; premodern Denmark	LONG-TERM SURVIVAL; BRAIN-INJURY; OSTEOLOGICAL PARADOX; ENAMEL HYPOPLASIA; CHILDHOOD STRESS; SKELETAL SAMPLES; LIFE EXPECTANCY; POPULATION; DEATH; AGE	To date, no estimates of the long-term effect of cranial vault fractures on the risk of dying have been generated from historical or prehistoric skeletons. Excess mortality provides a perspective on the efficacy of modern treatment, as well as the human cost of cranial injuries largely related to interpersonal violence in past populations. Three medieval to early modern Danish skeletal samples are used to estimate the effect of selective mortality on males with cranial vault injuries who survived long enough for bones to heal. The risk of dying for these men was 6.2 times higher than it was for their uninjured counterparts, estimated through a simulation study based on skeletal observations. That is about twice the increased risk of dying experienced by modern people with traumatic brain injuries. The mortality data indicate the initial trauma was probably often accompanied by brain injury. Although the latter cannot be directly observed in skeletal remains, it can be inferred through the relative risks of dying. The ability to identify the effects of selective mortality in this skeletal sample indicates it must be taken into account in paleopathological research. The problem is analogous to extrapolating from death register data to modern communities, so epidemiological studies based on mortality data have the same inherent possibility of biases as analyses of ancient skeletons.	[Boldsen, Jesper L.] Univ Southern Denmark, Inst Forens Med, Dept Anthropol, DK-5260 Odense S, Denmark; [Milner, George R.] Penn State Univ, Dept Anthropol, University Pk, PA 16802 USA; [Weise, Svenja] Max Planck Inst Demog Res, D-18057 Rostock, Germany		Boldsen, JL (corresponding author), Univ Southern Denmark, Inst Forens Med, Dept Anthropol, DK-5260 Odense S, Denmark.	ost@psu.edu; jboldsen@health.sdu.dk			G.R.M.'s grant from American-Scandinavian Foundation	The late Ulla Freund's assistance with the skeletal materials is much appreciated. Her insights and familiarity with the collections are sorely missed. This work was partly supported by G.R.M.'s grant from the American-Scandinavian Foundation.	Baguley I, 2000, BRAIN INJURY, V14, P505; Baguley IJ, 2012, MED J AUSTRALIA, V196, P40, DOI 10.5694/mja11.10090; Boldsen J, 2000, HIKUIN, V27, P233; Boldsen JL, 2006, AM J PHYS ANTHROPOL, V130, P344, DOI 10.1002/ajpa.20363; Boldsen JL, 2007, AM J PHYS ANTHROPOL, V132, P59, DOI 10.1002/ajpa.20467; Boldsen JL, 2012, BLACKW COMPANION ANT, P114; Boldsen JL, 1997, INTEGRATING ARCHAEOL, V24, P229; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Brown AW, 2004, NEUROREHABILITATION, V19, P37; BYERS SN, 1994, CURR ANTHROPOL, V35, P282, DOI 10.1086/204274; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Cohen M. N., 1997, INTEGRATING ARCHAEOL, P242; Cohen M. N., 2007, ANCIENT HLTH SKELETA, P320; COHEN MN, 1994, CURR ANTHROPOL, V35, P629, DOI 10.1086/204323; Cohen MN, 1992, CURR ANTHROPOL, V33, P358; DeWitte SN, 2008, P NATL ACAD SCI USA, V105, P1436, DOI 10.1073/pnas.0705460105; Duray SM, 1996, AM J PHYS ANTHROPOL, V99, P275; Faergemann Christian, 2007, J Forensic Leg Med, V14, P20, DOI 10.1016/j.jcfm.2006.01.001; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; GOODMAN AH, 1988, AM ANTHROPOL, V90, P936, DOI 10.1525/aa.1988.90.4.02a00120; GOODMAN AH, 1993, CURR ANTHROPOL, V34, P281, DOI 10.1086/204170; Grauer AL, 1996, AM J PHYS ANTHROPOL, V100, P531, DOI 10.1002/(SICI)1096-8644(199608)100:4<531::AID-AJPA7>3.0.CO;2-T; Grell Ole Peter, 1997, HLTH CARE POOR RELIE, V4, p[13, 15, 26]; Hanawalt BA, 1986, TIES BOUND; Hansen BD, 1996, STORE DANSKE ENCYKLO, P237; Harrison-Felix C, 2012, J HEAD TRAUMA REHAB, V27, pE45, DOI 10.1097/HTR.0b013e31827340ba; Harrod RP, 2014, CAM S BIO EVOL ANTHR, V67, P103; JACKES M, 1993, CURR ANTHROPOL, V34, P434, DOI 10.1086/204188; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Metzler I, 2013, SOCIAL HIST DIABILIT; Metzler I, 2011, HISTORY COMPASS, V9, P45, DOI 10.1111/j.1478-0542.2010.00746.x; Milner G. R., 2013, DEAD TELL TALES ESSA, P172; Milner GR, 2012, AM J PHYS ANTHROPOL, V148, P98, DOI 10.1002/ajpa.22047; Milner GR, 2011, ANTHROPOL ANZ, V68, P415, DOI 10.1127/0003-5548/2011/0152; Palubeckaite Z, 2002, INT J OSTEOARCHAEOL, V12, P189, DOI 10.1002/oa.607; Petersen H. C., 2006, URBANISM PREINDUSTRI, P110; Pinker, 2011, BETTER ANGELS OUR NA; Ratcliff G, 2005, DISABIL REHABIL, V27, P305, DOI 10.1080/09638280400018338; SAUNDERS SR, 1993, YEARB PHYS ANTHROPOL, V36, P127; Shavelle R, 2000, J Insur Med, V32, P163; Strauss D, 1999, J INSUR MED, V31, P104; Usher BM, 2000, THESIS PENNSYLVANIA; WALKER AE, 1971, ARCH NEUROL-CHICAGO, V24, P95, DOI 10.1001/archneur.1971.00480320023001; Walker P. L., 1997, TROUBLED TIMES VIOLE, P145; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; Weber J, 2001, AM J PHYS ANTHROPOL, V114, P352, DOI 10.1002/ajpa.1047.abs; WEISS GH, 1982, ARCH NEUROL-CHICAGO, V39, P741, DOI 10.1001/archneur.1982.00510240003001; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; WOOD JW, 1994, CURR ANTHROPOL, V35, P631; Wright L. E., 2003, J ARCHAEOL RES, V11, P43, DOI [10.1023/A:1021200925063, DOI 10.1023/A:1021200925063]	50	18	18	1	8	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	FEB 10	2015	112	6					1721	1726		10.1073/pnas.1412511112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8XL	WOS:000349204200036	25624493	Bronze, Green Published			2022-02-06	
J	Gan, M; Moussaud, S; Jiang, PZ; McLean, PJ				Gan, Ming; Moussaud, Simon; Jiang, Peizhou; McLean, Pamela J.			Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction	NEUROBIOLOGY OF AGING			English	Article						Alpha-synuclein; ATP; Luhmes cells; P2X1 receptor; Parkinson's disease; Purinergic signaling	TRAUMATIC BRAIN-INJURY; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASES; CEREBRAL-ISCHEMIA; IN-VIVO; CELLS; OLIGOMERS; INFLAMMATION; ACTIVATION; ADENOSINE	The pathologic hallmark of Parkinson's disease (PD) is the accumulation of alpha-synuclein (alpha syn) in susceptible neurons in the form of Lewy bodies and Lewy neurites. The etiology of PD remains unclear. Because brain injury has been suggested to facilitate alpha syn aggregation, we investigated whether cellular breakdown products from damaged cells can act on neighboring healthy cells and cause intracellular alpha syn accumulation and/or aggregation. Using 2 neuronal cell models, we found that extracellular adenosine triphosphate (ATP) induced a significant increase in intracellular alpha syn levels between 24 and 48 hours after treatment. Further investigation revealed that the observed alpha syn accumulation is a result of lysosome dysfunction caused by extracellular ATP-induced elevation of lysosomal pH. Interestingly, P2X1 receptor appears to mediate the cells' response to extracellular ATP. Although Ca2+ influx via P2X1 receptor is necessary for alpha syn accumulation, Ca2+ influx per se is not sufficient for increased alpha syn accumulation. These findings provide new insight into our knowledge of the role of P2X receptors in PD pathogenesis and may be helpful in identifying new therapeutic targets for PD. (C) 2015 Elsevier Inc. All rights reserved.	[Gan, Ming; Moussaud, Simon; Jiang, Peizhou; McLean, Pamela J.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [McLean, Pamela J.] Mayo Clin, Mayo Grad Sch, Jacksonville, FL USA		McLean, PJ (corresponding author), Mayo Clin, Dept Neurosci, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	mclean.pamela@mayo.edu		Moussaud, Simon/0000-0002-6340-9511; McLean, Pamela/0000-0003-4870-5715	NIH NS [073740]; Mayo Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS073740] Funding Source: NIH RePORTER	This work was supported by NIH NS 073740 (Pamela J. McLean) and the Mayo Clinic. The authors thank Ann-Marie Baine for excellent technical assistance.	Apolloni S, 2009, FEBS J, V276, P354, DOI 10.1111/j.1742-4658.2008.06796.x; Bours Martijn Jan Leo, 2011, Front Biosci (Schol Ed), V3, P1443; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bramlett HM, 2003, EXP NEUROL, V184, P27, DOI 10.1016/S0014-4886(03)00401-1; Clark RSB, 1997, J NEUROSCI, V17, P9172; Danzer KM, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-42; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Virgilio F, 2003, DRUG DEVELOP RES, V59, P171, DOI 10.1002/ddr.10191; Di Virgilio F, 2000, J AUTONOM NERV SYST, V81, P59, DOI 10.1016/S0165-1838(00)00114-4; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Ebrahimi-Fakhari D, 2011, J NEUROSCI, V31, P14508, DOI 10.1523/JNEUROSCI.1560-11.2011; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Gourine AV, 2007, J PHYSIOL-LONDON, V585, P305, DOI 10.1113/jphysiol.2007.143933; Greco NJ, 2001, BLOOD, V98, P100, DOI 10.1182/blood.V98.1.100; Guha S, 2013, FASEB J, V27, P4500, DOI 10.1096/fj.13-236166; Hirsch Etienne C, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS210, DOI 10.1016/S1353-8020(11)70065-7; Hodges RR, 2011, INVEST OPHTH VIS SCI, V52, P3254, DOI 10.1167/iovs.10-7042; Hracsko Z, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-28; Inscho EW, 1999, HYPERTENSION, V33, P195, DOI 10.1161/01.HYP.33.1.195; Iyer SS, 2009, P NATL ACAD SCI USA, V106, P20388, DOI 10.1073/pnas.0908698106; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jiang PZ, 2013, NEUROBIOL AGING, V34, P1504, DOI 10.1016/j.neurobiolaging.2012.11.001; Jin QH, 2004, CELL MOL LIFE SCI, V61, P1816, DOI 10.1007/s00018-004-4143-7; Kawamura H, 2012, IMMUNOLOGY, V136, P448, DOI 10.1111/j.1365-2567.2012.03601.x; Kew J.N.C., 2010, ION CHANNELS STRUCTU; Korngreen A, 1996, J PHYSIOL-LONDON, V497, P53, DOI 10.1113/jphysiol.1996.sp021749; Kurashima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2023; Lee PC, 2012, NEUROLOGY, V79, P2061, DOI 10.1212/WNL.0b013e3182749f28; Liu J, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-6; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; North RA, 2013, MOL PHARMACOL, V83, P759, DOI 10.1124/mol.112.083758; Planchard MS, 2014, PROTEIN SCI, V23, P1369, DOI 10.1002/pro.2521; Prasai P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-90; Prots I, 2013, J BIOL CHEM, V288, P21742, DOI 10.1074/jbc.M113.451815; Putcha P, 2010, J PHARMACOL EXP THER, V332, P849, DOI 10.1124/jpet.109.158436; Rettinger J, 2003, J GEN PHYSIOL, V121, P451, DOI 10.1085/jgp.200208730; Rodriguez-Grande B, 2013, BRAIN BEHAV IMMUN, V29, P51, DOI 10.1016/j.bbi.2012.11.017; Ryu JK, 2008, NEUROREPORT, V19, P1715, DOI 10.1097/WNR.0b013e3283179333; Schildknecht S, 2009, J NEUROCHEM, V110, P13; Schildknecht S, 2013, ALTEX-ALTERN ANIM EX, V30, P427, DOI 10.14573/altex.2013.4.427; Seminario-Vidal L, 2009, METHODS MOL BIOL, V574, P25, DOI 10.1007/978-1-60327-321-3_3; Sperlagh B, 2011, CURR TOP MED CHEM, V11, P1034, DOI 10.2174/156802611795347564; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; Stern ST, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-20; Tanaka K, 2010, PLANT PHYSIOL, V154, P705, DOI 10.1104/pp.110.162503; Trabanelli S, 2012, J IMMUNOL, V189, P1303, DOI 10.4049/jimmunol.1103800; Unal-Cevik I, 2011, J CEREBR BLOOD F MET, V31, P913, DOI 10.1038/jcbfm.2010.170; Uryu K, 2003, EXP NEUROL, V184, P214, DOI 10.1016/S0014-4886(03)00245-0; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Volonte C, 2003, CNS NEUROL DISORD-DR, V2, P403, DOI 10.2174/1568007033482643	53	18	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	FEB	2015	36	2					1209	1220		10.1016/j.neurobiolaging.2014.10.037			12	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Geriatrics & Gerontology; Neurosciences & Neurology	CF3MZ	WOS:000352454400066	25480524	Green Accepted			2022-02-06	
J	Odijk, M; van der Wouden, EJ; Olthuis, W; Ferrari, MD; Tolner, EA; van den Maagdenberg, AMJM; van den Berg, A				Odijk, M.; van der Wouden, E. J.; Olthuis, W.; Ferrari, M. D.; Tolner, E. A.; van den Maagdenberg, A. M. J. M.; van den Berg, A.			Microfabricated solid-state ion-selective electrode probe for measuring potassium in the living rodent brain: Compatibility with DC-EEG recordings to study spreading depression	SENSORS AND ACTUATORS B-CHEMICAL			English	Article						Neuroprobe; Ion selective electrode; Spreading depression; Microfabrication	ELECTROCHEMICAL DEPOSITION; POTENTIAL STABILITY; CONDUCTING POLYMERS; BULK OPTODES; SENSORS; OXYGEN; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); MIGRAINE; TRANSDUCERS; MEMBRANES	There is considerable need in neuroscience research to reliably measure concentrations of extracellular ions in the living brain as the dynamics of ion levels increasingly is considered to play a key role in the pathophysiology of many brain disorders. Unfortunately, most probes currently used for direct measurement of extracellular ion concentrations in living brain tissue in experimental animals have considerable limitations. They are custom-made glass capillary ion-selective microelectrodes that are fragile, timeconsuming to prepare, and can practically only be used to measure at one depth and one location in the brain. We here present the design and fabrication of a novel type of miniaturized probe that can simultaneously measure, in the brain of a living animal, multiple parameters relevant to the neurological phenomenon of spreading depression (SD) at multiple depths and locations. SD is characterized by a slowly propagating wave of initial neuronal and glial cell depolarization that is followed by depression of activity. SD is accompanied by a massive redistribution of ions, including K+, between intracellular and extracellular compartments and is considered important in brain diseases such as stroke, traumatic brain injury, and migraine with aura. This work focuses on the functionalization of fabricated probes for measuring changes in extracellular K+ concentration (and its associated changes in neuronal activity) using an ion-selective potentiometric sensor. We show that the choice of conductive polymer and the method of electro-deposition is critical to obtain low cross-sensitivity for pH and O-2. The sensor's response to IC is approximately linear between 2 and 40 mM with a voltage-response of 39 mV/log[K+]. Proof-of-principle in vivo brain recordings were performed in the cortex of a wild-type mouse during induction of cortical SD. We reliably measured the theoretically expected rise and fall of brain tissue K+ levels during a locally induced cortical SD. We envisage that our probe can be of great use to reliably measure K+, without being affected by pH or O-2 changes, in the living brain and be widely applicable in neuroscience research. (C) 2014 Elsevier B.V All rights reserved.	[Odijk, M.; van der Wouden, E. J.; Olthuis, W.; van den Berg, A.] Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands; [Ferrari, M. D.; Tolner, E. A.; van den Maagdenberg, A. M. J. M.] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RA Leiden, Netherlands; [van den Maagdenberg, A. M. J. M.] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RA Leiden, Netherlands		Odijk, M (corresponding author), Univ Twente, MESA Inst Nanotechnol, NL-7500 AE Enschede, Netherlands.	m.odijk@utwente.nl	van den Berg, Albert/B-4648-2013; Odijk, Mathieu/I-5880-2012; Tolner, Else/J-9201-2015; Ferrari, Michel D./ABE-3758-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Olthuis, Wouter/AAA-7585-2021	van den Berg, Albert/0000-0001-9019-933X; Odijk, Mathieu/0000-0002-4467-9604; Ferrari, Michel D./0000-0001-9691-9449; Olthuis, Wouter/0000-0002-7018-1383	NWONetherlands Organization for Scientific Research (NWO); EU-funded Marie Curie Career Integration [294233]; Marie Curie IAPP Program BRAINPATH [612360]; FP7 Project EUROHEADPAIN	The authors would like to thank Lennart de Vreede for assistance during probe fabrication and Sandra van Heiningen for assistance during the in vivo mouse experiment. This work is funded by the NWO Spinoza prizes received by A. van den Berg and M.D. Ferrari, the EU-funded Marie Curie Career Integration Grant (no. 294233; E.A. Tolner), Marie Curie IAPP Program BRAINPATH (no. 612360; E.A. Tolner & A.M.J.M. van den Maagdenberg), and FP7 Project EUROHEADPAIN (no. 602633; M.D. Ferrari 82 A.MJ.M. van den Maagdenberg).	Bakker E, 1997, CHEM REV, V97, P3083, DOI 10.1021/cr940394a; Bobacka J, 1999, ANAL CHEM, V71, P4932, DOI 10.1021/ac990497z; Bobacka J, 2006, ELECTROANAL, V18, P7, DOI 10.1002/elan.200503384; Bobacka J, 2000, J ELECTROANAL CHEM, V489, P17, DOI 10.1016/S0022-0728(00)00206-0; Bobacka J, 2008, CHEM REV, V108, P329, DOI 10.1021/cr068100w; Boulton AA, 1990, NEUROPHYSIOLOGICAL T; Buhlmann P, 1998, CHEM REV, V98, P1593, DOI 10.1021/cr970113+; CHAN ADC, 1992, ANAL CHEM, V64, P2512, DOI 10.1021/ac00045a010; Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Faridbod F, 2008, SENSORS-BASEL, V8, P2331, DOI 10.3390/s8042331; Hajj-Hassan M, 2008, SENSORS-BASEL, V8, P7636, DOI 10.3390/s8127636; Han JH, 2001, ANALYST, V126, P2040, DOI 10.1039/b105585m; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lian XY, 2004, BRAIN RES, V1012, P177, DOI 10.1016/j.brainres.2004.04.011; LIMEZAWA Y, 1995, PURE APPL CHEM, V67, P507; Michalska A, 2006, ANAL BIOANAL CHEM, V384, P391, DOI 10.1007/s00216-005-0132-4; Mikhel'son KN, 2008, RUSS J GEN CHEM+, V78, P2445, DOI 10.1134/S1070363208120268; Mustain WE, 2007, J ELECTROCHEM SOC, V154, pA668, DOI 10.1149/1.2735915; O'Neill RD, 2004, BIOSENS BIOELECTRON, V19, P1521, DOI 10.1016/j.bios.2003.12.004; Pandey PC, 1998, SENSOR ACTUAT B-CHEM, V46, P61, DOI 10.1016/S0925-4005(97)00332-8; Pawlowski P, 2011, TALANTA, V84, P814, DOI 10.1016/j.talanta.2011.02.018; Piilgaard H, 2009, J CEREBR BLOOD F MET, V29, P1517, DOI 10.1038/jcbfm.2009.73; Pijanowska DG, 2004, SENSOR ACTUAT B-CHEM, V103, P350, DOI 10.1016/j.snb.2004.04.108; Schuhmann W, 1997, BIOSENS BIOELECTRON, V12, P1157, DOI 10.1016/S0956-5663(97)00086-9; SOMJEN GG, 1984, BRAIN RES, V311, P186, DOI 10.1016/0006-8993(84)91416-1; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; van de Ven RCG, 2007, ARCH NEUROL-CHICAGO, V64, P643, DOI 10.1001/archneur.64.5.643; Vazquez M, 2002, SENSOR ACTUAT B-CHEM, V82, P7, DOI 10.1016/S0925-4005(01)00983-2; Veder JP, 2011, ANALYST, V136, P3252, DOI 10.1039/c1an15267j; Yuzawa I, 2012, J CEREBR BLOOD F MET, V32, P376, DOI 10.1038/jcbfm.2011.148; Zachara JE, 2004, SENSOR ACTUAT B-CHEM, V101, P207, DOI 10.1016/j.snb.2004.02.052; Zwickl T, 1998, ANAL SCI, V14, P57, DOI 10.2116/analsci.14.57	33	18	18	0	95	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0925-4005			SENSOR ACTUAT B-CHEM	Sens. Actuator B-Chem.	FEB	2015	207		B		SI		945	953		10.1016/j.snb.2014.06.138			9	Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry; Electrochemistry; Instruments & Instrumentation	AU9EU	WOS:000345895400009					2022-02-06	
J	Salga, M; Jourdan, C; Durand, MC; Hangard, C; Denormandie, P; Carlier, RY; Genet, F				Salga, Marjorie; Jourdan, Claire; Durand, Marie-Christine; Hangard, Chloe; Denormandie, Philippe; Carlier, Robert-Yves; Genet, Francois			Sciatic nerve compression by neurogenic heterotopic ossification: use of CT to determine surgical indications	SKELETAL RADIOLOGY			English	Article						Heterotopic ossification; Sciatic nerve compression; CT; Electroneuromyography; Traumatic brain injury; Spinal cord injury	POSTERIOR FRACTURE-DISLOCATION; TRAUMATIC BRAIN; INJURED PATIENT; ULNAR NERVE; HIP; ENTRAPMENT; MANAGEMENT; PALSY; BONE	To describe the characteristics of neurogenic heterotopic ossification (NHO) based on clinical tests, electroneuromyography (ENMG) and CT in a database of patients with lesions of the central nervous system who required sciatic nerve neurolysis along with posterior hip NHO resection, and to determine the respective roles of ENMG and CT in the management of posterior hip NHOs in patients who are unable to communicate or express pain. The consistency of the ENMG results with clinical findings, CT results and macroscopic signs of lesions was retrospectively assessed after sciatic nerve neurolysis and ablation of 55 posterior hip NHOs. Sciatic nerve neurolysis was necessary in 55 cases (47.4 %; 55 out of 116). CT showed contact of the NHO with the nerve in all cases: 5 in contact with no deflection, 3 in contact with deflection, 21 moulded into a gutter and 26 entrapped in the NHO. There were clinical signs of sciatic nerve lesion in 21.8 % of cases (12 out of 55). ENMG showed signs of sciatic nerve lesions in only 55.6 % (10 out of 18), only 4 of whom presented with clinical signs of a nerve lesion. No significant relationship was found between clinical symptoms and ENMG findings of sciatic nerve compression (n = 13, p = 0.77). Nerve compression by NHO is likely an underdiagnosed condition, particularly in patients who are unable to communicate. Diagnosis of sciatic compression by NHO should be based on regular clinical examinations and CT. ENMG is not sufficiently sensitive to be used alone for surgical decision-making.	[Salga, Marjorie; Jourdan, Claire; Genet, Francois] Hop Raymond Poincare, APHP, Dept Phys Med & Rehabil, CIC IT 805, F-92380 Garches, France; [Jourdan, Claire] Univ Versailles St Quentin Yvelines, EA4047, Versailles, France; [Durand, Marie-Christine] Hop Raymond Poincare, APHP, Dept Neurophysiol, CIC IT 805, F-92380 Garches, France; [Durand, Marie-Christine; Denormandie, Philippe; Genet, Francois] Univ Versailles St Quentin Yvelines, EA 4497, GRCTH, Versailles, France; [Hangard, Chloe; Carlier, Robert-Yves] Hop Raymond Poincare, APHP, Dept Med Imaging, CIC IT 805, F-92380 Garches, France; [Denormandie, Philippe] Hop Raymond Poincare, APHP, Dept Orthopaed Surg, CIC IT 805, F-92380 Garches, France; [Genet, Francois] Hop Instruct Armees Percy, Mil Med Serv, Dept Phys Med & Rehabil, F-92140 Clamart, France		Genet, F (corresponding author), Hop Raymond Poincare, APHP, Dept Phys Med & Rehabil, CIC IT 805, 104 Bd Raymond Poincare, F-92380 Garches, France.	francois.genet@rpc.aphp.fr					Abayev B, 2005, NEUROLOGIST, V11, P184, DOI 10.1097/01.nrl.0000160557.86676.63; Aubut JAL, 2011, NEUROREHABILITATION, V28, P151, DOI 10.3233/NRE-2011-0643; Baird Evan O, 2009, J Orthop Surg Res, V4, P12, DOI 10.1186/1749-799X-4-12; BROOKE MM, 1991, ARCH PHYS MED REHAB, V72, P425; Carlier RY, 2005, J BONE JOINT SURG BR, V87B, P301, DOI 10.1302/0301-620X.87B3.14737; Chua H. C., 1997, SMJ, V38, P447; De Jonghe B, 2008, NEUROL CLIN, V26, P507, DOI 10.1016/j.ncl.2008.03.001; Della Santa D R, 1990, Ann Chir Main Memb Super, V9, P38, DOI 10.1016/S0753-9053(05)80435-1; DERIAN PS, 1974, SOUTH MED J, V67, P209, DOI 10.1097/00007611-197402000-00020; Fikry T, 2004, Chir Main, V23, P109, DOI 10.1016/j.main.2004.02.008; Gallucci GL, 2003, J SHOULDER ELB SURG, V12, P637, DOI 10.1016/S1058-2746(03)00043-0; Genet F, 2012, J HEAD TRAUMA REHAB, V27, P443, DOI 10.1097/HTR.0b013e31822b54ba; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Hamdi MF, 2010, NEUROCHIRURGIE, V56, P340, DOI 10.1016/j.neuchi.2010.05.003; Humphreys DB, 2007, J NEUROSURG, V107, P314, DOI 10.3171/JNS-07/08/0314; Keenan MAE, 2004, J HEAD TRAUMA REHAB, V19, P143, DOI 10.1097/00001199-200403000-00006; KLEIMAN SG, 1971, J BONE JOINT SURG AM, VA 53, P781, DOI 10.2106/00004623-197153040-00019; Kline DG, 1998, J NEUROSURG, V89, P13, DOI 10.3171/jns.1998.89.1.0013; Manidakis N, 2009, J BONE JOINT SURG BR, V91B, P253, DOI 10.1302/0301-620X.91B2.21183; ORZEL JA, 1985, J NUCL MED, V26, P125; REINSTEIN L, 1983, ARCH PHYS MED REHAB, V64, P65; Safaz I, 2008, AM J PHYS MED REHAB, V87, P65, DOI 10.1097/PHM.0b013e31815b5b4d; Teasell RW, 2010, SPINAL CORD, V48, P512, DOI 10.1038/sc.2009.175; THAKKAR DH, 1981, INJURY, V13, P207, DOI 10.1016/0020-1383(81)90240-0; Topuz K, 2011, BRIT J NEUROSURG, V25, P509, DOI 10.3109/02688697.2011.566380; WAINAPEL SF, 1985, ARCH PHYS MED REHAB, V66, P512	26	18	19	0	5	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-2348	1432-2161		SKELETAL RADIOL	Skeletal Radiol.	FEB	2015	44	2					233	240		10.1007/s00256-014-2003-6			8	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Radiology, Nuclear Medicine & Medical Imaging	AX4LQ	WOS:000346904500009	25218150				2022-02-06	
J	Young, LA; Rule, GT; Bocchieri, RT; Burns, JM				Young, Lee Ann; Rule, Gregory T.; Bocchieri, Robert T.; Burns, Jennie M.			Biophysical Mechanisms of Traumatic Brain Injuries	SEMINARS IN NEUROLOGY			English	Article						traumatic brain injury; blunt trauma; blast; ballistic; physics; acceleration; diffuse axonal injury	HEAD; MILD; CONCUSSION; FOOTBALL; BLUNT; RISK; EPIDEMIOLOGY; BIOMECHANICS; RESPONSES	Despite years of effort to prevent traumatic brain injuries (TBIs), the occurrence of TBI in the United States alone has reached epidemic proportions. When an external force is applied to the head, it is converted into stresses that must be absorbed into the brain or redirected by a helmet or other protective equipment. Complex interactions of the head, neck, and jaw kinematics result in strains in the brain. Even relatively mild mechanical trauma to these tissues can initiate a neurochemical cascade that leads to TBI. Civilians and warfighters can experience head injuries in both combat and noncombat situations from a variety of threats, including ballistic and blunt impact, acceleration, and blast. It is critical to understand the physics created by these threats to develop meaningful improvements to clinical care, injury prevention, and mitigation. Here the authors review the current state of understanding of the complex loading conditions that lead to TBI and characterize how these loads are transmitted through soft tissue, the skull and into the brain, resulting in TBI. In addition, gaps in knowledge and injury thresholds are reviewed, as these must be addressed to better design strategies that reduce TBI incidence and severity.	[Young, Lee Ann] Appl Res Associates Inc, Phys Secur & Appl Sci Sect, Dallas, TX 75240 USA; [Rule, Gregory T.; Burns, Jennie M.] Appl Res Associates Inc, Phys Secur & Appl Sci Sect, San Antonio, TX USA; [Bocchieri, Robert T.] Appl Res Associates Inc, Silicon Valley Off, Los Altos, CA USA		Young, LA (corresponding author), Appl Res Associates Inc, Phys Secur & Appl Sci Sect, 13915 Preston Valley Pl, Dallas, TX 75240 USA.	lyoung@ara.com					Adams J H, 1983, Acta Neurochir Suppl (Wien), V32, P15; Adams J H, 1981, Acta Neuropathol Suppl, V7, P26; Cernak I, 1996, J TRAUMA, V40, pS100, DOI 10.1097/00005373-199603001-00023; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Committee on Review of Test Protocols Used by the DoD to Test Combat Helmets. Board on Army Science and Technology; Division on Engineering and Physical Sciences; National Research Council Review of Department of Defense Test Protocols for Combat Helmets, 2014, TEST PROT BACKF DEF; Courtney AC, 2009, MED HYPOTHESES, V72, P76, DOI 10.1016/j.mehy.2008.08.015; Dagro A.M., 2013, PRELIMINARY INVESTIG; Department of Energy, 1980, MAN PRED BLAST FRAG; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Faul M, 2010, TRAUMATIC BRAIN INJU; Gennarelli TA, 1979, P 23 STAPP CAR CRASH; Goeller J, 2013, CAVITATION POSSIBLE; Gorske T., 2014, PENNS PSYCH ASS ANN; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; Gurdjian ES., 1973, HEAD INJURY ANTIQUIT; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Hutchinson J, 1998, APPL MATH COMPUT, V96, P1, DOI 10.1016/S0096-3003(97)10106-0; King AI, 2000, ANNU REV BIOMED ENG, V2, P55, DOI 10.1146/annurev.bioeng.2.1.55; King AI, 2003, INT RES COUNC BIOM I; KRAUS JF, 1994, SEMIN NEUROL, V14, P1, DOI 10.1055/s-2008-1041052; KRAUS JF, 1988, J TRAUMA, V28, P1637, DOI 10.1097/00005373-198812000-00004; Lemonick DM, 2011, AM J CLIN MED, V8, P134; Levine B, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00009; LISSNER HR, 1960, SURG GYNECOL OBSTET, V111, P329; Lockhart P, 2011, J TRAUMA, V70, pE29, DOI 10.1097/TA.0b013e3181de3f4b; Long J, 2013, COMBINED EFFECTS PRI; MacPherson D, 2005, BULL PEN MOD DYN INC; McIntire BJ, 2005, 200512 USAARL; Moss WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.108702; Needham CE, 2010, SHOCK WAVE HIGH PRES, P1, DOI 10.1007/978-3-642-05288-0; Needham CE, FRONT NEURO IN PRESS; Nyein M, 2008, 26 ARM SCI C DEC 1 4; OMMAYA AK, 1994, INT J IMPACT ENG, V15, P535, DOI 10.1016/0734-743X(94)80033-6; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panzer MB, 2014, EXP NEUROL, V261, P120, DOI 10.1016/j.expneurol.2014.07.002; Panzer MB, 2012, NAT NEUR SOC ANN M J; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Prasad P, 1982, POSITION US DELEGATI; Przekwas A, 2011, ASME 2011 INT MECH E; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Raymond DE, 2008, ASME SUMM BIOENG C J; Richmond DR., 1968, ESTIMATE MANS TOLERA; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Slobonik BA, 1980, SPH 4 HELMET DAMAGE; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Theeler BJ, 2010, HEADACHE, V50, P1262, DOI 10.1111/j.1526-4610.2010.01700.x; U.S. National Academies of Science Committee on Gulf War and Health: Brain Injury in Veterans and Long Term Health Outcomes, 2008, MULT PERS TRAUM BRAI; Versace J., 1971, P15 STAPP CAR CRASH; Wood G, 2013, INT RES COUNC BIOM I; Yoganandan N, 2005, SOLID MECH APPL, V124, P173; Yoganandan N, 1997, J TRAUMA, V42, P266, DOI 10.1097/00005373-199702000-00014; Yu AW, 2012, BIOM ENG SOC ANN M O; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C, 1995, 39 STAPP CAR CRASH C, P121; Zhu F, 2013, INT J NUMER METH BIO, V29, P392, DOI 10.1002/cnm.2518	63	18	18	1	33	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	FEB	2015	35	1					5	11		10.1055/s-0035-1544242			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	CC4AP	WOS:000350293300003	25714862				2022-02-06	
J	Ahmed, M; Sriganesh, K; Vinay, B; Rao, GSU				Ahmed, Masud; Sriganesh, Kamath; Vinay, Byrappa; Rao, Ganne S. Umamaheswara			Acute kidney injury in survivors of surgery for severe traumatic brain injury: Incidence, risk factors, and outcome from a tertiary neuroscience center in India	BRITISH JOURNAL OF NEUROSURGERY			English	Article						acute kidney injury; incidence; outcome; predictive factors; traumatic brain injury	ACUTE-RENAL-FAILURE; CRITICALLY-ILL PATIENTS; HOSPITAL MORTALITY; FLUID BALANCE; HEAD-INJURY; COMPLICATIONS; NEPHROTOXICITY; THERAPY	Background. Non-neurological complications like acute kidney injury (AKI) can affect outcome of traumatic brain injury (TBI). This study aims to analyze the incidence, predictive factors, and impact of AKI in operated patients with severe TBI. Methods. We retrospectively reviewed the data of 395 patients who underwent surgery for severe TBI and survived to be discharged from the hospital over a 1-year period. Of these, 95 patients were finally included in the analysis. Their demographic data, laboratory parameters, and clinical courses were reviewed. Diagnosis and staging of AKI was made using Acute Kidney Injury Network (AKIN) criteria. Results. The incidence of AKI was 11.6% (11 patients). Out of the11 patients who had AKI, 7 were in stage I (63.6%), 3 were in stage II (27.3%), and 1 in stage III (9.1%). Nine Patients (81.8%) developed AKI within 5 days of admission. Aminoglycoside therapy had an association with occurrence of AKI. There was no mortality and none of the patients required renal replacement therapy (RRT). Renal function of all these patients returned to baseline before hospital discharge. Hospital stay and intensive care unit (ICU) stay were longer and Glasgow coma scale (GCS) was lower in patients with AKI when compared with patients without AKI group at discharge. Conclusion. Reversible AKI without need for RRT occurred in nearly12% of patients with severe TBI requiring surgical intervention. Aminoglycoside therapy was the only predictive factor for the occurrence of AKI. Patients with AKI have a longer period of mechanical ventilation, longer ICU and hospital stay, and poorer GCS at discharge.	[Ahmed, Masud] Univ Dhaka, Combined Mil Hosp, Dhaka 1000, Bangladesh; [Sriganesh, Kamath; Vinay, Byrappa; Rao, Ganne S. Umamaheswara] Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Neuroanaesthesia, Bangalore, Karnataka, India		Sriganesh, K (corresponding author), NIMHANS, Dept Neuroanaesthesia, Fac Block, Bangalore 560029, Karnataka, India.	drsri23@rediffmail.com					Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Alderson P, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000196.pub2; Bagshaw SM, 2008, RENAL FAILURE, V30, P581, DOI 10.1080/08860220802134649; Bellomo R, 2008, CRIT CARE MED, V36, pS179, DOI 10.1097/CCM.0b013e318169167f; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chou CY, 2011, ARTIF ORGANS, V35, pE11, DOI 10.1111/j.1525-1594.2010.01115.x; Corral L, 2012, CRIT CARE, V16, DOI 10.1186/cc11243; Davenport A, 2001, AM J KIDNEY DIS, V37, P457, DOI 10.1053/ajkd.2001.22068; Fang L, 2010, RENAL FAILURE, V32, P673, DOI 10.3109/0886022X.2010.486492; Ghallab M, 1995, Saudi J Kidney Dis Transpl, V6, P294; Godin M, 2013, NEPHRON CLIN PRACT, V123, P238, DOI 10.1159/000354713; Harbrecht BG, 2007, AM SURGEON, V73, P836; Ho KM, 2006, BMJ-BRIT MED J, V333, P420, DOI 10.1136/bmj.38902.605347.7C; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Lefering R, 2008, J TRAUMA, V65, P1036, DOI 10.1097/TA.0b013e318184ee48; Li N, 2011, NEUROCRIT CARE, V14, P377, DOI 10.1007/s12028-011-9511-1; Mascia L, 2008, INTENS CARE MED, V34, P720, DOI 10.1007/s00134-007-0974-7; Mehta RL, 2003, J AM SOC NEPHROL, V14, P2178, DOI 10.1097/01.ASN.0000079042.13465.1A; Moore EM, 2010, RENAL FAILURE, V32, P1060, DOI 10.3109/0886022X.2010.510234; Musu M, 2011, EUR REV MED PHARMACO, V15, P1461; Mutter TC, 2013, COCHRANE DB SYST REV, V7, DOI DOI 10.1002/14651858.CD007594.PUB3; Ostermann M, 2007, CRIT CARE MED, V35, P1837, DOI 10.1097/01.CCM.0000277041.13090.0A; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Prescott GJ, 2007, NEPHROL DIAL TRANSPL, V22, P2513, DOI 10.1093/ndt/gfm264; Rybak MJ, 1999, ANTIMICROB AGENTS CH, V43, P1549, DOI 10.1128/AAC.43.7.1549; Schetz M, 2008, J AM SOC NEPHROL, V19, P571, DOI 10.1681/ASN.2006101091; Schirmer-Mikalsen K, 2007, ACTA ANAESTH SCAND, V51, P1194, DOI 10.1111/j.1399-6576.2007.01372.x; Schmidt-Ott KM, 2011, NEPHROL DIAL TRANSPL, V26, P762, DOI 10.1093/ndt/gfr006; Schortgen F, 2001, LANCET, V357, P911, DOI 10.1016/S0140-6736(00)04211-2; Tamma PD, 2013, JAMA PEDIATR, V167, P903, DOI 10.1001/jamapediatrics.2013.196; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uchino S, 2004, CRIT CARE MED, V32, P1669, DOI 10.1097/01.CCM.0000132892.51063.2F; Venkataram R, 2001, CONTRIB NEPHROL, V132, P158; Vitaz TW, 2001, J TRAUMA, V51, P369, DOI 10.1097/00005373-200108000-00025; Vivino G, 1998, INTENS CARE MED, V24, P808, DOI 10.1007/s001340050670; Zeng JS, 2013, J NEUROSURG, V119, P1228, DOI 10.3171/2013.7.JNS122131; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	37	18	19	1	5	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2015	29	4					544	548		10.3109/02688697.2015.1016892			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CR4MM	WOS:000361306900013	25796992				2022-02-06	
J	Burkhart, KJ; Franke, S; Wegmann, K; Ries, C; Dehlinger, F; Muller, LP; Hollinger, B				Burkhart, K. J.; Franke, S.; Wegmann, K.; Ries, C.; Dehlinger, F.; Mueller, L. P.; Hollinger, B.			Mason I fracture - a simple injury?	UNFALLCHIRURG			German	Article						Radial head fracture; Complications; Elbow instability; Elbow osteoarthritis; Elbow stiffness	RADIAL HEAD FRACTURES; NECK FRACTURES; FIXATION	Mason I fractures of the radial head are judged to be simple injuries that can generally be treated nonoperatively. According to the current literature mainly good and excellent results can be expected. We present a case series of patients presenting to us due to complications of Mason I fractures. We reviewed all cases of patients that were treated because of complaints following Mason I radial head fractures. In all, 16 patients (10 men and 6 women) were identified. Mean age was 37 years (range 16-59 years). Mean time between trauma and surgery was 25 months (range 1-108 months). Ten patients developed painful osteoarthritis with elbow stiffness and loose bodies, 4 patients suffered a posterolateral rotatory instability that had to be treated with ligament reconstruction, 1 patient presented with a combined medial and lateral instability, and 1 patient with a symptomatic hypertophic plica posterolateralis. Diagnotics and therapeutic concepts of these complications will be presented. In light of the complications, Mason I fractures must be reevaluated. They remain the domain of conservative treatment but close follow-up is recommended to recognize possible complications early in order to prevent stiffness, chronic instabilities, and osteoarthritis.	[Burkhart, K. J.; Wegmann, K.; Ries, C.; Mueller, L. P.] Univ Klinikum Koln, Klin & Poliklin Orthopadie & Unfallchirurg, D-50937 Cologne, Germany; [Franke, S.; Ries, C.; Dehlinger, F.; Hollinger, B.] Arcus Sportklin Pforzheim, Pforzheim, Germany		Burkhart, KJ (corresponding author), Univ Klinikum Koln, Klin & Poliklin Orthopadie & Unfallchirurg, Kerpener Str 62, D-50937 Cologne, Germany.	klaus.burkhart@uk-koeln.de	Mueller, Lars P/N-1700-2017	Mueller, Lars P/0000-0001-9769-6865			Akesson T, 2006, J BONE JOINT SURG AM, V88A, P1909, DOI 10.2106/JBJS.E.01052; Burkhart KJ, 2010, INJURY, V41, P1015, DOI 10.1016/j.injury.2010.03.001; Burkhart KJ, 2007, J HAND SURG-AM, V32A, P1569, DOI 10.1016/j.jhsa.2007.08.023; Duckworth AD, 2011, J TRAUMA, V71, P643, DOI 10.1097/TA.0b013e3181f8fa5f; Hausmann JT, 2009, J TRAUMA, V66, P457, DOI 10.1097/TA.0b013e31817fdedd; Herbertsson P, 2005, J SHOULDER ELB SURG, V14, P73, DOI 10.1016/j.jse.2004.07.001; Itamura J, 2005, J SHOULDER ELB SURG, V14, P421, DOI 10.1016/j.jse.2004.11.003; JOHNSTON G W, 1962, Ulster Med J, V31, P51; Kaas L, 2011, J SHOULDER ELB SURG, V20, P1282, DOI 10.1016/j.jse.2011.06.011; Kaas L, 2010, ACTA ORTHOP, V81, P373, DOI 10.3109/17453674.2010.483988; Kaas L, 2010, J SHOULDER ELB SURG, V19, P520, DOI 10.1016/j.jse.2009.10.015; Koslowsky TC, 2007, J BONE JOINT SURG BR, V89B, P1545, DOI 10.1302/0301-620X.89B11.19433; Lindenhovius ALC, 2009, J TRAUMA, V67, P143, DOI 10.1097/TA.0b013e31818234d6; Liow RYL, 2002, INJURY, V33, P801, DOI 10.1016/S0020-1383(02)00164-X; MASON ML, 1954, BRIT J SURG, V42, P123, DOI 10.1002/bjs.18004217203; ODRISCOLL SW, 1991, J BONE JOINT SURG AM, V73A, P440, DOI 10.2106/00004623-199173030-00015; Pike JM, 2009, J HAND SURG-AM, V34A, P557, DOI 10.1016/j.jhsa.2008.12.024; Struijs PAA, 2007, ARCH ORTHOP TRAUM SU, V127, P125, DOI 10.1007/s00402-006-0240-4; WESELEY MS, 1983, J TRAUMA, V23, P36, DOI 10.1097/00005373-198301000-00007	19	18	18	0	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0177-5537	1433-044X		UNFALLCHIRURG	Unfallchirurg	JAN	2015	118	1					9	17		10.1007/s00113-013-2532-9			9	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	CA5AZ	WOS:000348920800006	24452244				2022-02-06	
S	Fife, TD; Kalra, D		Braaten, D		Fife, Terry D.; Kalra, Deepak			Persistent vertigo and dizziness after mild traumatic brain injury	DIZZINESS AND BALANCE DISORDERS	Annals of the New York Academy of Sciences		English	Article; Book Chapter						postconcussion syndrome; postconcussion dizziness; vertigo; mild traumatic brain injury; diffuse axonal injury; traumatic vestibulopathy; traumatic vestibular migraine	MINOR HEAD-INJURY; SPORTS-RELATED CONCUSSION; POSTCONCUSSION SYNDROME; POSTTRAUMATIC MIGRAINE; DIAGNOSTIC-CRITERIA; VESTIBULAR NEURITIS; CLINICAL-FEATURES; TEMPORAL WINDOW; SYMPTOMS; VULNERABILITY	Vertigo, dizziness, and disequilibrium are common symptoms following concussion or mild traumatic brain injury (mTBI). Dizziness and vertigo may be the result of trauma to the peripheral vestibular system or the central nervous system, or, in some cases, may be due to anxiety, depression, or posttraumatic stress disorder; these mechanisms are not mutually exclusive. While most peripheral vestibular disorders can be identified by testing and examination, those without inner-ear causes that have persisting complaints of dizziness and motion sickness are more difficult to understand and to manage. Some of these patients exhibit features compatible with vestibular migraine and may be treated successfully with migraine-preventative medications. This paper reviews the nonotogenic causes of persisting dizziness, the possible mechanisms, and the pathophysiology, as a framework for patient management and for future research.	[Fife, Terry D.; Kalra, Deepak] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Fife, Terry D.] Univ Arizona, Coll Med, Dept Neurol, Phoenix, AZ USA		Fife, TD (corresponding author), Barrow Neurol Inst, 240 W Thomas Rd,Suite 301, Phoenix, AZ 85013 USA.	tfife@email.arizona.edu	Fife, Terry/M-1135-2019				Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Balaban CD, 2011, J VESTIBUL RES-EQUIL, V21, P315, DOI 10.3233/VES-2011-0428; Best C, 2006, J NEUROL NEUROSUR PS, V77, P658, DOI 10.1136/jnnp.2005.072934; Bisdorff Alexandre R, 2011, Ther Adv Neurol Disord, V4, P183, DOI 10.1177/1756285611401647; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; CDC, 2003, REP C MILD TRAUM BRA; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Curthoys IS, 2013, SEMIN NEUROL, V33, P231, DOI 10.1055/s-0033-1354595; Donaldson CJ, 2010, OTOLARYNG HEAD NECK, V143, P820, DOI 10.1016/j.otohns.2010.09.024; Donovan V, 2014, J CEREBR BLOOD F MET, V34, P715, DOI 10.1038/jcbfm.2014.6; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Fife TD, 2013, SEMIN NEUROL, V33, P238, DOI 10.1055/s-0033-1354599; Fotuhi M, 2009, J NEUROL, V256, P711, DOI 10.1007/s00415-009-5050-5; Fourtassi M, 2011, CLIN NEUROL NEUROSUR, V113, P716, DOI 10.1016/j.clineuro.2011.07.010; Haas DC, 1996, CEPHALALGIA, V16, P486, DOI 10.1046/j.1468-2982.1996.1607486.x; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Jeong SH, 2013, SEMIN NEUROL, V33, P185, DOI 10.1055/s-0033-1354598; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kleffelgaard I, 2012, DISABIL REHABIL, V34, P788, DOI 10.3109/09638288.2011.619624; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lannsjo M, 2009, BRAIN INJURY, V23, P213, DOI 10.1080/02699050902748356; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Lempert T, 2012, J VESTIBUL RES-EQUIL, V22, P167, DOI 10.3233/VES-2012-0453; Loder E, 2012, HEADACHE, V52, P930, DOI 10.1111/j.1526-4610.2012.02185.x; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Manzari L, 2012, EUR ARCH OTO-RHINO-L, V269, P2441, DOI 10.1007/s00405-012-2127-z; Margulies S, 2000, J CLIN NEUROSCI, V7, P495, DOI 10.1054/jocn.1999.0773; Marzo SJ, 2004, LARYNGOSCOPE, V114, P1720, DOI 10.1097/00005537-200410000-00008; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mihalik JP, 2013, AM J SPORT MED, V41, P1490, DOI 10.1177/0363546513487982; Monstad P, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-45; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Naguib MB, 2012, J LARYNGOL OTOL, V126, P26, DOI 10.1017/S002221511100291X; Pelosi S, 2013, AM J OTOLARYNG, V34, P490, DOI 10.1016/j.amjoto.2013.04.008; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Prigatano GP, 2011, CURR OPIN PSYCHIATR, V24, P243, DOI 10.1097/YCO.0b013e328344698b; Ruckenstein MJ, 2009, OTOLARYNG CLIN N AM, V42, P71, DOI 10.1016/j.otc.2008.09.011; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schonfeld U, 2010, ACTA OTO-LARYNGOL, V130, P702, DOI 10.3109/00016480903397686; Sigurdardottir S, 2009, BRAIN INJURY, V23, P489, DOI 10.1080/02699050902926309; Smitherman TA, 2013, HEADACHE, V53, P775, DOI 10.1111/head.12063; Staab JP, 2007, ARCH OTOLARYNGOL, V133, P170, DOI 10.1001/archotol.133.2.170; Staab Jeffrey P, 2012, Continuum (Minneap Minn), V18, P1118, DOI 10.1212/01.CON.0000421622.56525.58; Staab JP, 2003, LARYNGOSCOPE, V113, P1714, DOI 10.1097/00005537-200310000-00010; Stolte B., 2014, CEPHALALGIA; Tarlaci S, 2009, CLIN NEUROPHARMACOL, V32, P254, DOI 10.1097/WNF.0b013e3181a8c84f; Todd NPM, 2008, NEUROSCI LETT, V444, P36, DOI 10.1016/j.neulet.2008.08.011; Unden J, 2009, SCAND J CLIN LAB INV, V69, P13, DOI 10.1080/00365510802651833; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x; Whelan-Goodinson R, 2009, J HEAD TRAUMA REHAB, V24, P324, DOI 10.1097/HTR.0b013e3181a712aa; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9; Wood RL, 2011, BRAIN INJURY, V25, P1296, DOI 10.3109/02699052.2011.624569; Zakzanis KK, 2011, ARCH CLIN NEUROPSYCH, V26, P461, DOI 10.1093/arclin/acr021	67	18	20	0	17	BLACKWELL SCIENCE PUBL	OXFORD	OSNEY MEAD, OXFORD OX2 0EL, ENGLAND	0077-8923			ANN NY ACAD SCI	Ann.NY Acad.Sci.		2015	1343						97	105		10.1111/nyas.12678			9	Clinical Neurology; Otorhinolaryngology	Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Otorhinolaryngology	BC5NT	WOS:000353404000011	25728715				2022-02-06	
J	Kertmen, H; Gurer, B; Yilmaz, ER; Kanat, MA; Arikok, AT; Erguder, BI; Hasturk, AE; Ergil, J; Sekerci, Z				Kertmen, Hayri; Gurer, Bora; Yilmaz, Erdal Resit; Kanat, Mehmet Ali; Arikok, Ata Turker; Erguder, Berrin Imge; Hasturk, Askin Esen; Ergil, Julide; Sekerci, Zeki			Antioxidant and antiapoptotic effects of darbepoetin-alpha against traumatic brain injury in rats	ARCHIVES OF MEDICAL SCIENCE			English	Article						antiapoptosis; antioxidation; darbepoetin-alpha; methylprednisolone; neuroprotection; rat; traumatic brain injury	ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; SPINAL-CORD ISCHEMIA; LIPID-PEROXIDATION; OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; XANTHINE-OXIDASE; IMPACT INJURY; FREE-RADICALS; HEAD-INJURY	Introduction: In this study, we tried to determine whether darbepoetin-alpha would protect the brain from oxidative stress and apoptosis in a rat traumatic brain injury model. Material and methods: The animals were randomized into four groups; group 1 (sham), group 2 (trauma), group 3 (darbepoetin a), group 4 (methylprednisolone). In the sham group only the skin incision was performed. In all the other groups, a moderate traumatic brain injury modelwas applied. Results: Following trauma both glutathione peroxidase, superoxide dismutase levels decreased (p < 0.001 for both); darbepoetin-a increased the activity of both antioxidant enzymes (p = 0.001 and p < 0.001 respectively). Trauma caused significant elevation in the nitric oxide synthetase and xanthine oxidase levels (p < 0.001 for both). Administration of darbepoetin-a significantly decreased the levels of nitric oxide synthetase and xanthine oxidase (p < 0.001 for both). Also, trauma caused significant elevation in the nitric oxide levels (p < 0.001); darbepoetin-a administration caused statistically significant reduction in the nitric oxide levels (p < 0.001). On the other hand, malondialdehyde levels were increased following trauma (p < 0.001), and darbepoetin a significantly reduced the malondialdehyde levels (p < 0.001). Due to the elevated apoptotic activity following the injury, caspase-3 activity increased significantly. Darbepoetin-a treatment significantly inhibited apoptosis by lowering the caspase-3 activity (p < 0.001). In the darbepoetin group, histopathological score was lower than the trauma group (p = 0.016). Conclusions: In this study, darbepoetin-a was shown to be at least as effective as methylprednisolone in protecting brain from oxidative stress, lipid peroxidation and apoptosis.	[Kertmen, Hayri; Gurer, Bora; Yilmaz, Erdal Resit; Sekerci, Zeki] Minist Hlth, Diskapi Yildirim Beyazit Educ & Res Hosp, Neurosurg Clin, Ankara, Turkey; [Kanat, Mehmet Ali] Minist Hlth, Refik Saydam Natl Publ Hlth Agcy, Ankara, Turkey; [Arikok, Ata Turker] Minist Hlth, Diskapi Yildirim Beyazit Educ & Res Hosp, Dept Pathol, Ankara, Turkey; [Erguder, Berrin Imge] Ankara Univ, Dept Biochem, TR-06100 Ankara, Turkey; [Hasturk, Askin Esen] Minist Hlth, Oncol Training & Res Hosp, Dept Neurosurg, Ankara, Turkey; [Ergil, Julide] Minist Hlth, Dept Anesthesiol, Diskapi Yildirim Beyazit Educ & Res Hosp, Ankara, Turkey		Gurer, B (corresponding author), Diskapi Yildirim Beyazit Egitim & Arastirma, Minist Hlth, Diskapi Yildirim Beyazit Educ & Res Hosp, Irfan Bastug Cad SB, Hastanesi 1, TR-06110 Ankara, Turkey.	boragurer@gmail.com	ali, mehmet/AAA-3233-2022; HASTURK, ASKIN ESEN/AAE-5065-2019; KANAT, Mehmet Ali/ABG-9355-2021; Erguder, Imge/AAZ-5673-2020; Gurer, Bora/K-1177-2012	KANAT, Mehmet Ali/0000-0003-3494-4563; Gurer, Bora/0000-0003-1500-6184			Akcora B, 2007, INT J UROL, V14, P846, DOI 10.1111/j.1442-2042.2007.01844.x; Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Ates E, 2005, ANZ J SURG, V75, P1100, DOI 10.1111/j.1445-2197.2005.03612.x; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Awasthi D, 1997, SURG NEUROL, V47, P575, DOI 10.1016/S0090-3019(96)00461-2; Banks WA, 2004, EUR J PHARMACOL, V505, P93, DOI 10.1016/j.ejphar.2004.10.035; Belayev L, 2005, STROKE, V36, P1065, DOI 10.1161/01.STR.0000160753.36093.da; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Cassis P, 2011, TRANSPLANTATION, V92, P271, DOI 10.1097/TP.0b013e3182241106; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chang CM, 2009, NEUROREPORT, V20, P968, DOI 10.1097/WNR.0b013e32832d0a28; Chattopadhyay A, 2000, BIOCHEM PHARMACOL, V59, P419, DOI 10.1016/S0006-2952(99)00277-4; Cherian L, 2007, J PHARMACOL EXP THER, V322, P789, DOI 10.1124/jpet.107.119628; d'Uscio LV, 2010, HYPERTENSION, V55, P998, DOI 10.1161/HYPERTENSIONAHA.110.150623; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; Dolgun H, 2010, J CLIN NEUROSCI, V17, P486, DOI 10.1016/j.jocn.2009.07.108; Durak I, 2001, ACTA ANAESTH SCAND, V45, P119, DOI 10.1034/j.1399-6576.2001.450118.x; Egrie JC, 2002, ONCOLOGY-NY, V16, P13; Egrie JC, 2001, NEPHROL DIAL TRANSPL, V16, P3, DOI 10.1093/ndt/16.suppl_3.3; Elliott S, 2008, EXP HEMATOL, V36, P1573, DOI 10.1016/j.exphem.2008.08.003; EVANS PH, 1993, BRIT MED BULL, V49, P577, DOI 10.1093/oxfordjournals.bmb.a072632; Fan P, 2003, J NEUROTRAUM, V20, P437, DOI 10.1089/089771503765355513; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2006, J NEUROSURG-SPINE, V4, P310, DOI 10.3171/spi.2006.4.4.310; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; HALL ED, 1989, FREE RADICAL BIO MED, V6, P303, DOI 10.1016/0891-5849(89)90057-9; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; IKEDA Y, 1990, NEUROSURGERY, V27, P1; ITOH T, 1986, STROKE, V17, P1284, DOI 10.1161/01.STR.17.6.1284; Jones NC, 2004, J NEUROPATH EXP NEUR, V63, P708, DOI 10.1093/jnen/63.7.708; KANEMITSU H, 1989, BRAIN RES, V499, P367, DOI 10.1016/0006-8993(89)90786-5; Kaptanoglu E, 2004, NEUROSURG REV, V27, P113, DOI 10.1007/s10143-003-0300-y; Katavetin P, 2007, BIOCHEM BIOPH RES CO, V359, P928, DOI 10.1016/j.bbrc.2007.05.207; Keane RW, 2001, J NEUROPATH EXP NEUR, V60, P422, DOI 10.1093/jnen/60.5.422; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kontos H A, 1986, Cent Nerv Syst Trauma, V3, P257; KRANTZ SB, 1991, BLOOD, V77, P419; Lappin T, 2003, ONCOLOGIST, V8, P15, DOI 10.1634/theoncologist.8-suppl_1-15; Liu DX, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-23; Lotocki G, 2003, J CEREBR BLOOD F MET, V23, P1129, DOI 10.1097/01.WCB.0000086938.68719.E0; Lukacova N, 1996, NEUROCHEM RES, V21, P869, DOI 10.1007/BF02532334; MARKHAM A, 1995, DRUGS, V49, P232, DOI 10.2165/00003495-199549020-00008; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; Marti HH, 2000, NEWS PHYSIOL SCI, V15, P225; Mesenge C, 1996, J NEUROTRAUM, V13, P209, DOI 10.1089/neu.1996.13.209; Nishio S, 1997, ACT NEUR S, V70, P84; Ozdemir D, 2005, PHYSIOL RES, V54, P631; PAGLIA DE, 1967, J LAB CLIN MED, V70, P158; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; PRAJDA N, 1975, FEBS LETT, V59, P245, DOI 10.1016/0014-5793(75)80385-1; Qian H, 1997, NEUROCHEM RES, V22, P1231, DOI 10.1023/A:1021980929422; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sadamoto Y, 1998, BIOCHEM BIOPH RES CO, V253, P26, DOI 10.1006/bbrc.1998.9748; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Sakurai M, 2003, J THORAC CARDIOV SUR, V125, P370, DOI 10.1067/mtc.2003.112; Schaller B.J, 2006, ARCH MED SCI, V2, P146; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; SIESJO BK, 1993, ANN EMERG MED, V22, P959, DOI 10.1016/S0196-0644(05)82736-2; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; SOUTHORN PA, 1988, MAYO CLIN PROC, V63, P390, DOI 10.1016/S0025-6196(12)64862-9; Springborg JB, 2002, BRIT J PHARMACOL, V135, P823, DOI 10.1038/sj.bjp.0704521; SUN Y, 1988, CLIN CHEM, V34, P497; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Ucar T, 2006, J TRAUMA, V60, P558, DOI 10.1097/01.ta.0000209172.75637.db; Ustun ME, 2001, J TRAUMA, V51, P22, DOI 10.1097/00005373-200107000-00004; Ustun ME, 2001, J NEUROSURG ANESTH, V13, P227; Wada K, 1998, J NEUROSURG, V89, P807, DOI 10.3171/jns.1998.89.5.0807; Wennersten A, 2003, ACTA NEUROPATHOL, V105, P281, DOI 10.1007/s00401-002-0649-y; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; Yang WS, 2011, FREE RADICAL BIO MED, V50, P1242, DOI 10.1016/j.freeradbiomed.2011.02.005; Yilmaz ER, 2013, ACTA NEUROCHIR, V155, P141, DOI 10.1007/s00701-012-1501-3; Yilmaz ER, 2012, ACTA NEUROCHIR, V154, P1037, DOI 10.1007/s00701-012-1298-0; Yurdakoc A, 2008, ACTA ANAESTH SCAND, V52, P658, DOI 10.1111/j.1399-6576.2008.01635.x	78	18	18	1	8	TERMEDIA PUBLISHING HOUSE LTD	POZNAN	KLEEBERGA ST 2, POZNAN, 61-615, POLAND	1734-1922	1896-9151		ARCH MED SCI	Arch. Med. Sci.		2015	11	5					1119	1128		10.5114/aoms.2015.54869			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU0RE	WOS:000363225600028	26528358				2022-02-06	
J	Matschke, J; Buttner, A; Bergmann, M; Hagel, C; Puschel, K; Glatzel, M				Matschke, Jakob; Buettner, Andreas; Bergmann, Markus; Hagel, Christian; Pueschel, Klaus; Glatzel, Markus			Encephalopathy and death in infants with abusive head trauma is due to hypoxic-ischemic injury following local brain trauma to vital brainstem centers	INTERNATIONAL JOURNAL OF LEGAL MEDICINE			English	Article						Abusive head trauma; Non-accidental head injury; Shaken baby syndrome; Child abuse; Diffuse axonal injury; Neuropathology	DIFFUSE AXONAL INJURY; SHAKEN-BABY SYNDROME; PRECURSOR PROTEIN IMMUNOHISTOCHEMISTRY; CENTRAL-NERVOUS-SYSTEM; YOUNG-CHILDREN; BETA-APP; NONACCIDENTAL INJURY; FORENSIC PRACTICE; ONDINES CURSE; NEUROPATHOLOGY	Infants with abusive head trauma (AHT) have diffuse brain damage with potentially fatal brain swelling. The pathogenesis of the brain damage remains unclear. We hypothesize that brain damage in AHT is due to hypoxic-ischemic injury with hypoxic-ischemic encephalopathy (HIE) rather than primary traumatic brain injury (TBI) with traumatic diffuse axonal injury (tDAI). We studied brain tissue of AHT victims. Primary outcome measure was the presence of primary traumatic versus hypoxic-ischemic brain injury. The diagnosis of tDAI followed a standardized semiquantitative diagnostic approach yielding a 4-tiered grading scheme (definite, possible, improbable, and none). In addition, results of quantitative immunohistochemical analysis in a subgroup of AHT victims with instant death were compared with matched SIDS controls. In our cohort of 50 AHT victims, none had definite tDAI (no tDAI in 30, tDAI possible in 2, and tDAI improbable in 18). Instead, all AHT victims showed morphological findings indicative of HIE. Furthermore, the subgroup with instant death showed significantly higher counts of damaged axons with accumulation of amyloid precursor protein (APP) in the brainstem adjacent to the central pattern generator of respiratory activity (CPG) (odds ratio adjusted for age, sex, brain weight, and APP-count in other regions = 3.1; 95 % confidence interval = 1.2 to 7.7; p = 0.015). AHT victims in our cohort do not have diffuse TBI or tDAI. Instead, our findings indicate that the encephalopathy in AHT is the due to hypoxic-ischemic injury probably as the result of respiratory arrest due to local damage to parts of the CPG in the brainstem.	[Matschke, Jakob] Univ Med Ctr Hamburg Eppendorf, Forens Neuropathol Unit, D-20246 Hamburg, Germany; [Matschke, Jakob; Hagel, Christian; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, D-20246 Hamburg, Germany; [Buettner, Andreas] Univ Rostock, Fac Med, Inst Legal Med, D-18055 Rostock, Germany; [Bergmann, Markus] Klinikum Bremen Mitte, Inst Clin Neuropathol, Bremen, Germany; [Pueschel, Klaus] Univ Med Ctr Hamburg Eppendorf, Inst Legal Med, D-20246 Hamburg, Germany		Matschke, J (corresponding author), Univ Med Ctr Hamburg Eppendorf, Forens Neuropathol Unit, D-20246 Hamburg, Germany.	matschke@uke.de	Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011; Buttner, Andreas/I-5974-2014; Matschke, Jakob/F-6641-2013	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Buttner, Andreas/0000-0002-6676-4957; Matschke, Jakob/0000-0001-6080-0198			ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Adamsbaum C, 2010, PEDIATRICS, V126, P546, DOI 10.1542/peds.2009-3647; Barnes Patrick D, 2007, Top Magn Reson Imaging, V18, P53, DOI 10.1097/RMR.0b013e3180d0a455; Barnes PD, 2010, SEMIN PEDIATR NEUROL, V17, P7, DOI 10.1016/j.spen.2010.01.005; Bell E, 2011, CHILD ABUSE NEGLECT, V35, P74, DOI 10.1016/j.chiabu.2010.11.001; Biron D, 2005, CHILD ABUSE NEGLECT, V29, P1347, DOI 10.1016/j.chiabu.2005.05.003; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Brennan LK, 2009, J NEUROS-PEDIATR, V3, P232, DOI 10.3171/2008.11.PEDS0835; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; CAFFEY J, 1972, AM J DIS CHILD, V124, P161, DOI 10.1001/archpedi.1972.02110140011001; CALDER IM, 1984, J CLIN PATHOL, V37, P1095, DOI 10.1136/jcp.37.10.1095; Case Mary E., 2007, Legal Medicine, V9, P83, DOI 10.1016/j.legalmed.2006.11.017; Case ME, 2001, AM J FOREN MED PATH, V22, P112, DOI 10.1097/00000433-200106000-00002; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; Choudhary AK, 2012, RADIOLOGY, V262, P216, DOI 10.1148/radiol.11102390; Christian CW, 2009, PEDIATRICS, V123, P1409, DOI 10.1542/peds.2009-0408; Dolinak D, 2006, ARCH PATHOL LAB MED, V130, P712; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Engel S, 2000, ACTA NEUROPATHOL, V100, P313, DOI 10.1007/s004019900172; Esernio-Jenssen D, 2011, PEDIATRICS, V127, P649, DOI 10.1542/peds.2010-1770; Garcia AJ, 2011, PROG BRAIN RES, V188, P31, DOI 10.1016/B978-0-444-53825-3.00008-5; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; Geddes JF, 2001, BRAIN, V124, P1299, DOI 10.1093/brain/124.7.1299; Geddes JF, 2001, BRAIN, V124, P1290, DOI 10.1093/brain/124.7.1290; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; Gleckman AM, 1999, ARCH PATHOL LAB MED, V123, P146; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; HADLEY MN, 1989, NEUROSURGERY, V24, P536, DOI 10.1227/00006123-198904000-00008; Hart BL, 1996, AM J FOREN MED PATH, V17, P217, DOI 10.1097/00000433-199609000-00008; Itabashi HH, 2007, FORENSIC NEUROPATHOL; Johnson DL, 1995, PEDIATR NEUROSURG, V23, P305, DOI 10.1159/000120976; Johnson MW, 2011, J FORENSIC SCI, V56, P1198, DOI 10.1111/j.1556-4029.2011.01814.x; Kaya SS, 1999, BRAIN RES, V818, P23, DOI 10.1016/S0006-8993(98)01204-9; Keenan HT, 2010, CHILD ABUSE NEGLECT, P35; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Kinney Hannah C, 2009, Dev Psychobiol, V51, P223, DOI 10.1002/dev.20367; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kinney H, 2009, ACTA NEUROPATHOL, V117, P247, DOI 10.1007/s00401-009-0490-7; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; Kuhn J, 2005, ACTA NEUROPATHOL, V110, P579, DOI 10.1007/s00401-005-1090-9; Leestma JE, 2009, FORENSIC NEUROPATHOL; LINDENBERG R, 1969, ARCH PATHOL, V87, P298; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Matschke J, 2008, RECHTSMEDIZIN, V18, P29, DOI 10.1007/s00194-007-0487-2; Matschke J, 2008, RECHTSMEDIZIN, V18, P36, DOI 10.1007/s00194-007-0488-1; Matschke J, 2008, RECHTSMEDIZIN, V18, P7, DOI 10.1007/s00194-007-0490-7; Matschke J, 2007, AM J FOREN MED PATH, V28, P141, DOI 10.1097/01.paf.0000257396.79742.e9; Matschke J, 2009, PEDIATRICS, V124, P1587, DOI 10.1542/peds.2008-3734; Matschke J, 2009, INT J LEGAL MED, V123, P189, DOI 10.1007/s00414-008-0293-8; Medana IM, 2002, AM J PATHOL, V160, P655, DOI 10.1016/S0002-9440(10)64885-7; Mellen NM, 2012, CURR OPIN NEUROBIOL, V22, P676, DOI 10.1016/j.conb.2012.01.001; Mendoza M, 2013, NEUROLOGY, V80, pE13, DOI 10.1212/WNL.0b013e31827b9096; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1263, DOI 10.1097/00005072-199912000-00007; Oehmichen M, 1999, INT J LEGAL MED, V112, P261, DOI 10.1007/s004140050246; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Oehmichen M, 2008, ACTA NEUROPATHOL, V116, P317, DOI 10.1007/s00401-008-0356-4; Oehmichen M, 2009, ACTA NEUROPATHOL, V117, P267, DOI 10.1007/s00401-008-0459-y; Ramirez JM, 1996, CURR OPIN NEUROBIOL, V6, P817, DOI 10.1016/S0959-4388(96)80033-X; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Reichard RR, 2003, J NEUROTRAUM, V20, P347, DOI 10.1089/089771503765172309; Richerson GB, 2012, MED PHYSL CELLULAR M, P725; Shannon P, 1998, ACTA NEUROPATHOL, V95, P625, DOI 10.1007/s004010050849; Sieswerda-Hoogendoorn T, 2012, EUR J PEDIATR, V171, P415, DOI 10.1007/s00431-011-1598-z; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Smith DH, 2003, NEUROMOL MED, V4, P59, DOI 10.1385/NMM:4:1-2:59; Smith JC, 2009, PHILOS T R SOC B, V364, P2577, DOI 10.1098/rstb.2009.0081; Smith Lisa H, 2003, Semin Pediatr Neurol, V10, P235, DOI 10.1016/S1071-9091(03)00076-7; Springer JE, 2002, J BIOCHEM MOL BIOL, V35, P94; Squier W, 2011, FORENSIC SCI INT, V212, pE31, DOI 10.1016/j.forsciint.2011.04.027; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Stadelmann C, 2000, CELL TISSUE RES, V301, P19, DOI 10.1007/s004410000203; Streit WJ, 1996, NEUROTOXICOLOGY, V17, P671; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; VOWLES GH, 1987, J CLIN PATHOL, V40, P185, DOI 10.1136/jcp.40.2.185; Yam PS, 1997, BRAIN RES, V760, P150, DOI 10.1016/S0006-8993(97)00290-4	82	18	19	0	13	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-9827	1437-1596		INT J LEGAL MED	Int. J. Legal Med.	JAN	2015	129	1					105	114		10.1007/s00414-014-1060-7			10	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	AX8IS	WOS:000347153900013	25107298				2022-02-06	
J	Mikell, CB; Banks, GP; Frey, HP; Youngerman, BE; Nelp, TB; Karas, PJ; Chan, AK; Voss, HU; Connolly, ES; Claassen, J				Mikell, Charles B.; Banks, Garrett P.; Frey, Hans-Peter; Youngerman, Brett E.; Nelp, Taylor B.; Karas, Patrick J.; Chan, Andrew K.; Voss, Henning U.; Connolly, E. Sander; Claassen, Jan			Frontal Networks Associated With Command Following After Hemorrhagic Stroke	STROKE			English	Article						coma; intracerebral hemorrhage; subarachnoid hemorrhage	DEFAULT-MODE NETWORK; ANTERIOR CINGULATE CORTEX; TRAUMATIC BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; RESTING-STATE; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; COGNITIVE CONTROL; CONSCIOUSNESS; COMA	Background and Purpose-Level of consciousness is frequently assessed by command-following ability in the clinical setting. However, it is unclear what brain circuits are needed to follow commands. We sought to determine what networks differentiate command following from noncommand following patients after hemorrhagic stroke. Methods-Structural MRI, resting-state functional MRI, and electroencephalography were performed on 25 awake and unresponsive patients with acute intracerebral and subarachnoid hemorrhage. Structural injury was assessed via volumetric T1-weighted MRI analysis. Functional connectivity differences were analyzed against a template of standard resting-state networks. The default mode network (DMN) and the task-positive network were investigated using seed-based functional connectivity. Networks were interrogated by pairwise coherence of electroencephalograph leads in regions of interest defined by functional MRI. Results-Functional imaging of unresponsive patients identified significant differences in 6 of 16 standard resting-state networks. Significant voxels were found in premotor cortex, dorsal anterior cingulate gyrus, and supplementary motor area. Direct interrogation of the DMN and task-positive network revealed loss of connectivity between the DMN and the orbitofrontal cortex and new connections between the task-positive network and DMN. Coherence between electrodes corresponding to right executive network and visual networks was also decreased in unresponsive patients. Conclusions-Resting-state functional MRI and electroencephalography coherence data support a model in which multiple, chiefly frontal networks are required for command following. Loss of DMN anticorrelation with task-positive network may reflect a loss of inhibitory control of the DMN by motor-executive regions. Frontal networks should thus be a target for future investigations into the mechanism of responsiveness in the intensive care unit environment.	[Mikell, Charles B.; Banks, Garrett P.; Youngerman, Brett E.; Nelp, Taylor B.; Karas, Patrick J.; Chan, Andrew K.; Connolly, E. Sander] Columbia Univ, Med Ctr, Dept Neurol Surg, New York, NY 10032 USA; [Voss, Henning U.] Cornell Univ, Weill Cornell Med Coll, Dept Radiol, New York, NY 10021 USA; [Frey, Hans-Peter; Claassen, Jan] Columbia Univ, Med Ctr, Dept Neurol, Div Neurocrit Care, New York, NY 10032 USA		Mikell, CB (corresponding author), Columbia Univ, Med Ctr, Dept Neurol Surg, 710 W 168th St, New York, NY 10032 USA.	cbm2104@columbia.edu	Voss, Henning/C-2194-2009; Claassen, Jan/AAA-5451-2020	Voss, Henning/0000-0003-2811-2074; Frey, Hans-Peter/0000-0002-1026-008X; Youngerman, Brett/0000-0002-4792-3190			Bakker AM, 2007, STROKE, V38, P2496, DOI 10.1161/STROKEAHA.107.484220; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bollimunta A, 2011, J NEUROSCI, V31, P4935, DOI 10.1523/JNEUROSCI.5580-10.2011; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Brefel-Courbon C, 2007, ANN NEUROL, V62, P102, DOI 10.1002/ana.21110; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bruno MA, 2012, J NEUROL, V259, P1087, DOI 10.1007/s00415-011-6303-7; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; Cavanagh JF, 2014, TRENDS COGN SCI, V18, P414, DOI 10.1016/j.tics.2014.04.012; Chatelle C, 2014, NEUROREHAB NEURAL RE, V28, P149, DOI 10.1177/1545968313503220; Chen AC, 2013, P NATL ACAD SCI USA, V110, P19944, DOI 10.1073/pnas.1311772110; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Cravo AM, 2013, J NEUROSCI, V33, P4002, DOI 10.1523/JNEUROSCI.4675-12.2013; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Edlow BL, 2012, J NEUROPATH EXP NEUR, V71, P531, DOI 10.1097/NEN.0b013e3182588293; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grote S, 2011, J NEUROTRAUM, V28, P527, DOI 10.1089/neu.2010.1433; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Hermans G, 2008, CRIT CARE, V12, DOI 10.1186/cc7100; Larson-Prior LJ, 2009, P NATL ACAD SCI USA, V106, P4489, DOI 10.1073/pnas.0900924106; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Mennes M, 2010, NEUROIMAGE, V50, P1690, DOI 10.1016/j.neuroimage.2010.01.002; Mizuhara H, 2007, NEUROIMAGE, V36, P232, DOI 10.1016/j.neuroimage.2007.02.026; Molaee-Ardekani B, 2007, P ANN INT IEEE EMBS, P1294, DOI 10.1109/IEMBS.2007.4352534; Moreno DR, 2010, NEUROLOGY, V75, P1871, DOI 10.1212/WNL.0b013e3181feb259; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Nagaratnam N, 2004, J CLIN NEUROSCI, V11, P25, DOI 10.1016/j.jocn.2003.04.002; Norton L, 2012, NEUROLOGY, V78, P175, DOI 10.1212/WNL.0b013e31823fcd61; Parvizi J, 2003, BRAIN, V126, P1524, DOI 10.1093/brain/awg166; Purdon PL, 2013, P NATL ACAD SCI USA, V110, pE1142, DOI 10.1073/pnas.1221180110; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Schiff ND, 2007, NATURE, V448, P600, DOI 10.1038/nature06041; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Sherrington CS, 1906, INTEGRATIVE ACTION N; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Smith E, 2005, BMJ-BRIT MED J, V330, P406, DOI 10.1136/bmj.330.7488.406; Soddu A, 2012, HUM BRAIN MAPP, V33, P778, DOI 10.1002/hbm.21249; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; TEASDALE G, 1974, LANCET, V2, P81; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vinck M, 2010, NEUROIMAGE, V51, P112, DOI 10.1016/j.neuroimage.2010.01.073; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yang H, 2007, NEUROIMAGE, V36, P144, DOI 10.1016/j.neuroimage.2007.01.054	63	18	19	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JAN	2015	46	1					49	+		10.1161/STROKEAHA.114.007645			16	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	AX1XB	WOS:000346735800023	25492905	Bronze			2022-02-06	
S	Thompson, HJ; Vavilala, MS; Rivara, FP		Conley, YP		Thompson, Hilaire J.; Vavilala, Monica S.; Rivara, Frederick P.			Common Data Elements and Federal Interagency Traumatic Brain Injury Research Informatics System for TBI Research	ANNUAL REVIEW OF NURSING RESEARCH, VOL 33: TRAUMATIC BRAIN INJURY	Annual Review of Nursing Research-Series		English	Article; Book Chapter							WORKING GROUP; RECOMMENDATIONS; DEMOGRAPHICS; BIOSPECIMENS	Despite increased attention to traumatic brain injury (TBI), there remains no specific treatment and available interventions focus rather on the prevention of secondary injury. One of the reasons posited for the lack of a successful therapy is the amalgamation of various types of injuries under the same severity category in clinical trials. Informatics approaches have been suggested as a means to develop an improved classification system for TBI. As a result of federal interagency efforts, common data elements (CDEs) for TBI have now been developed. Further, the Federal Interagency Traumatic Brain Injury Research Informatics System (FITBIR) has been created and is now available for TBI researchers to both add and retrieve data. This chapter will discuss the goals, development, and evolution of the CDEs and FITBIR and discuss how these tools can be used to support TBI research. A specific exemplar using the CDEs and lessons learned from working with the CDEs and FITBIR are included to aid future researchers.	[Thompson, Hilaire J.] Univ Washington, Sch Nursing, Seattle, WA 98195 USA; [Vavilala, Monica S.; Rivara, Frederick P.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Vavilala, Monica S.] Univ Washington, Dept Anesthesiol & Pain Med, Seattle, WA USA		Thompson, HJ (corresponding author), Univ Washington, Sch Nursing, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077913, R01 NS077913] Funding Source: Medline		Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Centers for Disease Control, 2001, TRAUM BRAIN INJ US R; Federal Interagency Traumatic Brain Injury Research Informatics System (FITBIR), 2014, FAQS; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; Miller AC, 2012, J NEUROTRAUM, V29, P634, DOI 10.1089/neu.2011.1932; National Institute of Neurologic Disorders and Stroke (NINDS), 2014, NINDS COMM DAT EL; Pope AM, 1991, DISABILITY AM NATL A; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Stead LG, 2013, INT J EMERG MED, V6, DOI 10.1186/1865-1380-6-5; Tsaousides T, 2011, J HEAD TRAUMA REHAB, V26, P265, DOI 10.1097/HTR.0b013e3182225271; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	16	18	18	0	0	SPRINGER PUBLISHING CO	NEW YORK	11 WEST 42ND STREET, 15TH FLOOR, NEW YORK, NY 10036 USA	0739-6686	1944-4028	978-0-8261-2922-2; 978-0-8261-7162-7	ANNU REV NURS RES-SE			2015	33						1	11		10.1891/0739-6686.33.1			11	Nursing	Book Citation Index – Social Sciences & Humanities (BKCI-SSH); Book Citation Index – Science (BKCI-S)	Nursing	BI5YI	WOS:000412973800002	25946381	Green Accepted			2022-02-06	
J	Yen, HC; Chen, TW; Yang, TC; Wei, HJ; Hsu, JC; Lin, CL				Yen, H. -C.; Chen, T. -W.; Yang, T-C.; Wei, H. -J.; Hsu, J. -C.; Lin, C. -L.			Levels of F-2-isoprostanes, F-4-neuroprostanes, and total nitrate/nitrite in plasma and cerebrospinal fluid of patients with traumatic brain injury	FREE RADICAL RESEARCH			English	Article						head injury; lipid peroxidation; sedative; outcome; nitric oxide	NITRIC-OXIDE; OXIDATIVE STRESS; LIPID-PEROXIDATION; HEAD-INJURY; SUBARACHNOID HEMORRHAGE; DOCOSAHEXAENOIC ACID; INTRALIPID INFUSION; MASS-SPECTROMETRY; PRACTICAL SCALE; IN-VIVO	Several events occurring during the secondary damage of traumatic brain injury (TBI) can cause oxidative stress. F-2-isoprostanes (F-2-IsoPs) and F-4-neuroprostanes (F-4-NPs) are specific lipid peroxidation markers generated from arachidonic acid and docosahexaenoic acid, respectively. In this study, we evaluated oxidative stress in patients with moderate and severe TBI. Since sedatives are routinely used to treat TBI patients and propofol has been considered an antioxidant, TBI patients were randomly treated with propofol or midazolam for 72 h postoperation. We postoperatively collected cerebrospinal fluid (CSF) and plasma from 15 TBI patients for 6-10 d and a single specimen of CSF or plasma from 11 controls. Compared with the controls, the TBI patients exhibited elevated levels of F-2-IsoPs and F-4-NPs in CSF throughout the postsurgery period regardless of the sedative used. Compared with the group of patients who received midazolam, those who received propofol exhibited markedly augmented levels of plasma F-2-IsoPs, which were associated with higher F-4-NPs levels and lower total nitrate/nitrite levels in CSF early in the postsurgery period. Furthermore, the higher CSF F-2-IsoPs levels correlated with 6-month and 12-month worse outcomes, which were graded according to the Glasgow Outcome Scale. The results demonstrate enhanced oxidative damage in the brain of TBI patients and the association of higher CSF levels of F-2-IsoPs with a poor outcome. Moreover, propofol treatment might promote lipid peroxidation in the circulation, despite possibly suppressing nitric oxide or peroxynitrite levels in CSF, because of the increased loading of the lipid components from the propofol infusion.	[Yen, H. -C.; Chen, T. -W.; Wei, H. -J.] Chang Gung Univ, Grad Inst, Coll Med, Taoyuan, Taiwan; [Yen, H. -C.; Chen, T. -W.; Wei, H. -J.] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan; [Yang, T-C.; Lin, C. -L.] Chang Gung Mem Hosp, Dept Neurosurg, Taoyuan, Taiwan; [Yang, T-C.; Hsu, J. -C.; Lin, C. -L.] Chang Gung Univ, Taoyuan, Taiwan; [Hsu, J. -C.] Chang Gung Mem Hosp, Dept Anesthesiol, Taoyuan, Taiwan		Hsu, JC; Lin, CL (corresponding author), Chang Gung Mem Hosp, 5 Fu Shin St, Taoyuan 333, Taiwan.	hsujcs@cgmh.org.tw; 3480@adm.cgmh.org.tw		Lin, Chih-Lung/0000-0003-0649-4243	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [NSC 98-2314-B-182A-041-MY2, NSC 97-2320-B-182-012-MY3, NSC 95-2314-B-182-050-MY2]; Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRPD1B0341]	This work was supported by grants (NSC 98-2314-B-182A-041-MY2 to Chih-Lung Lin, NSC 97-2320-B-182-012-MY3 to Hsiu-Chuan Yen, and NSC 95-2314-B-182-050-MY2 to Jee-Ching Hsu) from Ministry of Science and Technology (formerly known as National Science Council), Taiwan; and a grant from Chang Gung Memorial Hospital, Taiwan (CMRPD1B0341) to H.-C. Yen.	Arneson KO, 2007, METHOD ENZYMOL, V433, P127, DOI 10.1016/S0076-6879(07)33007-3; Ballester M, 2011, EUR J ANAESTH, V28, P874, DOI 10.1097/EJA.0b013e32834bea2a; Base S, 2011, PROSTAG LEUKOTR ESS, V84, P123, DOI 10.1016/j.plefa.2010.11.006; Basu S, 2001, RESUSCITATION, V50, P341, DOI 10.1016/S0300-9572(01)00351-3; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Belik J, 2010, FREE RADICAL BIO MED, V48, P177, DOI 10.1016/j.freeradbiomed.2009.10.043; Chang EF, 2005, J CEREBR BLOOD F MET, V25, P1401, DOI 10.1038/sj.jcbfm.9600147; Chen TW, 2009, FREE RADICAL BIO MED, V47, pS108; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Corcoran TB, 2011, ANTIOXID REDOX SIGN, V15, P2663, DOI 10.1089/ars.2011.4125; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Florian JP, 2010, EXP PHYSIOL, V95, P486, DOI 10.1113/expphysiol.2009.050997; Florian JP, 2010, CLIN SCI, V118, P61, DOI 10.1042/CS20090063; HELBOCK HJ, 1993, PEDIATRICS, V91, P83; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Hsieh YP, 2009, FREE RADICAL BIO MED, V47, P814, DOI 10.1016/j.freeradbiomed.2009.06.026; JENNETT B, 1975, LANCET, V1, P480; Kandasamy R, 2013, INT J NEUROSCI, V123, P385, DOI 10.3109/00207454.2012.761983; Kasprzak HA, 2001, J NEUROTRAUM, V18, P793, DOI 10.1089/089771501316919157; Kessler U, 2005, PEDIATR SURG INT, V21, P197, DOI 10.1007/s00383-004-1319-z; Kirsch M, 2003, ARCH BIOCHEM BIOPHYS, V418, P133, DOI 10.1016/j.abb.2003.07.002; Kohnen SL, 2003, NITRIC OXIDE-BIOL CH, V8, P170, DOI 10.1016/S1089-8603(03)00013-2; Krogh-Madsen R, 2008, AM J PHYSIOL-ENDOC M, V294, pE371, DOI 10.1152/ajpendo.00507.2007; Lin CL, 2006, FREE RADICAL BIO MED, V40, P1466, DOI 10.1016/j.freeradbiomed.2005.12.019; Liu W, 2009, FREE RADICAL BIO MED, V47, P1101, DOI 10.1016/j.freeradbiomed.2009.07.028; Liu YC, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-8; Ma L, 2013, BRAZ J MED BIOL RES, V46, P299, DOI 10.1590/1414-431X20122379; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Marik PE, 2004, CURR PHARM DESIGN, V10, P3639, DOI 10.2174/1381612043382846; Milne GL, 2007, METHOD ENZYMOL, V433, P113, DOI 10.1016/S0076-6879(07)33006-1; Milne GL, 2013, FREE RADICAL BIO MED, V59, P36, DOI 10.1016/j.freeradbiomed.2012.09.030; Montuschi P, 2007, CURR MED CHEM, V14, P703, DOI 10.2174/092986707780059607; Morrow JD, 2006, CURR PHARM DESIGN, V12, P895, DOI 10.2174/138161206776055985; Mouithys-Mickalad A, 1998, BIOCHEM BIOPH RES CO, V249, P833, DOI 10.1006/bbrc.1998.9235; Nayak C, 2008, NEUROL RES, V30, P461, DOI 10.1179/016164107X251790; Nayak C, 2007, CLIN CHEM LAB MED, V45, P629, DOI 10.1515/CCLM.2007.123; O'Connell KM, 2013, BIOL RES NURS, V15, P253, DOI 10.1177/1099800411431823; Ozturk E, 2008, PROG NEURO-PSYCHOPH, V32, P81, DOI 10.1016/j.pnpbp.2007.07.016; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Paolin A, 2002, NEUROSURGERY, V51, P949, DOI 10.1227/01.NEU.0000027881.33381.3F; Peng M, 2014, INFLAMM RES, V63, P411, DOI 10.1007/s00011-014-0713-9; Prasertsom W, 1996, ARCH DIS CHILD-FETAL, V74, pF95, DOI 10.1136/fn.74.2.F95; Roberts DJ, 2012, DRUGS, V72, P1881, DOI 10.2165/11636220-000000000-00000; Roberts LJ, 2004, CHEM PHYS LIPIDS, V128, P173, DOI 10.1016/j.chemphyslip.2003.09.016; Roberts LJ, 1998, J BIOL CHEM, V273, P13605, DOI 10.1074/jbc.273.22.13605; Roberts LJ, 2000, FREE RADICAL BIO MED, V28, P505, DOI 10.1016/S0891-5849(99)00264-6; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Shiva S, 2013, REDOX BIOL, V1, P40, DOI 10.1016/j.redox.2012.11.005; Silvers KM, 2001, ACTA PAEDIATR, V90, P242, DOI 10.1080/080352501300067433; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; TEASDALE G, 1974, LANCET, V2, P81; Tisdall MM, 2013, NEUROCRIT CARE, V19, P65, DOI 10.1007/s12028-011-9633-5; Urwin SC, 2004, DRUG SAFETY, V27, P107, DOI 10.2165/00002018-200427020-00003; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; Varma S, 2003, J NEUROTRAUM, V20, P781, DOI 10.1089/089771503767870005; Vasileiou I, 2009, EUR J PHARMACOL, V605, P1, DOI 10.1016/j.ejphar.2009.01.007; Weber JT, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00060; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yen HC, 2015, FREE RADICAL RES, V49, P861, DOI 10.3109/10715762.2015.1014812; Yen HC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/810915	62	18	18	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1071-5762	1029-2470		FREE RADICAL RES	Free Radic. Res.		2015	49	12					1419	1430		10.3109/10715762.2015.1080363			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD4KW	WOS:000369892800002	26271312	Green Submitted			2022-02-06	
J	Kjeldgaard, D; Forchhammer, HB; Teasdale, TW; Jensen, RH				Kjeldgaard, Dorte; Forchhammer, Hysse B.; Teasdale, Thomas W.; Jensen, Rigmor H.			Cognitive behavioural treatment for the chronic post-traumatic headache patient: a randomized controlled trial	JOURNAL OF HEADACHE AND PAIN			English	Article						Chronic post-traumatic headache; Treatment; Cognitive therapy; Brain concussion; RCT	CLINICAL-TRIALS; INJURY; CONCUSSION; EFFICACY; THERAPY	Background: Chronic post-traumatic headache (CPTH) after mild head injury can be difficult to manage. Research is scarce and successful interventions are lacking. To evaluate the effect of a group-based Cognitive Behavioural Therapy (CBT) intervention in relation to headache, pain perception, psychological symptoms and quality of life in patients with CPTH. Methods: Ninety patients with CPTH according to ICHD-2 criteria were enrolled from the Danish Headache Center into a randomized, controlled trial. Patients were randomly assigned to either a waiting list group or to a nine-week CBT group intervention. At baseline and after 26 weeks all patients completed the Rivermead Post Concussion Symptoms Questionnaire, SF-36, SCL-90-R and a headache diary. Results: The CBT had no effect on headache and pressure pain thresholds and only a minor impact on the CPTH patients' quality of life, psychological distress, and the overall experience of symptoms. The waiting-list group experienced no change in headache but, opposed to the treatment group, a significant decrease in somatic and cognitive symptoms indicating a spontaneous remission over time. Conclusions: Our primarily negative findings confirm that management of patients with CPTH still remains a considerable challenge. Psychological group therapy with CBT might be effective in an earlier stage of CPTH and in less severely affected patients but our findings strongly underline the need for randomized controlled studies to test the efficacy of psychological therapy.	[Kjeldgaard, Dorte] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, Copenhagen, Denmark; [Forchhammer, Hysse B.] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Copenhagen, Denmark; [Teasdale, Thomas W.] Univ Copenhagen, Fac Social Sci, Dept Psychol, Copenhagen, Denmark; [Jensen, Rigmor H.] Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, DK-2600 Glostrup, Copenhagen, Denmark		Jensen, RH (corresponding author), Univ Copenhagen, Glostrup Hosp, Dept Neurol, Danish Headache Ctr, Nordre Ringvej 69, DK-2600 Glostrup, Copenhagen, Denmark.	rigmor.jensen@regionh.dk			LundbeckLundbeck Corporation [R67-A6507]; Danish "Helsefonden" [2099B033]; AllerganAbbVieAllergan; PfizerPfizer	The research received grants from Lundbeck (R67-A6507) and the Danish "Helsefonden" (2099B033).; DK received honoraria and travel funding from Allergan and Pfizer. HBF, TWT and RHJ have not received any funding relating to this study. RHJ is a board member of EHMTIC, EHF, LTB, ATI, Linde Gas and Neurocore.	Aaseth K, 2008, CEPHALALGIA, V28, P705, DOI 10.1111/j.1468-2982.2008.01577.x; Altman D.G., 1990, PRACTICAL STAT MED R; Baandrup L, 2005, CEPHALALGIA, V25, P132, DOI 10.1111/j.1468-2982.2004.00818.x; Beck J.S., 2011, COGNITIVE BEHAV THER, V2nd ed; Bendtsen L, 1996, ARCH NEUROL-CHICAGO, V53, P373, DOI 10.1001/archneur.1996.00550040113021; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bjorner JB, 1998, J CLIN EPIDEMIOL, V51, P991, DOI 10.1016/S0895-4356(98)00091-2; de Groot FM, 2011, J MANIP PHYSIOL THER, V34, P297, DOI 10.1016/j.jmpt.2011.04.007; DiTommaso C, 2014, HEADACHE, V54, P511, DOI 10.1111/head.12254; Ellis PD, 2010, ESSENTIAL GUIDE TO EFFECT SIZES: STATISTICAL POWER, META-ANALYSIS AND THE INTERPRETATION OF RESEARCH RESULTS, P1; Evans RW, 2010, HEADACHE, V50, P716, DOI 10.1111/j.1526-4610.2010.01645.x; Ferguson RJ, 1996, COGNITIVE BEHAV TREA, P615; Gladstone J, 2009, HEADACHE, V49, P1097, DOI 10.1111/j.1526-4610.2009.01461.x; Gurr B, 2005, BRAIN INJURY, V19, P481, DOI 10.1080/02699050400005176; Ham LP, 1996, BIOFEEDBACK SELF-REG, V21, P93, DOI 10.1007/BF02284689; Hickling EJ, 1992, HEADACHE Q-CURR TREA, V3, P285; JACOBSON RR, 1995, J PSYCHOSOM RES, V39, P675, DOI 10.1016/0022-3999(95)00006-5; Jensen R, 2011, CEPHALALGIA, V31, P1549, DOI 10.1177/0333102411424212; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kjeldgaard D, 2014, THESIS U COPENHAGEN; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Lange RT, 2011, J HEAD TRAUMA REHAB, V26, P127, DOI 10.1097/HTR.0b013e3181e4622a; Lew HL, 2006, AM J PHYS MED REHAB, V85, P619, DOI 10.1097/01.phm.0000223235.09931.c0; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; MEDINA JL, 1992, HEADACHE, V32, P180, DOI 10.1111/j.1526-4610.1992.hed3204180.x; Munksgaard SB, 2012, HEADACHE, V52, P1120, DOI 10.1111/j.1526-4610.2012.02191.x; Nash JM, 2004, PAIN MED, V5, P178, DOI 10.1111/j.1526-4637.2004.04031.x; Olsen LR, 2004, ACTA PSYCHIAT SCAND, V110, P225, DOI 10.1111/j.1600-0447.2004.00399.x; Penzien DB, 2005, HEADACHE, V45, pS110, DOI 10.1111/j.1526-4610.2005.4502004.x; RUSSELL MB, 1992, CEPHALALGIA, V12, P369, DOI 10.1111/j.1468-2982.1992.00369.x; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Stetter F, 2002, APPL PSYCHOPHYS BIOF, V27, P45, DOI 10.1023/A:1014576505223; Sullivan K, 2011, J HEAD TRAUMA REHAB, V26, P170, DOI 10.1097/HTR.0b013e3181e47f95; Tatrow K, 2003, APPL PSYCHOPHYS BIOF, V28, P267, DOI 10.1023/A:1027326808356; WARE JE, 1995, MED CARE, V33, pAS264, DOI 10.1097/00005650-199501001-00005; Ware JE, 2001, QUAL LIFE RES, V10, P405, DOI 10.1023/A:1012588218728; Watanabe TK, 2012, PM&R, V4, P129, DOI 10.1016/j.pmrj.2011.06.003; Zasler ND, 2011, J HEAD TRAUMA REHAB, V26, P397, DOI 10.1097/HTR.0b013e31822721f8; Zeeberg P, 2005, CEPHALALGIA, V25, P1159, DOI 10.1111/j.1468-2982.2005.00980.x; [No title captured]	40	18	18	0	11	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1129-2369	1129-2377		J HEADACHE PAIN	J. Headache Pain	DEC 2	2014	15								81	10.1186/1129-2377-15-81			11	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AW4WA	WOS:000346277100001	25441170	gold, Green Published			2022-02-06	
J	Andre-Obadia, N; Sauleau, P; Cheliout-Heraut, F; Convers, P; Debs, R; Eisermann, M; Gavaret, M; Isnard, J; Jung, J; Kaminska, A; Kubis, N; Lemesle, M; Maillard, L; Mazzola, L; Michel, V; Montavont, A; N'Guyen, S; Navarro, V; Parain, D; Perin, B; Rosenberg, SD; Sediri, H; Soufflet, C; Szurhaj, W; Taussig, D; Touzery-de Villepin, A; Vercueil, L; Lamblin, MD				Andre-Obadia, N.; Sauleau, P.; Cheliout-Heraut, F.; Convers, P.; Debs, R.; Eisermann, M.; Gavaret, M.; Isnard, J.; Jung, J.; Kaminska, A.; Kubis, N.; Lemesle, M.; Maillard, L.; Mazzola, L.; Michel, V.; Montavont, A.; N'Guyen, S.; Navarro, V.; Parain, D.; Perin, B.; Rosenberg, S. D.; Sediri, H.; Soufflet, C.; Szurhaj, W.; Taussig, D.; Touzery-de Villepin, A.; Vercueil, L.; Lamblin, M. D.			French Guidelines on electroencephalogram	NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY			French	Article						Guidelines; Electroencephalogram; Electroencephalography; Adult; Child; Neonatal care; Intensive care unit; Brain death; Epilepsy; Telemedicine; High-resolution electroencephalogram; Magnetoencephalogram; Video-EEG; Ambulatory EEG; Sleep-deprived EEG	INTENSIVE-CARE-UNIT; NONCONVULSIVE STATUS EPILEPTICUS; TERM VIDEO-EEG; TRAUMATIC BRAIN-INJURY; PSYCHOGENIC NONEPILEPTIC SEIZURES; NMDA-RECEPTOR ENCEPHALITIS; CRITICALLY-ILL PATIENTS; SLEEP-DEPRIVED EEG; QUALITY-STANDARDS-SUBCOMMITTEE; ANTIEPILEPTIC DRUG-WITHDRAWAL	Electroencephalography allows the functional analysis of electrical brain cortical activity and is the gold standard for analyzing electrophysiological processes involved in epilepsy but also in several other dysfunctions of the central nervous system. Morphological imaging yields complementary data, yet it cannot replace the essential functional analysis tool that is EEG. Furthermore, EEG has the great advantage of being non-invasive, easy to perform and allows control tests when follow-up is necessary, even at the patient's bedside. Faced with the advances in knowledge, techniques and indications, the Societe de Neurophysiologie Clinique de Longue Francaise (SNCLF) and the Ligue Francaise Contre l'Epilepsie (LFCE) found it necessary to provide an update on EEG recommendations. This article will review the methodology applied to this work, refine the various topics detailed in the following chapters. It will go over the summary of recommendations for each of these chapters and underline proposals for writing an EEG report. Some questions could not be answered by the review of the literature; in those cases, an expert advice was given by the working and reading groups in addition to the guidelines. (C) 2014 Elsevier Masson SAS. All rights reserved.	[Andre-Obadia, N.; Isnard, J.; Jung, J.; Montavont, A.] Hosp Civils Lyon, Hop Neurol P Wertheimer, Serv Neurophysiol & Epileptol, F-69677 Bron, France; [Mazzola, L.] Univ Lyon 1, CRNL, Equipe NeuroPain, Inserm U 1028, F-69677 Bron, France; [Sauleau, P.] Univ Rennes 1, Fac Med, EA Comportement & Noyaux Gris Cent 4712, F-35043 Rennes, France; [Sauleau, P.] CHU Rennes 2, Unite Explorat Fonct Neurol, F-35033 Rennes 9, France; [Cheliout-Heraut, F.] UVSQ, CHU Garches, Serv Physiol Explorat Fonct, F-92380 Garches, France; [Convers, P.] CHU St Etienne, Hop Nord, Serv Neurol, F-42055 St Etienne 2, France; [Convers, P.] UCB Lyon 1, UJM St Etienne, Inserm U1028, F-42055 St Etienne 2, France; [Debs, R.] CHU Toulouse, Serv Neurol, TSA 40031, F-31059 Toulouse 9, France; [Eisermann, M.; Kaminska, A.; Soufflet, C.] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct Neurol, F-75015 Paris, France; [Eisermann, M.; Kaminska, A.; Soufflet, C.] INSERM, U1129, Paris, France; [Eisermann, M.; Kaminska, A.; Soufflet, C.] Univ Paris 05, CEA, F-91191 Gif Sur Yvette, France; [Gavaret, M.] Hop La Timone, AP HM, Serv Neurophysiol Clin, F-13385 Marseille, France; [Gavaret, M.] Inst Neurosci Syst, Inserm UMR 1106, F-13385 Marseille 05, France; [Gavaret, M.] Aix Marseille Univ, Fac Med, F-13385 Marseille 5, France; [Jung, J.] CRNL, Equipe Brain Dynam & Cognit, Inserm U 1028, F-69677 Bron, France; [Jung, J.] Univ Lyon 1, F-69677 Bron, France; [Kubis, N.] Univ Paris Diderot, Sorbonne Paris Cite, Hop Lariboisiere, AP HP,Serv Physiol Clin Explorat Fonct, F-75010 Paris, France; [Kubis, N.] Hop Lariboisiere, Unite Inserm965 Paris 7, F-75475 Paris 10, France; [Lemesle, M.] CHU Dijon, Serv Neurophysiol Clin, F-21079 Dijon, France; [Maillard, L.] CHU Nancy, Serv Neurol, F-54000 Nancy, France; [Maillard, L.] CNRS, CRAN, UMR 7039, F-54506 Vandoeuvre Les Nancy, France; [Maillard, L.] Univ Lorraine, Fac Med, F-54505 Vandoeuvre Les Nancy, France; [Mazzola, L.] Hop Nord St Etienne, Serv Neurol, Unite Neurophysiol Clin, F-42055 St Etienne 2, France; [Michel, V.] CHU Bordeaux, EFSN, F-33076 Bordeaux, France; [Michel, V.] Univ Bordeaux, CNRS, IMN, UMR 3493, F-33076 Bordeaux, France; [Montavont, A.] HFME, Serv Epilepsie Sommeil & Explorat Fonct Neuropedi, F-69677 Bron, France; [N'Guyen, S.] CHU Angers, Unite Neurol Pediat, F-49100 Angers, France; [N'Guyen, S.] Univ Angers, LUNAM, LARIS EA 7315, F-49016 Angers, France; [Navarro, V.] Hop La Pitie Salpetriere, AP HP, Unite Epilepsie, F-75013 Paris, France; [Navarro, V.] Hop La Pitie Salpetriere, AP HP, Dept Clin Neurophysiol, F-75013 Paris, France; [Navarro, V.] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, CNRS,UMR 7225,Inserm UMR S975, F-75651 Paris 13, France; [Parain, D.] CHU Charles Nicolle, Serv Neurophysiol Clin, F-76031 Rouen, France; [Perin, B.] CHU Amiens, Serv Neurol, Serv Explorat Fonct Syst Nerveux, F-80054 Amiens 1, France; [Rosenberg, S. D.] CHU Clermont Ferrand, Hop Gabriel Montpied, Serv Neurol & Neurophysiol Clin, F-63000 Clermont Ferrand, France; [Rosenberg, S. D.] Univ Auvergne, IGCNC, EA 7282, UMR ISIT 6284, F-63001 Clermont Ferrand, France; [Sediri, H.; Lamblin, M. D.] CHRU, Hop Roger Salengro, Serv Neurophysiol clin, F-59037 Lille, France; [Szurhaj, W.] Univ Henri Warembourg, Fac Med, F-59045 Lille, France; [Taussig, D.] Fdn Adolphe De Rothschild, Serv Neurochirurg Pediat, F-75019 Paris, France; [Touzery-de Villepin, A.] Hop Arnaud De Villeneuve, Unite Neurophysiol Clin Enfant, F-34295 Montpellier, France; [Vercueil, L.] CHU Grenoble, EFSN, F-38043 Grenoble 09, France; [Vercueil, L.] Grenoble Inst Neurosciences, Unite Inserm U836 9, F-38043 Grenoble 09, France		Andre-Obadia, N (corresponding author), Hosp Civils Lyon, Hop Neurol P Wertheimer, Serv Neurophysiol & Epileptol, 59 Blvd Pinel, F-69677 Bron, France.	nathalie.obadia-andre@chu-lyon.fr	Gavaret, Martine/AAT-1334-2020; VERCUEIL, Laurent/AAN-2941-2021; Sauleau, Paul/ABC-4459-2020	Gavaret, Martine/0000-0002-5790-2254; VERCUEIL, Laurent/0000-0003-3323-0091; Kubis, Nathalie/0000-0002-9637-3682; Andre-Obadia, Nathalie/0000-0002-0940-7224; Navarro, Vincent/0000-0003-0077-8114; Kaminska, Anna/0000-0003-3805-6651; Szurhaj, William/0000-0003-4112-3691; Convers, Philippe/0000-0003-4672-5819			Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Abend NS, 2009, NEUROLOGY, V72, P1931, DOI 10.1212/WNL.0b013e3181a82687; Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Abend NS, 2013, NEUROLOGY, V81, P383, DOI 10.1212/WNL.0b013e31829c5cfe; Abend NS, 2011, J PEDIATR-US, V159, P479, DOI 10.1016/j.jpeds.2011.02.004; Absalom AR, 2009, CRIT CARE, V13, DOI 10.1186/cc7776; Abubakr A, 2005, EPILEPSY BEHAV, V7, P447, DOI 10.1016/j.yebeh.2005.06.012; Abubakr A, 2005, EPILEPSY BEHAV, V6, P433, DOI 10.1016/j.yebeh.2005.01.003; Abubakr A, 2010, J CLIN NEUROSCI, V17, P1503, DOI 10.1016/j.jocn.2009.12.037; Ahmad S A Bazir, 2011, Pract Neurol, V11, P355, DOI 10.1136/practneurol-2011-000084; Airoldi L, 1999, J CLIN NEUROPHYSIOL, V16, P456, DOI 10.1097/00004691-199909000-00007; Alsaadi TM, 2004, SEIZURE-EUR J EPILEP, V13, P32, DOI 10.1016/S1059-1311(03)00072-4; Alvarez V, 2013, CRIT CARE, V17, DOI 10.1186/cc12879; Alving J, 2009, SEIZURE-EUR J EPILEP, V18, P470, DOI 10.1016/j.seizure.2009.04.005; Amantini A, 2012, MINERVA ANESTESIOL, V78, P1067; American Academy of Pediatrics Subcommittee on Febrile Seizures, 2011, PEDIATRICS, P389; American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P211; American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P205; American Clinical Neurophysiology Society, 2006, Am J Electroneurodiagnostic Technol, V46, P198; American Electroencephalographic Society, 1994, J CLIN NEUROPHYSIOL, V11, P30; American Electroencephalographic Society, 1994, J CLIN NEUROPHYSIOL, V11, P14; Angeleri F, 1975, SLEEP 1974, P196; ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; ANNEGERS JF, 1986, EPILEPSIA, V27, P43, DOI 10.1111/j.1528-1157.1986.tb03499.x; [Anonymous], 1994, J Clin Neurophysiol, V11, P111; [Anonymous], 1994, J Clin Neurophysiol, V11, P2; [Anonymous], 2004, C CONS; [Anonymous], 1998, TOURS NEUROPHYSIOLOG, P103; Appleton RE, 2012, ARCH DIS CHILD, V97, P1073, DOI 10.1136/archdischild-2012-302822; Arain AM, 2011, EPILEPSY BEHAV, V21, P364, DOI 10.1016/j.yebeh.2011.06.003; Arain AM, 2009, J CLIN NEUROPHYSIOL, V26, P17, DOI 10.1097/WNP.0b013e3181969032; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Arciniegas DB, 2011, INT J PSYCHOPHYSIOL, V82, P41, DOI 10.1016/j.ijpsycho.2011.03.004; Armelisasso C, 2004, CLIN EEG NEUROSCI, V35, P97, DOI 10.1177/155005940403500209; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Arya R, 2013, EPILEPSIA, V54, P828, DOI 10.1111/epi.12073; Asano E, 2005, EPILEPSY RES, V66, P129, DOI 10.1016/j.eplepsyres.2005.07.012; Ashwal S, 1997, CLIN PERINATOL, V24, P859, DOI 10.1016/S0095-5108(18)30154-4; Ashwal S, 2004, NEUROLOGY, V62, P851, DOI 10.1212/01.WNL.0000117981.35364.1B; Atkinson M, 2012, SEIZURE-EUR J EPILEP, V21, P124, DOI 10.1016/j.seizure.2011.10.004; Attarian H, 2003, NEUROLOGY, V61, P402, DOI 10.1212/01.WNL.0000073138.94582.7E; Badawy RAB, 2011, CLIN NEUROPHYSIOL, V122, P1086, DOI 10.1016/j.clinph.2010.10.048; Bagic AI, 2011, J CLIN NEUROPHYSIOL, V28; Bagic AI, 2011, J CLIN NEUROPHYSIOL, V28, P348, DOI 10.1097/WNP.0b013e3182272fed; Baheti NN, 2011, EPILEPSY RES, V97, P12, DOI 10.1016/j.eplepsyres.2011.06.014; Bancaud J, 1969, Rev Otoneuroophtalmol, V41, P299; Bancaud J., 1965, STEREOENCEPHALOGRAPH; Barber PA, 2000, ACTA NEUROL SCAND, V101, P53, DOI 10.1034/j.1600-0404.2000.00010.x; Barkley GL, 2004, CLIN NEUROPHYSIOL, V115, P1001, DOI 10.1016/j.clinph.2003.12.011; Bartolomei F, 2004, REV NEUROL-FRANCE, V160, pS81; Battaglia A, 1999, AM J MED GENET, V82, P60, DOI 10.1002/(SICI)1096-8628(19990101)82:1<60::AID-AJMG12>3.0.CO;2-4; Bauer G, 2005, ELECTROENCEPHALOGRAP, P701; Baumgartner C, 2004, CLIN NEUROPHYSIOL, V115, P1010, DOI 10.1016/j.clinph.2003.12.010; BAZIL CW, 1994, EPILEPSIA, V35, P768, DOI 10.1111/j.1528-1157.1994.tb02509.x; Beghi E, 2013, EPILEPSIA, V54, P2, DOI 10.1111/epi.12305; Benbadis SR, 2009, NEUROLOGY, V73, P843, DOI 10.1212/WNL.0b013e3181b78425; Benbadis Selim R, 2007, Pract Neurol, V7, P323, DOI 10.1136/jnnp.2007.124370; Benbadis SR, 2004, EPILEPSIA, V45, P1150, DOI 10.1111/j.0013-9580.2004.14504.x; Berg AT, 2012, EPILEPSY BEHAV, V23, P193, DOI 10.1016/j.yebeh.2012.01.015; Berg AT, 1996, EPILEPSIA, V37, P24, DOI 10.1111/j.1528-1157.1996.tb00507.x; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; BERGONZI P, 1972, Rivista di Neurologia, V42, P506; Bernier GP, 1987, COMMENTARY INTRACRAN, P323; Bhatia M, 1996, J Assoc Physicians India, V44, P393; BICKFORD RG, 1955, J CLIN INVEST, V34, P790, DOI 10.1172/JCI103134; Billard C, 2010, ARCH PEDIATRIE, V17, P350, DOI 10.1016/j.arcped.2010.01.012; Binnie C, 2005, TECHNIQUES CLIN NEUR, P267; Binnie CD, 1999, CLIN NEUROPHYSIOL, V110, P1671, DOI 10.1016/S1388-2457(99)00125-X; Bleck Thomas P, 2012, Continuum (Minneap Minn), V18, P560, DOI 10.1212/01.CON.0000415428.61277.90; BLUME WT, 1991, ANN NEUROL, V29, P638, DOI 10.1002/ana.410290611; Blume WT, 1996, ADV NEUROL, V70, P309; Bonanni L, 2008, BRAIN, V131, P690, DOI 10.1093/brain/awm322; Bonkowsky JL, 2009, J CHILD NEUROL, V24, P709, DOI 10.1177/0883073808329532; BOON P, 1994, EUR NEUROL, V34, P33, DOI 10.1159/000119507; BORA I, 1995, J NEUROL, V242, P157, DOI 10.1007/BF00936889; BORTONE E, 1994, ELECTROEN CLIN NEURO, V90, P323, DOI 10.1016/0013-4694(94)90048-5; Bottaro FJ, 2007, EPILEPSIA, V48, P966, DOI 10.1111/j.1528-1167.2007.01033.x; Bouet R, 2012, NEUROIMAGE, V59, P3955, DOI 10.1016/j.neuroimage.2011.10.052; Boulanger JM, 2006, CAN J NEUROL SCI, V33, P175, DOI 10.1017/S0317167100004935; Boulard G, 2005, Ann Fr Anesth Reanim, V24, P836, DOI 10.1016/j.annfar.2005.05.020; Bourez-Swart MD, 2009, CLIN NEUROPHYSIOL, V120, P1916, DOI 10.1016/j.clinph.2009.08.015; Brand DA, 2005, PEDIATRICS, V115, P885, DOI 10.1542/peds.2004-0847; Breen P, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-49; Bricolo A, 1990, HDB CLIN NEUROLOGY, P193; BRIDGERS SL, 1985, NEUROLOGY, V35, P1767, DOI 10.1212/WNL.35.12.1767; BRIDGERS SL, 1985, NEUROLOGY, V35, P166, DOI 10.1212/WNL.35.2.166; Briel RCG, 1999, J NEUROL NEUROSUR PS, V66, P401, DOI 10.1136/jnnp.66.3.401; Brodbeck V, 2011, BRAIN, V134, P2887, DOI 10.1093/brain/awr243; Bruce DA, 2000, CHILD NERV SYST, V16, P724, DOI 10.1007/s003810000336; BUCHNER H, 1990, EUR NEUROL, V30, P138, DOI 10.1159/000117330; Burgess RC, 2011, J CLIN NEUROPHYSIOL, V28, P355, DOI 10.1097/WNP.0b013e3182272ffe; Bussiere M, 2005, NEUROCRIT CARE, V2, P29, DOI 10.1385/NCC:2:1:029; Butler CR, 2008, BRAIN, V131, P2243, DOI 10.1093/brain/awn127; Buzea C E, 1995, J Neurosci Nurs, V27, P292; CALLAGHAN N, 1988, NEW ENGL J MED, V318, P942, DOI 10.1056/NEJM198804143181502; Cambier DM, 2001, ACTA NEUROL SCAND, V103, P231, DOI 10.1034/j.1600-0404.2001.103004231.x; Camfield PR, 1996, EPILEPSIA, V37, pS60, DOI 10.1111/j.1528-1157.1996.tb06023.x; Campos C, 2012, INT J MED INFORM, V81, P404, DOI 10.1016/j.ijmedinf.2012.01.006; Cardinale F, 2013, NEUROSURGERY, V72, P353, DOI 10.1227/NEU.0b013e31827d1161; Carpay JA, 1997, EPILEPSIA, V38, P595, DOI 10.1111/j.1528-1157.1997.tb01145.x; Carrette E, 2011, SEIZURE-EUR J EPILEP, V20, P414, DOI 10.1016/j.seizure.2011.01.015; Cascino GD, 2002, EPILEPSIA, V43, P80, DOI 10.1046/j.1528-1157.43.s.3.14.x; Casetta I, 1999, ACTA NEUROL SCAND, V99, P329, DOI 10.1111/j.1600-0404.1999.tb07360.x; Catenoix H, 2008, NEUROLOGY, V71, P1719, DOI 10.1212/01.wnl.0000335166.20451.88; CAVAZZUTI GB, 1980, EPILEPSIA, V21, P43, DOI 10.1111/j.1528-1157.1980.tb04043.x; CHADWICK D, 1993, BRIT MED J, V306, P1374; Chan D, 2004, NEUROLOGY, V62, P1628, DOI 10.1212/01.WNL.0000123103.89419.B7; Chang BS, 2002, J CLIN NEUROPHYSIOL, V19, P152, DOI 10.1097/00004691-200203000-00006; Chassoux F, 2000, BRAIN, V123, P1733, DOI 10.1093/brain/123.8.1733; Chemmanam T, 2009, J CLIN NEUROPHYSIOL, V26, P123, DOI 10.1097/WNP.0b013e31819d8030; CHEN LS, 1995, PEDIATR NEUROL, V12, P220, DOI 10.1016/0887-8994(95)00021-7; Cheron G, 2004, ARCH PEDIATRIE, V11, P692, DOI 10.1016/j.arcped.2004.03.052; CILLESSEN JPM, 1994, STROKE, V25, P1968, DOI 10.1161/01.STR.25.10.1968; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Claassen J, 2006, NEUROCRIT CARE, V4, P103, DOI 10.1385/NCC:4:2:103; Claassen J, 2005, J CLIN NEUROPHYSIOL, V22, P92, DOI 10.1097/01.WNP.0000145006.02048.3A; Claassen J, 2004, CLIN NEUROPHYSIOL, V115, P2699, DOI 10.1016/j.clinph.2004.06.017; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Claus JJ, 1999, CLIN NEUROPHYSIOL, V110, P825, DOI 10.1016/S1388-2457(98)00076-5; CLELAND PG, 1981, BRIT MED J, V283, P1364, DOI 10.1136/bmj.283.6303.1364; Clinique Bdlsdn, 1989, NEUROPHYSIOL CLIN, V19, P339; Coates S, 2012, J TELEMED TELECARE, V18, P243, DOI 10.1258/jtt.2012.111003; COHEN D, 1968, SCIENCE, V161, P784, DOI 10.1126/science.161.3843.784; Cohen D, 1989, ELECTROENCEPHALOGRAM; Cokar O, 2004, SEIZURE-EUR J EPILEP, V13, P264, DOI 10.1016/S1059-1311(03)00155-9; Collins SJ, 2006, BRAIN, V129, P2278, DOI 10.1093/brain/awl159; COSELLI JS, 1988, ANN THORAC SURG, V45, P638, DOI 10.1016/S0003-4975(10)64766-2; Cossu M, 2005, NEUROSURGERY, V57, P706, DOI 10.1227/01.NEU.0000176656.33523.1e; Cossu M, 2014, J NEUROL NEUROSUR PS, V85, P611, DOI 10.1136/jnnp-2013-305514; Cottenceau V, 2008, ANESTH ANALG, V107, P1676, DOI 10.1213/ane.0b013e318184e9ab; COURJON J, 1970, EPILEPSIA, V11, P29, DOI 10.1111/j.1528-1157.1970.tb03863.x; Courjon JSE, 1972, HDB ELECTROENCEPHALO, V14B, P1; Crepeau AZ, 2014, RESUSCITATION, V85, P785, DOI 10.1016/j.resuscitation.2014.01.019; Crepeau AZ, 2013, NEUROLOGY, V80, P339, DOI 10.1212/WNL.0b013e31827f089d; Crespel A, 2004, EPILEPSIES, P121; Cross JH, 2006, EPILEPSIA, V47, P952, DOI 10.1111/j.1528-1167.2006.00569.x; Curzi-Dacalova L, 1996, MANUEL TECHNIQUES EN; da Conceicao PO, 2012, SEIZURE-EUR J EPILEP, V21, P583, DOI 10.1016/j.seizure.2012.06.002; da Silva A M, 1992, Acta Neurochir Suppl (Wien), V55, P56; Dalmagro CL, 2005, EPILEPSIA, V46, P1442, DOI 10.1111/j.1528-1167.2005.70904.x; Dalmau J, 2004, BRAIN, V127, P1831, DOI 10.1093/brain/awh203; Dalmau J, 2008, LANCET NEUROL, V7, P1091, DOI 10.1016/S1474-4422(08)70224-2; DANZL DF, 1994, NEW ENGL J MED, V331, P1756, DOI 10.1056/NEJM199412293312607; Das RR, 2009, NEUROCRIT CARE, V10, P368, DOI 10.1007/s12028-008-9142-3; Dash D, 2012, EPILEPTIC DISORD, V14, P290, DOI 10.1684/epd.2012.0529; DAVIS TL, 1990, ARCH INTERN MED, V150, P2027, DOI 10.1001/archinte.150.10.2027; de Almeida AN, 2006, J NEUROSURG, V104, P483, DOI 10.3171/jns.2006.104.4.483; De Deyne C, 1998, INTENS CARE MED, V24, P1294, DOI 10.1007/s001340050765; De Jonghe B, 2008, ANN FR ANESTH, V27, P641, DOI 10.1016/j.annfar.2008.05.003; De Jonghe B, 2005, CRIT CARE MED, V33, P120, DOI 10.1097/01.CCM.0000150268.04228.68; De Jonghe B, 2000, INTENS CARE MED, V26, P275, DOI 10.1007/s001340051150; de Toffol B, 1997, NEUROPHYSIOL CLIN, V27, P383, DOI 10.1016/S0987-7053(97)88804-1; DEGEN R, 1987, EUR NEUROL, V26, P51, DOI 10.1159/000116312; DEGEN R, 1991, EPILEPSIA, V32, P515, DOI 10.1111/j.1528-1157.1991.tb04686.x; Del Felice A, 2011, EPILEPSY RES, V96, P123, DOI 10.1016/j.eplepsyres.2011.05.015; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Derambure P, 2001, EVALUATION NEUROPHYS, P271; DeRoos ST, 2009, PEDIATRICS, V123, P703, DOI 10.1542/peds.2008-0357; Deuschl G, 2002, GUIDE PRATIQUE NEURO; Di Gennaro G, 2012, CLIN NEUROPHYSIOL, V123, P486, DOI 10.1016/j.clinph.2011.08.011; Dike GL, 1997, J NEUROL NEUROSUR PS, V62, P200, DOI 10.1136/jnnp.62.2.200; Dobesberger J, 2011, EPILEPSIA, V52, P443, DOI 10.1111/j.1528-1167.2010.02782.x; Doi M, 2005, INTENS CARE MED, V31, P41, DOI 10.1007/s00134-004-2516-x; DOPPELBAUER A, 1993, ACTA NEUROL SCAND, V87, P345; Dreyfus-Brissac C, 1979, PERINATAL MED, P379; DUCHOWNY M, 1992, J CHILD NEUROL, V7, P66, DOI 10.1177/088307389200700112; Dunand AC, 2002, NEUROPHYSIOL CLIN, V32, P2, DOI 10.1016/S0987-7053(01)00288-X; DUNCAN JS, 1987, EPILEPSIA, V28, P259, DOI 10.1111/j.1528-1157.1987.tb04216.x; Durand G, 1994, EPIDEMIOLOGIE ETIOLO; EBERSOLE JS, 1983, NEUROLOGY, V33, P853, DOI 10.1212/WNL.33.7.853; Eisenschenk S, 2001, CLIN NEUROPHYSIOL, V112, P836, DOI 10.1016/S1388-2457(01)00517-X; Eisermann M, 2010, NEUROPEDIATRICS, V41, P163, DOI 10.1055/s-0030-1267920; ELAD B, 1994, ELECTROEN CLIN NEURO, V90, P313, DOI 10.1016/0013-4694(94)90150-3; Eleftheriadis N, 2003, ACTA NEUROL SCAND, V107, P142, DOI 10.1034/j.1600-0404.2003.02092.x; Elgavish RA, 2011, J CLIN NEUROPHYSIOL, V28, P311, DOI 10.1097/WNP.0b013e31821c3aa9; Elger CE, 2000, EPILEPSIA, V41, pS9; Eliashiv DS, 2002, NEUROLOGY, V59, P1600, DOI 10.1212/01.WNL.0000032493.83875.0B; ELLINGSON RJ, 1984, J CLIN NEUROPHYSIOL, V1, P83, DOI 10.1097/00004691-198401000-00005; ENGEL J, 1993, ELECTROEN CLIN NEURO, V87, P437, DOI 10.1016/0013-4694(93)90158-R; FAGAN KJ, 1990, NEUROLOGY, V40, P1689, DOI 10.1212/WNL.40.11.1689; Falco C, 2005, CLIN NEUROPHYSIOL, V116, P1771, DOI 10.1016/j.clinph.2005.04.012; Farias ST, 2003, EPILEPSY BEHAV, V4, P424, DOI 10.1016/S1525-5050(03)00143-4; Fattouch J, 2012, EPILEPSY BEHAV, V25, P32, DOI 10.1016/j.yebeh.2012.07.001; Faulkner HJ, 2012, CLIN NEUROPHYSIOL, V123, P1732, DOI 10.1016/j.clinph.2012.01.023; Faulkner HJ, 2012, SEIZURE-EUR J EPILEP, V21, P491, DOI 10.1016/j.seizure.2012.04.015; Feyissa AM, 2014, J NEUROL SCI, V336, P109, DOI 10.1016/j.jns.2013.10.018; Ficker DM, 1997, J CLIN NEUROPHYSIOL, V14, P230, DOI 10.1097/00004691-199705000-00008; Finocchi C, 1996, ITAL J NEUROL SCI, V17, P341, DOI 10.1007/BF01999896; Fischer C, 1997, NEUROPHYSIOL CLIN, V27, P373, DOI 10.1016/S0987-7053(97)88803-X; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fitch K, 2001, RANDUCLA APPROPRIATE; Fitzsimons M, 2000, J CLIN NEUROPHYSIOL, V17, P59, DOI 10.1097/00004691-200001000-00006; Flink R, 2002, ACTA NEUROL SCAND, V106, P1, DOI 10.1034/j.1600-0404.2002.01361.x; Fohlen M, 2008, NEUROCHIRURGIE, V54, P347, DOI 10.1016/j.neuchi.2008.02.050; Fohlen M, 2004, NEUROPEDIATRICS, V35, P336, DOI 10.1055/s-2004-830410; Foley CM, 2000, J CHILD NEUROL, V15, P49, DOI 10.1177/088307380001500111; Fountain NB, 2001, J CLIN NEUROPHYSIOL, V18, P345, DOI 10.1097/00004691-200107000-00006; Fountain NB, 1998, J CLIN NEUROPHYSIOL, V15, P69, DOI 10.1097/00004691-199801000-00009; Fountas KN, 2004, STEREOT FUNCT NEUROS, V82, P165, DOI 10.1159/000081881; Frenzel D, 2002, INTENS CARE MED, V28, P178, DOI 10.1007/s00134-001-1183-4; Freye Enno, 2005, J Clin Monit Comput, V19, P1, DOI 10.1007/s10877-005-0712-z; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Friedman DE, 2009, J CLIN NEUROPHYSIOL, V26, P213, DOI 10.1097/WNP.0b013e3181b2f2da; Gaetz M, 2001, J HEAD TRAUMA REHAB, V16, P386, DOI 10.1097/00001199-200108000-00008; Gambardella A, 1996, ELECTROEN CLIN NEURO, V98, P243, DOI 10.1016/0013-4694(95)00266-9; Gandelman-Marton R, 2011, ACTA NEUROL SCAND, V124, P202, DOI 10.1111/j.1600-0404.2010.01453.x; GANJI S, 1993, CLIN ELECTROENCEPHAL, V24, P44, DOI 10.1177/155005949302400110; Garcia-Larrea L., 1993, Neurophysiologie Clinique, V23, P141; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; Gavaret M, 2008, NEUROCHIRURGIE, V54, P185, DOI 10.1016/j.neuchi.2008.02.014; Gavaret M, 2004, J CLIN NEUROPHYSIOL, V21, P267, DOI 10.1097/01.WNP.0000139929.06455.82; Gavaret M, 2006, J CLIN NEUROPHYSIOL, V23, P358, DOI 10.1097/01.wnp.0000214588.94843.c2; Gawel M, 2007, J NEUROL SCI, V257, P11, DOI 10.1016/j.jns.2007.01.046; Geets W, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P253, DOI 10.1016/S0370-4475(83)80036-7; Genow A, 2004, NEUROIMAGE, V21, P444, DOI 10.1016/j.neuroimage.2003.08.029; Gerstner T, 2006, SEIZURE-EUR J EPILEP, V15, P443, DOI 10.1016/j.seizure.2006.05.007; Ghougassian DF, 2004, EPILEPSIA, V45, P928, DOI 10.1111/j.0013-9580.2004.51003.x; Giorgi FS, 2013, CLIN NEUROPHYSIOL, V124, P2101, DOI 10.1016/j.clinph.2013.04.342; Gitiaux C, 2013, CLIN NEUROPHYSIOL, V124, P2354, DOI 10.1016/j.clinph.2013.05.023; Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014; Goldenholz DM, 2009, HUM BRAIN MAPP, V30, P1077, DOI 10.1002/hbm.20571; Gonzalez-Martinez J, 2013, EPILEPSIA, V54, P323, DOI 10.1111/j.1528-1167.2012.03672.x; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; GREGORY RP, 1993, ELECTROEN CLIN NEURO, V86, P75, DOI 10.1016/0013-4694(93)90069-8; GRIGG MM, 1987, ARCH NEUROL-CHICAGO, V44, P948, DOI 10.1001/archneur.1987.00520210048018; GRONSETH GS, 1995, NEUROLOGY, V45, P1263, DOI 10.1212/WNL.45.7.1263; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; Gueguen B, 1998, NEUROPHYSIOL CLIN, V28, P134, DOI 10.1016/S0987-7053(98)80024-5; Guellerin J, 2012, J CLIN NEUROPHYSIOL, V29, P160, DOI 10.1097/WNP.0b013e31824d949f; Guenot M, 2004, EPILEPSIA, V45, P1368, DOI 10.1111/j.0013-9580.2004.17704.x; Guenot M, 2011, ADV TECH STAND NEURO, V36, P61, DOI 10.1007/978-3-7091-0179-7_4; Guenot M, 2001, STEREOT FUNCT NEUROS, V77, P29, DOI 10.1159/000064595; Guerit JM, 2009, NEUROPHYSIOL CLIN, V39, P71, DOI 10.1016/j.neucli.2009.03.002; Guerit JM, 2009, LIVER INT, V29, P789, DOI 10.1111/j.1478-3231.2009.02030.x; Guerit JM, 2004, ANN FR ANESTH, V23, P99, DOI 10.1016/j.annfar.2004.01.002; Guerit JM, 2002, GUIDE PRATIQUE NEURO; Guerreiro CAM, 2002, J CLIN NEUROPHYSIOL, V19, P204, DOI 10.1097/00004691-200206000-00003; Hader WJ, 2013, EPILEPSIA, V54, P840, DOI 10.1111/epi.12161; HAMALAINEN MS, 1989, IEEE T BIO-MED ENG, V36, P165, DOI 10.1109/10.16463; Hamelin S, 2004, REV NEUROL S4, V18; Hamelin S, 2005, EPILEPSIES, V17, P64; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Haseeb A, 2007, EPILEPSY RES, V76, P131, DOI 10.1016/j.eplepsyres.2007.07.007; Haupt WF, 1999, J NEUROL, V246, P432, DOI 10.1007/s004150050378; Hauser WA, 1998, NEW ENGL J MED, V338, P429, DOI 10.1056/NEJM199802123380704; HAUSER WA, 1990, NEUROLOGY, V40, P1163, DOI 10.1212/WNL.40.8.1163; Haut SR, 2002, EPILEPSIA, V43, P711, DOI 10.1046/j.1528-1157.2002.26401.x; Heers M, 2010, SEIZURE-EUR J EPILEP, V19, P397, DOI 10.1016/j.seizure.2010.06.004; Hellstrom-Westas L, 2006, SEMIN FETAL NEONAT M, V11, P503, DOI 10.1016/j.siny.2006.07.011; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF97, DOI 10.1136/fn.72.2.F97; HELLSTROMWESTAS L, 1985, ACTA PAEDIATR SCAND, V74, P741, DOI 10.1111/j.1651-2227.1985.tb10024.x; HENCHEY R, 1995, NEUROLOGY, V45, P977, DOI 10.1212/WNL.45.5.977; Hessen E, 2009, BRAIN INJURY, V23, P234, DOI 10.1080/02699050902748349; HILL RA, 1994, CAN J NEUROL SCI, V21, pS12, DOI 10.1017/S0084255900007488; HILZ MJ, 1991, INTENS CARE MED, V17, P87, DOI 10.1007/BF01691429; Hirsch LJ, 2005, J CLIN NEUROPHYSIOL, V22, P128, DOI 10.1097/01.WNP.0000158701.89576.4C; Hirsch LJ, 2004, J CLIN NEUROPHYSIOL, V21, P332; Holmes GL, 1996, EPILEPSIA, V37, P14, DOI 10.1111/j.1528-1157.1996.tb01815.x; Holmes MD, 2004, EPILEPSIA, V45, P618, DOI 10.1111/j.0013-9580.2004.63803.x; HOPKINS A, 1988, LANCET, V1, P721; HORMES JT, 1988, ARCH NEUROL-CHICAGO, V45, P814, DOI 10.1001/archneur.1988.00520310132033; Huang LC, 2014, CLIN EEG NEUROSCI, V45, P126, DOI 10.1177/1550059413490930; HUGHES JR, 1980, ELECTROEN CLIN NEURO, V48, P583, DOI 10.1016/0013-4694(80)90293-X; HUGHES JR, 1980, NEUROLOGY, V30, P1148, DOI 10.1212/WNL.30.11.1148; Hui ACF, 2001, EPILEPSIA, V42, P94, DOI 10.1046/j.1528-1157.2001.99352.x; HUNTER J, 1949, ELECTROEN CLIN NEURO, V1, P113, DOI 10.1016/0013-4694(49)90014-0; Huppertz HJ, 2001, NEUROIMAGE, V13, P15, DOI 10.1006/nimg.2000.0680; Hussain E, 2014, J PEDIATR GASTR NUTR, V58, P449, DOI 10.1097/MPG.0000000000000271; Hyllienmark L, 2007, EUR J PAEDIATR NEURO, V11, P70, DOI 10.1016/j.ejpn.2006.11.005; Ikeda A, 2003, CURRENT PRACTICE CLI, P348; Irani SR, 2011, ANN NEUROL, V69, P892, DOI 10.1002/ana.22307; ITOH N, 1994, CLIN ELECTROENCEPHAL, V25, P164, DOI 10.1177/155005949402500411; JABBARI B, 1979, CLIN ELECTROENCEPHAL, V10, P190, DOI 10.1177/155005947901000403; JAYAKAR P, 1992, J CLIN NEUROPHYSIOL, V9, P288, DOI 10.1097/00004691-199204010-00009; Jelic V, 2009, CLIN EEG NEUROSCI, V40, P129, DOI 10.1177/155005940904000211; JENNETT B, 1975, EPILEPSIA, V16, P251, DOI 10.1111/j.1528-1157.1975.tb06055.x; JENNETT WB, 1969, LANCET, V1, P1023; Jerbi K, 2004, NEUROIMAGE, V22, P779, DOI 10.1016/j.neuroimage.2004.02.010; Jette N, 2006, ARCH NEUROL-CHICAGO, V63, P1750, DOI 10.1001/archneur.63.12.1750; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; Johnson N, 2010, NEUROLOGY, V75, P1480, DOI 10.1212/WNL.0b013e3181f8831a; Johnston JM, 2006, J NEUROSURG, V105, P343, DOI 10.3171/ped.2006.105.5.343; Jonas J, 2011, J NEUROL NEUROSUR PS, V82, P928, DOI 10.1136/jnnp.2009.200329; Jordan KG, 2004, J CLIN NEUROPHYSIOL, V21, P341; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Jung J, 2013, BRAIN, V136, P3176, DOI 10.1093/brain/awt213; Kagan-Kushnir T, 2005, J CHILD NEUROL, V20, P197, DOI 10.1177/08830738050200030601; Kahn A, 2004, EUR J PEDIATR, V163, P108, DOI 10.1007/s00431-003-1365-x; Kalita J, 2006, Electromyogr Clin Neurophysiol, V46, P139; Kamel JT, 2010, EPILEPSY BEHAV, V19, P608, DOI 10.1016/j.yebeh.2010.09.026; Kanemura H, 2012, BRAIN DEV-JPN, V34, P302, DOI 10.1016/j.braindev.2011.07.007; KANNER AM, 1990, NEUROLOGY, V40, P1404, DOI 10.1212/WNL.40.9.1404; Kaplan PW, 2006, EPILEPSIA, V47, P2071, DOI 10.1111/j.1528-1167.2006.00849.x; Kaplan PW, 2012, EPILEPSY BEHAV, V24, P1, DOI 10.1016/j.yebeh.2011.11.029; Kaplan PW, 2004, J CLIN NEUROPHYSIOL, V21, P307; Kaplan PW, 1998, CLIN ELECTROENCEPHAL, V29, P120, DOI 10.1177/155005949802900302; Karakis I, 2010, J CLIN NEUROPHYSIOL, V27, P100, DOI 10.1097/WNP.0b013e3181d649e4; Kayser MS, 2010, AM J PSYCHIAT, V167, P1039, DOI 10.1176/appi.ajp.2010.09101547; KAYSERGATCHALIAN MC, 1980, ELECTROEN CLIN NEURO, V49, P608, DOI 10.1016/0013-4694(80)90401-0; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Keranen T, 2002, SEIZURE-EUR J EPILEP, V11, P269, DOI 10.1053/seiz.2001.0608; Kho LK, 2006, NEUROLOGY, V67, P1047, DOI 10.1212/01.wnl.0000237555.12146.66; Kifune A, 2000, EPILEPSIA, V41, P909, DOI 10.1111/j.1528-1157.2000.tb00263.x; Kim H, 2011, J NEUROSURG-PEDIATR, V8, P49, DOI 10.3171/2011.4.PEDS10519; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; King MA, 1998, LANCET, V352, P1007, DOI 10.1016/S0140-6736(98)03543-0; King W A, 1994, Neurosurg Clin N Am, V5, P767; Kipervasser S, 2007, ACTA NEUROL SCAND, V116, P221, DOI 10.1111/j.1600-0404.2007.00888.x; Kirkham FJ, 2012, INTENS CARE MED, V38, P853, DOI 10.1007/s00134-012-2529-9; Kirkpatrick MP, 2011, EPILEPSY BEHAV, V20, P392, DOI 10.1016/j.yebeh.2010.11.020; Klinger D, 1991, EPILPSY SLEEP DEPRIV, P217; Knight WA, 2013, EPILEPSY RES, V106, P396, DOI 10.1016/j.eplepsyres.2013.06.018; Knowlton RC, 2006, ANN NEUROL, V59, P835, DOI 10.1002/ana.20857; Knowlton RC, 2008, ANN NEUROL, V64, P25, DOI 10.1002/ana.21389; Knowlton RC, 2009, ANN NEUROL, V65, P716, DOI 10.1002/ana.21660; Ko TS, 1999, CLIN NEUROPHYSIOL, V110, P1245, DOI 10.1016/S1388-2457(99)00068-1; Kobayashi K, 2005, EPILEPSIA, V46, P1098, DOI 10.1111/j.1528-1167.2005.63004.x; Koenig MA, 2006, NEUROL CLIN, V24, P89, DOI 10.1016/j.ncl.2005.11.003; Koessler L, 2008, NEUROIMAGE, V41, P914, DOI 10.1016/j.neuroimage.2008.02.039; Koessler L, 2007, NEUROPHYSIOL CLIN, V37, P97, DOI 10.1016/j.neucli.2007.03.002; Koessler L, 2011, ANN BIOMED ENG, V39, P983, DOI 10.1007/s10439-010-0230-0; Koessler L, 2010, NEUROIMAGE, V51, P642, DOI 10.1016/j.neuroimage.2010.02.067; Kovacs GG, 2005, HUM GENET, V118, P166, DOI 10.1007/s00439-005-0020-1; KRAMER U, 1994, BRAIN DEV-JPN, V16, P304, DOI 10.1016/0387-7604(94)90028-0; Krauss GL, 2005, NEUROLOGY, V64, P1879, DOI 10.1212/01.WNL.0000163991.97456.03; Krishnamurthy KB, 1999, EPILEPSIA, V40, P759, DOI 10.1111/j.1528-1157.1999.tb00775.x; Kubicki S, 1991, Epilepsy Res Suppl, V2, P217; Kull LL, 2005, J CLIN NEUROPHYSIOL, V22, P107, DOI 10.1097/01.WNP.0000158361.24544.2D; Kurtz P, 2009, CURR OPIN CRIT CARE, V15, P99, DOI 10.1097/MCC.0b013e3283294947; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwong KL, 2003, PEDIATR NEUROL, V29, P46, DOI 10.1016/S0887-8994(03)00028-6; LABAR DR, 1991, ELECTROEN CLIN NEURO, V78, P325, DOI 10.1016/0013-4694(91)90094-K; Lamblin MD, 2011, NEUROPHYSIOL CLIN, V41, P1, DOI 10.1016/j.neucli.2010.12.001; Lamblin MD, 1999, NEUROPHYSIOL CLIN, V29, P123, DOI 10.1016/S0987-7053(99)80051-3; Lancman ME, 1996, J NEUROL SCI, V142, P54, DOI 10.1016/0022-510X(96)00092-5; Landre E, 2004, EPILEPSIES, V16, P213; Lantz G, 2003, CLIN NEUROPHYSIOL, V114, P63, DOI 10.1016/S1388-2457(02)00337-1; Larsson PG, 2010, EPILEPSY BEHAV, V19, P348, DOI 10.1016/j.yebeh.2010.07.021; Lasierra N, 2009, IEEE ENG MED BIO, P5211, DOI 10.1109/IEMBS.2009.5334076; LAURITZEN M, 1981, CEPHALALGIA, V1, P63, DOI 10.1111/j.1468-2982.1981.tb00010.x; Lawn ND, 2003, MAYO CLIN PROC, V78, P1363, DOI 10.4065/78.11.1363; Leach JP, 2006, J NEUROL NEUROSUR PS, V77, P1040, DOI 10.1136/jnnp.2005.084871; Leach JP, 2005, SEIZURE-EUR J EPILEP, V14, P514, DOI 10.1016/j.seizure.2005.08.008; Legriel S, 2009, NEUROCRIT CARE, V11, P338, DOI 10.1007/s12028-009-9246-4; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Liedorp M, 2009, DEMENT GERIATR COGN, V27, P18, DOI 10.1159/000182422; Lindsten H, 2001, EPILEPSIA, V42, P1025, DOI 10.1046/j.1528-1157.2001.0420081025.x; Liporace J, 1998, EPILEPSY RES, V32, P357, DOI 10.1016/S0920-1211(98)00069-2; Lobello K, 2006, EPILEPSY BEHAV, V8, P261, DOI 10.1016/j.yebeh.2005.10.010; LOGAR C, 1994, EUR NEUROL, V34, P29, DOI 10.1159/000119506; Loiseau P, 1984, LES EPILEPSIES, P167; Lossius MI, 2008, EPILEPSIA, V49, P455, DOI 10.1111/j.1528-1167.2007.01323.x; Loula P, 1997, J Telemed Telecare, V3, P89, DOI 10.1258/1357633971930922; MADKOUR O, 1993, J NEUROL SCI, V119, P8, DOI 10.1016/0022-510X(93)90186-3; Maillard L, 2009, CLIN NEUROPHYSIOL, V120, P1628, DOI 10.1016/j.clinph.2009.06.022; Maillard L, 2011, J COGNITIVE NEUROSCI, V23, P782, DOI 10.1162/jocn.2010.21434; Malow BA, 2002, NEUROLOGY, V59, P1371, DOI 10.1212/01.WNL.0000031810.15811.9E; Mani R, 2012, RESUSCITATION, V83, P840, DOI 10.1016/j.resuscitation.2012.02.015; Pardal-Fernandez JM, 2012, EUR J PAEDIATR NEURO, V16, P749, DOI 10.1016/j.ejpn.2012.03.008; Marinig R, 2000, CLIN NEUROPHYSIOL, V111, pS47, DOI 10.1016/S1388-2457(00)00401-6; MARSAN CA, 1970, EPILEPSIA, V11, P361, DOI 10.1111/j.1528-1157.1970.tb03903.x; Martin RC, 1998, SEIZURE-EUR J EPILEP, V7, P385, DOI 10.1016/S1059-1311(05)80007-X; Martz GU, 2009, NEUROCRIT CARE, V11, P223, DOI 10.1007/s12028-009-9215-y; MASQUIN A, 1963, EPILEPSIA, V4, P285, DOI 10.1111/j.1528-1157.1963.tb05226.x; MATTSON RH, 1965, ARCH NEUROL-CHICAGO, V13, P310, DOI 10.1001/archneur.1965.00470030090009; McBride AE, 2002, EPILEPSIA, V43, P165, DOI 10.1046/j.1528-1157.2002.24401.x; McCabe PH, 2003, NEUROLOGY, V60, P975, DOI 10.1212/01.WNL.0000053748.83309.28; McCoy B, 2013, J CLIN NEUROPHYSIOL, V30, P106, DOI 10.1097/WNP.0b013e3182872919; McGonigal A, 2004, J NEUROL NEUROSUR PS, V75, P771, DOI 10.1136/jnnp.2003.024893; McGonigal A, 2002, J NEUROL NEUROSUR PS, V72, P549; McGonigal A, 2007, BRAIN, V130, P3169, DOI 10.1093/brain/awm218; McHugh JC, 2009, IRISH J MED SCI, V178, P263, DOI 10.1007/s11845-009-0317-5; Meinitzer A, 2008, CLIN CHEM LAB MED, V46, P1732, DOI 10.1515/CCLM.2008.335; MELLERIO F, 1970, ELECTROEN CLIN NEURO, V29, P101; Merlet I, 1998, ELECTROEN CLIN NEURO, V107, P206, DOI 10.1016/S0013-4694(98)00055-8; Merlet I, 1999, CLIN NEUROPHYSIOL, V110, P1013, DOI 10.1016/S1388-2457(98)00062-5; Meunier S, 2001, ANN NEUROL, V50, P521, DOI 10.1002/ana.1234; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Millichap JG, 2006, CLIN EEG NEUROSCI, V37, P190, DOI 10.1177/155005940603700305; Minahan R E, 1997, New Horiz, V5, P406; Minassian BA, 1999, ANN NEUROL, V46, P627, DOI 10.1002/1531-8249(199910)46:4<627::AID-ANA11>3.0.CO;2-C; Mirsattari SM, 2009, EPILEPSY RES, V84, P28, DOI 10.1016/j.eplepsyres.2008.12.002; Mohan KK, 1996, ACTA NEUROL SCAND, V94, P320, DOI 10.1111/j.1600-0404.1996.tb07073.x; Moien-Afshari F, 2009, CAN J NEUROL SCI, V36, P587, DOI 10.1017/S0317167100008088; Mondello Epifanio, 2002, J Clin Monit Comput, V17, P271, DOI 10.1023/A:1021250320103; Morenski John D, 2003, J Intensive Care Med, V18, P211, DOI 10.1177/0885066603254359; MORRIS GL, 1994, ELECTROEN CLIN NEURO, V91, P229, DOI 10.1016/0013-4694(94)90073-6; Morris GL, 1997, J MED ENG TECHNOL, V21, P47, DOI 10.3109/03091909709008404; Mosbah A, 2014, EPILEPSIA, V55, P699, DOI 10.1111/epi.12565; Mosher JC, 1999, J CLIN NEUROPHYSIOL, V16, P225, DOI 10.1097/00004691-199905000-00004; Muniz J, 2010, EPILEPSY BEHAV, V18, P472, DOI 10.1016/j.yebeh.2010.06.014; Murahara T, 2013, EPILEPTIC DISORD, V15, P197, DOI 10.1684/epd.2013.0567; Murri L, 1998, NEUROPHYSIOL CLIN, V28, P249, DOI 10.1016/S0987-7053(98)80115-9; Musialowicz T, 2010, EPILEPSIA, V51, P1580, DOI 10.1111/j.1528-1167.2009.02514.x; MUSICCO M, 1993, NEUROLOGY, V43, P478; Naeije G, 2012, EPILEPSY BEHAV, V23, P330, DOI 10.1016/j.yebeh.2012.01.023; Nair DR, 2008, CLIN NEUROPHYSIOL, V119, P11, DOI 10.1016/j.clinph.2007.09.117; Nakagawa TA, 2011, PEDIATRICS, V128, pE720, DOI 10.1542/peds.2011-1511; Navarro V, 2009, REANIMATION, V18, P26; Navarro V, 2009, REANIMATION, V18, P33; Navelet Y, 1998, NEUROPHYSIOL CLIN, V28, P435, DOI 10.1016/S0987-7053(99)80027-6; NAVELET Y, 1990, Neurophysiologie Clinique, V20, P237, DOI 10.1016/S0987-7053(05)80113-3; NEUFELD MY, 1992, NEUROLOGY, V42, P444, DOI 10.1212/WNL.42.2.444; NEUFELD MY, 1988, ACTA NEUROL SCAND, V78, P1, DOI 10.1111/j.1600-0404.1988.tb03609.x; Neufeld MY, 2000, EPILEPSY RES, V42, P197, DOI 10.1016/S0920-1211(00)00183-2; Ney JP, 2013, NEUROLOGY, V81, P2002, DOI 10.1212/01.wnl.0000436948.93399.2a; NICOLAIDES P, 1995, ARCH DIS CHILD, V72, P522, DOI 10.1136/adc.72.6.522; Niedermeyer E, 2000, ELECTROENCEPHALOGRAP; Nilsson D, 2009, EPILEPSIA, V50, P2085, DOI 10.1111/j.1528-1167.2009.02135.x; Nitzkin J L, 1997, Telemed J, V3, P141, DOI 10.1089/tmj.1.1997.3.141; Noachtar S, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P21; Noachtar S, 2009, EPILEPSY BEHAV, V15, P22, DOI 10.1016/j.yebeh.2009.02.035; Noe KH, 2011, EPILEPSY RES, V93, P84, DOI 10.1016/j.eplepsyres.2010.10.014; Noe KH, 2009, MAYO CLIN PROC, V84, P495, DOI 10.1016/S0025-6196(11)60580-6; Noone ML, 2007, EPILEPSIA, V48, P390, DOI 10.1111/j.1528-1167.2007.00921.x; Nordli DR, 2006, EPILEPSIA, V47, P26, DOI 10.1111/j.1528-1167.2006.00656.x; Nordli DR, 2012, NEUROLOGY, V79, P2180, DOI 10.1212/WNL.0b013e3182759766; NOUSIAINEN U, 1989, ARCH NEUROL-CHICAGO, V46, P1171, DOI 10.1001/archneur.1989.00520470025019; Nuwer M, 1997, NEUROLOGY, V49, P277, DOI 10.1212/WNL.49.1.277; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; O'Sullivan SS, 2007, EPILEPSY BEHAV, V11, P77, DOI 10.1016/j.yebeh.2007.04.003; Ojemann SG, 2003, J NEUROSURG, V98, P465, DOI 10.3171/jns.2003.98.3.0465; Onal C, 2003, J NEUROSURG, V98, P1017, DOI 10.3171/jns.2003.98.5.1017; Ong C, 2012, NEUROCRIT CARE, V17, P39, DOI 10.1007/s12028-012-9728-7; Osredkar D, 2005, PEDIATRICS, V115, P327, DOI 10.1542/peds.2004-0863; Ossenblok P, 2007, EPILEPSIA, V48, P2139, DOI 10.1111/j.1528-1167.2007.01223.x; Oster I, 2010, J PAEDIATR CHILD H, V46, P373, DOI 10.1111/j.1440-1754.2010.01754.x; Outin H, 2009, REV NEUROL-FRANCE, V165, P297, DOI 10.1016/j.neurol.2009.01.048; PAILLAS JE, 1970, EPILEPSIA, V11, P5, DOI 10.1111/j.1528-1157.1970.tb03860.x; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; Panzica F, 1999, CLIN NEUROPHYSIOL, V110, P593, DOI 10.1016/S1388-2457(98)00031-5; PAOLIN A, 1995, INTENS CARE MED, V21, P657, DOI 10.1007/BF01711544; Parisi P, 2013, SEIZURE-EUR J EPILEP, V22, P253, DOI 10.1016/j.seizure.2013.01.013; Park KI, 2009, SEIZURE-EUR J EPILEP, V18, P94, DOI 10.1016/j.seizure.2008.07.001; Parmeggiani A, 2010, BRAIN DEV-JPN, V32, P783, DOI 10.1016/j.braindev.2010.07.003; Passaro AD, 2011, BRAIN RES, V1416, P44, DOI 10.1016/j.brainres.2011.08.017; PASSIER PECA, 1994, HEADACHE, V34, P56, DOI 10.1111/j.1526-4610.1994.hed3401056.x; Peraita-Adrados R, 2001, NEUROPHYSIOL CLIN, V31, P34, DOI 10.1016/S0987-7053(00)00242-2; Perrin MW, 2010, EPILEPSY BEHAV, V19, P32, DOI 10.1016/j.yebeh.2010.06.006; PERRY TR, 1983, PUBLIC HEALTH REP, V98, P384; Piantino JA, 2013, PEDIATR CRIT CARE ME, V14, P601, DOI 10.1097/PCC.0b013e318291755a; Pires LA, 2001, ARCH INTERN MED, V161, P1889, DOI 10.1001/archinte.161.15.1889; Plouin P, 2005, LEEG EN PEDIAT; Pohlmann-Eden B, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01445.x; Ponten SC, 2010, SEIZURE-EUR J EPILEP, V19, P580, DOI 10.1016/j.seizure.2010.09.007; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; POWNER DJ, 1976, JAMA-J AM MED ASSOC, V236, P1123, DOI 10.1001/jama.236.10.1123; Praline J, 2007, CLIN NEUROPHYSIOL, V118, P2149, DOI 10.1016/j.clinph.2007.07.003; PRATT KL, 1968, ELECTROEN CLIN NEURO, V24, P11, DOI 10.1016/0013-4694(68)90061-8; PRIVITERA M, 1994, EPILEPSY RES, V18, P155, DOI 10.1016/0920-1211(94)90008-6; Quigg M, 2002, EPILEPSY BEHAV, V3, P455, DOI 10.1016/S1525-5050(02)00524-3; Ramelli GP, 1998, ELECTROEN CLIN NEURO, V107, P374, DOI 10.1016/S0013-4694(98)00094-7; Reardon KA, 1999, J CLIN NEUROSCI, V6, P492, DOI 10.1016/S0967-5868(99)90007-3; REISNER T, 1979, J NEUROL, V221, P93, DOI 10.1007/BF00313106; REITE M, 1976, ELECTROEN CLIN NEURO, V40, P59, DOI 10.1016/0013-4694(76)90179-6; Reuber M, 2003, ANN NEUROL, V53, P305, DOI 10.1002/ana.3000; Riker RR, 2003, PHARMACOTHERAPY, V23, P1087, DOI 10.1592/phco.23.10.1087.32766; Rikir E, 2014, ADDED VALUE ELECT SO; Riquet A, 2011, SEIZURE-EUR J EPILEP, V20, P18, DOI 10.1016/j.seizure.2010.09.011; Riviello JJ, 2013, J CLIN NEUROPHYSIOL, V30, P143, DOI 10.1097/WNP.0b013e3182872b0e; RIVIEREZ M, 1991, ACTA NEUROCHIR, V110, P17, DOI 10.1007/BF01402042; Robinson AA, 2011, EPILEPSY BEHAV, V21, P76, DOI 10.1016/j.yebeh.2011.03.014; Rodin E, 1991, Epilepsy Res Suppl, V2, P265; Roger J, 2005, EPILEPTIC SYNDROMES; Roks G, 2008, J NEUROL NEUROSUR PS, V79, P377, DOI 10.1136/jnnp.2007.125385; Rosenow F, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2007.01359.x; Rossetti AO, 2010, CRIT CARE, V14, DOI 10.1186/cc9276; Rossetti AO, 2005, ARCH NEUROL-CHICAGO, V62, P1698, DOI 10.1001/archneur.62.11.1698; Rossi G F, 1991, Epilepsy Res Suppl, V2, P23; Roustan JP, 2005, ANESTH ANALG, V101, P1141, DOI 10.1213/01.ane.0000167782.47957.e1; Rozza L, 1996, Telemed J, V2, P267, DOI 10.1089/tmj.1.1996.2.267; Rumpl E, 2005, ELECTROENCEPHALOGRAP, P415; Rundgren M, 2006, INTENS CARE MED, V32, P836, DOI 10.1007/s00134-006-0178-6; Saab ME, 2005, CLIN NEUROPHYSIOL, V116, P427, DOI 10.1016/j.clinph.2004.08.004; Sackellares JC, 2011, EPILEPSY BEHAV, V22, pS69, DOI 10.1016/j.yebeh.2011.08.028; SAINIO K, 1983, ELECTROEN CLIN NEURO, V56, P117, DOI 10.1016/0013-4694(83)90066-4; SALINSKY M, 1987, EPILEPSIA, V28, P331, DOI 10.1111/j.1528-1157.1987.tb03652.x; SAMMARITANO M, 1991, NEUROLOGY, V41, P290, DOI 10.1212/WNL.41.2_Part_1.290; Samson-Dollfus D, 1998, ELECTROENCEPHALOGRAP; Sanchez SM, 2013, EPILEPSIA, V54, P1419, DOI 10.1111/epi.12261; Sand T, 1991, Funct Neurol, V6, P7; Sander J, 2012, EUR J PEDIATR, V171, P675, DOI 10.1007/s00431-011-1640-1; Sanders P T, 1996, J Neurosci Nurs, V28, P305; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; SAVAGE DD, 1985, STROKE, V16, P626, DOI 10.1161/01.STR.16.4.626; Schauble B, 2003, CLIN NEUROPHYSIOL, V114, P32, DOI 10.1016/S1388-2457(02)00343-7; Scheepers B, 1998, SEIZURE-EUR J EPILEP, V7, P403, DOI 10.1016/S1059-1311(05)80010-X; Scheltens-de Boer M, 2009, EPILEPSIA, V50, P13, DOI 10.1111/j.1528-1167.2009.02211.x; Scherg M, 1999, J CLIN NEUROPHYSIOL, V16, P214, DOI 10.1097/00004691-199905000-00003; SCHERZER E, 1978, EUR NEUROL, V17, P38, DOI 10.1159/000114919; Scheuer ML, 2004, J CLIN NEUROPHYSIOL, V21, P353; Scheuer ML, 2002, EPILEPSIA, V43, P114, DOI 10.1046/j.1528-1157.43.s.3.7.x; Schevon CA, 2007, EPILEPSIA, V48, P539, DOI 10.1111/j.1528-1167.2006.00962.x; Schlede N, 2011, J NEUROL SCI, V310, P75, DOI 10.1016/j.jns.2011.05.034; Schmitt SE, 2012, NEUROLOGY, V79, P1094, DOI 10.1212/WNL.0b013e3182698cd8; Schomer DL, 1999, J CLIN NEUROPHYSIOL, V16, P116, DOI 10.1097/00004691-199903000-00004; World Health Organisation, 1998, WKLY EPIDEMIOL REC; [Anonymous], 1995, Neurology, V45, P1012; Lv YD, 2013, INT J NEUROSCI, V123, P196, DOI 10.3109/00207454.2012.746334; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Schreiner A, 2003, CLIN ELECTROENCEPHAL, V34, P140, DOI 10.1177/155005940303400307; Sediri H, 2007, REV NEUROL-FRANCE, V163, P248, DOI 10.1016/S0035-3787(07)90399-9; Seiler L, 2012, J NEUROSCI NURS, V44, pE1, DOI 10.1097/JNN.0b013e3182478c7c; Seneviratne U, 2012, EPILEPSIA, V53, P234, DOI 10.1111/j.1528-1167.2011.03344.x; Shafer PO, 2011, EPILEPSY BEHAV, V20, P502, DOI 10.1016/j.yebeh.2010.12.048; Shafer PO, 2012, EPILEPSY BEHAV, V25, P449, DOI 10.1016/j.yebeh.2012.07.014; SHAFER SQ, 1988, EPILEPSIA, V29, P590, DOI 10.1111/j.1528-1157.1988.tb03767.x; Shafi MM, 2012, NEUROLOGY, V79, P1796, DOI 10.1212/WNL.0b013e3182703fbc; Shahwan A, 2010, EPILEPSIA, V51, P1198, DOI 10.1111/j.1528-1167.2009.02517.x; Shevell M, 2003, NEUROLOGY, V60, P367, DOI 10.1212/01.WNL.0000031431.81555.16; Shinnar S, 2000, ANN NEUROL, V48, P140, DOI 10.1002/1531-8249(200008)48:2<140::AID-ANA2>3.0.CO;2-Y; Shinnar S, 1996, PEDIATRICS, V98, P216; Shoar Z, 2013, J PEDIATR ENDOCR MET, V26, P561, DOI 10.1515/jpem-2012-0321; Sieradzan K, 2013, J NEUROL NEUROSUR PS, V84, DOI 10.1136/jnnp-2013-306573.104; SILLANPAA M, 1993, EPILEPSIA, V34, P930, DOI 10.1111/j.1528-1157.1993.tb02114.x; Singh RK, 2012, J PEDIATR-US, V160, P291, DOI 10.1016/j.jpeds.2011.07.048; Smith SJM, 2005, J NEUROL NEUROSUR PS, V76, P2, DOI 10.1136/jnnp.2005.069245; SOIKKELI R, 1991, ELECTROEN CLIN NEURO, V79, P159, DOI 10.1016/0013-4694(91)90134-P; Sorbi S, 2012, EUR J NEUROL, V19, P1159, DOI 10.1111/j.1468-1331.2012.03784.x; Soriani S, 1996, EUR J PEDIATR, V155, P126, DOI 10.1007/BF02075766; Sousa NAD, 2005, ARQ NEURO-PSIQUIAT, V63, P383, DOI 10.1590/S0004-282X2005000300003; Specchio LM, 2002, J NEUROL NEUROSUR PS, V72, P22, DOI 10.1136/jnnp.72.1.22; SPENCER SS, 1990, NEUROLOGY, V40, P74, DOI 10.1212/WNL.40.1.74; Sperli F, 2006, EPILEPSIA, V47, P981, DOI 10.1111/j.1528-1167.2006.00550.x; Spindler M, 2013, J CLIN NEUROPHYSIOL, V30, P339, DOI 10.1097/WNP.0b013e31829ddcdb; Stefan H, 2011, SEIZURE-EUR J EPILEP, V20, P97, DOI 10.1016/j.seizure.2010.10.035; Steiner I, 2010, EUR J NEUROL, V17, P999, DOI 10.1111/j.1468-1331.2010.02970.x; Steinhoff BJ, 2004, ANN NEUROL, V56, P702, DOI 10.1002/ana.20261; Stewart CP, 2010, NEUROLOGY, V75, P1501, DOI 10.1212/WNL.0b013e3181f9619e; Stockard JJBRG, 1975, HDB CLIN NEUROLOGY, V23, P217; Sullivan Joseph E 3rd, 2007, Am J Electroneurodiagnostic Technol, V47, P127; Sullivan R, 2012, CLIN TOXICOL, V50, P141, DOI 10.3109/15563650.2011.654209; SUNDARAM M, 1990, ELECTROEN CLIN NEURO, V75, P358, DOI 10.1016/0013-4694(90)90114-Y; Surbeck W, 2011, EPILEPSIA, V52, P458, DOI 10.1111/j.1528-1167.2010.02910.x; Sutter R, 2013, CLIN NEUROPHYSIOL, V124, P1952, DOI 10.1016/j.clinph.2013.03.031; Sutter R, 2013, CRIT CARE MED, V41, P1124, DOI 10.1097/CCM.0b013e318275882f; Sutter R, 2011, EPILEPSIA, V52, P453, DOI 10.1111/j.1528-1167.2010.02888.x; SVEINBJORNSDOTTIR S, 1993, EPILEPSIA, V34, P493, DOI 10.1111/j.1528-1157.1993.tb02590.x; Szurhaj W, 2004, REV NEUROL-FRANCE, V160, P1113, DOI 10.1016/S0035-3787(04)71153-4; Szurhaj W, 2001, REANIMATION, V10, P368; TAGHAVY A, 1992, INT J NEUROSCI, V66, P251; TALAIRACH J, 1974, NEUROCHIRURGIE, V20, P1; Talairach J., 1973, PROG NEUROL SURG, V5, P287, DOI [10.1159/000394343, DOI 10.1159/000394343]; Tao JX, 2005, EPILEPSIA, V46, P669, DOI 10.1111/j.1528-1167.2005.11404.x; Tatum WO, 2001, J CLIN NEUROPHYSIOL, V18, P14, DOI 10.1097/00004691-200101000-00004; Taussig D, 2012, STEREOTAXY EPILEPSY, P21; Taussig D, 2012, SEIZURE-EUR J EPILEP, V21, P631, DOI 10.1016/j.seizure.2012.07.004; THOMAS P, 1992, NEUROLOGY, V42, P104, DOI 10.1212/WNL.42.1.104; Tieder JS, 2013, J PEDIATR-US, V163, P94, DOI 10.1016/j.jpeds.2012.12.086; Tinuper P, 1996, NEUROLOGY, V47, P76, DOI 10.1212/WNL.47.1.76; TORRES F, 1961, ARCH NEUROL-CHICAGO, V5, P28, DOI 10.1001/archneur.1961.00450130030005; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Trenite DGAKN, 1999, EPILEPSIA, V40, P75, DOI 10.1111/j.1528-1157.1999.tb00911.x; Trenite DKN, 2012, EPILEPSIA, V53, P16, DOI 10.1111/j.1528-1167.2011.03319.x; Trevathan Edwin, 2006, Am J Electroneurodiagnostic Technol, V46, P4; Trinh-Duc A, 2006, CRISES CONVULSIVES A; TROJABORG W, 1992, CLIN ELECTROENCEPHAL, V23, P72, DOI 10.1177/155005949202300206; Uldal SB, 2004, J TELEMED TELECARE, V10, P11, DOI 10.1258/135763304322764121; Van CA, 2003, CURRENT PRACTICE CLI, P463; Van Gompel JJ, 2010, J NEUROSURG, V113, P32, DOI 10.3171/2009.12.JNS091073; van Putten MJAM, 2004, STROKE, V35, P2489, DOI 10.1161/01.STR.0000144649.49861.1d; van Vliet J, 2012, CLIN EEG NEUROSCI, V43, P161, DOI 10.1177/1550059411433612; VANDONSELAAR CA, 1992, ARCH NEUROL-CHICAGO, V49, P231, DOI 10.1001/archneur.1992.00530270045017; VANDONSELAAR CA, 1991, LANCET, V337, P46, DOI 10.1016/0140-6736(91)93361-C; Varela HL, 2007, J CLIN NEUROPHYSIOL, V24, P390, DOI 10.1097/WNP.0b013e31812f6c11; VECCHIERINI-BLINEAU M F, 1992, Neurophysiologie Clinique, V22, P179, DOI 10.1016/S0987-7053(05)80214-X; Veggiotti P, 2012, EPILEPTIC DISORD, V14, P1, DOI 10.1684/epd.2012.0482; Velasco TR, 2006, EPILEPSIA, V47, P1300, DOI 10.1111/j.1528-1167.2006.00547.x; VELDHUIZEN R, 1983, ELECTROEN CLIN NEURO, V55, P505, DOI 10.1016/0013-4694(83)90161-X; Velis D, 2007, EPILEPSIA, V48, P379, DOI 10.1111/j.1528-1167.2007.00920.x; Velly L, 2012, Ann Fr Anesth Reanim, V31, pe145, DOI 10.1016/j.annfar.2012.04.019; Vendrame M, 2011, PEDIATR NEUROL, V44, P427, DOI 10.1016/j.pediatrneurol.2011.01.004; Veran O, 2010, EPILEPSIA, V51, P1030, DOI 10.1111/j.1528-1167.2009.02410.x; Vercueil L, 2013, EPILEPSY BEHAV, V27, P307, DOI 10.1016/j.yebeh.2013.02.007; Verrotti A, 2012, EPILEPTIC DISORD, V14, P349, DOI 10.1684/epd.2012.0539; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 1997, ELECTROEN CLIN NEURO, V103, P607, DOI 10.1016/S0013-4694(97)00071-0; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Vespa PM, 1999, J CLIN NEUROPHYSIOL, V16, P1, DOI 10.1097/00004691-199901000-00001; Vignal JP, 2008, FUNCTIONAL LOCALIZAT; Villanueva V, 2011, NEUROLOGIA, V26, P6, DOI 10.1016/j.nrl.2010.09.029; Vivien B, 2003, ANESTHESIOLOGY, V99, P9, DOI 10.1097/00000542-200307000-00006; Vivien B, 2001, ANN FR ANESTH, V20, P370; Voller B, 1999, BRAIN INJURY, V13, P821, DOI 10.1080/026990599121214; Vrba J, 2001, METHODS, V25, P249, DOI 10.1006/meth.2001.1238; Wallois F, 2007, NEUROPHYSIOL CLIN, V37, P149, DOI 10.1016/j.neucli.2007.07.001; Wang LH, 2013, J NEUROL, V260, P498, DOI 10.1007/s00415-012-6664-6; Wang L, 2012, EPILEPSY RES, V98, P116, DOI 10.1016/j.eplepsyres.2011.06.008; Wang YH, 2007, P ANN INT IEEE EMBS, P553; Wassmer E, 2001, DEV MED CHILD NEUROL, V43, P136, DOI 10.1017/S0012162201210251; Welschehold S, 2012, DTSCH ARZTEBL INT, V109, P624, DOI 10.3238/arztebl.2012.0624; Wennberg R, 2011, CLIN NEUROPHYSIOL, V122, P1295, DOI 10.1016/j.clinph.2010.11.019; Wieser HG, 2006, CLIN NEUROPHYSIOL, V117, P935, DOI 10.1016/j.clinph.2005.12.007; WIESER HG, 1991, EPILEPSIA, V32, P838, DOI 10.1111/j.1528-1157.1991.tb05540.x; Wijdicks EFM, 2002, NEUROLOGY, V58, P20, DOI 10.1212/WNL.58.1.20; WIJDICKS EFM, 1995, NEUROLOGY, V45, P1003, DOI 10.1212/WNL.45.5.1003; WIKSWO JP, 1993, ELECTROEN CLIN NEURO, V87, P1, DOI 10.1016/0013-4694(93)90169-V; WILLIAMS GW, 1985, NEUROLOGY, V35, P1714, DOI 10.1212/WNL.35.12.1714; Williams K, 2011, EPILEPSIA, V52, P1130, DOI 10.1111/j.1528-1167.2011.03070.x; WINER JW, 1991, NEUROSURGERY, V29, P739, DOI 10.1227/00006123-199111000-00016; Wirrell EC, 1996, EPILEPSIA, V37, P459, DOI 10.1111/j.1528-1157.1996.tb00592.x; Woollacott IOC, 2010, EPILEPSY BEHAV, V17, P228, DOI 10.1016/j.yebeh.2009.12.002; Wright WL, 2007, J NEUROL SCI, V261, P10, DOI 10.1016/j.jns.2007.04.027; WYLLIE E, 1988, NEUROPEDIATRICS, V19, P80, DOI 10.1055/s-2008-1052406; Wyllie E, 1998, PEDIATR NEUROL, V19, P179, DOI 10.1016/S0887-8994(98)00062-9; YAMATANI M, 1994, EPILEPSIA, V35, P1199, DOI 10.1111/j.1528-1157.1994.tb01789.x; Yang LH, 2013, NEUROL MED-CHIR, V53, P12, DOI 10.2176/nmc.53.12; Yen DJ, 2001, EPILEPSIA, V42, P251, DOI 10.1046/j.1528-1157.2001.15100.x; Yogarajah M, 2009, J NEUROL NEUROSUR PS, V80, P305, DOI 10.1136/jnnp.2008.144634; Young GB, 2006, CLIN NEUROPHYSIOL, V117, P1376, DOI 10.1016/j.clinph.2006.02.006; Young GB, 2009, CAN J NEUROL SCI, V36, pS89; Young GB, 2006, ACTA NEUROL SCAND, V114, P67, DOI 10.1111/j.1600-0404.2006.00651.x; Young GB, 1996, NEUROLOGY, V47, P83; Young GB, 1999, J CLIN NEUROPHYSIOL, V16, P40, DOI 10.1097/00004691-199901000-00003; Zappella M, 2010, BRAIN DEV-JPN, V32, P739, DOI 10.1016/j.braindev.2010.05.004; Zerr I, 2000, NEUROLOGY, V55, P811, DOI 10.1212/WNL.55.6.811; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zhang YC, 2009, EPILEPSY BEHAV, V15, P303, DOI 10.1016/j.yebeh.2009.04.008; ZIVIN L, 1968, BRAIN, V91, P751, DOI 10.1093/brain/91.4.751; Zumsteg D, 2005, CLIN NEUROPHYSIOL, V116, P2810, DOI 10.1016/j.clinph.2005.08.009; Zumsteg D, 2000, EPILEPSIA, V41, pS55, DOI 10.1111/j.1528-1157.2000.tb01535.x	626	18	18	0	25	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	ISSY-LES-MOULINEAUX	65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE	0987-7053	1769-7131		NEUROPHYSIOL CLIN	Neurophysiol. Clin.-Clin. Neurophysiol.	DEC	2014	44	6					515	612		10.1016/j.neucli.2014.10.001			98	Clinical Neurology; Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	AZ1OH	WOS:000348007600001	25435392				2022-02-06	
J	Dvela-Levitt, M; Cohen-Ben Ami, H; Rosen, H; Shohami, E; Lichtstein, D				Dvela-Levitt, Moran; Cohen-Ben Ami, Hagit; Rosen, Haim; Shohami, Esther; Lichtstein, David			Ouabain Improves Functional Recovery following Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						cardiac steroids; cell viability; closed head injury; Na+, K+-ATPase	CLOSED-HEAD INJURY; ATPASE ACTIVITY; PATHOPHYSIOLOGY; DIGITALIS; ISCHEMIA; MICE; RAT; NEUROPROTECTION; NEUROGENESIS; PHARMACOLOGY	The cardiac steroid ouabain binds to Na+, K+-ATPase and inhibits its activity. Administration of the compound to animals and humans causes an increase in the force of contraction of heart muscle and stabilizes heart rate. In addition, this steroid promotes the growth of cardiac, vascular, and neuronal cells both in vitro and in vivo. We studied the effects of ouabain on mouse recovery following closed head injury (CHI), a model for traumatic brain injury. We show that chronic (three times a week), but not acute, intraperitoneal administration of a low dose (1 mu g/kg) of ouabain significantly improves mouse recovery and functional outcome. The improvement in mouse performance was accompanied by a decrease in lesion size, estimated 43 d following the trauma. In addition, mice that underwent CHI and were treated with ouabain showed an increase in the number of proliferating cells in the subventricular zone and in the area surrounding the site of injury. Determination of the identity of the proliferating cells in the area surrounding the trauma showed that whereas there was no change in the proliferation of endothelial cells or astrocytes, neuronal cell proliferation almost doubled in the ouabain-treated mice in comparison with that of the vehicle animals. These results point to a neuroprotective effects of low doses of ouabain and imply its involvement in brain recovery and neuronal regeneration. This suggests that ouabain and maybe other cardiac steroids may be used for the treatment of traumatic brain injury.	[Dvela-Levitt, Moran; Cohen-Ben Ami, Hagit; Lichtstein, David] Hebrew Univ Hadassah Med Sch, Dept Med Neurobiol, IL-91120 Jerusalem, Israel; [Rosen, Haim] Hebrew Univ Hadassah Med Sch, Dept Microbiol, IL-91120 Jerusalem, Israel; [Rosen, Haim] Hebrew Univ Hadassah Med Sch, Dept Mol Genet, IL-91120 Jerusalem, Israel; [Shohami, Esther] Hebrew Univ Hadassah Med Sch, Dept Pharmacol, IL-91120 Jerusalem, Israel		Lichtstein, D (corresponding author), Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Med Neurobiol, POB 12272, IL-91120 Jerusalem, Israel.	davidli@ekmd.huji.ac.il			Federico Foundation; Hoffman Leadership and Responsibility Fellowship Program	We would like to thank Mr. Yoni Levitt for his assistance in analyzing the immunostaining images. This work was supported in part by the Federico Foundation (D.L) and the Hoffman Leadership and Responsibility Fellowship Program (M.D.L).	Bagrov AY, 2009, PHARMACOL REV, V61, P9, DOI 10.1124/pr.108.000711; Bauman Jerry L, 2006, Am J Cardiovasc Drugs, V6, P77, DOI 10.2165/00129784-200606020-00002; Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Correa GD, 2005, BRAIN RES, V1049, P89, DOI 10.1016/j.brainres.2005.04.082; Cuny GD, 2009, CURR PHARM DESIGN, V15, P3919, DOI 10.2174/138161209789649330; Dvela M, 2012, AM J PHYSIOL-CELL PH, V302, pC442, DOI 10.1152/ajpcell.00336.2011; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Furstenwerth H, 2010, INT J CLIN PRACT, V64, P1591, DOI 10.1111/j.1742-1241.2010.02395.x; Gao JY, 2002, J GEN PHYSIOL, V119, P297, DOI 10.1085/jgp.20028501; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin K, 2007, J NEUROIMMUNE PHARM, V2, P236, DOI 10.1007/s11481-007-9076-0; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; LICHTSTEIN D, 1985, BRAIN RES, V325, P13, DOI 10.1016/0006-8993(85)90297-5; Lichtstein D, 2001, NEUROCHEM RES, V26, P971, DOI 10.1023/A:1012340702763; LICHTSTEIN D, 1985, NEUROCHEM INT, V7, P709, DOI 10.1016/0197-0186(85)90069-5; Lima FD, 2008, BEHAV BRAIN RES, V193, P306, DOI 10.1016/j.bbr.2008.05.013; Liu J., 1802, BIOCH BIOPHYS ACTA, P1237; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Matsumoto S, 2008, NEUROSCI LETT, V439, P241, DOI 10.1016/j.neulet.2008.05.032; Murata Y, 1996, JPN J PHARMACOL, V72, P347, DOI 10.1254/jjp.72.347; Mustafa AG, 2013, NEUROSCIENCES, V18, P222; Nesher M, 2007, LIFE SCI, V80, P2093, DOI 10.1016/j.lfs.2007.03.013; Oselkin M, 2010, NEUROSCI LETT, V473, P67, DOI 10.1016/j.neulet.2009.10.021; Qiu J, 2007, BIOL PHARM BULL, V30, P247, DOI 10.1248/bpb.30.247; Shein NA, 2007, J NEUROCHEM, V103, P1523, DOI 10.1111/j.1471-4159.2007.04862.x; Shioda N, 2009, INT REV NEUROBIOL, V85, P375, DOI 10.1016/S0074-7742(09)85026-5; Sibarov DA, 2012, J PHARMACOL EXP THER, V343, P596, DOI 10.1124/jpet.112.198341; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Tsenter J, 2008, J NEUROTRAUM, V25, P324, DOI 10.1089/neu.2007.0452; Wang JKT, 2006, P NATL ACAD SCI USA, V103, P10461, DOI 10.1073/pnas.0600930103; Wasserstrom JA, 2005, AM J PHYSIOL-HEART C, V289, pH1781, DOI 10.1152/ajpheart.00707.2004; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x	38	18	19	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2014	31	23					1942	1947		10.1089/neu.2014.3544			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AT6US	WOS:000345075500007	25007121	Green Published			2022-02-06	
J	Hannon, MJ; Thompson, CJ				Hannon, Mark J.; Thompson, Christopher J.			Neurosurgical Hyponatremia	JOURNAL OF CLINICAL MEDICINE			English	Article						hyponatremia; neurosurgery; SIADH; SAH; TBI	TRAUMATIC BRAIN-INJURY; SALT-WASTING SYNDROME; IMPAIRED WATER-EXCRETION; CARE RESOURCE BURDEN; SUBARACHNOID HEMORRHAGE; ANTIDIURETIC-HORMONE; GLUCOCORTICOID DEFICIENCY; INAPPROPRIATE SECRETION; PITUITARY DYSFUNCTION; INDEPENDENT PREDICTOR	Hyponatremia is a frequent electrolyte imbalance in hospital inpatients. Acute onset hyponatremia is particularly common in patients who have undergone any type of brain insult, including traumatic brain injury, subarachnoid hemorrhage and brain tumors, and is a frequent complication of intracranial procedures. Acute hyponatremia is more clinically dangerous than chronic hyponatremia, as it creates an osmotic gradient between the brain and the plasma, which promotes the movement of water from the plasma into brain cells, causing cerebral edema and neurological compromise. Unless acute hyponatremia is corrected promptly and effectively, cerebral edema may manifest through impaired consciousness level, seizures, elevated intracranial pressure, and, potentially, death due to cerebral herniation. The pathophysiology of hyponatremia in neurotrauma is multifactorial, but most cases appear to be due to the syndrome of inappropriate antidiuretic hormone secretion (SIADH). Classical treatment of SIADH with fluid restriction is frequently ineffective, and in some circumstances, such as following subarachnoid hemorrhage, contraindicated. However, the recently developed vasopressin receptor antagonist class of drugs provides a very useful tool in the management of neurosurgical SIADH. In this review, we summarize the existing literature on the clinical features, causes, and management of hyponatremia in the neurosurgical patient.	[Hannon, Mark J.] St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England; [Thompson, Christopher J.] Beaumont Hosp, RCSI Med Sch, Acad Dept Endocrinol, Dublin, Ireland		Hannon, MJ (corresponding author), St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England.	mark.hannon@bartshealth.nhs.uk; christhompson@beaumont.ie			PfizerPfizer; Novo Nordisk.Novo Nordisk	Some of the research work referred to was sponsored by Pfizer and Novo Nordisk.	Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha Amar, 2005, Am J Med, V118, P1416; Amin Alpesh, 2013, J Med Econ, V16, P415, DOI 10.3111/13696998.2013.766615; Amin A, 2012, J HOSP MED, V7, P634, DOI 10.1002/jhm.1973; Andrioli Massimiliano, 2006, Pituitary, V9, P289, DOI 10.1007/s11102-006-0408-5; Arafah BM, 2006, J CLIN ENDOCR METAB, V91, P3725, DOI 10.1210/jc.2006-0674; ARIEFF AI, 1976, MEDICINE, V55, P121, DOI 10.1097/00005792-197603000-00002; Ayus JC, 2000, ANN INTERN MED, V132, P711, DOI 10.7326/0003-4819-132-9-200005020-00005; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; Berendes E, 1997, LANCET, V349, P245, DOI 10.1016/S0140-6736(96)08093-2; Berl T, 2010, J AM SOC NEPHROL, V21, P705, DOI 10.1681/ASN.2009080857; Buckley MS, 2013, ANN PHARMACOTHER, V47, P1194, DOI 10.1177/1060028013503126; Cerda-Esteve M, 2008, EUR J INTERN MED, V19, P249, DOI 10.1016/j.ejim.2007.06.019; Cernak I, 1999, BRAIN INJURY, V13, P1005; Citerio G, 2007, INTENS CARE MED, V33, P1580, DOI 10.1007/s00134-007-0700-5; Clayton JA, 2006, QJM-INT J MED, V99, P505, DOI 10.1093/qjmed/hcl071; CLUITMANS FHM, 1990, AM J MED, V88, P161, DOI 10.1016/0002-9343(90)90467-R; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Decaux G, 2010, CRIT CARE, V14, DOI 10.1186/cc9292; Deitelzweig S, 2013, ADV THER, V30, P71, DOI 10.1007/s12325-012-0073-1; Della Corte F, 1998, CRIT CARE MED, V26, P1419; Ellis SJ, 1995, QJM-MON J ASSOC PHYS, V88, P905; Erkut ZA, 1998, J CLIN ENDOCR METAB, V83, P2066, DOI 10.1210/jc.83.6.2066; Fraser JF, 2006, NEUROSURGERY, V59, P222, DOI 10.1227/01.NEU.0000223440.35642.6E; Gill G, 2006, CLIN ENDOCRINOL, V65, P246, DOI 10.1111/j.1365-2265.2006.02583.x; GULLANS SR, 1993, ANNU REV MED, V44, P289, DOI 10.1146/annurev.med.44.1.289; HACKL JM, 1991, INTENS CARE MED, V17, P25, DOI 10.1007/BF01708405; Hannon MJ, 2014, J CLIN ENDOCR METAB, V99, P291, DOI 10.1210/jc.2013-3032; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Hannon MJ, 2011, BEST PRACT RES CL EN, V25, P783, DOI 10.1016/j.beem.2011.06.001; Hannon MJ, 2010, EUR J ENDOCRINOL, V162, pS5, DOI 10.1530/EJE-09-1063; Hannon MJ, 2012, J CLIN ENDOCR METAB, V97, P1423, DOI 10.1210/jc.2011-3201; Hertz L, 2000, J NEUROSCI RES, V62, P480, DOI 10.1002/1097-4547(20001115)62:4<480::AID-JNR2>3.0.CO;2-K; Higashihara E, 2011, CLIN J AM SOC NEPHRO, V6, P2499, DOI 10.2215/CJN.03530411; Hoorn EJ, 2006, NEPHROL DIAL TRANSPL, V21, P70, DOI 10.1093/ndt/gfi082; Human T, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.03.003; Ishikawa S, 2004, J NEUROENDOCRINOL, V16, P293, DOI 10.1111/j.0953-8194.2004.01177.x; ISOTANI E, 1994, STROKE, V25, P2198, DOI 10.1161/01.STR.25.11.2198; Jahangiri A, 2013, J NEUROSURG, V119, P1478, DOI 10.3171/2013.7.JNS13273; Janneck M, 2014, MINERVA ENDOCRINOL, V39, P27; Jeon SB, 2013, EUR NEUROL, V70, P142, DOI 10.1159/000350844; Kao L, 2009, PITUITARY, V12, P347, DOI 10.1007/s11102-009-0188-9; Kengne FG, 2009, KIDNEY INT, V76, P614, DOI 10.1038/ki.2009.254; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Kuramatsu JB, 2014, STROKE, V45, P1285, DOI 10.1161/STROKEAHA.113.004136; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; LINAS SL, 1980, KIDNEY INT, V18, P58, DOI 10.1038/ki.1980.110; Lindner G, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2012.05.001; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Marik PE, 2008, CRIT CARE MED, V36, P1937, DOI 10.1097/CCM.0b013e31817603ba; Mees SMD, 2011, NEUROCRIT CARE, V14, P176, DOI 10.1007/s12028-011-9504-0; MICKEL HS, 1990, BIOCHEM BIOPH RES CO, V172, P92, DOI 10.1016/S0006-291X(05)80177-9; Mohan S, 2013, AM J MED, V126, P1127, DOI 10.1016/j.amjmed.2013.07.021; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; NELSON PB, 1981, J NEUROSURG, V55, P938, DOI 10.3171/jns.1981.55.6.0938; OELKERS W, 1989, NEW ENGL J MED, V321, P492, DOI 10.1056/NEJM198908243210802; Oh MS, 1999, NEPHRON, V82, P110, DOI 10.1159/000045385; Palmer BF, 2000, NEPHROL DIAL TRANSPL, V15, P262, DOI 10.1093/ndt/15.2.262; Parenti G, 2011, J ENDOCRINOL INVEST, V34, P361, DOI [10.1007/BF03347460, 10.3275/7242]; Peri A, 2013, J CLIN ENDOCR METAB, V98, P1321, DOI 10.1210/jc.2012-4082; PETERS JP, 1950, T ASSOC AM PHYSICIAN, V63, P57; Pierrakos C, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-13; Revilla-Pacheco FR, 2005, NEUROL RES, V27, P418, DOI 10.1179/016164105X17152; ROBERTSON GL, 1989, NEW ENGL J MED, V321, P538, DOI 10.1056/NEJM198908243210810; Rodrigues B, 2014, J STROKE CEREBROVASC, V23, P850, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.011; Rogers IR, 2011, CLIN J SPORT MED, V21, P200, DOI 10.1097/JSM.0b013e31821a6450; ROJIANI AM, 1994, ACTA NEUROPATHOL, V88, P287; Saito T, 2001, KIDNEY INT, V60, P1266, DOI 10.1046/j.1523-1755.2001.00965.x; Sajadieh A, 2009, AM J MED, V122, P679, DOI 10.1016/j.amjmed.2008.11.033; Schrier RW, 2006, NEW ENGL J MED, V355, P2099, DOI 10.1056/NEJMoa065181; Sherlock M, 2006, CLIN ENDOCRINOL, V64, P250, DOI 10.1111/j.1365-2265.2006.02432.x; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; Sherlock M, 2010, EUR J ENDOCRINOL, V162, pS13, DOI 10.1530/EJE-09-1057; SIVAKUMAR V, 1994, NEUROSURGERY, V34, P269, DOI 10.1227/00006123-199402000-00010; Soupart A, 2007, NEPHROL DIAL TRANSPL, V22, P1856, DOI 10.1093/ndt/gfm138; Stelfox HT, 2008, CRIT CARE, V12, DOI 10.1186/cc7162; STERNS RH, 1993, AM J PHYSIOL, V264, pF833, DOI 10.1152/ajprenal.1993.264.5.F833; Sterns RH, 2006, AM J MED, V119, pS12, DOI 10.1016/j.amjmed.2006.05.003; Sturdik I, 2014, EUR J INTERN MED, V25, P379, DOI 10.1016/j.ejim.2014.02.002; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tzoulis P, 2014, CLIN ENDOCRINOL, V81, P401, DOI 10.1111/cen.12429; Verbalis JG, 1998, SEMIN NEPHROL, V18, P3; VERBALIS JG, 1989, BAILLIERE CLIN ENDOC, V3, P499, DOI 10.1016/S0950-351X(89)80013-8; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; Verbalis JG, 2010, J BONE MINER RES, V25, P554, DOI 10.1359/jbmr.090827; Waikar SS, 2009, AM J MED, V122, P857, DOI 10.1016/j.amjmed.2009.01.027; WIJDICKS EFM, 1985, ANN NEUROL, V17, P137, DOI 10.1002/ana.410170206; WRIGHT DG, 1979, BRAIN, V102, P361, DOI 10.1093/brain/102.2.361; ZERBE R, 1980, ANNU REV MED, V31, P315, DOI 10.1146/annurev.me.31.020180.001531; Zilberberg MD, 2008, CURR MED RES OPIN, V24, P1601, DOI 10.1185/03007990802081675; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	97	18	19	0	0	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2077-0383		J CLIN MED	J. Clin. Med.	DEC	2014	3	4					1084	1104		10.3390/jcm3041084			21	Medicine, General & Internal	Emerging Sources Citation Index (ESCI)	General & Internal Medicine	V18NL	WOS:000214758000002	26237593	Green Published, gold, Green Submitted			2022-02-06	
J	Wang, CZ; Pahk, JB; Balaban, CD; Miller, MC; Wood, AR; Vipperman, JS				Wang, Chenzhi; Pahk, Jae Bum; Balaban, Carey D.; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.			Computational Study of Human Head Response to Primary Blast Waves of Five Levels from Three Directions	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; PATHOLOGY; EXPOSURE	Human exposure to blast waves without any fragment impacts can still result in primary blast-induced traumatic brain injury (bTBI). To investigate the mechanical response of human brain to primary blast waves and to identify the injury mechanisms of bTBI, a three-dimensional finite element head model consisting of the scalp, skull, cerebrospinal fluid, nasal cavity, and brain was developed from the imaging data set of a human female. The finite element head model was partially validated and was subjected to the blast waves of five blast intensities from the anterior, right lateral, and posterior directions at a stand-off distance of one meter from the detonation center. Simulation results show that the blast wave directly transmits into the head and causes a pressure wave propagating through the brain tissue. Intracranial pressure (ICP) is predicted to have the highest magnitude from a posterior blast wave in comparison with a blast wave from any of the other two directions with same blast intensity. The brain model predicts higher positive pressure at the site proximal to blast wave than that at the distal site. The intracranial pressure wave invariably travels into the posterior fossa and vertebral column, causing high pressures in these regions. The severities of cerebral contusions at different cerebral locations are estimated using an ICP based injury criterion. Von Mises stress prevails in the cortex with a much higher magnitude than in the internal parenchyma. According to an axonal injury criterion based on von Mises stress, axonal injury is not predicted to be a cause of primary brain injury from blasts.	[Wang, Chenzhi; Miller, Mark C.; Wood, Adam R.; Vipperman, Jeffrey S.] Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA; [Pahk, Jae Bum] Univ Pittsburgh, Dept Chem & Petr Engn, Pittsburgh, PA 15261 USA; [Balaban, Carey D.] Univ Pittsburgh, Pittsburgh, PA USA		Vipperman, JS (corresponding author), Univ Pittsburgh, Dept Mech Engn & Mat Sci, Pittsburgh, PA 15260 USA.	jsv@pitt.edu	Balaban, Carey/I-3467-2017; Balaban, Carey/O-6586-2019	Balaban, Carey/0000-0002-3570-3844; Balaban, Carey/0000-0002-3570-3844; Vipperman, Jeffrey/0000-0001-5585-954X	University of PittsburghUniversity of Pittsburgh; National Science Foundation (NSF)National Science Foundation (NSF); NSFNational Science Foundation (NSF) [1130289]; National Institute of Biomedical Imaging and BioEngineeringUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)	The authors gratefully acknowledge the University of Pittsburgh and National Science Foundation (NSF) for the funding support. This material is based upon work supported by the NSF under Grant No. 1130289. Thanks are also expressed for the MRI data obtained from The International Consortium for Brain Mapping (ICBM 2011). The ICBM project (Principal Investigator John Mazziotta, M.D, University of California, Los Angeles) is supported by the National Institute of Biomedical Imaging and BioEngineering. ICBM is the result of efforts of co-investigators from UCLA, Montreal Neurologic Institute, University of Texas at San Antonio, and the Institute of Medicine, Juelich/Heinrich Heine University - Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avidan V, 2005, AM J SURG, V190, P927, DOI 10.1016/j.amjsurg.2005.08.022; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Benzinger TLS, 2009, J NEUROTRAUM, V26, P2127, DOI [10.1089/neu.2009.0885, 10.1089/neu.2009-0885]; Chafi MS, 2010, ANN BIOMED ENG, V38, P490, DOI 10.1007/s10439-009-9813-z; Chen Y, 2011, BRAIN INJURY, V25, P641, DOI 10.3109/02699052.2011.580313; Cooper PW., 1996, EXPLOSIVES ENG; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Friedlander FG, 1976, WAVE EQUATION CURVED; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; Grujicic M, 2011, J MATER ENG PERFORM, V20, P877, DOI 10.1007/s11665-010-9724-z; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hoffer ME, 2013, PSYCHIAT ANN, V43, P318, DOI 10.3928/00485713-20130703-06; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hoffer ME, 2010, OTOL NEUROTOL, V31, P232, DOI 10.1097/MAO.0b013e3181c993c3; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kocsis JD, 2009, J REHABIL RES DEV, V46, P667, DOI 10.1682/JRRD.2008.08.0100; Lee E, 1973, JWL EQUATION STATE C; Lee E.L., 1968, ADIABATIC EXPANSION; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; MURTHY JMK, 1979, J NEUROSURG, V50, P260, DOI 10.3171/jns.1979.50.2.0260; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Nyein MK, 2010, P NATL ACAD SCI USA, V107, P20703, DOI 10.1073/pnas.1014786107; Rafaels K, 2011, J NEUROTRAUM, V28, P2319, DOI 10.1089/neu.2009.1207; Rogers GFC, 1980, THERMODYNAMIC TRANSP; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; Shattuck DW, 2002, MED IMAGE ANAL, V6, P129, DOI 10.1016/S1361-8415(02)00054-3; SHUCK LZ, 1972, J BASIC ENG-T ASME, V94, P905, DOI 10.1115/1.3425588; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wang C, 2011, P IMECE 2011; Wang C, 2012, P IMECE 2012; Ward C, 1980, P 24 STAPP CAR CRASH; Warden DL, 2005, J NEUROTRAUM, V22, P1178; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749	42	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2014	9	11							e113264	10.1371/journal.pone.0113264			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU3SG	WOS:000345533200085	25409326	Green Accepted, gold, Green Published			2022-02-06	
J	Jagnoor, J; Cameron, ID				Jagnoor, Jagnoor; Cameron, Ian D.			Traumatic brain injury - support for injured people and their carers	AUSTRALIAN FAMILY PHYSICIAN			English	Article						brain injuries; traumatic; rehabilitation; general practice		Background Traumatic brain injury (TBI) is a major cause of lifelong disability and death worldwide, but is considered a 'silent epidemic' as society is largely unaware of the magnitude of the problem. TBI is a complex injury with a broad spectrum of symptoms and disabilities. Patients with a TBI may have a range of physical, mental, cognitive and social problems. Objective This article provides a summary of the available evidence for assessing TBI and managing the common mental health, physical and cognitive/behavioural issues associated with TBI. Discussion Translational and clinical research has revealed that TBI can no longer be regarded as a single clinical entity with a defined outcome. Each type of injury can lead to a distinct clinical condition that requires careful assessment and appropriate management to reduce long-term disability. In this article we discuss some of the more common health issues related to TBI.	[Jagnoor, Jagnoor; Cameron, Ian D.] Univ Sydney, Royal N Shore Hosp, Rehabil Studies Unit, Kolling Inst, St Leonards, NSW 2065, Australia		Jagnoor, J (corresponding author), Univ Sydney, Royal N Shore Hosp, Rehabil Studies Unit, Kolling Inst, St Leonards, NSW 2065, Australia.	jagnoor.jagnoor@sydney.edu.au		jagnoor, Jagnoor/0000-0002-5276-9095			Ankri J, 2005, INT J GERIATR PSYCH, V20, P254, DOI 10.1002/gps.1275; Antony MM, 1998, PSYCHOL ASSESSMENT, V10, P176, DOI 10.1037/1040-3590.10.2.176; Arciniegas David B, 2005, Neuropsychiatr Dis Treat, V1, P311; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Finfer S, 2004, NEW ENGL J MED, V350, P2247; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Khan F, 2003, MED J AUSTRALIA, V178, P290, DOI 10.5694/j.1326-5377.2003.tb05199.x; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Niemela M, 2014, GEN HOSP PSYCHIAT, V36, P337, DOI 10.1016/j.genhosppsych.2013.12.012; NSW Government, CAR SUPP PATHW PEOPL; Pirkis Jane, 2005, Aust New Zealand Health Policy, V2, P8, DOI 10.1186/1743-8462-2-8; Ponsford J, 2004, BRAIN INJURY, V18, P603, DOI 10.1080/02699050310001646152; Ponsford J., 2012, TRAUMATIC BRAIN INJU, V2nd Edition; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rees PM, 2003, ARCH PHYS MED REHAB, V84, P1885, DOI 10.1016/j.apmr.2003.03.001; Ruff RM, 2011, NEUROREHABILITATION, V28, P167, DOI 10.3233/NRE-2011-0646; Schwartz L, 2003, J PEDIATR PSYCHOL, V28, P251, DOI 10.1093/jpepsy/jsg013; TEASDALE G, 1974, LANCET, V2, P81; TREVENA L, 2004, CLIN PRACTICE GUIDEL; UZZELL BP, 1996, RECOVERY TRAUMATIC B	29	18	19	0	5	ROYAL AUSTRALIAN COLLEGE GENERAL PRACTITIONERS	SOUTH MELBOURNE	1 PALMERSTON CRESCENT, SOUTH MELBOURNE, VICTORIA 3205, AUSTRALIA	0300-8495			AUST FAM PHYSICIAN	Aust. Fam. Physician	NOV	2014	43	11					758	763					6	Primary Health Care; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41WU	WOS:000209577100018	25393460				2022-02-06	
J	McKinlay, A; Grace, RC; McLellan, T; Roger, D; Clarbour, J; MacFarlane, MR				McKinlay, Audrey; Grace, Randolph C.; McLellan, Tracey; Roger, Derek; Clarbour, Jane; MacFarlane, Martin R.			Predicting Adult Offending Behavior for Individuals Who Experienced a Traumatic Brain Injury During Childhood	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						head injury; offending; outcomes; predictors; traumatic brain injury	PSYCHOSOCIAL OUTCOMES; HEAD-INJURY; NEUROPSYCHOLOGICAL FUNCTION; MENTAL-DISORDERS; CHILDREN; ADOLESCENTS; MILD; PREVALENCE; CRIMINALITY; PERFORMANCE	Objectives: To examine whether individuals who experienced a childhood traumatic brain injury (TBI) are at increased risk for subsequent offending behavior, to identify the emotional characteristics of adults who experienced childhood TBI, and to examine whether these predict offending behavior. Participants: Individuals from the Canterbury region who had experienced a childhood (<18 years of age) injury event and were now 18 years or older and more than 5 years postinjury (between 18 and 30 years of age). Three groups were formed: (1) moderate/severe TBI (n = 62); (2) mild TBI (n = 58); and (3) fracture control group (n = 38). Setting: University of Canterbury. Main Measures: A semistructured interview assessed lifetime involvement in offending behavior; the Emotional Behavior Scale measured internalizing and externalizing behaviors, including malevolent aggression, social anxiety, and social self-esteem. Results: Compared with controls, there was an increased risk of offending behavior (mild TBI: odds ratio = 8.7; moderate/severe TBI odds ratio = 20.4). Binary logistic regression analysis revealed that the strongest predictors of offending behavior were TBI status, higher levels of malevolent aggression, and age at injury. Conclusions: Individuals who experienced childhood TBI are at increased risk of offending behavior. Emotional behavior measures were useful predictors of offending behavior, offering opportunity for intervention.	[McKinlay, Audrey] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [McKinlay, Audrey; Grace, Randolph C.; McLellan, Tracey; Roger, Derek] Univ Canterbury, Dept Psychol, Christchurch 1, New Zealand; [Clarbour, Jane] Univ York, Dept Psychol, York YO10 5DD, N Yorkshire, England; [MacFarlane, Martin R.] Christchurch Hosp, Dept Neurosurg, Christchurch, New Zealand		McKinlay, A (corresponding author), Univ Melbourne, Melbourne Sch Psychol Sci, Melbourne, Vic 3010, Australia.	audrey.mckinlay@unimelb.edu.au		Grace, Randolph/0000-0003-1115-6089; McKinlay, Audrey/0000-0001-9846-8514	Health Research Council/Accident Compensation Corporation of New Zealand	Dr McKinlay was supported by a postdoctoral fellowship from the Health Research Council/Accident Compensation Corporation of New Zealand.	Anderson SW, 2000, DEV NEUROPSYCHOL, V18, P281, DOI 10.1207/S1532694202Anderson; Anderson V, 2005, BRAIN INJURY, V19, P699, DOI 10.1080/02699050400025281; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Catroppa C, 2007, J PEDIATR PSYCHOL, V32, P354, DOI 10.1093/jpepsy/jsl019; Clarbour J, 2004, J CHILD PSYCHOL PSYC, V45, P496, DOI 10.1111/j.1469-7610.2004.00240.x; Clarbour J, 2000, FORENSIC UPDATE, V62, P10; Clarbour J, 1999, P BRIT PSYCH SOC SOC; Clarbour J, 2001, BRIT PSYCH SOC DIV F; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; EWINGCOBBS L, 1986, J HEAD TRAUMA REHAB, V1, P57; Ferguson PL, 2012, J HEAD TRAUMA REHAB, V27, pE11, DOI 10.1097/HTR.0b013e31824e5f47; Fergusson DM, 1998, J EMOT BEHAV DISORD, V6, P2, DOI 10.1177/106342669800600101; Fergusson DM, 1997, J CHILD PSYCHOL PSYC, V38, P633, DOI 10.1111/j.1469-7610.1997.tb01690.x; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hawley CA, 2003, BRAIN INJURY, V17, P105, DOI 10.1080/0269905021000010131; Hawley CA, 2002, BRAIN INJURY, V16, P969, DOI 10.1080/02699050210147239; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Mangeot S, 2002, CHILD NEUROPSYCHOL, V8, P271, DOI 10.1076/chin.8.4.271.13503; Max JE, 1998, J AM ACAD CHILD PSY, V37, P841, DOI 10.1097/00004583-199808000-00014; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Max JE, 2004, DEV NEUROPSYCHOL, V25, P159, DOI 10.1207/s15326942dn2501&2_9; Max JE, 1998, BRAIN INJURY, V12, P41; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2002, J NEUROL NEUROSUR PS, V73, P281, DOI 10.1136/jnnp.73.3.281; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLellan T, 2013, BRAIN INJURY, V27, P1032, DOI 10.3109/02699052.2013.794965; Nelson H.E., 1991, NATL ADULT READING T, V2nd ed.; Schofield PW, 2006, BRAIN INJURY, V20, P499, DOI 10.1080/02699050600664749; Shaw P, 2005, J COGNITIVE NEUROSCI, V17, P1410, DOI 10.1162/0898929054985491; Shiroma EJ, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e3182571c14; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Soomro NH, 2012, PAK J SOC CLIN PSYCH, V10, P10; Tiihonen J, 1997, AM J PSYCHIAT, V154, P840; Timonen M, 2002, PSYCHIAT RES, V113, P217, DOI 10.1016/S0165-1781(02)00269-X; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Wall Sarah E, 2011, Clin Child Psychol Psychiatry, V16, P301, DOI 10.1177/1359104511401187; Warriner EM, 2003, J CLIN EXP NEUROPSYC, V25, P904, DOI 10.1076/jcen.25.7.904.16494; Williams H, 2010, TLS-TIMES LIT SUPPL, P20; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	42	18	18	0	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2014	29	6					507	513		10.1097/HTR.0000000000000000			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AT7LI	WOS:000345117800011	24263174				2022-02-06	
J	Porter, KK; Constantinidou, F; Marron, KH				Porter, Kelly Knollman; Constantinidou, Fofi; Marron, Kathleen Hutchinson			Speech-Language Pathology and Concussion Management in Intercollegiate Athletics: The Miami University Concussion Management Program	AMERICAN JOURNAL OF SPEECH-LANGUAGE PATHOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; SPORTS-RELATED CONCUSSION; HIGH-SCHOOL; NEUROCOGNITIVE PERFORMANCE; COLLEGIATE; IMPACT; SYMPTOMS; RECOVERY; STATEMENT; HISTORY	Purpose: The Miami University Concussion Management Program was established in 1999 to assess, manage, and monitor athletes who sustain concussions and experience neurobehavioral and neurocognitive symptoms secondary to their injury. The purpose of this article is to describe the established procedures of one of the oldest universitybased interdisciplinary concussion management programs that is coordinated by speech-language pathologists (SLP). Method: The theoretical and clinical underpinnings of baseline and postconcussion neurocognitive assessment and management procedures are discussed. Additionally, 2 illustrative case studies are presented to demonstrate the evolution and implementation of the interdisciplinary concussion management protocol and to present different patterns of concussion symptoms and recovery. Paper and computer-based neurocognitive assessment protocols are discussed and integrated in the case studies. Results/Conclusions: Successful management of sport-related concussion requires an interdisciplinary team that understands the unique neurobehavioral and neurocognitive symptoms associated with sports concussions. SLPs can play a valuable role on the interdisciplinary team in the prompt and appropriate management of postconcussion symptoms so that athletes can successfully return to their athletic, academic, and social activities.	[Porter, Kelly Knollman; Constantinidou, Fofi; Marron, Kathleen Hutchinson] Miami Univ, Oxford, OH 45056 USA; [Constantinidou, Fofi] Univ Cyprus, Nicosia, Cyprus		Porter, KK (corresponding author), Miami Univ, Oxford, OH 45056 USA.	knollmkk@miamioh.edu		Constantinidou, Fofi/0000-0002-7928-8363			Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Benton A., 1978, MULTILINGUAL APHASIA; Bernstein DM, 1999, BRAIN INJURY, V13, P151, DOI 10.1080/026990599121683; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Breed ST, 2004, ARCH PHYS MED REHAB, V85, pS61, DOI 10.1016/j.apmr.2003.08.115; Bruce JM, 2009, NEUROSURGERY, V64, P100, DOI 10.1227/01.NEU.0000336310.47513.C8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Cobb Sarah, 2004, J Sch Nurs, V20, P262; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 2004, STUD NEUROPSYCHOL DE, P111; Constantinidou F., 2005, ARCHIVES OF PHYSICAL, V86, pe13; Covassin T, 2008, J ATHL TRAINING, V43, P119, DOI 10.4085/1062-6050-43.2.119; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dashnaw ML, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.10.FOCUS12284; Devick S., 2010, KING DEVICK TEST; Duff M. C., 2009, ASHA LEADER; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Echemendia RJ, 2001, NEUROPSYCHOL REV, V11, P69, DOI 10.1023/A:1016651217141; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Granito V. J. Jr., 2001, Journal of Sport Behavior, V24, P63; Guilmette TJ, 2007, BRAIN INJURY, V21, P1039, DOI 10.1080/02699050701633080; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Heyanka DJ, 2013, INT J NEUROSCI, V123, P526, DOI 10.3109/00207454.2013.771261; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jotwani V, 2010, CURR SPORT MED REP, V9, P21, DOI 10.1249/JSR.0b013e3181ccb55e; Kelly JP, 2000, SEMIN NEUROL, V20, P165, DOI 10.1055/s-2000-9835; Klove H., 1963, LAFAYETTE INSTRUMENT; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Macleod AD, 2010, MED HYPOTHESES, V74, P1033, DOI 10.1016/j.mehy.2010.01.002; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; Marshall S, 2012, CAN FAM PHYSICIAN, V58, P257; McCrea M, 2013, BRIT J SPORT MED, V47, P272, DOI 10.1136/bjsports-2013-092145; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nideffer R. M., 2001, APPLIED SPORT PSYCHO, P321; Ptito A, 2007, NEUROREHABILITATION, V22, P217; Ravdin LD, 2003, CLIN J SPORT MED, V13, P21, DOI 10.1097/00042752-200301000-00005; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Salvatore AP, 2011, J MED SPEECH-LANG PA, V19, P1; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Smith A., 1980, SYMBOL DIGITS MODALI; Webbe FM, 2003, CLIN SPORT MED, V22, P577, DOI 10.1016/S0278-5919(02)00103-5; Wertheimer JC, 2008, J HEAD TRAUMA REHAB, V23, P273, DOI 10.1097/01.HTR.0000336840.76209.a1; [No title captured]	57	18	18	0	29	AMER SPEECH-LANGUAGE-HEARING ASSOC	ROCKVILLE	2200 RESEARCH BLVD, #271, ROCKVILLE, MD 20850-3289 USA	1058-0360	1558-9110		AM J SPEECH-LANG PAT	Am. J. Speech-Lang. Pathol.	NOV	2014	23	4					507	519		10.1044/2014_AJSLP-13-0126			13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	AU5ZR	WOS:000345682400002	25089035				2022-02-06	
J	Roach, JP; Acker, SN; Bensard, DD; Sirotnak, AP; Karrer, FM; Partrick, DA				Roach, Jonathan P.; Acker, Shannon N.; Bensard, Denis D.; Sirotnak, Andrew P.; Karrer, Frederick M.; Partrick, David A.			Head injury pattern in children can help differentiate accidental from non-accidental trauma	PEDIATRIC SURGERY INTERNATIONAL			English	Article						Child abuse; Abusive head trauma; Subdural hemorrhage; Diffuse axonal injury; Non-accidental trauma	BRAIN-INJURY; YOUNG-CHILDREN; ABUSE	Our aim was to define the radiographic findings that help differentiate abusive head trauma (AHT) from accidental head injury. Our trauma registry was queried for all children a parts per thousand currency sign5 years of age presenting with traumatic brain injury (TBI) from 1996-2011. Of 2,015 children with TBI, 71 % had accidental injury and 29 % had AHT. Children with AHT were more severely injured (ISS 22.1 vs 14.4; p < 0.0001) and had a higher mortality rate (15 vs 5 %; p < 0.0001). Patients with AHT had higher rates of diffuse axonal injury (14 vs 8 %; p < 0.0001) and subdural hemorrhage (76 vs 23 %; p < 0.0001). Children with accidental injury had higher rates of skull fractures (52 vs 21 %; p < 0.0001) and epidural hemorrhages (11 vs 3 %). AHT occurred in 29 % of children and resulted in increased mortality rates. These children had higher rates of subdural hemorrhages and diffuse axonal injury. Physicians initially evaluating injured children must maintain a high index of suspicion for abuse in those who present with subdural hematoma or diffuse axonal injury.	[Roach, Jonathan P.; Acker, Shannon N.; Karrer, Frederick M.; Partrick, David A.] Childrens Hosp Colorado, Dept Pediat Surg, Aurora, CO 80045 USA; [Bensard, Denis D.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; [Sirotnak, Andrew P.] Childrens Hosp Colorado, Kempe Child Protect Team, Aurora, CO 80045 USA		Acker, SN (corresponding author), Childrens Hosp Colorado, Dept Pediat Surg, 13123 E 16th Ave,B323, Aurora, CO 80045 USA.	shannon.acker@ucdenver.edu					Acker SN, 2014, J PEDIATR SURG, V49, P338, DOI 10.1016/j.jpedsurg.2013.10.008; Arbogast KB, 2005, PEDIATRICS, V116, P180, DOI 10.1542/peds.2004-2671; Barsness KA, 2003, J TRAUMA, V54, P1107, DOI 10.1097/01.TA.0000068992.01030.A8; Bonnier C, 2007, J CHILD NEUROL, V22, P519, DOI 10.1177/0883073807302604; Chang DC, 2004, J TRAUMA, V57, P1189, DOI 10.1097/01.TA.0000145076.05111.E1; Chiesa A, 2009, PEDIATR CLIN N AM, V56, P317, DOI 10.1016/j.pcl.2009.02.001; Ewing-Cobbs L, 1998, PEDIATRICS, V102, P300, DOI 10.1542/peds.102.2.300; Ewing-Cobbs L, 2000, CHILD NERV SYST, V16, P25, DOI 10.1007/s003810050006; Flaherty EG, 2005, PEDIATR ANN, V34, P349, DOI 10.3928/0090-4481-20050501-08; Fujiwara T, 2008, PEDIATRICS, V122, pE841, DOI 10.1542/peds.2008-0387; HAHN YS, 1983, CHILD BRAIN, V10, P229; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; KEMPE CH, 1962, JAMA-J AM MED ASSOC, V181, P17, DOI 10.1001/jama.1962.03050270019004; Oehmichen M, 2005, NEUROPEDIATRICS, V36, P240, DOI 10.1055/s-2005-872812; Roaten JB, 2006, J PEDIATR SURG, V41, P2013, DOI 10.1016/j.jpedsurg.2006.08.028; Tung GA, 2006, PEDIATRICS, V118, P626, DOI 10.1542/peds.2006-0130; Vinchon M, 2005, J NEUROSURG, V102, P380, DOI 10.3171/ped.2005.102.4.0380	17	18	19	0	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-0358	1437-9813		PEDIATR SURG INT	Pediatr. Surg. Int.	NOV	2014	30	11					1103	1106		10.1007/s00383-014-3598-3			4	Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics; Surgery	AS5UX	WOS:000344335900003	25252922				2022-02-06	
J	Smedema, SM				Smedema, Susan Miller			Core Self-Evaluations and Well-Being in Persons With Disabilities	REHABILITATION PSYCHOLOGY			English	Article						core self-evaluation; subjective well-being; persons with disabilities	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; POSITIVE PSYCHOLOGY; JOB-SATISFACTION; SOCIAL SUPPORT; EFFICACY; PEOPLE; ESTEEM; HEALTH; NEUROTICISM	Purpose: The purpose of this article is to introduce the concept of core self-evaluations (CSE), which is conceptualized as the overall, fundamental perception that individuals have about their worth and capability as people (Judge, Locke, Durham, & Kluger, 1998). CSE is a higher order variable that is reflective of the self-concept and comprises personality traits including self-esteem, generalized self-efficacy, locus of control, and emotional stability. Method: In this article, the theoretical background of the CSE construct is reviewed, the existing literature on CSE in the general population is summarized, and future directions for the use of CSE in rehabilitation psychology research and clinical settings is proposed. Implications: CSE has great potential as a global positive contributor of well-being in persons with disabilities, and research addressing its relationship with outcomes such as well-being and its clinical applications has great promise to augment rehabilitation psychology practice in the future.	[Smedema, Susan Miller] Univ Wisconsin, Madison, WI 53706 USA		Smedema, SM (corresponding author), Univ Wisconsin, Dept Rehabil Psychol & Special Educ, 1000 Bascom Mall,Room 419, Madison, WI 53706 USA.	ssmedema@wisc.edu					BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI; Barone D., 1997, SOCIAL COGNITIVE PSY, DOI DOI 10.1007/978-1-4615-5843-9; Berry JW, 2007, J PERS ASSESS, V89, P292, DOI 10.1080/00223890701629813; BOLGER N, 1991, J PERS, V59, P355, DOI 10.1111/j.1467-6494.1991.tb00253.x; Burns RB., 1979, SELF CONCEPT THEORY; Chan F, 2009, REHABIL COUNS BULL, V52, P114, DOI 10.1177/0034355208323947; Chang CH, 2012, J MANAGE, V38, P81, DOI 10.1177/0149206311419661; Chronister J, 2013, J COMMUNITY PSYCHOL, V41, P582, DOI 10.1002/jcop.21558; Coopersmith, 1967, ANTECEDENTS SELF EST; COSTA PT, 1988, J PERS SOC PSYCHOL, V55, P258, DOI 10.1037/0022-3514.55.2.258; Csikszentmihalyi M, 2000, BOREDOM ANXIETY; Devereux PG, 2005, QUAL HEALTH RES, V15, P1360, DOI 10.1177/1049732305282200; Diener E, 2005, HDB POSITIVE PSYCHOL, P63; Dunn DS, 2005, REHABIL PSYCHOL, V50, P305, DOI 10.1037/0090-5550.50.3.305; Endermann M, 2009, SEIZURE-EUR J EPILEP, V18, P167, DOI 10.1016/j.seizure.2008.08.013; Eysenck H.J., 1990, HDB PERSONALITY THEO, P244; Eysenck HJ, 1975, MANUAL EYSENCK PERSO; Ferris DL, 2011, PERS PSYCHOL, V64, P137, DOI 10.1111/j.1744-6570.2010.01204.x; GARSKE GG, 1992, REHABIL COUNS BULL, V36, P44; Gomez V, 2012, J RES PERS, V46, P317, DOI 10.1016/j.jrp.2012.03.001; Hampton NZ, 2004, REHABIL COUNS BULL, V48, P31, DOI 10.1177/00343552040480010401; Hampton NZ, 2000, REHABIL COUNS BULL, V43, P66; HEINEMANN AW, 1982, REHABIL COUNS BULL, V25, P197; HEPPNER PP, 2005, HDB POSITIVE PSYCHOL, P288; James W., 1890, PRINCIPLES PSYCHOL, DOI [10.1037/11059-000, DOI 10.1037/11059-000]; Johnson RE, 2011, J APPL PSYCHOL, V96, P744, DOI 10.1037/a0021504; Judge TA, 1997, RES ORGAN BEHAV, V19, P151; Judge TA, 2005, J APPL PSYCHOL, V90, P257, DOI 10.1037/0021-9010.90.2.257; Judge TA, 1998, J APPL PSYCHOL, V83, P17, DOI 10.1037/0021-9010.83.1.17; Judge TA, 2003, PERS PSYCHOL, V56, P303, DOI 10.1111/j.1744-6570.2003.tb00152.x; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Judge TA, 2000, J APPL PSYCHOL, V85, P237, DOI 10.1037//0021-9010.85.2.237; Kammeyer-Mueller JD, 2009, J APPL PSYCHOL, V94, P177, DOI 10.1037/a0013214; Krause JS, 1998, REHABIL COUNS BULL, V41, P162; Kreuter M, 1998, SPINAL CORD, V36, P252, DOI 10.1038/sj.sc.3100592; Levenson H, 1981, RES LOCUS CONTROL CO, V1, P15; Li L, 1998, J SOC PSYCHOL, V138, P13, DOI 10.1080/00224549809600349; Linkowski D. C., 1974, REHABILITATION COUNS, V17, P28; Livneh H, 2005, J COUNS DEV, V83, P12, DOI 10.1002/j.1556-6678.2005.tb00575.x; Livneh HF, 1997, PSYCHOSOCIAL ADAPTAT; Maddux J., 2005, HDB POSITIVE PSYCHOL, P277; Maddux JE., 1995, SELF EFFICACY, P143, DOI [10.1007/978-1-4419-6868-5_5, DOI 10.1007/978-1-4419-6868-5_5]; MARINI I, 1995, REHABIL COUNS BULL, V38, P198; Marshak L.E., 1993, COUNSELING PERSONS P; Martz E., 2000, J APPL REHABILITATIO, V31, P14; MEHNERT T, 1990, REHABIL PSYCHOL, V35, P3, DOI 10.1037/0090-5550.35.1.3; Miller SM, 2009, DISABIL REHABIL, V31, P988, DOI 10.1080/09638280802378025; Nosek MA, 2003, SOC SCI MED, V56, P1737, DOI 10.1016/S0277-9536(02)00169-7; Nosek MA, 2001, J REHABIL, V67, P20; Packer E., 1985, OBJECTIVIST FORUM, V6, P1; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Post MWM, 1997, SPINAL CORD, V35, P109, DOI 10.1038/sj.sc.3100362; Reich J. W., 1997, HDB HLTH BEHAV RES, P93; Roessler R. T., 1978, PSYCHOSOCIAL ADJUSTM; Rosenberg M., 1979, CONCEIVING SELF; Rosenberg M., 1965, SOC ADOLESCENT SELF; ROTTER JB, 1966, PSYCHOL MONOGRAPHS, V0080; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.55.1.5; SHADISH WR, 1981, J CONSULT CLIN PSYCH, V49, P297, DOI 10.1037/0022-006X.49.2.297; Shnek ZM, 1997, ANN BEHAV MED, V19, P287, DOI 10.1007/BF02892293; Smedema SM, 2010, REHABIL COUNS BULL, V53, P131, DOI 10.1177/0034355209358272; Steel P, 2008, PSYCHOL BULL, V134, P138, DOI 10.1037/0033-2909.134.1.138; Tsaousis I, 2007, PERS INDIV DIFFER, V42, P1441, DOI 10.1016/j.paid.2006.10.025; Turner K. D., 1990, J REHABIL, V46, P19; Wells LE, 1976, SELF ESTEEM ITS CONC; Williams S.L., 1995, SELF EFFICACY ADAPTI, P69, DOI DOI 10.1007/978-1-4419-6868-5_3; World Health Organization, 2007, INT CLASS FUNCT DIS; Wright BA., 1983, PHYS DISABILITY PSYC; WRIGHT BA, 1960, PHYS DISABILITY PSYC; ZUROFF DC, 1980, J PERS SOC PSYCHOL, V39, P130, DOI 10.1037/0022-3514.39.1.130; [No title captured]	73	18	18	1	36	EDUCATIONAL PUBLISHING FOUNDATION-AMERICAN PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST, NE, WASHINGTON, DC 20002-4242 USA	0090-5550	1939-1544		REHABIL PSYCHOL	Rehabil. Psychol.	NOV	2014	59	4					407	414		10.1037/rep0000013			8	Psychology, Clinical; Rehabilitation	Social Science Citation Index (SSCI)	Psychology; Rehabilitation	AT8BQ	WOS:000345159200005	25383725				2022-02-06	
J	Raj, R; Siironen, J; Kivisaari, R; Hernesniemi, J; Skrifvars, MB				Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Hernesniemi, Juha; Skrifvars, Markus B.			Predicting Outcome after Traumatic Brain Injury: Development of Prognostic Scores Based on the IMPACT and the APACHE II	JOURNAL OF NEUROTRAUMA			English	Article						APACHE II; external validation; IMPACT; outcome; prognostic models; traumatic brain injury	CLINICAL-RESEARCH; CARE; MORTALITY; SEVERITY; VALIDATION; CLASSIFICATION; EPIDEMIOLOGY; PERFORMANCE; IMPROVEMENT; QUALITY	Prediction models are important tools for heterogeneity adjustment in clinical trials and for the evaluation of quality of delivered care to patients with traumatic brain injury (TBI). We sought to improve the predictive performance of the IMPACT (International Mission for Prognosis and Analysis of Clinical Trials) prognostic model by combining it with the APACHE II (Acute Physiology and Chronic Health Evaluation II) for 6-month outcome prediction in patients with TBI treated in the intensive care unit. A total of 890 patients with TBI admitted to a large urban level 1 trauma center in 2009-2012 comprised the study population. The IMPACT and the APACHE II scores were combined using binary logistic regression. A randomized, split-sample technique with secondary bootstrapping was used for model development and internal validation. Model performance was assessed by discrimination (by area under the curve [ AUC]), calibration, precision, and net reclassification improvement (NRI). Overall 6-month mortality was 22% and unfavorable neurological outcome 47%. The predictive power of the new combined IMPACT-APACHE II models was significantly superior, compared to the original IMPACT models (AUC, 0.81-0.82 vs. 0.84-0.85; p < 0.05) for 6-month mortality prediction, but not for unfavorable outcome prediction (AUC, 0.81-0.82 vs. 0.83; p > 0.05). However, NRI showed a significant improvement in risk stratification of patients with unfavorable outcome by the IMPACT-APACHE II models, compared to the original models (NRI, 5.4-23.2%; p < 0.05). Internal validation using split-sample and resample bootstrap techniques yielded equivalent results, indicating low grade of overestimation. Our findings show that by combining the APACHE II with the IMPACT, improved 6-month outcome predictive performance is achieved. This may be applicable for heterogeneity adjustment in forthcoming TBI studies.	[Raj, Rahul; Siironen, Jari; Kivisaari, Riku; Hernesniemi, Juha] Helsinki Univ Hosp, Dept Neurosurg, Helsinki 00029, Finland; [Skrifvars, Markus B.] Helsinki Univ Hosp, Dept Intens Care, Helsinki 00029, Finland		Raj, R (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB-266, Helsinki 00029, Finland.	rahul.br.raj@icloud.com	Raj, Rahul/K-7693-2012	Raj, Rahul/0000-0003-4243-9591	Helsinki University Hospital EVO grant [TYH2012142]; Medicinska Understodsforeningen Liv och Halsa; Maire Taponen foundation	The study was funded by a Helsinki University Hospital EVO grant (TYH2012142), Medicinska Understodsforeningen Liv och Halsa and by the Maire Taponen foundation. The authors express their gratitude to Jaakko Lappalainen (MD, PhD) and Professor Per Rosenberg (MD, PhD) for their valuable comments on the manuscript and to Giovanni Nattino (IRCCS-Istituto di Ricerche Farmacologiche "Mario Negri" Laboratory of Clinical Epidemiology) and Tuomas Selander (Science Service Center, Kuopio University Hospital) for their statistical assistance.	Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Finazzi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016110; Hemmila MR, 2010, J TRAUMA, V68, P253, DOI 10.1097/TA.0b013e3181cfc8e6; HILDEN J, 1978, METHOD INFORM MED, V17, P238; JENNETT B, 1975, LANCET, V1, P480; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Khuri SF, 2002, ARCH SURG-CHICAGO, V137, P20, DOI 10.1001/archsurg.137.1.20; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Kundu S, 2011, EUR J EPIDEMIOL, V26, P261, DOI 10.1007/s10654-011-9567-4; Le Gall JR, 2005, INTENS CARE MED, V31, P1618, DOI 10.1007/s00134-005-2825-8; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 2006, LANCET NEUROL, V5, P38, DOI 10.1016/S1474-4422(05)70253-2; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Papa L, 2013, J NEUROTRAUM, V30, P324, DOI 10.1089/neu.2012.2545; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; PICARD RR, 1990, AM STAT, V44, P140, DOI 10.2307/2684155; Pouw ME, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5913; Raj R, 2014, CRIT CARE, V18, DOI 10.1186/cc13814; Raj R, 2013, NEUROSURGERY, V73, P305, DOI 10.1227/01.neu.0000430326.40763.ec; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Seshan VE, 2013, STAT MED, V32, P1483, DOI 10.1002/sim.5648; Shann F, 2000, BRIT MED J, V320, P714, DOI 10.1136/bmj.320.7236.714; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Vassar MJ, 1999, J TRAUMA, V47, P324, DOI 10.1097/00005373-199908000-00017; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Weir J, 2012, J NEUROTRAUM, V29, P53, DOI 10.1089/neu.2011.2137	44	18	19	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1721	1732		10.1089/neu.2014.3361			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200005	24836936	Green Published			2022-02-06	
J	Vonder Haar, C; Maass, WR; Jacobs, EA; Hoane, MR				Vonder Haar, Cole; Maass, William R.; Jacobs, Eric A.; Hoane, Michael R.			Deficits in Discrimination after Experimental Frontal Brain Injury Are Mediated by Motivation and Can Be Improved by Nicotinamide Administration	JOURNAL OF NEUROTRAUMA			English	Article						animal models; controlled cortical impact; operant learning	CORTICAL CONTUSION INJURY; FUNCTIONAL RECOVERY; PREFRONTAL CORTEX; DECISION-MAKING; SELF-AWARENESS; LONG-TERM; RATS; BEHAVIOR; IMPACT; MOTOR	One of the largest challenges in experimental neurotrauma work is the development of models relevant to the human condition. This includes both creating similar pathophysiology as well as the generation of relevant behavioral deficits. Recent studies have shown that there is a large potential for the use of discrimination tasks in rats to detect injury-induced deficits. The literature on discrimination and TBI is still limited, however. The current study investigated motivational and motor factors that could potentially contribute to deficits in discrimination. In addition, the efficacy of a neuroprotective agent, nicotinamide, was assessed. Rats were trained on a discrimination task and motivation task, given a bilateral frontal controlled cortical impact TBI (+ 3.0 AP, 0.0 ML from bregma), and then reassessed. They were also assessed on motor ability and Morris water maze (MWM) performance. Experiment 1 showed that TBI resulted in large deficits in discrimination and motivation. No deficits were observed on gross motor measures; however, the vehicle group showed impairments in fine motor control. Both injured groups were impaired on the reference memory MWM, but only nicotinamide-treated rats were impaired on the working memory MWM. Nicotinamide administration improved performance on discrimination and motivation measures. Experiment 2 evaluated retraining on the discrimination task and suggested that motivation may be a large factor underlying discrimination deficits. Retrained rats improved considerably on the discrimination task. The tasks evaluated in this study demonstrate robust deficits and may improve the detection of pharmaceutical effects by being very sensitive to pervasive cognitive deficits that occur after frontal TBI.	[Vonder Haar, Cole; Maass, William R.; Jacobs, Eric A.; Hoane, Michael R.] So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, Ctr Integrated Res Cognit & Neural Sci, Carbondale, IL 62901 USA		Hoane, MR (corresponding author), So Illinois Univ, Dept Psychol, Restorat Neurosci Lab, MC 6502, Carbondale, IL 62901 USA.	mhoane@siu.edu		Vonder Haar, Cole/0000-0001-7949-2068; Hoane, Michael/0000-0001-7779-2657	SIUC Graduate School; SIUC Department of Psychology; SIUC Graduate and Professional Student Council	The authors would like to thank Travis Smith and Charles Frye for their assistance in this research. This work was funded in part by the SIUC Graduate School, SIUC Department of Psychology and the SIUC Graduate and Professional Student Council.	Anderson GD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00021; Andersson S, 2002, NEUROPSY NEUROPSY BE, V15, P184, DOI 10.1097/01.WNN.0000026596.88167.8E; [Anonymous], 2010, TRAUM BRAIN INJ US; Bauer DJ, 2011, NEUROBIOL LEARN MEM, V95, P166, DOI 10.1016/j.nlm.2010.12.009; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920; Clark L, 2004, BRAIN COGNITION, V55, P41, DOI 10.1016/s0278-2626(03)00284-7; COGGESHALL RE, 1992, TRENDS NEUROSCI, V15, P9, DOI 10.1016/0166-2236(92)90339-A; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; de Bruin JPC, 2001, NEUROBIOL LEARN MEM, V75, P164, DOI 10.1006/nlme.2000.3962; Fleming JM, 1996, BRAIN INJURY, V10, P1; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; GORMAN LK, 1993, BRAIN RES, V614, P29, DOI 10.1016/0006-8993(93)91014-J; Haar CV, 2011, BEHAV BRAIN RES, V224, P311, DOI 10.1016/j.bbr.2011.06.009; Hoane MR, 2008, NEUROSCIENCE, V154, P861, DOI 10.1016/j.neuroscience.2008.04.044; Hoane MR, 2006, J NEUROTRAUM, V23, P1535, DOI 10.1089/neu.2006.23.1535; Hoane MR, 2003, J NEUROTRAUM, V20, P1189, DOI 10.1089/089771503770802871; HOFFMAN SW, 1994, J NEUROTRAUM, V11, P417, DOI 10.1089/neu.1994.11.417; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jorge R, 2003, INT REV PSYCHIATR, V15, P317, DOI 10.1080/09540260310001606700; Klaidman L, 2003, PHARMACOLOGY, V69, P150, DOI 10.1159/000072668; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446; Martens KM, 2013, JOVE-J VIS EXP, DOI 10.3791/50033; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; McIntosh TK, 1989, J NEUROTRAUM, V6, P247, DOI 10.1089/neu.1989.6.247; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Peterson TC, 2012, J NEUROTRAUM, V29, P2823, DOI 10.1089/neu.2012.2471; Port A, 2002, BRAIN INJURY, V16, P277, DOI 10.1080/02699050110103274; Powell JH, 1996, J NEUROL NEUROSUR PS, V60, P416, DOI 10.1136/jnnp.60.4.416; Richardson NR, 1996, J NEUROSCI METH, V66, P1, DOI 10.1016/0165-0270(95)00153-0; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Skinner B. F., 1957, SCHEDULES REINFORCEM; Stafford D, 1998, J EXP ANAL BEHAV, V70, P123, DOI 10.1901/jeab.1998.70-123; Swan AA, 2011, J NEUROTRAUM, V28, P431, DOI 10.1089/neu.2010.1519; Temel Y, 2005, EXP NEUROL, V193, P43, DOI 10.1016/j.expneurol.2004.12.025; Temel Y, 2006, NEUROSCI LETT, V406, P138, DOI 10.1016/j.neulet.2006.07.036; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vonder Haar C, 2013, CLIN PHARM BIOPHAR S, VS1; Vonder Haar C, 2014, BRAIN INJURY, V28, P235, DOI 10.3109/02699052.2013.860473; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Zhao ZR, 2012, J NEUROTRAUM, V29, P2475, DOI 10.1089/neu.2012.2511	50	18	18	0	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2014	31	20					1711	1720		10.1089/neu.2014.3459			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	AP8BF	WOS:000342302200004	24934504	Green Published			2022-02-06	
J	Johnson, U; Lewen, A; Ronne-Engstrom, E; Howells, T; Enblad, P				Johnson, Ulf; Lewen, Anders; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per			Should the Neurointensive Care Management of Traumatic Brain Injury Patients be Individualized According to Autoregulation Status and Injury Subtype?	NEUROCRITICAL CARE			English	Article						Cerebral perfusion pressure; Cerebrovascular pressure autoregulation; Head injury; Outcome	CEREBRAL-BLOOD-FLOW; CEREBROVASCULAR PRESSURE REACTIVITY; HEAD-INJURY; CRITICAL THRESHOLDS; PERFUSION-PRESSURE; HYPEREMIA; EDEMA; THERAPY	The status of autoregulation is an important prognostic factor in traumatic brain injury (TBI), and is important to consider in the management of TBI patients. Pressure reactivity index (PRx) is a measure of autoregulation that has been thoroughly studied, but little is known about its variation in different subtypes of TBI. In this study, we examined the impact of PRx and cerebral perfusion pressure (CPP) on outcome in different TBI subtypes. 107 patients were retrospectively studied. Data on PRx, CPP, and outcome were collected from our database. The first CT scan was classified according to the Marshall classification system. Patients were assigned to "diffuse" (Marshall class: diffuse-1, diffuse-2, and diffuse-3) or "focal" (Marshall class: diffuse-4, evacuated mass lesion, and non-evacuated mass lesion) groups. 2 x 2 tables were constructed calculating the proportions of favorable/unfavorable outcome at different combinations of PRx and CPP. Low PRx was significantly associated with favorable outcome in the combined group (p = 0.002) and the diffuse group (p = 0.04), but not in the focal group (p = 0.06). In the focal group higher CPP values were associated with worse outcome (p = 0.02). In diffuse injury patients with disturbed autoregulation (PRx > 0.1), CPP > 70 mmHg was associated with better outcome (p = 0.03). TBI patients with diffuse injury may differ from those with mass lesions. In the latter higher levels of CPP may be harmful, possibly due to BBB disruption. In TBI patients with diffuse injury and disturbed autoregulation higher levels of CPP may be beneficial.	[Johnson, Ulf; Lewen, Anders; Ronne-Engstrom, Elisabeth; Howells, Tim; Enblad, Per] Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden		Johnson, U (corresponding author), Univ Uppsala Hosp, Dept Neurosci, Neurosurg Sect, S-75185 Uppsala, Sweden.	ulf.johnson@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Johnson, Ulf/0000-0002-3879-6476			AASLID R, 1989, STROKE, V20, P45, DOI 10.1161/01.STR.20.1.45; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Brady KM, 2009, PEDIATRICS, V124, pE1205, DOI 10.1542/peds.2009-0550; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS59, DOI 10.1089/neu.2007.9990; Budohoski KP, 2012, NEUROSURGERY, V71, P652, DOI 10.1227/NEU.0b013e318260feb1; Caricato A, 2012, CRIT CARE MED, V40, P2526, DOI 10.1097/CCM.0b013e318256b9af; Chieregato A, 2005, ACTA NEUROCHIR SUPPL, V95, P159; Chieregato A, 2009, NEUROSURGERY, V64, P705, DOI 10.1227/01.NEU.0000341872.17024.44; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Czosnyka M, 2009, NEUROCRIT CARE, V10, P373, DOI 10.1007/s12028-008-9175-7; Dengler J, 2013, NEUROCRIT CARE, V19, P74, DOI 10.1007/s12028-012-9686-0; DESALLES AAF, 1987, NEUROSURGERY, V21, P45, DOI 10.1227/00006123-198707000-00009; Dias C, 2014, NEUROCRIT CARE, V21, P124, DOI 10.1007/s12028-013-9918-y; Elf K, 2005, NEUROSURGERY, V56, P962, DOI 10.1227/01.NEU.0000158317.00603.40; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; JENNETT B, 1975, LANCET, V1, P480; Johnson U, 2010, NEUROSURGERY, V68, P21; Johnson U, 2011, NEUROSURGERY, V68, P714, DOI 10.1227/NEU.0b013e3182077313; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Kelly DF, 1996, J NEUROSURG, V85, P762, DOI 10.3171/jns.1996.85.5.0762; Lang EW, 2000, BRIT J NEUROSURG, V14, P117; MACFARLANE R, 1991, J NEUROSURG, V75, P845, DOI 10.3171/jns.1991.75.6.0845; Marmarou A, 2006, ACTA NEUROCHIR SUPPL, V96, P24; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; Ojha BK, 2005, SURG NEUROL, V64, P174, DOI 10.1016/j.surneu.2004.11.030; Panerai RB, 2004, BRIT J NEUROSURG, V18, P471, DOI 10.1080/02688690400012343; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; Sanchez-Porras R, 2012, ACTA NEUROCHIR, V154, P1575, DOI 10.1007/s00701-012-1423-0; SMIELEWSKI P, 1995, ULTRASOUND MED BIOL, V21, P599, DOI 10.1016/0301-5629(94)00154-6; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2003, STROKE, V34, P2404, DOI 10.1161/01.STR.0000089014.59668.04; Wei XE, 2012, J NEUROTRAUM, V29, P2413, DOI 10.1089/neu.2010.1510; Wei XE, 2011, J TRAUMA, V71, P1645, DOI 10.1097/TA.0b013e31823498eb; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zweifel C, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E2	38	18	18	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2014	21	2					259	265		10.1007/s12028-014-9954-2			7	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AQ9AR	WOS:000343132900013	24515639				2022-02-06	
J	Lorente, L; Martin, MM; Gonzalez-Rivero, AF; Ramos, L; Argueso, M; Caceres, JJ; Sole-Violan, J; Serrano, N; Rodriguez, ST; Jimenez, A; Borreguero-Leon, JM				Lorente, Leonardo; Martin, Maria M.; Gonzalez-Rivero, Agustin F.; Ramos, Luis; Argueso, Monica; Caceres, Juan J.; Sole-Violan, Jordi; Serrano, Nicolas; Rodriguez, Sergio T.; Jimenez, Alejandro; Borreguero-Leon, Juan M.			Serum soluble CD40 Ligand levels are associated with severity and mortality of brain trauma injury patients	THROMBOSIS RESEARCH			English	Article						sCD40L; Brain trauma; Patients; Mortality; Injury	TISSUE FACTOR; ENDOTHELIAL-CELLS; INFLAMMATION; EXPRESSION; PLATELETS; INVOLVEMENT; THROMBOSIS; DISEASE; EVENTS	Background: Serum soluble CD40 Ligand (sCD40L) levels, which exhibit prothrombotic and proinflammatory properties, have not been studied in patients with traumatic brain injury (TBI). Thus, the objective of this study was to determine whether serum sCD40L levels are associated with severity and mortality in patients with severe TBI. Methods: This was a prospective, observational and multicenter study carried out in six Spanish Intensive Care Units. Patients with severe TBI defined as Glasgow Coma Scale (GCS) lower than 9 were included, while those with Injury Severity Score (ISS) in non-cranial aspects higher than 9 were excluded. Serum levels of sCD40L were measured on the day of TBI. Endpoint was established in 30-day mortality. Results: We found higher serum sCD40L levels (P < 0.001) in non-surviving TBI patients (N = 27) than in survivor ones (N = 73). Logistic regression analysis showed that serum sCD40L levels were associated with 30-day mortality (OR = 1.58; 95% CI = 1.12-2.21; P = 0.008) controlling for APACHE-II score and computer tomography findings. The area under the curve (AUC) for serum sCD40L levels as predictor of 30-day mortality was 0.79 (95% CI = 0.70-0.86; P < 0.001). Survival analysis showed that patients with serum sCD40L levels higher than 2.11 ng/mL presented increased 30-day mortality than patients with lower levels (Hazard ratio = 9.0; 95% CI = 4.25-19.27; P < 0.001). We found an association between serum sCD40L levels and APACHE-II (rho = 0.33; P = 0.001), and GCS score (rho = -0.21; P = 0.04). Conclusions: To our knowledge, this is the first study reporting data on serum sCD40L levels in patients with severe TBI. The most relevant and newer findings of our study are that serum sCD40L levels in non-surviving patients with severe TBI are higher than in surviving ones, and that there are an association between serum sCD40L levels and TBI severity and mortality. (C) 2014 Elsevier Ltd. All rights reserved.	[Lorente, Leonardo; Serrano, Nicolas] Hosp Univ Canarias, Intens Care Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Martin, Maria M.; Rodriguez, Sergio T.] Hosp Univ Nuestra Senora Candelaria, Intens Care Unit, Santa Cruz De Tenerife 38010, Spain; [Gonzalez-Rivero, Agustin F.; Borreguero-Leon, Juan M.] Hosp Univ Canarias, Lab Deparment, San Cristobal la Laguna 38320, Santa Cruz De T, Spain; [Ramos, Luis] Hosp Gen La Palma, Intens Care Unit, Brena Alta, La Palma, Spain; [Argueso, Monica] Hosp Clin Univ Valencia, Intens Care Unit, Valencia 46004, Spain; [Caceres, Juan J.] Hosp Insular, Intens Care Unit, Las Palmas Gran Canaria 35016, Spain; [Sole-Violan, Jordi] Hosp Univ Dr Negrin, Intens Care Unit, Las Palmas Gran Canaria 35010, Spain; [Jimenez, Alejandro] Hosp Univ Canarias, Res Unit, San Cristobal la Laguna 38320, Santa Cruz De T, Spain		Lorente, L (corresponding author), Hosp Univ Canarias, Intens Care Unit, Ofra S-N, San Cristobal la Laguna 38320, Santa Cruz De T, Spain.	lorentemartin@msn.com		Argueso, Monica/0000-0001-5917-1056; Borreguero Leon, Juan Maria/0000-0001-7414-5278; Rodriguez Ramos, Sergio/0000-0003-1635-3604	Instituto de Salud Carlos III (Madrid, Spain)Instituto de Salud Carlos III [I3SNS-INT-11-063, I3SNS-INT-12-087]; Fondo Europeo de Desarrollo Regional (FEDER)European Commission	This study was supported, in part, by grants from Instituto de Salud Carlos III (I3SNS-INT-11-063 and I3SNS-INT-12-087) (Madrid, Spain) and co-financed with Fondo Europeo de Desarrollo Regional (FEDER).	Anand SX, 2003, THROMB HAEMOSTASIS, V90, P377, DOI 10.1160/TH03-05-0268; Andre P, 2002, NAT MED, V8, P247, DOI 10.1038/nm0302-247; Antoniades C, 2009, J AM COLL CARDIOL, V54, P669, DOI 10.1016/j.jacc.2009.03.076; Aukrust P, 2004, J AM COLL CARDIOL, V43, P2326, DOI 10.1016/j.jacc.2004.03.023; Aukrust P, 1999, CIRCULATION, V100, P614, DOI 10.1161/01.CIR.100.6.614; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Davi G, 2009, J ATHEROSCLER THROMB, V16, P707; Dominguez-Rodriguez A, 2007, THROMB RES, V121, P293, DOI 10.1016/j.thromres.2007.04.007; Ferro D, 2007, ARTERIOSCL THROM VAS, V27, P2763, DOI 10.1161/ATVBAHA.107.152777; Ferroni P, 2007, CURR MED CHEM, V14, P2170; Garlichs CD, 2003, STROKE, V34, P1412, DOI 10.1161/01.STR.0000074032.64049.47; Hamdan Righab, 2011, J Med Liban, V59, P65; Han SH, 2007, ATHEROSCLEROSIS, V190, P205, DOI 10.1016/j.atherosclerosis.2006.01.021; Hezi-Yamit A, 2005, P NATL ACAD SCI USA, V102, P12077, DOI 10.1073/pnas.0504526102; Kleinbaum D. G., 1998, APPL REGRESSION ANAL, P281; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Li J, 2004, CLIN CHEM, V50, P1696, DOI 10.1373/clinchem.2003.030940; Lorente L, 2011, CRIT CARE, V15, DOI 10.1186/cc10104; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lukasik M, 2012, PLATELETS, V23, P132, DOI 10.3109/09537104.2011.597528; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Mao De-Jun, 2011, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V27, P177; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; de Lizarrondo SM, 2012, ARTERIOSCL THROM VAS, V32, P1477, DOI 10.1161/ATVBAHA.112.248773; Miller DL, 1998, J LEUKOCYTE BIOL, V63, P373, DOI 10.1002/jlb.63.3.373; NOELLE RJ, 1992, P NATL ACAD SCI USA, V89, P6550, DOI 10.1073/pnas.89.14.6550; Prasad KSS, 2003, P NATL ACAD SCI USA, V100, P12367, DOI 10.1073/pnas.2032886100; Rovegno M, 2012, MED INTENSIVA, V36, P37, DOI 10.1016/j.medin.2011.06.008; Shantsila E, 2009, THROMB HAEMOSTASIS, V102, P916, DOI 10.1160/TH09-01-0023; Sivro A, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-42; Slupsky JR, 1998, THROMB HAEMOSTASIS, V80, P1008; TEASDALE G, 1974, LANCET, V2, P81; Varo N, 2003, CIRCULATION, V108, P1049, DOI 10.1161/01.CIR.0000088521.04017.13; Weber M, 2006, CLIN CHEM, V52, P888, DOI 10.1373/clinchem.2005.062083; Wible EF, 2010, NEUROTHERAPEUTICS, V7, P62, DOI 10.1016/j.nurt.2009.11.003; Zhao W, 2014, CHINESE MED J-PEKING, V127, P2218, DOI 10.3760/cma.j.issn.0366-6999.20133159; Zhou L, 1998, THROMB HAEMOSTASIS, V79, P1025	39	18	20	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	OCT	2014	134	4					832	836		10.1016/j.thromres.2014.07.034			5	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	AP8WU	WOS:000342360900013	25123332				2022-02-06	
J	Talbott, JF; Gean, A; Yuh, EL; Stiver, SI				Talbott, J. F.; Gean, A.; Yuh, E. L.; Stiver, S. I.			Calvarial Fracture Patterns on CT Imaging Predict Risk of a Delayed Epidural Hematoma following Decompressive Craniectomy for Traumatic Brain Injury	AMERICAN JOURNAL OF NEURORADIOLOGY			English	Article							ACUTE SUBDURAL-HEMATOMA; CONTRALATERAL EXTRADURAL HEMATOMA; CLINICAL-FEATURES; SURGERY; COMPLICATIONS; EVACUATION; SECONDARY	BACKGROUND AND PURPOSE: The development of a delayed epidural hematoma as a result of decompressive craniectomy represents an urgent and potentially lethal complication in traumatic brain injury. The goal of this study was to determine the incidence of delayed epidural hematoma and whether patterns of skull fractures on the preoperative CT scan could predict risk of a delayed epidural hematoma. MATERIALS AND METHODS: We retrospectively evaluated medical records and imaging studies for patients with acute traumatic brain injury who underwent a decompressive craniectomy during a 9-year period. We compared patterns of skull fractures contralateral to the side of the craniectomy with the occurrence of a postoperative delayed epidural hematoma. RESULTS: In a series of 203 patients undergoing decompressive craniectomy for acute traumatic brain injury, the incidence of a delayed epidural hematoma complication was 6% (12 of 203). All 12 patients who developed a delayed epidural hematoma had a contralateral calvarial fracture on preoperative CT at the site where the delayed epidural hematoma subsequently formed. A contralateral calvarial fracture has perfect sensitivity (100%) for subsequent development of delayed epidural hematoma in our study population. Moreover, a contralateral calvarial fracture involving 2 or more bone plates had an especially high diagnostic odds ratio of 41 for delayed epidural hematoma. CONCLUSIONS: Recognition of skull fracture patterns associated with delayed epidural hematoma following decompressive craniectomy may reduce morbidity and mortality by prompting early postoperative intervention in high-risk situations.	[Talbott, J. F.; Gean, A.; Yuh, E. L.] San Francisco Gen Hosp, Dept Radiol & Biomed Imaging, San Francisco, CA 94110 USA; [Talbott, J. F.; Gean, A.; Yuh, E. L.] San Francisco Gen Hosp, Brain & Spine Injury Ctr, San Francisco, CA 94110 USA; [Gean, A.; Stiver, S. I.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA		Talbott, JF (corresponding author), San Francisco Gen Hosp, Dept Radiol, 1001 Potrero Ave,Room 1X55F, San Francisco, CA 94110 USA.	Jason.talbott@ucsf.edu			Educational Symposia; Ceretom (Samsung)Samsung	Alisa Gean-UNRELATED: Board Membership: www.image32.com, Comments: no financial compensation yet; Consultancy: National Football League (NFL); Employment: www.hindsightwines.com (owner); Expert Testimony various legal firms (plaintiff and defense); Payment for Lectures and the Development of Educational Presentations: Educational Symposia (various courses and meetings, Tampa, Florida); Ceretom (Samsung); Royalties: Lippincott Williams & Wilkins, Comments: author, Brain Injury: Applications from War and Terrorism; Stock/Stock Options: GBLI (Global Indemnity), NASDAQ, and Ceretom (Samsung); Travel/Accommodations/Meeting Expenses Unrelated to Activities Listed: honoraria, University of California, San Francisco.	Bullock M Ross, 2006, Neurosurgery, V58, pS7; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; FEUERMAN T, 1988, NEUROSURGERY, V23, P480, DOI 10.1227/00006123-198810000-00013; Lasierra JLF, 2013, EUR J TRAUMA EMERG S, V39, P277, DOI 10.1007/s00068-013-0268-4; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Honeybul S, 2010, J CLIN NEUROSCI, V17, P430, DOI 10.1016/j.jocn.2009.09.007; Hutchinson P J, 2004, Curr Opin Crit Care, V10, P101, DOI 10.1097/00075198-200404000-00004; Hutchinson P, 2011, CAN J NEUROL SCI, V38, P541, DOI 10.1017/S0317167100012051; JENNETT B, 1975, LANCET, V1, P480; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Marion DW, 2006, NEUROSURGERY, V58, P655; Matsuno A, 2003, SURG NEUROL, V60, P23, DOI 10.1016/S0090-3019(03)00023-5; MEGURO K, 1987, NEUROSURGERY, V20, P326, DOI 10.1227/00006123-198702000-00023; Mohindra S, 2005, BRIT J NEUROSURG, V19, P490, DOI 10.1080/02688690500495216; Moon KS, 2007, J CLIN NEUROSCI, V14, P283, DOI 10.1016/j.jocn.2005.11.016; PETERSEN OF, 1984, NEURORADIOLOGY, V26, P363, DOI 10.1007/BF00327488; Plesnila N, 2007, PROG BRAIN RES, V161, P393, DOI 10.1016/S0079-6123(06)61028-5; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Su TM, 2008, J TRAUMA, V65, P1298, DOI 10.1097/TA.0b013e31815885d9; Su TM, 2011, J TRAUMA, V71, P833, DOI 10.1097/TA.0b013e31821b092a; Takeuchi S, 2012, J TRAUMA ACUTE CARE, V73, P1254, DOI 10.1097/TA.0b013e318265cc14; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Wen L, 2013, BRAIN INJURY, V27, P286, DOI 10.3109/02699052.2012.743180; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	27	18	21	0	2	AMER SOC NEURORADIOLOGY	DENVILLE	PO BOX 3000, DENVILLE, NJ 07834-9349 USA	0195-6108	1936-959X		AM J NEURORADIOL	Am. J. Neuroradiol.	OCT	2014	35	10					1930	1935		10.3174/ajnr.A4001			6	Clinical Neurology; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	AQ5YY	WOS:000342885700015	24948502	hybrid, Green Published			2022-02-06	
J	Ilie, G; Adlaf, EM; Mann, RE; Boak, A; Hamilton, H; Asbridge, M; Colantonio, A; Turner, NE; Rehm, J; Cusimano, MD				Ilie, Gabriela; Adlaf, Edward M.; Mann, Robert E.; Boak, Angela; Hamilton, Hayley; Asbridge, Mark; Colantonio, Angela; Turner, Nigel E.; Rehm, Juergen; Cusimano, Michael D.			The Moderating Effects of Sex and Age on the Association between Traumatic Brain Injury and Harmful Psychological Correlates among Adolescents	PLOS ONE			English	Article							GENDER-DIFFERENCES; RISK BEHAVIOR; UNITED-STATES; HEAD-INJURY; VALIDITY; HEALTH; WOMEN; PREVALENCE; DISORDERS; CHILDREN	Background: Although it is well established that sex is a risk factor in acquiring a traumatic brain injury (TBI) among adolescents, it has not been established whether it also moderates the influence of other TBI psychological health correlates. Methods and Findings: Data were derived from a 2011 population-based cross-sectional school survey, which included 9,288 Ontario 7th-12th graders who completed anonymous self-administered questionnaires in classrooms. Response rate was 62%. Preliminary analyses found no evidence of nonresponse bias in the reporting of TBI. TBI was defined as a hit or blow to the head that resulted in a 5 minutes loss of consciousness or at least one overnight hospitalization due to symptoms associated with it. Reports of lifetime TBI were more common among males than females (23.1%, 95% CI: 20.5, 25.8 vs. 17.1%, 95% CI: 14.7, 19.8). Thirteen correlates were examined and included cigarette smoking, elevated psychological distress, suicide ideation, bully victimization (at school, as well as cyber bullying), bullying others, cannabis use, cannabis dependence and drug use problems, physical injuries, daily smoking, drinking alcohol, binge drinking, use of cannabis, and poor academic performance. Among the outcomes examined, sex moderated the relationship between lifetime TBI and cigarette smoking. In addition, sex and age jointly moderated the relationship between lifetime TBI and daily smoking, alcohol use and physical injuries. Late adolescent males who reported lifetime TBI, relative to females, displayed elevated daily smoking and injuries, whereas their females counterparts displayed elevated past year drinking. Possible bias related to self-report procedures and the preclusion of causal inferences due to the cross-sectional nature of the data are limitations of this study. Conclusions: TBI differences in outcomes need to be assessed for potential moderating effects of sex and age. Results have important implications for more tailored injury prevention efforts.	[Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; [Ilie, Gabriela; Cusimano, Michael D.] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5B 1W8, Canada; [Adlaf, Edward M.; Mann, Robert E.; Boak, Angela; Hamilton, Hayley; Turner, Nigel E.; Rehm, Juergen] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Adlaf, Edward M.; Mann, Robert E.; Hamilton, Hayley; Colantonio, Angela; Turner, Nigel E.; Rehm, Juergen; Cusimano, Michael D.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Community Hlth & Epidemiol, Halifax, NS, Canada; [Asbridge, Mark] Dalhousie Univ, Dept Emergency Med, Halifax, NS, Canada; [Colantonio, Angela] Toronto Rehabil Inst, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Ilie, G (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada.	ilieg@smh.ca	Cusimano, Michael/X-4059-2019; Ilie, Gabriela/AAM-9122-2021; Turner, Nigel E/ABC-8263-2020	Turner, Nigel E/0000-0002-1035-2064; Colantonio, Angela/0000-0003-2094-4765; Chen, Xinguang/0000-0001-8263-643X	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; AUTO21, Networks of Centers of Excellence program - Natural Sciences and Engineering Research Council; Social Sciences and Humanities Research CouncilSocial Sciences and Humanities Research Council of Canada (SSHRC); Industry Canada; Ontario Ministry of Health and Long-Term CareMinistry of Health and Long-Term Care, Ontario; CIHR Research Chair in Gender Work and HealthCanadian Institutes of Health Research (CIHR) [CGW-126580]; Toronto Rehabilitation InstituteUniversity of Toronto	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, and the Ontario Neurotrauma Foundation. Additional funding was obtained from a grant from AUTO21, a member of the Networks of Centers of Excellence program that is administered and funded by the Natural Sciences and Engineering Research Council, the Social Sciences and Humanities Research Council, in partnership with Industry Canada; ongoing funding support from the Ontario Ministry of Health and Long-Term Care; a CIHR Research Chair in Gender Work and Health #?CGW-126580; and the Toronto Rehabilitation Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2004, J CLIN EPIDEMIOL, V57, P1202, DOI 10.1016/j.jclinepi.2003.11.011; Arnold C, 2014, LANCET NEUROL, V13, P136, DOI 10.1016/S1474-4422(13)70287-4; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Billette JM, 2013, 82624XWE; Body C, 1996, BRAIN INJURY, V10, P567, DOI 10.1080/026990596124133; Bowman SM, 2008, PEDIATRICS, V122, P988, DOI 10.1542/peds.2007-3511; Brown SB, 2012, HEALTH CARE WOMEN IN, V33, P896, DOI 10.1080/07399332.2012.673654; Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Centre for Disease Control and Prevention Traumatic Brain Injury in the United States, 2010, EM DEP VIS HOSP DEAT; Chase S, 2012, HEALTH CARE WOMEN IN, V33, P631, DOI 10.1080/07399332.2012.673652; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Colantonio A, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-102; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Cusimano MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061865; ESSELMAN PC, 1995, BRAIN INJURY, V9, P417, DOI 10.3109/02699059509005782; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; Fiore Anthony E., 2011, Morbidity and Mortality Weekly Report, V60, P1; Frances A, 2000, DSM 4 CLASSIFICATION; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harris JE, 2012, BRAIN INJURY, V26, P177, DOI 10.3109/02699052.2011.635361; Ilie G, J HEAD TRAUMA REHABI; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Ilie G, 2013, JAMA-J AM MED ASSOC, V309, P2550, DOI 10.1001/jama.2013.6750; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Knight JR, 2002, ARCH PEDIAT ADOL MED, V156, P607, DOI 10.1001/archpedi.156.6.607; Korn E.L., 1999, ANAL HLTH SURVEYS; Levy DT, 2004, MED SCI MONITOR, V10, pCR17; May A, 2011, ASSESSMENT, V18, P379, DOI 10.1177/1073191110374285; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McKinlay A, 2013, J HEAD TRAUMA REHABI; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Moore DW, 2010, NEUROPSYCHOL REHABIL, V20, P340, DOI 10.1080/09602010903250928; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Paglia-Boak A., 2011, CAMH RES DOCUMENT SE, V32; Paglia-Boak A, 2011, CAMH RES DOCUMENT SE, V34; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Renner C, 2012, BRAIN INJURY, V26, P1360, DOI 10.3109/02699052.2012.667592; Schmidt AT, 2012, INT J DEV NEUROSCI, V30, P225, DOI 10.1016/j.ijdevneu.2011.11.003; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; Tait RJ, 2003, AUST NZ J PSYCHIAT, V37, P374, DOI 10.1046/j.1440-1614.2003.01133.x; Tait RJ, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-171; Topolovec-Vranic Jane, 2014, CMAJ Open, V2, pE69, DOI 10.9778/cmajo.20130046; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; Zernicke R. F., 2009, Journal of Intercollegiate Sport, V2, P42	51	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2014	9	9							e108167	10.1371/journal.pone.0108167			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AR6CW	WOS:000343671700069	25268238	Green Published, gold			2022-02-06	
J	Scher, AI; Ross, GW; Sigurdsson, S; Garcia, M; Gudmundsson, LS; Sveinbojrnsdottir, S; Wagner, AK; Gudnason, V; Launer, LJ				Scher, Ann I.; Ross, G. Webster; Sigurdsson, Sigurdur; Garcia, Melissa; Gudmundsson, Larus S.; Sveinboejrnsdottir, Sigurlaug; Wagner, Amy K.; Gudnason, Vilmundur; Launer, Lenore J.			Midlife migraine and late-life parkinsonism AGES-Reykjavik Study	NEUROLOGY			English	Article							TRAUMATIC BRAIN-INJURY; RESTLESS LEGS SYNDROME; CHRONIC DAILY HEADACHE; DISEASE; IRON; DOPAMINE; RISK; DYSFUNCTION; PREVALENCE; FEATURES	Objective: In the present study, we tested the hypothesis that having migraine in middle age is related to late-life parkinsonism and a related disorder, restless legs syndrome (RLS), also known as Willis-Ekbom disease (WED). Methods: The AGES-Reykjavik cohort (born 1907-1935) has been followed since 1967. Headaches were classified based on symptoms assessed in middle age. From 2002 to 2006, 5,764 participants were reexamined to assess symptoms of parkinsonism, diagnosis of Parkinson disease (PD), family history of PD, and RLS/WED. Results: Subjects with midlife migraine, particularly migraine with aura (MA), were in later life more likely than others to report parkinsonian symptoms (odds ratio [OR] MA = 3.6 [95% CI 2.7-4.8]) and diagnosed PD (ORMA = 2.5 [95% CI 1.2-5.2]). Women with MA were more likely than others to have a parent (ORMA = 2.26 [95% CI 1.3-4.0]) or sibling (ORMA = 1.78 [95% CI 1.1-2.9]) with PD. Late-life RLS/WED was increased for headache generally. Associations were independent of cardiovascular disease and MRI-evident presumed ischemic lesions. Conclusions: These findings suggest there may be a common vulnerability to, or consequences of, migraine and multiple indicators of parkinsonism. Additional genetic and longitudinal observational studies are needed to identify candidate pathways that may account for the comorbid constellation of symptoms.	[Scher, Ann I.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA; [Scher, Ann I.; Garcia, Melissa; Launer, Lenore J.] NIA, Lab Epidemiol & Populat Sci, Bethesda, MD 20892 USA; [Ross, G. Webster] Vet Affairs Pacific Islands Hlth Care Syst, Honolulu, HI USA; [Ross, G. Webster] Pacific Hlth Res & Educ Inst, Honolulu, HI USA; [Sigurdsson, Sigurdur; Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gudmundsson, Larus S.] Univ Iceland, Sch Hlth Sci, Reykjavik, Iceland; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Sveinboejrnsdottir, Sigurlaug] Broomfield Hosp, Dept Neurol, Chelmsford, Essex, England; [Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA		Scher, AI (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.	ascher@usuhs.mil	Gudnason, Vilmundur/K-6885-2015; Gudnason, Vilmundur/AAE-7126-2019	Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Scher, Ann/0000-0003-4599-9834; Gudmundsson, Larus S/0000-0003-4660-1111	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [N01-AG-12100]; National Institute on Aging Intramural Program, Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [N01AG012100] Funding Source: NIH RePORTER	The AGES-Reykjavik Study was supported by NIH N01-AG-12100, the National Institute on Aging Intramural Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). The views expressed in this work are those of the authors and do not necessarily reflect the official policy or position of the Department of Defense or the US Government.	Allen RP, 2001, NEUROLOGY, V56, P263, DOI 10.1212/WNL.56.2.263; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Barbanti P, 2002, CEPHALALGIA, V22, P2, DOI 10.1046/j.1468-2982.2002.00313.x; Barbanti P, 2000, CEPHALALGIA, V20, P720, DOI 10.1046/j.1468-2982.2000.00123.x; Barbanti P, 2013, NEUROL SCI, V34, pS67, DOI 10.1007/s10072-013-1415-8; Bashir A, 2013, NEUROLOGY, V81, P1260, DOI 10.1212/WNL.0b013e3182a6cb32; Bigal ME, 2006, NEUROLOGY, V67, P246, DOI 10.1212/01.wnl.0000225186.76323.69; Charbit AR, 2010, CURR OPIN NEUROL, V23, P275, DOI 10.1097/WCO.0b013e3283378d5c; Colosimo C, 2010, J NEUROL, V257, P5, DOI 10.1007/s00415-009-5255-7; Connor JR, 2003, NEUROLOGY, V61, P304, DOI 10.1212/01.WNL.0000078887.16593.12; Couch JR, 2007, NEUROLOGY, V69, P1169, DOI 10.1212/01.wnl.0000276985.07981.0a; d'Onofrio F, 2012, NEUROL SCI, V33, pS55, DOI 10.1007/s10072-012-1042-9; Dahodwala N, 2012, PARKINSONISM RELAT D, V18, P216, DOI 10.1016/j.parkreldis.2011.09.003; de Laat KF, 2012, STROKE, V43, P2574, DOI 10.1161/STROKEAHA.112.657130; deRijk MC, 1997, J NEUROL NEUROSUR PS, V62, P10, DOI 10.1136/jnnp.62.1.10; Desseilles M, 2008, SLEEP, V31, P777, DOI 10.1093/sleep/31.6.777; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Granziera C, 2014, HUM BRAIN MAPP, V35, P1461, DOI 10.1002/hbm.22266; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Kruit MC, 2009, CEPHALALGIA, V29, P351, DOI 10.1111/j.1468-2982.2008.01723.x; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Noyce AJ, 2012, ANN NEUROL, V72, P893, DOI 10.1002/ana.23687; Scher AI, 2009, JAMA-J AM MED ASSOC, V301, P2563, DOI 10.1001/jama.2009.932; Schurks M, 2012, CEPHALALGIA, V32, P382, DOI 10.1177/0333102412439355; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; SIGURDSSON E, 1995, ANN INTERN MED, V122, P96, DOI 10.7326/0003-4819-122-2-199501150-00003; Silber MH, 2013, MAYO CLIN PROC, V88, P977, DOI 10.1016/j.mayocp.2013.06.016; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; Stankiewicz J, 2007, NEUROTHERAPEUTICS, V4, P371, DOI 10.1016/j.nurt.2007.05.006; Tanner CM, 1996, ANN EPIDEMIOL, V6, P438, DOI 10.1016/S1047-2797(96)00066-X; Tepper SJ, 2012, HEADACHE, V52, P236, DOI 10.1111/j.1526-4610.2011.02056.x; VANHILTEN JJ, 1992, CLIN NEUROL NEUROSUR, V94, pS168; WALTERS AS, 1995, MOVEMENT DISORD, V10, P634, DOI 10.1002/mds.870100517; Welch KMA, 2001, HEADACHE, V41, P629, DOI 10.1046/j.1526-4610.2001.041007629.x; Winter AC, 2013, CEPHALALGIA, V33, P130, DOI 10.1177/0333102412466965	40	18	18	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 30	2014	83	14					1246	1252		10.1212/wnl.0000000000000840			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AT3UN	WOS:000344860700010	25230997	Green Published			2022-02-06	
J	Ruhe, A; Fejer, R; Gansslen, A; Klein, W				Ruhe, Alexander; Fejer, Rene; Gaensslen, Axel; Klein, Wolfgang			Assessing Postural Stability in the Concussed Athlete: What to Do, What to Expect, and When	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						concussion; sports; balance; Balance Error Scoring System; Sensory Organization Test		Context: Postural stability assessment is included as part of the diagnostic and monitoring process for sports-related concussions. Particularly, the relatively simple Balance Error Scoring System ( BESS) and more sophisticated force plate measures like the Sensory Organization Test (SOT) are suggested. Evidence Acquisition: Relevant studies were identified via the following electronic databases: PubMed, MEDLINE, EMBASE, Web of Science, ScienceDirect, and CINAHL (1980 to July 2013). Inclusion was based on the evaluation of postural sway or balance in concussed athletes of any age or sex and investigating the reliability or validity of the included tests. Study Design: Clinical review. Results: Both the SOT and the BESS show moderate reliability, but a learning effect due to repetitive testing needs to be considered. Both tests indicate that postural stability returns to baseline by day 3 to 5 in most concussed athletes. While the BESS is a simple and valid method, it is sensitive to subjectivity in scoring and the learning effect. The SOT is very sensitive to even subtle changes in postural sway, and thus, more accurate than the BESS; however, it is a rather expensive method of balance testing. Conclusion: Both tests serve the purpose of monitoring balance performance in the concussed athlete; however, neither may serve as a stand-alone diagnostic or monitoring tool. Strength of Recommendation Taxonomy: B	[Ruhe, Alexander] Murdoch Univ, Sch Hlth Profess, Murdoch, WA, Australia; [Ruhe, Alexander] Praxis Chiroprakt, Porschestr 1, D-38440 Wolfsburg, Germany; [Fejer, Rene] Hosp Lillebaelt, Spine Ctr Southern Denmark, Middelfart, Denmark; [Fejer, Rene] Univ Southern Denmark, Inst Reg Hlth Serv Res, Odense, Denmark; [Gaensslen, Axel; Klein, Wolfgang] Klinikum Wolfsburg, Dept Trauma Surg Orthoped & Hand Surg, Wolfsburg, Germany		Ruhe, A (corresponding author), Praxis Chiroprakt, Porschestr 1, D-38440 Wolfsburg, Germany.	a.ruhe@chiropraktik-wolfsburg.de					Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2008, CLIN J SPORT MED, V18, P148, DOI 10.1097/JSM.0b013e318164f42a; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Broglio SP, 2009, J SCI MED SPORT, V12, P388, DOI 10.1016/j.jsams.2007.12.010; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; della Volpe R, 2006, GAIT POSTURE, V24, P349, DOI 10.1016/j.gaitpost.2005.10.009; Dickin DC, 2007, CLIN J SPORT MED, V17, P109, DOI 10.1097/JSM.0b013e31803bf647; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; FORDSMITH CD, 1995, ARCH PHYS MED REHAB, V76, P77, DOI 10.1016/S0003-9993(95)80047-6; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Guskiewicz KM, 2011, CLIN SPORT MED, V30, P89, DOI 10.1016/j.csm.2010.09.004; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2001, CLIN J SPORT MED, V11, P182, DOI 10.1097/00042752-200107000-00009; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leitner C, 2009, J ELECTROMYOGR KINES, V19, P380, DOI 10.1016/j.jelekin.2007.09.007; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2000, STANDARDIZED ASSESSM; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; NASHNER LM, 1990, NEUROL CLIN, V8, P331, DOI 10.1016/S0733-8619(18)30359-1; Onate JA, 2007, J ATHL TRAINING, V42, P446; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876; Peterson CL, 2003, CLIN J SPORT MED, V13, P230, DOI 10.1097/00042752-200307000-00006; Register-Mihalik JK, 2013, J HEAD TRAUMA REHAB, V28, P274, DOI 10.1097/HTR.0b013e3182585d37; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Ruhe A, 2013, SPORTVERLETZ SPORTSC, V27, P201, DOI 10.1055/s-0033-1356109; Ruhe A, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-162; Saether R, 2011, RES DEV DISABIL, V32, P727, DOI 10.1016/j.ridd.2010.11.007; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shumway-Cook A, 2007, MOTOR CONTROL TRANSL, P157; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Susco TM, 2004, J ATHL TRAINING, V39, P241; Tsang WW, 2004, ARCH PHYS MED REHAB, V85, P129, DOI 10.1016/j.apmr.2003.02.002; Valovich McLeod TC, 2006, J ATHL TRAINING, V47, P221; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Wrisley DM, 2007, ARCH PHYS MED REHAB, V88, P1049, DOI 10.1016/j.apmr.2007.05.003	53	18	18	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	SEP-OCT	2014	6	5					427	433		10.1177/1941738114541238			7	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	V20FU	WOS:000214873300009	25177420	Green Published			2022-02-06	
J	Schatz, P; Kelley, T; Ott, SD; Solomon, GS; Elbin, RJ; Higgins, K; Moser, RS				Schatz, Philip; Kelley, Timothy; Ott, Summer D.; Solomon, Gary S.; Elbin, R. J.; Higgins, Kate; Moser, Rosemarie Scolaro			Utility of Repeated Assessment After Invalid Baseline Neurocognitive Test Performance	JOURNAL OF ATHLETIC TRAINING			English	Article						baseline testing; concussion testing; invalid baseline; neuropsychological testing; ImPACT; head injuries	HIGH-SCHOOL; NEUROPSYCHOLOGICAL ASSESSMENT; BRAIN-INJURY; CONCUSSION; SPORTS; SYMPTOMS; ACADEMY	Context: Although the prevalence of invalid baseline neurocognitive testing has been documented, and repeated administration after obtaining invalid results is recommended, no empirical data are available on the utility of repeated assessment after obtaining invalid baseline results. Objective: To document the utility of readministering neurocognitive testing after an invalid baseline test. Design: Case series. Setting: Schools, colleges, and universities. Patients or Other Participants: A total of 156 athletes who obtained invalid results on ImPACT baseline neurocognitive testing and were readministered the ImPACT baseline test within a 2-week period (mean = 4 days). Main Outcome Measure(s): Overall prevalence of invalid results on reassessment, specific invalidity indicators at initial and follow-up baseline, dependent-samples analysis of variance, with Bonferroni correction for multiple comparisons. Results: Reassessment resulted in valid test results for 87.2% of the sample. Poor performance on the Design Memory and Three-Letter subscales were the most common reasons for athletes obtaining an invalid baseline result, on both the initial assessment and the reassessment. Significant improvements were noted on all ImPACT composite scores except for Reaction Time on reassessment. Of note, 40% of athletes showed slower reaction time scores on reassessment, perhaps reflecting a more cautious approach taken the second time. Invalid results were more likely to be obtained by athletes with a self-reported history of attention-deficit disorder or learning disability on reassessments (35%) than on initial baseline assessments (10%). Conclusions: Repeat assessment after the initial invalid baseline performance yielded valid results in nearly 90% of cases. Invalid results on a follow-up assessment may be influenced by a history of attention-deficit disorder or learning disability, the skills and abilities of the individual, or a particular test-taking approach; in these cases, a third assessment may not be useful.	[Schatz, Philip; Kelley, Timothy] St Josephs Univ, Philadelphia, PA 19131 USA; [Ott, Summer D.] Mem Hermann Ironman Sports Med Inst, Houston, TX USA; [Solomon, Gary S.] Vanderbilt Univ, Med Ctr, Dept Neurol Surg, Nashville, TN USA; [Elbin, R. J.] Univ Arkansas, Dept Human Performance Hlth Promot & Recreat, Fayetteville, AR 72701 USA; [Higgins, Kate] Sch Profess Psychol, Forest Inst, Springfield, MO USA; [Moser, Rosemarie Scolaro] Sports Concuss Ctr New Jersey, Lawrenceville, NJ USA		Schatz, P (corresponding author), St Josephs Univ, 5600 City Ave,222 Post Hall, Philadelphia, PA 19131 USA.	pschatz@sju.edu	Solomon, Gary/K-9011-2019				Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barth JT, 1989, MILD HEAD INJURY, P257; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Echemendia RJ, 2003, APPL NEUROPSYCHOL, V10, P48, DOI 10.1207/S15324826AN1001_7; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Erdal K, 2012, ARCH CLIN NEUROPSYCH, V27, P473, DOI 10.1093/arclin/acs050; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Law R, 2012, ANXIETY STRESS COPIN, V25, P711, DOI 10.1080/10615806.2011.630070; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Lovell M. R., 2002, Medicine & Science in Sports & Exercise, V34, pS298, DOI 10.1097/00005768-200205001-01680; Lovell MR, 1998, J HEAD TRAUMA REHAB, V13, P9, DOI 10.1097/00001199-199804000-00004; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lovell MR., CLIN INTERPRETIVE MA; Marvez A., PLAYERS MAY TRY BEAT; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Moser RS, 2013, APPL NEUROP IN PRESS; Neylan TC, 2010, CHRONOBIOL INT, V27, P1493, DOI 10.3109/07420528.2010.504992; Podell K, 2004, STUD NEUROPSYCHOL DE, P375; Reilly R., TALKING FOOTBALL ARC; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P236, DOI 10.1093/arclin/act009; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Schatz P, 2010, ARCH CLIN NEUROPSYCH, V25, P285, DOI 10.1093/arclin/acq022	25	18	18	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	SEP-OCT	2014	49	5					659	664		10.4085/1062-6050-49.3.37			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	AY4NN	WOS:000347555600013	25162778	Bronze, Green Published			2022-02-06	
J	Wang, YP; Hameed, MQ; Rakhade, SN; Iglesias, AH; Muller, PA; Mou, DL; Rotenberg, A				Wang, Yingpeng; Hameed, Mustafa Q.; Rakhade, Sanjay N.; Iglesias, Antonio H.; Muller, Paul A.; Mou, Dan-Lei; Rotenberg, Alexander			Hippocampal immediate early gene transcription in the rat fluid percussion traumatic brain injury model	NEUROREPORT			English	Article						glutamate; hippocampus; immediate early gene (IEG); MK801; N-methyl-D-aspartate; traumatic brain injury	NERVOUS-SYSTEM; EXPRESSION; APOPTOSIS; EPILEPSY; DENSITY; BDNF; FOS	Traumatic brain injury (TBI) is one of the leading causes of neurological disability and death in the USA across all age groups, ethnicities, and incomes. In addition to the short-term morbidity and mortality, TBI leads to epilepsy and severe neurocognitive symptoms, both of which are referenced to post-traumatic hippocampal dysfunction, although the mechanisms of such hippocampal dysfunction are incompletely understood. Here, we study the temporal profile of the transcription of three select immediate early gene (IEG) markers of neuronal hyperactivation, plasticity, and injury, c-fos, brain-derived neurotrophic factor (BDNF), and Bax, in the acute period following the epileptogenic lateral fluid percussion injury in a rodent TBI model. We found that lateral fluid percussion injury leads to enhanced expression of the selected IEGs within 24 h of TBI. Specifically, BDNF and c-fos increase maximally 1-6 h after TBI in the ipsilesional hippocampus, whereas Bax increases in the hippocampus bilaterally in this time window. Antagonism of the N-methyl-D-aspartate-type glutamate receptor by MK801 attenuates the increase in BDNF and Bax, which underscores a therapeutic role for N-methyl-D-aspartate-type glutamate receptor antagonism in the acute post-traumatic time period and suggests a value to a hippocampal IEG readout as an outcome after injury or acute therapeutic intervention. (c) 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins.	[Wang, Yingpeng; Hameed, Mustafa Q.; Rakhade, Sanjay N.; Muller, Paul A.; Rotenberg, Alexander] Harvard Univ, Sch Med, Dept Neurol, Boston Childrens Hosp, Boston, MA 02115 USA; [Hameed, Mustafa Q.] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurosurg, Boston, MA USA; [Iglesias, Antonio H.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA; [Wang, Yingpeng] Beijing Aerosp Gen Hosp, Dept Neurol, Beijing, Peoples R China; [Mou, Dan-Lei] Capital Med Univ, Beijing Youan Hosp, Ctr Infect Dis, Beijing, Peoples R China		Rotenberg, A (corresponding author), Boston Childrens Hosp, Dept Neurol, 300 Longwood Ave, Boston, MA 02115 USA.	alexander.rotenberg@childrens.harvard.edu	Hameed, Mustafa/G-3677-2014	Hameed, Mustafa/0000-0003-4004-5564	Boston Children's Hospital; Department of DefenseUnited States Department of Defense [PT073873]	The authors thank Dr Roman Gersner for his advice related to statistical analysis. This work was supported by the Boston Children's Hospital Translational Research Program (A.R.) and the Department of Defense PT073873 (A.R.).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Barwood CHS, 2013, BRAIN INJURY, V27, P671, DOI 10.3109/02699052.2013.775500; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Christensen J, 2009, LANCET, V373, P1105, DOI 10.1016/S0140-6736(09)60214-2; Colak T, 2012, INJURY, V43, P1264, DOI 10.1016/j.injury.2012.01.021; Conti AC, 1998, J NEUROSCI, V18, P5663; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Griesbach GS, 2002, J NEUROTRAUM, V19, P803, DOI 10.1089/08977150260190401; Hameed MQ, 2014, NEUROREPORT, V25, P532, DOI 10.1097/WNR.0000000000000132; Han Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064894; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; Li HH, 2004, J NEUROTRAUM, V21, P1141, DOI 10.1089/0897715041953777; Lu J, 2000, NEUROSCI LETT, V290, P89, DOI 10.1016/S0304-3940(00)01307-0; Luo Chun, 2002, Chin J Traumatol, V5, P24; Luo P, 2011, BRAIN RES BULL, V85, P313, DOI 10.1016/j.brainresbull.2011.05.004; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; Miyazaki S, 1989, INTRACRANIAL PRESSUR, P651; Pitkanen A, 2009, EPILEPSIA, V50, P21, DOI 10.1111/j.1528-1167.2008.02007.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Wang HC, 2014, NEUROCRIT CARE, V20, P119, DOI 10.1007/s12028-013-9944-9	25	18	19	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0959-4965	1473-558X		NEUROREPORT	Neuroreport	AUG 20	2014	25	12					954	959		10.1097/WNR.0000000000000219			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM9DN	WOS:000340180400013	24978397				2022-02-06	
J	Mazzone, GL; Nistri, A				Mazzone, Graciela L.; Nistri, Andrea			S100 beta as an early biomarker of excitotoxic damage in spinal cord organotypic cultures	JOURNAL OF NEUROCHEMISTRY			English	Article						colchicine; glutamate receptor; kainic acid; neuroprotection; spinal cord injury	TRAUMATIC BRAIN-INJURY; SKELETAL-MUSCLE COCULTURE; S-100-BETA PROTEIN; SLICE CULTURES; S100B PROTEIN; EMBRYONIC RAT; NEURONS; ASTROCYTES; KAINATE; CELLS	S100 beta is a cytoplasmic calcium-binding protein mainly expressed by glia and considered to be a useful biomarker for brain or spinal cord injury. Indeed, clinical studies suggest that the S100 beta concentration in serum or cerebrospinal fluid may predict lesion outcome and prognosis. The relation of S100 beta levels to damage severity and its timecourse remains, however, unclear. This study used a validated in vitro model of spinal cord injury induced by kainate-mediated excitotoxicity to investigate these issues. After 22 days in vitro, rat organotypic spinal cord slices were subjected to one transient application (1 h) of 1 or 100 mu M kainate followed by washout. While the lower kainate concentration did not evoke neuronal loss or S100 beta increase, the larger concentration elicited 40% neuronal death, no change in glial number and a delayed, significant rise in extracellular S100 beta that peaked at 24 h. This increase was associated with a stronger expression of the S100 beta protein as indicated by western blotting and immunohistochemistry. Application of the microtubule disrupting agent colchicine did not change the rise in S100 beta induced by kainate, an effect blocked by the glutamate receptor antagonists CNQX and APV. Our data suggest that excitotoxicity was followed by release of S100 beta perhaps from a readily releasable pool through a mechanism independent of microtubule assembly. The raised extracellular level of sloop appeared to reflect glial reactivity to the kainate-evoked lesion in accordance with the view that this protein may be involved in tissue protection and repair after acute injury.	[Mazzone, Graciela L.; Nistri, Andrea] Int Sch Adv Studies SISSA, Dept Neurosci, Trieste, Italy		Nistri, A (corresponding author), SISSA, Via Bonomea 265, I-34136 Trieste, Italy.	nistri@sissa.it		Mazzone, Graciela Lujan/0000-0003-3360-9931	European Fund for CrossBorder Cooperation (MINA project)	We thank Dr. Beatrice Pastore for her assistance with organotypic cultures. This study was supported by the European Fund for CrossBorder Cooperation (MINA project) between Italy and Slovenia. The authors declare no conflicts of interest.	Barateiro A, 2014, MOL NEUROBIOL, V49, P424, DOI 10.1007/s12035-013-8530-7; Cao F, 2008, J CLIN NEUROSCI, V15, P541, DOI 10.1016/j.jocn.2007.05.014; Cifra A, 2012, DEV NEUROBIOL, V72, P1140, DOI 10.1002/dneu.20991; Davey GE, 2001, J BIOL CHEM, V276, P30819, DOI 10.1074/jbc.M103541200; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Gentleman D, 1999, BRIT MED BULL, V55, P910, DOI 10.1258/0007142991902718; Gyorgy A, 2011, J NEUROTRAUM, V28, P1121, DOI 10.1089/neu.2010.1561; Kuzhandaivel Anujaianthi, 2011, Front Cell Neurosci, V5, P9, DOI 10.3389/fncel.2011.00009; Kuzhandaivel A, 2010, CELL MOL NEUROBIOL, V30, P1001, DOI 10.1007/s10571-010-9531-y; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Margaryan G, 2010, NEUROSCIENCE, V165, P996, DOI 10.1016/j.neuroscience.2009.10.066; Marquardt G, 2011, NEUROL RES, V33, P421, DOI 10.1179/1743132810Y.0000000005; Mazzone GL, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.431; Mazzone GL, 2011, NEUROSCIENCE, V190, P318, DOI 10.1016/j.neuroscience.2011.06.013; Mazzone GL, 2010, NEUROSCIENCE, V168, P451, DOI 10.1016/j.neuroscience.2010.03.055; Mazzone GL, 2011, CELL MOL NEUROBIOL, V31, P469, DOI 10.1007/s10571-010-9640-7; Mehta A, 2013, EUR J PHARMACOL, V698, P6, DOI 10.1016/j.ejphar.2012.10.032; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Rammes A, 1997, J BIOL CHEM, V272, P9496; RICKMANN M, 1995, NEUROSCIENCE, V67, P977, DOI 10.1016/0306-4522(94)00615-C; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Roybon L, 2013, CELL REP, V4, P1035, DOI 10.1016/j.celrep.2013.06.021; Schwab JM, 2006, PROG NEUROBIOL, V78, P91, DOI 10.1016/j.pneurobio.2005.12.004; Sorci G, 1998, BBA-MOL CELL RES, V1448, P277, DOI 10.1016/S0167-4889(98)00134-7; Sorci Guglielmo, 2013, World J Biol Chem, V4, P1, DOI 10.4331/wjbc.v4.i1.1; SPENGER C, 1991, EUR J NEUROSCI, V3, P1037, DOI 10.1111/j.1460-9568.1991.tb00041.x; STREIT J, 1991, EUR J NEUROSCI, V3, P1054, DOI 10.1111/j.1460-9568.1991.tb00042.x; Wang YF, 2009, J NEUROSCI, V29, P1743, DOI 10.1523/JNEUROSCI.4669-08.2009; Yokobori S, 2013, CNS NEUROSCI THER, V19, P556, DOI 10.1111/cns.12127	31	18	18	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	AUG	2014	130	4					598	604		10.1111/jnc.12748			7	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	AN3ZN	WOS:000340527500014	24766228	Bronze			2022-02-06	
J	Schober, ME; Requena, DF; Davis, LJ; Metzger, RR; Bennett, KS; Morita, D; Niedzwecki, C; Yang, ZH; Wang, KKW				Schober, Michelle E.; Requena, Daniela F.; Davis, Lizeth J.; Metzger, Ryan R.; Bennett, Kimberly S.; Morita, Denise; Niedzwecki, Christian; Yang, Zhihui; Wang, Kevin K. W.			Alpha II Spectrin breakdown products in immature Sprague Dawley rat hippocampus and cortex after traumatic brain injury	BRAIN RESEARCH			English	Article						Controlled cortical impact; Apoptosis; Excitotmdcity; Cell death; Developmental	CONTROLLED CORTICAL IMPACT; CEREBROSPINAL-FLUID; APOPTOTIC NEURODEGENERATION; CALPAIN; DEGRADATION; CHILDREN; NEURONS; AGE; VULNERABILITY; ACCUMULATION	After traumatic brain injury (TBI), proteolysis of Alpha II Spectrin by Calpain 1 produces 145 Spectrin breakdown products (SBDPs) while proteolysis by Caspase 3 produces 120 SBDPs. 145 and 120 SBDP immunoblotting reflects the relative importance of caspase-dependent apoptosis or calpain-dependent excitotoxic/necrotoxic cell death in brain regions over time. In the adult rat, controlled cortical impact (CCI) increased 120 SBDPs in the first hours, lasting a few days, and increased 145 SBDPs within the first few days lasting up to 14 days after injury. Little is known about SBDPs in the immature brain after TBI. Since development affects susceptibility to apoptosis after TBI, we hypothesized that CCI would increase 145 and 120 SBDPs in the immature rat brain relative to SHAM during the first 3 and 5 days, respectively. SBDPs were measured in hippocampi and cortices at post injury days (PID) 1, 2, 3, 5, 7 and 14 after CCI or SHAM surgery in the 17 day old Sprague Dawley rat. 145 SBDPs increased in both brain tissues ipsilateral to injury during the first 3 days, while changes in contralateral tissues were limited to PID2 cortex. 145 SBDPs elevations were more marked and enduring in hippocampus than in cortex. Against expectations, 120 SBDPs only increased in PID1 hippocampus and PID2 cortex. 145 SBDPs elevations occurred early after CCI, similar to previous studies in the adult rat, but resolved more quickly. The minimal changes in 120 SBDPs suggest that calpain-dependent, but not caspase-dependent, cell death predominates in the 17 day old rat after CCI. (C) 2014 Elsevier B.V. All rights reserved.	[Requena, Daniela F.; Davis, Lizeth J.] Univ Utah, Div Neonatol, Dept Pediat, Salt Lake City, UT 84132 USA; [Schober, Michelle E.; Bennett, Kimberly S.] Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT 84132 USA; [Metzger, Ryan R.] Univ Utah, Dept Surg, Salt Lake City, UT 84132 USA; [Morita, Denise] Univ Utah, Dept Pediat, Div Neurol, Salt Lake City, UT 84132 USA; [Niedzwecki, Christian] Univ Utah, Dept Pediat, Div Phys Med & Rehabil, Salt Lake City, UT 84132 USA; [Yang, Zhihui; Wang, Kevin K. W.] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarker Res, Dept Pediat, Gainesville, FL 32611 USA		Schober, ME (corresponding author), Univ Utah, Sch Med, Dept Pediat, Div Crit Care, Salt Lake City, UT 84132 USA.	michelle.schober@hsc.utah.edu		Wang, Kevin/0000-0002-9343-6473	PCMC Foundation Integrative [PCMCF-ISA-KS01-2011-01]; CHRCDA [NIH K12HD001410]; Divisions of Neonatology and Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City UT; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001410] Funding Source: NIH RePORTER	Funding for this study was provided by the PCMC Foundation Integrative Grant PCMCF-ISA-KS01-2011-01, the CHRCDA (NIH K12HD001410) and from the Divisions of Neonatology and Pediatric Critical Care Medicine, Department of Pediatrics, University of Utah, Salt Lake City UT.	Aikman J, 2006, DEV NEUROSCI-BASEL, V28, P457, DOI 10.1159/000094171; Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Bayly PV, 2006, BRAIN RES, V1107, P70, DOI 10.1016/j.brainres.2006.05.102; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bittigau P, 2004, EXP TOXICOL PATHOL, V56, P83, DOI 10.1016/j.etp.2004.04.006; Bittigau P, 2003, NEUROTOX RES, V5, P475, DOI 10.1007/BF03033158; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Cardali S, 2006, J Neurosurg Sci, V50, P25; Chen SF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045763; D'Amelio M, 2010, CELL DEATH DIFFER, V17, P1104, DOI 10.1038/cdd.2009.180; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Gobbel GT, 2007, CHILD NERV SYST, V23, P1171, DOI 10.1007/s00381-007-0345-2; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Huh JW, 2007, J NEUROTRAUM, V24, P1460, DOI 10.1089/neu.2006.3787; Jenkins LW, 2002, J NEUROTRAUM, V19, P715, DOI 10.1089/08977150260139101; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kochanek AR, 2006, DEV NEUROSCI-BASEL, V28, P410, DOI 10.1159/000094167; Kupina NC, 2003, EXP NEUROL, V180, P55, DOI 10.1016/S0014-4886(02)00048-1; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu MC, 2006, BIOCHEM J, V394, P715, DOI 10.1042/BJ20050905; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; O'Connor CA, 2007, EXP NEUROL, V205, P145, DOI 10.1016/j.expneurol.2007.01.034; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; Polster BM, 2003, CELL DEATH DIFFER, V10, P365, DOI 10.1038/sj.cdd.4401158; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Raghupathi R, 2007, J NEUROTRAUM, V24, P1596, DOI 10.1089/neu.2007.3790; Rhinn H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-62; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.1289/ehp.00108s3511; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saransaari P, 2003, AMINO ACIDS, V24, P213, DOI 10.1007/s00726-002-0310-z; Schober ME, 2010, J NEUROTRAUM, V27, P2011, DOI 10.1089/neu.2009.1226; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Valiyaveettil M, 2014, BRAIN RES, V1549, P32, DOI 10.1016/j.brainres.2013.12.031; Xu LJ, 2001, EXP NEUROL, V169, P416, DOI 10.1006/exnr.2001.7678; Yan XX, 2012, CURR GERIATR REP, V1, P85, DOI 10.1007/s13670-012-0009-2; Yeates KO, 2005, J AM ACAD CHILD PSY, V44, P574, DOI 10.1097/01.chi.0000159947.50523.64; Zhu C, 2005, CELL DEATH DIFFER, V12, P162, DOI 10.1038/sj.cdd.4401545	54	18	18	1	7	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUL 29	2014	1574						105	112		10.1016/j.brainres.2014.05.046			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AM6ZM	WOS:000340014500012	24929209	Green Accepted			2022-02-06	
J	Filippidis, AS; Liang, XY; Wang, WL; Parveen, S; Baumgarten, CM; Marmarou, CR				Filippidis, Aristotelis S.; Liang, Xiuyin; Wang, Weili; Parveen, Shanaaz; Baumgarten, Clive M.; Marmarou, Christina R.			Real-Time Monitoring of Changes in Brain Extracellular Sodium and Potassium Concentrations and Intracranial Pressure after Selective Vasopressin-1a Receptor Inhibition following Focal Traumatic Brain Injury in Rats	JOURNAL OF NEUROTRAUMA			English	Article						AQP4; cations; TBI; V1a receptor; vasopressin	CEREBRAL-ARTERY OCCLUSION; PHORBOL-MYRISTATE ACETATE; ATRIAL-NATRIURETIC-PEPTIDE; KINASE-C ACTIVATOR; ARGININE-VASOPRESSIN; AQP4 EXPRESSION; SPREADING DEPOLARIZATIONS; ANTAGONIST SR49059; WATER TRANSPORT; EDEMA FORMATION	Brain swelling and increased intracranial pressure (ICP) following traumatic brain injury (TBI) contribute to poor outcome. Vasopressin-1a receptors (V1aR) and aquaporin-4 (AQP4) regulate water transport and brain edema formation, perhaps in part by modulating cation fluxes. After focal TBI, V1aR inhibitors diminish V1aR and AQP4, reduce astrocytic swelling and brain edema. We determined whether V1aR inhibition with SR49059 after lateral controlled-cortical-impact (CCI) injury affects extracellular Na+ and K+ concentrations ([Na+](e); [K+](e)). Ion-selective Na+ and K+ electrodes (ISE) and an ICP probe were implanted in rat parietal cortex, and [Na+](e), [K+](e), and physiological parameters were monitored for 5 h post-CCI. Sham-vehicle-ISE, CCI-vehicle-ISE and CCI-SR49059-ISE groups were studied, and SR49059 was administered 5 min to 5 h post-injury. We found a significant injury-induced decrease in [Na+](e) to 80.1 +/- 15 and 87.9 +/- 7.9 mM and increase in [K+](e) to 20.9 +/- 3.8 and 13.4 +/- 3.4 mM at 5 min post-CCI in CCI-vehicle-ISE and CCI-SR49059-ISE groups, respectively (p < 0.001 vs. baseline; ns between groups). Importantly, [Na+](e) in CCI-SR49059-ISE was reduced 5-20 min post-injury and increased to baseline at 25 min, whereas recovery in CCI-vehicle-ISE required more than 1 hr, suggesting SR49059 accelerated [Na+](e) recovery. In contrast, [K+](e) recovery took 45 min in both groups. Further, ICP was lower in the CCI-SR49059-ISE group. Thus, selective V1aR inhibition allowed faster [Na+](e) recovery and reduced ICP. By augmenting the [Na+](e) recovery rate, SR49059 may reduce trauma-induced ionic imbalance, blunting cellular water influx and edema after TBI. These findings suggest SR49059 and V1aR inhibitors are potential tools for treating cellular edema post-TBI.	[Filippidis, Aristotelis S.; Liang, Xiuyin; Wang, Weili; Parveen, Shanaaz; Marmarou, Christina R.] Virginia Commonwealth Univ, Dept Neurosurg, Med Coll Virginia, Richmond, VA 23298 USA; [Baumgarten, Clive M.; Marmarou, Christina R.] Virginia Commonwealth Univ, Dept Physiol & Biophys, Med Coll Virginia, Richmond, VA 23298 USA; [Baumgarten, Clive M.] Virginia Commonwealth Univ, Dept Internal Med, Med Coll Virginia, Richmond, VA 23298 USA		Marmarou, CR (corresponding author), Virginia Commonwealth Univ, Dept Neurosurg, 1101 East Marshall St,POB 980631, Richmond, VA 23298 USA.	crmarmar@vcu.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01NS019235, 5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS047463, R01NS019235] Funding Source: NIH RePORTER	This work was supported by NIH grant 5R01NS019235. Microscopy was performed at the VCU-Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, by NIH Core grant 5P30NS047463. SR49059 was a generous gift from Sanofi-Aventis Recherche Exploratoire, Montpellier, France.	Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252; Amorini AM, 2003, ACT NEUR S, V86, P261; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; CSERR HF, 1991, J PHYSIOL-LONDON, V442, P277, DOI 10.1113/jphysiol.1991.sp018793; CSERR HF, 1991, ADV COMP ENV PHYSL, P61; CSERR HF, 1992, PROG BRAIN RES, V91, P3; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059, DOI 10.1152/ajprenal.1989.256.6.F1059; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; Ding JY, 2009, NEUROSCI LETT, V453, P68, DOI 10.1016/j.neulet.2009.01.077; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DOCZI T, 1984, NEUROSURGERY, V14, P436, DOI 10.1227/00006123-198404000-00008; DOCZI T, 1982, NEUROSURGERY, V11, P402; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Elliott MB, 2009, BRAIN RES, V1305, P183, DOI 10.1016/j.brainres.2009.09.104; Fazzina G, 2010, J NEUROTRAUM, V27, P453, DOI 10.1089/neu.2008.0782; Fukuda AM, 2012, NEUROSCIENCE, V222, P366, DOI 10.1016/j.neuroscience.2012.06.033; Fukuda AM, 2013, J CEREBR BLOOD F MET, V33, P1621, DOI 10.1038/jcbfm.2013.118; Guo QM, 2006, EXP NEUROL, V198, P469, DOI 10.1016/j.expneurol.2005.12.013; Hamby ME, 2010, NEUROTHERAPEUTICS, V7, P494, DOI 10.1016/j.nurt.2010.07.003; Hartings JA, 2008, NEUROL RES, V30, P876, DOI 10.1179/174313208X309739; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Hartings JA, 2009, J NEUROTRAUM, V26, P1857, DOI [10.1089/neu.2009.0961, 10.1089/neu.2009-0961]; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Ito J, 1996, J NEUROSURG, V84, P97, DOI 10.3171/jns.1996.84.1.0097; Kagawa M, 1996, J NEUROTRAUM, V13, P273, DOI 10.1089/neu.1996.13.273; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P303; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P258; Kleindienst A, 2006, ACTA NEUROCHIR SUPPL, V96, P393; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; LANDGRAF R, 1992, PROG BRAIN RES, V91, P29; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LATZKOVITS L, 1993, AM J PHYSIOL, V264, pC603, DOI 10.1152/ajpcell.1993.264.3.C603; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; Liu XQ, 2010, NEUROCRIT CARE, V12, P124, DOI 10.1007/s12028-009-9277-x; Lu H, 2013, CHINESE MED J-PEKING, V126, P4316, DOI 10.3760/cma.j.issn.0366-6999.20131139; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P191, DOI 10.1007/978-3-7091-0693-8_32; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Marmarou CR, 2012, J NEUROTRAUM, V29, pA121; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; Niermann H, 2001, J NEUROSCI, V21, P3045, DOI 10.1523/JNEUROSCI.21-09-03045.2001; Okuno K, 2008, ACTA NEUROCHIR SUPPL, V102, P431, DOI 10.1007/978-3-211-85578-2_84; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Reinert M, 2000, Neurosurg Focus, V8, pe10; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Richter F, 2008, J CEREBR BLOOD F MET, V28, P984, DOI 10.1038/sj.jcbfm.9600594; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Sarabia R, 1988, Acta Neurochir Suppl (Wien), V42, P40; SAUL TG, 1982, J NEUROSURG, V56, P498, DOI 10.3171/jns.1982.56.4.0498; SERRADEILLEGAL C, 1993, J CLIN INVEST, V92, P224, DOI 10.1172/JCI116554; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; Stiefel MF, 2005, J NEUROSURG, V103, P707, DOI 10.3171/jns.2005.103.4.0707; Stiefel MF, 2002, J NEUROSURG, V97, P97, DOI 10.3171/jns.2002.97.1.0097; Sun MC, 2003, J NEUROSURG, V98, P565, DOI 10.3171/jns.2003.98.3.0565; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Taya K, 2008, ACTA NEUROCHIR SUPPL, V102, P425, DOI 10.1007/978-3-211-85578-2_83; Vajda Z, 2001, NEUROSURGERY, V49, P697, DOI 10.1097/00006123-200109000-00031; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Verkman AS, 2009, J EXP BIOL, V212, P1707, DOI 10.1242/jeb.024125; Zador Zsolt, 2009, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-540-79885-9_7	67	18	18	0	17	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL 15	2014	31	14					1258	1267		10.1089/neu.2013.3063			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AN4CA	WOS:000340534000003	24635833	Green Published			2022-02-06	
J	Liu, YQ; Liu, ZW; Li, XM; Luo, BW; Xiong, J; Gan, WT; Jiang, M; Zhang, ZY; Schluesener, HJ; Zhang, ZR				Liu, Yuqi; Liu, Zongwei; Li, Xiaoming; Luo, Bangwei; Xiong, Jian; Gan, Woting; Jiang, Man; Zhang, Zhiyuan; Schluesener, Hermann J.; Zhang, Zhiren			Accumulation of connective tissue growth factor(+) cells during the early phase of rat traumatic brain injury	DIAGNOSTIC PATHOLOGY			English	Article						Connective tissue growth factor; Astrocytes; Weight-drop model; Traumatic brain injury	EXPRESSION; SCLEROSIS; DISEASE; LESIONS	Background: Glial scar formation is a common histopathological feature of traumatic brain injury (TBI). Astrogliosis and expression of transforming growth factor beta (TGF-beta) are key components of scar formation and blood-brain barrier modulation. Connective tissue growth factor (CTGF) is considered a cytokine mediating the effects of TGF-beta. Methods: Here, we studied the CTGF expression in an open-skull weight-drop-induced TBI, with a focus on the early phase, most amenable to therapy. Results: In normal rat brains of our study, CTGF(+) cells were rarely observed. Significant parenchymal accumulation of CTGF(+) non-neuron cells was observed 72 h post-TBI and increased continuously during the investigating time. We also observed that the accumulated CTGF(+) non-neuron cells were mainly distributed in the perilesional areas and showed activated astrocyte phenotypes with typical stellate morphologic characteristics. Conclusion: Our observations demonstrated the time-dependent and lesion-associated accumulation of cellular CTGF expression in TBI, suggesting a pathological role of CTGF in TBI.	[Liu, Yuqi; Liu, Zongwei; Li, Xiaoming; Luo, Bangwei; Xiong, Jian; Gan, Woting; Jiang, Man; Zhang, Zhiren] Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China; [Zhang, Zhiyuan; Schluesener, Hermann J.] Univ Tubingen, Inst Brain Res, Tubingen, Germany		Zhang, ZR (corresponding author), Third Mil Med Univ, Inst Immunol, 30 Gaotanyan Main St, Chongqing 400038, Peoples R China.	zhangzhiren@yahoo.com	zhang, zhiren/I-1046-2014; Zhang, Zhiren/O-1012-2019	zhang, zhiren/0000-0002-5238-2835; Zhang, Zhiren/0000-0002-5238-2835	National Science and Technology Major Projects of New Drugs [2012ZX09103301-035]; SRF for ROCSScientific Research Foundation for the Returned Overseas Chinese Scholars; SRF for SEM	This investigation was supported by the National Science and Technology Major Projects of New Drugs (2012ZX09103301-035) and the SRF for ROCS, SEM.	Dammeier J, 1998, INT J BIOCHEM CELL B, V30, P909, DOI 10.1016/S1357-2725(98)00046-6; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Hertel M, 2000, EUR J NEUROSCI, V12, P376, DOI 10.1046/j.1460-9568.2000.00930.x; Hobbenaghi R, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-123; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Liu YQ, 2013, NEUROREPORT, V24, P281, DOI 10.1097/WNR.0b013e32835f2810; LOGAN A, 1994, EUR J NEUROSCI, V6, P355, DOI 10.1111/j.1460-9568.1994.tb00278.x; NORENBERG MD, 1994, J NEUROPATH EXP NEUR, V53, P213, DOI 10.1097/00005072-199405000-00001; Oemar BS, 1997, CIRCULATION, V95, P831; Rongchao Sun, 2012, Diagn Pathol, V7, P54, DOI 10.1186/1746-1596-7-54; Schwab JM, 2000, NEUROPATH APPL NEURO, V26, P434, DOI 10.1046/j.1365-2990.2000.00271.x; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Spliet WGM, 2003, ACTA NEUROPATHOL, V106, P449, DOI 10.1007/s00401-003-0741-y; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Ueberham U, 2003, NEUROSCIENCE, V116, P1, DOI 10.1016/S0306-4522(02)00670-X; Zhang Z, 2006, NEUROSCIENCE, V141, P637, DOI 10.1016/j.neuroscience.2006.04.027	17	18	18	0	6	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1746-1596			DIAGN PATHOL	Diagn. Pathol.	JUL 10	2014	9								141	10.1186/1746-1596-9-141			5	Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Pathology	AL7AG	WOS:000339284600001	25012526	Green Published, gold			2022-02-06	
J	Basmajian, HG; Choi, PD; Huh, K; Sankar, WN; Wells, L; Arkader, A				Basmajian, Hrayr G.; Choi, Paul D.; Huh, Kenneth; Sankar, Wudbhav N.; Wells, Lawrence; Arkader, Alexandre			Radial neck fractures in children: experience from two level-1 trauma centers	JOURNAL OF PEDIATRIC ORTHOPAEDICS-PART B			English	Article						elbow fracture; Judet; pediatric fractures; percutaneous reduction; radial head; radial neck	CLOSED REDUCTION; PERCUTANEOUS REDUCTION; HEAD; MANAGEMENT	The aim of this study was to compare different treatment modalities for different severities of pediatric radial neck fractures in a large cohort of patients and determine prognostic factors. A retrospective, comparative study was conducted of all children treated for different severities of radial neck fractures at two level-1 pediatric trauma centers between 1990 and 2007. Pertinent data were collected, and the outcome was measured by the Tibone criteria. Several variables were compared to determine the prognostic value. Seventy-eight children were identified, 35 male and 43 female, at an average age of 7.8 years (range 3-15 years). Twenty-nine of the 78 (37%) children had associated injuries. Fracture patterns varied in their severity. Nineteen patients needed casting alone; 16 required closed reduction; of the children requiring surgery, 26 responded to percutaneous reduction and 17 were severe enough to need open reduction. Complications occurred in 28/78 (36%) children, 24 of which were related to stiffness. Seventeen of the 19 (89%) fractures that were amenable to casting alone had excellent or good outcomes, as did 11/16 (69%) in the closed reduction group. Among children treated operatively, 19/26 (73%) patients who underwent percutaneous reduction had an excellent or good outcome. Only 6/17 (35%) of the severe cases who underwent open reduction had an excellent or good outcome. The treatment method, essentially dictated by the severity of the cases, did correlate with the outcome (P = 0.001). Compared with more severe fractures that required operative treatment, patients treated nonoperatively had a higher rate of excellent to good outcome (P = 0.018). In particular, patients who underwent percutaneous reduction alone had improved outcomes versus open reduction (P = 0.008). The outcome was not related to the presence of an associated injury (P= 0.302). Initial fracture severity, as graded by the Judet classification, correlated with the outcome (P = 0.004). Furthermore, age also expressed significance, as patients younger than 10 years of age tended to do better than those above 10 years of age (P = 0.025). Children with less severe radial neck fractures amenable to nonoperative treatment fare well. Operative treatment of these fractures, particularly in severe cases when an open (not percutaneous) reduction is needed, is associated with a higher risk of poor outcome. Children over 10 years of age, especially those with more severe initial angulation, tend to fare worse. The presence of associated injuries does not appear to increase the risk of a poor outcome after treatment. There is a high rate of complications (36%), stiffness being the most common (24). This large bi-center retrospective study from two level-1 pediatric trauma centers emphasizes that in severe cases of radial neck fractures, open treatment does not necessarily decrease the risk of a poor outcome. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.	[Choi, Paul D.; Huh, Kenneth; Arkader, Alexandre] Childrens Hosp Los Angeles, Div Orthopaed Surg, Los Angeles, CA 90027 USA; [Basmajian, Hrayr G.] Loma Linda Univ, Med Ctr, Dept Orthopaed Surg, Loma Linda, CA 92354 USA; [Sankar, Wudbhav N.; Wells, Lawrence] Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA 19104 USA		Basmajian, HG (corresponding author), Loma Linda Univ, Med Ctr, Dept Orthopaed Surg, 11406 Loma Linda Dr,Suite 218, Loma Linda, CA 92354 USA.	basmajianmd@gmail.com					BERNSTEIN SM, 1993, J PEDIATR ORTHOPED, V13, P85, DOI 10.1097/01241398-199301000-00017; DSOUZA S, 1993, J PEDIATR ORTHOPED, V13, P232; Evans MC, 1999, J PEDIATR ORTHOP B, V8, P93; FERAY C, 1969, PRESSE MED, V77, P2155; Golden DW, 2007, J PEDIATR ORTHOP B, V16, P144, DOI 10.1097/BPB.0b013e328010fcf2; Herring JA, 2002, TACHDJIANS PEDIAT OR, V5th; Hudak PL, 1996, AM J IND MED, V29, P602, DOI 10.1002/(SICI)1097-0274(199606)29:6<602::AID-AJIM4>3.0.CO;2-L; JUDET J, 1962, Ann Chir, V16, P1377; KAUFMAN B, 1989, J BONE JOINT SURG BR, V71, P66, DOI 10.1302/0301-620X.71B1.2915009; LINDHAM S, 1979, ACTA ORTHOP SCAND, V50, P79, DOI 10.3109/17453677909024093; Malmvik J, 2003, J PEDIATR ORTHOP B, V12, P63, DOI 10.1097/00009957-200301000-00012; MERCHAN ECR, 1994, J TRAUMA, V37, P812; METAIZEAU JP, 1980, REV CHIR ORTHOP, V66, P47; METAIZEAU JP, 1993, J PEDIATR ORTHOPED, V13, P355, DOI 10.1097/01241398-199305000-00015; Monson R, 2009, J PEDIATR ORTHOPED, V29, P243, DOI 10.1097/BPO.0b013e3181990745; Morrey BF, 2009, ELBOW ITS DISORDERS; Neher CG, 2003, J PEDIATR ORTHOPED, V23, P626, DOI 10.1097/01241398-200309000-00009; Patterson RF, 1934, J BONE JOINT SURG, V16, P695; PESUDO JV, 1982, CLIN ORTHOP RELAT R, P215; Radomisli TE, 1998, CLIN ORTHOP RELAT R, P30; Rockwood CA, 2006, ROCKWOOD WILKINS FRA, V6th; Schmittenbecher PP, 2005, J PEDIATR ORTHOPED, V25, P45; STEELE JA, 1992, J BONE JOINT SURG BR, V74, P760, DOI 10.1302/0301-620X.74B5.1527130; STEINBERG EL, 1988, J PEDIATR ORTHOPED, V8, P35, DOI 10.1097/01241398-198801000-00009; Stiefel D, 2001, J BONE JOINT SURG BR, V83B, P536, DOI 10.1302/0301-620X.83B4.11060; TIBONE JE, 1981, J BONE JOINT SURG AM, V63, P100, DOI 10.2106/00004623-198163010-00013	26	18	25	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1060-152X	1473-5865		J PEDIATR ORTHOP B	J. Pediatr. Orthop.-Part B	JUL	2014	23	4					369	374		10.1097/BPB.0000000000000057			6	Orthopedics; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Pediatrics	AI8DM	WOS:000337136400014	24811086				2022-02-06	
J	Kinsella, GJ; Olver, J; Ong, B; Gruen, R; Hammersley, E				Kinsella, Glynda J.; Olver, John; Ong, Ben; Gruen, Russell; Hammersley, Eleanor			Mild Traumatic Brain Injury in Older Adults: Early Cognitive Outcome	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic injury; Mild head injury; Older age; Orthopedic injury; Prospective memory; Cognition; Neuropsychological outcome	PROSPECTIVE MEMORY; FALLS; AGE; IMPAIRMENT; PREDICTION; RETRIEVAL; MORTALITY; CHILDREN; MODERATE; COSTS	Severe traumatic brain injury (TBI) in older age is associated with high rates of mortality. However, little is known about outcome following mild TBI (mTBI) in older age. We report on a prospective cohort study investigating 3 month outcome in older age patients admitted to hospital-based trauma services. First, 50 mTBI older age patients and 58 orthopedic controls were compared to 123 community control participants to evaluate predisposition and general trauma effects on cognition. Specific brain injury effects were subsequently evaluated by comparing the orthopedic control and mTBI groups. Both trauma groups had significantly lower performances than the community group on prospective memory (d = 0.82 to 1.18), attention set-shifting (d = -0.61 to -0.69), and physical quality of life measures (d = 0.67 to 0.84). However, there was only a small to moderate but non-significant difference in the orthopedic control and mTBI group performances on the most demanding task of prospective memory (d = 0.37). These findings indicate that, at 3 months following mTBI, older adults are at risk of poor cognitive performance but this is substantially accounted for by predisposition to injury or general multi-system trauma.	[Kinsella, Glynda J.; Ong, Ben; Hammersley, Eleanor] La Trobe Univ, Melbourne, Vic 3086, Australia; [Kinsella, Glynda J.] Caulfield Hosp, Dept Psychol, Melbourne, Vic, Australia; [Olver, John] Epworth Healthcare, Rehabil & Psychiat, Melbourne, Vic, Australia; [Olver, John; Gruen, Russell] Monash Univ, Fac Med, Melbourne, Vic 3004, Australia; [Gruen, Russell] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Gruen, Russell] Alfred Hosp, Dept Surg, Melbourne, Vic, Australia		Kinsella, GJ (corresponding author), La Trobe Univ, Melbourne, Vic 3086, Australia.	g.kinsella@latrobe.edu.au	Kinsella, Glynda/O-6347-2017	Kinsella, Glynda/0000-0002-5859-0934; Olver, John/0000-0001-7069-1191	Victorian Neurotrauma Initiative [DP 042]; Transport Accident Commission	The authors acknowledge the contribution to the research by Dr. Evrim March, Samuel Parsons, Dr. Bethan Potter, and Dr. Sarah Price; and the enthusiastic involvement of the participants in the assessment process. Conflicts of Interest: There are no conflicts of interest. Funding statement: This project was supported by a research grant from the Victorian Neurotrauma Initiative (GJK, J.O., B.O., grant number DP 042), and the Transport Accident Commission.	AharonPeretz J, 1997, BRAIN INJURY, V11, P871; Albert MS, 2001, J INT NEUROPSYCH SOC, V7, P631, DOI 10.1017/S1355617701755105; Australian Bureau of Statistics, 2009, AUSTR NZ CLASS OCC A; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Benedict, 2001, HOPKINS VERBAL LEARN; Bradley C, 2013, INJURY RES STAT SERI, V70; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cohen J., 2013, STAT POWER ANAL BEHA; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; Coronado VG, 2005, J HEAD TRAUMA REHAB, V20, P215, DOI 10.1097/00001199-200505000-00005; Delis DC., 2001, DELIS KAPLAN EXECUTI; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Dikmen S, 2010, J INT NEUROPSYCH SOC, V16, P401, DOI 10.1017/S1355617710000196; Einstein GO, 2005, CURR DIR PSYCHOL SCI, V14, P286, DOI 10.1111/j.0963-7214.2005.00382.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Fleming J, 2008, J INT NEUROPSYCH SOC, V14, P823, DOI 10.1017/S1355617708080971; Gennarelli TA., 2008, ABBREVIATED INJURY S; Gillespie LD, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007146.pub3; Goldstein FC, 2001, J INT NEUROPSYCH SOC, V7, P373, DOI 10.1017/S1355617701733115; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Harrison J, 2008, INJURY RES STAT SERI, V45; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kinsella GJ, 2009, J NEUROL NEUROSUR PS, V80, P730, DOI 10.1136/jnnp.2008.148346; Kreutzer J., 1993, J HEAD TRAUMA REHAB, V8, P75, DOI [10.1097/00001199-199308020-00009, DOI 10.1097/00001199-199308020-00009]; Larrabee GJ, 2013, CLIN NEUROPSYCHOL, V27, P215, DOI 10.1080/13854046.2013.769634; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McCrae M., 2008, MILD TRAUMATIC BRAIN; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2011, NEUROPSYCHOLOGIA, V49, P2147, DOI 10.1016/j.neuropsychologia.2010.12.029; McIntyre A, 2013, BRAIN INJURY, V27, P31, DOI 10.3109/02699052.2012.700086; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Paveza, 2006, HDB GERIATRIC ASSESS, P193; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pluijm SMF, 2006, OSTEOPOROSIS INT, V17, P417, DOI 10.1007/s00198-005-0002-0; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport MJ, 2006, AM J GERIAT PSYCHIAT, V14, P456, DOI 10.1097/01.JGP.0000199339.79689.8a; Rathlev NK, 2006, ACAD EMERG MED, V13, P302, DOI 10.1197/j.aem.2005.10.015; REITAN RM, 1995, CLIN NEUROPSYCHOL, V9, P50, DOI 10.1080/13854049508402057; Scuffham P, 2003, J EPIDEMIOL COMMUN H, V57, P740, DOI 10.1136/jech.57.9.740; Senathi-Raja D, 2010, NEUROPSYCHOLOGY, V24, P336, DOI 10.1037/a0018239; Shum D, 2011, NEUROPSYCHOLOGIA, V49, P2156, DOI 10.1016/j.neuropsychologia.2011.02.006; Stevens JA, 2006, INJURY PREV, V12, P290, DOI 10.1136/ip.2005.011015; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; TEASDALE G, 1974, LANCET, V2, P81; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tinetti ME, 2003, NEW ENGL J MED, V348, P42, DOI 10.1056/NEJMcp020719; United Nations, 2012, AG 21 CENT CEL CHALL; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Ware J.E., 2002, SCORE VERSION 2 SF 1; Wechsler D., 1997, WECHSLER MEMORY SCAL; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Wilson B., 2005, CAMBRIDGE PROSPECTIV; Woods SP, 2012, J INT NEUROPSYCH SOC, V18, P134, DOI 10.1017/S1355617711001263; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	58	18	18	1	15	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JUL	2014	20	6					663	671		10.1017/S1355617714000447			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	AL7PH	WOS:000339326300010	24834461				2022-02-06	
J	Spaite, DW; Bobrow, BJ; Stolz, U; Sherrill, D; Chikani, V; Barnhart, B; Sotelo, M; Gaither, JB; Viscusi, C; Adelson, PD; Denninghoff, KR				Spaite, Daniel W.; Bobrow, Bentley J.; Stolz, Uwe; Sherrill, Duane; Chikani, Vatsal; Barnhart, Bruce; Sotelo, Michael; Gaither, Joshua B.; Viscusi, Chad; Adelson, P. David; Denninghoff, Kurt R.			Evaluation of the Impact of Implementing the Emergency Medical Services Traumatic Brain Injury Guidelines in Arizona: The Excellence in Prehospital Injury Care (EPIC) Study Methodology	ACADEMIC EMERGENCY MEDICINE			English	Article							CEREBRAL-BLOOD-FLOW; RAPID-SEQUENCE INTUBATION; ADVANCED LIFE-SUPPORT; SEVERE HEAD-INJURY; HOSPITAL CARDIAC-ARREST; ENDOTRACHEAL INTUBATION; MAJOR TRAUMA; INTRAHOSPITAL TRANSPORT; PEDIATRIC-PATIENTS; EARLY VENTILATION	Traumatic brain injury (TBI) exacts a great toll on society. Fortunately, there is growing evidence that the management of TBI in the early minutes after injury may significantly reduce morbidity and mortality. In response, evidence-based prehospital and in-hospital TBI treatment guidelines have been established by authoritative bodies. However, no large studies have yet evaluated the effectiveness of implementing these guidelines in the prehospital setting. This article describes the background, design, implementation, emergency medical services (EMS) treatment protocols, and statistical analysis of a prospective, controlled (before/after), statewide study designed to evaluate the effect of implementing the EMS TBI guidelines-the Excellence in Prehospital Injury Care (EPIC) study (NIH/NINDS R01NS071049, "EPIC"; and 3R01NS071049-S1, "EPIC4Kids"). The specific aim of the study is to test the hypothesis that statewide implementation of the international adult and pediatric EMS TBI guidelines will significantly reduce mortality and improve nonmortality outcomes in patients with moderate or severe TBI. Furthermore, it will specifically evaluate the effect of guideline implementation on outcomes in the subgroup of patients who are intubated in the field. Over the course of the entire study (similar to 9 years), it is estimated that approximately 25,000 patients will be enrolled. (C) 2014 by the Society for Academic Emergency Medicine	[Spaite, Daniel W.; Bobrow, Bentley J.; Stolz, Uwe; Chikani, Vatsal; Barnhart, Bruce; Sotelo, Michael; Gaither, Joshua B.; Viscusi, Chad; Denninghoff, Kurt R.] Phoenix Childrens Hosp, Barrow Neurol Inst, Arizona Emergency Med Res Ctr, Tucson, AZ USA; [Spaite, Daniel W.; Stolz, Uwe; Barnhart, Bruce; Gaither, Joshua B.; Denninghoff, Kurt R.] Phoenix Childrens Hosp, Barrow Neurol Inst, Dept Emergency Med, Tucson, AZ USA; [Adelson, P. David] Univ Arizona, Coll Med, Dept Child Hlth Neurosurg, Tucson, AZ USA; [Bobrow, Bentley J.; Chikani, Vatsal] Arizona Dept Hlth Serv, Phoenix, AZ 85007 USA; [Bobrow, Bentley J.] Maricopa Integrated Hlth Syst, Phoenix, AZ USA; [Sherrill, Duane] Univ Arizona, Coll Publ Hlth, Tucson, AZ USA		Spaite, DW (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Arizona Emergency Med Res Ctr, Tucson, AZ USA.	dan@aemrc.arizona.edu	Adelson, David/W-2083-2019	Chikani, Vatsal/0000-0003-0904-7887; Spaite, Daniel/0000-0003-2601-6476	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071049]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS071049] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award R01NS071049. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelson PD, 1997, PEDIATR NEUROSURG, V26, P200; American Heart Association, PED ADV LIF SUPP PAL; Armitage P, 1975, SEQUENTIAL MED TRIAL; Aufderheide Tom P, 2004, Crit Care Med, V32, pS345, DOI 10.1097/01.CCM.0000134335.46859.09; Ausina A, 1998, ACT NEUR S, V71, P1; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bao Yinghui, 2000, Chin J Traumatol, V3, P210; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barton CW, 2005, ACAD EMERG MED, V12, P1, DOI 10.1197/j.aem.2004.08.043; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; Bloomfield GL, 1997, CRIT CARE MED, V25, P496, DOI 10.1097/00003246-199703000-00020; Bobrow BJ, 2008, PREHOSP EMERG CARE, V12, P381, DOI 10.1080/10903120802100670; Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; Bobrow BJ, 2013, ANN EMERG MED, V62, P47, DOI 10.1016/j.annemergmed.2012.12.020; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Bobrow BJ, 2009, ANN EMERG MED, V54, P656, DOI 10.1016/j.annemergmed.2009.06.011; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOYD CR, 1987, J TRAUMA, V27, P370, DOI 10.1097/00005373-198704000-00005; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; BRUCE DA, 1979, CHILD BRAIN, V5, P174; Bulger EM, 2005, J TRAUMA, V58, P718, DOI 10.1097/01.TA.0000159239.14181.BC; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; CARREL M, 1994, ANN FR ANESTH, V13, P326, DOI 10.1016/S0750-7658(94)80041-3; Champion H R, 2002, Scand J Surg, V91, P12; CHAMPION HR, 1995, J TRAUMA, V38, P94, DOI 10.1097/00005373-199501000-00024; CHAMPION HR, 1990, J TRAUMA, V30, P1356, DOI 10.1097/00005373-199011000-00008; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; Citerio G, 2001, CRIT CARE MED, V29, P1466, DOI 10.1097/00003246-200107000-00027; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cudnik MT, 2010, J EMERG MED, V38, P175, DOI 10.1016/j.jemermed.2008.01.022; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DARBY JM, 1988, NEUROSURGERY, V23, P84, DOI 10.1227/00006123-198807000-00014; Davis DP, 2008, RESUSCITATION, V76, P333, DOI 10.1016/j.resuscitation.2007.08.004; Davis DP, 2007, RESUSCITATION, V73, P354, DOI 10.1016/j.resuscitation.2006.09.015; Davis DP, 2007, PREHOSP EMERG CARE, V11, P1, DOI 10.1080/10903120601021093; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2005, ANN EMERG MED, V46, P115, DOI 10.1016/j.annemergmed.2005.01.024; Davis DP, 2005, NEUROCRIT CARE, V2, P165, DOI 10.1385/NCC:2:2:165; Davis DP, 2004, J TRAUMA, V57, P1, DOI 10.1097/01.TA.0000135503.71684.C8; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; Denninghoff KR, 2008, WEST J EMERG MED, V9, P184; Dunford JV, 2003, ANN EMERG MED, V42, P721, DOI 10.1016/S0196-0644(03)00660-7; Eckstein M, 2000, J TRAUMA, V48, P643, DOI 10.1097/00005373-200004000-00010; Engdahl J, 2000, RESUSCITATION, V43, P201, DOI 10.1016/S0300-9572(99)00154-9; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, TRAUMATIC BRAIN INJU; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P267, DOI 10.3109/02688699309023809; FIESCHI C, 1974, J NEUROL NEUROSUR PS, V37, P1378, DOI 10.1136/jnnp.37.12.1378; Fingerhut LA, 2002, INJ PREV, V8, P259, DOI 10.1136/ip.8.3.259; Finkelstein E., 2006, INCIDENCE EC BURDEN; Forbes ML, 1998, J NEUROSURG, V88, P549, DOI 10.3171/jns.1998.88.3.0549; Fortune JB, 1995, J TRAUMA, V39, P1091, DOI 10.1097/00005373-199512000-00014; Garrison HG, 2002, ANN EMERG MED, V40, P81, DOI 10.1067/mem.2002.124758; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; GENTLEMAN D, 1992, INT SURG, V77, P297; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; GORDON E, 1968, ACTA ANAESTH SCAND, V12, P51, DOI 10.1111/j.1399-6576.1968.tb00411.x; Helm M, 2002, BRIT J ANAESTH, V88, P345, DOI 10.1093/bja/88.3.345; Helmy A, 2007, BRIT J ANAESTH, V99, P32, DOI 10.1093/bja/aem139; HILL DA, 1993, AUST NZ J SURG, V63, P604, DOI 10.1111/j.1445-2197.1993.tb00466.x; Hsia RY, 2010, J TRAUMA, V68, P217, DOI 10.1097/TA.0b013e3181a0e66d; HURST JM, 1989, J TRAUMA, V29, P1637, DOI 10.1097/00005373-198912000-00008; Iezzoni LI, 2003, RISK ADJUSTMENT MEAS; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; Jankowitz BT, 2006, DEV NEUROSCI-BASEL, V28, P264, DOI 10.1159/000094153; JEFFREYS RV, 1981, LANCET, V2, P459; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KARIM MR, 1992, BIOMETRICS, V48, P631, DOI 10.2307/2532317; KAUFMANN CR, 1991, J TRAUMA, V31, P691, DOI 10.1097/00005373-199105000-00014; Keim SM, 2004, ACAD EMERG MED, V11, P1067, DOI 10.1197/j.aem.2004.04.014; Kiening KL, 1997, NEUROL RES, V19, P233, DOI 10.1080/01616412.1997.11740805; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; Kokoska ER, 1998, J PEDIATR SURG, V33, P333, DOI 10.1016/S0022-3468(98)90457-2; Kreutzer JS, 2001, BRAIN INJURY, V15, P763, DOI 10.1080/02699050010025786; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lewis F., 2008, AM HEART ASS RES SCI; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MacKenzie EJ, 2006, NEW ENGL J MED, V354, P366, DOI 10.1056/NEJMsa052049; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; Manley GT, 2000, J TRAUMA, V48, P1025, DOI 10.1097/00005373-200006000-00005; Marcin JP, 2002, CRIT CARE MED, V30, pS457, DOI 10.1097/00003246-200211001-00011; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; Marion DW, 2002, CRIT CARE MED, V30, P2619, DOI 10.1097/00003246-200212000-00001; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; McCullagh P., 1989, GEN LINEAR MODELS 2, V2; McCulloch CE, 2001, GEN LINEAR MIXED MOD; McLean Samuel A, 2002, Prehosp Emerg Care, V6, pS52; MCPHERSON K, 1990, STAT MED, V9, P595, DOI 10.1002/sim.4780090605; Miller J D, 1982, J R Coll Surg Edinb, V27, P292; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Nakamura Y, 2012, ANN EMERG MED, V60, P335, DOI 10.1016/j.annemergmed.2012.04.006; Newgard CD, 2004, ACAD EMERG MED, V11, P953, DOI 10.1197/j.aem.2004.02.530; Newgard CD, 2011, J AM COLL SURGEONS, V213, P709, DOI 10.1016/j.jamcollsurg.2011.09.012; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Obrist WD, 1987, CEREBRAL VASCULAR DI, V6, P241; Ong LC, 1996, PEDIATR NEUROSURG, V24, P285, DOI 10.1159/000121057; Ott R, 2000, J TRAUMA, V49, P729, DOI 10.1097/00005373-200010000-00023; Palmer S, 2001, J TRAUMA, V50, P657, DOI 10.1097/00005373-200104000-00010; Pepe Paul E, 2004, Crit Care Med, V32, pS414, DOI 10.1097/01.CCM.0000134264.88332.37; Pepe PE, 2005, CURR OPIN CRIT CARE, V11, P212, DOI 10.1097/01.ccx.0000163650.80601.24; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; POCOCK SJ, 1981, PERSPECTIVES MED STA; Poste Jennifer C, 2004, Air Med J, V23, P36, DOI 10.1016/j.amj.2004.04.006; Prause G, 1997, RESUSCITATION, V35, P145, DOI 10.1016/S0300-9572(97)00043-9; PRICE DJE, 1972, INJURY-BR J ACCIDENT, V3, P218, DOI 10.1016/0020-1383(72)90104-0; RAPHAELY RC, 1980, PEDIATR CLIN N AM, V27, P715; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; ROSE J, 1977, BRIT MED J, V2, P615, DOI 10.1136/bmj.2.6087.615; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SEELIG JM, 1986, INTRACRANIAL PRESSUR, P675; Senkowski CK, 1999, J AM COLL SURGEONS, V189, P491, DOI 10.1016/S1072-7515(99)00190-8; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P153, DOI 10.1136/jnnp.58.2.153; Shutter LA, 2008, ANN EMERG MED, V51, pS37, DOI 10.1016/j.annemergmed.2007.11.013; SILVERSTON P, 1989, BRIT MED J, V298, P711, DOI 10.1136/bmj.298.6675.711; SIOUTOS PJ, 1995, NEUROSURGERY, V36, P943, DOI 10.1227/00006123-199505000-00009; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Slutsky A S, 2000, Respir Res, V1, P73, DOI 10.1186/rr15; Spaite DW, 2008, RESUSCITATION, V79, P61, DOI 10.1016/j.resuscitation.2008.05.006; SPAITE DW, 1995, ANN EMERG MED, V26, P146, DOI 10.1016/S0196-0644(95)70144-3; SPAITE DW, 1993, ANN EMERG MED, V22, P638, DOI 10.1016/S0196-0644(05)81840-2; Spaite DW, 2001, ANN EMERG MED, V37, P657, DOI 10.1067/mem.2001.115215; Spaite DW, 2009, EMERGENCY MED SERVIC; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Stiell IG, 2007, NEW ENGL J MED, V356, P2156, DOI 10.1056/NEJMoa060334; Stiell IG, 2004, NEW ENGL J MED, V351, P647, DOI 10.1056/NEJMoa040325; Stiell IG, 1999, JAMA-J AM MED ASSOC, V281, P1175, DOI 10.1001/jama.281.13.1175; Stiell IG, 1999, ANN EMERG MED, V34, P256, DOI 10.1016/S0196-0644(99)70241-6; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Thomas SH, 2002, J TRAUMA, V52, P47, DOI 10.1097/00005373-200201000-00010; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tobias JD, 1996, PEDIATR EMERG CARE, V12, P249, DOI 10.1097/00006565-199608000-00003; Uhlig S, 2002, AM J PHYSIOL-LUNG C, V282, pL892, DOI 10.1152/ajplung.00124.2001; Wang HE, 2004, ANN EMERG MED, V44, P439, DOI 10.1016/j.annemergmed.2004.04.008; Wang HE, 2006, PREHOSP EMERG CARE, V10, P261, DOI 10.1080/10903120500541506; Warner KJ, 2007, J TRAUMA, V62, P1330, DOI 10.1097/TA.0b013e31804a8032; Warner KJ, 2007, TRAUMA, V9, P283, DOI 10.1177/1460408607088317	150	18	19	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	JUL	2014	21	7					818	830		10.1111/acem.12411			13	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	AN5AA	WOS:000340600200014	25112451	Green Accepted			2022-02-06	
J	Vasudevan, EVL; Glass, RN; Packel, AT				Vasudevan, Erin V. L.; Glass, Rebecca N.; Packel, Andrew T.			Effects of Traumatic Brain Injury on Locomotor Adaptation	JOURNAL OF NEUROLOGIC PHYSICAL THERAPY			English	Article						feedback control; feed-forward control; motor learning; locomotor adaptation; traumatic brain injury; walking	MOBILITY ASSESSMENT-TOOL; SPLIT-BELT TREADMILL; DIFFUSE AXONAL INJURY; NEUROPSYCHIATRIC SEQUELAE; CEREBELLAR ATROPHY; DOUBLE-BLIND; SWING PHASE; HEAD-INJURY; GAIT; MOTOR	Background and Purpose: Locomotor adaptation is a form of short-term learning that enables gait modifications and reduces movement errors when the environment changes. This adaptation is critical for community ambulation for example, when walking on different surfaces. While many individuals with traumatic brain injury (TBI) recover basic ambulation, less is known about recovery of more complex locomotor skills, like adaptation. The purpose of this study was to investigate how TBI affects locomotor adaptation. Methods: Fourteen adults with TBI and 11 nondisabled comparison participants walked for 15 minutes on a split-belt treadmill with 1 belt moving at 0.7 m/s, and the other at 1.4 m/s. Subsequently, aftereffects were assessed and de-adapted during 15 minutes of tied-belt walking (both belts at 0.7 m/s). Results: Participants with TBI showed greater asymmetry in inter-limb coordination on split-belts than the comparison group. Those with TBI did not adapt back to baseline symmetry, and some individuals did not store significant aftereffects. Greater asymmetry on split-belts and smaller aftereffects were associated with greater ataxia. Discussion: Participants with TBI were more perturbed by walking on split-belts and showed some impairment in adaptation. This suggests a reduced ability to learn a new form of coordination to compensate for environmental changes. Multiple interacting factors, including cerebellar damage and impairments in higher-level cognitive processes, may influence adaptation post-TBI. Conclusions: Gait adaptation to novel environment demands is impaired in persons with chronic TBI and may be an important skill to target in rehabilitation. Video Abstract Available (See Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A74) for more insights from the authors.	[Vasudevan, Erin V. L.; Glass, Rebecca N.; Packel, Andrew T.] Moss Rehabil Res Inst, Albert Einstein Healthcare Network, Motor Learning Lab, Elkins Pk, PA 19027 USA		Vasudevan, EVL (corresponding author), Moss Rehabil Res Inst, 50 Township Line Rd, Elkins Pk, PA 19027 USA.	vasudeve@einstein.edu	Packel, Andrew/AAJ-4840-2021; Vasudevan, Erin/F-7081-2017	Packel, Andrew/0000-0002-5048-1661; Vasudevan, Erin/0000-0003-1129-3489	Moss Rehabilitation Research Institute Peer Review Committee	This work has been supported by seed funding from the Moss Rehabilitation Research Institute Peer Review Committee.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bier JC, 2003, J NEUROL, V250, P693, DOI 10.1007/s00415-003-1061-9; Cantin JF, 2007, BRAIN INJURY, V21, P327, DOI 10.1080/02699050701209972; Catena RD, 2007, EXP BRAIN RES, V176, P23, DOI 10.1007/s00221-006-0596-2; Chen HY, 2006, CEREB CORTEX, V16, P1462, DOI 10.1093/bhj087; Choi JT, 2009, BRAIN, V132, P722, DOI 10.1093/brain/awn333; Chou LS, 2004, GAIT POSTURE, V20, P245, DOI 10.1016/j.gaitpost.2003.09.007; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Galea JM, 2011, CEREB CORTEX, V21, P1761, DOI 10.1093/cercor/bhq246; Gordon KE, 2010, J NEUROPHYSIOL, V104, P1325, DOI 10.1152/jn.00604.2009; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; GRILLNER S, 1985, ANNU REV NEUROSCI, V8, P233, DOI 10.1146/annurev.ne.08.030185.001313; HOLM S, 1979, SCAND J STAT, V6, P65; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; IWADATE Y, 1989, Neurosurgical Review, V12, P500, DOI 10.1007/BF01790695; Jayaram G, 2011, CEREB CORTEX, V21, P1901, DOI 10.1093/cercor/bhq263; JORDAN BD, 1988, ARCH NEUROL-CHICAGO, V45, P1207, DOI 10.1001/archneur.1988.00520350045014; Kahn JH, 2009, PHYS THER, V89, P474, DOI 10.2522/ptj.20080237; Katz DI, 2004, ARCH PHYS MED REHAB, V85, P865, DOI 10.1016/j.apmr.2003.11.020; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Kraus MF, 1999, TRAUMATIC BRAIN INJU, V14, P173; Lam T, 2006, J NEUROPHYSIOL, V95, P766, DOI 10.1152/jn.00473.2005; Lam T, 2008, NEUROREHAB NEURAL RE, V22, P438, DOI 10.1177/1545968308315595; Lam T, 2009, J NEUROL PHYS THER, V33, P129, DOI 10.1097/NPT.0b013e3181b57de5; Louis ED, 1996, ARCH NEUROL-CHICAGO, V53, P450, DOI 10.1001/archneur.1996.00550050080027; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Malone LA, 2012, J NEUROPHYSIOL, V108, P672, DOI 10.1152/jn.00391.2011; Malone LA, 2011, J NEUROSCI, V31, P15136, DOI 10.1523/JNEUROSCI.1367-11.2011; Malone LA, 2010, J NEUROPHYSIOL, V103, P1954, DOI 10.1152/jn.00832.2009; Martin TA, 1996, BRAIN, V119, P1183, DOI 10.1093/brain/119.4.1183; Mazaux JM, 1998, DISABIL REHABIL, V20, P435, DOI 10.3109/09638289809166108; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; McCulloch KL, 2010, J HEAD TRAUMA REHAB, V25, P155, DOI 10.1097/HTR.0b013e3181dc82e7; McFadyen BJ, 2003, J HEAD TRAUMA REHAB, V18, P512, DOI 10.1097/00001199-200311000-00005; McFadyen BJ, 2009, ARCH PHYS MED REHAB, V90, P1596, DOI 10.1016/j.apmr.2009.03.010; Saute JAM, 2012, CEREBELLUM, V11, P488, DOI 10.1007/s12311-011-0316-8; Morton SM, 2004, J NEUROPHYSIOL, V92, P2497, DOI 10.1152/jn.00129.2004; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Morton SM, 2006, J NEUROSCI, V26, P9107, DOI 10.1523/JNEUROSCI.2622-06.2006; Niimura K, 1999, NEUROLOGY, V52, P792, DOI 10.1212/WNL.52.4.792; Ochi F, 1999, J HEAD TRAUMA REHAB, V14, P105, DOI 10.1097/00001199-199904000-00002; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pearson KG, 2000, ANNU REV PHYSIOL, V62, P723, DOI 10.1146/annurev.physiol.62.1.723; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rao V, 2000, PSYCHOSOMATICS, V41, P95, DOI 10.1176/appi.psy.41.2.95; Regnaux JP, 2008, CLIN BIOMECH, V23, P762, DOI 10.1016/j.clinbiomech.2008.01.011; Reisman DS, 2007, BRAIN, V130, P1861, DOI 10.1093/brain/awm035; Reisman DS, 2010, PHYS THER, V90, P187, DOI 10.2522/ptj.20090073; Reisman DS, 2005, J NEUROPHYSIOL, V94, P2403, DOI 10.1152/jn.00089.2005; Ristori G, 2010, NEUROLOGY, V74, P839, DOI 10.1212/WNL.0b013e3181d31e23; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; SAHUQUILLO J, 1989, ACTA NEUROCHIR, V101, P149, DOI 10.1007/BF01410531; Saibene F, 2003, EUR J APPL PHYSIOL, V88, P297, DOI 10.1007/s00421-002-0654-9; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Savin DN, 2013, NEUROREHAB NEURAL RE, V27, P24, DOI 10.1177/1545968311434552; Schmahmann JD, 2009, NEUROSCIENCE, V162, P852, DOI 10.1016/j.neuroscience.2009.06.023; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Soto-Ares G, 2001, CHILD NERV SYST, V17, P263, DOI 10.1007/s003810000411; Spanos GK, 2007, AM J NEURORADIOL, V28, P537; Swaine BR, 1996, BRAIN INJURY, V10, P347, DOI 10.1080/026990596124368; Taylor JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002485; TEASDALE G, 1974, LANCET, V2, P81; THACH WT, 1992, ANNU REV NEUROSCI, V15, P403, DOI 10.1146/annurev.neuro.15.1.403; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Tison F, 2002, MOVEMENT DISORD, V17, P1248, DOI 10.1002/mds.10290; Torres-Oviedo G, 2010, J NEUROSCI, V30, P17015, DOI 10.1523/JNEUROSCI.4205-10.2010; Trouillas P, 1997, J NEUROL SCI, V145, P205, DOI 10.1016/S0022-510X(96)00231-6; Vallee M, 2006, ARCH PHYS MED REHAB, V87, P806, DOI 10.1016/j.apmr.2006.02.031; Vasudevan EVL, 2011, J NEUROSCI, V31, P3055, DOI 10.1523/JNEUROSCI.5781-10.2011; Vasudevan EVL, 2010, J NEUROPHYSIOL, V103, P183, DOI 10.1152/jn.00501.2009; Whyte J, 2010, DELISAS PHYS MED REH, V5, P575; Williams G, 2006, ARCH PHYS MED REHAB, V87, P437, DOI 10.1016/j.apmr.2005.10.028; Williams G, 2005, BRAIN INJURY, V19, P925, DOI 10.1080/02699050500058687; Williams GP, 2009, INT J THER REHABIL, V16, P370, DOI 10.12968/ijtr.2009.16.7.43046; Williams G, 2013, BRAIN INJURY, V27, P434, DOI 10.3109/02699052.2012.750754; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Williams G, 2009, ARCH PHYS MED REHAB, V90, P587, DOI 10.1016/j.apmr.2008.10.013; Williams GP, 2006, PHYS THER, V86, P395, DOI 10.1093/ptj/86.3.395; Williams GP, 2005, BRAIN INJURY, V19, P833, DOI 10.1080/02699050500058711	87	18	18	0	22	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1557-0576	1557-0584		J NEUROL PHYS THER	J. Neurol. Phys. Ther.	JUL	2014	38	3					172	182		10.1097/NPT.0000000000000049			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AL3UA	WOS:000339053700006	24892766				2022-02-06	
J	Natarajan, R; Singal, V; Benes, R; Gao, JL; Chan, H; Chen, HJ; Yu, YJ; Zhou, J; Wu, P				Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Chen, Haijun; Yu, Yongjia; Zhou, Jia; Wu, Ping			STAT3 Modulation to Enhance Motor Neuron Differentiation in Human Neural Stem Cells	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FIBROBLAST-GROWTH-FACTOR; SMALL-MOLECULE INHIBITOR; SPINAL-CORD-INJURY; ASTROCYTE DIFFERENTIATION; PROMOTES NEUROGENESIS; REACTIVE ASTROCYTES; SIGNALING PATHWAY; FETAL BRAIN; ACTIVATION	Spinal cord injury or amyotrophic lateral sclerosis damages spinal motor neurons and forms a glial scar, which prevents neural regeneration. Signal transducer and activator of transcription 3 (STAT3) plays a critical role in astrogliogenesis and scar formation, and thus a fine modulation of STAT3 signaling may help to control the excessive gliogenic environment and enhance neural repair. The objective of this study was to determine the effect of STAT3 inhibition on human neural stem cells (hNSCs). In vitro hNSCs primed with fibroblast growth factor 2 (FGF2) exhibited a lower level of phosphorylated STAT3 than cells primed by epidermal growth factor (EGF), which correlated with a higher number of motor neurons differentiated from FGF2-primed hNSCs. Treatment with STAT3 inhibitors, Stattic and Niclosamide, enhanced motor neuron differentiation only in FGF2-primed hNSCs, as shown by increased homeobox gene Hb9 mRNA levels as well as HB9(+) and microtubule-associated protein 2 (MAP2)(+) co-labeled cells. The increased motor neuron differentiation was accompanied by a decrease in the number of glial fibrillary acidic protein (GFAP)-positive astrocytes. Interestingly, Stattic and Niclosamide did not affect the level of STAT3 phosphorylation; rather, they perturbed the nuclear translocation of phosphorylated STAT3. In summary, we demonstrate that FGF2 is required for motor neuron differentiation from hNSCs and that inhibition of STAT3 further increases motor neuron differentiation at the expense of astrogliogenesis. Our study thus suggests a potential benefit of targeting the STAT3 pathway for neurotrauma or neurodegenerative diseases.	[Natarajan, Rajalaxmi; Singal, Vinamrata; Benes, Richard; Gao, Junling; Chan, Hoi; Wu, Ping] Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA; [Chen, Haijun; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Yu, Yongjia] Univ Texas Med Branch, Dept Radiat Oncol, Galveston, TX 77555 USA		Wu, P (corresponding author), Univ Texas Med Branch, Dept Neurosci & Cell Biol, Galveston, TX 77555 USA.	piwu@utmb.edu			John S. Dunn Research Foundation; TIRR Foundation Mission Connect; Gillson Longenbaugh Foundation; Moody Foundation	This study is supported by John S. Dunn Research Foundation, TIRR Foundation Mission Connect, Gillson Longenbaugh Foundation, and Moody Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Cao F, 2010, BIOCHEM BIOPH RES CO, V394, P843, DOI 10.1016/j.bbrc.2010.03.092; Chen HJ, 2013, EUR J MED CHEM, V62, P498, DOI 10.1016/j.ejmech.2013.01.023; Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082; Cheng PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022018; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dominguez E, 2008, J NEUROCHEM, V107, P50, DOI 10.1111/j.1471-4159.2008.05566.x; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gritti A, 1996, J NEUROSCI, V16, P1091; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Jordan PM, 2009, J NEUROSCI RES, V87, P318, DOI 10.1002/jnr.21856; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Lee S, 2013, P NATL ACAD SCI USA, V110, P11445, DOI 10.1073/pnas.1302676110; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Ojeda L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023414; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; Rai KS, 2007, EUR J NEUROSCI, V26, P1765, DOI 10.1111/j.1460-9568.2007.05820.x; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Rajan P, 1998, J NEUROSCI, V18, P3620; Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z; Schubert KO, 2005, EXP BRAIN RES, V165, P520, DOI 10.1007/s00221-005-2330-x; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shibata N, 2010, NEUROPATHOLOGY, V30, P353, DOI 10.1111/j.1440-1789.2009.01078.x; Shibata N, 2009, NEURODEGENER DIS, V6, P118, DOI 10.1159/000213762; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Tao Y, 1996, J COMP NEUROL, V376, P653, DOI 10.1002/(SICI)1096-9861(19961223)376:4<653::AID-CNE11>3.0.CO;2-N; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Walker Sarah R, 2012, JAKSTAT, V1, P292, DOI 10.4161/jkst.22662; Werner S, 2011, J NEUROSCI RES, V89, P1605, DOI 10.1002/jnr.22680; Wu P, 2002, NAT NEUROSCI, V5, P1271, DOI 10.1038/nn974; Yamauchi K, 2006, J NEUROCHEM, V96, P1060, DOI 10.1111/j.1471-4159.2005.03559.x	37	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 19	2014	9	6							e100405	10.1371/journal.pone.0100405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AN6QP	WOS:000340721500070	24945434	Green Published, Green Submitted, gold			2022-02-06	
J	Alsalaheen, BA; Whitney, SL; Marchetti, GF; Furman, JM; Kontos, AP; Collins, MW; Sparto, PJ				Alsalaheen, Bara A.; Whitney, Susan L.; Marchetti, Gregory F.; Furman, Joseph M.; Kontos, Anthony P.; Collins, Michael W.; Sparto, Patrick J.			Performance of High School Adolescents on Functional Gait and Balance Measures	PEDIATRIC PHYSICAL THERAPY			English	Article						activities of daily living; adolescence; gait; motor skills; postural balance; reproducibility of results; vestibular function tests/standards	SPORT-RELATED CONCUSSION; TO-STAND PERFORMANCE; MILD HEAD-INJURY; VESTIBULAR REHABILITATION; NORMATIVE DATA; OLDER-ADULTS; NEUROCOGNITIVE FUNCTION; POSTURAL STABILITY; ELDERLY PERSONS; BRAIN-INJURY	Purpose: To describe the performance of high school adolescents during common functional gait and balance measures used in vestibular physical therapy. Methods: A cross-sectional study of 91 participants determined their performance on the Activities-specific Balance Confidence (ABC) scale, Dynamic Gait Index, Functional Gait Assessment, Timed "Up and Go" (TUG), Five Times Sit to Stand (FTSTS) test, tests of gait speed (GS), and the Balance Error Scoring System. In a subset of this sample, GS, TUG, and the FTSTS were repeated twice to examine test-retest reliability. Results: The measures of GS, TUG, and FISTS were normally distributed. The Activities-specific Balance Confidence, Dynamic Gait Index, and Functional Gait Assessment exhibited a ceiling effect. The timed measures exhibited moderate to good reliability. Conclusions: These performance scores may provide end points for discharge from vestibular physical therapy. However, clinicians should be aware of the ceiling effect exhibited by some measures.	[Alsalaheen, Bara A.] Univ Michigan, Phys Therapy Dept, Flint, MI 48502 USA; [Whitney, Susan L.; Furman, Joseph M.; Sparto, Patrick J.] Univ Pittsburgh, Dept Phys Therapy, Pittsburgh, PA USA; [Whitney, Susan L.; Furman, Joseph M.; Sparto, Patrick J.] Univ Pittsburgh, Dept Otolaryngol, Pittsburgh, PA 15260 USA; [Kontos, Anthony P.; Collins, Michael W.] Univ Pittsburgh, Dept Orthoped Surg, Pittsburgh, PA USA; [Marchetti, Gregory F.] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Whitney, Susan L.] King Saud Univ, Dept Rehabil Sci, Riyadh, Saudi Arabia		Alsalaheen, BA (corresponding author), Univ Michigan, Phys Therapy Dept, 2157 William S White Bldg,303 E Kearsley St, Flint, MI 48502 USA.	Alsalahe@umflint.edu		Kontos, Anthony/0000-0002-3749-4310; Sparto, Patrick/0000-0002-8351-3789	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153] Funding Source: NIH RePORTER	The National Institutes of Health through Grants Number UL1 RR024153 and UL1TR000005 supported the project described.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Bressel E, 2007, J ATHL TRAINING, V42, P42; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Brown KE, 2006, ARCH PHYS MED REHAB, V87, P76, DOI 10.1016/j.apmr.2005.08.003; Bruininks, 1978, BRUININKS OSERETSKY; Cohen JS, 2009, CURR OPIN PEDIATR, V21, P288, DOI 10.1097/MOP.0b013e32832b1195; CSUKA M, 1985, AM J MED, V78, P77, DOI 10.1016/0002-9343(85)90465-6; Enticott JC, 2005, OTOL NEUROTOL, V26, P265, DOI 10.1097/00129492-200503000-00024; Evans MD, 1997, ARCH PHYS MED REHAB, V78, P725, DOI 10.1016/S0003-9993(97)90080-0; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Gill-Body KM, 2000, PHYS THER, V80, P748, DOI 10.1093/ptj/80.8.748; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; Hall TD, 2004, OTOL NEUROTOL, V25, P746, DOI 10.1097/00129492-200409000-00017; HERDMAN SJ, 1995, OTOLARYNG HEAD NECK, V113, P77, DOI 10.1016/S0194-5998(95)70148-6; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Hoffer ME, 2004, OTOL NEUROTOL, V25, P135, DOI 10.1097/00129492-200403000-00009; HORAK FB, 1992, OTOLARYNG HEAD NECK, V106, P175, DOI 10.1177/019459989210600220; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; Jette AM, 1999, J GERONTOL A-BIOL, V54, pM3, DOI 10.1093/gerona/54.1.M3; Kirkwood MW, 2006, PEDIATRICS, V117, P1359, DOI 10.1542/peds.2005-0994; Krebs DE, 2003, OTOLARYNG HEAD NECK, V128, P240, DOI 10.1067/mhn.2003.72; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Maskell F, 2006, BRAIN INJURY, V20, P293, DOI 10.1080/02699050500488041; Masson F, 1996, BRAIN INJURY, V10, P487, DOI 10.1080/026990596124205; McClincy MP, 2006, BRAIN INJURY, V20, P33, DOI 10.1080/02699050500309817; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; Meretta BM, 2006, J VESTIBUL RES-EQUIL, V16, P233; Mong YQ, 2010, ARCH PHYS MED REHAB, V91, P407, DOI 10.1016/j.apmr.2009.10.030; OBERG T, 1993, J REHABIL RES DEV, V30, P210; Oliaro SM, 1998, J ATHL TRAINING, V33, P36; Ostchega Y, 2000, J AM GERIATR SOC, V48, P1136, DOI 10.1111/j.1532-5415.2000.tb04792.x; Patel DR, 2005, SPORTS MED, V35, P671, DOI 10.2165/00007256-200535080-00002; Peretz C, 2006, MOVEMENT DISORD, V21, P2101, DOI 10.1002/mds.21113; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; POWELL LE, 1995, J GERONTOL A-BIOL, V50, pM28, DOI 10.1093/gerona/50A.1.M28; Reddy CC, 2009, CURR SPORT MED REP, V8, P10, DOI 10.1249/JSR.0b013e31819539ca; Reddy CC, 2008, PHYS MED REH CLIN N, V19, P247, DOI 10.1016/j.pmr.2007.12.002; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rockwood K, 2000, J GERONTOL A-BIOL, V55, pM70; Rose DJ, 2006, ARCH PHYS MED REHAB, V87, P1478, DOI 10.1016/j.apmr.2006.07.263; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Schaubert K, 2005, ISOKINET EXERC SCI, V13, P119, DOI 10.3233/IES-2005-0188; Schaubert KL, 2005, J STRENGTH COND RES, V19, P717, DOI 10.1519/R-15954.1; Schmidt JD, 2012, MED SCI SPORT EXER, V44, P1621, DOI 10.1249/MSS.0b013e318258a9fb; Shumway-Cook A., 1995, MOTOR CONTROL THEORY; ShumwayCook A, 1997, PHYS THER, V77, P812, DOI 10.1093/ptj/77.8.812; Steffen TM, 2002, PHYS THER, V82, P128, DOI 10.1093/ptj/82.2.128; Viccaro LJ, 2011, J AM GERIATR SOC, V59, P887, DOI 10.1111/j.1532-5415.2011.03336.x; Walker ML, 2007, PHYS THER, V87, P1468, DOI 10.2522/ptj.20060344; Whitney S. L., 2007, VESTIBULAR REHABILIT, P272; Whitney SL, 2005, PHYS THER, V85, P1034, DOI 10.1093/ptj/85.10.1034; Whitney SL, 2004, J VESTIBUL RES-EQUIL, V14, P397; Whitney Susan, 2003, Physiother Res Int, V8, P178, DOI 10.1002/pri.288; Whitney SL, 2007, ARCH PHYS MED REHAB, V88, P99, DOI 10.1016/j.apmr.2006.10.027; Wrisley DM, 2004, PHYS THER, V84, P906, DOI 10.1093/ptj/84.10.906; Wrisley DM, 2003, ARCH PHYS MED REHAB, V84, P1528, DOI 10.1016/S0003-9993(03)00274-0; Wrisley DM, 2002, OTOL NEUROTOL, V23, P483, DOI 10.1097/00129492-200207000-00016; Yardley L, 1998, BRIT J GEN PRACT, V48, P1136	68	18	18	1	23	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-5669	1538-005X		PEDIATR PHYS THER	Pediatr. Phys. Ther.	SUM	2014	26	2					191	199		10.1097/PEP.0000000000000037			9	Pediatrics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics; Rehabilitation	AK8RF	WOS:000338695000007	24675118	Green Accepted			2022-02-06	
J	Byers, AL; Yaffe, K				Byers, Amy L.; Yaffe, Kristine			Depression and dementias among military veterans	ALZHEIMERS & DEMENTIA			English	Article						Dementia; Alzheimer's disease; Cognitive impairment; Depression; Posttraumatic stress disorder; Traumatic brain injury; Older veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MILD COGNITIVE IMPAIRMENT; LATE-LIFE DEPRESSION; WHITE-MATTER HYPERINTENSITIES; CARDIOVASCULAR RISK-FACTORS; ALZHEIMERS-DISEASE; HIPPOCAMPAL VOLUME; MAJOR DEPRESSION; GERIATRIC DEPRESSION	Depression is very common throughout the course of veterans' lives, and dementia is common in late life. Previous studies suggest an association between depression and dementia in military veterans. The most likely biologic mechanisms that may link depression and dementia among military veterans include vascular disease, changes in glucocorticoid steroids and hippocampal atrophy, deposition of beta-amyloid plaques, inflammatory changes, and alterations of nerve growth factors. In addition, military veterans often have depression comorbid with posttraumatic stress disorder or traumatic brain injury. Therefore, in military veterans, these hypothesized biologic pathways going from depression to dementia are more than likely influenced by trauma-related processes. Treatment strategies for depression, posttraumatic stress disorder, or traumatic brain injury could alter these pathways and as a result decrease the risk for dementia. Given the projected increase of dementia, as well as the projected increase in the older segment of the veteran population, in the future, it is critically important that we understand whether treatment for depression alone or combined with other regimens improves cognition. In this review, we summarize the principal mechanisms of this relationship and discuss treatment implications in military veterans. (C) 2014 The Alzheimer's Association. All rights reserved.	[Byers, Amy L.; Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA; [Byers, Amy L.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA		Byers, AL (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94121 USA.	Amy.Byers@ucsf.edu			United States Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC)	Publication of this article was supported by the United States Army Medical Research and Materiel Command.	Alexapoulos GS, 2005, LANCET, V365, P1961, DOI 10.1016/S0140-6736(05)66665-2; Alexopoulos GS, 2006, BIOL PSYCHIAT, V60, P1304, DOI 10.1016/j.biopsych.2006.09.006; Alexopoulos GS, 1997, ARCH GEN PSYCHIAT, V54, P915; Alexopoulos GS, 2003, J AM GERIATR SOC, V51, P1178, DOI 10.1046/j.1532-5415.2003.51373.x; Angelucci F, 2005, MOL PSYCHIATR, V10, P345, DOI 10.1038/sj.mp.4001637; Apfel BA, 2011, BIOL PSYCHIAT, V69, P541, DOI 10.1016/j.biopsych.2010.09.044; Arean PA, 2010, AM J PSYCHIAT, V167, P1391, DOI 10.1176/appi.ajp.2010.09091327; Ballard C, 1996, J AFFECT DISORDERS, V36, P135, DOI 10.1016/0165-0327(95)00072-0; Ballard C, 2000, J AFFECT DISORDERS, V59, P97, DOI 10.1016/S0165-0327(99)00057-9; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Benjamin S, 2010, AM J GERIAT PSYCHIAT, V18, P323, DOI 10.1097/JGP.0b013e3181cabd2b; Bhalla RK, 2006, AM J GERIAT PSYCHIAT, V14, P419, DOI 10.1097/01.JGP.0000203130.45421.69; Bragin Valentin, 2005, Am J Alzheimers Dis Other Demen, V20, P21, DOI 10.1177/153331750502000103; BREMNER JD, 1995, AM J PSYCHIAT, V152, P973; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Butters Meryl A, 2008, Dialogues Clin Neurosci, V10, P345; Byers AL, 2012, AM J GERIAT PSYCHIAT, V20, P664, DOI 10.1097/JGP.0b013e31822001c1; Camus V, 2004, J AFFECT DISORDERS, V81, P1, DOI 10.1016/j.jad.2003.08.003; Caraci F, 2010, EUR J PHARMACOL, V626, P64, DOI 10.1016/j.ejphar.2009.10.022; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cereseto M, 2006, EUR J NEUROSCI, V24, P3354, DOI 10.1111/j.1460-9568.2006.05232.x; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Cho S, 2007, EXP NEUROL, V203, P274, DOI 10.1016/j.expneurol.2006.07.021; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Colla M, 2007, J PSYCHIATR RES, V41, P553, DOI 10.1016/j.jpsychires.2006.06.011; Corrada MM, 2008, NEUROLOGY, V71, P337, DOI 10.1212/01.wnl.0000310773.65918.cd; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2005, NEUROCHEM RES, V30, P877, DOI 10.1007/s11064-005-6960-y; de Groot JC, 2000, ARCH GEN PSYCHIAT, V57, P1071, DOI 10.1001/archpsyc.57.11.1071; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Devanand DP, 2003, INT J GERIATR PSYCH, V18, P123, DOI 10.1002/gps.802; Doraiswamy PM, 2003, J GERONTOL A-BIOL, V58, P1137, DOI 10.1093/gerona/58.12.M1137; Flicker L, 2008, CURR OPIN PSYCHIATR, V21, P551, DOI 10.1097/YCO.0b013e32830ef736; Flicker L, 2010, CLIN GERIATR MED, V26, P17, DOI 10.1016/j.cger.2009.12.005; Fumagalli F, 2008, CNS DRUGS, V22, P1005, DOI 10.2165/0023210-200822120-00004; Geerlings MI, 2008, NEUROLOGY, V70, P1258, DOI 10.1212/01.wnl.0000308937.30473.d1; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashioka Sadayuki, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P12; Hastings RS, 2004, NEUROPSYCHOPHARMACOL, V29, P952, DOI 10.1038/sj.npp.1300371; Herrera-Guzman I, 2009, J PSYCHIATR RES, V43, P855, DOI 10.1016/j.jpsychires.2008.10.015; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hickie I, 2005, BRIT J PSYCHIAT, V186, P197, DOI 10.1192/bjp.186.3.197; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Jessen F, 2009, PSYCHIAT GENET, V19, P99, DOI 10.1097/YPG.0b013e32832080ce; Johnson ML, 2004, AM J MANAG CARE, V10, P926; Jorm AF, 1998, NEUROLOGY, V51, P728, DOI 10.1212/WNL.51.3.728; Karege F, 2005, MOL BRAIN RES, V136, P29, DOI 10.1016/j.molbrainres.2004.12.020; Kim JJ, 2006, STRESS, V9, P1, DOI 10.1080/10253890600678004; Knable MB, 2004, MOL PSYCHIATR, V9, P609, DOI 10.1038/sj.mp.4001471; Korczyn AD, 2009, J NEUROL SCI, V283, P139, DOI 10.1016/j.jns.2009.02.346; Krishnan KRR, 1997, AM J PSYCHIAT, V154, P497; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Lapierre CB, 2007, J TRAUMA STRESS, V20, P933, DOI 10.1002/jts.20278; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Leinonen V, 2010, ANN NEUROL, V68, P446, DOI 10.1002/ana.22100; Leonard BE, 2007, NEUROCHEM RES, V32, P1749, DOI 10.1007/s11064-007-9385-y; Lezoualc'h F, 2007, EXP NEUROL, V205, P325, DOI 10.1016/j.expneurol.2007.02.001; Liebetrau M, 2008, STROKE, V39, P1960, DOI 10.1161/STROKEAHA.107.490797; Maccioni RB, 2009, ANN NY ACAD SCI, V1153, P240, DOI 10.1111/j.1749-6632.2008.03972.x; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; Maes M, 2009, METAB BRAIN DIS, V24, P27, DOI 10.1007/s11011-008-9118-1; Metti AL, 2013, J GERONTOL A-BIOL, V68, P74, DOI 10.1093/gerona/gls093; Morishima-Kawashima M, 2002, J NEUROSCI RES, V70, P392, DOI 10.1002/jnr.10355; Mowla A, 2007, J CLIN PSYCHOPHARM, V27, P67, DOI 10.1097/jcp.0b013e31802e0002; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nebes RD, 2003, J PSYCHIATR RES, V37, P99, DOI 10.1016/S0022-3956(02)00085-7; O'Brien JT, 2004, AM J PSYCHIAT, V161, P2081, DOI 10.1176/appi.ajp.161.11.2081; Okello A, 2009, NEUROLOGY, V72, P56, DOI 10.1212/01.wnl.0000338622.27876.0d; Park CR, 2008, LEARN MEMORY, V15, P271, DOI 10.1101/lm.721108; Park JH, 2007, DEMENT GERIATR COGN, V23, P67, DOI 10.1159/000097039; Pelton GH, 2008, INT J GERIATR PSYCH, V23, P670, DOI 10.1002/gps.1958; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Plantinga L, 2013, BRAIN BEHAV IMMUN, V30, P125, DOI 10.1016/j.bbi.2013.01.081; Rao R, 2000, INT J GERIATR PSYCH, V15, P419, DOI 10.1002/(SICI)1099-1166(200005)15:5<419::AID-GPS140>3.0.CO;2-9; Rapp MA, 2006, ARCH GEN PSYCHIAT, V63, P161, DOI 10.1001/archpsyc.63.2.161; Rapp MA, 2008, AM J GERIAT PSYCHIAT, V16, P168, DOI 10.1097/JGP.0b013e31816029ec; RICHLIE DG, 1991, ARCH INTERN MED, V151, P1433, DOI 10.1001/archinte.151.7.1433; Rojo LE, 2008, ARCH MED RES, V39, P1, DOI 10.1016/j.arcmed.2007.10.001; Rothman SM, 2010, NEUROMOL MED, V12, P56, DOI 10.1007/s12017-009-8107-9; SAPOLSKY RM, 1986, ENDOCR REV, V7, P284, DOI 10.1210/edrv-7-3-284; Sheline YI, 2003, AM J PSYCHIAT, V160, P1516, DOI 10.1176/appi.ajp.160.8.1516; Sheline YI, 2008, AM J PSYCHIAT, V165, P524, DOI 10.1176/appi.ajp.2007.07010175; Sierksma ASR, 2010, EUR J PHARMACOL, V626, P72, DOI 10.1016/j.ejphar.2009.10.021; Sorrells SF, 2007, BRAIN BEHAV IMMUN, V21, P259, DOI 10.1016/j.bbi.2006.11.006; Steffens DC, 2008, PSYCHOL MED, V38, P163, DOI 10.1017/S003329170700102X; Steffens DC, 2011, AM J GERIAT PSYCHIAT, V19, P4, DOI 10.1097/JGP.0b013e3181d6c245; Steffens DC, 2002, STROKE, V33, P1636, DOI 10.1161/01.STR.0000018405.59799.D5; Steffens DC, 2002, AM J GERIAT PSYCHIAT, V10, P62, DOI 10.1176/appi.ajgp.10.1.62; Streit WJ, 2009, ACTA NEUROPATHOL, V118, P475, DOI 10.1007/s00401-009-0556-6; Sun XY, 2008, ARCH GEN PSYCHIAT, V65, P542, DOI 10.1001/archpsyc.65.5.542; Svenningsson P, 2014, MOL PSYCHIAT; Svenningsson P, 2013, NAT REV NEUROSCI, V14, P673, DOI 10.1038/nrn3564; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Teodorczuk A, 2007, BRIT J PSYCHIAT, V191, P212, DOI 10.1192/bjp.bp.107.036756; Thomas AJ, 2004, J AFFECT DISORDERS, V79, P81, DOI 10.1016/S0165-0327(02)00349-x; Thomas AJ, 2002, ANN NY ACAD SCI, V977, P333, DOI 10.1111/j.1749-6632.2002.tb04835.x; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; van de Pol LA, 2006, NEUROLOGY, V66, P236, DOI 10.1212/01.wnl.0000194240.47892.4d; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Videbech P, 2004, AM J PSYCHIAT, V161, P1957, DOI 10.1176/appi.ajp.161.11.1957; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Whooley MA, 2006, JAMA-J AM MED ASSOC, V295, P2874, DOI 10.1001/jama.295.24.2874; Wolkowitz OM, 2010, DEPRESS ANXIETY, V27, P327, DOI 10.1002/da.20686; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; Yaffe K, 2003, NEUROLOGY, V61, P76, DOI 10.1212/01.WNL.0000073620.42047.D7; Yaffe K, 2011, ARCH NEUROL-CHICAGO, V68, P631, DOI 10.1001/archneurol.2011.82	114	18	19	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1552-5260	1552-5279		ALZHEIMERS DEMENT	Alzheimers. Dement.	JUN	2014	10	3		1			S166	S173		10.1016/j.jalz.2014.04.007			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	CP8GM	WOS:000360130700011	24924668	hybrid			2022-02-06	
J	Gupte, AA; Hocevar, SN; Lea, AS; Kulkarni, RD; Schain, DC; Casey, MJ; Zendejas-Ruiz, IR; Chung, WK; Mbaeyi, C; Roy, SL; Visvesvara, GS; da Silva, AJ; Tallaj, J; Eckhoff, D; Baddley, JW				Gupte, A. A.; Hocevar, S. N.; Lea, A. S.; Kulkarni, R. D.; Schain, D. C.; Casey, M. J.; Zendejas-Ruiz, I. R.; Chung, W. K.; Mbaeyi, C.; Roy, S. L.; Visvesvara, G. S.; da Silva, A. J.; Tallaj, J.; Eckhoff, D.; Baddley, J. W.			Transmission of Balamuthia mandrillaris Through Solid Organ Transplantation: Utility of Organ Recipient Serology to Guide Clinical Management	AMERICAN JOURNAL OF TRANSPLANTATION			English	Article						Amebic encephalitis; Balamuthia mandrillaris; donor-derived infection; miltefosine	FREE-LIVING AMEBAS; ACANTHAMOEBA SPP.; MENINGOENCEPHALITIS; ENCEPHALITIS; INFECTION; PATIENT; AGENT; PCR	A liver, heart, iliac vessel and two kidneys were recovered from a 39-year-old man who died of traumatic head injury and were transplanted into five recipients. The liver recipient 18 days posttransplantation presented with headache, ataxia and fever, followed by rapid neurologic decline and death. Diagnosis of granulomatous amebic encephalitis was made on autopsy. Balamuthia mandrillaris infection was confirmed with immunohistochemical and polymerase chain reaction (PCR) assays. Donor and recipients' sera were tested for B. mandrillaris antibodies. Donor brain was negative for Balamuthia by immunohistochemistry and PCR; donor serum Balamuthia antibody titer was positive (1:64). Antibody titers in all recipients were positive (range, 1:64-1:512). Recipients received a four-to five-drug combination of miltefosine or pentamidine, azithromycin, albendazole, sulfadiazine and fluconazole. Nausea, vomiting, elevated liver transaminases and renal insufficiency were common. All other recipients survived and have remained asymptomatic 24 months posttransplant. This is the third donor-derived Balamuthia infection cluster described in solid organ transplant recipients in the United States. As Balamuthia serologic testing is only available through a national reference laboratory, it is not feasible for donor screening, but may be useful to determine exposure status in recipients and to help guide chemotherapy.	[Gupte, A. A.; Kulkarni, R. D.; Schain, D. C.; Casey, M. J.; Zendejas-Ruiz, I. R.] Univ Florida, Coll Med, Gainesville, FL USA; [Hocevar, S. N.; Mbaeyi, C.; Roy, S. L.; Visvesvara, G. S.; da Silva, A. J.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Lea, A. S.; Chung, W. K.] Univ Texas Med Branch, Galveston, TX 77555 USA; [Tallaj, J.; Eckhoff, D.; Baddley, J. W.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA		Baddley, JW (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	jbaddley@uab.edu	Mbaeyi, Chukwuma/P-3984-2016; Mbaeyi, Chukwuma/AAC-5407-2022	Mbaeyi, Chukwuma/0000-0002-4519-3075	Intramural CDC HHS [CC999999] Funding Source: Medline		Ahmad AF, 2011, J EUKARYOT MICROBIOL, V58, P269, DOI 10.1111/j.1550-7408.2011.00541.x; Bravo FG, 2012, CURR INFECT DIS REP, V14, P391, DOI 10.1007/s11908-012-0266-4; Bravo FG, 2011, CURR OPIN INFECT DIS, V24, P112, DOI 10.1097/QCO.0b013e3283428d1e; Cary LC, 2010, PEDIATRICS, V125, pE699, DOI 10.1542/peds.2009-1797; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1165; Centers for Disease Control and Prevention (CDC), 2010, MMWR Morb Mortal Wkly Rep, V59, P1182; Deetz TR, 2003, CLIN INFECT DIS, V37, P1304, DOI 10.1086/379020; Doyle JS, 2011, J NEUROSURG, V114, P458, DOI 10.3171/2010.10.JNS10677; Dunnebacke TH, 2004, MICROBIOL-SGM, V150, P2837, DOI 10.1099/mic.0.27218-0; Jung SM, 2004, ARCH PATHOL LAB MED, V128, P466; Martinez DY, 2010, CLIN INFECT DIS, V51, pE7, DOI 10.1086/653609; Matin A, 2008, CLIN MICROBIOL REV, V21, P435, DOI 10.1128/CMR.00056-07; Niyyati M, 2009, PARASITOL RES, V106, P279, DOI 10.1007/s00436-009-1592-9; Qvarnstrom Y, 2006, J CLIN MICROBIOL, V44, P3589, DOI 10.1128/JCM.00875-06; Schuster FL, 2004, DRUG RESIST UPDATE, V7, P41, DOI 10.1016/j.drup.2004.01.002; Schuster FL, 2006, J EUKARYOT MICROBIOL, V53, P121, DOI 10.1111/j.1550-7408.2005.00082.x; Schuster FL, 2004, EMERG INFECT DIS, V10, P1510; Schuster FL, 2003, J CLIN MICROBIOL, V41, P3175, DOI 10.1128/JCM.41.7.3175-3180.2003; Schuster FL, 2003, J EUKARYOT MICROBIOL, V37, P1304; Schuster FL, 2008, J EUKARYOT MICROBIOL, V55, P313, DOI 10.1111/j.1550-7408.2008.00333.x; Schuster FL, 2009, CLIN INFECT DIS, V48, P879, DOI 10.1086/597260; Silva-Vergara ML, 2007, AM J TROP MED HYG, V77, P1096, DOI 10.4269/ajtmh.2007.77.1096; The Organ Procurement and Transplantation Network, 2012, GUID REP POT DEC LIV; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; VISVESVARA GS, 1990, J CLIN MICROBIOL, V28, P2750, DOI 10.1128/JCM.28.12.2750-2756.1990	25	18	19	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1600-6135	1600-6143		AM J TRANSPLANT	Am. J. Transplant.	JUN	2014	14	6					1417	1424		10.1111/ajt.12726			8	Surgery; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Surgery; Transplantation	AJ2UP	WOS:000337519500024	24840013	Green Accepted, Bronze			2022-02-06	
J	Crowe, LM; Anderson, V; Barton, S; Babl, FE; Catroppa, C				Crowe, Louise M.; Anderson, Vicki; Barton, Sarah; Babl, Franz E.; Catroppa, Cathy			Verbal Ability and Language Outcome Following Traumatic Brain Injury in Early Childhood	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						language; traumatic brain injury; children	CLOSED-HEAD-INJURY; YOUNG-CHILDREN; INFANTS; AGE; RECOVERY; SEQUELAE	Objective: To investigate language outcomes of TBI in preschool-aged children. Competent early language skills are pivotal for the future development of literacy skills. While previous research has reported that traumatic brain injury (TBI) places children at risk of language impairments, the majority of these studies have been conducted with school-aged children. Setting: Royal Children's Hospital, Melbourne, Australia. Participants: Children aged 4 to 6 years who had sustained a mild (N = 19) or moderate/severe (N = 16) TBI prior to 3 years of age and a control group (N = 20) of typically developing children matched for age, gender, and socioeconomic status. Main Measures: The Wechsler Preschool and Primary School Scale of Intelligence, Third Edition, measured Verbal IQ. The Clinical Evaluation of Language Fundamentals-Preschool version and the Bus Story Test measured language skills. Results: More severely injured children displayed greater impairments in verbal intellectual abilities and language skills compared with children with mild TBI and uninjured children. Children with mild TBI performed similarly to children in the control group. Conclusion: Language appears vulnerable to TBI and should be investigated as a matter of course in clinical assessments of TBI recovery.	[Crowe, Louise M.; Anderson, Vicki; Barton, Sarah; Babl, Franz E.; Catroppa, Cathy] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Crowe, Louise M.; Anderson, Vicki; Babl, Franz E.; Catroppa, Cathy] Univ Melbourne, Melbourne, Vic, Australia; [Anderson, Vicki; Babl, Franz E.] Royal Childrens Hosp, Melbourne, Vic, Australia		Crowe, LM (corresponding author), Royal Childrens Hosp, Australian Ctr Child Neuropsychol Studies, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	louise.crowe@mcri.edu.au	Catroppa, Cathy/AAX-9458-2021	Catroppa, Cathy/0000-0002-9750-0436; Crowe, Louise/0000-0003-4619-9708; Barton, Sarah/0000-0001-7077-0906	Foundation for Children; Victorian Government's Operational Infrastructure Support Program	This work was supported by a grant from the Foundation for Children and by the Victorian Government's Operational Infrastructure Support Program.	Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Case ME, 2008, BRAIN PATHOL, V18, P562, DOI 10.1111/j.1750-3639.2008.00202.x; Catroppa C, 2004, BRAIN LANG, V88, P68, DOI 10.1016/S0093-934X(03)00159-7; Chapman SB, 2001, J HEAD TRAUMA REHAB, V16, P441, DOI 10.1097/00001199-200110000-00004; Cohen J., 2013, STAT POWER ANAL BEHA; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Crowe LM, 2012, PEDIATRICS, V129, pE262, DOI 10.1542/peds.2011-0438; Dehaene-Lambertz G, 2006, TRENDS NEUROSCI, V29, P367, DOI 10.1016/j.tins.2006.05.011; Dennis M., 1989, CLIN NEUROPSYCHOLOGY; Didus E, 1999, Pediatr Rehabil, V3, P177; Ewing-Cobbs L, 1998, BRAIN LANG, V61, P395, DOI 10.1006/brln.1997.1884; Ewing-Cobbs L, 1997, J Int Neuropsychol Soc, V3, P581; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; HAHN YS, 1988, CHILD NERV SYST, V4, P34; Hanten G, 2009, TOP LANG DISORD, V29, P236, DOI 10.1097/TLD.0b013e3181b531f0; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Keenan HT, 2006, PEDIATRICS, V117, P317, DOI 10.1542/peds.2005-0979; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Lalloo R, 2003, INJURY, V34, P261, DOI 10.1016/S0020-1383(02)00277-2; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Levin HS, 2001, NEUROPSYCHOLOGIA, V39, P122, DOI 10.1016/S0028-3932(00)00111-1; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; MEHLER J, 1978, PERCEPTION, V7, P491, DOI 10.1068/p070491; Morse S, 1999, Pediatr Rehabil, V3, P139; Pankratz ME, 2007, LANG SPEECH HEAR SER, V38, P390, DOI 10.1044/0161-1461(2007/040); Paul R., 2007, LANGUAGE DISORDERS I; Pink B.N., 2006, AUSTR NZ STANDARD CL; Prasad MR, 1999, J CHILD NEUROL, V14, P496, DOI 10.1177/088307389901400803; REILLY PL, 1988, CHILD NERV SYST, V4, P30; Renfrew C, 1991, RENFREW BUS STORY MA; Schjolberg S, 2011, J DEV BEHAV PEDIATR, V32, P375, DOI 10.1097/DBP.0b013e31821bd1dd; Trudeau N, 2000, INT J LANG COMM DIS, V35, P227; van Kleeck A, 2011, J SPEECH LANG HEAR R, V54, P1546, DOI 10.1044/1092-4388(2011/10-0079); Wade SL, 2011, DEV PSYCHOL, V47, P119, DOI 10.1037/a0021028; Wechsler D., 2002, WECHSLER PRESCHOOL P; Wiig EH., 2006, CLIN EVALUATION LANG; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387	38	18	18	3	25	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAY-JUN	2014	29	3					217	223		10.1097/HTR.0b013e31829babfd			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AG9SE	WOS:000335759100009	23835877				2022-02-06	
J	Del Rossi, G; Malaguti, A; Del Rossi, S				Del Rossi, Gianluca; Malaguti, Alfonso; Del Rossi, Samanta			Practice Effects Associated With Repeated Assessment of a Clinical Test of Reaction Time	JOURNAL OF ATHLETIC TRAINING			English	Article						yardstick test; concussion-assessment battery; head injuries	PERFORMANCE; CONCUSSION; ALCOHOL; TASK	Context: Researchers have confirmed that the ruler-drop test could be included as part of a multifaceted concussion-assessment battery and potentially as a way to track recovery from head injury. However, it is unclear if this clinical test of reaction time would be characterized by inconsistent performance because of practice effects. Objective: To determine if the ruler-drop test is susceptible to practice effects after serial administration. Design: Descriptive laboratory study. Setting: Sports medicine research laboratory. Patients or Other Participants: Forty-three persons (age = 21.8 +/- 2.6 years). Intervention(s): Ten sessions were completed over 5 weeks. Participants completed 10 trials of the ruler-drop test during each session. Main Outcome Measure(s): The mean reaction times calculated for all participants from each test session were analyzed to determine if there was any meaningful change (ie, improvement) in reaction time over the course of the investigation. Results: Simple reaction time improved (ie, decreased) after repeated administration of the ruler-drop test, and the most pronounced improvement occurred between the first 2 test sessions. Between the first and second test sessions, reaction time decreased by almost 7 milliseconds, and there was an overall improvement of almost 13 milliseconds between the first and tenth sessions. Although the pairwise comparisons between the first and second and the first and third sessions were not significant, the change in mean reaction time between the first session and most of the other sessions was significant. We noted no differences when successive sessions were compared. Conclusions: To prevent practice-related improvements in reaction time, practitioners should allow at least 1 practice session before recording baseline results on the ruler-drop test.	[Del Rossi, Gianluca; Malaguti, Alfonso; Del Rossi, Samanta] Univ S Florida, Tampa, FL 33612 USA		Del Rossi, G (corresponding author), Univ S Florida, 13220 USF Laurel Dr,MDF 5117,Mail Code MDC 106, Tampa, FL 33612 USA.	gdelross@health.usf.edu	Del Rossi, Gianluca/AAR-5000-2020				Abernethy B, 2005, BIOPHYSICAL FDN HUMA, P227; Cote KA, 2009, J SLEEP RES, V18, P291, DOI 10.1111/j.1365-2869.2008.00733.x; Covassin T, 2010, PHYSICIAN SPORTSMED, V38, P87, DOI 10.3810/psm.2010.12.1830; Duff K, 2001, ARCH CLIN NEUROPSYCH, V16, P461; Eckner JT, 2011, PM&R, V3, P1092, DOI 10.1016/j.pmrj.2011.04.022; Eckner JT, 2011, J ATHL TRAINING, V46, P409; Eckner JT, 2011, PM&R, V3, P212, DOI 10.1016/j.pmrj.2010.12.003; Eckner JT, 2010, J ATHL TRAINING, V45, P327, DOI 10.4085/1062-6050-45.4.327; Eckner JT, 2009, PERCEPT MOTOR SKILL, V108, P717, DOI 10.2466/PMS.108.3.717-720; Hernandez OH, 2007, J STUD ALCOHOL DRUGS, V68, P276, DOI 10.15288/jsad.2007.68.276; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Jauch-Chara K, 2010, PSYCHONEUROENDOCRINO, V35, P624, DOI 10.1016/j.psyneuen.2009.09.018; MAYLOR EA, 1992, Q J EXP PSYCHOL-A, V44, P119, DOI 10.1080/14640749208401286; Udermann BE, 2004, PERCEPT MOTOR SKILL, V98, P409; Van Den Berg J, 2006, PERCEPT MOTOR SKILL, V102, P589, DOI 10.2466/PMS.102.2.589-599; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524	16	18	18	1	15	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	MAY-JUN	2014	49	3					356	359		10.4085/1062-6059-49.2.04			4	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	AQ4LJ	WOS:000342768200010	24673236	Green Published			2022-02-06	
J	Schramm, A; Ndayisaba, JP; Brinke, MAD; Hecht, M; Herrmann, C; Huber, M; Lobsien, E; Mehnert, S; Reuter, I; Stenner, A; van der Ven, C; Winterholler, M; Kupsch, A; Wissel, J				Schramm, Axel; Ndayisaba, Jean-Pierre; Brinke, Matthias Auf Dem; Hecht, Martin; Herrmann, Christoph; Huber, Martin; Lobsien, Elmar; Mehnert, Sabine; Reuter, Iris; Stenner, Andrea; van der Ven, Christian; Winterholler, Martin; Kupsch, Andreas; Wissel, Joerg			Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry	JOURNAL OF NEURAL TRANSMISSION			English	Article						Botulinum toxin A; Onabotulinumtoxin; Spasticity; Stroke; Traumatic brain injury; Multiple sclerosis; Cerebral palsy	TOXIN TYPE-A	This study aimed at providing real-life baseline, injection and outcome data for the treatment of various forms of spasticity with onabotulinumtoxin A in Germany. Prospective data were collected in an open multicenter patient registry from 2005 until 2010, encompassing the experience of ten specialized German centers in the treatment of spasticity using onabotulinumtoxin A in 508 patients with a total of 2005 treatment sessions. Disease entities comprised spasticity following stroke (both ischemic and hemorrhagic), traumatic brain injury, multiple sclerosis, cerebral palsy, and anoxia. Sustained improvement was observed in a variety of outcome parameters including goal attainment and motor performance scores for up to five repeated injection sessions. No significant differences between disease entities or between upper and lower limb treatment were observed with regard to efficacy and safety following onabotulinumtoxin A treatment. Minor to moderate side effects were reported in < 1 % of the study population. We conclude that repetitive treatment of focal and multifocal spasticity with onabotulinumtoxin A provides a safe and efficacious therapeutic strategy for patients with different disease entities of the central nervous system.	[Schramm, Axel] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Ndayisaba, Jean-Pierre] Med Univ Innsbruck, Dept Neurol, A-6020 Innsbruck, Austria; [Brinke, Matthias Auf Dem] Asklepios Klin Fuerstenhof, Dept Neurol, Bad Wildungen, Germany; [Hecht, Martin] Bezirkskrankenhaus Kaufbeuren, Dept Neurol, Kaufbeuren, Germany; [Herrmann, Christoph] Asklepios Kliniken Schildautal, Dept Neurol Rehabil, Seesen, Germany; [Huber, Martin] Therapiezentrum Burgau, Dept Neurol Rehabil, Burgau, Germany; [Lobsien, Elmar] Univ Med Berlin, Charite, Dept Neurol, Berlin, Germany; [Mehnert, Sabine; Reuter, Iris] Univ Giessen, Dept Neurol, D-35390 Giessen, Germany; [Stenner, Andrea] Paracelsus Kliniken, Dept Movement Disorders, Zwickau, Germany; [van der Ven, Christian] Neurol Rehazentrum Godeshohe, Bonn, Germany; [Winterholler, Martin] Krankenhaus Rummelsberg, Dept Neurol, Nurnberg, Germany; [Kupsch, Andreas] Univ Magdeburg, Dept Neurol & Stereotact Neurosurg, D-39106 Magdeburg, Germany; [Wissel, Joerg] Vivantes Klinikum Spandau, Dept Neurol, Berlin, Germany		Schramm, A (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany.	axel.schramm@uk-erlangen.de			Allergan-Germany, Ettlingen	This study was in part supported by an unrestricted educational grant of Allergan-Germany, Ettlingen. The authors report no conflict of interest with regard to the content of this article.	Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Collen F M, 1990, Int Disabil Stud, V12, P6; Ertzgaard P, 2011, J REHABIL MED, V43, P8, DOI 10.2340/16501977-0664; Esquenazi A, 2013, TOXICON, V67, P115, DOI 10.1016/j.toxicon.2012.11.025; Esquenazi A, 2012, AM J PHYS MED REHAB, V91, P729, DOI 10.1097/PHM.0b013e31824fa9ca; Kossmehl P, 2012, NEUROREHAB NEURAL RE, V26, P395; Lagalla G, 2000, AM J PHYS MED REHAB, V79, P377, DOI 10.1097/00002060-200007000-00010; Mehrholz J, 2007, ARCH PHYS MED REHAB, V88, P1314, DOI 10.1016/j.apmr.2007.06.764; Mohammadi B, 2010, NEUROL RES, V32, P309, DOI 10.1179/016164109X12478302362734; Wissel J, 2011, NERVENARZT, V82, P481, DOI 10.1007/s00115-010-3172-8; Wissel J, 2009, J REHABIL MED, V41, P13, DOI 10.2340/16501977-0303	11	18	19	0	1	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0300-9564	1435-1463		J NEURAL TRANSM	J. Neural Transm.	MAY	2014	121	5					521	530		10.1007/s00702-013-1145-3			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AF7ZE	WOS:000334933500008	24407377				2022-02-06	
J	Bilaniuk, JW; Adams, JM; DiFazio, LT; Siegel, BK; Allegra, JR; Lujan, JJ; Durling-Grover, R; Pawar, J; Rolandelli, RH; Nemeth, ZH				Bilaniuk, Jaroslaw W.; Adams, John M.; DiFazio, Louis T.; Siegel, Brian K.; Allegra, John R.; Lujan, Juan J.; Durling-Grover, Renay; Pawar, Joanne; Rolandelli, Rolando H.; Nemeth, Zoltan H.			Equestrian Trauma: Injury Patterns Vary among Age Groups	AMERICAN SURGEON			English	Article; Proceedings Paper	98th Annual Clinical Meeting of the American-College-of-Surgeons (ACS)	SEP 30-OCT 04, 2012	Chicago, IL	Amer Coll Surg			UNITED-STATES; PREVENTION; HORSES; RIDERS	Patients with equestrian injuries were identified in the trauma registry from 2004 to 2007. We a priori divided patients into three groups: 0 to 18 years, 19 to 49 years, and 50 years old or older. There were 284 patients identified with equestrian-related trauma. Injury Severity Score for the three major age categories 0 to 18 years, 19 to 49 years, and 50 years or older, were 3.47, 5.09, and 6.27, respectively. The most common body region injured among all patients was the head (26.1%). The most common injuries by age group were: 0 to 18 years, upper extremity fractures; 19 to 49 year olds, concussions; and 50 years or older, rib fractures. Significant differences were observed among the three age groups in terms of percent of patients with rib fractures: percent of patients with rib fractures was 2, 8, and 22 per cent in age groups 0 to 18, 19 to 49, and 50 years or older, respectively. We found different patterns of injuries associated with equestrian accidents by age. Head injuries were commonly seen among participants in equestrian activities and helmet use should be promoted to minimize the severity of closed head injuries. Injury patterns also seem to vary among the various age groups that ride horses. This information could be used to better target injury prevention efforts among these patients.	[Bilaniuk, Jaroslaw W.; Adams, John M.; DiFazio, Louis T.; Siegel, Brian K.; Lujan, Juan J.; Durling-Grover, Renay; Pawar, Joanne; Rolandelli, Rolando H.; Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ 07962 USA; [Allegra, John R.] Morristown Med Ctr, Dept Emergency Med, Morristown, NJ 07962 USA; [Nemeth, Zoltan H.] Rutgers State Univ, New Jersey Med Sch, Dept Surg, Newark, NJ 07102 USA		Bilaniuk, JW (corresponding author), Morristown Med Ctr, Dept Surg, 100 Madison Ave, Morristown, NJ 07962 USA.	Jaroslaw.Bilaniuk@atlantichealth.org					American Horse Council, NAT EC IMP US HORS I; Ball CG, 2007, AM J SURG, V193, P636, DOI 10.1016/j.amjsurg.2007.01.016; BUSCH HM, 1986, J TRAUMA, V26, P559, DOI 10.1097/00005373-198606000-00013; Carrillo EH, 2007, SCAND J SURG, V96, P79, DOI 10.1177/145749690709600115; *CDCP, 1990, MMWR-MORBID MORTAL W, V39, P329; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Frankel HL, 1998, AM SURGEON, V64, P151; Griffen M, 2002, SOUTHERN MED J, V95, P441, DOI 10.1097/00007611-200204000-00013; Hobbs Gregory D., 1994, Journal of Emergency Medicine, V12, P143, DOI 10.1016/0736-4679(94)90690-4; Ketai LH, 2000, INJURY, V31, P757, DOI 10.1016/S0020-1383(00)00108-X; Lim J, 2003, ANZ J SURG, V73, P567, DOI 10.1046/j.1445-2197.2003.02707.x; Loder RT, 2008, J TRAUMA, V65, P447, DOI 10.1097/TA.0b013e31817dac43; Mayberry JC, 2007, J TRAUMA, V62, P735, DOI 10.1097/ta.0b013e318031b5d4; Moss PS, 2002, EMERG MED J, V19, P412, DOI 10.1136/emj.19.5.412; Northey G., 2003, New Zealand Medical Journal, V116, P601; Norwood S, 2000, J TRAUMA, V48, P740, DOI 10.1097/00005373-200004000-00025; Petridou E, 2004, J TRAUMA, V56, P643, DOI 10.1097/01.TA.0000053470.38129.F4; Ronning R, 2001, AM J SPORT MED, V29, P581, DOI 10.1177/03635465010290051001; Sorli J M, 2000, Inj Prev, V6, P59, DOI 10.1136/ip.6.1.59; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858	20	18	18	0	5	SOUTHEASTERN SURGICAL CONGRESS	CUMMING	115 SAMARITAN DR, #200, CUMMING, GA 30040-2354 USA	0003-1348	1555-9823		AM SURGEON	Am. Surg.	APR	2014	80	4					396	402					7	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	AJ5RL	WOS:000337744400024	24887673				2022-02-06	
J	Lee, JJ; Segar, DJ; Asaad, WF				Lee, Jonathan J.; Segar, David J.; Asaad, Wael F.			Comprehensive Assessment of Isolated Traumatic Subarachnoid Hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						traumatic brain injury; subarachnoid hemorrhage; head injury; hospital transfer	MILD HEAD-INJURY; MINIMAL BRAIN-INJURY; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; ARTERIAL SPASM; UNITED-STATES; AXONAL INJURY; CT FINDINGS; MANAGEMENT; NIMODIPINE	Recent studies have shown that isolated traumatic subarachnoid hemorrhage (tSAH) in the setting of a high Glasgow Coma Scale (GCS) score (13-15) is a relatively less severe finding not likely to require operative neurosurgical intervention. This study sought to provide a more comprehensive assessment of isolated tSAH among patients with any GCS score, and to expand the analysis to examine the potential need for aggressive medical, endovascular, or open surgical interventions in these patients. By undertaking a retrospective review of all patients admitted to our trauma center from 2003-2012, we identified 661 patients with isolated tSAH. Only four patients (0.61%) underwent any sort of aggressive neurosurgical, medical, or endovascular intervention, regardless of GCS score. Most tSAH patients without additional systemic injury were discharged home (68%), including 53% of patients with a GCS score of 3-8. However, older patients were more likely to be discharged to a rehabilitation facility (p<0.01). There were six (1.7%) in-hospital deaths, and five patients of these patients were older than 80 years old. We conclude that isolated tSAH, regardless of admission GCS score, is a less severe intracranial injury that is highly unlikely to require aggressive operative, medical, or endovascular intervention, and is unlikely to be associated with major neurologic morbidity or mortality, except perhaps in elderly patients. Based upon our findings, we argue that impaired consciousness in the setting of isolated tSAH should strongly compel a consideration of non-traumatic factors in the etiology of the altered neurological status.	[Lee, Jonathan J.; Segar, David J.; Asaad, Wael F.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Asaad, Wael F.] Brown Inst Brain Sci, Providence, RI USA; [Asaad, Wael F.] Rhode Isl Hosp, Dept Neurosurg, Providence, RI 02903 USA; [Asaad, Wael F.] Rhode Isl Hosp, Norman Prince Neurosci Inst, Providence, RI 02903 USA		Asaad, WF (corresponding author), Rhode Isl Hosp, Dept Neurosurg, APC 633,593 Eddy St, Providence, RI 02903 USA.	wael_asaad@brown.edu	Asaad, Wael/I-8485-2012	Asaad, Wael/0000-0003-4406-9096; Segar, David/0000-0001-9369-1856	Department of Neurosurgery; Alpert Medical School of Brown University; Rhode Island Hospital	The authors wish to thank the support of the Department of Neurosurgery, the Alpert Medical School of Brown University and Rhode Island Hospital. All authors participated in designing the study, performing the analyses and writing the manuscript.	Almenawer SA, 2012, NEUROSURGERY, V71, pE561, DOI 10.1227/01.neu.0000417742.32171.86; ARUTIUNOV AI, 1974, J NEUROSURG, V40, P459, DOI 10.3171/jns.1974.40.4.0459; Babu MA, 2011, NEUROSURGERY, V69, P659, DOI 10.1227/NEU.0b013e31821bc667; Beaulieu C, 2000, MAGN RESON MED, V44, P110; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Boesiger BM, 2005, J EMERG MED, V29, P23, DOI 10.1016/j.jemermed.2005.02.002; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Conti A, 2008, ACTA NEUROCHIR, V150, P1197, DOI 10.1007/s00701-008-0141-0; Coronado VG., 2012, BRAIN INJURY MED PRI, P93; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Faul M, 2010, TRAUMATIC BRAIN INJU; Gomez PA, 2000, ACTA NEUROCHIR, V142, P373, DOI 10.1007/s007010050445; Harders A, 1996, J NEUROSURG, V85, P82, DOI 10.3171/jns.1996.85.1.0082; Holmes JF, 2006, AM J EMERG MED, V24, P167, DOI 10.1016/j.ajem.2005.08.009; HUBSCHMANN OR, 1985, J NEUROSURG, V62, P698, DOI 10.3171/jns.1985.62.5.0698; HUBSCHMANN OR, 1980, J NEUROSURG, V52, P456, DOI 10.3171/jns.1980.52.4.0456; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; KIWAK KJ, 1985, J NEUROSURG, V62, P865, DOI 10.3171/jns.1985.62.6.0865; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levy AS, 2011, J TRAUMA, V71, P1199, DOI 10.1097/TA.0b013e31822067fc; Lind CRP, 2005, ANZ J SURG, V75, P858, DOI 10.1111/j.1445-2197.2005.03574.x; Macmillan CSA, 2002, ACTA NEUROCHIR, V144, P853, DOI 10.1007/s00701-002-0966-x; MARTIN NA, 1995, J NEUROTRAUM, V12, P897, DOI 10.1089/neu.1995.12.897; Mattioli C, 2003, J NEUROSURG, V98, P37, DOI 10.3171/jns.2003.98.1.0037; MITTL RL, 1994, AM J NEURORADIOL, V15, P1583; Morais DF, 2008, ARQ NEURO-PSIQUIAT, V66, P53, DOI 10.1590/S0004-282X2008000100013; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Quigley MR, 2013, J TRAUMA ACUTE CARE, V74, P581, DOI 10.1097/TA.0b013e31827d6088; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Rosner J, 2013, NEUROSURGERY, V60, P98, DOI 10.1227/01.neu.0000430309.86573.2d; SAUNDERS RL, 1984, JAMA-J AM MED ASSOC, V252, P538, DOI 10.1001/jama.252.4.538; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; SHIGEMORI M, 1990, Neurologia Medico-Chirurgica, V30, P396, DOI 10.2176/nmc.30.396; Soustiel JF, 2002, ACTA NEUROCHIR, V144, P137, DOI 10.1007/s007010200016; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Tajeu G. S., 2013, J GERONTOL A; Taneda M, 1996, J NEUROSURG, V84, P762, DOI 10.3171/jns.1996.84.5.0762; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thomas S, 2000, ACTA NEUROCHIR SUPPL, V76, P203; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Vorst MV, 2007, J TRAUMA, V62, P199, DOI 10.1097/01.ta.0000238665.09611.4b; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vergouwen MDI, 2006, LANCET NEUROL, V5, P1029, DOI 10.1016/S1474-4422(06)70582-8; Walcott B. P., 2011, PLOS ONE, V6; Wang HP, 2011, J TRAUMA, V70, pE6, DOI 10.1097/TA.0b013e3181cda3b9; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092; WILKINS RH, 1970, J NEUROSURG, V32, P626, DOI 10.3171/jns.1970.32.6.0626; Yuan XQ, 1988, J NEUROTRAUM, V5, P289, DOI 10.1089/neu.1988.5.289	58	18	18	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 1	2014	31	7					595	609		10.1089/neu.2013.3152			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	AD7PB	WOS:000333455000001	24224706				2022-02-06	
J	Post, A; Hoshizaki, TB; Gilchrist, MD; Brien, S; Cusimano, MD; Marshall, S				Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan; Cusimano, Michael D.; Marshall, Shawn			The influence of acceleration loading curve characteristics on traumatic brain injury	JOURNAL OF BIOMECHANICS			English	Article						Traumatic brain injury; Principle components analysis; Kinematics	HUMAN HEAD; ELEMENT; IMPACT; BIOMECHANICS; DEFORMATION; PREDICTION; TISSUE	To prevent brain trauma, understanding the mechanism of injury is essential. Once the mechanism of brain injury has been identified, prevention technologies could then be developed to aid in their prevention. The incidence of brain injury is linked to how the kinematics of a brain injury event affects the internal structures of the brain. As a result it is essential that an attempt be made to describe how the characteristics of the linear and rotational acceleration influence specific traumatic brain injury lesions. As a result, the purpose of this study was to examine the influence of the characteristics of linear and rotational acceleration pulses and how they account for the variance in predicting the outcome of TBI lesions, namely contusion, subdural hematoma (SDH), subarachnoid hemorrhage (SAH), and epidural hematoma (EDH) using a principal components analysis (PCA). Monorail impacts were conducted which simulated falls which caused the TBI lesions. From these reconstructions, the characteristics of the linear and rotational acceleration were determined and used for a PCA analysis. The results indicated that peak resultant acceleration variables did not account for any of the variance in predicting TBI lesions. The majority of the variance was accounted for by duration of the resultant and component linear and rotational acceleration. In addition, the components of linear and rotational acceleration characteristics on the x, y, and z axes accounted for the majority of the remainder of the variance after duration. (C) 2014 Elsevier Ltd. All rights reserved.	[Post, Andrew; Hoshizaki, T. Blaine; Gilchrist, Michael D.; Brien, Susan] Univ Ottawa, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin 2, Ireland; [Brien, Susan] Hull Hosp, Gatineau, PQ, Canada; [Cusimano, Michael D.] St Michaels Hosp, Toronto, ON M5B 1W8, Canada; [Marshall, Shawn] Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada		Post, A (corresponding author), 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019	Cusimano, Michael/0000-0002-9989-0650; Post, Andrew/0000-0002-5960-5552	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR)	Funding for this research was provided by the Canadian Institutes of Health Research.	Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Darvish KK, 2001, MED ENG PHYS, V23, P633, DOI 10.1016/S1350-4533(01)00101-1; Donnelly BR, 1997, J BIOMECH ENG-T ASME, V119, P423, DOI 10.1115/1.2798289; Gadd C. W., 1966, P 10 STAPP CAR CRASH; GOLDSMITH W, 1981, J BIOMECH, V14, P883, DOI 10.1016/0021-9290(81)90016-6; GURDJIAN ES, 1947, JAMA-J AM MED ASSOC, V134, P1072, DOI 10.1001/jama.1947.02880300014005; HARDY WN, 1994, INT J IMPACT ENG, V15, P561, DOI 10.1016/0734-743X(94)80034-7; Hrapko M, 2006, BIORHEOLOGY, V43, P623; King A., 2003, P IRCOBI C LISB PORT; Kleiven S, 2006, INT J CRASHWORTHINES, V11, P65, DOI 10.1533/ijcr.2005.0384; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Nicolle Stephane, 2004, Stapp Car Crash J, V48, P239; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Post A, 2012, TRAUMA, V14, P327, DOI 10.1177/1460408612446573; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rashid B., 2014, J MECH BEHA IN PRESS; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Versace, 1971, P 15 STAPP CAR CRASH, DOI DOI 10.4271/710881; VIANO DC, 1989, J BIOMECH, V22, P403, DOI 10.1016/0021-9290(89)90201-7; Willinger R, 2003, INT J VEHICLE DES, V32, P94, DOI 10.1504/IJVD.2003.003239; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	28	18	19	0	12	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	MAR 21	2014	47	5					1074	1081		10.1016/j.jbiomech.2013.12.026			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	AE6GG	WOS:000334088000020	24484643	Green Accepted, Green Submitted			2022-02-06	
J	MacNeill, H; Telner, D; Sparaggis-Agaliotis, A; Hanna, E				MacNeill, Heather; Telner, Deanna; Sparaggis-Agaliotis, Alexandra; Hanna, Elizabeth			All for One and One for All: Understanding Health Professionals' Experience in Individual Versus Collaborative Online Learning	JOURNAL OF CONTINUING EDUCATION IN THE HEALTH PROFESSIONS			English	Article						online; computer-based education; interprofessional education; collaboration; innovative educational interventions; problem-based; case-based learning; small group; team learning; computer-supported collaborative learning (CSCL); synchronous online learning	EDUCATION	Introduction Computer-supported collaborative learning (CSCL) may facilitate continuing interprofessional education while overcoming barriers of time and place for busy health care professionals. The purpose of this study was to understand the experiences, advantages, and challenges of group versus individual online learning. Methods Fifteen multidisciplinary health professionals participated in a 12-week online course on either diabetes or traumatic brain injury. This consisted of background e-modules and a longitudinal build-a-case exercise, done either individually or as a group. Focus group sessions exploring participants' experiences after course completion and at 4 months were conducted, transcribed, and analyzed for recurring themes. Participant reflection homework and video-recorded group sessions were used for triangulation of results. Results Individual learners appreciated the flexibility and control, but experienced decreased motivation. Group learners appreciated the immediate feedback from their co-learners and felt social pressure to come to the weekly sessions prepared but expressed challenges in determining group goal-setting for the session. Both groups felt they learned about interprofessional roles; however, group learners described a richer learning experience and understanding of interprofessional roles through the online collaboration exercise. The intense resources necessary for interprofessional CSCL, including time, faculty development, and technological issues, are described. Discussion CSCL is a valuable educational strategy in online learning. While individual online learning may be better suited for short and simple educational interventions such as knowledge acquisition, CSCL seems to allow for richer and deeper learning in complex and interprofessional educational experiences. However, strategies, resources, and faculty development required to enhance CSCL need to be addressed carefully.	[MacNeill, Heather] Bridgepoint Act Healthcare, Med Educ & COIL, Toronto, ON M4M 2B5, Canada; [MacNeill, Heather] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada; [Telner, Deanna] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [Sparaggis-Agaliotis, Alexandra; Hanna, Elizabeth] Bridgepoint Act Healthcare, Toronto, ON M4M 2B5, Canada; [Hanna, Elizabeth] Univ Toronto, Dept Speech Language Pathol, Fac Med, Toronto, ON M5S 1A1, Canada		MacNeill, H (corresponding author), Bridgepoint Act Healthcare, 14 St Matthews Rd, Toronto, ON M4M 2B5, Canada.	hmacneill@bridgepointhealth.ca		MacNeill, Heather/0000-0001-9842-3578	Medical Education Research Grant (MERG) from the Royal College of Physicians and Surgeons of Canada (RCPSC); HSBC Bank of Canada	The authors report that this study was funded by a Medical Education Research Grant (MERG) from the Royal College of Physicians and Surgeons of Canada (RCPSC). The COIL project was funded by a nonrestrictive educational grant from HSBC Bank of Canada.	Cook DA, 2008, JAMA-J AM MED ASSOC, V300, P1181, DOI 10.1001/jama.300.10.1181; Cook DA, 2010, MED EDUC, V44, P765, DOI 10.1111/j.1365-2923.2010.03723.x; Delva D, 2008, J INTERPROF CARE, V22, P598, DOI 10.1080/13561820802201819; Garrison D. Randy, 2007, Internet and Higher Education, V10, P157, DOI 10.1016/j.iheduc.2007.04.001; Garrison DR, INTERNET HIGH ED, V2, P87; Gokhale A. A., 1995, J TECHNOLOGY ED, V7, DOI DOI 10.21061/JTE.V7I1.A.2; Guan JF, 2008, J CONTIN EDUC HEALTH, V28, P172, DOI 10.1002/chp.174; Hanna E, 2013, J INTERPROF CARE, V27, P298, DOI 10.3109/13561820.2012.723071; Harasim L, 1995, LEARNING NETWORKS FI; Hung D. W. L., 2001, Educational Media International, V38, P3, DOI 10.1080/09523980110037525; JOYES G, 2005, INT J TEACH LEARN HI, V17, P33; Kirschner F, 2009, COMPUT HUM BEHAV, V25, P306, DOI 10.1016/j.chb.2008.12.008; Kourdioukova EV, 2011, EUR J RADIOL, V78, P353, DOI 10.1016/j.ejrad.2010.08.041; Luke R, 2009, J CONTIN EDUC HEALTH, V29, P161, DOI 10.1002/chp.20030; Mac Neill H, 2010, INTERPROFESSIONAL E, P75; Mazmanian PE, 2002, JAMA-J AM MED ASSOC, V288, P1057, DOI 10.1001/jama.288.9.1057; Meads G, 2005, CASE FOR INTERPROFESSIONAL COLLABORATION: IN HEALTH AND SOCIAL CARE, P1, DOI 10.1002/9780470776308; Means B., 2010, EVALUATION EVIDENCE; Morgan RL, 2000, J INSTRUCTIONAL PSYC, V27, P53; Morse JM, 1995, QUALITATIVE RES METH; Oncu S, 2008, COMPUT EDUC, V57, P1098; Palloff RM, 2005, COLLABORATING ONLINE; Palloff RM, 2005, COLLABORATING ONLINE, p[3, 57]; Resta P, 2007, EDUC PSYCHOL REV, V19, P65, DOI 10.1007/s10648-007-9042-7; Roberts TS, 2007, EDUC TECHNOL SOC, V10, P257; Ryan David Patrick, 2004, J Contin Educ Health Prof, V24, P112, DOI 10.1002/chp.1340240208; Sargeant Joan, 2004, J Contin Educ Health Prof, V24, P227, DOI 10.1002/chp.1340240406; Sloffer S. J., 1999, 899 CRLT IND U; Stahl G, 2006, CAMB HANDB PSYCHOL, P409; Swan K. P., 2008, E MENTOR, V2; Triola MM, 2012, MED TEACH, V34, pE15, DOI 10.3109/0142159X.2012.638010; Valcke M, 2009, INTERNET HIGH EDUC, V12, P165, DOI 10.1016/j.iheduc.2009.08.003	32	18	18	1	28	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-1912	1554-558X		J CONTIN EDUC HEALTH	J. Contin. Educ. Health Prof.	SPR	2014	34	2					102	111		10.1002/chp.21226			10	Education, Scientific Disciplines; Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Health Care Sciences & Services	AJ4DV	WOS:000337622500003	24939352				2022-02-06	
J	Mysliwiec, V; Matsangas, P; Baxter, T; McGraw, L; Bothwell, NE; Roth, BJ				Mysliwiec, Vincent; Matsangas, Panagiotis; Baxter, Tristin; McGraw, Leigh; Bothwell, Nici E.; Roth, Bernard J.			Comorbid Insomnia and Obstructive Sleep Apnea in Military Personnel: Correlation With Polysomnographic Variables	MILITARY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; QUANTITATIVE CRITERIA; BREATHING DISORDERS; SOLDIERS; IRAQ; ASSOCIATION; AFGHANISTAN; DEPLOYMENT; ESZOPICLONE; PREVALENCE	Objectives: Military personnel undergoing polysomnography are typically diagnosed only with obstructive sleep apnea (OSA). Comorbid insomnia with OSA is a well-established, underappreciated diagnosis. We sought to determine if military personnel with mild OSA met clinical criteria for insomnia and if there was a pattern of polysomnogram (PSG) variables that identified insomnia in these patients. Methods: Retrospective chart review of military personnel with mild OSA; cluster analysis to describe PSG variables. Results: 206 personnel assessed, predominately male (96.6%), mean age 36.5 +/- 8.14 years, body mass index 30.2 +/- 3.66 kg/m(2) and apnea hypopnea index of 8.44 +/- 2.92 per hour; 167 (81.1%) met criteria for insomnia. Cluster analysis identified a group of patients (N = 52) with PSG variables of increased wakefulness after sleep onset 77.3 minutes (27.7) (p < 0.001) and decreased sleep efficiency 82.6% (5.82) (p < 0.001) consistent with insomnia. Patients in this group were more likely to meet criteria for insomnia with an odds ratio 5.27 (1.20, 23.1), (p = 0.009). Conclusions: The majority of military personnel with mild OSA meet criteria for insomnia. Roughly one-third of these patients can be identified by a pattern of PSG variables. Recognizing and treating both comorbid insomnia and OSA could improve clinical outcomes.	[Mysliwiec, Vincent; Baxter, Tristin; McGraw, Leigh; Bothwell, Nici E.; Roth, Bernard J.] Madigan Army Med Ctr, Dept Pulm, Tacoma, WA 98431 USA; [Matsangas, Panagiotis] Naval Postgrad Sch, Dept Operat Res, Monterey, CA 93943 USA		Mysliwiec, V (corresponding author), Madigan Army Med Ctr, Dept Pulm, 9040A Fitzsimmons Ave, Tacoma, WA 98431 USA.				Center for Neuroscience and Regenerative MedicineUnited States Department of Defense [60855]	The authors would like to thank Angela Mysliwiec, MD, Madigan Army Medical Center, for editing assistance and review of the manuscript. Dr. Angela Mysliwiec did not receive compensation for her contributions. This study was supported, in part, by grant no. 60855 from the Center for Neuroscience and Regenerative Medicine.	Al-Jawder SE, 2012, SLEEP BREATH, V16, P295, DOI 10.1007/s11325-011-0513-1; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS, V2nd; Bjornsdottir E, 2012, J SLEEP RES, V21, P131, DOI 10.1111/j.1365-2869.2011.00972.x; Chung KF, 2005, RESPIRATION, V72, P460, DOI 10.1159/000087668; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Edinger JD, 2004, SLEEP, V27, P1567, DOI 10.1093/sleep/27.8.1567; Gelis LA, 2010, MIL MED, V175, P567, DOI 10.7205/MILMED-D-09-00123; GUILLEMINAULT C, 1973, SCIENCE, V181, P856, DOI 10.1126/science.181.4102.856; HAURI PJ, 1983, SLEEP, V6, P326, DOI 10.1093/sleep/6.4.326; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iber C., 2007, AASM MANUAL SCORING, P7; Krakow B, 2001, CHEST, V120, P1923, DOI 10.1378/chest.120.6.1923; Krakow B, 2001, BIOL PSYCHIAT, V49, P948, DOI 10.1016/S0006-3223(00)01087-8; Krakow Barry, 2004, Sleep Breath, V8, P15, DOI 10.1007/s11325-004-0015-5; Krakow Barry, 2002, Sleep Breath, V6, P189; Krakow B, 2010, J NERV MENT DIS, V198, P734, DOI 10.1097/NMD.0b013e3181f4aca1; Krell Suzanne B, 2005, Sleep Breath, V9, P104, DOI 10.1007/s11325-005-0026-x; Lavie P, 2010, J SLEEP RES, V19, P1, DOI 10.1111/j.1365-2869.2010.00836.x; Lettieri CJ, 2008, SLEEP, V31, P1310; Lettieri CJ, 2005, J CLIN SLEEP MED, V1, P381; Lettieri CJ, 2009, ANN INTERN MED, V151, P696, DOI 10.7326/0003-4819-151-10-200911170-00006; Lichstein KL, 2003, BEHAV RES THER, V41, P427, DOI 10.1016/S0005-7967(02)00023-2; Lineberger MD, 2006, SLEEP, V29, P479, DOI 10.1093/sleep/29.4.479; Littner M, 2003, SLEEP, V26, P754, DOI 10.1093/sleep/26.6.754; Luxton DD, 2011, SLEEP, V34, P1189, DOI 10.5665/SLEEP.1236; Miller NL, 2011, BEHAV SLEEP MED, V9, P53, DOI 10.1080/15402002.2011.533994; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Mysliwiec V, 2013, CHEST, V143, P582, DOI 10.1378/chest.12-2269; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; Okun ML, 2009, J CLIN SLEEP MED, V5, P41; Ong JC, 2013, J CLIN PSYCHOL, V69, P1066, DOI 10.1002/jclp.21958; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Seelig AD, 2010, SLEEP, V33, P1615, DOI 10.1093/sleep/33.12.1615; Smith S, 2004, SLEEP MED, V5, P449, DOI 10.1016/j.sleep.2004.03.005; Steinbach M., 2005, INTRO DATA MINING, P487, DOI DOI 10.1016/0022-4405(81)90007-8; Toblin Robin L., 2012, Morbidity and Mortality Weekly Report, V61, P895; Wickwire EM, 2010, SLEEP MED, V11, P772, DOI 10.1016/j.sleep.2010.03.012; Wickwire EM, 2010, CHEST, V137, P1449, DOI 10.1378/chest.09-1485; Yang CM, 2011, J PSYCHOSOM RES, V70, P355, DOI 10.1016/j.jpsychores.2010.12.005	41	18	19	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR	2014	179	3					294	300		10.7205/MILMED-D-13-00396			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AN7UJ	WOS:000340806200014	24594464	Bronze			2022-02-06	
J	Silver, JM				Silver, Jonathan M.			Neuropsychiatry of Persistent Symptoms After Concussion	PSYCHIATRIC CLINICS OF NORTH AMERICA			English	Article						Concussion; Brain injury; Neuropsychiatry; Chronic symptoms	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; RANDOMIZED CONTROLLED-TRIAL; HEART-RATE-VARIABILITY; POSTCONCUSSION SYNDROME; FOLLOW-UP; MAJOR DEPRESSION; RECOVERY; RESONANCE; EXERCISE	A minority of individuals will continue to experience debilitating symptoms for more than several months after sustaining a concussion. These problems may have multiple causes, including persistence of the original concussion symptoms, but they also may be due to factors such as depression and anxiety, physical problems, and psychological issues (including coping with an adverse insurance and legal system). This article reviews the differential diagnosis and treatment strategies for patients with chronic symptoms that persist after a concussion.	NYU, Sch Med, New York, NY 10028 USA		Silver, JM (corresponding author), NYU, Sch Med, 40 East 83rd St,Suite 1E, New York, NY 10028 USA.	jonsilver@gmail.com					Ariely, 2009, PREDICTABLY IRRATION; Ariely D., 2010, UPSIDE IRRATIONALITY; Azulay J, 2013, J HEAD TRAUMA REHAB, V28, P323, DOI 10.1097/HTR.0b013e318250ebda; Bigler E.D., 2011, TXB TRAUMATIC BRAIN, P73, DOI DOI 10.1177/1753193410381840; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chamelian L, 2006, J NEUROPSYCH CLIN N, V18, P33, DOI 10.1176/appi.neuropsych.18.1.33; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda Kenneth J, 2008, Optometry, V79, P18, DOI 10.1016/j.optm.2007.10.004; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deb S, 1999, AM J PSYCHIAT, V156, P374; el Barzouhi A, 2013, NEW ENGL J MED, V368, P999, DOI 10.1056/NEJMoa1209250; FANN JR, 1995, AM J PSYCHIAT, V152, P1493; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Green W, 2010, J REHABIL RES DEV, V47, P183, DOI 10.1682/JRRD.2009.04.0041; Gurr B, 2001, BRAIN INJURY, V15, P387, DOI 10.1080/02699050010005904; Hanna-Pladdy B, 2001, CLIN NEUROPSYCHOL, V15, P289, DOI 10.1076/clin.15.3.289.10272; Herrmann N, 2009, J NEUROPSYCH CLIN N, V21, P181, DOI 10.1176/appi.neuropsych.21.2.181; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hou R, 2011, J NEUROL NEUROSUR PS, V83, P217; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kapoor N, 2011, TXB TRAUMATIC BRAIN, P363; Kim N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059382; Koren D, 1999, AM J PSYCHIAT, V156, P367; Lalwani AK, 2011, TXB TRAUMATIC BRAIN, P351; Larson EB, 2013, J INT NEUROPSYCH SOC, V19, P88, DOI 10.1017/S1355617712000999; Leddy JJ, 2013, J HEAD TRAUMA REHAB, V28, P241, DOI 10.1097/HTR.0b013e31826da964; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; McAllister TW, 2011, TXB TRAUMATIC BRAIN, P239; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; Meares S, 2008, J NEUROL NEUROSUR PS, V79, P300, DOI 10.1136/jnnp.2007.126565; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Paniak C, 2002, J CLIN EXP NEUROPSYC, V24, P187, DOI 10.1076/jcen.24.2.187.999; Pavawalla SP, 2013, J INT NEUROPSYCH SOC, V19, P305, DOI 10.1017/S135561771200135X; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Satz P, 1998, BRAIN INJURY, V12, P537, DOI 10.1080/026990598122313; Silver JM, 2012, J NEUROL NEUROSUR PS, V83, P836, DOI 10.1136/jnnp-2011-302078; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Steele Claude M., 2010, WHISTLING VIVALDI OT; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Sullivan KA, 2012, J HEAD TRAUMA REHAB, V27, P293, DOI 10.1097/HTR.0b013e31822123ce; Tharion Elizabeth, 2012, Indian J Physiol Pharmacol, V56, P80; Tsanadis J, 2008, CLIN NEUROPSYCHOL, V22, P1080, DOI 10.1080/13854040701796928; Vanderploeg RD, 2013, J HEAD TRAUMA REHAB, V28, P211, DOI 10.1097/HTR.0b013e31828b50db; Vaschillo E, 2002, APPL PSYCHOPHYS BIOF, V27, P1, DOI 10.1023/A:1014587304314; Wade DT, 1998, J NEUROL NEUROSUR PS, V65, P177, DOI 10.1136/jnnp.65.2.177; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Zasler ND, 2011, TXB TRAUMATIC BRAIN, P375; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	63	18	18	0	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0193-953X	1558-3147		PSYCHIAT CLIN N AM	Psychiatr. Clin. North Amer.	MAR	2014	37	1					91	+		10.1016/j.psc.2013.11.001			13	Psychiatry	Social Science Citation Index (SSCI)	Psychiatry	AD8UM	WOS:000333541200007	24529425				2022-02-06	
J	Almenar-Queralt, A; Falzone, TL; Shen, ZX; Lillo, C; Killian, RL; Arreola, AS; Niederst, ED; Ng, KS; Kim, SN; Briggs, SP; Williams, DS; Goldstein, LSB				Almenar-Queralt, Angels; Falzone, Tomas L.; Shen, Zhouxin; Lillo, Concepcion; Killian, Rhiannon L.; Arreola, Angela S.; Niederst, Emily D.; Ng, Kheng S.; Kim, Sonia N.; Briggs, Steven P.; Williams, David S.; Goldstein, Lawrence S. B.			UV Irradiation Accelerates Amyloid Precursor Protein (APP) Processing and Disrupts APP Axonal Transport	JOURNAL OF NEUROSCIENCE			English	Article						amyloid precursor protein; APP axonal vesicles; axonal transport; gamma-secretase; kinesin; UV-irradiation	TRAUMATIC BRAIN-INJURY; C-TERMINAL FRAGMENTS; KINESIN LIGHT-CHAIN; BETA-PROTEIN; ALZHEIMERS-DISEASE; GAMMA-SECRETASE; IN-VIVO; GROWTH-FACTOR; DNA-DAMAGE; TRAFFICKING ORGANELLE	Overexpression and/or abnormal cleavage of amyloid precursor protein (APP) are linked to Alzheimer's disease (AD) development and progression. However, the molecular mechanisms regulating cellular levels of APP or its processing, and the physiological and pathological consequences of altered processing are not well understood. Here, using mouse and human cells, we found that neuronal damage induced by UV irradiation leads to specific APP, APLP1, and APLP2 decline by accelerating their secretase-dependent processing. Pharmacological inhibition of endosomal/lysosomal activity partially protects UV-induced APP processing implying contribution of the endosomal and/or lysosomal compartments in this process. We found that a biological consequence of UV-induced gamma-secretase processing of APP is impairment of APP axonal transport. To probe the functional consequences of impaired APP axonal transport, we isolated and analyzed presumptive APP-containing axonal transport vesicles from mouse cortical synaptosomes using electron microscopy, biochemical, and mass spectrometry analyses. We identified a population of morphologically heterogeneous organelles that contains APP, the secretase machinery, molecular motors, and previously proposed and new residents of APP vesicles. These possible cargoes are enriched in proteins whose dysfunction could contribute to neuronal malfunction and diseases of the nervous system including AD. Together, these results suggest that damage-induced APP processing might impair APP axonal transport, which could result in failure of synaptic maintenance and neuronal dysfunction.	[Almenar-Queralt, Angels; Falzone, Tomas L.; Killian, Rhiannon L.; Arreola, Angela S.; Niederst, Emily D.; Ng, Kheng S.; Kim, Sonia N.; Goldstein, Lawrence S. B.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Lillo, Concepcion; Williams, David S.] Univ Calif San Diego, Dept Pharmacol & Neurosci, La Jolla, CA 92093 USA; [Shen, Zhouxin; Briggs, Steven P.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Almenar-Queralt, Angels; Arreola, Angela S.; Kim, Sonia N.; Goldstein, Lawrence S. B.] Sanford Consortium Regenerat Med, La Jolla, CA 92037 USA		Goldstein, LSB (corresponding author), Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.	lgoldstein@ucsd.edu	Lillo, Concepcion/A-6321-2009; Falzone, Tomas/W-2528-2019; Ng, Ted Kheng Siang/ABI-1863-2020	Lillo, Concepcion/0000-0001-5814-9826; Ng, Ted Kheng Siang/0000-0001-7348-0410; Kim, Sonia Nan/0000-0002-2998-2621; Falzone, Tomas/0000-0002-7984-1149	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG032180]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005131, R01AG032180] Funding Source: NIH RePORTER	This study was supported by the National Institute on Aging grant R01 AG032180. We thank Christine Vande Velde and Robert Vassar for providing the VDAC1 and BACE1 antibodies, respectively, and Laurent Taupenot for providing us with SH-SY5Y cells. We also thank Valeria Cavalli for technical expertise with synaptosome fractionations. We are grateful to Eddie Koo and David Kang for providing PSEN1/2 dKO MEFs and PSEN1/2 dKO rescued with PSEN1/2. We also thank Ivan Garcia-Bassets for providing LN-CaP cells and advice with GREAT analysis. We also thank Sol Reyna for her advice on statistical analysis. Finally, we thank Anthony H. Nguyen and Nisha Parmeswar for technical assistance.	Abe N, 2009, J BIOL CHEM, V284, P34628, DOI 10.1074/jbc.M109.035022; AMARATUNGA A, 1995, J NEUROCHEM, V64, P2374; AMARATUNGA A, 1995, J BIOL CHEM, V270, P17268, DOI 10.1074/jbc.270.29.17268; Araki Y, 2003, J BIOL CHEM, V278, P49448, DOI 10.1074/jbc.M306024200; Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Beher D, 1999, J NEUROCHEM, V72, P1564, DOI 10.1046/j.1471-4159.1999.721564.x; Brunholz S, 2012, EXP BRAIN RES, V217, P353, DOI 10.1007/s00221-011-2870-1; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chen XH, 2004, AM J PATHOL, V165, P357, DOI 10.1016/S0002-9440(10)63303-2; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; COLE GM, 1989, NEUROCHEM RES, V14, P933, DOI 10.1007/BF00965926; Corrigan F, 2012, BRAIN RES, V1451, P87, DOI 10.1016/j.brainres.2012.02.045; Cuesta A, 2009, FEBS LETT, V583, P2401, DOI 10.1016/j.febslet.2009.06.040; Cuesta A, 2009, BIOCHEM J, V418, P643, DOI 10.1042/BJ20081793; Falzone Tomas L, 2012, Methods Mol Biol, V846, P295, DOI 10.1007/978-1-61779-536-7_25; Falzone TL, 2009, J NEUROSCI, V29, P5758, DOI 10.1523/JNEUROSCI.0780-09.2009; Frykman S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008948; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Goldsbury C, 2006, TRAFFIC, V7, P873, DOI 10.1111/j.1600-0854.2006.00434.x; Goldstein LSB, 2012, PROG NEUROBIOL, V99, P186, DOI 10.1016/j.pneurobio.2012.03.006; Groemer TW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018754; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Haapasalo A, 2011, J ALZHEIMERS DIS, V25, P3, DOI 10.3233/JAD-2011-101065; Hata S, 2009, J BIOL CHEM, V284, P36024, DOI 10.1074/jbc.M109.057497; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821; Jin SM, 2008, CELL DEATH DIFFER, V15, P1375, DOI 10.1038/cdd.2008.49; Jin SM, 2007, CELL DEATH DIFFER, V14, P189, DOI 10.1038/sj.cdd.4402003; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kasa P, 2001, BRAIN RES, V909, P159, DOI 10.1016/S0006-8993(01)02679-8; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Konecna A, 2006, MOL BIOL CELL, V17, P3651, DOI 10.1091/mbc.E06-02-0112; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee PH, 2006, NEUROCHEM RES, V31, P821, DOI 10.1007/s11064-006-9086-y; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Li L, 2009, NEUROBIOL AGING, V30, P1091, DOI 10.1016/j.neurobiolaging.2007.10.011; Ludwig A, 2009, TRAFFIC, V10, P572, DOI 10.1111/j.1600-0854.2009.00886.x; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; Muresan V, 2009, J NEUROSCI, V29, P3565, DOI 10.1523/JNEUROSCI.2558-08.2009; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Oksvold MP, 2002, J CELL SCI, V115, P793; Papp H, 2002, NEUROCHEM INT, V41, P429, DOI 10.1016/S0197-0186(02)00014-1; Reis GF, 2012, MOL BIOL CELL, V23, P1700, DOI 10.1091/mbc.E11-11-0938; Repetto E, 2007, J BIOL CHEM, V282, P31504, DOI 10.1074/jbc.M704273200; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Rodrigues EM, 2012, HUM MOL GENET, V21, P4587, DOI 10.1093/hmg/dds297; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Rusu P, 2007, EUR J NEUROSCI, V25, P1079, DOI 10.1111/j.1460-9568.2007.05341.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; SCOTT JN, 1991, MOL BRAIN RES, V10, P315, DOI 10.1016/0169-328X(91)90090-K; Sheng JG, 2003, EXP NEUROL, V184, P1053, DOI 10.1016/j.expneurol.2003.08.018; Shi J, 2000, BRAIN RES, V853, P1, DOI 10.1016/S0006-8993(99)02113-7; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Somosy Z, 2000, MICRON, V31, P165, DOI 10.1016/S0968-4328(99)00083-9; Steuble M, 2012, BIOL OPEN, V1, P761, DOI 10.1242/bio.20121578; Steuble M, 2010, PROTEOMICS, V10, P3775, DOI 10.1002/pmic.201000384; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Szodorai A, 2009, J NEUROSCI, V29, P14534, DOI 10.1523/JNEUROSCI.1546-09.2009; Szpankowski L, 2012, P NATL ACAD SCI USA, V109, P8582, DOI 10.1073/pnas.1120510109; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Tokuda T, 1996, BIOCHEM BIOPH RES CO, V223, P165, DOI 10.1006/bbrc.1996.0863; Vagnoni A, 2012, HUM MOL GENET, V21, P2845, DOI 10.1093/hmg/dds109; Van den Heuvel C, 1999, EXP NEUROL, V159, P441, DOI 10.1006/exnr.1999.7150; Vogt L, 2001, MOL CELL NEUROSCI, V17, P151, DOI 10.1006/mcne.2000.0937; Volknandt W, 2012, EXP BRAIN RES, V217, P449, DOI 10.1007/s00221-012-3031-x; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Yamazaki T, 1996, J CELL SCI, V109, P999; Zhang H, 2012, J NEUROCHEM, V120, P9, DOI 10.1111/j.1471-4159.2011.07519.x	88	18	18	0	7	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	FEB 26	2014	34	9					3320	3339		10.1523/JNEUROSCI.1503-13.2014			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	AB8IX	WOS:000332034700020	24573290	Green Published, Bronze			2022-02-06	
J	Whealin, JM; Stotzer, RL; Pietrzak, RH; Vogt, D; Shore, J; Morland, L; Southwick, SM				Whealin, Julia M.; Stotzer, Rebecca L.; Pietrzak, Robert H.; Vogt, Dawne; Shore, Jay; Morland, Leslie; Southwick, Steven M.			Deployment-Related Sequelae and Treatment Utilization in Rural and Urban War Veterans in Hawaii	PSYCHOLOGICAL SERVICES			English	Article						military; Pacific Islands; mental health services; mental health access; mental health utilization	POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH-CARE; TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SERVICE USE; AFGHANISTAN VETERANS; NATIONAL SAMPLE; SOCIAL SUPPORT; ALCOHOL MISUSE; RISK-FACTORS	This study compared common deployment-related health issues and correlates of mental health service utilization among rural and urban veterans of Operation Enduring Freedom (OEF), Operation Iraqi Freedom (OIF), and Operation New Dawn (OND) living in Hawaii. Frequency of utilization of a broad range of mental health resources, including clergy/spiritual leaders, videoconference/online programs, and traditional/alternative healers, was also characterized. A random sample of 116 rural and 117 urban ethnoracially diverse veterans completed a mail survey. Rural veterans were more likely than urban veterans to meet screening criteria for posttraumatic stress disorder (PTSD), deployment-related concussion with persistent postconcussive symptoms, and alcohol use problems. Over one third of veterans who desired help for a mental health problem reported no current use of any services. Rural veterans were more likely than urban veterans to have accessed Veteran Readjustment Centers, but they did not differ with respect to utilization of other services. Correlates of mental health service utilization included higher education, PTSD, and lower mental-health-related quality of life. Results of this study underscore the need for dissemination efforts to enable OEF/OIF/OND veterans to access mental health resources.	[Whealin, Julia M.] VA Pacific Isl HealthCare Syst, Natl Ctr PTSD, Pacific Isl Div, Honolulu, HI 96819 USA; [Whealin, Julia M.] Univ Hawaii, John A Burns Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Stotzer, Rebecca L.] Univ Hawaii, Myron B Thompson Sch Social Work, Honolulu, HI 96822 USA; [Pietrzak, Robert H.] VA Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div, West Haven, CT USA; [Pietrzak, Robert H.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA; [Vogt, Dawne] VA Boston Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Womens Hlth Sci Div, Boston, MA USA; [Vogt, Dawne] Boston Univ, Dept Psychiat, Boston, MA 02215 USA; [Shore, Jay] US Dept Vet Affairs Off Rural Vet, Rural Hlth Resource Ctr Western Reg, Salt Lake City, UT USA; [Shore, Jay] Ctr Amer Indian & Alaska Native Hlth, Dept Psychiat, Denver, CO USA; [Morland, Leslie] VA Pacific Isl HealthCare Syst, Natl Ctr Posttraumat Stress Disorder, Pacific Isl Div, Honolulu, HI 96819 USA; [Morland, Leslie] Univ Hawaii, Sch Med, Dept Psychiat, Honolulu, HI 96822 USA; [Southwick, Steven M.] VA Connecticut Healthcare Syst, Natl Ctr Posttraumat Stress Disorder, Clin Neurosci Div, West Haven, CT USA; [Southwick, Steven M.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06520 USA		Whealin, JM (corresponding author), VA Pacific Isl HealthCare Syst, Natl Ctr PTSD, 3375 Koapaka St,Suite I-150, Honolulu, HI 96819 USA.	julia.whealin@va.gov	Whealin, Julia/J-8819-2015	Whealin, Julia/0000-0002-2876-6783			ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Andrews B, 2003, J TRAUMA STRESS, V16, P421, DOI 10.1023/A:1024478305142; Backhaus A, 2012, PSYCHOL SERV, V9, P111, DOI 10.1037/a0027924; Brewin CR, 2000, J CONSULT CLIN PSYCH, V68, P748, DOI 10.1037/0022-006X.68.5.748; Brooks E, 2012, PSYCHIAT SERV, V63, P862, DOI 10.1176/appi.ps.201100444; BUCHSBAUM DG, 1991, ANN INTERN MED, V115, P774, DOI 10.7326/0003-4819-115-10-774; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Cheak-Zamora NC, 2009, QUAL LIFE RES, V18, P727, DOI 10.1007/s11136-009-9483-1; Chermack ST, 2008, MED CARE, V46, P813, DOI 10.1097/MLR.0b013e318178eb08; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Corrigan PW, 2007, AUST PSYCHOL, V42, P90, DOI 10.1080/00050060701280573; Courtenay W.H., 2011, DYING BE MEN PSYCHOS; Cully JA, 2010, J RURAL HEALTH, V26, P225, DOI 10.1111/j.1748-0361.2010.00294.x; Dew B, 2007, J RURAL HEALTH, V23, P16, DOI 10.1111/j.1748-0361.2007.00119.x; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; Elhai JD, 2008, J PSYCHIATR RES, V42, P858, DOI 10.1016/j.jpsychires.2007.09.006; Elhai JD, 2007, J ANXIETY DISORD, V21, P580, DOI 10.1016/j.janxdis.2006.07.001; Ettenhofer ML, 2012, MIL MED, V177, P1272, DOI 10.7205/MILMED-D-12-00095; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fontana A, 2006, VETERANS AFFAIRS MIL; Fox JC, 2001, COMMUNITY MENT HLT J, V37, P421, DOI 10.1023/A:1017580013197; Girton R., 2011, VA PAC ISL HLTH CAR; Grubaugh AL, 2008, WOMEN HEALTH ISS, V18, P433, DOI 10.1016/j.whi.2008.08.001; Harpaz-Rotem I., 2012, DETERMINANTS P UNPUB; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Iverson GL, 2009, CLIN NEUROPSYCHOL, V23, P1299, DOI 10.1080/13854040903153902; Jones-Hazledine C., 2006, J RURAL COMMUNITY E, VE9, P1; KANIASTY K, 1995, CURR DIR PSYCHOL SCI, V4, P94, DOI 10.1111/1467-8721.ep10772341; King AC, 2004, J SUBST ABUSE TREAT, V26, P189, DOI 10.1016/S0740-5472(03)00210-1; Lebowitz MS, 2012, PSYCHIAT SERV, V63, P496, DOI 10.1176/appi.ps.201100265; Mangione TW, 1998, HDB APPL SOCIAL RES, P399; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mohamed S, 2009, PSYCHIAT SERV, V60, P914, DOI 10.1176/appi.ps.60.7.914; Naragon-Gainey K, 2012, PSYCHIAT SERV, V63, P942, DOI 10.1176/appi.ps.201100349; Nelson D. D., EXAMINING SELF UNPUB; OHARE W, 2006, US RURAL SOLDIERS AC; Petersen, 2008, PSYCHOL SERV, V5, P320, DOI [10.1037/a0013719, DOI 10.1037/A0013719]; Pole N, 2008, CLIN PSYCHOL-SCI PR, V15, P35, DOI 10.1111/j.1468-2850.2008.00109.x; Proctor S. P., 2011, Journal of Rural Social Sciences (JRSS), V26, P32; Quine S, 2003, Rural Remote Health, V3, P245; Riviere LA, 2011, J NERV MENT DIS, V199, P199, DOI 10.1097/NMD.0b013e31820caee4; Roberts RO, 1996, J CLIN EPIDEMIOL, V49, P989, DOI 10.1016/0895-4356(96)00143-6; Rost K, 1993, J Rural Health, V9, P57, DOI 10.1111/j.1748-0361.1993.tb00495.x; Santa Ana EJ, 2013, PSYCHOL SERV, V10, P304, DOI 10.1037/a0026511; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Sayer NA, 2007, J TRAUMA STRESS, V20, P15, DOI 10.1002/jts.20182; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Seal KH, 2011, DRUG ALCOHOL DEPEN, V116, P93, DOI 10.1016/j.drugalcdep.2010.11.027; Seal KH, 2009, AM J PUBLIC HEALTH, V99, P1651, DOI 10.2105/AJPH.2008.150284; Spoont MR, 2009, J TRAUMA STRESS, V22, P648, DOI 10.1002/jts.20470; Stecker T, 2007, PSYCHIAT SERV, V58, P1358, DOI 10.1176/appi.ps.58.10.1358; Steele Leah S, 2007, Healthc Policy, V3, P96; Stotzer R, 2012, ADV SOCIAL WORK, V13, P1; Struening FL, 2001, PSYCHIATR SERV, V52, P1633; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V1, DOI [10.1037/e527612010-001, DOI 10.1037/E527612010-001]; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; U.S. Department of Health and Human Services, 2011, FIN DAT COLL STAND R; U.S. Department of Veterans Affairs, 2012, COMM PROV TOOLK; *USDA, 2000, RUR URB COMM AR COD; Vogt D, 2011, PSYCHIAT SERV, V62, P135, DOI 10.1176/ps.62.2.pss6202_0135; Wallace AE, 2006, PSYCHIAT SERV, V57, P851, DOI 10.1176/appi.ps.57.6.851; Weathers FW, 1999, PSYCHOL ASSESSMENT, V11, P124, DOI 10.1037/1040-3590.11.2.124; Weeks WB, 2005, J HEALTHC MANAG, V50, P95, DOI 10.1097/00115514-200503000-00006; Weeks WB, 2004, AM J PUBLIC HEALTH, V94, P1762, DOI 10.2105/AJPH.94.10.1762; Weg MWV, 2012, AM J ADDICTION, V21, P31, DOI 10.1111/j.1521-0391.2011.00191.x; West AN, 2010, J RURAL HEALTH, V26, P301, DOI 10.1111/j.1748-0361.2010.00298.x; Williams EC, 2012, J RURAL HEALTH, V28, P202, DOI 10.1111/j.1748-0361.2011.00389.x; [No title captured], DOI DOI 10.1037/1541-1559.1.2.111	69	18	18	0	10	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	FEB	2014	11	1					114	123		10.1037/a0032782			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	AB6AL	WOS:000331869700013	24099457				2022-02-06	
J	Zhao, GW; Wang, Y; Li, YC; Jiang, ZL; Sun, L; Xi, X; He, P; Wang, GH; Xu, SH; Ma, DM; Ke, KF				Zhao, Guang-Wei; Wang, Yong; Li, Yong -Cai; Jiang, Zheng-Lin; Sun, Li; Xi, Xin; He, Peng; Wang, Guo-Hua; Xu, Shi-Hui; Ma, Dong-Ming; Ke, Kai-Fu			The neuroprotective effect of modified "Shengyu" decoction is mediated through an anti-inflammatory mechanism in the rat after traumatic brain injury	JOURNAL OF ETHNOPHARMACOLOGY			English	Article						Modified "Shengyu" decoction; Rat; Traumatic brain injury; Neuroprotection; Inflammatory response	MOTOR-PERFORMANCE; TRANSGENIC MICE; INFLAMMATION; CYTOKINES; INTERLEUKIN-6; ASTROCYTES; ACTIVATION; MANAGEMENT; MICROGLIA; ISCHEMIA	Ethnopharmacological relevance: "Shengyu" decoction, a traditional Chinese medicine, has been used to treat diseases with deficit in "qi" and "blood" induced frequently by profound loss of blood or by long sores with heavy pus, in which a potential anti-inflammatory effect is implied. The modified "Shengyu" decoction (MSD) used in the present study was designed on the basis of the "Shengyu" decoction, additional four herbs were added in. Many ingredients in these herbs have been demonstrated to be anti-inflammatory and thus MSD may be used for the treatment of traumatic brain injury (TBI). To evaluate the neuroprotective effect and the underlying mechanisms of MSD on the rat brain after TBI. Materials and methods: TBI was induced in the right cerebral cortex of male adult rats using Feeney's weight-drop method. The rats were administered a gavage of MSD (0.5, 1.0 or 2.0 ml/200 g) 6 h after TBI. The neurological functions, brain water content, contusion volume, and neuron loss were determined. The levels of TNF-alpha, IL-1 beta, IL-6, and IL-10 and the number of GFAP- and Iba1-positive cells in the brain ipsilateral to TBI were also measured. Moreover, the influence of MSD on these variables was observed at the same time. Results: The neurological deficits, brain water content, and neuron loss were significantly reduced after 1.0 or 2.0 ml/200 g of MSD treatment but not after 0.5 ml/200 g. In addition, treatment with MSD (1.0 ml/200 g) significantly increased the level of IL-10 and reduced the level of TNF-a and IL-10 and the number of GFAP- and lba1-positive cells after TBI. However, the contusion volume of brain tissue and the expression of IL-6 were not significantly changed. Conclusion: MSD may be a potential therapeutic for the treatment of TBI because MSD alleviated secondary brain injury induced by TBI. In addition, MSD inhibited the inflammatory response through reducing the expression of inflammatory cytokines and the activation of microglial cells and astrocytes in the brain tissue of rats after TBI. Therefore, a potential anti-inflammatory mechanism of the "Shengyu" decoction was confirmed, which may be one of the main reasons of "Shengyu" decoction used to treat diseases with obvious inflammatory responses. (C) 2013 Elsevier Ireland Ltd. All rights reserved.	[Zhao, Guang-Wei; Jiang, Zheng-Lin; Sun, Li; Wang, Guo-Hua] Nantong Univ, Inst Naut Med, Dept Neuropharmacol, Nantong 226001, Jiangsu, Peoples R China; [Li, Yong -Cai; He, Peng; Xu, Shi-Hui; Ma, Dong-Ming] Peoples Hosp Ningxia, Dept Neurosurg, Yinchuan 750021, Ningxia, Peoples R China; [Wang, Yong; Xi, Xin] Peoples Hosp Nantong, Dept Neurosurg & Chinese Med, Nantong 226001, Jiangsu, Peoples R China; [Zhao, Guang-Wei; Jiang, Zheng-Lin; Ke, Kai-Fu] Nantong Univ, Affiliated Hosp, Dept Neurol, Nantong 226001, Jiangsu, Peoples R China; [Zhao, Guang-Wei] Peoples Hosp Gaocheng, Dept Neurol, Hebei 052160, Peoples R China		Li, YC (corresponding author), Nantong Univ, Inst Naut Med, Dept Neuropharmacol, 19 Qixiu Rd, Nantong 226001, Jiangsu, Peoples R China.	yclee7833@hotmail.com; jiangzl@ntu.edu.cn			Natural Science Foundation of Ningxia [NZ10178]	This work was supported by the Natural Science Foundation of Ningxia (Grant NZ10178).	Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Bareyre F, 1997, J NEUROTRAUM, V14, P839, DOI 10.1089/neu.1997.14.839; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Chang H. M., 2001, PHARM APPL CHINESE M; Chao WW, 2010, J ETHNOPHARMACOL, V129, P244, DOI 10.1016/j.jep.2010.03.022; Chew E, 2009, J REHABIL RES DEV, V46, P851, DOI 10.1682/JRRD.2008.09.0120; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; Chua KSG, 2007, ANN ACAD MED SINGAP, V36, P31; COMBS DJ, 1987, STROKE, V18, P503, DOI 10.1161/01.STR.18.2.503; DEGRABA TJ, 1994, J CEREBR BLOOD F MET, V14, P262, DOI 10.1038/jcbfm.1994.33; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Hanisch UK, 2002, GLIA, V40, P140, DOI 10.1002/glia.10161; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Heyser CJ, 1997, P NATL ACAD SCI USA, V94, P1500, DOI 10.1073/pnas.94.4.1500; Ji Y.B., 2005, PHARM APPL COMPOUND; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Liu G.S., 2004, SECRET BOOK ORCHID C, V3; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Rubio-Perez JM, 2012, SCI WORLD J, DOI 10.1100/2012/756357; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; Or TCT, 2011, NEUROPHARMACOLOGY, V60, P823, DOI 10.1016/j.neuropharm.2010.12.002; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Rao VLR, 2000, EXP NEUROL, V161, P102, DOI 10.1006/exnr.1999.7269; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Schneider G, 2002, MAGN RESON MATER PHY, V14, P233, DOI 10.1016/S1352-8661(02)00068-6; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Wang T, 2012, J NEUROIMMUNOL, V245, P79, DOI 10.1016/j.jneuroim.2012.02.008; Wu Q., 1957, CORRECTION DRUGS PRE, V3; Xia L, 2012, J NEUROSCI RES, V90, P1424, DOI 10.1002/jnr.22811; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	40	18	18	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-8741			J ETHNOPHARMACOL	J. Ethnopharmacol.	JAN 10	2014	151	1					694	703		10.1016/j.jep.2013.11.041			10	Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine	AA3TU	WOS:000331017200075	24296086				2022-02-06	
J	Chitsabesan, P; Lennox, C; Theodosiou, L; Law, H; Bailey, S; Shaw, J				Chitsabesan, Prathiba; Lennox, Charlotte; Theodosiou, Louise; Law, Heather; Bailey, Sue; Shaw, Jenny			The development of the comprehensive health assessment tool for young offenders within the secure estate	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						young offenders; screening; mental health; physical health; substance misuse and neurodisability	CONCUSSION SYMPTOMS QUESTIONNAIRE; PSYCHIATRIC-DISORDERS; PERSISTENT; NEEDS; YOUTH; BOYS	Health inequalities are high among offending groups. The comprehensive health assessment tool (CHAT) is a semi-structured assessment developed to provide a standardised approach to health screening for all young offenders admitted to the secure estate. The four sections of the CHAT (physical health, mental health, substance misuse and neurodisability) were evaluated within a two-phased study of male adolescents (aged 15-18years) within a young offenders institution in the north-west of England. Within Phase 1, a consecutive sample of 127 new receptions was assessed using the physical health, mental health and substance misuse sections of the CHAT against a range of reference standard assessments. Phase 2 of the study evaluated the neurodisability section on 93 male adolescents against reference standard tools. The four sections of the CHAT demonstrated fair to good convergent validity when compared against reference standard tools in male offenders. The diagnostic accuracy rate was 76% for mental health, 63% for physical health, 83% for substance misuse and 53% for neurodisability when compared against reference standard assessment tools. The introduction of the CHAT offers the opportunity to enhance existing reception screening practices and create an integrated approach to the assessment of health needs across the secure estate.	[Chitsabesan, Prathiba; Lennox, Charlotte; Theodosiou, Louise; Shaw, Jenny] Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England; [Law, Heather] Greater Manchester West NHS Fdn Trust, Manchester, Lancs, England; [Bailey, Sue] Univ Cent Lancashire, Sch Social Work, London, England		Chitsabesan, P (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Manchester M13 9PL, Lancs, England.	pchitsabesan@nhs.net		shaw, jennifer/0000-0003-2569-7687; Lennox, Charlotte/0000-0001-9014-9965			American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Barnum, 2001, MASSACHUSETTS YOUTH; Berument SK, 1999, BRIT J PSYCHIAT, V175, P444, DOI 10.1192/bjp.175.5.444; British Psychological Society, 2001, LEARN DIS DEF CONT; Butcher JN, 1992, MMPI A MINNESOTA MUL; Centre for Mental Health, 2010, YOU JUST GET DO IT H; Chitsabesan P, 2006, BRIT J PSYCHIAT, V188, P534, DOI 10.1192/bjp.bp.105.010116; Chitsabesan P, 2007, J CHILD SERV, V2, P4, DOI 10.1108/17466660200700032; Constantino JN., 2002, SOCIAL RESPONSIVENES; De Meyrick J., 2003, HLTH ED, V103, P7, DOI [10.1108/09654280310459112, DOI 10.1108/09654280310459112]; Foxcroft C., 2004, PSYCHOL ASSESSMENT S; Golzari M, 2006, J ADOLESCENT HEALTH, V38, P776, DOI 10.1016/j.jadohealth.2005.06.008; Gregory J, 2011, INT J LANG COMM DIS, V46, P202, DOI 10.3109/13682822.2010.490573; Harrington R., 2005, MENTAL HLTH NEEDS EF; Hughes N., 2012, NOBODY CONNECTION PR; Johnson M., 1998, CANTERBURY THANET VE; Kaufman A.S., 1990, KAUFMAN BRIEF INTELL; King G., 2009, BRADLEY REPORT; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kroll L, 2002, LANCET, V359, P1975, DOI 10.1016/S0140-6736(02)08829-3; Lader D., 2000, PSYCHIAT MORBIDITY Y; Lennox C., CRIMINAL BE IN PRESS; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Meltzer H, 2000, MENTAL HLTH CHILDREN; MOFFITT TE, 1993, PSYCHOL REV, V100, P674, DOI 10.1037/0033-295X.100.4.674; Offender Health Research Network, 2013, COMPR HLTH ASS TOOL; Office of the Children's Commissioner, 2011, I THINK I MUST HAV B; Paley L, 2011, ARCH INTERN MED, V171, P1394, DOI 10.1001/archinternmed.2011.340; Perron Brian E, 2008, Crim Behav Ment Health, V18, P243, DOI 10.1002/cbm.702; Potter S, 2006, J NEUROL, V253, P1603, DOI 10.1007/s00415-006-0275-z; Prison Reform Trust, 2012, FAT FLAW HAS STAT LE; Royal College of Paediatrics and Child Health, 2013, HEALTHC STAND CHILDR; Ryan, 1996, SCHEDULE AFFECTIVE D; Ryan M., 2012, HLTH WELL BEING NEED; Teplin LA, 2002, ARCH GEN PSYCHIAT, V59, P1133, DOI 10.1001/archpsyc.59.12.1133; Urbina S, 1997, PSYCHOL TESTING; Vreugdenhil C, 2004, J AM ACAD CHILD PSY, V43, P97, DOI 10.1097/00004583-200401000-00019; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; Wiig E. H., 1989, TEST LANGUAGE COMPET; Williams H, 2010, TLS-TIMES LIT SUPPL, P20; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Youth Justice Board, 2012, SUBST MIS INT YOUNG	43	18	18	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.	JAN 2	2014	25	1					1	25		10.1080/14789949.2014.882387			25	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	303QZ	WOS:000330690600001					2022-02-06	
J	Atmaca, N; Yildirim, E; Guner, B; Kabakci, R; Bilmen, FS				Atmaca, Nurgul; Yildirim, Ebru; Guner, Bayram; Kabakci, Ruhi; Bilmen, Fatih Sultan			Effect of Resveratrol on Hematological and Biochemical Alterations in Rats Exposed to Fluoride	BIOMED RESEARCH INTERNATIONAL			English	Article							TRAUMATIC BRAIN-INJURY; SODIUM-FLUORIDE; INDUCED NEPHROTOXICITY; INDUCED HEPATOTOXICITY; OXIDATIVE STRESS; VITAMIN-E; FLUOROSIS; TOXICITY; PARAMETERS; PROTECTS	We investigated the protective effects of resveratrol on hematological and biochemical changes induced by fluoride in rats. A total of 28 rats were divided into 4 groups: control, resveratrol, fluoride, and fluoride/resveratrol (n = 7 each), for a total of 21 days of treatment. Blood samples were taken and hematological and biochemical parameters were measured. Compared to the control group, the fluoride-treated group showed significant differences in several hematological parameters, including decreases in WBC, RBC, and PLT counts and neutrophil ratio. The group that received resveratrol alone showed a decrease in WBC count compared to the control group. Furthermore, in comparison to the control group, the fluoride group showed significantly increased ALT enzyme activity and decreased inorganic phosphorus level. The hematological and biochemical parameters in the fluoride + resveratrol treated group were similar to control group. In the fluoride + resveratrol group, resveratrol restored the changes observed following fluoride treatment, including decreased counts of WBC, RBC, and PLT, decreased neutrophil ratio and inorganic phosphorus levels, and elevated ALT enzyme activity. The present study showed that fluoride caused adverse effects in rats and that resveratrol reduced hematological and biochemical alterations produced by fluoride exposure.	[Atmaca, Nurgul; Kabakci, Ruhi; Bilmen, Fatih Sultan] Kirikkale Univ, Fac Vet Med, Dept Physiol, TR-71451 Kirikkale, Turkey; [Yildirim, Ebru] Kirikkale Univ, Fac Vet Med, Dept Pharmacol Toxicol, TR-71451 Kirikkale, Turkey; [Guner, Bayram] Kirikkale Univ, Fac Vet Med, Dept Biochem, TR-71451 Kirikkale, Turkey		Atmaca, N (corresponding author), Kirikkale Univ, Fac Vet Med, Dept Physiol, TR-71451 Kirikkale, Turkey.	nurgulzengin@yahoo.com	KABAKCI, Ruhi/AAG-9512-2019	KABAKCI, Ruhi/0000-0001-9131-0933			Agha FE, 2012, LIFE SCI J, V9, P1260; ANDERSON RE, 1984, IN VITRO CELL DEV B, V20, P847, DOI 10.1007/BF02619630; Ates O, 2007, MOL CELL BIOCHEM, V294, P137, DOI 10.1007/s11010-006-9253-0; Bandyopadhyay B., 2012, INT J RES CHEM ENV, V2, P160; Barbier O, 2010, CHEM-BIOL INTERACT, V188, P319, DOI 10.1016/j.cbi.2010.07.011; Bharti VK, 2009, BIOL TRACE ELEM RES, V130, P131, DOI 10.1007/s12011-009-8320-2; Bouaziz H, 2006, PESTIC BIOCHEM PHYS, V86, P124, DOI 10.1016/j.pestbp.2006.02.004; Campbell T. W., 2012, Veterinary hematology and clinical chemistry, P225; CARLSON CH, 1960, P SOC EXP BIOL MED, V104, P235; Cetin N., 2004, EU J HLTH SCI, V13, P46; Dalaklioglu S, 2013, HUM EXP TOXICOL, V32, P662, DOI 10.1177/0960327112468178; Dissanayake C. B., 1991, International Journal of Environmental Studies, V38, P137, DOI 10.1080/00207239108710658; Do Amaral CL, 2008, ARCH TOXICOL, V82, P363, DOI 10.1007/s00204-007-0262-x; Donnelly LE, 2004, AM J PHYSIOL-LUNG C, V287, pL774, DOI 10.1152/ajplung.00110.2004; Eraslan G, 2007, PESTIC BIOCHEM PHYS, V88, P273, DOI 10.1016/j.pestbp.2007.01.002; Eren E, 2005, TOXICOL IND HEALTH, V21, P255, DOI 10.1191/0748233705th236oa; Ersoy IH, 2010, BIOL TRACE ELEM RES, V138, P22, DOI 10.1007/s12011-009-8595-3; Hismiogullari SE, 2013, KAFKAS UNIV VET FAK, V19, pA1, DOI 10.9775/kvfd.2012.6989; Juan ME, 2002, J NUTR, V132, P257, DOI 10.1093/jn/132.2.257; Kanbur M, 2009, FOOD CHEM TOXICOL, V47, P1184, DOI 10.1016/j.fct.2009.02.008; Karadeniz A, 2008, FLUORIDE, V41, P67; KARRAM MH, 1992, FLUORIDE, V25, P23; Khan AM, 2013, FLUORIDE, V46, P34; Khandare AL, 2000, FLUORIDE, V33, P33; Machalinska A, 2002, FLUORIDE, V35, P81; Machalinski B, 2000, FLUORIDE, V33, P168; Mittal M, 2007, DRUG CHEM TOXICOL, V30, P263, DOI 10.1080/01480540701380075; MOHIUDDIN SM, 1989, INDIAN VET J, V66, P1089; Mokni M, 2007, NEUROCHEM RES, V32, P981, DOI 10.1007/s11064-006-9255-z; MULLENIX PJ, 1995, NEUROTOXICOL TERATOL, V17, P169, DOI 10.1016/0892-0362(94)00070-T; MURPHY AJ, 1992, J BIOL CHEM, V267, P16995; Naresh K., 2011, J ADV RES BIOL SCI, V3, P58; Paul V, 1998, ENVIRON TOXICOL PHAR, V6, P187, DOI 10.1016/S1382-6689(98)00033-7; PILLAI KS, 1988, TOXICOL LETT, V44, P21, DOI 10.1016/0378-4274(88)90125-7; Priya CAYB, 1997, FLUORIDE, V30, P51; Rao A. V. B., 2010, AM EUR J TOXICOL SCI, V2, P93; Ravichandran B, 2012, TOXICOL ENVIRON CHEM, V94, P2052, DOI 10.1080/02772248.2012.723485; Shashi A, 2001, FLUORIDE, V34, P34; Silan C, 2007, BIOL PHARM BULL, V30, P79, DOI 10.1248/bpb.30.79; Sonmez U, 2007, NEUROSCI LETT, V420, P133, DOI 10.1016/j.neulet.2007.04.070; Susheela AK, 1999, CURR SCI INDIA, V77, P1250; Susheela AK, 2001, FLUORIDE, V34, P181; Tatlidede E, 2009, FREE RADICAL RES, V43, P195, DOI 10.1080/10715760802673008; Trivedi MH, 2012, FLUORIDE, V45, P13; Tunali-Akbay T, 2010, J PHARM PHARM SCI, V13, P303, DOI 10.18433/J30K5Q; [王五一 Wang Wuyi], 2002, [土壤与环境, Soil and environmental sciences], V11, P383; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; Xiong XZ, 2007, ENVIRON RES, V103, P112, DOI 10.1016/j.envres.2006.05.008; ZEIGER E, 1993, ENVIRON MOL MUTAGEN, V21, P309, DOI 10.1002/em.2850210402	49	18	20	0	3	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								698628	10.1155/2014/698628			5	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AJ2NI	WOS:000337492600001	24995323	Green Published, gold, Green Submitted			2022-02-06	
J	Bobkova, NV; Medvinskaya, NI; Kamynina, AV; Aleksandrova, IY; Nesterova, IV; Samokhin, AN; Koroev, DO; Filatova, MP; Nekrasov, PV; Abramov, AY; Leonov, SV; Volpina, OM				Bobkova, N. V.; Medvinskaya, N. I.; Kamynina, A. V.; Aleksandrova, I. Y.; Nesterova, I. V.; Samokhin, A. N.; Koroev, D. O.; Filatova, M. P.; Nekrasov, P. V.; Abramov, A. Y.; Leonov, S. V.; Volpina, O. M.			Immunization with either prion protein fragment 95-123 or the fragment-specific antibodies rescue memory loss and neurodegenerative phenotype of neurons in olfactory bulbectomized mice	NEUROBIOLOGY OF LEARNING AND MEMORY			English	Article						Prion; Peptide; Amyloid; Antibody; Bulbectomy; Memory	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; HEAD-INJURY; CEREBROSPINAL-FLUID; ENDOTHELIAL-CELLS; MOUSE MODEL; RISK-FACTOR; IMPAIRMENT; PRPC; LOCALIZATION	Epidemiological studies demonstrated association between head injury (I-II) and the subsequent development of Alzheimer's disease (AD). Certain hallmarks of AD, e.g. amyloid-beta (A beta) containing deposits, may be found in patients following traumatic BI (TBI). Recent studies uncover the cellular prion protein, PrPC, as a receptor for soluble polymeric forms of A beta (sA beta) which are an intermediate of such deposits. We aimed to test the hypothesis that targeting of PrPC can prevent A beta related spatial memory deficits in olfactory bulbectomized (OBX) mice utilized here to resemble some clinical features of AD, such as increased level of A beta, memory loss and deficit of the CNS cholin- and serotonin-ergic systems. We demonstrated that immunization with the a.a. 95-123 fragment of cellular prion (PrP-I) recovered cortical and hippocampus neurons from OBX induced degeneration, rescued spatial memory loss in Morris water maze test and significantly decrease the A beta level in brain tissue of these animals. Affinity purified anti-PrP-I antibodies rescued pre-synaptic biomarker synaptophysin eliciting similar effect on memory of OBX mice, and protected hippocampal neurones from A beta(25-35)-induced toxicity in vitro. Immunization OBX mice with a.a. 200-213 fragment of cellular prion (PrP-II) did not reach a significance in memory protection albeit having similar to PrP-I immunization impact on A beta level in brain tissue. The observed positive effect of targeting the PrP-I by either active or passive immunization on memory of OBX mice revealed the involvement of the PrPC in AD-like pathology induced by olfactory bulbectomy. This OBX model may be a useful tool for mechanistic and preclinical therapeutic investigations into the association between PrPC and AD. (C) 2013 Elsevier Inc. All rights reserved.	[Bobkova, N. V.; Medvinskaya, N. I.; Aleksandrova, I. Y.; Nesterova, I. V.; Samokhin, A. N.; Nekrasov, P. V.; Leonov, S. V.] Russian Acad Sci, Inst Cell Biophys, Pushchino 142292, Russia; [Leonov, S. V.] CDRI, Dept Biol, Chimki 141400, Moscow Region, Russia; [Leonov, S. V.] Moscow Inst Phys & Technol, Inst Pereulok, BioBusiness Incubator, Dolgoprudnyi 141700, Moscow Region, Russia; [Kamynina, A. V.; Koroev, D. O.; Filatova, M. P.; Volpina, O. M.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia; [Abramov, A. Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England		Leonov, SV (corresponding author), Russian Acad Sci, Inst Cell Biophys, Ul Inst Skaya 3, Pushchino 142292, Russia.	nbobkova@mail.ru; nmedvinskaya@rambler.ru; aneskaminina@mail.ru; iualex@rambler.ru; nprivat@rambler.ru; sam.alexandre@gmail.com; koroev@mx.ibch.ru; filatova07@mail.ru; pgta01@mail.ru; a.abramov@ucl.ac.uk; sergey.leonov@yahoo.com; volpina@ibch.ru	Samokhin, Alexander/C-4865-2015; Nekrasov, Pavel/P-2016-2017; Kamynina, Anna/R-6461-2016; Abramov, Andrey/AAC-6712-2019; Leonov, Sergey V/M-5514-2013; Abramov, Andrey Y/H-9053-2012; Bobkova, Natalia/D-6379-2015; Volpina, Olga/P-7454-2017; Filatova, Margarita/J-1106-2018; Nesterova, Inna/D-2227-2015	Samokhin, Alexander/0000-0002-3299-4906; Nekrasov, Pavel/0000-0002-5168-5404; Abramov, Andrey/0000-0002-7646-7235; Leonov, Sergey V/0000-0002-3425-723X; Abramov, Andrey Y/0000-0002-7646-7235; Nesterova, Inna/0000-0002-0492-0600; Volpina, Olga/0000-0003-0740-6110; Kamynina, Anna/0000-0002-9107-3891	RASRussian Academy of SciencesRegione Sardegna; Federal Targeted Program "Scientific & Scientific-Pedagogical Human Resources for Innovative Russia" [8128]; RFBRRussian Foundation for Basic Research (RFBR) [13-04-40106-H]	The study was supported with the program RAS "Fundamental sciences to medicine 2009-2013", Federal Targeted Program "Scientific & Scientific-Pedagogical Human Resources for Innovative Russia in 2009-2013" (8128), and RFBR Grant No. 13-04-40106-H.	Abramov AY, 2003, J NEUROSCI, V23, P5088; Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Aleksandrova IY, 2004, BIOCHEMISTRY-MOSCOW+, V69, P176, DOI 10.1023/B:BIRY.0000018948.04559.ab; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Barry AE, 2011, J NEUROSCI, V31, P7259, DOI 10.1523/JNEUROSCI.6500-10.2011; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bobkova N V, 2004, Neurosci Behav Physiol, V34, P671, DOI 10.1023/B:NEAB.0000036005.70153.3b; Bobkova N, 2008, BRAIN RES, V1232, P185, DOI 10.1016/j.brainres.2008.07.036; Bobkova NV, 2001, B EXP BIOL MED+, V131, P427, DOI 10.1023/A:1017907511482; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Calella AM, 2010, EMBO MOL MED, V2, P306, DOI 10.1002/emmm.201000082; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Deane R, 2007, CURR ALZHEIMER RES, V4, P191, DOI 10.2174/156720507780362245; Deli MA, 2000, NEUROREPORT, V11, P3931, DOI 10.1097/00001756-200011270-00064; Desai V, 2008, AM J CLIN NUTR, V88, p855S, DOI 10.1093/ajcn/88.3.855S; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; Franz G, 2003, NEUROLOGY, V60, P1457, DOI 10.1212/01.WNL.0000063313.57292.00; Gimbel DA, 2010, J NEUROSCI, V30, P6367, DOI 10.1523/JNEUROSCI.0395-10.2010; Girl R., 2000, AM J PHYSIOL, V279, pC1772; Gunther EC, 2010, J MOL MED, V88, P331, DOI 10.1007/s00109-009-0568-7; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Han F, 2008, J PHARMACOL EXP THER, V326, P127, DOI 10.1124/jpet.108.137471; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; Hartman RE, 2002, J NEUROSCI, V22, P10083; Hawkes C, 2003, MOVEMENT DISORD, V18, P364, DOI 10.1002/mds.10379; Hozumi S, 2003, BEHAV BRAIN RES, V138, P9, DOI 10.1016/S0166-4328(02)00183-3; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kamynina AV, 2010, J ALZHEIMERS DIS, V21, P249, DOI 10.3233/JAD-2010-091474; Kovacs T, 2004, AGEING RES REV, V3, P215, DOI 10.1016/j.arr.2003.10.003; Kovacs T, 2001, NEUROREPORT, V12, P285, DOI 10.1097/00001756-200102120-00021; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Le Pichon CE, 2008, J COMP NEUROL, V508, P487, DOI 10.1002/cne.21698; Lee HCB, 2003, BIOL PSYCHIAT, V54, P353, DOI 10.1016/S0006-3223(03)00543-2; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Luukinen H, 1999, NEUROLOGY, V52, P557, DOI 10.1212/WNL.52.3.557; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORTIMER JA, 1985, NEUROLOGY, V35, P264, DOI 10.1212/WNL.35.2.264; MOSER M, 1995, NEURON, V14, P509, DOI 10.1016/0896-6273(95)90307-0; Nakajima A, 2007, J PHARMACOL SCI, V105, P122, DOI 10.1254/jphs.SC0070155; Nemetz PN, 1999, AM J EPIDEMIOL, V149, P32; Nesterova I V, 2008, Neurosci Behav Physiol, V38, P349, DOI 10.1007/s11055-008-0048-5; Nesterova IV, 1997, PROG NEURO-PSYCHOPH, V21, P127, DOI 10.1016/S0278-5846(96)00163-7; Oboznaya MB, 2007, CELL MOL NEUROBIOL, V27, P271, DOI 10.1007/s10571-006-9108-y; Ostrovskaya RU, 2007, J PSYCHOPHARMACOL, V21, P611, DOI 10.1177/0269881106071335; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Pentzek M, 2007, AGING CLIN EXP RES, V19, P255; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Picard-Hagen N, 2006, J GEN VIROL, V87, P3723, DOI 10.1099/vir.0.81859-0; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Prinz M, 2004, J NEUROSCI, V24, P5974, DOI 10.1523/JNEUROSCI.0122-04.2004; Reuber M, 2001, J NEUROL NEUROSUR PS, V71, P412, DOI 10.1136/jnnp.71.3.412; Rial D, 2009, NEUROSCIENCE, V164, P896, DOI 10.1016/j.neuroscience.2009.09.005; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Sadowski MJ, 2009, NEUROBIOL DIS, V34, P267, DOI 10.1016/j.nbd.2009.01.013; Sales N, 1998, EUR J NEUROSCI, V10, P2464, DOI 10.1046/j.1460-9568.1998.00258.x; Schwarz A, 2003, NEUROSCI LETT, V350, P187, DOI 10.1016/S0304-3940(03)00907-8; Shyu WC, 2005, J NEUROSCI, V25, P8967, DOI 10.1523/JNEUROSCI.1115-05.2005; Smith C, 2003, NEUROPATH APPL NEURO, V29, P496, DOI 10.1046/j.1365-2990.2003.00488.x; Struble RG, 1998, BRAIN RES, V780, P129, DOI 10.1016/S0006-8993(97)01187-6; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Udenfriend S., 1987, PEPTIDES ANAL SYNTHE, P9; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Viegas P, 2006, J CELL SCI, V119, P4634, DOI 10.1242/jcs.03222; Volkel D, 2001, TRANSFUSION, V41, P441, DOI 10.1046/j.1537-2995.2001.41040441.x; WARNER MD, 1986, BIOL PSYCHIAT, V21, P116, DOI 10.1016/0006-3223(86)90013-2; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; Wisniewski T, 2010, BBA-MOL BASIS DIS, V1802, P847, DOI 10.1016/j.bbadis.2010.05.004; Yamamoto T, 1997, BEHAV BRAIN RES, V83, P57, DOI 10.1016/S0166-4328(97)86046-9	77	18	20	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1074-7427	1095-9564		NEUROBIOL LEARN MEM	Neurobiol. Learn. Mem.	JAN	2014	107						50	64		10.1016/j.nlm.2013.10.019			15	Behavioral Sciences; Neurosciences; Psychology; Psychology, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	287SK	WOS:000329562300007	24239620				2022-02-06	
J	Cifu, DX; Hoke, KW; Wetzel, PA; Wares, JR; Gitchel, G; Carne, W				Cifu, David X.; Hoke, Kathy W.; Wetzel, Paul A.; Wares, Joanna R.; Gitchel, George; Carne, William			Effects of hyperbaric oxygen on eye tracking abnormalities in males after mild traumatic brain injury	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						blast injury; blinded; concussion; eye tracking; hyperbaric oxygen; postconcussive syndrome; randomized; saccades; sham controlled; traumatic brain injury	POST-CONCUSSION SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; NEURAL STEM-CELLS; POSTCONCUSSION SYMPTOMS; THERAPY; RATS; PERSISTENT; MOVEMENTS; MILITARY; RECOVERY	The effects of hyperbaric oxygen (HBO2) on eye movement abnormalities in 60 military servicemembers with at least one mild traumatic brain injury (mTBI) from combat were examined in a single-center, randomized, double-blind, sham-controlled, prospective study at the Naval Medicine Operational Training Center. During the 10 wk of the study, each subject was delivered a series of 40, once a day, hyperbaric chamber compressions at a pressure of 2.0 atmospheres absolute (ATA). At each session, subjects breathed one of three preassigned oxygen fractions (10.5%, 75%, or 100%) for 1 h, resulting in an oxygen exposure equivalent to breathing either surface air, 100% oxygen at 1.5 ATA, or 100% oxygen at 2.0 ATA, respectively. Using a standardized, validated, computerized eye tracking protocol, fixation, saccades, and smooth pursuit eye movements were measured just prior to intervention and immediately postintervention. Between-and within-groups testing of pre-and postintervention means revealed no significant differences on eye movement abnormalities and no significant main effect for HBO2 at either 1.5 ATA or 2.0 ATA equivalent compared with the sham-control. This study demonstrated that neither 1.5 nor 2.0 ATA equivalent HBO2 had an effect on postconcussive eye movement abnormalities after mTBI when compared with a sham-control.	[Cifu, David X.; Carne, William] Virginia Commonwealth Univ, Dept PM&R, Richmond, VA 23298 USA; [Cifu, David X.] US Dept Vet Affairs, Phys Med & Rehabil Program Off, Richmond, VA USA; [Hoke, Kathy W.; Wares, Joanna R.] Univ Richmond, Dept Math & Comp Sci, Richmond, VA 23173 USA; [Wetzel, Paul A.; Gitchel, George] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA 23298 USA		Carne, W (corresponding author), Virginia Commonwealth Univ, Dept PM&R, 1223 East Marshall St, Richmond, VA 23298 USA.	lasile@aol.com		Cifu, David/0000-0003-1600-9387	Air Force Medical Support Agency Medical Modernization Directorate; 711th Human Performance Wing; U.S. Navy Bureau of Medicine and Surgery; U.S. Army Medical Materiel Development Activity; Defense Advanced Research Projects AgencyUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA) [N66001-09-2-206]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; U.S. Army Medical Research Acquisition Activity [W81XWH-08-2-0178]; DoDUnited States Department of Defense; VA Chronic Effects of Neurotrauma Consortium [W81XWH-13-2-0095]	This material was based on work funded by the Air Force Medical Support Agency Medical Modernization Directorate and the 711th Human Performance Wing for the primary study, the U.S. Navy Bureau of Medicine and Surgery for contract funding temporary duty requirements, and the U.S. Army Medical Materiel Development Activity for end of study contract funding. Dr. Cifu's efforts were supported, in part, through a Defense Advanced Research Projects Agency grant (N66001-09-2-206) and a contract from the U.S. Army Medical Materiel Development Activity. Dr. Carne's efforts were supported, in part, through contracts from the U.S. Army Medical Materiel Development Activity and the Defense and Veterans Brain Injury Center. This work was funded primarily by the U.S. Army Medical Research Acquisition Activity (award W81XWH-08-2-0178) with support from the Defense and Veterans Brain Injury Center. Following completion of the study, additional support came from the DoD and VA Chronic Effects of Neurotrauma Consortium (grant W81XWH-13-2-0095).	Cifu D.X., 2009, CRIT REV PHYS REHABI, V21, P197, DOI DOI 10.1615/CRITREVPHYSREHABI1MED.V2113-4.10; Cifu DX, 2014, ANN NEUROL, V75, P277, DOI 10.1002/ana.24067; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Cifu DX, 2014, J HEAD TRAUMA REHABI; Cifu DX, 2011, OVERCOMING POSTDEVEL; Eyres S, 2005, CLIN REHABIL, V19, P878, DOI 10.1191/0269215505cr905oa; Gesell L.B., 2008, HYPERBARIC OXYGEN TH; Harch P.G., 2002, P 2 INT S HYP OXYG C; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; HEITGER MH, 2008, C P IEEE ENG MED BIO, P3570; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Lange RT, 2013, J NEUROTRAUM, V30, P958, DOI 10.1089/neu.2012.2743; Leigh RJ, 2006, NEUROLOGY EYE MOVEME; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Peng ZY, 2008, BRAIN RES, V1212, P71, DOI 10.1016/j.brainres.2008.03.027; Ramat S, 2007, BRAIN, V130, P10, DOI 10.1093/brain/awl309; Rockswold SB, 2007, NEUROL RES, V29, P162, DOI 10.1179/016164107X181798; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Suh M, 2006, NEUROSCI LETT, V401, P108, DOI 10.1016/j.neulet.2006.02.074; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Walker RL, 2010, PSYCHOL SERV, V7, P136, DOI 10.1037/a0019684; Wang XL, 2008, BRAIN RES, V1222, P87, DOI 10.1016/j.brainres.2008.05.016; Wang XL, 2007, NEUROREPORT, V18, P1753, DOI 10.1097/WNR.0b013e3282f0ec09; Weaver LK, 2012, UNDERSEA HYPERBAR M, V39, P807; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Yang YJ, 2008, UNDERSEA HYPERBAR M, V35, P113; Zhou ZW, 2007, J NEUROSURG, V106, P687, DOI 10.3171/jns.2007.106.4.687	31	18	18	0	7	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2014	51	7					1047	1055		10.1682/JRRD.2014.01.0013			9	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	AU8JB	WOS:000345841300004	25436771	Bronze			2022-02-06	
J	Goverover, Y; Genova, H; Griswold, H; Chiaravalloti, N; DeLuca, J				Goverover, Yael; Genova, Helen; Griswold, Hali; Chiaravalloti, Nancy; DeLuca, John			Metacognitive knowledge and online awareness in persons with multiple sclerosis	NEUROREHABILITATION			English	Article						Impaired self-awareness; error-monitoring; activities of daily living; cognition; quality of life; multiple sclerosis	TRAUMATIC BRAIN-INJURY; QUALITY-OF-LIFE; SELF-AWARENESS; FUNCTIONAL ASSESSMENT; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTION; NEUROPSYCHOLOGY; METAMEMORY; COMPETENCE; VALIDATION	BACKGROUND: Recent models of self-awareness draw a distinction between intellectual awareness (metacognitive knowledge of disabilities) and online awareness of errors (emergent and anticipatory awareness). OBJECTIVE: The present study compared these two types of self-awareness (metacognitive knowledge of disabilities and online awareness) in individuals with multiple sclerosis (MS) and healthy participants. The relationship between self-awareness and functional performance was also examined. METHODS: Participants included 18 individuals with MS and 16 healthy controls (HC) between the ages of 27 and 60. Intellectual awareness was assessed via discrepancy scores on the Functional Behavior Profile (FBP) between participants and their informants. Online Awareness was examined using self-prediction and self-assessment of performance on a functional task. RESULTS: Participants with MS had significantly lower levels of intellectual awareness relative to HCs. The MS group demonstrated worse prediction online awareness than HCs. However, assessment online awareness did not differ between groups, indicating that experience with a task can improve online awareness in persons with MS. CONCLUSION: This study highlights the necessity of adopting a multidimensional approach to assessing the multifaceted phenomenon of self-awareness in MS. In addition, it provides initial evidence to support a self-awareness treatment model for persons with MS.	[Goverover, Yael] NYU, New York, NY 10012 USA; [Goverover, Yael; Genova, Helen; Griswold, Hali; Chiaravalloti, Nancy; DeLuca, John] Kessler Fdn, West Orange, NJ USA; [Genova, Helen; Chiaravalloti, Nancy; DeLuca, John] Rutgers State Univ, New Jersey Med Sch, Dept Phys Med & Rehabil, Newark, NJ 07102 USA; [Griswold, Hali] Fairleigh Dickinson Univ, Teaneck, NJ USA		Goverover, Y (corresponding author), NYU, Steinhardt Sch Culture Educ & Human Dev, Dept Occupat Therapy, 35 West 4th St,11th Floor, New York, NY 10012 USA.	yg243@nyu.edu		Chiaravalloti, Nancy/0000-0003-2943-7567	national multiple sclerosis societyNational Multiple Sclerosis Society [RG 3935A2/2, PP1331]	This research was supported by the national multiple sclerosis society (Grant #: RG 3935A2/2 and # PP1331). This study was presented in part at the 40th Annual Meeting of the International Neuropsychological Society in Montreal, Canada, February 2012.	BAUM C, 1993, GERONTOLOGIST, V33, P403, DOI 10.1093/geront/33.3.403; Benedict RHB, 2002, J NEUROPSYCH CLIN N, V14, P44, DOI 10.1176/appi.neuropsych.14.1.44; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Brassington JC, 1998, NEUROPSYCHOL REV, V8, P43, DOI 10.1023/A:1025621700003; Bruck W, 2003, NEUROL SCI, V24, pS265, DOI 10.1007/s10072-003-0170-7; Carone DA, 2005, J INT NEUROPSYCH SOC, V11, P574, DOI 10.1017/S135561770505068X; Cella DF, 1996, NEUROLOGY, V47, P129, DOI 10.1212/WNL.47.1.129; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Crosson B., 1989, J HEAD TRAUMA REHAB, V4, P46, DOI [DOI 10.1097/00001199-198909000-00008, 10.1097/00001199-198909000-00008]; Fleming J., 2013, INT ENCY REHABILITAT; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Geraci L, 2010, CONSCIOUS COGN, V19, P606, DOI 10.1016/j.concog.2010.03.015; GORDON PA, 1994, J REHABIL, V60, P34; Goverover Y, 2005, MULT SCLER J, V11, P203, DOI 10.1191/1352458505ms1153oa; Goverover Y, 2004, J CLIN EXP NEUROPSYC, V26, P737, DOI 10.1080/13803390490509321; Goverover Y, 2007, BRAIN INJURY, V21, P913, DOI 10.1080/02699050701553205; Goverover Y, 2010, ARCH PHYS MED REHAB, V91, P252, DOI 10.1016/j.apmr.2009.09.022; Goverover Y, 2009, REHABIL PSYCHOL, V54, P60, DOI 10.1037/a0014556; Hoerold D, 2008, EXP BRAIN RES, V186, P509, DOI 10.1007/s00221-008-1341-9; Irvine KA, 2008, BRAIN, V131, P1464, DOI 10.1093/brain/awn080; Kaszniak AW, 1996, LEARN INDIVID DIFFER, V8, P355, DOI 10.1016/S1041-6080(96)90023-0; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nelson T. O., 1992, METACOGNITION CORE R; Nyenhuis DL, 1998, J PERS ASSESS, V70, P386, DOI 10.1207/s15327752jpa7002_14; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Randolph JJ, 2001, CLIN NEUROPSYCHOL, V15, P357, DOI 10.1076/clin.15.3.357.10278; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherman TE, 2008, J CLIN EXP NEUROPSYC, V30, P301, DOI 10.1080/13803390701380617; Simioni S, 2009, J INT NEUROPSYCH SOC, V15, P291, DOI 10.1017/S1355617709090262; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; STUSS DT, 1992, BRAIN COGNITION, V20, P8, DOI 10.1016/0278-2626(92)90059-U; Toglia J, 2000, NEUROREHABILITATION, V15, P57; Toglia J, 2010, BRAIN INJURY, V24, P664, DOI 10.3109/02699051003610474; Zakzanis KK, 2000, ARCH CLIN NEUROPSYCH, V15, P115, DOI 10.1016/S0887-6177(98)00157-7; [No title captured]	36	18	18	0	15	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	2					315	323		10.3233/NRE-141113			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AQ7OE	WOS:000343007000017	24990022				2022-02-06	
J	Haslach, HW; Leahy, LN; Riley, P; Gullapalli, R; Xu, S; Hsieh, AH				Haslach, Henry W., Jr.; Leahy, Lauren N.; Riley, Peter; Gullapalli, Rao; Xu, Su; Hsieh, Adam H.			Solid-extracellular fluid interaction and damage in the mechanical response of rat brain tissue under confined compression	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Brain tissue damage; Confined compression; Solid-fluid interaction; Extracellular fluid; Models of injury; Permeability; Rat brain	CENTRAL-NERVOUS-SYSTEM; ARTICULAR-CARTILAGE; FINITE DEFORMATION; WHITE-MATTER; PERMEABILITY; NEURONS; TENSION; STRESS; INJURY; MODEL	The mechanical processes that underlie mild traumatic brain injury from physical insults are not well understood. One aspect in particular that has not been examined is the tissue fluid, which is known to be critical in the mechanical function of other organs. To investigate the contributions of solid-fluid interactions to brain tissue mechanics, we performed confined compression tests, that force the extracellular fluid (ECF) to flow in the direction of the deformation, on 6.35 mm diameter, 3 mm long cylindrical samples excised from various regions of rat brains. Two types of tests in deformation control, (1) quasi-static, slow and moderate constant strain rate tests at 0.64 x 10(-5)/s, 0.001/s and 1/s to large strains and (2) several applications of slow linear deformation to 5% strain each followed by stress relaxation are employed to explore the solid-fluid interaction. At slow and moderate compressive strain rates, we observed stress peaks in the applied strain range at about 11%, whose magnitudes exhibited statistically significant dependence on strain rate. These data suggest that the ECF carries load until the tissue is sufficiently damaged to permit pathological fluid flow. Under the slow ramp rate in the ramp-relaxation cycles protocol, commonly used to estimate permeability, the stress relaxes to zero after the first cycle, rather than to a non-zero equilibrium stress corresponding to the applied strain, which further implicates mechanical damage. Magnetic resonance imaging (MRI) of changes in tissue microstructure during confined compression, before and after compression, provides further evidence of tissue damage. The solid-fluid interactions, reflected in the morphology of the stress-stretch curves and supported by the MRI data, suggest that increases in hydrostatic pressure in the ECF may contribute to mechanical damage of brain tissue. (C) 2013 Elsevier Ltd. All rights reserved.	[Haslach, Henry W., Jr.; Leahy, Lauren N.; Riley, Peter] Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA; [Hsieh, Adam H.] Univ Maryland, Fischell Dept Biomech Engn, College Pk, MD 20742 USA; [Gullapalli, Rao; Xu, Su] Univ Maryland, Sch Med, Dept Diagnost Radiol & Nucl Med, Baltimore, MD 21201 USA		Haslach, HW (corresponding author), Univ Maryland, Dept Mech Engn, College Pk, MD 20742 USA.	haslach@umd.edu		Hsieh, Adam/0000-0003-3162-1152	University of Maryland SEED grant; Center for Energetics Concepts Development of the University of Maryland-College Park	This work was supported in part by a University of Maryland SEED grant and by the Center for Energetics Concepts Development of the University of Maryland-College Park.	Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bonneh-Barkay D, 2009, BRAIN PATHOL, V19, P573, DOI 10.1111/j.1750-3639.2008.00195.x; Burgin LV, 2008, J MATER SCI-MATER M, V19, P703, DOI 10.1007/s10856-007-3187-2; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; DENNERLL TJ, 1989, J CELL BIOL, V109, P3073, DOI 10.1083/jcb.109.6.3073; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Franceschini G, 2006, J MECH PHYS SOLIDS, V54, P2592, DOI 10.1016/j.jmps.2006.05.004; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Hilgetag CC, 2006, PLOS COMPUT BIOL, V2, P146, DOI 10.1371/journal.pcbi.0020022; HOLMES MH, 1986, J BIOMECH ENG-T ASME, V108, P372, DOI 10.1115/1.3138633; Kaczmarek M, 1997, B MATH BIOL, V59, P295; Liu QL, 2011, J MECH BEHAV BIOMED, V4, P974, DOI 10.1016/j.jmbbm.2011.02.009; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller K, 2002, J BIOMECH, V35, P483, DOI 10.1016/S0021-9290(01)00234-2; MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344, DOI 10.2106/00004623-198466030-00005; Parpura V, 2000, P NATL ACAD SCI USA, V97, P8629, DOI 10.1073/pnas.97.15.8629; Perie D, 2005, J BIOMECH, V38, P2164, DOI 10.1016/j.jbiomech.2004.10.002; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Prevost TP, 2011, ACTA BIOMATER, V7, P83, DOI 10.1016/j.actbio.2010.06.035; REULEN HJ, 1977, J NEUROSURG, V46, P24, DOI 10.3171/jns.1977.46.1.0024; Shafieian M, 2009, J BIOMECH, V42, P2136, DOI 10.1016/j.jbiomech.2009.05.041; Shulyakov AV, 2009, BIOMECH MODEL MECHAN, V8, P415, DOI 10.1007/s10237-008-0147-9; Simon B.R., 1992, APPL MECH REV, V45, P191, DOI [10.1115/1.3121397, DOI 10.1115/1.3121397]; Simon BR, 1998, INT J SOLIDS STRUCT, V35, P5021, DOI 10.1016/S0020-7683(98)00107-3; Soltz MA, 2006, J BIOMECH, V39, P594, DOI 10.1016/j.jbiomech.2005.09.020; STRICH S, 1961, LANCET, V1961, P443; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Xu G, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001683; Xu G, 2009, BIOMECH MODEL MECHAN, V8, P253, DOI 10.1007/s10237-008-0131-4	35	18	18	4	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JAN	2014	29				SI		138	150		10.1016/j.jmbbm.2013.08.027			13	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	294ZF	WOS:000330085700013	24084652				2022-02-06	
J	LeBlanc, J; de Guise, E; Champoux, MC; Couturier, C; Lamoureux, J; Marcoux, J; Maleki, M; Feyz, M				LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Lamoureux, Julie; Marcoux, Judith; Maleki, Mohammed; Feyz, Mitra			Early conversational discourse abilities following traumatic brain injury: An acute predictive study	BRAIN INJURY			English	Article						Acute care; conversational discourse; outcome; Protocole Montreal d'evaluation de la communication; traumatic brain injury	SOCIAL COMMUNICATION-SKILLS; CLOSED-HEAD-INJURY; COGNITIVE RESERVE; REHABILITATION; INTEGRATION; OUTCOMES; ADULTS; SCALE; MILD; DISABILITY	Primary objective: To date, little information is available regarding communication and conversational discourse proficiency post-traumatic brain injury (TBI) in the acute care phase. The main goal of this study was to examine how conversational discourse impairment following TBI predicts early outcome. Factors which influence conversational discourse performance were also explored. Methods: The conversational discourse checklist of the Protocole Montreal d'evaluation de la communication (D-MEC) was administered in an acute tertiary care trauma centre to 195 adults within 3 weeks post-TBI. Outcome was measured with the Disability Rating Scale (DRS), the extended Glasgow Outcome Scale (GOS-E) and included discharge destinations from acute care. Main outcomes and results: Linear regression results showed that the D-MEC total score, age and initial GCS score accounted for 50% of the variation of the DRS scores. The DRS score was lower, signifying better outcome, when the total D-MEC score was higher, the subject was younger and when the initial GCS score was higher. Moreover, D-MEC performance significantly predicted the moderate and severe disability categories of the GOS-E and the probability of requiring rehabilitation (p < 0.05). Conclusion: These results provide additional information to guide healthcare professionals in predicting overall outcome acutely post-TBI.	[LeBlanc, Joanne; de Guise, Elaine; Champoux, Marie-Claude; Couturier, Celine; Feyz, Mitra] McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [de Guise, Elaine; Marcoux, Judith; Maleki, Mohammed] McGill Univ, Ctr Hlth, Dept Neurosurg, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Lamoureux, Julie] Univ Montreal, Social & Prevent Med Dept, Montreal, PQ, Canada		LeBlanc, J (corresponding author), McGill Univ, Ctr Hlth, Traumat Brain Injury Program, Montreal Gen Hosp Site,Room D13-124, Montreal, PQ H3G 1A4, Canada.	joanne.leblanc@mcgill.ca					Blake ML, 2006, AM J SPEECH-LANG PAT, V15, P255, DOI 10.1044/1058-0360(2006/024); Bracy C., 2005, BRAIN IMPAIR, V6, P1, DOI DOI 10.1375/brim.6.1.1.65476; Braden C, 2010, BRAIN INJURY, V24, P1298, DOI 10.3109/02699052.2010.506859; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Bruin J., 2006, NEWTEST COMMAND COMP; CANNITO M P, 1988, Seminars in Speech and Language, V9, P117, DOI 10.1055/s-0028-1082459; Cattelani R, 2002, BRAIN INJURY, V16, P51, DOI 10.1080/02699050110088821; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cifu DX, 1997, ARCH PHYS MED REHAB, V78, P125, DOI 10.1016/S0003-9993(97)90252-5; Coelho C., 2002, APHASIOLOGY, V16, P659, DOI [10.1080/02687030244000275, DOI 10.1080/02687030244000275]; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2003, APHASIOLOGY, V17, P499, DOI 10.1080/02687030344000111; Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Cote H., 2004, REEDUCATION ORTHOPHO, V219, P107; Dagher JH, 2013, BRAIN INJURY, V27, P189, DOI 10.3109/02699052.2012.729288; Dahlberg C, 2006, BRAIN INJURY, V20, P425, DOI 10.1080/02699050600664574; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Damico J. S., 1985, COMMUNICATION SKILLS, P165; Dawson DR, 2004, BRAIN INJURY, V18, P221, DOI 10.1080/02699050310001617406; Deguise E, 2008, J HEAD TRAUMA REHAB, V23, P294, DOI 10.1097/01.HTR.0000336842.53338.f4; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Douglas JM, 2000, APHASIOLOGY, V14, P251, DOI 10.1080/026870300401469; Field SJ, 2000, BRAIN LANG, V74, P213, DOI 10.1006/brln.2000.2335; Fonseca RP, 2008, SPAN J PSYCHOL, V11, P678, DOI 10.1017/S1138741600004686; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; GLOSSER G, 1992, J GERONTOL, V47, pP266, DOI 10.1093/geronj/47.4.P266; GRANGER CV, 1990, ARCH PHYS MED REHAB, V71, P870; Hagen C, 1981, TOP LANG DIS, V1, P73; Hagen C, 1979, LEVELS COGNITIVE FUN; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Heaton R.K., 1981, WISCONSIN CARD SORTI; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Joanette Y, 2004, PROTOCOLE MONTREAL E; Kemper S, 2001, PSYCHOL AGING, V16, P600, DOI 10.1037//0882-7974.16.4.600; Le K., 2011, ASHA LEADER, V16, P18, DOI [10.1044/leader.FTR4.16022011.18, DOI 10.1044/LEADER.FTR4.16022011.18, DOI 10.1044/leader.FTR4.16022011.18]; LeBlanc J, 2006, BRAIN INJURY, V20, P1391, DOI 10.1080/02699050601081927; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; MCDONALD S, 1999, COMMUNICATION DISORD; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Novack TA, 2000, BRAIN INJURY, V14, P987; Pastorek NJ, 2004, J INT NEUROPSYCH SOC, V10, P807, DOI 10.1017/S1355617704106012; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Ropacki MT, 2003, ARCH CLIN NEUROPSYCH, V18, P643, DOI 10.1016/S0887-6177(02)00153-1; Sandhaug M, 2010, BRAIN INJURY, V24, P740, DOI 10.3109/02699051003652849; Shadden B B, 1997, Semin Speech Lang, V18, P143; Sherer M, 2002, ARCH PHYS MED REHAB, V83, P183, DOI 10.1053/apmr.2002.28802; Smith A., 1982, SYMBOL DIGIT MODALIT; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow P, 1997, BRAIN INJURY, V11, P409; Steel J, 2013, BRAIN INJURY, V27, P819, DOI 10.3109/02699052.2013.775492; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stout CE, 2000, J MED SPEECH-LANG PA, V8, P15; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P30, DOI 10.1097/HTR.0b013e3182048f7c; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Tompkins CA, 2012, ARCH PHYS MED REHAB, V93, pS61, DOI 10.1016/j.apmr.2011.10.015; Tucker FM, 1998, BRAIN INJURY, V12, P783, DOI 10.1080/026990598122179; Wechsler D., 1981, WECHSLER INTELLIGENC, V3rd; Ylvisaker Mark, 1992, Seminars in Speech and Language, V13, P239, DOI 10.1055/s-2008-1064200; [No title captured], DOI DOI 10.1097/00001199-198812000-00004	69	18	21	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	7					951	958		10.3109/02699052.2014.888760			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AH9XL	WOS:000336498600009	24826957				2022-02-06	
J	Munivenkatappa, A; Rajeswaran, J; Devi, BI; Bennet, N; Upadhyay, N				Munivenkatappa, Ashok; Rajeswaran, Jamuna; Devi, Bhagavatula Indira; Bennet, Niranjana; Upadhyay, Neeraj			EEG Neurofeedback therapy: Can it attenuate brain changes in TBI?	NEUROREHABILITATION			English	Article						EEG-NFT; TBI; MRI scan; neuropsychological scores; in vivo changes	INJURY; SCALE	BACKGROUND: Electroencephalogram Neurofeedback therapy (EEG-NFT) has several potential beneficial effects in terms of improving cognition and electrophysiological regulation among patients with brain injury. However, in vivo structural and functional changes remain less explored. OBJECTIVE: The aim of the present study is to explore EEG-NFT induced in vivo changes in traumatic brain injury (TBI) patients. METHOD: Two patients with mean age of 15 years with moderate head injury who had more than seven post concussion symptoms and poor cognitive performances (<5 percentile) were subjected to 20 sessions of EEG-NFT. The neuropsychological test scores, post concussion symptoms and MRI scan of the brain were recorded pre-post to EEG-NFT. RESULTS: During EEG-NFT the cognitive scores and concussion symptoms improved significantly (p < 0.05). The EEG-NFT has shown significant increase in cortical grey matter (GM) volumes (p < 0.0001) and fractional anisotropy (FA) of cortical white matter (WM) tracts (p < 0.0001, voxel max 60 and above). There was a significant decrease in global, local efficiency, cost and clustering coefficient of functional connectivity (Wilcoxon Sign Rank Test p < 0.05). Interestingly there was a significant increase in thalamo-cortical connection (increase FA value) after EEG-NFT. CONCLUSION: The EEG-NFT therapy has shown significant changes in structural and functional connectivity among young moderately injured TBI patients.	[Munivenkatappa, Ashok] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Neurosci, Bangalore, Karnataka, India; [Rajeswaran, Jamuna; Bennet, Niranjana] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Psychol, Bangalore, Karnataka, India; [Devi, Bhagavatula Indira; Upadhyay, Neeraj] Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Neurosurg, Bangalore, Karnataka, India		Rajeswaran, J (corresponding author), Natl Inst Mental Hlth & Neurosci NIMHANS, Dept Clin Psychol, Bangalore, Karnataka, India.	drjamunarajan@gmail.com	Munivenkatappa, Ashok/ABA-5952-2021	Upadhyay, Neeraj/0000-0001-5165-9727			Freesurfer, MART CTR BIOM IM; JENNETT B, 1975, LANCET, V1, P480; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Levin HS, 2001, J NEUROTRAUM, V18, P575, DOI 10.1089/089771501750291819; Lubar JF, 1997, APPL PSYCHOPHYS BIOF, V22, P111, DOI 10.1023/A:1026276228832; Podell K, 2010, PSYCHIAT CLIN N AM, V33, P855, DOI 10.1016/j.psc.2010.08.003; Rima E. L., 2002, J NEUROTHERAPY, V5, P45; Timothy P. T., 2000, J NEUROTHERAPY, V4, P27; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073	9	18	18	0	26	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2014	35	3					481	484		10.3233/NRE-141140			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AS8UO	WOS:000344523600014	25238859				2022-02-06	
J	Pieper, P; Garvan, C				Pieper, Pam; Garvan, Cynthia			Health-related quality-of-life in the first year following a childhood concussion	BRAIN INJURY			English	Article						Children; concussion; mild brain injury; paediatric; outcome; quality-of-life	TRAUMATIC BRAIN-INJURY; PEDIATRIC POPULATION; CHILDREN; ADOLESCENTS; PEDSQL(TM)-4.0; PERSPECTIVES; RELIABILITY; INVENTORY; VALIDITY; OUTCOMES	Objectives: (1) To compare pre-injury health-related quality-of-life (HRQoL) of children who have sustained mild traumatic brain injury (mTBI) to their HRQoL at 1, 3, 6 and 12 months post-injury and (2) to compare the HRQoL of children with mTBI, children with mild non-brain injuries and children who were uninjured at the same time points. Child and parent responses were obtained for both objectives. Patients and methods: This prospective cohort study involved a self-selected convenience sample to evaluate child and parent perspectives of the HRQoL of 5-17 year old children with mTBI using the PedsQL Generic Core Scales and Cognitive Functioning Scale. Total sample size was 120 child/parent dyads, with 40 dyads each in the study and two control groups. Children who required hospitalization greater than 24 hours were excluded from the study. Results: HRQoL of children with mTBI was not significantly different between pre- and post-injury at all-time points. However, children and parents in the mild non-brain injury group reported significantly lower physical HRQoL 1 month post-injury. Conclusions: Children with mTBI had similar pre- and post-injury HRQoL. Thus, children who sustain mTBI and have significantly lower HRQoL within the first year post-injury merit further evaluation.	[Pieper, Pam] Univ Florida, Coll Nursing, Jacksonville, FL 32209 USA; [Garvan, Cynthia] Univ Florida, Hlth Sci Ctr, Gainesville, FL USA		Pieper, P (corresponding author), Univ Florida, Coll Nursing, 653 W 8th St,L-4, Jacksonville, FL 32209 USA.	pam.pieper@jax.ufl.edu			American Pediatric Surgical Nurses Association; Florida Nurses Association	The authors would like to thank Mary Bear, PhD, RN for contributions to the conception and design of this study and Debra McDonald of the University of Florida College of Nursing Office of Research Support for editorial assistance. This research was supported by grants from the American Pediatric Surgical Nurses Association and the Florida Nurses Association. The Quality of Life study described in this paper was carried out using the PedsQL, developed by Dr. James W. Varni.	Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Bland JM, 1997, BRIT MED J, V314, P572, DOI 10.1136/bmj.314.7080.572; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Ding R, 2006, J PEDIATR ORTHOPED, V26, P157, DOI 10.1097/01.bpo.0000218521.98244.7e; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; FARMER MY, 1987, PEDIATR NEUROSCI, V13, P304, DOI 10.1159/000120348; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul M, 2010, TRAUMATIC BRAIN INJU; Gagnon I, 2005, J HEAD TRAUMA REHAB, V20, P436, DOI 10.1097/00001199-200509000-00005; Gagnon I, 2008, BRAIN INJURY, V22, P161, DOI 10.1080/02699050701867381; Gardner Helen, 2012, Nurse Res, V19, P6; Haas B K, 1999, Image J Nurs Sch, V31, P215, DOI 10.1111/j.1547-5069.1999.tb00483.x; Haverman L, 2011, BMC PEDIATR, V11, DOI 10.1186/1471-2431-11-3; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; Limond J, 2009, BRAIN INJURY, V23, P617, DOI 10.1080/02699050902997870; McCarthy ML, 2007, J TRAUMA, V63, pS122, DOI 10.1097/TA.0b013e31815accdf; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; McCarthy ML, 2005, ARCH PHYS MED REHAB, V86, P1901, DOI 10.1016/j.apmr.2005.03.026; Mitra B, 2007, J PAEDIATR CHILD H, V43, P154, DOI 10.1111/j.1440-1754.2007.01035.x; Nacajauskaite O, 2006, BRAIN DEV-JPN, V28, P507, DOI 10.1016/j.braindev.2006.02.010; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Pieper P., 2011, J TRAUMA NURS, V18, P11, DOI [10.1097/JTN.0b013e31820e3f31, DOI 10.1097/JTN.0B013E31820E3F31]; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Ravens-Sieberer U, 2002, RESTOR NEUROL NEUROS, V20, P151; Rivara FP, 2007, J TRAUMA, V63, pS155, DOI 10.1097/TA.0b013e31815acd92; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Souza Ligia Maria Do N, 2007, Dev Neurorehabil, V10, P35, DOI 10.1080/13638490600822239; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; UNICEF Innocenti Research Center, 2007, REP CARD 7 CHILD POV; Varni JW, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-1; Varni JW, 2003, AMBUL PEDIATR, V3, P329, DOI 10.1367/1539-4409(2003)003<0329:TPAAPP>2.0.CO;2; Winthrop AL, 2010, CURR OPIN PEDIATR, V22, P346, DOI 10.1097/MOP.0b013e3283394351; Young NL, 2009, J CLIN EPIDEMIOL, V62, P314, DOI 10.1016/j.jclinepi.2008.06.011	36	18	18	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2014	28	1					105	113		10.3109/02699052.2013.847208			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	274CC	WOS:000328581700013	24180478				2022-02-06	
J	Purins, K; Lewen, A; Hillered, L; Howells, T; Enblad, P				Purins, Karlis; Lewen, Anders; Hillered, Lars; Howells, Tim; Enblad, Per			Brain tissue oxygenation and cerebral metabolic patterns in focal and diffuse traumatic brain injury	FRONTIERS IN NEUROLOGY			English	Article						brain tissue oxygenation; cerebral metabolism; traumatic brain injury; cerebral ischemia; Neurovent-PTO	MEMBRANE PHOSPHOLIPID DEGRADATION; INTRACEREBRAL MICRODIALYSIS; PERFUSION-PRESSURE; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; INTERSTITIAL GLYCEROL; ARTERY OCCLUSION; ISCHEMIA; MANAGEMENT; RELEASE	Introduction: Neurointensive care of traumatic brain injury (TBI) patients is currently based on intracranial pressure (ICP) and cerebral perfusion pressure (CPP) targeted protocols. There are reasons to believe that knowledge of brain tissue oxygenation (BtipO(2)) would add information with the potential of improving patient outcome. The aim of this study was to examine B(ti)pO(2) and cerebral metabolism using the Neurovent-PTO probe and cerebral microdialysis (MD) in TBI patients. Methods: Twenty-three severe TBI patients with monitoring of physiological parameters, ICP CPP B(ti)pO(2), and MD for biomarkers of energy metabolism (glucose, lactate, and pyruvate) and cellular distress (glutamate, glycerol) were included. Patients were grouped according to injury type (focal/diffuse) and placement of the Neurovent-PTO probe and MD catheter (injured/non-injured hemisphere). Results: We observed different patterns in B(ti)pO(2) and MD biomarkers in diffuse and focal injury where placement of the probe also influenced the results (ipsilateral/contralateral). In all groups, despite fairly normal levels of ICP and CPP, increased MD levels of glutamate, glycerol, or the L/P ratio were observed at B(ti)pO(2) <5 mmHg, indicating increased vulnerability of the brain at this level. Conclusion: Monitoring of B(ti)pO(2) adds important information in addition to traditional ICP and CPP surveillance. Because of the different metabolic responses to very low B(ti)pO(2) in the individual patient groups we submit that brain tissue oximetry is a complementary tool rather than an alternative to MD monitoring.	[Purins, Karlis; Lewen, Anders; Hillered, Lars; Howells, Tim; Enblad, Per] Uppsala Univ, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden		Purins, K (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg Sect, Uppsala, Sweden.; Purins, K (corresponding author), Uppsala Univ, Neurosurg Sect, Univ Uppsala Hosp, Dept Neurosci, SE-75185 Uppsala, Sweden.	karlis.purins@neuro.uu.se	Lewen, Anders/A-5156-2013	Lewen, Anders/0000-0003-4925-1348; Hillered, Lars/0000-0002-2808-9292	Swedish Research CouncilSwedish Research CouncilEuropean Commission; Swedish Brain Foundation; Selander Foundation; Ahlen Foundation; Uppsala University Hospital	Inger Stahl Myllyaho is acknowledged for excellent laboratory assistance. Financial support: the study was supported by The Swedish Research Council, Swedish Brain Foundation, Selander Foundation, Ahlen Foundation, and funds from the Uppsala University Hospital.	Bardt TF, 1998, ACT NEUR S, V71, P153; Beynon C, 2012, J NEUROTRAUM, V29, P2109, DOI 10.1089/neu.2012.2365; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; BULLOCK R, 1992, J NEUROTRAUM, V9, pS443; Bullock R, 1998, J NEUROSURG, V89, P507, DOI 10.3171/jns.1998.89.4.0507; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Clausen F, 2012, J NEUROTRAUM, V29, P766, DOI 10.1089/neu.2011.1754; Clausen T, 2005, J NEUROSURG, V103, P233, DOI 10.3171/jns.2005.103.2.0233; Dings J, 1998, NEUROL RES, V20, pS71; Enblad P, 1996, J CEREBR BLOOD F MET, V16, P637, DOI 10.1097/00004647-199607000-00014; Enblad P, 2001, STROKE, V32, P1574, DOI 10.1161/01.STR.32.7.1574; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Frykholm P, 2001, J NEUROL NEUROSUR PS, V71, P455, DOI 10.1136/jnnp.71.4.455; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Howells T, 2005, J NEUROSURG, V102, P311, DOI 10.3171/jns.2005.102.2.0311; Hutchinson PJ, 2002, J CEREBR BLOOD F MET, V22, P735, DOI 10.1097/00004647-200206000-00012; KATAYAMA Y, 1991, BRAIN RES, V558, P136, DOI 10.1016/0006-8993(91)90730-J; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marklund N, 1997, NEUROREPORT, V8, P1457, DOI 10.1097/00001756-199704140-00026; Nilsson OG, 1999, NEUROSURGERY, V45, P1176, DOI 10.1097/00006123-199911000-00032; NILSSON P, 1990, J CEREBR BLOOD F MET, V10, P631, DOI 10.1038/jcbfm.1990.115; Nordstrom CH, 2003, ANESTHESIOLOGY, V98, P809, DOI 10.1097/00000542-200304000-00004; Orakcioglu B, 2010, NEUROSURGERY, V67, P1716, DOI 10.1227/NEU.0b013e3181f9bb5b; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Persson L, 1996, J NEUROSURG, V84, P606, DOI 10.3171/jns.1996.84.4.0606; Purins K, 2012, NEUROCRIT CARE, V16, P462, DOI 10.1007/s12028-012-9675-3; Purins K, 2011, CRIT CARE MED, V39, P512, DOI 10.1097/CCM.0b013e318206b824; Purins K, 2010, ACTA NEUROCHIR, V152, P681, DOI 10.1007/s00701-009-0532-x; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Samuelsson C, 2007, J CEREBR BLOOD F MET, V27, P1309, DOI 10.1038/sj.jcbfm.9600433; Sarrafzadeh A S, 2000, Neurosurg Focus, V9, pe2; Sarrafzadeh AS, 2004, STROKE, V35, P638, DOI 10.1161/01.STR.0000116101.66624.F1; Schulz MK, 2000, J NEUROSURG, V93, P808, DOI 10.3171/jns.2000.93.5.0808; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Sundstrom T, 2007, J NEUROTRAUM, V24, P147, DOI 10.1089/neu.2006.0099; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Vespa P, 1998, J NEUROSURG, V89, P971, DOI 10.3171/jns.1998.89.6.0971; Vespa PM, 2007, CRIT CARE MED, V35, P1153, DOI 10.1097/01.CCM.0000259466.66310.4F	48	18	18	1	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								64	10.3389/fneur.2014.00064			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300064	24817863	Green Published, gold			2022-02-06	
J	Ripley, DL; Morey, CE; Gerber, D; Harrison-Felix, C; Brenner, LA; Pretz, CR; Cusick, C; Wesnes, K				Ripley, David L.; Morey, Clare E.; Gerber, Don; Harrison-Felix, Cynthia; Brenner, Lisa A.; Pretz, Christopher R.; Cusick, Chris; Wesnes, Keith			Atomoxetine for attention deficits following traumatic brain injury: Results from a randomized controlled trial	BRAIN INJURY			English	Article						Attention; atomoxetine; cognitive drug research; controlled trial; norepinephrine; traumatic brain injury	COMPUTERIZED ASSESSMENT SYSTEM; WORLD-HEALTH-ORGANIZATION; HYPERACTIVITY DISORDER; COGNITIVE FUNCTION; ADULTS; ADHD; ADOLESCENTS; DEMENTIA; CHILDREN; RIVASTIGMINE	Objective: To determine if atomoxetine would improve attention impairment following traumatic brain injury (TBI). Setting: Outpatients from a free-standing, private, not-for-profit rehabilitation hospital. Population: Fifty-five adult participants with a history of a single moderate-to-severe TBI, who were at least 1 year from injury and with self-reported complaints of attention difficulties. Intervention: Atomoxetine, a selective norepinephrine re-uptake inhibitor with a primary indication for attention dosed at 40 mg twice a day for 2 weeks, compared to placebo. Design: Randomized double-blind placebo controlled trial, with placebo run-in. Measures: Cognitive Drug Research (CDR), Computerized Cognitive Assessment System, Stroop Color and Word Test, Adult ADHD Self-Report Scale (ASRS-v1.1), Neurobehavioural Functioning Inventory (NFI). Results: Atomoxetine was well-tolerated by the subject sample. The use of atomoxetine by individuals with reported attention difficulty following TBI did not significantly improve scores on measures of attention, the CDR Power of Attention domain or the Stroop Interference score. In addition, no significant relationship was found between atomoxetine use and self-reported symptoms of attention or depression. Conclusion: Atomoxetine did not significantly improve performance on measures of attention among individuals post-TBI with difficulties with attention. This study follows a trend of other pharmacological studies not demonstrating significant results among those with a history of TBI. Various possibilities are discussed, including the need for a more sophisticated system of classification of TBI.	[Ripley, David L.] Northwestern Univ, Rehabil Inst Chicago, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA; [Morey, Clare E.; Gerber, Don; Harrison-Felix, Cynthia; Brenner, Lisa A.; Pretz, Christopher R.; Cusick, Chris] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Neurol, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado, Sch Med, Dept Phys Med & Rehabil, Aurora, CO USA; [Wesnes, Keith] Bracket Global, Goring On Thames, England; [Wesnes, Keith] Swinburne Univ Technol, Ctr Human Psychopharmacol, Melbourne, Vic, Australia		Ripley, DL (corresponding author), Rehabil Inst Chicago, Chicago, IL 60611 USA.	dripley@ric.org	Brenner, Lisa A./AAG-2442-2019; Wesnes, Keith A/D-7148-2018	Wesnes, Keith/0000-0002-4498-8511; Ripley, David/0000-0002-5349-1830	Rocky Mountain Regional Brain Injury System - US Department of Education's National Institute on Disability and Rehabilitation Research [H133A070022]; Lilly Research LaboratoriesEli Lilly	This research was supported by the Rocky Mountain Regional Brain Injury System (Grant number H133A070022) which was funded by an award from the US Department of Education's National Institute on Disability and Rehabilitation Research. The contents of this publication are the opinions of the authors and do not necessarily reflect the views of the Department of Education. Additionally, this research received investigator-initiated support from Lilly Research Laboratories, who provided active drug and placebo for this project.	BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; Buitelaar JK, 2004, EUR CHILD ADOLES PSY, V13, P249, DOI 10.1007/s00787-004-0401-3; Christman AK, 2004, PHARMACOTHERAPY, V24, P1020, DOI 10.1592/phco.24.11.1020.36146; DACKIS C A, 1990, Advances in Alcohol and Substance Abuse, V9, P9; Golden CJ., 2002, STROOP COLOR WORD TE; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Hwang BH, 1999, NEUROSCI LETT, V265, P151, DOI 10.1016/S0304-3940(99)00241-4; James W., 1980, PRINCIPLES PSYCHOL; Keith MS, 1998, BRAIN INJURY, V12, P1037, DOI 10.1080/026990598121945; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Mathias JL, 2007, NEUROPSYCHOLOGY, V21, P212, DOI 10.1037/0894-4105.21.2.212; Michelson D, 2003, BIOL PSYCHIAT, V53, P112, DOI 10.1016/S0006-3223(02)01671-2; PONSFORD JL, 1995, BRAIN INJURY, V9, P1, DOI 10.3109/02699059509004565; Preti Antonio, 2002, Curr Opin Investig Drugs, V3, P272; SAS Institute Inc, 2011, SAS 9 3 SOFTW; Sauer JM, 2004, J PHARMACOL EXP THER, V308, P410, DOI 10.1124/jpet.103.058727; Shostak, 2010, COMMON STAT METHODS; Simpson D, 2004, CNS DRUGS, V18, P397, DOI 10.2165/00023210-200418060-00011; Spencer T, 2004, PSYCHIAT CLIN N AM, V27, P373, DOI 10.1016/j.psc.2003.12.001; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Wernicke JF, 2002, J CLIN PSYCHIAT, V63, P50; Wernicke JF, 2003, DRUG SAFETY, V26, P729, DOI 10.2165/00002018-200326100-00006; Wesnes KA, 2003, APPETITE, V41, P329, DOI 10.1016/j.appet.2003.08.009; Wesnes KA, 2005, NEUROLOGY, V65, P1654, DOI 10.1212/01.wnl.0000184517.69816.e9; Wesnes KA, 2002, DEMENT GERIATR COGN, V13, P183, DOI 10.1159/000048651; Wesnes KA, COGNITIVE DRUG RES C; Wesnes KA, 2008, NEURODEGENER DIS, V5, P261, DOI 10.1159/000113719; Whiteneck G, 2001, COLORADO TRAUMATIC B; ZERBE RL, 1985, J PHARMACOL EXP THER, V232, P139	34	18	18	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2014	28	12					1514	1522		10.3109/02699052.2014.919530			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	AR6UD	WOS:000343717700003	25180876				2022-02-06	
J	Sharma, S; Gomez, D; deMestral, C; Hsiao, M; Rutka, J; Nathens, AB				Sharma, Sunjay; Gomez, David; deMestral, Charles; Hsiao, Marvin; Rutka, James; Nathens, Avery B.			Emergency Access to Neurosurgical Care for Patients with Traumatic Brain Injury	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							OUTCOMES	BACKGROUND: Traumatic brain injury (TBI) is one of the most common causes of injury-related morbidity and mortality. Access to neurosurgical services is critical to optimal outcomes through reduction of secondary injury. We sought to evaluate variations in access to neurosurgical care across a regional trauma system. STUDY DESIGN: This is a population-based retrospective cohort study of patients who sustained isolated severe TBI from 2005 to 2009. Administrative datasets capturing all emergency department visits and hospitalizations were linked deterministically. Differences between access to a trauma center (TC), defined as direct transport from scene or transfer from a nontrauma center (NTC) as opposed to no access, were evaluated; this included patient level determinants of access to TC and delineation of mortality differences between TC and NTC care. Transfer patterns from NTC to TC were also evaluated. RESULTS: We identified 9,448 patients with isolated severe TBI. Almost two-thirds (60%, n = 5,701) received initial care at an NTC. Of these patients, 30% (n = 1,737) were subsequently transferred to a TC. Thirty-day mortality rates of patients treated at a TC vs NTC were 19% vs 18%, respectively (p = 0.19). Among patients younger than 65 years, 67% received TC care; only 41% of patients older than 65 were treated at a TC (p < 0.01). Mechanism, age, brain hemorrhage, and injury severity were associated with TC care. CONCLUSIONS: Considerable variation in delivery of initial care to TBI patients was identified. Factors such as age and injury characteristics were associated with TC access. Because early TC care in TBI confers survival benefits, the demonstrated variability necessitates improvements in access to care for patients with severe head injuries. (C) 2014 by the American College of Surgeons	[Sharma, Sunjay; Rutka, James] Univ Toronto, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Gomez, David; deMestral, Charles; Hsiao, Marvin; Nathens, Avery B.] Univ Toronto, Dept Surg, Div Gen Surg, Toronto, ON, Canada		Sharma, S (corresponding author), Toronto Western Hosp, Div Neurosurg, WW 4-427, Toronto, ON M5T 2S8, Canada.	sunjay.sharma@gmail.com	Sharma, Sunjay/AAR-7129-2021	Sharma, Sunjay/0000-0001-7826-9075; Gomez, David/0000-0002-0926-2547	Institute for Clinical Evaluative Sciences (ICES)University of Toronto; Ontario Ministry of Health and Long-Term Care (MOHLTC)Ministry of Health and Long-Term Care, Ontario	This study was supported by the Institute for Clinical Evaluative Sciences (ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES, the Ontario MOHLTC, or ROC Investigators is intended or should be inferred. The authors have no other financial disclosures or any conflict of interest to declare.	Caro D. H., 2011, GLOBAL J HLTH SCI, V3, P19, DOI DOI 10.5539/GJHS.V3N1P19; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Finkelstein E., 2006, INCIDENCE EC BURDEN; Haas B, 2012, CAN J SURG, V55, P21, DOI 10.1503/cjs.017510; Yeritsyan N., 2011, GEOGRAPHIC ACCESS PR; Zygun DA, 2005, CAN J NEUROL SCI, V32, P87, DOI 10.1017/S0317167100016930	9	18	18	1	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	JAN	2014	218	1					51	57		10.1016/j.jamcollsurg.2013.10.005			7	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	276KM	WOS:000328749200011	24355876				2022-02-06	
J	Smyth, K; Sandhu, SS; Crawford, S; Dewey, D; Parboosingh, J; Barlow, KM				Smyth, Kim; Sandhu, Sandeep S.; Crawford, Susan; Dewey, Deborah; Parboosingh, Jillian; Barlow, Karen M.			The role of serotonin receptor alleles and environmental stressors in the development of post-concussive symptoms after pediatric mild traumatic brain injury	DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY			English	Article							MAJOR DEPRESSION; PSYCHIATRIC-DISORDERS; CHILDREN; ADOLESCENTS	AimTo determine whether post-injury depressive symptoms, and pre-injury major life stressors and genetic factors (HTR1A C(-1019)G alleles; rs6295) are more common in children with mild traumatic brain injury (mTBI) who develop postconcussion syndrome (PCS) symptoms compared with children with asymptomatic mTBI. MethodThis was a cross-sectional study of 47 symptomatic children (32 males, 15 females; mean age 14y [SD 3y 3mo]) who experienced post-concussive symptoms for 7 or more days and 42 asymptomatic children (26 males 16 females; mean age 13y 6mo [SD 3y 1mo]) after mTBI. Outcome measures were the Postconcussion Symptoms Inventory (PCSI), the Children's Depression Inventory (CDI), standard questionnaire of previous life events, and buccal DNA analysis to determine genotype and allele frequencies for the HTR1A C(-1019)G polymorphism. ResultsDepressive symptoms were uncommon. CDI scores did not differ between groups. Allelic and genotypic frequencies for HTR1A C(-1019)G were similar in both groups. Symptomatic children continued to have elevated PCS scores compared with asymptomatic children 1.72 (SD 0.69) years later and had experienced significantly more life stressors (Wald (1)=8.51, p=0.004). InterpretationHTR1A polymorphisms do not differ in children with PCS. Children who have experienced more significant life stresses are more likely to develop PCS symptoms after mTBI.	[Smyth, Kim; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Dept Pediat, Sect Pediat Neurol, Calgary, AB T3B 6A8, Canada; [Sandhu, Sandeep S.; Crawford, Susan; Dewey, Deborah; Barlow, Karen M.] Alberta Childrens Prov Gen Hosp, Res Inst, Calgary, AB T3B 6A8, Canada; [Parboosingh, Jillian] Univ Calgary, Dept Med Genet, Calgary, AB, Canada		Barlow, KM (corresponding author), Alberta Childrens Prov Gen Hosp, Div Pediat Neurol, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8, Canada.	karen.barlow@albertahealthservices.ca	Barlow, Karen/I-6492-2019; Barlow, Karen/C-1323-2014	Barlow, Karen/0000-0003-2612-8507; Barlow, Karen/0000-0003-2612-8507; Dewey, Deborah/0000-0002-1323-5832	Alberta Children's Hospital Foundation	This study was funded by a research grant provided by the Alberta Children's Hospital Foundation.	Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bloom DR, 2001, J AM ACAD CHILD PSY, V40, P572, DOI 10.1097/00004583-200105000-00017; Busch CR, 1998, NEUROPSYCHOL REV, V8, P95, DOI 10.1023/A:1025661200911; Chan F, 2008, BRAIN INJURY, V22, P471, DOI 10.1080/02699050802084886; CODDINGTON RD, 1972, J PSYCHOSOM RES, V16, P205, DOI 10.1016/0022-3999(72)90045-1; Giza CC, 2001, J ATHL TRAINING, V36, P228; GLASS KL, 2005, ANN M INT NEUR SOC F; Grant KE, 2004, J CLIN CHILD ADOLESC, V33, P412, DOI 10.1207/s15374424jccp3302_23; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; JORGE RE, 1993, J AFFECT DISORDERS, V27, P233, DOI 10.1016/0165-0327(93)90047-N; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; KNIGHT D, 1988, J CHILD PSYCHOL PSYC, V29, P853, DOI 10.1111/j.1469-7610.1988.tb00758.x; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lemonde S, 2003, J NEUROSCI, V23, P8788; Luis CA, 2002, J CLIN EXP NEUROPSYC, V24, P270, DOI 10.1076/jcen.24.3.270.982; Massagli TL, 2004, ARCH PHYS MED REHAB, V85, P1428, DOI 10.1016/j.apmr.2003.12.036; Max JE, 1997, J AM ACAD CHILD PSY, V36, P1278, DOI 10.1097/00004583-199709000-00021; Max JE, 2012, INT J DEV NEUROSCI, V30, P239, DOI 10.1016/j.ijdevneu.2011.12.005; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Patten SB, 2013, SOC PSYCH PSYCH EPID, V48, P927, DOI 10.1007/s00127-012-0603-9; Ponsford J, 1999, J HEAD TRAUMA REHAB, V14, P360, DOI 10.1097/00001199-199908000-00005; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; SMUCKER MR, 1986, J ABNORM CHILD PSYCH, V14, P25, DOI 10.1007/BF00917219; Taylor HG, 2010, NEUROPSYCHOLOGY, V24, P148, DOI 10.1037/a0018112; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	27	18	18	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0012-1622	1469-8749		DEV MED CHILD NEUROL	Dev. Med. Child Neurol.	JAN	2014	56	1					73	77		10.1111/dmcn.12263			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	267WG	WOS:000328128400015	23992222	Bronze			2022-02-06	
J	Sundaramurthy, A; Chandra, N				Sundaramurthy, Aravind; Chandra, Namas			A parametric approach to shape field-relevant blast wave profiles in compressed-gas-driven shock tube	FRONTIERS IN NEUROLOGY			English	Article						primary blast injury; explosion modeling; shock tube; blast induced neurotrauma; shock tube adjustable parameters; shock wave parameters	BRAIN-INJURY; MECHANISMS; RAT; PATHOPHYSIOLOGY; OVERPRESSURE; EXPOSURES; IMPACT; MODEL	Detonation of a high-explosive produces shock-blast wave, shrapnel, and gaseous products. While direct exposure to blast is a concern near the epicenter, shock-blast can affect subjects, even at farther distances. When a pure shock-blast wave encounters the subject, in the absence of shrapnels, fall, or gaseous products the loading is termed as primary blast loading and is the subject of this paper. The wave profile is characterized by blast overpressure, positive time duration, and impulse and called herein as shock-blast wave parameters (SWPs). These parameters in turn are uniquely determined by the strength of high explosive and the distance of the human subjects from the epicenter. The shape and magnitude of the profile determine the severity of injury to the subjects. As shown in some of our recent works (1-3), the profile not only determines the survival of the subjects (e.g., animals) but also the acute and chronic biomechanical injuries along with the following biochemical sequelae. It is extremely important to carefully design and operate the shock tube to produce field-relevant SWPs. Furthermore, it is vital to identify and eliminate the artifacts that are inadvertently introduced in the shock-blast profile that may affect the results. In this work, we examine the relationship between shock tube adjustable parameters (SAPs) and SWPs that can be used to control the blast profile; the results can be easily applied to many of the laboratory shock tubes. Further, replication of shock profile (magnitude and shape) can be related to field explosions and can be a standard in comparing results across different laboratories. Forty experiments are carried out by judiciously varying SAPs such as membrane thickness, breech length (66.68-1209.68 mm), measurement location, and type of driver gas (nitrogen, helium). The effects SAPs have on the resulting shock-blast profiles are shown. Also, the shock-blast profiles of a TNT explosion from ConWep software is compared with the profiles obtained from the shock tube. To conclude, our experimental results demonstrate that a compressed-gas shock tube when designed and operated carefully can replicate the blast time profiles of field explosions accurately. Such a faithful replication is an essential first step when studying the effects of blast induced neurotrauma using animal models.	[Sundaramurthy, Aravind; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Newark, NJ 07102 USA		Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Sundaramurthy, Aravind/O-2047-2019	Sundaramurthy, Aravind/0000-0002-0359-8680	US Army Research Office	We kindly acknowledge the financial support provided by the US Army Research Office. We are also grateful for Brandon Perry and Veera Selvan for their contribution to some of the experimental work.	[Anonymous], 2006, AEP55 NATO, V2; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chandra N., 2011, U.S. provisional patent application, Patent No. 61542354; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fischer H, 2010, US MILITARY CASUALTY; Ganpule S, 2013, BIOMECH MODEL MECHAN, V12, P511, DOI 10.1007/s10237-012-0421-8; Gould K., 1981, HIGH EXPLOSIVE FIELD; HSD, HOM SEC BOMB THREAT; Kinney G.F., 1985, EXPLOSIVE SHOCKS AIR; Kleinschmit NN, 2011, THESIS U NEBRASKA LI; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Kuppuswamy VS, 2013, THESIS U NEBRASKA LI; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Mott D, 2008, APS DIV FLUID DYN M, V53; PAYMAN W, 1946, PROC R SOC LON SER-A, V186, P293, DOI 10.1098/rspa.1946.0045; Prima V, 2013, J NEUROTRAUM, V30, P1881, DOI 10.1089/neu.2012.2758; Rafaels K, 2010, THESIS U VIRGINIA CH; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Ritzel D., 1997, P 21 INT S SHOCK WAV, P97; Ritzel D. V., 2011, P HFM 207 NATO S SUR; Ropper A, 2011, NEW ENGL J MED, V364, P2156, DOI 10.1056/NEJMe1102187; Ruff RL, 2008, J REHABIL RES DEV, V45, P941, DOI 10.1682/JRRD.2008.02.0028; Saljo A, 2011, NEUROIMAGE, V54, pS83, DOI 10.1016/j.neuroimage.2010.05.050; Skotak M, 2013, J NEUROTRAUM, V30, P1147, DOI 10.1089/neu.2012.2652; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Zhu Feng, 2010, Stapp Car Crash J, V54, P211	33	18	18	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								253	10.3389/fneur.2014.00253			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300239	25520701	Green Published, gold			2022-02-06	
J	Tai, YT; Lee, WY; Lee, FP; Lin, TJ; Shih, CL; Wang, JY; Chiu, WT; Hung, KS				Tai, Yu-Ting; Lee, Wen-Yuan; Lee, Fei-Peng; Lin, Tien-Jen; Shih, Chia-Lin; Wang, Jia-Yi; Chiu, Wen-Ta; Hung, Kuo-Sheng			Low Dose of Valproate Improves Motor Function after Traumatic Brain Injury	BIOMED RESEARCH INTERNATIONAL			English	Article							MECHANISMS; DAMAGE; RATS	Background. Traumatic brain injuries (TBIs) are a major health care problem worldwide. Approximately 1.5 million new TBI cases occur annually in the United States, with mortality rates ranging between 35% and 40% in severe patients. Despite the incidence of these injuries and their substantial socioeconomic implications, no specific pharmacological intervention is available for clinical use. Several studies have indicated that 300 mg/kg or 400 mg/kg of valproate (VPA) exhibits neuroprotective effects in animal models. However, humans cannot tolerate high doses of VPA. This study aims to investigate whether 30 mg/kg of VPA administered to rats affects TBIs. Methods. We used a rat model to test the effects of 30 mg/kg of VPA on TBIs. Molecular identifications for histone acetylation and phosphorylation of cAMP response element-binding protein (CREB) and phosphorylated extracellular signal regulated kinase (ERK) were performed. Results. The results indicated that treating adult rats with VPA after This significantly decreased the contusion volume and recovery of contusion-related skilled forelimb reaching deficits. Applying VPA also increased histone acetylation, p-ERK, and p-CREB expression in the brain. Furthermore, applying VPA reduced inflammation, glial fibrillary acidic protein activation, and apoptosis. Conclusion. This study found that 30 mg/kg of VPA assists in treating TBIs in rat models.	[Tai, Yu-Ting] Taipei Med Univ, Wan Fang Hosp, Dept Anesthesiol, Taipei 116, Taiwan; [Lee, Wen-Yuan] China Med Univ, China Med Univ Hosp, Dept Neurosurg, Taipei Branch, Taipei, Taiwan; [Lee, Fei-Peng] Taipei Med Univ, Wan Fang Hosp, Sch Med, Clin Res Ctr,Dept Otolaryngol, Taipei, Taiwan; [Lin, Tien-Jen; Shih, Chia-Lin; Chiu, Wen-Ta; Hung, Kuo-Sheng] Taipei Med Univ, Wan Fang Hosp, Grad Inst Injury Prevent & Control, Clin Res Ctr,Dept Neurosurg, Taipei 116, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Coll Med, Grad Inst Biomed Sci, Taipei, Taiwan		Hung, KS (corresponding author), Taipei Med Univ, Wan Fang Hosp, Grad Inst Injury Prevent & Control, Clin Res Ctr,Dept Neurosurg, 111,Sect 3,Hsing Long Rd, Taipei 116, Taiwan.	kshung25@gmail.com		Fei-Peng, Lee/0000-0002-6788-4336; Hung, Kuo-Sheng/0000-0002-4147-0960; Wang, Jia-Yi/0000-0002-9106-3351	Center of Excellence for Clinical Trial and Research in Neuroscience from the Department of Health, Taiwan [DOH101-TD-B-111-003]; National Science Counsel, TaiwanMinistry of Science and Technology, Taiwan [NSC 99-2314-B-038-004-MY3, NSC 102-2321-B-038-003, NSC 99-2323-B-038-003]	The authors thank Dr. Shih-Yen Tsai from the Research Service, Edward Hines Jr. VA Hospital, USA, for technical support in the skilled forelimb reaching test. This study was partly supported by Grants of Center of Excellence for Clinical Trial and Research in Neuroscience from the Department of Health, Taiwan, DOH101-TD-B-111-003, and the National Science Counsel, Taiwan, NSC 99-2314-B-038-004-MY3, NSC 102-2321-B-038-003 and NSC 99-2323-B-038-003.	Beauchamp K, 2008, MOL MED, V14, P731, DOI 10.2119/2008-00050.Beauchamp; Brandt C, 2006, NEUROPHARMACOLOGY, V51, P789, DOI 10.1016/j.neuropharm.2006.05.021; Chatpun S, 2011, J TRAUMA, V70, P787, DOI [10.1097/TA.0b013e3181e7954f, 10.1155/2010/479364]; Dash PK, 2002, NEUROSCIENCE, V114, P755, DOI 10.1016/S0306-4522(02)00277-4; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Miller Laura C, 2008, Expert Rev Neurother, V8, P1817, DOI 10.1586/14737175.8.12.1817; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; Rosenberg G, 2007, CELL MOL LIFE SCI, V64, P2090, DOI 10.1007/s00018-007-7079-x; Rouaux C, 2007, J NEUROSCI, V27, P5535, DOI 10.1523/JNEUROSCI.1139-07.2007; Sacrey LAR, 2009, BEHAV BRAIN RES, V204, P153, DOI 10.1016/j.bbr.2009.05.035; Shein NA, 2009, FASEB J, V23, P4266, DOI 10.1096/fj.09-134700; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Whishaw IQ, 2005, BEHAV LAB RAT HDB TE; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085; Zhang XP, 2005, CRIT CARE, V9, P66, DOI 10.1186/cc2950	22	18	18	0	5	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2314-6133	2314-6141		BIOMED RES INT	Biomed Res. Int.		2014	2014								980657	10.1155/2014/980657			8	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Biotechnology & Applied Microbiology; Research & Experimental Medicine	AA8SS	WOS:000331365800001	24689067	Green Published, gold, Green Submitted			2022-02-06	
J	Thelin, EP; Nelson, DW; Ghatan, PH; Bellander, BM				Thelin, Eric P.; Nelson, David W.; Ghatan, Per Hamid; Bellander, Bo-Michael			Microdialysis monitoring of CSF parameters in severe traumatic brain injury patients: a novel approach	FRONTIERS IN NEUROLOGY			English	Article						TBI; microdialysis; cerebrospinal fluid; lactate; pyruvate; outcome	CEREBROSPINAL-FLUID; CEREBRAL MICRODIALYSIS; INTRACEREBRAL MICRODIALYSIS; SUBARACHNOID HEMORRHAGE; INTRACRANIAL-PRESSURE; EXTRACELLULAR FLUID; LACTATE PYRUVATE; METABOLIC CRISIS; GLUCOSE; BLOOD	Background: Neuro-intensive care following traumatic brain injury (TBI) is focused on preventing secondary insults that may lead to irreversible brain damage. Microdialysis (MD) is used to detect deranged cerebral metabolism. The clinical usefulness of the MD is dependent on the regional localization of the MD catheter. The aim of this study was to analyze a new method of continuous cerebrospinal fluid (CSF) monitoring using the MD technique. The method was validated using conventional laboratory analysis of CSF samples. MD-CSF and regional MD-Brain samples were correlated to patient outcome. Materials and Methods: A total of 14 patients suffering from severe TBI were analyzed. They were monitored using (1) a MD catheter (CMA64-iView, n=7448 MD samples) located in a CSF-pump connected to the ventricular drain and (2) an intraparenchymal MD catheter (CMA70, n=8358 MD samples). CSF-lactate and CSF-glucose levels were monitored and were compared to MD-CSF samples. MD-CSF and MD-Brain parameters were correlated to favorable (Glasgow Outcome Score extended, GOSe 6-8) and unfavorable (GOSe 1-5) outcome. Results: Levels of glucose and lactate acquired with the CSF-MD technique could be correlated to conventional levels. The median MD recovery using the CMA64 catheter in CSF was 0.98 and 0.97 for glucose and lactate, respectively. Median MD-CSF (CMA 64) lactate (p=0.0057) and pyruvate (p=0.0011) levels were significantly lower in the favorable outcome group compared to the unfavorable group. No significant difference in outcome was found using the lactate:pyruvate ratio (LPR), or any of the regional MD-Brain monitoring in our analyzed cohort. Conclusion:This new technique of global MD-CSF monitoring correlates with conventional CSF levels of glucose and lactate, and the MD recovery is higher than previously described. Increase in lactate and pyruvate, without any effect on the LPR, correlates to unfavorable outcome, perhaps related to the presence of erythrocytes in the CSF.	[Thelin, Eric P.; Bellander, Bo-Michael] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Bldg R2 02, S-17176 Stockholm, Sweden; [Nelson, David W.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Anesthesiol & Intens Care, Stockholm, Sweden; [Ghatan, Per Hamid] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden		Thelin, EP (corresponding author), Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Bldg R2 02, S-17176 Stockholm, Sweden.	eric.thelin@ki.se	Viani, Rafael/V-1196-2018; Thelin, Eric Peter/K-2144-2012	Thelin, Eric Peter/0000-0002-2338-4364; Nelson, David/0000-0003-2530-8207			Abi-Saab WM, 2002, J CEREBR BLOOD F MET, V22, P271, DOI 10.1097/00004647-200203000-00004; Armin SS, 2006, NEUROL RES, V28, P445, DOI 10.1179/016164106X115053; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; Benjamin RK, 2004, NEURO-ONCOLOGY, V6, P65, DOI 10.1215/S1152851703000103; BENVENISTE H, 1989, J NEUROCHEM, V52, P1741, DOI 10.1111/j.1471-4159.1989.tb07252.x; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BRONDSTED HE, 1970, J PHYSIOL-LONDON, V208, P187, DOI 10.1113/jphysiol.1970.sp009113; Chen Jeff W, 2012, Surg Neurol Int, V3, P57, DOI 10.4103/2152-7806.96868; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; COPES WS, 1988, J TRAUMA, V28, P69, DOI 10.1097/00005373-198801000-00010; CROCKARD HA, 1972, EUR NEUROL, V8, P151, DOI 10.1159/000114569; Dahlin AP, 2010, ANAL CHEM, V82, P4376, DOI 10.1021/ac1007706; DESALLES AAF, 1986, J NEUROSURG, V65, P615, DOI 10.3171/jns.1986.65.5.0615; Engstrom M, 2005, J NEUROSURG, V102, P460, DOI 10.3171/jns.2005.102.3.0460; Eymann R, 2012, ACTA NEUROCHIR SUPPL, V113, P181, DOI 10.1007/978-3-7091-0923-6_36; Foley N, 2008, J NEUROTRAUM, V25, P1415, DOI 10.1089/neu.2008.0628; Fox E, 2002, J PHARMACOL EXP THER, V301, P1003, DOI 10.1124/jpet.301.3.1003; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; GRANHOLM L, 1969, SCAND J CLIN LAB INV, V23, P361, DOI 10.3109/00365516909081702; GUERRAROMERO L, 1992, J INFECT DIS, V166, P546, DOI 10.1093/infdis/166.3.546; Gustavsson A, 2011, EUR NEUROPSYCHOPHARM, V21, P718, DOI 10.1016/j.euroneuro.2011.08.008; Hage C, 2010, DIABETES TECHNOL THE, V12, P291, DOI 10.1089/dia.2009.0150; Hillered L, 2005, J NEUROTRAUM, V22, P3, DOI 10.1089/neu.2005.22.3; Hillered L, 1998, J NEUROL NEUROSUR PS, V64, P486, DOI 10.1136/jnnp.64.4.486; Hlatky R, 2004, J NEUROTRAUM, V21, P894, DOI 10.1089/0897715041526195; HOCHWALD GM, 1983, NEUROSCIENCE, V10, P1035, DOI 10.1016/0306-4522(83)90241-5; HOCHWALD GM, 1985, J NEUROCHEM, V44, P1832, DOI 10.1111/j.1471-4159.1985.tb07176.x; Hutchinson PJ, 2000, J NEUROSURG, V93, P37, DOI 10.3171/jns.2000.93.1.0037; JACOBSON I, 1985, J NEUROSCI METH, V15, P263, DOI 10.1016/0165-0270(85)90107-4; Johnston Andrew J, 2002, Curr Opin Crit Care, V8, P121, DOI 10.1097/00075198-200204000-00006; Kerner A, 2007, NEUROL RES, V29, P647, DOI 10.1179/016164107X248983; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Lew HL, 2003, AM J PHYS MED REHAB, V82, P53, DOI [10.1097/00002060-200301000-00009, 10.1097/01.PHM.0000043771.90606.81]; Linsler S, 2013, ACTA NEUROCHIR, V155, P1589, DOI 10.1007/s00701-012-1562-3; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; MORI K, 1993, ACTA NEUROCHIR, V125, P20, DOI 10.1007/BF01401823; Myles PS, 2007, BRIT J ANAESTH, V99, P309, DOI 10.1093/bja/aem214; NAROTAM PK, 1994, NEUROSURGERY, V34, P409, DOI 10.1227/00006123-199403000-00004; NAU R, 1992, EUR J CLIN PHARMACOL, V42, P181, DOI 10.1007/BF00278481; Nelson DW, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-21; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; Nelson DW, 2004, CRIT CARE MED, V32, P2428, DOI 10.1097/01.CCM.0000147688.08813.9C; Nielsen TH, 2013, ACTA ANAESTH SCAND, V57, P229, DOI 10.1111/j.1399-6576.2012.02783.x; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; POSNER JB, 1967, ARCH NEUROL-CHICAGO, V16, P492, DOI 10.1001/archneur.1967.00470230044005; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rooyackers O, 2013, ACTA ANAESTH SCAND, V57, P214, DOI 10.1111/j.1399-6576.2012.02787.x; Rooyackers O, 2010, ACTA ANAESTH SCAND, V54, P841, DOI 10.1111/j.1399-6576.2010.02264.x; Rostami Elham, 2011, J Diabetes Sci Technol, V5, P596; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Sasaki M, 1996, J NUCL MED, V37, P1174; Seifman MA, 2008, J CEREBR BLOOD F MET, V28, P684, DOI 10.1038/sj.jcbfm.9600603; Siesj? BK., 1978, BRAIN ENERGY METABOL; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; SKOGSEID IM, 1992, ACTA NEUROCHIR, V115, P106, DOI 10.1007/BF01406367; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; Stern P, 2007, TUMOR BIOL, V28, P84, DOI 10.1159/000098441; TEASDALE G, 1974, LANCET, V2, P81; Thelin EP, 2013, J NEUROTRAUM, V30, P519, DOI 10.1089/neu.2012.2553; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Toczylowska B, 2006, BRAIN RES, V1104, P183, DOI 10.1016/j.brainres.2006.05.057; Veening JG, 2010, FLUIDS BARRIERS CNS, V7, DOI 10.1186/1743-8454-7-1; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; WATERHOUSE JM, 1970, J NEUROL SCI, V10, P305, DOI 10.1016/0022-510X(70)90157-7; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang WM, 2013, CLIN BIOCHEM, V46, P694, DOI 10.1016/j.clinbiochem.2012.11.008	71	18	18	0	4	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.		2014	5								159	10.3389/fneur.2014.00159			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	V42QW	WOS:000209629300152	25228896	gold, Green Published			2022-02-06	
J	Wei, X; Li, Y; Sun, XD; Zhu, XT; Feng, YH; Liu, J; Jiang, YJ; Shang, H; Cui, LW; Cao, YM				Wei, Xu; Li, Ying; Sun, Xiaodan; Zhu, Xiaotong; Feng, Yonghui; Liu, Jun; Jiang, Yongjun; Shang, Hong; Cui, Liwang; Cao, Yaming			Erythropoietin Protects against Murine Cerebral Malaria through Actions on Host Cellular Immunity	INFECTION AND IMMUNITY			English	Article							REGULATORY T-CELLS; BLOOD-BRAIN-BARRIER; DENDRITIC CELLS; PLASMODIUM-FALCIPARUM; IN-VITRO; RESPONSES; INNATE; CD8(+); MODEL; INDUCTION	Cerebral malaria (CM) is associated with excessive host proinflammatory responses and endothelial activation. The hematopoietic hormone erythropoietin (EPO) possesses neuroprotective functions in animal models of ischemic-hypoxic, traumatic, and inflammatory injuries. In the Plasmodium berghei ANKA model of experimental CM (ECM), recombinant human EPO (rhEPO) has shown evident protection against ECM. To elucidate the mechanism of EPO in this ECM model, we investigated the effect of rhEPO on host cellular immune responses. We demonstrated that improved survival of mice with ECM after rhEPO treatment was associated with reduced endothelial activation and improved integrity of the blood-brain barrier. Our results revealed that rhEPO downregulated the inflammatory responses by directly inhibiting the levels and functions of splenic dendritic cells. Conversely, rhEPO treatment led to significant expansion of regulatory T cells and increased expression of the receptor cytotoxic T lymphocyte antigen 4 (CTLA-4). The data presented here provide evidence of the direct effect of rhEPO on host cellular immunity during ECM.	[Wei, Xu; Li, Ying; Sun, Xiaodan; Zhu, Xiaotong; Feng, Yonghui; Liu, Jun; Cao, Yaming] China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang, Liaoning, Peoples R China; [Jiang, Yongjun; Shang, Hong] China Med Univ, Hosp 1, Dept Lab Med, Shenyang, Liaoning, Peoples R China; [Jiang, Yongjun; Shang, Hong] China Med Univ, Hosp 1, Minist Hlth, Key Lab AIDS Immunol, Shenyang, Liaoning, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA		Cao, YM (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang, Liaoning, Peoples R China.	luc2@psu.edu; ymcao@mail.cmu.edu.cn			National Institute of Allergy and Infectious Diseases, NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI099611, U19AI089672]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI099611, U19AI089672] Funding Source: NIH RePORTER	This study was funded by the National Institute of Allergy and Infectious Diseases, NIH (R01AI099611 to Y.C. and U19AI089672 to L.C.).	Agnello D, 2002, BRAIN RES, V952, P128, DOI 10.1016/S0006-8993(02)03239-0; Arcasoy MO, 2008, BRIT J HAEMATOL, V141, P14, DOI 10.1111/j.1365-2141.2008.07014.x; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bauer PR, 2002, MICROCIRCULATION, V9, P463, DOI 10.1038/sj.mn.7800159; Belayev L, 1996, BRAIN RES, V739, P88, DOI 10.1016/S0006-8993(96)00815-3; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Brines M, 2006, KIDNEY INT, V70, P246, DOI 10.1038/sj.ki.5001546; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines M, 2004, P NATL ACAD SCI USA, V101, P14907, DOI 10.1073/pnas.0406491101; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Cao Ya-Ming, 1998, Parasitology International, V47, P157, DOI 10.1016/S1383-5769(98)00014-2; Casals-Pascual C, 2008, P NATL ACAD SCI USA, V105, P2634, DOI 10.1073/pnas.0709715105; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chen G, 2009, PARASITOLOGY, V136, P1107, DOI 10.1017/S0031182009990370; Chen SJ, 2010, CLIN EXP IMMUNOL, V162, P210, DOI 10.1111/j.1365-2249.2010.04238.x; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Core A, 2011, EXP PARASITOL, V127, P500, DOI 10.1016/j.exppara.2010.09.010; D'Andrea RJ, 2000, EXP HEMATOL, V28, P231, DOI 10.1016/S0301-472X(99)00159-9; DEKOSSODO S, 1993, STEM CELLS, V11, P41, DOI 10.1002/stem.5530110108; deWalick S, 2007, J IMMUNOL, V178, P6033, DOI 10.4049/jimmunol.178.10.6033; do Rosario APF, 2012, INT J PARASITOL, V42, P549, DOI 10.1016/j.ijpara.2012.03.010; Dodoo D, 2002, J INFECT DIS, V185, P971, DOI 10.1086/339408; Favre N, 1999, MICROBES INFECT, V1, P961, DOI 10.1016/S1286-4579(99)80513-9; Gramaglia I, 2006, NAT MED, V12, P1417, DOI 10.1038/nm1499; Guermonprez P, 2002, ANNU REV IMMUNOL, V20, P621, DOI 10.1146/annurev.immunol.20.100301.064828; Hansen DS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000771; Haque A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001221; Hempel C, 2011, AM J PATHOL, V179, P1939, DOI 10.1016/j.ajpath.2011.06.027; Ing R, 2006, J IMMUNOL, V176, P441, DOI 10.4049/jimmunol.176.1.441; Jangpatarapongsa K, 2008, EUR J IMMUNOL, V38, P2697, DOI 10.1002/eji.200838186; Jelkmann W, 2005, CURR PHARM BIOTECHNO, V6, P65; Kaiser K, 2006, J INFECT DIS, V193, P987, DOI 10.1086/500844; Katz O, 2007, EUR J IMMUNOL, V37, P1584, DOI 10.1002/eji.200637025; KRANTZ SB, 1991, BLOOD, V77, P419; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Kurtzhals JAL, 1997, BRIT J HAEMATOL, V97, P169, DOI 10.1046/j.1365-2141.1997.82654.x; Li WP, 2004, ANN NEUROL, V56, P767, DOI 10.1002/ana.20274; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Lifshitz L, 2009, MOL IMMUNOL, V46, P713, DOI 10.1016/j.molimm.2008.10.004; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Marti HH, 2004, J EXP BIOL, V207, P3233, DOI 10.1242/jeb.01049; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Medana IM, 2006, INT J PARASITOL, V36, P555, DOI 10.1016/j.ijpara.2006.02.004; Mittelman M, 2001, P NATL ACAD SCI USA, V98, P5181, DOI 10.1073/pnas.081275298; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; Nie CQ, 2007, INFECT IMMUN, V75, P2275, DOI 10.1128/IAI.01783-06; Pouniotis DS, 2005, J IMMUNOL, V175, P3525, DOI 10.4049/jimmunol.175.6.3525; Prutchi-Sagiv S, 2006, BRIT J HAEMATOL, V135, P660, DOI 10.1111/j.1365-2141.2006.06366.x; Renia L, 2012, VIRULENCE, V3, P193, DOI 10.4161/viru.19013; Sagiv SP, 2008, EXP HEMATOL, V36, P1682, DOI 10.1016/j.exphem.2008.07.010; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Villegas-Mendez A, 2012, J IMMUNOL, V189, P968, DOI 10.4049/jimmunol.1200688; Wiese L, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-3; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yamakuchi M, 2007, P NATL ACAD SCI USA, V104, P1301, DOI 10.1073/pnas.0602035104; Yanez DM, 1996, J IMMUNOL, V157, P1620; Yuan RR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001924; Zheng W, 2009, FOLIA PARASIT, V56, P242, DOI 10.14411/fp.2009.028	63	18	21	0	9	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567	1098-5522		INFECT IMMUN	Infect. Immun.	JAN	2014	82	1					165	173		10.1128/IAI.00929-13			9	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	278OM	WOS:000328899600017	24126529	Green Published, Bronze			2022-02-06	
J	Kauser, H; Sahu, S; Kumar, S; Panjwani, U				Kauser, H.; Sahu, S.; Kumar, S.; Panjwani, U.			GUANFACINE IS AN EFFECTIVE COUNTERMEASURE FOR HYPOBARIC HYPDXIA-INDUCED COGNITIVE DECLINE	NEUROSCIENCE			English	Article						hypobaric hypoxia; guanfacine; prefrontal cortex; dendritic morphology	MEDIAL PREFRONTAL CORTEX; TRAUMATIC BRAIN-INJURY; WORKING-MEMORY; DENDRITIC SPINES; TYROSINE-HYDROXYLASE; PYRAMIDAL NEURONS; EXTENDED-RELEASE; BIOGENIC-AMINES; SPATIAL MEMORY; HYPOXIA	Hypobaric hypoxia (HH), an environmental stress resulting from ascent to high altitude, affects perception, memory, judgment, and attention, resulting in degradation of many aspects of normal functioning. Alpha 2A adrenergic agonist, guanfacine proved to be beneficial in the amelioration of neurological outcomes of many neuropsychiatric disorders involving adrenergic imbalance and neurodegeneration. Adrenergic dysregulation and neuronal damage have been implicated in hypoxia-induced cognitive deficits, however, efficacy of guanfacine as a countermeasure for HH-induced cognitive decline remains to be evaluated. We, therefore, have studied the effect of this drug on the HH-induced cognitive deficits, adrenergic dysfunction and neuronal damage. Rats were exposed to HH at a simulated altitude of 25,000 feet for 7 days and received an IM injection of either saline or guanfacine at a dose of 1 mg/kg. Adrenergic transmission was evaluated by biomarkers i.e. norepinephrine (NE), dopamine (DA) and tyrosine hydroxylase (TH) in medial prefrontal cortex (PFC) by biochemical and immunohistochemical assays. Spine and dendritic morphology of pyramidal neurons in layer ll of medial PFC was studied using Golgi Cox staining and Neurolucida neuronal tracing. The cognitive performance was assessed by Delayed Alternation Task using a T-Maze. There was a significant reduction in HH-induced increases in NE, DA and TH levels with guanfacine treatment. Guanfacine rescued HH-induced dendritic atrophy and mushroom type spine loss. The spatial working memory deficits induced by HH were significantly ameliorated with guanfacine treatment. Furthermore, the cognitive performance showed a positive correlation with dendritic arbors and spine numbers. These results showed that the HH-induced cognitive decline is associated with adrenergic dysregulation and neuronal damage in layer II of medial PFC, and that guanfacine treatment during HH ameliorated these functional and morphological deficits. The study suggests a potential role of the alpha-2A adrenergic agonist, guanfacine, in amelioration of PFC dysfunction caused by high altitude exposure. (C) 2013 IBRO. Published by Elsevier Ltd. All rights reserved.	[Kauser, H.; Sahu, S.; Kumar, S.; Panjwani, U.] DRDO, DIPAS, Delhi 110054, India		Panjwani, U (corresponding author), DRDO, DIPAS, Neurophysiol Div, Lucknow Rd, Delhi 110054, India.	usha_dipas@rediffmail.com		Sahu, Surajit/0000-0002-9529-3939	Defence Research and Development Organization, Ministry of Defence, Government of IndiaDefence Research & Development Organisation (DRDO); Department of Science and Technology, Government of IndiaDepartment of Science & Technology (India)	We would like to thank Prof. Shashi Wadhwa, Department of Anatomy, All India Institute of Medical Sciences for extending the morphological and morphometric analysis facility. The first author, H. Kauser, is the WOS-B fellow of the Department of Science and Technology, Government of India. This study was funded by the Defence Research and Development Organization, Ministry of Defence, Government of India and the Department of Science and Technology, Government of India.	ADAMS JH, 1975, BRIT J ANAESTH, V47, P121, DOI 10.1093/bja/47.2.121; Arnsten AFT, 2000, NEURAL PLAST, V7, P133, DOI 10.1155/NP.2000.133; ARNSTEN AFT, 1988, J NEUROSCI, V8, P4287; Arnsten AFT, 2007, CEREB CORTEX, V17, pI6, DOI 10.1093/cercor/bhm033; Arnsten AFT, 2012, NEURON, V76, P223, DOI 10.1016/j.neuron.2012.08.038; Arnsten Amy F. T., 2012, Yale Journal of Biology and Medicine, V85, P45; Baitharu I, 2013, BEHAV BRAIN RES, V240, P76, DOI 10.1016/j.bbr.2012.11.005; Birnbaum SG, 2004, SCIENCE, V306, P882, DOI 10.1126/science.1100021; Birnbaum SG, 2000, PHARMACOL BIOCHEM BE, V67, P397, DOI 10.1016/S0091-3057(00)00306-3; BYLUND DB, 1988, TRENDS PHARMACOL SCI, V9, P356, DOI 10.1016/0165-6147(88)90254-4; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; CAVALETTI G, 1990, INT J SPORTS MED, V11, P176, DOI 10.1055/s-2007-1024787; Connor DF, 2013, J CHILD ADOL PSYCHOP, V23, P244, DOI 10.1089/cap.2012.0119; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Delatour B, 2000, BEHAV BRAIN RES, V109, P113, DOI 10.1016/S0166-4328(99)00168-0; Engelhard K, 2003, ANESTH ANALG, V97, P1155, DOI 10.1213/01.ANE.0000078576.93190.6F; Franowicz JS, 2002, J NEUROSCI, V22, P8771; Friedman JI, 2001, NEUROPSYCHOPHARMACOL, V25, P402, DOI 10.1016/S0893-133X(01)00249-4; GARRIDO E, 1993, INT J SPORTS MED, V14, P232, DOI 10.1055/s-2007-1021169; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hains AB, 2009, P NATL ACAD SCI USA, V106, P17957, DOI 10.1073/pnas.0908563106; HARDEBO JE, 1980, ANN NEUROL, V8, P1, DOI 10.1002/ana.410080102; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Hu J, 2008, BRAIN RES, V1199, P37, DOI 10.1016/j.brainres.2007.12.073; Jain V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062235; Jentsch JD, 2008, BRAIN RES, V1246, P41, DOI 10.1016/j.brainres.2008.10.006; Ji XH, 2008, NEUROPSYCHOPHARMACOL, V33, P2263, DOI 10.1038/sj.npp.1301603; Jin Xin-Chun, 2007, Shengli Xuebao, V59, P739; KIECHEL JR, 1980, BRIT J CLIN PHARMACO, V10, pS25, DOI 10.1111/j.1365-2125.1980.tb04901.x; Kobori N, 2011, NEUROSCIENCE, V172, P293, DOI 10.1016/j.neuroscience.2010.10.048; Kobori N, 2006, J NEUROTRAUM, V23, P1094, DOI 10.1089/neu.2006.23.1094; KRAMER AF, 1993, HUM FACTORS, V35, P329, DOI 10.1177/001872089303500208; LARSEN JK, 1978, PHYSIOL PSYCHOL, V6, P15; Leuner B, 2010, J NEUROSCI, V30, P13499, DOI 10.1523/JNEUROSCI.3388-10.2010; LIEBERMAN P, 1994, NATURE, V372, P325, DOI 10.1038/372325a0; Liston C, 2006, J NEUROSCI, V26, P7870, DOI 10.1523/JNEUROSCI.1184-06.2006; Ma D, 2005, BR MED B, V71, P77, DOI DOI 10.1086/433195; Ma DQ, 2004, EUR J PHARMACOL, V502, P87, DOI 10.1016/j.ejphar.2004.08.044; Maiti P, 2008, BEHAV BRAIN RES, V189, P233, DOI 10.1016/j.bbr.2008.01.007; Malhotra PA, 2006, ANN NEUROL, V59, P186, DOI 10.1002/ana.20701; McAllister TW, 2011, INT J PSYCHOPHYSIOL, V82, P107, DOI 10.1016/j.ijpsycho.2011.06.022; Miner LH, 2006, J NEUROSCI, V26, P1571, DOI 10.1523/JNEUROSCI.4450-05.2006; Nellgard BMG, 1999, BRAIN RES, V847, P262, DOI 10.1016/S0006-8993(99)02059-4; Pudovkina OL, 2001, BRAIN RES, V906, P38, DOI 10.1016/S0006-8993(01)02553-7; RAO BSS, 1993, BRAIN RES, V627, P216; Ray K, 2011, NEUROCHEM INT, V58, P112, DOI 10.1016/j.neuint.2010.11.003; REGARD M, 1989, NEUROLOGY, V39, P210, DOI 10.1212/WNL.39.2.210; Ren WW, 2012, MOL CELL NEUROSCI, V49, P205, DOI 10.1016/j.mcn.2011.10.001; Rodway GW, 2003, HEART LUNG, V32, P353, DOI 10.1016/j.hrtlng.2003.08.002; Sahu S, 2012, PHYTOMEDICINE, V19, P924, DOI 10.1016/j.phymed.2012.05.005; Sallee FR, 2009, J AM ACAD CHILD PSY, V48, P155, DOI 10.1097/CHI.0b013e318191769e; Salvatore MF, 2001, J NEUROCHEM, V79, P349, DOI 10.1046/j.1471-4159.2001.00593.x; Savourey G, 2003, EUR J APPL PHYSIOL, V89, P122, DOI 10.1007/s00421-002-0789-8; SHUKITTHALE B, 1994, BEHAV NEURAL BIOL, V62, P244, DOI 10.1016/S0163-1047(05)80023-8; Singh-Curry V, 2011, J NEUROL NEUROSUR PS, V82, P688, DOI 10.1136/jnnp.2009.195792; Tanila H, 1999, EUR J NEUROSCI, V11, P599, DOI 10.1046/j.1460-9568.1999.00464.x; TAYLOR RB, 1983, J CHROMATOGR, V277, P101, DOI 10.1016/S0378-4347(00)84827-6; Titus ADJ, 2007, NEUROSCIENCE, V145, P265, DOI 10.1016/j.neuroscience.2006.11.037; TROUVIN JH, 1986, GEN PHARMACOL, V17, P69, DOI 10.1016/0306-3623(86)90013-3; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; Wilson MH, 2009, LANCET NEUROL, V8, P175, DOI 10.1016/S1474-4422(09)70014-6; Zhang Yonghua, 2005, Current Neuropharmacology, V3, P317, DOI 10.2174/157015905774322534	63	18	18	0	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	DEC 19	2013	254						110	119		10.1016/j.neuroscience.2013.09.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	255ZN	WOS:000327279400010	24056194				2022-02-06	
J	Ren, CH; Zoltewicz, S; Guingab-Cagmat, J; Anagli, J; Gao, MQ; Hafeez, A; Li, N; Cao, JQ; Geng, XK; Kobeissy, F; Mondello, S; Larner, SF; Hayes, RL; Ji, XM; Ding, YC				Ren, Changhong; Zoltewicz, Susie; Guingab-Cagmat, Joy; Anagli, John; Gao, Mingqing; Hafeez, Adam; Li, Ning; Cao, Jinqiang; Geng, Xiaokun; Kobeissy, Firas; Mondello, Stefania; Larner, Stephen F.; Hayes, Ronald L.; Ji, Xunming; Ding, Yuchuan			Different expression of ubiquitin C-terminal hydrolase-L1 and alpha II-spectrin in ischemic and hemorrhagic stroke: Potential biomarkers in diagnosis	BRAIN RESEARCH			English	Article						Stroke; Biomarker; Ischemia; Hemorrhagia; Ubiquitin C-terminal hydrolase-L1; alpha II-Spectrin	TRAUMATIC BRAIN-INJURY; CEREBRAL-ARTERY OCCLUSION; FIBRILLARY ACIDIC PROTEIN; INTRACEREBRAL HEMORRHAGE; CEREBROSPINAL-FLUID; BREAKDOWN PRODUCTS; MARKERS; RATS; NEURODEGENERATION; IDENTIFICATION	The two primary categories of stroke, ischemic and hemorrhagic, both have fundamentally different mechanisms and thus different treatment options. These two stroke categories were applied to rat models to identify potential biomarkers that can distinguish between them. Ischemic stroke was induced by middle cerebral artery occlusion (MCAO) without reperfusion while hemorrhagic stroke was induced by injecting collagenase IV into the striatum. Brain hemispheres and biofluids were collected at two time points: 3 and 6 h after stroke. Known molecules were tested on the rat samples via quantitative immunoblotting (injured brain, CSF) and Banyan's proprietary ELISA assays (CSF, serum). The injured brain quantitative analyses revealed that ell-spectrin breakdown products (SBDP150, SBDP145) were strongly increased after 6 h ischemia. In CSF, SBDP145 and ubiquitin C-terminal hydrolase-L1 (UCH-L1) levels were elevated after 6 h ischemic stroke detected by Western blot and ELISA. In serum UCH-L1 levels were increased after 3 and 6 h of ischemia detected by ELISA. However, levels of those proteins in hemorrhagic stroke remain normal. In summary, in both the brain and the biofluids, SBDPs and UCH-L1 were elevated after ischemic but not hemorrhagic stroke. These molecules behaved differently in the two stroke models and thus may be capable of being differentiated. (C) 2013 Elsevier B.V. All rights reserved.	[Ren, Changhong; Gao, Mingqing; Li, Ning; Cao, Jinqiang; Geng, Xiaokun; Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Inst Hypoxia Med, Beijing 100053, Peoples R China; [Zoltewicz, Susie; Guingab-Cagmat, Joy; Anagli, John; Mondello, Stefania; Larner, Stephen F.; Hayes, Ronald L.] Banyan Biomarkers Inc, Banyan Labs, Alachua, FL USA; [Ren, Changhong; Zoltewicz, Susie; Guingab-Cagmat, Joy; Anagli, John; Li, Ning; Larner, Stephen F.; Hayes, Ronald L.; Ji, Xunming; Ding, Yuchuan] Xuanwu Banyan Biomarker Res & Assay Ctr, Beijing 100053, Peoples R China; [Hafeez, Adam; Ding, Yuchuan] Wayne State Univ Sch Med, Dept Neurosurg, Detroit, MI USA; [Ji, Xunming] Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Beijing 100053, Peoples R China; [Kobeissy, Firas] Univ Florida, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL 32611 USA		Ji, XM (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Neurosurg, Chang Chun Rd 45, Beijing 100053, Peoples R China.	jixm@ccmu.edu.cn	Mondello, Stefania/A-1813-2012; Kobeissy, Firas/E-7042-2017; Ji, Xunming/AAN-3370-2021	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; 	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171241]; Program of Excellent Talents of Beijing [2011D005018000007]	This work is supported by the Program of National Natural Science Foundation of China (81171241) and the Program of Excellent Talents of Beijing (2011D005018000007).	Allard L, 2004, PROTEOMICS, V4, P2242, DOI 10.1002/pmic.200300809; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; Chalela JA, 2007, LANCET, V369, P293, DOI 10.1016/S0140-6736(07)60151-2; Cuadrado E, 2010, J NEUROPATH EXP NEUR, V69, P1105, DOI 10.1097/NEN.0b013e3181f8c539; CUNNINGHAM RT, 1991, EUR J CLIN INVEST, V21, P497, DOI 10.1111/j.1365-2362.1991.tb01401.x; Dambinova SA, 2003, CLIN CHEM, V49, P1752, DOI 10.1373/49.10.1752; Ding YC, 2002, STROKE, V33, P2492, DOI 10.1161/01.STR.0000028237.15541.CC; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2009, NEUROLOGY, V73, P393, DOI 10.1212/WNL.0b013e3181b05ef9; Gardali S., 2006, J NEUROSURG SCI, V50, P25; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Kent DM, 2003, STROKE, V34, P464, DOI 10.1161/01.STR.0000051506.43212.8B; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Lescuyer P, 2004, PROTEOMICS, V4, P2234, DOI 10.1002/pmic.200300822; Lewis SB, 2007, J NEUROSURG, V107, P792, DOI 10.3171/JNS-07/10/0792; Liu MC, 2010, EUR J NEUROSCI, V31, P722, DOI 10.1111/j.1460-9568.2010.07097.x; Lloyd-Jones D, 2010, CIRCULATION, V121, P948, DOI 10.1161/CIRCULATIONAHA.109.192666; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MATIASGUIU J, 1986, ACTA NEUROL SCAND, V73, P461, DOI 10.1111/j.1600-0404.1986.tb04585.x; Matsushita K, 2000, J CEREBR BLOOD F MET, V20, P396, DOI 10.1097/00004647-200002000-00022; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pineda JA, 2007, J NEUROTRAUM, V24, P354, DOI 10.1089/neu.2006.003789; RIEDERER BM, 1986, J CELL BIOL, V102, P2088, DOI 10.1083/jcb.102.6.2088; Takahashi M, 1999, CLIN CHEM, V45, P1307; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Weiss ES, 2009, ANN THORAC SURG, V88, P543, DOI 10.1016/j.athoracsur.2009.04.016; Whiteley W, 2011, J ROY COLL PHYS EDIN, V41, P152, DOI 10.4997/JRCPE.2011.207; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; WILKINSON KD, 1992, BIOCHEM SOC T, V20, P631, DOI 10.1042/bst0200631; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543	33	18	19	1	21	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	DEC 2	2013	1540						84	91		10.1016/j.brainres.2013.09.051			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	264WI	WOS:000327911300008	24140110				2022-02-06	
J	Honeybul, S; Gillett, GR; Ho, K				Honeybul, Stephen; Gillett, Grant R.; Ho, Kwok			Futility in Neurosurgery: A Patient-Centered Approach	NEUROSURGERY			English	Article						Ethics; Futility; Severe traumatic brain injury	MIDDLE CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; SUBARACHNOID HEMORRHAGE; MALIGNANT INFARCTION; CONTROLLED-TRIAL; HEAD-INJURY; HEMICRANIECTOMY; MULTICENTER; MANAGEMENT	The concept of futility has been a source of discussion for many years. Even though it is tempting to propose that an action or clinical intervention should be deemed futile if it does not achieve the goals of that action, further clarification is needed in terms of the nature of the likely outcomes of an intervention and the probabilities of various outcomes being achieved. The outcome, in an age of balance between autonomy and necessity, should, at a minimum, be acceptable to the person on whom the intervention is to be performed. This is especially the case when considering outcome following decompressive craniectomy for severe traumatic brain injury, in which certain outcomes are likely to be severely impaired states that the patient would consider unacceptable. In this article, we use some key ethical concepts such as substantial benefit and the risk of unbearable badness to explore the concept of futility in severe traumatic brain injury and, by linking that to recent advances in neurosurgical science, propose a pragmatic patient-centered approach to deal with the concept of futility.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA, Australia; [Honeybul, Stephen] Royal Perth Hosp, Perth, WA 6001, Australia; [Gillett, Grant R.] Univ Otago, Dunedin Hosp, Dunedin, New Zealand; [Gillett, Grant R.] Univ Otago, Otago Bioeth Ctr, Dunedin, New Zealand; [Ho, Kwok] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Perth, WA, Australia.	stephen.honeybul@health.wa.gov.au	Ho, Kwok M./E-3546-2010	Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Adamo MA, 2008, J NEUROSURG, V108, P174, DOI 10.3171/JNS/2008/108/01/0174; Buschmann U, 2007, ACTA NEUROCHIR, V149, P59, DOI 10.1007/s00701-006-1069-x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; Coutinho JM, 2009, STROKE, V40, P2233, DOI 10.1161/STROKEAHA.108.543421; Dombrowski KE, 2011, BRIT J NEUROSURG, V25, P249, DOI 10.3109/02688697.2010.544784; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; Foerch C, 2004, J NEUROSURG, V101, P248, DOI 10.3171/jns.2004.101.2.0248; Gillett G, 2001, NEW ZEAL MED J, V114, P188; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Gillett G, 2011, J BIOETHIC INQ, V8, P145, DOI 10.1007/s11673-011-9292-4; Guresir E, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0954; Helft PR, 2000, NEW ENGL J MED, V343, P293, DOI 10.1056/NEJM200007273430411; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Holtkamp M, 2001, J NEUROL NEUROSUR PS, V70, P226, DOI 10.1136/jnnp.70.2.226; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2011, ANAESTH INTENS CARE, V39, P659, DOI 10.1177/0310057X1103900420; Honeybul S, 2012, PLOS ONE, P7; Honeybul S, 2013, WORLD NEUROSURG, V79, P159, DOI 10.1016/j.wneu.2012.08.012; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Honeybul S, 2009, J NEUROTRAUM, V26, P2179, DOI 10.1089/neu.2009.0989; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Juttler E, 2007, STROKE, V38, P2518, DOI 10.1161/STROKEAHA.107.485649; Kiphuth IC, 2010, NEUROCRIT CARE, V13, P380, DOI 10.1007/s12028-010-9449-8; Kontopoulos V, 2002, ACTA NEUROCHIR, V144, P791, DOI 10.1007/s00701-002-0948-z; Leonhardt G, 2002, J NEUROL, V249, P1433, DOI 10.1007/s00415-002-0875-1; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nilsson P, 2009, EUR J NEUROL, V16, P639, DOI 10.1111/j.1468-1331.2009.02547.x; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Puetz V, 2007, LANCET NEUROL, V6, P580, DOI 10.1016/S1474-4422(07)70160-6; Rabelino GAG, 2008, PEDIATR NEUROL, V39, P201, DOI 10.1016/j.pediatrneurol.2008.06.006; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Vahedi K, 2007, LANCET NEUROL, V6, P215, DOI 10.1016/S1474-4422(07)70036-4	39	18	18	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0148-396X	1524-4040		NEUROSURGERY	Neurosurgery	DEC	2013	73	6					917	922		10.1227/NEU.0000000000000014			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	300QM	WOS:000330478600017	23756747				2022-02-06	
J	Le, Q; Gelinas, C; Arbour, C; Rodrigue, N				Le, Quynh; Gelinas, Celine; Arbour, Caroline; Rodrigue, Nathalie			Description of Behaviors in Nonverbal Critically Ill Patients With a Traumatic Brain Injury When Exposed to Common Procedures in the Intensive Care Unit: A Pilot Study	PAIN MANAGEMENT NURSING			English	Article							PAIN OBSERVATION TOOL; ADULT; RELIABILITY; VALIDATION	Behavioral indicators are strongly recommended for pain assessment in nonverbal patients. Although pain-related behaviors have been studied in critically ill patients, those with a traumatic brain injury (TBI) have been either excluded or underrepresented. Because these patients also likely experience pain, research is urgently needed to generate knowledge in this field. This pilot study aimed to explore pain-related behaviors of critically ill TBI patients when exposed to common procedures in the intensive care unit (ICU), using video recording at the bedside and a newly developed coding system. Ten TBI patients hospitalized in the ICU participated. A 44-item behavioral checklist created from existing tools was used as a coding system to identify behaviors before, during, and 20 minutes after a nociceptive procedure (turning) and a nonnociceptive procedure (noninvasive blood pressure [NIBP]). Patients were video recorded to check for interrater agreement between two trained observers. TBI patients exhibited more behaviors during turning than at rest or during NIBP (p < .001). The following behaviors were observed during turning: levator contraction (n = 7), frowning (n = 5), opening eyes (n = 5), weeping eyes (n = 5), raising eyebrows (n = 5), activating the ventilator alarms (n = 7), and muscle tension (n = 5). No change in behaviors was noted during NIBP. After educational training and using videos, the average percentage of agreement for observed behaviors between two trained research assistants was 96%. Pain in critically ill TBI patients can be detrimental to health and recovery. ICU clinicians should be aware of pain-related behaviors to enable better detection and treatment in this highly vulnerable group. (C) 2013 by the American Society for Pain Management Nursing	[Le, Quynh; Gelinas, Celine; Arbour, Caroline] McGill Univ, Sch Nursing, Montreal, PQ H3A 2A7, Canada; [Gelinas, Celine; Arbour, Caroline] McGill Univ, Jewish Gen Hosp, Ctr Nursing Res, Montreal, PQ H3T 1E2, Canada; [Gelinas, Celine; Arbour, Caroline] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ H3T 1E2, Canada; [Gelinas, Celine; Arbour, Caroline] Quebec Interuniv Nursing Intervent Res Grp, Montreal, PQ, Canada; [Rodrigue, Nathalie] McGill Univ, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3A 2A7, Canada		Gelinas, C (corresponding author), McGill Univ, Sch Nursing, 3506 Univ St, Montreal, PQ H3A 2A7, Canada.	celine.gelinas@mcgill.ca					[Anonymous], 1979, Pain, V6, P249; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Dunwoody Colleen J, 2008, J Perianesth Nurs, V23, pS15, DOI 10.1016/j.jopan.2007.11.007; Feeley N, 2009, CAN J NURS RES, V41, P84; Gelinas C, 2007, CLIN J PAIN, V23, P497, DOI 10.1097/ajp.0b013e31806a23fb; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Gelinas C, 2011, INT J NURS STUD, V48, P1495, DOI 10.1016/j.ijnurstu.2011.03.012; Gelinas C, 2009, J CRIT CARE, V24, DOI 10.1016/j.jcrc.2009.01.013; GOODWIN LD, 1981, RES NURS HEALTH, V4, P323, DOI 10.1002/nur.4770040308; Haidet KK, 2009, RES NURS HEALTH, V32, P465, DOI 10.1002/nur.20334; Herr K, 2011, PAIN MANAG NURS, V12, P230, DOI 10.1016/j.pmn.2011.10.002; International Association for the Study of Pain, 2011, PAIN TERM; Keay KA, 2002, EXP PHYSIOL, V87, P275, DOI 10.1113/eph8702355; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Li D, 2008, J PAIN, V9, P2, DOI 10.1016/j.jpain.2007.08.009; Marmo L, 2010, PAIN MANAG NURS, V11, P134, DOI 10.1016/j.pmn.2009.05.007; Marr A., 2004, CENTRAL NERVOUS SYST; Martelli M. F., 2006, BRAIN INJURY MED PRI, P723; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; O'Donnell ML, 2010, J TRAUMA, V69, P627, DOI 10.1097/TA.0b013e3181bc0923; Payen JF, 2001, CRIT CARE MED, V29, P2258, DOI 10.1097/00003246-200112000-00004; Pudas-Tahka SM, 2009, J ADV NURS, V65, P946, DOI 10.1111/j.1365-2648.2008.04947.x; Puntillo K A, 2001, Am J Crit Care, V10, P238; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Rotondi AJ, 2002, CRIT CARE MED, V30, P746, DOI 10.1097/00003246-200204000-00004; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Shannon Kathleen, 2003, Intensive Crit Care Nurs, V19, P154, DOI 10.1016/S0964-3397(03)00027-2; Stanik-Hutt J A, 2001, Am J Crit Care, V10, P252; TEASDALE G, 1974, LANCET, V2, P81; Themessl-Huber M, 2008, PATIENT EDUC COUNS, V71, P157, DOI 10.1016/j.pec.2008.01.015; Young James A, 2007, Phys Med Rehabil Clin N Am, V18, P145, DOI 10.1016/j.pmr.2006.11.008	32	18	19	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1524-9042	1532-8635		PAIN MANAG NURS	Pain Manag. Nurs.	DEC	2013	14	4					E251	E261		10.1016/j.pmn.2012.02.005			11	Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing	269QD	WOS:000328256100019	24315278				2022-02-06	
J	Keenan, HT; Murphy, NA; Staheli, R; Savitz, LA				Keenan, Heather T.; Murphy, Nancy A.; Staheli, Russ; Savitz, Lucy A.			Healthcare Utilization in the First Year After Pediatric Traumatic Brain Injury in an Insured Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						child; health services; pediatric; screening; traumatic brain injury	CHILDREN; SERVICES; ADOLESCENTS; TRENDS; FAMILY; TBI; PERFORMANCE; CHILDHOOD; DEATHS; MATRIX	Objective: To compare the healthcare use by children with and without a traumatic brain injury (TBI) in the year following injury to understand whether children access primary care. Participants: Children 0 to 15 years with a TBI (N = 545) and (N = 2310) uninjured age and sex-matched comparisons. Setting: A full benefits healthcare plan from 2000 to 2007. Main Measures: Mean annual healthcare utilization. Results: Children with TBI had higher mean annual outpatient visits (4.2 vs 3.5, P =.001), but similar mean annual general pediatric visits (2.7 vs 2.8, P =.3) than comparison children. More cases than comparisons attended a general pediatric visit (80.0% vs 73.3%, risk ratio = 1.1, 95% CI: 1.0-1.1). However, approximately 50% of children older than 7 years who had an intracranial injury did not attend a general pediatric visit and those were slightly more likely to receive specialty care (adjusted risk ratio = 1.1, 95% CI: 1.0-1.2). These children did not appear to be substituting specialty for primary care. Conclusions: Children with a full benefits insurance plan do not access primary care routinely after TBI. These findings present a challenge for designing a system to screen children after TBI.	[Keenan, Heather T.; Murphy, Nancy A.] Univ Utah, Dept Pediat, Salt Lake City, UT 84158 USA; [Staheli, Russ; Savitz, Lucy A.] Intermt Healthcare, Salt Lake City, UT USA		Keenan, HT (corresponding author), Univ Utah, Dept Pediat, POB 581289, Salt Lake City, UT 84158 USA.	heather.keenan@hsc.utah.edu					Aitken ME, 2009, PEDIATRICS, V123, P199, DOI 10.1542/peds.2008-0607; [Anonymous], 1999, JAMA, V282, P974; Attar Mohammad A, 2005, J Perinatol, V25, P36, DOI 10.1038/sj.jp.7211203; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Clark DE, 2006, INJURY PREV, V12, P111, DOI 10.1136/ip.2005.010058; Edwards P, 2006, BMJ-BRIT MED J, V333, P119, DOI 10.1136/bmj.38875.757488.4F; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Faul M, 2010, TRAUMATIC BRAIN INJU; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Glang A, 2004, NEUROREHABILITATION, V19, P219; Glang A, 2010, J HEAD TRAUMA REHAB, V25, P426, DOI 10.1097/HTR.0b013e3181fb8f45; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Hooper S R, 2001, N C Med J, V62, P350; Irwin CE, 2009, PEDIATRICS, V123, pE565, DOI 10.1542/peds.2008-2601; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kaye AJ, 2010, J TRAUMA, V68, P1396, DOI 10.1097/TA.0b013e3181cf7d1b; KINSELLA G, 1995, J PEDIATR PSYCHOL, V20, P753, DOI 10.1093/jpepsy/20.6.753; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Mandalis A, 2007, DEV NEUROPSYCHOL, V32, P683, DOI 10.1080/87565640701376045; Medical home initiatives for children with special needs project advisory committee. American Academy of Pediatrics, 2002, PEDIATRICS 1, V110, P184; Ornstein TJ, 2009, J CHILD PSYCHOL PSYC, V50, P506, DOI 10.1111/j.1469-7610.2008.01997.x; Prigatano GP, 2006, J HEAD TRAUMA REHAB, V21, P505, DOI 10.1097/00001199-200611000-00005; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Statistics NCfH, 2001, ICD 9 CM INT CLASS D; Strickland BB, 2011, PEDIATRICS, V127, P604, DOI 10.1542/peds.2009-3555; Yeates KO, 2009, PEDIATRICS, V123, P735, DOI 10.1542/peds.2008-1056	32	18	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					426	432		10.1097/HTR.0b013e31825935b8			7	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200006	22691966				2022-02-06	
J	Kiss, P; Vadasz, G; Kiss-Illes, B; Horvath, G; Tamas, A; Reglodi, D; Koppan, M				Kiss, Peter; Vadasz, Gyongyver; Kiss-Illes, Blanka; Horvath, Gabor; Tamas, Andrea; Reglodi, Dora; Koppan, Miklos			Environmental Enrichment Decreases Asphyxia-Induced Neurobehavioral Developmental Delay in Neonatal Rats	INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES			English	Article						asphyxia; enriched environment; reflex development; motor coordination	HYPOXIC-ISCHEMIC ENCEPHALOPATHY; ACUTE PERINATAL ASPHYXIA; EXCITATORY AMINO-ACIDS; TRAUMATIC BRAIN-INJURY; ANXIETY-LIKE BEHAVIOR; GROWTH-FACTOR 1; MONOSODIUM GLUTAMATE; NEUROLOGICAL REFLEXES; CEREBROSPINAL-FLUID; NEUROTROPHIC FACTOR	Perinatal asphyxia during delivery produces long-term disability and represents a major problem in neonatal and pediatric care. Numerous neuroprotective approaches have been described to decrease the effects of perinatal asphyxia. Enriched environment is a popular strategy to counteract nervous system injuries. The aim of the present study was to investigate whether enriched environment is able to decrease the asphyxia-induced neurobehavioral developmental delay in neonatal rats. Asphyxia was induced in ready-to-deliver mothers by removing the pups by caesarian section after 15 min of asphyxia. Somatic and neurobehavioral development was tested daily and motor coordination weekly. Our results show that rats undergoing perinatal asphyxia had a marked developmental delay and worse performance in motor coordination tests. However, pups kept in enriched environment showed a decrease in the developmental delay observed in control asphyctic pups. Rats growing up in enriched environment did not show decrease in weight gain after the first week and the delay in reflex appearance was not as marked as in control rats. In addition, the development of motor coordination was not as strikingly delayed as in the control group. Short-term neurofunctional outcome are known to correlate with long-term deficits. Our results thus show that enriched environment could be a powerful strategy to decrease the deleterious developmental effects of perinatal asphyxia.	[Kiss, Peter; Vadasz, Gyongyver; Kiss-Illes, Blanka; Horvath, Gabor; Tamas, Andrea; Reglodi, Dora] Univ Pecs, Dept Anat, PTE MTA Lendulet PACAP Res Team, H-7624 Pecs, Hungary; [Koppan, Miklos] Univ Pecs, Dept Obstet & Gynecol, H-7624 Pecs, Hungary		Reglodi, D (corresponding author), Univ Pecs, Dept Anat, PTE MTA Lendulet PACAP Res Team, H-7624 Pecs, Hungary.	peter.kiss@aok.pte.hu; vadaszgyongyi@gmail.com; blanka.illes@gmail.com; gabor.horvathmd@gmail.com; andreatamassz@gmail.com; dora.reglodi@aok.pte.hu; mkoppan@gmail.com			OTKAOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA) [K104984, PD109644]; TAMOP [4.2.2.B-10/1-2010-0029, 4.2.2.A-11/1/KONV-2012-0024, 4.2.4.A/2-11-1-2012-0001]; Arimura Foundation; NAP Program; PTE-MTA "Lendulet" Program; Bolyai ScholarshipHungarian Academy of Sciences; University of Pecs Research Grant [AOK-KA 2013]	This study was supported by OTKA K104984, PD109644, TAMOP (4.2.2.B-10/1-2010-0029, 4.2.2.A-11/1/KONV-2012-0024), Arimura Foundation, NAP Program, PTE-MTA "Lendulet" Program, Bolyai Scholarship, University of Pecs Research Grant AOK-KA 2013, TAMOP 4.2.4.A/2-11-1-2012-0001 "National Excellence Program".	Adriani W, 2006, PSYCHOPHARMACOLOGY, V184, P155, DOI 10.1007/s00213-005-0223-0; Allende-Castro C, 2012, NEUROTOX RES, V22, P79, DOI 10.1007/s12640-012-9310-2; Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; ALTMAN J, 1975, ANIM BEHAV, V23, P896, DOI 10.1016/0003-3472(75)90114-1; Baldini S, 2013, J NEUROSCI, V33, P11715, DOI 10.1523/JNEUROSCI.3541-12.2013; Baroncelli L, 2013, NEUROSCIENCE, V236, P313, DOI 10.1016/j.neuroscience.2013.01.036; BONESTROO HJ, 2013, NEUROSCIENCE, V35, P197; Bustamante D, 2007, EXP BRAIN RES, V177, P358, DOI 10.1007/s00221-006-0679-0; Capani F, 2009, EXP NEUROL, V219, P404, DOI 10.1016/j.expneurol.2009.06.007; Cebral E, 2011, BRAIN RES BULL, V84, P31, DOI 10.1016/j.brainresbull.2010.10.003; Chen Y, 1997, NEUROSCI LETT, V221, P77, DOI 10.1016/S0304-3940(96)13293-6; Clayton Kellie, 2003, Physical & Occupational Therapy in Pediatrics, V23, P43, DOI 10.1300/J006v23n01_04; Comeau W, 2008, DEV PSYCHOBIOL, V50, P134, DOI 10.1002/dev.20253; Dam K, 2000, DEV BRAIN RES, V121, P179, DOI 10.1016/S0165-3806(00)00044-4; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; DellAnna E, 1997, EXP BRAIN RES, V115, P105, DOI 10.1007/PL00005670; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Farkas J, 2009, BRAIN RES BULL, V79, P208, DOI 10.1016/j.brainresbull.2008.12.011; Fernandez-Teruel A, 1997, BEHAV GENET, V27, P513, DOI 10.1023/A:1021400830503; Frizzo JK, 2010, CELL MOL NEUROBIOL, V30, P683, DOI 10.1007/s10571-009-9492-1; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; HAGBERG H, 1993, ACTA PAEDIATR, V82, P925, DOI 10.1111/j.1651-2227.1993.tb12601.x; Hagberg H, 2009, J CHILD NEUROL, V24, P1141, DOI 10.1177/0883073809338212; Hannigan JH, 2007, NEUROSCI BIOBEHAV R, V31, P202, DOI 10.1016/j.neubiorev.2006.06.019; HEBB DO, 1947, AM PSYCHOL, V2, P302; Herrera-Marschitz M, 2011, NEUROTOX RES, V19, P603, DOI 10.1007/s12640-010-9208-9; HILL JM, 1991, PEPTIDES, V12, P187, DOI 10.1016/0196-9781(91)90186-S; Holopainen IE, 2012, PHARMACOL BIOCHEM BE, V100, P825, DOI 10.1016/j.pbb.2011.03.016; Horvath G, 2013, INT J MOL SCI, V14, P19054, DOI 10.3390/ijms140919054; Imanaka A, 2008, BEHAV BRAIN RES, V186, P91, DOI 10.1016/j.bbr.2007.07.039; Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Kajta M, 2009, NEUROCHEM INT, V55, P265, DOI 10.1016/j.neuint.2009.03.010; Keilhoff G, 2010, NEUROSCIENCE, V171, P869, DOI 10.1016/j.neuroscience.2010.09.024; Kiss P, 2007, NEUROTOX RES, V12, P85, DOI 10.1007/BF03033917; Kiss P, 2005, NEUROTOX RES, V8, P235, DOI 10.1007/BF03033977; KISS P, 2013, INT J MOL SCI, V14, P1; Kiss P, 2011, NEUROSCI LETT, V487, P400, DOI 10.1016/j.neulet.2010.10.065; Kiss P, 2009, BRAIN RES, V1255, P42, DOI 10.1016/j.brainres.2008.12.018; Klawitter V, 2007, EXP BRAIN RES, V180, P139, DOI 10.1007/s00221-006-0842-7; Kondo M, 2012, NEURON, V73, P743, DOI 10.1016/j.neuron.2011.12.020; Kumral A, 2006, BIOL NEONATE, V89, P205, DOI 10.1159/000089951; Kusaka K, 2004, SYNAPSE, V54, P223, DOI 10.1002/syn.20086; Landi S, 2009, J NEUROSCI, V29, P10809, DOI 10.1523/JNEUROSCI.1857-09.2009; Lehnardt S, 2007, J NEUROIMMUNOL, V190, P28, DOI 10.1016/j.jneuroim.2007.07.023; Leuthner SR, 2004, PEDIATR CLIN N AM, V51, P737, DOI 10.1016/j.pcl.2004.01.016; Lubics A, 2005, BEHAV BRAIN RES, V157, P157, DOI 10.1016/j.bbr.2004.06.019; MALISKA D, 2002, FOLIA NEUROPATHOL, V40, P177; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Morales P, 2008, J NEUROSCI RES, V86, P2650, DOI 10.1002/jnr.21715; Morales P, 2007, NEUROTOX RES, V12, P81, DOI 10.1007/BF03033903; Morales P, 2010, EXP BRAIN RES, V202, P1, DOI 10.1007/s00221-009-2103-z; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; NOBREGA JN, 1992, DEV PSYCHOBIOL, V25, P183, DOI 10.1002/dev.420250304; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; OLSSON T, 1994, MOL BRAIN RES, V23, P349, DOI 10.1016/0169-328X(94)90246-1; Pereira LO, 2007, NEUROBIOL LEARN MEM, V87, P101, DOI 10.1016/j.nlm.2006.07.003; Ortuzar N, 2011, J NEURAL TRANSM, V118, P135, DOI 10.1007/s00702-010-0496-2; Pattison KF, 2013, ANIM COGN, V16, P429, DOI 10.1007/s10071-012-0583-x; Ravenelle R, 2013, BEHAV BRAIN RES, V252, P49, DOI 10.1016/j.bbr.2013.05.041; Reglodi D, 2003, BEHAV BRAIN RES, V140, P131, DOI 10.1016/S0166-4328(02)00289-9; REYNOLDS S, 2013, AUTISM RES; Richter SH, 2013, BEHAV BRAIN RES, V252, P287, DOI 10.1016/j.bbr.2013.06.021; RIIKONEN RS, 1992, PEDIATR NEUROL, V8, P37, DOI 10.1016/0887-8994(92)90050-9; Robertson CL, 2009, EXP NEUROL, V218, P371, DOI 10.1016/j.expneurol.2009.04.030; Rojas JJ, 2013, EXP NEUROL, V241, P25, DOI 10.1016/j.expneurol.2012.11.026; SARNAT HB, 1976, NEUROLOGY, V33, P696; Schneider JS, 2001, BRAIN RES, V896, P48, DOI 10.1016/S0006-8993(00)03249-2; Simola N, 2008, EXP BRAIN RES, V185, P595, DOI 10.1007/s00221-007-1186-7; SMART JL, 1971, BRAIN RES, V28, P85, DOI 10.1016/0006-8993(71)90526-9; SMART JL, 1971, BRAIN RES, V33, P303, DOI 10.1016/0006-8993(71)90105-3; Souza SK, 2013, METAB BRAIN DIS, V28, P25, DOI 10.1007/s11011-012-9367-x; Strata F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015326; Sun XM, 2008, INT J DEV NEUROSCI, V26, P363, DOI 10.1016/j.ijdevneu.2007.11.005; Szabadfi K, 2009, BRAIN RES, V1259, P107, DOI 10.1016/j.brainres.2009.01.004; Ten VS, 2003, BEHAV BRAIN RES, V145, P209, DOI 10.1016/S0166-4328(03)00146-3; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; UJHAZY E, FOOD CHEM T IN PRESS; Van de Berg WDJ, 2002, EXP NEUROL, V174, P29, DOI 10.1006/exnr.2001.7855; Vannucci RC, 2000, AM J PERINAT, V17, P113, DOI 10.1055/s-2000-9293; VANNUCCI RC, 1993, PEDIATR NEUROL, V9, P29, DOI 10.1016/0887-8994(93)90006-X; Vazquez-Sanroman D, 2013, BEHAV BRAIN RES, V243, P118, DOI 10.1016/j.bbr.2012.12.047; Vlassaks E, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-14; Yang T, 2011, BRAIN RES, V1383, P317, DOI 10.1016/j.brainres.2011.01.081; YU K, 2013, BRAIN RES; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	87	18	18	0	17	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1422-0067			INT J MOL SCI	Int. J. Mol. Sci.	NOV	2013	14	11					22258	22273		10.3390/ijms141122258			16	Biochemistry & Molecular Biology; Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	274RR	WOS:000328624400066	24232451	Green Published, gold, Green Submitted			2022-02-06	
J	Kourtidou, P; McCauley, SR; Bigler, ED; Traipe, E; Wu, TC; Chu, ZLD; Hunter, JV; Li, XQ; Levin, HS; Wilde, EA				Kourtidou, Paraskevi; McCauley, Stephen R.; Bigler, Erin D.; Traipe, Elfrides; Wu, Trevor C.; Chu, Zili D.; Hunter, Jill V.; Li, Xiaoqi; Levin, Harvey S.; Wilde, Elisabeth A.			Centrum Semiovale and Corpus Callosum Integrity in Relation to Information Processing Speed in Patients With Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						centrum semiovale; corpus callosum; diffusion tensor imaging; magnetization transfer imaging; processing speed; traumatic axonal injury; traumatic brain injury	DIFFUSE AXONAL INJURY; WHITE-MATTER; COEFFICIENT; RECOVERY; MODERATE; MEMORY; TBI	Objectives: This study investigated white matter alterations in the corpus callosum (CC) and centrum semiovale (CSO), using diffusion tensor imaging and magnetization transfer imaging, in participants with severe traumatic brain injury (TBI) and related these changes to processing speed measures. Participants and Methods: Fourteen adult participants with severe TBI underwent neuroimaging and assessment, using the Symbol Digit Modalities Test and Trail-Making Test, Part B, at approximately 6 months postinjury. Thirteen demographically similar, neurologically intact adults were imaged for comparison. Results: The TBI group demonstrated lower fractional anisotropy (FA) for the right CSO and higher apparent diffusion coefficient (ADC) for the CSO bilaterally than the control group. Lower FA and higher ADC were noted in all CC regions. Magnetization transfer imaging revealed smaller magnetization transfer ratios (MTRs) in the right and left CSO and CC genu and splenium. Written Symbol Digit Modalities Test performance was related to right CSO FA, bilateral CSO ADC, CC FA, and right CSO MTR, whereas oral Symbol Digit Modalities Test was related to right CSO FA, ADC, and MTR. Trail-Making Test, Part B, was related to right CSO FA and MTR. Conclusions: Advanced neuroimaging modalities such as diffusion tensor imaging and magnetization transfer imaging demonstrate significant alterations in white matter, which are related to processing speed. These techniques may be useful in quantifying the extent of injury even in normal appearing white matter after TBI.	[Kourtidou, Paraskevi] Univ Athens, Postgrad Program Clin Neuropsychol, Sch Med, Athens, Greece; [Kourtidou, Paraskevi] Univ Texas Hlth Sci Ctr, Houston, TX 77225 USA; [McCauley, Stephen R.; Traipe, Elfrides; Wu, Trevor C.; Li, Xiaoqi; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Phys Med & Rehabil Alliance, Houston, TX 77030 USA; [McCauley, Stephen R.; Traipe, Elfrides; Wu, Trevor C.; Li, Xiaoqi; Levin, Harvey S.; Wilde, Elisabeth A.] Univ Texas Houston, Sch Med, Houston, TX 77030 USA; [Traipe, Elfrides; Chu, Zili D.; Hunter, Jill V.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [McCauley, Stephen R.; Levin, Harvey S.; Wilde, Elisabeth A.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Traipe, Elfrides; Chu, Zili D.; Hunter, Jill V.] Texas Childrens Hosp, Dept Pediat Radiol, Houston, TX 77030 USA; [Bigler, Erin D.; Wu, Trevor C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Neurosci, Provo, UT 84602 USA; [Bigler, Erin D.] Univ Utah, Dept Psychiat, Salt Lake City, UT USA; [Bigler, Erin D.] Univ Utah, Utah Brain Inst, Salt Lake City, UT USA		Wilde, EA (corresponding author), Baylor Coll Med, 1709 Dryden Rd,Ste 1200, Houston, TX 77030 USA.	ewilde@bcm.edu		Kourtidou, Evie/0000-0001-6058-5424	Dana Foundation; organization committee of the clinical neuropsychology program of the Medical School, National and Kapodistrian University of Athens, Greece; University of Texas Health Science Center at Houston, Texas	Funding for this project was provided by a grant from the Dana Foundation (PI: Dr Wilde). The authors thank the organization committee of the clinical neuropsychology program of the Medical School, National and Kapodistrian University of Athens, Greece, and The University of Texas Health Science Center at Houston, Texas (A. C. Papanicolaou, D. Vassilopoulos, I. Evdokimidis, I. Zalonis, S. G. Papageorgiou, C. Potagas, and N. Smyrnis), for their financial assistance to author P. K. They also thank Jonathan Chia, Vipulkumar Patel, and Dr Ponnada Narayana for their assistance in the development and implementation of the magnetic resonance sequences and Joshua Cooper for his assistance in manuscript preparation.	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bagley LJ, 2000, J MAGN RESON IMAGING, V11, P1, DOI 10.1002/(SICI)1522-2586(200001)11:1<1::AID-JMRI1>3.0.CO;2-H; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; DOUSSET V, 1992, RADIOLOGY, V182, P483, DOI 10.1148/radiology.182.2.1732968; Duckworth JL, 2010, CURR OPIN CRIT CARE, V16, P92, DOI 10.1097/MCC.0b013e3283374900; Ewing-Cobbs L, 2008, NEUROIMAGE, V42, P1305, DOI 10.1016/j.neuroimage.2008.06.031; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Goetz P, 2004, J NEUROTRAUM, V21, P645, DOI 10.1089/0897715041269731; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Hammeke T. A., 2003, NEUROPSYCHIATRY, P1149; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; KAIL R, 1994, ACTA PSYCHOL, V86, P199, DOI 10.1016/0001-6918(94)90003-5; Kennedy JE, 2003, CLIN NEUROPSYCHOL, V17, P303, DOI 10.1076/clin.17.3.303.18091; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Le Bihan D, 2002, NMR BIOMED, V15, P431, DOI 10.1002/nbm.798; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Lockwood-Estrin G, 2012, J NEUROSCI METH, V205, P182, DOI 10.1016/j.jneumeth.2011.12.014; Mamere AE, 2009, AM J NEURORADIOL, V30, P947, DOI 10.3174/ajnr.A1477; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; McGowan JC, 2000, AM J NEURORADIOL, V21, P875; McGowan JC, 1999, MAGN RESON MED, V41, P727, DOI 10.1002/(SICI)1522-2594(199904)41:4<727::AID-MRM11>3.0.CO;2-6; Netsch T, 2004, IEEE T MED IMAGING, V23, P789, DOI 10.1109/TMI.2004.827479; O'Jile JR, 2006, ARCH CLIN NEUROPSYCH, V21, P293, DOI 10.1016/j.acn.2006.03.003; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Porto L, 2011, EUR J PAEDIATR NEURO, V15, P493, DOI 10.1016/j.ejpn.2011.06.004; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rassovsky Y, 2006, J CLIN EXP NEUROPSYC, V28, P581, DOI 10.1080/13803390500434474; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shum DHK, 1990, CLIN NEUROPSYCHOL, V4, P151, DOI DOI 10.1080/13854049008401508; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Sinson G, 2001, AM J NEURORADIOL, V22, P143; Smith A., 1982, SYMBOL DIGIT MODALIT; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; VILKKI J, 1994, NEUROPSYCHOLOGIA, V32, P1257, DOI 10.1016/0028-3932(94)90107-4; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; WOLFF SD, 1989, MAGNET RESON MED, V10, P135, DOI 10.1002/mrm.1910100113; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	48	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2013	28	6					433	441		10.1097/HTR.0b013e3182585d06			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	299AA	WOS:000330365200007	22832369				2022-02-06	
J	Kulstad, E; Metzger, AK; Courtney, DM; Rees, J; Shanley, P; Matsuura, T; McKnite, S; Lurie, K				Kulstad, Erik; Metzger, Anja K.; Courtney, D. Mark; Rees, Jennifer; Shanley, Patrick; Matsuura, Timothy; McKnite, Scott; Lurie, Keith			Induction, maintenance, and reversal of therapeutic hypothermia with an esophageal heat transfer device	RESUSCITATION			English	Article						Therapeutic hypothermia; esophageal; cooling; temperature maintenance; medical device; swine mode	HOSPITAL CARDIAC-ARREST; TRAUMATIC BRAIN-INJURY; INTENSIVE-CARE-UNIT; TARGET TEMPERATURE; COMATOSE SURVIVORS; SURFACE; SAFETY	Aim of the study: To evaluate a novel esophageal heat transfer device for use in inducing, maintaining, and reversing hypothermia. We hypothesized that this device could successfully induce, maintain (within a 1 degrees C range of goal temperature), and reverse, mild therapeutic hypothermia in a large animal model over a 30-h treatment protocol. Methods: Five female Yorkshire swine, weighing a mean of 65 kg (range 61-70) kg each, were anesthetized with inhalational isoflurane via endotracheal intubation and instrumented. The esophageal device was connected to an external chiller and then placed into the esophagus and connected to wall suction. Reduction to goal temperature was achieved by setting the chiller to cooling mode, and a 24 h cooling protocol was completed before rewarming and recovering the animals. Histopathologic analysis was scheduled for 3-14 days after protocol completion. Results: Average baseline temperature for the 5 animals was 38.6 degrees C (range 38.1-39.2 degrees C). All swine were cooled successfully, with average rate of temperature decrease of 1.3 degrees C/h (range 1.1-1.9)degrees C/h. Standard deviation from goal temperature averaged 0.2 degrees C throughout the steady-state maintenance phase, and no treatment for shivering was necessary during the protocol. Histopathology of esophageal tissue showed no adverse effects from the device. Conclusion: A new esophageal heat transfer device successfully and safely induced, maintained, and reversed therapeutic hypothermia in large swine. Goal temperature was maintained within a narrow range, and thermogenic shivering did not occur. These findings suggest a useful new modality to induce therapeutic hypothermia. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.	[Kulstad, Erik] Advocate Christ Med Ctr, Dept Emergency Med, Oak Lawn, IL 60453 USA; [Metzger, Anja K.] Univ Minnesota, Med Ctr, Dept Emergency Med, Minneapolis, MN 55455 USA; [Courtney, D. Mark] Northwestern Univ, Feinberg Sch Med, Dept Emergency Med, Chicago, IL 60611 USA; [Rees, Jennifer] Adv Circulatory Syst Inc, Roseville, MN 55113 USA; [Shanley, Patrick] Northwestern Univ, Evanston, IL 60208 USA; [Matsuura, Timothy] Univ Minnesota, Minneapolis, MN 55455 USA; [McKnite, Scott; Lurie, Keith] Minneapolis Med Res Fdn Inc, Minneapolis, MN 55455 USA		Kulstad, E (corresponding author), Advocate Christ Med Ctr, Dept Emergency Med, Oak Lawn, IL 60453 USA.	kulstad@uic.edu		Kulstad, Erik/0000-0002-9331-8266	National Science FoundationNational Science Foundation (NSF) [1142664]	Funded by a grant from the National Science Foundation (Award Number 1142664). The authors were solely responsible for study design, collection, analysis, and interpretation of data, the writing of the manuscript, and the decision to submit the manuscript for publication.	Abella BS, 2005, RESUSCITATION, V64, P181, DOI 10.1016/j.resuscitation.2004.09.014; Al-Senani FM, 2004, RESUSCITATION, V62, P143, DOI 10.1016/j.resuscitation.2004.02.016; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brooks SC, 2008, RESUSCITATION, V77, P286, DOI 10.1016/j.resuscitation.2008.01.017; Choi HA, 2011, NEUROCRIT CARE, V14, P389, DOI 10.1007/s12028-010-9474-7; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Flint AC, 2007, NEUROCRIT CARE, V7, P109, DOI 10.1007/s12028-007-0068-y; Froehler MT, 2010, EXPERT REV CARDIOVAS, V8, P593, DOI [10.1586/erc.09.129, 10.1586/ERC.09.129]; Gillies MA, 2010, RESUSCITATION, V81, P1117, DOI 10.1016/j.resuscitation.2010.05.001; Hoedemaekers CW, 2007, CRIT CARE, V11, DOI 10.1186/cc6104; Holzer M, 2002, NEW ENGL J MED, V346, P549; Jaber S, 2007, INTENS CARE MED, V33, P917, DOI 10.1007/s00134-007-0594-2; KASTANOS N, 1983, CRIT CARE MED, V11, P362, DOI 10.1097/00003246-198305000-00009; Kelly FE, 2010, ANAESTHESIA, V65, P505, DOI 10.1111/j.1365-2044.2009.06237.x; Knapik P, 2012, RESUSCITATION, V83, P208, DOI 10.1016/j.resuscitation.2011.09.001; Knapik P, 2011, KARDIOL POL, V69, P1157; Kory P, 2011, RESUSCITATION, V82, P15, DOI 10.1016/j.resuscitation.2010.08.020; Kulstad EB, 2012, WORLD J EMERG MED, V3, P118, DOI [10.5847/wjem.j.1920-8642.2012.02.007, 10.5847/wjem.j.issn.1920-8642.2012.02.007]; Levi AD, 2010, NEUROSURGERY, V66, P670, DOI 10.1227/01.NEU.0000367557.77973.5F; Lopez-de-Sa E, 2012, CIRCULATION, V126, P2826, DOI 10.1161/CIRCULATIONAHA.112.136408; Merchant RM, 2009, CIRC-CARDIOVASC QUAL, V2, P421, DOI 10.1161/CIRCOUTCOMES.108.839605; Nielsen N, 2012, AM HEART J, V163, P541, DOI 10.1016/j.ahj.2012.01.013; Patel PV, 2011, THER HYPOTHERMIA TEM, V1, DOI 10.1089/ther.2011.0015; Shankaran S, 2010, NEW ENGL J MED, V362, P1051, DOI 10.1056/NEJMc0912848; Sinclair HL, 2010, CRIT CARE, V14, DOI 10.1186/cc8220; Vaicys V, 2012, AM J EMERG MED, V30, P932, DOI 10.1016/j.ajem.2011.04.026; Wissler EH, 1998, J APPL PHYSIOL, V85, P35, DOI 10.1152/jappl.1998.85.1.35	27	18	21	0	4	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	NOV	2013	84	11					1619	1624		10.1016/j.resuscitation.2013.06.019			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	275DA	WOS:000328654800033	23827887	hybrid			2022-02-06	
J	Liu, X; Sha, O; Cho, EYP				Liu, Xia; Sha, Ou; Cho, Eric Y. P.			Remote Ischemic Postconditioning Promotes the Survival of Retinal Ganglion Cells after Optic Nerve Injury	JOURNAL OF MOLECULAR NEUROSCIENCE			English	Article						Retinal ganglion cell; Optic nerve; Remote ischemic postconditioning; Neuroprotection	IN-VITRO; RAT; TOLERANCE; PROTECTS; HSP27; NEUROPROTECTION; REGENERATION; NEURONS; SYSTEM	Ischemic conditioning, the application of a mild ischemic stimulus to an ischemia-sensitive structure like the heart or brain either before (preconditioning) or after (postconditioning) its exposure to a lethal ischemic insult, is known to switch on endogenous protective mechanisms. However, most studies of its neuroprotective effect in the central nervous system (CNS) have focused on ischemic damage or related conditions like hypoxia, while its potential in treating other neural diseases remains uncertain. In particular, the recent discovery of remote ischemic postconditioning whereby mild ischemia applied to a region remote from the target after the main ischemic insult also confers protection offers an attractive paradigm to study its potential in other types of neural injury. Retinal ganglion cells damaged by optic nerve transection undergo extensive cell death. However, application of a series of mild ischemic/reperfusion cycles to the hind limb (limb remote ischemic postconditioning) at 10 min or 6 h after optic nerve cut was found to promote ganglion cell survival at 7 days post-injury, with the 10 min postconditioning still exerting protection at 14 days post-injury. Concomitant with the increased ganglion cell survival, 51 % more ganglion cells expressed the small heat shock protein HSP27, when remote ischemic postconditioning was performed at 10 min post-injury, as compared to the sham conditioning group. Our results highlight the potential of using remote ischemic postconditioning as a noninvasive neuroprotective strategy in different CNS disorders like spinal cord and traumatic brain injury.	[Liu, Xia; Cho, Eric Y. P.] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Sha, Ou] Shenzhen Univ, Sch Med, Dept Preclin Med, Guangzhou, Guangdong, Peoples R China		Cho, EYP (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China.	eric-cho@cuhk.edu.hk	Cho, Eric/AAF-9597-2020	Cho, Eric/0000-0001-7469-8622	General Research Fund of the Research Grants Council of Hong Kong [CUHK463309]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81171154]; Chinese University of Hong KongChinese University of Hong Kong	This study was supported by the General Research Fund CUHK463309 of the Research Grants Council of Hong Kong (E.Y.P. Cho), the National Natural Science Foundation of China (81171154, O. Sha), and a postgraduate studentship of the Chinese University of Hong Kong (X. Liu). The authors are grateful to Ms. Anny Cheung for the technical help provided.	Belforte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023763; Brown IR, 2007, ANN NY ACAD SCI, V1113, P147, DOI 10.1196/annals.1391.032; Cho EYP, 2005, ARVO 2005 ANN M; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Dreixler JC, 2010, EXP EYE RES, V91, P844, DOI 10.1016/j.exer.2010.06.015; Fernandez DC, 2011, AM J PATHOL, V178, P2264, DOI 10.1016/j.ajpath.2011.01.040; Fernandez DC, 2009, INVEST OPHTH VIS SCI, V50, P3922, DOI 10.1167/iovs.08-3344; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Krueger-Naug AMR, 2002, NEUROSCIENCE, V110, P653, DOI 10.1016/S0306-4522(01)00453-5; Latchman DS, 2005, INT J HYPERTHER, V21, P393, DOI 10.1080/02656730400023664; Lim SY, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00027; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Pignataro G, 2008, J CEREBR BLOOD F MET, V28, P232, DOI 10.1038/sj.jcbfm.9600559; Ren CC, 2009, BRAIN RES, V1288, P88, DOI 10.1016/j.brainres.2009.07.029; Ren CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003851; Roth S, 2004, BRAIN RES BULL, V62, P461, DOI 10.1016/j.brainresbull.2003.07.006; Sun F, 2010, CURR OPIN NEUROBIOL, V20, P510, DOI 10.1016/j.conb.2010.03.013; Sun J, 2012, J CEREBR BLOOD F MET, V32, P851, DOI 10.1038/jcbfm.2011.199; Sun XC, 2010, EXP NEUROL, V224, P347, DOI 10.1016/j.expneurol.2010.04.009; Wang JY, 2008, STROKE, V39, P983, DOI 10.1161/STROKEAHA.107.499079; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; Xing BZ, 2008, STROKE, V39, P2362, DOI 10.1161/STROKEAHA.107.507939; Zhao H, 2012, CURR DRUG TARGETS, V13, P173, DOI 10.2174/138945012799201621; Zhou YL, 2011, STROKE, V42, P439, DOI 10.1161/STROKEAHA.110.592162	25	18	19	1	22	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0895-8696	1559-1166		J MOL NEUROSCI	J. Mol. Neurosci.	NOV	2013	51	3					639	646		10.1007/s12031-013-0036-2			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	235IH	WOS:000325710500001	23733254				2022-02-06	
J	Roebuck-Spencer, TM; Vincent, AS; Gilliland, K; Johnson, DR; Cooper, DB				Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Gilliland, Kirby; Johnson, Dan R.; Cooper, Douglas B.			Initial Clinical Validation of an Embedded Performance Validity Measure within the Automated Neuropsychological Metrics (ANAM)	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Computer-based testing; Performance Validity Testing; ANAM; Simulators; Neuropsychology	TRAUMATIC BRAIN-INJURY; RESPONSE BIAS; MEMORY; TESTS; COMPONENTS; BATTERY; DYSFUNCTION; CONCUSSION; SIMULATION; INDICATORS	The measurement of effort and performance validity is essential for computerized testing where less direct supervision is needed. The clinical validation of an Automated Neuropsychological Metrics-Performance Validity Index (ANAM-PVI) was examined by converting ANAM test scores into a common metric based on their relative infrequency in an outpatient clinic sample with presumed good effort. Optimal ANAM-PVI cut-points were determined using receiver operator characteristic (ROC) curve analyses and an a priori specificity of 90. Sensitivity/specificity was examined in available validation samples (controls, simulators, and neurorehabilitation patients). ANAM-PVI scores differed between groups with simulators scoring the highest. ROC curve analysis indicated excellent discriminability of ANAM-PVI scores 5 to detect simulators versus controls (area under the curve 0.858; odds ratio for detecting suboptimal performance 15.6), but resulted in a 27 false-positive rate in the clinical sample. When specificity in the clinical sample was set at 90, sensitivity decreased (68), but was consistent with other embedded effort measures. Results support the ANAM-PVI as an embedded effort measure and demonstrate the value of sample-specific cut-points in groups with cognitive impairment. Examination of different cut-points indicates that clinicians should choose sample-specific cut-points based on sensitivity and specificity rates that are most appropriate for their patient population with higher cut-points for those expected to have severe cognitive impairment (e.g., dementia or severe acquired brain injury).	[Roebuck-Spencer, Tresa M.; Vincent, Andrea S.; Gilliland, Kirby] Univ Oklahoma, Cognit Sci Res Ctr, Norman, OK 73072 USA; [Johnson, Dan R.] Washington & Lee Univ, Lexington, VA 24450 USA; [Cooper, Douglas B.] SAMMC, Dept Neurol, Def & Vet Brain Injury Ctr, Ft Sam Houston, TX USA		Roebuck-Spencer, TM (corresponding author), Univ Oklahoma, Cognit Sci Res Ctr, 3200 Marshall Ave,Suite 260, Norman, OK 73072 USA.	tresa@ou.edu			U.S. Army Medical Research Acquisition Activity [W81XWH-09-1-0707]	This work was supported in part by the U.S. Army Medical Research Acquisition Activity, 1054 Patchel Street, Fort Detrick, MD 21702-5012, Project W81XWH-09-1-0707.	Allen L. M., 2006, CARB COMPUTERIZED AS; Bianchini KJ, 2001, CLIN NEUROPSYCHOL, V15, P19, DOI 10.1076/clin.15.1.19.1907; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Bleiberg J, 2000, CLIN NEUROPSYCHOL, V14, P287, DOI 10.1076/1385-4046(200008)14:3;1-P;FT287; Bolan B, 2002, J CLIN EXP NEUROPSYC, V24, P154, DOI 10.1076/jcen.24.2.154.1000; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bryan C, 2012, J HEAD TRAUMA REHAB, V27, P45, DOI 10.1097/HTR.0b013e318238f146; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Cercy S. P., 1997, CLIN ASSESSMENT MALI, P85; Cognitive Science Research Center (CSRC), 2012, ANAM4 COR ADM MAN; Coldren RL, 2012, MIL MED, V177, P179, DOI 10.7205/MILMED-D-11-00278; Dunn TM, 2003, ARCH CLIN NEUROPSYCH, V18, P121, DOI 10.1016/S0887-6177(01)00188-3; Friedl KE, 2007, ARCH CLIN NEUROPSYCH, V22, pS7, DOI 10.1016/j.acn.2006.10.002; Greve KW, 2004, ARCH CLIN NEUROPSYCH, V19, P533, DOI 10.1016/j.acn.2003.08.002; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; HOHLE RH, 1965, J EXP PSYCHOL, V69, P382, DOI 10.1037/h0021740; Johnson D. R., 2009, NAT AC NEUR NEW ORL; Kabat MH, 2001, CLIN NEUROPSYCHOL, V15, P498, DOI 10.1076/clin.15.4.498.1882; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kelly MP, 2012, ARCH CLIN NEUROPSYCH, V27, P375, DOI 10.1093/arclin/acs036; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Larrabee G. J., 2007, ASSESSMENT MALINGERE, P80; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Lowe M, 2007, ARCH CLIN NEUROPSYCH, V22, pS89, DOI 10.1016/j.acn.2006.10.010; Luce RD, 1986, RESPONSE TIMES THEIR; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Madden DJ, 1999, J COGNITIVE NEUROSCI, V11, P511, DOI 10.1162/089892999563571; McCaffrey RJ, 2007, ARCH CLIN NEUROPS S1, V22, P1; McDiarmid Melissa A, 2002, Mil Med, V167, P123; Rahill AA, 1996, AVIAT SPACE ENVIR MD, V67, P640; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Rees LM, 1998, PSYCHOL ASSESSMENT, V10, P10, DOI 10.1037/1040-3590.10.1.10; Reicker LI, 2008, ARCH CLIN NEUROPSYCH, V23, P419, DOI 10.1016/j.acn.2008.02.003; ROSE FE, 1995, CLIN NEUROPSYCHOL, V9, P124, DOI 10.1080/13854049508401594; Schmiedek F, 2007, J EXP PSYCHOL GEN, V136, P414, DOI 10.1037/0096-3445.136.3.414; Silverberg ND, 2007, CLIN NEUROPSYCHOL, V21, P841, DOI 10.1080/13854040600850958; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Suhr J.A., 2007, ASSESSMENT MALINGERE, P287; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; Thompson G. B., 2005, VSVT VICTORIA SYMPTO; van Gorp WG, 1999, J CLIN EXP NEUROPSYC, V21, P245; Vincent AS, 2008, MIL MED, V173, P836, DOI 10.7205/MILMED.173.9.836; Vincent AS, 2012, MIL MED, V177, P256, DOI 10.7205/MILMED-D-11-00289; Vincent AS, 2012, MIL MED, V177, P248, DOI 10.7205/MILMED-D-11-00156; Wilken JA, 2003, MULT SCLER, V9, P119, DOI 10.1191/1352458503ms893oa; Wilken JA, 2007, ARCH CLIN NEUROPSYCH, V22, pS127, DOI 10.1016/j.acn.2006.10.007; Willison J, 2006, ARCH CLIN NEUROPSYCH, V21, P41, DOI 10.1016/j.acn.2005.07.005; Woodhouse J, 2013, CLIN NEUROPSYCHOL, V27, P376, DOI 10.1080/13854046.2012.762427	52	18	18	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	NOV	2013	28	7					700	710		10.1093/arclin/act055			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	243AS	WOS:000326289300008	23887185	Bronze			2022-02-06	
J	Siman-Tov, M; Radomislensky, I; Peleg, K				Siman-Tov, Maya; Radomislensky, Irina; Peleg, Kobi		ITG	Reduction in trauma mortality in Israel during the last decade (2000-2010): The impact of changes in the trauma system	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Survival; Mortality trend; Inpatient death	INJURED PATIENTS; SURVIVAL; STATE; EPIDEMIOLOGY; VOLUME; CARE	Hypothesis: Following the introduction of changes to the trauma system there would be a period of time during which the impact on mortality would be minimal. A decrease in mortality rates would be noted as the TS matured and would continue over time. Design: A retrospective cohort study of all severely injured patients (injury severity score >= 16) recorded in the Israeli National Trauma Registry at six level I trauma centres in Israel from 2000 to 2010. Inpatient death rates were examined overall and by sub groups. Setting: The National Trauma Registry contains hospitalized patients, transfer patients to or from other hospitals and those who died in the emergency department. It excludes patients who were dead on arrival, discharged following treatment in the emergency department, and patients whose injuries by definition are not classified as trauma. Main outcome measures: In-hospital mortality Results: Data included 23,143 severe trauma patients available for analysis. Inpatient mortality rates decreased significantly from 16% in 2000 to 11% in 2010. The odds ratio for mortality in 2010 vs. 2000, adjusted for year, age, sex, mechanism of injury, traumatic brain injury, penetrating injury, and severity of injury (ISS >= 25), was 0.53, confirming a downward trend. Conclusions: A steady significant reduction in the inpatient mortality rate for severe trauma patients hospitalized at all level I trauma centres in Israel between 2000 and 2010 was observed. Although a single factor that explains the reduction was not identified, evidently the establishment of the trauma system brought about a significant decrease in hospital mortality. Integrated cooperation between components of the national trauma system in Israel over the years may explain the reduction. (c) 2012 Elsevier Ltd. All rights reserved.	[Siman-Tov, Maya; Radomislensky, Irina; Peleg, Kobi] Gertner Inst Epidemiol & Hlth Policy Res, Israel Natl Ctr Trauma & Emergency Med Res, Tel Hashomer, Israel; [Peleg, Kobi] Tel Aviv Univ, Sch Publ Hlth, Dept Disaster Management, IL-69978 Tel Aviv, Israel		Peleg, K (corresponding author), Chaim Sheba Med Ctr, Gertner Inst Epidemiol & Hlth Policy Res, Israel Natl Ctr Trauma & Emergency Med Res, IL-52621 Tel Hashomer, Israel.	kobip@gertner.health.gov.il					Abernathy JH, 2002, AM SURGEON, V68, P182; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Barquist E, 2000, J TRAUMA, V49, P63, DOI 10.1097/00005373-200007000-00009; Celso B, 2006, J TRAUMA, V60, P371, DOI 10.1097/01.ta.0000197916.99629.eb; Cooper A, 2000, J TRAUMA, V48, P16, DOI 10.1097/00005373-200001000-00004; Cothren CC, 2007, WORLD J SURG, V31, P1507, DOI 10.1007/s00268-007-9087-2; DEMETRIADES D, 1995, ARCH SURG-CHICAGO, V130, P216; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Heruti R J, 1997, Harefuah, V133, P155; Israel Ministry of Health, 1992, REV COMM REP TRAUM C; Kuhne CA, 2005, WORLD J SURG, V29, P1476, DOI 10.1007/s00268-005-7796-y; Liberman M, 2005, SURGERY, V137, P647, DOI 10.1016/j.surg.2005.03.011; MacKenzie EJ, 1999, J TRAUMA, V47, pS34, DOI 10.1097/00005373-199909001-00008; Mann NC, 2001, J TRAUMA, V50, P1111, DOI 10.1097/00005373-200106000-00022; Mann NC, 1999, J TRAUMA, V47, pS25, DOI 10.1097/00005373-199909001-00007; Melton SM, 2003, J TRAUMA, V54, P273, DOI 10.1097/01.TA.0000038506.54819.11; Michaelson Moshe, 1997, Harefuah, V133, P656; MULLINS RJ, 1994, JAMA-J AM MED ASSOC, V271, P1919, DOI 10.1001/jama.271.24.1919; Nathens AB, 2000, J TRAUMA, V48, P25, DOI 10.1097/00005373-200001000-00005; Nathens AB, 2000, JAMA-J AM MED ASSOC, V283, P1990, DOI 10.1001/jama.283.15.1990; O'Keefe GE, 1999, ANN SURG, V229, P409, DOI 10.1097/00000658-199903000-00015; Peleg K, 2004, ARCH SURG-CHICAGO, V139, P1231, DOI 10.1001/archsurg.139.11.1231; Rogers FB, 2001, J TRAUMA, V50, P409, DOI 10.1097/00005373-200103000-00003; Sampalis JS, 2009, ANN SURG, V249, P488, DOI 10.1097/SLA.0b013e31819a8b4f; SHACKFORD SR, 1987, ARCH SURG-CHICAGO, V122, P523; Shafi S, 2006, J TRAUMA, V61, P1374, DOI 10.1097/01.ta.0000246698.07125.c0; SMITH RF, 1990, J TRAUMA, V30, P1066, DOI 10.1097/00005373-199009000-00002; World Health Organization, 2010, VIOL INJ FACTS	28	18	20	0	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	NOV	2013	44	11					1448	1452		10.1016/j.injury.2012.08.054			5	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	227ZT	WOS:000325155000012	23021368				2022-02-06	
J	Szabo, AJ; Alosco, ML; Fedor, A; Gunstad, J				Szabo, Ashley J.; Alosco, Michael L.; Fedor, Andrew; Gunstad, John			Invalid Performance and the ImPACT in National Collegiate Athletic Association Division I Football Players	JOURNAL OF ATHLETIC TRAINING			English	Article						concussions; neuropsychological tests; malingering	SPORTS-RELATED CONCUSSION; TEST-RETEST RELIABILITY; HIGH-SCHOOL; VALIDITY; SCORES; RISK	Context: Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) is a computerized cognitive test battery commonly used for concussion evaluation. An important aspect of these procedures is baseline testing, but researchers have suggested that many users do not use validity indices to ensure adequate effort during testing. No one has examined the prevalence of invalid performance for college football players. Objective: To examine the prevalence of invalid scores on ImPACT testing. Design: Cross-sectional study. Setting: National Collegiate Athletic Association Division I university. Patients or Other Participants: A total of 159 athletes (age = 20.3 +/- 1.41 years; range = 17.8-23.7 years) from a Division I collegiate football team participated. Intervention(s): An informational intervention regarding the importance of concussion testing to promote safety was administered before testing for the most recent season. Main Outcome Measure(s): We examined preseason ImPACT testing data across a 3-year period (total assessments = 269). Based on invalid and sandbagging indices denoted by the ImPACT manual, protocols were examined to indicate how many invalid indices each athlete had. Results: A total of 27.9% (n = 75) of assessments were suggestive of invalid scores, with 4.1% (n = 11) suggesting invalid responding only, 17.5% (n = 47) indicating "sandbagging" only, and 6.3% (n = 17) showing both invalid and sandbagging responding. The informational intervention did not reduce the prevalence of invalid responding. Conclusions: These findings highlight the need for further information about the ImPACT validity indices and whether they truly reflect poor effort. Future work is needed to identify practices to reliably target and reduce invalid responding.	[Szabo, Ashley J.; Alosco, Michael L.; Fedor, Andrew; Gunstad, John] Kent State Univ, Dept Psychol, Kent, OH 44242 USA		Gunstad, J (corresponding author), Kent State Univ, Dept Psychol, 221 Kent Hall, Kent, OH 44242 USA.	jgunstad@kent.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [DK075119, HL089311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL089311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R56DK075119, R01DK075119] Funding Source: NIH RePORTER	Indirect funding for this project was provided by grants DK075119 and HL089311 from the National Institutes of Health.	Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; BARTH JT, 2006, SPORTS NEUROPSYCHOLO, P3; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Brown CN, 2007, J ATHL TRAINING, V42, P515; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Freeman JR, 2005, TXB TRAUMATIC BRAIN, P453; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Groth-Marnat G., 2003, HDB PSYCHOL ASSESSME, P66; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; Hunt TN, 2009, J ATHL TRAINING, V44, P405, DOI 10.4085/1062-6050-44.4.405; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Kirkwood MW, 2010, CLIN NEUROPSYCHOL, V24, P860, DOI 10.1080/13854040903527287; Lezak M., 2004, NEUROPSYCHOLOGICAL A, P100; Lovell MR, 2004, AM J SPORT MED, V32, P47, DOI 10.1177/0363546503260723; Lovell MR, IMPACT VERSION 6 0 C; Randolph C, 2011, CURR SPORT MED REP, V10, P21, DOI 10.1249/JSR.0b013e318207831d; Randolph C, 2009, J INT NEUROPSYCH SOC, V15, P512, DOI 10.1017/S135561770909064X; Ratliff-Crain J, 1999, PSYCHOL HEALTH, V14, P625, DOI 10.1080/08870449908410754; Rimal RN, 2010, J APPL SOC PSYCHOL, V40, P287, DOI 10.1111/j.1559-1816.2009.00574.x; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2006, APPL NEUROPSYCHOL, V13, P151, DOI 10.1207/s15324826an1303_2; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008	27	18	18	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	NOV-DEC	2013	48	6					851	855		10.4085/1062-6050-48.6.20			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	268AW	WOS:000328141200016	24151810	Green Published			2022-02-06	
J	Szmydynger-Chodobska, J; Gandy, JR; Varone, A; Shan, RZ; Chodobski, A				Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam			Synergistic Interactions between Cytokines and AVP at the Blood-CSF Barrier Result in Increased Chemokine Production and Augmented Influx of Leukocytes after Brain Injury	PLOS ONE			English	Article							CHOROID-PLEXUS; VASOPRESSIN V-1A; V-2 RECEPTORS; EXPRESSION; DAMAGE; MICE; INFILTRATION; TISSUE; CELLS; RATS	Several lines of evidence indicate that the blood-cerebrospinal fluid barrier (BCSFB), which primarily resides in the choroid plexus (CP), plays a significant pathophysiological role not only in neuroinflammatory diseases, such as multiple sclerosis, but also in traumatic brain injury (TBI). Here we investigated how arginine vasopressin (AVP) regulates function of the BCSFB in the context of post-traumatic neuroinflammation. It has previously been shown that AVP exacerbates various forms of brain injury, but the mechanisms underlying this AVP action are poorly understood. Type 1A AVP receptor is highly expressed on the CP epithelium and the CP synthesizes AVP. Using the controlled cortical impact model of TBI, we demonstrated decreased post-traumatic production of proinflammatory mediators by the CP and reduced influx of inflammatory cells across the BCSFB in AVP-deficient Brattleboro rats when compared with Long-Evans rats, a parental strain for Brattleboro rats. Arginine vasopressin was also found to play an important role in post-traumatic activation of c-Jun Nterminal kinase (JNK) in the CP. In the CP epithelial cell cultures, AVP augmented the tumor necrosis factor-alpha- and interleukin-1 beta-dependent increase in synthesis of proinflammatory mediators, including neutrophil chemoattractants, an action largely dependent on the JNK signaling pathway. Under in vivo conditions, a selective JNK inhibitor decreased the post-traumatic production of neutrophil chemoattractants by the CP and reduced the influx of neutrophils across the BCSFB. These results provide evidence for the synergistic interactions between proinflammatory cytokines and AVP, a ligand for G protein-coupled receptors, and support a pathophysiological role of AVP in post-traumatic neuroinflammation.	[Szmydynger-Chodobska, Joanna; Gandy, Jessica R.; Varone, Andrew; Shan, Rongzi; Chodobski, Adam] Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA		Szmydynger-Chodobska, J (corresponding author), Brown Univ, Dept Emergency Med, Alpert Med Sch, Neurotrauma & Brain Barriers Res Lab, Providence, RI 02912 USA.	Joanna_Szmydynger-Chodobska@brown.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS49479]; Department of Emergency Medicine at the Alpert Medical School of Brown University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS049479] Funding Source: NIH RePORTER	This work was supported by grant NS49479 from the NIH (to AC) and by funds from the Department of Emergency Medicine at the Alpert Medical School of Brown University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstead WM, 1996, J NEUROTRAUM, V13, P115, DOI 10.1089/neu.1996.13.115; Armstead WM, 2001, STROKE, V32, P1408, DOI 10.1161/01.STR.32.6.1408; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Chodobski A, 2013, VASCULAR ME IN PRESS; HANAZAWA S, 1993, J BIOL CHEM, V268, P9526; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kenne E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-17; Kim DS, 2003, MOL IMMUNOL, V40, P633, DOI 10.1016/j.molimm.2003.07.001; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Marques F, 2008, J CEREBR BLOOD F MET, V28, P450, DOI 10.1038/sj.jcbfm.9600557; NAKAGAWA H, 1994, BIOCHEM J, V301, P545, DOI 10.1042/bj3010545; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0; Schmitt C, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-187; Semple BD, 2010, NEUROBIOL DIS, V40, P394, DOI 10.1016/j.nbd.2010.06.015; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Strazielle N, 2000, J NEUROPATH EXP NEUR, V59, P561, DOI 10.1093/jnen/59.7.561; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Szmydynger-Chodobska J, 2006, NEUROENDOCRINOLOGY, V84, P339, DOI 10.1159/000097989; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szmydynger-Chodobska Joanna, 2007, Cerebrospinal Fluid Res, V4, P11, DOI 10.1186/1743-8454-4-11; Szmydynger-Chodobska J, 2009, J CEREBR BLOOD F MET, V29, P1503, DOI 10.1038/jcbfm.2009.71; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Utagawa A, 2008, BRAIN RES, V1207, P155, DOI 10.1016/j.brainres.2008.02.057; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; Wang YF, 2006, J NEUROCHEM, V98, P1046, DOI 10.1111/j.1471-4159.2006.03950.x; Xu Miao, 2007, Chin J Traumatol, V10, P90; Zheng W, 2002, BRAIN RES, V958, P371, DOI 10.1016/S0006-8993(02)03683-1	30	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 1	2013	8	11							e79328	10.1371/journal.pone.0079328			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245XZ	WOS:000326499300075	24223928	Green Published, Green Submitted, gold			2022-02-06	
J	Kuo, CP; Wen, LL; Chen, CM; Huh, B; Cherng, CH; Wong, CS; Liaw, WJ; Yeh, CC; Lin, BF; Wu, CT				Kuo, Chang-Po; Wen, Li-Li; Chen, Chun-Mei; Huh, Billy; Cherng, Chen-Hwan; Wong, Chih-Shung; Liaw, Wen-Jinn; Yeh, Chun-Chang; Lin, Bo-Feng; Wu, Ching-Tang			Attenuation of neurological injury with early baicalein treatment following sub arachnoid hemorrhage in rats Laboratory investigation	JOURNAL OF NEUROSURGERY			English	Article						subarachnoid hemorrhage; neurological injury; baicalein lutamate; oxidative stress; vascular disorders	EXPERIMENTAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; CEREBRAL VASOSPASM; GLUTAMATE TRANSPORTERS; EXPRESSION; EDEMA; ASTROCYTES; DEFICITS; DEATH	Object. Baicalein has been shown to offer neuroprotection in the ischemic brain, but its effect in subarachnoid hemorrhage (SAH) is unknown. The authors used a double-hemorrhage model to study the role of early baicalein treatment in SAH. Methods. Subarachnoid hemorrhage was induced in male Wistar rats through a repeat injection of autologous blood at a 48-hour interval. Rats subjected or not subjected to SAH received a 30-mg/kg baicalein injection 3 hours after SAH and daily for 6 consecutive days, and results were compared with those obtained in vehicle-treated control rats. Mortality of the rats was recorded. Neurological outcome was assessed daily. Cerebrospinal fluid dialysates were collected and examined for glutamate concentrations. Cerebral vasospasm (CVS), brain water content, neuron variability, expression of glutamate transporter-1 (GLT-1), immunoreactivity of astrocyte, and level of malondialdehyde, activities of superoxide dismutase (SOD), and catalase in brain tissues content were determined on post-SAH Day 7. Results. Mortality rate, neuronal degeneration, brain water content, and CVS were decreased and neurological function improved in the baicalein-treated rats. Baicalein increased astrocyte activity and preserved GLT-1, which attenuated the glutamate surge after SAH. Baicalein also provided antioxidative stress by preserving activities of SOD and catalase and decreased malondialdehydelevel after SAH. The glutamate, body weight, neurological scores, and glial fibrillary acidic protein activity were significantly correlated. The CVS was correlated with neuronal degeneration, and GLT-1 was correlated with oxidative stress. Conclusions. Early baicalein treatment attenuated CVS and limited neurological injury following SAH. These data may indicate clinical utility for baicalein as an adjunct therapy to reduce brain injury and improve patient outcomes.	[Kuo, Chang-Po; Chen, Chun-Mei; Cherng, Chen-Hwan; Liaw, Wen-Jinn; Yeh, Chun-Chang; Lin, Bo-Feng; Wu, Ching-Tang] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Lin, Bo-Feng] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; Triserv Gen Hosp, Taipei, Taiwan; [Wen, Li-Li] En Chu Kong Hosp, Dept Clin Lab, New Taipei City, Taiwan; [Huh, Billy] Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; [Wong, Chih-Shung] Cathay Gen Hosp, Dept Anesthesiol, Taipei, Taiwan		Wu, CT (corresponding author), Natl Def Med Ctr, Dept Anesthesiol, Sect 2,Chenggung Rd,Neihu 114, Taipei, Taiwan.	aneswu@gmail.com	Wu, Zhi-Fu/ABE-6379-2020		National Science Council, Taiwan, Republic of ChinaMinistry of Science and Technology, Taiwan [NSC 96-2314-B-016-013]	This work was supported by a grant from the National Science Council (NSC 96-2314-B-016-013), Taiwan, Republic of China. The authors have no personal financial or institutional interest in any of the drugs, materials, or devices described in this article.	Anderson CM, 2000, GLIA, V32, P1; Cahill J, 2006, J CEREBR BLOOD F MET, V26, P1463, DOI 10.1038/sj.jcbfm.9600307; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Claassen J, 2002, STROKE, V33, P1225, DOI 10.1161/01.STR.0000015624.29071.1F; Davalos A, 1997, STROKE, V28, P708, DOI 10.1161/01.STR.28.4.708; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Germano A, 2007, J NEUROTRAUM, V24, P732, DOI 10.1089/neu.2006.0181; Gules I, 2002, AM J PHYSIOL-HEART C, V283, pH2551, DOI 10.1152/ajpheart.00616.2002; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Jeon H, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-103; Jin G, 2008, STROKE, V39, P2538, DOI 10.1161/STROKEAHA.108.514927; Kerman M, 2012, J MOL HISTOL, V43, P49, DOI 10.1007/s10735-011-9376-9; KUBO M, 1984, CHEM PHARM BULL, V32, P2724; Kuo CP, 2011, ANESTHESIOLOGY, V115, P1229, DOI 10.1097/ALN.0b013e31823306f0; Lee HH, 2003, BRAIN RES, V986, P103, DOI 10.1016/S0006-8993(03)03197-4; Lo EH, 2005, STROKE, V36, P189, DOI 10.1161/01.STR.0000153069.96296.fd; Lopez-Redondo F, 2000, MOL BRAIN RES, V76, P429, DOI 10.1016/S0169-328X(00)00022-X; O'Callaghan James P, 2005, Expert Opin Drug Saf, V4, P433, DOI 10.1517/14740338.4.3.433; Ostrowski RP, 2006, NEUROL RES, V28, P399, DOI 10.1179/016164106X115008; Prunell GF, 2005, J NEUROSURG, V102, P1046, DOI 10.3171/jns.2005.102.6.1046; Rossi DJ, 2007, NAT NEUROSCI, V10, P1377, DOI 10.1038/nn2004; Rothoerl RD, 2006, CEREBROVASC DIS, V22, P143, DOI 10.1159/000093243; Sabri M, 2008, BRAIN RES, V1238, P163, DOI 10.1016/j.brainres.2008.08.031; Seckin H, 2008, SURG NEUROL, V70, P344, DOI 10.1016/j.surneu.2007.07.052; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; Stegmayr B, 2004, STROKE, V35, P2059, DOI 10.1161/01.STR.0000138451.07853.b6; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Sullivan SM, 2010, BRAIN RES, V1319, P164, DOI 10.1016/j.brainres.2010.01.010; Sung CS, 2004, BRAIN RES, V1015, P145, DOI 10.1016/j.brainres.2004.04.068; Van Landeghem FKH, 2006, J NEUROTRAUM, V23, P1518, DOI 10.1089/neu.2006.23.1518; Vicente E, 2009, BRAIN RES, V1251, P204, DOI 10.1016/j.brainres.2008.11.032; Wu CT, 2011, ANESTH ANALG, V112, P666, DOI 10.1213/ANE.0b013e318207c51f; Xi G, 2002, ACT NEUR S, V81, P253	35	18	19	0	9	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2013	119	4					1028	1037		10.3171/2013.4.JNS121919			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	225LM	WOS:000324964400033	23724981				2022-02-06	
J	Walder, B; Robin, X; Rebetez, MML; Copin, JC; Gasche, Y; Sanchez, JC; Turck, N				Walder, Bernhard; Robin, Xavier; Rebetez, Marie My Lien; Copin, Jean-Christophe; Gasche, Yvan; Sanchez, Jean-Charles; Turck, Natacha			The Prognostic Significance of the Serum Biomarker Heart-Fatty Acidic Binding Protein in Comparison with S100b in Severe Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						blood biomarkers; outcome prediction; traumatic brain injury	TROPONIN-T; EPIDEMIOLOGY; MORTALITY; PROFILES; MODELS; MARKER; SCALE; INDEX	The outcome after severe traumatic brain injury (TBI) is largely unfavorable, with approximately two thirds of patients suffering from severe disabilities or dying during the first 6 months. Existing predictive models displayed only limited utility for outcome prediction in individual patients. Time courses of heart-fatty acidic binding protein (H-FABP) and their association with outcome were investigated and compared with S100b. Forty-nine consecutive patients with severe TBI (sTBI; Head component of the Abbreviated Injury Scale [HAIS] >3) with mono and multiple trauma were enrolled in this study. Enzyme-linked immunosorbent assay measured blood concentrations of H-FABP and S100b at 6, 12, 24, and 48h after TBI. Outcome measures were conscious state at 14 days (Glasgow Coma Scale), disability (Glasgow Outcome Scale Extended; GOSE), and mortality at 3 months. Univariate logistic regression analysis and receiver operating characteristic curves analysis were carried out. Maximal H-FABP and S100b concentrations were observed at 6h after TBI (34.4 +/- 34.0 and 0.64 +/- 0.99ng/mL, respectively). Patients with multi-trauma had significantly higher H-FABP concentrations at 24 and 48h (22.6 +/- 25.6 and 12.4 +/- 18.2ng/mL, respectively), compared to patients with mono trauma (6.9 +/- 5.1 and 3.7 +/- 4.2ng/mL, respectively). In the first 48h, H-FABP and S100b were inversely correlated with the GOSE at 3 months; H-FABP at 48h predicted mortality with 75% sensitivity and 93% specificity. Early blood levels of H-FABP after sTBI have prognostic significance for survival and disability.	[Walder, Bernhard; Rebetez, Marie My Lien] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland; [Robin, Xavier; Sanchez, Jean-Charles; Turck, Natacha] Univ Geneva, Dept Human Prot Sci, Translat Biomarker Grp, CH-1211 Geneva, Switzerland; [Copin, Jean-Christophe; Gasche, Yvan] Univ Geneva, Geneva Neurosci Ctr, CH-1211 Geneva, Switzerland; [Copin, Jean-Christophe; Gasche, Yvan] Univ Hosp Geneva, Dept Intens Care, Geneva, Switzerland; [Copin, Jean-Christophe] Univ Hosp Geneva, Dept Neurosurg, Geneva, Switzerland		Turck, N (corresponding author), Univ Geneva, Ctr Med Univ, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	natacha.turck@unige.ch	Robin, Xavier/A-1680-2009	Robin, Xavier/0000-0002-6813-3200			Alhadi HA, 2004, QJM-INT J MED, V97, P187, DOI 10.1093/qjmed/hch037; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Ben Abdesselam O, 2003, CLIN CHEM, V49, P836, DOI 10.1373/49.5.836; Bohmer AE, 2011, NEUROSURGERY, V68, P1624, DOI 10.1227/NEU.0b013e318214a81f; Bouillon B, 1999, RESTOR NEUROL NEUROS, V14, P85; Dinh W, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-41; Farias SE, 2011, J TRAUMA, V71, P1211, DOI 10.1097/TA.0b013e3182092c62; Garcia-Valdecasas S, 2011, ACTA CARDIOL, V66, P315, DOI 10.1080/AC.66.3.2114131; Garthe E, 1999, J TRAUMA, V47, P309, DOI 10.1097/00005373-199908000-00016; Gullo JD, 2011, NEUROCRIT CARE, V14, P194, DOI 10.1007/s12028-010-9462-y; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Inoue K, 2011, CIRC J, V75, P2813, DOI 10.1253/circj.CJ-11-0598; Kleindienst A, 2010, CARDIOVASC PSYCHIAT, V2010; Ley EJ, 2011, J SURG RES, V170, P253, DOI 10.1016/j.jss.2011.03.006; Lin ZX, 2011, CLIN CHIM ACTA, V412, P1678, DOI 10.1016/j.cca.2011.05.031; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McCann CJ, 2009, AM J CARDIOL, V103, P22, DOI 10.1016/j.amjcard.2008.08.026; McKeating EG, 1998, ACT NEUR S, V71, P200; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Morochovic R, 2009, EUR J NEUROL, V16, P1112, DOI 10.1111/j.1468-1331.2009.02653.x; Muehlschlegel JD, 2010, ANESTH ANALG, V111, P1101, DOI 10.1213/ANE.0b013e3181dd9516; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Okamoto F, 2000, CLIN CHEM LAB MED, V38, P231, DOI 10.1515/CCLM.2000.034; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Pielmaier L, 2011, BRAIN INJURY, V25, P259, DOI 10.3109/02699052.2010.542429; Rainey T, 2009, RESUSCITATION, V80, P341, DOI 10.1016/j.resuscitation.2008.11.021; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Schiavi Paolo, 2012, Acta Biomed, V83, P5; Sofijanova A, 2012, Prilozi, V33, P147; Stein DM, 2012, J NEUROTRAUM, V29, P1140, DOI 10.1089/neu.2011.2149; Topolovec-Vranic J, 2011, J TRAUMA, V71, pS478, DOI 10.1097/TA.0b013e318232fa70; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; von Elm E, 2008, SWISS MED WKLY, V138, P327, DOI 2008/23/smw-12025; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wilson JTL, 2002, J NEUROTRAUM, V19, P999, DOI 10.1089/089771502760341910; Wunderlich MT, 2005, J NEUROL, V252, P718, DOI 10.1007/s00415-005-0725-z; Zanier ER, 2008, ACTA NEUROCHIR SUPPL, V102, P339, DOI 10.1007/978-3-211-85578-2_65; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200; Zuercher M, 2009, BRAIN INJURY, V23, P371, DOI 10.1080/02699050902926267	42	18	20	0	11	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 1	2013	30	19					1631	1637		10.1089/neu.2012.2791			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	227WQ	WOS:000325146800003	23590685				2022-02-06	
J	Korngold, C; Farrell, HM; Fozdar, M				Korngold, Caleb; Farrell, Helen M.; Fozdar, Manish			The National Football League and Chronic Traumatic Encephalopathy: Legal Implications	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							SELF-REPORTED CONCUSSIONS; PROFESSIONAL FOOTBALL; NEUROPSYCHOLOGICAL PERFORMANCE; RECURRENT CONCUSSION; PLAYERS; BRAIN; INJURIES; DEPRESSION; AFTERMATH; RISK	The growing awareness of chronic traumatic encephalopathy (CTE) has the potential to change the public perception and on-field rules of the National Football League (NFL). More than 3,000 ex-NFL players or their relatives are engaged in litigation alleging that the NFL failed to acknowledge and address the neuropsychiatric risks associated with brain injuries that result from playing in the NFL. This article explores the intersection between the medical and legal aspects of CTE in the NFL from a forensic psychiatry perspective.	[Korngold, Caleb; Farrell, Helen M.] Harvard Univ, Sch Med, Boston, MA USA; [Korngold, Caleb] Harvard Longwood Psychiat Residency Training Prog, Boston, MA USA; [Korngold, Caleb; Farrell, Helen M.] Beth Israel Deaconess Med Ctr, Boston, MA 02116 USA; [Fozdar, Manish] Triangle Forens Neuropsychiat, Raleigh, NC USA; [Fozdar, Manish] Duke Univ, Med Ctr, Durham, NC USA; [Fozdar, Manish] Univ N Carolina, Chapel Hill, NC USA		Farrell, HM (corresponding author), Beth Israel Deaconess Med Ctr, 173 Commonwealth Ave,5R, Boston, MA 02116 USA.	hfarrell@bidmc.harvard.edu					[Anonymous], 2012, NIELSENWIRE     0130; [Anonymous], 2012, ESPN COM NEWS S 0504; [Anonymous], 2011, BLOOMBERGBUSINE 0127; [Anonymous], 2012, USAFOOTBALL     0817; [Anonymous], 2012, ESPN COM NEWS S 0503; Associated Press, 2011, ASS PRESS; Ax Joseph, 2012, REUTERS; Badenhausen K, 2011, FORBES          0909; Barber P, 1996, FOOTBALL AM CELEBRAT; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P262, DOI 10.1017/S1355617709991287; Boren C, 2013, WASHINGTON POST 0829; Casson IR, 2008, NEUROL CLIN, V26, P217, DOI 10.1016/j.ncl.2007.11.005; Casson IR, 2010, SPORTS HEALTH, V2, P471, DOI 10.1177/1941738110383963; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cook B, 2007, NBC SPORTS      0204; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1989, BRIT MED J, V298, P105, DOI 10.1136/bmj.298.6666.105; Dart T, 2012, TIMES; Fainaru S, 2012, ESPN            1116; Futterman Matthew, 2012, WALL STREET J; Gavett BE, 2011, CURR OPIN NEUROL, V24, P525, DOI 10.1097/WCO.0b013e32834cd477; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Granacher RP., 2003, TRAUMATIC BRAIN INJU; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; GUTERMAN A, 1987, SPORTS MED, V4, P194, DOI 10.2165/00007256-198704030-00004; Jordan BD, 2000, SEMIN NEUROL, V20, P179, DOI 10.1055/s-2000-9826; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lapchick R, 2011, 2011 RACIAL GENDER R; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McLuskey D, 2011, MULTIPLE CIT; National Football League, 2012, NFL DON 30 MILL NAT; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Ozanian M, 2012, FORBES          0905; Parlour R R, 1980, Bull Am Acad Psychiatry Law, V8, P445; Pellman E, 2004, NEUROSURGERY, V55, P860, DOI 10.1227/01.NEU.0000137657.00146.7D; Pellman EJ, 2005, NEUROSURGERY, V56, P79, DOI 10.1227/01.NEU.0000150180.16552.8D; Pellman EJ, 2004, NEUROSURGERY, V55, P1100, DOI 10.1227/01.NEU.0000147063.12873.F5; Pellman EJ, 2004, NEUROSURGERY, V54, P81, DOI 10.1227/01.NEU.0000097267.54786.54; Pellman Elliot J, 2006, Neurosurg Focus, V21, pE12; Porter MD, 2003, CLIN J SPORT MED, V13, P339, DOI 10.1097/00042752-200311000-00002; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Schuck PH, 1994, FACULTY SCHOLARSHIP; Schwarz A, 2011, NY TIMES; Searcy T, 2012, FORBES          0925; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Spiotta AM, 2011, WORLD NEUROSURG, V75, P175, DOI 10.1016/j.wneu.2011.01.019; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; The Nielsen Company, 2009, GUID SUP BOWL XLIII; Tierney M, 2012, NY TIMES; United States Army, 2012, NFL ARM BOTH WORK CO; Wall SE, 2006, J NEUROL NEUROSUR PS, V77, P518, DOI 10.1136/jnnp.2004.061044; Zazryn T, 2007, SPORTS MED, V37, P467, DOI 10.2165/00007256-200737060-00001	59	18	17	1	27	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law	SEP 1	2013	41	3					430	436					7	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	AN8LT	WOS:000340856400014	24051597				2022-02-06	
J	Williams, C; Wood, RL				Williams, Claire; Wood, Rodger Ll			The Impact of Alexithymia on Relationship Quality and Satisfaction Following Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						affective symptoms; alexithymia; brain injuries; emotions; family relations; marital status; traumatic brain injury	CLOSED-HEAD-INJURY; DYADIC ADJUSTMENT; MARITAL SATISFACTION; SCALE; RECOGNITION; INDIVIDUALS; PERSONALITY; STABILITY; AWARENESS; DISTRESS	Objectives: To explore relationship quality and satisfaction in couples following traumatic brain injury (TBI), obtaining the perspective of both patients with TBI and their noninjured partner; to examine the impact of alexithymia on ratings of relationship quality and satisfaction following TBI. Participants: A total of 47 patients with TBI and their noninjured partners. Measures: Twenty-item Toronto Alexithymia Scale; Index of Marital Satisfaction; and Dyadic Adjustment Scale. Results: Significant differences emerged between patients with TBI and their noninjured partners on measures of relationship quality and satisfaction, with patients reporting significantly fewer relationship problems and greater levels of overall relationship satisfaction. In contrast, the noninjured partners of patients with TBI and acquired alexithymia reported significantly lower ratings of overall relationship quality, adjustment, consensus, and cohesion. Conclusion: The presence of alexithymia in persons with TBI is an important factor affecting relationship quality and satisfaction. Future research should continue to explore the impact of emotional deficit disorders following TBI on the quality of relationships following injury and, in turn, the risk of relationship breakdown.	[Williams, Claire; Wood, Rodger Ll] Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales		Williams, C (corresponding author), Swansea Univ, Coll Human & Hlth Sci, Dept Psychol, Brain Injury Res Grp, Swansea SA2 8PP, W Glam, Wales.	claire.williams@swansea.ac.uk		Williams, Claire/0000-0002-0791-744X			AIDA Y, 1991, SEX ROLES, V24, P43, DOI 10.1007/BF00288702; Allerdings MD, 2001, BRAIN COGNITION, V47, P304; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Becerra R, 2002, BRAIN INJURY, V16, P633, DOI 10.1080/02699050110119817; BOND MR, 1984, CLOSED HEAD INJURY P, P148; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burba B, 2006, CAN J PSYCHIAT, V51, P468, DOI 10.1177/070674370605100709; Burleson BR, 1997, J MARRIAGE FAM, V59, P884, DOI 10.2307/353790; Burridge AC, 2007, NEUROPSYCHOL REHABIL, V17, P95, DOI 10.1080/09602010500505070; Carey M. P., 1993, PSYCHOL ASSESSMENT, V5, P238, DOI DOI 10.1037/1040-3590.5.2.238; Cohen J., 1998, STAT POWER ANAL BEHA, V2nd; CRANE DR, 1991, AM J FAM THER, V19, P60, DOI 10.1080/01926189108250835; Fischer J., 1994, MEASURES CLIN PRACTI; Gill CJ, 2011, J HEAD TRAUMA REHAB, V26, P56, DOI 10.1097/HTR.0b013e3182048ee9; GODFREY HPD, 1993, J CLIN EXP NEUROPSYC, V15, P503, DOI 10.1080/01688639308402574; Godwin EE, 2011, J HEAD TRAUMA REHAB, V26, P43, DOI 10.1097/HTR.0b013e3182048f54; Gosling J, 1999, BRAIN INJURY, V13, P785; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; Hudson W.W., 1982, CLIN MEASUREMENT PAC; Humphreys TP, 2009, PERS INDIV DIFFER, V46, P43, DOI 10.1016/j.paid.2008.09.002; Koponen S, 2005, PSYCHOSOM MED, V67, P807, DOI 10.1097/01.psy.0000181278.92249.e5; Koskinen S, 1998, BRAIN INJURY, V12, P631, DOI 10.1080/026990598122205; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; KURDEK LA, 1985, J HOMOSEXUAL, V12, P85; Lane RD, 1996, PSYCHOSOM MED, V58, P203, DOI 10.1097/00006842-199605000-00002; Lewis F M, 1995, Oncol Nurs Forum, V22, P943; Liss M, 1990, Int J Rehabil Res, V13, P309, DOI 10.1097/00004356-199012000-00004; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P870, DOI 10.1136/jnnp.48.9.870; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Luminet O, 2001, PSYCHOTHER PSYCHOSOM, V70, P254, DOI 10.1159/000056263; Lumley MA, 1996, J PSYCHOSOM RES, V41, P505, DOI 10.1016/S0022-3999(96)00222-X; Mallinckrodt B, 2005, J COUNS PSYCHOL, V52, P358, DOI 10.1037/0022-0167.52.3.358; MANN LS, 1994, PSYCHOL REP, V74, P563, DOI 10.2466/pr0.1994.74.2.563; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Meeks BS, 1998, J SOC PERS RELAT, V15, P755, DOI 10.1177/0265407598156003; Norman GR, 1993, PDQ STAT; Northouse L, 2001, J BEHAV MED, V24, P115, DOI 10.1023/A:1010772913717; O'CARROLL R E, 1991, Brain Injury, V5, P303, DOI 10.3109/02699059109008100; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Oddy M, 2001, SEX RELATSH THER, V16, P247, DOI [10.1080/14681990125256, DOI 10.1080/14681990125256]; Office for National Statistics, DIV ENGL WAL AG MARR; PARKER JDA, 1993, PSYCHOTHER PSYCHOSOM, V59, P197, DOI 10.1159/000288664; Parker JDA, 2001, PERS INDIV DIFFER, V30, P107, DOI 10.1016/S0191-8869(00)00014-3; PASINI A, 1992, COMPR PSYCHIAT, V33, P42, DOI 10.1016/0010-440X(92)90078-5; PETERS L C, 1992, Brain Injury, V6, P461, DOI 10.3109/02699059209008141; Peters LC, 2002, BRAIN INJURY, V6, P461; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Ridout N, 2010, EAT BEHAV, V11, P1, DOI 10.1016/j.eatbeh.2009.07.008; ROLLINS BC, 1974, J MARRIAGE FAM, V36, P271, DOI 10.2307/351153; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Salminen JK, 1999, J PSYCHOSOM RES, V46, P75, DOI 10.1016/S0022-3999(98)00053-1; SPANIER GB, 1982, J MARRIAGE FAM, V44, P731, DOI 10.2307/351593; SPANIER GB, 1976, J MARRIAGE FAM, V38, P15, DOI 10.2307/350547; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; Taylor G. J., 1997, DISORDERS AFFECT REG; TAYLOR GJ, 1991, PSYCHOSOMATICS, V32, P153, DOI 10.1016/S0033-3182(91)72086-0; TEASDALE G, 1974, LANCET, V2, P81; Vanheule S, 2007, PSYCHOPATHOLOGY, V40, P14, DOI 10.1159/000096385; Vanheule S, 2007, J CLIN PSYCHOL, V63, P109, DOI 10.1002/jclp.20324; WALKER JG, 1992, J PEDIATR PSYCHOL, V17, P345, DOI 10.1093/jpepsy/17.3.345; Weinryb RM, 1996, PERS INDIV DIFFER, V20, P13, DOI 10.1016/0191-8869(95)00137-U; WILLER BS, 1991, ARCH PHYS MED REHAB, V72, P460; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Williams KR, 2001, BRAIN INJURY, V15, P349, DOI 10.1080/026990501750111319; Wood RL, 2005, PSYCHOLOGIST, V18, P138; Wood RL, 1997, BRAIN INJURY, V11, P491, DOI 10.1080/713802183; Wood RLL, 2009, BRAIN INJURY, V23, P649, DOI 10.1080/02699050902970786; Wood RL, 2007, J INT NEUROPSYCH SOC, V13, P471, DOI 10.1017/S1355617707070518	74	18	18	1	13	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2013	28	5					E21	E30		10.1097/HTR.0b013e318267b0ab			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	298ZU	WOS:000330364600003	23076095				2022-02-06	
J	Yim, J; Babbage, DR; Zupan, B; Neumann, D; Willer, B				Yim, Jackki; Babbage, Duncan R.; Zupan, Barbra; Neumann, Dawn; Willer, Barry			The relationship between facial affect recognition and cognitive functioning after traumatic brain injury	BRAIN INJURY			English	Article						Affect; cognitive functioning; emotion; facial affect; traumatic brain injury	EMOTION RECOGNITION; NONVERBAL-COMMUNICATION; SOCIAL COGNITION; IMPAIRMENT; EXPRESSION; DEFICITS; MIND; DISSOCIATION; PERCEPTION; BATTERY	Primary objective: There is considerable evidence suggesting facial affect recognition and cognitive functions are impaired in many people with moderate-to-severe traumatic brain injury (TBI). However, little is known about the relationship between these two domains in the TBI population. Research design: This study investigated the relationship between facial affect recognition and cognitive functioning in 75 adults with moderate-to-severe TBI. Methods and procedures: Participants were administered three facial affect recognition tests and a computerized cognitive test battery that assessed seven cognitive domains. Main outcomes and results: Deficits in facial affect recognition were significantly correlated with impairments in non-verbal memory, working memory, speed of processing, verbal memory and verbal delayed memory. No significant relationship was found between executive dysfunction and facial affect recognition impairments. Non-verbal memory, working memory and speed of processing significantly predicted overall facial affect recognition performance. Conclusions: It is concluded that impairment in several cognitive processes may contribute to facial affect recognition deficits in TBI, in particular non-verbal memory, working memory and speed of processing. Furthermore, executive functioning may not be a critical factor in facial affect recognition, but would most likely be important in deciding what to do once facial affect is perceived.	[Yim, Jackki] Massey Univ, Sch Psychol, Wellington, New Zealand; [Babbage, Duncan R.] Auckland Univ Technol, Hlth & Rehabil Res Inst, Auckland 1142, New Zealand; [Zupan, Barbra] Brock Univ, Dept Appl Linguist, St Catharines, ON L2S 3A1, Canada; [Neumann, Dawn] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA; [Willer, Barry] SUNY Buffalo, Buffalo, NY 14260 USA		Babbage, DR (corresponding author), Auckland Univ Technol, Hlth & Rehabil Res Inst, Private Bag 92006, Auckland 1142, New Zealand.	duncan.babbage@aut.ac.nz		Barbra, Zupan/0000-0002-4603-333X; Babbage, Duncan/0000-0002-9259-9246	National Institute on Disability and Rehabilitation Research [H133G080043]	Supported by the National Institute on Disability and Rehabilitation Research (grant no. H133G080043). The data presented in this study was collected as part of a registered clinical trial-ClinicalTrials.gov identifier: NCT00283153.	Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Allerdings MD, 2006, BRAIN COGNITION, V60, P193, DOI 10.1016/j.bandc.2004.09.018; Babbage DR, 2011, NEUROPSYCHOLOGY, V25, P277, DOI 10.1037/a0021908; Barrett LF, 2007, TRENDS COGN SCI, V11, P327, DOI 10.1016/j.tics.2007.06.003; Bowers D., 1991, FLORIDA AFFECT BATTE; Brookshire R. H., 1993, DISCOURSE COMPREHENS; Cherniss C, 2010, IND ORGAN PSYCHOL-US, V3, P110, DOI 10.1111/j.1754-9434.2010.01231.x; Darby D, 2002, NEUROLOGY, V59, P1042, DOI 10.1212/WNL.59.7.1042; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Driscoll DM, 2011, J NEUROTRAUM, V28, P319, DOI 10.1089/neu.2010.1523; Falleti MG, 2006, J CLIN EXP NEUROPSYC, V28, P1095, DOI 10.1080/13803390500205718; Gendron M, 2012, EMOTION, V12, P314, DOI 10.1037/a0026007; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Henry JD, 2009, J INT NEUROPSYCH SOC, V15, P277, DOI 10.1017/S1355617709090195; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Lee SJ, 2009, PSYCHIAT INVEST, V6, P156, DOI 10.4306/pi.2009.6.3.156; Maruff P, 2009, ARCH CLIN NEUROPSYCH, V24, P165, DOI 10.1093/arclin/acp010; Mathersul D, 2009, J CLIN EXP NEUROPSYC, V31, P278, DOI 10.1080/13803390802043619; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; Middleton JA, 2001, ADV PSYCHIAT TREAT, V7, P257, DOI DOI 10.1192/APT.7.4.257; NOWICKI S, 1994, J NONVERBAL BEHAV, V18, P9, DOI 10.1007/BF02169077; Nowicki S., 2004, DIAGNOSTIC ANAL NONV; Phillips LH, 2008, EMOTION, V8, P184, DOI 10.1037/1528-3542.8.2.184; Pinkham AE, 2003, AM J PSYCHIAT, V160, P815, DOI 10.1176/appi.ajp.160.5.815; Radice-Neumann D, 2007, BRAIN INJURY, V21, P807, DOI 10.1080/02699050701504281; Roebuck-Spencer T, 2008, TXB CLIN NEUROPSYCHO, P411; Sachs G, 2004, SCHIZOPHR RES, V68, P27, DOI 10.1016/S0920-9964(03)00131-2; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shamay-Tsoory SG, 2007, PSYCHIAT RES, V149, P11, DOI 10.1016/j.psychres.2005.10.018; Spell LA, 2000, J NONVERBAL BEHAV, V24, P285, DOI 10.1023/A:1006675230193; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Tonks J, 2008, BRAIN INJURY, V22, P325, DOI 10.1080/02699050801968303; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P113, DOI 10.1080/13803390902806543	34	18	18	1	16	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	SEP	2013	27	10					1155	1161		10.3109/02699052.2013.804203			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	204KW	WOS:000323365200008	23895556				2022-02-06	
J	Zou, S; Chisholm, R; Tauskela, JS; Mealing, GA; Johnston, LJ; Morris, CE				Zou, Shan; Chisholm, Roderick; Tauskela, Joseph S.; Mealing, Geoff A.; Johnston, Linda J.; Morris, Catherine E.			Force Spectroscopy Measurements Show That Cortical Neurons Exposed to Excitotoxic Agonists Stiffen before Showing Evidence of Bleb Damage	PLOS ONE			English	Article							GATED CHANNEL ACTIVITY; ANOXIC DEPOLARIZATION; MECHANICAL-PROPERTIES; MEMBRANE TENSION; SODIUM-CHANNELS; CA1 NEURONS; CALCIUM; NA+; CYTOSKELETON; INJURY	In ischemic and traumatic brain injury, hyperactivated glutamate (N-methyl-D-aspartic acid, NMDA) and sodium (Nav) channels trigger excitotoxic neuron death. Na+, Ca++ and H2O influx into affected neurons elicits swelling (increased cell volume) and pathological blebbing (disassociation of the plasma membrane's bilayer from its spectrin-actomyosin matrix). Though usually conflated in injured tissue, cell swelling and blebbing are distinct processes. Around an injury core, salvageable neurons could be mildly swollen without yet having suffered the bleb-type membrane damage that, by rendering channels leaky and pumps dysfunctional, exacerbates the excitotoxic positive feedback spiral. Recognizing when neuronal inflation signifies non-lethal osmotic swelling versus blebbing should further efforts to salvage injury-penumbra neurons. To assess whether the mechanical properties of osmotically-swollen versus excitotoxically-blebbing neurons might be cytomechanically distinguishable, we measured cortical neuron elasticity (gauged via atomic force microscopy (AFM)-based force spectroscopy) upon brief exposure to hypotonicity or to excitotoxic agonists (glutamate and Nav channel activators, NMDA and veratridine). Though unperturbed by solution exchange per se, elasticity increased abruptly with hypotonicity, with NMDA and with veratridine. Neurons then invariably softened towards or below the pre-treatment level, sometimes starting before the washout. The initial channel-mediated stiffening bespeaks an abrupt elevation of hydrostatic pressure linked to NMDA or Nav channel-mediated ion/H2O fluxes, together with increased [Ca++](int)-mediated submembrane actomyosin contractility. The subsequent softening to below-control levels is consistent with the onset of a lethal level of bleb damage. These findings indicate that dissection/identification of molecular events during the excitotoxic transition from stiff/swollen to soft/blebbing is warranted and should be feasible.	[Zou, Shan; Chisholm, Roderick; Tauskela, Joseph S.; Mealing, Geoff A.; Johnston, Linda J.] Natl Res Council Canada, Ottawa, ON, Canada; [Morris, Catherine E.] Ottawa Hosp Res Inst, Ottawa, ON, Canada		Johnston, LJ (corresponding author), Natl Res Council Canada, Ottawa, ON, Canada.	Linda.Johnston@nrc-cnrc.gc.ca	Zou, Shan/AAD-5515-2020	Zou, Shan/0000-0002-2480-6821; Morris, Catherine/0000-0002-7401-6545	National Research Council Canada	This work was funded by the National Research Council Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasiak KJ, 2004, NEUROSCIENCE, V126, P31, DOI 10.1016/S0306-4522(03)00425-1; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Boal, 2002, MECH CELL; Bobryshev YV, 2013, PATHOBIOLOGY, V80, P24, DOI 10.1159/000339430; Brisson CD, 2012, J NEUROPHYSIOL, V108, P419, DOI 10.1152/jn.00090.2012; Calabrese B, 2002, BIOPHYS J, V83, P2560, DOI 10.1016/S0006-3495(02)75267-3; Callies C, 2011, J CELL SCI, V124, P1936, DOI 10.1242/jcs.084657; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chao DM, 2010, PROG NEUROBIOL, V90, P439, DOI 10.1016/j.pneurobio.2009.12.007; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chorzalska A, 2010, CELL MOL BIOL LETT, V15, P406, DOI 10.2478/s11658-010-0012-6; Dai JW, 1998, J NEUROSCI, V18, P6681; Devaux JJ, 2010, J PHYSIOL-LONDON, V588, P4719, DOI 10.1113/jphysiol.2010.196022; Douglas HA, 2011, J NEUROPHYSIOL, V105, P1482, DOI 10.1152/jn.00817.2010; Elkin BS, 2007, J NEUROTRAUM, V24, P812, DOI 10.1089/neu.2006.0169; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Gerencser AA, 2009, J NEUROCHEM, V110, P990, DOI 10.1111/j.1471-4159.2009.06194.x; Hains BC, 2004, EXP NEUROL, V188, P365, DOI 10.1016/j.expneurol.2004.04.001; Hasbani MJ, 1998, EXP NEUROL, V154, P241, DOI 10.1006/exnr.1998.6929; Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI 10.1515/crll.1882.92.156; Ikeda J, 1996, J NEUROSCI RES, V43, P613; Inoue H, 2007, J NEUROSCI, V27, P1445, DOI 10.1523/JNEUROSCI.4694-06.2007; Irmscher M, 2012, BIOPHYS J, V102, P698, DOI 10.1016/j.bpj.2011.12.054; Ishmael JE, 2007, BRAIN RES, V1143, P46, DOI 10.1016/j.brainres.2007.01.061; JOHNSON KL, 1971, PROC R SOC LON SER-A, V324, P301, DOI 10.1098/rspa.1971.0141; Johnson KL, 1985, CONTACT MECH; Kasas S, 2005, CELL MOTIL CYTOSKEL, V62, P124, DOI 10.1002/cm.20086; Kelly CV, 2009, J BIOL PHYS, V35, P279, DOI 10.1007/s10867-009-9167-7; Koenig X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020300; LANGTON PD, 1993, J PHYSIOL-LONDON, V471, P1; Li P, 2008, J NEUROSCI, V28, P11970, DOI 10.1523/JNEUROSCI.3724-08.2008; Liu XX, 2008, J MEMBRANE BIOL, V226, P17, DOI 10.1007/s00232-008-9135-3; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Lulevich V, 2010, ULTRAMICROSCOPY, V110, P1435, DOI 10.1016/j.ultramic.2010.07.009; Manno S, 2002, P NATL ACAD SCI USA, V99, P1943, DOI 10.1073/pnas.042688399; Markin VS, 1999, BIOPHYS J, V76, P2852, DOI 10.1016/S0006-3495(99)77439-4; Maxwell WL, 1996, MICROSC RES TECHNIQ, V34, P522, DOI 10.1002/(SICI)1097-0029(19960815)34:6<522::AID-JEMT4>3.0.CO;2-L; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; Mere J, 2005, BIOCHEM J, V386, P47, DOI 10.1042/BJ20041054; MILTON RL, 1990, J NEUROSCI, V10, P885; Morris C.E., 2011, CELL PHYSL SOURCE BO, P493; Morris CE, 2012, PROG BIOPHYS MOL BIO, V110, P245, DOI 10.1016/j.pbiomolbio.2012.07.003; Morris CE, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00019; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Muller M, 2000, J NEUROPHYSIOL, V84, P1869, DOI 10.1152/jn.2000.84.4.1869; Nestor MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016197; Ohta S, 1996, J CEREBR BLOOD F MET, V16, P915, DOI 10.1097/00004647-199609000-00015; Okuyama K, 2000, EUR J PHARMACOL, V398, P209, DOI 10.1016/S0014-2999(00)00305-8; Rasband MN, 2013, CURR BIOL, V23, pR197, DOI 10.1016/j.cub.2013.01.050; Sakaguchi T, 1999, NEUROSCI LETT, V274, P135, DOI 10.1016/S0304-3940(99)00702-8; Sanchez D, 2008, BIOPHYS J, V95, P3017, DOI 10.1529/biophysj.108.129551; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Sheetz MP, 2006, ANNU REV BIOPH BIOM, V35, P417, DOI 10.1146/annurev.biophys.35.040405.102017; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Spagnoli C, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.031916; Spedden E, 2012, BIOPHYS J, V103, P868, DOI 10.1016/j.bpj.2012.08.005; Star EN, 2002, NAT NEUROSCI, V5, P239, DOI 10.1038/nn811; Steltenkamp S, 2006, SMALL, V2, P1016, DOI 10.1002/smll.200600018; Sun GC, 2006, ACTA PHARMACOL SIN, V27, P1537, DOI 10.1111/j.1745-7254.2006.00452.x; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Takahashi M, 1996, BRAIN RES, V735, P1, DOI 10.1016/S0006-8993(96)00536-7; Tauskela JS, 2012, J NEUROCHEM, V122, P470, DOI 10.1111/j.1471-4159.2012.07791.x; Tauskela JS, 2008, J BIOL CHEM, V283, P34667, DOI 10.1074/jbc.M805624200; Tauskela JS, 2005, FASEB J, V19, P1734, DOI 10.1096/fj.05-3795fje; Tauskela JS, 2003, AM J PHYSIOL-CELL PH, V285, pC899, DOI 10.1152/ajpcell.00110.2003; Underhill SM, 2007, NEUROBIOL DIS, V25, P284, DOI 10.1016/j.nbd.2006.09.011; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; WAN X, 1995, J MEMBRANE BIOL, V145, P21; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wang JA, 2009, AM J PHYSIOL-CELL PH, V297, pC823, DOI 10.1152/ajpcell.00505.2008; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Wilson JR, 2014, WORLD NEUROSURG, V81, P825, DOI 10.1016/j.wneu.2013.01.001; Wu BJ, 2001, J EXP BIOL, V204, P4271; Xiang K, 2012, EPILEPSY RES, V99, P293, DOI 10.1016/j.eplepsyres.2011.12.011; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yilmaz C, 2009, TURK NEUROSURG, V19, P367; Zhang J, 2012, BRAIN RES, V1471, P129, DOI 10.1016/j.brainres.2012.06.031; Zhang Y, 2000, J PHYSIOL-LONDON, V523, P117, DOI 10.1111/j.1469-7793.2000.t01-1-00117.x	82	18	18	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2013	8	8							e73499	10.1371/journal.pone.0073499			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	211BX	WOS:000323880200083	24023686	Green Published, Green Submitted, gold			2022-02-06	
J	Wondrusch, C; Schuster-Amft, C				Wondrusch, C.; Schuster-Amft, C.			A standardized motor imagery introduction program (MIIP) for neuro-rehabilitation: development and evaluation	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						motor imagery introduction program (MIIP); CNS lesion; sensorimotor impairments; mental practice; stroke; multiple sclerosis; Parkinson's disease	MENTAL PRACTICE; GAIT REHABILITATION; STROKE; POSTSTROKE; PEOPLE; KNOWLEDGE; EDUCATION; EFFICACY	Background: For patients with central nervous system (CNS) lesions and sensorimotor impairments a solid motor imagery (MI) introduction is crucial to understand and use MI to improve motor performance. The study's aim was to develop and evaluate a standardized MI group introduction program (MIIP) for patients after stroke, multiple sclerosis (MS), Parkinson's disease (PD), and traumatic brain injury (TBI). Methods: Phase 1: Based on literature a MIIP was developed comprising MI theory (definition, type, mode, perspective, planning) and MI practice (performance, control). Phase 2: Development of a 27-item self-administered MIIP evaluation questionnaire, assessing MI knowledge self-evaluation of the ability to perform MI and patient satisfaction with the MIIP. Phase 3: Evaluation of MIIP and MI questionnaire by 2 independent MI experts based on predefined criteria and 2 patients using semi-structured interviews. Phase 4: Case series with a pre-post design to evaluate MIIP (3 x 30 min) using the MI questionnaire, Imaprax, Kinaesthetic and Visual Imagery Questionnaire, and Mental Chronometry. The paired t-test and the Wilcoxon signed-rank test were used to determine significant changes. Results: Data of eleven patients were analysed (5 females; age 62.3 +/- 14.1 years). Declarative MI knowledge improved significantly from 5.4 +/- 2.2 to 8.8 +/- 2.9 (p = 0.010). Patients demonstrated good satisfaction with MIIP (mean satisfaction score: 83.2 +/- 11.4%). MI ability remained on a high level but showed no significant change, except a significant decrease in the Kinaesthetic and Visual Imagery Questionnaire score. Conclusion: The presented MIIP seems to be valid and feasible for patients with CNS lesions and sensorimotor impairments resulting in improved MI knowledge. MIIP sessions can be held in groups of four or less. MI ability and Mental Chronometry remained unchanged after 3 training sessions.	[Wondrusch, C.] Zurich Univ Appl Sci, Inst Physiotherapy, Sch Hlth Profess, Winterthur, Switzerland; [Schuster-Amft, C.] Reha Rheinfelden, Res Dept, CH-4310 Rheinfelden, Switzerland; [Schuster-Amft, C.] Bern Univ Appl Sci, Inst Rehabil & Performance Technol, Dept Engn & Informat Technol, Burgdorf, Switzerland		Schuster-Amft, C (corresponding author), Reha Rheinfelden, Res Dept, Salinenstr 98, CH-4310 Rheinfelden, Switzerland.	c.schuster@reha-rhf.ch	Schuster, Corina/B-6939-2008	Schuster-Amft, Corina/0000-0003-1120-4423			Annett J, 1996, COGNITIVE BRAIN RES, V3, P65, DOI 10.1016/0926-6410(95)00030-5; Barclay-Goddard RE, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005950.pub4; Bovend'Eerdt TJ, 2010, ARCH PHYS MED REHAB, V91, P939, DOI 10.1016/j.apmr.2010.03.008; Bovend'Eerdt TJH, 2012, DISABIL REHABIL, V34, P2192, DOI 10.3109/09638288.2012.676703; Bovend'Eerdt TJH, 2009, CLIN REHABIL, V23, P137, DOI 10.1177/0269215508097298; Braun S, 2008, CLIN REHABIL, V22, P579, DOI 10.1177/0269215508090066; Braun SM, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2010.07.009; Buhner M., 2006, EINFUHRUNGIN TEST FR; Casby A, 1998, IRISH J PSYCHOL, V19, P525, DOI 10.1080/03033910.1998.10558212; CLARK LV, 1960, RES QUART, V31, P560, DOI 10.1080/10671188.1960.10613109; Clasen H., 2010, MESSUNG LERNERFOLG G; Crosbie JH, 2004, CLIN REHABIL, V18, P60, DOI 10.1191/0269215504cr702oa; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dickstein R, 2004, PHYS THER, V84, P1167, DOI 10.1093/ptj/84.12.1167; Dunsky A, 2006, INT J REHABIL RES, V29, P351, DOI 10.1097/MRR.0b013e328010f559; Edelmann W, 2012, LERNPSYCHOLOGIE; Etnier JL, 1996, SPORT PSYCHOL, V10, P48, DOI 10.1123/tsp.10.1.48; Foltran FA, 2012, REV BRAS FISIOTER, V16, P128, DOI 10.1590/S1413-35552012005000023; Fournier JF, 2000, PERCEPT MOTOR SKILL, V90, P367, DOI 10.2466/PMS.90.2.367-370; GAUTHIER L, 1987, AM J OCCUP THER, V41, P360, DOI 10.5014/ajot.41.6.360; Guillot A, 2005, BRAIN RES REV, V50, P387, DOI 10.1016/j.brainresrev.2005.09.004; Guillot A, 2010, J SPORT SCI, V28, P291, DOI 10.1080/02640410903473828; Hemayattalab R, 2010, RES DEV DISABIL, V31, P81, DOI 10.1016/j.ridd.2009.07.022; Heremans E, 2012, NEUROREHAB NEURAL RE, V26, P27, DOI 10.1177/1545968311411055; Holmes PS, 2001, J APPL SPORT PSYCHOL, V13, P60, DOI 10.1080/10413200109339004; Ietswaart M, 2011, BRAIN, V134, P1373, DOI 10.1093/brain/awr077; Immenroth M, 2007, ANN SURG, V245, P385, DOI 10.1097/01.sla.0000251575.95171.b3; Klauer K. J., 2012, LEHREN LERNEN; Klauer K. J, 2012, LEHREN LERNEN EINFUH; Kornspan A.S., 2004, J MENTAL IMAG, V28, P59; Liu KP, 2004, ARCH PHYS MED REHAB, V85, P1403, DOI 10.1016/j.apmr.2003.12.035; Liu KPY, 2004, BRAIN INJURY, V18, P1163, DOI 10.1080/02699050410001671883; Lotze M, 2006, J PHYSIOL-PARIS, V99, P386, DOI 10.1016/j.jphysparis.2006.03.012; Madan CR, 2012, COGN PROCESS, V13, P211, DOI 10.1007/s10339-012-0438-z; Malouin F, 2008, NEUROREHAB NEURAL RE, V22, P330, DOI 10.1177/1545968307313499; Malouin Francine, 2007, J Neurol Phys Ther, V31, P20; Malouin F, 2008, ARCH PHYS MED REHAB, V89, P311, DOI 10.1016/j.apmr.2007.11.006; Malouin F, 2009, J NEUROL PHYS THER, V33, P195, DOI 10.1097/NPT.0b013e3181c2112b; Malouin F, 2010, PHYS THER, V90, P240, DOI 10.2522/ptj.20090029; Marzano R. J., 1988, DIMENSIONS THINKING, P13; Meng K, 2009, REHABILITATION, V48, P335, DOI 10.1055/s-0029-1239575; Nickols F., 2000, KNOWLEDGE MANAGEMENT, P12; SCHMIDT J, 1989, PSYCHOTHER PSYCH MED, V39, P248; Schuster C, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-106; Schuster C, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/503190; Schuster C, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-11; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Shambrook CJ, 1996, J APPL SPORT PSYCHOL, V8, P27, DOI 10.1080/10413209608406306; Sidaway B, 2005, PHYS THER, V85, P1053, DOI 10.1093/ptj/85.10.1053; Smith D., 2001, Journal of Sport Behavior, V24, P408; SONNENSCHEIN I, 1990, PSYCHOL ERZ UNTERR, V37, P232; Sorrell JT, 2009, J DENT EDUC, V73, P1293; START KB, 1964, RES QUART, V35, P316, DOI 10.1080/10671188.1964.10613316; VANGYN GH, 1990, J SPORT EXERCISE PSY, V12, P366, DOI 10.1123/jsep.12.4.366; WARNER L, 1988, PHYS THER, V68, P516, DOI 10.1093/ptj/68.4.516; Wuthrich-Schneider E., 2000, SCHWEIZERISCHE ARZTE, V81, P1116; Yoo EY, 2006, CLIN REHABIL, V20, P388, DOI 10.1191/0269215506cr962oa; [No title captured]	58	18	20	1	22	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	AUG 22	2013	7								477	10.3389/fnhum.2013.00477			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	204LD	WOS:000323365900001	23986676	Green Published, gold			2022-02-06	
J	Funderud, I; Lovstad, M; Lindgren, M; Endestad, T; Due-Tonnessen, P; Meling, TR; Knight, RT; Solbakk, AK				Funderud, Ingrid; Lovstad, Marianne; Lindgren, Magnus; Endestad, Tor; Due-Tonnessen, Paulina; Meling, Torstein R.; Knight, Robert T.; Solbakk, Anne-Kristin			Preparatory attention after lesions to the lateral or orbital prefrontal cortex - An event-related potentials study	BRAIN RESEARCH			English	Article						Event-related potentials; Contingent negative variation (CNV); Lateral prefrontal cortex; Orbitofrontal cortex	CONTINGENT NEGATIVE-VARIATION; CLOSED HEAD-INJURY; HUMAN BRAIN; FRONTAL-CORTEX; CNV; PERFORMANCE; COMPONENT; NETWORKS; HUMANS; AREAS	The prefrontal cortex (PFC) plays a central role in preparatory and anticipatory attentional processes. To investigate whether subregions of the PFC play differential roles in these processes we investigated the effect of focal lesions to either lateral prefrontal (lateral PFC; n=11) or orbitofrontal cortex (OFC; n=13) on the contingent negative variation (CNV), an electrophysiological index of preparatory brain processes. The CNV was studied using a Go/NoGo delayed response task where an auditory 51 signaled whether or not an upcoming visual S2 was a Go or a NoGo stimulus. Neither early (500-1000 ms) nor late (3200-3700 ms) phase Go trial CNV amplitude was reduced for any of the patient groups in comparison to controls. However, the lateral PFC group showed enhanced Go trial early CNV and reduced late CNV Go/NoGo differentiation. These data suggests that normal orienting and evaluation as reflected by the CNV is intact after OFC lesions. The enhanced early CNV after lateral PFC damage may be due to failure in inhibition and the reduced late CNV difference wave confirms a deficit in preparatory attention after damage to this frontal subregion. (C) 2013 Elsevier B.V. All rights reserved.	[Funderud, Ingrid; Lindgren, Magnus; Endestad, Tor; Solbakk, Anne-Kristin] Natl Hosp Norway, Oslo Univ Hosp, Dept Psychosomat Med, Div Surg & Clin Neurosci, N-0424 Oslo, Norway; [Lovstad, Marianne] Sunnaas Rehabil Hosp, Nesodden, Norway; [Lindgren, Magnus] Lund Univ, Dept Psychol, S-22100 Lund, Sweden; [Endestad, Tor] Univ Oslo, Dept Psychol, N-0316 Oslo, Norway; [Due-Tonnessen, Paulina] Natl Hosp Norway, Oslo Univ Hosp, Dept Radiol, N-0424 Oslo, Norway; [Meling, Torstein R.] Natl Hosp Norway, Oslo Univ Hosp, Dept Neurosurg, N-0424 Oslo, Norway; [Knight, Robert T.] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Knight, Robert T.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA		Funderud, I (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Dept Psychosomat Med, Div Surg & Clin Neurosci, Pb 4950 Nydalen, N-0424 Oslo, Norway.	ifunderu@ous-hf.no	Meling, Torstein/Q-2568-2019	Meling, Torstein/0000-0001-6595-0873; Endestad, Tor/0000-0002-4403-6887; Funderud, Ingrid/0000-0002-4481-7237; Due-Tonnessen, Paulina/0000-0002-3615-1914	Southeastern Norway Regional Health Authority [SUN-001-SS, 2008047]; Research Council of NorwayResearch Council of Norway [186504/V50]; National Institute of Neurological Disorders and Stroke, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS21135, PO 40813]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS040813, R01NS021135, R56NS021135, R37NS021135] Funding Source: NIH RePORTER	This research is supported by the Southeastern Norway Regional Health Authority (Grants SUN-001-SS and 2008047), the Research Council of Norway (Grant 186504/V50), and the National Institute of Neurological Disorders and Stroke, USA (NS21135 and PO 40813). The authors would like to thank Bradley Voytek for assistance on ERP analysis and establishment of scripts for analyzing EEG data in Mat lab, and Haakon Engen and Clay Campbell Clayworth for support in establishing routines for lesion reconstructions. This work forms part of a doctoral thesis to be submitted to the Department of Psychology at the University of Oslo.	Barcelo F, 2007, CEREB CORTEX, V17, pI51, DOI 10.1093/cercor/bhm111; BASILE LFH, 1994, ELECTROEN CLIN NEURO, V90, P157, DOI 10.1016/0013-4694(94)90007-8; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Brunia CHM, 2001, INT J PSYCHOPHYSIOL, V43, P59, DOI 10.1016/S0167-8760(01)00179-9; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Curry S H, 1980, Prog Brain Res, V54, P507, DOI 10.1016/S0079-6123(08)61668-4; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DIPELLEGRINO G, 1991, BRAIN, V114, P951; Fan J, 2007, J NEUROSCI, V27, P2272, DOI 10.1523/JNEUROSCI.3470-06.2007; Fassbender C, 2006, HUM BRAIN MAPP, V27, P819, DOI 10.1002/hbm.20223; Ferree TC, 2001, CLIN NEUROPHYSIOL, V112, P536, DOI 10.1016/S1388-2457(00)00533-2; Flores AB, 2009, BRAIN COGNITION, V71, P129, DOI 10.1016/j.bandc.2009.04.011; Funderud I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048504; GEMBA H, 1990, NEUROSCI LETT, V113, P275, DOI 10.1016/0304-3940(90)90597-3; Gomez CA, 2007, BRAIN RES BULL, V73, P40, DOI 10.1016/j.brainresbull.2007.01.015; Gomez CM, 2003, NEUROIMAGE, V20, P216, DOI 10.1016/S1053-8119(03)00295-7; Gomez CM, 2001, BRAIN TOPOGR, V13, P149, DOI 10.1023/A:1007816201345; Hartikainen KM, 2012, J CLIN EXP NEUROPSYC, V34, P588, DOI 10.1080/13803395.2012.666231; Herrmann CS, 2001, NEUROSCI BIOBEHAV R, V25, P465, DOI 10.1016/S0149-7634(01)00027-6; Hultin L, 1996, ELECTROEN CLIN NEURO, V98, P435, DOI 10.1016/0013-4694(96)95507-8; Ikeda A, 1996, ELECTROEN CLIN NEURO, V98, P206, DOI 10.1016/0013-4694(95)00239-1; IOANNIDES AA, 1994, ELECTROEN CLIN NEURO, V91, P399, DOI 10.1016/0013-4694(94)90125-2; Knight RT, 1999, ACTA PSYCHOL, V101, P159, DOI 10.1016/S0001-6918(99)00004-9; KOK A, 1978, BIOL PSYCHOL, V6, P219, DOI 10.1016/0301-0511(78)90024-8; Liu AK, 1998, P NATL ACAD SCI USA, V95, P8945, DOI 10.1073/pnas.95.15.8945; Loveless N E, 1974, Biol Psychol, V1, P303, DOI 10.1016/0301-0511(74)90005-2; LOVELESS NE, 1974, J GERONTOL, V29, P52, DOI 10.1093/geronj/29.1.52; Low M., 1979, PROG CLIN NEUROPHYS, V6, P258; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; MCCARTHY G, 1978, NEUROPSYCHOLOGIA, V16, P571, DOI 10.1016/0028-3932(78)90085-4; NAATANEN R, 1987, PSYCHOPHYSIOLOGY, V24, P375, DOI 10.1111/j.1469-8986.1987.tb00311.x; Nagai Y, 2004, NEUROIMAGE, V21, P1232, DOI 10.1016/j.neuroimage.2003.10.036; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; PFURTSCHELLER G, 1982, J NEUROL NEUROSUR PS, V45, P1106, DOI 10.1136/jnnp.45.12.1106; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; ROHRBAUGH JW, 1976, SCIENCE, V191, P1055, DOI 10.1126/science.1251217; ROSAHL SK, 1995, CEREB CORTEX, V5, P123, DOI 10.1093/cercor/5.2.123; Rosler F, 1997, BIOL PSYCHOL, V45, P109, DOI 10.1016/S0301-0511(96)05225-8; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; Rule RR, 2002, COGN AFFECT BEHAV NE, V2, P264, DOI 10.3758/CABN.2.3.264; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; Stuss DT, 2007, PHILOS T R SOC B, V362, P901, DOI 10.1098/rstb.2007.2096; Stuss DT, 1995, ANN NY ACAD SCI, V769, P191, DOI 10.1111/j.1749-6632.1995.tb38140.x; Stuss DT, 2003, BRAIN, V126, P2363, DOI 10.1093/brain/awg237; van Leeuwen TH, 1998, BEHAV BRAIN RES, V94, P97, DOI 10.1016/S0166-4328(97)00173-3; Voytek B, 2010, NEURON, V68, P401, DOI 10.1016/j.neuron.2010.09.018; Voytek B, 2010, J COGNITIVE NEUROSCI, V22, P2491, DOI 10.1162/jocn.2009.21384; WALTER WG, 1964, NATURE, V203, P380, DOI 10.1038/203380a0; Wascher E, 1996, PSYCHOPHYSIOLOGY, V33, P262, DOI 10.1111/j.1469-8986.1996.tb00423.x; Wechsler D., 2011, WECHSLER ABBREVIATED; Weerts T C, 1973, Biol Psychol, V1, P1, DOI 10.1016/0301-0511(73)90010-0; Zappoli R, 2000, INT J PSYCHOPHYSIOL, V38, P109; Zappoli R, 2002, INT J PSYCHOPHYSIOL, V44, P117, DOI 10.1016/S0167-8760(01)00197-0	57	18	19	0	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	AUG 21	2013	1527						174	188		10.1016/j.brainres.2013.06.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	215QM	WOS:000324225400017	23831520	Green Accepted			2022-02-06	
J	Majdan, M; Mauritz, W; Wilbacher, I; Janciak, I; Brazinova, A; Rusnak, M; Leitgeb, J				Majdan, Marek; Mauritz, Walter; Wilbacher, Ingrid; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin; Leitgeb, Johannes			Traumatic brain injuries caused by traffic accidents in five European countries: outcome and public health consequences	EUROPEAN JOURNAL OF PUBLIC HEALTH			English	Article							ADMISSION CHARACTERISTICS; PRACTICAL SCALE; ROAD-USER; HOSPITALIZATION; VALIDATION; SEVERITY; PROFILES; IMPACT; TABLES; COMA	Background: Road traffic accidents (RTAs) have been identified by public health organizations as being of major global concern. Traumatic brain injuries (TBIs) are among the most severe injuries and are in a large part caused by RTA. The objective of this article is to analyse the severity and outcome of TBI caused by RTA in different types of road users in five European countries. Methods: The demographic, severity and outcome measures of 683 individuals with RTA-related TBI from Austria, Slovakia, Bosnia, Croatia and Macedonia were analysed. Five types of road users (car drivers, car passengers, motorcyclists, bicyclists and pedestrians) were compared using univariate and multivariate statistical methods. Short-term outcome [intensive care unit (ICU) survival] and last available long-term outcome of patients were analysed. Results: In our data set, 44% of TBI were traffic related. The median age of patients was 32.5 years, being the lowest (25 years) in car passengers. The most severe and extensive injuries were reported in pedestrians. Pedestrians had the lowest rate of ICU survival (60%) and favourable long-term outcome (46%). Drivers had the highest ICU survival (73%) and car passengers had the best long-term outcome (59% favourable). No differences in the outcome were found between countries with different economy levels. Conclusion: TBI are significantly associated with RTA and thus, tackling them together could be more effective. The population at highest risk of RTA-related TBI are young males (in our sample median age: 32.5 years). Pedestrians have the most severe TBI with the worst outcome. Both groups should be a priority for public health action.	[Majdan, Marek; Brazinova, Alexandra; Rusnak, Martin] Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Trnava 91843, Slovakia; [Majdan, Marek; Mauritz, Walter; Wilbacher, Ingrid; Janciak, Ivan; Brazinova, Alexandra; Rusnak, Martin] INRO, Vienna, Austria; [Leitgeb, Johannes] Med Univ Vienna, Dept Traumatol, Vienna, Austria		Majdan, M (corresponding author), Trnava Univ, Fac Hlth Care & Social Work, Dept Publ Hlth, Hornopotocna 23, Trnava 91843, Slovakia.	mmajdan@igeh.org	Rusnak, Martin/K-9349-2016; Brazinova, Alexandra/C-4265-2016; Majdan, Marek/K-5017-2012	Rusnak, Martin/0000-0003-3321-1042; Brazinova, Alexandra/0000-0003-0625-256X; Majdan, Marek/0000-0001-8037-742X; Mauritz, Walter/0000-0001-9043-3712	European UnionEuropean Commission [ICA2-CT-2002-100]; Austrian Worker's Compensation Board (AUVA) [FK 33/2003]; 'Jubilee Fund' of the Austrian National Bank [8987]; European UnionEuropean Commission; Austrian National Bank (Jubilee Fund); Austrian Worker's Compensation Board; Ala and Ralph Isham	Funding for our work was received from European Union (Project 'Research-Treat- BI'; 6th Framework Program: INCO-DEV: International Cooperation with Developing Countries 1998-2002; Contract number: ICA2-CT-2002-100); Austrian Worker's Compensation Board (AUVA; Contract number FK 33/2003); the 'Jubilee Fund' of the Austrian National Bank (Project number 8987); the International Neurotrauma Research Organisation is supported by an annual grant from Mrs Ala Auersperg-Isham and Mr Ralph Isham, and donations from various sources. Grants from European Union, Austrian National Bank (Jubilee Fund), Austrian Worker's Compensation Board, Ala and Ralph Isham and other private sponsors. Conflicts of interest:	Association for the Advancement of Automotive Medicine (AAAM), 1990, ABBR INJ SCAL 1990 R; Bener Abdulbari, 2009, Int Emerg Nurs, V17, P52, DOI 10.1016/j.ienj.2008.07.007; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Campbell M. J., 2002, STAT SQUARE ONE; COLLINS BA, 1993, NEW ZEAL MED J, V106, P514; Harruff RC, 1998, ACCIDENT ANAL PREV, V30, P11, DOI 10.1016/S0001-4575(97)00057-2; Hukkelhoven CWPM, 2005, J NEUROTRAUM, V22, P1025, DOI 10.1089/neu.2005.22.1025; Javouhey E, 2006, ACCIDENT ANAL PREV, V38, P225, DOI 10.1016/j.aap.2005.08.001; JENNETT B, 1975, LANCET, V1, P480; LANGLEY J, 1994, ACCIDENT ANAL PREV, V26, P549, DOI 10.1016/0001-4575(94)90046-9; Lydersen S, 2007, STAT MED, V26, P4328, DOI 10.1002/sim.2839; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2011, BRAIN INJURY, V25, P797, DOI 10.3109/02699052.2011.581642; Markogiannakis H, 2006, EMERG MED J, V23, P27, DOI 10.1136/emj.2004.022392; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; Mauritz W, 2011, EUR J TRAUMA EMERG S, V37, P387, DOI 10.1007/s00068-010-0053-6; Mayou R, 2003, INJURY, V34, P197, DOI 10.1016/S0020-1383(02)00285-1; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Mohan D, 2003, B WORLD HEALTH ORGAN, V81, P684; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Peden RS Margie, 2004, WORLD REPORT ROAD TR; Rochette LM, 2009, J SAFETY RES, V40, P353, DOI 10.1016/j.jsr.2009.08.003; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Santamarina-Rubio E, 2007, ACCIDENT ANAL PREV, V39, P1, DOI 10.1016/j.aap.2006.06.019; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Team R.C., 2011, R LANG ENV STAT COMP; TEASDALE G, 1974, LANCET, V2, P81; Wong E, 2002, J EMERG MED, V22, P139, DOI 10.1016/S0736-4679(01)00455-3; World Bank, 2011, WE CLASS COUNTR; World Health Organization, 2009, GLOB STAT REP ROAD S	32	18	19	0	12	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1101-1262			EUR J PUBLIC HEALTH	Eur. J. Public Health	AUG	2013	23	4					682	687		10.1093/eurpub/cks074			6	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	190KH	WOS:000322338200028	22689382	Bronze			2022-02-06	
J	Salas, CE; Gross, JJ; Rafal, RD; Vinas-Guasch, N; Turnbull, OH				Salas, Christian E.; Gross, James J.; Rafal, Robert D.; Vinas-Guasch, Nestor; Turnbull, Oliver H.			Concrete behaviour and reappraisal deficits after a left frontal stroke: A case study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Brain injury; Concrete behaviour; Reappraisal; Emotion regulation; Abstraction; Rehabilitation	TRAUMATIC BRAIN-INJURY; EMOTION REGULATION; PREFRONTAL CORTEX; COGNITIVE CONTROL; EXECUTIVE FUNCTIONS; ASSESSMENT BATTERY; HOSPITAL ANXIETY; SELF-REGULATION; VERBAL FLUENCY; EVERYDAY LIFE	Concrete behaviour, the inability to disengage from immediate experience in order to manipulate ideas and thoughts, has long been understood to be a common problem after frontal lobe lesions. However, there has been little consideration of the impact that concreteness may have on emotional functioning, specifically in the use of thinking to manipulate emotional responses. One widely studied emotion regulation strategy is reappraisal, which depends on several frontal lobe related cognitive control processes. While there have been numerous neuroimaging findings on reappraisal, no study has used brain injured patients to investigate this issue. The present case study is the first to describe the capacity to generate reappraisals in a patient (Mrs M), whose behaviour became concrete after a left prefrontal stroke. Using a picture-based reappraisal paradigm, her performance was compared to non-concrete brain-lesioned patients, and neurologically healthy controls. Although Mrs M showed relatively preserved overall cognitive function, she was completely unable to spontaneously generate reappraisals. In striking contrast, once external support was offered, in the form of prompts, her capacity to reappraise dramatically improved. The results are analysed in terms of three neuropsychological capacities - all compromised in Mrs M - previously proposed as reappraisal components: response inhibition, abstraction, and verbal fluency. A number of implications for rehabilitation are discussed, including how the use of prompting may facilitate reappraisal capacity.	[Salas, Christian E.; Rafal, Robert D.; Vinas-Guasch, Nestor; Turnbull, Oliver H.] Bangor Univ, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales; [Gross, James J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Salas, Christian E.] Inst Psiquiatr JH Barak, Unidad Psicoterapia Dinam, Santiago, Chile		Salas, CE (corresponding author), Bangor Univ, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales.	pspa35@bangor.ac.uk	Gross, James/AAM-4104-2020	Vinas-Guasch, Nestor/0000-0002-8661-0103	Government of Chile; Institute for the Study of Affective Neuroscience	This article was supported by a PhD studentship awarded by the Government of Chile to Christian Salas, and by the Institute for the Study of Affective Neuroscience. We appreciate the support and encouragement received by Fergus Gracey while writing this article. We are also grateful of Becca Henderson for helping us to recruit the participants of the study.	Abreau B. C., 2009, LIFE BALANCE MULTIDI, P223; Alexander MP, 2007, NEUROLOGY, V68, P1515, DOI 10.1212/01.wnl.0000261482.99569.fb; Anderson, 1997, IOWA SCALES PERSONAL; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; Barkley RA, 2001, NEUROPSYCHOL REV, V11, P1, DOI 10.1023/A:1009085417776; Barrash J., 2011, J CLIN EXPT NEUROPSY, V33, P1; Beer J. S., 2007, HDB EMOTION REGULATI; Beldarrain MG, 2005, COGNITIVE BRAIN RES, V24, P723, DOI 10.1016/j.cogbrainres.2005.03.013; Benson D.F., 1986, FRONTAL LOBES; Bowen C., 2010, RELATIONAL APPROACH; Bowles B, 2007, P NATL ACAD SCI USA, V104, P16382, DOI 10.1073/pnas.0705273104; Burgess PW, 2006, J INT NEUROPSYCH SOC, V12, P194, DOI 10.1017/S1355617706060310; Carthy T, 2010, BEHAV RES THER, V48, P384, DOI 10.1016/j.brat.2009.12.013; Cattran CJ, 2011, BRAIN INJURY, V25, P1035, DOI 10.3109/02699052.2011.607787; CICERONE KD, 1992, NEUROREHABILITATION, V2, P12, DOI DOI 10.3233/NRE-1992-2304; Costafreda SG, 2006, HUM BRAIN MAPP, V27, P799, DOI 10.1002/hbm.20221; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; Dawkins N, 2006, BRAIN INJURY, V20, P1235, DOI 10.1080/02699050601076414; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demanet J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00336; DERENZI E, 1978, CORTEX, V14, P41, DOI 10.1016/S0010-9452(78)80006-9; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DREWE E A, 1975, Cortex, V11, P8; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Goel V, 2010, WIRES COGN SCI, V1, P613, DOI 10.1002/wcs.71; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Goldstein K, 1936, J NEUROL PSYCHOPATHO, V17, P27; Goldstein K., 1942, AFTEREFFECTS BRAIN I; Goldstein K, 1941, PSYCHOL MONOGR, V53, P1; Goldstein K, 1936, PSYCHIAT QUART, V10, P586, DOI 10.1007/BF01563142; Green MJ, 2006, ACTA NEUROPSYCHIATR, V18, P144, DOI 10.1111/j.1601-5215.2006.00149.x; Gross J.J., 2007, EMOTION REGULATION C, V1st; Gross J. J., 2007, HDB EMOTION REGULATI, V1, P87; Gross JJ, 2011, EMOT REV, V3, P8, DOI 10.1177/1754073910380974; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI [DOI 10.1037/1089-2680.2.3.271, 10.1037/1089-2680.2.3.271]; Gross JJ., 2007, HDB EMOTION REGULATI, P3, DOI DOI 10.1080/00140130600971135; Guedj E, 2008, J NEUROL SCI, V273, P84, DOI 10.1016/j.jns.2008.06.035; Gyurak A, 2012, COGNITION EMOTION, V26, P103, DOI 10.1080/02699931.2011.557291; Gyurak A, 2009, COGN AFFECT BEHAV NE, V9, P144, DOI 10.3758/CABN.9.2.144; Hanfmann E, 1944, PSYCHOL MONOGR, V57, P1; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Cunha PJ, 2010, ADDICT BEHAV, V35, P875, DOI 10.1016/j.addbeh.2010.05.005; Jones SR, 2009, PRIVATE SPEECH, EXECUTIVE FUNCTIONING, AND THE DEVELOPMENT OF VERBAL SELF-REGULATION, P69; JONESGOTMAN M, 1977, NEUROPSYCHOLOGIA, V15, P653, DOI 10.1016/0028-3932(77)90070-7; Joormann J., 2005, COGNITIVE LIMITATION, DOI [10.1017/CBO9780511720413.012, DOI 10.1017/CB09780511720413.012, DOI 10.1017/CBO9780511720413.012]; Judd T, 1999, NEUROPSYCHOTHERAPY C; Kalisch R, 2009, NEUROSCI BIOBEHAV R, V33, P1215, DOI 10.1016/j.neubiorev.2009.06.003; Klonoff P. S., 2010, PSYCHOTHERAPY BRAIN; Lang P. J., 2008, TECH REP A 8; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; LHERMITTE F, 1986, ANN NEUROL, V19, P326, DOI 10.1002/ana.410190404; Lieberman MD, 2011, EMOTION, V11, P468, DOI 10.1037/a0023503; Luria A.R., 1966, HIGHER CORTICAL FUNC; Luria A. R., 1960, PERSPECTIVES PERSONA, V139-149; LURIA AR, 1959, WORD, V15, P341, DOI 10.1080/00437956.1959.11659703; Luria AR, 1963, RESTORATION FUNCTION; Maguire EA, 2006, BRAIN, V129, P2894, DOI 10.1093/brain/awl286; McDonald S., 2010, J CLIN EXPT NEUROPSY, P1; McRae K, 2012, EMOTION, V12, P250, DOI 10.1037/a0026351; McRae K, 2012, J RES PERS, V46, P2, DOI 10.1016/j.jrp.2011.10.003; McRae K, 2012, SOC COGN AFFECT NEUR, V7, P253, DOI 10.1093/scan/nsq103; McRae K, 2010, J COGNITIVE NEUROSCI, V22, P248, DOI 10.1162/jocn.2009.21243; Mesulam MM, 2000, PRINCIPLES BEHAV COG; Mesulam MM, 2002, PRINCIPLES FRONTAL L, P8, DOI [10.1093/acprof:oso/9780195134971.003.0002, DOI 10.1093/ACPROF:OSO/9780195134971.003.0002]; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Morin Alain, 2012, Open Neuroimag J, V6, P78, DOI 10.2174/1874440001206010078; Muller U, 2009, PRIVATE SPEECH, EXECUTIVE FUNCTIONING, AND THE DEVELOPMENT OF VERBAL SELF-REGULATION, P53; Niven K, 2009, EMOTION, V9, P498, DOI 10.1037/a0015962; Obonsawin MC, 2007, J NEUROL NEUROSUR PS, V78, P1239, DOI 10.1136/jnnp.2004.052654; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Oei NYL, 2012, SOC COGN AFFECT NEUR, V7, P403, DOI 10.1093/scan/nsr024; Ogden J., 1996, FRACTURED MINDS CASE; PERRET E, 1974, NEUROPSYCHOLOGIA, V12, P323, DOI 10.1016/0028-3932(74)90047-5; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; PONSFORD J, 1995, TRAUMATIC BRAIN INJU; PRIGATANO GP, 1989, B MENNINGER CLIN, V53, P414; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Ray RD, 2010, EMOTION, V10, P587, DOI 10.1037/a0019015; Rees SA, 2011, INT J INCLUSIVE EDUC, V15, P925, DOI 10.1080/13603110903464361; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Rime B., 2007, HDB EMOTION REGULATI, P466; Robertson I., 1994, TEST EVERYDAY ATTENT; Robertson I H, 1996, J Int Neuropsychol Soc, V2, P525; Robinson G, 2012, BRAIN, V135, P2202, DOI 10.1093/brain/aws142; Robinson G, 2010, NEUROPSYCHOLOGIA, V48, P1652, DOI 10.1016/j.neuropsychologia.2010.02.010; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; ROVNER BW, 1987, HOSP PRACT, V22, P99; Salas C. E., 2011, EMOTION, DOI [10.1037/a002581, DOI 10.1037/A002581]; Salas C. E., 2012, NEUROPSYCHOANALYSIS, V14, P77, DOI DOI 10.1080/15294145.2012.10773691; Salas C. E., OPENING NEW IN PRESS; Salas C.E., 2013, J NEURO DISABIL PSYC, V1, P1; Sarazin M, 1998, NEUROLOGY, V51, P142, DOI 10.1212/WNL.51.1.142; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; SCHERER KR, 1986, MOTIV EMOTION, V10, P295, DOI 10.1007/BF00992106; Scherer KR, 2004, SOC SCI INFORM, V43, P499, DOI 10.1177/0539018404047701; Schiltz C, 2006, CEREB CORTEX, V16, P574, DOI 10.1093/cercor/bhj005; Schmeichel BJ, 2008, J PERS SOC PSYCHOL, V95, P1526, DOI 10.1037/a0013345; Scott JG, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P219, DOI 10.1007/978-0-387-76978-3_10; Shallice T., 2008, CORTEX, P1; Sheppes G, 2011, PERS SOC PSYCHOL REV, V15, P319, DOI 10.1177/1088868310395778; Sherer M, 1998, J INT NEUROPSYCH SOC, V4, P380, DOI 10.1017/S1355617798003804; STERN RA, 1994, CLIN NEUROPSYCHOL, V8, P309, DOI 10.1080/13854049408404137; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Tate RL, 1999, CORTEX, V35, P39, DOI 10.1016/S0010-9452(08)70784-6; Urry HL, 2010, EMOTION, V10, P125, DOI 10.1037/a0017434; Vanderhasselt M. A., 2012, BIOL PSYCHOL, P1; Vygotsky L.V., 1986, THOUGHT LANGUAGE; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED; Whitmer AJ, 2007, PSYCHOL SCI, V18, P546, DOI 10.1111/j.1467-9280.2007.01936.x; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Winsler A, 2009, PRIVATE SPEECH, EXECUTIVE FUNCTIONING, AND THE DEVELOPMENT OF VERBAL SELF-REGULATION, P3; Ylvisaker M., 2000, BRAIN IMPAIR, V1, P12, DOI [DOI 10.1375/BRIM.1.1.12, 10.1375/brim.1.1.12]; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	121	18	18	0	20	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.	AUG 1	2013	23	4					467	500		10.1080/09602011.2013.784709			34	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	187WG	WOS:000322151600001	23551078				2022-02-06	
J	Sillesen, M; Jin, G; Oklu, R; Albadawi, H; Imam, AM; Jepsen, CH; Hwabejire, JO; Ostrowski, SR; Johansson, PI; Rasmussen, LS; Alam, HB				Sillesen, Martin; Jin, Guang; Oklu, Rahmi; Albadawi, Hassan; Imam, Ayesha M.; Jepsen, Cecilie H.; Hwabejire, John O.; Ostrowski, Sisse R.; Johansson, Par I.; Rasmussen, Lars S.; Alam, Hasan B.			Fresh-frozen plasma resuscitation after traumatic brain injury and shock attenuates extracellular nucleosome levels and deoxyribonuclease 1 depletion	SURGERY			English	Article							ENDOTHELIAL GLYCOCALYX; DNA TRAPS; HISTONES; MARKER; PATHOGENESIS; INFLAMMATION; DEGRADATION; MORTALITY; DEATH; MODEL	Introduction. Traumatic brain injury and shock are among the leading causes of trauma-related mortality. We have previously shown that fresh-frozen plasma (FFP) resuscitation reduces the size of brain lesion and associated swelling compared with crystalloids. We hypothesized that this, effect would be associated with an attenuation of circulating nucleosome levels, a biomarker of injury with cytotoxic potential, through reconstitution of circulating deoxyribonuclease-1 (DNAse1), an enzyme identified as critical in nucleosome clearance from the circulation. Methods. Twelve swine underwent a protocol of traumatic brain injury followed by 40% volume-controlled hemorrhage. Animals were left in shock (mean arterial pressure of 35 mmHg) for 2 hours before they were resuscitated with normal saline (NS) or FFP Circulating levels of nucleosomes and DNAse1 were measured whereas extracellular nucleosomes were quantified on brain histology. Lesion size and brain swelling were also quantified. Results. Nucleosome levels were significantly greater in the NS group 6 hours after resuscitation (0.32 mU vs 0.15 mU, P = .030) whereas DNAse1 levels were substantially greater in the FFP group (9.82 ng/mL vs 4.54 ng/mL, P = .010). Circulating nucleosomes levels correlated with lesion size (rho = 0.79, P = .002) as well as brain swelling (rho = 0.89, P < .001) whereas DNAse1 levels correlated with brain swelling (rho = -0.61, P =.036) but not lesion size (rho = -0.47, P = .124). Brain staining revealed nucleosome extracellularization in both groups, but this appeared more frequent in the NS-resuscitated animals. Conclusion. Our results show that resuscitation with FFP attenuates circulating. nucleosome levels and prevents DNAse1 depletion. These factors may play a role in the neuroprotective effects observed during early resuscitation with FFP.	[Sillesen, Martin; Jin, Guang; Imam, Ayesha M.; Jepsen, Cecilie H.; Hwabejire, John O.; Alam, Hasan B.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Trauma Emergency Surg & Surg Crit Care,Dept S, Boston, MA USA; [Sillesen, Martin; Rasmussen, Lars S.] Copenhagen Univ Hosp, Dept Anesthesia, Ctr Head & Orthoped, Copenhagen, Denmark; [Jin, Guang; Alam, Hasan B.] Univ Ann Arbor Hosp, Dept Surg, Ann Arbor, MI USA; [Oklu, Rahmi] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Vasc Imaging & Intervent, Boston, MA USA; [Albadawi, Hassan] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Vasc & Endovasc Surg, Boston, MA USA; [Ostrowski, Sisse R.; Johansson, Par I.] Copenhagen Univ Hosp, Sect Transfus Med, Copenhagen, Denmark; [Johansson, Par I.] Univ Texas Hlth Sci Ctr Houston, Dept Surg, Houston, TX 77030 USA		Alam, HB (corresponding author), Univ Michigan Hosp, Taubman Ctr 5331 2920, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	alamh@med.umich.edu	Johansson, Par I/P-9283-2015; oklu, rahmi/AAY-4676-2021; Ostrowski, Sisse R/E-7423-2011	Johansson, Par I/0000-0001-9778-5964; Ostrowski, Sisse R/0000-0001-5288-3851; Sillesen, Martin/0000-0001-9494-5475; Rasmussen, Lars/0000-0002-7480-3004	U.S. Army Medical Research Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [GRANTT00521959]; Rigshospitalet (Copenhagen University Hospital, Denmark); Tryg Foundation (Denmark)	The study was funded by U.S. Army Medical Research Materiel Command (GRANTT00521959; to H.A.), a grant from Rigshospitalet (Copenhagen University Hospital, Denmark; to M.S.), and L.S.R. has received a grant from the Tryg Foundation (Denmark).	Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS7; Brill A, 2012, J THROMB HAEMOST, V10, P136, DOI 10.1111/j.1538-7836.2011.04544.x; Brown LM, 2011, J TRAUMA, V71, pS358, DOI 10.1097/TA.0b013e318227f152; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; De Meyer SF, 2012, ARTERIOSCL THROM VAS, V32, P1884, DOI 10.1161/ATVBAHA.112.250993; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Fuchs TA, 2011, BLOOD, V118, P3708, DOI 10.1182/blood-2011-01-332676; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Geiger S, 2007, J NEUROL, V254, P617, DOI 10.1007/s00415-006-0407-5; Hakkim A, 2010, P NATL ACAD SCI USA, V107, P9813, DOI 10.1073/pnas.0909927107; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Jin G, 2012, SHOCK, V38, P49, DOI 10.1097/SHK.0b013e3182574778; Johansson PI, 2011, ANN SURG, V254, P194, DOI 10.1097/SLA.0b013e318226113d; Kawai Y, 2004, CIRCULATION, V109, P2398, DOI 10.1161/01.CIR.0000129232.61483.43; Kominato Y, 2007, BBA-GEN SUBJECTS, V1770, P1567, DOI 10.1016/j.bbagen.2007.08.012; Kozar RA, 2011, ANESTH ANALG, V112, P1289, DOI 10.1213/ANE.0b013e318210385c; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Longstaff C, 2013, J BIOL CHEM, V288, P6946, DOI 10.1074/jbc.M112.404301; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Mannherz H G, 1995, Curr Top Microbiol Immunol, V198, P161; Martinez-Valle F, 2009, LUPUS, V18, P418, DOI 10.1177/0961203308098189; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; Meng W, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/149560; Oklu R, 2012, J VASC INTERV RADIOL, V23, P712, DOI 10.1016/j.jvir.2012.01.072; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053	29	18	18	0	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0039-6060			SURGERY	Surgery	AUG	2013	154	2					197	205		10.1016/j.surg.2013.04.002			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	196UB	WOS:000322801800008	23889948				2022-02-06	
J	Khaksari, M; Mahmmodi, R; Shahrokhi, N; Shabani, M; Joukar, S; Aqapour, M				Khaksari, Mohammad; Mahmmodi, Reza; Shahrokhi, Nader; Shabani, Mohammad; Joukar, Siavash; Aqapour, Mobin			The Effects of Shilajit on Brain Edema, Intracranial Pressure and Neurologic Outcomes following the Traumatic Brain Injury in Rat	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Brain edema; Intracranial pressure; Rat; Shilajit; Trauma	MICROGLIAL ACTIVATION; METALLOPROTEINASES; INHIBITORS; BARRIER	Objective(s): Brain edema is one of the most serious causes of death within the first few days after trauma brain injury (TBI). In this study we have investigated the role of Shilajit on brain edema, blood-brain barrier (BBB) permeability, intracranial pressure (ICP) and neurologic outcomes following brain trauma. Materials and Methods: Diffuse traumatic brain trauma was induced in rats by drop of a 250 g weight from a 2 m high (Marmarou's methods). Animals were randomly divided into 5 groups including sham, TBI, TBI-vehicle, TBI-Shi150 group and TBI-Shi250 group. Rats were undergone intraperitoneal injection of Shilajit and vehicle at 1, 24, 48 and 72 hr after trauma. Brain water content, BBB permeability, ICP and neurologic outcomes were finally measured. Results: Brain water and Evans blue dye contents showed significant decrease in Shilajit-treated groups compared to the TBI-vehicle and TBI groups. Intracranial pressure at 24, 48 and 72 hr after trauma had significant reduction in Shilajit-treated groups as compared to TBI-vehicle and TBI groups (P<0.001). The rate of neurologic outcomes improvement at 4, 24, 48 and 72 hr after trauma showed significant increase in Shilajit-treated groups in comparison to theTBI-vehicle and TBI groups (P<0.001). Conclusion: The present results indicated that Shilajit may cause in improvement of neurologic outcomes through decreasing brain edema, disrupting of BBB, and ICP after the TBI.	[Khaksari, Mohammad; Joukar, Siavash] Kerman Univ Med Sci, Physiol Res Ctr, Kerman, Iran; [Mahmmodi, Reza] Jiroft Educ, Jiroft, Iran; [Shahrokhi, Nader; Shabani, Mohammad] Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran; [Aqapour, Mobin] Mobin Kahroba Kimia Co, Kerman, Iran		Shahrokhi, N (corresponding author), Kerman Univ Med Sci, Neurosci Res Ctr, Kerman, Iran.	nshahrokhi@kmu.ac.ir	Shahrokhi, Nader/AAV-3747-2020; Haddad, Mohammad Khaksari/AAB-9025-2019; Shabani, Mohammad/AAZ-3682-2020	Shahrokhi, Nader/0000-0002-0149-7819; Haddad, Mohammad Khaksari/0000-0003-0770-4281; Shabani, Mohammad/0000-0002-2082-5849; Joukar, Siyavash/0000-0002-9937-6985	Neuroscience Research Center of Kerman University of Medical Sciences, Kerman, Iran	The present study was financially supported by the Neuroscience Research Center of Kerman University of Medical Sciences, Kerman, Iran.	Agarwal SP, 2007, PHYTOTHER RES, V21, P401, DOI 10.1002/ptr.2100; Aiello A, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1093/ecam/nen072; Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; [Anonymous], 1991, B D MATERIA MED AYUR; [Anonymous], 1992, PHYTOTHER RES, V6, P163; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; BHATTACHARYA SK, 1995, PHYTOTHER RES, V9, P56, DOI 10.1002/ptr.2650090113; BHATTACHARYA SK, 1992, PHYTOTHER RES, V6, P163, DOI 10.1002/ptr.2650060315; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Domowicz MS, 2011, BRAIN RES, V1389, P35, DOI 10.1016/j.brainres.2011.03.006; Education MoHaM, 2001, DEV COORD STAT YB MO; Faden AI, 2011, ANN NEUROL, V70, P345, DOI 10.1002/ana.22555; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Garedew A, 2004, THERMOCHIM ACTA, V417, P301, DOI 10.1016/j.tca.2003.09.034; GHOSAL S, 1993, PHYTOTHER RES, V7, P29, DOI 10.1002/ptr.2650070109; GHOSAL S, 1989, PHYTOTHER RES, V3, P249, DOI 10.1002/ptr.2650030606; GHOSAL S, 1990, PURE APPL CHEM, V62, P1285, DOI 10.1351/pac199062071285; Ghosal S, 1988, PHYTOTHER RES, V2, P187, DOI [10.1002/ptr.2650020408, DOI 10.1002/PTR.2650020408]; GOEL RK, 1990, J ETHNOPHARMACOL, V29, P95, DOI 10.1016/0378-8741(90)90102-Y; Jaeger M, 2010, CRIT CARE MED, V38, P1343, DOI 10.1097/CCM.0b013e3181d45530; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; KEL'GINBAEV N S, 1973, Eksperimental'naya Khirurgiya i Anesteziologiya, V18, P31; Keshavarzi Z, 2012, IRAN J BASIC MED SCI, V15, P1102; Khaksari M, 2011, CAN J PHYSIOL PHARM, V89, P31, DOI [10.1139/Y10-103, 10.1139/y10-103]; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Lee H, 2005, J NUTR, V135, P544, DOI 10.1093/jn/135.3.544; Lu J, 2009, FRONT BIOSCI-LANDMRK, V14, P3795, DOI 10.2735/3489; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Meena Harsahay, 2010, Int J Ayurveda Res, V1, P37, DOI 10.4103/0974-7788.59942; MILDE LN, 1985, ANESTHESIOLOGY, V63, P371, DOI 10.1097/00000542-198510000-00005; Mohd Aamir Mirza MNA, 2010, INT J CURRENT PHARM, V1, P2; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Oddo M, 2011, NEUROSURGERY, V69, P1037, DOI 10.1227/NEU.0b013e3182287ca7; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pegg CC, 2010, J NEUROSCI METH, V187, P8, DOI 10.1016/j.jneumeth.2009.12.002; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Roberts I, 1998, J NEUROL NEUROSUR PS, V65, P729, DOI 10.1136/jnnp.65.5.729; Rogatsky GG, 2005, BRAIN RES, V1047, P131, DOI 10.1016/j.brainres.2005.02.049; Rooker S, 2003, J NEUROSCI METH, V131, P75, DOI 10.1016/S0165-0270(03)00233-4; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sarkaki AR, 2011, J NEUROTRAUM, V18; Shahlaie K, 2009, NEUROCRIT CARE, V10, P61, DOI 10.1007/s12028-008-9138-z; Shahrokhi N, 2010, CAN J PHYSIOL PHARM, V88, P414, DOI [10.1139/Y09-126, 10.1139/y09-126]; SHAKUROV A Sh, 1965, Ortop Travmatol Protez, V26, P24; Spassov V, 1994, EUR NEUROPSYCHOPHARM, V4, P396; Takasugi Y, 2005, EXP ANIM TOKYO, V54, P193, DOI 10.1538/expanim.54.193; Thawatchai Phaechamud JC, 2008, SILPAKORN U SIENCE T, V2, P7; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Yin H, 2011, KOREAN J PHYSIOL PHA, V15, P285, DOI 10.4196/kjpp.2011.15.5.285	50	18	20	0	4	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	JUL	2013	16	7					858	864					7	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	298LL	WOS:000330325300008	23997917				2022-02-06	
J	Kim, JY; Kim, N; Yenari, MA; Chang, WH				Kim, Jong Youl; Kim, Nuri; Yenari, Midori A.; Chang, Wenhan			Hypothermia and Pharmacological Regimens that Prevent Overexpression and Overactivity of the Extracellular Calcium-Sensing Receptor Protect Neurons against Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						calcilytics; calcium-sensing receptor; CaSR; controlled cortical impact; extracellular calcium-sensing receptor; hypothermia, neuroprotection; traumatic brain injury; type B GABA receptor	CLOMETHIAZOLE ACUTE STROKE; OUTWARD K+ CHANNEL; EXPRESSION; SECRETION; IMPACT; CELLS	Traumatic brain injury (TBI) leads to acute functional deficit in the brain. Molecular events underlying TBI remain unclear. In mouse brains, we found controlled cortical impact (CCI) injury induced overexpression of the extracellular calcium-sensing receptor (CaSR), which is known to stimulate neuronal activity and accumulation of intracellular Ca2+ and concurrent down-regulation of type B or metabotropic GABA receptor 1 (GABA-B-R1), a prominent inhibitory pathway in the brain. These changes in protein expression preceded and were closely associated with the loss of brain tissue, as indicated by the increased size of cortical cavity at impact sites, and the development of motor deficit, as indicated by the increased frequency of right-biased swing and turn in the CCI mice. Mild hypothermia, an established practice of neuroprotection for brain ischemia, partially but significantly blunted all of the above effects of CCI. Administration of CaSR antagonist NPS89636 mimicked hypothermia to reduce loss of brain tissue and motor functions in the CCI mice. These data together support the concept that CaSR overexpression and overactivity play a causal role in potentiating TBI potentially by stimulating excitatory neuronal responses and by interfering with inhibitory GABA-B-R signaling and that the CaSR could be a novel target for neuroprotection against TBI.	[Kim, Jong Youl; Chang, Wenhan] Univ Calif San Francisco, Endocrine Unit, San Francisco, CA 94143 USA; [Kim, Jong Youl; Kim, Nuri; Yenari, Midori A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA		Chang, WH (corresponding author), Vet Affairs Med Ctr, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	Yenari@alum.mit.edu; Wenhan.chang@alum.mit.edu		Hegelmeyer, Nuri/0000-0003-3606-0155	NIH NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG21353]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS40516, P50 NS014543]; Department of DefenseUnited States Department of Defense; Department of Veterans AffairsUS Department of Veterans Affairs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50NS014543, R01NS040516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG021353] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX001960] Funding Source: NIH RePORTER	We thank Dr. Edward Nemeth for providing the invaluable NPS89636 compound for this study. This work was supported by grants from: NIH NIA (AG21353 to WC), NINDS (NS40516, P50 NS014543 to MAY), the Department of Defense (WC, MAY), and Department of Veterans Affairs (WC, MAY).	Bandyopadhyay S, 2007, J NEUROSCI RES, V85, P882, DOI 10.1002/jnr.21177; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Chang EF, 2003, J NEUROSCI, V23, P3689; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Chang WH, 2004, CELL CALCIUM, V35, P183, DOI 10.1016/j.ceca.2003.10.012; Chattopadhyay N, 1999, GLIA, V26, P64, DOI 10.1002/(SICI)1098-1136(199903)26:1<64::AID-GLIA7>3.0.CO;2-X; Chattopadhyay N, 1999, J NEUROCHEM, V72, P1915, DOI 10.1046/j.1471-4159.1999.0721915.x; Chattopadhyay N, 2007, AM J PHYSIOL-ENDOC M, V292, pE523, DOI 10.1152/ajpendo.00372.2005; Davies SL, 2007, J BIOL CHEM, V282, P15048, DOI 10.1074/jbc.M607469200; Davies SL, 2006, AM J PHYSIOL-CELL PH, V290, pC1543, DOI 10.1152/ajpcell.00482.2005; DeLorenzo RJ, 2005, PHARMACOL THERAPEUT, V105, P229, DOI 10.1016/j.pharmthera.2004.10.004; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Dixon CE, 1998, J NEUROTRAUM, V15, P95, DOI 10.1089/neu.1998.15.95; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; FAROOQUI AA, 1994, J NEUROSCI RES, V38, P6, DOI 10.1002/jnr.490380103; Gilby KL, 2005, BRAIN RES, V1035, P196, DOI 10.1016/j.brainres.2004.12.015; Kim J.Y., 2011, 41 SOC NEUR ANN M WA; Kim JY, 2011, TRANSL STROKE RES, V2, P195, DOI 10.1007/s12975-011-0082-4; Kumar S, 2010, BONE, V46, P534, DOI 10.1016/j.bone.2009.09.028; Lyden P, 2002, STROKE, V33, P122, DOI 10.1161/hs0102.101478; Lyden P, 2001, NEUROLOGY, V57, P1199, DOI 10.1212/WNL.57.7.1199; Munoz A, 2002, J COMP NEUROL, V449, P166, DOI 10.1002/cne.10287; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Povlishock JT, 2009, J NEUROTRAUM, V26, P333, DOI 10.1089/neu.2008.0604; Shah MP, 2011, STROKE RES TREAT, V2011, DOI 10.4061/2011/791639; Sun JH, 2010, AM J PHYSIOL-HEART C, V299, pH1309, DOI 10.1152/ajpheart.00373.2010; Tang MN, 2007, J NUCL MED, V48, P1822, DOI 10.2967/jnumed.107.041335; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wahlgren N G, 2000, J Stroke Cerebrovasc Dis, V9, P32, DOI 10.1053/jscd.2000.19320; Wahlgren NG, 1999, STROKE, V30, P21, DOI 10.1161/01.STR.30.1.21; Washburn DLS, 1999, EUR J NEUROSCI, V11, P1947, DOI 10.1046/j.1460-9568.1999.00619.x; Yano S, 2004, CELL CALCIUM, V35, P257, DOI 10.1016/j.ceca.2003.10.008; Ye CP, 2000, BONE, V27, P21, DOI 10.1016/S8756-3282(00)00288-X; Yenari MA, 2000, BRAIN RES, V885, P208, DOI 10.1016/S0006-8993(00)02942-5; YOUNG W, 1992, J NEUROTRAUM, V9, pS9	35	18	20	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	13					1170	1176		10.1089/neu.2012.2691			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	174WB	WOS:000321186400008	23360235	Green Published, Green Submitted			2022-02-06	
J	Taylor, AN; Tio, DL; Sutton, RL				Taylor, Anna N.; Tio, Delia L.; Sutton, Richard L.			Restoration of Neuroendocrine Stress Response by Glucocorticoid Receptor or GABA(A) Receptor Antagonists after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bicuculline; corticosterone; glutamic acid decarboxylase 67; mifepristone; parvalbumin	CORTICOTROPIN-RELEASING HORMONE; PREFRONTAL CORTEX; EXPRESSION; RAT; DEXAMETHASONE; INVOLVEMENT; SECONDARY; VETERANS; NEURONS; AXIS	We previously reported that traumatic brain injury (TBI) produced by moderate controlled cortical impact (CCI) attenuates the stress response of the hypothalamic-pituitary-adrenal (HPA) axis between 21 and 70 days postinjury and enhances the sensitivity of the stress response to glucocorticoid negative feedback. In the current study, we investigated two possible mechanisms for the CCI-induced attenuation of the HPA stress response-i.e, glucocorticoid receptor (GR) and GABA-mediated inhibition of the HPA axis, with the GR antagonist, mifepristone (RU486), or the GABA(A)-receptor antagonist, bicuculline. In addition, we examined the effect of moderate CCI on GR and inhibitory neurons histologically in subfields of the hippocampus, medial prefrontal cortex, and amygdala. We show that at 30-min after onset of restraint stress, GR as well as GABA antagonism with MIFE or BIC, respectively, reversed the attenuating effects of moderate CCI on the stress-induced HPA response. Our histological results demonstrate that moderate CCI led to a loss of glutamic acid decarboxylase 67 or parvalbumin-positive inhibitory neurons within regions of the hippocampus and amygdala but did not lead to significant increases in GR in these regions. These findings indicate that suppression of the stress-induced HPA response after moderate CCI is mediated by the inhibitory actions of both GR and GABA, with a corresponding loss of inhibitory neurons within brain regions with neural pathways affecting limbic stress-integrative pathways.	[Taylor, Anna N.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; [Taylor, Anna N.; Sutton, Richard L.] Univ Calif Los Angeles, David Geffen Sch Med, Brain Injury Res Ctr, Dept Neurobiol, Los Angeles, CA 90095 USA; [Tio, Delia L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA		Taylor, AN (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, 10833 Le Conte Ave,Box 951763, Los Angeles, CA 90095 USA.	ataylor@mednet.ucla.edu			UCLA Brain Injury Research Center	We thank Tracy Papathakis, Yvonne Xuanhang Pham, and Amanda Dao for their excellent technical assistance and Sima Ghavim for her expert assistance with the histological preparations. This research was supported by the UCLA Brain Injury Research Center.	Agha A, 2007, BRIT J NEUROSURG, V21, P210, DOI 10.1080/02688690701253331; Akana SF, 2001, J NEUROENDOCRINOL, V13, P625, DOI 10.1046/j.1365-2826.2001.00676.x; Beleslin DB, 1997, ALCOHOL, V14, P167, DOI 10.1016/S0741-8329(96)00140-1; Benvenga S, 2000, J CLIN ENDOCR METAB, V85, P1353, DOI 10.1210/jc.85.4.1353; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cernak I, 1999, BRAIN INJURY, V13, P1005; Cohan P, 2005, CRIT CARE MED, V33, P2358, DOI 10.1097/01.CCM.0000181735.51183.A7; Cullinan WE, 2008, BRAIN STRUCT FUNCT, V213, P63, DOI 10.1007/s00429-008-0192-2; de Kloet CS, 2007, PSYCHONEUROENDOCRINO, V32, P215, DOI 10.1016/j.psyneuen.2006.12.009; de Kloet ER, 2000, EUR J PHARMACOL, V405, P187, DOI 10.1016/S0014-2999(00)00552-5; Di S, 2009, J NEUROSCI, V29, P393, DOI 10.1523/JNEUROSCI.4546-08.2009; DIORIO D, 1993, J NEUROSCI, V13, P3839; Furay AR, 2008, ENDOCRINOLOGY, V149, P5482, DOI 10.1210/en.2008-0642; Gibson CJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-38; Golarai G, 2001, J NEUROSCI, V21, P8523, DOI 10.1523/JNEUROSCI.21-21-08523.2001; Gottesfeld Z, 2002, J NEUROTRAUM, V19, P317, DOI 10.1089/089771502753594882; Grundy PL, 2001, J NEUROTRAUM, V18, P1373, DOI 10.1089/08977150152725669; Guo AL, 1996, J ENDOCRINOL INVEST, V19, P83, DOI 10.1007/BF03349841; Haller J, 2008, FRONT NEUROENDOCRIN, V29, P273, DOI 10.1016/j.yfrne.2007.10.004; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; HERMAN JP, 1993, CELL MOL NEUROBIOL, V13, P349, DOI 10.1007/BF00711577; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Kobori N, 2006, J NEUROSCI, V26, P4236, DOI 10.1523/JNEUROSCI.4687-05.2006; Kohda K, 2007, NEUROSCIENCE, V148, P22, DOI 10.1016/j.neuroscience.2007.05.041; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; Miklos IH, 2002, NEUROSCIENCE, V113, P581, DOI 10.1016/S0306-4522(02)00147-1; Moro N, 2010, EXP NEUROL, V225, P391, DOI 10.1016/j.expneurol.2010.07.013; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V400; Roe SY, 1998, EUR J NEUROSCI, V10, P553, DOI 10.1046/j.1460-9568.1998.00064.x; Shohami E, 1995, J NEUROTRAUM, V12, P1069, DOI 10.1089/neu.1995.12.1069; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; Tasker JG, 2006, ENDOCRINOLOGY, V147, P5549, DOI 10.1210/en.2006-0981; Taylor AN, 2002, J NEUROTRAUM, V19, P1597, DOI 10.1089/089771502762300256; Taylor AN, 2008, J NEUROTRAUM, V25, P311, DOI 10.1089/neu.2007.0486; Taylor AN, 2010, J NEUROTRAUM, V27, P1081, DOI 10.1089/neu.2009.1252; Taylor AN, 2006, J NEUROTRAUM, V23, P1802, DOI 10.1089/neu.2006.23.1802; Toth Z, 1997, J NEUROSCI, V17, P8106; Walilko T, 2009, J TRAUMA, V67, P1311, DOI 10.1097/TA.0b013e31819adc36; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	42	18	19	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2013	30	14					1250	1256		10.1089/neu.2012.2847			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	183MV	WOS:000321821100005	23384619	Green Published			2022-02-06	
J	Schoch, KM; von Reyn, CR; Bian, JF; Telling, GC; Meaney, DF; Saatman, KE				Schoch, Kathleen M.; von Reyn, Catherine R.; Bian, Jifeng; Telling, Glenn C.; Meaney, David F.; Saatman, Kathryn E.			Brain injury-induced proteolysis is reduced in a novel calpastatin-overexpressing transgenic mouse	JOURNAL OF NEUROCHEMISTRY			English	Article						calcium; calpain; CRMP-2; protease; sodium channel; spectrin	ALPHA-II-SPECTRIN; CALPAIN-MEDIATED PROTEOLYSIS; BREAKDOWN PRODUCTS; NEURITE OUTGROWTH; PROTEIN-2 CRMP2; PRION PROTEIN; INHIBITOR; MICE; NEURODEGENERATION; CLEAVAGE	The calpain family of calcium-dependent proteases has been implicated in a variety of diseases and neurodegenerative pathologies. Prolonged activation of calpains results in proteolysis of numerous cellular substrates including cytoskeletal components and membrane receptors, contributing to cell demise despite coincident expression of calpastatin, the specific inhibitor of calpains. Pharmacological and gene-knockout strategies have targeted calpains to determine their contribution to neurodegenerative pathology; however, limitations associated with treatment paradigms, drug specificity, and genetic disruptions have produced inconsistent results and complicated interpretation. Specific, targeted calpain inhibition achieved by enhancing endogenous calpastatin levels offers unique advantages in studying pathological calpain activation. We have characterized a novel calpastatin-overexpressing transgenic mouse model, demonstrating a substantial increase in calpastatin expression within nervous system and peripheral tissues and associated reduction in protease activity. Experimental activation of calpains via traumatic brain injury resulted in cleavage of -spectrin, collapsin response mediator protein-2, and voltage-gated sodium channel, critical proteins for the maintenance of neuronal structure and function. Calpastatin overexpression significantly attenuated calpain-mediated proteolysis of these selected substrates acutely following severe controlled cortical impact injury, but with no effect on acute hippocampal neurodegeneration. Augmenting calpastatin levels may be an effective method for calpain inhibition in traumatic brain injury and neurodegenerative disorders.	[Schoch, Kathleen M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Schoch, Kathleen M.; Saatman, Kathryn E.] Univ Kentucky, Coll Med, Dept Physiol, Lexington, KY 40536 USA; [von Reyn, Catherine R.; Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [von Reyn, Catherine R.] Janelia Farm Res Campus HHMI, Ashburn, VA USA; [Bian, Jifeng; Telling, Glenn C.] Colorado State Univ, PRC, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA		Saatman, KE (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, B473 Biomed & Biol Sci Res Bldg BBSRB,741 South L, Lexington, KY 40536 USA.	k.saatman@uky.edu	Bian, Jifeng/AAE-6262-2019; Telling, Glenn C/G-1217-2019	Bian, Jifeng/0000-0001-6838-9938; Telling, Glenn C/0000-0002-6294-1805; von Reyn, Catherine/0000-0002-5753-2134; Meaney, David/0000-0002-0954-4122	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [F31 NS071804, T32 DA0222738, P30 NS051220, P01 NS058484, P01 NS056202]; Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) [6-12]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [F31NS071804, P01NS056202, P30NS051220, P01NS058484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [T32DA022738] Funding Source: NIH RePORTER	This work was funded by NIH grants F31 NS071804 (KMS), T32 DA0222738 (KMS), P30 NS051220, P01 NS058484 (KES), and P01 NS056202 (DFM), and Kentucky Spinal Cord and Head Injury Research Trust (KSCHIRT) 6-12 (KES). The authors have no conflicts of interest.	Anagli J, 2009, BIOCHEM BIOPH RES CO, V385, P94, DOI 10.1016/j.bbrc.2009.04.141; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Barmada S, 2004, NEUROBIOL DIS, V16, P527, DOI 10.1016/j.nbd.2004.05.005; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Bretin S, 2006, J NEUROCHEM, V98, P1252, DOI 10.1111/j.1471-4159.2006.03969.x; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; Brittain JM, 2009, J BIOL CHEM, V284, P31375, DOI 10.1074/jbc.M109.009951; Camins A, 2006, CNS DRUG REV, V12, P135, DOI 10.1111/j.1527-3458.2006.00135.x; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Institute of Laboratory Animal Resources (US), 2011, COMM CAR US LAB AN G; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Kupina NC, 2001, J NEUROTRAUM, V18, P1229, DOI 10.1089/089771501317095269; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; MAKI M, 1987, FEBS LETT, V223, P174, DOI 10.1016/0014-5793(87)80531-8; McCollum AT, 2006, EXP NEUROL, V202, P506, DOI 10.1016/j.expneurol.2006.07.016; Moldoveanu T, 2008, NATURE, V456, P404, DOI 10.1038/nature07353; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Paxinos GFK., 2001, MOUSE BRAIN STEREOTA, V2nd ed.; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Posmantur R, 1997, NEUROSCIENCE, V77, P875, DOI 10.1016/S0306-4522(96)00483-6; Quinn CC, 1999, J NEUROBIOL, V41, P158, DOI 10.1002/(SICI)1097-4695(199910)41:1<158::AID-NEU19>3.3.CO;2-S; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rahajeng J, 2010, J BIOL CHEM, V285, P31918, DOI 10.1074/jbc.C110.166066; Rao MV, 2008, J NEUROSCI, V28, P12241, DOI 10.1523/JNEUROSCI.4119-08.2008; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Saatman KE, 2010, NEUROTHERAPEUTICS, V7, P31, DOI 10.1016/j.nurt.2009.11.002; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; Saatman KE, 2000, J CEREBR BLOOD F MET, V20, P66, DOI 10.1097/00004647-200001000-00010; Sato K, 2011, J NEUROCHEM, V117, P504, DOI 10.1111/j.1471-4159.2011.07222.x; Schoch KM, 2012, EXP NEUROL, V236, P371, DOI 10.1016/j.expneurol.2012.04.022; Sorimachi H, 2011, P JPN ACAD B-PHYS, V87, P287, DOI 10.2183/pjab.87.287; Taghian K, 2012, J NEUROTRAUM, V29, P1728, DOI 10.1089/neu.2011.2063; Thompson SN, 2010, J NEUROTRAUM, V27, P2233, DOI 10.1089/neu.2010.1474; Touma E, 2007, EUR J NEUROSCI, V26, P3368, DOI 10.1111/j.1460-9568.2007.05943.x; von Reyn CR, 2012, J NEUROCHEM, V121, P793, DOI 10.1111/j.1471-4159.2012.07735.x; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Wilson SM, 2012, NEUROSCIENCE, V210, P451, DOI 10.1016/j.neuroscience.2012.02.038; Yuen TJ, 2009, J NEUROSCI RES, V87, P3620, DOI 10.1002/jnr.22161; Zhang ZQ, 2007, J NEUROTRAUM, V24, P460, DOI 10.1089/neu.2006.0078; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	48	18	18	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042			J NEUROCHEM	J. Neurochem.	JUN	2013	125	6					909	920		10.1111/jnc.12144			12	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	159JM	WOS:000320041700011	23305291	Green Accepted			2022-02-06	
J	Hibino, S; Mase, M; Shirataki, T; Nagano, Y; Fukagawa, K; Abe, A; Nishide, Y; Aizawa, A; Iida, A; Ogawa, T; Abe, J; Hatta, T; Yamada, K; Kabasawa, H				Hibino, Shin; Mase, Mitsuhito; Shirataki, Tatsuaki; Nagano, Yuri; Fukagawa, Kazutoshi; Abe, Akiko; Nishide, Yukiko; Aizawa, Ayumi; Iida, Akihiko; Ogawa, Tetsuo; Abe, Junko; Hatta, Takeshi; Yamada, Kazuo; Kabasawa, Hidehiro			Oxyhemoglobin Changes During Cognitive Rehabilitation After Traumatic Brain Injury Using Near Infrared Spectroscopy	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						traumatic brain injury; cognitive impairment; rehabilitation; near infrared spectroscopy	ANTERIOR PREFRONTAL CORTEX; WORKING-MEMORY; CHILDREN	To investigate cerebral reactions to cognitive rehabilitation tasks, oxyhemoglobin changes were compared in 9 patients with cognitive impairments after traumatic brain injury (TBI) and 47 healthy controls using functional near infrared spectroscopy (fNIRS) during nine cognitive rehabilitation tasks employed at Nagoya City Rehabilitation Center. Forty-seven measurement channels were placed on the frontal to temporal cortices, and organized into seven channel regions. Oxyhemoglobin changes were normalized based on the mean oxyhemoglobin value at the resting state, and integrated throughout a task. Statistical analyses of the differences between the TBI patients and controls were performed with the two-sided Mann-Whitney U test. Oxyhemoglobin changes were high for both controls and TBI patients in the lateral frontal regions. Oxyhemoglobin changes in TBI patients tended to be higher than controls in the medial frontal regions for most training tasks, and significant differences (p < 0.05) were seen for two tasks in the medial frontal regions. Different regions were activated during the tasks in TBI patients compared to controls. fNIRS measurement is useful in the evaluation of changes of neuronal activities during rehabilitation tasks in TBI patients.	[Hibino, Shin; Shirataki, Tatsuaki; Nagano, Yuri; Fukagawa, Kazutoshi; Abe, Akiko; Nishide, Yukiko; Aizawa, Ayumi; Iida, Akihiko; Ogawa, Tetsuo; Kabasawa, Hidehiro] Nagoya City Rehabil Ctr, Nagoya, Aichi, Japan; [Mase, Mitsuhito; Yamada, Kazuo] Nagoya City Univ, Grad Sch Med Sci, Dept Neurosurg, Nagoya, Aichi 4678601, Japan; [Abe, Junko] Gifu Univ Med Sci, Dept Nursing, Gifu, Japan; [Hatta, Takeshi] Kansai Univ Welf Sci, Fac Hlth Sci Welf, Osaka, Japan		Mase, M (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Neurosurg, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mitmase@med.nagoya-cu.ac.jp			General Insurance Association of Japan	This research was supported by grants from the General Insurance Association of Japan.	Burton MW, 2000, J COGNITIVE NEUROSCI, V12, P679, DOI 10.1162/089892900562309; Christodoulou C, 2001, J NEUROL NEUROSUR PS, V71, P161, DOI 10.1136/jnnp.71.2.161; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Department of Veterans Affairs, 2009, VA DOD CLIN PRACT GU; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hoshi Y, 2001, J APPL PHYSIOL, V90, P1657, DOI 10.1152/jappl.2001.90.5.1657; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Malia KB, 1977, BRAINWAVE R INFORM 1; Matsuda G, 2006, NEUROIMAGE, V29, P706, DOI 10.1016/j.neuroimage.2005.08.019; Meyers J. E., 1996, REY COMPLEX FIGURE T; Reynolds JR, 2006, CEREB CORTEX, V16, P519, DOI 10.1093/cercor/bhi131; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Simons JS, 2005, NEUROPSYCHOLOGIA, V43, P1774, DOI 10.1016/j.neuropsychologia.2005.02.004; Tsujimoto S, 2004, CEREB CORTEX, V14, P703, DOI 10.1093/cercor/bhh030; Turner GR, 2008, NEUROLOGY, V71, P812, DOI 10.1212/01.wnl.0000325640.18235.1c; Wechsler D., 1981, WAIS R MANUAL WECHSL; Wilson B.A., 1985, RIVERMEAD BEHAV MEMO; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	20	18	19	1	6	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.	MAY	2013	53	5					299	303		10.2176/nmc.53.299			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	149GY	WOS:000319308200004	23708220	Bronze			2022-02-06	
J	Liu, CX; Wu, WJ; Zhang, B; Xiang, J; Zou, J				Liu, Chunxing; Wu, Wenjie; Zhang, Bin; Xiang, Jie; Zou, Jian			Temporospatial expression and cellular localization of glutamine synthetase following traumatic spinal cord injury in adult rats	MOLECULAR MEDICINE REPORTS			English	Article						glutamine synthetase; spinal cord injury; glutamate; glial cells	EXCITATORY AMINO-ACID; TUMOR-NECROSIS-FACTOR; NEURAL STEM-CELLS; CEREBRAL-CORTEX; ASTROCYTES; MICROGLIA; BRAIN; DIFFERENTIATION; INVOLVEMENT; RECEPTORS	Glutamine synthetase (GS) is an enzyme involved in an endogenous mechanism of protection against glutamate neurotoxicity and is important in the regulation of astrocyte migration. To date, limited information is available concerning the expression of GS in normal spinal cords and following injury. In the present study, GS expression was identified in astrocytes, oligodendrocytes and microglia in normal rat spinal cords. Following traumatic spinal cord injury (SCI), the glutamate concentration increased rapidly at 1 h and returned to baseline rapidly. However, the GS activity and protein levels were found to decrease at 4 h and then increase gradually from day 3 following SCI. The quantification of astrocytes, oligodendrocytes and activated microglia/macrophages, as well as immunohistochemistry staining of day 7 post-injured spinal cords, indicated that the astrocytes and microglia/macrophages contributed to the increase in GS. Collectively, the results provided evidence for the temporospatial expression and location of GS following SCI and suggested that the changes in GS levels may contribute to glutamate neurotoxicity and glial cell response following SCI.	[Liu, Chunxing] Huadong Sanitarium, Dept Clin Testing, Wuxi 214065, Jiangsu, Peoples R China; [Wu, Wenjie] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200127, Peoples R China; [Zhang, Bin; Zou, Jian] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Clin Lab Sci, Wuxi 214023, Peoples R China; [Zhang, Bin; Xiang, Jie; Zou, Jian] Wuxi Clin Sci Res Inst, Wuxi 214023, Jiangsu, Peoples R China		Zou, J (corresponding author), Nanjing Med Univ, Wuxi Peoples Hosp, Dept Clin Lab Sci, 299 Qingyang Rd, Wuxi 214023, Peoples R China.	zoujan@gmail.com	Zou, Jian/V-9067-2019		Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81000527]; Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK2010159]; Science and Technology Development Program of Huadong Sanitarium [201001]	The current study was supported by grants from the Natural Science Foundation of China (no. 81000527), the Natural Science Foundation of Jiangsu Province (no. BK2010159) and the Science and Technology Development Program of Huadong Sanitarium (no. 201001). The authors would like to thank BiomedWorld Bioscience Ltd., Co., for their editing of the manuscript.	Baldwin SA, 1998, J NEUROTRAUM, V15, P1015, DOI 10.1089/neu.1998.15.1015; Benton RL, 2000, NEUROSCI LETT, V291, P1, DOI 10.1016/S0304-3940(00)01362-8; CALDANI M, 1982, EXPERIENTIA, V38, P1199, DOI 10.1007/BF01959739; Chretien F, 2002, NEUROPATH APPL NEURO, V28, P410, DOI 10.1046/j.1365-2990.2002.00426.x; Coulter DA, 2012, GLIA, V60, P1215, DOI 10.1002/glia.22341; Egnaczyk GF, 2003, PROTEOMICS, V3, P689, DOI 10.1002/pmic.200300407; Eid T, 2012, NEUROCHEM RES, V37, P2339, DOI 10.1007/s11064-012-0766-5; Hu JG, 2004, J NEUROSCI RES, V78, P637, DOI 10.1002/jnr.20317; Lang B, 2004, NEUROSCIENCE, V128, P775, DOI 10.1016/j.neuroscience.2004.06.033; Levy HL, 2005, NEW ENGL J MED, V353, P1968, DOI 10.1056/NEJMe058227; Lu HZ, 2008, BRAIN BEHAV IMMUN, V22, P1217, DOI 10.1016/j.bbi.2008.06.006; Lu HZ, 2010, DIFFERENTIATION, V80, P228, DOI 10.1016/j.diff.2010.09.179; Mills CD, 2001, J NEUROCHEM, V79, P835, DOI 10.1046/j.1471-4159.2001.00630.x; Moore CS, 2012, AM J PATHOL, V180, P12, DOI 10.1016/j.ajpath.2011.09.008; POLITIS MJ, 1985, BRAIN RES, V359, P183, DOI 10.1016/0006-8993(85)91427-1; Romero-Aleman MM, 2004, EXP NEUROL, V188, P74, DOI 10.1016/j.expneurol.2004.03.014; Saitoh F, 2010, J NEUROSCI, V30, P1204, DOI 10.1523/JNEUROSCI.3591-09.2010; Shaked I, 2002, J NEUROCHEM, V83, P574, DOI 10.1046/j.1471-4159.2002.01168.x; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Suarez I, 2002, NEUROCHEM INT, V41, P123, DOI 10.1016/S0197-0186(02)00033-5; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Wang XF, 2006, ACTA NEUROPATHOL, V111, P220, DOI 10.1007/s00401-005-0016-x; Xie Z, 2004, GLIA, V45, P170, DOI 10.1002/glia.10314; Xu B, 2012, TOXICOLOGY, V300, P112, DOI 10.1016/j.tox.2012.06.006; Yan P, 2003, EXP NEUROL, V183, P286, DOI 10.1016/S0014-4886(03)00135-3; Zou J, 2011, NEUROCHEM INT, V58, P404, DOI 10.1016/j.neuint.2010.12.018; Zou J, 2010, NEUROCHEM INT, V56, P577, DOI 10.1016/j.neuint.2009.12.021	27	18	19	2	6	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997			MOL MED REP	Mol. Med. Rep.	MAY	2013	7	5					1431	1436		10.3892/mmr.2013.1383			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	136TF	WOS:000318385600012	23525248	Bronze			2022-02-06	
J	Sanganahalli, BG; Herman, P; Hyder, F; Kannurpatti, SS				Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed; Kannurpatti, Sridhar S.			Mitochondrial Functional State Impacts Spontaneous Neocortical Activity and Resting State fMRI	PLOS ONE			English	Article							RAT SOMATOSENSORY CORTEX; BOLD SIGNAL FLUCTUATIONS; NEURONAL-ACTIVITY; DEFAULT NETWORK; IN-VIVO; INTERHEMISPHERIC SYNCHRONY; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; SLOW OSCILLATIONS; CALCIUM-UPTAKE	Mitochondrial Ca2+ uptake, central to neural metabolism and function, is diminished in aging whereas enhanced after acute/sub-acute traumatic brain injury. To develop relevant translational models for these neuropathologies, we determined the impact of perturbed mitochondrial Ca2+ uptake capacities on intrinsic brain activity using clinically relevant markers. From a multi-compartment estimate of probable baseline Ca2+ ranges in the brain, we hypothesized that reduced or enhanced mitochondrial Ca2+ uptake capacity would decrease or increase spontaneous neuronal activity respectively. As resting state fMRI-BOLD fluctuations and stimulus-evoked BOLD responses have similar physiological origins [ 1] and stimulus-evoked neuronal and hemodynamic responses are modulated by mitochondrial Ca2+ uptake capacity [2,3] respectively, we tested our hypothesis by measuring hemodynamic fluctuations and spontaneous neuronal activities during normal and altered mitochondrial functional states. Mitochondrial Ca2+ uptake capacity was perturbed by pharmacologically inhibiting or enhancing the mitochondrial Ca2+ uniporter (mCU) activity. Neuronal electrical activity and cerebral blood flow (CBF) fluctuations were measured simultaneously and integrated with fMRI-BOLD fluctuations at 11.7T. mCU inhibition reduced spontaneous neuronal activity and the resting state functional connectivity (RSFC), whereas mCU enhancement increased spontaneous neuronal activity but reduced RSFC. We conclude that increased or decreased mitochondrial Ca2+ uptake capacities lead to diminished resting state modes of brain functional connectivity.	[Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06510 USA; [Hyder, Fahmeed] Yale Univ, Sch Med, Dept Biomed Engn, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Dept Magnet Resonance Res Ctr, New Haven, CT USA; [Sanganahalli, Basavaraju G.; Herman, Peter; Hyder, Fahmeed] Yale Univ, Sch Med, Core Ctr Quantitat Neurosci Magnet Resonance, New Haven, CT USA; [Kannurpatti, Sridhar S.] UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA		Kannurpatti, SS (corresponding author), UMDNJ New Jersey Med Sch, Dept Radiol, Newark, NJ USA.	kannursr@umdnj.edu	Hyder, Fahmeed/A-2644-2015; Sanganahalli, Basavaraju G/C-3296-2008	Hyder, Fahmeed/0000-0001-7822-4002; Sanganahalli, Basavaraju G/0000-0002-0851-6621; Herman, Peter/0000-0003-2218-9652	American Heart AssociationAmerican Heart Association [0930132N]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P30NS052519]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH067528] Funding Source: NIH RePORTER	This work was supported by grants from the American Heart Association 0930132N (SK) and National Institute of Health P30NS052519 (FH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Hanna JR, 2007, NEURON, V56, P924, DOI 10.1016/j.neuron.2007.10.038; Bardutzky J, 2005, J CEREBR BLOOD F MET, V25, P968, DOI 10.1038/sj.jcbfm.9600095; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Budd SL, 1996, J NEUROCHEM, V66, P403, DOI 10.1046/j.1471-4159.1996.66010403.x; Busche MA, 2012, P NATL ACAD SCI US; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chen XW, 2011, NATURE, V475, P501, DOI 10.1038/nature10193; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DUCHEN MR, 1992, BIOCHEM J, V283, P41, DOI 10.1042/bj2830041; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Hedden T, 2009, J NEUROSCI, V29, P12686, DOI 10.1523/JNEUROSCI.3189-09.2009; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Huttunen JK, 2008, NEUROIMAGE, V39, P775, DOI 10.1016/j.neuroimage.2007.06.042; Hyder F, 2010, P NATL ACAD SCI USA, V107, P10773, DOI 10.1073/pnas.1005135107; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; Kannurpatti SS, 2008, J CEREBR BLOOD F MET, V28, P772, DOI 10.1038/sj.jcbfm.9600574; Kannurpatti SS, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00007; Kannurpatti SS, 2010, MAGN RESON IMAGING, V28, P466, DOI 10.1016/j.mri.2009.12.007; Kannurpatti SS, 2000, NEUROCHEM RES, V25, P1527, DOI 10.1023/A:1026602100160; Kannurpatti SS BB, 2003, MAP REVERSIBLE MODUL, P1856; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; Kreiner L, 2006, J BIOL CHEM, V281, P4691, DOI 10.1074/jbc.M511971200; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESLIE SW, 1985, BRAIN RES, V329, P177, DOI 10.1016/0006-8993(85)90523-2; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Luu P, 2001, J CLIN NEUROPHYSIOL, V18, P302, DOI 10.1097/00004691-200107000-00002; Masamoto K, 2012, J CEREBR BLOOD F MET, V32, P1233, DOI 10.1038/jcbfm.2012.50; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Moreira PI, 2006, J ALZHEIMERS DIS, V9, P101; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; Nemoto EM, 2005, ADV EXP MED BIOL, V566, P83; Nicholls DG, 2005, CELL CALCIUM, V38, P311, DOI 10.1016/j.ceca.2005.06.011; Nielsen AN, 2001, J PHYSIOL-LONDON, V533, P773, DOI 10.1111/j.1469-7793.2001.00773.x; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Paxinos G, 1996, RAT BRAIN STEREOTAXI; Pizoli CE, 2011, P NATL ACAD SCI USA, V108, P11638, DOI 10.1073/pnas.1109144108; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; Robb-Gaspers LD, 1998, EMBO J, V17, P4987, DOI 10.1093/emboj/17.17.4987; Sanganahalli BG, 2009, J NEUROSCI, V29, P1707, DOI 10.1523/JNEUROSCI.5549-08.2009; Sanganahalli BG, 2013, J CEREBRAL IN PRESS; Sarnat HB, 2011, CAN J NEUROL SCI, V38, P909, DOI 10.1017/S0317167100012518; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Schulz K, 2012, NAT METHODS, V9, P597, DOI [10.1038/nmeth.2013, 10.1038/NMETH.2013]; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Simpson PB, 2000, J BIOENERG BIOMEMBR, V32, P5, DOI 10.1023/A:1005552126516; Simpson PB, 1998, BRAIN RES REV, V26, P72, DOI 10.1016/S0165-0173(97)00056-8; Soane L, 2007, J NEUROSCI RES, V85, P3407, DOI 10.1002/jnr.21498; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Tsytsarev V, 2012, J NEUROSCI METH, V203, P136, DOI 10.1016/j.jneumeth.2011.09.005; Ueki M, 1992, ACTA ANAESTH SCAND, V36, P5; Verkhratsky A, 2012, MOL CELL ENDOCRINOL, V353, P45, DOI 10.1016/j.mce.2011.08.039; Vern BA, 1997, BRAIN RES, V775, P233, DOI 10.1016/S0006-8993(97)01028-7; Vern BA, 1998, ADV EXP MED BIOL, V454, P561; VITORICA J, 1986, BRAIN RES, V378, P36, DOI 10.1016/0006-8993(86)90284-2; Zetterling M, 2010, NEUROSURGERY, V66, P1102, DOI 10.1227/01.NEU.0000370893.04586.73; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	72	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 1	2013	8	5							e63317	10.1371/journal.pone.0063317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	147KY	WOS:000319167000106	23650561	Green Published, Green Submitted, gold			2022-02-06	
J	Li, WC; Jiang, DM; Hu, N; Qi, XT; Qiao, B; Luo, XJ				Li, Wei-Chao; Jiang, Dian-Ming; Hu, Ning; Qi, Xiao-Tong; Qiao, Bo; Luo, Xiao-Ji			Lipopolysaccharide preconditioning attenuates neuroapoptosis and improves functional recovery through activation of Nrf2 in traumatic spinal cord injury rats	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article						lipopolysaccharide; Nrf2; apoptosis; function recovery; spinal cord injury	NF-KAPPA-B; CELL-DEATH; INFLAMMATORY RESPONSE; APOPTOSIS; ISCHEMIA; BRAIN; INDUCTION; TOLERANCE; PROTECTS; DAMAGE	The previous studies suggested that low-dose lipopolysaccharide (LPS) provides neuroprotection against subsequent challenge with ischemic/reperfusion injury in the brain. But there were few reports about the neuroprotective effects of low-dose LPS against spinal cord injury (SCI). In this study, we evaluated the effect of low-dose LPS preconditioning on neuroapoptosis status after traumatic SCI (TSCI), using a standardized contusion model (NYU, New York University, impactor). SCI-induced rats were randomly divided into three groups: sham operation, control (receiving only normal saline) and LPS preconditioning (0.2 mg/kg, ip; 72 hours before injury). Neurologic function was assessed by the Basso, Beattie and Bresnahan (BBB) score at 6, 12, 24, 48 and 72 hours after TSCI. Rats were sacrificed at 72 hours postinjury. Histological changes were studied using Nissl staining. Apoptotic neural cells were assessed using the TdT-mediated dUTP Nick End Labeling (TUNEL) assay. Nuclear factor erythroid 2-related factor 2 (Nrf2) and caspase-3 were detected with immunohistochemistry and Western blot. LPS preconditioning reduced neuron apoptosis, improved neurologic outcome and actived Nrf2 expression. Moreover, Histological changes and the number of apoptotic cells were correlated with Nrf2 expression after the rats suffered the SCI. Our results suggest that LPS preconditioning exerted a neuroprotective effect against TSCI in rats, and activation of Nrf2 was believed to be one of the contributing mechanisms.	[Li, Wei-Chao; Jiang, Dian-Ming; Hu, Ning; Qi, Xiao-Tong; Qiao, Bo; Luo, Xiao-Ji] Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, Chongqing 400016, Peoples R China		Jiang, DM (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Orthoped Surg, 1 Youyi Rd, Chongqing 400016, Peoples R China.	jdm571026@vip.163.com			University Development Program, Chongqing	This study was supported by a scholarship from the University Development Program, Chongqing.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bingham D, 2011, BRAIN RES BULL, V85, P403, DOI 10.1016/j.brainresbull.2011.04.007; Byrnes KR, 2007, BRAIN, V130, P2977, DOI 10.1093/brain/awm179; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Cittelly DM, 2008, EXP NEUROL, V210, P295, DOI 10.1016/j.expneurol.2007.03.001; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Fansa I, 2009, J INT MED RES, V37, P520, DOI 10.1177/147323000903700228; Furuya K, 2005, J NEUROSURG, V103, P715, DOI 10.3171/jns.2005.103.4.0715; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Hirose K, 2004, THROMB HAEMOSTASIS, V91, P162, DOI 10.1160/TH03-06-0385; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jalabi W, 2009, CLEV CLIN J MED, V76, P97; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2009, J NEUROTRAUM, V26, P131, DOI 10.1089/neu.2008.0655; Lastres-Becker I, 2006, J NEUROIMMUNOL, V173, P108, DOI 10.1016/j.jneuroim.2005.12.006; Lee SM, 2003, J NEUROTRAUM, V20, P1017, DOI 10.1089/089771503770195867; Liu XZ, 1997, J NEUROSCI, V17, P5395; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Mallard C, 2007, SEMIN FETAL NEONAT M, V12, P280, DOI 10.1016/j.siny.2007.01.014; Mao L, 2012, J TRAUMA ACUTE CARE, V72, P189, DOI 10.1097/TA.0b013e31821bf541; Mao L, 2011, J SURG RES, V170, pE105, DOI 10.1016/j.jss.2011.05.049; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Naidu KA, 2003, ANESTH ANALG, V97, P857, DOI 10.1213/01.ANE.0000072800.66277.CC; Omata Y, 2008, FREE RADICAL BIO MED, V45, P1437, DOI 10.1016/j.freeradbiomed.2008.08.018; Orio M, 2007, STROKE, V38, P2812, DOI 10.1161/STROKEAHA.107.486837; Pereira JE, 2009, EXP NEUROL, V220, P71, DOI 10.1016/j.expneurol.2009.07.030; Pignataro G, 2009, FEBS J, V276, P46, DOI 10.1111/j.1742-4658.2008.06769.x; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rosenzweig HL, 2004, STROKE, V35, P2576, DOI 10.1161/01.STR.0000143450.04438.ae; Rupinder SK, 2007, VASC PHARMACOL, V46, P383, DOI 10.1016/j.vph.2007.01.006; Shuman SL, 1997, J NEUROSCI RES, V50, P798, DOI 10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2-Y; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Thimmulappa RK, 2006, J CLIN INVEST, V116, P984, DOI 10.1172/JCI25790; Yune TY, 2004, J NEUROTRAUM, V21, P293, DOI 10.1089/089771504322972086	37	18	21	0	23	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.	APR	2013	123	4					240	247		10.3109/00207454.2012.755181			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	107BS	WOS:000316190300005	23215850				2022-02-06	
J	Lu, XCM; Mountney, A; Chen, ZY; Wei, G; Cao, Y; Leung, LY; Khatri, V; Cunningham, T; Tortella, FC				Lu, Xi-Chun May; Mountney, Andrea; Chen, Zhiyong; Wei, Guo; Cao, Ying; Leung, Lai Yee; Khatri, Vivek; Cunningham, Tracy; Tortella, Frank C.			Similarities and Differences of Acute Nonconvulsive Seizures and Other Epileptic Activities following Penetrating and Ischemic Brain Injuries in Rats	JOURNAL OF NEUROTRAUMA			English	Article						EEG rat; MCAO; NCS; PBBI	INTENSIVE-CARE-UNIT; FOCAL CEREBRAL-ISCHEMIA; PERIODIC EEG PATTERNS; TRANSHEMISPHERIC DIASCHISIS; CLINICAL-SIGNIFICANCE; GLYPROMATE ANALOG; CRITICALLY-ILL; DISCHARGES; MODEL; STROKE	The similarities and differences between acute nonconvulsive seizures (NCS) and other epileptic events, for example, periodic epileptiform discharges (PED) and intermittent rhythmic delta activities (IRDA), were characterized in rat models of penetrating and ischemic brain injuries. The NCS were spontaneously induced by either unilateral frontal penetrating ballistic-like brain injury (PBBI) or permanent middle cerebral artery occlusion (pMCAO), and were detected by continuous electroencephalogram (EEG) monitoring begun immediately after the injury and continued for 72 h or 24 h, respectively. Analysis of NCS profiles (incidence, frequency, duration, and time distribution) revealed a high NCS incidence in both injury models. The EEG waveform expressions of NCS and PED exhibited intrinsic variations that resembled human electrographic manifestations of post-traumatic and post-ischemic ictal and inter-ictal events, but these waveform variations were not distinguishable between the two types of brain injury. However, the NCS after pMCAO occurred more acutely and intensely (latency = 0.6 h, frequency = 25 episodes/rat) compared with the PBBI-induced NCS (latency = 24 h, frequency = 10 episodes/rat), such that the most salient features differentiating post-traumatic and post-ischemic NCS were the intensity and time distribution of the NCS profiles. After pMCAO, nearly 50% of the seizures occurred within the first 2 h of injury, whereas after PBBI, NCS occurred sporadically (0-5%/h) throughout the 72 h recording period. The PED were episodically associated with NCS. By contrast, the IRDA appeared to be independent of other epileptic events. This study provided comprehensive comparisons of post-traumatic and post-ischemic epileptic profiles. The identification of the similarities and differences across a broad spectrum of epileptic events may lead to differential strategies for post-traumatic and post-stroke seizure interventions.	[Lu, Xi-Chun May; Mountney, Andrea; Chen, Zhiyong; Wei, Guo; Cao, Ying; Leung, Lai Yee; Khatri, Vivek; Cunningham, Tracy; Tortella, Frank C.] Walter Reed Army Inst Res, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, Silver Spring, MD 20910 USA		Lu, XCM (corresponding author), Walter Reed Army Inst Res, Branch Brain Trauma Neuroprotect & Neurorestorat, Ctr Mil Psychiat & Neurosci, 503 Robert Grant Ave, Silver Spring, MD 20910 USA.	may.lu@us.army.mil	Leung, Lai Yee/H-8204-2013				ANDREWS RJ, 1991, STROKE, V22, P943, DOI 10.1161/01.STR.22.7.943; Baykan B, 2000, SEIZURE-EUR J EPILEP, V9, P402, DOI 10.1053/seiz.2000.0435; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; BRENNER RP, 1990, J CLIN NEUROPHYSIOL, V7, P249, DOI 10.1097/00004691-199004000-00007; Brigo F, 2011, EPILEPSY BEHAV, V20, P254, DOI 10.1016/j.yebeh.2010.11.009; Carrera E, 2006, NEUROLOGY, V67, P99, DOI 10.1212/01.wnl.0000223361.90278.ca; CHATRIAN GE, 1964, ELECTROEN CLIN NEURO, V17, P177, DOI 10.1016/0013-4694(64)90149-X; Chong DJ, 2005, J CLIN NEUROPHYSIOL, V22, P79, DOI 10.1097/01.WNP.0000158699.78529.AF; COBB WA, 1945, J NEUROL NEUROSUR PS, V8, P65, DOI 10.1136/jnnp.8.3-4.65; Andraus MEC, 2012, ARQ NEURO-PSIQUIAT, V70, P145, DOI 10.1590/S0004-282X2012000200014; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; DELAPAZ D, 1981, ARCH NEUROL-CHICAGO, V38, P713, DOI 10.1001/archneur.1981.00510110073012; Dudek FE, 2010, EPILEPSY CURR, V10, P91, DOI 10.1111/j.1535-7511.2010.01368.x; Fitzpatrick W, 2007, CAN J NEUROL SCI, V34, P443, DOI 10.1017/S0317167100007332; Garcia-Morales I, 2002, J CLIN NEUROPHYSIOL, V19, P172, DOI 10.1097/00004691-200203000-00009; Garzon E, 2001, NEUROLOGY, V57, P1175, DOI 10.1212/WNL.57.7.1175; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2003, EXP NEUROL, V179, P139, DOI 10.1016/S0014-4886(02)00013-4; Jirsch J, 2007, CLIN NEUROPHYSIOL, V118, P1660, DOI 10.1016/j.clinph.2006.11.312; JORDAN KG, 1995, NEUROL CLIN, V13, P579, DOI 10.1016/S0733-8619(18)30035-5; JORDAN KG, 1993, J CLIN NEUROPHYSIOL, V10, P445, DOI 10.1097/00004691-199310000-00006; Juhasz C, 1997, ACTA NEUROL SCAND, V96, P397; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Lu XCM, 2001, NEUROPATH APPL NEURO, V27, P481, DOI 10.1046/j.1365-2990.2001.00357.x; Lu XCM, 2009, J CEREBR BLOOD F MET, V29, P1924, DOI 10.1038/jcbfm.2009.109; Lu XCM, 2011, J NEUROTRAUM, V28, P71, DOI 10.1089/neu.2010.1471; Lu XCM, 2009, J NEUROTRAUM, V26, P141, DOI 10.1089/neu.2008.0629; Luckl J, 2008, BRAIN RES, V1191, P157, DOI 10.1016/j.brainres.2007.11.037; Mecarelli O, 2011, CEREBROVASC DIS, V31, P191, DOI 10.1159/000321872; Niedzielska K, 2000, Neurol Neurochir Pol, V34, P467; Niedzielska K, 2001, Neurol Neurochir Pol, V35, P595; Orta DS, 2009, ARCH NEUROL-CHICAGO, V66, P985, DOI 10.1001/archneurol.2009.137; Pandian JD, 2004, ARCH NEUROL-CHICAGO, V61, P1090, DOI 10.1001/archneur.61.7.1090; SCHRAEDER PL, 1980, EPILEPSIA, V21, P647, DOI 10.1111/j.1528-1157.1980.tb04318.x; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Vespa PM, 2003, NEUROLOGY, V60, P1441, DOI 10.1212/01.WNL.0000063316.47591.B4; Williams AJ, 2005, J NEUROTRAUM, V22, P313, DOI 10.1089/neu.2005.22.313; Williams AJ, 2004, J PHARMACOL EXP THER, V311, P220, DOI 10.1124/jpet.104.069146; Williams AJ, 2006, NEUROSCI LETT, V408, P183, DOI 10.1016/j.neulet.2006.08.086; Williams AJ, 2006, J NEUROTRAUM, V23, P1828, DOI 10.1089/neu.2006.23.1828; Yemisci M, 2003, SEIZURE-EUR J EPILEP, V12, P465, DOI 10.1016/S1059-1311(02)00351-5; Zweckberger K, 2010, NEUROSCI LETT, V470, P150, DOI 10.1016/j.neulet.2009.12.075	43	18	18	0	6	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	APR	2013	30	7					580	590		10.1089/neu.2012.2641			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	133PD	WOS:000318150300009	23234254				2022-02-06	
J	Mojtahedi, S; Kordi, MR; Hosseini, SE; Omran, SF; Soleimani, M				Mojtahedi, Shima; Kordi, Mohammad Reza; Hosseini, Seyed Ebrahim; Omran, Simin Fallah; Soleimani, Masoud			Effect of treadmill running on the expression of genes that are involved in neuronal differentiation in the hippocampus of adult male rats	CELL BIOLOGY INTERNATIONAL			English	Article						BDNF; hippocampus; miR-124; NRSF/REST; treadmill running; TrkB	TRAUMATIC BRAIN-INJURY; MOUSE DENTATE GYRUS; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; MESSENGER-RNA; POSTSYNAPTIC DENSITIES; HUNTINGTONS-DISEASE; PHYSICAL-ACTIVITY; PROGENITOR CELLS; NERVOUS-SYSTEM	Gene expression in the rodent brain is dependent on exercise. However, our findings regarding this fact are inadequate. The aim of this study was to evaluate the effect of exercise intensity on changes in factors involved in neuronal differentiation and plasticity in the hippocampus of adult male rats. Thus, the effects of 2 weeks treadmill running at of low (11m/min) and high (25m/min) intensities, 30min/day for 14 consecutive days on the expression of two genes, microRNA-124 and neuron-restrictive silencer factor/RE1-silencing transcription factor (REST) as well as changes of two proteins of brain-derived neurotrophic factor (BDNF) and tyrosine kinase B (TrkB) were analysed. Using quantitative real-time PCR techniques have shown that both exercise intensities reduced the expression of REST (31% in low exercise intensity, 52% in high exercise intensity) and elevated the expression of miR-124 (3.8-fold in low exercise intensity, 11.9-fold in high exercise intensity) significantly (P0.05). This suggests that exercise probably through the changes in these genes is involved in neuronal differentiation in the hippocampus of rats. BDNF and TrkB levels were measured by ELISA. Exercise, at low intensity, increased TrkB (4.51ng/L vs. 3.73ng/L) and BDNF (11.97ng/L vs. 11.08ng/L) proteins significantly (P0.05), while at high intensity, the changes in comparison with the control group were not significant. Expression levels during the exercise programme with high intensity were dramatic for miR-124 and less dramatic for REST compared with low intensity exercise programme.	[Mojtahedi, Shima; Kordi, Mohammad Reza; Omran, Simin Fallah] Univ Tehran, Fac Phys Educ & Sport Sci, Dept Exercise Physiol, Tehran, Iran; [Hosseini, Seyed Ebrahim] Islamic Azad Univ, Sabzevar Branch, Sabzevar, Iran; [Soleimani, Masoud] Tarbiat Modares Univ, Dept Hematol, Tehran, Iran; [Soleimani, Masoud] Stem Cell Technol Res Ctr, Dept Stem Cell Biol, Tehran, Iran		Soleimani, M (corresponding author), Tarbiat Modares Univ, Dept Hematol, Tehran, Iran.	soleim_m@modares.ac.ir	Hosseini, Seyed Ebrahim/AAC-9627-2020; Kordi, Mohammadreza/AAD-8148-2020	Hosseini, Seyed Ebrahim/0000-0002-8683-2590; Kordi, Mohammadreza/0000-0002-7999-4292; mojtahedi, shima/0000-0003-3592-0010			Aoki C, 2000, J NEUROSCI RES, V59, P454, DOI 10.1002/(SICI)1097-4547(20000201)59:3<454::AID-JNR21>3.0.CO;2-H; Balkowiec A, 2002, J NEUROSCI, V22, P10399; Bequet F, 2001, ACTA PHYSIOL SCAND, V173, P223, DOI 10.1046/j.1365-201X.2001.00859.x; Briones Teresita L, 2005, Biol Res Nurs, V6, P167, DOI 10.1177/1099800404271328; Calderone A, 2003, J NEUROSCI, V23, P2112; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Chandrasekar V, 2011, NEUROPSYCHOPHARMACOL, V36, P1149, DOI 10.1038/npp.2010.250; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chen MJ, 2009, HIPPOCAMPUS, V19, P962, DOI 10.1002/hipo.20579; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fabel K, 2009, FRONT NEUROGENESIS, V10, P30; Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Gomez-Merino D, 2001, NEUROSCI LETT, V301, P143, DOI 10.1016/S0304-3940(01)01626-3; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hartmann M, 2001, EMBO J, V20, P5887, DOI 10.1093/emboj/20.21.5887; Hennigan A, 2007, BIOCHEM SOC T, V35, P424, DOI 10.1042/BST0350424; Huang AM, 2006, J NEURAL TRANSM, V113, P803, DOI 10.1007/s00702-005-0359-4; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Itoh T, 2011, J NEURAL TRANSM, V118, P1263, DOI 10.1007/s00702-011-0629-2; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kernie SG, 2010, NEUROBIOL DIS, V37, P267, DOI 10.1016/j.nbd.2009.11.002; Khabour OF, 2010, HIPPOCAMPUS, V20, P637, DOI 10.1002/hipo.20657; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SY, 1998, MOL BRAIN RES, V55, P20, DOI 10.1016/S0169-328X(97)00349-5; Liu YF, 2009, J PHYSIOL-LONDON, V587, P3221, DOI 10.1113/jphysiol.2009.173088; Llorens-Martin M, 2006, HIPPOCAMPUS, V16, P480, DOI 10.1002/hipo.20175; Lou SJ, 2008, BRAIN RES, V1210, P48, DOI 10.1016/j.brainres.2008.02.080; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Mehler MF, 2008, PROG NEUROBIOL, V86, P305, DOI 10.1016/j.pneurobio.2008.10.001; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Neeper SA, 1996, BRAIN RES, V726, P49, DOI 10.1016/0006-8993(96)00273-9; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Ramsbottom R, 2010, J SPORT SCI, V28, P843, DOI 10.1080/02640411003702686; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shimojo M, 2004, LIFE SCI, V74, P2213, DOI 10.1016/j.lfs.2003.08.045; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Uda M, 2006, BRAIN RES, V1104, P64, DOI 10.1016/j.brainres.2006.05.066; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Widenfalk J, 1999, NEUROSCI RES, V34, P125, DOI 10.1016/S0168-0102(99)00051-6; Wu CW, 2008, J APPL PHYSIOL, V105, P1585, DOI 10.1152/japplphysiol.90775.2008; Wu K, 1996, MOL BRAIN RES, V43, P286, DOI 10.1016/S0169-328X(96)00211-2; Yoon BC, 2009, NEUROREHABILITATION, V24, P291, DOI 10.3233/NRE-2009-0481; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	64	18	20	2	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-6995	1095-8355		CELL BIOL INT	Cell Biol. Int.	APR	2013	37	4					276	283		10.1002/cbin.10022			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	107MP	WOS:000316222000002	23427087				2022-02-06	
J	Ramaiah, VK; Sharma, D; Ma, L; Prathep, S; Hoffman, NG; Vavilala, MS				Ramaiah, Vijay Kumar; Sharma, Deepak; Ma, Li; Prathep, Sumidtra; Hoffman, Noah G.; Vavilala, Monica S.			Admission oxygenation and ventilation parameters associated with discharge survival in severe pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Traumatic brain injury; Oxygenation; Ventilation	SEVERE HEAD-INJURY; CEREBRAL-BLOOD-FLOW; HYPEROXIA; CHILDREN; HYPERVENTILATION; PREDICTORS; TOXICITY	Current Brain Trauma Foundation guidelines recommend avoiding hypoxemia after severe pediatric traumatic brain injury (TBI). Yet, recent studies on optimum admission oxygenation and ventilation parameters associated with discharge survival in pediatric TBI are lacking. After IRB approval, a retrospective study involving pediatric patients ages a parts per thousand currency sign14 years with severe TBI (head Abbreviated Injury Scale (AIS) score of a parts per thousand yen3, Glasgow Coma Scale score of a parts per thousand currency sign8 on admission) admitted to Harborview Medical Center (level 1 pediatric trauma center), Seattle, WA, during 2003 to 2007 was performed. Admission demographics, clinical data, and laboratory characteristics were abstracted. Hypoxemia was defined as PaO2 < 60 mmHg, hypocarbia was defined as PaCO2 a parts per thousand currency signaEuro parts per thousand 35 mmHg, and hypercarbia was defined as PaCO2 a parts per thousand yenaEuro parts per thousand 46 mmHg. One hundred ninety-four patients met inclusion criteria of which 162 (83.5 %) patients survived. Admission hypoxemia occurred in nine (5.6 %) patients who survived and eight (25 %) patients who died (p < 0.001). Children with admission PaCO2 between 36 and 45 mmHg had greater discharge survival compared with those with both admission hypocarbia (PaCO2 a parts per thousand currency signaEuro parts per thousand 35 mmHg) and hypercarbia (PaCO2 a parts per thousand yenaEuro parts per thousand 46 mmHg). Admission PaO2 301-500 mmHg (adjusted odds ratio (AOR), 8.02 (95 % confidence interval (CI), 1.73-37.10); p = 0.008) and admission PaCO2 = 36-45 mmHg (AOR, 5.47 (95 % CI, 1.30-23.07); p = 0.02) were independently associated with discharge survival. Discharge survival after severe pediatric TBI was associated with admission PaO2 301-500 mmHg and PaCO2 = 36-45 mmHg. Admission hypocarbia and hypercarbia were each associated with increased discharge mortality.	[Ramaiah, Vijay Kumar; Sharma, Deepak; Ma, Li; Prathep, Sumidtra; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98104 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Dept Neurol Surg, Seattle, WA 98104 USA; [Hoffman, Noah G.] Univ Washington, Dept Lab Med, Seattle, WA 98104 USA; [Sharma, Deepak; Vavilala, Monica S.] Univ Washington, Harborview Med Ctr, Harborview Injury Prevent & Res Ctr, Seattle, WA 98104 USA		Vavilala, MS (corresponding author), Univ Washington, Harborview Med Ctr, Dept Anesthesiol & Pain Med, 325 9Th Ave,POB 359724, Seattle, WA 98104 USA.	vavilala@uw.edu			 [R01NS072308-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	R01NS072308-03	Adelson P David, 2003, Pediatr Crit Care Med, V4, pS12; Bitterman N, 2004, UNDERSEA HYPERBAR M, V31, P63; Bostek C C, 1989, AANA J, V57, P231; Davis DP, 2009, J NEUROTRAUM, V26, P2217, DOI 10.1089/neu.2009.0940; Demchenko IT, 2007, AM J PHYSIOL-LUNG C, V293, pL229, DOI 10.1152/ajplung.00450.2006; Diringer MN, 2008, CURR OPIN CRIT CARE, V14, P167, DOI 10.1097/MCC.0b013e3282f57552; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Feickert HJ, 1999, J TRAUMA, V47, P33, DOI 10.1097/00005373-199907000-00008; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Jenkinson S G, 1993, New Horiz, V1, P504; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; MAYER TA, 1985, ANN EMERG MED, V14, P1178, DOI 10.1016/S0196-0644(85)81025-8; Menzel M, 1999, J NEUROSURG ANESTH, V11, P240, DOI 10.1097/00008506-199910000-00003; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; PIGULA FA, 1993, J PEDIATR SURG, V28, P310, DOI 10.1016/0022-3468(93)90223-8; Rossi S, 2000, ACTA NEUROCHIR SUPPL, V76, P243; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Tasman W, 2006, AM J OPHTHALMOL, V141, P167, DOI 10.1016/j.ajo.2005.07.034; TEPAS JJ, 1990, J PEDIATR SURG, V25, P92, DOI 10.1016/S0022-3468(05)80170-8; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011	23	18	19	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	APR	2013	29	4					629	634		10.1007/s00381-012-1984-5			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	106FI	WOS:000316127800014	23207977	Green Accepted			2022-02-06	
J	Blasiole, B; Bayir, H; Vagni, VA; Janesko-Feldman, K; Cheikhi, A; Wisniewski, SR; Long, JB; Atkins, J; Kagan, V; Kochanek, PM				Blasiole, Brian; Bayir, Huelya; Vagni, Vincent A.; Janesko-Feldman, Keri; Cheikhi, Amin; Wisniewski, Stephen R.; Long, Joseph B.; Atkins, James; Kagan, Valerian; Kochanek, Patrick M.			Effect of Hyperoxia on Resuscitation of Experimental Combined Traumatic Brain Injury and Hemorrhagic Shock in Mice	ANESTHESIOLOGY			English	Article							SEVERE HEAD-INJURY; FOCAL CEREBRAL-ISCHEMIA; FLUID PERCUSSION INJURY; NORMOBARIC HYPEROXIA; BLOOD-FLOW; OXIDATIVE STRESS; CEREBROSPINAL-FLUID; NEURONAL DEATH; OXYGEN-THERAPY; CARDIAC-ARREST	Background: Hypotension and hypoxemia worsen traumatic brain injury outcomes. Hyperoxic resuscitation is controversial. The authors proposed that hyperoxia would improve hemodynamics and neuronal survival by augmenting oxygen delivery despite increased oxidative stress and neuroinflammation in experimental combined controlled cortical impact plus hemorrhagic shock in mice. Methods: Adult C57BL6 mice received controlled cortical impact followed by 35 min of hemorrhagic shock (mean arterial pressure, 25-27 mmHg). The resuscitation phase consisted of lactated Ringer's boluses titrated to mean arterial pressure greater than 70 mmHg. Definitive care included returning shed blood. Either oxygen or room air was administered during the resuscitation phases. Brain tissue levels of oxidative stress and inflammatory markers were measured at 24 h and hippocampal neuronal survival was quantified at 7 days. Results: Hyperoxia markedly increased brain tissue oxygen tension approximately four-to fivefold (n = 8) and reduced resuscitation fluid requirements approximately 15% (n = 53; both P < 0.05). Systemic and cerebral physiologic variables were not significantly affected by hyperoxia. Hippocampal neuron survival was approximately 40% greater with oxygen versus room air (n = 18, P = 0.03). However, ascorbate depletion doubled with oxygen versus room air (n = 11, P < 0.05). Brain tissue cytokines and chemokines were increased approximately 2-to 20-fold (n = 10) after combined controlled cortical impact injury plus hemorrhagic shock, whereas hyperoxia shifted cytokines toward a proinflammatory profile. Conclusions: Hyperoxic resuscitation of cortical impact plus hemorrhagic shock reduced fluid requirements and increased brain tissue oxygen tension and hippocampal neuronal survival but exacerbated ascorbate depletion and neuroinflammation. The benefits of enhanced oxygen delivery during resuscitation of traumatic brain injury may outweigh detrimental increases in oxidative stress and neuroinflammation.	[Blasiole, Brian; Bayir, Huelya; Vagni, Vincent A.; Janesko-Feldman, Keri; Cheikhi, Amin; Wisniewski, Stephen R.; Long, Joseph B.; Atkins, James; Kagan, Valerian; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15260 USA		Kochanek, PM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, 3434 5th Ave, Pittsburgh, PA 15260 USA.	kochanekpm@ccm.upmc.edu	Kochanek, Patrick M/D-2371-2015	Kochanek, Patrick M/0000-0002-2627-913X; Wisniewski, Stephen/0000-0002-3877-9860; Kagan, Valerian E./0000-0002-7245-1885	United States Army, Tacoma, Washington [W81XWH-09-2-0187]	Received from the Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Submitted for publication May 17, 2012. Accepted for publication November 8, 2012. Supported by W81XWH-09-2-0187 from the United States Army, Tacoma, Washington.	Adelson PD, 2011, CHILD NERV SYST, V27, P1465, DOI 10.1007/s00381-011-1476-z; Amick Jonathan E., 2001, Pediatr Crit Care Med, V2, P260, DOI 10.1097/00130478-200107000-00013; Atkins JL, 2007, AM J PHYSIOL-HEART C, V292, pH776, DOI 10.1152/ajpheart.00381.2006; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Bayir H, 2004, J NEUROTRAUM, V21, P1, DOI 10.1089/089771504772695896; Bayir H, 2002, PEDIATR RES, V51, P571, DOI 10.1203/00006450-200205000-00005; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Belikova NA, 2011, J NEUROSCI METH, V201, P185, DOI 10.1016/j.jneumeth.2011.08.001; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Benedict FG, 1911, AM J PHYSIOL, V28, P1; Bitterman H, 1996, AM J PHYSIOL-HEART C, V271, pH203, DOI 10.1152/ajpheart.1996.271.1.H203; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; CAMPBELL IL, 1993, P NATL ACAD SCI USA, V90, P10061, DOI 10.1073/pnas.90.21.10061; Carlos TM, 1997, J LEUKOCYTE BIOL, V61, P279, DOI 10.1002/jlb.61.3.279; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLARK RSB, 1994, J NEUROTRAUM, V11, P499, DOI 10.1089/neu.1994.11.499; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; DALY WJ, 1967, J CLIN INVEST, V46, P1617, DOI 10.1172/JCI105654; DEJOURS P, 1962, PHYSIOL REV, V42, P335, DOI 10.1152/physrev.1962.42.3.335; DeKosky ST, 1996, ANN NEUROL, V39, P123, DOI 10.1002/ana.410390118; Dennis AM, 2009, J NEUROTRAUM, V26, P889, DOI 10.1089/neu.2008.0512; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; EGGERS GWN, 1962, J APPL PHYSIOL, V17, P75, DOI 10.1152/jappl.1962.17.1.75; Exo JL, 2009, J NEUROTRAUM, V26, P2403, DOI 10.1089/neu.2009.0980; Figaji AA, 2010, NEUROCRIT CARE, V12, P430, DOI 10.1007/s12028-010-9344-3; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Flynn EP, 2002, ANN NEUROL, V52, P566, DOI 10.1002/ana.10322; Foley LM, 2009, J NEUROTRAUM, V26, P1509, DOI 10.1089/neu.2008.0747; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Hemerka JN, 2012, J NEUROTRAUM, V29, P2192, DOI 10.1089/neu.2011.2303; Jadidi-Niaragh F, 2011, SCAND J IMMUNOL, V74, P1, DOI 10.1111/j.1365-3083.2011.02536.x; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kim HY, 2005, ANN NEUROL, V57, P571, DOI 10.1002/ana.20430; Kochanek PM, 2010, JAMA-J AM MED ASSOC, V303, P2190, DOI 10.1001/jama.2010.715; Koedel U, 2007, AM J PATHOL, V171, P200, DOI 10.2353/ajpath.2007.060821; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Li ZJ, 2011, AM J PATHOL, V178, P1106, DOI 10.1016/j.ajpath.2010.12.001; Liu SM, 2006, J CEREBR BLOOD F MET, V26, P1274, DOI 10.1038/sj.jcbfm.9600277; Liu YB, 1998, STROKE, V29, P1679, DOI 10.1161/01.STR.29.8.1679; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mills PH, 2012, MAGN RESON MED, V67, P278, DOI 10.1002/mrm.22998; Milone SD, 1999, CAN J PHYSIOL PHARM, V77, P124, DOI 10.1139/cjpp-77-2-124; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nelson TJ, 2006, J AM COLL SURGEONS, V202, P418, DOI 10.1016/j.jamcollsurg.2005.11.011; Nygardas M, 2011, GENE THER, V18, P646, DOI 10.1038/gt.2011.4; Otto VI, 2001, NEUROREPORT, V12, P2059, DOI 10.1097/00001756-200107030-00053; Pasgaard T, 2007, ACTA PHYSIOL, V191, P285, DOI 10.1111/j.1748-1716.2007.01745.x; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rousseau A, 2005, ACTA PHYSIOL SCAND, V183, P231, DOI 10.1111/j.1365-201X.2005.01405.x; Shein SL, 2011, CRIT CARE MED S, V38, pA144; Shellington DK, 2011, CRIT CARE MED, V39, P494, DOI 10.1097/CCM.0b013e318206b1fa; Shin HK, 2007, BRAIN, V130, P1631, DOI 10.1093/brain/awm071; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Singhal AB, 2002, NEUROLOGY, V58, P945, DOI 10.1212/WNL.58.6.945; Singhal AB, 2002, J CEREBR BLOOD F MET, V22, P861, DOI 10.1097/00004647-200207000-00011; Singhal AB, 2007, STROKE, V38, P2851, DOI 10.1161/STROKEAHA.107.487280; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Sukhotnik I, 2002, SHOCK, V18, P277, DOI 10.1097/00024382-200209000-00013; Sullivan PG, 1999, J NEUROSCI, V19, P6248; Tang MK, 2010, J CEREBR BLOOD F MET, V30, P119, DOI 10.1038/jcbfm.2009.194; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; Vereczki V, 2006, J CEREBR BLOOD F MET, V26, P821, DOI 10.1038/sj.jcbfm.9600234; Vilalta A, 2011, J NEUROTRAUM, V28, P1139, DOI 10.1089/neu.2010.1720; Waisman D, 2003, AM J PHYSIOL-HEART C, V285, pH643, DOI 10.1152/ajpheart.00900.2002; Walson KH, 2011, CRIT CARE MED, V39, P335, DOI 10.1097/CCM.0b013e3181ffda0e; WHITEHORN WV, 1946, AM J PHYSIOL, V146, P61; Zanier ER, 2003, J NEUROTRAUM, V20, P409, DOI 10.1089/089771503765355496; Zhao D, 2011, J CLIN IMMUNOL, V31, P719, DOI 10.1007/s10875-011-9534-6; Zhao WH, 2006, J NEUROCHEM, V99, P1176, DOI 10.1111/j.1471-4159.2006.04172.x	85	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	MAR	2013	118	3					649	663		10.1097/ALN.0b013e318280a42d			15	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	093LH	WOS:000315192900022	23299361	Bronze			2022-02-06	
J	Uysal, N; Baykara, B; Kiray, M; Cetin, F; Aksu, I; Dayi, A; Gurpinar, T; Ozdemir, D; Arda, MN				Uysal, Nazan; Baykara, Basak; Kiray, Muge; Cetin, Ferihan; Aksu, Ilkay; Dayi, Ayfer; Gurpinar, Tugba; Ozdemir, Durgul; Arda, M. Nuri			Combined Treatment with Progesterone and Magnesium Sulfate Positively Affects Traumatic Brain Injury in Immature Rats	TURKISH NEUROSURGERY			English	Article						Traumatic brain injury; Immature rat; Spatial learning and memory; Apoptosis; VEGF; Magnesium sulfate; Progesterone	INDUCED HIPPOCAMPAL DAMAGE; METHYL-D-ASPARTATE; COGNITIVE DYSFUNCTION; NEUROTROPHIC FACTOR; HEAD TRAUMA; CELL-DEATH; MEMORY; CHILDREN; ANTAGONISTS; ACTIVATION	AIM: It is well known that head trauma results in damage in hippocampal and cortical areas of the brain and impairs cognitive functions. The aim of this study is to explore the neuroprotective effect of combination therapy with magnesium sulphate (MgSO4) and progesterone in the 7-days-old rat pups subjected to contusion injury. MATERIAL and METHODS: Progesterone (8 mg/kg) and MgSO4 (150 mg/kg) were injected intraperitoneally immediately after induction of traumatic brain injury. Half of groups were evaluated 24 hours later, the remaining animals 3 weeks after trauma or sham surgery. Anxiety levels were assessed with open field activity and elevated plus maze; learning and memory performance were evaluated with Morris Water maze in postnatal 27 days. RESULTS: Combined therapy with progesterone and magnesium sulfate significantly attenuated trauma-induced neuronal death, increased brain VEGF levels and improved spatial memory deficits that appear later in life. Brain VEGF levels were higher in rats that received combined therapy compared to rats that received either medication alone. Moreover, rats that received combined therapy had reduced hipocampus and prefrontal cortex apoptosis in the acute period. CONCLUSION: These results demonstrate that combination of drugs with different mechanisms of action may be preferred in the treatment of head trauma.	[Uysal, Nazan; Kiray, Muge; Cetin, Ferihan; Aksu, Ilkay; Dayi, Ayfer] Dokuz Eylul Univ, Fac Med, Dept Physiol, Izmir, Turkey; [Baykara, Basak] Dokuz Eylul Univ, High Sch Phys Therapy & Rehabil, Izmir, Turkey; [Gurpinar, Tugba] Celal Bayar Univ, Dept Pharmacol, Fac Med, Manisa, Turkey; [Ozdemir, Durgul] Dokuz Eylul Univ, Dept Pediat, Fac Med, Izmir, Turkey; [Arda, M. Nuri] Dokuz Eylul Univ, Dept Neurosurg, Fac Med, Izmir, Turkey		Uysal, N (corresponding author), Dokuz Eylul Univ, Fac Med, Dept Physiol, Izmir, Turkey.	nazan.uysal@deu.edu.tr	dayi, ayfer/O-9503-2019; Baykara, Basak/AAC-6504-2019	dayi, ayfer/0000-0002-4102-1399; Baykara, Basak/0000-0002-4178-2235; Uysal, Nazan/0000-0002-2348-7427			Adelson PD, 1998, J CHILD NEUROL, V13, P2, DOI 10.1177/088307389801300102; Altura BM, 2003, NEUROSCI LETT, V341, P189, DOI 10.1016/S0304-3940(03)00134-4; Bayir H, 2003, CRIT CARE CLIN, V19, P529, DOI 10.1016/S0749-0704(03)00014-9; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; CHOI DW, 1987, J NEUROSCI, V7, P369; Conte V., 2003, EUR J TRAUMA, V7, P335; Cook NL, 2009, MAGNESIUM RES, V22, P225, DOI 10.1684/mrh.2009.0189; Cutler SM, 2006, EXP NEUROL, V200, P378, DOI 10.1016/j.expneurol.2006.02.137; Dang J, 2011, BRAIN BEHAV IMMUN, V25, P715, DOI 10.1016/j.bbi.2011.01.013; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Enomoto T, 2005, J NEUROTRAUM, V22, P783, DOI 10.1089/neu.2005.22.783; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; GARFINKEL L, 1985, Magnesium, V4, P60; GENTILE NT, 1993, ANN EMERG MED, V22, P1028, DOI 10.1016/S0196-0644(05)82746-5; Guthrie E, 1999, CHILD ADOL PSYCH CL, V8, P807; Heath DL, 1999, J NEUROSURG, V90, P504, DOI 10.3171/jns.1999.90.3.0504; Heath DL, 1999, J CLIN NEUROSCI, V6, P505, DOI 10.1016/S0967-5868(99)90011-5; Heath DL, 2001, J NEUROTRAUM, V18, P465, DOI 10.1089/089771501750171074; Kahraman S, 2003, CLIN CHIM ACTA, V334, P211, DOI 10.1016/S0009-8981(03)00235-3; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Klur S, 2009, HIPPOCAMPUS, V19, P800, DOI 10.1002/hipo.20562; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; Lu KT, 2011, J NEUROTRAUM, V28, P441, DOI 10.1089/neu.2010.1473; Luoma JI, 2011, STEROIDS, V76, P845, DOI 10.1016/j.steroids.2011.02.013; MCDONALD JW, 1988, BRAIN RES, V459, P200, DOI 10.1016/0006-8993(88)90306-X; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Osteen CL, 2001, J NEUROTRAUM, V18, P141, DOI 10.1089/08977150150502587; Ozdemir D, 2005, NEUROSCI LETT, V385, P234, DOI 10.1016/j.neulet.2005.05.055; Ozdemir D, 2012, NEUROSCI LETT, V507, P84, DOI 10.1016/j.neulet.2011.11.059; Pifarre P, 2010, J NEUROCHEM, V112, P807, DOI 10.1111/j.1471-4159.2009.06518.x; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; Polderman KH, 2000, CRIT CARE MED, V28, P2022, DOI 10.1097/00003246-200006000-00057; Sen AP, 2010, NEUROTHERAPEUTICS, V7, P91, DOI 10.1016/j.nurt.2009.10.014; Slutsky I, 2010, NEURON, V65, P165, DOI 10.1016/j.neuron.2009.12.026; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; Temkin NR, 2007, LANCET NEUROL, V6, P29, DOI 10.1016/S1474-4422(06)70630-5; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; VINK R, 1988, J BIOL CHEM, V263, P757; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wright DW, 2007, ANN EMERG MED, V49, P391, DOI 10.1016/j.annemergmed.2006.07.932; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C	46	18	23	0	12	TURKISH NEUROSURGICAL SOC	BAHCELIEVLER	TASKENT CADDESI 13-4, BAHCELIEVLER, ANKARA 06500, TURKEY	1019-5149			TURK NEUROSURG	Turk. Neurosurg.	MAR	2013	23	2					129	137		10.5137/1019-5149.JTN.5582-11.1			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	123GH	WOS:000317375900001	23546895	Bronze			2022-02-06	
J	Tang, DD; Hu, L; Li, H; Zhang, QL; Chen, AT				Tang, Dandan; Hu, Li; Li, Hong; Zhang, Qinglin; Chen, Antao			The Neural Dynamics of Conflict Adaptation within a Look-to-Do Transition	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL MECHANISMS; TRAUMATIC BRAIN-INJURY; INDUCED BEHAVIORAL-ADJUSTMENT; STROOP TASK; SEQUENTIAL MODULATIONS; PREFRONTAL CORTEX; RESPONSE CONFLICT; EXECUTIVE CONTROL; DECISION-MAKING	Background: For optimal performance in conflict situations, conflict adaptation (conflict detection and adjustment) is necessary. However, the neural dynamics of conflict adaptation is still unclear. Methods: In the present study, behavioral and electroencephalography (EEG) data were recorded from seventeen healthy participants during performance of a color-word Stroop task with a novel look-to-do transition. Within this transition, participants looked at the Stroop stimuli but no responses were required in the 'look' trials; or made manual responses to the Stroop stimuli in the 'do' trials. Results: In the 'look' trials, the amplitude modulation of N450 occurred exclusively in the right-frontal region. Subsequently, the amplitude modulation of sustained potential (SP) emerged in the posterior parietal and right-frontal regions. A significantly positive correlation between the modulation of reconfiguration in the 'look' trials and the behavioral conflict adaptation in the 'do' trials was observed. Specially, a stronger information flow from right-frontal region to posterior parietal region in the beta band was observed for incongruent condition than for congruent condition. In the 'do' trials, the conflict of 'look' trials enhanced the amplitude modulations of N450 in the right-frontal and posterior parietal regions, but decreased the amplitude modulations of SP in these regions. Uniquely, a stronger information flow from centro-parietal region to right-frontal region in the theta band was observed for il condition than for cl condition. Conclusion: All these findings showed that top-down conflict adaptation is implemented by: (1) enhancing the sensitivity to conflict detection and the adaptation to conflict resolution; (2) modulating the effective connectivity between parietal region and right-frontal region.	[Tang, Dandan; Hu, Li; Zhang, Qinglin; Chen, Antao] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Fac Psychol, Chongqing, Peoples R China; [Li, Hong; Chen, Antao] Liaoning Normal Univ, Res Ctr Psychol Dev & Educ, Dalian, Liaoning, Peoples R China		Chen, AT (corresponding author), Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Fac Psychol, Chongqing, Peoples R China.	xscat@swu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31170980, 81271477]; Foundation for the Author of National Excellent Doctoral Dissertation of PR ChinaFoundation for the Author of National Excellent Doctoral Dissertation of China [201107]; New Century Excellent Talents in UniversityProgram for New Century Excellent Talents in University (NCET) [NCET-11-0698]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [SWU1009001]	Funding support was provided by the National Natural Science Foundation of China (31170980, 81271477), the Foundation for the Author of National Excellent Doctoral Dissertation of PR China (201107), the New Century Excellent Talents in University (NCET-11-0698), and the Fundamental Research Funds for the Central Universities (SWU1009001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2007, PSYCHON B REV, V14, P742, DOI 10.3758/BF03196831; Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Appelbaum LG, 2009, CEREB CORTEX, V19, P2508, DOI 10.1093/cercor/bhp036; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Chen AT, 2011, INT J PSYCHOPHYSIOL, V80, P129, DOI 10.1016/j.ijpsycho.2011.02.012; Clayson PE, 2011, PSYCHOPHYSIOLOGY, V48, P1621, DOI 10.1111/j.1469-8986.2011.01265.x; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; di Pellegrino G, 2007, J COGNITIVE NEUROSCI, V19, P275, DOI 10.1162/jocn.2007.19.2.275; Donohue SE, 2011, COGN AFFECT BEHAV NE, P1; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Egner T., 2007, HYPNOSIS CONSCIOUS S, P29; Engel AK, 2010, CURR OPIN NEUROBIOL, V20, P156, DOI 10.1016/j.conb.2010.02.015; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Fellows LK, 2005, CEREB CORTEX, V15, P58, DOI 10.1093/cercor/bhh108; Freitas AL, 2007, PSYCHOL SCI, V18, P1040, DOI 10.1111/j.1467-9280.2007.02022.x; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Hazeltine E, 2011, J EXP PSYCHOL HUMAN, V37, P1898, DOI 10.1037/a0024662; Hommel B, 2004, PSYCHOL RES-PSYCH FO, V68, P1, DOI 10.1007/s00426-003-0132-y; Hu L, 2012, NEUROIMAGE, V62, P217, DOI 10.1016/j.neuroimage.2012.03.094; Hwang K, 2010, J NEUROSCI, V30, P15535, DOI 10.1523/JNEUROSCI.2825-10.2010; Iyer A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000444; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim C, 2010, NEUROSCI LETT, V476, P156, DOI 10.1016/j.neulet.2010.04.019; Lamers MJM, 2011, Q J EXP PSYCHOL, V64, P1056, DOI 10.1080/17470218.2010.523792; Larson MJ, 2012, DEV NEUROPSYCHOL, V37, P343, DOI 10.1080/87565641.2011.650337; Larson MJ, 2012, J INT NEUROPSYCH SOC, V18, P323, DOI 10.1017/S1355617711001779; Larson MJ, 2012, NEUROPSYCHOLOGIA, V50, P426, DOI 10.1016/j.neuropsychologia.2011.12.021; Larson MJ, 2011, INT J PSYCHOPHYSIOL, V82, P69, DOI 10.1016/j.ijpsycho.2011.02.018; Larson MJ, 2009, J INT NEUROPSYCH SOC, V15, P927, DOI 10.1017/S1355617709990701; Larson MJ, 2009, NEUROPSYCHOLOGIA, V47, P663, DOI 10.1016/j.neuropsychologia.2008.11.013; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Liu PD, 2012, J COGN PSYCHOL, V24, P457, DOI 10.1080/20445911.2011.651080; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Mansouri FA, 2009, NAT REV NEUROSCI, V10, P141, DOI 10.1038/nrn2538; Markela-Lerenc J, 2004, COGNITIVE BRAIN RES, V18, P278, DOI 10.1016/j.cogbrainres.2003.10.013; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; Mayr U, 2009, PSYCHOL RES-PSYCH FO, V73, P794, DOI 10.1007/s00426-008-0191-1; Milde T, 2010, NEUROIMAGE, V50, P960, DOI 10.1016/j.neuroimage.2009.12.110; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MULLER HJ, 1989, J EXP PSYCHOL HUMAN, V15, P315, DOI 10.1037/0096-1523.15.2.315; Nieuwenhuis S, 2006, MEM COGNITION, V34, P1260, DOI 10.3758/BF03193270; Notebaert W, 2006, PSYCHON B REV, V13, P112, DOI 10.3758/BF03193821; Peng WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034163; Perlstein WM, 2006, NEUROPSYCHOLOGIA, V44, P260, DOI 10.1016/j.neuropsychologia.2005.05.009; Posner MI, 1975, INFORM PROCESSING CO, P55; Posner MI, 1998, ROYAL SOC, V353, P1915; Purmann S, 2009, PSYCHON B REV, V16, P350, DOI 10.3758/PBR.16.2.350; Roelofs A, 2006, P NATL ACAD SCI USA, V103, P13884, DOI 10.1073/pnas.0606265103; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Sheth SA, 2012, NATURE, V488, P218, DOI 10.1038/nature11239; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Sturmer B, 2002, J EXP PSYCHOL HUMAN, V28, P1345, DOI 10.1037//0096-1523.28.6.1345; Ullsperger M, 2005, COGN AFFECT BEHAV NE, V5, P467, DOI 10.3758/CABN.5.4.467; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Verguts T, 2008, PSYCHOL REV, V115, P518, DOI 10.1037/0033-295X.115.2.518; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2005, EXP BRAIN RES, V167, P38, DOI 10.1007/s00221-005-2366-y; West R, 2004, PSYCHOPHYSIOLOGY, V41, P739, DOI 10.1111/j.1469-8986.2004.00205.x; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; West R, 2000, CEREB CORTEX, V10, P748, DOI 10.1093/cercor/10.8.748; Zysset S, 2001, NEUROIMAGE, V13, P29, DOI 10.1006/nimg.2000.0665	72	18	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 28	2013	8	2							e57912	10.1371/journal.pone.0057912			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	098DA	WOS:000315524900197	23469102	Green Published, gold, Green Submitted			2022-02-06	
J	Park, HJ; Machado, AG; Cooperrider, J; Havan, TF; Johnson, M; Krishna, V; Chen, ZH; Gale, JT				Park, Hyun-Joo; Machado, Andre G.; Cooperrider, Jessica; Havan Truong-Furmaga; Johnson, Matthew; Krishna, Vibhuti; Chen, Zhihong; Gale, John T.			Semi-automated method for estimating lesion volumes	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Lesion volume; Stroke; Traumatic brain injury; Cell death; Lesion estimation; Computational method	MOTOR CORTEX STIMULATION; FOCAL CEREBRAL-ISCHEMIA; ELECTRICAL-STIMULATION; MULTIPLE-SCLEROSIS; RECOVERY; STROKE; INJURY; RAT	Accurately measuring the volume of tissue damage in experimental lesion models is crucial to adequately control for the extent and location of the lesion, variables that can dramatically bias the outcome of preclinical studies. Many of the current commonly used techniques for this assessment, such as measuring the lesion volume with primitive software macros and plotting the lesion location manually using atlases, are time-consuming and offer limited precision. Here we present an easy to use semi-automated computational method for determining lesion volume and location, designed to increase precision and reduce the manual labor required. We compared this novel method to currently used methods and demonstrate that this tool is comparable or superior to current techniques in terms of precision and has distinct advantages with respect to user interface, labor intensiveness and quality of data presentation. (c) 2012 Elsevier B.V. All rights reserved.	[Park, Hyun-Joo; Machado, Andre G.; Cooperrider, Jessica; Havan Truong-Furmaga; Johnson, Matthew; Krishna, Vibhuti; Chen, Zhihong; Gale, John T.] Cleveland Clin, Dept Neurosci, Lerner Res Inst, Cleveland, OH 44195 USA; [Machado, Andre G.; Gale, John T.] Cleveland Clin, Neurol Inst, Ctr Neurol Restorat, Cleveland, OH 44195 USA		Gale, JT (corresponding author), Cleveland Clin, Dept Neurosci, 9500 Euclid Ave,NC30, Cleveland, OH 44195 USA.	galej@ccf.org	Machado, Andre GG/B-7572-2014	Machado, Andre GG/0000-0002-8132-5610; Chen, zhihong/0000-0001-7403-7015; Johnson, Matthew/0000-0002-0264-8498	NIH grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01HD061363]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061363] Funding Source: NIH RePORTER	The research was funded by an NIH grant: 5R01HD061363.	Adkins-Muir DL, 2003, NEUROL RES, V25, P780, DOI 10.1179/016164103771953853; Bagnato F, 2011, MULT SCLER J, V17, P1424, DOI 10.1177/1352458511414601; Baker KB, 2010, EXP NEUROL, V226, P259, DOI 10.1016/j.expneurol.2010.08.019; Brown JA, 2003, NEUROL RES, V25, P815, DOI 10.1179/016164103771953907; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; COOK LT, 1980, IEEE T BIO-MED ENG, V27, P493, DOI 10.1109/TBME.1980.326663; Criminisi A, 1999, IMAGE VISION COMPUT, V17, P625, DOI 10.1016/S0262-8856(98)00183-8; Darling WG, 2011, EXP NEUROL, V231, P56, DOI 10.1016/j.expneurol.2011.05.015; Di Stefano G, 2000, J NEUROL NEUROSUR PS, V69, P210, DOI 10.1136/jnnp.69.2.210; GOLDBERG SN, 1995, ACAD RADIOL, V2, P399; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Lee VM, 1996, STROKE, V27, P2110, DOI 10.1161/01.STR.27.11.2110; Machado AG, 2009, BRAIN RES, V1280, P107, DOI 10.1016/j.brainres.2009.05.007; Merino JG, 2007, STROKE, V38, P2919, DOI 10.1161/STROKEAHA.107.485995; MEYERS D, 1992, ACM T GRAPHIC, V11, P228, DOI 10.1145/130881.131213; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rivers CS, 2006, STROKE, V37, P98, DOI 10.1161/01.STR.0000195197.66606.bb; Wieshmann UC, 1997, EPILEPSIA, V38, P1238, DOI 10.1111/j.1528-1157.1997.tb01222.x; Windle V, 2006, EXP NEUROL, V201, P324, DOI 10.1016/j.expneurol.2006.04.012; Wolf SL, 2006, JAMA-J AM MED ASSOC, V296, P2095, DOI 10.1001/jama.296.17.2095; Zivadinov R, 2012, NEUROIMAGE, V59, P331, DOI 10.1016/j.neuroimage.2011.07.045	21	18	18	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	FEB 15	2013	213	1					76	83		10.1016/j.jneumeth.2012.12.010			8	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	098JC	WOS:000315544500010	23261655	Green Accepted			2022-02-06	
J	Tajuddin, NF; Przybycien-Szymanska, MM; Pak, TR; Neafsey, EJ; Collins, MA				Tajuddin, Nuzhath F.; Przybycien-Szymanska, Magdalena M.; Pak, Toni R.; Neafsey, Edward J.; Collins, Michael A.			Effect of repetitive daily ethanol intoxication on adult rat brain: Significant changes in phospholipase A2 enzyme levels in association with increased PARP-1 indicate neuroinflammatory pathway activation	ALCOHOL			English	Article						Alcohol; Neuroinflammation; PLA2; AQP4; Neurodegeneration; Arachidonic acid; PARP-1; Parthanatos	ALCOHOL-RELATED DEMENTIA; NF-KAPPA-B; DOCOSAHEXAENOIC ACID; SLICE CULTURES; CELL-DEATH; IN-VIVO; NEURONAL DEGENERATION; LIPID-PEROXIDATION; INDUCED APOPTOSIS; OXIDATIVE STRESS	Collaborating on studies of subchronic daily intoxication in juvenile and adult rats, we examined whether the repetitive ethanol treatments at these two life stages altered levels of key neuroinflammation-associated proteins-aquaporin-4 (AQP4), certain phospholipase A2 (PLA2) enzymes, PARP-1 and caspase-3-in hippocampus (HC) and entorhinal cortex (EC). Significant changes in the proteins could implicate activation of specific neuroinflammatory signaling pathways in these rats as well as in severely binge-intoxicated adult animals that are reported to incur degeneration of vulnerable neurons in HC and EC. Male Wistar rats, ethanol-intoxicated (3 g/kg i.p.) once daily for 6 days over an 8-day interval beginning at 37 days old and repeated at age 68-75 days, were sacrificed 1 h after the day 75 dose (blood ethanol, 200-230 mg/dl). Analysis of HC with an immunoblot technique showed that AQP4, Ca+2-dependent PLA2 (cPLA2 IVA), phosphorylated (activated) p-cPLA2, cleaved (89 kD) PARP (c-PARP), and caspase-3 levels were significantly elevated over controls, whereas Ca+2-independent PLA2 (iPLA2 VIA) was reduced similar to 70%; however, cleaved caspase-3 was undetectable. In the EC, AQP4 was unchanged, but cPLA2 and p-cPLA2 were significantly increased while iPLA2 levels were diminished (similar to 40%) similar to HC, although just outside statistical significance (p = 0.06). In addition, EC levels of PARP-1 and c-PARP were significantly increased. The ethanol-induced activation of cPLA2 in association with reduced iPLA2 mirrors PLA2 changes in reports of neurotrauma and also of dietary omega-3 fatty acid depletion. Furthermore, the robust PARP-1 elevations accompanied by negligible caspase-3 activation indicate that repetitive ethanol intoxication may be potentiating non-apoptotic neurodegenerative processes such as parthanatos. Overall, the repetitive ethanol treatments appeared to instigate previously unappreciated neuroinflammatory pathways in vivo. The data provide insights into mechanisms of binge ethanol abuse that might suggest new therapeutic approaches to counter neurodegeneration and dementia. (C) 2013 Elsevier Inc. All rights reserved.	[Tajuddin, Nuzhath F.; Neafsey, Edward J.; Collins, Michael A.] Loyola Univ, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, Maywood, IL 60153 USA; [Przybycien-Szymanska, Magdalena M.; Pak, Toni R.] Loyola Univ, Dept Cell & Mol Physiol, Stritch Sch Med, Maywood, IL 60153 USA		Collins, MA (corresponding author), Loyola Univ, Dept Mol Pharmacol & Therapeut, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	mcollin@lumc.edu	Neafsey, Edward J./ABG-3419-2021		NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [U01AA018279, R01AG033605, R21AA018398]; Loyola Alcohol Research Program [T32AA013527]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG033605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [R21AA018398, T32AA013527, U01AA018279] Funding Source: NIH RePORTER	The research was supported by NIH U01AA018279, R01AG033605, R21AA018398, and Loyola Alcohol Research Program (T32AA013527). Robert M. Mitchell, Ph.D., is acknowledged for helpful discussions and initial technical assistance. Grace Sun, Ph.D. is thanked for recommendations concerning PLA2 antibodies.	ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Adibhatla RM, 2008, BMB REP, V41, P560, DOI 10.5483/BMBRep.2008.41.8.560; Adibhatla RM, 2007, BRAIN RES, V1134, P199, DOI 10.1016/j.brainres.2006.11.080; Alfonso-Loeches S, 2010, J NEUROSCI, V30, P8285, DOI 10.1523/JNEUROSCI.0976-10.2010; Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387; Basavarajappa BS, 1998, BIOCHEM PHARMACOL, V55, P515, DOI 10.1016/S0006-2952(97)00501-7; Basavarajappa BS, 1997, ALCOHOL CLIN EXP RES, V21, P1199, DOI 10.1097/00000374-199710000-00007; Bazan NG, 2011, ANNU REV NUTR, V31, P321, DOI 10.1146/annurev.nutr.012809.104635; Bobba A, 2008, INT J MOL MED, V21, P737; Brown J, 2009, NEUROCHEM RES, V34, P260, DOI 10.1007/s11064-008-9765-y; CARLEN PL, 1994, ALCOHOL CLIN EXP RES, V18, P1330, DOI 10.1111/j.1530-0277.1994.tb01432.x; Chaitanya GV, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-31; Cippitelli A, 2010, NEUROBIOL LEARN MEM, V94, P538, DOI 10.1016/j.nlm.2010.09.006; Collins MA, 1996, ALCOHOL CLIN EXP RES, V20, P284, DOI 10.1111/j.1530-0277.1996.tb01641.x; Collins MA, 1998, FASEB J, V12, P221, DOI 10.1096/fasebj.12.2.221; Collins Michael A, 2012, Front Biosci (Elite Ed), V4, P1358; Collins MA, 2012, NEUROTOX RES, V21, P70, DOI 10.1007/s12640-011-9276-5; Crews FT, 2011, BRAIN BEHAV IMMUN, V25, pS4, DOI 10.1016/j.bbi.2011.03.003; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; ECKARDT MJ, 1986, ALCOHOL CLIN EXP RES, V10, P123, DOI 10.1111/j.1530-0277.1986.tb05058.x; Floreani NA, 2010, J NEUROIMMUNE PHARM, V5, P533, DOI 10.1007/s11481-010-9213-z; Friis MB, 2008, AM J PHYSIOL-CELL PH, V294, pC1552, DOI 10.1152/ajpcell.00571.2007; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Goracci G, 2010, MOL NEUROBIOL, V41, P274, DOI 10.1007/s12035-010-8108-6; Gotz ME, 2001, ALCOHOL CLIN EXP RES, V25, P717, DOI 10.1111/j.1530-0277.2001.tb02272.x; Gunnarson E, 2004, NEUROSCIENCE, V129, P947, DOI 10.1016/j.neuroscience.2004.08.022; Gupta S, 2008, BRIT J PSYCHIAT, V193, P351, DOI 10.1192/bjp.bp.108.051425; Hassa PO, 2002, CELL MOL LIFE SCI, V59, P1534, DOI 10.1007/s00018-002-8527-2; Hernandez M, 1998, J BIOL CHEM, V273, P606, DOI 10.1074/jbc.273.1.606; Kim HW, 2012, PSYCHOPHARMACOLOGY, V222, P663, DOI 10.1007/s00213-012-2671-7; Kinsey GR, 2008, J LIPID RES, V49, P1477, DOI 10.1194/jlr.M800030-JLR200; Koivusalo M, 2009, J BIOL CHEM, V284, P6595, DOI 10.1074/jbc.R800049200; Kolko M, 2003, NEUROSCI LETT, V338, P164, DOI 10.1016/S0304-3940(02)01385-X; Kramer RM, 1996, J LIPID MEDIAT CELL, V14, P3, DOI 10.1016/0929-7855(96)01501-5; Lambert IH, 2006, ACTA PHYSIOL, V187, P75, DOI 10.1111/j.1748-1716.2006.01557.x; LEHTONEN JYA, 1995, BIOPHYS J, V68, P1888, DOI 10.1016/S0006-3495(95)80366-8; Li LH, 2011, FASEB J, V25, P1556, DOI 10.1096/fj.10-177279; Luo J, 2001, J NEUROCHEM, V76, P1354, DOI 10.1046/j.1471-4159.2001.00129.x; Ma MT, 2011, NEUROCHEM RES, V36, P347, DOI 10.1007/s11064-010-0340-y; MAJCHROWICZ E, 1975, PSYCHOPHARMACOLOGIA, V43, P245, DOI 10.1007/BF00429258; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Moses G. S., 2006, J NEUROINFLAMM, P3; Obernier JA, 2002, PHARMACOL BIOCHEM BE, V72, P521, DOI 10.1016/S0091-3057(02)00715-3; Obernier JA, 2002, ALCOHOL CLIN EXP RES, V26, P547, DOI 10.1097/00000374-200204000-00016; Ong WY, 2010, CURR MED CHEM, V17, P2746, DOI 10.2174/092986710791859289; Pacher P, 2008, AM J PATHOL, V173, P2, DOI 10.2353/ajpath.2008.080019; Przybycien-Szymanska MM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018350; Rao JS, 2007, MOL PSYCHIATR, V12, P151, DOI 10.1038/sj.mp.4001887; Roberta A, 2010, CURR NEUROPHARMACOL, V8, P84, DOI 10.2174/157015910791233178; Saadoun S, 2010, NEUROSCIENCE, V168, P1036, DOI 10.1016/j.neuroscience.2009.08.019; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Simonyi A, 2002, ALCOHOL CLIN EXP RES, V26, P352, DOI 10.1097/00000374-200203000-00008; Sripathirathan K, 2009, J NEUROTRAUM, V26, P261, DOI 10.1089/neu.2008.0682; Strokin M, 2006, NEUROSCIENCE, V140, P547, DOI 10.1016/j.neuroscience.2006.02.026; Sun GY, 2010, NEUROMOL MED, V12, P133, DOI 10.1007/s12017-009-8092-z; Switzer R. C., 1982, ANAT REC, V202, p186A; Tomas-Camardiel M, 2004, J NEUROCHEM, V91, P891, DOI 10.1111/j.1471-4159.2004.02759.x; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yang HC, 1999, J NEUROCHEM, V73, P1278, DOI 10.1046/j.1471-4159.1999.0731278.x; Zou J, 2010, ALCOHOL CLIN EXP RES, V34, P777, DOI 10.1111/j.1530-0277.2010.01150.x	63	18	19	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0741-8329			ALCOHOL	Alcohol	FEB	2013	47	1					39	45		10.1016/j.alcohol.2012.09.003			7	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse; Pharmacology & Pharmacy; Toxicology	083UC	WOS:000314489700009	23102656	Green Accepted			2022-02-06	
J	Matsumoto, M; Imura, T; Fukazawa, T; Sun, Y; Takeda, M; Kajiume, T; Kawahara, Y; Yuge, L				Matsumoto, Masaya; Imura, Takeshi; Fukazawa, Takahiro; Sun, Yanan; Takeda, Masaaki; Kajiume, Teruyuki; Kawahara, Yumi; Yuge, Louis			Electrical stimulation enhances neurogenin2 expression through beta-catenin signaling pathway of mouse bone marrow stromal cells and intensifies the effect of cell transplantation on brain injury	NEUROSCIENCE LETTERS			English	Article						Bone marrow stromal cells; Neural differentiation; Electrical stimulation; Neurogenin2; beta-catenin	STEM-CELLS; GENE-EXPRESSION; RAT; DIFFERENTIATION	Bone marrow stromal cells (BMSCs) have received significant attention for its use in neural regeneration. However, neural replacement by transplanted BMSCs was not very effective. Recently, the gene transfection method has improved the capability of cell transplantation; however, this method results in canceration and immune rejection. We induced the differentiation of mouse BMSCs into neural cells using electrical stimulation and transplanted the cells into traumatic brain injury (TBI) model mice. We found that the electrically stimulated cells have good potential to differentiate into neural cells and contribute to recovery from TBI without differentiating into astrocytes. In addition, we found that electrical stimulation enhanced neurogenin2 (Ngn2) expression. Ngn2 is involved in neural differentiation and inhibits astrocytic differentiation during cell growth. Furthermore, we found that this enhancement of Ngn2 expression occurred through beta-catenin signaling pathway. This study may contribute to the use of BMSCs for neural replacement in central nervous system diseases. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Matsumoto, Masaya; Imura, Takeshi; Fukazawa, Takahiro; Sun, Yanan; Yuge, Louis] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Bioenvironm Adaptat Sci, Hiroshima 7348551, Japan; [Takeda, Masaaki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Neurosurg, Hiroshima 7348551, Japan; [Kajiume, Teruyuki] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pediat, Hiroshima 7348551, Japan; [Kawahara, Yumi; Yuge, Louis] Space Biolabs Co Ltd, Hiroshima, Japan		Yuge, L (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Bioenvironm Adaptat Sci, Hiroshima 7348551, Japan.	ryuge@hiroshima-u.ac.jp	Imura, Takeshi/A-7157-2018	Kajiume, Teruyuki/0000-0002-4068-3921	Japanese Physical Therapy Association; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23300201] Funding Source: KAKEN	The authors thank Dr. Masaru Okabe at Osaka University for kindly providing GFP mice and Hiroyuki Uwatoko and Kyosuke Nakata at the Division of Bio-Environmental Adaptation Sciences, Graduate School of Biomedical and Health Sciences, Hiroshima University for technical support. The work was supported by a grant from the Japanese Physical Therapy Association in 2012.	Chen JL, 2000, NEUROPHARMACOLOGY, V39, P711, DOI 10.1016/S0028-3908(00)00006-X; Chen JL, 2003, J NEUROSCI RES, V73, P778, DOI 10.1002/jnr.10691; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Hong GM, 2012, TOXICOL SCI, V129, P146, DOI 10.1093/toxsci/kfs186; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kimura K, 1998, J BIOTECHNOL, V63, P55, DOI 10.1016/S0168-1656(98)00075-3; Kondo T, 2011, STEM CELLS, V29, P836, DOI 10.1002/stem.624; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Qu RJ, 2007, NEUROPATHOLOGY, V27, P355, DOI 10.1111/j.1440-1789.2007.00792.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Yamada M, 2007, STEM CELLS, V25, P562, DOI 10.1634/stemcells.2006-0011; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhao L, 2007, CELL BIOL INT, V31, P916, DOI 10.1016/j.cellbi.2007.02.006	14	18	19	1	20	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	JAN 15	2013	533						71	76		10.1016/j.neulet.2012.10.023			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	077GN	WOS:000314016000014	23142721				2022-02-06	
J	Yeiser, LA; Villasana, LE; Raber, J				Yeiser, Lauren A.; Villasana, Laura E.; Raber, Jacob			ApoE isoform modulates effects of cranial Fe-56 irradiation on spatial learning and memory in the water maze	BEHAVIOURAL BRAIN RESEARCH			English	Article						ApoE; Water maze; Open field; Irradiation; Hippocampal function	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-E GENOTYPE; OBJECT RECOGNITION; ALZHEIMERS-DISEASE; MICE; SEX; ATHEROSCLEROSIS; RADIATION; AGE; SUSCEPTIBILITY	Apolipoprotein E, which plays an important role in lipid transport and metabolism and neuronal repair, might modulate the CNS risk following Fe-56 irradiation exposure during space missions. In this study, we investigated this risk by behavioral and cognitive testing male E2, E3, and E4 mice 3 months following cranial Fe-56 irradiation. In the open field, mice irradiated with 2 Gy showed higher activity levels than sham-irradiated mice or mice irradiated with 1 Gy. In addition, E2 mice showed higher activity and lower measures of anxiety than E3 and E4 mice in the open field and elevated zero maze. During hidden platform training, sham-irradiated mice showed most robust learning, 1 Gy irradiated mice reduced learning, and 2 Gy irradiated mice no improvement over the four sessions. In the water maze probe trials, sham-irradiated E2. E3, and E4 mice and E2 and E4 mice irradiated with 1 Gy showed spatial memory retention, but E3 mice irradiated with 1 Gy, and E2, E3, and E4 mice irradiated with 2 Gy did not. Thus, cranial Fe-56 irradiation increases activity levels in the open field and impairs spatial learning and memory in the water maze. E3 mice are more susceptible than E2 or E4 mice to impairments in spatial memory retention in the water maze, indicating that apoE isoform modulates the CNS risk following space missions. (C) 2012 Elsevier B.V. All rights reserved.	[Yeiser, Lauren A.; Villasana, Laura E.; Raber, Jacob] Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Dept Neurol, Portland, OR 97201 USA; [Raber, Jacob] Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Portland, OR 97201 USA		Raber, J (corresponding author), Oregon Hlth & Sci Univ, Dept Behav Neurosci, 3181 SW Sam Jackson Pkwy,Mail Code 1-470, Portland, OR 97239 USA.	raberj@ohsu.edu			 [NNJ05HE63G];  [NSCOR NNX10AD59G (NASA)]	This work was supported by NNJ05HE63G and NSCOR NNX10AD59G (NASA).	Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Berteau-Pavy F, 2007, NEUROSCIENCE, V147, P6, DOI 10.1016/j.neuroscience.2007.03.005; Brichtova E, 2008, CHILD NERV SYST, V24, P349, DOI 10.1007/s00381-007-0459-6; Crawford FC, 2002, NEUROLOGY, V58, P1115, DOI 10.1212/WNL.58.7.1115; Cucinotta F., 2011, RISK ACUTE LATE CENT; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Haley GE, 2012, INT J RADIAT ONCOL, V84, P793, DOI 10.1016/j.ijrobp.2011.12.049; Haley GE, 2010, AGE, V32, P283, DOI 10.1007/s11357-010-9137-9; Higuchi Y, 2002, J RADIAT RES, V43, pS219; Huynh H., 1976, J EDUC STAT, V1, P69, DOI [10.3102/10769986001001069, DOI 10.3102/10769986001001069, 10.2307/1164736]; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Knouff C, 1999, J CLIN INVEST, V103, P1579, DOI 10.1172/JCI6172; Moran LM, 2009, J NEUROTRAUM, V26, P1489, DOI 10.1089/neu.2008.0767; Nathoo N, 2003, J CLIN PATHOL-MOL PA, V56, P132, DOI 10.1136/mp.56.3.132; Olsen R, 2012, GENES BRAIN BEHAV; POIRIER J, 1994, TRENDS NEUROSCI, V17, P525, DOI 10.1016/0166-2236(94)90156-2; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2011, RADIAT RES, V80, P567; Rabin B, 2008, EFFECTS EXPOSURE HEA; Rabin BM, 2009, ADV SPACE RES, V43, P1193, DOI 10.1016/j.asr.2009.01.015; ROSES AD, 1995, ARZNEIMITTEL-FORSCH, V45-1, P413; Shukitt-Hale B, 2000, RADIAT RES, V154, P28, DOI 10.1667/0033-7587(2000)154[0028:SLAMDI]2.0.CO;2; Shukitt-Hale B, 2003, ADV SPACE RES-SERIES, V31, P119, DOI 10.1016/S0273-1177(02)00878-5; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Sullivan PM, 1998, J CLIN INVEST, V102, P130, DOI 10.1172/JCI2673; Villasana L, 2010, RADIAT ENVIRON BIOPH, V49, P421, DOI 10.1007/s00411-010-0290-4; Villasana LE, 2011, INT J RADIAT ONCOL, V80, P567, DOI 10.1016/j.ijrobp.2010.12.034	29	18	18	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328			BEHAV BRAIN RES	Behav. Brain Res.	JAN 15	2013	237						207	214		10.1016/j.bbr.2012.09.029			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	051IG	WOS:000312119200028	23018124				2022-02-06	
J	Brenkert, TE; Estrada, CM; McMorrow, SP; Abramo, TJ				Brenkert, Timothy E.; Estrada, Cristina M.; McMorrow, Sheila P.; Abramo, Thomas J.			Intravenous Hypertonic Saline Use in the Pediatric Emergency Department	PEDIATRIC EMERGENCY CARE			English	Article						hypertonic saline; 3% saline; traumatic brain injury; TBI; diabetic ketoacidosis	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE; CEREBRAL EDEMA; DIABETIC-KETOACIDOSIS; CHILDREN; HYPERTENSION; MANAGEMENT	Objectives: The objective of this study was to describe the use, dosing, and administration of intravenous hypertonic saline (IHS) use in a pediatric emergency department. Methods: This was a retrospective chart review of patients 0 to 18 years receiving IHS as part of their management in a pediatric ED with an annual volume of more than 50,000 visits. Results: Over 4 years, 56 patients received IHS as part of their management in the emergency department. Clinical scenarios for IHS administration included traumatic brain injury with concern for increased intracranial pressure in 19 patients (34%), diabetic ketoacidosis with altered mental status in 18 (32%), hyponatremia without seizure activity in 6 (10.7%), hyponatremic seizure in 3 (5.4%), and altered mental status secondary to a nontraumatic, non-diabetic ketoacidosis cause in 10 (17.9%). The median age of the patients was 11.3 years (interquartile range, 6-13.9 years) receiving a median dose of 4.1 mL/kg (interquartile range, 3.08-5 mL/kg) of IHS. The median time for administration of the IHS was 17 minutes, with 87% of doses given via peripheral intravenous catheters. Approximately one fourth (26.8%) of patients received their dose in 10 minutes or less, with 7.2% of patients receiving a bolus of IHS in 3 minutes or less. We found no evidence of adverse effects. Conclusions: Intravenous hypertonic saline use is increasing within the pediatric emergency department. Within this institution, it is most frequently used at a dosing range of 3 to 5 mL/kg and does not require central venous access for rapid infusion.	[Brenkert, Timothy E.] Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, Cincinnati, OH 45229 USA; [Estrada, Cristina M.; McMorrow, Sheila P.; Abramo, Thomas J.] Monroe Carell Jr Childrens Hosp Vanderbilt, Dept Pediat, Div Emergency Med, Nashville, TN USA		Brenkert, TE (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Emergency Med, 3333 Burnet Ave,ML 2008, Cincinnati, OH 45229 USA.	timothy.brenkert@cchmc.org		Abramo MD, Thomas/0000-0003-2331-4582			Adelson P David, 2003, Pediatr Crit Care Med, V4, pS40; Banks CJ, 2008, EMERG MED AUSTRALAS, V20, P294, DOI 10.1111/j.1742-6723.2008.01086.x; Bohn D, 2002, CURR OPIN PEDIATR, V14, P287, DOI 10.1097/00008480-200206000-00001; Curtis J R, 2001, Pediatr Diabetes, V2, P191, DOI 10.1034/j.1399-5448.2001.20409.x; Doyle JA, 2001, J TRAUMA, V50, P367, DOI 10.1097/00005373-200102000-00030; Drobin D, 2002, ANESTHESIOLOGY, V96, P1371, DOI 10.1097/00000542-200206000-00016; Dunger DB, 2004, ARCH DIS CHILD, V89, P188, DOI 10.1136/adc.2003.044875; FISHER B, 1992, J NEUROSURG ANESTH, V4, P4, DOI 10.1097/00008506-199201000-00002; Forsyth LL, 2008, PHARMACOTHERAPY, V28, P469, DOI 10.1592/phco.28.4.469; Francony G, 2008, CRIT CARE MED, V36, P795, DOI 10.1097/CCM.0B013E3181643B41; Hinson HE, 2011, J INTENSIVE CARE MED, P1; HUANG PP, 1995, ANN SURG, V221, P543, DOI 10.1097/00000658-199505000-00012; Kamat Pradip, 2003, Pediatr Crit Care Med, V4, P239, DOI 10.1097/01.PCC.0000059340.19010.CE; Khanna S, 2000, CRIT CARE MED, V28, P1144, DOI 10.1097/00003246-200004000-00038; Peterson B, 2000, CRIT CARE MED, V28, P1136, DOI 10.1097/00003246-200004000-00037; REED RL, 1991, J TRAUMA, V31, P8, DOI 10.1097/00005373-199101000-00002; SARNAIK AP, 1991, CRIT CARE MED, V19, P758, DOI 10.1097/00003246-199106000-00005; Schimetta W, 2002, WIEN KLIN WOCHENSCHR, V114, P89; Yildizdas D, 2006, INDIAN PEDIATR, V43, P771; Zeng HK, 2010, NEUROSCIENCE, V166, P878, DOI 10.1016/j.neuroscience.2009.12.076	20	18	19	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0749-5161			PEDIATR EMERG CARE	Pediatr. Emerg. Care	JAN	2013	29	1					71	73		10.1097/PEC.0b013e31827b54c3			3	Emergency Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Pediatrics	064FY	WOS:000313059600016	23283268				2022-02-06	
J	Chen, CY; Noble-Haeusslein, LJ; Ferriero, D; Semple, BD				Chen, Chien-Yi; Noble-Haeusslein, Linda J.; Ferriero, Donna; Semple, Bridgette D.			Traumatic Injury to the Immature Frontal Lobe: A New Murine Model of Long-Term Motor Impairment in the Absence of Psychosocial or Cognitive Deficits	DEVELOPMENTAL NEUROSCIENCE			English	Article						Traumatic brain injury; Frontal lobe; Behavior; Pathology; Development; Motor deficit	BRAIN-INJURY; SOCIAL-BEHAVIOR; CHILDREN; GAIT; RECOVERY; ANXIETY; LESIONS; SENSORIMOTOR; MAZE; RATS	Traumatic brain injury in children commonly involves the frontal lobes and is associated with distinct structural and behavioral changes. Despite the clinical significance of injuries localized to this region during brain development, the mechanisms underlying secondary damage and long-term recovery are poorly understood. Here, we have characterized the first model of unilateral focal traumatic injury to the developing frontal lobe. Male C57BI/6J mice at postnatal day (p)21, an age approximating a toddler-aged child, received a controlled cortical impact or sham surgery to the left frontal lobe and were euthanized 1 or 7 days later. A necrotic cavity and local inflammatory response were largely confined to the unilateral frontal lobe, dorsal corpus callosum and striatum anterior to the bregma. While cell death and accumulated B-amyloid precursor protein were characteristic features of the pericontusional motor cortex, corpus callosum, cingulum and dorsal striatum, underlying structures including the hippocampus showed no overt pathology. To determine the long-term functional consequences of injury at p21, two additional cohorts were subjected to a battery of behavioral tests in adolescence (p35-45) or adulthood (p70-80). In both cohorts, brain-injured mice showed normal levels of anxiety, sociability, spatial learning and memory. The signature phenotypic features were deficits in motor function and motor learning, coincident with a reduction in ipsilateral cortical brain volumes. Together, these findings demonstrate classic morphological features of a focal traumatic injury, including early cell death and axonal injury, and long-term volumetric loss of cortical volumes. The presence of deficits in sensorimotor function and coordination in the absence of abnormal findings related to anxiety, sociability and memory likely reflects several variables, including the unique location of the injury and the emergence of favorable compensatory mechanisms during subsequent brain development. (C) 2013 S. Karger AG, Basel	[Chen, Chien-Yi; Noble-Haeusslein, Linda J.; Semple, Bridgette D.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Univ Calif San Francisco, Dept Phys Therapy & Rehabil Sci, San Francisco, CA 94143 USA; [Ferriero, Donna] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Ferriero, Donna] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Noble-Haeusslein, Linda J.] Natl Taiwan Univ Hosp, Taipei, Taiwan; [Chen, Chien-Yi] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Chen, Chien-Yi] Grad Inst Clin Med, Taipei, Taiwan; [Semple, Bridgette D.] Univ Melbourne, Dept Med, Royal Melbourne Hosp, Melbourne Brain Ctr, Melbourne, Vic, Australia		Semple, BD (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 513 Parnassus Ave,Room HSE-722, San Francisco, CA 94143 USA.	Bridgette.Semple@ucsf.edu	Chen, Chien-Yi/A-9680-2015	Chen, Chien-Yi/0000-0002-6030-2655	National Institutes of Health/National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS050159, NS077767]; American Australian Association; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077767, R01NS050159] Funding Source: NIH RePORTER	Funding was provided by National Institutes of Health/National Institute of Neurological Disorders and Stroke grants R01 NS050159 and NS077767 (L.J.N.-H.), a Sir Keith Murdoch Postdoctoral Fellowship from the American Australian Association (B.D.S.) and a CJ Martin Overseas Biomedical Postdoctoral Fellowship from the National Health and Medical Research Council of Australia (B.D.S.).	Adelson PD, 2013, CHILD NERV SYST, V29, P43, DOI 10.1007/s00381-012-1932-4; Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Ajao DO, 2012, J NEUROTRAUM, V29, P2060, DOI 10.1089/neu.2011.1883; Anderson V, 2005, J INT NEUROPSYCH SOC, V11, P817, DOI 10.1017/S1355617705051052; Anderson V, 2012, INT J DEV NEUROSCI, V30, P217, DOI 10.1016/j.ijdevneu.2011.09.008; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bravo TP, 2008, BRAIN RES, V1205, P100, DOI 10.1016/j.brainres.2008.01.102; Cestari V, 2007, CAN J EXP PSYCHOL, V61, P13, DOI 10.1037/cjep2007002; Claus CP, 2010, DEV NEUROSCI-BASEL, V32, P454, DOI 10.1159/000316805; Depino AM, 2007, BEHAV BRAIN RES, V177, P254, DOI 10.1016/j.bbr.2006.11.025; Duvoisin RM, 2011, BEHAV BRAIN RES, V221, P50, DOI 10.1016/j.bbr.2011.02.049; Eslinger PJ, 2000, DEV NEUROPSYCHOL, V18, P297, DOI 10.1207/S1532694203Eslinger; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Goldman P S, 1974, Neurosci Res Program Bull, V12, P217; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Hu PP, 2013, NEUROSCI LETT, V534, P177, DOI 10.1016/j.neulet.2012.12.038; Jacobs R, 2007, CORTEX, V43, P792, DOI 10.1016/S0010-9452(08)70507-0; Jadhav V, 2007, J NEUROSURG, V106, P680, DOI 10.3171/jns.2007.106.4.680; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; Katz-Leurer M, 2008, BRAIN INJURY, V22, P153, DOI 10.1080/02699050801895399; Kilbourne M, 2009, J NEUROTRAUM, V26, P2233, DOI 10.1089/neu.2009.0968; Kolb B, 2000, DEV NEUROPSYCHOL, V18, P423, DOI 10.1207/S1532694208Kolb; KOLB B, 1985, BEHAV NEUROSCI, V99, P691, DOI 10.1037/0735-7044.99.4.691; KOLB B, 1987, BEHAV BRAIN RES, V26, P119, DOI 10.1016/0166-4328(87)90161-6; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lalonde R, 2008, J NEUROSCI METH, V171, P48, DOI 10.1016/j.jneumeth.2008.02.003; Langlois J. A., 2000, TRAUMATIC BRAIN INJU; Laviola G, 2003, NEUROSCI BIOBEHAV R, V27, P19, DOI 10.1016/S0149-7634(03)00006-X; Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Levin HS, 2004, J INT NEUROPSYCH SOC, V10, P305, DOI 10.1017/S1355617704102129; Lindner MD, 1998, J NEUROTRAUM, V15, P199, DOI 10.1089/neu.1998.15.199; Martens KM, 2012, J NEUROTRAUM, V29, P2505, DOI 10.1089/neu.2012.2388; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Oni MB, 2010, J CHILD NEUROL, V25, P976, DOI 10.1177/0883073809356034; Potts Mathew B, 2006, NeuroRx, V3, P143; Prins ML, 1998, J NEUROTRAUM, V15, P799, DOI 10.1089/neu.1998.15.799; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rudebeck PH, 2006, SCIENCE, V313, P1310, DOI 10.1126/science.1128197; Rudebeck PH, 2007, EUR J NEUROSCI, V26, P2315, DOI 10.1111/j.1460-9568.2007.05844.x; Ryan BC, 2008, BEHAV BRAIN RES, V193, P235, DOI 10.1016/j.bbr.2008.06.002; Salchner P, 2004, BEHAV BRAIN RES, V151, P1, DOI 10.1016/j.bbr.2003.07.002; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Semple BD, 2012, J NEUROTRAUM, V29, P2672, DOI 10.1089/neu.2012.2595; Spear L, 2000, ALCOHOL RES HEALTH, V24, P115; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Spencer-Smith M, 2009, DEV NEUROREHABIL, V12, P279, DOI 10.3109/17518420903090701; Spreng M, 2002, BEHAV BRAIN RES, V128, P103, DOI 10.1016/S0166-4328(01)00266-2; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Tsuru-Aoyagi K, 2009, ANN NEUROL, V65, P540, DOI 10.1002/ana.21600; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wilde EA, 2012, INT J DEV NEUROSCI, V30, P267, DOI 10.1016/j.ijdevneu.2012.01.003; Williams G, 2010, J HEAD TRAUMA REHAB, V25, P366, DOI 10.1097/HTR.0b013e3181cd3600; Yang Mu, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0826s56; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Yoneyama-Sarnecky T, 2010, DEV NEUROSCI-BASEL, V32, P81, DOI 10.1159/000258700	62	18	19	0	17	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0378-5866	1421-9859		DEV NEUROSCI-BASEL	Dev. Neurosci.		2013	35	6					474	490		10.1159/000355874			17	Developmental Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Developmental Biology; Neurosciences & Neurology	268PW	WOS:000328184000004	24247103	Green Accepted, Bronze			2022-02-06	
J	De La Rue-Evans, L; Nesbitt, K; Oka, RK				De La Rue-Evans, Linda; Nesbitt, Karen; Oka, Roberta K.			Sleep Hygiene Program Implementation in Patients with Traumatic Brain Injury	REHABILITATION NURSING			English	Article						brain injury; evidence-based practice; quality improvement	LONG-TERM DISABILITY; UNITED-STATES; DISTURBANCE; VETERANS; INSOMNIA; STROKE	Purpose Traumatic brain injury (TBI) is a serious public health problem. The impact of TBI on the individual is multifaceted and includes neurocognitive, behavioral, and psychiatric disturbances as well as greater predisposition for dementia. A common but significant problem reported by patients after TBI is sleep disturbance. The purpose of this manuscript is twofold: (1) to describe our experience with implementation of the newly developed sleep hygiene guidelines; and (2) to report our preliminary results of implementation of the sleep hygiene guidelines on TBI patient outcomes. Methods A mixed methods approach was used to assess implementation of sleep hygiene guidelines and to gather preliminary data on outcomes. Results Although not statistically significant, the average self-reported sleep duration of these TBI patients was slightly higher in 2010 than 2009, with a FIM score that was similar for both time points. In 2009, the mean change in functional independence measure (FIM) score (n=34) was 1.44. In 2010, the mean change in FIM score (n=33) was 1.42. In 2009, most patients (n=13) admitted to the hospital continued to take medications and were discharged with a sleep aid. In 2010, most patients reported a change in their sleep medication prescriptions (on medications at admission and none at discharge) or had continued to take their prescribed sleep medications from admission to discharge (n=12). Conclusion Sleep disorders have a major impact on health outcomes in patients with TBI. To optimize rehabilitation and ultimately improve functional outcomes of patients with TBI, implementation of evidence-based clinical guidelines for sleep is imperative. We report our initial experience with implementation of sleep guidelines.	[De La Rue-Evans, Linda; Nesbitt, Karen; Oka, Roberta K.] VA Palo Alto Hlth Care Syst, Dept Nursing, Palo Alto, CA USA		Oka, RK (corresponding author), VA HCS Palo Alto, 3801 Miranda Ave,MS 118, Palo Alto, CA 94304 USA.	roberta.oka@va.gov					Buxton OM, 2012, ANN INTERN MED, V157, P170, DOI [10.7326/0003-4819-156-12-201208070-00472, 10.7326/0003-4819-157-3-201208070-00472]; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001; Faul M, 2010, TRAUMATIC BRAIN INJU; Fischer H., 2010, CRS REPORT C, P1; Hsueh IP, 2002, J NEUROL NEUROSUR PS, V73, P188, DOI 10.1136/jnnp.73.2.188; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Mitchell MD, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-40; O'Hara R, 2009, J REHABIL RES DEV, V46, P837, DOI 10.1682/JRRD.2008.10.0140; Orff HJ, 2009, J HEAD TRAUMA REHAB, V24, P155, DOI 10.1097/HTR.0b013e3181a0b281; Rosenfeld JV, 2010, INJURY, V41, P437, DOI 10.1016/j.injury.2009.11.018; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	20	18	19	0	20	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0278-4807			REHABIL NURS	Rehabil. Nurs.	JAN-FEB	2013	38	1					2	10		10.1002/rnj.66			9	Nursing; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Nursing; Rehabilitation	084EY	WOS:000314521600002	23365000				2022-02-06	
J	Goodrich, GL; Martinsen, GL; Flyg, HM; Kirby, J; Asch, SM; Brahm, KD; Brand, JM; Cajamarca, D; Cantrell, JL; Chong, T; Dziadul, JA; Hetrick, BJ; Huang, MA; Ihrig, C; Ingalla, SP; Meltzer, BR; Rakoczy, CM; Rone, A; Schwartz, E; Shea, JE				Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Asch, Steven M.; Brahm, Karen D.; Brand, John M.; Cajamarca, Diana; Cantrell, Jenette L.; Chong, Theresa; Dziadul, John A.; Hetrick, Barbara J.; Huang, Michael A.; Ihrig, Carolyn; Ingalla, Shanida P.; Meltzer, Bradley R.; Rakoczy, Chrystyna M.; Rone, Ashley; Schwartz, Elliot; Shea, Jane E.			Development of a mild traumatic brain injury-specific vision screening protocol: A Delphi study	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						accommodation; binocular vision; consensus; convergence insufficiency; Delphi method; mild traumatic brain injury; oculomotor; optometrist; traumatic brain injury; visual symptoms	POST-CONCUSSION SYNDROME; CONVERGENCE INSUFFICIENCY; PHYSICAL-EXAMINATION; VISUAL FUNCTION; POLYTRAUMA; PREVALENCE; GUIDELINES; SYMPTOMS; VETERANS; HISTORY	Although traumatic brain injury (TBI) can happen to anyone at any time, the wars in Iraq and Afghanistan have brought it renewed attention. Fortunately, most cases of TBI from the recent conflicts are mild TBI (mTBI). Still, many physical, psychological, and social problems are associated with mTBI. Among the difficulties encountered are oculomotor and vision problems, many of which can impede daily activities such as reading. Therefore, correct diagnosis and treatment of these mTBI-related vision problems is an important part of patient recovery. Numerous eye care providers in the Department of Veterans Affairs, in military settings, and in civilian practices specialize and are proficient in examining patients who have a history of TBI. However, many do not have this level of experience working with and treating patients with mTBI. Recognizing this, we used a modified Delphi method to derive expert opinions from a panel of 16 optometrists concerning visual examination of the patient with mTBI. This process resulted in a clinical tool containing 17 history questions and 7 examination procedures. This tool provides a set of clinical guidelines that can be used as desired by any eye care provider either as a screening tool or adjunct to a full eye examination when seeing a patient with a history of mTBI. The 757 goal of this process was to provide optimal and uniform vision care for the patient with mTBI.	[Goodrich, Gregory L.; Martinsen, Gary L.; Flyg, Heidi M.; Kirby, Jennine; Asch, Steven M.; Ingalla, Shanida P.] Dept Vet Affairs VA Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Brahm, Karen D.] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Brand, John M.] VA Salt Lake City Hlth Care Syst, Salt Lake City, UT USA; [Cajamarca, Diana] West Palm Beach VA Med Ctr VAMC, W Palm Beach, FL USA; [Cantrell, Jenette L.] Bay Pines VA Healthcare Syst, Bay Pines, FL USA; [Chong, Theresa] VA Southern Nevada Healthcare Syst, North Las Vegas, NV USA; [Dziadul, John A.] Viera VA Outpatient Clin, Viera, FL USA; [Hetrick, Barbara J.] Jonathan M Wainwright Mem VAMC, Walla Walla, WA USA; [Huang, Michael A.] VA Mission Valley Clin, San Diego, CA USA; [Ihrig, Carolyn] VA Western New York Healthcare Syst, Buffalo, NY USA; [Meltzer, Bradley R.] Northport VAMC, Northport, NY USA; [Rakoczy, Chrystyna M.] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Rone, Ashley] Lexington VAMC, Lexington, KY USA; [Schwartz, Elliot] VA New York Harbor Healthcare Syst, New York, NY USA; [Shea, Jane E.] VA St Louis Hlth Care Syst, St Louis, MO USA		Goodrich, GL (corresponding author), VA Palo Alto Hlth Care Syst, 795 Willow Rd,Bldg T-365, Menlo Pk, CA 94025 USA.	Gregorv.Goodrich@va.gov	Goodrich, Gregory L./AAF-7184-2019		VA Health Services Research & Development QUERI [RRP 11-008]	This material was based on work supported by a VA Health Services Research & Development QUERI (grant RRP 11-008).	[Anonymous], 2011, POL BLAST REL INJ QU; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Bigler ED, 2008, J INT NEUROPSYCH SOC, V14, P1, DOI 10.1017/S135561770808017X; Borsting E, 1999, OPTOMETRY VISION SCI, V76, P221, DOI 10.1097/00006324-199904000-00025; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Campbell SM, 1999, MED CARE, V37, P964, DOI 10.1097/00005650-199909000-00012; Campbell SM, 2000, BRIT MED J, V321, P425, DOI 10.1136/bmj.321.7258.425; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Centers for Disease Control and Prevention, 2013, MAN PEOPL HAV TBI; Ciuffreda Kenneth J, 2007, Optometry, V78, P155, DOI 10.1016/j.optm.2006.11.011; Ciuffreda KJ, 2011, OPTOMETRY, V82, P337, DOI 10.1016/j.optm.2011.03.006; Cohen M, 1989, Brain Inj, V3, P187, DOI 10.3109/02699058909004551; Cohen Y, 2010, OPTOMETRY, V81, P28, DOI 10.1016/j.optm.2008.10.019; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Defense and Veterans Brain Injury Center, 2013, DOD WORLDW NUMB TBI; Douglas RS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1155, DOI 10.1001/archophthalmol.2009.232; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; GOSS DA, 1992, CURR OPIN OPHTHALMOL, V3, P78, DOI 10.1097/00055735-199202000-00011; HAMPTON JR, 1975, BRIT MED J, V2, P486, DOI 10.1136/bmj.2.5969.486; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hokoda S C, 1985, J Am Optom Assoc, V56, P560; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Keeney S, 2006, J ADV NURS, V53, P205, DOI 10.1111/j.1365-2648.2006.03716.x; Keeney S, 2001, INT J NURS STUD, V38, P195, DOI 10.1016/S0020-7489(00)00044-4; King NS, 2003, BRIT J PSYCHIAT, V183, P276, DOI 10.1192/bjp.183.4.276; Kingston J, 2010, J VISUAL IMPAIR BLIN, V104, P603, DOI 10.1177/0145482X1010401006; Kraus MF, 2007, COGN BEHAV NEUROL, V20, P170, DOI 10.1097/WNN.0b013e318142badb; Lara F, 2001, OPHTHAL PHYSL OPT, V21, P70, DOI 10.1046/j.1475-1313.2001.00540.x; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; MILHOLLAND AV, 1973, NEW ENGL J MED, V288, P1272, DOI 10.1056/NEJM197306142882405; Mittenberg W, 2001, J CLIN EXP NEUROPSYC, V23, P829, DOI 10.1076/jcen.23.6.829.1022; Murphy M K, 1998, Health Technol Assess, V2, pi; Myint J, 2010, EYE, V24, P1509, DOI 10.1038/eye.2010.62; PETERSON MC, 1992, WESTERN J MED, V156, P163; Powell C, 2003, J ADV NURS, V41, P376, DOI 10.1046/j.1365-2648.2003.02537.x; Powell JM, 2008, ARCH PHYS MED REHAB, V89, P1550, DOI 10.1016/j.apmr.2007.12.035; Rand Corporation, 2013, DELPH METH; Scheiman M, 2005, ARCH OPHTHALMOL-CHIC, V123, P14, DOI 10.1001/archopht.123.1.14; SCHOENBAUM SC, 1976, NEW ENGL J MED, V295, P759, DOI 10.1056/NEJM197609302951405; Stelmack J, 2004, J REHABIL RES DEV, V41, P233, DOI 10.1682/JRRD.2004.02.0233; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Thiagarajan P, 2011, OPHTHAL PHYSL OPT, V31, P456, DOI 10.1111/j.1475-1313.2011.00831.x; Tobacman JK, 2003, MED DECIS MAKING, V23, P122, DOI 10.1177/0272989X03251241; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; WILLIAMS PL, 1994, J ADV NURS, V19, P180, DOI 10.1111/j.1365-2648.1994.tb01066.x; Wold JE, 2003, J CATARACT REFR SURG, V29, P1878, DOI 10.1016/S0886-3350(03)00667-9	51	18	18	0	20	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2013	50	6					757	768		10.1682/JRRD.2012.10.0184			12	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	217HJ	WOS:000324350200005	24203539	Bronze			2022-02-06	
J	Peruzzaro, ST; Gallagher, J; Dunkerson, J; Fluharty, S; Mudd, D; Hoane, MR; Smith, JS				Peruzzaro, Sarah T.; Gallagher, Jonathan; Dunkerson, Jacob; Fluharty, Sarah; Mudd, David; Hoane, Michael R.; Smith, Jeffrey S.			The impact of enriched environment and transplantation of murine cortical embryonic stem cells on recovery from controlled cortical contusion injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; recovery of function; CCI; embryonic stem cells; enriched environment	TRAUMATIC BRAIN-INJURY; FRONTAL-CORTEX LESIONS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; FUNCTIONAL RECOVERY; COGNITIVE DEFICITS; SENSORIMOTOR FUNCTION; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; FOCAL ISCHEMIA	Purpose: The effectiveness of embryonic stem cell (eSC) therapy has been explored in many models of neurological disease and several research groups have shown that eSC treatment leads to improved outcomes in pre-clinical models of traumatic brain injury (TBI). Though functional recovery occurs, few surviving eSCs appear to develop neuronal characteristics; instead the majority of the surviving eSC express glial phenotypes. Additionally, researchers have shown that enriching the post-surgical environment of the subject promotes functional recovery following TBI. The purpose of the current project was to determine if post-surgical environmental enrichment (EE) impacts the survival, migration, and integration of eSCs in a rodent model of TBI and if the presence of these cells lead to improved outcomes. Methods: In the current study, the medial frontal cortex (MFC) of rats was injured using a controlled cortical impact (CCI) device. Immediately following injury the rats were placed into either EE or standard environment (SE) housing and then seven days post-injury rats received either murine cortical eSC or media. Behavioral testing consisted of the Morris water maze (MWM), Barnes Maze (BM), and Rotarod tasks (RR). Results: On the MWM task, TBI/eSC/EE animals performed as well as the Sham/SE and Sham/EE groups. The TBI/eSC/SE, TBI/Media/EE, and TBI/Media/SE groups were impaired compared to the controls. By the end of training on the BM there were no differences between the Sham, TBI/Media/EE, and TBI/eSC/EE groups. On the RR task all animals placed in the EE performed equally well and significantly better than their SE housed counterparts. By the end of training on the RR task, the TBI/eSC/EE group performed as well as the sham counterparts, and though not significant they also surpassed the performance of the injured animals that received enrichment or eSC treatment alone. Conclusions: Combing therapeutic strategies with enriching the post-injury environment is likely to be an important addition to determining the efficacy of pre-clinical therapies.	[Peruzzaro, Sarah T.] Univ Portland, Portland, OR 97203 USA; [Gallagher, Jonathan; Dunkerson, Jacob; Fluharty, Sarah; Mudd, David; Smith, Jeffrey S.] Saginaw Valley State Univ, Brain Res Lab, University Ctr, MI 48710 USA; [Hoane, Michael R.] So Illinois Univ, Restorat Neurosci Lab, Carbondale, IL 62901 USA		Smith, JS (corresponding author), Saginaw Valley State Univ, Crystal M Lange Coll Hlth & Human Serv, Dept Hlth Sci, Malcolm & Lois Field Endowed Chair Hlth Sci, 7400 Bay Rd, University Ctr, MI 48710 USA.	jsmith12@svsu.edu		Hoane, Michael/0000-0001-7779-2657; Smith, Jeffrey/0000-0001-5499-4475	Support of Mentors and their Students (SOMAS) program; M.J. Murdock Charitable Trust; Hewlett Packard	This work was supported by funding from the Support of Mentors and their Students (SOMAS) program, the M.J. Murdock Charitable Trust, and Hewlett Packard. The authors would also like to thank Russ Wood, Pam Ward, Kasey Moritz, Robert Underly, Cole Vonder Haar, Danielle Friend, and Kyle Fink for their technical assistance with the project.	Adekoya Nelson, 2002, MMWR Surveill Summ, V51, P1; Albensi BC, 2003, BRAIN INJURY, V17, P653, DOI 10.1080/0269905031000107142; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Becerra GD, 2007, BEHAV BRAIN RES, V179, P118, DOI 10.1016/j.bbr.2007.01.024; Cao QL, 2002, J NEUROSCI RES, V68, P501, DOI 10.1002/jnr.10240; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Dahlqvist P, 2004, EUR J NEUROSCI, V19, P2288, DOI 10.1111/j.0953-816X.2004.03248.x; de Witt BW, 2011, NEUROREHAB NEURAL RE, V25, P343, DOI 10.1177/1545968310390520; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dobrossy MD, 2004, EUR J NEUROSCI, V19, P159, DOI 10.1111/j.1460-9568.2004.03105.x; Eaton MJ, 2008, BEHAV BRAIN RES, V194, P236, DOI 10.1016/j.bbr.2008.07.001; ERB DE, 1991, EXP BRAIN RES, V83, P253; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Gaulke LJ, 2005, MOL BRAIN RES, V141, P138, DOI 10.1016/j.molbrainres.2005.08.011; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; GENTILINI M, 1985, J NEUROL NEUROSUR PS, V48, P137, DOI 10.1136/jnnp.48.2.137; GRABOWSKI M, 1995, EXP NEUROL, V133, P96, DOI 10.1006/exnr.1995.1011; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; HAMM RJ, 1992, J NEUROTRAUM, V9, P11, DOI 10.1089/neu.1992.9.11; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hamm RJ, 1996, J NEUROTRAUM, V13, P41, DOI 10.1089/neu.1996.13.41; HELD JM, 1985, BEHAV NEUROSCI, V99, P678, DOI 10.1037/0735-7044.99.4.678; Hicks AU, 2007, NEUROSCIENCE, V146, P31, DOI 10.1016/j.neuroscience.2007.01.020; Hicks AU, 2008, BRAIN RES, V1231, P103, DOI 10.1016/j.brainres.2008.07.041; Hicks AU, 2009, EUR J NEUROSCI, V29, P562, DOI 10.1111/j.1460-9568.2008.06599.x; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Ickes BR, 2000, EXP NEUROL, V164, P45, DOI 10.1006/exnr.2000.7415; Itoh T, 2005, NEUROREPORT, V16, P1687, DOI 10.1097/01.wnr.0000183330.44112.ab; Johansson BB, 2004, RESTOR NEUROL NEUROS, V22, P163; Johansson BB, 2002, J CEREBR BLOOD F MET, V22, P89, DOI 10.1097/00004647-200201000-00011; Kempermann G, 1999, HIPPOCAMPUS, V9, P321, DOI 10.1002/(SICI)1098-1063(1999)9:3<321::AID-HIPO11>3.0.CO;2-C; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kline AE, 2007, BEHAV BRAIN RES, V177, P186, DOI 10.1016/j.bbr.2006.11.036; Kline AE, 2012, J NEUROTRAUM, V29, P1960, DOI 10.1089/neu.2012.2385; Kline AE, 2010, J NEUROTRAUM, V27, P2021, DOI 10.1089/neu.2010.1535; Kolb B, 1999, CAN J EXP PSYCHOL, V53, P62, DOI 10.1037/h0087300; Kolb B, 1991, CEREB CORTEX, V1, P189, DOI 10.1093/cercor/1.2.189; Komitova M, 2005, STROKE, V36, P1278, DOI 10.1161/01.STR.0000166197.94147.59; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; Lu L, 2003, EXP NEUROL, V183, P600, DOI 10.1016/S0014-4886(03)00248-6; Maegele M, 2005, EUR J NEUROSCI, V21, P2406, DOI 10.1111/j.1460-9568.2005.04070.x; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; Nygren J, 2006, STROKE, V37, P2824, DOI 10.1161/01.STR.0000244769.39952.90; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; PONSFORD JL, 1995, BRAIN INJURY, V9, P11, DOI 10.3109/02699059509004566; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; Riess P, 2007, J NEUROTRAUM, V24, P216, DOI 10.1089/neu.2006.0141; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Ruttan L, 2008, ARCH PHYS MED REHAB, V89, pS69, DOI 10.1016/j.apmr.2008.07.007; Scaccianoce S, 2006, BEHAV BRAIN RES, V168, P323, DOI 10.1016/j.bbr.2005.04.024; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Smith JS, 2000, NEURAL PLAST, V7, P73, DOI 10.1155/NP.2000.73; Stein DG, 2003, J HEAD TRAUMA REHAB, V18, P317, DOI 10.1097/00001199-200307000-00004; Stein DG, 2010, AM J ROENTGENOL, V194, P20, DOI 10.2214/AJR.09.3407; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004	60	18	19	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028			RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2013	31	4					431	450		10.3233/RNN-120299			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	171NC	WOS:000320935100007	23531530				2022-02-06	
J	Preece, MHW; Geffen, GM; Horswill, MS				Preece, Megan H. W.; Geffen, Gina M.; Horswill, Mark S.			Return-to-driving expectations following mild traumatic brain injury	BRAIN INJURY			English	Article						Brain concussion; mild head injury; fitness-to-drive; automobile driving; motor vehicles; attitudes	EMERGENCY-DEPARTMENT ASSESSMENT; HAZARD PERCEPTION; HEAD-INJURY; OLDER DRIVERS; CONCUSSION; PREDICTION; KNOWLEDGE; ATTITUDES; SYMPTOMS	Aim: Although individuals recovering from mild traumatic brain injury (MTBI) could pose a risk to road safety, little is known about their intentions regarding return-to-driving. Reported are the expectations of a sample of emergency department patients with MTBI regarding their recovery and return-to-driving. Method: Eighty-one patients with MTBI were recruited from an emergency department. Participants completed an 11-item questionnaire measuring expectations regarding recovery from injury; five of the items addressed return-to-driving. Results: Only 48% of the sample intended to reduce their driving following their injury. However, those that did intend to reduce their driving nominated a mean duration of 16.59 days (SD = 31.68) of reduced exposure. A logistic regression found that previous head injury experience and an interaction between pain and previous head injury experience predicted intentions to reduce driving. Similarly, a multiple regression revealed that pain level contributed significantly to the variance in time estimates of return-to-driving. Conclusion: The finding that half the individuals recovering from MTBI do not intend to moderate their driving exposure post-injury is cause for concern, as another study has shown that driving performance is compromised in this group immediately after injury.	[Preece, Megan H. W.] Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4122, Australia; [Preece, Megan H. W.; Geffen, Gina M.; Horswill, Mark S.] Univ Queensland, Sch Psychol, Brisbane, Qld 4072, Australia		Preece, MHW (corresponding author), Griffith Univ, Sch Appl Psychol, Brisbane, Qld 4122, Australia.	megan.preece@griffithuni.edu.au	Preece, Megan/A-7186-2013; Horswill, Mark/J-9029-2019	Preece, Megan/0000-0003-4852-8712; Horswill, Mark/0000-0002-0286-6292			Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Darby P, 2009, SAFETY SCI, V47, P436, DOI 10.1016/j.ssci.2008.05.004; Ferrari R, 2001, CLIN NEUROL NEUROSUR, V103, P254, DOI 10.1016/S0303-8467(01)00161-5; Fung M, 2006, BRAIN INJURY, V20, P889, DOI 10.1080/02699050600831934; Horswill MS, 2011, ACCIDENT ANAL PREV, V43, P2121, DOI 10.1016/j.aap.2011.05.035; Horswill MS, 2010, J INT NEUROPSYCH SOC, V16, P939, DOI 10.1017/S135561771000055X; Hux K, 2006, BRAIN INJURY, V20, P547, DOI 10.1080/02699050600676784; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Linden MA, 2006, ARCH CLIN NEUROPSYCH, V21, P763, DOI 10.1016/j.acn.2006.08.010; Mackenzie JA, 2005, BRIT J CLIN PSYCHOL, V44, P417, DOI 10.1348/014466505X35696; McKenna F.P., 1999, J INT ASS TRAFFIC SA, V23, P26; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; McLellan T, 2010, J INT NEUROPSYCH SOC, V16, P705, DOI 10.1017/S1355617710000524; Preece MHW, 2010, NEUROPSYCHOLOGY, V24, P493, DOI 10.1037/a0018903; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sheedy J, 2006, J CLIN EXP NEUROPSYC, V28, P755, DOI 10.1080/13803390591000864; Sheedy J, 2009, J HEAD TRAUMA REHAB, V24, P333, DOI 10.1097/HTR.0b013e3181aea51f; Smith SS, 2009, ACCIDENT ANAL PREV, V41, P729, DOI 10.1016/j.aap.2009.03.016; Snell D, 2009, J CLIN EXP NEUROPSYC, V31, P20, DOI 10.1080/13803390801978849; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; Weber M, 2010, BRAIN INJURY, V24, P1364, DOI 10.3109/02699052.2010.507110; Wechsler D, 1981, WESCHLER ADULT INTEL; Wells P, 2008, STUDY LEARNER NEW DR	25	18	18	0	18	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	2013	27	1					83	91		10.3109/02699052.2012.722260			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	059IY	WOS:000312699300009	23252439	Green Published			2022-02-06	
J	Self, M; Driver, S; Stevens, L; Warren, AM				Self, Megan; Driver, Simon; Stevens, Laurel; Warren, Ann Marie			Physical Activity Experiences of Individuals Living With a Traumatic Brain Injury: A Qualitative Research Exploration	ADAPTED PHYSICAL ACTIVITY QUARTERLY			English	Article						health promotion; group interviews; rehabilitation; needs assessment	HEALTH-PROMOTION INTERVENTION; ACTIVITY PARTICIPATION; PUBLIC-HEALTH; PEOPLE; ADULTS; DISABILITY; REHABILITATION; DEPRESSION; BEHAVIORS; AQUATICS	Traumatic brain injury (TBI) is a significant public health issue due to the incidence, complexity, and cost associated with treatment. The purpose of this study was to determine physical activity (PA) knowledge, attitudes, intentions, and barriers among individuals with a TBI undergoing outpatient rehabilitation. Seventeen participants completed a series of group interviews regarding their PA needs. A qualitative research design was adopted and trustworthiness was established through investigator triangulation of data. A cross-case analysis was completed to identify themes and conceptual patterns. The main themes identified were (a) an inability to differentiate between PA and physical therapy, (b) a limited knowledge of PA health benefits and the relationship to rehabilitation, and (c) an interest in participating in a PA based health promotion program. Future interventions should educate individuals about PA, the associated health benefits, and the role PA plays in the rehabilitation process.	[Self, Megan] Univ N Texas, Denton, TX 76203 USA; [Driver, Simon] Oregon State Univ, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Stevens, Laurel] Baylor Inst Rehabil, Dallas, TX USA; [Warren, Ann Marie] Baylor Univ, Med Ctr, Dallas, TX USA		Self, M (corresponding author), Univ N Texas, Denton, TX 76203 USA.			driver, simon/0000-0003-2356-432X; Warren, Ann Marie/0000-0002-3753-5573			Abdullah N, 2004, CALIF J HLTH PROMOT, V2, P42; [Anonymous], 1998, NIH Consens Statement, V16, P1; ARMSTRONG C, 1991, J REHABIL, V57, P15; Bateman A, 2001, ARCH PHYS MED REHAB, V82, P174, DOI 10.1053/apmr.2001.19744; Brain Injury Association of America, 2012, BIAA AD NEW TBI DEF; Centers for Disease Control and Prevention, 2010, TRAUM BRAIN INJ; Centers for Disease Control and Prevention, 2011, DAT 2012 HLTH PEOPL; Chogahara M, 1998, J AGING PHYS ACTIV, V6, P1, DOI 10.1123/japa.6.1.1; Clarke D., 2004, MIXING METHODS PSYCH; Cresswell JW., 1998, QUALITATIVE INQUIRY; Dalton C, 2012, CLIN REHABIL, V26, P165, DOI 10.1177/0269215511405230; Driver S, 2006, ADAPT PHYS ACT Q, V23, P148, DOI 10.1123/apaq.23.2.148; Driver S, 2006, BRAIN INJURY, V20, P133, DOI 10.1080/02699050500443822; Driver S, 2005, BRAIN INJURY, V19, P1067, DOI 10.1080/02699050500149338; Driver S, 2004, BRAIN INJURY, V18, P847, DOI 10.1080/02699050410001671856; Driver S., 2009, J COGNITIVE REHABILI, V33, P4, DOI DOI 10.1519/SSC.0B013E318211F99D; Driver S, 2008, ADAPT PHYS ACT Q, V25, P289, DOI 10.1123/apaq.25.4.289; Driver S, 2012, BRAIN INJURY, V26, P1482, DOI 10.3109/02699052.2012.694568; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; Driver S, 2009, BRAIN INJURY, V23, P203, DOI 10.1080/02699050802695574; Driver SJ, 2007, ADAPT PHYS ACT Q, V24, P160, DOI 10.1123/apaq.24.2.160; Fines L., 1994, J COGNITIVE REHABILI, P10; Finkelstein E., 2006, INCIDENCE EC BURDEN; Finset A, 2000, BRAIN INJURY, V14, P887; FINSET A, 1995, BRAIN INJURY, V9, P141, DOI 10.3109/02699059509008187; Fleming J, 2011, BRAIN INJURY, V25, P806, DOI 10.3109/02699052.2011.585508; Glaser B., 1967, DISCOVERY GROUNDED T; Goodwin DL, 2004, ADAPT PHYS ACT Q, V21, P122, DOI 10.1123/apaq.21.2.122; Harter S., 1987, CONT ISSUES DEV PSYC, P219; Henwood T, 2011, AGEING SOC, V31, P1330, DOI 10.1017/S0144686X10001406; Irwin K, 2011, STRENGTH COND J, V33, P43, DOI 10.1519/SSC.0b013e318210e899; Jones David B, 2009, Res Q Exerc Sport, V80, P710; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Leech NL, 2007, SCHOOL PSYCHOL QUART, V22, P557, DOI 10.1037/1045-3830.22.4.557; Lollar DJ, 2003, ANNU REV PUBL HEALTH, V24, P195, DOI 10.1146/annurev.publhealth.24.100901.140844; Lox CL., 2003, PSYCHOL EXERCISE INT; McPherson KM, 2009, CLIN REHABIL, V23, P296, DOI 10.1177/0269215509102980; Meadows LM, 2001, NATURE QUALITATIVE E; MORTON MV, 1995, BRAIN INJURY, V9, P81, DOI 10.3109/02699059509004574; National Institute of Neurological Disorders and Stroke, 2002, NIH PUBL, V02-158; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037/0022-006X.51.3.390; Ravesloot C, 2005, REHABIL PSYCHOL, V50, P239, DOI 10.1037/0090-5550.50.3.239; Ravesloot CH, 2007, HEALTH EDUC RES, V22, P522, DOI 10.1093/her/cyl114; Reavenall S, 2010, INT J THER REHABIL, V17, P360, DOI 10.12968/ijtr.2010.17.7.48893; Rimmer JH, 2008, AM J LIFESTYLE MED, V2, P409, DOI 10.1177/1559827608317397; Rimmer JH, 2000, AM J PREV MED, V18, P332, DOI 10.1016/S0749-3797(00)00129-X; Stuijbergen AK, 2003, ARCH PHYS MED REHAB, V84, P467, DOI 10.1053/apmr.2003.50028; Thomas D. R., 2003, GEN INDUCTIVE APPROA; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; U.S. Department of Health and Human Services, 2010, PROM PHYS ACT GUID C; US Department of Health and Human Services, 2010, HLTH PEOPL 2020 ROAD; Wise EK, 2010, ARCH PHYS MED REHAB, V91, P1357, DOI 10.1016/j.apmr.2010.06.009; Ylvisaker M, 2003, J HEAD TRAUMA REHAB, V18, P7, DOI 10.1097/00001199-200301000-00005; YLVISAKER M, 1999, COLLABORATIVE BRAIN; Zhang Y, 2012, FUNGAL DIVERS, V53, P1, DOI 10.1007/s13225-011-0117-x; [No title captured]	57	18	18	0	28	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0736-5829	1543-2777		ADAPT PHYS ACT Q	Adapt. Phys. Act. Q.	JAN	2013	30	1					20	39		10.1123/apaq.30.1.20			20	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	074XM	WOS:000313848400002	23283024				2022-02-06	
J	Sreenivasan, S; Garrick, T; McGuire, J; Smee, DE; Dow, D; Woehl, D				Sreenivasan, Shoba; Garrick, Thomas; McGuire, James; Smee, Daniel E.; Dow, Daniel; Woehl, Daniel			Critical Concerns in Iraq/Afghanistan War Veteran-Forensic Interface: Combat-Related Postdeployment Criminal Violence	JOURNAL OF THE AMERICAN ACADEMY OF PSYCHIATRY AND THE LAW			English	Article							AFGHANISTAN; IRAQ	Identifying whether there is a nexus between Iraq and Afghanistan combat injuries and civilian violence on return from deployment is complicated by differences in reactions of individuals to combat exposure, the overlapping effects of traumatic brain injury (TBI) and posttraumatic stress disorder (PTSD), and the low base rate of civilian violence after combat exposure. Moreover, the overall prevalence of violence among returning Iraq and Afghanistan combat war veterans has not been well documented. Malingered symptoms and either exaggeration or outright fabrication of war zone exposure are challenges to rendering forensic opinions, with the risk reduced by accessing military documents that corroborate war zone duties and exposure. This article serves as a first step toward understanding what may potentiate violence among returning Iraq and Afghanistan veterans. We offer a systematic approach toward the purpose of forensic case formulation that addresses whether combat duty/war zone exposure and associated clinical conditions are linked to criminal violence on return to civilian life.	[Sreenivasan, Shoba] Greater Angeles VA Healthcare Syst Forens Outreac, Los Angeles, CA USA; [Sreenivasan, Shoba] USC Keck Sch Med, Los Angeles, CA USA; [Garrick, Thomas] UCLA David Geffen Sch Med, Los Angeles, CA USA; [Garrick, Thomas] Gen Hosp Psychiat, Greater Angeles VA Healthcare Syst Med Ctr, Los Angeles, CA USA; [McGuire, James] Vet Justice Programs, VHA, Los Angeles, CA USA; [Smee, Daniel E.] Univ So Calif, Sch Social Work, Los Angeles, CA 90089 USA		Garrick, T (corresponding author), GLA VA Med Ctr, 11301 Wilshire Blvd,116-AC, Los Angeles, CA 90073 USA.	thomas.garrick@va.gov					American Psychiatric Association, 1980, DIAGN STAT MAN MENT; Burchett K, 2008, NEWSLETTER SECTION 7, P13; Daniel DL, 2008, POSTTRAUMATIC STRESS; DiLulio JJ, 2008, WEEKLY STANDARD; Elbogen EB, 2010, AM J PSYCHIAT, V167, P1051, DOI 10.1176/appi.ajp.2010.09050739; Grover EM, 2008, PACE L REV, V594; Hoge CW, 2009, NEW ENGL J MED, V360, P1588, DOI 10.1056/NEJMp0810606; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook JG, 2010, WIDENER LAW SCH L 10, V43, P1; Howell T, 2012, MILITARY        0306; Iverson GL, 2010, J HEAD TRAUMA REHAB, V25, P313, DOI 10.1097/HTR.0b013e3181d6f9bd; Killgore WDS, 2008, J PSYCHIATR RES, V42, P1112, DOI 10.1016/j.jpsychires.2008.01.001; Kolb RK, 2006, VETERANS FOREIGN WAR, P12; LeardMann CA, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1273; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; Miller L, 2012, AGGRESS VIOLENT BEH, V17, P354, DOI 10.1016/j.avb.2012.03.007; MONROE SM, 1991, PSYCHOL BULL, V110, P406, DOI 10.1037/0033-2909.110.3.406; Mumola CJ, 1996, PUBLICATION NCJ, V178888; Nidiffer FD, 2007, BRAIN INJURY, V4, P26; Noonan ME., 2007, 217199 NCJ US DEP JU; Pitman R. K., 1998, PTSD RES Q, V9, P1; Sontag Deborah, 2008, NY TIMES        0120; Sparr L F, 1987, Bull Am Acad Psychiatry Law, V15, P141; Tanielian T., 2008, INVISIBLE WOUNDS WAR; US Army, 2012, ARM 2020 GEN HLTH DI; Walter Reed Army Institute of Research Land, BATTL TRAIN; Walter Reed Army Institute of Research (WRAIR), 2005, BATTL TRAIN; Walter Reed Army Institute of Research (WRAIR), 2005, BATTL TRAIN; Ziejewski M., 2007, BRAIN INJ PROF, V4, P10	29	18	18	0	20	AMER ACAD PSYCHIATRY & LAW	BLOOMFIELD	ONE REGENCY DR, PO BOX 30, BLOOMFIELD, CT 06002 USA	1093-6793	1943-3662		J AM ACAD PSYCHIATRY	J. Am. Acad. Psychiatry Law		2013	41	2					263	273					11	Law; Psychiatry	Social Science Citation Index (SSCI)	Government & Law; Psychiatry	185CJ	WOS:000321942500012	23771940				2022-02-06	
J	Xie, BW; Park, D; Van Beek, ER; Blankevoort, V; Orabi, Y; Que, I; Kaijzel, EL; Chan, A; Hogg, PJ; Lowik, CWGM				Xie, B-W; Park, D.; Van Beek, E. R.; Blankevoort, V.; Orabi, Y.; Que, I.; Kaijzel, E. L.; Chan, A.; Hogg, P. J.; Lowik, C. W. G. M.			Optical imaging of cell death in traumatic brain injury using a heat shock protein-90 alkylator	CELL DEATH & DISEASE			English	Article						traumatic brain injury; cryolesion; apoptosis; necrosis; GSAO; optical imaging	IN-VIVO; APOPTOSIS; NECROSIS; EXPRESSION; TISSUES; MODEL; MICE	Traumatic brain injury is a major public health concern and is characterised by both apoptotic and necrotic cell death in the lesion. Anatomical imaging is usually used to assess traumatic brain injuries and there is a need for imaging modalities that provide complementary cellular information. We sought to non-invasively image cell death in a mouse model of traumatic brain injury using a near-infrared fluorescent conjugate of a synthetic heat shock protein-90 alkylator, 4-(N-(S-glutathionylacetyl) amino) phenylarsonous acid (GSAO). GSAO labels both apoptotic and necrotic cells coincident with loss of plasma membrane integrity. The optical GSAO specifically labelled apoptotic and necrotic cells in culture and did not accumulate in healthy organs or tissues in the living mouse body. The conjugate is a very effective imager of cell death in brain lesions. The optical GSAO was detected by fluorescence intensity and GSAO bound to dying/dead cells was detected from prolongation of the fluorescence lifetime. An optimal signal-to-background ratio was achieved as early as 3 h after injection of the probe and the signal intensity positively correlated with both lesion size and probe concentration. This optical GSAO offers a convenient and robust means to non-invasively image apoptotic and necrotic cell death in brain and other lesions. Cell Death and Disease (2013) 4, e473; doi:10.1038/cddis.2012.207; published online 24 January 2013	[Xie, B-W; Van Beek, E. R.; Blankevoort, V.; Orabi, Y.; Que, I.; Kaijzel, E. L.; Chan, A.; Lowik, C. W. G. M.] Leiden Univ, Dept Radiol, Med Ctr, NL-2333 ZA Leiden, Netherlands; [Park, D.; Hogg, P. J.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Park, D.; Hogg, P. J.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia		Hogg, PJ (corresponding author), Univ New S Wales, Lowy Canc Res Ctr, Bldg C25, Sydney, NSW 2052, Australia.	p.hogg@unsw.edu.au		Hogg, Philip/0000-0001-6486-2863; Kaijzel, Eric/0000-0003-3118-9910; Park, Danielle/0000-0002-2888-5563; Chan, Alan/0000-0001-6949-9274	Dutch Centre for Translational Molecular Medicine, project [03O-202]; ENCITE project [201842]; National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia; Cancer Council New South WalesCancer Council New South Wales	This study is supported by the Dutch Centre for Translational Molecular Medicine, project MUSIS (grant 03O-202), the ENCITE project 201842, the National Health and Medical Research Council of Australia and the Cancer Council New South Wales.	ADAMS E, 1990, INORG CHEM, V29, P1500, DOI 10.1021/ic00333a012; Akers WJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2982535; Ardeshirpour Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031881; Beekman CAC, 2011, APPL RADIAT ISOTOPES, V69, P656, DOI 10.1016/j.apradiso.2010.12.012; Blankenberg FG, 2008, CANCER BIOL THER, V7, P1525, DOI 10.4161/cbt.7.10.6934; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Erten A, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3509111; Faul M, 2010, TRAUMATIC BRAIN INJU, P1; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; Goiffon RJ, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3095800; Grzybicki D, 1998, ACTA NEUROPATHOL, V95, P98, DOI 10.1007/s004010050770; Hall DJ, 2012, J CEREBR BLOOD F MET, V32, P23, DOI 10.1038/jcbfm.2011.119; Hanshaw RG, 2005, BIOORGAN MED CHEM, V13, P5035, DOI 10.1016/j.bmc.2005.04.071; Herron TJ, 2012, CIRC RES, V110, P609, DOI 10.1161/CIRCRESAHA.111.247494; Hotta N, 2005, MOL BRAIN RES, V133, P71, DOI 10.1016/j.molbrainres.2004.09.027; Kim JJ, 2011, NEUROTHERAPEUTICS, V8, P39, DOI 10.1007/s13311-010-0003-3; Lederle W, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-26; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; MERYMAN HT, 1956, SCIENCE, V124, P515, DOI 10.1126/science.124.3221.515; Nardai G, 2000, ARCH BIOCHEM BIOPHYS, V384, P59, DOI 10.1006/abbi.2000.2075; Niu G, 2010, J NUCL MED, V51, P1659, DOI 10.2967/jnumed.110.078584; Park D, 2011, J AM CHEM SOC, V133, P2832, DOI 10.1021/ja110226y; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Smith BA, 2012, ACS CHEM NEUROSCI, V3, P530, DOI 10.1021/cn3000197; Steinbach JP, 1999, NEUROPATH APPL NEURO, V25, P468; Stoffel M, 2004, J NEUROTRAUM, V21, P733, DOI 10.1089/0897715041269678; Taruttis A, 2012, AM J ROENTGENOL, V199, P263, DOI 10.2214/AJR.11.8431; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Wen JY, 2007, TECHNOL CANCER RES T, V6, P635, DOI 10.1177/153303460700600607; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xie BW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031875; Xiong CY, 2011, J MED CHEM, V54, P1825, DOI 10.1021/jm101477d; Zhao M, 2009, ANTI-CANCER AGENT ME, V9, P1018, DOI 10.2174/187152009789377691	35	18	18	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JAN	2013	4								e473	10.1038/cddis.2012.207			8	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	101IE	WOS:000315767600023	23348587	Green Published, gold			2022-02-06	
J	Choi, JS; Leem, JW; Lee, KH; Kim, SS; Suh-Kim, H; Jung, SJ; Kim, UJ; Lee, BH				Choi, Ji Soo; Leem, Joong Woo; Lee, Kyung Hee; Kim, Sung-Soo; Suh-Kim, Haeyoung; Jung, Se Jung; Kim, Un Jeng; Lee, Bae Hwan			Effects of Human Mesenchymal Stem Cell Transplantation Combined with Polymer on Functional Recovery Following Spinal Cord Hemisection in Rats	KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY			English	Article						Electrophysiology; Mesenchymal stem cells; Polymer; Spinal cord injury	MARROW STROMAL CELLS; TRAUMATIC BRAIN INJURY; BONE-MARROW; ADULT-RAT; GUIDANCE CHANNELS; NUCLEUS NEURONS; TISSUE-REPAIR; SCHWANN-CELLS; IN-VITRO; REGENERATION	The spontaneous axon regeneration of damaged neurons is limited after spinal cord injury (SCI). Recently, mesenchymal stem cell (MSC) transplantation was proposed as a potential approach for enhancing nerve regeneration that avoids the ethical issues associated with embryonic stem cell transplantation. As SCI is a complex pathological entity, the treatment of SCI requires a multipronged approach. The purpose of the present study was to investigate the functional recovery and therapeutic potential of human MSCs (hMSCs) and polymer in a spinal cord hemisection injury model. Rats were subjected to hemisection injuries and then divided into three groups. Two groups of rats underwent partial thoracic hemisection injury followed by implantation of either polymer only or polymer with hMSCs. Another hemisection-only group was used as a control. Behavioral, electrophysiological and immunohistochemical studies were performed on all rats. The functional recovery was significantly improved in the polymer with hMSC-transplanted group as compared with control at five weeks after transplantation. The results of electrophysiologic study demonstrated that the latency of somatosensory-evoked potentials (SSEPs) in the polymer with hMSC-transplanted group was significantly shorter than in the hemisection-only control group. In the results of immunohistochemical study, beta-gal-positive cells were observed in the injured and adjacent sites after hMSC transplantation. Surviving hMSCs differentiated into various cell types such as neurons, astrocytes and oligodendrocytes. These data suggest that hMSC transplantation with polymer may play an important role in functional recovery and axonal regeneration after SCI, and may be a potential therapeutic strategy for SCI.	[Choi, Ji Soo; Leem, Joong Woo; Jung, Se Jung; Kim, Un Jeng; Lee, Bae Hwan] Yonsei Univ, Dept Physiol, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Choi, Ji Soo; Leem, Joong Woo; Jung, Se Jung; Kim, Un Jeng; Lee, Bae Hwan] Yonsei Univ, Brain Res Inst, Coll Med, Seoul 120752, South Korea; [Lee, Kyung Hee] Dongseo Univ, Dept Dent Hyg, Div Hlth Sci, Pusan 617716, South Korea; [Kim, Sung-Soo; Suh-Kim, Haeyoung] Ajou Univ, Sch Med, Dept Anat, Suwon 443721, South Korea; [Kim, Sung-Soo] Ajou Univ, Sch Med, Ctr Cell Death Regulating Biodrug, Suwon 443721, South Korea		Lee, BH (corresponding author), Yonsei Univ, Dept Physiol, Coll Med, Brain Korea Project Med Sci 21, CPO Box 8044, Seoul 120752, South Korea.	bhlee@yuhs.ac		Suh-Kim, Haeyoung/0000-0001-8175-1209; Kim, Sung-Soo/0000-0003-3591-5932; Lee, Bae H./0000-0003-4719-9021; Kim, Un Jeng/0000-0003-0968-0252; Leem, Joong/0000-0002-1605-2230	Stem Cell Research Center of the 21st Century Frontier Research ProgramMinistry of Education, Science and Technology, Republic of Korea [SC4140]; Basic Science Research Program through the National Research Foundation [2005-0049404, 20090076605]; Ministry of Education, Science and TechnologyMinistry of Education, Science and Technology, Republic of Korea	The research was supported by grants from the Stem Cell Research Center of the 21st Century Frontier Research Program (SC4140) and from Basic Science Research Program (No. 2005-0049404, 20090076605) through the National Research Foundation funded by the Ministry of Education, Science and Technology.	Akiyama Y, 2002, J NEUROSCI, V22, P6623; Ankeny DP, 2004, EXP NEUROL, V190, P17, DOI 10.1016/J.expneurol.2004.05.045; Azizi SA, 1998, P NATL ACAD SCI USA, V95, P3908, DOI 10.1073/pnas.95.7.3908; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen G, 2010, CHINESE MED J-PEKING, V123, P2424, DOI 10.3760/cma.j.issn.0366-6999.2010.17.025; Chopp M, 2002, LANCET NEUROL, V1, P92, DOI 10.1016/S1474-4422(02)00040-6; Chopp M, 2000, NEUROREPORT, V11, P3001, DOI 10.1097/00001756-200009110-00035; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Himes BT, 2006, NEUROREHAB NEURAL RE, V20, P278, DOI 10.1177/1545968306286976; HIMES BT, 1994, J COMP NEUROL, V339, P117, DOI 10.1002/cne.903390111; Himes BT, 2001, J NEUROSCI RES, V65, P549, DOI 10.1002/jnr.1185; Hofstetter CP, 2002, P NATL ACAD SCI USA, V99, P2199, DOI 10.1073/pnas.042678299; HOULE JD, 1994, J NEURAL TRANSP PLAS, V5, P115, DOI 10.1155/NP.1994.115; Jendelova P, 2004, J NEUROSCI RES, V76, P232, DOI 10.1002/jnr.20041; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kang CE, 2009, TISSUE ENG PT A, V15, P595, DOI 10.1089/ten.tea.2007.0349; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Lee KH, 2007, ACTA NEUROBIOL EXP, V67, P13; Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X; Li Y, 2001, NEUROLOGY, V56, P1666, DOI 10.1212/WNL.56.12.1666; Liu WG, 2011, NEUROL RES, V33, P686, DOI 10.1179/1743132810Y.0000000031; Liu Y, 2002, EXP NEUROL, V178, P150, DOI 10.1006/exnr.2002.7977; Lu D, 2001, NEUROREPORT, V12, P559, DOI 10.1097/00001756-200103050-00025; Lu DY, 2001, J NEUROTRAUM, V18, P813, DOI 10.1089/089771501316919175; Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Maquet V, 2001, BIOMATERIALS, V22, P1137, DOI 10.1016/S0142-9612(00)00357-4; Neuhuber B, 2005, BRAIN RES, V1035, P73, DOI 10.1016/j.brainres.2004.11.055; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Oudega M, 2001, BIOMATERIALS, V22, P1125, DOI 10.1016/S0142-9612(00)00346-X; Piantino J, 2006, EXP NEUROL, V201, P359, DOI 10.1016/j.expneurol.2006.04.020; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Quertainmont R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039500; Sasaki M, 2001, GLIA, V35, P26, DOI 10.1002/glia.1067; Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Siddall PJ, 2000, IASP NEWSLETTER, V3; Tsai EC, 2004, J NEUROTRAUM, V21, P789, DOI 10.1089/0897715041269687; Woerly S, 2001, J NEUROSCI RES, V66, P1187; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; Wu SF, 2003, J NEUROSCI RES, V72, P343, DOI 10.1002/jnr.10587; Yazdani SO, 2012, TISSUE CELL, V44, P205, DOI 10.1016/j.tice.2012.03.003; Yoon YW, 2004, SOMATOSENS MOT RES, V21, P25, DOI 10.1080/0899022042000201272; Zhang YQ, 2012, CELLS TISSUES ORGANS, V195, P313, DOI 10.1159/000327724; Zurita M, 2004, NEUROREPORT, V15, P1105, DOI 10.1097/00001756-200405190-00004; Zurita M, 2006, NEUROSCI LETT, V402, P51, DOI 10.1016/j.neulet.2006.03.069	47	18	19	0	16	KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY	SEOUL	C/O EDITORIAL OFFICE, 448-13 SEOKYO-DONG, SEOUL, SOUTH KOREA	1226-4512			KOREAN J PHYSIOL PHA	KOREAN J. PHYSIOL. PHARMACOL.	DEC	2012	16	6					405	411		10.4196/kjpp.2012.16.6.405			7	Pharmacology & Pharmacy; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy; Physiology	060AZ	WOS:000312749300006	23269903	Green Published, Green Submitted			2022-02-06	
J	Orman, JA; Geyer, D; Jones, J; Schneider, EB; Grafman, J; Pugh, MJ; DuBose, J				Orman, Jean A.; Geyer, Dennis; Jones, John; Schneider, Eric B.; Grafman, Jordan; Pugh, Mary Jo; DuBose, Joseph			Epidemiology of moderate-to-severe penetrating versus closed traumatic brain injury in the Iraq and Afghanistan wars	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic and penetrating brain injury; military; epidemiology; Operation Enduring Freedom/Iraqi Freedom; Operation New Dawn	COMBAT WOUNDS; FREEDOM; HOSPITALIZATIONS; BATTLEFIELD	BACKGROUND: US combat operations in Iraq and Afghanistan have resulted in a greater proportion of service members with head and neck wounds caused by explosions compared with that of previous wars. Although penetrating traumatic brain injury (TBI) is frequently associated with these wounds, the epidemiology of penetrating TBI from these conflicts has not been well described. METHODS: The Joint Theater Trauma Registry was queried for January 2003 through December 2010 to identify all patients with moderate-to-severe brain injury with a maximum Abbreviated Injury Scale (AIS) score of the head of 3 or greater and a diagnosis of penetrating or closed TBI in accordance with the Department of Defense Traumatic Brain Injury Surveillance definition. The epidemiology of these injuries was examined, including demographics, TBI severity, overall injury severity, and surgical interventions provided. RESULTS: A total of 1,255 TBI patients (774 penetrating, 481 closed) meeting criteria were identified. Penetrating brain injuries were more severe, more likely to be battle related, and less likely to be isolated injuries than a group of moderate-to-severe closed TBIs within the same range of anatomic injury severity. During the 5-year period of the Iraq war with the largest numbers of TBIs (2004-2008), the numbers of penetrating TBIs exceeded closed TBIs by a ratio of 2:1. During the 3-year period of the Afghanistan war with the greatest numbers of TBIs (2008-2010), the ratio of penetrating to closed TBIs was substantially lower, approximately 1.3:1. CONCLUSION: This study represents the first comprehensive report on the epidemiology of moderate-to-severe penetrating and closed TBIs resulting from the wars in Iraq and Afghanistan using Joint Theater Trauma Registry data. With the maturing theater of conflicts, penetrating TBIs were substantially less predominant compared with closed TBIs. While this finding may reflect changes in the use of protective measures and tactics or improvements in diagnosis of closed TBIs, additional research is needed to identify the reason for this shift and the subsequent effect on outcome after combat-related TBIs. (J Trauma Acute Care Surg. 2012;73: S496-S502. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Orman, Jean A.] USA, Inst Surg Res, ATTN MCMR SRR, Ft Sam Houston, TX 78234 USA; [Orman, Jean A.; Pugh, Mary Jo] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Geyer, Dennis] San Antonio Mil Med Ctr, Dept Surg, Neurosurg Serv, San Antonio, TX USA; [Pugh, Mary Jo] S Texas Vet Hlth Care Syst, San Antonio, TX USA; [Schneider, Eric B.] Johns Hopkins Sch Med, Ctr Surg Trials & Outcomes Res, Baltimore, MD USA; [DuBose, Joseph] Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; [Jones, John] Northwestern Univ, Rehabil Inst Chicago, Chicago, IL 60611 USA; [Grafman, Jordan] Northwestern Univ, Dept Phys Med & Rehabil, Chicago, IL 60611 USA		Orman, JA (corresponding author), USA, Inst Surg Res, ATTN MCMR SRR, 3698 Chambers Pass, Ft Sam Houston, TX 78234 USA.	Jean.A.Orman@amedd.army.mil	Pugh, Mary Jo/K-5336-2019	Pugh, Mary Jo/0000-0003-4196-7763; Grafman, Jordan H./0000-0001-8645-4457	South Texas Veterans Healthcare System; Veterans AffairsUS Department of Veterans Affairs [I01HX000329] Funding Source: NIH RePORTER	We acknowledge JTTR for providing data for this study and Ms. Susan West and Ms. Celina Garcia of the JTTR staff for their invaluable assistance in preparing the data set. Some work for this study was supported by resources of the South Texas Veterans Healthcare System.	Aarabi B, 2000, NEUROSURG FOCUS, V8, P1, DOI DOI 10.3171/F0C.2000.8.1.155; [Anonymous], 2010, 09033 DEP DEF; [Anonymous], 1990, ABBR INJ SCAL 1990 R; Armed Forces Health Surveillance Center, NEUROLOGY; Army Dismounted Complex Blast Injury Task Force, 2011, DISM COMPL BLAST INJ; Belasco Amy, 2009, TROOP LEVELS AFGHAN; Bell RS, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS1022; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Belmont PJ, 2012, J TRAUMA ACUTE CARE, V73, P3, DOI 10.1097/TA.0b013e318250bfb4; Belmont PJ, 2010, J TRAUMA, V68, P204, DOI 10.1097/TA.0b013e3181bdcf95; Burrelli DF, 2012, WOMEN COMBAT ISSUES; Carey ME, 2000, NEUROSURGERY, V47, P678, DOI 10.1097/00006123-200009000-00031; Centers for Disease Control and Prevention, 2012, DRG INT CLASS DIS 9; Champion HR, 2009, J TRAUMA, V66, P1468, DOI 10.1097/TA.0b013e3181a27e7f; Department of Defense, DOD WORLDW NUMB TBI; DuBose JJ, 2011, J TRAUMA, V70, P11, DOI 10.1097/TA.0b013e318207c563; Duckworth JL, 2012, PATHOPHYSIO IN PRESS; Eastridge BJ, 2011, J TRAUMA, V71, pS4, DOI 10.1097/TA.0b013e318221147b; Ecker RD, 2011, J NEUROSURG, V115, P124, DOI 10.3171/2011.2.JNS101490; Eisenburg MF, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.2.FOCUS108; Feickert Andrew, 2008, MINE RESISTANT AMBUS; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Glenn Michael Alan, 2008, J Trauma Nurs, V15, P181, DOI 10.1097/01.JTN.0000343323.47463.aa; Heltemes KJ, 2011, MIL MED, V176, P132, DOI 10.7205/MILMED-D-09-00238; Institute of Medicine, 2009, GULF WAR HLTH, V7; Jaffee MS, 2009, SYSTEMS ENG IMPROVE; Joint Theater Trauma System, 2007, CLIN PRACTICE GUIDEL; Lanska DJ, 2009, ANN NEUROL, V66, P444, DOI 10.1002/ana.21822; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Ling GSF, 2010, ANNU REV MED, V61, P457, DOI 10.1146/annurev.med.60.071207.140903; Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Ramasamy A, 2008, J TRAUMA, V65, P910, DOI 10.1097/TA.0b013e3181848cf6; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; SALAZAR AM, 1985, NEUROLOGY, V35, P1406, DOI 10.1212/WNL.35.10.1406; Santiago LA, 2012, BRAIN INJURY, V26, P107, DOI 10.3109/02699052.2011.635363; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	38	18	21	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	DEC	2012	73			5			S496	S502		10.1097/TA.0b013e318275473c			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	056QT	WOS:000312506900020	23192076				2022-02-06	
J	Stmwoo, H; Chang, WH; Kwon, JY; Kim, TW; Lee, JY; Kim, YH				Stmwoo, Hyuk; Chang, Won Hyuk; Kwon, Jeong-Yi; Kim, Tae-Won; Lee, Ji-Young; Kim, Yun-Hee			Hippotherapy in Adult Patients with Chronic Brain Disorders: A Pilot Study	ANNALS OF REHABILITATION MEDICINE-ARM			English	Article						Brain disorder; Hippotherapy; Balance; Gait		Objective To investigate the effects of hippotherapy for adult patients with brain disorders. Method Eight chronic brain disorder patients (7 males, mean age 42.4 +/- 16.6 years) were recruited. The mean duration from injury was 7.9 +/- 7.7 years. The diagnoses were stroke (n=5), traumatic brain disorder (n=2), and cerebral palsy (n=l). Hippotherapy sessions were conducted twice a week for eight consecutive weeks in an indoor riding arena. Each hippotherapy session lasted 30 minutes. All participants were evaluated by the Berg balance scale, Tinetti Performance-Oriented Mobility Assessment, 10 Meter Walking Test, Functional Ambulatory Category, Korean Beck Depression Inventory, and Hamilton Depression Rating Scale. We performed baseline assessments twice just before starting hippotherapy. We also assessed the participants immediately after hippotherapy and at eight weeks after hippotherapy. Results All participants showed no difference in balance, gait function, and emotion between the two baseline assessments before hippotherapy. During the eight-week hippotherapy program, all participants showed neither adverse effects nor any accidents; all had good compliance. After hippotherapy, there were significant improvements in balance and gait speed in comparison with the baseline assessment (p<0.05), and these effects were sustained for two months after hippotherapy. However, there was no significant difference in emotion after hippotherapy. Conclusion We could observe hippotherapy to be a safe and effective alternative therapy for adult patients with brain disorders in improving balance and gait function. Further future studies are warranted to delineate the benefits of hippotherapy on chronic stroke patients.	[Stmwoo, Hyuk; Chang, Won Hyuk; Kwon, Jeong-Yi; Kim, Tae-Won; Lee, Ji-Young; Kim, Yun-Hee] Sungkyunkwan Univ, Sch Med, Dept Phys & Rehabil Med, Samsung Med Ctr, 50 Ilwon Dong, Seoul 135710, South Korea		Chang, WH (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Phys & Rehabil Med, Samsung Med Ctr, 50 Ilwon Dong, Seoul 135710, South Korea.	wh.chang@samsung.com					Benda W, 2003, J ALTERN COMPLEM MED, V9, P817, DOI 10.1089/107555303771952163; BERTOTI DB, 1988, PHYS THER, V68, P1505; Casady Renee L, 2004, Pediatr Phys Ther, V16, P165, DOI 10.1097/01.PEP.0000136003.15233.0C; CiprianyDacko LM, 1997, ARCH PHYS MED REHAB, V78, P1160, DOI 10.1016/S0003-9993(97)90145-3; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hammer Ann, 2005, Physiotherapy Theory and Practice, V21, P51, DOI 10.1080/09593980590911525; HOLDEN MK, 1984, PHYS THER, V64, P35, DOI 10.1093/ptj/64.1.35; Jung HY, 2006, ANN REHABIL MED-ARM, V30, P611; Lechner HE, 2003, SPINAL CORD, V41, P502, DOI 10.1038/sj.sc.3101492; Lechner HE, 2007, ARCH PHYS MED REHAB, V88, P1241, DOI 10.1016/j.apmr.2007.07.015; McGee MC, 2009, PEDIATR PHYS THER, V21, P212, DOI 10.1097/PEP.0b013e3181a39532; McGibbon NH, 2009, ARCH PHYS MED REHAB, V90, P966, DOI 10.1016/j.apmr.2009.01.011; McGibbon NH, 1998, DEV MED CHILD NEUROL, V40, P754; Rhee M. K., 1995, KOREAN J PSYCHOPATHO, V4, P77; RICHARDS CL, 1993, ARCH PHYS MED REHAB, V74, P612, DOI 10.1016/0003-9993(93)90159-8; Shurtleff TL, 2009, ARCH PHYS MED REHAB, V90, P1185, DOI 10.1016/j.apmr.2009.01.026; Silkwood-Sherer Debbie, 2007, J Neurol Phys Ther, V31, P77; Snider Laurie, 2007, Phys Occup Ther Pediatr, V27, P5; Sterba JA, 2002, DEV MED CHILD NEUROL, V44, P301; Sterba JA, 2007, DEV MED CHILD NEUROL, V49, P68, DOI 10.1017/S0012162207000175; Strauss I, 1995, HIPPOTHERAPY NEUROPH, P11; WADE DT, 1983, ARCH PHYS MED REHAB, V64, P24	24	18	18	1	12	KOREAN ACAD REHABILITATION MEDICINE	SEOUL	5F, YOUNGHAN BLDG, 742-22 BANPO-DONG, SEOCHO-GU, SEOUL, 137-040, SOUTH KOREA	2234-0645	2234-0653		ANN REHABIL MED-ARM	Ann. Rehabil. Med.-ARM	DEC	2012	36	6					756	761		10.5535/arm.2012.36.6.756			6	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	VC5FD	WOS:000433812800002	23342306	gold, Green Published, Green Submitted			2022-02-06	
J	Wang, Y; Guo, F; Pan, CF; Lou, YL; Zhang, PQ; Guo, SC; Yin, JH; Deng, ZF				Wang, Yang; Guo, Fei; Pan, Changfu; Lou, Yuanlei; Zhang, Pengqi; Guo, Shangchun; Yin, Junhui; Deng, Zhifeng			Effects of low temperatures on proliferation-related signaling pathways in the hippocampus after traumatic brain injury	EXPERIMENTAL BIOLOGY AND MEDICINE			English	Article						miRNA; microarray; neurogenesis; traumatic brain injury; low-temperature exposure	CLOSED-HEAD INJURY; MICRORNA EXPRESSION; RAT; NEUROGENESIS; NEURONS; CELLS; HYPOTHERMIA; NOTCH; MICE	To evaluate the influence of low temperatures on the proliferation of neural stem cells (NSCs) and the regulation of their signaling pathways after brain trauma, we examined changes in the expression levels of specific miRNAs and their target genes. We also evaluated NSC proliferation in the hippocampus after brain trauma under low-temperature conditions. We found that the expression profile of miRNAs in the hippocampus after trauma changed at both normal and low temperatures, and the expression of miR-34a decreased significantly lower in rats exposed to low temperatures. There was significant proliferation of endogenous NSCs in the hippocampus after brain trauma at both temperatures, but NSC proliferation was slower at low temperatures. In addition, the expression of Notch1 significantly increased in the hippocampus after brain trauma at both temperatures. However, at low temperatures, the degree of up-regulation of Notch signaling molecules was significantly lower. We conclude that low-temperature environments can inhibit the proliferation of endogenous NSCs in the hippocampus, possibly by alleviating the effects of miR-34a down-regulation and Notch signaling up-regulation induced by traumatic brain injury.	[Wang, Yang; Guo, Shangchun; Yin, Junhui] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Inst Orthopaed Surg, Shanghai 200233, Peoples R China; [Wang, Yang; Guo, Fei; Lou, Yuanlei] Nanchang Univ, Inst Urol, Nanchang 330006, Peoples R China; [Pan, Changfu; Deng, Zhifeng] Nanchang Univ, Affiliated Hosp 3, Dept Neurosurg, Nanchang 330006, Peoples R China; [Zhang, Pengqi; Deng, Zhifeng] Shanghai Jiao Tong Univ, Dept Neurosurg, Affiliated Peoples Hosp 6, Shanghai 200233, Peoples R China		Deng, ZF (corresponding author), Nanchang Univ, Affiliated Hosp 3, Dept Neurosurg, Nanchang 330006, Peoples R China.	dengzf63@126.com	Guo, Shang-Chun/M-6246-2018	Guo, Shang-Chun/0000-0001-6285-6750; , Fei/0000-0003-2397-8629	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81160154]; National Key Technology RD ProgramNational Key Technology R&D Program [2008BAI68B06]	This work was supported by the National Natural Science Foundation of China (81160154) and the National Key Technology R&D Program (2008BAI68B06).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Fineberg SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038562; Golant A, 2008, J AM ACAD ORTHOP SUR, V16, P704, DOI 10.5435/00124635-200812000-00003; Han Y, 2008, CHIN OCCUP MED, V35, P515; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kanagawa T, 2006, BRAIN RES, V1111, P36, DOI 10.1016/j.brainres.2006.06.112; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; Nagao M, 2007, MOL CELL BIOL, V27, P3982, DOI 10.1128/MCB.00170-07; Oya S, 2009, NEUROSCIENCE, V158, P683, DOI 10.1016/j.neuroscience.2008.10.043; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Richardson RM, 2007, NEUROSURG CLIN N AM, V18, P169, DOI 10.1016/j.nec.2006.10.007; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wang XM, 2009, J CEREBR BLOOD F MET, V29, P1644, DOI 10.1038/jcbfm.2009.83	21	18	19	2	17	ROYAL SOC MEDICINE PRESS LTD	LONDON	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND	1535-3702			EXP BIOL MED	Exp. Biol. Med.	DEC	2012	237	12					1424	1432		10.1258/ebm.2012.012123			9	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	082GS	WOS:000314380900007	23354401				2022-02-06	
J	Martinez-Vargas, M; Rojo, FE; Tabla-Ramon, E; Navarro-Arguelles, H; Ortiz-Lailzon, N; Hernandez-Chavez, A; Solis, B; Tapia, RM; Arredondo, AP; Morales-Gomez, J; Gonzalez-Rivera, R; Nava-Talavera, K; Navarro, L				Martinez-Vargas, Marina; Estrada Rojo, Francisco; Tabla-Ramon, Erika; Navarro-Argueelles, Hilda; Ortiz-Lailzon, Nathan; Hernandez-Chavez, Alejandro; Solis, Barbara; Martinez Tapia, Ricardo; Perez Arredondo, Adan; Morales-Gomez, Julio; Gonzalez-Rivera, Ruben; Nava-Talavera, Karen; Navarro, Luz			Sleep deprivation has a neuroprotective role in a traumatic brain injury of the rat	NEUROSCIENCE LETTERS			English	Article						Traumatic brain injury; Sleep deprivation; Neuroprotection	CEREBRAL-ISCHEMIA; GENE-EXPRESSION; GROWTH-FACTOR; INCREASES; GLUTAMATE; RECOVERY; STROKE; CORTEX; EEG	During the process of a brain injury, responses to produce damage and cell death are activated, but self-protective responses that attempt to maintain the integrity and functionality of the brain are also activated. We have previously reported that the recovery from a traumatic brain injury (TBI) is better in rats if it occurs during the dark phase of the diurnal cycle when rats are in the waking period. This suggests that wakefulness causes a neuroprotective role in this type of injury. Here we report that 24 h of total sleep deprivation after a TBI reduces the morphological damage and enhances the recovery of the rats, as seen on a neurobiological scale. (C) 2012 Elsevier Ireland Ltd. All rights reserved.	[Martinez-Vargas, Marina; Estrada Rojo, Francisco; Tabla-Ramon, Erika; Navarro-Argueelles, Hilda; Ortiz-Lailzon, Nathan; Hernandez-Chavez, Alejandro; Solis, Barbara; Martinez Tapia, Ricardo; Perez Arredondo, Adan; Morales-Gomez, Julio; Nava-Talavera, Karen; Navarro, Luz] Univ Nacl Autonoma Mexico Apdo, Depto Fisiol, Fac Med, Mexico City 04510, DF, Mexico		Navarro, L (corresponding author), Univ Nacl Autonoma Mexico Apdo, Depto Fisiol, Fac Med, Postal 70-250, Mexico City 04510, DF, Mexico.	lnavarro@servidor.unam.mx	Martinez-Tapia, Ricardo Jesus/AAU-4219-2020; Navarro, Luz/A-4983-2013; Navarro, Luz/Q-9086-2019	Martinez-Tapia, Ricardo Jesus/0000-0003-3460-7065; Perez-Arredondo, Adan/0000-0002-0479-6734; HERNANDEZ CHAVEZ, ALEJANDRO/0000-0002-9876-0600; MARTINEZ-VARGAS, MARINA/0000-0002-3729-2161	PAPIITPrograma de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) [IN 222209, IN221212]	Supported by grants PAPIIT IN 222209 and IN221212. Thanks to Dr. Ellis Glazier for editing this English-language text.	Barriga-Ibars C, 2005, REV NEUROLOGIA, V40, P548, DOI 10.33588/rn.4009.2005250; Bettendorff L, 1996, SLEEP, V19, P65, DOI 10.1093/sleep/19.1.65; Brandt JA, 2001, BRAIN RES, V898, P105, DOI 10.1016/S0006-8993(01)02149-7; COHEN HB, 1965, SCIENCE, V150, P1318, DOI 10.1126/science.150.3701.1318; Corbett D, 1998, PROG NEUROBIOL, V54, P531, DOI 10.1016/S0301-0082(97)00078-6; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; Endo T, 1997, PSYCHIAT RES, V66, P97, DOI 10.1016/S0165-1781(96)03029-6; EVERSON CA, 1989, SLEEP, V12, P13, DOI 10.1093/sleep/12.1.13; Ezpleta S.D., APUNTES NEUROLOGIA; Faul M, 2010, TRAUMATIC BRAIN INJU; Feinberg I, 1999, SLEEP, V22, P1021, DOI 10.1093/sleep/22.8.1021; Gao B, 2010, SLEEP, V33, P879, DOI 10.1093/sleep/33.7.879; Hsu JC, 2003, BRAIN RES, V984, P170, DOI 10.1016/S0006-8993(03)03128-7; Hunter AJ, 2000, NEUROPHARMACOLOGY, V39, P806, DOI 10.1016/S0028-3908(99)00262-2; IYER KS, 1988, P NATL ACAD SCI USA, V85, P3653, DOI 10.1073/pnas.85.10.3653; Junek A, 2010, NEUROSCIENCE, V170, P1140, DOI 10.1016/j.neuroscience.2010.08.018; Kazanis I, 2003, BRAIN RES, V991, P34, DOI 10.1016/S0006-8993(03)03525-X; KUSHIDA CA, 1989, SLEEP, V12, P22, DOI 10.1093/sleep/12.1.22; Leker RR, 2002, BRAIN RES REV, V39, P55, DOI 10.1016/S0165-0173(02)00157-1; Martinez-Vargas M, 2003, NEUROSCIENCE, V117, P197, DOI 10.1016/S0306-4522(02)00820-5; Martinez-Vargas M, 2006, NEUROSCI LETT, V400, P21, DOI 10.1016/j.neulet.2006.02.010; Moldovan M, 2010, EXP NEUROL, V222, P135, DOI 10.1016/j.expneurol.2009.12.023; Montes-Rodriguez CJ, 2004, NEUROSCI LETT, V360, P133, DOI 10.1016/j.neulet.2004.02.053; RECHTSCHAFFEN A, 1983, SCIENCE, V221, P182, DOI 10.1126/science.6857280; Rechtschaffen A, 1999, SLEEP, V22, P11, DOI 10.1093/sleep/22.1.11; Salgado-Delgado R, 2008, NEUROSCIENCE, V154, P922, DOI 10.1016/j.neuroscience.2008.03.066; Scheepens A, 2000, J PEDIATR ENDOCR MET, V13, P1483; Schwierin B, 1999, NEUROSCI LETT, V261, P61, DOI 10.1016/S0304-3940(98)01006-4; Spiegel K, 2003, REV NEUROL-FRANCE, V159, pS11; Sritharan K, 2009, BRIT J HOSP MED, V70, pM156, DOI 10.12968/hmed.2009.70.Sup10.44641; Tononi G, 2001, NEUROPSYCHOPHARMACOL, V25, pS28, DOI 10.1016/S0893-133X(01)00322-0; Toppila J, 1996, J SLEEP RES, V5, P115, DOI 10.1046/j.1365-2869.1996.d01-66.x; Wang Sheng-Xu, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P888; Weil ZM, 2009, EXP NEUROL, V218, P129, DOI 10.1016/j.expneurol.2009.04.018; WIRZJUSTICE A, 1981, PSYCHIAT RES, V5, P67, DOI 10.1016/0165-1781(81)90062-7; Zhang F, 2010, MOLECULES, V15, P5246, DOI 10.3390/molecules15085246; Zucconi GG, 2006, BRAIN RES BULL, V69, P375, DOI 10.1016/j.brainresbull.2006.01.009; Zunzunegui C, 2011, SLEEP, V34, P1261, DOI 10.5665/SLEEP.1252	38	18	18	0	12	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	NOV 7	2012	529	2					118	122		10.1016/j.neulet.2012.09.037			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	039RK	WOS:000311264000004	23022503				2022-02-06	
J	Forman, JL; Lopez-Valdes, FJ; Pollack, K; Heredero-Ordoyo, R; Molinero, A; Mansilla, A; Fildes, B; Segui-Gomez, M				Forman, Jason L.; Lopez-Valdes, Francisco J.; Pollack, Keshia; Heredero-Ordoyo, Rafael; Molinero, Aquilino; Mansilla, Alberto; Fildes, Brian; Segui-Gomez, Maria			Injuries among powered two-wheeler users in eight European countries: A descriptive analysis of hospital discharge data	ACCIDENT ANALYSIS AND PREVENTION			English	Article						Motorcycles; Two-wheelers; Hospital discharge; Epidemiology; Injury; Biomechanics	PATTERNS; TRAUMA	Powered two-wheelers (PTWs - mopeds, motorcycles, and scooters) remain the most dangerous form of travel on today's roads. This study used hospital discharge data from eight European countries to examine the frequencies and patterns of injury among PM users (age >= 14 years), the predicted incidence of the loss of functional ability, and the mechanisms of the head injuries observed (all in light of increased helmet use). Of 977,557 injured patients discharged in 2004, 12,994 were identified as having been injured in PTW collisions. Lower extremity injuries accounted for 26% (25.6-26.7, 95% C.I.) of the total injuries, followed by upper extremity injuries (20.7%: 20.3-21.2), traumatic brain injuries (TBI) (18.5%: 18-19), and thoracic injuries (8.2%: 7.8-8.5). Approximately 80% of the lower extremity injury cases were expected to exhibit some functional disability one year following discharge (predicted Functional Capacity Index, pFCI-AIS98 < 100), compared to 47% of the upper extremity injury cases and 24% of the TBI cases. Although it occurred less frequently, patients that were expected to experience some functional limitation from TBI were predicted to fair worse on average (lose more functional ability) than patients expected to have functional limitations from extremity injuries. Cerebral concussion was the most common head injury observed (occurring in 56% of head injury cases), with most concussion cases (78%) exhibiting no other head injury. Among the AIS3+ head injuries that could be mapped to an injury mechanism, 48% of these were associated with a translational-impact mechanism, and 37% were associated with a rotational mechanism. The observation of high rates of expected long-term disability suggests that future efforts aim to mitigate lower and upper extremity injuries among PTW users. Likewise, the high rates of concussion and head injuries associated with a rotational mechanism provide goals for the next phase of PTW user head protection. (C) 2011 Elsevier Ltd. All rights reserved.	[Forman, Jason L.; Lopez-Valdes, Francisco J.; Heredero-Ordoyo, Rafael; Segui-Gomez, Maria] Univ Navarra, ECIP, Navarra 31080, Spain; [Pollack, Keshia; Segui-Gomez, Maria] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Injury Res & Policy, Baltimore, MD USA; [Lopez-Valdes, Francisco J.; Segui-Gomez, Maria] Univ Virginia, Ctr Appl Biomech, Charlottesville, VA 22911 USA; [Molinero, Aquilino] Fdn CIDAUT, Boecillo 47151, Castilla, Spain; [Molinero, Aquilino] Fdn CIDAUT, Leon 47151, Spain; [Mansilla, Alberto] Univ Valladolid, E-47011 Valladolid, Spain; [Fildes, Brian] Monash Univ, MUARC Europe, Prato Ctr, I-59100 Prato, Italy		Forman, JL (corresponding author), Univ Navarra, ECIP, Irunlarrea 1,Ed Castanos, Navarra 31080, Spain.	jlf3m@virginia.edu; fjl2j@virginia.edu; kpollack@jhsph.edu; rhereder@unav.es; aqumol@cidaut.es; albman@eis.uva.es; Brian.Fildes@muarc.monash.edu.au; msegui@unav.es	Lopez-Valdes, Francisco/AAG-5519-2019; Lopez-Valdes, Francisco J/I-3649-2012	Lopez-Valdes, Francisco J/0000-0003-3167-5732; Forman, Jason/0000-0001-8705-3997			AAAM, 2008, ABBR INJ SEV SCAL AI; AAAM, 1998, ABBR INJ SEV SCAL AI; ACEM, 2008, 20 ACEM, P16; Arbogast K.B., 2005, P INT RES COUNC BIOM; Arregui-Dalmases C, 2010, ACCIDENT ANAL PREV, V42, P1164, DOI 10.1016/j.aap.2010.01.005; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Barnes Jo, 2009, Ann Adv Automot Med, V53, P195; Center for Injury Research and Policy of the Johns Hopkins University School of Public Health and Trianalytics Inc., 1998, ICDMAP 90 PROGR MAP; Coben JH, 2004, AM J PREV MED, V27, P355, DOI 10.1016/j.amepre.2004.08.002; European Center for Injury Prevention at Universidad de Navarra, 2007, ALG CALC FUNCT CAP I; European Center for Injury Prevention at Universidad de Navarra, 2007, ALG TRANSL ICD 10 CO; European Center for Injury Prevention at Universidad de Navarra, 2007, ALG CALC BAR MATR IC; European Center for Injury Prevention at Universidad de Navarra, 2008, ALG EST TYP FORC REL; Fingerhut LA, 2006, INJURY PREV, V12, P24, DOI 10.1136/ip.2005.009076; Fitzharris M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-11; Gennarelli Thomas A., 1993, Journal of Emergency Medicine, V11, P5; Hinds JD, 2007, INJURY, V38, P1131, DOI 10.1016/j.injury.2007.06.012; LaTorre G, 2002, EUR J PUBLIC HEALTH, V12, P99, DOI 10.1093/eurpub/12.2.99; Liu BC, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004333.pub3; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MacKenzie EJ, 1996, J TRAUMA, V41, P799, DOI 10.1097/00005373-199611000-00006; MacKenzie EJ, 2002, QUAL LIFE RES, V11, P797, DOI 10.1023/A:1020820017658; MacKenzie EJ, 1986, P AAAM, V30, P135; MARGANITT B, 1990, AM J PUBLIC HEALTH, V80, P1463, DOI 10.2105/AJPH.80.12.1463; Martin P., 2003, P 31 INT WORKSH INJ; Monk JP, 2009, CAN J SURG, V52, pE235; Robertson A, 2002, SPINE, V27, P2825, DOI 10.1097/00007632-200212150-00019; SafetyNet, 2009, POW 2 WHEEL; Schuller E., 1984, P 26 STAPP CAR CRASH, P259; Segui-Gomez M, 2007, INJURY PREV, V13, P429, DOI 10.1136/ip.2007.017475; Segui-Gomez M, 2008, INJURY RELATED HOSPI; WHO, 2004, WORLD REP ROAD TRAFF; WHO (World Health Organization), 1992, INT CLASS DIS V 10 I; World Health Organization, 2009, GLOB STAT REP ROAD S; ZETTAS JP, 1979, J TRAUMA, V19, P833, DOI 10.1097/00005373-197911000-00007	36	18	18	2	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0001-4575	1879-2057		ACCIDENT ANAL PREV	Accid. Anal. Prev.	NOV	2012	49				SI		229	236		10.1016/j.aap.2011.02.020			8	Ergonomics; Public, Environmental & Occupational Health; Social Sciences, Interdisciplinary; Transportation	Social Science Citation Index (SSCI)	Engineering; Public, Environmental & Occupational Health; Social Sciences - Other Topics; Transportation	074WI	WOS:000313845300027	23036399				2022-02-06	
J	Honeybul, S; Gillett, G; Ho, K; Lind, C				Honeybul, Stephen; Gillett, Grant; Ho, Kwok; Lind, Christopher			Ethical considerations for performing decompressive craniectomy as a life-saving intervention for severe traumatic brain injury	JOURNAL OF MEDICAL ETHICS			English	Article								In all fields of clinical medicine, there is an increasing awareness that outcome must be assessed in terms of quality of life and cost effectiveness, rather than merely length of survival. This is especially the case when considering decompressive craniectomy for severe traumatic brain injury. The procedure itself is technically straightforward and involves temporarily removing a large section of the skull vault in order to provide extra space into which the injured brain can expand. A number of studies have demonstrated many patients going on to make a good long-term functional recovery, however, this is not always the case and a significant number survive but are left with severe neurocognitive impairment. Unfortunately, many of these patients are young adults who were previously fit and well and are, therefore, likely to spend many years in a condition that they may feel to be unacceptable, and this raises a number of ethical issues regarding consent and resource allocation. In an attempt to address these issues, we have used the analytical framework proposed by Jonsen, that requires systematic consideration of medical indications, patient preferences, quality of life and contextual features.	[Honeybul, Stephen] Sir Charles Gairdner Hosp, Dept Neurosurg, Perth, WA 6009, Australia; [Gillett, Grant] Univ Otago, Bioeth Ctr, Dunedin Hosp & Otago, Dunedin, Otago, New Zealand; [Ho, Kwok] Univ Western Australia, Dept Intens Care Med, Perth, WA 6009, Australia; [Ho, Kwok] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Lind, Christopher] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia		Honeybul, S (corresponding author), Sir Charles Gairdner Hosp, Dept Neurosurg, Hosp Ave, Perth, WA 6009, Australia.	stephen.honeybul@health.wa.gov.au	Lind, Christopher/K-3629-2012; Ho, Kwok M./E-3546-2010	Lind, Christopher/0000-0001-9991-1725; Ho, Kwok M./0000-0002-6705-6004			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Beauchamp T. L., 2001, PRINCIPLES BIOMEDICA, V5th, P69; Boddington Paula, 1992, Bioethics, V6, P201, DOI 10.1111/j.1467-8519.1992.tb00198.x; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Fagerlin A, 2004, HASTINGS CENT REP, V34, P30, DOI 10.2307/3527683; Fins JJ, 2009, ANN NY ACAD SCI, V1157, P131, DOI 10.1111/j.1749-6632.2009.04473.x; Ho KM, 2011, J TRAUMA, V71, P1637, DOI 10.1097/TA.0b013e31823a08f1; Ho KM, 2011, CRIT CARE MED, V39, P2495, DOI 10.1097/CCM.0b013e318225764e; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032375; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Honeybul S, 2011, J NEUROTRAUM, V28, P13, DOI 10.1089/neu.2010.1584; Honeybul S, 2010, J NEUROTRAUM, V27, P1225, DOI 10.1089/neu.2010.1316; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jonsen A R, 1986, Law Med Health Care, V14, P172; Jonsen AR, 2006, CLIN OTHICS PRACTICA; Kerridge IH, 1999, MED J AUSTRALIA, V171, P239, DOI 10.5694/j.1326-5377.1999.tb123629.x; Kiphuth IC, 2010, NEUROCRIT CARE, V13, P380, DOI 10.1007/s12028-010-9449-8; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Perkins HS, 2007, ANN INTERN MED, V147, P51, DOI 10.7326/0003-4819-147-1-200707030-00008; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Schiff ND, 2005, NEUROLOGY, V64, P514, DOI 10.1212/01.WNL.0000150883.10285.44; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Timmons SD, 2011, NEW ENGL J MED, V365, P373, DOI 10.1056/NEJMc1106421; Wood RL, 2006, J NEUROL NEUROSUR PS, V77, P71, DOI 10.1136/jnnp.2005.065540	28	18	18	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	NOV	2012	38	11					657	661		10.1136/medethics-2012-100672			5	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	030PE	WOS:000310581800004	22807572				2022-02-06	
J	Kopterides, P; Theodorakopoulou, M; Nikitas, N; Ilias, I; Vassiliadi, DA; Orfanos, SE; Tsangaris, I; Maniatis, NA; Tsantes, AE; Travlou, A; Dimitriadis, G; Armaganidis, A; Ungerstedt, U; Dimopoulou, I				Kopterides, Petros; Theodorakopoulou, Maria; Nikitas, Nikitas; Ilias, Ioannis; Vassiliadi, Dimitra Argiro; Orfanos, Stylianos E.; Tsangaris, Iraklis; Maniatis, Nikolaos A.; Tsantes, Argirios E.; Travlou, Anthi; Dimitriadis, George; Armaganidis, Apostolos; Ungerstedt, Urban; Dimopoulou, Ioanna			Red blood cell transfusion affects microdialysis-assessed interstitial lactate/pyruvate ratio in critically ill patients with late sepsis	INTENSIVE CARE MEDICINE			English	Article						Transfusion; Sepsis; Lactate; Microdialysis; Microcirculation; Metabolism	TRAUMATIC BRAIN-INJURY; CARDIAC-SURGERY; ORGAN FAILURE; SEPTIC SHOCK; OXYGENATION; ANEMIA; MULTICENTER; METABOLISM; INFECTION; CARE	The aim of this study was to explore the effect of red blood cell (RBC) transfusion on microdialysis-assessed interstitial fluid metabolic parameters in septic patients. We conducted a retrospective study of 37 patients with severe sepsis/septic shock requiring transfusion of one to two RBC units. Interstitial fluid metabolic alterations were monitored by a microdialysis catheter inserted in the subcutaneous adipose tissue. Samples were collected before (T0) and after transfusion at two time-points: T1a and T1b; median post-transfusion times of 120 [interquartile range (IQR); 45-180] and 360 (IQR; 285-320) min. Lactate, pyruvate, glycerol and glucose concentrations were measured with a bedside analyzer, and the lactate/pyruvate (LP) ratio was calculated automatically. RBC transfusions decreased the LP ratio from (T0) 18.80 [interquartile range (IQR); 14.85-27.45] to (T1a) 17.80 (IQR; 14.35-25.20; P < 0.05) and (T1b) 17.90 (IQR; 14.45-22.75; P < 0.001), while there was also significant interindividual variation. Post-transfusion LP ratio changes at T1a [r = -0.42; 95 % confidence interval (CI), -0.66 to -0.098; P = 0.01] and T1b (r = -0.68; 95 % [CI], -0.82 to -0.44; P < 0.001) were significantly correlated with the pre-transfusion LP ratio, but not with baseline demographic characteristics, vital signs, severity scores, hemoglobin level and blood lactate. RBC storage time and leukocyte reduction had no influence on the tissue metabolic response to transfusion. Tissue oxygenation is affected by RBC transfusion in critically ill septic patients. Monitoring of tissue LP ratio by microdialysis may represent a useful method for individual clinical management.	[Kopterides, Petros; Theodorakopoulou, Maria; Nikitas, Nikitas; Orfanos, Stylianos E.; Tsangaris, Iraklis; Maniatis, Nikolaos A.; Armaganidis, Apostolos; Dimopoulou, Ioanna] Univ Athens, Attiko Univ Hosp, Dept Crit Care Med 2, Sch Med, Athens 12462, Greece; [Ilias, Ioannis] Elena Hosp, Dept Endocrinol, Athens, Greece; [Vassiliadi, Dimitra Argiro; Dimitriadis, George] Univ Athens, Attiko Univ Hosp, Dept Internal Med 2, Sch Med, Athens 12462, Greece; [Tsantes, Argirios E.; Travlou, Anthi] Univ Athens, Attiko Univ Hosp, Sch Med, Hematol Lab, Athens 12462, Greece; [Tsantes, Argirios E.; Travlou, Anthi] Univ Athens, Attiko Univ Hosp, Sch Med, Blood Bank Unit, Athens 12462, Greece; [Ungerstedt, Urban] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden		Kopterides, P (corresponding author), Univ Athens, Attiko Univ Hosp, Dept Crit Care Med 2, Sch Med, 1 Rimini St, Athens 12462, Greece.	petkop@ath.forthnet.gr	Tsangaris, Iraklis/AAA-3627-2020; Ilias, Ioannis/AAA-2927-2020; ILIAS, IOANNIS/AAI-4033-2020; Vassiliadi, Dimitra/ABF-8100-2021	Tsangaris, Iraklis/0000-0003-4395-0471; ILIAS, IOANNIS/0000-0001-5718-7441; 			Ba VN, 2003, CRIT CARE MED, V31, P406, DOI 10.1097/01.CCM.0000048623.00778.3F; Corwin HL, 2000, CRIT CARE MED, V28, P3098, DOI 10.1097/00003246-200008000-00079; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Creteur J, 2009, CRIT CARE, V13, DOI 10.1186/cc8009; De Backer D, 2002, AM J RESP CRIT CARE, V166, P98, DOI 10.1164/rccm.200109-016OC; De Backer D, 2010, CURR OPIN CRIT CARE, V16, P250, DOI 10.1097/MCC.0b013e3283383621; Dellinger R Phillip, 2008, Crit Care Med, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dimopoulou I, 2011, SHOCK, V35, P343, DOI 10.1097/SHK.0b013e318206aafa; Doerschug KC, 2007, AM J PHYSIOL-HEART C, V293, pH1065, DOI 10.1152/ajpheart.01237.2006; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gogos C, 2010, CRIT CARE, V14, DOI 10.1186/cc9031; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Hollenberg SM, 2010, INTENS CARE MED, V36, P1807, DOI 10.1007/s00134-010-1973-7; Jhanji S, 2009, INTENS CARE MED, V35, P671, DOI 10.1007/s00134-008-1325-z; Kopterides P, 2011, INTENS CARE MED, V37, P1756, DOI 10.1007/s00134-011-2336-8; Lelubre C, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-43; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MARIK PE, 1993, JAMA-J AM MED ASSOC, V269, P3024, DOI 10.1001/jama.269.23.3024; Mohnle P, 2011, INTENS CARE MED, V37, P97, DOI 10.1007/s00134-010-2017-z; Nichol AD, 2010, CRIT CARE, V14, DOI 10.1186/cc8888; Oliver E, 2009, INTENS CARE MED, V35, P1548, DOI 10.1007/s00134-009-1526-0; Orlov D, 2009, TRANSFUSION, V49, P682, DOI 10.1111/j.1537-2995.2008.02022.x; Ospina-Tascon G, 2010, INTENS CARE MED, V36, P949, DOI 10.1007/s00134-010-1843-3; Pojar M, 2008, EUR J CARDIO-THORAC, V33, P899, DOI 10.1016/j.ejcts.2008.01.039; Pottecher J, 2010, INTENS CARE MED, V36, P1867, DOI 10.1007/s00134-010-1966-6; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Ruggieri AJ, 2010, CRIT CARE CLIN, V26, P567, DOI 10.1016/j.ccc.2010.04.007; Sakr Y, 2007, CRIT CARE MED, V35, P1639, DOI 10.1097/01.CCM.0000269936.73788.32; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Ungerstedt U, 2004, CURR PHARM DESIGN, V10, P2145, DOI 10.2174/1381612043384105; Vallet B, 2007, BEST PRACT RES-CLIN, V21, P173, DOI 10.1016/j.bpa.2007.02.003; Vallet B, 2010, CRIT CARE, V14, DOI 10.1186/cc8854; Vincent JL, 2002, JAMA-J AM MED ASSOC, V288, P1499, DOI 10.1001/jama.288.12.1499; Wang JK, 2010, VOX SANG, V98, P2, DOI 10.1111/j.1423-0410.2009.01223.x; Westbrook A, 2010, INTENS CARE MED, V36, P1138, DOI 10.1007/s00134-010-1867-8; Zallen G, 1999, AM J SURG, V178, P570, DOI 10.1016/S0002-9610(99)00239-1; Zygun DA, 2009, CRIT CARE MED, V37, P1074, DOI 10.1097/CCM.0b013e318194ad22	37	18	19	0	9	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	NOV	2012	38	11					1843	1850		10.1007/s00134-012-2635-8			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	026CN	WOS:000310250500014	22777518				2022-02-06	
J	Li, L; Chopp, M; Ding, GL; Qu, CS; Li, QJ; Lu, M; Wang, SY; Nejad-Davarani, SP; Mahmood, A; Jiang, Q				Li, Lian; Chopp, Michael; Ding, Guang Liang; Qu, Chang Sheng; Li, Qing Jiang; Lu, Mei; Wang, Shiyang; Nejad-Davarani, Siamak P.; Mahmood, Asim; Jiang, Quan			MRI measurement of angiogenesis and the therapeutic effect of acute marrow stromal cell administration on traumatic brain injury	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						angiogenesis; marrow stromal cells; MRI; perfusion; ventricular dilation	CEREBRAL-BLOOD-FLOW; ENDOTHELIAL GROWTH-FACTOR; ISCHEMIC BOUNDARY ZONE; BONE-MARROW; ADULT RATS; STROKE; TRANSPLANTATION; NEUROGENESIS; EXPRESSION; PERFUSION	Using magnetic resonance imaging (MRI), the present study was undertaken to investigate the therapeutic effect of acute administration of human bone marrow stromal cells (hMSCs) on traumatic brain injury (TBI) and to measure the temporal profile of angiogenesis after the injury with or without cell intervention. Male Wistar rats (300 to 350 g, n=18) subjected to controlled cortical impact TBI were intravenously injected with 1 mL of saline (n=9) or hMSCs in suspension (n=9, 3x10(6) hMSCs) 6 hours after TBI. In-vivo MRI acquisitions of T2-weighted imaging, cerebral blood flow (CBF), three-dimensional (3D) gradient echo imaging, and blood-to-brain transfer constant (Ki) of contrast agent were performed on all animals 2 days after injury and weekly for 6 weeks. Sensorimotor function and spatial learning were evaluated. Volumetric changes in the trauma-induced brain lesion and the lateral ventricles were tracked and quantified using T2 maps, and hemodynamic alteration and blood-brain barrier permeability were monitored by CBF and Ki, respectively. Our data show that transplantation of hMSCs 6 hours after TBI leads to reduced cerebral atrophy, early and enhanced cerebral tissue perfusion and improved functional outcome compared with controls. The hMSC treatment increases angiogenesis in the injured brain, which may promote neurologic recovery after TBI. Journal of Cerebral Blood Flow & Metabolism (2012) 32, 2023-2032; doi:10.1038/jcbfm.2012.106; published online 11 July 2012	[Li, Lian; Chopp, Michael; Ding, Guang Liang; Li, Qing Jiang; Nejad-Davarani, Siamak P.; Jiang, Quan] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael; Wang, Shiyang; Jiang, Quan] Oakland Univ, Dept Phys, Rochester, MI USA; [Qu, Chang Sheng; Mahmood, Asim] Henry Ford Hosp, Dept Neurosurg, Detroit, MI 48202 USA; [Lu, Mei] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA		Jiang, Q (corresponding author), Henry Ford Hosp, Dept Neurol, B126,Educ & Res Bldg,2799 W Grand Blvd, Detroit, MI 48202 USA.	qjiang1@hfhs.org	Wang, Shiyang/C-1729-2012; Nejad-Davarani, Siamak/AAH-8399-2021	Li, Lian/0000-0003-0097-1184; Nejad-Davarani, Siamak/0000-0002-2415-6689; Ding, Guangliang/0000-0003-1286-5901	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P50 NS23393, RO1 NS064134, RO1 NS48349, RO1 NS43324, HL64766]; Mort and Brigitte Harris Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL064766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS043324, R01NS048349, P50NS023393, R01NS064134] Funding Source: NIH RePORTER	This work was supported by National Institute of Neurological Disorders and Stroke grants, P50 NS23393, RO1 NS064134, RO1 NS48349, RO1 NS43324, HL64766, and the Mort and Brigitte Harris Foundation.	Bonne O, 2003, PSYCHIAT RES-NEUROIM, V124, P141, DOI 10.1016/S0925-4927(03)00109-4; Borlongan CV, 2004, BRAIN RES, V1009, P26, DOI 10.1016/j.brainres.2004.02.050; CHEN HH, 1994, STROKE, V25, P1651, DOI 10.1161/01.STR.25.8.1651; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen JL, 2003, CIRC RES, V92, P692, DOI 10.1161/01.RES.0000063425.51108.8D; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Chopp M, 2007, STROKE, V38, P827, DOI 10.1161/01.STR.0000250235.80253.e9; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; Ewing JR, 2003, MAGN RESON MED, V50, P283, DOI 10.1002/mrm.10524; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Jiang Q, 2005, NEUROIMAGE, V28, P698, DOI 10.1016/j.neuroimage.2005.06.063; Kochanek PM, 2002, J NEUROTRAUM, V19, P1029, DOI 10.1089/089771502760341947; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Li L, 2006, J CEREBR BLOOD F MET, V26, P1366, DOI 10.1038/sj.jcbfm.9600288; Li LA, 2011, J NEUROTRAUM, V28, P535, DOI 10.1089/neu.2010.1619; Li L, 2010, J CEREBR BLOOD F MET, V30, P653, DOI 10.1038/jcbfm.2009.238; Li L, 2009, STROKE, V40, P936, DOI 10.1161/STROKEAHA.108.527713; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Opydo-Chanek M, 2007, ACTA NEUROBIOL EXP, V67, P187; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pettersson A, 2000, LAB INVEST, V80, P99, DOI 10.1038/labinvest.3780013; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P313, DOI 10.1097/00005072-199904000-00001; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Qu CS, 2011, BRAIN RES, V1371, P129, DOI 10.1016/j.brainres.2010.10.088; Rossignol J, 2009, J CELL MOL MED, V13, P2547, DOI 10.1111/j.1582-4934.2009.00657.x; Seevinck PR, 2010, ANGIOGENESIS, V13, P101, DOI 10.1007/s10456-010-9174-0; Shen LH, 2010, GLIA, V58, P1074, DOI 10.1002/glia.20988; Shen Q, 2004, J CEREBR BLOOD F MET, V24, P887, DOI 10.1097/01.WCB.0000124321.60992.87; Tha-Zuchman O, 2010, J CEREB BLOOD FLOW M, V30, P1008; Wu HT, 2011, NEUROSURGERY, V68, P1363, DOI 10.1227/NEU.0b013e31820c06b9; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Xiong Y, 2009, BRAIN RES, V1263, P183, DOI 10.1016/j.brainres.2009.01.032; Zacharek A, 2007, J CEREBR BLOOD F MET, V27, P1684, DOI 10.1038/sj.jcbfm.9600475	40	18	19	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X			J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	NOV	2012	32	11					2023	2032		10.1038/jcbfm.2012.106			10	Endocrinology & Metabolism; Hematology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	033AV	WOS:000310765600007	22781331	Green Published, Bronze			2022-02-06	
J	O'Neil-Pirozzi, TM; Goldstein, R; Strangman, GE; Glenn, MB				O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Strangman, Gary E.; Glenn, Mel B.			Test-re-test reliability of the Hopkins Verbal Learning Test-Revised in individuals with traumatic brain injury	BRAIN INJURY			English	Article						Test-re-test reliability; traumatic brain injury; memory	TEST-RETEST RELIABILITY; RELIABLE CHANGE INDEXES; VIRTUAL PLANNING TEST; CLOSED HEAD-INJURY; ALTERNATE FORMS; MEMORY TESTS; REHABILITATION; RECOGNITION; RIVASTIGMINE; DEVICES	Primary objective: To determine test-re-test reliability of the Hopkins Verbal Learning Test-Revised (HVLT-R) in a group of individuals with traumatic brain injury (TBI). Research design: Single-group repeated measures design. Methods and procedures: Seventy-five individuals with TBI were administered the HVLT-R twice, with 6-8 weeks between the two test sessions. Main outcomes and results: Test-re-test reliability on HVLT-R scoring parameters ranged from 0.537-0.818, with seven of the eight scoring parameters exhibiting r>0.6. At re-test, scores did not significantly change on any of the eight HVLT-R scoring parameters. Conclusions: HVLT-R use with individuals with TBI is supported. Test-re-test reliability of total recall and delayed recall sub-scores was particularly high.	[O'Neil-Pirozzi, Therese M.] Northeastern Univ, Speech Language Pathol & Audiol Dept, Boston, MA 02115 USA; [O'Neil-Pirozzi, Therese M.; Goldstein, Richard; Strangman, Gary E.; Glenn, Mel B.] Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Boston, MA USA; [Goldstein, Richard; Glenn, Mel B.] Harvard Univ, Sch Med, Boston, MA USA; [Strangman, Gary E.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA		O'Neil-Pirozzi, TM (corresponding author), Northeastern Univ, Speech Language Pathol & Audiol Dept, 103 Forsyth Bldg, Boston, MA 02115 USA.	t.oneil-pirozzi@neu.edu		Strangman, Gary/0000-0001-8896-2164	National Institute on Disability and Rehabilitation Research, US Department of EducationUS Department of Education [H133A020513]	This work was supported in part by grant #H133A020513 from the National Institute on Disability and Rehabilitation Research, US Department of Education. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Baddeley AD, 2001, J COGNITIVE NEUROSCI, V13, P357, DOI 10.1162/08989290151137403; Benedict, 2001, HOPKINS VERBAL LEARN; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Benedict RHB, 1998, J CLIN EXP NEUROPSYC, V20, P339, DOI 10.1076/jcen.20.3.339.822; Benedict RHB, 2005, J INT NEUROPSYCH SOC, V11, P727, DOI 10.1017/S1355617705050782; Bird CM, 2003, BRIT J CLIN PSYCHOL, V42, P407, DOI 10.1348/014466503322528946; Brandt J, 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; BUTTERS N, 1986, CORTEX, V22, P11, DOI 10.1016/S0010-9452(86)80030-2; Chu BC, 2007, J CLIN EXP NEUROPSYC, V29, P617, DOI 10.1080/13803390600878893; Consensus conference, 1999, J AM MED ASS, V282, P974; Dawson B., 2004, BASIC CLIN BIOSTATIS; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 1987, CALIFORNIA VERBAL LE; Hart T, 2003, BRAIN INJURY, V17, P401, DOI 10.1080/0269905021000038438; Johnson MK, 1990, BRAIN ORG MEMORY CEL, P106; Kennedy M, 2006, AHSA LEAD, V11, P34; Lengenfelder J, 2007, REHABIL PSYCHOL, V52, P290, DOI 10.1037/0090-5550.52.3.290; Levin HS., 1982, NEUROBEHAVIORAL CONS; Lowe C, 1998, NEUROPSYCHOLOGIA, V36, P915, DOI 10.1016/S0028-3932(98)00036-0; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Morey CE, 2003, BRAIN INJURY, V17, P809, DOI 10.1080/0269905031000088586; Moscovitch M, 2005, DYNAMIC COGNITIVE PROCESSES, P333, DOI 10.1007/4-431-27431-6_14; O'Neil-Pirozzi TM, 2010, BRAIN INJURY, V24, P509, DOI 10.3109/02699051003601697; O'Neil-Pirozzi TM, 2010, J HEAD TRAUMA REHAB, V25, P43, DOI 10.1097/HTR.0b013e3181bf24b1; O'Neil-Pirozzi TM, 2005, BRAIN INJURY, V19, P1191, DOI 10.1080/02699050500149916; O'Neil-Pirozzi TM, 2004, BRAIN INJURY, V18, P179, DOI 10.1080/0269905031000149560; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; RASMUSSON DX, 1995, ARCH CLIN NEUROPSYCH, V10, P21, DOI 10.1016/0887-6177(94)E0001-6; Rousson V, 2002, STAT MED, V21, P3431, DOI 10.1002/sim.1253; RYAN T V, 1992, Brain Injury, V6, P175, DOI 10.3109/02699059209029656; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Silver JM, 2006, NEUROLOGY, V67, P748, DOI 10.1212/01.wnl.0000234062.98062.e9; Silver JM, 2009, BRAIN INJURY, V23, P123, DOI 10.1080/02699050802649696; Sohlberg M., 2001, COGNITIVE REHABILITA; Sohlberg M. M., 2005, REHABILITATION TRAUM, P47; Steinberg WJ, 2010, MENTAL MEASUREMENTS, P16; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Tulving E., 2000, OXFORD HDB MEMORY, P33; Watkins MP., 2015, FDN CLIN RES APPL PR, V3rd; Wilson BA, 1998, NEUROPSYCHOL REHABIL, V8, P213, DOI 10.1080/713755570; Woods SP, 2005, ASSESSMENT, V12, P96, DOI 10.1177/1073191104270342; Woods SP, 2006, ARCH CLIN NEUROPSYCH, V21, P413, DOI 10.1016/j.acn.2006.06.002; [No title captured]	44	18	18	1	14	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	NOV	2012	26	12					1425	1430		10.3109/02699052.2012.694561			6	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	022DL	WOS:000309935400003	22715921				2022-02-06	
J	Shafaroodi, H; Moezi, L; Fakhrzad, A; Hassanipour, M; Rezayat, M; Dehpour, AR				Shafaroodi, Hamed; Moezi, Leila; Fakhrzad, Ali; Hassanipour, Mahsa; Rezayat, Mehdi; Dehpour, Ahmad Reza			The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice	NEUROLOGICAL RESEARCH			English	Article						Atorvastatin; Convulsion; Seizure; Nitric oxide; Mice	SMOOTH-MUSCLE-CELLS; A REDUCTASE INHIBITORS; PENTYLENETETRAZOL-INDUCED SEIZURES; TRAUMATIC BRAIN-INJURY; SYNTHASE EXPRESSION; ALZHEIMER-DISEASE; MESSENGER-RNA; BLOOD-FLOW; STATIN; SIMVASTATIN	Objectives: In addition to reducing the serum level of cholesterol, statins have various pleiotropic effects such as increasing nitric oxide and reducing oxidative stress, neuroinflammation, and neurotoxicity. Increasing evidence indicates that statins are neuroprotective in several conditions, including stroke, cerebral ischemia and traumatic brain injury. However, only a few studies have investigated whether statins modulate seizure activity. Methods: In the current study, we investigated whether acute treatment with atorvastatin alters the seizures induced by electroshock or pentylenetetrazole in mice. We also evaluated whether nitrergic system is involved in the effects of acute atorvastatin on seizure. Results: The results of the present study demonstrate that acute atorvastatin (10 and 20 mg/kg) treatment decreased the incidence of tonic seizure and death in electroshock-induced seizure model. We also showed that acute atorvastatin (10 mg/kg) treatment increased the clonic seizure threshold in pentylenetetrazole-seizure model. Acute L-NAME (5 mg/kg), a non-selective inhibitor of nitric oxide synthase, or aminoguanidine (100 mg/kg), a selective inhibitor of inducible nitric oxide synthase, administration prevented the anti-convulsant effect of atorvastatin in electroshock-induced seizure model. We also demonstrated that acute L-NAME (5 mg/kg) or aminoguanidine (100 mg/kg) administration decreased the enhanced clonic latency of clonic seizure threshold induced by atorvastatin in mice in pentylenetetrazole model. Discussion: In conclusion, anti-convulsant effect of atorvastatin was demonstrated in two seizure models of electroshock and intraperitoneal pentylenetetrazole. Nitric oxide release, probably through inducible nitric oxide synthase at least in part is responsible for this effect.	[Moezi, Leila; Fakhrzad, Ali] Shiraz Univ Med Sci, Sch Med, Dept Pharmacol, Shiraz, Iran; [Shafaroodi, Hamed; Hassanipour, Mahsa; Rezayat, Mehdi] Islamic Azad Univ, Dept Pharmacol & Toxicol, Pharmaceut Sci Branch, Tehran, Iran; [Shafaroodi, Hamed; Hassanipour, Mahsa; Rezayat, Mehdi] Islamic Azad Univ, Pharmaceut Sci Res Ctr, Tehran, Iran; [Dehpour, Ahmad Reza] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran		Moezi, L (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Pharmacol, Shiraz, Iran.	moezile@yahoo.com	Dehpour, Ahmad Reza/I-6422-2019; moezi, leila/D-5127-2012; Hassanipour, Mahsa/H-1732-2017	Dehpour, Ahmad Reza/0000-0002-8001-5565; moezi, leila/0000-0002-6990-9138; Hassanipour, Mahsa/0000-0003-2350-0326			Angalakuditi M, 2011, NEUROPSYCH DIS TREAT, V7, P585, DOI 10.2147/NDT.S24966; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BUISSON A, 1993, NEUROREPORT, V4, P444, DOI 10.1097/00001756-199304000-00027; Chen H, 2000, HYPERTENSION, V36, P923, DOI 10.1161/01.HYP.36.6.923; Chen SF, 2007, LIFE SCI, V81, P288, DOI 10.1016/j.lfs.2007.05.023; Endres M, 1998, P NATL ACAD SCI USA, V95, P8880, DOI 10.1073/pnas.95.15.8880; Funck VR, 2011, EPILEPSIA, V52, P2094, DOI 10.1111/j.1528-1167.2011.03261.x; Hattori Y, 2002, CARDIOVASC RES, V54, P649, DOI 10.1016/S0008-6363(02)00266-3; Hemandez-Romero MD, 2008, J NEUROCHEM, V105, P445, DOI 10.1111/j.1471-4159.2007.05148.x; Homayoun H, 2002, EPILEPSY RES, V48, P33, DOI 10.1016/S0920-1211(01)00316-3; John S, 2001, J AM COLL CARDIOL, V37, P1351, DOI 10.1016/S0735-1097(01)01128-7; Johnson-Anuna LN, 2007, J NEUROCHEM, V101, P77, DOI 10.1111/j.1471-4159.2006.04375.x; KARATINOS J, 1995, CLIN NEUROPHARMACOL, V18, P482, DOI 10.1097/00002826-199512000-00002; Khavandgar S, 2003, PHARMACOL BIOCHEM BE, V74, P795, DOI 10.1016/S0091-3057(02)01077-8; Kolyada AY, 2001, HYPERTENSION, V38, P1024, DOI 10.1161/hy1101.093103; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Kupferberg H, 2001, EPILEPSIA, V42, P7, DOI 10.1046/j.1528-1157.2001.0420s4007.x; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Laufs U, 1997, J BIOL CHEM, V272, P31725, DOI 10.1074/jbc.272.50.31725; Laufs U, 1998, CIRCULATION, V97, P1129, DOI 10.1161/01.CIR.97.12.1129; Lee JK, 2008, NEUROSCI LETT, V440, P260, DOI 10.1016/j.neulet.2008.05.112; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Macaulay RJB, 1999, J NEURO-ONCOL, V42, P1, DOI 10.1023/A:1006164406202; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; MONCADA S, 1991, PHARMACOL REV, V43, P109; MULSCH A, 1994, NEUROREPORT, V5, P2325; Nidhi G, 1999, METHOD FIND EXP CLIN, V21, P609; Omori H, 2002, BRIT J CLIN PHARMACO, V54, P395, DOI 10.1046/j.1365-2125.2002.01677.x; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; OSONOE K, 1994, BRAIN RES, V663, P338, DOI 10.1016/0006-8993(94)91283-1; Piermartiri TCB, 2009, NEUROTOX RES, V16, P106, DOI 10.1007/s12640-009-9057-6; Ramirez C, 2011, J ALZHEIMERS DIS, V24, P161, DOI 10.3233/JAD-2010-101653; Rangel P, 2005, ARQ NEURO-PSIQUIAT, V63, P972, DOI 10.1590/S0004-282X2005000600013; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Selley ML, 2005, BRAIN RES, V1037, P1, DOI 10.1016/j.brainres.2004.02.083; Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753; STARR MS, 1993, PHARMACOL BIOCHEM BE, V45, P321, DOI 10.1016/0091-3057(93)90246-P; Stepien KM, 2012, EUR J PHARMACOL, V674, P20, DOI 10.1016/j.ejphar.2011.10.030; Tannous M, 1999, THROMB HAEMOSTASIS, V82, P1390; THEARD MA, 1995, NEUROREPORT, V6, P921, DOI 10.1097/00001756-199504190-00024; Vaughan CJ, 2000, J AM COLL CARDIOL, V35, P1, DOI 10.1016/S0735-1097(99)00525-2; Wang HC, 2007, EXP NEUROL, V206, P59, DOI 10.1016/j.expneurol.2007.03.031; Wang J, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008386.pub2; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; WOODBURY LA, 1952, AM J PHYSIOL, V170, P661, DOI 10.1152/ajplegacy.1952.170.3.661; WOODBURY LA, 1952, ARCH INT PHARMACOD T, V92, P97; Zacco A, 2003, J NEUROSCI, V23, P11104	47	18	19	0	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	NOV	2012	34	9					847	853		10.1179/1743132812Y.0000000080			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	027NJ	WOS:000310359100003	22909758				2022-02-06	
J	Tsan, JY; Zeber, JE; Stock, EM; Sun, FF; Copeland, LA				Tsan, Jack Y.; Zeber, John E.; Stock, Eileen M.; Sun, Fangfang; Copeland, Laurel A.			Primary Care Mental Health Integration and Treatment Retention Among Iraq and Afghanistan War Veterans	PSYCHOLOGICAL SERVICES			English	Article						integrated care; mental health services; primary care; posttraumatic stress disorder; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; PSYCHIATRIC-DIAGNOSES; RETURNING VETERANS; MEDICAL-CARE; SERVICES; AFFAIRS; PTSD; ACCESS; SYSTEM	Despite the high prevalence of posttraumatic stress disorder (PTSD) and medical comorbidity among veterans from Iraq/Afghanistan (OEF/OIF), keeping these patients engaged in health care is challenging. Primary Care Mental Health Integration (PC-MHI), an initiative in the Veterans Health Administration (VA), sought to improve access to mental health care from within primary care. This study examined the lag between first PC-MHI visit and next mental/medical care visit, if any, and the relationship of PC-MHI with short-term (subsequent year) and long-term (4 years later) use of VA. We identified 2,470 OEF/OIF veterans receiving care during fiscal year 2006 (FY06) in a regional VA health care system. Unconditional survival analysis modeled time to next mental/medical visit and logistic regression modeled short- and long-term care as a function of PC-MHI, demo-graphics, and clinical covariates. Of 181 patients in the PC-MHI program, 60%/ 18% returned for mental/medical care within 1 month, and 82%/74% within 1 year. Sixty-one percent (1,503) were still using the VA in FY09. Short-term mental care was related to prior-year PC-MHI. Consistent correlates of short- and long-term mental/medical care included physical comorbidity and Priority 1 status. Most patients attended mental health appointments subsequent to PC-MHI, and PC-MHI was correlated with mental health treatment retention in adjusted models for our cohort. Need for treatment, notably VA Priority 1 status and physical comorbidity, were the primary correlates of care-seeking. Developing innovative approaches to engaging new veterans in care remains imperative as multiple options will be necessary to meet the needs of these complex patients.	[Tsan, Jack Y.] US Dept Vet Affairs, VISN 17 Ctr Excellence Res Returning War Vet, Waco, TX 76711 USA; [Tsan, Jack Y.] Texas A&M Hlth Sci Ctr, Houston, TX USA		Tsan, JY (corresponding author), US Dept Vet Affairs, VISN 17 Ctr Excellence Res Returning War Vet, 4800 Mem Dr 151C, Waco, TX 76711 USA.	Jack.Tsan@va.gov	Copeland, Laurel A/C-3763-2017	Copeland, Laurel A/0000-0002-9478-0209			Atun R, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-780; Ayalon L, 2007, AM J GERIAT PSYCHIAT, V15, P906, DOI 10.1097/JGP.0b013e318135113e; Batten SV, 2008, J CLIN PSYCHOL, V64, P928, DOI 10.1002/jclp.20513; Blazina C, 2001, PSYCHOTHERAPY, V38, P297, DOI 10.1037/0033-3204.38.3.297; Block R, 2008, PSYCHIAT SERV, V59, P860, DOI 10.1176/ps.2008.59.8.860; Brawer PA, 2010, FAM SYST HEALTH, V28, P175, DOI 10.1037/a0020342; Brown MC, 2011, J NERV MENT DIS, V199, P797, DOI 10.1097/NMD.0b013e31822fc9bf; Butler M, 2011, J AMBUL CARE MANAG, V34, P113, DOI 10.1097/JAC.0b013e31820ef605; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Copeland Laurel A, 2011, Depress Res Treat, V2011, P370962, DOI 10.1155/2011/370962; Copeland LA, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-84; Copeland LA, 2011, J AFFECT DISORDERS, V130, P226, DOI 10.1016/j.jad.2010.10.017; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Druss BG, 2001, ARCH GEN PSYCHIAT, V58, P861, DOI 10.1001/archpsyc.58.9.861; Frayne SM, 2011, J GEN INTERN MED, V26, P33, DOI 10.1007/s11606-010-1497-4; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Gravely AA, 2011, J REHABIL RES DEV, V48, P21, DOI 10.1682/JRRD.2009.08.0116; Harpaz-Rotem I, 2011, PSYCHIAT SERV, V62, P22, DOI 10.1176/ps.62.1.pss6201_0022; Jakupcak M, 2008, J NERV MENT DIS, V196, P425, DOI 10.1097/NMD.0b013e31817108ed; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Krahn DD, 2006, PSYCHIAT SERV, V57, P946, DOI 10.1176/appi.ps.57.7.946; Petersen, 2008, PSYCHOL SERV, V5, P320, DOI [10.1037/a0013719, DOI 10.1037/A0013719]; Pfeiffer PN, 2011, PSYCHIAT SERV, V62, P422, DOI 10.1176/ps.62.4.pss6204_0422; Pomerantz A, 2008, GEN HOSP PSYCHIAT, V30, P546, DOI 10.1016/j.genhosppsych.2008.09.004; Pomerantz AS, 2010, FAM SYST HEALTH, V28, P78, DOI 10.1037/a0020341; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Post EP, 2010, FAM SYST HEALTH, V28, P83, DOI 10.1037/a0020130; Pugh MJV, 2005, EPILEPSIA, V46, P1820, DOI 10.1111/j.1528-1167.2005.00291.x; Reger MA, 2009, J CLIN PSYCHIAT, V70, P1266, DOI 10.4088/JCP.08m04361; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Selim Alfredo J, 2004, J Ambul Care Manage, V27, P281; Shiner B, 2009, MIL MED, V174, P1024, DOI 10.7205/MILMED-D-03-6608; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Spoont MR, 2010, PSYCHIAT SERV, V61, P58, DOI 10.1176/appi.ps.61.1.58; Summerall EL, 2010, PSYCHIAT ANN, V40, P563, DOI 10.3928/00485713-20101022-07; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Watts BV, 2007, QUAL SAF HEALTH CARE, V16, P378, DOI 10.1136/qshc.2007.022418; WIERZBICKI M, 1993, PROF PSYCHOL-RES PR, V24, P190, DOI 10.1037/0735-7028.24.2.190; Worley MJ, 2010, J SUBST ABUSE TREAT, V39, P124, DOI 10.1016/j.jsat.2010.05.009; Yano EM, 2010, J GEN INTERN MED, V25, P56, DOI 10.1007/s11606-009-1116-4; Zeiss AM, 2008, J CLIN PSYCHOL MED S, V15, P73, DOI 10.1007/s10880-008-9100-4; Zivin K, 2010, MED CARE, V48, P843, DOI 10.1097/MLR.0b013e3181e5792b	44	18	18	0	11	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	1541-1559	1939-148X		PSYCHOL SERV	Psychol. Serv.	NOV	2012	9	4			SI		336	348		10.1037/a0028308			13	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	036ZP	WOS:000311071100002	22545824				2022-02-06	
J	Saadat, SMS; Bidabadi, E; Saadat, SNS; Mashouf, M; Salamat, F; Yousefzadeh, S				Saadat, Seyed Mohammad Seyed; Bidabadi, Elham; Saadat, Seyedeh Nazanin Seyed; Mashouf, Mehryar; Salamat, Fatemeh; Yousefzadeh, Shahrokh			Association of persistent hyperglycemia with outcome of severe traumatic brain injury in pediatric population	CHILDS NERVOUS SYSTEM			English	Article						Brain injury; Hyperglycemia; Mortality; Child	SEVERE HEAD-INJURY; PREDICTOR; CHILDREN	Hyperglycemia is a common secondary insult associated with an increased risk of mortality and poor outcome in traumatic brain injury (TBI), but the effect of hyperglycemia on outcomes of severe TBI in children and adolescents is less apparent. The aim of this study was to evaluate the association of hyperglycemia with mortality in pediatric patients with severe TBI. In this cross-sectional study, data of all children and adolescents with severe TBI admitted to Poursina Hospital in Rasht, including age, gender, Glasgow Coma Scale (GCS) upon admission, mortality rate, hospital length of stay, and serial blood glucose during the first three consecutive ICU days following admission, were reviewed from April 2007 to May 2011. After univariate analysis and adjustment for related covariates, logistic regression model was established to determine the association between persistent hyperglycemia and outcome. One-hundred and twenty-two children were included with a median admission GCS of 6 (interquartile range (IQR) 5-7) and a median age of 13 years (IQR 7.75-17). Among them, 91 were boys (74.6 %) and 31 were girls (26.6 %); the overall mortality was 40.2 % (n = 49). Patients who died had a significantly greater blood glucose levels than survivors for the first 3 days of admission (P = 0.003, P < 0.001, P = 0.001, respectively). Moreover, persistent hyperglycemia during the first 3 days of admission had an adjusted odds ratio of 11.11 for mortality (P < 0.001). Early hyperglycemia is associated with poor outcome, and persistent hyperglycemia is a powerful and independent predictor of mortality in children and adolescents with severe TBI.	[Saadat, Seyed Mohammad Seyed; Bidabadi, Elham; Saadat, Seyedeh Nazanin Seyed; Salamat, Fatemeh] Guilan Univ Med Sci, Med Students Res Comm, Rasht 4165855695, Iran; [Mashouf, Mehryar] Arya Hosp, Dept Neurosurg, Rasht, Iran; [Yousefzadeh, Shahrokh] Poursina Hosp, Dept Neurosurg, Rasht, Iran		Bidabadi, E (corresponding author), Guilan Univ Med Sci, Med Students Res Comm, 15-135 Ave Golsar, Rasht 4165855695, Iran.	mashoof@mail.com	Bidabadi, Elham/D-2879-2019	Yousefzadeh-Chabok, Shahrokh/0000-0002-8825-3015; Seyedsaadat, Seyed Mohammad/0000-0002-8219-6144; Bidabadi, Elham/0000-0002-1067-3335; Seyed Saadat, Seyed Mohammad/0000-0001-8188-3455			Asilioglu N, 2011, J PEDIAT-BRAZIL, V87, P325, DOI [10.1590/S0021-75572011000400009, 10.2223/JPED.2097]; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cochran A, 2003, J TRAUMA, V55, P1035, DOI 10.1097/01.TA.0000031175.96507.48; Griesdale DEG, 2009, NEUROCRIT CARE, V11, P311, DOI 10.1007/s12028-009-9249-1; Jeremitsky E, 2005, J TRAUMA, V58, P47, DOI 10.1097/01.TA.0000135158.42242.B1; Kan CH, 2009, MALAYS J MED SCI, V16, P25; Kreutziger J, 2009, J TRAUMA, V67, P704, DOI 10.1097/TA.0b013e3181b22e37; Krug EG, 2000, AM J PUBLIC HEALTH, V90, P523, DOI 10.2105/AJPH.90.4.523; Langlois JA, 2006, TRAUMATIC BRAIN INJU; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Melo JRT, 2010, ACTA NEUROCHIR, V152, P1559, DOI 10.1007/s00701-010-0680-z; PARISH RA, 1988, J TRAUMA, V28, P517, DOI 10.1097/00005373-198804000-00017; Salim A, 2009, AM SURGEON, V75, P25; Melo JRT, 2009, ARQ NEURO-PSIQUIAT, V67, P804, DOI 10.1590/S0004-282X2009000500004	14	18	19	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	OCT	2012	28	10					1773	1777		10.1007/s00381-012-1753-5			5	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	010YW	WOS:000309131400016	22526446				2022-02-06	
J	McIntosh, AS				McIntosh, Andrew S.			Biomechanical considerations in the design of equipment to prevent sports injury	PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART P-JOURNAL OF SPORTS ENGINEERING AND TECHNOLOGY			English	Article						Biomechanics; equipment; sports injury; injury prevention	RANDOMIZED CONTROLLED-TRIAL; RUGBY UNION FOOTBALL; RISK COMPENSATION; HEAD; RECONSTRUCTION; EPIDEMIOLOGY; CONCUSSION; IMPACTS	The international market for sports equipment is enormous. One component of that market is explicitly equipment to prevent injury, and ideally all equipment should enable performance without causing injury. This paper will describe a biomechanical approach to the design of equipment to prevent sports injury. Elements in this approach include understanding and applying: injury risk management methods to set objectives; injury mechanisms; human tolerance to loads; range of sports loads (normal and abnormal); objectives of sport and sports skills; efficacy and effectiveness of current and past equipment; user expectations (usability, mass, aesthetics); standards requirements; setting performance objectives; identifying and testing materials; assessing materials and component testing; prototype testing; final product; and product evaluation and continuous control.	[McIntosh, Andrew S.] Univ New S Wales, Fac Sci, Sydney, NSW 2052, Australia; [McIntosh, Andrew S.] Monash Univ, Australian Ctr Res Sports Injury & Its Prevent AC, Clayton, Vic 3800, Australia		McIntosh, AS (corresponding author), Univ New S Wales, Fac Sci, Sydney, NSW 2052, Australia.	a.mcintosh@unsw.edu.au					[Anonymous], 2005, 145722005 BSIEN; [Anonymous], 2008, 2063 ASNZS; Bahr R, 2005, BRIT J SPORT MED, V39, P324, DOI 10.1136/bjsm.2005.018341; Balendra G, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.038950; Benson BW, 2009, BRIT J SPORT MED, V43, pI56, DOI 10.1136/bjsm.2009.058271; Daly RM, 2001, BRIT J SPORT MED, V35, P8, DOI 10.1136/bjsm.35.1.8; Emery CA, 2010, BRIT J SPORT MED, V44, P555, DOI 10.1136/bjsm.2010.074377; Finch C, 2005, INJURY PREV, V11, P242, DOI 10.1136/ip.2004.006882; Finch CF, 2011, SPORTS MED, V41, P59, DOI 10.2165/11537260-000000000-00000; Finch CF, 2004, SPORTS SAFETY AUSTR; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Greenwald RM, 2008, NEUROSURGERY, V62, P789, DOI 10.1227/01.neu.0000318162.67472.ad; Hagel B, 2004, CLIN J SPORT MED, V14, P193, DOI 10.1097/00042752-200407000-00001; Hootman JM, 2007, J ATHL TRAINING, V42, P311; ISO AN, 2009, 31000 ISO AN ASNZS; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Larkins PA, 2003, SPORTS INJURIES REPO; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; McBain K, 2012, BRIT J SPORT MED, V46, P174, DOI 10.1136/bjsm.2010.081182; McIntosh A, 1995, P 37 STAPP CAR CRASH; McIntosh AS, 2009, MED SCI SPORT EXER, V41, P306, DOI 10.1249/MSS.0b013e3181864bee; McIntosh AS, 2000, BRIT J SPORT MED, V34, P337, DOI 10.1136/bjsm.34.5.337; McIntosh AS, 2005, SOLID MECH APPL, V124, P231; McIntosh AS, 2005, BRIT J SPORT MED, V39, P314, DOI 10.1136/bjsm.2005.018200; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Olsen OE, 2003, SCAND J MED SCI SPOR, V13, P299, DOI 10.1034/j.1600-0838.2003.00329.x; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Prasad P., 1985, SAE TECHNICAL PAPER; Quarrie KL, 2005, BRIT J SPORT MED, V39, P650, DOI 10.1136/bjsm.2004.016022; Rowson S, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3130454; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Verhagen EALM, 2010, BRIT J SPORT MED, V44, P1082, DOI 10.1136/bjsm.2010.076406	33	18	19	2	43	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1754-3371			P I MECH ENG P-J SPO	Proc. Inst. Mech. Eng. Part P-J. Sport. Eng. Technol.	SEP-DEC	2012	226	P3-4			SI		193	199		10.1177/1754337111431024			7	Engineering, Mechanical; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Sport Sciences	999NH	WOS:000308320000006					2022-02-06	
J	Orringer, DA; Vago, DR; Golby, AJ				Orringer, Daniel A.; Vago, David R.; Golby, Alexandra J.			Clinical Applications and Future Directions of Functional MRI	SEMINARS IN NEUROLOGY			English	Article						functional magnetic resonance imaging (fMRI); blood oxygenation level dependent (BOLD); tractography; tumor mapping; language lateralization; traumatic brain injury (TBI); epilepsy surgery	MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; TEMPORAL-LOBE EPILEPSY; SUBGENUAL PREFRONTAL CORTEX; ALZHEIMERS-DISEASE; MAJOR DEPRESSION; WORKING-MEMORY; PREOPERATIVE ASSESSMENT; EEG-FMRI; CHOLINERGIC ENHANCEMENT	First described for use in mapping the human visual cortex in 1991, functional magnetic resonance imaging (fMRI) is based on blood-oxygen level dependent (BOLD) changes in cortical regions that occur during specific tasks. Typically, an overabundance of oxygenated (arterial) blood is supplied during activation of brain areas. Consequently, the venous outflow from the activated areas contains a higher concentration of oxyhemoglobin, which changes the paramagnetic properties of the tissue that can be detected during a T2-star acquisition. fMRI data can be acquired in response to specific tasks or in the resting state. fMRI has been widely applied to studying physiologic and pathophysiologic diseases of the brain. This review will discuss the most common current clinical applications of fMRI as well as emerging directions.	[Orringer, Daniel A.; Vago, David R.; Golby, Alexandra J.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Orringer, Daniel A.; Vago, David R.; Golby, Alexandra J.] Harvard Univ, Sch Med, Boston, MA USA		Golby, AJ (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	agolby@partners.org	Vago, David/P-5264-2014; Vago, David/I-4341-2019	Vago, David/0000-0002-6269-9027; Vago, David/0000-0002-6269-9027; Orringer, Daniel/0000-0001-6427-8376	NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R25CA089017] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [P41RR019703, U41RR019703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41EB015898] Funding Source: NIH RePORTER; NCI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R25 CA089017] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [U41 RR019703] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [P41 EB015898] Funding Source: Medline		Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Atlas SW, 1996, NEUROSURGERY, V38, P329, DOI 10.1097/00006123-199602000-00019; Beauregard M, 1998, NEUROREPORT, V9, P3253, DOI 10.1097/00001756-199810050-00022; BELLIVEAU JW, 1991, SCIENCE, V254, P716, DOI 10.1126/science.1948051; Berman MG, 2011, SOC COGN AFFECT NEUR, V6, P548, DOI 10.1093/scan/nsq080; Bewernick BH, 2010, BIOL PSYCHIAT, V67, P110, DOI 10.1016/j.biopsych.2009.09.013; Binder JR, 2008, EPILEPSIA, V49, P1377, DOI 10.1111/j.1528-1167.2008.01625.x; Binder JR, 2011, EPILEPSY BEHAV, V20, P214, DOI 10.1016/j.yebeh.2010.08.004; Bizzi A, 2008, RADIOLOGY, V248, P579, DOI 10.1148/radiol.2482071214; Blomstedt P, 2011, ACTA PSYCHIAT SCAND, V123, P4, DOI 10.1111/j.1600-0447.2010.01625.x; Bremner J Douglas, 2002, CNS Spectr, V7, P129; BREMNER JD, 2002, CNS SPECTRUMS, V7, P135; Celone KA, 2006, J NEUROSCI, V26, P10222, DOI 10.1523/JNEUROSCI.2250-06.2006; Chen CM, 2008, RADIOLOGY, V248, P971, DOI 10.1148/radiol.2483071280; Cheung MC, 2009, J NEUROL NEUROSUR PS, V80, P1099, DOI 10.1136/jnnp.2009.173161; Chhatwal JP, 2012, J ALZHEIMERS DIS, V31, pS155, DOI 10.3233/JAD-2012-120730; Damasio A., 1994, DESCARTES ERROR EMOT; Dickerson BC, 2004, ANN NEUROL, V56, P27, DOI 10.1002/ana.20163; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dickerson BC, 2008, NEUROPSYCHOLOGIA, V46, P1624, DOI 10.1016/j.neuropsychologia.2007.11.030; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; DREVETS WC, 2004, NEUROBIOLOGY MENTAL, P461; Dupont S, 2010, RADIOLOGY, V255, P128, DOI 10.1148/radiol.09091079; Epstein J, 2006, AM J PSYCHIAT, V163, P1784, DOI 10.1176/appi.ajp.163.10.1784; Frings L, 2008, EPILEPSY RES, V78, P161, DOI 10.1016/j.eplepsyres.2007.11.006; Fu CHY, 2008, BIOL PSYCHIAT, V64, P505, DOI 10.1016/j.biopsych.2008.04.033; Gasco J, 2009, STEREOT FUNCT NEUROS, V87, P395, DOI 10.1159/000258080; Gasser T, 2005, NEUROIMAGE, V26, P685, DOI 10.1016/j.neuroimage.2005.02.022; Gasser T, 2011, ACTA NEUROCHIR SUPPL, V109, P61, DOI 10.1007/978-3-211-99651-5_10; George MS, 1997, J NEUROPSYCH CLIN N, V9, P55; GEORGE MS, 1994, BIOL PSYCHIAT, V35, P647, DOI 10.1016/0006-3223(94)90776-5; Giussani C, 2010, NEUROSURGERY, V66, P113, DOI 10.1227/01.NEU.0000360392.15450.C9; Golby A, 2005, BRAIN, V128, P773, DOI 10.1093/brain/awh400; Goldapple K, 2004, ARCH GEN PSYCHIAT, V61, P34, DOI 10.1001/archpsyc.61.1.34; Grady CL, 2003, J NEUROSCI, V23, P986, DOI 10.1523/jneurosci.23-03-00986.2003; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Gron G, 2002, ANN NEUROL, V51, P491, DOI 10.1002/ana.10157; Hall WA, 2005, SURG NEUROL, V64, P20, DOI 10.1016/j.surneu.2004.08.099; Hall Walter A, 2009, Top Magn Reson Imaging, V19, P205, DOI 10.1097/RMR.0b013e3181934a09; Hamalainen A, 2007, NEUROBIOL AGING, V28, P1889, DOI 10.1016/j.neurobiolaging.2006.08.008; Hasler G, 2004, NEUROPSYCHOPHARMACOL, V29, P1765, DOI 10.1038/sj.npp.1300506; Heller AS, 2009, P NATL ACAD SCI USA, V106, P22445, DOI 10.1073/pnas.0910651106; Holodny AI, 1999, AM J NEURORADIOL, V20, P609; Hou BL, 2006, NEUROIMAGE, V32, P489, DOI 10.1016/j.neuroimage.2006.04.188; Janszky J, 2006, EPILEPSIA, V47, P921, DOI 10.1111/j.1528-1167.2006.00514.x; Jimenez De La Pena M, 2012, RADIOLOGIA; Johnson SC, 2006, NEUROBIOL AGING, V27, P1604, DOI 10.1016/j.neurobiolaging.2005.09.017; Kapsalakis IZ, 2012, RADIOL RES PRACT, V2012, DOI 10.1155/2012/727810; Kennedy SH, 2001, AM J PSYCHIAT, V158, P899, DOI 10.1176/appi.ajp.158.987.899; Kim MJJ, 2005, AM J NEURORADIOL, V26, P1980; Koylu B, 2008, BRAIN RES, V1223, P73, DOI 10.1016/j.brainres.2008.05.075; Krings T, 2001, J NEUROL NEUROSUR PS, V70, P749, DOI 10.1136/jnnp.70.6.749; Lee TMC, 2002, EPILEPSIA, V43, P283, DOI 10.1046/j.1528-1157.2002.09901.x; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Ludemann L, 2006, J MAGN RESON IMAGING, V23, P435, DOI 10.1002/jmri.20530; Machulda MM, 2003, NEUROLOGY, V61, P500, DOI 10.1212/01.WNL.0000079052.01016.78; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1997, J NEUROPSYCH CLIN N, V9, P471; Mayberg HS, 1997, NEUROREPORT, V8, P1057, DOI 10.1097/00001756-199703030-00048; Mayer AR, 2009, HUM BRAIN MAPP, V30, P4152, DOI 10.1002/hbm.20836; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McAllister TW, 1999, NEUROLOGY, V53, P1300, DOI 10.1212/WNL.53.6.1300; Moeller F, 2009, NEUROLOGY, V73, P2023, DOI 10.1212/WNL.0b013e3181c55d17; Nimsky C, 2006, NEUROL RES, V28, P482, DOI 10.1179/016164106X115125; Nimsky C, 2011, NEUROSURG CLIN N AM, V22, P269, DOI 10.1016/j.nec.2010.11.005; Ota T, 2009, BRIT J NEUROSURG, V23, P406, DOI 10.1080/02688690902838815; Petrella JR, 2011, NEUROLOGY, V76, P511, DOI 10.1212/WNL.0b013e31820af94e; Petrella JR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001104; Phillips ML, 2003, BIOL PSYCHIAT, V54, P504, DOI 10.1016/S0006-3223(03)00168-9; Powell HWR, 2008, J NEUROL NEUROSUR PS, V79, P686, DOI 10.1136/jnnp.2007.115139; Price CJ, 2006, J MAGN RESON IMAGING, V23, P816, DOI 10.1002/jmri.20580; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Ries ML, 2008, J AM GERIATR SOC, V56, P920, DOI 10.1111/j.1532-5415.2008.01684.x; Roessler K, 2005, J NEUROL NEUROSUR PS, V76, P1152, DOI 10.1136/jnnp.2004.050286; Roux FE, 2003, NEUROSURGERY, V53, P1342, DOI 10.1227/01.NEU.0000093424.71086.8F; Roux FE, 2003, NEUROSURGERY, V52, P1335, DOI 10.1227/01.NEU.0000064803.05077.40; Sabsevitz DS, 2003, NEUROLOGY, V60, P1788, DOI 10.1212/01.WNL.0000068022.05644.01; Sakatani K, 2003, ACT NEUR S, V87, P59; Salek-Haddadi A, 2006, BRAIN RES, V1088, P148, DOI 10.1016/j.brainres.2006.02.098; Saykin AJ, 2004, BRAIN, V127, P1574, DOI 10.1093/brain/awh177; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schwindt GC, 2009, NEUROIMAGE, V45, P181, DOI 10.1016/j.neuroimage.2008.11.024; Shanks MF, 2007, MAGN RESON IMAGING, V25, P848, DOI 10.1016/j.mri.2007.02.005; Sheline YI, 2003, BIOL PSYCHIAT, V54, P338, DOI 10.1016/S0006-3223(03)00347-0; Shinoura N, 2007, STEREOT FUNCT NEUROS, V85, P99, DOI 10.1159/000098524; Signorelli F, 2003, MINIM INVAS NEUROSUR, V46, P265; Signorelli F, 2001, NEUROL SCI, V22, P3, DOI 10.1007/s100720170029; Small SA, 1999, ANN NEUROL, V45, P466, DOI 10.1002/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Sperling R, 2003, NEUROIMAGE, V20, P1400, DOI 10.1016/S1053-8119(03)00391-4; Sperling RA, 2003, J NEUROL NEUROSUR PS, V74, P44, DOI 10.1136/jnnp.74.1.44; Spiers HJ, 2001, BRAIN, V124, P2476, DOI 10.1093/brain/124.12.2476; Stulemeijer M, 2010, J NEUROTRAUM, V27, P1585, DOI 10.1089/neu.2010.1298; Suarez RO, 2009, EPILEPSY BEHAV, V16, P288, DOI 10.1016/j.yebeh.2009.07.034; Swanson SJ, 2007, NEUROPSYCHOL REV, V17, P491, DOI 10.1007/s11065-007-9050-x; Ulmer JL, 2003, AM J NEURORADIOL, V24, P213; Vago DR, 2011, NEUROSURG CLIN N AM, V22, P279, DOI 10.1016/j.nec.2011.01.003; Wagner K, 2012, J NEUROL NEUROSUR PS, V83, P503, DOI 10.1136/jnnp-2011-300417; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wierenga CE, 2011, NEUROPSYCHOLOGIA, V49, P392, DOI 10.1016/j.neuropsychologia.2010.12.011; Wilke M, 2011, HUM BRAIN MAPP, V32, P1882, DOI 10.1002/hbm.21156; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Zijlmans M, 2007, BRAIN, V130, P2343, DOI 10.1093/brain/awm141	109	18	18	0	30	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	0271-8235	1098-9021		SEMIN NEUROL	Semin. Neurol.	SEP	2012	32	4					466	475		10.1055/s-0032-1331816			10	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	077AD	WOS:000313999400014	23361489	Green Accepted			2022-02-06	
J	Vidal, PG; Goodman, AM; Colin, A; Leddy, JJ; Grady, MF				Vidal, Paul G.; Goodman, Arlene M.; Colin, Amy; Leddy, John J.; Grady, Matthew F.			Rehabilitation Strategies for Prolonged Recovery in Pediatric and Adolescent Concussion	PEDIATRIC ANNALS			English	Article							SPORTS-RELATED CONCUSSION; CEREBRAL CONCUSSION; POSTURAL CONTROL; EXERCISE; HEADACHE		[Vidal, Paul G.] Specialized Phys Therapy LLC, Cherry Hill, NJ 08003 USA; [Goodman, Arlene M.] Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA USA; [Goodman, Arlene M.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA USA; [Colin, Amy] Childrens Hosp Philadelphia, Dept Speech Language Pathol, Philadelphia, PA USA; [Leddy, John J.] SUNY Buffalo, UB Orthopaed & Sports Med, Buffalo, NY 14260 USA; [Grady, Matthew F.] Childrens Hosp Philadelphia, Philadelphia, PA USA; [Grady, Matthew F.] Univ Penn, Div Pediat Orthoped & Sports Med, Dept Surg, Philadelphia, PA 19104 USA; [Grady, Matthew F.] Univ Penn, Div Pediat Orthoped & Sports Med, Dept Pediat, Philadelphia, PA 19104 USA		Vidal, PG (corresponding author), Specialized Phys Therapy LLC, 1919 Greentree Rd, Cherry Hill, NJ 08003 USA.	specializedpt@verizon.net					Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Children's Hospital of Philadelphia, CONC CAR KIDS MINDS; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gottshall Kim R, 2005, Int Tinnitus J, V11, P81; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Herdman SJ, 2003, ARCH OTOLARYNGOL, V129, P819, DOI 10.1001/archotol.129.8.819; Herdman SJ, 2007, VESTIBULAR REHABILIT; Jull G, 2002, SPINE, V27, P1835, DOI 10.1097/00007632-200209010-00004; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2011, CLIN J SPORT MED, V21, P89, DOI 10.1097/JSM.0b013e3181fdc721; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; Register-Mihalik JK, 2008, NEUROSURGERY, V63, P76, DOI 10.1227/01.NEU.0000335073.39728.CE; Scheiman M, 2002, OPTOMETRY VISION SCI, V79, P151, DOI 10.1097/00006324-200203000-00009; Working Group on Cognitive-Communication Disorders of ASHA's Special Interest Division I Language Learning and Education; and Division 2 Neurophysiology and Neurogenic Speech and Language Disorders, ROL SPEECH LANG PATH; Wrisley DM, 2000, J ORTHOP SPORT PHYS, V30, P755, DOI 10.2519/jospt.2000.30.12.755; Yeates KO, 2010, J INT NEUROPSYCH SOC, V16, P953, DOI 10.1017/S1355617710000986	20	18	18	0	17	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086 USA	0090-4481	1938-2359		PEDIATR ANN	Pediatr. Annu.	SEP	2012	41	9					E186	E191		10.3928/00904481-20120827-10			6	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	082NM	WOS:000314398700003	22953976				2022-02-06	
J	Johnson, JE; Turkstra, LS				Johnson, Jacqueline E.; Turkstra, Lyn S.			Inference in conversation of adults with traumatic brain injury	BRAIN INJURY			English	Article						Inference; communication; implicature; language; pragmatics; brain injury	COMPREHENSION; LANGUAGE; ADOLESCENTS; ABILITY; SKILLS	Objective: To examine elaborative and automatic linguistic inferences in conversations between adults with and without traumatic brain injury (TBI) and their frequent communication partners. Design and methods: Participants with TBI were four female and three male adults and seven female communication partners. Comparison peers were two males and five females and one male and six female communication partners. Each participant completed 20-minute video-recorded conversation with his or her frequent communication partner. Conversations were transcribed, implicatures were identified and the percentage of correct inferences was determined. Inferences were categorized as automatic or elaborative and as missed or understood. Results: Participants in both groups made significantly more errors on elaborative inferences than automatic inferences and participants with TBI made significantly more elaborative inference errors than comparison peers. There was no significant between-groups difference in error rates for automatic inferences. Conclusions: Individuals with TBI may show impairments in social language skills not only on standardized tests but also in everyday conversations. This may contribute to everyday partners' perceptions of social communication problems in adults with TBI.	[Turkstra, Lyn S.] Univ Wisconsin, Dept Communicat Disorders, Madison, WI 53706 USA		Turkstra, LS (corresponding author), Univ Wisconsin, Dept Communicat Disorders, Madison, WI 53706 USA.	lsturkstra@wisc.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921			Angeleri R, 2008, BRAIN LANG, V107, P229, DOI 10.1016/j.bandl.2008.01.002; Bergemalm PO, 2005, INT J AUDIOL, V44, P39, DOI 10.1080/14992020400022546; Brownell H, 1998, RIGHT HEMISPHERE LANGUAGE COMPREHENSION, P309; Colvin C.Randall., 1997, EMPATHIC ACCURACY, P169; Dennis M, 2001, J AUTISM DEV DISORD, V31, P47, DOI 10.1023/A:1005661613288; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Ferstl EC, 2002, NEUROPSYCHOLOGY, V16, P292, DOI 10.1037//0894-4105.16.3.292; Grice HP, 1975, SPEECH ACTS, P17; Letts C, 2001, INT J LANG COMM DIS, V36, P307; MacWhinney B., 2008, CHILDES PROJECT TOOL, V3rd; McDonald, 2000, METAPHOR SYMBOL, V15, P85, DOI DOI 10.1080/10926488.2000.9678866; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; MCDONALD S, 1992, APPL PSYCHOLINGUIST, V13, P295, DOI 10.1017/S0142716400005658; McDonald S, 1999, BRAIN LANG, V68, P486, DOI 10.1006/brln.1999.2124; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; MILTON SB, 1984, CLIN APHASIOLOGY C P, P114; Moran C, 2005, BRAIN INJURY, V19, P743, DOI 10.1080/02699050500110199; Osterhout L., 1990, PSYCHOL LEARN MOTIV, V25, P17, DOI DOI 10.1016/S0079-7421(08)60246-7; STINSON L, 1992, J PERS SOC PSYCHOL, V62, P787, DOI 10.1037/0022-3514.62.5.787; Togher L., 1999, COMMUNICATION DISORD, P1; Tompkins CA, 2009, APHASIOLOGY, V23, P1016, DOI 10.1080/02687030802588858; Turkstra LS, 1996, BRAIN INJURY, V10, P329, DOI 10.1080/026990596124359; Virtue S, 2006, MEM COGNITION, V34, P1341, DOI 10.3758/BF03193276	24	18	18	0	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	AUG	2012	26	9					1118	1126		10.3109/02699052.2012.666370			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	971GI	WOS:000306191400009	22642382				2022-02-06	
J	Pielmeier, U; Rousing, ML; Andreassen, S; Nielsen, BS; Haure, P				Pielmeier, Ulrike; Rousing, Mark Lillelund; Andreassen, Steen; Nielsen, Birgitte Steenfeldt; Haure, Pernille			Decision support for optimized blood glucose control and nutrition in a neurotrauma intensive care unit: preliminary results of clinical advice and prediction accuracy of the Glucosafe system	JOURNAL OF CLINICAL MONITORING AND COMPUTING			English	Article						Hyperglycemia; Blood glucose; Decision support; Nutrition; Insulin therapy; Critical care; Prediction error	GLYCEMIC CONTROL; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; CRITICAL ILLNESS; ABSORPTION; SECRETION; INDIVIDUALS; THERAPY; SEPSIS; HUMANS	Assessment of glycemic control with model-based decision support ("Glucosafe") in neurotrauma intensive care patients in an ongoing randomized controlled trial with a blood glucose (BG) target of 5-8 mmol/L. Assessment of BG prediction accuracy of the model and assessment of the effect that two potential model extensions would have on prediction accuracy in this trial. In the intervention group insulin infusion rates and nutrition are varied based on Glucosafe's decision support. In the control group, the caloric target is 25-30 kcal/kg per day and insulin is regulated according to department rules. BG concentrations, insulin infusion rates, and feed rates are compared from the data of 12 consecutive patients. BG measurements are predicted retrospectively and the mean relative prediction error is calculated using (1) the current model from the trial, (2) the current model modified by using a BG-dependent variable endogenous insulin appearance rate, (3) the current model modified by a patient-specific carbohydrate absorption factor. BG control was improved by Glucosafe. 76 % of BG measurements in Glucosafe patients were in the 5-8 mmol/L band (Controls: 51 %). BG means (log-normal) +/- A SD were 7.0 +/- A 1.19 mmol/L in Glucosafe patients compared to 8.0 +/- A 1.24 mmol/L in controls (P = 0.05). Mean caloric intake was 93.5 +/- A 15 % of resting energy expenditure in Glucosafe patients (Controls: 129 +/- A 29 %). The BG-dependent variable insulin appearance rate had no measurable effect on prediction accuracy. The patient-specific carbohydrate absorption factor improved prediction accuracy significantly (P = 0.001). Glucosafe advice reduces hyperglycemia in neurotrauma intensive care patients. Further parameterization can improve model prediction accuracy.	[Pielmeier, Ulrike; Rousing, Mark Lillelund; Andreassen, Steen] Aalborg Univ, Ctr Model Based Med Decis Support, DK-9220 Aalborg, Denmark; [Nielsen, Birgitte Steenfeldt; Haure, Pernille] Aalborg Hosp, Neuroorthotrauma Intens Care Unit, Aalborg, Denmark		Pielmeier, U (corresponding author), Aalborg Univ, Ctr Model Based Med Decis Support, Fredrik Bajers Vej 7, DK-9220 Aalborg, Denmark.	upiel@hst.aau.dk; mlr@hst.aau.dk; sa@hst.aau.dk		Andreassen, Steen/0000-0001-5379-7373; Pielmeier, Ulrike/0000-0002-5987-8331			Casaer MP, 2011, NEW ENGL J MED, V365, P506, DOI 10.1056/NEJMoa1102662; Chapman MJ, 2009, CRIT CARE, V13, DOI 10.1186/cc8021; Chase JG, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-11; Dalla Man C, 2005, DIABETES, V54, P3265, DOI 10.2337/diabetes.54.11.3265; Dalla Man C, 2004, AM J PHYSIOL-ENDOC M, V287, pE637, DOI 10.1152/ajpendo.00319.2003; Deane AM, 2011, CRIT CARE MED, V39, P1282, DOI 10.1097/CCM.0b013e31820ee21f; Ellger B, 2008, ANAESTHESIST, V57, P43, DOI 10.1007/s00101-007-1285-7; Gale SC, 2007, AM SURGEON, V73, P454; Kalfon P, 2008, CRIT CARE, V12, DOI 10.1186/cc6915; Krishnan JA, 2003, CHEST, V124, P297, DOI 10.1378/chest.124.1.297; Kronenberg HM, 2008, WILLIAMS TXB ENDOCRI, P1348; Kuo P, 2010, J CLIN ENDOCR METAB, V95, P3893, DOI 10.1210/jc.2009-2514; Marik PE, 2010, CHEST, V137, P544, DOI 10.1378/chest.09-1737; Mehta RL, 2007, J AM SOC NEPHROL, V18, P2623, DOI 10.1681/ASN.2007010109; Meier JJ, 2005, DIABETES, V54, P1649, DOI 10.2337/diabetes.54.6.1649; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Pielmeier U., 2010, UKACC INT C CONTR CO, P839; Pielmeier U, 2010, IFAC P SERIES, P67; Pielmeier U, 2010, J CRIT CARE, V25, P97, DOI 10.1016/j.jcrc.2009.10.003; Pielmeier U, 2010, COMPUT METH PROG BIO, V97, P211, DOI 10.1016/j.cmpb.2009.06.004; Rady MY, 2005, MAYO CLIN PROC, V80, P1558, DOI 10.4065/80.12.1558; SUNDERLAND PM, 1992, NEUROSURGERY, V31, P246, DOI 10.1227/00006123-199208000-00009; Thompson B Taylor, 2008, J Diabetes Sci Technol, V2, P357; THORSTEINSSON B, 1990, DAN MED BULL, V37, P143; VANCAUTER E, 1992, DIABETES, V41, P368, DOI 10.2337/diabetes.41.3.368; Waeschle RM, 2008, CRIT CARE, V12, DOI 10.1186/cc7097; Wallia A, 2011, ENDOCR PRACT, V17, P546, DOI 10.4158/EP10343.OR; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964	28	18	18	0	6	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1387-1307			J CLIN MONIT COMPUT	J. Clin. Monitor. Comp.	AUG	2012	26	4					319	328		10.1007/s10877-012-9364-y			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	970KZ	WOS:000306128800009	22581038				2022-02-06	
J	Byard, RW; Gabrielian, L; Helps, SC; Thornton, E; Vink, R				Byard, Roger W.; Gabrielian, Levon; Helps, Stephen C.; Thornton, Emma; Vink, Robert			Further Investigations into the Speed of Cerebral Swelling Following Blunt Cranial Trauma	JOURNAL OF FORENSIC SCIENCES			English	Article						forensic science; traumatic brain injury; intracranial pressure; blunt craniocerebral trauma; lucid interval; impact; shaking	SHAKEN-BABY SYNDROME; BRAIN-INJURY; INTRACRANIAL-PRESSURE; HEAD-INJURY; MODEL; EDEMA; SHEEP; RATS	An anesthetized sheep model of traumatic brain injury (TBI) has been developed to assess early changes in intracranial pressure (ICP) following closed head injury. Immediately after TBI, a transient (<10 min) hypertensive response occurred, followed by significant and prolonged systemic hypotension. ICP demonstrated a biphasic response, being seven times baseline values of 8 +/- 2 mm Hg 10 min after injury, decreasing to 25 +/- 2 mm Hg by 30 min, and then increasing to values exceeding 30 mm Hg by 4 h postinjury. ICP was always significantly higher than baseline values, which combined with hypotension, reduced cerebral perfusion pressure to less than 60% of normal. This early and sustained increase in ICP after craniocerebral trauma acutely alters cerebral perfusion pressure and brain oxygenation and provides a potential pathophysiological explanation for immediate clinical manifestations in humans following significant TBI.	[Byard, Roger W.; Gabrielian, Levon; Helps, Stephen C.; Thornton, Emma; Vink, Robert] Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Adelaide, SA 5005, Australia		Byard, RW (corresponding author), Univ Adelaide, Sch Med Sci, Adelaide Ctr Neurosci Res, Frome Rd, Adelaide, SA 5005, Australia.	roger.byard@adelaide.edu.au	Vink, Robert/J-7351-2012; Vink, Robert/S-5616-2019	Vink, Robert/0000-0002-4885-0667; Vink, Robert/0000-0002-4885-0667; Byard, Roger/0000-0002-0524-5942	Neurosurgical Research Foundation (Australia); National Health and Medical Research Council of AustraliaNational Health and Medical Research Council of Australia	Funded, in part, by the Neurosurgical Research Foundation (Australia) and by a grant from the National Health and Medical Research Council of Australia.	Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bull JW, 1969, P ROY SOC MED, V12, P1301; Byard Roger W, 2009, Leg Med (Tokyo), V11 Suppl 1, pS128, DOI 10.1016/j.legalmed.2009.02.001; Byard RW, 2010, SUDDEN DEATH YOUNG; Chadwick DL, 1998, PEDIATRICS, V101, P321, DOI 10.1542/peds.101.2.321; Denton S, 2003, AM J FOREN MED PATH, V24, P371, DOI 10.1097/01.paf.0000097851.18478.16; Duhaime AC, 1998, NEW ENGL J MED, V338, P1822, DOI 10.1056/NEJM199806183382507; Engelborghs K, 1998, J NEUROSURG, V89, P796, DOI 10.3171/jns.1998.89.5.0796; HUMPHREYS RP, 1990, CHILD NERV SYST, V6, P139, DOI 10.1007/BF00308490; Krous Henry F, 2005, Forensic Sci Med Pathol, V1, P9, DOI 10.1385/FSMP:1:1:009; Lewis SB, 1996, J NEUROTRAUM, V13, P505, DOI 10.1089/neu.1996.13.505; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; O'Connor CA, 2006, ACTA NEUROCHIR SUPPL, V96, P121; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; Plunkett J, 2001, AM J FOREN MED PATH, V22, P1, DOI 10.1097/00000433-200103000-00001; Treggiari MM, 2007, NEUROCRIT CARE, V6, P104, DOI 10.1007/s12028-007-0012-1; Van den Heuvel C, 2004, J NEUROTRAUM, V21, P1562, DOI 10.1089/0897715042441783; Vink R, 2008, ACTA NEUROCHIR SUPPL, V102, P189, DOI 10.1007/978-3-211-85578-2_37	19	18	18	0	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-1198			J FORENSIC SCI	J. Forensic Sci.	JUL	2012	57	4					973	975		10.1111/j.1556-4029.2012.02109.x			3	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	967HE	WOS:000305896700016	22372694				2022-02-06	
J	Kung, WM; Lin, FH; Hsiao, SH; Chiu, WT; Chyau, CC; Lu, SH; Hwang, B; Lee, JH; Lin, MS				Kung, Woon-Man; Lin, Feng-Huei; Hsiao, Sheng-Huang; Chiu, Wen-Ta; Chyau, Charng-Cherng; Lu, Shing-Hwa; Hwang, Betau; Lee, Jia-Hua; Lin, Muh-Shi			New Reconstructive Technologies after Decompressive Craniectomy in Traumatic Brain Injury: The Role of Three-Dimensional Titanium Mesh	JOURNAL OF NEUROTRAUMA			English	Article						cosmesis; decompressive craniectomy; head injury; quality of life; reconstruction; three-dimensional titanium mesh	HYDROXYAPATITE CEMENT; CRANIOFACIAL SURGERY; SKULL DEFECTS; CRANIOPLASTY; COMPLICATIONS; EXPERIENCE; CHILDREN; REPAIR; BONE	Functional and aesthetic reconstruction after wide decompressive craniectomy directly correlates with subsequent quality of life. Advancements in the development of biomaterials have now made three-dimensional (3-D) titanium mesh a new option for the repair of skull defects after craniectomy. The purpose of this study was to review aesthetic and surgical outcomes and complications of patients who had skull defects repaired with 3-D titanium mesh. The records of 40 adult patients (31 unilateral craniectomies and 9 bilateral craniectomies) who underwent a computer-assisted designed titanium mesh implant at a university hospital from January 2008 to January 2010 were retrospectively reviewed. Aesthetic outcomes, cranial nerve V and VII function, and complications (hardware extrusions, meningitis, osteomyelitis, brain abscess, and pneumocephalus) were evaluated. The craniofacial symmetry, implant stability, and functional outcomes were excellent for all patients. No patients had trigeminal or facial dysfunction. All had excellent cosmetic results as measured by post-reduction radiographs and personal and family perceptions of the forehead contour. Two patients had delayed wound healing and subsequent subclinical wound infections, which resolved after treatment with antibiotics for 2 weeks. Craniofacial skeletal reconstruction with 3-D titanium mesh results in excellent forehead contour and cosmesis, and subsequently a better quality of life with few complications. Titanium mesh reconstruction offers a favorable alternative to other graft materials in the repair of large skull defects.	[Kung, Woon-Man; Lin, Feng-Huei] Natl Taiwan Univ, Coll Med, Inst Biomed Engn, Taipei 10764, Taiwan; [Kung, Woon-Man; Lin, Feng-Huei] Natl Taiwan Univ, Coll Engn, Taipei 10764, Taiwan; [Kung, Woon-Man; Chyau, Charng-Cherng] Hungkuang Univ, Coll Med & Nursing, Dept Biotechnol, Taichung, Taiwan; [Kung, Woon-Man] Chang Bing Show Chwan Mem Hosp, Dept Neurosurg, Changhua, Taiwan; [Lin, Feng-Huei] Natl Hlth Res Inst, Div Med Engn, Miaoli, Taiwan; [Hsiao, Sheng-Huang; Lee, Jia-Hua] Taipei City Hosp, Renai Branch, Dept Neurosurg, Taipei, Taiwan; [Lu, Shing-Hwa] Dept Urol, Taipei, Taiwan; [Hwang, Betau] Dept Pediat, Taipei, Taiwan; Taipei City Hosp, Zhong Xiao Branch, Taipei, Taiwan; [Lin, Muh-Shi] New Taipei City Hosp, Dept Neurosurg, Taipei 115, Taiwan; [Lu, Shing-Hwa; Lin, Muh-Shi] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Surg, Taipei 112, Taiwan; [Chiu, Wen-Ta; Lin, Muh-Shi] Taipei Med Univ, Coll Med, Sch Med, Dept Surg, Taipei, Taiwan; [Hwang, Betau] Natl Yang Ming Univ, Sch Med, Fac Med, Dept Pediat, Taipei 112, Taiwan		Lin, MS (corresponding author), New Taipei City Hosp, Dept Neurosurg, 87 Tongde Rd, Taipei 115, Taiwan.	neurosurgery2005@yahoo.com.tw	Lin, Feng-Huei/E-3970-2010; Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/U-7004-2019; Kung, Woon-Man/Q-3012-2019	Lin, 林牧熹 醫學博士 法學碩士 Muh-Shi/0000-0002-9798-8160; Kung, Woon-Man/0000-0001-8311-2902			Adamo MA, 2009, J NEUROSURG-PEDIATR, V3, P334, DOI 10.3171/2008.12.PEDS08310; Agner C, 1997, CRIT REV NEUROSURG, V7, P365, DOI 10.1007/s003290050048; Bandyopadhyay T K, 2005, Med J Armed Forces India, V61, P36, DOI 10.1016/S0377-1237(05)80116-9; Cabraja M, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS091; Chang S., 2003, BARROW Q, V19, P9; Chang V, 2010, J NEUROSURG, V112, P1120, DOI 10.3171/2009.6.JNS09133; Durham SR, 2003, NEUROSURGERY, V52, P842, DOI 10.1227/01.NEU.0000054220.01290.8E; Eufinger H, 1998, PLAST RECONSTR SURG, V102, P300, DOI 10.1097/00006534-199808000-00002; Gooch MR, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.3.FOCUS0962; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146, DOI 10.1177/019459988509300202; Janecka IP, 2000, ARCH OTOLARYNGOL, V126, P396, DOI 10.1001/archotol.126.3.396; Ju DT, 2008, ACTA NEUROCHIR SUPPL, V101, P169; KAISER A, 1993, EUR J PEDIATR SURG, V3, P236, DOI 10.1055/s-2008-1063551; Kuttenberger JJ, 2001, J CRANIO MAXILL SURG, V29, P75, DOI 10.1054/jcms.2001.0197; Lakhani RS, 2001, ARCH OTOLARYNGOL, V127, P665, DOI 10.1001/archotol.127.6.665; Lee JW, 2011, J KOREAN NEUROSURG S, V50, P231, DOI 10.3340/jkns.2011.50.3.231; Magni G, 2007, J NEUROSURG ANESTH, V19, P229, DOI 10.1097/ANA.0b013e31806e5f5a; MALIS LI, 1989, NEUROSURGERY, V25, P351, DOI 10.1227/00006123-198909000-00005; Marbacher S, 2008, J CRANIOFAC SURG, V19, P490, DOI 10.1097/SCS.0b013e3181534ae8; Marchac D, 2008, J PLAST RECONSTR AES, V61, P744, DOI 10.1016/j.bjps.2007.10.055; Matic DB, 2004, J CRANIOFAC SURG, V15, P415, DOI 10.1097/00001665-200405000-00012; PSILLAKIS JM, 1979, PLAST RECONSTR SURG, V64, P827, DOI 10.1097/00006534-197912000-00023; Schirmer CM, 2008, NEUROCRIT CARE, V8, P456, DOI 10.1007/s12028-008-9082-y; Scholz M, 2007, J CRANIO MAXILL SURG, V35, P388, DOI 10.1016/j.jcms.2007.06.006; Seyithanoglu H, 2006, J INSTANB FAC MED, V69, P44; Staffa G, 2007, ACTA NEUROCHIR, V149, P161, DOI 10.1007/s00701-006-1078-9; Timmons RL, 1982, NEUROLOGICAL SURGERY, V4, P2228; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Winn H.R., 2011, YOUMANS NEUROLOGICAL, V1; Zonenshayn M, 2004, J NEUROSURG, V100, P537, DOI 10.3171/ped.2004.100.5.0537	31	18	20	1	12	MARY ANN LIEBERT INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	JUL	2012	29	11					2030	2037		10.1089/neu.2011.2220			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	983CX	WOS:000307095800004	22452382				2022-02-06	
J	Prins, ML				Prins, Mayumi L.			Cerebral ketone metabolism during development and injury	EPILEPSY RESEARCH			English	Article						Brain; Development; Ketones; Injury; Metabolism; Neuroprotection	TRAUMATIC BRAIN-INJURY; CONTROLLED CORTICAL IMPACT; FUNCTION IMPROVING AGENT; D-BETA-HYDROXYBUTYRATE; KETOGENIC DIET; RAT-BRAIN; ADULT RATS; GLUCOSE-UTILIZATION; JUVENILE RATS; IN-VIVO	Cerebral metabolism of ketones is a normal part of the process of brain development. While the mature brain relies on glucose as a primary fuel source, metabolism of ketone bodies remains an alternative energy source under conditions of starvation. The neuroprotective properties of brain ketone metabolism make this alternative substrate a viable therapeutic option for various pathologies. Since the ability to revert to utilizing ketones as an alternative substrate is greatest in the younger post-weaned brain, this particular therapeutic approach remains an untapped resource particularly for pediatric pathological conditions. Published by Elsevier B.V.	Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA 90095 USA		Prins, ML (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Brain Injury Res Ctr, Dept Neurosurg, Semel Room 18-228,Box 957039, Los Angeles, CA 90095 USA.	mprins@mednet.ucla.edu	Prins, Mayumi/J-9571-2015	Prins, Mayumi/0000-0001-7694-9739	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01 NS058489-01A2, P01 NS058489, R01 NS104311, R01 NS110757] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS058489] Funding Source: NIH RePORTER		Appelberg KS, 2009, J NEUROTRAUM, V26, P497, DOI 10.1089/neu.2008.0664; Bartnik BL, 2005, J NEUROTRAUM, V22, P1052, DOI 10.1089/neu.2005.22.1052; BOOTH RFG, 1980, J NEUROCHEM, V34, P17, DOI 10.1111/j.1471-4159.1980.tb04616.x; CREMER JE, 1976, BIOCHIM BIOPHYS ACTA, V448, P633, DOI 10.1016/0005-2736(76)90120-6; DAHLQUIST G, 1976, PEDIATR RES, V10, P910, DOI 10.1203/00006450-197611000-00002; Deng-Bryant Y., 2011, J NEUROTRAU IN PRESS; Deng-Bryant Y, 2009, J NEUROTRAUM, V26, pA80; Haces ML, 2008, EXP NEUROL, V211, P85, DOI 10.1016/j.expneurol.2007.12.029; Hasselbalch SG, 1996, AM J PHYSIOL-ENDOC M, V270, pE746, DOI 10.1152/ajpendo.1996.270.5.E746; HASSELBALCH SG, 1994, J CEREBR BLOOD F MET, V14, P125, DOI 10.1038/jcbfm.1994.17; HAWKINS RA, 1971, BIOCHEM J, V122, P13, DOI 10.1042/bj1220013; Hu ZG, 2009, ANN CLIN LAB SCI, V39, P76; Hu ZG, 2009, BRAIN INJURY, V23, P459, DOI 10.1080/02699050902788469; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Juge N, 2010, NEURON, V68, P99, DOI 10.1016/j.neuron.2010.09.002; KAMMULA RG, 1976, AM J PHYSIOL, V231, P1490, DOI 10.1152/ajplegacy.1976.231.5.1490; Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x; Kweon GR, 2004, J BIOL CHEM, V279, P51783, DOI 10.1074/jbc.M407336200; LaManna JC, 2009, ADV EXP MED BIOL, V645, P301, DOI 10.1007/978-0-387-85998-9_45; LEONG SF, 1984, BIOCHEM J, V218, P131, DOI 10.1042/bj2180131; Maalouf M, 2009, BRAIN RES REV, V59, P293, DOI 10.1016/j.brainresrev.2008.09.002; Masuda R, 2005, J NEUROSCI RES, V80, P501, DOI 10.1002/jnr.20464; MILLER AL, 1986, METAB BRAIN DIS, V1, P53, DOI 10.1007/BF00998477; MOORE TJ, 1976, AM J PHYSIOL, V230, P619, DOI 10.1152/ajplegacy.1976.230.3.619; Mukherjee P, 2002, BRIT J CANCER, V86, P1615, DOI 10.1038/sj.bjc.6600298; NEHLIG A, 1988, J NEUROSCI, V8, P2321; NISSELBA.JS, 1969, ANAL BIOCHEM, V27, P212, DOI 10.1016/0003-2697(69)90025-6; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Prins ML, 2006, DEV NEUROSCI-BASEL, V28, P447, DOI 10.1159/000094170; Prins M, 2007, J NEUROTRAUM, V24, P1267; Prins ML, 2009, J NEUROTRAUM, V26, P1083, DOI 10.1089/neu.2008-0769; Prins ML, 2005, J NEUROSCI RES, V82, P413, DOI 10.1002/jnr.20633; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Randle P J, 1966, Recent Prog Horm Res, V22, P1; REDIES C, 1989, AM J PHYSIOL, V256, pE805, DOI 10.1152/ajpendo.1989.256.6.E805; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; Ritter AM, 1996, J NEUROTRAUM, V13, P473, DOI 10.1089/neu.1996.13.473; RUDERMAN NB, 1974, BIOCHEM J, V138, P1; Ruskin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008349; SAUDUBRAY JM, 1981, J PEDIATR-US, V98, P904, DOI 10.1016/S0022-3476(81)80583-5; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Stafford P., 2010, NUTR METAB, V11, P710; Sullivan PG, 2004, ANN NEUROL, V55, P576, DOI 10.1002/ana.20062; Suzuki M, 2002, JPN J PHARMACOL, V89, P36, DOI 10.1254/jjp.89.36; Suzuki M, 2001, JPN J PHARMACOL, V87, P143, DOI 10.1254/jjp.87.143; Thomas S, 2000, J NEUROTRAUM, V17, P649, DOI 10.1089/089771500415409; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Yamada KA, 2005, NEUROSCI LETT, V385, P210, DOI 10.1016/j.neulet.2005.05.038; YOSHINO A, 1991, BRAIN RES, V561, P106, DOI 10.1016/0006-8993(91)90755-K; Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5; Ziegler DR, 2003, NEUROCHEM RES, V28, P1793, DOI 10.1023/A:1026107405399	55	18	18	0	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0920-1211			EPILEPSY RES	Epilepsy Res.	JUL	2012	100	3			SI		218	223		10.1016/j.eplepsyres.2011.09.027			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	988ZQ	WOS:000307530400004	22104087	Green Accepted			2022-02-06	
J	Roussel, M; Dujardin, K; Henon, H; Godefroy, O				Roussel, Martine; Dujardin, Kathy; Henon, Hilde; Godefroy, Olivier			Is the frontal dysexecutive syndrome due to a working memory deficit? Evidence from patients with stroke	BRAIN			English	Article						brain injury; ischaemic stroke; frontal lobe; executive functions; working memory	DUAL-TASK PERFORMANCE; TRAUMATIC BRAIN-INJURY; COGNITIVE IMPAIRMENT; EXECUTIVE FUNCTIONS; ALZHEIMERS-DISEASE; REHEARSAL; DEMENTIA; SYSTEM; INTERFERENCE; COMPONENT	Although frontal dysexecutive disorders are frequently considered to be due to working memory deficit, this has not been systematically examined and very little evidence is available for impairment of working memory in frontal damage. The objective of this study was to examine the components of working memory, their anatomy and the relations with executive functions in patients with stroke involving the frontal or posterior cortex. The study population consisted of 29 patients (frontal: n = 17; posterior: n = 12) and 29 matched controls. Phonological loop (letter and word spans, phonological store; rehearsal process), visuospatial sketchpad (visuospatial span) and the central executive (working memory span, dual task and updating process) were examined. The group comparison analysis showed impairment in the frontal group of: (i) verbal spans (P < 0.03); (ii) with a deficit of the rehearsal process (P = 0.006); (iii) visuospatial span (P = 0.04); (iv) working memory span (P = 0.001) that disappeared after controlling for verbal span and (v) running memory (P = 0.05) unrelated to updating conditions. The clinical anatomical correlation study showed that impairment of the central executive depended on frontal and posterior lesion. Cognitive dysexecutive disorders were observed in 11/20 patients with central executive deficit and an inverse dissociation was observed in two patients. Receiver operating characteristic curve analysis indicated that cognitive dysexecutive disorders had the highest ability to discriminate frontal lesions (area under curve = 0.844, 95% confidence interval: 0.74-0.95; P = 0.0001; central executive impairment: area under curve = 0.732, 95% confidence interval: 0.57-0.82; P = 0.006). This study reveals that frontal lesions induce mild impairment of short-term memory associated with a deficit of the rehearsal process supporting the role of the frontal lobe in this process; the central executive depends on lesions in the frontal lobe and posterior regions accounting for its low frequency and the negative results of group studies. Finally, the frontal dysexecutive syndrome cannot be attributed to central executive impairment, although it may contribute to some dysexecutive disorders.	[Roussel, Martine; Godefroy, Olivier] Univ Hosp Amiens, Lab Funct Neurosci EA4559, Dept Neurol, F-80054 Amiens, France; [Dujardin, Kathy; Henon, Hilde] Univ Hosp Lille, Dept Neurol, F-59037 Lille, France		Roussel, M (corresponding author), Hop Nord Amiens, Serv Neurol, F-80054 Amiens, France.	roussel.martine@chu-amiens.fr	DUJARDIN, Kathy/H-5037-2011	DUJARDIN, Kathy/0000-0002-0110-574X; Godefroy, Olivier/0000-0001-6789-6620			Anastasi A., 1988, PSYCHOL TESTING; Andres P, 2002, NEUROPSYCHOLOGIA, V40, P835, DOI 10.1016/S0028-3932(01)00182-8; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Azouvi P, 2009, PROG BRAIN RES, V177, P89, DOI 10.1016/S0079-6123(09)17708-7; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; BADDELEY A, 1986, Q J EXP PSYCHOL-A, V38, P603, DOI 10.1080/14640748608401616; BADDELEY A, 1988, BRAIN COGNITION, V7, P212, DOI 10.1016/0278-2626(88)90031-0; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A.D., 1986, WORKING MEMORY; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Barbey AK, 2011, CEREB CORTEX, V21, P789, DOI 10.1093/cercor/bhq153; Bates E, 2003, NAT NEUROSCI, V6, P448, DOI 10.1038/nn1050; Beato R, 2008, ARQ NEURO-PSIQUIAT, V66, P147, DOI 10.1590/S0004-282X2008000200001; Beauregard J, 1971, TEST AUTOMATISMES VE; Belleville S, 1996, NEUROPSYCHOLOGIA, V34, P195, DOI 10.1016/0028-3932(95)00097-6; BELLEVILLE S, 1992, BRAIN LANG, V43, P713, DOI 10.1016/0093-934X(92)90092-S; Collette F, 1999, NEUROPSYCHOLOGIA, V37, P905, DOI 10.1016/S0028-3932(98)00148-1; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Cowey CM, 1996, MEMORY, V4, P19, DOI 10.1080/741940668; D'Esposito M, 2006, J INT NEUROPSYCH SOC, V12, P248, DOI 10.1017/S1355617706060322; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; D'Esposito M, 1999, NEUROPSYCHOLOGIA, V37, P1303, DOI 10.1016/S0028-3932(99)00021-4; D'Esposito M, 2007, PHILOS T R SOC B, V362, P761, DOI 10.1098/rstb.2007.2086; De Renzi E, 1975, Cortex, V11, P341; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351, DOI 10.2214/ajr.149.2.351; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Godefroy O, 1996, BRAIN, V119, P191, DOI 10.1093/brain/119.1.191; Godefroy O, 1999, CORTEX, V35, P1, DOI 10.1016/S0010-9452(08)70782-2; Godefroy O, 2002, NEUROPSYCHOLOGIA, V40, P2234, DOI 10.1016/S0028-3932(02)00109-4; Godefroy O, 1998, BRAIN, V121, P1545, DOI 10.1093/brain/121.8.1545; Godefroy O, 2010, ANN NEUROL, V68, P855, DOI 10.1002/ana.22117; Goldman-Rakic P.S., 2011, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; Hillary FG, 2011, BRAIN, V134, P1555, DOI 10.1093/brain/awr043; Huntley JD, 2010, INT J GERIATR PSYCH, V25, P121, DOI 10.1002/gps.2314; Leclercq M, 2000, J CLIN EXP NEUROPSYC, V22, P339, DOI 10.1076/1380-3395(200006)22:3;1-V;FT339; LEZAK MD, 1982, INT J PSYCHOL, V17, P281, DOI 10.1080/00207598208247445; Luria A.R., 1966, HIGHER CORTICAL FUNC; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Miyake A., 1999, MODELS WORKING MEMOR, P442; MORRIS N, 1990, BRIT J PSYCHOL, V81, P111, DOI 10.1111/j.2044-8295.1990.tb02349.x; MORRIS RG, 1988, J NEUROL NEUROSUR PS, V51, P757, DOI 10.1136/jnnp.51.6.757; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Norman D., 1986, CONSCIOUSNESS SELF R, P1, DOI DOI 10.1007/978-1-4757-0629-1_1; OWEN AM, 1990, NEUROPSYCHOLOGIA, V28, P1021, DOI 10.1016/0028-3932(90)90137-D; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Pillon B, 2018, HDB NEUROPSYCHOLOGY; POLLACK I, 1959, J EXP PSYCHOL, V57, P137, DOI 10.1037/h0046137; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raven J.C., 1965, GUIDE USING COLOURED; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Sachdev PS, 2004, NEUROLOGY, V62, P912, DOI 10.1212/01.WNL.0000115108.65264.4B; SHALLICE T, 1982, PHILOS T ROY SOC B, V298, P199, DOI 10.1098/rstb.1982.0082; Shallice T., 1990, NEUROPSYCHOLOGICAL I, P11, DOI DOI 10.1017/CBO9780511665547.003; Signoret JL, 1991, BATTERIE EVALUATION; Stablum F, 2000, PSYCHOL RES-PSYCH FO, V63, P265, DOI 10.1007/s004269900002; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Vallar G, 1997, NEUROPSYCHOLOGIA, V35, P795, DOI 10.1016/S0028-3932(96)00127-3; Vilkki J, 1996, NEUROPSYCHOLOGIA, V34, P1051, DOI 10.1016/0028-3932(96)00028-0; Vilkki JA, 2002, NEUROPSYCHOLOGIA, V40, P340, DOI 10.1016/S0028-3932(01)00090-2; WARRINGTON EK, 1969, BRAIN, V92, P885, DOI 10.1093/brain/92.4.885; Waters GS, 1996, Q J EXP PSYCHOL-A, V49, P51, DOI 10.1080/027249896392801; WATERS GS, 1992, J MEM LANG, V31, P54, DOI 10.1016/0749-596X(92)90005-I; Wechsler D, 1989, WAISR ECHELLE INTELL	70	18	18	0	18	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2012	135		7				2192	2201		10.1093/brain/aws132			10	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	966GQ	WOS:000305826300018	22637543	Bronze			2022-02-06	
J	Bukur, M; Kurtovic, S; Berry, C; Tanios, M; Ley, EJ; Salim, A				Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Ley, Eric J.; Salim, Ali			Pre-Hospital Hypothermia is Not Associated with Increased Survival After Traumatic Brain Injury	JOURNAL OF SURGICAL RESEARCH			English	Article; Proceedings Paper	Annual Meeting of the Association-of-Academic-Surgery (AAS)/6th Annual Academic-Surgical Congress	FEB 01-03, 2011	Huntington Beach, CA	Assoc Acad Surg (AAS), Acad Surg		traumatic brain injury; pre-hospital hypothermia; mortality; outcomes	CEREBRAL BLOOD-FLOW; THERAPEUTIC HYPOTHERMIA; MODERATE HYPOTHERMIA; MILD HYPOTHERMIA; ADMISSION HYPOTHERMIA; EARLY COAGULOPATHY; ORGAN DYSFUNCTION; PROTEIN-LEVELS; HEAD-INJURY; EXPRESSION	Background. Conclusions from in vivo and in vitro studies suggest hypothermia may be protective in traumatic brain injury (TBI). Few studies evaluated the effect of admission temperature on outcomes. The purpose of this study is to examine the relationship between admission hypothermia and mortality in patients with isolated, blunt, moderate to severe TBI. Methods. The Los Angeles Trauma Database was queried for all patients >= 14 y of age with isolated, blunt, moderate to severe TBI (head abbreviated injury score (AIS) >= 3, all other < 3), admitted between 2005 and 2009. The study population was then stratified into two groups by admission temperature: hypothermic (<= 35 degrees C) and normothermic (> 35 degrees C). Demographic characteristics and outcomes were compared between groups. Logistic regression analysis was used to determine the relationship between admission hypothermia and mortality. Results. A total of 1834 patients were analyzed and then stratified into two groups: hypothermic (n = 44) and normothermic (n = 1790). There was a significant difference noted in overall mortality (25% versus 7%), with the hypothermic group being four times more likely to succumb to their injuries. After adjusting for confounding factors, admission hypothermia was independently associated with increased mortality (AOR 2.5; 95% CI 1.1-6.3; P = 0.04). Conclusions. Although in-vivo and in-vitro studies demonstrate induced hypothermia may be protective in TBI, our study demonstrates that admission hypothermia was associated with increased mortality in isolated, blunt, moderate to severe TBI. Further prospective research is needed to elucidate the role of thermoregulation in patients sustaining TBI. (C) 2012 Elsevier Inc. All rights reserved.	[Bukur, Marko; Kurtovic, Silvia; Berry, Cherisse; Tanios, Mina; Ley, Eric J.; Salim, Ali] Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, Los Angeles, CA 90048 USA		Salim, A (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Div Trauma & Crit Care, 8700 Beverly Blvd,Suite 8215 N, Los Angeles, CA 90048 USA.	ali.salim@cshs.org	Berry, Cherisse/AAO-5701-2020	Bukur, Marko/0000-0002-1850-7147			Adelson PD, 2005, NEUROSURGERY, V56, P740, DOI 10.1227/01.NEU.0000156471.50726.26; ALDERSON P, 2000, COCHRANE DB SYST REV, V2; Arican N, 2006, INT J NEUROSCI, V116, P1249, DOI 10.1080/00207450600550303; Atkins CM, 2007, EUR J NEUROSCI, V26, P810, DOI 10.1111/j.1460-9568.2007.05720.x; Badjatia N, 2009, CRIT CARE MED, V37, pS250, DOI 10.1097/CCM.0b013e3181aa5e8d; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Biswas AK, 2002, CRIT CARE MED, V30, P2742, DOI 10.1097/00003246-200212000-00020; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS7, DOI DOI 10.1089/NEU.2007.9995; Broessner G, 2009, STROKE, V40, pE657, DOI 10.1161/STROKEAHA.109.557652; Chatzipanteli K, 1999, J NEUROCHEM, V72, P2047, DOI 10.1046/j.1471-4159.1999.0722047.x; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Demetriades D, 2006, J TRAUMA, V61, P868, DOI 10.1097/01.ta.0000219135.33398.f3; den Hartog AW, 2010, CRIT CARE, V14, DOI 10.1186/cc9077; Dietrich WD, 2010, NEUROTHERAPEUTICS, V7, P43, DOI 10.1016/j.nurt.2009.10.015; Eddy VA, 2000, SURG CLIN N AM, V80, P845, DOI 10.1016/S0039-6109(05)70099-2; Ehrlich MP, 2002, ANN THORAC SURG, V73, P191, DOI 10.1016/S0003-4975(01)03273-8; Enriquez P, 2004, CURR PHARM DESIGN, V10, P2131; Fildes J, 2008, ATLS ADV TRAUMA LIFE; Fukudome EY, 2009, CRIT CARE MED, V37, pS265, DOI 10.1097/CCM.0b013e3181aa60ac; GLOBUS MYT, 1995, J NEUROCHEM, V65, P1704; GOSS JR, 1995, J NEUROTRAUM, V12, P159, DOI 10.1089/neu.1995.12.159; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Henderson WR, 2003, INTENS CARE MED, V29, P1637, DOI 10.1007/s00134-003-1848-2; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Jiang JY, 2006, J NEUROTRAUM, V23, P1847, DOI 10.1089/neu.2006.23.1847; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jiang JY, 2004, NEUROSURGERY, V54, P713, DOI 10.1227/01.NEU.0000109535.58429.49; Kemp CD, 2008, AM SURGEON, V74, P866; Kinoshita K, 2002, J NEUROSURG, V97, P945, DOI 10.3171/jns.2002.97.4.0945; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Lotocki G, 2006, EUR J NEUROSCI, V24, P2283, DOI 10.1111/j.1460-9568.2006.05123.x; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; LYETH BG, 1993, MOL CHEM NEUROPATHOL, V18, P247, DOI 10.1007/BF03160117; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maier CM, 2002, NEUROBIOL DIS, V11, P28, DOI 10.1006/nbdi.2002.0513; Maxwell WL, 1999, J NEUROTRAUM, V16, P1225, DOI 10.1089/neu.1999.16.1225; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; Ottochian M, 2009, J TRAUMA, V67, P81, DOI 10.1097/TA.0b013e318188b934; Polderman KH, 2008, LANCET, V371, P1955, DOI 10.1016/S0140-6736(08)60837-5; Polderman KH, 2009, CRIT CARE MED, V37, P1101, DOI 10.1097/CCM.0b013e3181962ad5; Polderman KH, 2005, CRIT CARE MED, V33, P2744, DOI 10.1097/01.CCM.0000190427.88735.19; Sambasivan CN, 2009, CURR OPIN CRIT CARE, V15, P560, DOI 10.1097/MCC.0b013e328331f57c; Selladurai BM, 1997, BRIT J NEUROSURG, V11, P398; Shaz BH, 2009, ANESTH ANALG, V108, P1760, DOI 10.1213/ane.0b013e3181a0b6c6; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; TAFT WC, 1993, J CEREBR BLOOD F MET, V13, P796, DOI 10.1038/jcbfm.1993.101; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Truettner JS, 2005, J CEREBR BLOOD F MET, V25, P1505, DOI 10.1038/sj.jcbfm.9600150; Vitarbo EA, 2004, NEUROSURGERY, V55, P416, DOI 10.1227/01.NEU.0000130036.52521.2C; Walters JH, 2011, RESUSCITATION, V82, P508, DOI 10.1016/j.resuscitation.2011.01.021; Wang GJ, 2002, NEUROSCIENCE, V114, P1081, DOI 10.1016/S0306-4522(02)00350-0; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Zygun DA, 2005, CRIT CARE MED, V33, P654, DOI 10.1097/01.ccm.0000155911.01844.54	58	18	20	0	6	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4804	1095-8673		J SURG RES	J. Surg. Res.	JUN 1	2012	175	1					24	29		10.1016/j.jss.2011.07.003			6	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	934UP	WOS:000303472500010	21872881				2022-02-06	
J	Covassin, T; Bay, E				Covassin, Tracey; Bay, Esther			Are There Gender Differences in Cognitive Function, Chronic Stress, and Neurobehavioral Symptoms After Mild-to-Moderate Traumatic Brain Injury?	JOURNAL OF NEUROSCIENCE NURSING			English	Article							SEX-DIFFERENCES; ALLOSTATIC LOAD; DEPRESSIVE SYMPTOMS; RISK-FACTORS; HEAD-INJURY; CONCUSSION; IMPACT; HIPPOCAMPUS; EPIDEMIOLOGY; METAANALYSIS	Research is inconclusive on whether gender differences exist in cognitive function in persons who sustain a mild-to-moderate traumatic brain injury (TBI). Furthermore, it is also unclear whether there is a relationship between chronic stress and cognitive function in these persons. The purpose of this integrative review is to determine whether gender differences exist in cognitive function, neurobehavioral symptoms, and chronic stress levels after a mild-to-moderate TBI. Participants (n = 72) were recruited from eight outpatient rehabilitation centers. Participants completed the demographic questions, the Immediate Postconcussion Assessment Cognitive Testing neurocognitive test battery, the Perceived Stress Scale-14, and the Neurobehavioral Functioning Inventory (NFI). Gender differences were present on verbal memory composite scores (p = .033), with women performing worse than men. There were no other between-gender differences on cognitive tasks, neurobehavioral symptoms, or chronic stress. Higher chronic stress levels result in a decrease in verbal memory (p = .015) and motor processing speed (p = .006) and slower reaction time (p = .007) for women. As male NFI cognition scores increased, motor processing speed scores decreased (p = .012) and reaction time got slower (p = .019), whereas women exhibited decreased verbal memory (p = .017) and slower reaction time (p =.034). As NFI motor symptoms increased, men exhibited decreased verbal memory (p = .005), visual memory (p = .002), and motor processing speed (p =.002) and slower reaction time (p = .002). Overall, this study only found gender differences on verbal memory composite scores, whereas the remaining cognitive tasks, neurobehavioral symptoms, and chronic stress did not indicate gender differences. Correlations between chronic stress, neurobehavioral symptoms, and cognitive function differed in both men and women with TBI. Persons in the chronic phase of recovery from a TBI may benefit from training in compensatory strategies for verbal memory deficits and stress management.	[Covassin, Tracey] Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA; [Bay, Esther] Univ Michigan, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Covassin, T (corresponding author), Michigan State Univ, Dept Kinesiol, E Lansing, MI 48824 USA.	covassin@msu.edu			Michigan State University Office of the Vice President for Research	Funding to conduct this study was given to Esther Bay from the Michigan State University Office of the Vice President for Research.	Bangasser DA, 2010, NEUROSCI BIOBEHAV R, V34, P1223, DOI 10.1016/j.neubiorev.2010.02.002; Bay E, 2002, J NURS SCHOLARSHIP, V34, P221, DOI 10.1111/j.1547-5069.2002.00221.x; Bay E, 2008, BRAIN INJURY, V22, P233, DOI 10.1080/02699050801953073; Bay E, 2009, J NEUROSCI NURS, V41, P298, DOI 10.1097/JNN.0b013e3181b6be81; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bruce-Keller AJ, 2007, J NEUROTRAUM, V24, P203, DOI 10.1089/neu.2006.0163; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cohen S, 1995, MEASURING STRESS GUI; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; EMERSON CS, 1993, BRAIN RES, V608, P95, DOI 10.1016/0006-8993(93)90778-L; Farace E, 2000, J NEUROSURG, V93, P539, DOI 10.3171/jns.2000.93.4.0539; Faul M, 2010, TRAUMATIC BRAIN INJU; FENTON G, 1993, BRIT J PSYCHIAT, V162, P493, DOI 10.1192/bjp.162.4.493; Gianaros PJ, 2007, NEUROIMAGE, V35, P795, DOI 10.1016/j.neuroimage.2006.10.045; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Hughes RB, 2005, WOMEN HEALTH ISS, V15, P14, DOI 10.1016/j.whi.2004.09.001; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2002, ARCH CLIN NEUROPSYCH, V17, P770; Kajantie E, 2006, PSYCHONEUROENDOCRINO, V31, P151, DOI 10.1016/j.psyneuen.2005.07.002; Kessels RPC, 2001, BRAIN RES REV, V35, P295, DOI 10.1016/S0165-0173(01)00058-3; KREUTZER J, 1999, NEUROBEHAVIORAL FUNC; Kreutzer JS, 1996, ARCH PHYS MED REHAB, V77, P116, DOI 10.1016/S0003-9993(96)90155-0; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lovell M. R., 2008, IMPACT 2006 5 0 CLIN; Lovell MR, 2001, IMMEDIATE POSTCONCUS; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; McEwen BS, 2003, BIOL PSYCHIAT, V54, P200, DOI 10.1016/S0006-3223(03)00177-X; McEwen BS, 2002, NEUROBIOL AGING, V23, P921, DOI 10.1016/S0197-4580(02)00027-1; McEwen BS, 2001, ANN NY ACAD SCI, V933, P265, DOI 10.1111/j.1749-6632.2001.tb05830.x; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; NeuroHealth Systems, 2001, IMM POSTC ASS COGN T; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Raskin SA, 1998, CLIN NEUROPSYCHOL, V12, P21, DOI 10.1076/clin.12.1.21.1724; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; RUTHERFORD WH, 1979, INJURY, V10, P225, DOI 10.1016/0020-1383(79)90015-9; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schopp LH, 2001, J CLIN PSYCHOL MED S, V8, P181, DOI 10.1023/A:1011369620254; Slewa-Younan S, 2008, J NEUROL NEUROSUR PS, V79, P1197, DOI 10.1136/jnnp.2008.147983; TEASDALE G, 1974, LANCET, V2, P81; Tsushima WT, 2009, BRAIN INJURY, V23, P809, DOI 10.1080/02699050903200530; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; World Health Organization, 1993, ICD 10 CLASS MENT BE	47	18	18	1	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0888-0395			J NEUROSCI NURS	J. Neurosci. Nurs.	JUN	2012	44	3					124	133		10.1097/JNN.0b013e318252737d			10	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	937QZ	WOS:000303674600004	22555349				2022-02-06	
J	Hassanpour, K; Hotz-Boendermaker, S; Dokladal, P; Curt, A				Hassanpour, Katayun; Hotz-Boendermaker, Sabina; Dokladal, Petra; Curt, Armin		European Multictr Study Human	Low depressive symptoms in acute spinal cord injury compared to other neurological disorders	JOURNAL OF NEUROLOGY			English	Article						Depressive symptoms; Spinal cord injury; Beck Depression Inventory; ASIA; Neurological disorders	INVENTORY-FAST SCREEN; MAJOR DEPRESSION; CHRONIC PAIN; STROKE; PREVALENCE; PEOPLE; INDIVIDUALS; SITUATION; DISTRESS; VALIDITY	The aim of the study was to reveal the incidence and time course of depressive symptoms following acute spinal cord injury (SCI) in relation to clinical outcomes for comparison to other neurological disorders with severe impairment. In patients with acute traumatic SCI (n = 130), combined follow up assessments of neurological and functional outcomes, pain and patient-rated affective factors (e.g. mood, anxiety) were prospectively (1, 3, 6, 12 months after injury) collected during rehabilitation and follow up in out-patient clinics. We related these to the severity of depressive symptoms (no, mild, moderate and severe) based on the Beck Depression Inventory (BDI) scores. The mean 65% of patients showed no depressive symptoms and 30% mild depressive symptoms, while less than 5% presented moderate to severe depressive symptoms. The group findings and symptoms in individual patients remained stable over 1 year though patients revealed significant clinical recovery. Although two-thirds of the patients experienced pain, BDI scores were not related to pain intensity. BDI mean scores were only slightly higher than in control populations, but rather low compared to patients with other neurological disorders (e.g. stroke and multiple sclerosis) that are also associated with severe functional impairment. The prevalence of depressive symptoms following acute SCI is rather low and remains stable within the first year after injury despite the severe neurological impairment and loss of independency. In comparison to other neurological disorders that also involve brain function SCI patients seem to be less challenged by depressive symptoms that constitute additional burdens to respond to the severe functional impairments.	[Hassanpour, Katayun; Hotz-Boendermaker, Sabina; Dokladal, Petra; Curt, Armin] Balgrist Univ Hosp, Spinal Cord Injury Ctr, CH-8008 Zurich, Switzerland		Hotz-Boendermaker, S (corresponding author), Balgrist Univ Hosp, Spinal Cord Injury Ctr, Forchstr 340, CH-8008 Zurich, Switzerland.	shotz@paralab.balgrist.ch	Hotz, S/AAL-7043-2020	Hotz, S/0000-0001-9455-6074	International Foundation for Research in Paraplegia (IFP); International Spinal Research Trust (ISRT) [CLI006]; Swiss National Science Foundation (SNF)Swiss National Science Foundation (SNSF) [PMPDP3-124282]	We would like to thank the EM-SCI study group, especially Rene Koller from Zurich and Dr. F. Rohrich of the Berufsgenossenschaftliche Kliniken Bergmannstrost, Halle (Germany). The following centers participated in this study: K. Rohl, MD, Berufsgenossenschaftliche Kliniken Bergmannstrost, Halle (Germany); N. Weidner and R. Rupp, University Clinic of Heidelberg (Germany); R. D. Sambale, MD, Orthopadische Klinik Hessisch-Lichtenau (Germany); J. Harms, MD, SRH Klinikum Karlsbad-Langensteinbach (Germany); D. Maier, MD, Berufsgenossenschaftliche Klinik in Murnau (Germany), Y.-B. Kalke, MD, Rehabilitationskrankhaus Ulm (Germany) and, M. Schubert, MD, Balgrist University Hospital, Zurich (Switzerland). We are grateful to Boris Quednow, MD, Psychiatric University Hospital Zurich, for his helpful comments on the manuscript. We would also like to thank all the patients for their willingness to invest their time in this study. Supported by the International Foundation for Research in Paraplegia (IFP) and the International Spinal Research Trust (ISRT; Stage II of the Clinical Initiative: CLI006) and the Swiss National Science Foundation (SNF, PMPDP3-124282).	Alajbegovic A, 2009, ACTA CLIN CROAT, V48, P3; ASIA, 2003, INT STAND NEUR CLASS; Ayuso-Mateos JL, 2001, BRIT J PSYCHIAT, V179, P308, DOI 10.1192/bjp.179.4.308; Benedict RHB, 2003, MULT SCLER J, V9, P393, DOI 10.1191/1352458503ms902oa; Binks TM, 1997, ANN NY ACAD SCI, V821, P430, DOI 10.1111/j.1749-6632.1997.tb48297.x; Boekamp JR, 1996, INT J PSYCHIAT MED, V26, P329, DOI 10.2190/CMU6-24AH-E4JG-8KBN; Bombardier CH, 2004, ARCH PHYS MED REHAB, V85, P1749, DOI 10.1016/j.apmr.2004.07.348; Cairns DM, 1996, ARCH PHYS MED REHAB, V77, P329, DOI 10.1016/S0003-9993(96)90079-9; Craig A, 2009, SPINAL CORD, V47, P108, DOI 10.1038/sc.2008.115; Elliott TR, 1996, ARCH PHYS MED REHAB, V77, P816, DOI 10.1016/S0003-9993(96)90263-4; Erban P, 2006, CLIN NEUROL NEUROSUR, V108, P384, DOI 10.1016/j.clineuro.2005.06.008; FRANK RG, 1985, AM J PSYCHIAT, V142, P252; Hackett ML, 2005, STROKE, V36, P2296, DOI 10.1161/01.STR.0000183622.75135.a4; Healey AK, 2008, INT J GERIATR PSYCH, V23, P531, DOI 10.1002/gps.1933; Hoffman JM, 2011, ARCH PHYS MED REHAB, V92, P411, DOI 10.1016/j.apmr.2010.10.036; HOHMANN GW, 1975, CLIN ORTHOP RELAT R, P81; HOUSE A, 1991, BRIT J PSYCHIAT, V158, P83, DOI 10.1192/bjp.158.1.83; Jensen MP, 2005, SPINAL CORD, V43, P704, DOI 10.1038/sj.sc.3101777; Kemp BJ, 2004, J SPINAL CORD MED, V27, P22, DOI 10.1080/10790268.2004.11753726; KENDALL PC, 1987, COGNITIVE THER RES, V11, P289, DOI 10.1007/BF01186280; Kennedy P, 2000, SPINAL CORD, V38, P498, DOI 10.1038/sj.sc.3101021; Kennedy P, 2000, ARCH PHYS MED REHAB, V81, P932, DOI 10.1053/apmr.2000.5580; Klose L, 2011, KLIN PSYCHIAT PSYCHO; Kotila M, 1998, STROKE, V29, P368, DOI 10.1161/01.STR.29.2.368; Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55; Lude P, 2005, SPINAL CORD, V43, P102, DOI 10.1038/sj.sc.3101688; Merrick Daniel, 2010, BMC Res Notes, V3, P190, DOI 10.1186/1756-0500-3-190; Osteraker AL, 2005, SPINAL CORD, V43, P223, DOI 10.1038/sj.sc.3101703; Rampello L, 2004, PSYCHOPHARMACOLOGY, V173, P73, DOI 10.1007/s00213-003-1698-1; Saikkonen J, 2004, SPINAL CORD, V42, P459, DOI 10.1038/sj.sc.3101618; Siddall PJ, 2003, PAIN, V103, P249, DOI 10.1016/S0304-3959(02)00452-9; SILLER J, 1969, REHABIL LIT, V30, P290; Spinal cord medicine consortium, 1998, J SPINAL CORD MED, V21, P248; Taylor L, 2010, EUR J NEUROL, V17, P1047, DOI 10.1111/j.1468-1331.2010.02960.x; Tedman BM, 1997, J NEUROL SCI, V152, pS75, DOI 10.1016/S0022-510X(97)00249-9; Tirch D, 1999, J Spinal Cord Med, V22, P284; van Hedel HJ, 2011, NEUROREHABIL NE 0602; Widerstrom-Noga EG, 2003, SPINAL CORD, V41, P600, DOI 10.1038/sj.sc.3101511; Wittchen HU, 2005, EUR NEUROPSYCHOPHARM, V15, P357, DOI 10.1016/j.euroneuro.2005.04.012	39	18	18	0	9	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	JUN	2012	259	6					1142	1150		10.1007/s00415-011-6316-2			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	953IB	WOS:000304859300019	22095042	Green Accepted, Green Submitted			2022-02-06	
J	James, ML; Wang, HC; Cantillana, V; Lei, BL; Kernagis, DN; Dawson, HN; Klaman, LD; Laskowitz, DT				James, Michael L.; Wang, Haichen; Cantillana, Viviana; Lei, Beilei; Kernagis, Dawn N.; Dawson, Hana N.; Klaman, Lori D.; Laskowitz, Daniel T.			TT-301 Inhibits Microglial Activation and Improves Outcome after Central Nervous System Injury in Adult Mice	ANESTHESIOLOGY			English	Article							TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; APOLIPOPROTEIN-E; MOUSE MODEL; WATER-MAZE; PROINFLAMMATORY CYTOKINE; FUNCTIONAL RECOVERY; UP-REGULATION; CELL-DEATH; INFLAMMATION	Background: Microglial inhibition may reduce secondary tissue injury and improve functional outcome following acute brain injury. Utilizing clinically relevant murine models of traumatic brain injury and intracerebral hemorrhage, neuroinflammatory responses and functional outcome were examined in the presence of a potential microglial inhibitor, TT-301. Methods: TT-301 or saline was administered following traumatic brain injury or intracerebral hemorrhage, and then for four subsequent days. The effect of TT-301 on neuroinflammatory responses and neuronal viability was assessed, as well as short-term vestibulomotor deficit (Rotorod) and long-term neurocognitive impairment (Morris water maze). Finally differential gene expression profiles of mice treated with TT-301 were compared with those of vehicle. Results: Reduction in F4/80+ staining was demonstrated at 1 and 10 days, but not 28 days, after injury in mice treated with TT-301 (n = 6). These histologic findings were associated with improved neurologic function as assessed by Rotorod, which improved by 52.7% in the treated group by day 7, and Morris water maze latencies, which improved by 232.5% as a function of treatment (n = 12; P < 0.05). Similar benefit was demonstrated following intracerebral hemorrhage, in which treatment with TT-301 was associated with functional neurologic improvement of 39.6% improvement in Rotorod and a reduction in cerebral edema that was independent of hematoma volume (n = 12; P < 0.05). Differential gene expression was evaluated following treatment with TT-301, and hierarchical cluster analysis implicated involvement of the Janus kinase-Signal Transducer and Activator of Transcription pathway after administration of TT-301 (n = 3/group). Conclusions: Modulation of neuroinflammatory responses through TT-301 administration improved histologic and functional parameters in murine models of acute neurologic injury.	[James, Michael L.; Lei, Beilei; Laskowitz, Daniel T.] Duke Univ, Dept Anesthesiol, Durham, NC 27710 USA; [James, Michael L.; Wang, Haichen; Cantillana, Viviana; Dawson, Hana N.; Laskowitz, Daniel T.] Duke Univ, Dept Med Neurol, Durham, NC 27710 USA; [James, Michael L.; Wang, Haichen; Lei, Beilei; Laskowitz, Daniel T.] Duke Univ, Multidisciplinary Neuroprotect Labs, Med Ctr, Durham, NC 27710 USA; [Kernagis, Dawn N.] Duke Univ, Dept Pathol, Durham, NC 27710 USA; [Klaman, Lori D.] Transit Therapeut Inc, Preclin Res, Toronto, ON, Canada		James, ML (corresponding author), Duke Univ, Dept Anesthesiol, Box 3904, Durham, NC 27710 USA.	michael.james@duke.edu	James, Michael L./AAJ-5592-2020	James, Michael L./0000-0002-8715-5210	Transition Therapeutics	Received from the Departments of Anesthesiology and Medicine (Neurology), Duke University, Durham, North Carolina. Submitted for publication January 26, 2011. Accepted for publication February 3, 2012. Supported by a grant from Transition Therapeutics. Toronto, Ontario, Canada (to Dr. Laskowitz), the American Heart Association Scientist Development Grant, Dallas, Texas (to Dr. James), and the Foundation of Anesthesia Education and Research, Rochester, Minnesota (to Dr. James). TT-301 was provided by Transition Therapeutics. Dr. Laskowitz serves as consultant for Transition Therapeutics.	Allaman I, 2011, TRENDS NEUROSCI, V34, P76, DOI 10.1016/j.tins.2010.12.001; Bahniwal M, 2011, J NEUROIMMUNOL, V233, P65, DOI 10.1016/j.jneuroim.2010.11.016; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Broderick J, 2007, STROKE, V38, P2001, DOI 10.1161/STROKEAHA.107.183689; Bulger EM, 2002, CRIT CARE MED, V30, P1870, DOI 10.1097/00003246-200208000-00033; Chen CJ, 2011, NEUROCHEM INT, V58, P234, DOI 10.1016/j.neuint.2010.12.009; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Dawson HN, 2007, J NEUROSCI, V27, P9155, DOI 10.1523/JNEUROSCI.5492-06.2007; Feigin VL, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004583.pub2; Hamm RJ, 2001, J NEUROTRAUM, V18, P1207, DOI 10.1089/089771501317095241; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Holscher C, 1999, BEHAV BRAIN RES, V100, P225, DOI 10.1016/S0166-4328(98)00134-X; Hoofien D, 2001, BRAIN INJURY, V15, P189; Hu WH, 2007, BIOORG MED CHEM LETT, V17, P414, DOI 10.1016/j.bmcl.2006.10.028; Huang CF, 2008, J NEUROIMMUNOL, V204, P118, DOI 10.1016/j.jneuroim.2008.07.004; James ML, 2010, J NEUROTRAUM, V27, P217, DOI 10.1089/neu.2009.1022; James ML, 2009, STROKE, V40, P632, DOI 10.1161/STROKEAHA.108.530402; James ML, 2008, NEUROCRIT CARE, V9, P139, DOI 10.1007/s12028-007-9030-2; Kellner CP, 2010, STROKE, V41, pS99, DOI 10.1161/STROKEAHA.110.597476; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; Laskowitz DT, 2007, J NEUROTRAUM, V24, P1093, DOI 10.1089/neu.2006.0192; Laskowitz DT, 2010, J NEUROTRAUM, V27, P1983, DOI 10.1089/neu.2010.1396; LEENEN PJM, 1994, J IMMUNOL METHODS, V174, P5, DOI 10.1016/0022-1759(94)90005-1; Leung Lai Yee, 2008, Molecular & Cellular Biomechanics, V5, P155; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Park EJ, 2003, J BIOL CHEM, V278, P14747, DOI 10.1074/jbc.M210819200; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; Rao V, 2002, PSYCHIAT CLIN N AM, V25, P43, DOI 10.1016/S0193-953X(03)00052-2; ROSENBERG GA, 1990, ACT NEUR S, V51, P280; Saijo K, 2010, ADV IMMUNOL, V106, P21, DOI 10.1016/S0065-2776(10)06002-5; Satriotomo I, 2006, J NEUROCHEM, V98, P1353, DOI 10.1111/j.1471-4159.2006.04051.x; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Zhu K, 2003, J BIOL CHEM, V278, P21869, DOI 10.1074/jbc.M213052200	39	18	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-3022	1528-1175		ANESTHESIOLOGY	Anesthesiology	JUN	2012	116	6					1299	1311		10.1097/ALN.0b013e318253a02a			13	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	946MR	WOS:000304356500020	22487803	Bronze			2022-02-06	
J	Franssen, RA; Rzucidlo, AM; Franssen, CL; Hampton, JE; Benkovic, SA; Bardi, M; Kinsley, CH; Lambert, KG				Franssen, R. Adam; Rzucidlo, Amanda M.; Franssen, Catherine L.; Hampton, J. Ezekiel; Benkovic, Stanley A., Jr.; Bardi, Massimo; Kinsley, Craig H.; Lambert, Kelly G.			Reproductive experience facilitates recovery from kainic acid-induced neural insult in female Long-Evans rats	BRAIN RESEARCH			English	Article						Traumatic brain injury; Maternal behavior; Memory; Neurotoxicity; Gliosis	RECEPTOR ISOFORMS EXPRESSION; REACTIVE ASTROCYTES; BRAIN-INJURY; PROGESTERONE; HIPPOCAMPUS; NEUROPROTECTION; MOTHERHOOD; MEMORY; EXCITOTOXICITY; LACTATION	The hormones of pregnancy and lactation (e.g., estrogen, progesterone, and oxytocin) have been shown to modulate learning, memory, and the restructuring of brain areas not traditionally associated with maternal behavior. Given the impact of reproductive experience on plasticity of brain areas such as the hippocampus, kainic acid (KA) was used in the current study to induce hippocampal-specific neurotoxic insult in adult multiparous and virgin Long-Evans rats. In Experiment I, Fluoro-Jade B, an indicant of degenerating cells, revealed significant neuronal damage in KA-treated hippocampi at 16 h post-injection in both maternal and virgin rats. In Experiment H, maternal and virgin rats were assessed in spatial and novel object preference tasks to determine the effects of KA on subsequent behavioral and cognitive responses. Twenty-four hours post injection, saline maternal animals exhibited superior memory in a spatial task. Further, maternal saline-injected rats were more similar to maternal KA-injected rats than both the virgin groups. Forty-eight hours following the KA or saline injection, compared to virgins, maternal animals demonstrated enhanced memory in the novel object memory test, regardless of type of injection. Further, neurobiological assessments in Experiment II indicated that virgin KA exposed rats had significantly more glial fibrillary acidic protein (GFAP)-immunoreactivity in the hippocampus, suggesting that they were in an earlier stage of neural recovery compared to maternal animals or, alternatively, may have exhibited more trauma than maternal animals. Together, these data suggest that the previously reported plasticity of the maternal brain may facilitate neural and behavioral recovery from neural insults. (c) 2012 Elsevier B.V. All rights reserved.	[Lambert, Kelly G.] Randolph Macon Coll, Dept Psychol, Copley Sci Ctr 138, Ashland, VA 23005 USA; [Franssen, R. Adam] Longwood Univ, Dept Biol & Environm Sci, Farmville, VA 23909 USA; [Benkovic, Stanley A., Jr.] Neurosci Associates, Knoxville, TN 37934 USA; [Kinsley, Craig H.] Univ Richmond, Dept Psychol, Richmond, VA 23173 USA; [Bardi, Massimo] Marshall Univ, Dept Psychol, Huntington, WV 25575 USA		Lambert, KG (corresponding author), Randolph Macon Coll, Dept Psychol, Copley Sci Ctr 138, 304 Caroline St, Ashland, VA 23005 USA.	klambert@rmc.edu		Lambert, Kelly/0000-0003-1626-5129; Bardi, Massimo/0000-0001-9333-3493	R-MC Psychology Department; Joan and Macon Brock Professorship; Schapiro Undergraduate Research Fellowship program	This research was funded by the R-MC Psychology Department, the Joan and Macon Brock Professorship, and the Schapiro Undergraduate Research Fellowship program. Appreciation is also extended to the valuable contributions of Anya Baranova, Ph.D. and Eleanor Shea.	Azcoitia I., 2011, TRENDS ENDOCRIN MET, V119, P1084; Azcoitia I, 2010, EUR J NEUROSCI, V32, P1995, DOI 10.1111/j.1460-9568.2010.07516.x; Barha CK, 2011, EXP NEUROL, V231, P72, DOI 10.1016/j.expneurol.2011.05.016; Barker GRI, 2007, J NEUROSCI, V27, P2948, DOI 10.1523/JNEUROSCI.5289-06.2007; Barreto G, 2009, ENDOCRINOLOGY, V150, P5010, DOI 10.1210/en.2009-0352; Baulieu EE, 2000, STEROIDS, V65, P605, DOI 10.1016/S0039-128X(00)00173-2; Benkovic SA, 2004, BRAIN RES, V1024, P59, DOI 10.1016/j.brainres.2004.07.021; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; Cabrera V, 2009, NEUROSCI LETT, V461, P136, DOI 10.1016/j.neulet.2009.06.017; Carroll JC, 2007, J NEUROSCI, V27, P13357, DOI 10.1523/JNEUROSCI.2718-07.2007; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Franssen CL, 2011, J NEUROENDOCRINOL, V23, P1177, DOI 10.1111/j.1365-2826.2011.02225.x; Gatewood JD, 2005, BRAIN RES BULL, V66, P91, DOI 10.1016/j.brainresbull.2005.03.016; Gibson CL, 2005, EXP NEUROL, V193, P522, DOI 10.1016/j.expneurol.2005.01.009; Guerra-Araiza C, 2003, J NEUROENDOCRINOL, V15, P984, DOI 10.1046/j.1365-2826.2003.01088.x; Guerra-Araiza C, 2000, LIFE SCI, V66, P1743, DOI 10.1016/S0024-3205(00)00497-5; Guerra-Araiza C, 2001, BRAIN RES BULL, V54, P13, DOI 10.1016/S0361-9230(00)00410-X; He J, 2004, EXP NEUROL, V189, P404, DOI 10.1016/j.expneurol.2004.06.008; Hilton GD, 2006, ENDOCRINOLOGY, V147, P1246, DOI 10.1210/en.2005-1258; Irwin RW, 2008, ENDOCRINOLOGY, V149, P3167, DOI 10.1210/en.2007-1227; KESSLAK JP, 1986, BEHAV NEUROSCI, V100, P280, DOI 10.1037/0735-7044.100.2.280; Kinsley CH, 2006, SCI AM, V294, P72, DOI 10.1038/scientificamerican0106-72; Kinsley CH, 2006, HORM BEHAV, V49, P131, DOI 10.1016/j.yhbeh.2005.05.017; Kinsley CH, 1999, NATURE, V402, P137, DOI 10.1038/45957; Kinsley CH, 2008, J NEUROENDOCRINOL, V20, P515, DOI 10.1111/j.1365-2826.2008.01667.x; Kinsley CH, 2008, ARCH SEX BEHAV, V37, P43, DOI 10.1007/s10508-007-9277-x; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Lambert KG, 2005, PHYSIOL BEHAV, V84, P799, DOI 10.1016/j.physbeh.2005.03.012; Lambert KG., 2008, PARENTAL BRAIN; Love G, 2005, BEHAV NEUROSCI, V119, P1084, DOI 10.1037/0735-7044.119.4.1084; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; Morales T, 2011, J NEUROENDOCRINOL, V23, P994, DOI 10.1111/j.1365-2826.2011.02141.x; NADLER JV, 1978, NATURE, V271, P676, DOI 10.1038/271676a0; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P10506, DOI 10.1073/pnas.1334098100; Nilsen J, 2002, ENDOCRINOLOGY, V143, P205, DOI 10.1210/en.143.1.205; OLNEY JW, 1979, BRAIN RES, V176, P91, DOI 10.1016/0006-8993(79)90872-2; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Panter S. S., 1992, PRINCIPLES PRACTICE, P32; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Salmaso N, 2005, NEUROSCIENCE, V134, P1431, DOI 10.1016/j.neuroscience.2005.05.038; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schumacher M, 2007, PHARMACOL THERAPEUT, V116, P77, DOI 10.1016/j.pharmthera.2007.06.001; Sofroniew MV, 2005, NEUROSCIENTIST, V11, P400, DOI 10.1177/1073858405278321; SPERK G, 1983, NEUROSCIENCE, V10, P1301, DOI 10.1016/0306-4522(83)90113-6; Stein DG, 2008, BRAIN RES REV, V57, P386, DOI 10.1016/j.brainresrev.2007.06.012; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vanoye-Carlo A, 2008, HORM BEHAV, V53, P112, DOI 10.1016/j.yhbeh.2007.09.004; Warner R. C., 2007, APPL STAT; Yudofsky S.C., 2005, TXB TRAUMATIC BRAIN, P27	51	18	18	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	MAY 15	2012	1454						80	89		10.1016/j.brainres.2012.03.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	944GB	WOS:000304186200007	22483962				2022-02-06	
J	Triebel, KL; Martin, RC; Novack, TA; Dreer, L; Turner, C; Pritchard, PR; Raman, R; Marson, DC				Triebel, K. L.; Martin, R. C.; Novack, T. A.; Dreer, L.; Turner, C.; Pritchard, P. R.; Raman, R.; Marson, D. C.			Treatment consent capacity in patients with traumatic brain injury across a range of injury severity	NEUROLOGY			English	Article							DECISION-MAKING CAPACITY; MILD HEAD-INJURY; PERFUSION; AMNESIA; IMPAIRMENT; CONCUSSION; RECOVERY; 3T; CT	Objective: To investigate medical decision-making capacity (MDC) in patients with acute traumatic brain injury (TBI) across a range of injury severity. Methods: We evaluated MDC cross-sectionally 1 month after injury in 40 healthy controls and 86 patients with TBI stratified by injury severity (28 mild [mTBI], 15 complicated mild [cmTBI], 43 moderate/severe [msevTBI]). We compared group performance on the Capacity to Consent to Treatment Instrument and its 5 consent standards (expressing choice, reasonable choice, appreciation, reasoning, understanding). Capacity impairment ratings (no impairment, mild/moderate impairment, severe impairment) on the consent standards were also assigned to each participant with TBI using cut scores referenced to control performance. Results: One month after injury, the mTBI group performed equivalently to controls on all consent standards. In contrast, the cmTBI group was impaired relative to controls on the understanding standard. No differences emerged between the mTBI and cmTBI groups. The msevTBI group was impaired on almost all standards relative to both control and mTBI groups, and on the understanding standard relative to the cmTBI group. Capacity compromise (mild/moderate or severe impairment ratings) on the 3 clinically complex standards (understanding, reasoning, appreciation) occurred in 10%-30% of patients with mTBI, 50% of patients with cmTBI, and 50%-80% of patients with msevTBI. Conclusions: One month following injury, MDC is largely intact in patients with mTBI, but is impaired in patients with cmTBI and msevTBI. Impaired MDC is prevalent in acute TBI and is strongly related to injury severity. Neurology (R) 2012;78:1472-1478	[Triebel, K. L.; Martin, R. C.; Turner, C.; Marson, D. C.] Univ Alabama Birmingham, Dept Neurol, Div Neuropsychol, Birmingham, AL 35294 USA; [Novack, T. A.] Univ Alabama Birmingham, Dept Phys Med & Rehabil, Birmingham, AL USA; [Dreer, L.] Univ Alabama Birmingham, Dept Ophthalmol, Birmingham, AL USA; [Pritchard, P. R.] Univ Alabama Birmingham, Dept Surg, Div Neurosurg, Birmingham, AL USA; [Raman, R.] UCSD, Dept Family & Prevent Med, San Diego, CA USA		Marson, DC (corresponding author), Univ Alabama Birmingham, Dept Neurol, Div Neuropsychol, Birmingham, AL 35294 USA.	dmarson@uab.edu	triebel, kristen/A-6569-2019	triebel, kristen/0000-0001-9161-7847; Martin, Roy/0000-0001-9328-0846	National Institute on Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01HD053074]; NIH (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1R01 HD053074, 2R01 AG021927-06A1, CDC MM-1042, NIA 2R01 AG021927-06A1]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30 AG031054, R01 AG021927, 1P50 AG16582, 1R01 AG021927, P30AG031054]; NIH for NICHD [1R01 HD053074]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [K23 EY017327]; EyeSight Foundation of Alabama; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Medtronic Spine LLC; NIH (NIA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [AG021927, AG16582, AG24904, AG10483]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD053074] Funding Source: NIH RePORTER	Supported by the National Institute on Child Health and Human Development (1R01HD053074) (Dr. Marson, PI).; Dr. Triebel receives research support from the NIH (NICHD 1R01 HD053074 and 2R01 AG021927-06A1) and has received research support from the National Institute on Aging (P30 AG031054 and R01 AG021927). Dr. Martin receives research support from the NIH (NICHD 1R01 HD053074, 2R01 AG021927-06A1, and CDC MM-1042) and has received research support from the NIA (1P50 AG16582 and 1R01 AG021927). Dr. Novack receives research support from the NIH for NICHD 1R01 HD053074. Dr. Dreer receives research support from the National Eye Institute (K23 EY017327), the EyeSight Foundation of Alabama, and Research to Prevent Blindness, and has received research support from the National Institute on Aging (P30AG031054). Ms. Turner receives research support from the NIH for NICHD 1R01 HD053074. Dr. Pritchard receives research support from the NIH for NICHD 1R01 HD053074 and from Medtronic Spine LLC, and has served as a training and educational consultant for Medtronic/Kyphon. Dr. Marson serves as a consultant to Medivation, Inc. and for the American Bar Association and American Psychological Association; receives research support from the NIH (NICHD 1R01 HD053074 and NIA 2R01 AG021927-06A1); has received research support from the NIH (NIA AG021927, AG16582, NIA Director's Supplementary Reserve, AG24904, and AG10483); and receives royalty payments as coinventor of CCTI assessment instrument, which is owned by UAB Research Foundation (since 1996). Go to Neurology.org for full disclosures.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; APPELBAUM PS, 1988, NEW ENGL J MED, V319, P1635, DOI 10.1056/NEJM198812223192504; Borgaro SR, 2003, BRAIN INJURY, V17, P189, DOI 10.1080/0269905021000013183; Bushnik T, 2008, ARCH PHYS MED REHAB, V89, P894, DOI 10.1016/j.apmr.2008.03.001; Dahmer E., 1993, J HEAD TRAUMA REHAB, V8, P12, DOI [10.1097/00001199-199308020-00004, DOI 10.1097/00001199-199308020-00004]; de Guise E, 2010, CLIN NEUROPSYCHOL, V24, P1113, DOI 10.1080/13854046.2010.506199; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Dreer LE, 2008, REHABIL PSYCHOL, V53, P486, DOI 10.1037/a0013798; Dymek MP, 1999, J FORENSIC NEUROPSYC, V1, P27, DOI DOI 10.1300/J151V01N01_; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Iverson GL, 2006, BRAIN INJURY, V20, P1335, DOI 10.1080/02699050601082156; Kraus J, 2009, J HEAD TRAUMA REHAB, V24, P344, DOI 10.1097/HTR.0b013e3181ae35fd; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Marson DC, 2005, ARCH PHYS MED REHAB, V86, P889, DOI 10.1016/j.apmr.2004.09.020; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M.A., 2007, MILD TRAUMATIC BRAIN; MCKINLAY W, 1999, REHABILITATION ADULT, P74; Metting Z, 2010, J NEUROTRAUM, V27, P2183, DOI 10.1089/neu.2010.1395; Metting Z, 2009, ANN NEUROL, V66, P809, DOI 10.1002/ana.21785; MILLER JD, 1993, J NEUROL NEUROSUR PS, V56, P440, DOI 10.1136/jnnp.56.5.440; Okonkwo O, 2007, NEUROLOGY, V69, P1528, DOI 10.1212/01.wnl.0000277639.90611.d9; Pentland B, 1999, REHABILITATION ADULT, P42; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rosenthal M, 2000, HANDBOOK OF REHABILITATION PSYCHOLOGY, P49, DOI 10.1037/10361-003; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; SPSS, 2004, STAT PACK SOC SCI SP; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Triebel KL, 2009, NEUROLOGY, V73, P2086, DOI 10.1212/WNL.0b013e3181c67bce; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289	34	18	18	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0028-3878			NEUROLOGY	Neurology	MAY	2012	78	19					1472	1478		10.1212/WNL.0b013e3182553c38			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	939AW	WOS:000303776900008	22496195	Green Published			2022-02-06	
J	Chiba, Y; Kuroda, S; Osanai, T; Shichinohe, H; Houkin, K; Iwasaki, Y				Chiba, Yasuhiro; Kuroda, Satoshi; Osanai, Toshiya; Shichinohe, Hideo; Houkin, Kiyohiro; Iwasaki, Yoshinobu			Impact of ageing on biological features of bone marrow stromal cells (BMSC) in cell transplantation therapy for CNS disorders: Functional enhancement by granulocyte-colony stimulating factor (G-CSF)	NEUROPATHOLOGY			English	Article						ageing; bone marrow stromal cell (BMSC); brain freezing injury; G-CSF; transplantation	MESENCHYMAL STEM-CELLS; MICE CEREBRAL INFARCT; SPINAL-CORD; INJURY; DIFFERENTIATION; SENESCENCE; EXPRESSION; RECOVERY; CULTURE; YOUNG	This study was designed to clarify the effects of donor age on biological features of bone marrow stromal cells (BMSC), one of the candidates for cell transplantation therapy for CNS disorders, because many aged patients might require such therapy. This study was also aimed to test whether ex vivo treatments with granulocyte-colony stimulating factor (G-CSF) could modify biological properties of BMSC from aged donors and enhance its therapeutic effects in an animal model of traumatic brain injury. The BMSC were harvested from young (6-week-old) and aged (100-week-old) rats. The ageing significantly increased the senescence-associated beta-galactosidase (SA-beta-gal) activity of the cultured BMSC, and decreased their proliferative capacity and production of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF). As the next step, the rats were subjected to brain freezing injury by applying liquid nitrogen onto the neocortex through the thinned skull. The 6-week BMSC, 100-week BMSC, G-CSF-treated 100-week BMSC or vehicle were stereotactically injected into the ipsilateral striatum at 7 days post-injury. Transplantation of the 6-week BMSC, but not 100-week BMSC, significantly improved locomotor function. However, treatment of the 100-week BMSC with 0.1 mu mol of G-CSF significantly improved their proliferation activity and growth factor production, and recovered therapeutic effects in the injured brain. In conclusion, donor age may largely determine biological aspects of BMSC. G-CSF may contribute to improve the outcome of BMSC transplantation therapy for CNS disorders in aged patients.	[Kuroda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, Sapporo, Hokkaido 0608638, Japan		Kuroda, S (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	skuroda@med.hokudai.ac.jp	Osanai, Toshiya/AAF-3011-2020; Shichinohe, Hideo/G-5367-2012; Houkin, Kiyohiro/G-5364-2012		Ministry of Education, Science and Culture of JapanMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [19390371, 20591701, 20390377, 21390400, 23390342]; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [23390342] Funding Source: KAKEN	This study was supported by Grant-in-aid from the Ministry of Education, Science and Culture of Japan (No.19390371, 20591701, 20390377, 21390400, and 23390342). The authors sincerely thank Yumiko Shinohe for her technical assistance with cell cultures and immunohistochemistry.	Beausejour C., 2007, V180, P67; Chiba Y, 2009, NEUROSURGERY, V64, P991, DOI 10.1227/01.NEU.0000341905.57162.1D; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Garcia R, 2004, BIOCHEM BIOPH RES CO, V316, P753, DOI 10.1016/j.bbrc.2004.02.111; Gu Y, 2010, J MOL NEUROSCI, V40, P332, DOI 10.1007/s12031-009-9304-6; Hokari M, 2008, J NEUROSCI RES, V86, P1024, DOI 10.1002/jnr.21572; Hokari M, 2009, CYTOKINE, V46, P260, DOI 10.1016/j.cyto.2009.02.008; Itosaka H, 2009, NEUROPATHOLOGY, V29, P248, DOI 10.1111/j.1440-1789.2008.00971.x; Jiang S, 2008, J MOL CELL CARDIOL, V44, P582, DOI 10.1016/j.yjmcc.2007.11.014; Kinnaird T, 2004, CIRC RES, V94, P678, DOI 10.1161/01.RES.0000118601.37875.AC; Kuroda S, 2011, J STEM CELLS REGEN, V7, P2; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Lee JB, 2004, BRAIN RES PROTOC, V14, P37, DOI 10.1016/j.brainresprot.2004.09.004; Lu J, 2006, NEUROSCI LETT, V398, P12, DOI 10.1016/j.neulet.2005.12.053; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Maruichi K, 2009, NEUROPATHOLOGY, V29, P422, DOI 10.1111/j.1440-1789.2008.00995.x; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Sethe S, 2006, AGEING RES REV, V5, P91, DOI 10.1016/j.arr.2005.10.001; Shichinohe H, 2004, BRAIN RES PROTOC, V13, P166, DOI 10.1016/j.brainresprot.2004.04.004; Shichinohe H, 2007, BRAIN RES, V1183, P138, DOI 10.1016/j.brainres.2007.08.091; Shichinohe H, 2006, J NUCL MED, V47, P486; Stenderup K, 2003, BONE, V33, P919, DOI 10.1016/j.bone.2003.07.005; von Aulock Sonja, 2004, Curr Opin Investig Drugs, V5, P1148; Wagner W, 2010, AGING-US, V2, P224, DOI 10.18632/aging.100136; Wagner W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005846; Wang YQ, 2008, CHINESE MED J-PEKING, V121, P2290, DOI 10.1097/00029330-200811020-00015; Welte K, 1985, Haematol Blood Transfus, V29, P398; Wilkins A, 2009, STEM CELL RES; Wright KT, 2008, SPINAL CORD, V46, P811, DOI 10.1038/sc.2008.77; Yamaguchi S, 2006, BRAIN RES, V1087, P15, DOI 10.1016/j.brainres.2006.02.127; Yano S, 2005, BRAIN RES, V1065, P60, DOI 10.1016/j.brainres.2005.10.031; Yasuda H, 2010, J NEUROSURG, V112, P336, DOI 10.3171/2009.2.JNS08495; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zhuo YF, 2010, J THORAC CARDIOV SUR, V139, P1286, DOI 10.1016/j.jtcvs.2009.08.052	34	18	21	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	APR	2012	32	2					139	148		10.1111/j.1440-1789.2011.01255.x			10	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	915DH	WOS:000302003500005	21981141				2022-02-06	
J	LaPar, DJ; Rosenberger, LH; Walters, DM; Hedrick, TL; Swenson, BR; Young, JS; Dossett, LA; May, AK; Sawyer, RG				LaPar, Damien J.; Rosenberger, Laura H.; Walters, Dustin M.; Hedrick, Traci L.; Swenson, Brian R.; Young, Jeffrey S.; Dossett, Lesly A.; May, Addison K.; Sawyer, Robert G.			Severe Traumatic Head Injury Affects Systemic Cytokine Expression	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	123rd Annual Meeting of the Southern-Surgical-Association	DEC, 2011	Hot Springs, VA	So Surg Assoc			TUMOR-NECROSIS-FACTOR; BRAIN-INJURY; CEREBROSPINAL-FLUID; INTERLEUKIN-6; PATHOGENESIS; INFLAMMATION; DYSFUNCTION; SURVIVAL; ALPHA; CELLS	BACKGROUND: The neuroimmunologic effect of traumatic head injury remains ill-defined. This study aimed to characterize systemic cytokine profiles among traumatically injured patients to assess the effect of traumatic head injury on the systemic inflammatory response. STUDY DESIGN: For 5 years, 1,022 patients were evaluated from a multi-institutional Trauma Immunomodulatory Database. Patients were stratified by presence of severe head injury (SHI; head Injury Severity Score >= 4, n = 335) vs nonsevere head injury (NHI; head Injury Severity Score <= 3, n = 687). Systemic cytokine expression was quantified by ELISA within 72 hours of admission. Patient factors, outcomes, and cytokine profiles were compared by univariate analyses. RESULTS: SHI patients were more severely injured with higher mortality, despite similar ICU infection and ventilator-associated pneumonia rates. Expression of early proinflammatory cytokines, interleukin-6 (p < 0.001) and tumor necrosis factor-alpha (p = 0.02), was higher among NHI patients, and expression of immunomodulatory cytokines, interferon-gamma (p = 0.01) and interleukin-12 (p = 0.003), was higher in SHI patients. High tumor necrosis factor-alpha levels in NHI patients were associated with mortality (p = 0.01), increased mechanical ventilation (p = 0.02), and development of ventilator-associated pneumonia (p = 0.01). Alternatively, among SHI patients, high interleukin-2 levels were associated with survival, decreased mechanical ventilation, and absence of ventilator-associated pneumonia. CONCLUSIONS: The presence of severe traumatic head injury significantly alters systemic cytokine expression and exerts an immunomodulatory effect. Early recognition of these profiles can allow for targeted intervention to reduce patient morbidity and mortality. (J Am Coll Surg 2012;214:478-488. (C) 2012 by the American College of Surgeons)	[LaPar, Damien J.; Rosenberger, Laura H.; Walters, Dustin M.; Hedrick, Traci L.; Swenson, Brian R.; Young, Jeffrey S.; Sawyer, Robert G.] Univ Virginia, Dept Surg, Div Trauma & Surg Crit Care, Charlottesville, VA 22903 USA; [Dossett, Lesly A.; May, Addison K.] Vanderbilt Univ, Dept Surg, Med Ctr, Div Trauma & Surg Crit Care, Nashville, TN 37240 USA		LaPar, DJ (corresponding author), Univ Virginia, Dept Surg, Div Trauma & Surg Crit Care, POB 800681, Charlottesville, VA 22903 USA.	djl8w@virginia.edu	Hedrick, Traci/AAG-9788-2019; Dossett, Lesly/I-8881-2019	Dossett, Lesly/0000-0001-8060-1073; Sawyer, Robert/0000-0002-8155-2661	NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL007849] Funding Source: NIH RePORTER; NHLBI NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32 HL007849, T32 HL007849-11A1] Funding Source: Medline		BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Boddie DE, 2003, BRIT J NEUROSURG, V17, P405, DOI 10.1080/02688690310001611198; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Bone RC, 1997, CHEST, V112, P235, DOI 10.1378/chest.112.1.235; Correale J, 2004, J NEUROL, V251, P1304, DOI 10.1007/s00415-004-0649-z; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Delgado-Rodriguez M, 1999, J HOSP INFECT, V41, P203, DOI 10.1016/S0195-6701(99)90017-8; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HELLING TS, 1988, J TRAUMA, V28, P1575, DOI 10.1097/00005373-198811000-00009; Helmy A, 2011, PROG NEUROBIOL, V95, P352, DOI 10.1016/j.pneurobio.2011.09.003; Hranjec T, 2010, J AM COLL SURGEONS, V210, P833, DOI 10.1016/j.jamcollsurg.2009.12.042; Jones NC, 2005, EUR J NEUROSCI, V22, P72, DOI 10.1111/j.1460-9568.2005.04221.x; Kadhim Hazim J, 2008, J Intensive Care Med, V23, P236, DOI 10.1177/0885066608318458; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; Kossmann T, 1996, BRAIN RES, V713, P143, DOI 10.1016/0006-8993(95)01501-9; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; MILLER C H, 1991, Neurological Research, V13, P117; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Morganti-Kossmann MC, 2001, SHOCK, V16, P165, DOI 10.1097/00024382-200116030-00001; MorgantiKossman MC, 1997, MOL PSYCHIATR, V2, P133, DOI 10.1038/sj.mp.4000227; OTT L, 1994, J NEUROTRAUM, V11, P447, DOI 10.1089/neu.1994.11.447; QUATTROCCHI K B, 1991, Neurological Research, V13, P13; QUATTROCCHI KB, 1991, J NEUROSURG, V75, P766, DOI 10.3171/jns.1991.75.5.0766; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; SATOH T, 1988, MOL CELL BIOL, V8, P3546, DOI 10.1128/MCB.8.8.3546; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Whalen MJ, 2000, CRIT CARE MED, V28, P929, DOI 10.1097/00003246-200004000-00003; Xu Jiaquan, 2010, Natl Vital Stat Rep, V58, P1; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	32	18	21	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	APR	2012	214	4					478	486		10.1016/j.jamcollsurg.2011.12.015			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	921NW	WOS:000302485300019	22342787	Green Accepted			2022-02-06	
J	Sahni, T; Jain, M; Prasad, R; Sogani, SK; Singh, VP				Sahni, Tarun; Jain, Madhur; Prasad, Rajendra; Sogani, Shanti K.; Singh, Varindera. P.			Use of hyperbaric oxygen in traumatic brain injury: Retrospective analysis of data of 20 patients treated at a tertiary care centre	BRITISH JOURNAL OF NEUROSURGERY			English	Article						brain; cognitive function; brain ischemia; hyperbaric oxygen therapy; neurorehabilitation; traumatic brain injury	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; TECHNETIUM-99M-HMPAO SPECT; INTRACRANIAL-PRESSURE; CLINICAL-TRIALS; THERAPY; METABOLISM; DYSFUNCTION; IMPROVEMENT; MODERATE	Traumatic brain injury (TBI) related impact results in a permanent need for help in performing daily activities. Standard treatment consists of removing the cause, restore perfusion, support metabolic requirement and limit inflammatory and oxidative damage. Hyperbaric oxygen therapy (HBOT) is one such newer promising treatment that enhances neurological recovery to some extent. HBOT is intermittent inhalation of 100% oxygen at greater than normal atmospheric pressure and is internationally accepted for its role in well-defined indications. It is hypothesised that HBO has a role in reviving 'idling neurons', also called the ischemic penumbra defined as area of reduced cerebral blood flow, abolished synaptic activity but preserved structural integrity. We carried out a retrospective analysis of medical records of 20 patients of TBI who had been treated with HBOT in addition to standard management. These were placed in Group A (test group) and received at least 30 sessions of HBO along with standard treatment. The patients were assessed along the Disability Rating Scale (DRS), Glasgow coma scale (GCS) and Rancho Los Amigos Scale (RLAS). Another 20 patients of TBI, matched in age and severity of brain injury, who received standard treatment but not HBOT, were selected as the control group (Group B). Assessment on the DRS showed maximum improvement in patients with scores of 22-24 (vegetative state). The percentage of patients in the test group fell from 45% to 5% whereas only 20% patients in Group B had similar progress. After the treatment, a significantly higher proportion of HBOT treated subjects showed a good response in cognitive functions, as measured by RLA. In group A, 90% patients had a score of <= 3 and in Group B 95% had a similar score, which improved to >= 3 in 60% patients versus 30% patients respectively. In both groups maximum patients are in 1-6 months post-injury category and within the groups this category showed the greatest recovery, with a greater improvement in the test group as compared to control group.	[Sahni, Tarun; Jain, Madhur] Indraprastha Apollo Hosp, Dept Hyperbar Oxygen Therapy, New Delhi 110076, India; [Prasad, Rajendra; Sogani, Shanti K.; Singh, Varindera. P.] Indraprastha Apollo Hosp, Dept Neurosurg, New Delhi 110076, India		Sahni, T (corresponding author), Indraprastha Apollo Hosp, Dept Internal & Hyperbar Med, Delhi Mathura Rd, New Delhi 110076, India.	tarun.sahni@adventhcg.com					Adamides AA, 2006, ANZ J SURG, V76, P163, DOI 10.1111/j.1445-2197.2006.03674.x; Al-Waili NS, 2005, ADV THER, V22, P659, DOI 10.1007/BF02849960; Barrett KF, 2004, UNDERSEA HYPERBAR M, V31, P395; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Daugherty WP, 2004, J NEUROSURG, V101, P499, DOI 10.3171/jns.2004.101.3.0499; DEMOPOULOS HB, 1982, PATHOLOGY OXYGEN, P127; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; Fam SS, 2003, CURR MED CHEM, V10, P1723, DOI 10.2174/0929867033457115; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Golden Z, 2006, DISABIL REHABIL, V28, P1379, DOI 10.1080/09638280600638364; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; GRAY BG, 1992, J NUCL MED, V33, P52; Harch PG, 2007, BRAIN RES, V1174, P120, DOI 10.1016/j.brainres.2007.06.105; Harch PG, TXB HYPERBARIC MED; Hardy P, 2007, J NEUROL SCI, V253, P94, DOI 10.1016/j.jns.2006.12.005; HOLBACH KH, 1974, ACTA NEUROCHIR, V30, P247, DOI 10.1007/BF01405583; Holbach KH, 1977, P 6 INT C HYP MED, VE, P104; HOLBACH KH, 1973, ADV NEUROSURG, V1, P158; ICHISE M, 1994, J NUCL MED, V35, P217; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; Lifshitz J, 2004, MITOCHONDRION, V4, P705, DOI 10.1016/j.mito.2004.07.021; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Liu Zhan, 2006, Chin J Traumatol, V9, P168; Magnoni S, 2003, J NEUROSURG, V98, P952, DOI 10.3171/jns.2003.98.5.0952; McDonagh M, 2004, ARCH PHYS MED REHAB, V85, P1198, DOI 10.1016/j.apmr.2003.12.026; Menzel M, 1999, J NEUROSURG, V91, P1, DOI 10.3171/jns.1999.91.1.0001; MILLER JD, 1971, ARCH NEUROL-CHICAGO, V24, P210, DOI 10.1001/archneur.1971.00480330038003; MINK RB, 1995, STROKE, V26, P2307, DOI 10.1161/01.STR.26.12.2307; MOGAMI H, 1969, J NEUROSURG, V31, P636, DOI 10.3171/jns.1969.31.6.0636; Murr R, 1996, ACTA NEUROCHIR, V138, P928, DOI 10.1007/BF01411281; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Neubauer RA, 2005, J AM PHYS SURGEONS, V2; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Palzur E, 2008, BRAIN RES, V1221, P126, DOI 10.1016/j.brainres.2008.04.078; Puvanachandra P, 2009, PAK J NEUROL SCI, V4, P27; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363	40	18	25	0	9	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.	APR	2012	26	2					202	207		10.3109/02688697.2011.626879			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	912XP	WOS:000301835000008	22085249				2022-02-06	
J	Zouridakis, G; Patidar, U; Situ, N; Rezaie, R; Castillo, EM; Levin, HS; Papanicolaou, AC				Zouridakis, George; Patidar, Udit; Situ, Ning; Rezaie, Roozbeh; Castillo, Eduardo M.; Levin, Harvey S.; Papanicolaou, Andrew C.			FUNCTIONAL CONNECTIVITY CHANGES IN MILD TRAUMATIC BRAIN INJURY ASSESSED USING MAGNETOENCEPHALOGRAPHY	JOURNAL OF MECHANICS IN MEDICINE AND BIOLOGY			English	Article						Functional connectivity; traumatic brain injury; Granger causality; MEG	COHERENT OSCILLATIONS; NETWORKS; SYNCHRONIZATION; DYNAMICS	In this study, we analyzed brain connectivity profiles from 10 mild traumatic brain injury (mTBI) patients and 10 age- and gender-matched normal controls. We computed Granger causality measures from magnetoencephalographic (MEG) activity obtained at the resting state, in an attempt to understand how the default network is affected by mTBI. A connectivity matrix was computed for each subject individually and then group templates were estimated by averaging all matrices in each group. Furthermore, we performed classification of the subjects using support vector machines and Fisher's criterion to rank the features and identify the best subset for maximum separation of the groups. Our results show that a combined model based on connectivity matrices and graph theory measures can provide a minimum of 85% classification accuracy in separating the two groups, with a sensitivity and specificity of 90% and 80%, respectively. These findings suggest that analysis of functional connectivity patterns may provide a valuable tool for early detection of mTBI.	[Zouridakis, George; Patidar, Udit; Situ, Ning] Univ Houston, Dept Comp Sci, Houston, TX 77204 USA; [Rezaie, Roozbeh; Castillo, Eduardo M.; Papanicolaou, Andrew C.] Univ Texas Med Sch, Ctr Clin Neurosci, Houston, TX USA; [Levin, Harvey S.] Baylor Coll Med, Cognit Neurosci Lab, Houston, TX 77030 USA		Zouridakis, G (corresponding author), Univ Houston, Dept Comp Sci, 218 Philip G Hoffman Hall, Houston, TX 77204 USA.	zouridakis@uh.edu	Zouridakis, George/R-8876-2019	Zouridakis, George/0000-0002-7770-9857; Rezaie, Roozbeh/0000-0002-7494-339X	GEAR; Institute for Space Systems Operations; Texas Learning and Computation Center at the University of Houston; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P01NS056202]; Mission Connect Translational Research Consortium from the Department of Defense [PTO74693P2]	This work was supported in part by a GEAR award, the Institute for Space Systems Operations, and the Texas Learning and Computation Center at the University of Houston, by Award P01NS056202 from the National Institute of Neurological Disorders and Stroke, and award PTO74693P2 Mission Connect Translational Research Consortium from the Department of Defense.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; [Anonymous], MISSION CONNECT MILD; Bartolomei F, 2006, CLIN NEUROPHYSIOL, V117, P2039, DOI 10.1016/j.clinph.2006.05.018; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Boake C, 2005, NEUROSURGERY, V56, P994, DOI 10.1227/01.NEU.0000158319.38230.C3; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Classen J, 1998, J NEUROPHYSIOL, V79, P1567, DOI 10.1152/jn.1998.79.3.1567; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fallani FDV, 2008, IEEE T NEUR SYS REH, V16, P442, DOI 10.1109/TNSRE.2008.2006196; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lago-Fernandez LF, 2000, PHYS REV LETT, V84, P2758, DOI 10.1103/PhysRevLett.84.2758; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; National Center for Injury Prevention and Control, 2003, C MILD TRAUM BRAIN I; National Institute of Neurological Disorders and Stroke Traumatic Brain Injury: Hope through research National Institutes of Health, 2002, NIH PUBL; Patidar U, 2010, THESIS U HOUSTON; Pollonini L, 2010, BRAIN TOPOGR, V23, P221, DOI 10.1007/s10548-010-0139-9; Pollonini P, 2010, 2010 ANN INT C IEEE, P1730; Rappelsberger P., 1994, Brain Topography, V7, P121, DOI 10.1007/BF01186770; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seth AK, 2005, NETWORK-COMP NEURAL, V16, P35, DOI 10.1080/09548980500238756; Seth AK, 2007, NEURAL COMPUT, V19, P910, DOI 10.1162/neco.2007.19.4.910; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Thompson E, 2001, TRENDS COGN SCI, V5, P418, DOI 10.1016/S1364-6613(00)01750-2; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zouridakis G, 2007, 2007 JOINT MEETING OF THE 6TH INTERNATIONAL SYMPOSIUM ON NONINVASIVE FUNCTIONAL SOURCE IMAGING OF THE BRAIN AND HEART AND THE INTERNATIONAL CONFERENCE ON FUNCTIONAL BIOMEDICAL IMAGING, P226	37	18	18	0	7	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-5194	1793-6810		J MECH MED BIOL	J. Mech. Med. Biol.	APR	2012	12	2							1240006	10.1142/S0219519412400064			13	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	925BA	WOS:000302733800006					2022-02-06	
J	Loske, P; Boato, F; Hendrix, S; Piepgras, J; Just, I; Ahnert-Hilger, G; Holtje, M				Loske, Peter; Boato, Francesco; Hendrix, Sven; Piepgras, Johannes; Just, Ingo; Ahnert-Hilger, Gudrun; Hoeltje, Markus			Minimal essential length of Clostridium botulinum C3 peptides to enhance neuronal regenerative growth and connectivity in a non-enzymatic mode	JOURNAL OF NEUROCHEMISTRY			English	Article						C3 transferase; regeneration; RhoA; spinal cord injury	SPINAL-CORD-INJURY; RHO; RECEPTOR; PROTEIN; OUTGROWTH; MOTONEURONS; INHIBITOR; EXOENZYME; RECOVERY; INSIGHTS	C3 ADP-ribosyltransferase is a valuable tool to study Rho-dependent cellular processes. In the current study we investigated the impact of enzyme-deficient peptides derived from Clostridium botulinum C3 transferase in the context of neuronal process elongation and branching, synaptic connectivity, and putative beneficial effects on functional outcome following traumatic injury to the CNS. By screening a range of peptidic fragments, we identified three short peptides from C3bot that promoted axon and dendrite outgrowth in cultivated hippocampal neurons. Furthermore, one of these fragments, a 26-amino acid peptide covering the residues 156181 enhanced synaptic connectivity in primary hippocampal culture. This peptide was also effective to foster axon outgrowth and re-innervation in organotypical brain slice culture. To evaluate the potential of the 26mer to foster repair mechanisms after CNS injury we applied this peptide to mice subjected to spinal cord injury by either compression impact or hemisection. A single local administration at the site of the lesion improved locomotor recovery. In addition, histological analysis revealed an increased serotonergic input to lumbar motoneurons in treated compared with control mice. Pull-down assays showed that lesion-induced up-regulation of RhoA activity within the spinal cord was largely blocked by C3bot peptides despite the lack of enzymatic activity.	[Hoeltje, Markus] Charite, Inst Integrat Neuroanat, Ctr Anat, D-10115 Berlin, Germany; [Boato, Francesco; Hendrix, Sven] Hasselt Univ, Dept Morphol, Hasselt, Belgium; [Boato, Francesco; Hendrix, Sven] Hasselt Univ, Inst Biomed, Hasselt, Belgium; [Just, Ingo] Hannover Med Sch MHH, Inst Toxicol, Hannover, Germany		Holtje, M (corresponding author), Charite, Inst Integrat Neuroanat, Ctr Anat, Philippstr 12, D-10115 Berlin, Germany.	markus.hoeltje@charite.de	Hendrix, Sven/F-4059-2010	Hendrix, Sven/0000-0003-2344-7369; Boato, Francesco/0000-0001-9741-8021	Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG) [HO 3249/2-1, JU 231/5-1, SPP1394]; Berlin-Brandenburg Center for Regenerative Therapies; Flemish Research Council (FWO)FWO	The authors are indebted to Birgit Metze, Annemarie Lochner and Julia Konig for their engaged and skillful technical assistance. Work was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) to MH and GAH (HO 3249/2-1), IJ (JU 231/5-1) and SH (SPP1394). This study was also supported in part by grants from the Berlin-Brandenburg Center for Regenerative Therapies and the Flemish Research Council (FWO) to SH. All authors declare no conflicts of interest.	Ahnert-Hilger G, 2004, J NEUROCHEM, V90, P9, DOI 10.1111/j.1471-4159.2004.02475.x; Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; Albertinazzi C, 1998, J CELL BIOL, V142, P815, DOI 10.1083/jcb.142.3.815; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bertrand J, 2007, NEUROBIOL DIS, V25, P65, DOI 10.1016/j.nbd.2006.08.008; Boato F, 2010, J CELL SCI, V123, P1652, DOI 10.1242/jcs.066050; Boido M, 2009, EUR J NEUROSCI, V30, P833, DOI 10.1111/j.1460-9568.2009.06879.x; Chen HX, 2007, J NEUROSCI, V27, P8378, DOI 10.1523/JNEUROSCI.0872-07.2007; Conrad S, 2005, J COMP NEUROL, V487, P166, DOI 10.1002/cne.20561; Dergham P, 2002, J NEUROSCI, V22, P6570; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005; Hechler D, 2006, BRAIN RES REV, V52, P160, DOI 10.1016/j.brainresrev.2006.01.005; Hechler D, 2010, EXP BRAIN RES, V205, P215, DOI 10.1007/s00221-010-2355-7; Henneberger C, 2005, EUR J NEUROSCI, V21, P431, DOI 10.1111/j.1460-9568.2005.03869.x; Holtje M, 2009, FASEB J, V23, P1115, DOI 10.1096/fj.08-116855; Jin Z, 1997, J NEUROSCI, V17, P6256; Just I, 2011, N-S ARCH PHARMACOL, V383, P247, DOI 10.1007/s00210-010-0589-3; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kalil K, 2000, J NEUROBIOL, V44, P145, DOI 10.1002/1097-4695(200008)44:2<145::AID-NEU5>3.0.CO;2-X; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li X, 2007, J NEUROPHYSIOL, V97, P1236, DOI 10.1152/jn.00995.2006; McKerracher L, 2006, J NEUROTRAUM, V23, P309, DOI 10.1089/neu.2006.23.309; Menetry J, 2008, PROTEIN SCI, V17, P878, DOI 10.1110/ps.073398508; Mullner A, 2008, EUR J NEUROSCI, V27, P326, DOI 10.1111/j.1460-9568.2007.06006.x; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Schmitt KRL, 2007, NEUROSCI RES, V59, P68, DOI 10.1016/j.neures.2007.05.011; Schmitt KRL, 2010, BRAIN PATHOL, V20, P771, DOI 10.1111/j.1750-3639.2009.00358.x; Schweigreiter R, 2004, MOL CELL NEUROSCI, V27, P163, DOI 10.1016/j.mcn.2004.06.004; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sheng HX, 2004, J NEUROTRAUM, V21, P595, DOI 10.1089/089771504774129928; Sieber-Blum M, 2006, MOL CELL NEUROSCI, V32, P67, DOI 10.1016/j.mcn.2006.02.003; Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5; Ung RV, 2008, EUR J NEUROSCI, V28, P2231, DOI 10.1111/j.1460-9568.2008.06508.x; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Wilde C, 2002, J BIOL CHEM, V277, P14771, DOI 10.1074/jbc.M201072200; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	42	18	19	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	MAR	2012	120	6					1084	1096		10.1111/j.1471-4159.2012.07657.x			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	903JL	WOS:000301112500020	22239108	Bronze			2022-02-06	
J	Talving, P; Lustenberger, T; Inaba, K; Lam, L; Mohseni, S; Chan, LD; Demetriades, D				Talving, Peep; Lustenberger, Thomas; Inaba, Kenji; Lam, Lydia; Mohseni, Shahin; Chan, Linda; Demetriades, Demetrios			Erythropoiesis-Stimulating Agent Administration and Survival After Severe Traumatic Brain Injury A Prospective Study	ARCHIVES OF SURGERY			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; NEUROPROTECTION; ANGIOGENESIS; EFFICACY; HEALTH; ALPHA	Objective: To validate previous findings of the effects of erythropoiesis-stimulating agent (ESA) administration following severe traumatic brain injury. Design: Prospective observational study of all patients with severe traumatic brain injury admitted to the surgical intensive care unit (SICU) at our institution from January 1, 2009, to December 31, 2010 (head Abbreviated Injury Scale score >= 3). Propensity scores were calculated to match patients who received ESA within 30 days after admission to patients who did not receive ESA. Patients: A total of 566 patients with severe traumatic brain injury were admitted to the SICU. After matching in a 1:1 ratio, 75 matched pairs were analyzed. Main Outcome Measures: A Glasgow Coma Scale score (difference between admission and SICU discharge), in-hospital morbidity, and mortality. Results: Patients who received ESA and control subjects who did not receive ESA had similar age, mechanisms of injury, vital signs on admission, Abbreviated Injury Scale scores, Injury Severity Scores, and specific intracranial injuries. Patients who received ESA experienced significantly longer lengths of stay in the SICU (mean [SD], 16.1 [1.3] days vs 8.6 [0.8] days; P < .001) and comparable SICU-free days. There was no statistically significant difference in the incidence of major in-hospital complications including deep venous thrombosis and pulmonary embolism when comparing the 2 study cohorts. The Delta Glasgow Coma Scale mean [standard error of the mean] score was 3.0 [0.4] and 2.4 [0.5] in patients who received ESA and those who did not, respectively (P=.33). However, in-hospital mortality was significantly lower for patients who received ESA compared with those who did not (9.3% vs 25.3%; odds ratio, 0.25; 95% CI, 0.08-0.75; P=.012). Conclusions: Erythropoiesis-stimulating agent administration demonstrates a significant survival advantage without an increase in morbidity in patients with severe traumatic brain injury.	[Talving, Peep] Univ So Calif, Keck Sch Med, Div Acute Care Surg, Dept Surg, Los Angeles, CA 90033 USA		Talving, P (corresponding author), Univ So Calif, Keck Sch Med, Div Acute Care Surg, Dept Surg, 1200 N State St,C5L100, Los Angeles, CA 90033 USA.	peep.talving@surgery.usc.edu	Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015	Talving, Peep/0000-0002-9741-2073			ANAGNOSTOU A, 1994, P NATL ACAD SCI USA, V91, P3974, DOI 10.1073/pnas.91.9.3974; Bennett CL, 2008, JAMA-J AM MED ASSOC, V299, P914, DOI 10.1001/jama.299.8.914; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Caucio L, 2008, J TRAUMA, V65, P297; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Chong ZZ, 2002, J HEMATOTH STEM CELL, V11, P863, DOI 10.1089/152581602321080529; Chong ZZ, 2002, CIRCULATION, V106, P2973, DOI 10.1161/01.CIR.0000039103.58920.1F; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; Corwin HL, 2006, TRANSFUS MED REV, V20, P27, DOI 10.1016/j.tmrv.2005.08.002; Corwin HL, 2002, JAMA-J AM MED ASSOC, V288, P2827, DOI 10.1001/jama.288.22.2827; Corwin HL, 2007, NEW ENGL J MED, V357, P965, DOI 10.1056/NEJMoa071533; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Fauchere JC, 2008, PEDIATRICS, V122, P375, DOI 10.1542/peds.2007-2591; Genc S, 2004, RESTOR NEUROL NEUROS, V22, P105; Grasso G, 2002, P NATL ACAD SCI USA, V99, P5627, DOI 10.1073/pnas.082097299; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2009, NEUROSURGERY, V65, P763, DOI 10.1227/01.NEU.0000347475.73347.5F; Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Juul SE, 2008, PEDIATRICS, V122, P383, DOI 10.1542/peds.2007-2711; Maiese K, 2004, RESTOR NEUROL NEUROS, V22, P87; Maiese K, 2005, JAMA-J AM MED ASSOC, V293, P90, DOI 10.1001/jama.293.1.90; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Napolitano LM, 2008, J TRAUMA, V65, P285, DOI 10.1097/TA.0b013e31817f2c6e; Nichol AD, 2009, INJURY, V40, P471, DOI 10.1016/j.injury.2009.01.002; Sakamaki K, 2004, CURR NEUROVASC RES, V1, P305, DOI 10.2174/1567202043362072; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Talving P, 2010, ANN SURG, V251, P1, DOI 10.1097/SLA.0b013e3181b844fa; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009	30	18	21	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0004-0010	1538-3644		ARCH SURG-CHICAGO	Arch. Surg.	MAR	2012	147	3					251	255		10.1001/archsurg.2011.1838			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	910LC	WOS:000301637200011	22430906	Bronze			2022-02-06	
J	Modig, F; Fransson, PA; Magnusson, M; Patel, M				Modig, Fredrik; Fransson, Per-Anders; Magnusson, Mans; Patel, Mitesh			Blood alcohol concentration at 0.06 and 0.10% causes a complex multifaceted deterioration of body movement control	ALCOHOL			English	Article						Postural control; Balance; Alcohol; Adaptation; Vision; Body movements	MOTOR COORDINATION; SUPPORT SURFACES; POSTURAL CONTROL; EYE-MOVEMENTS; ETHANOL; ADAPTATION; BALANCE; STIMULATION; INGESTION; INJURIES	Alcohol-related falls are recognized as a major contributor to the occurrence of traumatic brain injury. The control of upright standing balance is complex and composes of contributions from several partly independent mechanisms such as appropriate information from multiple sensory systems and correct feedback and feed forward movement control. Analysis of multisegmented body movement offers a rarely used option for detecting the fine motor problems associated with alcohol intoxication. The study aims were to investigate whether (1) alcohol intoxication at 0.06 and 0.10% blood alcohol concentration (BAC) affected the body movements under unperturbed and perturbed standing; and (2) alcohol affected the ability for sensorimotor adaptation. Body movements were recorded in 25 participants (13 women and 12 men, mean age 25.1 years) at five locations (ankle, knee, hip, shoulder, and head) during quiet standing and during balance perturbations from pseudorandom pulses of calf muscle vibration over 200 s with eyes closed or open. Tests were performed at 0.00, 0.06, and 0.10% BAC. The study revealed several significant findings: (1) an alcohol dose-specific effect; (2) a direction-specific stability decrease from alcohol intoxication; (3) a movement pattern change related to the level of alcohol intoxication during unperturbed standing and perturbed standing; (4) a sensorimotor adaptation deterioration with increased alcohol intoxication; and (5) that vision provided a weaker contribution to postural control during alcohol intoxication. Hence, alcohol intoxication at 0.06 and 0.10% BAC causes a complex multifaceted deterioration of human postural control. (C) 2012 Elsevier Inc. All rights reserved.	[Modig, Fredrik; Fransson, Per-Anders; Magnusson, Mans; Patel, Mitesh] Lund Univ, Dept Clin Sci, S-22185 Lund, Sweden		Fransson, PA (corresponding author), Lund Univ, Dept Clin Sci, S-22185 Lund, Sweden.	Per-Anders.Fransson@med.lu.se		Patel, Mitesh/0000-0001-6926-941X; Fransson, Per-Anders/0000-0002-9789-1748; Patel, Mitesh/0000-0002-3594-5448; Magnusson, Mans/0000-0002-4266-1996			Abroms BD, 2006, PSYCHOPHARMACOLOGY, V188, P324, DOI 10.1007/s00213-006-0524-y; Altman D.G., 1990, PRACTICAL STAT MED R; ASHBY P, 1977, ANN NEUROL, V1, P478, DOI 10.1002/ana.410010513; Bastian AJ, 2008, CURR OPIN NEUROL, V21, P628, DOI 10.1097/WCO.0b013e328315a293; Belmeguenai A, 2008, J NEUROPHYSIOL, V100, P3167, DOI 10.1152/jn.90384.2008; Blackburn JT, 2003, CLIN BIOMECH, V18, P655, DOI 10.1016/S0268-0033(03)00091-3; Boonstra TW, 2008, J NEUROPHYSIOL, V100, P2158, DOI 10.1152/jn.90474.2008; Connor J, 2004, EPIDEMIOLOGY, V15, P337, DOI 10.1097/01.ede.0000120045.58295.86; Corna S, 1999, EXP BRAIN RES, V124, P331, DOI 10.1007/s002210050630; DICK RB, 1989, BRIT J IND MED, V46, P111; DIENER HC, 1983, Z RECHTSMED, V90, P159, DOI 10.1007/BF02116226; Fransson M, 2005, MED SCI LAW, V45, P61, DOI 10.1258/rsmmsl.45.1.61; Fransson PA, 2007, EUR J APPL PHYSIOL, V101, P81, DOI 10.1007/s00421-007-0476-x; Fransson PA, 2007, J VESTIBUL RES-EQUIL, V17, P47; Fransson PA, 2010, CLIN NEUROPHYSIOL, V121, P2134, DOI 10.1016/j.clinph.2010.05.003; FUSTER JM, 1985, ALCOHOL, V2, P611, DOI 10.1016/0741-8329(85)90088-6; Gomez S, 2008, CLIN NEUROPHYSIOL, V119, P617, DOI 10.1016/j.clinph.2007.10.058; Gomez S, 2009, GAIT POSTURE, V30, P93, DOI 10.1016/j.gaitpost.2009.03.009; Granata KP, 2008, J ELECTROMYOGR KINES, V18, P172, DOI 10.1016/j.jelekin.2007.06.008; Hafstrom A, 2007, NEUROREPORT, V18, P391, DOI 10.1097/WNR.0b013e328013e3eb; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; Johansson R., 1993, SYSTEM MODELING IDEN; Johnston JJE, 2004, EMERG MED J, V21, P185, DOI 10.1136/emj.2003.006130; Kool B, 2008, ALCOHOL, V42, P383, DOI 10.1016/j.alcohol.2008.04.004; KUBO T, 1990, AM J OTOLARYNG, V11, P416, DOI 10.1016/0196-0709(90)90121-B; Lockhart DB, 2007, NAT NEUROSCI, V10, P1329, DOI 10.1038/nn1986; Moser A, 1998, J NEUROL, V245, P542, DOI 10.1007/s004150050240; MULLIKINKILPATRICK D, 1994, EUR J PHARM-ENVIRON, V270, P17, DOI 10.1016/0926-6917(94)90076-0; Nieschalk M, 1999, INT J LEGAL MED, V112, P253, DOI 10.1007/s004140050245; Oie KS, 2002, COGNITIVE BRAIN RES, V14, P164, DOI 10.1016/S0926-6410(02)00071-X; Pai YC, 1999, J BIOMECH, V32, P779, DOI 10.1016/S0021-9290(99)00074-3; Patel M, 2010, EXP BRAIN RES, V202, P431, DOI 10.1007/s00221-009-2150-5; Patel M, 2009, CLIN NEUROPHYSIOL, V120, P601, DOI 10.1016/j.clinph.2008.11.026; Pavol MJ, 2002, EXP BRAIN RES, V145, P528, DOI 10.1007/s00221-002-1143-4; Servais L, 2005, BRAIN RES, V1055, P171, DOI 10.1016/j.brainres.2005.07.026; Talving P, 2010, J TRAUMA, V68, P357, DOI 10.1097/TA.0b013e3181bb80bf; Testa M, 2006, ALCOHOL CLIN EXP RES, V30, P339, DOI 10.1111/j.1530-0277.2006.00039.x; THYSSEN HH, 1981, Z RECHTSMED, V87, P257; TIANWU H, 1995, ACTA OTO-LARYNGOL, P127; Tjernstrom F, 2002, GAIT POSTURE, V15, P75, DOI 10.1016/S0966-6362(01)00175-8; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TREISTMAN SN, 1991, ANN NY ACAD SCI, V625, P249, DOI 10.1111/j.1749-6632.1991.tb33844.x; VOGELSPROTT MD, 1979, PSYCHOPHARMACOLOGY, V61, P287, DOI 10.1007/BF00432274; WANG MQ, 1992, PERCEPT MOTOR SKILL, V75, P1095, DOI 10.2466/PMS.75.8.1095-1106; WOOLLACOTT MH, 1983, EXP NEUROL, V80, P55, DOI 10.1016/0014-4886(83)90006-7	45	18	18	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0741-8329	1873-6823		ALCOHOL	Alcohol	FEB	2012	46	1					75	88		10.1016/j.alcohol.2011.06.001			14	Substance Abuse; Pharmacology & Pharmacy; Toxicology	Science Citation Index Expanded (SCI-EXPANDED)	Substance Abuse; Pharmacology & Pharmacy; Toxicology	885DC	WOS:000299757700009	21816558	Green Submitted			2022-02-06	
J	Xu, JF; Liu, WG; Dong, XQ; Yang, SB; Fan, J				Xu, Jin-Fang; Liu, Wei-Guo; Dong, Xiao-Qiao; Yang, Song-Bin; Fan, Jing			Change in plasma gelsolin level after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Gelsolin; traumatic brain injury; mortality; prognosis	SCAVENGER SYSTEM; HEAD-INJURY; ACTIN; SERUM; DEPRESSION; PREDICTOR; MORTALITY; PROTECTS; OUTCOMES; S100B	BACKGROUND: Plasma gelsolin depletion has been associated with poor outcome of critically ill patients. However, there is a paucity of data available on circulating plasma gelsolin concentration in traumatic brain injury (TBI). Thus, we sought to investigate change in plasma gelsolin level after TBI and to evaluate its relation with disease outcome. METHODS: Fifty healthy controls and 94 patients with acute severe TBI were included. Plasma samples were obtained on admission and at days 1, 2, 3, 5, and 7. Its concentration was measured by enzyme-linked immunosorbent assay. RESULTS: Twenty-six patients (27.7%) died from TBI in a month. After TBI, plasma gelsolin level in patients decreased during the 6-hour period immediately, was at the nadir in 24 hours, increased gradually thereafter, and was substantially lower than that in healthy controls during the 7-day period. A multivariate analysis showed plasma gelsolin level was an independent predictor for 1-month mortality (odds ratio, 0.941; 95% confidence interval, 0.895-0.989; p = 0.017) and positively associated with Glasgow Coma Scale (GCS) score (t = 6.538, p < 0.001). A receiver operating characteristic curve identified that a baseline plasma gelsolin level <52.7 mg/L predicted 1-month mortality with 88.5% sensitivity and 79.4% specificity (area under the curve, 0.869; 95% confidence interval, 0.783-0.930). The predictive value of the gelsolin concentration was thus similar to that of GCS scores (p = 0.185). However, gelsolin did not statistically significantly improve the area under the curve of GCS scores (p = 0.517). CONCLUSIONS: Decreased plasma gelsolin level is associated with GCS scores and an independent prognostic marker of mortality after TBI. Reversing plasma gelsolin deficiency may be an effective treatment for TBI. (J Trauma. 2012; 72: 491-496. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Xu, Jin-Fang; Liu, Wei-Guo; Fan, Jing] Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, Hangzhou 310000, Zhejiang, Peoples R China; [Dong, Xiao-Qiao] Nanjing Med Univ, Hangzhou Municipal Peoples Hosp 1, Dept Neurosurg, Hangzhou, Zhejiang, Peoples R China; [Yang, Song-Bin] Shengzhou Peoples Hosp, Dept Neurosurg, Shenzhou, Peoples R China		Liu, WG (corresponding author), Zhejiang Univ, Dept Neurosurg, Affiliated Hosp 2, Sch Med, 88 Jiefang Rd, Hangzhou 310000, Zhejiang, Peoples R China.	lwgxjf@163.com					Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Bucki R, 2005, BIOCHEMISTRY-US, V44, P9590, DOI 10.1021/bi0503504; Christofidou-Solomidou M, 2002, LUNG, V180, P91, DOI 10.1007/s004080000084; Christofidou-Solomidou M, 2002, J INVEST MED, V50, P54, DOI 10.2310/6650.2002.33518; Dahl B, 1999, SHOCK, V12, P102, DOI 10.1097/00024382-199908000-00002; DiNubile MJ, 2002, BLOOD, V100, P4367, DOI 10.1182/blood-2002-06-1672; Endres M, 1999, J CLIN INVEST, V103, P347, DOI 10.1172/JCI4953; Goetzl EJ, 2000, J BIOL CHEM, V275, P14573, DOI 10.1074/jbc.275.19.14573; GORDON E, 1995, J NEUROSURG ANESTH, V7, P235, DOI 10.1097/00008506-199510000-00001; Guntert A, 2010, J ALZHEIMERS DIS, V21, P585, DOI 10.3233/JAD-2010-100279; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; Huang S, 1997, CLIN INFECT DIS, V24, P951, DOI 10.1093/clinids/24.5.951; ITO H, 1992, GASTROENTEROLOGY, V102, P1686, DOI 10.1016/0016-5085(92)91731-I; JANMEY PA, 1987, BLOOD, V70, P524; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KWIATKOWSKI DJ, 1988, J BIOL CHEM, V263, P8239; KWIATKOWSKI DJ, 1986, NATURE, V323, P455, DOI 10.1038/323455a0; Laird AM, 2004, J TRAUMA, V56, P1058, DOI 10.1097/01.TA.0000123267.39011.9F; Lee PS, 2007, CRIT CARE MED, V35, P849, DOI 10.1097/01.CCM.0000253815.26311.24; Lee PS, 2006, ANN SURG, V243, P399, DOI 10.1097/01.sla.0000201798.77133.55; LEE WM, 1992, NEW ENGL J MED, V326, P1335; Lesko MM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-72; LIND SE, 1986, J CLIN INVEST, V78, P736, DOI 10.1172/JCI112634; LIND SE, 1988, AM REV RESPIR DIS, V138, P429, DOI 10.1164/ajrccm/138.2.429; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Moppett IK, 2007, BRIT J ANAESTH, V99, P18, DOI 10.1093/bja/aem128; Mounzer KC, 1999, AM J RESP CRIT CARE, V160, P1673, DOI 10.1164/ajrccm.160.5.9807137; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; Osborn TM, 2007, AM J PHYSIOL-CELL PH, V292, pC1323, DOI 10.1152/ajpcell.00510.2006; Petzold A, 2002, CRIT CARE MED, V30, P2705, DOI 10.1097/00003246-200212000-00015; Rosengart MR, 2002, SHOCK, V17, P109, DOI 10.1097/00024382-200202000-00005; Rothenbach PA, 2004, J APPL PHYSIOL, V96, P25, DOI 10.1152/japplphysiol.01074.2002; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; Spiotta AM, 2010, J NEUROSURG, V113, P571, DOI 10.3171/2010.1.JNS09506; Suhler E, 1997, CRIT CARE MED, V25, P594, DOI 10.1097/00003246-199704000-00007; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wang HH, 2008, CRIT CARE, V12, DOI 10.1186/cc6988; Yildirim F, 2008, EXP NEUROL, V210, P531, DOI 10.1016/j.expneurol.2007.11.031; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0	41	18	19	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	FEB	2012	72	2					491	496		10.1097/TA.0b013e318226ec39			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	898ZN	WOS:000300781000049	22439219				2022-02-06	
J	Abrishamkar, S; Safavi, M; Honarmand, A				Abrishamkar, Saeid; Safavi, Mohammadreza; Honarmand, Azim			Effect of erythropoietin on Glasgow Coma Scale and Glasgow Outcome Scale in patient with diffuse axonal injury	JOURNAL OF RESEARCH IN MEDICAL SCIENCES			English	Article						Erythropoietin; Outcome; Diffuse Axonal Injury	IN-VITRO; RECEPTOR; NEUROPROTECTION; APOPTOSIS; PROTECTS; INHIBITION; EXPRESSION; RECOVERY; CALCIUM; NEURONS	BACKGROUND: Erythropoietin (EPO) as a major stimulator of red blood cell (RBC) production play a key role on brain protection and have a caring effect on neurons from hypoxic or traumatic injury. The objective of this trial was to study the safety and efficacy of recombinant human EPO (rhEPO) on level of consciousness and other outcomes in patient with post traumatic diffuse axonal injury (PTDAI). METHODS: In a controlled double-blind randomized clinical trial, 54 patients aged 20-47 years were randomly allocated to 2 groups. Subjects in intervention group (n = 27) received 2000U open-label rhEPO (Erythropoietin-beta; Roche, Grenzach-Wyhlen, Germany) subcutaneously for six doses in two weeks (on days: 2, 4, 6, 8 and 10). The efficacies of the intervention were evaluated by GCS (Glasgow Coma Scale) and GOS (Glasgow Outcome Scale). RESULTS: The patients that were treated by rhEPO improved earlier with the difference between the treatment groups occurring on the day 10 (score differences of 9.6 for GCS and 1.9 for GOS). The better course of the rhEPO-treated patients continued throughout the remaining study period. The hematocrit and red blood cell counts did not increase to levels exceeding the normal range in rhEPO patients. CONCLUSIONS: Intravenous EPO was well tolerated in diffuse axonal injury and was associated with an improvement in patients' outcome in 2 weeks.	[Safavi, Mohammadreza; Honarmand, Azim] Isfahan Univ Med Sci, Anesthesiol & Crit Care Res Ctr, Esfahan, Iran; [Abrishamkar, Saeid] Isfahan Univ Med Sci, Dept Neurosurg, Esfahan, Iran		Safavi, M (corresponding author), Isfahan Univ Med Sci, Anesthesiol & Crit Care Res Ctr, Esfahan, Iran.	safavi@med.mui.ac.ir	Abrishamkar, Saeid/A-1437-2018; honarmand, azim/E-7215-2012	Abrishamkar, Saeid/0000-0001-8860-5204			Assandri R, 1999, J PHYSIOL-LONDON, V516, P343, DOI 10.1111/j.1469-7793.1999.0343v.x; Bao HF, 1999, BLOOD, V93, P3757, DOI 10.1182/blood.V93.11.3757.411a34_3757_3773; Bernaudin M, 1999, J CEREBR BLOOD F MET, V19, P643, DOI 10.1097/00004647-199906000-00007; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Calapai G, 2000, EUR J PHARMACOL, V401, P349, DOI 10.1016/S0014-2999(00)00466-0; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Feng Dongxia, 2000, Chin J Traumatol, V3, P85; Fisher M, 2000, ARCH INTERN MED, V160, P3196, DOI 10.1001/archinte.160.21.3196; Gorio A, 2002, P NATL ACAD SCI USA, V99, P9450, DOI 10.1073/pnas.142287899; Grasso G, 2004, NEUROSCIENTIST, V10, P93, DOI 10.1177/1073858403259187; Grasso G, 2001, J Neurosurg Sci, V45, P7; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; Kawakami M, 2001, J BIOL CHEM, V276, P39469, DOI 10.1074/jbc.M105832200; Kirkness Catherine J, 2004, Biol Res Nurs, V5, P299, DOI 10.1177/1099800404263050; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; Morishita E, 1997, NEUROSCIENCE, V76, P105, DOI 10.1016/s0306-4522(96)00306-5; Mostafa G, 2002, J TRAUMA, V53, P430, DOI 10.1097/00005373-200209000-00006; Ozturk E, 2005, PROG NEURO-PSYCHOPH, V29, P920, DOI 10.1016/j.pnpbp.2005.04.028; Roof RL, 1999, PHYSIOL BEHAV, V68, P81, DOI 10.1016/S0031-9384(99)00162-6; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Shein NA, 2005, J CEREBR BLOOD F MET, V25, P1456, DOI 10.1038/sj.jcbfm.9600142; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; Siren AL, 2006, BRAIN, V129, P480, DOI 10.1093/brain/awh703; Siren AL, 2001, ACTA NEUROPATHOL, V101, P271, DOI 10.1007/s004010000297; TAN CC, 1991, KIDNEY INT, V40, P69, DOI 10.1038/ki.1991.181; Verdonck O, 2007, J CEREBR BLOOD F MET, V27, P1369, DOI 10.1038/sj.jcbfm.9600443; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Yamamoto M, 2004, NEUROSCIENCE, V128, P163, DOI 10.1016/j.neuroscience.2004.06.026; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	31	18	19	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1735-1995	1735-7136		J RES MED SCI	J. Res. Med. Sci.	JAN	2012	17	1					51	56					6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	997OY	WOS:000308176700008	23248657				2022-02-06	
J	Chiu, CD; Chen, TY; Chin, LT; Shen, CC; Huo, J; Ma, SY; Chen, HM; Chu, CH				Chiu, Cheng-Di; Chen, Tze-Yung; Chin, Li-Te; Shen, Chiung-Chyi; Huo, Jie; Ma, Shin-Yi; Chen, Han-Min; Chu, Chi-Hong			Investigation of the effect of hyperglycemia on intracerebral hemorrhage by proteomic approaches	PROTEOMICS			English	Article						Albumin; Animal proteomics; Hematoma; Intracerebral hemorrhage; Rats	TRAUMATIC BRAIN-INJURY; SERUM-ALBUMIN; ENDOTHELIAL-CELLS; EXPERIMENTAL STROKE; CEREBRAL-ISCHEMIA; HYPERBARIC-OXYGEN; GENE-EXPRESSION; IN-VITRO; APOPTOSIS; RAT	Intracerebral hemorrhage (ICH) is associated with high mortality and disability, and hyperglycemia worsens the clinical and neurological outcomes of patients with ICH. In this study, we utilized proteomic approaches to investigate the role of hyperglycemia in ICH. Hyperglycemia was induced by intraperitoneal injection of streptozotocin (STZ) in adult SpragueDawley male rats; ICH was induced by stereotaxic infusion of collagenase/heparin into the right striatum. It was observed that the size of induced hemorrhage was significantly larger in the hyperglycemic group (n=6 in each group). On the first day after ICH, an apparent decrease in the bilateral grasp was also observed for the lesioned hyperglycemic rats compared with normoglycemic ones. When employing 2-DE and MS to examine the proteomes of perihematomal and control regions in individual hyperglycemic and normoglycemic rats, eight differentially expressed protein targets were identified. Most noteworthy, in response to ICH significant increase of albumin was ubiquitously observed in the brains of normoglycemic rats but not in the brains of hyperglycemic rats. Coincidentally, more significant neuronal apoptosis were found in the perihematomal regions of hyperglycemic rats. These observations described suggest the protection role of albumin in acute stage of ICH, which may be dependent on different blood sugar levels.	[Huo, Jie; Chen, Han-Min] Catholic Fu Jen Univ, Dept Life Sci, Taipei, Taiwan; [Chiu, Cheng-Di; Chin, Li-Te; Ma, Shin-Yi; Chu, Chi-Hong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Chiu, Cheng-Di; Chen, Tze-Yung] Taichung Tzu Chi Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Chiu, Cheng-Di] Taichung Hosp, Dept Neurosurg, Taichung, Taiwan; [Chin, Li-Te] Natl Chiayi Univ, Dept Microbiol Immunol & Biopharmaceut, Chiayi, Taiwan; [Shen, Chiung-Chyi] Taichung Vet Gen Hosp, Dept Neurosurg, Taichung, Taiwan; [Ma, Shin-Yi] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Neurosurg, Taipei, Taiwan; [Chen, Han-Min] Catholic Fu Jen Univ, Biomed & Photon Interdisciplinary Res Ctr, Taipei, Taiwan; [Chu, Chi-Hong] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Surg, Taipei, Taiwan		Chen, HM (corresponding author), Catholic Fu Jen Univ, Dept Life Sci, 510 Zhongzheng Rd, New Taipei City 24205, Taiwan.	056489@mail.fju.edu.tw; hong18002@hotmail.com		Chiu, Cheng-Di/0000-0003-0369-0935			AbuLebdeh HS, 1996, BAILLIERE CLIN ENDOC, V10, P589, DOI 10.1016/S0950-351X(96)80741-5; Arboix A, 2002, ACTA NEUROL SCAND, V105, P282, DOI 10.1034/j.1600-0404.2002.1o170.x; Ardizzone TD, 2004, STROKE, V35, P2587, DOI 10.1161/01.STR.0000143451.14228.ff; Aronowski J, 2005, NEUROL RES, V27, P268, DOI 10.1179/016164105X25225; Bakris G, 2003, J HUM HYPERTENS, V17, P7, DOI 10.1038/sj.jhh.1001444; BANKEY PE, 1990, J TRAUMA, V30, P1181, DOI 10.1097/00005373-199010000-00001; Belayev L, 2005, STROKE, V36, P326, DOI 10.1161/01.STR.0000152949.31366.3d; Belayev L, 2002, STROKE, V33, P1077, DOI 10.1161/hs0402.105555; Belayev L, 2001, STROKE, V32, P553, DOI 10.1161/01.STR.32.2.553; Bellin C, 2006, HORM METAB RES, V38, P732, DOI 10.1055/s-2006-955084; Bernard F, 2008, J TRAUMA, V64, P872, DOI 10.1097/TA.0b013e31803428cc; Bruno A, 2010, CURR TREAT OPTION NE, V12, P492, DOI 10.1007/s11940-010-0093-6; Busik JV, 2008, DIABETES, V57, P1952, DOI 10.2337/db07-1520; Callaghan MJ, 2005, ANTIOXID REDOX SIGN, V7, P1476, DOI 10.1089/ars.2005.7.1476; Carmichael ST, 2008, J CEREBR BLOOD F MET, V28, P1860, DOI 10.1038/jcbfm.2008.77; Chin LT, 2010, J PROTEOME RES, V9, P3091, DOI 10.1021/pr100005u; Ciccone A, 2008, NEUROL SCI, V29, pS256, DOI 10.1007/s10072-008-0955-9; Cook NL, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-7; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; Ergul A, 2009, VASC PHARMACOL, V51, P44, DOI 10.1016/j.vph.2009.02.004; Faraco G, 2007, J NEUROCHEM, V103, P590, DOI 10.1111/j.1471-4159.2007.04788.x; Ferro Jose M, 2006, Cerebrovasc Dis, V21 Suppl 2, P127, DOI 10.1159/000091712; FIORAVANTI M, 1987, RES CLIN LAB, V17, P171; Godoy DA, 2008, NEUROCRIT CARE, V9, P217, DOI 10.1007/s12028-008-9063-1; HALLIWELL B, 1988, BIOCHEM PHARMACOL, V37, P569, DOI 10.1016/0006-2952(88)90126-8; Hankins J, 2006, J INFUS MURS, V29, P260, DOI 10.1097/00129804-200609000-00004; Huang FP, 2002, J NEUROSURG, V96, P287, DOI 10.3171/jns.2002.96.2.0287; Keep RF, 2008, ACT NEUR S, V105, P73; Lee Loretta T, 2009, Crit Care Nurs Clin North Am, V21, P507, DOI 10.1016/j.ccell.2009.08.002; Levetan Claresa S, 2004, Endocr Pract, V10 Suppl 2, P34; Lin CY, 2009, PROTEOMICS, V9, P696, DOI 10.1002/pmic.200700470; Lundsgaard-Hansen P, 1986, Curr Stud Hematol Blood Transfus, P1; MacManus JP, 2000, J NEUROTRAUM, V17, P899, DOI 10.1089/neu.2000.17.899; NAHON JL, 1988, J BIOL CHEM, V263, P11436; Nakagami H, 2005, CURR DIABETES REV, V1, P59, DOI 10.2174/1573399052952550; Panagos PD, 2002, EMERG MED CLIN N AM, V20, P631, DOI 10.1016/S0733-8627(02)00015-9; Paolino Alison S, 2005, J Neurosci Nurs, V37, P130; Pasternak JJ, 2008, MAYO CLIN PROC, V83, P406, DOI 10.4065/83.4.406; Peeling J, 2001, EXP NEUROL, V167, P341, DOI 10.1006/exnr.2000.7564; Pineda JA, 2004, BRAIN PATHOL, V14, P202, DOI 10.1111/j.1750-3639.2004.tb00054.x; Power C, 2003, ANN NEUROL, V53, P731, DOI 10.1002/ana.10553; Qin Z, 2008, ACTA NEUROCHIR SUPPL, V105, P113; Qin ZY, 2007, STROKE, V38, P1362, DOI 10.1161/01.STR.0000259660.62865.eb; Roche M, 2008, FEBS LETT, V582, P1783, DOI 10.1016/j.febslet.2008.04.057; Schiller M, 2008, APOPTOSIS, V13, P319, DOI 10.1007/s10495-007-0168-3; Shamay A, 2005, J DAIRY SCI, V88, P569, DOI 10.3168/jds.S0022-0302(05)72719-3; Shen CC, 2010, CURR NEUROVASC RES, V7, P6, DOI 10.2174/156720210790820208; Simpson R. J., 2003, QUANTIFYING PROTEIN; Song EC, 2003, STROKE, V34, P2215, DOI 10.1161/01.STR.0000088060.83709.2C; Stead LG, 2010, NEUROCRIT CARE, V13, P67, DOI 10.1007/s12028-010-9355-0; Syroid DE, 2000, J NEUROSCI, V20, P5741, DOI 10.1523/JNEUROSCI.20-15-05741.2000; TUCKER VL, 1995, SHOCK, V3, P189, DOI 10.1097/00024382-199503000-00006; Tuvemo T, 1997, ACTA PAEDIATR, V86, P7; Vannucci SJ, 2001, J CEREBR BLOOD F MET, V21, P52, DOI 10.1097/00004647-200101000-00007; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Yano M, 2004, REDOX REP, V9, P111, DOI 10.1179/135100004225004779; Yao DC, 2010, DIABETES, V59, P249, DOI 10.2337/db09-0801; Zhang Y, 2008, J ZHEJIANG UNIV-SC B, V9, P871, DOI 10.1631/jzus.B0820130; Zoellner H, 1999, MICROVASC RES, V57, P162, DOI 10.1006/mvre.1998.2126; Zoellner H, 1996, J CELL SCI, V109, P2571	61	18	18	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1615-9853	1615-9861		PROTEOMICS	Proteomics	JAN	2012	12	1					113	123		10.1002/pmic.201100256			11	Biochemical Research Methods; Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	872WL	WOS:000298841000014	22065606				2022-02-06	
J	Hargrave, DD; Nupp, JM; Erickson, RJ				Hargrave, David D.; Nupp, Jason M.; Erickson, Rey J.			Two brief measures of executive function in the prediction of driving ability after acquired brain injury	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Stroke; Brain injury; Driving; Prediction; Executive functioning; Rehabilitation	FRONTAL ASSESSMENT BATTERY; STROKE; FITNESS; FAB; VALIDITY; DISEASE; TESTS	The question of fitness to drive following acquired brain injury is commonly encountered in rehabilitation settings. Pre-driving assessments are usually performed prior to on-road assessments, but there is no uniformity as to the instruments employed. Neuropsychological tests are often employed to assess different functional domains. One domain that has been suggested to be critical to driving is executive functioning. The present study examined the utility of the Frontal Assessment Battery (FAB) and the Trail Making Test Part B (TMTB) in predicting on-road driving performance after stroke or traumatic brain injury. While the TMTB has previously been demonstrated to be useful in this regard, the FAB has never been examined for this purpose. Participants were 76 patients referred for driving assessment after diagnosis of stroke or traumatic brain injury. Results indicated that scores on the TMTB, but not the FAB, were significantly predictive of on-road driving performance (p<.05). A cutoff score of 90 seconds or greater on the TMTB correctly identified 77% of those failing on-road evaluation. Implications and limitations are discussed.	[Hargrave, David D.; Nupp, Jason M.; Erickson, Rey J.] HealthONE Spalding Rehabil Hosp, Aurora, CO USA		Hargrave, DD (corresponding author), Univ Kansas, Sch Med, Dept Psychiat & Behav Sci, 7859 E Rockhill,Suite 105, Wichita, KS 67206 USA.	dhargrave@kumc.edu					Akinwuntan AE, 2006, NEUROREHAB NEURAL RE, V20, P417, DOI 10.1177/1545968306287157; Barrash J, 2010, J INT NEUROPSYCH SOC, V16, P679, DOI 10.1017/S1355617710000470; Bouillon L, 2006, AM J OCCUP THER, V60, P420, DOI 10.5014/ajot.60.4.420; Brouwer WH, 1997, NEUROPSYCHOL REHABIL, V7, P177, DOI 10.1080/713755536; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Devos H, 2011, NEUROLOGY, V76, P747, DOI 10.1212/WNL.0b013e31820d6300; Dubois B, 2000, NEUROLOGY, V55, P1621, DOI 10.1212/WNL.55.11.1621; Fisk GD, 1998, BRAIN INJURY, V12, P683; GRIGSBY J, 1992, PERCEPT MOTOR SKILL, V74, P883, DOI 10.2466/PMS.74.3.883-892; Korner-Bitensky N, 2006, AM J OCCUP THER, V60, P428, DOI 10.5014/ajot.60.4.428; Korteling JE, 1996, ARCH PHYS MED REHAB, V77, P138, DOI 10.1016/S0003-9993(96)90158-6; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Lipton AM, 2005, NEUROLOGY, V65, P726, DOI 10.1212/01.wnl.0000174437.73416.7b; Lundqvist A, 1997, APPL NEUROPSYCHOL, V4, P220, DOI 10.1207/s15324826an0404_3; Lunqvist A., 2000, APPL COGNITIVE PSYCH, V14, P135; Marshall S. C., 2007, TOPICS STROKE REHABI, V19; Matsui H, 2006, J GERIATR PSYCH NEUR, V19, P41, DOI 10.1177/0891988705284714; McKenna P, 2004, BRIT J CLIN PSYCHOL, V43, P325, DOI 10.1348/0144665031752952; Paviour DC, 2005, NEUROCASE, V11, P274, DOI 10.1080/13554790590962933; Prigatano GP, 2010, CLIN NEUROPSYCHOL, V24, P468, DOI 10.1080/13854040802585048; Radford KA, 2004, BRAIN INJURY, V18, P775, DOI 10.1080/02699050310001657394; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, J HEAD TRAUMA REHAB, V17, P38, DOI 10.1097/00001199-200202000-00006; Silverberg ND, 2009, J INT NEUROPSYCH SOC, V15, P94, DOI 10.1017/S1355617708090139; Slachevsky A, 2004, ARCH NEUROL-CHICAGO, V61, P1104, DOI 10.1001/archneur.61.7.1104; Soderstrom ST, 2006, SCAND J PSYCHOL, V47, P419, DOI 10.1111/j.1467-9450.2006.00550.x; Tamietto M, 2006, NEUROREHABILITATION, V21, P81; Yale S. H., 2003, CLIN MED RES, V1, P77	30	18	18	0	7	PSYCHOLOGY PRESS	HOVE	27 CHURCH RD, HOVE BN3 2FA, EAST SUSSEX, ENGLAND	0960-2011			NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2012	22	4					489	500		10.1080/09602011.2012.662333			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	995SC	WOS:000308031600001	22360153				2022-02-06	
J	Kenardy, J; Le Brocque, R; Hendrikz, J; Iselin, G; Anderson, V; McKinlay, L				Kenardy, Justin; Le Brocque, Robyne; Hendrikz, Joan; Iselin, Greg; Anderson, Vicki; McKinlay, Lynne			Impact of Posttraumatic Stress Disorder and Injury Severity on Recovery in Children with Traumatic Brain Injury	JOURNAL OF CLINICAL CHILD AND ADOLESCENT PSYCHOLOGY			English	Article							QUALITY-OF-LIFE; EXECUTIVE FUNCTION; HEALTH; ADOLESCENTS; HOSPITALIZATION; PERFORMANCE; ADMISSION; SYMPTOMS; MEDIATOR; YOUTH	The adverse impact on recovery of posttraumatic stress disorder (PTSD) in mild traumatic brain injury (TBI) has been demonstrated in returned veterans. The study assessed this effect in children's health outcomes following TBI and extended previous work by including a full range of TBI severity, and improved assessment of PTSD within a longitudinal design. There were 205 children and adolescents (6 to 15 years of age) who experienced a TBI that were assessed at 2, 3, 6, 12, and 18 months following the TBI. Severity of TBI was classified as mild, moderate, or severe. After controlling for the impact of the severity of TBI, premorbid behavioral and emotional problems and executive function, children with TBI and PTSD did not experience as much psychosocial recovery as those without PTSD. Furthermore the level of psychosocial function was no better than that experienced by children with a severe TBI. In contrast, severe TBI was predictive of a poorer physical recovery in the first 6 months, after which recovery was equivalent across all severity levels.	[Kenardy, Justin; Le Brocque, Robyne; Hendrikz, Joan; Iselin, Greg] Univ Queensland, Ctr Natl Res Disabil & Rehabil Med, Brisbane, Qld 4029, Australia; [McKinlay, Lynne] Royal Childrens Hosp, Queensland Paediat Rehabil Serv, Melbourne, Vic, Australia		Kenardy, J (corresponding author), Univ Queensland, Sch Med, Ctr Natl Res Disabil & Rehabil Med, Royal Brisbane & Womens Hosp, Edith Cavell Bldg, Brisbane, Qld 4029, Australia.	j.kenardy@uq.edu.au	Le Brocque, Robyne/F-4848-2010; Kenardy, Justin/F-2085-2010; Kenardy, Justin A/H-6603-2014	Le Brocque, Robyne/0000-0002-4574-1254; Kenardy, Justin A/0000-0001-9475-8450; McKinlay, Lynne/0000-0002-6677-0628			Aaron J, 1999, J PEDIATR PSYCHOL, V24, P335, DOI 10.1093/jpepsy/24.4.335; Achenbach T. M., 2001, MANUAL ASEBA SCH AGE; Aitken ME, 2002, PEDIATRICS, V110, P337, DOI 10.1542/peds.110.2.337; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V. A., DISABILITY IN PRESS; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Apa Pesidential Task Force, 2006, AM PSYCHOL, V61, P271, DOI 10.1037/0003-066X.61.4.271; Bryant RA, 2001, CLIN PSYCHOL REV, V21, P931; Carrion VG, 2007, PEDIATRICS, V119, P509, DOI 10.1542/peds.2006-2028; Carrion VG, 2010, J PEDIATR PSYCHOL, V35, P559, DOI 10.1093/jpepsy/jsp112; *CDCP, 2000, TRAUM BRAIN INJ US A; Ciccetti D., 1984, VINELAND ADAPTIVE BE; COSTER WJ, 1994, AM J OCCUP THER, V48, P211, DOI 10.5014/ajot.48.3.211; Daviss WB, 2000, J AM ACAD CHILD PSY, V39, P576, DOI 10.1097/00004583-200005000-00011; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Young MC, 2007, J TRAUMA STRESS, V20, P751, DOI 10.1002/jts.20235; Erickson SJ, 2010, DEV NEUROREHABIL, V13, P175, DOI 10.3109/17518420903479867; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; Fay TB, 2009, NEUROPSYCHOLOGY, V23, P271, DOI 10.1037/a0014936; Friedman Matthew J., 1995, P507; Ganesalingam K, 2007, J INT NEUROPSYCH SOC, V13, P298, DOI 10.1017/S1355617707070324; Gioia G.A., 2000, BRIEF BEHAV RATING I; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Horneman G, 2005, INT J REHABIL RES, V28, P245, DOI 10.1097/00004356-200509000-00007; Iselin G, 2010, J ANXIETY DISORD, V24, P774, DOI 10.1016/j.janxdis.2010.05.011; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; Kenardy J, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-92; Kenardy JA, 2006, PEDIATRICS, V118, P1002, DOI 10.1542/peds.2006-0406; KRIEL RL, 1989, PEDIATR NEUROL, V5, P296, DOI 10.1016/0887-8994(89)90021-0; Landgraf JM, 1996, CHILD HLTH QUESTIONN; McCarthy ML, 2006, ARCH PEDIAT ADOL MED, V160, P252, DOI 10.1001/archpedi.160.3.252; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Murray BL, 2008, J PEDIATR PSYCHOL, V33, P435, DOI 10.1093/jpepsy/jsm078; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Muscara F, 2008, J NEUROPSYCHOL, V2, P445, DOI 10.1348/174866407X250820; Nader K., 1996, CLIN ADMINISTERED PT; Olsson KA, 2008, J ANXIETY DISORD, V22, P1447, DOI 10.1016/j.janxdis.2008.02.007; Petersen C, 2008, BRAIN INJURY, V22, P215, DOI 10.1080/02699050801935245; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; SAPOLSKY RM, 1990, J NEUROSCI, V10, P2897, DOI 10.1523/jneurosci.10-09-02897.1990; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Scheeringa MS, 2006, AM J PSYCHIAT, V163, P644, DOI 10.1176/appi.ajp.163.4.644; Schnurr P. P., 2004, TRAUMA HLTH PHYS HLT, P247, DOI DOI 10.1037/10723-010; Slomine BS, 2002, BRAIN INJURY, V16, P759, DOI 10.1080/02699050210127286; Stallard P, 1998, BRIT MED J, V317, P1619, DOI 10.1136/bmj.317.7173.1619; Stancin T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e34; Taylor HG, 1999, NEUROPSYCHOLOGY, V13, P76, DOI 10.1037/0894-4105.13.1.76; TEASDALE G, 1974, LANCET, V2, P81; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; Wells R, 2009, DEV NEUROREHABIL, V12, P12, DOI 10.1080/17518420902773109; Winston FK, 2003, JAMA-J AM MED ASSOC, V290, P643, DOI 10.1001/jama.290.5.643; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92	54	18	18	0	6	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1537-4416	1537-4424		J CLIN CHILD ADOLESC	J. Clin. Child Adolesc. Psychol.		2012	41	1					5	14		10.1080/15374416.2012.632348			10	Psychology, Clinical; Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	915WN	WOS:000302058400002	22233241				2022-02-06	
J	Kolakowsky-Hayner, SA; Wright, J; Shem, K; Medel, R; Duong, T				Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Shem, Kazuko; Medel, Robert; Thao Duong			An effective community-based mentoring program for return to work and school after brain and spinal cord injury	NEUROREHABILITATION			English	Article						Mentoring; peer support; community-based; traumatic brain injury; spinal cord injury	PORTLAND ADAPTABILITY INVENTORY; DISABILITY RATING-SCALE; YOUNG-ADULTS; SELF-ESTEEM; REHABILITATION; TRANSITION; PARTICIPATION; EMPLOYMENT; INDEPENDENCE; INDIVIDUALS	Information is presented on a community-based mentoring program, developed to work with existing community agencies and provide structure to the frequently confusing network of services for young adults, ages 16 to 26 years, with a recently acquired disability including TBI, SCI, and other neurological disorders. The over-arching goal of the Mentoring Program was to improve the ability of individuals with disabilities to access and maximally utilize the services and programs that are available in the community. The two objectives of this study were: 1) to demonstrate continuing increases in standardized measures of community integration from the time of enrollment in the program to the time of exit from the program, and 2) to improve the percentage of youth and young adults with disabilities who successfully access post-secondary education or employment opportunities. 53 participants had post-secondary education as a goal. 12 participants had an employment goal. 12 participants had both education and employment as a combined goal. It was not uncommon for participants to change goals. Of those with education goals, 23/53 achieved educational goals and 7/53 achieved employment goals. Of those with vocational goals, 5/12 achieved vocational goals and 1/12 achieved educational goals. Of those with both goals, 5/12 achieved educational goals and 1/12 achieved vocational goals. Significant community integration and independence improvements were noted for program participants (CHART Mobility and Cognitive Independence, M2PI, DRS, and SRS). Overall, findings suggest that mentoring can be beneficial toward achieving the goals of post-secondary education, employment and community independence for individuals with disabilities; specifically those with traumatic brain injury, spinal cord injury and other neurological disorders.	[Kolakowsky-Hayner, Stephanie A.; Wright, Jerry; Medel, Robert] Santa Clara Valley Med Ctr, Rehabil Res Ctr, San Jose, CA 95128 USA; [Shem, Kazuko; Thao Duong] Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, San Jose, CA 95128 USA		Kolakowsky-Hayner, SA (corresponding author), Santa Clara Valley Med Ctr, Rehabil Res Ctr, 751 S Bacom Ave, San Jose, CA 95128 USA.	Stephanie.Hayner@hhs.sccgov.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909			Altman IM, 2010, ARCH PHYS MED REHAB, V91, P1697, DOI 10.1016/j.apmr.2010.08.001; Anderson D, 2007, J VOCAT REHABIL, V27, P57; Becky J., 2000, LONGITUDINAL STUDY V; Bjorkdahl A, 2010, BRAIN INJURY, V24, P1061, DOI 10.3109/02699052.2010.494588; Boake C, 1996, ARCH PHYS MED REHAB, V77, P765, DOI 10.1016/S0003-9993(96)90254-3; Bohac DL, 1997, BRAIN INJURY, V11, P469, DOI 10.1080/713802185; Constantinidou F, 2005, J HEAD TRAUMA REHAB, V20, P143, DOI 10.1097/00001199-200503000-00003; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; Cullen LA, 1998, INT J REHABIL RES, V21, P389, DOI 10.1097/00004356-199812000-00005; Davies PS, 2009, J VOCAT REHABIL, V30, P133, DOI 10.3233/JVR-2009-0459; DIENER E, 1984, PSYCHOL BULL, V95, P542, DOI 10.1037/0033-2909.95.3.542; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Eicher V, 2012, ARCH PHYS MED REHAB, V93, P100, DOI 10.1016/j.apmr.2011.06.038; Fadyl JK, 2010, J OCCUP REHABIL, V20, P69, DOI 10.1007/s10926-009-9204-1; Fraas M, 2010, BRAIN INJURY, V24, P50, DOI 10.3109/02699050903446781; Fraker T, 2009, J VOCAT REHABIL, V30, P223, DOI 10.3233/JVR-2009-0463; Gilworth G, 2009, WORK, V34, P95, DOI 10.3233/WOR-2009-0906; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; HALL K, 1985, ARCH PHYS MED REHAB, V66, P35; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; Hammond FM, 2001, J HEAD TRAUMA REHAB, V16, P318, DOI 10.1097/00001199-200108000-00003; Hamzat TK, 2008, SCAND J DISABIL RES, V10, P166, DOI 10.1080/15017410802120964; Hasnain R, 2009, J VOCAT REHABIL, V31, P175, DOI 10.3233/JVR-2009-0487; Hibbard MR, 2002, J HEAD TRAUMA REHAB, V17, P112, DOI 10.1097/00001199-200204000-00004; Hofgren C, 2010, WORK, V36, P431, DOI 10.3233/WOR-2010-1039; Horn L., 1999, STUD DIS POSTS ED PR; Kean J, 2011, J NEUROTRAUM, V28, P745, DOI 10.1089/neu.2010.1573; Lidal IB, 2007, DISABIL REHABIL, V29, P1341, DOI 10.1080/09638280701320839; Luecking RG, 2009, J VOCAT REHABIL, V30, P241, DOI 10.3233/JVR-2009-0464; Malec J., 2005, MAYO PORTLAND ADAPTA; Malec J. F., 1994, J HEAD TRAUMA REHAB, V9, P1, DOI [10. 1097/ 00001199- 199412000- 00003, DOI 10.1097/00001199-199412000-00003]; Malec JF, 2004, BRAIN INJURY, V18, P563, DOI 10.1080/02699050310001646134; Malec JF, 2001, ARCH PHYS MED REHAB, V82, P885, DOI 10.1053/apmr.2001.23895; Murphy GC, 2003, J REHABIL MED, V35, P276, DOI 10.1080/16501970310015209; Oddson B, 2006, DEV MED CHILD NEUROL, V48, P918, DOI 10.1017/S0012162206002003; Osgood DW, 2010, FUTURE CHILD, V20, P209; Ottomanelli L, 2009, J SPINAL CORD MED, V32, P503, DOI 10.1080/10790268.2009.11754553; Ownsworth T, 2010, WORK, V36, P381, DOI 10.3233/WOR-2010-1041; Pavot W, 2009, SOC INDIC RES SER, V39, P101, DOI 10.1007/978-90-481-2354-4_5; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rutkowski S, 2009, PHYS MED REH CLIN N, V20, P535, DOI 10.1016/j.pmr.2009.06.003; Shames J, 2007, DISABIL REHABIL, V29, P1387, DOI 10.1080/09638280701315011; Shandra CL, 2008, J VOCAT REHABIL, V29, P117; Struchen MA, 2011, J HEAD TRAUMA REHAB, V26, P4, DOI 10.1097/HTR.0b013e3182048e98; Trexler LE, 2010, J HEAD TRAUMA REHAB, V25, P440, DOI 10.1097/HTR.0b013e3181d41139; U. S. Department of Labor Office of Disability Employment Policy, 2010, EMPL STAT CIV POP SE; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2009, BRAIN INJURY, V23, P385, DOI 10.1080/02699050902838165; VITALIANO PP, 1991, PSYCHOL AGING, V6, P392, DOI 10.1037/0882-7974.6.3.392; WHITENECK GG, 1992, ARCH PHYS MED REHAB, V73, P519; [No title captured]	51	18	18	0	37	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2012	31	1					63	73		10.3233/NRE-2012-0775			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	976SU	WOS:000306605900007	22523017				2022-02-06	
J	Pieracci, FM; Moore, EE; Beauchamp, K; Tebockhorst, S; Barnett, CC; Bensard, DD; Burlew, CC; Biffl, WL; Stoval, RT; Johnson, JL				Pieracci, Fredric M.; Moore, Ernest E.; Beauchamp, Kathryn; Tebockhorst, Seth; Barnett, Carlton C.; Bensard, Denis D.; Burlew, Clay C.; Biffl, Walter L.; Stoval, Robert T.; Johnson, Jeffrey L.			A cost-minimization analysis of phenytoin versus levetiracetam for early seizure pharmacoprophylaxis after traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Traumatic brain injury; seizures; pharmacoeconomics; cost-effectiveness; outcomes	UNITED-STATES; PROPHYLAXIS; PREVENTION; RISK	BACKGROUND: Recent data indicate comparable efficacy and safety for levetiracetam (LEV) when compared with phenytoin (PHT) for prophylaxis of early seizures after traumatic brain injury. The purpose of this study was to conduct a cost-minimization analysis, from the perspective of both the acute care institution (cost) and patient (charges), comparing these two strategies. METHODS: A decision tree was constructed to include baseline event probabilities obtained from detailed literature review, costs, and charges. Monte Carlo simulation was used to derive the mean costs and charges per patient treated with the LEV when compared with the PHT strategy. Adverse event probabilities, costs, charges, and frequency of laboratory determination for the PHT group were varied in sensitivity analyses. RESULTS: Literature review indicated equal efficacy of PHT versus LEV for early seizure prevention. The PHT strategy was superior to the LEV strategy from both the institutional (mean cost per patient $151.24 vs. $411.85, respectively) and patient (mean charge per patient $2,302.58 vs. $3,498.40, respectively) perspectives. Varying both baseline adverse event probabilities and frequency of laboratory testing did not alter the superiority of the PHT strategy. LEV replaced PHT as the dominant strategy only when the cost/charge of treating mental status deterioration was increased markedly above baseline. CONCLUSIONS: From both institutional and patient perspectives, PHT is less expensive than LEV for routine pharmacoprophylaxis of early seizures among traumatic brain injury patients. Pending compelling efficacy data, LEV should not replace PHT as a first-line agent for this indication. (J Trauma. 2012;72: 276-281. Copyright (C) 2012 by Lippincott Williams & Wilkins)	[Pieracci, Fredric M.; Moore, Ernest E.; Tebockhorst, Seth; Barnett, Carlton C.; Bensard, Denis D.; Burlew, Clay C.; Biffl, Walter L.; Stoval, Robert T.; Johnson, Jeffrey L.] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Div Trauma & Acute Care Surg,Dept Surg, Denver, CO 80206 USA; [Beauchamp, Kathryn] Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Dept Neurosurg, Denver, CO 80206 USA		Pieracci, FM (corresponding author), Univ Colorado, Hlth Sci Ctr, Denver Hlth Med Ctr, Div Trauma & Acute Care Surg,Dept Surg, 777 Bannock St MC0206, Denver, CO 80206 USA.	fredric.pieracci@dhha.org	MUNOZ, ROSA ANA/H-3964-2018	MUNOZ, ROSA ANA/0000-0002-7504-2163			Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Claassen J, 2007, NEUROLOGY, V69, P1356, DOI 10.1212/01.wnl.0000281664.02615.6c; Drummond MF, 1997, METHODS EC EVALUATIO, P305; Jones KE, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E3; KILPATRICK CJ, 1992, ARCH NEUROL-CHICAGO, V49, P509, DOI 10.1001/archneur.1992.00530290097017; Lim DA, 2009, J NEURO-ONCOL, V93, P349, DOI 10.1007/s11060-008-9781-4; Merrell RT, 2010, J NEUROSURG, V113, P1176, DOI 10.3171/2010.5.JNS091367; Mockenhaupt M, 2005, NEUROLOGY, V64, P1134, DOI 10.1212/01.WNL.0000156354.20227.F0; PECHADRE JC, 1991, PRESSE MED, V20, P841; Rekling JC, 2003, NEUROSCI LETT, V335, P167, DOI 10.1016/S0304-3940(02)01193-X; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schierhout G, 2001, COCHRANE DB SYST REV, V4; Shah D, 2009, SEIZURE-EUR J EPILEP, V18, P676, DOI 10.1016/j.seizure.2009.09.003; So EL, 1996, NEUROLOGY, V46, P350, DOI 10.1212/WNL.46.2.350; Szaflarski JP, 2010, NEUROCRIT CARE, V12, P165, DOI 10.1007/s12028-009-9304-y; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71	20	18	20	3	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JAN	2012	72	1					276	281		10.1097/TA.0b013e31823df31f			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	898IF	WOS:000300734800050	22310136				2022-02-06	
J	Rudstam, H; Gower, WS; Cook, L				Rudstam, Hannah; Gower, Wendy; Cook, LaWanda			Beyond yellow ribbons: Are employers prepared to hire, accommodate and retain returning veterans with disabilities?	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Veterans; post traumatic stress disorder; PTSD; traumatic brain injury; TBI; disability; employers; signature disabilities; recruiting; hiring; accommodating and retaining veterans		Are employers ready to hire, retain and accommodate veterans with disabilities (VWDs) returning from engagements in Iraq and Afghanistan? A survey of 1,083 human resource professionals examined employer readiness in three areas: knowledge, beliefs/willingness and actions/practices, with an emphasis on the signature disabilities of Post Traumatic Stress Disorder (PTSD) and Traumatic Brain Injury (TBI). Overall, employers surveyed did have willingness to employ VWDs and saw some benefits in doing so. Yet, they had key knowledge gaps around accommodating workers with PTSD and TBI and around disclosure issues. In the area of respondent willingness to employ VWDs, findings indicated most employers believed VWDs would benefit their organizations and would perform as well as other workers. Yet, they believed employing VWDs would involve more costs and more of a manager's time and were largely unsure if workers with PTSD were more likely than others to be violent in the workplace. Respondents' actions/practices indicated that the majority were not using recruitment or other resources specific to VWDs and had scant experience in accommodating workers with PTSD and TBI. Implications of these findings are discussed in terms of research and application to impact employer knowledge, willingness and practices around employing VWDs.	[Rudstam, Hannah; Gower, Wendy; Cook, LaWanda] Cornell Univ, DBTAC Northeast ADA Ctr, Employment & Disabil Inst, Ithaca, NY 14853 USA		Rudstam, H (corresponding author), Cornell Univ, ILR Sch, 201 Dolgen Hall, Ithaca, NY 14853 USA.	hhr5@cornell.edu			U.S. Department of Education through the National Institute for Disability and Rehabilitation Research (NIDRR) [H133A060088]	The DBTAC - Northeast ADA Center provides training and technical assistance on the Americans with Disabilities Act in New York, New Jersey, Puerto Rico, and the U. S. Virgin Islands. This center is funded by a grant from the U.S. Department of Education through the National Institute for Disability and Rehabilitation Research (NIDRR) grant number H133A060088.	Ajzen I, 2010, FRONT SOC PSYCHOL, P289; AXELROD R, 2010, TERMS ENGAGEMENT NEW; Burke HS, 2009, J REHABIL, V75, P5; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Kotter JP., 2002, HEART CHANGE REAL LI; Robinson D. G., 2008, PERFORMANCE CONSULTI; Rudstam H. H., 2010, P ADA NAT NETW RES C, P51; Rudstam HH, 2010, HIRING OUR HEROES VE; Society for Human Resource Management (SHRM), 2010, EMPL MIL PERS RECR V; Tanielan T, 2008, INVISIBLE WOUNDS WAR; Williamson V., 2009, INVISIBLE WOUNDS PSY	11	18	18	0	1	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2012	36	2					87	95		10.3233/JVR-2012-0584			9	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	V72CM	WOS:000211619900002					2022-02-06	
J	Connon, FF; Namdarian, B; Ee, JLC; Drummond, KJ; Miller, JA				Connon, Francis F.; Namdarian, Benjamin; Ee, Joanne L. C.; Drummond, Katharine J.; Miller, Julie A.			Do Routinely Repeated Computed Tomography Scans in Traumatic Brain Injury Influence Management? A Prospective Observational Study in a Level 1 Trauma Center	ANNALS OF SURGERY			English	Article							MINIMAL HEAD-INJURY; CT; MODERATE; UTILITY	Objective: To prospectively examine the clinical role of routine repeat computed tomographic scans of the brain (CTB) in patients with traumatic head injury. Summary Background Data: The use of routine serial CTB after traumatic head injury is recommended by some authors, but remains controversial. Methods: From March 2007 to October 2008, all patients with traumatic head injury admitted to the Royal Melbourne Hospital, a metropolitan, Level I trauma center, were prospectively studied. After the initial computed tomography brain scans, any subsequent CTBs were assessed and were recorded as being either "clinically indicated" or "routine" and ensuing medical and surgical management. Inpatient information was recorded and comparisons made according to indication for CTB, Glasgow Coma Scale, and management changes. Results: A total of 651 patients were admitted with traumatic head injury over the 20-month study period. Of those, 39 underwent immediate craniotomy/craniectomy and were excluded from analysis. Another 25 were excluded due to incomplete data, leaving 591 patients for analysis. Of the 591 assessed, 401 were discharged with no further computed tomography investigation. One hundred and ninety patients underwent a total of 305 repeat brain scans, of which 149 were clinically indicated, whereas 156 were obtained as a "routine" investigation with no deterioration in patients' neurological status. Of the repeated scans, 71 were improved, 169 were unchanged, and 64 were worse. None of the 156 patients who received a "routine" CTB required a change in management. The 149 CTB performed for clinical deterioration resulted in a change in management in 28 patients (19%). The patients who underwent "indicated" computed tomographic scans and subsequently required a change in management were on average younger (P < 0.001) and more severely head injured (P = 0.001) than the patients not requiring a change in management. Conclusions: No patients from our cohort with a "routine" repeat CTB required a change in management. Given the costs and potential risks of routine repeat CTB, and lack of demonstrable benefit, the practice should be reconsidered. Repeat CTB is clearly indicated in patients with deteriorating neurological status, especially younger and more severely head-injured patients.	[Connon, Francis F.; Namdarian, Benjamin; Ee, Joanne L. C.; Miller, Julie A.] Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia; [Drummond, Katharine J.] Univ Melbourne, Royal Melbourne Hosp, Dept Neurosurg, Parkville, Vic 3050, Australia		Miller, JA (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Surg, Parkville, Vic 3050, Australia.	Julie.miller@mh.org.au		Namdarian, Benjamin/0000-0002-4209-1639			Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; BEIR, 2006, HLTH RISKS EXP LOW L; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Chao A, 2001, J TRAUMA, V51, P870, DOI 10.1097/00005373-200111000-00008; COPE DN, 1988, ARCH PHYS MED REHAB, V69, P483; Figg RE, 2003, J TRAUMA, V55, P1061, DOI 10.1097/01.TA.0000096712.90133.5C; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Lee TT, 1997, ACTA NEUROCHIR, V139, P1042, DOI 10.1007/BF01411558; ROBERSON FC, 1979, SURG NEUROL, V12, P161; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Tabori U, 2000, CRIT CARE MED, V28, P840, DOI 10.1097/00003246-200003000-00038; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89	14	18	18	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0003-4932			ANN SURG	Ann. Surg.	DEC	2011	254	6					1028	1031		10.1097/SLA.0b013e318219727f			4	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	852RM	WOS:000297375200029	22112983				2022-02-06	
J	Konstantinidis, A; Inaba, K; Dubose, J; Barmparas, G; Talving, P; David, JS; Lam, L; Demetriades, D				Konstantinidis, Agathoklis; Inaba, Kenji; Dubose, Joe; Barmparas, Galinos; Talving, Peep; David, Jean-Stephane; Lam, Lydia; Demetriades, Demetrios			The Impact of Nontherapeutic Hypothermia on Outcomes After Severe Traumatic Brain Injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Hypothermia; Trauma; Severe brain injury; Mortality; Intensive care unit; Admission	SEVERE HEAD-INJURY; ADMISSION HYPOTHERMIA; MODERATE HYPOTHERMIA; COAGULOPATHY; COAGULATION; HYPOTENSION; MANAGEMENT; HEMORRHAGE; PREDICTOR; MORTALITY	Introduction: In patients with isolated severe traumatic brain injury (TBI), the effect of controlled, therapeutic hypothermia on outcomes has been studied extensively. What is not well understood, however, and the purpose of this study, was to examine the impact of noninduced, nontherapeutic hypothermia on outcomes in these patients. Methods: A retrospective review of the institutional trauma registry at the Los Angeles County + University of Southern California Medical Center was performed to identify all trauma patients admitted to the surgical intensive care unit (SICU) with isolated severe TBI from January 2000 to December 2008. Patients were classified as hypothermic (core temperature [Tc] <= 35 degrees C) or normothermic (Tc >35 degrees C) based on their first Tc recorded on SICU admission. The primary outcome measure was in-hospital mortality, and secondary outcomes included SICU and hospital length of stay. Results: During the study period, 1,403 patients sustaining an isolated severe TBI were admitted to the SICU. After excluding 122 patients with missing temperature data, 1,281 patients were analyzed. Hypothermia (Tc <35 degrees C) on SICU admission was identified in 10.9% (n = 140) of the study population, with the remaining 89.1% (n = 1,141) being normothermic (Tc >35 degrees C). After adjusting for differences in baseline characteristics between the two groups, patients who were hypothermic on SICU admission were found to be significantly less likely to survive (odds ratio, 2.9; 95% confidence interval, 1.3, 6.7; p < 0.013). A penetrating mechanism of injury, Injury Severity Score >= 25, and undergoing an exploratory laparotomy before admission were found to be independent risk factors for the development of hypothermia on SICU admission. Conclusion: For patients who have sustained isolated severe TBI, the presence of noninduced, nontherapeutic hypothermia on SICU admission is associated with a significant increase in mortality. The impact of preventative measures used to avoid the development of hypothermia and the effectiveness of measures for restoring normothermia warrant further investigation.	[Konstantinidis, Agathoklis; Inaba, Kenji; Barmparas, Galinos; Talving, Peep; Lam, Lydia; Demetriades, Demetrios] Univ So Calif, Div Trauma Surg & Surg Crit Care, Los Angeles Cty Med Ctr, Los Angeles, CA 90033 USA; [Dubose, Joe] Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD USA; Univ Lyon 1, F-69365 Lyon, France; [David, Jean-Stephane] HCL, Lyon Sud Hosp, Dept Anesthesiol & Crit Care, Lyon, France		Inaba, K (corresponding author), Univ So Calif, Div Trauma Surg & Surg Crit Care, USC LAC Mad Ctr, 1200 N State St,Inpatient Tower C,Room C5L100, Los Angeles, CA 90033 USA.	kinaba@surgery.usc.edu	INABA, KENJI/AAC-8532-2020; Talving, Peep/E-6015-2013; Talving, Peep/G-8621-2015; David, Jean Stephane/H-9399-2019; Barmparas, Galinos/L-6530-2019	Talving, Peep/0000-0002-9741-2073; David, Jean Stephane/0000-0001-6274-7044; 			*AM COLL SURG, 2008, AM COLL SURG COMM TR; Arthurs Z, 2006, AM J SURG, V191, P610, DOI 10.1016/j.amjsurg.2006.02.010; Bergstein JM, 1996, ANN EMERG MED, V27, P39, DOI 10.1016/S0196-0644(96)70294-9; BERNABEI AF, 1992, J TRAUMA, V33, P835, DOI 10.1097/00005373-199212000-00007; BEST R, 1985, AM J EMERG MED, V3, P48, DOI 10.1016/0735-6757(85)90013-0; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Clifton GL, 2001, NEW ENGL J MED, V344, P556, DOI 10.1056/NEJM200102223440803; Clifton GL, 2002, J NEUROTRAUM, V19, P293, DOI 10.1089/089771502753594864; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; FRIED SJ, 1986, J TRAUMA, V26, P183, DOI 10.1097/00005373-198602000-00016; Gentilello LM, 1997, ANN SURG, V226, P439, DOI 10.1097/00000658-199710000-00005; GREGORY JS, 1991, J TRAUMA, V31, P795, DOI 10.1097/00005373-199106000-00009; Harris OA, 2002, ARCH NEUROL-CHICAGO, V59, P1077, DOI 10.1001/archneur.59.7.1077; Harris OA, 2009, J NEUROSURG, V110, P1256, DOI 10.3171/2009.1.JNS081320; Hildebrand F, 2009, UNFALLCHIRURG, V112, P959, DOI 10.1007/s00113-009-1683-1; Hutchison JS, 2008, NEW ENGL J MED, V358, P2447, DOI 10.1056/NEJMoa0706930; Inaba K, 2009, WORLD J SURG, V33, P864, DOI 10.1007/s00268-009-9936-2; JURKOVICH GJ, 1987, J TRAUMA, V27, P1019, DOI 10.1097/00005373-198709000-00011; KEIMOWITZ RM, 1973, J NEUROSURG, V39, P178, DOI 10.3171/jns.1973.39.2.0178; Kirkpatrick AW, 1999, CAN J SURG, V42, P333; Kongsayreepong S, 2003, ANESTH ANALG, V96, P826, DOI 10.1213/01.ANE.0000048822.27698.28; Kushimoto S, 2003, J NEUROTRAUM, V20, P357, DOI 10.1089/089771503765172318; Lenhardt Rainer, 2010, Front Biosci (Schol Ed), V2, P1145; Lewis FR, 1997, ANN SURG, V226, P447; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Martin RS, 2005, SHOCK, V24, P114, DOI 10.1097/01.shk.0000169726.25189.b1; Metz C, 1996, J NEUROSURG, V85, P533, DOI 10.3171/jns.1996.85.4.0533; Murshid WR, 2002, BRIT J NEUROSURG, V16, P362, DOI 10.1080/0268869021000007597; NICODEMUS HF, 1981, CRIT CARE MED, V9, P325, DOI 10.1097/00003246-198104000-00009; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; PALLADINO WG, 1983, J SURG RES, V34, P388, DOI 10.1016/0022-4804(83)90087-2; Polderman KH, 2002, INTENS CARE MED, V28, P1563, DOI 10.1007/s00134-002-1511-3; ROBERTS S, 1994, UROLOGY, V44, P832, DOI 10.1016/S0090-4295(94)80166-5; Scherer RU, 1998, CRIT CARE MED, V26, P149, DOI 10.1097/00003246-199801000-00031; Shafi S, 2005, J TRAUMA, V59, P1081, DOI 10.1097/01.ta.0000188647.03665.fd; SHIOZAKI T, 1993, J NEUROSURG, V79, P363, DOI 10.3171/jns.1993.79.3.0363; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEINEMANN S, 1990, J TRAUMA, V30, P200, DOI 10.1097/00005373-199002000-00011; STONER HB, 1980, CLIN SCI, V59, P19, DOI 10.1042/cs0590019; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TOUHO H, 1986, NEUROSURGERY, V19, P523, DOI 10.1227/00006123-198610000-00005; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Wang HE, 2005, CRIT CARE MED, V33, P1296, DOI 10.1097/01.CCM.0000165965.31895.80; Zehtabchi S, 2008, RESUSCITATION, V76, P52, DOI 10.1016/j.resuscitation.2007.06.024	44	18	20	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	DEC	2011	71	6					1627	1631		10.1097/TA.0b013e3182159e31			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	869RT	WOS:000298616400033	21537207				2022-02-06	
J	Wen, L; Wang, H; Wang, F; Gong, JB; Li, G; Huang, X; Zhan, RY; Yang, XF				Wen, L.; Wang, H.; Wang, F.; Gong, J. B.; Li, G.; Huang, X.; Zhan, R. Y.; Yang, X. F.			A prospective study of early versus late craniectomy after traumatic brain injury	BRAIN INJURY			English	Article						decompressive craniectomy; outcome; traumatic brain injury	EARLY DECOMPRESSIVE CRANIECTOMY; SURGICAL-MANAGEMENT; HEAD-INJURY	Background: Decompressive craniectomy is an important method for managing traumatic brain injury (TBI). At present, controversies about this procedure exist, especially about the optimum operative time for patients with TBI. Methods: A prospective study was performed at the First Affiliated Hospital, College of Medicine, Zhejiang University. From January 2008 to December 2009, 25 patients who underwent early decompressive craniectomy were included in the study group, and 19 patients who underwent "late'' decompressive craniectomy as a second-tier therapy for intracranial hypertension were included as a comparison group. Results: The 30-day mortality after the operation was 16% in the study group. The overall mortality rate was 20% at the 6-month follow-up. A total of 52% of the patients (13 patients) had good outcomes, and 7 patients remained in a severely disabled or vegetative state. In the comparison group, 4 patients died, and 12 had good outcomes at the 6-month follow-up. The remaining 3 patients had poor outcomes. The study group was well matched with the comparison group. However, the outcomes in the study group were not better than those in the comparison group, as evaluated by the 6-month GOS score. Conclusion: Early decompressive craniectomy as a first-tier therapy for intracranial hypertension did not improve patient outcome when compared with "late'' decompressive craniectomy for managing TBI.	[Yang, X. F.] Zhejiang Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China		Yang, XF (corresponding author), Zhejiang Univ, Coll Med, Dept Neurosurg, Affiliated Hosp 1, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China.	jediwen@163.com					Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Boret H, 2006, ACTA ANAESTH SCAND, V50, P252, DOI 10.1111/j.1399-6576.2005.00862.x; Cavusoglu H, 2010, ULUS TRAVMA ACIL CER, V16, P119; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2008, J CRIT CARE, V23, P387, DOI 10.1016/j.jcrc.2007.05.002; HASE U, 1978, ACTA NEUROCHIR, V45, P1, DOI 10.1007/BF01774379; Leitgeb J, 2007, WIEN KLIN WOCHENSCHR, V119, P56, DOI 10.1007/s00508-006-0764-1; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Rubiano AM, 2009, ULUS TRAVMA ACIL CER, V15, P28; Schneider GH, 2002, ACT NEUR S, V81, P77; The Brain Trauma Foundation, 2000, J NEUROTRAUM, V17, P457; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9	14	18	19	0	8	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0269-9052			BRAIN INJURY	Brain Inj.	DEC	2011	25	13-14					1318	1324		10.3109/02699052.2011.608214			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	847MI	WOS:000296976600007	21902550				2022-02-06	
J	Appelboom, G; Zoller, SD; Piazza, MA; Szpalski, C; Bruce, SS; McDowell, MM; Vaughan, KA; Zacharia, BE; Hickman, Z; D'Ambrosio, A; Feldstein, NA; Anderson, RCE				Appelboom, Geoffrey; Zoller, Stephen D.; Piazza, Matthew A.; Szpalski, Caroline; Bruce, Samuel S.; McDowell, Michael M.; Vaughan, Kerry A.; Zacharia, Brad E.; Hickman, Zachary; D'Ambrosio, Anthony; Feldstein, Neil A.; Anderson, Richard C. E.			Traumatic brain injury in pediatric patients: evidence for the effectiveness of decompressive surgery	NEUROSURGICAL FOCUS			English	Article						clinical trial; pediatric; traumatic brain injury; decompressive surgery	CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; LONG-TERM POTENTIATION; INTRACRANIAL HYPERTENSION; PERFUSION-PRESSURE; CHILDREN; CRANIECTOMY; IMPACT; ADULT; METABOLISM	Traumatic brain injury (TBI) is the current leading cause of death in children over 1 year of age. Adequate management and care of pediatric patients is critical to ensure the best functional outcome in this population. In their controversial trial, Cooper et al. concluded that decompressive craniectomy following TBI did not improve clinical outcome of the analyzed adult population. While the study did not target pediatric populations, the results do raise important and timely clinical questions regarding the effectiveness of decompressive surgery in pediatric patients. There is still a paucity of evidence regarding the effectiveness of this therapy in a pediatric population, and there is an especially noticeable knowledge gap surrounding age-stratified interventions in pediatric trauma. The purposes of this review are to first explore the anatomical variations between pediatric and adult populations in the setting of TBI. Second, the authors assess how these differences between adult and pediatric populations could translate into differences in the impact of decompressive surgery following TBI. (DOI: 10.3171/2011.8.FOCUS11177)	[Appelboom, Geoffrey; Zoller, Stephen D.; Piazza, Matthew A.; Bruce, Samuel S.; McDowell, Michael M.; Vaughan, Kerry A.; Zacharia, Brad E.; Hickman, Zachary; D'Ambrosio, Anthony; Feldstein, Neil A.; Anderson, Richard C. E.] Columbia Univ Coll Phys & Surg, Dept Neurol Surg, Neurol Inst, New York, NY 10032 USA; [Szpalski, Caroline] NYU, Dept Plast & Craniofacial Surg, New York, NY USA		Appelboom, G (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol Surg, Neurol Inst, 710 W 168th St,Room 431, New York, NY 10032 USA.	ga2294@columbia.edu	Hickman, Zachary L./O-6335-2017; Zacharia, Brad/P-1726-2019	Hickman, Zachary L./0000-0001-5535-0268; Zacharia, Brad/0000-0002-2078-7635; Zoller, Stephen/0000-0002-6581-8159			*AANS CNS BRAIN TR, 2007, J NEUROTRAUMA S1, V24, pS55; Abdullah Jafri Malin, 2005, Asian J Surg, V28, P163, DOI 10.1016/S1015-9584(09)60334-1; Adelson P David, 2003, Pediatr Crit Care Med, V4, pS25; Anderson VA, 2005, J NEUROL NEUROSUR PS, V76, P401, DOI 10.1136/jnnp.2003.019174; Anderson V, 2009, J HEAD TRAUMA REHAB, V24, P303, DOI 10.1097/HTR.0b013e3181ada830; Aya-ay J, 2005, EXP NEUROL, V193, P149, DOI 10.1016/j.expneurol.2004.11.021; Bauer R, 1999, PEDIATR NEUROSURG, V30, P62, DOI 10.1159/000028765; Bayir H, 2009, CRIT CARE MED, V37, P689, DOI 10.1097/CCM.0b013e318194abf2; BERGER MS, 1985, J NEUROSURG, V62, P194, DOI 10.3171/jns.1985.62.2.0194; Bittigau D, 1999, ANN NEUROL, V45, P724, DOI 10.1002/1531-8249(199906)45:6<724::AID-ANA6>3.0.CO;2-P; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Carter BG, 1999, INTENS CARE MED, V25, P722, DOI 10.1007/s001340050936; Chambers IR, 2006, J NEUROL NEUROSUR PS, V77, P234, DOI 10.1136/jnnp.2005.072215; Cho DY, 1995, PEDIATR NEUROSURG, V23, P192, DOI 10.1159/000120958; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; D'Ambrosio R, 1998, BRAIN RES, V786, P64, DOI 10.1016/S0006-8993(97)01412-1; Danton GH, 2003, J NEUROPATH EXP NEUR, V62, P127, DOI 10.1093/jnen/62.2.127; ESPARZA J, 1985, CHILD NERV SYST, V1, P109, DOI 10.1007/BF00706691; GAAB MR, 1990, ACT NEUR S, V51, P326; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Giza CC, 2006, J NEUROTRAUM, V23, P950, DOI 10.1089/neu.2006.23.950; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Guerra WKW, 1999, INTENS CARE MED, V25, P1327; Hieu PD, 1996, CHILD NERV SYST, V12, P270; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Kan P, 2006, J NEUROSURG, V105, P337, DOI 10.3171/ped.2006.105.5.337; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; KERR FWL, 1968, MAYO CLIN PROC, V43, P852; KRAUS JF, 1990, AM J DIS CHILD, V144, P684, DOI 10.1001/archpedi.1990.02150300082022; Kunze E, 1998, ACT NEUR S, V71, P16; LEVIN HS, 1992, NEUROSURGERY, V31, P435, DOI 10.1227/00006123-199209000-00008; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P127, DOI 10.1016/j.nurt.2009.10.020; Madikians A, 2009, CURR TREAT OPTION NE, V11, P393, DOI 10.1007/s11940-009-0044-2; Margulies SS, 2000, J BIOMECH ENG-T ASME, V122, P364, DOI 10.1115/1.1287160; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; Olivecrona M, 2007, J NEUROTRAUM, V24, P927, DOI 10.1089/neu.2005.356E; OMMAYA AK, 1971, J BIOMECH, V4, P13, DOI 10.1016/0021-9290(71)90011-X; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PFENNINGER J, 1983, INTENS CARE MED, V9, P13, DOI 10.1007/BF01693699; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Prins ML, 2001, J NEUROTRAUM, V18, P31, DOI 10.1089/089771501750055758; REEVES TM, 1995, EXP BRAIN RES, V106, P248; SETTERGREN G, 1980, ACTA PAEDIATR SCAND, V69, P457, DOI 10.1111/j.1651-2227.1980.tb07114.x; SHARPLES PM, 1995, J NEUROL NEUROSUR PS, V58, P145, DOI 10.1136/jnnp.58.2.145; STRINGER WA, 1993, AM J NEURORADIOL, V14, P475; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Timofeev I, 2008, J NEUROSURG, V108, P66, DOI 10.3171/JNS/2008/108/01/0066; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; Vavilala Monica S, 2002, Int Anesthesiol Clin, V40, P69; Venkatesh B, 2004, INTENS CARE MED, V30, P510, DOI 10.1007/s00134-003-2102-7	53	18	19	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2011	31	5							E5	10.3171/2011.8.FOCUS11177			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	844QL	WOS:000296762300006	22044104				2022-02-06	
J	Bao, YJ; Li, LZ; Li, XG; Wang, YJ				Bao, Yi-Jun; Li, Li-Zhuo; Li, Xin-Guo; Wang, Yun-Jie			17Beta-estradiol differentially protects cortical pericontusional zone from programmed cell death after traumatic cerebral contusion at distinct stages via non-genomic and genomic pathways	MOLECULAR AND CELLULAR NEUROSCIENCE			English	Article						Akt; 17Beta-estradiol; Caspase-3; Cortical pericontusional zone; ERK1/2; Survivin	ESTROGEN-RECEPTOR-ALPHA; BRAIN-INJURY; INDUCED NEUROPROTECTION; HIPPOCAMPAL-NEURONS; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; KINASE PATHWAYS; RAT HIPPOCAMPUS; ACTIVATION; PHOSPHORYLATION	Pericontusional zone (PCZ) of traumatic cerebral contusion is a target of pharmacological intervention. Our previous study indicated that 17beta-estradiol has a protective role in PCZ after traumatic cerebral contusion via the upregulation of estrogen receptor (ER) alpha mRNA induction and protein expression as well as inhibition of caspase-3 activation, suggesting that genomic signaling pathway is implicated in the protective effect of 17beta-estrodiol. Recent findings demonstrated that 17beta-estradiol also acts on the extranuclear/membrane ER to activate non-genomic signaling pathway to regulate cellular functions and exert the protective effect in the brain. It is still unclear how and whether genomic and non-genomic pathways of 17beta-estradiol are involved in the neuroprotection in PCZ. Our current study demonstrates that 17beta-estradiol activates ERK1/2 and Akt at the early stage and induces ERalpha and survivin mRNA at the late stage to modulate its protection via the suppression of caspase-3 activation in PCZ. These findings suggest that 17beta-estrodiol differentially plays its protective roles via genomic and non-genomic signaling pathways in PCZ after traumatic cerebral contusion. (C) 2011 Elsevier Inc. All rights reserved.	[Bao, Yi-Jun; Li, Xin-Guo; Wang, Yun-Jie] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang 110001, Liaoning, Peoples R China; [Li, Li-Zhuo] China Med Univ, Shengjing Hosp, Emergency Dept, Shenyang 110004, Peoples R China		Bao, YJ (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, 155 Nanjingbei St, Shenyang 110001, Liaoning, Peoples R China.	neurobao3@hotmail.com; wyj024@vip.sina.com			Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China [20071051]	This study was supported by Grant from Natural Science Foundation of Liaoning Provincial Science and Technology Commission, Liaoning, China (No. 20071051).	Azcoitia I, 1999, GLIA, V26, P260; Bekinschtein P, 2008, P NATL ACAD SCI USA, V105, P2711, DOI 10.1073/pnas.0711863105; BINDER M, 1984, HISTOCHEM J, V16, P1003, DOI 10.1007/BF01003854; Chaban VV, 2004, ENDOCRINOLOGY, V145, P3788, DOI 10.1210/en.2004-0149; Chen SH, 2009, CRIT CARE MED, V37, P3097, DOI 10.1097/CCM.0b013e3181bc7986; Choi YC, 2004, FUND CLIN PHARMACOL, V18, P547, DOI 10.1111/j.1472-8206.2004.00284.x; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Dubal DB, 1999, J NEUROSCI, V19, P6385; Dubal DB, 2001, P NATL ACAD SCI USA, V98, P1952, DOI 10.1073/pnas.98.4.1952; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gorosito SV, 2008, NEUROSCIENCE, V154, P1173, DOI 10.1016/j.neuroscience.2008.05.001; Green PS, 2000, INT J DEV NEUROSCI, V18, P347, DOI 10.1016/S0736-5748(00)00017-4; Ho KJ, 2002, ARTERIOSCL THROM VAS, V22, P1952, DOI 10.1161/01.ATV.0000041200.85946.4A; Johnson EA, 2005, EXP BRAIN RES, V167, P17, DOI 10.1007/s00221-005-2362-2; Jover-Mengual T, 2007, ENDOCRINOLOGY, V148, P1131, DOI 10.1210/en.2006-1137; Kelly MJ, 2009, MOL CELL ENDOCRINOL, V308, P17, DOI 10.1016/j.mce.2009.03.008; Kow LM, 2004, P NATL ACAD SCI USA, V101, P12354, DOI 10.1073/pnas.0404889101; Lee SJ, 2001, ANNU REV PHARMACOL, V41, P569, DOI 10.1146/annurev.pharmtox.41.1.569; Li LZ, 2011, NEUROCHEM INT, V58, P126, DOI 10.1016/j.neuint.2010.11.006; Liu M, 2010, MINERVA ENDOCRINOL, V35, P127; Madak-Erdogan Z, 2008, MOL ENDOCRINOL, V22, P2116, DOI 10.1210/me.2008-0059; Marin R, 2009, J STEROID BIOCHEM, V114, P2, DOI 10.1016/j.jsbmb.2008.12.014; Milner TA, 2001, J COMP NEUROL, V429, P355; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nakajo Y, 2008, BRAIN RES, V1241, P103, DOI 10.1016/j.brainres.2008.08.080; Nishio M, 2004, NEUROSCI LETT, V355, P109, DOI 10.1016/j.neulet.2003.10.064; Noshita N, 2002, NEUROBIOL DIS, V9, P294, DOI 10.1006/nbdi.2002.0482; Otani N, 2002, J NEUROTRAUM, V19, P1587, DOI 10.1089/089771502762300247; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Razandi M, 1999, MOL ENDOCRINOL, V13, P307, DOI 10.1210/me.13.2.307; Russell KS, 2000, P NATL ACAD SCI USA, V97, P5930, DOI 10.1073/pnas.97.11.5930; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; Simoncini T, 2004, STEROIDS, V69, P537, DOI 10.1016/j.steroids.2004.05.009; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Singer CA, 1999, J NEUROSCI, V19, P2455; Singh M, 1999, J NEUROSCI, V19, P1179; Singh M, 2001, ENDOCRINE, V14, P407, DOI 10.1385/ENDO:14:3:407; Sullivan PG, 2002, BRAIN RES, V949, P88, DOI 10.1016/S0006-8993(02)02968-2; Taguchi Yasuto, 2004, Nucl Recept, V2, P5, DOI 10.1186/1478-1336-2-5; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Wu TW, 2005, NEUROSCIENCE, V135, P59, DOI 10.1016/j.neuroscience.2004.12.027; Yang LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009851; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008; Zhang QG, 2006, J NEUROCHEM, V98, P1886, DOI 10.1111/j.1471-4159.2006.04020.x; Zhang QG, 2009, J NEUROSCI, V29, P13823, DOI 10.1523/JNEUROSCI.3574-09.2009; Zhao LZ, 2007, BRAIN RES, V1172, P48, DOI 10.1016/j.brainres.2007.06.092	48	18	18	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1044-7431			MOL CELL NEUROSCI	Mol. Cell. Neurosci.	NOV	2011	48	3					185	194		10.1016/j.mcn.2011.07.004			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	836AF	WOS:000296077700001	21803156				2022-02-06	
J	Debenham, S; Sabit, B; Saluja, RS; Lamoureux, J; Bajsarowicz, P; Maleki, M; Marcoux, J				Debenham, Sierra; Sabit, Behzad; Saluja, Rajeet S.; Lamoureux, Julie; Bajsarowicz, Paul; Maleki, Mohammad; Marcoux, Judith			A Critical Look at Phenytoin Use for Early Post-Traumatic Seizure Prophylaxis	CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES			English	Article							TRAUMATIC BRAIN-INJURY; HEAD-INJURY; RISK-FACTORS; TOMOGRAPHY; EPILEPSY; CLASSIFICATION	Backround: The American Academy of Neurology recommended using phenytoin or carbamazepine to prevent early post-traumatic seizures (PTS) in severe traumatic brain injuries (TBI). In this study, we examined the effects of using phenytoin prophylaxis on mild, moderate, and severe TBIs. There have been no studies looking at compliance rate and side effects of systematic use of phenytoin at a large population scale. The goal of this study is to determine 1) the proportion of TBI patients receiving phenytoin prophylaxis; 2) which parameters decided when to decide administer phenytoin; 3) prophylaxis efficacy and complication rate. Methods: We retrospectively studied all patients admitted with a TBI over a two year-period and collected the following information: age, GCS score, CT-scan Marshall grade, incidence of early PTS, incidence of phenytoin use and time delay, side effects, and incidence of over-dosage or under-dosage. Results: 1008 patients were included. 5.4% had early PTS, 2.3 % while on prophylaxis and 3.1% while not on prophylaxis, 1.9% before reaching the hospital and 1.2% prior to phenytoin administration while in hospital. Delay of administration was 5 hours. 64.8% received prophylaxis and physicians used positive CT scan as the primary decision-making parameter (p<.001). Compliance with guidelines was 99.7%. Adverse reactions occurred in 0.5%. Levels were drawn in 42.2% (52% therapeutic, 41% low, 7% high). Conclusions: Phenytoin is used according to guidelines, with CT scan being the main decision factor for its use. The frequency of early PTS rate is low and side effects are rare. However, earlier administration of phenytoin and adequate levels could further prevent early PTS.	[Maleki, Mohammad; Marcoux, Judith] McGill Univ, Dept Neurosurg, Montreal Gen Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Sabit, Behzad] McGill Univ, Fac Med, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Saluja, Rajeet S.] McGill Univ, Montreal Neurol Hosp, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Bajsarowicz, Paul] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; [Debenham, Sierra] Bringham Young Univ, Provo, UT USA		Marcoux, J (corresponding author), McGill Univ, Dept Neurosurg, Montreal Gen Hosp, Ctr Hlth, 1650 Cedar Ave,Room L7-524, Montreal, PQ H3G 1A4, Canada.						Agrawal A, 2006, CLIN NEUROL NEUROSUR, V108, P433, DOI 10.1016/j.clineuro.2005.09.001; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; Bao YH, 2011, J NEUROTRAUM, V28, P35, DOI 10.1089/neu.2010.1383; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; *BRAIN TRAUM FDN G, 2007, J NEUROTRAUM S1, pS83; Chang BS, 2003, NEUROLOGY, V60, P10, DOI 10.1212/01.WNL.0000031432.05543.14; Darrah SH, 2011, J NEUROTRAUM, V28, P43, DOI 10.1089/neu.2010.1521; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Franko J, 2006, J TRAUMA, V61, P107, DOI 10.1097/01.ta.0000224220.89528.fc; Grisar T, 2005, ACTA NEUROL BELG, V105, P5; GUTMAN MB, 1992, J NEUROSURG, V77, P9, DOI 10.3171/jns.1992.77.1.0009; Hess Dean R, 2004, Respir Care, V49, P1171; Iudice A, 2000, DRUGS, V59, P1091, DOI 10.2165/00003495-200059050-00005; Jacka MJ, 2007, CAN J NEUROL SCI, V34, P307, DOI 10.1017/S0317167100006727; Khan AA, 2010, INT J EMERG MED, V3, P187, DOI 10.1007/s12245-010-0180-1; Liberman M, 2004, J TRAUMA, V56, P1330, DOI 10.1097/01.TA.0000071297.76727.8B; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; *MIN HLTH SERV, 2002, GUID PLANN BRAIN INJ; Saboori M, 2007, CLIN NEUROL NEUROSUR, V109, P399, DOI 10.1016/j.clineuro.2007.01.013; Schierhout G, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000173; SCHYNOLL W, 1993, AM J EMERG MED, V11, P321, DOI 10.1016/0735-6757(93)90160-D; TEASDALE G, 1974, LANCET, V2, P81; Teasell R, 2007, BRAIN INJURY, V21, P201, DOI 10.1080/02699050701201854; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; WEISS GH, 1983, ARCH NEUROL-CHICAGO, V40, P7, DOI 10.1001/archneur.1983.04050010027006	26	18	19	1	5	CANADIAN JOURNAL NEUROLOGICAL SCIENCES INC	CALGARY	709-7015 MACLEOD TRAIL SW, CALGARY, AB T2H 2K6, CANADA	0317-1671			CAN J NEUROL SCI	Can. J. Neurol. Sci.	NOV	2011	38	6					896	901		10.1017/S031716710001249X			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	853AE	WOS:000297397800017	22030429	Bronze			2022-02-06	
J	Rockenstein, E; Ubhi, K; Pham, E; Michael, S; Doppler, E; Novak, P; Inglis, C; Mante, M; Adame, A; Alvarez, XA; Moessler, H; Masliah, E				Rockenstein, Edward; Ubhi, Kiren; Pham, Emiley; Michael, Sarah; Doppler, Edith; Novak, Philipp; Inglis, Chandra; Mante, Michael; Adame, Anthony; Alvarez, X. Anton; Moessler, Herbert; Masliah, Eliezer			Beneficial Effects of a Neurotrophic Peptidergic Mixture Persist for a Prolonged Period Following Treatment Interruption in a Transgenic Model of Alzheimer's Disease	JOURNAL OF NEUROSCIENCE RESEARCH			English	Article						amyloid precursor protein; neurodegeneration; synapses; water maze; Cerebrolysin	NERVE GROWTH-FACTOR; NOOTROPIC DRUG CEREBROLYSIN; FIMBRIA-FORNIX TRANSECTION; SPATIAL MEMORY IMPAIRMENT; TRAUMATIC BRAIN-INJURY; FACTOR GENE-THERAPY; SHORT-TERM; NEURODEGENERATIVE DISEASES; FUNCTIONAL RECOVERY; BASAL FOREBRAIN	Neurodegenerative disorders such as Alzheimer's disease (AD) are characterized by the loss of neurotrophic factors, and experimental therapeutical approaches to AD have investigated the efficacy of replacing or augmenting neurotrophic factor activity. Cerebrolysin, a peptide mixture with neurotrophic-like effects, has been shown to improve cognition in patients with AD and to reduce synaptic and behavioral deficits in transgenic (tg) mice overexpressing the amyloid precursor protein (APP). However, it is unclear how long-lasting the beneficial effects of Cerebrolysin are and whether or not behavioral and neuropathological alterations will reappear following treatment interruption. The objective of the present study was to investigate the consequences of interrupting Cerebrolysin treatment (washout effect) 3 and 6 months after the completion of a 3-month treatment period in APP tg mice. We demonstrate that, in APP tg mice, Cerebrolysin-induced amelioration of memory deficits in the water maze and reduction of neurodegenerative pathology persist for 3 months after treatment interruption; however, these effects dissipate 6 months following treatment termination. Immunohistochemical analysis demonstrated that the decrease in neocortical and hippocampal amyloid plaque load observed in Cerebrolysin-treated APP tg mice immediately after treatment was no longer apparent at 3 months after treatment interruption, indicating that the beneficial effects of Cerebrolysin at this time point were independent of its effect on amyloid-beta deposition. In conclusion, the results demonstrate that the effects of Cerebrolysin persist for a significant period of time following treatment termination and suggest that this prolonged effect may involve the neurotrophic factor-like activity of Cerebrolysin. (C) 2011 Wiley-Liss, Inc.	[Rockenstein, Edward; Ubhi, Kiren; Pham, Emiley; Michael, Sarah; Inglis, Chandra; Mante, Michael; Adame, Anthony; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, Sch Med, La Jolla, CA 92093 USA; [Doppler, Edith; Novak, Philipp; Moessler, Herbert] EVER Neuro Pharma, Div Res, Unterach, Austria; [Alvarez, X. Anton] EuroEspes Biomed Res Ctr, Dept Neuropharmacol, La Coruna, Spain; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, Sch Med, La Jolla, CA 92093 USA		Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, Sch Med, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG05131]; EVER Pharma; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R37AG018440, P50AG005131] Funding Source: NIH RePORTER	Contract grant sponsor: NIH; Contract grant number: AG05131; Contract grant sponsor: EVER Pharma.	Alvarez XA, 2011, EUR J NEUROL, V18, P59, DOI 10.1111/j.1468-1331.2010.03092.x; Alvarez XA, 2006, EUR J NEUROL, V13, P43, DOI 10.1111/j.1468-1331.2006.01222.x; Alvarez XA, 2003, INT CLIN PSYCHOPHARM, V18, P271, DOI 10.1097/07.yic.0000085765.24936.9a; Alvarez XA, 2000, J NEURAL TRANSM-SUPP, P315; Alvarez XA, 2008, J NEURAL TRANSM, V115, P683, DOI 10.1007/s00702-008-0024-9; Chana G, 2006, NEUROLOGY, V67, P1486, DOI 10.1212/01.wnl.0000240066.02404.e6; Chana G, 2003, BIOL PSYCHIAT, V53, P1086, DOI 10.1016/S0006-3223(03)00114-8; Chen HH, 2007, NEUROBIOL AGING, V28, P1148, DOI 10.1016/j.neurobiolaging.2006.05.036; CHEN KS, 1995, J NEUROSCI, V15, P2819; Deigner HP, 2000, EXPERT OPIN INV DRUG, V9, P747, DOI 10.1517/13543784.9.4.747; DeKosky ST, 1996, NEURODEGENERATION, V5, P417, DOI 10.1006/neur.1996.0056; EBEWENeuroPharmaGmbH, 2009, CER SOL INJ SUMM PRO; FISCHER W, 1987, NATURE, V329, P65, DOI 10.1038/329065a0; FrancisTurner L, 1996, NEUROSCI LETT, V202, P193, DOI 10.1016/0304-3940(95)12240-0; FrancisTurner L, 1996, J NEURAL TRANSM-SUPP, P277; Funke M, 1998, J NEURAL TRANSM-SUPP, P385; HEFTI F, 1986, J NEUROSCI, V6, P2155; KROMER LF, 1987, SCIENCE, V235, P214, DOI 10.1126/science.3798108; LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206; Mallory M, 1999, ACTA NEUROPATHOL, V97, P437, DOI 10.1007/s004010051012; MARKOWSKA AL, 1994, J NEUROSCI, V14, P4815; MartinezSerrano A, 1996, P NATL ACAD SCI USA, V93, P6355, DOI 10.1073/pnas.93.13.6355; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MASLIAH E, 1995, HISTOL HISTOPATHOL, V10, P509; Masliah E, 1999, PHARMACOL BIOCHEM BE, V62, P239, DOI 10.1016/S0091-3057(98)00144-0; Masliah E, 2006, J ALZHEIMERS DIS, V9, P91; Maslow K., 2010, ALZHEIMERS DEMENT, V6, P158; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MUFSON EJ, 1995, NEUROREPORT, V6, P1063, DOI 10.1097/00001756-199505090-00028; Muresanu DF, 2008, J NEUROL SCI, V267, P112, DOI 10.1016/j.jns.2007.10.016; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Onose G, 2009, J Med Life, V2, P350; Pham E, 2010, FEBS J, V277, P3051, DOI 10.1111/j.1742-4658.2010.07719.x; Plosker GL, 2010, CNS DRUGS, V24, P263, DOI 10.2165/11204820-000000000-00000; Plosker GL, 2009, DRUG AGING, V26, P893, DOI 10.2165/11203320-000000000-00000; Reinprecht I, 1999, HISTOCHEM J, V31, P394; Rockenstein E, 2005, J BIOL CHEM, V280, P32957, DOI 10.1074/jbc.M507016200; Rockenstein E, 2005, J NEURAL TRANSM, V112, P269, DOI 10.1007/s00702-004-0181-4; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2002, J NEURAL TRANSM-SUPP, P327; Rockenstein E, 2001, J NEUROSCI RES, V66, P573, DOI 10.1002/jnr.1247; Rockenstein E, 2007, ADV DRUG DELIVER REV, V59, P1093, DOI 10.1016/j.addr.2007.08.013; Rockenstein E, 2007, J NEUROSCI, V27, P1981, DOI 10.1523/JNEUROSCI.4321-06.2007; Rockenstein E, 2007, ACTA NEUROPATHOL, V113, P265, DOI 10.1007/s00401-006-0166-5; Rockenstein E, 2006, J NEUROSCI RES, V83, P1252, DOI 10.1002/jnr.20818; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; RUTHER E, 1994, PHARMACOPSYCHIATRY, V27, P32, DOI 10.1055/s-2007-1014271; Ruther E, 2000, J NEURAL TRANSM, V107, P815, DOI 10.1007/s007020070061; Satou T, 2000, J NEURAL TRANSM, V107, P1253, DOI 10.1007/s007020070015; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; SCOTT SA, 1995, J NEUROSCI, V15, P6213; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; SVENDSEN CN, 1991, ANN NY ACAD SCI, V640, P91; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; TROJANOWSKI JQ, 1995, NEUROBIOL AGING, V16, P335, DOI 10.1016/0197-4580(94)00176-2; Tuszynski MH, 2007, ALZ DIS ASSOC DIS, V21, P179, DOI 10.1097/WAD.0b013e318068d6d2; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; TUSZYNSKI MH, 1995, P NATL ACAD SCI USA, V92, P4621, DOI 10.1073/pnas.92.10.4621; Ubhi K, 2009, ACTA NEUROPATHOL, V117, P699, DOI 10.1007/s00401-009-0505-4; Valouskova V, 1996, J NEURAL TRANSM-SUPP, P280; Veinbergs I, 2000, J NEURAL TRANSM-SUPP, P273; WILLIAMS LR, 1991, CAN J NEUROL SCI, V18, P403, DOI 10.1017/S0317167100032546; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; Windisch M, 1998, J NEURAL TRANSM-SUPP, P289; Wronski R, 2000, J NEURAL TRANSM, V107, P145, DOI 10.1007/s007020050013; Zhang CL, 2010, J NEUROSCI RES, V88, P3275, DOI 10.1002/jnr.22495	66	18	22	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0360-4012	1097-4547		J NEUROSCI RES	J. Neurosci. Res.	NOV	2011	89	11					1812	1821		10.1002/jnr.22712			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	827LN	WOS:000295430100011	21793038	Green Accepted			2022-02-06	
J	Sayer, NA; Nelson, D; Nugent, S				Sayer, Nina A.; Nelson, Dave; Nugent, Sean			Evaluation of the Veterans Health Administration Traumatic Brain Injury Screening Program in the Upper Midwest	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						Department of Veterans Affairs; health services needs and demands; rehabilitation; screening; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; COLLEGIATE FOOTBALL PLAYERS; ENDURING FREEDOM; NCAA CONCUSSION; BLAST INJURIES; IRAQI FREEDOM; MEDICAL-CARE; AFGHANISTAN; IMPAIRMENT; EXPLOSIONS	Objective: To evaluate the Veterans Health Administration's traumatic brain injury (TBI) screening program in terms of predictors of screening and positive-screen follow-up. Design: Retrospective administrative data study. Multiple logistic regression analyses were used to estimate the odds of TBI screening at a given appointment and among those screening positive, follow-up in a TBI/polytrauma specialty clinic. Participants: A total of 15 973 Iraq and Afghanistan war veterans treated at a Veterans Affairs medical center in the upper Midwest during the first 18 months of the TBI screening program. Results: Almost 90% of Iraq and Afghanistan veteran patients were offered TBI screening and 17% screened positive. Screening rates increased over time and varied by facility. Appointment type predicted screening with increased likelihood of screening during primary care and TBI/polytrauma clinic appointments. Younger, male, and army veterans without psychiatric diagnoses were more likely to be screened. Fifty-two percent of positive TBI screens had subsequent appointments in a TBI/polytrauma specialty clinic during the study period. Rates of follow-up in the clinic increased over time and varied by facility and patient characteristics. Conclusions: Within the upper Midwest, Veterans Health Administration has had greater success implementing TBI screening than ensuring follow-up of positive screens in a specialty clinic. Research is needed on barriers to follow-up of positive screens and the outcomes of TBI screening and subsequent specialty care.	[Sayer, Nina A.; Nelson, Dave; Nugent, Sean] Ctr Chron Dis Outcomes Res, VA Med Ctr, Minneapolis, MN 55417 USA; [Sayer, Nina A.; Nelson, Dave] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA		Sayer, NA (corresponding author), Ctr Chron Dis Outcomes Res, VA Med Ctr, 152-2E,1 Vet Dr, Minneapolis, MN 55417 USA.	nina.sayer@va.gov	Nelson, David/G-7142-2011; Sayer, Nina/E-3249-2016	Nelson, David/0000-0003-1163-1222; 	Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Quality Enhancement Research Initiative (QUERI) [QUERI LIP PLY 05-403-5]	This article represents original and valid research that has not been previously published and is not under consideration for publication elsewhere. This research was supported by a Department of Veterans Affairs (VA) Health Services Research and Development (HSR&D) Quality Enhancement Research Initiative (QUERI) locally initiated project (QUERI LIP PLY 05-403-5). The content of this article presents the findings and conclusions of the authors and does not necessarily represent the VA or HSR&D. Portions of these data were presented at the VA HSR&D, 2008, QUERI national meeting in Phoenix, Arizona.	American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; ANDERSEN RM, 1995, J HEALTH SOC BEHAV, V36, P1, DOI 10.2307/2137284; Babcock-Parziale JL, 2009, EVALUATION VAS TBI C; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Bhattacharjee Y, 2008, SCIENCE, V319, P406, DOI 10.1126/science.319.5862.406; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Carlson KF, 2010, 08025 HSR D CDA; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, 2003, EXPL BLAST INJ PRIM; Clark ME, 2007, J REHABIL RES DEV, V44, P179, DOI 10.1682/JRRD.2006.05.0057; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Department of Veterans Affairs Office of Quality and Performance and Department of Defense Quality Management Directorate USAMC, 2009, VA DOD CLIN PRACT GU; Department of Veterans Affairs Veterans Health Administration, 2009, POL TRUAM BRAIN INJ; Department of Veterans Affairs Veterans Health Administration, 2010, SCREEN EV POSS TRAUM; Department of Veterans Affairs VHA Support Services Center, 2009, COMPR TBI EV SUMM RE; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson GL, 2004, BRAIN INJURY, V18, P433, DOI 10.1080/02699050310001617352; Jaycox L, 2008, INVISIBLE WOUNDS WAR; Kluger Y, 2003, ISRAEL MED ASSOC J, V5, P235; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Leibovici D, 1996, J TRAUMA, V41, P1030, DOI 10.1097/00005373-199612000-00015; Lew HL, 2007, J REHABIL RES DEV, V44, P1027, DOI 10.1682/JRRD.2007.05.0073; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M., 2008, MILD TRAUMATIC BRAIN; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; RICCITIELLO R, 2006, NEWSWEEK        0317; Sayer NA, 2009, J REHABIL RES DEV, V46, P703, DOI 10.1682/JRRD.2009.01.0008; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Scott SG, 2006, J AM OSTEOPATH ASSOC, V106, P265; Seal KH, 2008, AM J PUBLIC HEALTH, V98, P714, DOI 10.2105/AJPH.2007.115519; Sigford BJ, 2008, ARCH PHYS MED REHAB, V89, P160, DOI 10.1016/j.apmr.2007.09.015; Stein MB, 2009, AM J PSYCHIAT, V166, P768, DOI 10.1176/appi.ajp.2009.08101604; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; *US GOV ACC OFF, 2008, GAO08276; VA Office of Inspector General, 2010, 0902093211 VA OFF IN; Vanderploeg RD, 2009, TBI SCREENING INSTRU; VHA Health Information Management Office of Health Data and Informatics, 2008, FACT SHEET INT COD G; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wojcik BE, 2010, AM J PREV MED, V38, pS108, DOI 10.1016/j.amepre.2009.10.006	46	18	18	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2011	26	6					454	467		10.1097/HTR.0b013e3181ff393c			14	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	859AC	WOS:000297845000002	22094545				2022-02-06	
J	Yokobori, S; Watanabe, A; Matsumoto, G; Onda, H; Masuno, T; Fuse, A; Kushimoto, S; Yokota, H				Yokobori, Shoji; Watanabe, Akihiro; Matsumoto, Gaku; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Kushimoto, Shigeki; Yokota, Hiroyuki			Time Course of Recovery From Cerebral Vulnerability After Severe Traumatic Brain Injury: A Microdialysis Study	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article						Severe brain injury; Biomarker; Microdialysis; Cerebral vascular autoregulation; Neurointensive care	BLOOD-FLOW; HEAD-INJURY; INTRACEREBRAL MICRODIALYSIS; METABOLISM; CARE; HYPOPERFUSION; CIRCULATION; FRACTURES; VASOSPASM; FIXATION	Background: The aim of this study was to evaluate the time course of recovery from cerebral vulnerability, using microdialysis (MD) technique and cerebral vascular autoregulation measurement, to clarify the appropriate timing of subsequent major surgical procedures, and to minimize the possibility of secondary brain injury in patients with severe traumatic brain injury (STBI). Methods: In 3,470 MD samples of 25 patients with STBI, cerebral extracellular biomarkers (glucose, lactate, pyruvate, glycerol, and glutamate) were measured. In addition, to estimate cerebral vascular autoregulaton, the pressure reactivity index (PRx) was calculated with intracranial pressure (ICP) and mean arterial pressure. The data with ICP, cerebral perfusion pressure (CPP), and PRx were collected hourly for 7 days after injury and they were compared with MD biomarkers daily. Results: During the study period, the average ICP and CPP remained stable and were within the threshold of STBI treatment guidelines. After injury, the extracellular glucose concentration decreased, and the levels of glycerol, glutamate, and lactate/pyruvate ratio (LPR), which indicate cerebral ischemia and neural cell damage, increased. On the fourth day after injury, the extracellular glucose concentration improved, and the value of LPR decreased. The average PRx decreased daily and became negative on the fifth day after injury. Conclusion: Our results indicated that cerebral vascular autoregulation would recover on the fourth day after STBI, and cerebral perfusion might be increased by recovery of autoregulation. Thus, subsequent nonemergent surgery should be performed at least 4 days after STBI to prevent secondary brain injury. In addition, we should keep in mind that the cerebral vulnerability might persist for 4 days after suffering STBI.	[Yokobori, Shoji; Watanabe, Akihiro; Matsumoto, Gaku; Onda, Hidetaka; Masuno, Tomohiko; Fuse, Akira; Kushimoto, Shigeki; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, Tokyo 113, Japan		Yokobori, S (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Lois Pope LIFE Ctr Ee 3 25, 1095 NW 14th Terrace, Miami, FL 33136 USA.	SYokobori@med.miami.edu			Mitsui Sumitomo Insurance Welfare FoundationMitsui Sumitomo Insurance Welfare Foundation	Supported by a grant from Mitsui Sumitomo Insurance Welfare Foundation.	Bellander BM, 2004, INTENS CARE MED, V30, P2166, DOI 10.1007/s00134-004-2461-8; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Czosnyka M, 1996, STROKE, V27, P1829, DOI 10.1161/01.STR.27.10.1829; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Diedler J, 2010, J NEUROL SCI, V295, P16, DOI 10.1016/j.jns.2010.05.027; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; Hlatky R, 2004, NEUROCRIT CARE, V1, P69, DOI 10.1385/NCC:1:1:69; Japan Society of Neurotraumatology Committee of Guidelines for the Treatment and Management of Severe Traumatic Brain Injury, 2006, NEUROTRAUMATOLOGY S, V29, P15; Jeremitsky E, 2003, J TRAUMA, V54, P312, DOI 10.1097/01.TA.0000037876.37236.D6; Kalb DC, 1998, SURGERY, V124, P739, DOI 10.1067/msy.1998.91395; Kelly DF, 1997, J NEUROSURG, V86, P633, DOI 10.3171/jns.1997.86.4.0633; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; MUIZELAAR JP, 1989, J NEUROSURG, V71, P63, DOI 10.3171/jns.1989.71.1.0063; Nordstrom CH, 2010, CHILD NERV SYST, V26, P465, DOI 10.1007/s00381-009-1035-z; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; Oertel M, 2005, J NEUROSURG, V103, P812, DOI 10.3171/jns.2005.103.5.0812; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1983, J NEUROSURG, V59, P439, DOI 10.3171/jns.1983.59.3.0439; PERSSON L, 1992, J NEUROSURG, V76, P72, DOI 10.3171/jns.1992.76.1.0072; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; ROBERTSON CS, 1992, J NEUROL NEUROSUR PS, V55, P594, DOI 10.1136/jnnp.55.7.594; Samuelsson C, 2009, J NEUROSURG, V111, P910, DOI 10.3171/2008.8.JNS0889; Soustiel JF, 2007, NEUROL RES, V29, P654, DOI 10.1179/016164107X240017; Stahl M., 2002, Current Pharmaceutical Biotechnology, V3, P165, DOI 10.2174/1389201023378373; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; The Brain Trauma Foundation, 2007, J NEUROTRAUM, V24, P7; Tuttle MS, 2009, J TRAUMA, V67, P602, DOI 10.1097/TA.0b013e3181aa21c0; Vespa PM, 2003, J CEREBR BLOOD F MET, V23, P865, DOI 10.1097/01.WCB.0000076701.45782.EF; Yokota H, 2007, NEUROL MED-CHIR, V47, P383, DOI 10.2176/nmc.47.383	32	18	19	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-5282	1529-8809		J TRAUMA	J. Trauma-Injury Infect. Crit. Care	NOV	2011	71	5					1235	1240		10.1097/TA.0b013e3182140dd7			6	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	849IG	WOS:000297118600030	21502877				2022-02-06	
